	CHROM	POS	REF	ALT	Location	SYMBOL	Gene_full_name	GLOWgenes	VARIANT_CLASS	07-0602_GT	07-0602_VF	07-0602_AD	07-0602_DP	07-0602_GQ	07-0602_ROH	Existing_variation	Genomic_region	CANONICAL	Feature	Feature_type	BIOTYPE	Consequence	INTRON	EXON	HGVSc	HGVSp	DISTANCE	STRAND	Interpro_domain	CLNSIG	CLNREVSTAT	CLNDN	OMIM_phenotype	Orphanet_disorder	Orphanet_association_type	HPO_name	PUBMED	gnomADg_AF	gnomADg_AC	gnomADg_AN	gnomADg_nhomalt	gnomADg_cov_median	gnomADg_cov_perc_20x	gnomADg_filter	gnomADg_popmax	gnomADg_AF_popmax	gnomADg_AC_popmax	gnomADg_AF_nfe	gnomADg_AC_nfe	gnomADe_AF	gnomADe_AC	gnomADe_AN	gnomADe_nhomalt	gnomADe_cov_median	gnomADe_cov_perc_20x	gnomADe_filter	gnomADe_popmax	gnomADe_AF_popmax	gnomADe_AC_popmax	gnomADe_AF_nfe	gnomADe_AC_nfe	kaviar_AF	kaviar_AC	CSVS_AF	CSVS_AC	FJD_MAF_AF	FJD_MAF_AC	denovoVariants_SAMPLE_CT	CADD_PHRED	CADD_RAW	MutScore	N_Pathogenic_pred	N_Benign_pred	N_predictions	Pathogenic_pred	Benign_pred	SpliceAI_SYMBOL	SpliceAI_DS_AG	SpliceAI_DS_AL	SpliceAI_DS_DG	SpliceAI_DS_DL	SpliceAI_DP_AG	SpliceAI_DP_AL	SpliceAI_DP_DG	SpliceAI_DP_DL	ada_score	rf_score	MaxEntScan_alt	MaxEntScan_diff	MaxEntScan_ref	LoFtool	ExACpLI	gnomAD_exomes_CCR	phastCons30way_mammalian	phyloP30way_mammalian	MGI_mouse_phenotype	GTEx_V8_gene	GTEx_V8_tissue	Expression_GNF-Atlas	Pathway_KEGG	GO_biological_process	GO_cellular_component	GO_molecular_function	Interactions_IntAct
63	chr1	6007259	G	A	chr1:6007259	NPHP4	nephrocystin 4	0.0	SNV	0/1	0.36	16_9	25	99	False	rs190940697,CM051570	EXONIC	YES	NM_015102.5	Transcript	protein_coding	missense_variant		9/30	NM_015102.5:c.1024C>T	NP_055917.1:p.Arg342Cys		-1.0	.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Nephronophthisis|Nephronophthisis_4|Senior-Loken_syndrome_4|not_specified	Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive	Senior-Loken syndrome;Juvenile nephronophthisis	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Tubulointerstitial fibrosis;Autosomal recessive inheritance;Renal corticomedullary cysts;Stage 5 chronic kidney disease;Nephronophthisis;Growth delay;Polydipsia;Polyuria;Renal tubular atrophy;Anemia;Rod-cone dystrophy;Autosomal recessive inheritance;Nephronophthisis;Polydipsia;Heterogeneous;Anemia;Severely reduced visual acuity;Stage 5 chronic kidney disease;Rotary nystagmus;Amblyopia;Polyuria;Progressive visual loss;Premature ovarian insufficiency;Nephronophthisis;Hypertension;Short stature;Global developmental delay;Cone-shaped epiphysis;Abnormality of retinal pigmentation;Retinal dystrophy;Cataract;Abnormality of bone mineral density;Ataxia;Congenital hepatic fibrosis;Stage 5 chronic kidney disease		0.00134789	205.0	152090.0	0.0	33	0.97	PASS	amr	0.00589082	90.0	0.00105833	72.0	0.00164098	409.0	249242.0	1.0	65	1.0	PASS	sas	0.00542484	166.0	0.00115925	131.0	0.0013504	210	0.002	5.0	0.00202	23.0		25.6	3.663266	0.324	13	8	21	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HVAR_pred,LRT_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-XF_coding_pred	NPHP4	0.0	0.0	0.0	0.0	-16.0	31.0	1.0	-41.0						0.021	0.0	0.0	1.0	1.176	cellular phenotype; pigmentation phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	.	signal transduction;visual behavior;actin cytoskeleton organization;flagellated sperm motility;hippo signaling;photoreceptor cell outer segment organization;photoreceptor cell maintenance;retina development in camera-type eye;negative regulation of canonical Wnt signaling pathway;ciliary basal body-plasma membrane docking;cell-cell adhesion;positive regulation of bicellular tight junction assembly	nucleus;centrosome;cytosol;cell-cell junction;bicellular tight junction;photoreceptor connecting cilium;ciliary basal body;ribbon synapse;ciliary base	structural molecule activity;protein binding	INVS[26638075];HSP90AB1[26638075];TUBAL3[26638075];INTU[26644512];IRS4[26638075];JADE1[22654112];RPAP3[26638075];CEP128[26638075];RPGR[26638075;20664800;unassigned1312];STIP1[26638075];NUDCD3[26638075];NUDCD2[26638075];PPP4R2[26496610];BAG2[26638075];NPHP1[26638075;27173435;15661758;unassigned1312];TUBB1[27173435;unassigned1312];PTK2B[15661758];ECT2[unassigned1312];TEFM[unassigned1312];HSPA8[26638075];HSP90AA1[26638075];NUDC[26638075];CLUH[unassigned1312];HSPA1L[26638075];NEK4[unassigned1312];TUBB[26638075];PIH1D1[26638075];HSPA6[26638075];AIP[26638075];CACYBP[26638075];RPGRIP1L[17558407;26638075;27173435;unassigned1312;16339905];HSPA2[26638075];TUBB4B[26638075];RPP25L[unassigned1312];DDB1[22863007];RPGRIP1[26638075;16339905];TUBB2B[26638075];DNAJC7[26638075];DAAM1[26644512];GKAP1[unassigned1312];TTC4[26638075];SPIRE1[26644512];SUGT1[26638075];FKBP4[26638075];RAF1[unassigned1312];BCAR1[15661758];HSPA1A[26638075];CEP89[26638075];
201	chr1	94568686	C	T	chr1:94568686	ABCA4	ATP binding cassette subfamily A member 4	0.0	SNV	0/1	0.68	13_27	40	99	False	rs62646862,CM011903,COSV104677865	EXONIC	YES	NM_000350.3	Transcript	protein_coding	missense_variant		5/50	NM_000350.3:c.455G>A	NP_000341.2:p.Arg152Gln		-1.0	.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Stargardt_disease_1|Stargardt_disease|not_specified|ABCA4-Related_Disorders|not_provided	Retinal dystrophy, early-onset severe, 248200 (3), Autosomal recessive; Retinitis pigmentosa 19, 601718 (3), Autosomal recessive; {Macular degeneration, age-related, 2}, 153800 (3), Autosomal dominant; Cone-rod dystrophy 3, 604116 (3); Fundus flavimaculatus, 248200 (3), Autosomal recessive; Stargardt disease 1, 248200 (3), Autosomal recessive	Stargardt disease;Retinitis pigmentosa;Cone rod dystrophy	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Constriction of peripheral visual field;Attenuation of retinal blood vessels;Autosomal recessive inheritance;Rod-cone dystrophy;Nyctalopia;Retinal pigment epithelial atrophy;Optic disc pallor;Abnormal electroretinogram;Reduced visual acuity;Bone spicule pigmentation of the retina;Autosomal dominant inheritance;Visual loss;Autosomal recessive inheritance;Central scotoma;Color vision defect;Cone/cone-rod dystrophy;X-linked recessive inheritance;Nyctalopia;Reduced visual acuity;Retinal pigment epithelial atrophy;Central scotoma;Retinal pigment epithelial mottling;Color vision defect;Yellow/white lesions of the macula;Macular degeneration;Aplasia/Hypoplasia of the macula;Abnormality of visual evoked potentials;Paroxysmal involuntary eye movements;Retinal thinning;Abnormal choroid morphology;Abnormality of macular pigmentation;Abnormal foveal morphology;Photophobia;Visual impairment;Color vision defect;Abnormality of retinal pigmentation;Nyctalopia;Retinitis pigmentosa inversa;Autosomal recessive inheritance;Macular degeneration;Bull's eye maculopathy;Hyperinsulinemia;Optic atrophy;Nystagmus;Abnormal retinal vascular morphology;Obesity;Hypoplasia of penis;Cataract;Abnormality of retinal pigmentation;Keratoconus;Progressive night blindness;Ophthalmoplegia;Abnormal testis morphology;Atypical scarring of skin;Hyperreflexia;Sensorineural hearing impairment;Blindness;Type II diabetes mellitus;Conductive hearing impairment;Photophobia;Intellectual disability;Anteverted nares;Abnormal electroretinogram;Wide nasal bridge;Hypogonadism;Glaucoma;Macular degeneration;Autosomal dominant inheritance	25525159,28118664,22264887,11385708,23143460	0.00283273	431.0	152150.0	3.0	33	0.97	PASS	amr	0.00478124	73.0	0.00430616	293.0	0.00259123	651.0	251232.0	2.0	100	1.0	PASS	nfe	0.00369803	420.0	0.00369803	420.0	0.0025916	403	0.007	22.0	0.00693	79.0		18.21	1.801488	0.298	6	13	19	M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	ABCA4	0.0	0.03	0.0	0.0	-2.0	12.0	12.0	5.0						0.0107	0.0	0.0	0.523	0.138	pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; homeostasis/metabolism phenotype; immune system phenotype; 			.	ABC transporters	retinoid metabolic process;phospholipid transfer to membrane;lipid transport;visual perception;phototransduction, visible light;phospholipid translocation;photoreceptor cell maintenance;transmembrane transport	integral component of plasma membrane;membrane;intracellular membrane-bounded organelle;photoreceptor disc membrane	phospholipid-translocating ATPase activity;transporter activity;lipid transporter activity;eye pigment precursor transporter activity;ATP binding;phospholipid transporter activity;ATPase activity;ATPase activity, coupled to transmembrane movement of substances;phosphatidylethanolamine-translocating ATPase activity	KDM5B[24937458];RALY[30021884];
1250	chr1	243589789	A	G	chr1:243589789	SDCCAG8	serologically defined colon cancer antigen 8	0.0	SNV	0/1	0.53	17_19	36	99	False	rs756352013	EXONIC	YES	NM_001350248.2	Transcript	protein_coding	synonymous_variant		17/19	NM_001350248.2:c.2010A>G	NP_001337177.1:p.Leu670%3D		1.0		Likely_benign	criteria_provided,_single_submitter	Senior-Loken_syndrome_7|Bardet-Biedl_syndrome_16	Senior-Loken syndrome 7, 613615 (3), Autosomal recessive; Bardet-Biedl syndrome 16, 615993 (3), Autosomal recessive	Senior-Loken syndrome;Bardet-Biedl syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Hearing impairment;Intellectual disability;Respiratory distress;Recurrent otitis media;Global developmental delay;Retinal degeneration;Renal agenesis;Renal dysplasia;Rod-cone dystrophy;Renal cyst;Hypogonadism;Obesity;Renal insufficiency;Cognitive impairment;External genital hypoplasia;Autosomal recessive inheritance;Bronchiolitis;Hearing impairment;Cryptorchidism;Hypoplasia of the ovary;Low-set, posteriorly rotated ears;Hypogonadism;Nephrotic syndrome;Nystagmus;Multicystic kidney dysplasia;Generalized hirsutism;Short stature;Obesity;Abnormal electroretinogram;Hepatic fibrosis;Pigmentary retinopathy;Neurological speech impairment;Short neck;Downslanted palpebral fissures;Postaxial hand polydactyly;Finger syndactyly;Skeletal muscle atrophy;Hypertension;Intellectual disability;Prominent nasal bridge;Hypoplasia of penis;Medial flaring of the eyebrow;Retinal degeneration;Autosomal recessive inheritance;Nephronophthisis;Progressive visual loss;Premature ovarian insufficiency;Nephronophthisis;Hypertension;Short stature;Global developmental delay;Cone-shaped epiphysis;Abnormality of retinal pigmentation;Retinal dystrophy;Cataract;Abnormality of bone mineral density;Ataxia;Congenital hepatic fibrosis;Stage 5 chronic kidney disease		1.97065e-05	3.0	152234.0	0.0	32	0.97	PASS	nfe	4.40995e-05	3.0	4.40995e-05	3.0	2.78576e-05	7.0	251278.0	0.0	78	1.0	PASS	amr	0.000144584	5.0	1.76041e-05	2.0	0.0000064	1			0.00035	4.0		10.12	0.578306		0	0	0			SDCCAG8	0.0	0.0	0.0	0.01	1.0	-49.0	48.0	-28.0						0.879	0.0	51.033910977			mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; vision/eye phenotype; renal/urinary system phenotype; growth/size/body region phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			.	.	G2/M transition of mitotic cell cycle;neuron migration;centrosome cycle;regulation of G2/M transition of mitotic cell cycle;establishment of cell polarity;microtubule organizing center organization;tube formation;ciliary basal body-plasma membrane docking	centrosome;centriole;cytosol;cell-cell junction;centriolar satellite	protein binding	OFD1[26638075;27173435;unassigned1312];TRAF6[17353931];CEP164[22863007];SRSF2[22863007];UBE2N[27173435;unassigned1312];TSC1[17355907];ZNF423[22863007];TNS2[25814554];
1442	chr10	55581921	G	A	chr10:55581921	PCDH15	protocadherin related 15	0.0	SNV	0/1	0.59	12_17	29	99	False	rs111033445,CM1613929	EXONIC	YES	NM_001142763.2	Transcript	protein_coding	synonymous_variant		35/35	NM_001142763.2:c.5586C>T	NP_001136235.1:p.Ala1862%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Usher_syndrome_type_1|Usher_syndrome_type_1F|not_specified|not_provided	Usher syndrome, type 1D/F digenic, 601067 (3), Autosomal recessive, Digenic recessive; Deafness, autosomal recessive 23, 609533 (3), Autosomal recessive; Usher syndrome, type 1F, 602083 (3), Autosomal recessive	Usher syndrome type 1;Autosomal recessive non-syndromic sensorineural deafness type DFNB	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Congenital sensorineural hearing impairment;Motor delay;Rod-cone dystrophy;Autosomal recessive inheritance;Infantile onset;Sensorineural hearing impairment;Hallucinations;Anxiety;Abnormal cochlea morphology;Aplasia/Hypoplasia of the cerebellum;Iris hypopigmentation;Schizophrenia;Abnormal electroretinogram;Subcortical cerebral atrophy;Cerebral cortical atrophy;Abnormality of dental enamel;Global developmental delay;High hypermetropia;Visual loss;Sensorineural hearing impairment;Scotoma;Depressivity;Intellectual disability;Hemianopia;Nyctalopia;Vestibular hypofunction;Cataract;Ataxia;Rod-cone dystrophy;Autosomal recessive inheritance;Vestibular dysfunction;Hearing impairment	24033266	0.00160524	244.0	152002.0	1.0	32	0.96	PASS	nfe	0.00276422	188.0	0.00276422	188.0	0.00177021	445.0	251382.0	1.0	100	1.0	PASS	nfe	0.00306149	348.0	0.00306149	348.0	0.0018778	292	0.003	10.0	0.00193	22.0		0.238	-0.361942		0	0	0			PCDH15	0.0	0.01	0.0	0.0	-28.0	49.0	47.0	-42.0						0.995	0.0	35.496764506			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; muscle phenotype; cellular phenotype; 			temporal lobe;dorsal root ganglion;atrioventricular node;skin;superior cervical ganglion;	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;sensory perception of sound;photoreceptor cell maintenance;inner ear development;sensory perception of light stimulus;equilibrioception	photoreceptor outer segment;extracellular region;integral component of plasma membrane;stereocilium;synapse	calcium ion binding	NUDCD1[29021621];
4731	chr10	73499446	A	G	chr10:73499446	CDH23	cadherin related 23	0.0	SNV	0/1	0.23	20_6	26	99	False	rs200635365,CM164998,COSV56490661	EXONIC	YES	NM_022124.6	Transcript	protein_coding	missense_variant		36/70	NM_022124.6:c.4405A>G	NP_071407.4:p.Ile1469Val		1.0	Cadherin-like&Cadherin-like,Cadherin-like&Cadherin-like	Uncertain_significance	criteria_provided,_multiple_submitters,_no_conflicts	Usher_syndrome_type_1|Usher_syndrome_type_1D|Deafness,_autosomal_recessive_12|not_specified|not_provided	Usher syndrome, type 1D, 601067 (3), Autosomal recessive, Digenic recessive; {Pituitary adenoma 5, multiple types}, 617540 (3), Autosomal dominant; Usher syndrome, type 1D/F digenic, 601067 (3), Autosomal recessive, Digenic recessive; Deafness, autosomal recessive 12, 601386 (3), Autosomal recessive	Prolactinoma;Usher syndrome type 1;Familial isolated pituitary adenoma;Autosomal recessive non-syndromic sensorineural deafness type DFNB;TSH-secreting pituitary adenoma;Cushing disease	Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in	Autosomal recessive inheritance;Prelingual sensorineural hearing impairment;Abnormality of the eye;Autosomal dominant inheritance;Adult onset;Incomplete penetrance;Pituitary adenoma;Cranial nerve VI palsy;Osteoporosis;Abnormal hair quantity;Female hypogonadism;Ptosis;Adrenocorticotropin deficient adrenal insufficiency;Enlarged pituitary gland;Oculomotor nerve palsy;Diplopia;Goiter;Blindness;Sudden loss of visual acuity;Internal ophthalmoplegia;Infertility;Weight loss;Increased circulating gonadotropin level;Increased circulating prolactin concentration;Adrenocorticotropic hormone deficiency;Osteopenia;Growth hormone excess;Pallor;Palpitations;Tremor;Irregular menstruation;Increased thyroid-stimulating hormone level;Secondary growth hormone deficiency;Impotence;Euthyroid hyperthyroxinemia;Fourth cranial nerve palsy;Decreased circulating ACTH level;Delayed puberty;Decreased fertility in females;Hypotension;Vomiting;Hypertension;Gynecomastia;Supraventricular arrhythmia;Vertigo;Progressive visual loss;Headache;Seizure;Male hypogonadism;Decreased female libido;Pericardial effusion;Bitemporal hemianopia;Hypogonadotropic hypogonadism;Easy fatigability;Decreased fertility in males;Hyperhidrosis;Periodic hypokalemic paresis;Hypokalemia;Fatigue;Abnormal visual field test;Ventricular arrhythmia;Congestive heart failure;Thyroid crisis;Infertility;Sleep disturbance;Bipolar affective disorder;Onychomycosis;Recurrent skin infections;Psychosis;Pituitary adenoma;Headache;Round face;Hypertension;Truncal obesity;Metrorrhagia;Acne;Abdominal pain;Immunodeficiency;Recurrent fractures;Osteoporosis;Avascular necrosis;Visual loss;Myopathy;Bruising susceptibility;Failure to thrive;Telangiectasia of the skin;Cataract;Hypokalemia;Cardiomyopathy;Premature ovarian insufficiency;Menorrhagia;Lethargy;Adrenal hyperplasia;Diabetes mellitus;Generalized hirsutism;Venous thrombosis;Anxiety;Thin skin;Depressivity;Generalized hyperpigmentation;Lipodystrophy;Nephrolithiasis;Fatigue;Hallucinations;Anxiety;Abnormal cochlea morphology;Aplasia/Hypoplasia of the cerebellum;Iris hypopigmentation;Schizophrenia;Abnormal electroretinogram;Subcortical cerebral atrophy;Cerebral cortical atrophy;Abnormality of dental enamel;Global developmental delay;High hypermetropia;Visual loss;Sensorineural hearing impairment;Scotoma;Depressivity;Intellectual disability;Hemianopia;Nyctalopia;Vestibular hypofunction;Cataract;Ataxia;Blindness;Hypogonadotropic hypogonadism;Amenorrhea;Internal ophthalmoplegia;Irregular menstruation;Easy fatigability;Cranial nerve VI palsy;Dyspareunia;Sudden loss of visual acuity;Decreased circulating ACTH level;Growth hormone excess;Vertigo;Bitemporal hemianopia;Galactorrhea;Headache;Hypotension;Decreased female libido;Secondary growth hormone deficiency;Oculomotor nerve palsy;Pallor;Female hypogonadism;Impotence;Decreased fertility in females;Pituitary hypothyroidism;Osteopenia;Delayed puberty;Seizure;Progressive visual loss;Adrenocorticotropin deficient adrenal insufficiency;Abnormal hair quantity;Fatigue;Fourth cranial nerve palsy;Osteoporosis;Decreased fertility in males;Male hypogonadism;Ptosis;Gynecomastia;Vomiting;Adrenocorticotropic hormone deficiency;Diplopia;Rod-cone dystrophy;Autosomal recessive inheritance;Vestibular dysfunction;Hearing impairment	24033266	0.000210346	32.0	152130.0	0.0	33	0.97	PASS	sas	0.00227838	11.0	0.000293988	20.0	0.000302979	75.0	247542.0	0.0	40	0.89	PASS	sas	0.00115185	35.0	0.000276623	31.0	0.0003151	49			0.00035	4.0		22.0	2.300536	0.362	5	12	17	LRT_pred,M-CAP_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	CDH23	0.0	0.0	0.0	0.0	0.0	-45.0	-1.0	31.0						0.591	0.05	0.0	0.424	1.312	cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; reproductive system phenotype; 			pons;ciliary ganglion;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;globus pallidus;cerebellum;	.	calcium ion transport;homophilic cell adhesion via plasma membrane adhesion molecules;visual perception;sensory perception of sound;locomotory behavior;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;photoreceptor cell maintenance;response to stimulus;sensory perception of light stimulus;equilibrioception;regulation of cytosolic calcium ion concentration;inner ear receptor cell stereocilium organization	plasma membrane;membrane;integral component of membrane;stereocilium	calcium ion binding;protein binding	SLC9A3R2[27173435;unassigned1312];NCKAP1[27173435;unassigned1312];CYFIP1[27173435;unassigned1312];NXN[27173435;unassigned1312];ABI1[27173435;unassigned1312];USH1C[19297620];GOPC[27173435;unassigned1312];WASF1[27173435;unassigned1312];
4776	chr10	94376553	A	G	chr10:94376553	KIF11	kinesin family member 11	0.0	SNV	0/1	0.5	12_12	24	99	False		EXONIC	YES	NM_004523.4	Transcript	protein_coding	synonymous_variant		9/22	NM_004523.4:c.1092A>G	NP_004514.2:p.Glu364%3D		1.0					Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3), Autosomal dominant	Microcephaly-lymphedema-chorioretinopathy syndrome	Disease-causing germline mutation(s) in	Autosomal dominant inheritance;Agitation;Hypermetropia;Anteverted nares;Myopia;Attention deficit hyperactivity disorder;Intellectual disability, mild;Sleep disturbance;Simplified gyral pattern;Microphthalmia;Long philtrum;Seizure;Prominent forehead;Lymphedema;Thin upper lip vermilion;Epicanthus;Sloping forehead;Depressed nasal bridge;Nystagmus;Reduced visual acuity;Optic atrophy;Incomplete penetrance;Protruding ear;Flat occiput;Microcephaly;Aggressive behavior;Deep philtrum;Mandibular prognathia;Corneal opacity;Variable expressivity;Cataract;Retinal detachment;Broad nasal tip;Upslanted palpebral fissure;Retinal fold;Chorioretinal lacunae;Myopic astigmatism;Microcornea;Chorioretinal dysplasia;Downslanted palpebral fissures;Thick lower lip vermilion;Sloping forehead;Pointed chin;Full cheeks;Abnormal eyelash morphology;Retinal dystrophy;Long philtrum;Muscle stiffness;Melanonychia;Microcephaly;Cataract;Wide nasal bridge;Atrial septal defect;Skin ulcer;Leukonychia;Subcutaneous nodule;Venous thrombosis;Upslanted palpebral fissure;Global developmental delay;Retinal detachment;Cellulitis;Wide nose;Retinal dysplasia;Erysipelas;Chylothorax;Intellectual disability;Specific learning disability;Microphthalmia;Blindness;Protruding ear;Panniculitis;Severe short stature;Anophthalmia;Abnormal toenail morphology;Lymphedema;Dry skin;Ptosis;Status epilepticus;Amblyopia;Thickened skin;Abnormal nasolacrimal system morphology;Visual loss;Retinopathy;Optic atrophy;Epicanthus;Lymphoma;Spasticity;Rigidity;Glaucoma;Chorioretinal dysplasia;Anteverted nares;Thick vermilion border;Underdeveloped supraorbital ridges;Muscular hypotonia;Leukemia;Gangrene;Myopia;Scaling skin;Abnormality of retinal pigmentation						32	0.96											42	0.78														12.1	0.818545		0	0	0			KIF11	0.0	0.0	0.01	0.0	0.0	2.0	0.0	36.0						0.0258	1.0	83.852130804			embryo phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; 			pons;tumor;superior cervical ganglion;	.	mitotic cell cycle;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;microtubule-based movement;spindle organization;mitotic spindle organization;mitotic centrosome separation;antigen processing and presentation of exogenous peptide antigen via MHC class II;regulation of mitotic centrosome separation;cell division;mitotic spindle assembly	spindle pole;nucleus;spindle;cytosol;kinesin complex;microtubule;spindle microtubule;membrane;protein-containing complex;mitotic spindle	microtubule motor activity;ATP binding;microtubule binding;ATP-dependent microtubule motor activity, plus-end-directed;ATPase activity;protein kinase binding	DHRS13[26496610];RBM28[26496610];ANKLE2[26496610];RPL32[26496610];SUV39H1[26496610];PRR3[26496610];HSPB8[26496610];CETN2[26496610];HDLBP[26496610];ARID4B[26496610];TMEM131L[26496610];ADARB2[26496610];AP2A2[26496610];EDC4[26496610];DUSP11[26496610];FAM122A[26496610];C2orf69[26496610];MED14[26496610];RPL36AL[26496610];MLST8[26496610];DGCR8[26496610];SNRPD3[26496610];IKBKE[14743216];PCID2[26496610];ANXA1[26496610];ZGRF1[26496610];CEP295[26496610];SPATS2[26496610];RPS6[26496610];MTUS1[26496610];ACSL5[26496610];PRKCA[26496610];RPS3A[26496610];DDX51[26496610];IRAK4[26496610];ACSL3[26496610];ANK3[26496610];GTPBP4[26496610];ILVBL[26496610];KATNAL2[26929214];RPL37A[26496610];ULK2[20562859];ANKS6[26496610];FLYWCH1[26496610];TLN1[26496610];RPL28[26496610];PPP1R15A[29109149];LUZP1[26496610];KMT2A[26496610];HIST1H2BK[26496610];NOL7[26496610];NOLC1[26496610];GATA3[26028330];AP3M1[26496610];LDHA[26496610];MTA1[26028330];HIST1H3A[26496610];CALD1[26496610];NT5DC3[26496610];ZKSCAN8[26496610];ORC2[26496610];MAP4[26496610];DECR1[26496610];ABCA1[25170080];BRPF1[26496610];H3F3B[26496610];CEP350[26496610];MRPL27[26496610];PLEKHA5[26496610];CDC5L[20467437];TRIP4[26496610];PNMA3[26496610];RPL23A[26496610];LAMB1[26496610];PEX14[21525035];SNW1[20467437];MYO1C[26496610];TNIP3[19615732];EIF3I[26496610];FASN[26496610];TACC3[26496610];SPIRE2[26496610];PDE3A[26496610];DYNLRB1[26496610];RBM45[26496610];ACTR10[26496610];PFKM[26496610];EIF3A[26496610];RPS23[26496610];
4779	chr10	94397041	A	G	chr10:94397041	KIF11	kinesin family member 11	0.0	SNV	0/1	0.35	17_9	26	99	False		EXONIC	YES	NM_004523.4	Transcript	protein_coding	missense_variant		15/22	NM_004523.4:c.1976A>G	NP_004514.2:p.Lys659Arg		1.0					Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3), Autosomal dominant	Microcephaly-lymphedema-chorioretinopathy syndrome	Disease-causing germline mutation(s) in	Autosomal dominant inheritance;Agitation;Hypermetropia;Anteverted nares;Myopia;Attention deficit hyperactivity disorder;Intellectual disability, mild;Sleep disturbance;Simplified gyral pattern;Microphthalmia;Long philtrum;Seizure;Prominent forehead;Lymphedema;Thin upper lip vermilion;Epicanthus;Sloping forehead;Depressed nasal bridge;Nystagmus;Reduced visual acuity;Optic atrophy;Incomplete penetrance;Protruding ear;Flat occiput;Microcephaly;Aggressive behavior;Deep philtrum;Mandibular prognathia;Corneal opacity;Variable expressivity;Cataract;Retinal detachment;Broad nasal tip;Upslanted palpebral fissure;Retinal fold;Chorioretinal lacunae;Myopic astigmatism;Microcornea;Chorioretinal dysplasia;Downslanted palpebral fissures;Thick lower lip vermilion;Sloping forehead;Pointed chin;Full cheeks;Abnormal eyelash morphology;Retinal dystrophy;Long philtrum;Muscle stiffness;Melanonychia;Microcephaly;Cataract;Wide nasal bridge;Atrial septal defect;Skin ulcer;Leukonychia;Subcutaneous nodule;Venous thrombosis;Upslanted palpebral fissure;Global developmental delay;Retinal detachment;Cellulitis;Wide nose;Retinal dysplasia;Erysipelas;Chylothorax;Intellectual disability;Specific learning disability;Microphthalmia;Blindness;Protruding ear;Panniculitis;Severe short stature;Anophthalmia;Abnormal toenail morphology;Lymphedema;Dry skin;Ptosis;Status epilepticus;Amblyopia;Thickened skin;Abnormal nasolacrimal system morphology;Visual loss;Retinopathy;Optic atrophy;Epicanthus;Lymphoma;Spasticity;Rigidity;Glaucoma;Chorioretinal dysplasia;Anteverted nares;Thick vermilion border;Underdeveloped supraorbital ridges;Muscular hypotonia;Leukemia;Gangrene;Myopia;Scaling skin;Abnormality of retinal pigmentation						33	0.97											56	0.71														17.1	1.640827	0.062	1	18	19	fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	KIF11	0.0	0.0	0.0	0.03	1.0	-20.0	13.0	25.0						0.0258	1.0	57.495841945	0.997	0.324	embryo phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; 			pons;tumor;superior cervical ganglion;	.	mitotic cell cycle;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;microtubule-based movement;spindle organization;mitotic spindle organization;mitotic centrosome separation;antigen processing and presentation of exogenous peptide antigen via MHC class II;regulation of mitotic centrosome separation;cell division;mitotic spindle assembly	spindle pole;nucleus;spindle;cytosol;kinesin complex;microtubule;spindle microtubule;membrane;protein-containing complex;mitotic spindle	microtubule motor activity;ATP binding;microtubule binding;ATP-dependent microtubule motor activity, plus-end-directed;ATPase activity;protein kinase binding	DHRS13[26496610];RBM28[26496610];ANKLE2[26496610];RPL32[26496610];SUV39H1[26496610];PRR3[26496610];HSPB8[26496610];CETN2[26496610];HDLBP[26496610];ARID4B[26496610];TMEM131L[26496610];ADARB2[26496610];AP2A2[26496610];EDC4[26496610];DUSP11[26496610];FAM122A[26496610];C2orf69[26496610];MED14[26496610];RPL36AL[26496610];MLST8[26496610];DGCR8[26496610];SNRPD3[26496610];IKBKE[14743216];PCID2[26496610];ANXA1[26496610];ZGRF1[26496610];CEP295[26496610];SPATS2[26496610];RPS6[26496610];MTUS1[26496610];ACSL5[26496610];PRKCA[26496610];RPS3A[26496610];DDX51[26496610];IRAK4[26496610];ACSL3[26496610];ANK3[26496610];GTPBP4[26496610];ILVBL[26496610];KATNAL2[26929214];RPL37A[26496610];ULK2[20562859];ANKS6[26496610];FLYWCH1[26496610];TLN1[26496610];RPL28[26496610];PPP1R15A[29109149];LUZP1[26496610];KMT2A[26496610];HIST1H2BK[26496610];NOL7[26496610];NOLC1[26496610];GATA3[26028330];AP3M1[26496610];LDHA[26496610];MTA1[26028330];HIST1H3A[26496610];CALD1[26496610];NT5DC3[26496610];ZKSCAN8[26496610];ORC2[26496610];MAP4[26496610];DECR1[26496610];ABCA1[25170080];BRPF1[26496610];H3F3B[26496610];CEP350[26496610];MRPL27[26496610];PLEKHA5[26496610];CDC5L[20467437];TRIP4[26496610];PNMA3[26496610];RPL23A[26496610];LAMB1[26496610];PEX14[21525035];SNW1[20467437];MYO1C[26496610];TNIP3[19615732];EIF3I[26496610];FASN[26496610];TACC3[26496610];SPIRE2[26496610];PDE3A[26496610];DYNLRB1[26496610];RBM45[26496610];ACTR10[26496610];PFKM[26496610];EIF3A[26496610];RPS23[26496610];
5100	chr11	31822405		G	chr11:31822404-31822405	PAX6	paired box 6	0.0	insertion	0|1	0.16	26_5	31	99	False		SPLICING	YES	NM_001368910.2	Transcript	protein_coding	frameshift_variant,splice_region_variant			NM_001368910.2:c.601-1_601insC	NP_001355839.1:p.Val201ArgfsTer13		-1.0					Optic nerve hypoplasia, 165550 (3), Autosomal dominant; Cataract with late-onset corneal dystrophy, 106210 (3), Autosomal dominant; ?Coloboma, ocular, 120200 (3), Autosomal dominant; ?Coloboma of optic nerve, 120430 (3), Autosomal dominant; Aniridia, 106210 (3), Autosomal dominant; Anterior segment dysgenesis 5, multiple subtypes, 604229 (3), Autosomal dominant; ?Morning glory disc anomaly, 120430 (3), Autosomal dominant; Foveal hypoplasia 1, 136520 (3), Autosomal dominant; Keratitis, 148190 (3), Autosomal dominant	WAGR syndrome;Aniridia-cerebellar ataxia-intellectual disability syndrome;Foveal hypoplasia-presenile cataract syndrome;Autosomal dominant keratitis;Isolated optic nerve hypoplasia/aplasia;Isolated aniridia;Peters anomaly;Morning glory disc anomaly;Coloboma of choroid and retina;Coloboma of optic disc;Coloboma of macula;Coloboma of eyelid;Coloboma of eye lens;Coloboma of iris	Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Aniridia;Scanning speech;Ataxia;Abnormality of movement;Global developmental delay;Hearing abnormality;Muscular hypotonia;Intellectual disability;Mask-like facies;Abnormality of the pulmonary artery;Keratitis;Autosomal dominant inheritance;Opacification of the corneal stroma;Cataract;Optic atrophy;Abnormality of vision;Nystagmus;Generalized hyperpigmentation;Strabismus;Optic nerve aplasia;Reduced visual acuity;Remnants of the hyaloid vascular system;Peters anomaly;Optic nerve coloboma;Morning glory anomaly;Microphthalmia;Vesicoureteral reflux;Corneal opacity;Ventriculomegaly;Nystagmus;Chorioretinal coloboma;Autosomal dominant inheritance;Growth delay;Aplasia/Hypoplasia of the iris;Cryptorchidism;Displacement of the urethral meatus;Ptosis;Glaucoma;Hearing abnormality;Everted lower lip vermilion;Short stature;Dysfunction of lateral corticospinal tracts;Micrognathia;Nystagmus;Microcephaly;Visual impairment;Ambiguous genitalia;Cataract;Scoliosis;Intellectual disability;Obesity;Unilateral microphthalmos;Growth delay;Peripheral vitreous opacities;Abnormal best corrected visual acuity test;Ventriculomegaly;Pseudopapilledema;Chorioretinal coloboma;Neurodevelopmental delay;EEG abnormality;Aplasia/Hypoplasia of the iris;Optic nerve hypoplasia;Vesicoureteral reflux;Corneal opacity;Abnormal involuntary eye movements;Optic disc hypoplasia;Retinal detachment;Autosomal dominant inheritance;Optic nerve coloboma;Peters anomaly;Corneal opacity;Nystagmus;Developmental glaucoma;Autosomal recessive inheritance;Strabismus;Hypoplasia of the fovea;Polymicrogyria;Cataract;Nystagmus;Optic nerve hypoplasia;Aniridia;Hypoplasia of the corpus callosum;Glaucoma;Glucose intolerance;Opacification of the corneal stroma;Autosomal dominant inheritance;Increased proinsulin:insulin ratio;Reduced visual acuity;Abnormality of the optic disc;Visual impairment;Optic nerve hypoplasia;Optic nerve aplasia;Autosomal dominant inheritance;Gonadoblastoma;Intellectual disability;Abnormal vagina morphology;Autosomal dominant inheritance;Nephroblastoma;Renal insufficiency;Nephropathy;Streak ovary;Hypospadias;Somatic mutation;Obesity;Cryptorchidism;Contiguous gene syndrome;Abnormality of the uterus;Aniridia;Nystagmus;Peters anomaly;Visual loss;Cataract;Aplasia/Hypoplasia of the macula;Glaucoma;Aniridia;Subcapsular cataract;Developmental glaucoma;Nystagmus;Anterior synechiae of the anterior chamber;Strabismus;Thinning of Descemet membrane;Peters anomaly;Central opacification of the cornea;Visual impairment;Congenital nystagmus;Presenile cataracts;Autosomal dominant inheritance;Hypoplasia of the fovea;Amblyopia;Optic nerve coloboma;Strabismus;Abnormality of retinal pigmentation;Nystagmus;Retinal detachment;Cataract						32	0.97											100	1.0																	0	0	0			PAX6	0.02	0.02	0.0	0.0	-17.0	0.0	0.0	-10.0						0.0409	1.0	98.195511084			neoplasm; pigmentation phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; embryo phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; craniofacial phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; digestive/alimentary phenotype; muscle phenotype; endocrine/exocrine gland phenotype; taste/olfaction phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			amygdala;beta cell islets;occipital lobe;prefrontal cortex;superior cervical ganglion;parietal lobe;cerebellum peduncles;globus pallidus;medulla oblongata;cerebellum;	Maturity onset diabetes of the young	negative regulation of transcription by RNA polymerase II;establishment of mitotic spindle orientation;blood vessel development;eye development;cell fate determination;neuron migration;negative regulation of protein phosphorylation;positive regulation of neuroblast proliferation;lens development in camera-type eye;type B pancreatic cell differentiation;pancreatic A cell development;transcription by RNA polymerase II;smoothened signaling pathway;axon guidance;central nervous system development;salivary gland morphogenesis;visual perception;response to wounding;regulation of asymmetric cell division;animal organ morphogenesis;dorsal/ventral axis specification;positive regulation of gene expression;oligodendrocyte cell fate specification;cerebral cortex regionalization;forebrain dorsal/ventral pattern formation;commitment of neuronal cell to specific neuron type in forebrain;forebrain-midbrain boundary formation;regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification;regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification;regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment;pituitary gland development;habenula development;signal transduction involved in regulation of gene expression;keratinocyte differentiation;regulation of cell migration;positive regulation of epithelial cell differentiation;lacrimal gland development;protein localization to organelle;eye photoreceptor cell development;glucose homeostasis;negative regulation of neuron differentiation;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;regulation of timing of cell differentiation;embryonic camera-type eye morphogenesis;neuron fate commitment;astrocyte differentiation;negative regulation of epithelial cell proliferation;negative regulation of neurogenesis;retina development in camera-type eye;iris morphogenesis;cornea development in camera-type eye;positive regulation of core promoter binding;cellular response to leukemia inhibitory factor;negative regulation of neural precursor cell proliferation	nuclear chromatin;nucleus;nucleoplasm;cytoplasm;cytosol	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II core promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;chromatin binding;DNA-binding transcription factor activity;protein binding;transcription factor binding;protein kinase binding;ubiquitin protein ligase binding;histone acetyltransferase binding;co-SMAD binding;R-SMAD binding;HMG box domain binding	IPO13[16189514];UBXN2B[unassigned1304];GEMIN2[unassigned1304];CIB3[unassigned1304];UBE3A[29426014];HOMER3[16098226;unassigned1304];HOXA1[unassigned1304];SLC12A8[unassigned1304];WASHC3[unassigned1304];CSNK2A1[unassigned1304];THOC1[unassigned1304];ACOT12[unassigned1304];KCTD7[unassigned1304];GPANK1[unassigned1304];HGS[unassigned1304];UBE2V1[26496610];ATP6V0D2[unassigned1304];TRIM11[16098226];CGGBP1[unassigned1304];GCM2[unassigned1304];LXN[unassigned1304];SET[unassigned1304];USHBP1[unassigned1304];GMPS[26496610];PSORS1C2[unassigned1304];EIF1AD[unassigned1304];HMBOX1[unassigned1304];AP5M1[26496610];EPB41L2[26496610];SEC14L4[unassigned1304];ZBED1[unassigned1304];APOB[26496610];HOXC9[unassigned1304];LONRF1[unassigned1304];HOXC8[unassigned1304];GAS2L2[unassigned1304];AP1M1[unassigned1304];BANP[unassigned1304];ATP6V1C2[unassigned1304];TXNDC5[unassigned1304];BCL2L15[unassigned1304];UBE2F[unassigned1304];TRAP1[26496610];POLR3GL[unassigned1304];STAC[unassigned1304];SPDYC[unassigned1304];EAF1[unassigned1304];ESRRG[unassigned1304];LARP4[unassigned1304];VCX2[unassigned1304];CDK3[unassigned1304];PIN1[unassigned1304];HNRNPC[unassigned1304];SAE1[unassigned1304];UBE2K[unassigned1304];NFKBID[unassigned1304];ZNF410[unassigned1304];UBE2M[26496610];C2CD6[unassigned1304];RBM26[26496610];NGLY1[unassigned1304];PRKAG1[unassigned1304];HMGB3[unassigned1304];CXorf38[unassigned1304];CKS1B[unassigned1304];FYCO1[26496610];RBM4[26496610];CHAF1A[unassigned1304];SUMO1[21084637];NKIRAS2[21988832];ARIH2[unassigned1304];TLK2[unassigned1304];TCP11L1[unassigned1304];TLK1[unassigned1304];UBXN7[unassigned1304];ZNF124[unassigned1304];KRTAP9-3[unassigned1304];PDE4C[unassigned1304];DHPS[unassigned1304];KRTAP9-8[unassigned1304];MRPL53[unassigned1304];TRAPPC6A[unassigned1304];CINP[unassigned1304];EFHC1[unassigned1304];PICK1[unassigned1304];MAPRE1[unassigned1304];KANK2[unassigned1304];CCDC103[unassigned1304];MIPOL1[unassigned1304];C1orf109[unassigned1304];CTNNA3[unassigned1304];NCDN[unassigned1304];PCNT[26496610];MISP[unassigned1304];SRSF11[unassigned1304];LNPK[unassigned1304];MARCKSL1[26496610];NFYC[unassigned1304];LYSMD1[unassigned1304];GRHL2[unassigned1304];MFAP1[unassigned1304];POLR3C[unassigned1304];MORN3[unassigned1304];TRIP10[unassigned1304];CCDC6[unassigned1304];QRICH1[unassigned1304];PPIL4[unassigned1304];RAN[26496610];FAM50B[unassigned1304];SPG21[unassigned1304];SIGLEC6[unassigned1304];CCL26[unassigned1304];
5193	chr11	31822406		TTGGTATGTTATCGTTGGTACAGACCCCCTCGGACAGTAATCTGTCTCGGATTTCCCAAGCAAAGATGGACGGGCACTCCCGCTTATACTGGGCTATTT	chr11:31822405-31822406	PAX6	paired box 6	0.0	insertion	0|1	0.16	26_5	31	99	False		SPLICING	YES	NM_001368910.2	Transcript	protein_coding	splice_acceptor_variant	7/13		NM_001368910.2:c.601-2_601-1insAAATAGCCCAGTATAAGCGGGAGTGCCCGTCCATCTTTGCTTGGGAAATCCGAGACAGATTACTGTCCGAGGGGGTCTGTACCAACGATAACATACCAA			-1.0					Optic nerve hypoplasia, 165550 (3), Autosomal dominant; Cataract with late-onset corneal dystrophy, 106210 (3), Autosomal dominant; ?Coloboma, ocular, 120200 (3), Autosomal dominant; ?Coloboma of optic nerve, 120430 (3), Autosomal dominant; Aniridia, 106210 (3), Autosomal dominant; Anterior segment dysgenesis 5, multiple subtypes, 604229 (3), Autosomal dominant; ?Morning glory disc anomaly, 120430 (3), Autosomal dominant; Foveal hypoplasia 1, 136520 (3), Autosomal dominant; Keratitis, 148190 (3), Autosomal dominant	WAGR syndrome;Aniridia-cerebellar ataxia-intellectual disability syndrome;Foveal hypoplasia-presenile cataract syndrome;Autosomal dominant keratitis;Isolated optic nerve hypoplasia/aplasia;Isolated aniridia;Peters anomaly;Morning glory disc anomaly;Coloboma of choroid and retina;Coloboma of optic disc;Coloboma of macula;Coloboma of eyelid;Coloboma of eye lens;Coloboma of iris	Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Aniridia;Scanning speech;Ataxia;Abnormality of movement;Global developmental delay;Hearing abnormality;Muscular hypotonia;Intellectual disability;Mask-like facies;Abnormality of the pulmonary artery;Keratitis;Autosomal dominant inheritance;Opacification of the corneal stroma;Cataract;Optic atrophy;Abnormality of vision;Nystagmus;Generalized hyperpigmentation;Strabismus;Optic nerve aplasia;Reduced visual acuity;Remnants of the hyaloid vascular system;Peters anomaly;Optic nerve coloboma;Morning glory anomaly;Microphthalmia;Vesicoureteral reflux;Corneal opacity;Ventriculomegaly;Nystagmus;Chorioretinal coloboma;Autosomal dominant inheritance;Growth delay;Aplasia/Hypoplasia of the iris;Cryptorchidism;Displacement of the urethral meatus;Ptosis;Glaucoma;Hearing abnormality;Everted lower lip vermilion;Short stature;Dysfunction of lateral corticospinal tracts;Micrognathia;Nystagmus;Microcephaly;Visual impairment;Ambiguous genitalia;Cataract;Scoliosis;Intellectual disability;Obesity;Unilateral microphthalmos;Growth delay;Peripheral vitreous opacities;Abnormal best corrected visual acuity test;Ventriculomegaly;Pseudopapilledema;Chorioretinal coloboma;Neurodevelopmental delay;EEG abnormality;Aplasia/Hypoplasia of the iris;Optic nerve hypoplasia;Vesicoureteral reflux;Corneal opacity;Abnormal involuntary eye movements;Optic disc hypoplasia;Retinal detachment;Autosomal dominant inheritance;Optic nerve coloboma;Peters anomaly;Corneal opacity;Nystagmus;Developmental glaucoma;Autosomal recessive inheritance;Strabismus;Hypoplasia of the fovea;Polymicrogyria;Cataract;Nystagmus;Optic nerve hypoplasia;Aniridia;Hypoplasia of the corpus callosum;Glaucoma;Glucose intolerance;Opacification of the corneal stroma;Autosomal dominant inheritance;Increased proinsulin:insulin ratio;Reduced visual acuity;Abnormality of the optic disc;Visual impairment;Optic nerve hypoplasia;Optic nerve aplasia;Autosomal dominant inheritance;Gonadoblastoma;Intellectual disability;Abnormal vagina morphology;Autosomal dominant inheritance;Nephroblastoma;Renal insufficiency;Nephropathy;Streak ovary;Hypospadias;Somatic mutation;Obesity;Cryptorchidism;Contiguous gene syndrome;Abnormality of the uterus;Aniridia;Nystagmus;Peters anomaly;Visual loss;Cataract;Aplasia/Hypoplasia of the macula;Glaucoma;Aniridia;Subcapsular cataract;Developmental glaucoma;Nystagmus;Anterior synechiae of the anterior chamber;Strabismus;Thinning of Descemet membrane;Peters anomaly;Central opacification of the cornea;Visual impairment;Congenital nystagmus;Presenile cataracts;Autosomal dominant inheritance;Hypoplasia of the fovea;Amblyopia;Optic nerve coloboma;Strabismus;Abnormality of retinal pigmentation;Nystagmus;Retinal detachment;Cataract						32	0.97											100	1.0																	0	0	0																	0.0409	1.0				neoplasm; pigmentation phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; embryo phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; craniofacial phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; digestive/alimentary phenotype; muscle phenotype; endocrine/exocrine gland phenotype; taste/olfaction phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			amygdala;beta cell islets;occipital lobe;prefrontal cortex;superior cervical ganglion;parietal lobe;cerebellum peduncles;globus pallidus;medulla oblongata;cerebellum;	Maturity onset diabetes of the young	negative regulation of transcription by RNA polymerase II;establishment of mitotic spindle orientation;blood vessel development;eye development;cell fate determination;neuron migration;negative regulation of protein phosphorylation;positive regulation of neuroblast proliferation;lens development in camera-type eye;type B pancreatic cell differentiation;pancreatic A cell development;transcription by RNA polymerase II;smoothened signaling pathway;axon guidance;central nervous system development;salivary gland morphogenesis;visual perception;response to wounding;regulation of asymmetric cell division;animal organ morphogenesis;dorsal/ventral axis specification;positive regulation of gene expression;oligodendrocyte cell fate specification;cerebral cortex regionalization;forebrain dorsal/ventral pattern formation;commitment of neuronal cell to specific neuron type in forebrain;forebrain-midbrain boundary formation;regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification;regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification;regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment;pituitary gland development;habenula development;signal transduction involved in regulation of gene expression;keratinocyte differentiation;regulation of cell migration;positive regulation of epithelial cell differentiation;lacrimal gland development;protein localization to organelle;eye photoreceptor cell development;glucose homeostasis;negative regulation of neuron differentiation;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;regulation of timing of cell differentiation;embryonic camera-type eye morphogenesis;neuron fate commitment;astrocyte differentiation;negative regulation of epithelial cell proliferation;negative regulation of neurogenesis;retina development in camera-type eye;iris morphogenesis;cornea development in camera-type eye;positive regulation of core promoter binding;cellular response to leukemia inhibitory factor;negative regulation of neural precursor cell proliferation	nuclear chromatin;nucleus;nucleoplasm;cytoplasm;cytosol	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II core promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;chromatin binding;DNA-binding transcription factor activity;protein binding;transcription factor binding;protein kinase binding;ubiquitin protein ligase binding;histone acetyltransferase binding;co-SMAD binding;R-SMAD binding;HMG box domain binding	IPO13[16189514];UBXN2B[unassigned1304];GEMIN2[unassigned1304];CIB3[unassigned1304];UBE3A[29426014];HOMER3[16098226;unassigned1304];HOXA1[unassigned1304];SLC12A8[unassigned1304];WASHC3[unassigned1304];CSNK2A1[unassigned1304];THOC1[unassigned1304];ACOT12[unassigned1304];KCTD7[unassigned1304];GPANK1[unassigned1304];HGS[unassigned1304];UBE2V1[26496610];ATP6V0D2[unassigned1304];TRIM11[16098226];CGGBP1[unassigned1304];GCM2[unassigned1304];LXN[unassigned1304];SET[unassigned1304];USHBP1[unassigned1304];GMPS[26496610];PSORS1C2[unassigned1304];EIF1AD[unassigned1304];HMBOX1[unassigned1304];AP5M1[26496610];EPB41L2[26496610];SEC14L4[unassigned1304];ZBED1[unassigned1304];APOB[26496610];HOXC9[unassigned1304];LONRF1[unassigned1304];HOXC8[unassigned1304];GAS2L2[unassigned1304];AP1M1[unassigned1304];BANP[unassigned1304];ATP6V1C2[unassigned1304];TXNDC5[unassigned1304];BCL2L15[unassigned1304];UBE2F[unassigned1304];TRAP1[26496610];POLR3GL[unassigned1304];STAC[unassigned1304];SPDYC[unassigned1304];EAF1[unassigned1304];ESRRG[unassigned1304];LARP4[unassigned1304];VCX2[unassigned1304];CDK3[unassigned1304];PIN1[unassigned1304];HNRNPC[unassigned1304];SAE1[unassigned1304];UBE2K[unassigned1304];NFKBID[unassigned1304];ZNF410[unassigned1304];UBE2M[26496610];C2CD6[unassigned1304];RBM26[26496610];NGLY1[unassigned1304];PRKAG1[unassigned1304];HMGB3[unassigned1304];CXorf38[unassigned1304];CKS1B[unassigned1304];FYCO1[26496610];RBM4[26496610];CHAF1A[unassigned1304];SUMO1[21084637];NKIRAS2[21988832];ARIH2[unassigned1304];TLK2[unassigned1304];TCP11L1[unassigned1304];TLK1[unassigned1304];UBXN7[unassigned1304];ZNF124[unassigned1304];KRTAP9-3[unassigned1304];PDE4C[unassigned1304];DHPS[unassigned1304];KRTAP9-8[unassigned1304];MRPL53[unassigned1304];TRAPPC6A[unassigned1304];CINP[unassigned1304];EFHC1[unassigned1304];PICK1[unassigned1304];MAPRE1[unassigned1304];KANK2[unassigned1304];CCDC103[unassigned1304];MIPOL1[unassigned1304];C1orf109[unassigned1304];CTNNA3[unassigned1304];NCDN[unassigned1304];PCNT[26496610];MISP[unassigned1304];SRSF11[unassigned1304];LNPK[unassigned1304];MARCKSL1[26496610];NFYC[unassigned1304];LYSMD1[unassigned1304];GRHL2[unassigned1304];MFAP1[unassigned1304];POLR3C[unassigned1304];MORN3[unassigned1304];TRIP10[unassigned1304];CCDC6[unassigned1304];QRICH1[unassigned1304];PPIL4[unassigned1304];RAN[26496610];FAM50B[unassigned1304];SPG21[unassigned1304];SIGLEC6[unassigned1304];CCL26[unassigned1304];
5394	chr11	76891430	G	A	chr11:76891430	MYO7A	myosin VIIA	0.0	SNV	0/1	0.71	11_27	38	99	False	rs199607235,COSV68683577	EXONIC	YES	NM_000260.4	Transcript	protein_coding	missense_variant		22/49	NM_000260.4:c.2597G>A	NP_000251.3:p.Arg866His		1.0	.,.,.,.,.,.	Uncertain_significance	criteria_provided,_multiple_submitters,_no_conflicts	Usher_syndrome_type_1B|not_specified|not_provided	Deafness, autosomal recessive 2, 600060 (3), Autosomal recessive; Usher syndrome, type 1B, 276900 (3), Autosomal recessive; Deafness, autosomal dominant 11, 601317 (3), Autosomal dominant	Usher syndrome type 2;Usher syndrome type 1;Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Cataract;Schizophrenia;Visual loss;Scotoma;Hemianopia;Nystagmus;Depressivity;Abnormal electroretinogram;Nyctalopia;Anxiety;Aplasia/Hypoplasia of the cerebellum;Hallucinations;Abnormality of dental enamel;Microdontia;Iris hypopigmentation;Ataxia;Carious teeth;Sensorineural hearing impairment;Cerebral cortical atrophy;Subcortical cerebral atrophy;Abnormality of dental color;Myopia;Autosomal dominant inheritance;Bilateral sensorineural hearing impairment;Vertigo;Autosomal recessive inheritance;Vertigo;Congenital onset;Sensorineural hearing impairment;Hallucinations;Anxiety;Abnormal cochlea morphology;Aplasia/Hypoplasia of the cerebellum;Iris hypopigmentation;Schizophrenia;Abnormal electroretinogram;Subcortical cerebral atrophy;Cerebral cortical atrophy;Abnormality of dental enamel;Global developmental delay;High hypermetropia;Visual loss;Sensorineural hearing impairment;Scotoma;Depressivity;Intellectual disability;Hemianopia;Nyctalopia;Vestibular hypofunction;Cataract;Ataxia;Visual loss;Undetectable electroretinogram;Autosomal recessive inheritance;Sensorineural hearing impairment;Motor delay;Rod-cone dystrophy;Heterogeneous;Absent vestibular function		2.62898e-05	4.0	152150.0	0.0	33	0.97	PASS	nfe	4.40943e-05	3.0	4.40943e-05	3.0	1.62327e-05	4.0	246416.0	0.0	57	0.91	PASS	afr	6.58588e-05	1.0	8.98941e-06	1.0	0.0000129	2						25.6	3.652917	0.389	12	7	19	PolyPhen,LRT_pred,M-CAP_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred	MYO7A	0.02	0.0	0.0	0.0	8.0	-10.0	8.0	0.0						0.026	0.0	0.0	0.963	1.176	growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; hematopoietic system phenotype; reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; vision/eye phenotype; 			pons;ciliary ganglion;testis - seminiferous tubule;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;adrenal gland;testis;skeletal muscle;adrenal cortex;	.	phagolysosome assembly;intracellular protein transport;lysosome organization;visual perception;sensory perception of sound;actin filament-based movement;cellular protein localization;eye photoreceptor cell development;mechanoreceptor differentiation;post-embryonic animal organ morphogenesis;sensory perception of light stimulus;equilibrioception;pigment granule transport;auditory receptor cell stereocilium organization	photoreceptor outer segment;photoreceptor inner segment;cytoplasm;lysosomal membrane;cytosol;microvillus;cell cortex;apical plasma membrane;myosin VII complex;photoreceptor connecting cilium;stereocilium;melanosome;synapse;stereocilium base;upper tip-link density	microfilament motor activity;protein binding;calmodulin binding;ATP binding;protein domain specific binding;spectrin binding;actin-dependent ATPase activity;protein homodimerization activity;ADP binding;protein N-terminus binding;actin filament binding	RIPOR1[unassigned1312];NEK4[25798074];STK38L[30108113];RPE65[21493626];
5527	chr11	117280499	A	C	chr11:117280499	CEP164	centrosomal protein 164	0.0	SNV	0|1	0.15	11_2	13	51	False		EXONIC	YES	NM_014956.5	Transcript	protein_coding	missense_variant		30/33	NM_014956.5:c.3914A>C	NP_055771.4:p.Asp1305Ala		1.0					Nephronophthisis 15, 614845 (3), Autosomal recessive	Senior-Loken syndrome	Disease-causing germline mutation(s) in	Cerebellar vermis hypoplasia;Blindness;Hepatic failure;Obesity;Polydactyly;Seizure;Retinal degeneration;Nystagmus;Global developmental delay;Autosomal recessive inheritance;Nephronophthisis;Progressive visual loss;Premature ovarian insufficiency;Nephronophthisis;Hypertension;Short stature;Global developmental delay;Cone-shaped epiphysis;Abnormality of retinal pigmentation;Retinal dystrophy;Cataract;Abnormality of bone mineral density;Ataxia;Congenital hepatic fibrosis;Stage 5 chronic kidney disease		1.32654e-05	2.0	150768.0	0.0	32	0.94	AS_VQSR	nfe	1.47767e-05	1.0	1.47767e-05	1.0					100	1.0														1.251	-0.117504	0.008	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CEP164	0.01	0.0	0.0	0.07	46.0	-18.0	-24.0	45.0						0.884	0.0	41.689754618	0.001	-0.271	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;testis - interstitial;dorsal root ganglion;superior cervical ganglion;testis;	.	G2/M transition of mitotic cell cycle;DNA repair;regulation of G2/M transition of mitotic cell cycle;cell division;cilium assembly;ciliary basal body-plasma membrane docking	extracellular space;nucleoplasm;cytoplasm;centrosome;centriole;cytosol;intracellular membrane-bounded organelle;ciliary transition fiber	protein binding	USP36[26638075];TOP2B[26638075];C1orf131[26638075];DDX47[26638075];NVL[26638075];WDR3[26638075];AATF[26638075];CEP128[26638075];YY1[26638075];PCM1[26638075];CSRP2[26638075];KAT5[22863007];NKRF[26638075];CLP1[unassigned1304];CHEK1[22863007];DBT[26638075];IDH3B[26638075];LONP1[26638075];ZNF326[26638075];CAPN1[26638075];CCDC92[22863007];RPP38[26638075];CTSB[26638075];OFD1[26638075];SUPT16H[26638075];RBFOX2[26638075];GPX1[26638075];RFC2[26638075];NSUN2[26638075];STX8[26638075];SSR3[26638075];ECH1[26638075];DDX56[26638075];SENP3[26638075];EBNA1BP2[26638075];SRSF2[22863007;26638075];NCBP3[26638075];VN1R5[26638075];SDCCAG8[22863007];MTPN[26638075];RNASEH2B[26496610];NUP205[26638075];DDX24[26638075];PEF1[26638075];DDX23[26638075];NMD3[26638075];SNU13[26638075];PDS5B[26638075];RPF2[26638075];PPM1F[26638075];TTBK2[22863007];HSPD1[30021884];TIMM23B[26638075];DNAJB6[26638075];PDCD11[26638075];TRA2B[26638075];LDHD[26496610];DVL3[22863007];NPHP3[22863007];SRSF10[26638075];BTF3[26638075];HSPA9[30021884];SSRP1[26638075];MAPK14[21988832];NIN[26638075];GLUD2[26638075];TBL3[26638075];TNIP2[unassigned1774];CEBPZ[26638075];NOL11[26638075];CEP89[26638075];
5569	chr12	48368085	G	A	chr12:48368085	COL2A1	collagen type II alpha 1 chain	0.0	SNV	0/1	0.42	14_10	24	99	False	rs12721379	EXONIC	YES	NM_001844.5	Transcript	protein_coding	synonymous_variant		53/54	NM_001844.5:c.4104C>T	NP_001835.3:p.Pro1368%3D		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Stickler_syndrome_type_1|Type_II_Collagenopathies|not_specified|not_provided	?Vitreoretinopathy with phalangeal epiphyseal dysplasia, 619248 (3), Autosomal dominant; Czech dysplasia, 609162 (3), Autosomal dominant; Achondrogenesis, type II or hypochondrogenesis, 200610 (3), Autosomal dominant; Spondyloperipheral dysplasia, 271700 (3), Autosomal dominant; SMED Strudwick type, 184250 (3), Autosomal dominant; ?Epiphyseal dysplasia, multiple, with myopia and deafness, 132450 (3), Autosomal dominant; SED congenita, 183900 (3), Autosomal dominant; Kniest dysplasia, 156550 (3), Autosomal dominant; Stickler syndrome, type I, nonsyndromic ocular, 609508 (3), Autosomal dominant; Osteoarthritis with mild chondrodysplasia, 604864 (3), Autosomal dominant; Stickler syndrome, type I, 108300 (3), Autosomal dominant; Platyspondylic skeletal dysplasia, Torrance type, 151210 (3), Autosomal dominant; Spondyloepiphyseal dysplasia, Stanescu type, 616583 (3), Autosomal dominant; Avascular necrosis of the femoral head, 608805 (3), Autosomal dominant; Legg-Calve-Perthes disease, 150600 (3), Autosomal dominant	Multiple epiphyseal dysplasia, Beighton type;Legg-Calv�-Perthes disease;Czech dysplasia, metatarsal type;Kniest dysplasia;Weissenbacher- Zweymuller syndrome;Spondyloperipheral dysplasia-short ulna syndrome;Autosomal dominant rhegmatogenous retinal detachment;Spondyloepiphyseal dysplasia, Stanescu type;Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis;Spondyloepimetaphyseal dysplasia congenita, Strudwick type;Achondrogenesis type 2;Hypochondrogenesis;Spondylometaphyseal dysplasia, 'corner fracture' type;Spondylometaphyseal dysplasia, Schmidt type;Stickler syndrome type 1;Dysspondyloenchondromatosis;Familial avascular necrosis of femoral head;Platyspondylic dysplasia, Torrance type;Spondyloepiphyseal dysplasia congenita	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Narrow chest;Cleft palate;Limitation of joint mobility;Hearing impairment;Osteoarthritis;Abnormality of epiphysis morphology;Short neck;Broad forehead;Short stature;Retinal detachment;Scoliosis;Platyspondyly;Glaucoma;Talipes equinovarus;Cataract;Flat face;Coxa vara;Short thorax;Myopia;Micromelia;Skeletal dysplasia;Hyperlordosis;Nystagmus;Hypertelorism;Kyphosis;Limited hip movement;Impairment of activities of daily living;Groin pain;Short stepped shuffling gait;Flattened femoral head;Hip pain;Lower limb asymmetry;Hip osteoarthritis;Restrictive ventilatory defect;Vitreoretinopathy;Muscular hypotonia;Limited elbow movement;Coxa vara;Short neck;Retinal detachment;Pectus carinatum;Kyphosis;Autosomal dominant inheritance;Malar flattening;Flat face;Waddling gait;Platyspondyly;Hip dislocation;Limited hip movement;Flattened epiphysis;Cleft palate;Talipes equinovarus;Hypoplasia of the odontoid process;Cervical myelopathy;Ovoid vertebral bodies;Delayed pubic bone ossification;Myopia;Generalized hypotonia;Respiratory distress;Lumbar hyperlordosis;Delayed calcaneal ossification;Limitation of knee mobility;Barrel-shaped chest;Spondyloepiphyseal dysplasia;Scoliosis;Neonatal short-trunk short stature;Tracheomalacia;Umbilical hernia;Autosomal dominant inheritance;Hip dislocation;Enlarged joints;Coronal cleft vertebrae;Short neck;Conductive hearing impairment;Respiratory distress;Motor delay;Cleft palate;Round face;Splayed epiphyses;Myopia;Platyspondyly;Retinal detachment;Hip contracture;Gait disturbance;Lumbar kyphoscoliosis;Midface retrusion;Coxa vara;Abnormal cartilage collagen;Depressed nasal bridge;Dumbbell-shaped long bone;Inguinal hernia;Proptosis;Cataract;Recurrent otitis media;Hypoplastic pelvis;Flared metaphysis;Malar flattening;Delayed epiphyseal ossification;Flattened, squared-off epiphyses of tubular bones;Disproportionate short-trunk short stature;Autosomal dominant inheritance;Avascular necrosis of the capital femoral epiphysis;Delayed skeletal maturation;Short stature;Multifactorial inheritance;C1-C2 subluxation;Cleft palate;Metaphyseal dappling;Narrow greater sciatic notch;Pectus carinatum;Protuberant abdomen;Hypoplasia of the odontoid process;Hypoplastic pubic bone;Club-shaped proximal femur;Coxa vara;Hyperlordosis;Inguinal hernia;Autosomal dominant inheritance;Pes planus;Genu valgum;Metaphyseal irregularity;Scoliosis;Brachydactyly;Myopia;Severe short stature;Spondyloepimetaphyseal dysplasia;Platyspondyly;Delayed pubic bone ossification;Anterior rib cupping;Coxa vara;Platyspondyly;Gait disturbance;Abnormality of epiphysis morphology;Hypertelorism;Abnormality of the metaphysis;Kyphosis;Disproportionate short stature;Spondyloepimetaphyseal dysplasia;Osteoarthritis;Short thorax;Respiratory distress;Myopia;Flat face;Hyperlordosis;Retinal detachment;Genu valgum;Abnormality of the sternum;Short femoral neck;Micromelia;Talipes equinovarus;Scoliosis;Genu varum;Cleft palate;Hypoplasia of the odontoid process;Metaphyseal irregularity;Ovoid vertebral bodies;Mild short stature;Coxa vara;Hyperlordosis;Scoliosis;Recurrent fractures;Kyphosis;Genu valgum;Tetralogy of Fallot;Abnormality of the wrist;Pes planus;Hypoplasia of the odontoid process;Spondylometaphyseal dysplasia;Micromelia;Beaking of vertebral bodies;Platyspondyly;Cataract;Glaucoma;Scoliosis;Morbus Scheuermann;Osteoarthritis;Midface retrusion;Membranous vitreous appearance;Mitral valve prolapse;Bifid uvula;Cleft palate;Arachnodactyly;Kyphosis;Arthropathy;Spondyloepiphyseal dysplasia;Autosomal dominant inheritance;Submucous cleft hard palate;Blindness;Pierre-Robin sequence;Pectus excavatum;Sensorineural hearing impairment;Anteverted nares;Disproportionate tall stature;Depressed nasal bridge;Irregular femoral epiphysis;Spondylolisthesis;Retinal detachment;Malar flattening;Myopia;Conductive hearing impairment;Short stature;Micromelia;Hypoplastic pelvis;Metaphyseal dysplasia;Genu valgum;Joint dislocation;Platyspondyly;Abnormality of the wrist;Spondylometaphyseal dysplasia;Short long bone;Myopia;Kyphoscoliosis;Joint stiffness;Short stature;Platyspondyly;Knee osteoarthritis;Hip osteoarthritis;Beaking of vertebral bodies;Heberden's node;Autosomal dominant inheritance;Irregular vertebral endplates;Schmorl's node;Narrow iliac wings;Short femoral neck;Irregular vertebral endplates;Short metatarsal;Waddling gait;Growth abnormality;Arthralgia;Flat capital femoral epiphysis;Short toe;Platyspondyly;Flexion contracture;Thoracic kyphosis;Narrow femoral neck;Short metacarpal;Intervertebral space narrowing;Coxa vara;Scoliosis;Autosomal dominant inheritance;Prominent forehead;Genu varum;Narrow chest;Short foot;Pulmonary hypoplasia;Hypoplastic pelvis;Metaphyseal cupping;Short palm;Abnormality of the carpal bones;Polyhydramnios;Depressed nasal bridge;Hypoplastic scapulae;Micromelia;Cleft palate;Disproportionate short-limb short stature;Skeletal dysplasia;Short distal phalanx of finger;Hypoplasia of the capital femoral epiphysis;Abdominal distention;Malar flattening;Hydrops fetalis;Low-set ears;Platyspondyly;Short thorax;Cystic hygroma;Postaxial hand polydactyly;Aplasia/Hypoplasia of the lungs;Abnormality of cardiovascular system morphology;Micromelia;Macrocephaly;Frontal bossing;Narrow chest;Short neck;Umbilical hernia;Flat face;Hydrops fetalis;Long philtrum;Thickened nuchal skin fold;Abdominal distention;Lethal skeletal dysplasia;Short nose;Abnormal enchondral ossification;Disproportionate short-limb short stature;Anteverted nares;Polyhydramnios;Micrognathia;Femoral hernia;Arthralgia;Stiff neck;Spondyloepiphyseal dysplasia;Autosomal dominant inheritance;Platyspondyly;Beaking of vertebral bodies;Trismus;Coxa valga;Hypoplastic ilia;Kyphoscoliosis;Autosomal dominant inheritance;Asteroid hyalosis;Brachydactyly;Flat face;Conductive hearing impairment;Myopia;Coxa valga;Retinal thinning;Short stature;Epiphyseal dysplasia;Genu valgum;Cataract;Narrow mouth;Short phalanx of finger;Round face;Cartilage destruction;Skeletal muscle atrophy;Short stature;Avascular necrosis;Delayed skeletal maturation;Joint dislocation;Arthralgia;Abnormality of the dentition;Myopia;Autosomal dominant inheritance;Rhegmatogenous retinal detachment;Abnormal vitreous humor morphology;Short ribs;Protuberant abdomen;Thin ribs;Short neck;Lethal skeletal dysplasia;Macrocephaly;Flat acetabular roof;Abnormality of the abdominal wall;Neonatal short-limb short stature;Narrow chest;Severe limb shortening;Coarse facial features;Severe platyspondyly;Disc-like vertebral bodies;Metaphyseal cupping;Hypoplastic ischia;Short long bone;Hypoplastic pubic bone;Decreased cranial base ossification;Autosomal dominant inheritance;Hypoplastic ilia;Stillbirth;Broad long bones;Abdominal distention;Disproportionate short-trunk short stature;Disproportionate short-limb short stature;Absent vertebral body mineralization;Edema;Short ribs;Short long bone;Cleft palate;Hypoplastic iliac wing;Autosomal dominant inheritance;Cystic hygroma;Horizontal ribs;Polyhydramnios;Barrel-shaped chest;Hydrops fetalis;Short tubular bones of the hand;Abnormality of the foot;Coxa vara;Genu varum;Ovoid vertebral bodies;Hypoplasia of the odontoid process;Short femoral neck;Waddling gait;Spondylometaphyseal dysplasia;Autosomal dominant inheritance;Scoliosis;Pectus carinatum;Metaphyseal irregularity;Short stature;Hyperconvex vertebral body endplates;Hypoplasia of the maxilla;Arthralgia;Osteoarthritis;Mitral valve prolapse;Retinal detachment;Platyspondyly;Short nose;Sensorineural hearing impairment;Abnormality of vertebral epiphysis morphology;Skeletal dysplasia;Cleft palate;Intellectual disability;Proptosis;Myopia;Long philtrum;Visual loss;Joint hyperflexibility;Cataract;Abnormal vitreous humor morphology;Epiphyseal dysplasia;Genu valgum;Conductive hearing impairment;Anonychia;Retinal dysplasia;Myopia;Cataract;Round face;Narrow mouth;Flat face;Short palm;Short toe;Flat capital femoral epiphysis;Spondyloepiphyseal dysplasia;Short distal phalanx of the 5th finger;Kyphosis;Hypoplasia of the ulna;Flat acetabular roof;Short metatarsal;Barrel-shaped chest;Short stature;Midface retrusion;Shortening of all middle phalanges of the fingers;Limited elbow extension;Short distal phalanx of the 2nd finger;Short thumb;Short distal phalanx of finger;Autosomal dominant inheritance;Malar flattening;Acetabular spurs;Pugilistic facies;Shortening of all proximal phalanges of the fingers;Broad palm;Short foot;Sensorineural hearing impairment;Platyspondyly;Cone-shaped epiphyses of the phalanges of the hand;Short distal phalanx of the 3rd finger;Pectus carinatum;Brachydactyly;Short metacarpal;Broad thumb;Absent styloid process of ulna;Short distal phalanx of the 4th finger;Micrognathia;Osteoarthritis;Hyperlordosis;Hip dislocation;Skeletal dysplasia;Joint stiffness;Flattened, squared-off epiphyses of tubular bones;Scoliosis;Enlarged thorax;Kyphosis;Dumbbell-shaped long bone;Respiratory distress;Vitreoretinopathy;Hypoplastic pelvis;Rhizomelia;Depressed nasal bridge;Midface retrusion;Platyspondyly;Coxa vara;Flared metaphysis;Ptosis;Short thorax;Disproportionate short-trunk short stature;Myopia;Retinopathy;Cataract;Cleft palate;Tracheomalacia;Micromelia;Glaucoma;Glossoptosis;Tracheal stenosis;Hearing impairment;Round face;Ectopia lentis;Retinal detachment;Proptosis;Avascular necrosis of the capital femoral epiphysis;Autosomal dominant inheritance;Generalized osteoporosis;Glossoptosis;Malar flattening;Sensorineural hearing impairment;Osteoarthritis;Cleft palate;Arthralgia;Pectus excavatum;Pectus carinatum;Abnormal metacarpal morphology;Long philtrum;Exostoses;Micrognathia;Abnormality of fibula morphology;Delayed skeletal maturation;Anisospondyly;Pretibial blistering;Exostoses;Multiple enchondromatosis;Spondylometaphyseal dysplasia;Intellectual disability;Lower limb asymmetry;Enlarged joints;Osteoarthritis;Vertebral segmentation defect;Short stature;Abnormality of ulnar metaphysis;Skin erosion;Platyspondyly;Genu valgum;Generalized joint laxity;Joint dislocation;Cerebral calcification;Kyphoscoliosis;Metaphyseal enchondromatosis;Short stature;Limitation of joint mobility;Short metacarpal;Abnormality of vertebral epiphysis morphology;Hypoplasia of the ulna;Type E brachydactyly;Platyspondyly;Abnormality of pelvic girdle bone morphology;Abnormality of the metaphysis;Cone-shaped epiphysis;Pectus carinatum;Micromelia	25741868	0.00469218	714.0	152168.0	3.0	32	0.96	PASS	nfe	0.00714307	486.0	0.00714307	486.0	0.00492721	1238.0	251258.0	5.0	62	1.0	PASS	nfe	0.0080181	911.0	0.0080181	911.0	0.0051124	795	0.011	37.0	0.01039	118.0		11.27	0.714256		0	0	0			COL2A1	0.04	0.0	0.0	0.0	-19.0	24.0	-19.0	-3.0						0.00641	1.0	24.200266046			homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; 			pons;ciliary ganglion;appendix;trachea;dorsal root ganglion;uterus corpus;trigeminal ganglion;atrioventricular node;superior cervical ganglion;fetal liver;	Cell Communication;Focal adhesion;ECM-receptor interaction	skeletal system development;cartilage condensation;tissue homeostasis;endochondral ossification;chondrocyte differentiation;heart morphogenesis;proteoglycan metabolic process;central nervous system development;visual perception;sensory perception of sound;regulation of gene expression;extracellular matrix organization;collagen fibril organization;notochord development;inner ear morphogenesis;regulation of immune response;cartilage development;roof of mouth development;limb bud formation;embryonic skeletal joint morphogenesis;cartilage development involved in endochondral bone morphogenesis;otic vesicle development;cellular response to BMP stimulus;anterior head development;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	extracellular region;collagen trimer;collagen type II trimer;basement membrane;extracellular space;endoplasmic reticulum lumen;extracellular matrix;collagen-containing extracellular matrix	extracellular matrix structural constituent;extracellular matrix structural constituent conferring tensile strength;MHC class II protein binding;identical protein binding;proteoglycan binding;metal ion binding;platelet-derived growth factor binding	HYAL1[21988832];KEAP1[unassigned1304];COCH[19013156];RELA[21988832];
5721	chr13	50129660	G	C	chr13:50129660	RCBTB1	RCC1 and BTB domain containing protein 1	0.0	SNV	0/1	0.43	20_15	35	99	False	rs139714193	EXONIC	YES	NM_001352500.2	Transcript	protein_coding	missense_variant		6/13	NM_001352500.2:c.594C>G	NP_001339429.1:p.Asp198Glu		-1.0	.,.	Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	Retinal dystrophy with or without extraocular anomalies, 617175 (3), Autosomal recessive	Reticular dystrophy of the retinal pigment epithelium	Disease-causing germline mutation(s) in	Secondary amenorrhea;Premature ovarian insufficiency;Autosomal recessive inheritance;Pulmonary fibrosis;Reduced visual acuity;Retinal dystrophy;Goiter		0.00128812	196.0	152160.0	2.0	32	0.96	PASS	amr	0.00228968	35.0	0.00161708	110.0	0.00184153	463.0	251422.0	1.0	43	0.99	PASS	amr	0.00237076	82.0	0.00192595	219.0	0.0015627	243	0.002	7.0	0.00304	29.0		20.8	2.122531	0.071	4	15	19	LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	RCBTB1	0.0	0.0	0.0	0.0	50.0	-10.0	-14.0	-4.0						0.462	0.0	0.0	0.994	1.176	.			pons;ciliary ganglion;amygdala;thyroid;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;atrioventricular node;trigeminal ganglion;	.	chromatin organization;cell cycle	nucleus;cytoplasm	.	FOXR2[25609649];GABARAPL2[20562859];MAP1LC3B[20562859];GABARAPL1[20562859];MAP1LC3A[20562859];HSP90AB1[22939624];NUDCD1[29021621];GABARAP[20562859];PTBP3[22575643];
6107	chr16	1413031	C	T	chr16:1413031	GNPTG	N-acetylglucosamine-1-phosphate transferase subunit gamma	0.0	SNV	0/1	0.41	10_7	17	99	False	rs193302860,CM093845	EXONIC	YES	NM_032520.5	Transcript	protein_coding	missense_variant		11/11	NM_032520.5:c.857C>T	NP_115909.1:p.Thr286Met		1.0		Uncertain_significance	criteria_provided,_multiple_submitters,_no_conflicts	Mucolipidosis_type_III_gamma|not_provided	Mucolipidosis III gamma, 252605 (3), Autosomal recessive	Mucolipidosis type III gamma	Disease-causing germline mutation(s) (loss of function) in	Autosomal recessive inheritance;Dysostosis multiplex;Aortic regurgitation;Increased serum iduronate sulfatase level;Abnormality of the hand;Intellectual disability, mild;Joint stiffness;Scoliosis;Abnormality of the rib cage;Hyperlordosis;Short neck;Myopia;Arthralgia;Short stature;Genu valgum;Opacification of the corneal stroma;Pectus carinatum;Flat capital femoral epiphysis;Coarse facial features;Kyphosis;Increased serum beta-hexosaminidase;Flared iliac wings;Aortic valve stenosis	20301784,24123366	0.000387938	59.0	152086.0	0.0	33	0.97	PASS	afr	0.000966044	40.0	0.000117588	8.0	0.000195002	49.0	251280.0	0.0	100	1.0	PASS	afr	0.000615764	10.0	0.000255111	29.0	0.0002379	37	0.0	1.0	0.00079	9.0		6.806	0.268731	0.013	5	15	20	Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MutationTaster_pred,FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GNPTG	0.0	0.03	0.0	0.0	-1.0	-33.0	-2.0	32.0						0.331	0.0		0.0	-1.376	homeostasis/metabolism phenotype; 			pons;amygdala;adrenal gland;globus pallidus;	.	N-glycan processing to lysosome;carbohydrate phosphorylation	Golgi membrane;Golgi apparatus;extracellular exosome	UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity;protein homodimerization activity	UPF1[15231747];ANAPC15[26496610];SRPK1[23602568];
6506	chr17	6386883	C	T	chr17:6386883	PITPNM3	PITPNM family member 3	0.0	SNV	0/1	0.73	6_16	22	99	False	rs61755430,COSV52594516	EXONIC	YES	NM_031220.4	Transcript	protein_coding	missense_variant		6/20	NM_031220.4:c.541G>A	NP_112497.2:p.Val181Ile		-1.0	.,.	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Retinitis_pigmentosa|Cone-rod_dystrophy_5|not_specified|not_provided	Cone-rod dystrophy 5, 600977 (3), Autosomal dominant	Cone rod dystrophy	Disease-causing germline mutation(s) in	Macular degeneration;Photophobia;Reduced visual acuity;Autosomal dominant inheritance;Cone dystrophy;Color vision defect;Photophobia;Visual impairment;Color vision defect;Abnormality of retinal pigmentation;Nyctalopia		0.00616731	937.0	151930.0	9.0	31	0.94	PASS	nfe	0.00950196	646.0	0.00950196	646.0	0.00568806	1428.0	251052.0	7.0	100	0.99	PASS	nfe	0.00946205	1074.0	0.00946205	1074.0	0.0059934	932	0.012	39.0	0.00947	108.0		23.0	2.736627	0.084	4	14	18	SIFT,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	PITPNM3	0.0	0.0	0.0	0.01	-27.0	5.0	39.0	5.0						0.064	1.0	0.0	0.974	0.129	.			pons;subthalamic nucleus;trigeminal ganglion;superior cervical ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	Purine metabolism;Gap junction;Long-term depression	phosphatidylinositol biosynthetic process;endoplasmic reticulum to Golgi vesicle-mediated transport;phospholipid transport	cytosol;endomembrane system;membrane;COPII-coated ER to Golgi transport vesicle;cell projection;cell body	phospholipase activity;calcium ion binding;protein binding;lipid binding;phosphatidylinositol transporter activity;receptor tyrosine kinase binding	VAPA[26496610];ALDH1B1[30021884];HNRNPC[30021884];CCL18[21481794];
6629	chr17	36491083	T	T	chr17:36491083	GPR179	G protein-coupled receptor 179	0.0	SNV	0/1	0.25	27_9	36	99	False	rs4550493,COSV60742365	EXONIC	YES	NM_001004334.4	Transcript	protein_coding	synonymous_variant		7/11	NM_001004334.4:c.1478G>A	NP_001004334.3:p.His493%3D		-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Congenital_stationary_night_blindness,_type_1E|not_specified|not_provided	Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3), Autosomal recessive	Congenital stationary night blindness	Disease-causing germline mutation(s) in	Strabismus;Nystagmus;X-linked recessive inheritance;Reduced visual acuity;Autosomal recessive inheritance;Myopia;Congenital stationary night blindness;High myopia;Strabismus;Reduced visual acuity;Abnormality of macular pigmentation;Nyctalopia;Optic disc hypoplasia;Nystagmus						0	0.0							0.0488007	7882.0	161514.0	260.0	68	0.57	PASS	nfe	0.0548659	3518.0	0.0548659	3518.0	0.0314011	4883	0.034	112.0	0.04252	485.0		17.76	1.741023	0.079	0	0	0			GPR179	0.0	0.0	0.0	0.0	-2.0	37.0	37.0	17.0						0.585	0.0	0.0			vision/eye phenotype; 			.	.	G protein-coupled receptor signaling pathway;visual perception	plasma membrane;integral component of membrane	G protein-coupled receptor activity	HIST2H2BF[30021884];
7194	chr2	63719990	C	T	chr2:63719990	WDPCP	WD repeat containing planar cell polarity effector	0.0	SNV	0/1	0.34	23_12	35	99	True	rs200322968,CM150610	SPLICING	YES	NM_015910.7	Transcript	protein_coding	missense_variant,splice_region_variant		2/18	NM_015910.7:c.160G>A	NP_056994.3:p.Asp54Asn		-1.0	.,.,.	Uncertain_significance	criteria_provided,_multiple_submitters,_no_conflicts	Congenital_heart_defects,_hamartomas_of_tongue,_and_polysyndactyly|Bardet-Biedl_syndrome_15|Bardet-Biedl_syndrome|Orofaciodigital_syndrome	?Bardet-Biedl syndrome 15, 615992 (3), Autosomal recessive; Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3), Autosomal recessive	Meckel syndrome;Heart defect-tongue hamartoma-polysyndactyly syndrome;Bardet-Biedl syndrome	Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Talipes;Cataract;Anophthalmia;Situs inversus totalis;Hypertelorism;Microphthalmia;Preaxial hand polydactyly;Accessory spleen;Aplasia/Hypoplasia of the corpus callosum;Hydrocephalus;Pancreatic cysts;Multicystic kidney dysplasia;Aplasia/Hypoplasia of the iris;Urethral atresia;Dandy-Walker malformation;Microcornea;Anencephaly;Optic atrophy;Furrowed tongue;Cryptorchidism;Congenital hepatic fibrosis;Cystic liver disease;Asplenia;Pancreatic fibrosis;Sclerocornea;Ureteral duplication;Microcephaly;Lobar holoprosencephaly;Postaxial hand polydactyly;True hermaphroditism;Bowing of the long bones;Encephalocele;Micrognathia;Male pseudohermaphroditism;Sloping forehead;Abnormal chorioretinal morphology;Aplasia/Hypoplasia of the tongue;Cleft palate;Oligohydramnios;Full cheeks;Postaxial foot polydactyly;Depressed nasal ridge;Low-set, posteriorly rotated ears;Patent ductus arteriosus;Subvalvular aortic stenosis;2-3 finger syndactyly;Benign neoplasm of the central nervous system;Cryptorchidism;Hamartoma of tongue;Hearing impairment;Cryptorchidism;Hypoplasia of the ovary;Low-set, posteriorly rotated ears;Hypogonadism;Nephrotic syndrome;Nystagmus;Multicystic kidney dysplasia;Generalized hirsutism;Short stature;Obesity;Abnormal electroretinogram;Hepatic fibrosis;Pigmentary retinopathy;Neurological speech impairment;Short neck;Downslanted palpebral fissures;Postaxial hand polydactyly;Finger syndactyly;Skeletal muscle atrophy;Hypertension;Intellectual disability;Prominent nasal bridge;Hypoplasia of penis;Medial flaring of the eyebrow;Autosomal recessive inheritance;2-3 finger syndactyly;Hamartoma of tongue;Complete atrioventricular canal defect;Broad hallux;Hypertelorism;Postaxial hand polydactyly;Coarctation of aorta;Subvalvular aortic stenosis	20671153,25427950,27158779	9.87986e-05	15.0	151824.0	0.0	31	0.94	PASS	nfe	0.000191171	13.0	0.000191171	13.0	0.000132781	33.0	248530.0	0.0	73	0.97	PASS	nfe	0.000213068	24.0	0.000213068	24.0	0.0000643	10	0.0	1.0				34.0	5.864429	0.78	12	8	20	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	WDPCP	0.0	0.0	0.0	0.79	4.0	0.0	4.0	0.0	0.999995037813048	0.996	2.001	4.145	6.146		0.0	0.0	0.998	1.026	vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; renal/urinary system phenotype; respiratory system phenotype; embryo phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); craniofacial phenotype; cellular phenotype; 			.	.	kidney development;auditory receptor cell morphogenesis;smoothened signaling pathway;regulation of fibroblast migration;regulation of embryonic cell shape;septin cytoskeleton organization;regulation of protein localization;embryonic digit morphogenesis;camera-type eye development;establishment of protein localization;regulation of focal adhesion assembly;digestive system development;roof of mouth development;cilium assembly;respiratory system development;cardiovascular system development;glomerular visceral epithelial cell migration;regulation of ruffle assembly;regulation of establishment of cell polarity	plasma membrane;axoneme;cell cortex;apical plasma membrane;axonemal basal plate	.	.
12599	chr8	10467590		CCTCTAACTGCACCCCCTCTTCTTGCAGCCCTTCTTCTGTTTTAGTCCCCTCTAACTGCACCCCCTCTTCTTGCAGCCCTTCTTCTGTTTTAGTCC	chr8:10467589-10467590	RP1L1	RP1 like 1	0.0	insertion	1|1	0.95	2_37	39	88	False		EXONIC	YES	NM_178857.6	Transcript	protein_coding	inframe_insertion		4/4	NM_178857.6:c.4018_4019insGGACTAAAACAGAAGAAGGGCTGCAAGAAGAGGGGGTGCAGTTAGAGGGGACTAAAACAGAAGAAGGGCTGCAAGAAGAGGGGGTGCAGTTAGAGG	NP_849188.4:p.Glu1339_Glu1340insGlyThrLysThrGluGluGlyLeuGlnGluGluGlyValGlnLeuGluGlyThrLysThrGluGluGlyLeuGlnGluGluGlyValGlnLeuGlu		-1.0					Occult macular dystrophy, 613587 (3), Autosomal dominant; Retinitis pigmentosa 88, 618826 (3), Autosomal recessive	Occult macular dystrophy	Disease-causing germline mutation(s) in	Macular dystrophy;Autosomal dominant inheritance;Slow decrease in visual acuity;Abnormal multifocal electroretinogram		0.000582528	70.0	120166.0	2.0	34	0.81	PASS	nfe	0.00073902	42.0	0.00073902	42.0					100	0.99																	0	0	0																	0.523		0.0			nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; 			.	.	visual perception;axoneme assembly;intracellular signal transduction;photoreceptor cell development;photoreceptor cell maintenance;retina development in camera-type eye	photoreceptor outer segment;microtubule;axoneme;photoreceptor connecting cilium	.	ARL3[18588884];FYN[17474147];GRB2[17474147];NCK1[17474147];
12601	chr8	10468638	G	A	chr8:10468638	RP1L1	RP1 like 1	0.0	SNV	0/1	0.38	25_15	40	99	False	rs761717063	EXONIC	YES	NM_178857.6	Transcript	protein_coding	synonymous_variant		4/4	NM_178857.6:c.2970C>T	NP_849188.4:p.Pro990%3D		-1.0					Occult macular dystrophy, 613587 (3), Autosomal dominant; Retinitis pigmentosa 88, 618826 (3), Autosomal recessive	Occult macular dystrophy	Disease-causing germline mutation(s) in	Macular dystrophy;Autosomal dominant inheritance;Slow decrease in visual acuity;Abnormal multifocal electroretinogram		3.28571e-05	5.0	152174.0	0.0	33	0.98	PASS	nfe	7.35143e-05	5.0	7.35143e-05	5.0	4.48058e-05	11.0	245504.0	0.0	100	0.98	PASS	nfe	7.24454e-05	8.0	7.24454e-05	8.0	0.0000257	4						0.094	-0.49228		0	0	0			RP1L1	0.0	0.0	0.01	0.0	-35.0	28.0	29.0	27.0						0.523					nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; 			.	.	visual perception;axoneme assembly;intracellular signal transduction;photoreceptor cell development;photoreceptor cell maintenance;retina development in camera-type eye	photoreceptor outer segment;microtubule;axoneme;photoreceptor connecting cilium	.	ARL3[18588884];FYN[17474147];GRB2[17474147];NCK1[17474147];
12630	chr8	38871509	G	A	chr8:38871509	ADAM9	ADAM metallopeptidase domain 9	0.0	SNV	0/1	0.58	15_21	36	99	False	rs146980702	EXONIC	YES	NM_003816.3	Transcript	protein_coding	missense_variant		4/22	NM_003816.3:c.280G>A	NP_003807.1:p.Val94Ile		1.0	Peptidase M12B, propeptide,Peptidase M12B, propeptide,Peptidase M12B, propeptide	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Cone-rod_dystrophy_9|not_specified|not_provided	Cone-rod dystrophy 9, 612775 (3), Autosomal recessive	Cone rod dystrophy	Disease-causing germline mutation(s) in	Photophobia;Visual impairment;Color vision defect;Abnormality of retinal pigmentation;Nyctalopia;Autosomal recessive inheritance;Cone/cone-rod dystrophy;Visual impairment		0.00251418	382.0	151938.0	0.0	32	0.95	PASS	nfe	0.00466272	317.0	0.00466272	317.0	0.00211264	531.0	251344.0	1.0	86	1.0	PASS	nfe	0.00397649	452.0	0.00397649	452.0	0.0024244	377	0.002	8.0	0.00231	26.0		22.0	2.289101	0.12	3	18	21	LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	ADAM9	0.01	0.0	0.0	0.0	-23.0	-8.0	-4.0	-1.0						0.458	0.83	0.0	1.0	1.172	pigmentation phenotype; neoplasm; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; 			.	.	activation of MAPKK activity;membrane protein ectodomain proteolysis;cell adhesion;cell-matrix adhesion;transforming growth factor beta receptor signaling pathway;integrin-mediated signaling pathway;response to manganese ion;cell migration;keratinocyte differentiation;cell adhesion mediated by integrin;positive regulation of cell adhesion mediated by integrin;cell-cell adhesion mediated by integrin;positive regulation of macrophage fusion;response to tumor necrosis factor;response to laminar fluid shear stress;monocyte activation;response to hydrogen peroxide;positive regulation of protein secretion;positive regulation of membrane protein ectodomain proteolysis;PMA-inducible membrane protein ectodomain proteolysis;response to glucocorticoid;positive regulation of keratinocyte migration;response to calcium ion;cellular response to lipopolysaccharide;response to antineoplastic agent	extracellular space;focal adhesion;cell surface;integral component of membrane;basolateral plasma membrane;intrinsic component of external side of plasma membrane;extracellular exosome	metalloendopeptidase activity;protein kinase C binding;integrin binding;protein binding;collagen binding;metallopeptidase activity;SH3 domain binding;laminin binding;metal ion binding	MAD2L2[10531379;10527948];CANX[29568061];PACSIN3[10531379];KIF2C[26496610];SH3GL2[10531379];
12692	chr8	43054556	C	T	chr8:43054556	HGSNAT	heparan-alpha-glucosaminide N-acetyltransferase	0.0	SNV	0|1	0.43	21_16	37	99	False	rs200678234	EXONIC	YES	NM_001363227.2	Transcript	protein_coding	synonymous_variant		19/19	NM_001363227.2:c.1839C>T	NP_001350156.1:p.Val613%3D		1.0		Likely_benign	criteria_provided,_single_submitter	Mucopolysaccharidosis,_MPS-III-C|Retinitis_pigmentosa_73	Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3), Autosomal recessive; Retinitis pigmentosa 73, 616544 (3), Autosomal recessive	Retinitis pigmentosa;Sanfilippo syndrome type C	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Pallor;Autosomal recessive inheritance;Nyctalopia;Constriction of peripheral visual field;Rod-cone dystrophy;Retinal atrophy;Hyperinsulinemia;Optic atrophy;Nystagmus;Abnormal retinal vascular morphology;Obesity;Hypoplasia of penis;Cataract;Abnormality of retinal pigmentation;Keratoconus;Progressive night blindness;Ophthalmoplegia;Abnormal testis morphology;Atypical scarring of skin;Hyperreflexia;Sensorineural hearing impairment;Blindness;Type II diabetes mellitus;Conductive hearing impairment;Photophobia;Intellectual disability;Anteverted nares;Abnormal electroretinogram;Wide nasal bridge;Hypogonadism;Glaucoma;Seizure;Recurrent upper respiratory tract infections;Thickened ribs;Hepatomegaly;Dense calvaria;Hyperactivity;Cellular metachromasia;Coarse hair;Dysostosis multiplex;Kyphoscoliosis;Diarrhea;Splenomegaly;Hernia;Ovoid thoracolumbar vertebrae;Synophrys;Heparan sulfate excretion in urine;Everted lower lip vermilion;Motor delay;Hearing impairment;Motor deterioration;Dysphagia;Loss of speech;Coarse facial features;Growth abnormality;Asymmetric septal hypertrophy;Hirsutism;Variable expressivity;Sleep disturbance;Autosomal recessive inheritance;Rod-cone dystrophy;Joint stiffness;Intellectual disability;Dolichocephaly		0.000723113	110.0	152120.0	2.0	33	0.95	PASS	afr	0.00236646	98.0	0.000102887	7.0	0.000199611	47.0	235458.0	0.0	24	0.62	PASS	afr	0.00255208	37.0	4.70615e-05	5.0	0.0001929	30	0.001	2.0	0.00053	6.0		0.002	-1.075653		0	0	0			HGSNAT	0.06	0.0	0.0	0.0	37.0	-25.0	-45.0	-9.0						0.388	0.0	92.479302919			renal/urinary system phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; 			kidney;trachea;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;adrenal gland;skeletal muscle;	Glycosaminoglycan degradation;Glycan structures - degradation	glycosaminoglycan catabolic process;lysosomal transport;neutrophil degranulation;protein complex oligomerization	lysosomal membrane;plasma membrane;integral component of membrane;specific granule membrane;tertiary granule membrane	heparan-alpha-glucosaminide N-acetyltransferase activity;transferase activity, transferring acyl groups	.
12822	chr8	97172846	C	T	chr8:97172846	GDF6	growth differentiation factor 6	0.0	SNV	0/1	0.55	15_18	33	99	False	rs776298591,COSV54625620	EXONIC	YES	NM_001001557.4	Transcript	protein_coding	synonymous_variant		1/2	NM_001001557.4:c.75G>A	NP_001001557.1:p.Gln25%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Microphthalmia with coloboma 6, digenic, 613703 (3), Autosomal dominant; Microphthalmia, isolated 4, 613094 (3); Leber congenital amaurosis 17, 615360 (3), Autosomal recessive; Multiple synostoses syndrome 4, 617898 (3), Autosomal dominant; Klippel-Feil syndrome 1, autosomal dominant, 118100 (3), Autosomal dominant	Leber congenital amaurosis;Isolated Klippel-Feil syndrome;Colobomatous microphthalmia	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in	Abnormality of neuronal migration;Severely reduced visual acuity;Aplasia/Hypoplasia of the cerebellar vermis;Encephalocele;Seizure;Abnormal electroretinogram;Muscular hypotonia;Abnormality of retinal pigmentation;Abnormality of the optic disc;Nystagmus;Global developmental delay;Cataract;Hearing impairment;Keratoconus;Intellectual disability;Hemiplegia/hemiparesis;Autosomal recessive inheritance;Ultra-low vision with retained motion projection;Hypoplasia of the fovea;Bilateral microphthalmos;Abnormal temporal bone morphology;Optic disc hypoplasia;Coloboma;Nystagmus;Digenic inheritance;Autosomal dominant inheritance;Visual impairment;Tarsal synostosis;Brachydactyly;Pes planus;Broad foot;Overlapping toe;Autosomal dominant inheritance;Otosclerosis;Microphthalmia;Postaxial polydactyly;Autosomal dominant inheritance;Absent testis;Coloboma;Short neck;Hearing impairment;Abnormal sacrum morphology;Cognitive impairment;Spina bifida;Hemiplegia/hemiparesis;Webbed neck;Abnormal cranial nerve morphology;Cleft palate;Sprengel anomaly;Abnormal vertebral segmentation and fusion;Ectopic anus;Renal hypoplasia/aplasia;Cervical C2/C3 vertebral fusion;Abnormality of the shoulder;Abnormality of the ribs;Low posterior hairline;Ventricular septal defect;Anal atresia;Scoliosis;Facial asymmetry;Congenital muscular torticollis;Unilateral renal agenesis;Sprengel anomaly;Cervical C2/C3 vertebral fusion;Autosomal dominant inheritance;Heterogeneous;Facial asymmetry;Short neck;Cervicomedullary schisis;Mixed hearing impairment;Limited neck range of motion;Abnormality of the ribs;Bimanual synkinesia;Low posterior hairline;Variable expressivity;Posterior fossa cyst;Webbed neck;Scoliosis;Cleft palate;Congenital muscular torticollis;Abnormal vertebral segmentation and fusion;Abnormality of cardiovascular system morphology;Abnormality of limb bone morphology						33	0.98							3.99664e-06	1.0	250210.0	0.0	100	0.99	PASS	amr	2.89402e-05	1.0	0.0	0.0	0.0000064	1						13.0	0.938963		0	0	0			GDF6	0.0	0.0	0.0	0.0	-2.0	-1.0	-2.0	-1.0							0.91	68.127342715			mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; vision/eye phenotype; skeleton phenotype; growth/size/body region phenotype; craniofacial phenotype; 			.	TGF-beta signaling pathway	apoptotic process;regulation of signaling receptor activity;positive regulation of pathway-restricted SMAD protein phosphorylation;BMP signaling pathway;positive regulation of chondrocyte differentiation;activin receptor signaling pathway;regulation of apoptotic process;regulation of MAPK cascade;fat cell differentiation;positive regulation of neuron differentiation;positive regulation of transcription, DNA-templated;cell development;pathway-restricted SMAD protein phosphorylation;SMAD protein signal transduction;positive regulation of p38MAPK cascade;retinal cell apoptotic process	extracellular space	cytokine activity;transforming growth factor beta receptor binding;growth factor activity;protein homodimerization activity	TNFAIP6[18586671];
12991	chr8	100791158	G	A	chr8:100791158	VPS13B	vacuolar protein sorting 13 homolog B	0.0	SNV	0/1	0.42	14_10	24	99	False	rs111751379	EXONIC	YES	NM_017890.5	Transcript	protein_coding	missense_variant		42/62	NM_017890.5:c.7753G>A	NP_060360.3:p.Glu2585Lys		1.0	.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Retinitis_pigmentosa|Cohen_syndrome|History_of_neurodevelopmental_disorder|not_specified|not_provided	Cohen syndrome, 216550 (3), Autosomal recessive	Cohen syndrome	Disease-causing germline mutation(s) in	Myopia;Intrauterine growth retardation;Kyphosis;Prominent nasal bridge;Iris coloboma;Sandal gap;Gingival overgrowth;Microcephaly;Aplasia/Hypoplasia of the earlobes;Clinodactyly of the 5th finger;Narrow palm;Micrognathia;Nystagmus;Joint hyperflexibility;Cat cry;Chorioretinal dystrophy;Tapered finger;Abnormality of retinal pigmentation;Muscular hypotonia;Neutropenia;Abnormality of skin pigmentation;Hypoplasia of the zygomatic bone;Pectus excavatum;Reduced number of teeth;Neurological speech impairment;Cryptorchidism;Arachnodactyly;Finger syndactyly;Failure to thrive in infancy;High, narrow palate;Macrodontia;Scoliosis;Thick eyebrow;Preauricular skin tag;Hypoplasia of the maxilla;Obesity;Short philtrum;Mitral valve prolapse;Short stature;Open mouth;Feeding difficulties in infancy;Optic atrophy;Weak cry;Aplasia/Hypoplasia of the tongue;Genu valgum;Downslanted palpebral fissures;Intellectual disability;Slender toe;Long eyelashes;Cubitus valgus;Delayed puberty;Ventricular septal defect;Abnormality of the hip bone;Seizure;Low anterior hairline;Microphthalmia;Sensorineural hearing impairment;Strabismus;Global developmental delay;Thick hair;Decreased fetal movement;Joint hypermobility;Pes planus;Convex nasal ridge;Mitral valve prolapse;Microcephaly;Short metatarsal;Bone spicule pigmentation of the retina;Single transverse palmar crease;Visual impairment;Short metacarpal;Neutropenia;Lumbar hyperlordosis;Downslanted palpebral fissures;Narrow palm;Thick corpus callosum;Hypoplasia of the maxilla;Feeding difficulties in infancy;Seizure;Growth hormone deficiency;Neonatal hypotonia;Childhood-onset truncal obesity;Open mouth;Optic atrophy;Chorioretinal dystrophy;Autosomal recessive inheritance;Prominent nasal bridge;Thoracic scoliosis;Micrognathia;Cubitus valgus;Short stature;Reduced visual acuity;Cerebellar hypoplasia;Intellectual disability;Bull's eye maculopathy;Myopia;High, narrow palate;Nyctalopia;Motor delay;Tapered finger;Laryngomalacia;Delayed puberty;Facial hypotonia;Generalized hypotonia;Short philtrum;Macrodontia of permanent maxillary central incisor;Narrow palm;Thick eyebrow;Genu valgum;Small for gestational age;Leukopenia	25741868,23757202	0.00304938	464.0	152162.0	4.0	32	0.97	PASS	nfe	0.00501249	341.0	0.00501249	341.0	0.00326006	818.0	250916.0	3.0	95	1.0	PASS	nfe	0.00546144	619.0	0.00546144	619.0	0.0032218	501	0.006	20.0	0.00631	72.0		13.99	1.086033	0.032	3	16	19	MutationAssessor_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	VPS13B	0.0	0.0	0.0	0.0	-4.0	-37.0	-4.0	20.0						0.933	0.0	0.0	0.342	0.169	.			pons;ciliary ganglion;appendix;subthalamic nucleus;dorsal root ganglion;cingulate cortex;trigeminal ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;	.	protein transport	.	.	TGOLN2[29568061];HSPA8[30021884];DNAJC7[26496610];HIST3H3[30021884];CSNK1E[23455922];HIST1H1A[30021884];BET1[29568061];
13107	chr9	103014608	G	A	chr9:103014608	INVS	inversin	0.0	SNV	0/1	0.35	20_11	31	99	False	rs140255233	EXONIC	YES	NM_014425.5	Transcript	protein_coding	synonymous_variant		9/17	NM_014425.5:c.1122G>A	NP_055240.2:p.Lys374%3D		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Nephronophthisis|not_provided	Nephronophthisis 2, infantile, 602088 (3), Autosomal recessive	Senior-Loken syndrome;Infantile nephronophthisis	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hyperkalemia;Autosomal recessive inheritance;Renal cortical microcysts;Hypertension;Enlarged kidney;Elevated serum creatinine;Pulmonary hypoplasia;Nephronophthisis;Absence of renal corticomedullary differentiation;Respiratory failure;Hyperkalemic metabolic acidosis;Pulmonary insufficiency;Hyperechogenic kidneys;Stage 5 chronic kidney disease;Situs inversus totalis;Respiratory insufficiency;Chronic tubulointerstitial nephritis;Oligohydramnios;Progressive visual loss;Premature ovarian insufficiency;Nephronophthisis;Hypertension;Short stature;Global developmental delay;Cone-shaped epiphysis;Abnormality of retinal pigmentation;Retinal dystrophy;Cataract;Abnormality of bone mineral density;Ataxia;Congenital hepatic fibrosis;Stage 5 chronic kidney disease		0.000256289	39.0	152172.0	0.0	33	0.97	PASS	nfe	0.000338036	23.0	0.000338036	23.0	0.000151216	38.0	251296.0	0.0	100	1.0	PASS	nfe	0.00022009	25.0	0.00022009	25.0	0.0001543	24	0.0	1.0	0.00053	6.0		11.56	0.750209		0	0	0			INVS	0.0	0.0	0.0	0.0	29.0	-43.0	-17.0	24.0						0.912	0.0	81.44282213			liver/biliary system phenotype; respiratory system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); digestive/alimentary phenotype; renal/urinary system phenotype; cellular phenotype; immune system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; 			ciliary ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;	.	multicellular organism development;Wnt signaling pathway;negative regulation of canonical Wnt signaling pathway	nucleus;cytoplasm;spindle;microtubule;cilium;membrane	protein binding;calmodulin binding	ZNF512B[15231748];DDB1[22863007];TTC30B[21602787];TRAF3IP2[27173435;unassigned1312];CHCHD6[27173435;unassigned1312];PINX1[17353931];NPHP4[26638075];B9D1[26638075];HIF1AN[16189514;27173435;unassigned1312];B9D2[21602787];CALM1[21602787];
13792	chr13	21148610	T	C	chr13:21148610	IFT88	intraflagellar transport 88	9.0	SNV	0/1	0.49	18_18	37	99	False	rs201009750	EXONIC	YES	NM_001318493.2	Transcript	protein_coding	missense_variant		3/27	NM_001318493.2:c.113T>C	NP_001305422.1:p.Ile38Thr		1.0	.,.,.					Retinitis pigmentosa	Disease-causing germline mutation(s) in	Hyperinsulinemia;Optic atrophy;Nystagmus;Abnormal retinal vascular morphology;Obesity;Hypoplasia of penis;Cataract;Abnormality of retinal pigmentation;Keratoconus;Progressive night blindness;Ophthalmoplegia;Abnormal testis morphology;Atypical scarring of skin;Hyperreflexia;Sensorineural hearing impairment;Blindness;Type II diabetes mellitus;Conductive hearing impairment;Photophobia;Intellectual disability;Anteverted nares;Abnormal electroretinogram;Wide nasal bridge;Hypogonadism;Glaucoma		0.000229958	35.0	152202.0	0.0	32	0.97	PASS	amr	0.00170157	26.0	5.87907e-05	4.0	0.000440735	109.0	247314.0	1.0	31	0.76	PASS	amr	0.00233295	78.0	0.000195757	22.0	0.0004887	76	0.005	16.0	0.00504	48.0		13.38	0.992892	0.018	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	IFT88	0.0	0.0	0.0	0.0	1.0	5.0	4.0	-4.0						0.635	0.0	0.0	0.982	0.125	respiratory system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; skeleton phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; 			ciliary ganglion;pons;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;skeletal muscle;	.	kidney development;intraciliary transport involved in cilium assembly;inner ear receptor cell stereocilium organization;cilium assembly;regulation of cilium assembly;non-motile cilium assembly;regulation of autophagosome assembly	centrosome;centriole;cilium;intraciliary transport particle B;motile cilium;ciliary basal body;sperm flagellum;ciliary tip;ciliary base;non-motile cilium	protein binding;kinesin binding	TTC26[27173435;unassigned1312];CCDC120[unassigned1304];TRAF3IP1[27173435;unassigned1312];IFT172[27173435;unassigned1312];SMC6[26496610];ENO1[27173435];PHB2[27173435];HSPB11[27173435;unassigned1312];IFT52[27173435;unassigned1312];CASP14[27173435];CAPN7[unassigned1304];IFT57[27173435;unassigned1312];TGM3[27173435];UNC45A[27173435];PRMT5[27173435];HSP90AA1[27173435];TBCCD1[20168327];TUBB[27173435];CSNK2A2[26496610];IFT80[27173435;unassigned1312];EML2[unassigned1304];WDR77[27173435];ITPKB[unassigned1304];IFT88[27173435];AZGP1[27173435];PPM1B[27173435];IFT81[27173435;unassigned1312];IFT46[27173435;unassigned1312];SLC25A5[27173435];VCP[27173435];SERPINB12[27173435];CDKN2AIP[26496610];CIAO1[27173435];HSPD1[27173435];IFT74[27173435;unassigned1312];EEF2KMT[unassigned1304];SMNDC1[17353931];EIF4B[27173435];CCT4[27173435];SMARCE1[unassigned1304];HSPA5[27173435];LCA5[26638075];EEF2[27173435];DNAJC16[27173435];ZWINT[26496610];PRRC2A[14667819];IFT20[27173435;unassigned1312];ICK[unassigned1312];IFT22[27173435;unassigned1312];PC[27173435];TTC30B[27173435;unassigned1312];TTC30A[27173435;unassigned1312];IFT27[27173435;unassigned1312];CLUAP1[27173435;unassigned1312];HSPA1A[27173435];MSRB1[unassigned1304];
15619	chr11	118427727	G	A	chr11:118427727	IFT46	intraflagellar transport 46	22.0	SNV	0/1	0.53	17_19	36	99	False	rs142901726,COSV50593959	EXONIC	YES	NM_020153.4	Transcript	protein_coding	missense_variant		5/13	NM_020153.4:c.232C>T	NP_064538.3:p.Arg78Trp		-1.0	.,.,.,.,.,.,.,.					.	.	.		0.00320294	487.0	152048.0	1.0	32	0.96	PASS	sas	0.00703934	34.0	0.00405763	276.0	0.00345243	853.0	247072.0	6.0	29	0.83	PASS	sas	0.00735052	223.0	0.00353584	391.0	0.0033118	515	0.005	16.0				19.37	1.953727	0.207	1	18	19	fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	IFT46	0.0	0.01	0.0	0.0	30.0	33.0	-11.0	-17.0							0.95	0.0	0.617	-0.121	nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			pons;superior cervical ganglion;trigeminal ganglion;atrioventricular node;cingulate cortex;globus pallidus;	.	smoothened signaling pathway;biological_process;intraciliary transport involved in cilium assembly;intraciliary transport;protein stabilization;cilium assembly	cytoplasm;centrosome;cilium;intraciliary transport particle B;motile cilium;ciliary basal body;ciliary tip	molecular_function;protein C-terminus binding	TTC26[27173435;unassigned1312];DGKE[27173435;unassigned1312];IFT172[27173435;unassigned1312];LCA5[26638075];IFT80[27173435;unassigned1312];HSPB11[27173435;unassigned1312];CEP128[26638075];IFT20[27173435;unassigned1312];IFT74[27173435;unassigned1312];IFT52[27173435;unassigned1312];IFT22[27173435;unassigned1312];IFT88[27173435;unassigned1312];TTC30B[27173435;unassigned1312];IFT81[27173435;unassigned1312];TTC30A[27173435;unassigned1312];IFT27[27173435;unassigned1312];PRPF31[27173435;unassigned1312];IFT57[unassigned1312];CLUAP1[unassigned1312];
17715	chr17	18023568	T	C	chr17:18023568	MYO15A	myosin XVA	79.0	SNV	0/1	0.44	19_15	34	99	False	rs200532919,CM1513016	EXONIC	YES	NM_016239.4	Transcript	protein_coding	missense_variant		2/66	NM_016239.4:c.1454T>C	NP_057323.3:p.Val485Ala		1.0	.,.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Cleft_palate|Low-set_ears|Agenesis_of_maxillary_lateral_incisor|Global_developmental_delay|Congenital_diaphragmatic_hernia|Seizure|Low_posterior_hairline|Infantile_axial_hypotonia|Severe_global_developmental_delay|Profound_global_developmental_delay|Deafness,_autosomal_recessive_3|not_specified|not_provided	Deafness, autosomal recessive 3, 600316 (3), Autosomal recessive	Autosomal recessive non-syndromic sensorineural deafness type DFNB	Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Profound sensorineural hearing impairment	24033266,26445815	0.000900333	137.0	152166.0	1.0	33	0.99	PASS	amr	0.002028	31.0	0.00102926	70.0	0.00102566	254.0	247646.0	2.0	60	0.99	PASS	sas	0.0016999	52.0	0.000990647	111.0	0.0008553	133	0.001	2.0	0.0007	8.0		25.6	3.660639	0.255	8	12	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	MYO15A	0.0	0.0	0.0	0.01	23.0	-1.0	28.0	-2.0						0.0478		0.0	1.0	1.029	vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	sensory perception of sound;locomotory behavior;inner ear morphogenesis	cytoplasm;myosin complex;stereocilium;extracellular exosome	motor activity;actin binding;calmodulin binding;ATP binding	EPS8[16169070];USP13[16169070];HSF4[25036637];FASLG[19807924];
19159	chr20	34079058	G	T	chr20:34079058	CEP250	centrosomal protein 250	108.0	SNV	0/1	0.5	16_17	34	99	False	rs145916875,COSV100698855	EXONIC	YES	NM_007186.6	Transcript	protein_coding	missense_variant		22/35	NM_007186.6:c.2775G>T	NP_009117.2:p.Lys925Asn		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Cone-rod dystrophy and hearing loss 2, 618358 (3), Autosomal recessive	.	.	Sensorineural hearing impairment;Photophobia;Autosomal recessive inheritance		0.000887189	135.0	152166.0	0.0	31	0.96	PASS	amr	0.00248724	38.0	0.00123486	84.0	0.000819745	202.0	246418.0	1.0	49	0.79	PASS	amr	0.00249004	85.0	0.000942532	105.0	0.0009003	140	0.007	23.0				15.63	1.383952	0.054	3	16	19	LRT_pred,MutationAssessor_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	CEP250	0.0	0.0	0.0	0.0	-14.0	-45.0	6.0	1.0						0.939	0.0	0.0	1.0	0.223	.			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;cingulate cortex;atrioventricular node;parietal lobe;skeletal muscle;	.	G2/M transition of mitotic cell cycle;mitotic cell cycle;protein localization;regulation of G2/M transition of mitotic cell cycle;centriole-centriole cohesion;regulation of centriole-centriole cohesion;protein localization to organelle;ciliary basal body-plasma membrane docking;positive regulation of protein localization to centrosome;non-motile cilium assembly	centrosome;centriole;microtubule organizing center;cytosol;cilium;protein-containing complex;perinuclear region of cytoplasm;extracellular exosome	protein binding;protein C-terminus binding;protein kinase binding;protein domain specific binding	ATF7IP[15231748];ATP5IF1[30021884];PSMD6[17353931];ATP5F1B[30021884];CEP152[26297806];CANX[30021884];SASS6[15665853];PLEKHA5[20936779];MYH9[26496610];SIK2[20708153];YWHAZ[20618440];YWHAH[17979178];
22631	chr14	51245511	C	A	chr14:51245511	NIN	ninein	194.0	SNV	0/1	0.58	10_14	24	99	False	rs547438612	EXONIC	YES	NM_020921.4	Transcript	protein_coding	synonymous_variant		6/31	NM_020921.4:c.447G>T	NP_065972.4:p.Thr149%3D		-1.0					?Seckel syndrome 7, 614851 (3), Autosomal recessive	Microcephalic primordial dwarfism, Dauber type	Disease-causing germline mutation(s) in	Hip dysplasia;Madelung deformity;Prominent nose;Obesity;Delayed skeletal maturation;Microcephaly;Severe postnatal growth retardation;Primary amenorrhea;Microtia;Abnormality of the carpal bones;Clinodactyly of the 5th finger;Short middle phalanx of the 5th finger;Seizure;Lumbar scoliosis;Global developmental delay;Severe intrauterine growth retardation;Hypotelorism;Short stature;Bilateral breast hypoplasia;Subglottic stenosis;Limb undergrowth;Intellectual disability, severe;Autosomal recessive inheritance;Abnormality of the carpal bones;Intellectual disability, severe;Microcephaly;Seizure;Hypoplasia of the uterus;Hypotelorism;Hip dysplasia;Microtia;Primary amenorrhea;Prominent nose;Severe global developmental delay;Clinodactyly;Intrauterine growth retardation;Central hypothyroidism;Lumbar scoliosis;Madelung deformity;Delayed skeletal maturation;Severe short stature	25741868	6.57402e-06	1.0	152114.0	0.0	32	0.96	PASS	nfe	1.46994e-05	1.0	1.46994e-05	1.0	3.97652e-06	1.0	251476.0	0.0	81	1.0	PASS	sas	3.26627e-05	1.0	0.0	0.0	0.0000064	1						2.963	0.021856		0	0	0			NIN	0.0	0.0	0.0	0.0	2.0	11.0	-7.0	-28.0						0.943	0.0	17.006969425			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	.	protein localization;centriole-centriole cohesion;corpus callosum morphogenesis;corticospinal tract morphogenesis;positive regulation of microtubule polymerization;microtubule anchoring at centrosome;collateral sprouting;positive regulation of axonogenesis;centrosome localization;centrosome-templated microtubule nucleation	pericentriolar material;spindle pole;nucleus;nucleolus;centrosome;centriole;plasma membrane;dendrite;microtubule minus-end;axonal growth cone;apical part of cell;mitotic spindle;mitotic spindle pole;ciliary transition fiber;centriolar subdistal appendage	calcium ion binding;protein binding;GTP binding;kinase binding	GPATCH1[26638075];WDR83[26638075];TTF2[26638075];AMOT[19615732];CEP128[26638075];EIF4ENIF1[26638075];CSPP1[26638075];PMPCB[26638075];HMGN3[26638075];RAB2A[26638075];CEP131[26638075];ECH1[26638075];DYNC1LI1[26638075];DYNC1LI2[26638075];TXLNA[26638075];MAP7D3[26638075];TP53[26638075];SNU13[26638075];HMMR[26638075];CCNB2[26638075];CCNB1[26638075];DHX35[26638075];MYH13[26496610];TP53BP2[26638075];ISOC1[26638075];CEP192[26638075];PIBF1[26638075];FAM83B[26638075];CARMIL2[26638075];CCDC138[26638075];CEP350[26638075];PLK1[26638075];RASSF8[26638075];ANLN[26638075];DIAPH3[26638075];ARPC3[26638075];FGFR1OP[26638075];CC2D1A[26638075];GSK3B[11004522;15147888;17139249];CEP164[26638075];KIAA1671[26638075];KIF14[26638075];BICD1[17139249];TTC28[26638075];TCHP[26638075];PCM1[26638075];ACTR1A[26638075];DBT[26638075];CNTRL[26638075];CEP170[26638075];ERC1[26638075];HIST1H1A[30021884];ARFGEF3[26638075];YWHAH[26638075];UNC45A[26638075];IQCB1[26638075];OFD1[26638075];UPF1[26638075];ACTR2[26638075];AXIN1[19390532];CKAP2[26638075];HAUS4[26638075];HAUS3[26638075];HAUS6[26638075];HAUS5[26638075];HAUS1[26638075];POC5[26638075];PALLD[26638075];NME7[26638075];SSX2IP[26638075];DYNC1I2[26638075];CAMK2D[26638075];AHCY[26638075];DCTN2[26638075];LUZP1[26638075];DCTN1[26638075];DOT1L[26496610];TTK[26638075];HECTD1[26638075];HAUS8[26638075];HAUS7[26638075];ENTR1[26638075];CLASP1[26638075];RTRAF[15147888];CLASP2[26638075];DYNC1H1[26638075];SVIL[26638075];CSNK1A1[26638075];MGA[26638075];NCKAP5L[26638075];AP3D1[26638075];SAMD4B[26638075];BAIAP2[26638075];TJP1[26638075];CENPE[26638075];NEDD1[26638075];ABI1[15048123];BAX[26496610];SPC24[26638075];TNRC6B[26638075];
23145	chr17	4619819		G	chr17:4619818-4619819	ARRB2	arrestin beta 2	212.0	insertion	0/1	0.14	18_3	22	63	False	rs1332076577	EXONIC	YES	NM_001257328.2	Transcript	protein_coding	frameshift_variant		5/15	NM_001257328.2:c.273dup	NP_001244257.1:p.Pro92AlafsTer36		1.0						.	.	.		0.000123894	18.0	145286.0	0.0	31	0.92	AS_VQSR	eas	0.00178971	8.0	1.51943e-05	1.0	0.0	0.0	247032.0	0.0	46	0.95	AC0_RF				0.0	0.0											0	0	0			ARRB2	0.01	0.0	0.0	0.01	35.0	-13.0	-33.0	-2.0						0.575	0.77	9.470233251			mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; 			white blood cells;whole blood;bone marrow;	MAPK signaling pathway;Olfactory transduction	negative regulation of protein phosphorylation;G protein-coupled receptor internalization;desensitization of G protein-coupled receptor signaling pathway by arrestin;positive regulation of receptor internalization;transcription by RNA polymerase II;transforming growth factor beta receptor signaling pathway;G protein-coupled receptor signaling pathway;dopamine receptor signaling pathway;brain development;adult walking behavior;positive regulation of gene expression;protein transport;protein ubiquitination;protein deubiquitination;platelet activation;negative regulation of protein ubiquitination;positive regulation of protein ubiquitination;receptor internalization;negative regulation of NF-kappaB transcription factor activity;positive regulation of synaptic transmission, dopaminergic;negative regulation of interleukin-1 beta production;negative regulation of interleukin-12 production;negative regulation of interleukin-6 production;negative regulation of tumor necrosis factor production;positive regulation of collagen biosynthetic process;positive regulation of peptidyl-serine phosphorylation;negative regulation of toll-like receptor signaling pathway;negative regulation of GTPase activity;negative regulation of smooth muscle cell apoptotic process;follicle-stimulating hormone signaling pathway;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;proteasome-mediated ubiquitin-dependent protein catabolic process;negative regulation of neuron apoptotic process;negative regulation of natural killer cell mediated cytotoxicity;positive regulation of peptidyl-tyrosine phosphorylation;detection of temperature stimulus involved in sensory perception of pain;positive regulation of protein kinase B signaling;negative regulation of protein kinase B signaling;positive regulation of calcium ion transport;Wnt signaling pathway, planar cell polarity pathway;excitatory postsynaptic potential;cell chemotaxis;regulation of androgen receptor signaling pathway;membrane organization;positive regulation of ERK1 and ERK2 cascade;negative regulation of release of cytochrome c from mitochondria;positive regulation of epithelial cell apoptotic process;positive regulation of DNA biosynthetic process;positive regulation of cardiac muscle cell differentiation	nucleus;cytoplasm;endosome;cytosol;plasma membrane;clathrin-coated pit;postsynaptic density;basolateral plasma membrane;endocytic vesicle;cytoplasmic vesicle;dendritic spine;intracellular membrane-bounded organelle;postsynaptic membrane	G protein-coupled receptor binding;signaling receptor binding;protein binding;enzyme binding;protein domain specific binding;ubiquitin protein ligase binding;alpha-1A adrenergic receptor binding;alpha-1B adrenergic receptor binding;angiotensin receptor binding;type 1 angiotensin receptor binding;D1 dopamine receptor binding;follicle-stimulating hormone receptor binding;type 2A serotonin receptor binding;platelet activating factor receptor binding;protein-containing complex scaffold activity;identical protein binding;protein kinase B binding;protein-containing complex binding;mitogen-activated protein kinase binding;14-3-3 protein binding;arrestin family protein binding	RPL4[17620599];RPL30[17620599];RPL3[17620599];RPL31[17620599];ARPC5L[17620599];HNRNPU[17620599];HNRNPR[17620599];CSN2[17620599];ARR3[17620599];RXFP1[20664520];RPL6[17620599];ACTB[17620599];RPL7[17620599];RPS17[17620599];EDNRA[19202075];RPS19[17620599];SNRPD2[17620599];TRIM28[17620599];PPP2R1A[17620599];SNRPD1[17620599];AKT2[19122674];CPNE1[17620599];RPL36[17620599];RPL35[17620599];AKT1[19122674];VPS35[17620599];BSN[17620599];RPS13[17620599];TMPO[17620599];SRRM2[17620599];SMARCC2[16169070];CSNK2A1[17620599];RPL21[17620599];RPL22[17620599];MED8[16169070];PHKA2[17620599];WDR77[17620599];MYL6[17620599];CLNS1A[17620599];MAP1B[17620599];BOLA2[17620599];AGTR1[28298427];RPL26[17620599];RPL28[17620599];UBA52[17620599];RPN2[17620599];SDC3[17620599];NOLC1[17353931;17620599];HTATSF1[17620599];STC2[16169070];EPB41L3[17620599];RBM10[17620599];SPTBN1[17620599];RAB11FIP5[17620599];SRPK2[17620599];XRCC6[17620599];ZRANB2[17620599];XRCC5[17620599];INSR[19122674];EIF2AK4[17620599];CCT6A[17620599];HNRNPM[17620599];HNRNPK[17620599];FASN[17620599];HNRNPF[17620599];HNRNPD[17620599];HNRNPC[17620599];CALM1[17620599];CDK13[17620599];RPLP1[17620599];SPIN3[17620599];RPLP0[17620599];CLTB[17620599];HIST2H2AB[17620599];CLTA[17620599];AP2A1[17620599];AP2A2[17620599];TUBA1C[17620599];TUBA1A[17620599];C1QBP[17620599];DHX15[17620599];SPIN1[17620599];RPLP2[17620599];SPTAN1[17620599];CLIC1[17620599];NINL[26638075];PRMT5[17620599];ANXA2[17620599];PRMT1[17620599];PABPC4[17620599];NSUN2[17620599];AP3B1[17353931];AP3B2[17620599];MRPL43[17353931];MRPL44[17353931];TUBB2A[17620599];CTTN[17620599;25241761];HNRNPH1[17620599];PABPC3[17620599];HNRNPH2[17620599];PABPC1[17620599];DBN1[17620599];ARHGEF6[17620599];ENG[22940691];SF3B2[17620599];SF3B3[17620599];WDR26[17620599];SPINDOC[17620599];RPL12[17620599];PTGER2[24069330];RPL11[17620599];EGFR[24658140];LIMA1[17620599];BCLAF1[17620599];TUBA3C[17620599];TCOF1[17353931;17620599];PES1[17353931];TWISTNB[17620599];CTNNA1[17620599;25241761];RPS3[17620599];RPL14[17620599];LEO1[17620599];FLNA[17620599];RPL15[17620599];RPS27A[17620599];RPL18[17620599];SF3B1[17620599];PAK5[17620599];NKTR[17620599];RPL19[17620599];DYNC1H1[17620599];NPM1[17620599];GSN[17620599];MAP3K1[17620599;25241761];HSPA1L[17620599];STAT1[17620599];IGKV1-5[17620599];AP3D1[17620599];RPA1[17620599];AP2B1[17620599];GPR3[24069330];TUBB4B[17620599];TUBB4A[17620599];HIPK3[15231748];BOP1[17353931];CENPF[17620599];CAPZA1[17620599];NEDD4[23208550];HNRNPA2B1[17620599];CAPZA2[17620599];SERBP1[17620599];HSPA1A[17620599];DGKE[17620599];CHRM1[24069330];CTNND1[17620599];ACTG2[17620599];EFTUD2[17620599];FBL[17353931;17620599];POTEKP[17620599];TUBB3[17620599];CFL1[17620599;17500066];KPNA4[17353931];CAPN1[17620599];KPNA3[17353931];MAP3K7[17620599];MAP3K5[19782076];MAP2K4[19782076];RPS7[17620599];RPS8[17620599];TMOD3[17620599];RPS6[17620599];PRPF4B[17620599];SDHA[17620599];DGKZ[17620599];TUBA4A[17620599];EEF1A1[17620599];ILF3[17620599];SMO[23877428];DKC1[17620599];HGS[23208550];RPL7L1[17353931];NCL[17620599];EEF1A2[17620599];ERH[17620599];HDGFL2[17620599];PPIA[17620599];S100A9[17620599];KPNB1[17620599];DDX5[17620599];VCP[17620599];RAB5C[17353931];PFKFB3[17620599];CUL5[17620599];DDX1[17620599];ANKRD11[26496610];ARHGAP17[17620599];ADRB1[18787115];ADRB2[23208550;24658140;17148612];ARHGAP21[17620599];UBB[17620599];KIF3A[23877428];UBR5[17620599];STK38[17620599];UBC[17620599];G3BP2[17620599];H1FX[17620599];DRD2[21256133];MYH10[17620599];HSPA8[17620599];HSPA5[17620599];NONO[17620599];ALYREF[17620599];HSPA6[17620599];EEF2[17620599];COPRS[17620599];MOB1A[17620599];AFDN[17620599];CDK7[17620599];CDK4[17620599];TRPV4[17620599];CDK3[17620599];MDM2[11588219;21988832];TAB1[17620599;25241761];MAP3K14[17620599];NOP10[17620599];TUBA8[17620599];LRP11[17620599];YWHAE[17620599];HSP90AB1[17620599];DDX3X[17620599];YWHAB[17620599];ILK[23877428];ARRB1[17353931;17620599;24069330];YBX1[17620599];ARRB2[17620599;24069330];HTR2A[26158621];PIK3C2A[17620599];YBX3[17620599];SYNE2[26496610];RPS4X[17620599];RPL7A[17620599];PTBP1[17620599];YWHAQ[17620599];CEP170[26638075];HIST1H1A[17620599];LBR[17620599];YWHAG[17620599];SCYL2[17620599];YWHAH[17620599];HIST1H1C[17620599];ARHGEF11[17620599];MYOCD[17620599];PPP1R12A[17620599];ARHGEF12[17620599];DCD[17620599];CHUK[17620599;25241761];PDE4D[17620599;20664520;19955404];H2AFX[17620599];KCNAB1[17620599];RPS3A[17620599];CTPS1[17620599];RANGAP1[17620599];PPM1A[17620599];PPM1B[17620599;25241761];SFPQ[17620599];PKM[17620599];NDUFS7[16169070];ACTBL2[17620599];THRAP3[17620599];POLR1A[17620599];POLR1B[17620599];TRAF6[19955404];POLR1C[17620599];MCM3[17620599];SAG[17620599];MYH9[17620599];GAPDH[17620599];CAMK2D[17620599];HDAC2[17620599];DDX27[17353931];HIST1H2BO[17620599];SRC[19122674;19202075];CDC42[20936779];MAPK9[19060904;25416956;unassigned1304];IGF2BP1[17620599];POLR2E[17620599];MAPK1[17620599;25241761];HNRNPA1[17620599];EIF4B[17620599];HNRNPA0[17620599];MAPK3[25241761];NOP56[17620599];NAA10[17620599];RPL35A[17620599];NAP1L1[17620599];MAPK10[19782076];WEE1[17620599];MYO1C[17620599];ACTC1[17620599];NPHS1[16968782];VIM[17620599];P4HB[17620599];CSNK1A1L[17620599];
27220	chr1	22188289	G	A	chr1:22188289	HSPG2	heparan sulfate proteoglycan 2	280.0	SNV	0/1	0.58	13_18	31	99	False	rs142433309	EXONIC	YES	NM_001291860.2	Transcript	protein_coding	missense_variant		39/97	NM_001291860.2:c.4919C>T	NP_001278789.1:p.Thr1640Met		-1.0	Laminin EGF domain&Laminin EGF domain&Laminin EGF domain&EGF-like calcium-binding domain&Laminin EGF domain&EGF-like domain	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Lethal_Kniest-like_syndrome|Schwartz-Jampel_syndrome|not_specified|not_provided	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive	Schwartz-Jampel syndrome;Dyssegmental dysplasia, Silverman-Handmaker type	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Umbilical hernia;Blue sclerae;Abnormality of the metaphysis;Atrial septal defect;Anisospondyly;Inguinal hernia;Joint stiffness;Disproportionate short-limb short stature;Cleft palate;Micrognathia;Depressed nasal ridge;Bowing of the long bones;Abnormality of pelvic girdle bone morphology;Respiratory insufficiency;Micromelia;Narrow chest;Narrow mouth;Micrognathia;Wide nasal bridge;Anisospondyly;Abnormality of the abdominal wall;Pulmonary hypoplasia;Short long bone;Thoracic hypoplasia;Overgrowth;Neonatal death;Posteriorly rotated ears;Disproportionate short-limb short stature;Autosomal recessive inheritance;Talipes equinovarus;Single umbilical artery;Malar flattening;Flat face;Short long bone;Bowing of the long bones;Cryptorchidism;Calvarial skull defect;Coxa valga;High pitched voice;Decreased testicular size;Anxiety;Scoliosis;Mask-like facies;Sprengel anomaly;Hyporeflexia;Ectopia lentis;Kyphosis;Osteoporosis;Pectus carinatum;Ptosis;Microcephaly;Abnormality of the pharynx;Abnormal eyebrow morphology;Elevated aldolase level;Microcornea;Wrist flexion contracture;Skeletal dysplasia;Short neck;Arrhythmia;Attention deficit hyperactivity disorder;Dysphonia;Increased number of teeth;Abnormality of immune system physiology;Testicular torsion;Micrognathia;Narrow mouth;Abnormality of the metaphysis;Apnea;Cachexia;Cleft palate;Hyperlordosis;Prenatal movement abnormality;Prominent nasal bridge;Visual impairment;Blepharophimosis;Aplasia/Hypoplasia affecting the eye;Abnormality of epiphysis morphology;Abnormality of the ribs;Everted lower lip vermilion;Long eyelashes in irregular rows;Weak voice;Skeletal muscle atrophy;Increased bone mineral density;Coxa vara;High palate;Abnormally ossified vertebrae;Malignant hyperthermia;Myotonia;Arthrogryposis multiplex congenita;Overfolded helix;Hip contracture;Odontogenic neoplasm;Skeletal muscle hypertrophy;Death in infancy;Full cheeks;Dental malocclusion;Metatarsus valgus;Inguinal hernia;Umbilical hernia;Joint stiffness;Polyhydramnios;Pulmonary arterial hypertension;Protrusio acetabuli;Low-set, posteriorly rotated ears;Elevated serum creatine kinase;Laryngomalacia;Abnormality of the ureter;Pectus excavatum;Wormian bones;Muscle weakness;Spinal rigidity;Strabismus;Respiratory insufficiency;Micromelia;Myopia;Hypertelorism;Platyspondyly;EMG abnormality;Intellectual disability;Delayed skeletal maturation;Flexion contracture of toe;Low anterior hairline;Blepharospasm;Pursed lips;Long philtrum;Abnormally straight spine;Flat face;Short stature;Cataract;Talipes equinovarus;Feeding difficulties in infancy;Generalized hirsutism;Genu valgum;Elbow dislocation;Myopathy;Nephrolithiasis;Pes planus;Distichiasis;Hip dysplasia;Gait disturbance;Hypertonia;Irritability;Shoulder flexion contracture;Myalgia;Trismus;Autosomal recessive inheritance;Narrow mouth;Short neck;Decreased testicular size;Anterior bowing of long bones;Coronal cleft vertebrae;Delayed skeletal maturation;Shoulder flexion contracture;Flexion contracture of toe;Low-set ears;Lumbar hyperlordosis;Myopia;Hip contracture;Malar flattening;Congenital hip dislocation;Overfolded helix;Intellectual disability;Weak voice;Pursed lips;Wrist flexion contracture;Pectus carinatum;Pes planus;Myotonia;Platyspondyly;Kyphoscoliosis;Narrow palpebral fissure;Generalized hirsutism;Abnormality of femoral epiphysis;Osteoporosis;Coxa valga;Short stature;Inguinal hernia;Talipes equinovarus;Blepharophimosis;Coxa vara;Hyporeflexia;Skeletal muscle atrophy;Joint contracture of the hand;Metaphyseal widening;Microcornea;Umbilical hernia;Full cheeks;Muscle weakness;High pitched voice;Long eyelashes in irregular rows;Micrognathia;Cataract;Malignant hyperthermia;Flat face;Ptosis;Skeletal muscle hypertrophy	24088041,26633545	0.00170182	259.0	152190.0	1.0	33	0.98	PASS	nfe	0.00270477	184.0	0.00270477	184.0	0.00150434	376.0	249944.0	1.0	94	0.96	PASS	nfe	0.00245952	278.0	0.00245952	278.0	0.0014083	219	0.003	9.0	0.00438	50.0		28.3	4.06769	0.222	14	7	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred	HSPG2	0.0	0.0	0.0	0.0	26.0	47.0	-27.0	-43.0						0.588	0.0	0.0	0.966	1.167	growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype; embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; skeleton phenotype; 			.	ECM-receptor interaction	retinoid metabolic process;angiogenesis;glycosaminoglycan biosynthetic process;glycosaminoglycan catabolic process;lipid metabolic process;receptor-mediated endocytosis;inflammatory response;brain development;negative regulation of angiogenesis;cell differentiation;extracellular matrix organization;cellular protein metabolic process;cardiovascular system development	extracellular region;basement membrane;extracellular space;Golgi lumen;plasma membrane;focal adhesion;lysosomal lumen;collagen-containing extracellular matrix;extracellular exosome;plasma membrane protein complex	amyloid-beta binding;calcium ion binding;protein binding;protein C-terminus binding;extracellular matrix structural constituent conferring compression resistance;low-density lipoprotein particle receptor binding	GRN[12900424;21596751];FLT1[21596751];PYHIN1[25665578];ATN1[16713569];FN1[19738201];CACNA1A[21078624];FGF1[24509440];KIF7[26496610];FGF2[24509440];ESR2[25604459];ADD1[26496610];GFI1B[16713569];PTTG1[26496610];KDR[23374253;21596751];GAR1[26496610];TCAP[23414517];GRB2[19380743];CCDC22[26496610];FGFR3[24509440];FGFR1[24509440];TMPO[26496610];
27338	chr3	53756419	G	A	chr3:53756419	CACNA1D	calcium voltage-gated channel subunit alpha1 D	285.0	SNV	0/1	0.48	17_16	33	99	False	rs1318572063	EXONIC	YES	NM_000720.4	Transcript	protein_coding	synonymous_variant		13/49	NM_000720.4:c.1644G>A	NP_000711.1:p.Leu548%3D		1.0		Uncertain_significance	criteria_provided,_single_submitter	not_provided	Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3), Autosomal dominant; Sinoatrial node dysfunction and deafness, 614896 (3), Autosomal recessive	Sinoatrial node dysfunction and deafness;Primary hyperaldosteronism-seizures-neurological abnormalities syndrome	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in	Bradycardia;Autosomal recessive inheritance;Hearing impairment;Athetosis;Pulmonary arterial hypertension;Second degree atrioventricular block;Nephrolithiasis;Intellectual disability, severe;Adrenal hyperplasia;Hypokalemia;Cerebral palsy;Cerebral visual impairment;Bilateral tonic-clonic seizure;Intracranial hemorrhage;Ventricular hypertrophy;Focal myoclonic seizure;Hypertension;Polydipsia;Nausea;Metabolic alkalosis;Tinnitus;Ventricular septal defect;Headache;Spastic paraplegia;Global developmental delay;Focal impaired awareness seizure;Epistaxis;Abnormal circulating renin;Hyperaldosteronism;EMG: impaired neuromuscular transmission;Caesarian section;Spastic tetraplegia;Hypertension;Left ventricular hypertrophy;Patent foramen ovale;Hypokalemia;Cerebral visual impairment;Nephrolithiasis;Global developmental delay;Metabolic alkalosis;Autosomal dominant inheritance;Ventricular septal defect;Decreased circulating renin level;Cerebral palsy;Bilateral tonic-clonic seizure;Pulmonary arterial hypertension;Athetosis;Biventricular hypertrophy		6.57004e-06	1.0	152206.0	0.0	33	0.98	PASS				0.0	0.0					98	1.0														12.06	0.813802		0	0	0			CACNA1D	0.0	0.0	0.0	0.0	2.0	-42.0	-38.0	0.0						0.0042	1.0	77.817736471			growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			pons;ciliary ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;cingulate cortex;parietal lobe;globus pallidus;	MAPK signaling pathway;Calcium signaling pathway;GnRH signaling pathway;Type II diabetes mellitus	calcium ion transport;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;sensory perception of sound;positive regulation of adenylate cyclase activity;regulation of insulin secretion;positive regulation of calcium ion transport;regulation of atrial cardiac muscle cell membrane repolarization;calcium ion import;calcium ion transmembrane transport;cardiac muscle cell action potential involved in contraction;membrane depolarization during cardiac muscle cell action potential;membrane depolarization during SA node cell action potential;regulation of heart rate by cardiac conduction;induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration;regulation of potassium ion transmembrane transporter activity;regulation of potassium ion transmembrane transport	plasma membrane;voltage-gated calcium channel complex;Z disc;cochlear hair cell ribbon synapse;integral component of presynaptic active zone membrane;L-type voltage-gated calcium channel complex	voltage-gated calcium channel activity;calcium channel activity;high voltage-gated calcium channel activity;ankyrin binding;metal ion binding;alpha-actinin binding;voltage-gated calcium channel activity involved in cardiac muscle cell action potential;voltage-gated calcium channel activity involved SA node cell action potential;voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels	ACTN2[19815520];BRK1[24439376];
29220	chr19	3590105	G	A	chr19:3590105	GIPC3	GIPC PDZ domain containing family member 3	314.0	SNV	0/1	0.37	24_14	38	99	False	rs138339125,COSV59259125	EXONIC	YES	NM_133261.3	Transcript	protein_coding	missense_variant		6/6	NM_133261.3:c.856G>A	NP_573568.1:p.Val286Ile		1.0	.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	not_specified|not_provided	Deafness, autosomal recessive 15, 601869 (3), Autosomal recessive	Autosomal recessive non-syndromic sensorineural deafness type DFNB	Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Prelingual sensorineural hearing impairment	24033266	0.00119558	182.0	152228.0	1.0	33	0.98	PASS	nfe	0.00217538	148.0	0.00217538	148.0	0.00116718	283.0	242464.0	0.0	89	0.75	PASS	nfe	0.00186875	204.0	0.00186875	204.0	0.0011125	173	0.001	4.0	0.00123	14.0		23.4	2.926912	0.236	8	12	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	GIPC3	0.0	0.0	0.01	0.0	6.0	-5.0	6.0	28.0						0.31	0.05	0.0	0.998	1.163	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	.	.	.	.	ST6GAL2[unassigned1304];PLEKHA2[unassigned1304];
29351	chr14	64518634	T	G	chr14:64518634	SYNE2	spectrin repeat containing nuclear envelope protein 2	322.0	SNV	0/1	0.48	16_15	31	99	False	rs143558316,COSV99051109	EXONIC	YES	NM_182914.3	Transcript	protein_coding	missense_variant		48/116	NM_182914.3:c.8003T>G	NP_878918.2:p.Leu2668Trp		1.0	.,.,.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Emery-Dreifuss_muscular_dystrophy_5,_autosomal_dominant	Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3), Autosomal dominant	Autosomal dominant Emery-Dreifuss muscular dystrophy	Disease-causing germline mutation(s) in	Kyphosis;Elbow flexion contracture;Decreased cervical spine flexion due to contractures of posterior cervical muscles;Supraventricular arrhythmia;Ventricular escape rhythm;Myotonia;Absent muscle fiber emerin;Respiratory insufficiency due to muscle weakness;Spinal rigidity;Scoliosis;Hypertrophic cardiomyopathy;Ichthyosis;Vocal cord paralysis;Pectus excavatum;Back pain;EMG: myopathic abnormalities;Increased LDL cholesterol concentration;Scapular winging;Joint stiffness;Proximal lower limb amyotrophy;Atrioventricular block;Rimmed vacuoles;Muscular hypotonia;Achilles tendon contracture;Waddling gait;Type 1 muscle fiber atrophy;Ptosis;Hyperlordosis;Limb-girdle muscular dystrophy;Toe walking;Proximal muscle weakness in lower limbs;Sprengel anomaly;Reduced tendon reflexes;Sudden cardiac death;Proximal upper limb amyotrophy;Obesity;Dilated cardiomyopathy;Lipodystrophy;Elevated serum creatine kinase;Hypertriglyceridemia;Proximal muscle weakness in upper limbs;Cardiomyopathy;Proximal amyotrophy;Proximal muscle weakness;Childhood onset;Muscular dystrophy;Arrhythmia;Autosomal dominant inheritance;Respiratory insufficiency;Elevated serum creatine kinase		0.000506006	77.0	152172.0	0.0	32	0.97	PASS	nfe	0.000955601	65.0	0.000955601	65.0	0.000276104	68.0	246284.0	0.0	100	0.99	PASS	nfe	0.000523135	58.0	0.000523135	58.0	0.0003858	60	0.0	1.0				10.09	0.574647	0.033	1	18	19	M-CAP_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SYNE2	0.0	0.0	0.0	0.0	26.0	47.0	16.0	-26.0						0.852	0.0	0.0	0.431	0.2	cellular phenotype; muscle phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); respiratory system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			ciliary ganglion;pons;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skin;skeletal muscle;	.	nuclear migration;centriole-centriole cohesion;nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration;positive regulation of cell migration;nuclear migration along microfilament;centrosome localization;cytoskeletal anchoring at nuclear membrane;regulation of cilium assembly	nucleus;nuclear envelope;nuclear outer membrane;nucleoplasm;cytoplasm;mitochondrion;centrosome;focal adhesion;integral component of membrane;aggresome;sarcoplasmic reticulum;Z disc;lamellipodium membrane;filopodium membrane;nuclear membrane;nuclear lumen;sarcoplasmic reticulum membrane;meiotic nuclear membrane microtubule tethering complex;intermediate filament cytoskeleton;extracellular exosome	actin binding;protein binding;actin filament binding	RNASEH2B[26496610];STXBP3[30021884];PRKDC[30021884];FHOD1[24880667];HDAC11[23752268];ARRB2[26496610];MEOX2[unassigned1304];MESD[30021884];RPL7A[30021884];HIF1AN[26972000];EMD[17462627];APPL1[23414517];TBC1D16[26496610];BRAP[25820252];SUN2[22632968;19933576;22555292];SUN1[22632968];JUN[25609649];MORC3[26496610];NPM1[30021884];HSPA5[30021884];SLX4IP[19596235];COL23A1[30021884];MAPK8IP2[21900206];SUPT5H[26496610];SOD1[26496610];PRPF4[26496610];MTNR1B[26514267];CDC37[25036637];ABI1[23414517];S100A4[26496610];BCAR1[28007913];
29537	chr11	59540763	C	T	chr11:59540763	STX3	syntaxin 3	328.0	SNV	0/1	0.55	10_12	22	99	False		EXONIC	YES	NM_004177.5	Transcript	protein_coding	missense_variant		2/11	NM_004177.5:c.110C>T	NP_004168.1:p.Ser37Phe		1.0	Syntaxin, N-terminal domain&Syntaxin, N-terminal domain&Syntaxin, N-terminal domain,Syntaxin, N-terminal domain&Syntaxin, N-terminal domain&Syntaxin, N-terminal domain,Syntaxin, N-terminal domain&Syntaxin, N-terminal domain&Syntaxin, N-terminal domain,.				Retinal dystrophy and microvillus inclusion disease, 619446 (3), Autosomal recessive; Diarrhea 12, with microvillus atrophy, 619445 (3), Autosomal recessive	Microvillus inclusion disease	Disease-causing germline mutation(s) (loss of function) in	Diarrhea;Dehydration;Hypovolemia;Metabolic acidosis;Abdominal distention;Abnormal renal physiology;Global developmental delay;Pruritus;Nephrocalcinosis;Villous atrophy						31	0.97											85	1.0														25.0	3.502676	0.281	6	15	21	SIFT,PolyPhen,MutationAssessor_pred,MutationTaster_pred,ClinPred_pred,LIST-S2_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	STX3	0.0	0.0	0.0	0.0	-7.0	3.0	4.0	1.0						0.429	0.63	83.430448619	0.999	0.938	adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			superior cervical ganglion;trigeminal ganglion;placenta;	SNARE interactions in vesicular transport	intracellular protein transport;exocytosis;vesicle fusion;positive regulation of cell population proliferation;synaptic vesicle docking;cytokine-mediated signaling pathway;neuron projection development;synaptic vesicle fusion to presynaptic active zone membrane;positive regulation of cell adhesion;vesicle docking;positive regulation of chemotaxis;long-term synaptic potentiation;exocytic insertion of neurotransmitter receptor to postsynaptic membrane;positive regulation of protein localization to plasma membrane;positive regulation of protein localization to cell surface	vacuole;plasma membrane;cell-cell junction;synaptic vesicle;endomembrane system;integral component of membrane;apical plasma membrane;lamellipodium;dendrite;growth cone;SNARE complex;melanosome;specific granule;azurophil granule;zymogen granule membrane;presynaptic membrane;neuron projection;presynaptic active zone membrane;extracellular exosome;Schaffer collateral - CA1 synapse;postsynapse;glutamatergic synapse	SNARE binding;SNAP receptor activity;protein binding;arachidonic acid binding	ZFYVE9[17693260];SNAP23[26359495];AQP6[unassigned1304];MSMO1[unassigned1304];SIN3B[26496610];CREB3L1[unassigned1304];CHORDC1[26496610];ZNF526[26496610];SNAP29[unassigned1304];JAGN1[unassigned1304];ELOVL4[unassigned1304];NCBP2[26496610];MMGT1[unassigned1304];SLC35C2[unassigned1304];GPX8[unassigned1304];THOC2[26496610];ZDHHC15[unassigned1304];MSH6[26496610];DNAJC5[29997244];ERGIC3[unassigned1304];PPIA[26496610];LLGL1[26496610];STX1A[unassigned1304];NAPB[25416956;unassigned1304];MGST3[unassigned1304];MTIF3[unassigned1304];SAMHD1[26496610];KRBOX4[26496610];FGD1[26496610];CPLX4[unassigned1304];PIK3R6[30021884];CDC42[26496610];GPR152[unassigned1304];CD79A[unassigned1304];G3BP1[26496610];GAR1[26496610];STX5[unassigned1304];STX4[25416956;unassigned1304];SCN3B[unassigned1304];STX2[unassigned1304];UGGT1[26496610];MAP3K2[26496610];MYEF2[26496610];LAMB3[26496610];TMEM132A[26496610];YIPF5[26496610];RMDN3[unassigned1304];COQ9[unassigned1304];FAM209A[unassigned1304];ZWINT[26496610];MANBAL[unassigned1304];PLEKHA7[28877994];FBXO31[26496610];MFSD14B[unassigned1304];FXYD3[unassigned1304];REEP4[unassigned1304];EBAG9[unassigned1304];CYB561[unassigned1304];
29564	chr3	49698524	C	T	chr3:49698524	BSN	bassoon presynaptic cytomatrix protein	330.0	SNV	0/1	0.53	9_10	19	99	False	rs148698248	EXONIC	YES	NM_003458.4	Transcript	protein_coding	synonymous_variant		6/12	NM_003458.4:c.9246C>T	NP_003449.2:p.Thr3082%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00344347	524.0	152172.0	2.0	33	0.97	PASS	nfe	0.00573394	390.0	0.00573394	390.0	0.00345544	858.0	248304.0	5.0	66	0.98	PASS	nfe	0.00558339	624.0	0.00558339	624.0	0.0036141	562	0.009	27.0				2.688	0.004295		0	0	0			BSN	0.0	0.0	0.0	0.0	15.0	-8.0	-44.0	17.0						0.126	1.0	14.041690078			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; muscle phenotype; 			caudate nucleus;amygdala;temporal lobe;prefrontal cortex;cingulate cortex;superior cervical ganglion;cerebellum peduncles;cerebellum;pons;occipital lobe;subthalamic nucleus;whole brain;parietal lobe;globus pallidus;medulla oblongata;thalamus;	.	chemical synaptic transmission;synapse assembly;protein localization to synapse;maintenance of presynaptic active zone structure;regulation of synaptic vesicle cycle;presynapse to nucleus signaling pathway	nucleus;synaptic vesicle;cell surface;postsynaptic density;cell junction;axon;dendrite;synaptic vesicle membrane;neuron projection terminus;presynaptic active zone;cytoskeleton of presynaptic active zone;excitatory synapse;Schaffer collateral - CA1 synapse;glutamatergic synapse;GABA-ergic synapse	metal ion binding;structural constituent of presynaptic active zone	ARRB2[17620599];CNTROB[26638075];
31692	chr7	21646259	G	T	chr7:21646259	DNAH11	dynein axonemal heavy chain 11	367.0	SNV	0|1	0.16	16_3	19	56	False	rs1209465431	SPLICING	YES	NM_001277115.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	19/81		NM_001277115.2:c.3766-6G>T			1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3), Autosomal recessive	Primary ciliary dyskinesia	Disease-causing germline mutation(s) in	Hydrocephalus;Pectus excavatum;Chronic otitis media;Tachypnea;Impaired nasal mucociliary clearance;Delayed speech and language development;Asthma;Atelectasis;Headache;Ectopic pregnancy;Nasal polyposis;Clubbing of fingers;Pulmonary obstruction;Asplenia;Scoliosis;Reduced sperm motility;Respiratory distress;Immotile cilia;Chronic sinusitis;Infertility;Chronic bronchitis;Corneal dystrophy;Glue ear;Pneumonia;Spontaneous abortion;Conductive hearing impairment;Recurrent respiratory infections;Situs inversus totalis;Cough;Bronchiectasis;Ventriculomegaly;Rhinitis;Halitosis;Autosomal recessive inheritance;Bronchiectasis;Recurrent respiratory infections;Ciliary dyskinesia;Situs inversus totalis		0.000432041	47.0	108786.0	0.0	26	0.67	AS_VQSR	eas	0.00251731	8.0	0.000231828	13.0					18	0.47														0.059	-0.556119		0	0	0			DNAH11	0.04	0.0	0.0	0.0	6.0	12.0	-6.0	6.0	2.44567246961622e-05	0.002	6.307	-1.604	4.703						growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; liver/biliary system phenotype; respiratory system phenotype; embryo phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; vision/eye phenotype; limbs/digits/tail phenotype; digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; 			.	.	regulation of cilium beat frequency;microtubule-based movement;determination of left/right symmetry;learning or memory;flagellated sperm motility;determination of left/right asymmetry in nervous system;epithelial cilium movement involved in determination of left/right asymmetry;cardiac septum morphogenesis;determination of heart left/right asymmetry;sperm flagellum movement involved in flagellated sperm motility	microtubule;dynein complex;9+0 motile cilium;9+2 motile cilium;proximal portion of axoneme	ATP binding;ATP-dependent microtubule motor activity, minus-end-directed;dynein light chain binding;dynein intermediate chain binding;dynein light intermediate chain binding	.
31693	chr7	21646262	C	A	chr7:21646262	DNAH11	dynein axonemal heavy chain 11	367.0	SNV	0|1	0.16	16_3	19	56	False		SPLICING	YES	NM_001277115.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	19/81		NM_001277115.2:c.3766-3C>A			1.0					Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3), Autosomal recessive	Primary ciliary dyskinesia	Disease-causing germline mutation(s) in	Hydrocephalus;Pectus excavatum;Chronic otitis media;Tachypnea;Impaired nasal mucociliary clearance;Delayed speech and language development;Asthma;Atelectasis;Headache;Ectopic pregnancy;Nasal polyposis;Clubbing of fingers;Pulmonary obstruction;Asplenia;Scoliosis;Reduced sperm motility;Respiratory distress;Immotile cilia;Chronic sinusitis;Infertility;Chronic bronchitis;Corneal dystrophy;Glue ear;Pneumonia;Spontaneous abortion;Conductive hearing impairment;Recurrent respiratory infections;Situs inversus totalis;Cough;Bronchiectasis;Ventriculomegaly;Rhinitis;Halitosis;Autosomal recessive inheritance;Bronchiectasis;Recurrent respiratory infections;Ciliary dyskinesia;Situs inversus totalis		8.75948e-05	10.0	114162.0	0.0	27	0.69	AS_VQSR	eas	0.000584454	2.0	5.09286e-05	3.0					19	0.5														15.7	1.396281		0	0	0			DNAH11	0.02	0.25	0.0	0.0	12.0	3.0	3.0	-7.0	0.975959040933225	0.86	1.818	2.885	4.703						growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; liver/biliary system phenotype; respiratory system phenotype; embryo phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; vision/eye phenotype; limbs/digits/tail phenotype; digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; 			.	.	regulation of cilium beat frequency;microtubule-based movement;determination of left/right symmetry;learning or memory;flagellated sperm motility;determination of left/right asymmetry in nervous system;epithelial cilium movement involved in determination of left/right asymmetry;cardiac septum morphogenesis;determination of heart left/right asymmetry;sperm flagellum movement involved in flagellated sperm motility	microtubule;dynein complex;9+0 motile cilium;9+2 motile cilium;proximal portion of axoneme	ATP binding;ATP-dependent microtubule motor activity, minus-end-directed;dynein light chain binding;dynein intermediate chain binding;dynein light intermediate chain binding	.
31736	chr8	128751134	C	T	chr8:128751134	MYC	MYC proto-oncogene, bHLH transcription factor	368.0	SNV	0/1	0.7	7_16	23	99	False	rs746958042	EXONIC	YES	NM_002467.6	Transcript	protein_coding	missense_variant		2/3	NM_002467.6:c.671C>T	NP_002458.2:p.Ala224Val		1.0	Transcription regulator Myc, N-terminal,Transcription regulator Myc, N-terminal,Transcription regulator Myc, N-terminal,Transcription regulator Myc, N-terminal,Transcription regulator Myc, N-terminal				Burkitt lymphoma, somatic, 113970 (3)	Burkitt lymphoma;High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement;Precursor T-cell acute lymphoblastic leukemia	Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in	Burkitt lymphoma;Somatic mutation;Immunodeficiency;Sporadic;Abnormality of the pancreas;Increased lactate dehydrogenase level;Gastrointestinal hemorrhage;Intestinal obstruction;Abnormality of the spleen;Abnormality of the lymph nodes;Abnormality of the liver;Hyperuricemia;Decreased proportion of CD4-positive helper T cells;Abnormality of the ovary;Abdominal pain;Neoplasm of the oral cavity;Nausea and vomiting;Abnormality of bone marrow cell morphology		3.28537e-05	5.0	152190.0	0.0	32	0.97	PASS	amr	0.000130839	2.0	2.93988e-05	2.0	3.255e-05	8.0	245776.0	0.0	52	0.97	PASS	nfe	6.32969e-05	7.0	6.32969e-05	7.0	0.0000193	3	0.001	2.0	0.00018	2.0		21.0	2.144952	0.193	2	16	18	LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	MYC	0.0	0.0	0.0	0.0	-20.0	-7.0	-2.0	-9.0								0.0	0.043	0.959	adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; embryo phenotype; neoplasm; pigmentation phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; digestive/alimentary phenotype; skeleton phenotype; 			ciliary ganglion;lung;white blood cells;tumor;trigeminal ganglion;skin;	MAPK signaling pathway;ErbB signaling pathway;Wnt signaling pathway;TGF-beta signaling pathway;Jak-STAT signaling pathway;Colorectal cancer;Endometrial cancer;Thyroid cancer;Bladder cancer;Chronic myeloid leukemia;Acute myeloid leukemia;Small cell lung cancer	G1/S transition of mitotic cell cycle;negative regulation of transcription by RNA polymerase II;MAPK cascade;branching involved in ureteric bud morphogenesis;positive regulation of mesenchymal cell proliferation;energy reserve metabolic process;chromatin remodeling;regulation of transcription by RNA polymerase II;cellular iron ion homeostasis;cellular response to DNA damage stimulus;cell cycle arrest;Notch signaling pathway;positive regulation of cell population proliferation;response to gamma radiation;regulation of gene expression;positive regulation of gene expression;oxygen transport;protein deubiquitination;cytokine-mediated signaling pathway;regulation of telomere maintenance;negative regulation of stress-activated MAPK cascade;protein-DNA complex disassembly;cellular response to UV;cellular response to drug;response to drug;negative regulation of apoptotic process;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;fibroblast apoptotic process;negative regulation of monocyte differentiation;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of fibroblast proliferation;negative regulation of fibroblast proliferation;positive regulation of epithelial cell proliferation;chromosome organization;negative regulation of cell division;positive regulation of telomerase activity;ERK1 and ERK2 cascade;response to growth factor;cellular response to hypoxia;positive regulation of metanephric cap mesenchymal cell proliferation;beta-catenin-TCF complex assembly;positive regulation of DNA methylation;positive regulation of DNA biosynthetic process;positive regulation of response to DNA damage stimulus	nuclear chromatin;nucleus;nucleoplasm;nucleolus;protein-containing complex	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;transcription factor binding;activating transcription factor binding;protein-containing complex binding;protein dimerization activity;repressing transcription factor binding;E-box binding	PGAP1[17353931];POP4[21150319];FZD10[21150319];NOC2L[17353931];RBPJ[21150319];PREX2[21150319];PSMD4[17314511];PSMD2[17314511;21150319];PSMD3[17314511];RBFOX2[21150319];ZNF281[17314511];MRTFA[21150319];ZFYVE21[26496610];LDOC1[20195357];BCR[17314511];PRKAR1B[21150319];SCO2[21150319];RFX7[21150319];PSME4[17314511];PADI2[21150319];SET[20195357];NLRX1[21150319];ABCB1[21150319];ABCB7[17314511];TARSL2[26496610];MRPL14[21150319];IQGAP1[17353931];IQGAP2[17353931;17314511];IQGAP3[17314511];GIGYF2[20195357];HSPH1[17314511];EXPH5[21150319];ABCA1[21150319];ABCA2[26496610];JUN[21150319];FN1[21150319];ABCA9[21150319];SETX[21150319];TBL2[21150319];LAS1L[17353931];FERMT3[21150319];EZH2[23079660];ARF4[17314511];ARF1[17289033];TUT4[21150319];NCAPG2[17353931];ECSIT[21150319];SHE[21150319];CHAF1B[21150319];IKBKG[20970423];ARG1[21150319];ACTL6A[17314511;25609649];SIRT5[23217706];SLC39A10[26496610];SIRT6[23217706];SIRT1[21807113];SRP9[21150319];SIRT2[23217706];PSMA5[17314511];MZT2B[21150319];MRPL53[21150319];PSMA3[17314511;21150319];PSMA4[17314511];PSMA1[17314511;26496610];TMEM33[17353931];PSMA2[17314511];CDC42EP1[21150319];KANK2[21150319];OAT[17314511];CCM2L[21150319];RPS27L[21150319];PSMA7[17314511];FAM117B[21150319];PSMB4[17314511];BTAF1[17353931];PSMB5[17314511];PSMB3[17314511];PSMB1[17314511];MICALL2[21150319];FLNA[21150319];CEPT1[17314511];CSMD2[21150319];MBD3[24048479];CENPV[21150319];USP9X[17353931];ARCN1[17353931];FOXR2[25609649];FOXR1[25609649];CENPF[26496610];PSMC6[17314511];SNX19[21150319];MYBBP1A[17353931;17314511];PSMC3[17314511;21988832];PSMC4[17314511];PSMC1[17314511;21150319];PSMC2[17314511];NCAPD3[17353931];LIMS1[21150319];KCNG3[21150319];RIF1[21150319];CSE1L[17314511];PDCD6[26496610];PLOD3[17314511];PLOD2[21150319];EIF4ENIF1[17314511];MTRF1[21150319];RUVBL2[17314511];RUVBL1[17314511];KPNA4[17314511];KPNA2[17314511;21988832];PITX2[21150319];MAP3K7[21150319];NOMO2[21150319];MAP3K5[21150319];IK[21150319];FBXW8[17314511];FBXW7[17157259;17314511;23791182];SARS[17314511];TUBA4A[17314511;21150319];PIAS2[17418410];FOXP1[21150319];MSH6[17353931;17314511];FRMD6[21150319];MSH2[17314511];MSH3[17314511];PKP1[25609649];SNRNP200[17353931;17314511];SQSTM1[17314511];KPNB1[17314511];TRABD2A[21150319];KMT2A[21150319];MAX[9680483;12821782;16352593;17353931;17157259;17314511;17418410;20691906;20936779;21150319;21988832;21807113;27705803;18620061;24951594;25609649;26496610;26267534;unassigned1304;16606833];TUBGCP2[17314511];ARL1[17314511];FOXO6[25609649];FOXO3[18393360];SBNO2[21150319];SMYD4[21150319];NPTX2[21150319];MDN1[17353931];ZBTB18[21150319];ZBTB17[16352593;18923429;26766587];NEK9[17314511];SDF2L1[21150319];BRPF1[26496610];SRD5A1[24951594];NRDC[21150319];GFPT1[21150319];MFHAS1[21150319];SP1[17418410];UST[20195357];PIN1[19131971;26655473];TUBGCP4[17353931];MCU[26496610];SLC25A1[17314511];MIPEP[21150319];CDCA7L[16829576];AKAP8L[17314511];FHL2[21150319];ETFA[17314511];ITGAL[21150319];ELFN1[21150319];ERC1[21150319];YAF2[21150319];UNC45A[17353931];DSP[17353931];TNFRSF18[21150319];MUC5AC[21150319];ARFGAP1[21150319];ADAMTS20[21150319];SLC25A10[21150319];TOP1[17314511;20195357];SLC25A12[17314511];SLC25A11[17314511];SLC25A13[17314511];ST6GALNAC6[21150319];GTF3C1[17314511];PPP1R15A[20195357];GTF3C2[17314511];GTF3C3[17353931;17314511];GTF3C4[17314511;21150319];ZBTB40[21150319];KIAA1569[21150319];GANAB[17314511;21150319];ELMSAN1[21150319];IGF2BP1[17314511];SH3BP4[21150319];IGF2BP3[21150319];IGF2BP2[17314511;21150319];HNRNPA0[17314511];NOP56[17353931;17314511];NDUFA8[17314511];NDUFA5[17314511];IMMT[21150319];MYO1D[21150319];MYO1B[17353931];EIF3I[17314511];EIF3E[17314511];ATXN10[26496610];EIF4A1[17314511];TONSL[21988832];IKZF2[21150319];CCAR2[17353931;17314511];C4A[21150319];LGALS1[21150319];TRIM28[17353931;17314511];SNRPD2[21150319];OPHN1[21150319];CDC26[21150319];DHX58[21150319];EPC1[21150319];PELO[17314511];TRIM21[21150319];LGALS7[21150319];TMPO[17314511];SMARCC1[17353931;17314511];SMARCC2[17353931];MOGS[17314511];HASPIN[17314511];PPA2[21150319];RIN3[21150319];ALPK3[21150319];KIF20B[21150319];TP53[21150319];NAIP[21150319];GCDH[17314511];CTR9[21150319];KALRN[21150319];MED12L[21150319];PCBP1[17314511];ZNF703[21150319];PCBP2[21150319];DHX37[17353931];SEC31B[21150319];ARSB[21150319];RBM10[21150319];RAB11FIP5[21150319];XRCC6[17314511];XRCC5[17314511];SMARCA5[17314511;21150319];MYO5A[17353931];PRG4[21150319];DCLK1[20195357];SMARCA4[17353931];ANLN[21150319];TF[21150319];MYO5C[17314511];NDUFAF3[21150319];NOL11[17353931];RCOR3[21150319];CALM1[21150319];SUV39H1[27705803];DIRAS2[21150319];ICA1[20195357];AP2A1[17353931];KIF12[21150319];SH3RF1[21150319];SPTLC1[17314511];DHX15[17314511];SDF4[21150319;26496610];MCF2L2[21150319];AASS[17314511];CCT3[17314511];CCT2[17314511];MRPS22[17314511];KIF25[21150319];IL16[21150319];AJAP1[21150319];IL1B[21150319];ARHGEF2[17353931;17314511];MFGE8[21150319];C2orf16[21150319];FOXC2[21150319];HEATR1[17353931];MRPS34[17314511];HSD17B4[21150319];NFIL3[21150319];HEATR3[17353931];CCT8[17314511];XDH[21150319];CCT5[17314511];EXOSC1[21150319];CCT4[17314511];DYNC1H1[17314511];MAP3K1[21150319];CAVIN1[21150319];CAVIN3[21150319];HUWE1[17314511];MYO9B[17314511];MYO9A[17314511];ACTL8[26496610];PPP1CA[17314511];MIB1[21150319];KLHL5[20195357];EPPK1[17353931];NEK11[21988832];OTUD4[21150319];SAMD9L[21150319];NUP188[17353931];UBE3C[17314511];RPP30[17314511;21150319];ST3GalIII[21150319];KNDC1[21150319];SRP14[17353931];ACTG1[21150319];PPIP5K2[21150319];PLAU[21988832];SNIP1[17157259];EP300[17157259];BAHCC1[21150319];RAG1[21150319];IL4R[21150319];DIMT1[17314511];DNAJB12[21150319];CYBA[21150319];ATAD3B[21150319];SDHA[21150319];MUC3A[21150319];MAP7D1[17353931;21150319];DNAJB11[21150319];GEMIN4[17353931];GEMIN5[21150319];WDFY3[21150319];DENND6B[21150319];RAF1[17314511];NPR1[21150319];DDX1[17314511];PDS5B[17353931;21150319];PDS5A[17353931];HIGD1A[17314511];ACACB[21150319];ACACA[17353931;21150319];CACNA1G[21150319];IRAK1[17314511];CALD1[21150319];CYC1[21150319];ECT2[17353931];CNMD[21150319];GCN1[17314511;20936779];PACSIN1[26496610];ZFHX3[21150319];PDHA2[21150319];CNTN5[21150319];NUP153[17314511];AP4B1[21150319];SDK1[21150319];CNOT11[21150319];NABP2[21150319];AMOTL2[21150319];UBA1[21150319];YWHAE[17314511];GSK3B[19131971;21150319;20713710];DDX3X[17314511];MAST4[21150319];YWHAB[17314511];DDX47[21150319];CHD9[26496610];CHD5[17353931];ATP2A2[17353931;17314511];CHD4[17314511];ADAR[26496610];TTC27[17314511];SEC61A1[17314511];YWHAQ[17314511];MYO18A[21150319];UQCRFS1[21150319];DACT1[21150319];UTP15[17353931];RBM15[26496610];NUP133[17353931;17314511];NCBP2[26496610];PLA2G4A[21150319];DDX51[21150319];DDX52[17314511];CIP2A[17632056];NAV2[21150319];ETV3[21150319];ETV6[21150319];EEF1G[17314511;21150319];RCN1[21150319];NAV3[21150319];NDUFS3[17314511];NDUFS2[17314511;21150319];NDUFS1[17314511];SHANK2[21150319];DDX24[17353931;21150319];DCTN1[17353931];DNAH8[21150319];DDX20[17353931;17314511];AGPAT1[21150319];POLD1[17314511];TDG[21150319;26496610];SLIT2[17314511];SPATA31E1[21150319];PDLIM4[21150319];PDLIM7[21150319];RBM39[21150319];RRM1[21150319];U2SURP[17314511];ACTC1[21150319];ERCC3[17314511];TAF2[21150319];RPL26L1[21150319];TAF1[26496610];IPO13[17314511];IPO11[17353931];RNH1[17314511];TRIO[26496610];TRRAP[9708738;17353931;17314511;21150319];WIPF1[21150319];FRMPD4[21150319];XYLT1[21150319];SMC6[21150319];SMC3[17353931];SMC4[17353931;17314511;21150319];SMC2[17353931;17314511];FAM122B[21150319];CSPP1[21150319];MYC[25609649];DIP2B[21150319];CDK5RAP2[21150319];DDX17[21150319];ACOT8[17314511];CLEC11A[21150319];AFAP1[21150319];DNAAF5[17353931];HCFC2[21150319];WDR77[17314511];NUP93[17353931;21150319];DYNC1LI1[21150319];ARMC6[17353931];BIN1[15992821];MAP1A[21150319];NUP98[21150319];PRR11[21150319];HOXB5[21150319];NUP205[17353931];TPH1[21150319];RPN2[17314511];PRKDC[17314511];CTBP1[21150319];MAPKAP1[17314511];RPN1[17314511];XKRX[21150319];PRDX1[21988832];SERPINH1[21150319];SSR1[21150319];CEP78[17353931];PNO1[26496610];PLK1[17314511];H3F3A[21150319];MCAT[26496610];FOSL2[21150319];PRRC2A[21150319];FOSL1[21150319];GLUD2[20195357];HNRNPK[17314511];HNRNPF[17314511];PPT1[17314511];MMS19[17353931;17314511];HNRNPC[17353931;21150319];CEP57[20195357];PHF20[21150319];PHF6[21150319];AIFM2[21150319];RARS[21150319];CEP55[21150319];BRD3[20195357];HELLS[17353931;17314511];ZNF121[17314511];SSR4[17314511];ANXA2[21150319];TCF12[21150319];GNL3[17353931];HADHB[17314511;21150319;26496610];NCOR2[21150319];HADHA[26496610];NCOR1[21150319];TCP1[17314511];EXOC4[17353931];EXOC3[17353931];PLIN3[26496610];TKT[21150319];EXOC1[17353931];AHNAK[21150319];RPL11[17599065];PPP1R2[20195357];RPL13[21150319];ZNF106[21150319];RPS2[21150319];SF3B1[20936779];RNF130[21150319];ZNF586[21150319];GPR158[21150319];KIDINS220[20195357];AGK[21150319];SQOR[17314511;21150319];ELP1[17314511];RRP1B[21150319];LRPPRC[17353931;17314511;21150319];MKLN1[17353931];ERP44[21150319];NUCB1[21988832];HSPA1A[21150319];CSF1[21150319];CTNND1[21150319];CLSTN1[21150319];IRS4[17314511];TMEM131L[21150319];IPO7[17314511];IPO4[17353931;17314511];RIMS2[21150319];TUBB6[21150319];IPO9[17353931;17314511];TUBB3[21150319];CFL1[21150319];SMARCAD1[17353931];TNR[21150319];GTF2I[17314511];MAGI1[21150319];MAP2K1[26496610];RALGAPA1[21150319];PGD[21150319];TEX2[21150319];OBSCN[21150319];NCL[17314511;24951594];ADNP[21150319];SNRPF[21150319];PHLDB2[21150319];CBFB[21150319];CUL1[16376880];UBR2[17314511];MAP3K20[26496610];KIAA0319[21150319];ZNF541[21150319];FANCI[17353931];FANCM[21150319];ZZEF1[21150319];CNOT4[21150319];CDK6[22094256];P4HA1[17314511];CDK4[21988832;22094256;24951594];CDK1[17314511];TPP1[21150319];MCM7[17353931;17314511];CALCOCO2[21150319];DUSP15[21150319];CYR61[17314511];SYNE1[21150319];PPP6C[17314511];PTBP1[21150319];METTL13[17353931];OPA1[17353931;21150319];SIN3B[24951594];SNRNP70[20195357];WDR5[17353931];IDH3B[17314511];UBTF[20195357;21150319];CEP170[21150319];TNPO1[21150319];LBR[17353931];TNPO3[17353931];IDH3A[17314511];RFC5[17314511];RFC3[17314511];GPX2[21988832];RFC4[17353931;21150319];RFC1[17353931];CHUK[21575199];RFC2[17314511];SMC1A[17353931];TSN[21150319];ASPM[21150319];PKM[21150319];MCM3[17353931];MCM4[21150319];HDAC2[17314511;20195357];HDAC3[23079660];LUZP1[21150319];HDAC1[17314511;24951594;26496610];DENND3[21150319];AMBRA1[25438055];TTN[21150319];FZR1[21150319];POLR2A[17314511;23079660];DNAJB6[17314511];POLR2B[17353931;17314511];BCO1[21150319];PLEKHH1[21150319];ZNF740[21150319];SEC11C[21150319];RNGTT[17314511];IDH3G[17314511];AHNAK2[21150319];RPRD2[21150319];PTPN14[17314511;21150319];ASS1[17314511];PML[21150319];ASXL1[21150319];RAD50[21150319];POLR3A[21150319];DNAJA3[17314511];CROCC[21150319];DNAJA2[17314511];CEBPZ[17353931];INSM1[21150319];ABRA[21150319];RPS16[21150319];LONP1[17314511];SKP2[16376880;17157259];TNS2[21150319];SKP1[16376880;17314511;21988832];METTL3[26496610];P3H1[21150319];RUNX2[21150319];RUNX1[21150319];XRN1[17314511];KARS[21150319];CYP2U1[21150319];TFAM[21150319];SUCLG2[21150319];SUCLG1[17314511;21150319];TMEM161A[26496610];TXN[21150319];TRPM1[21150319];MAATS1[21150319];PDCD11[17353931];LCN12[21150319];TP53BP1[20195357;29656893];TRMT1L[17314511];TRAP1[21150319];NMI[10597290];CCT6A[17314511];SMTN[21150319];HIST1H4A[23079660];STAG2[17353931];MAGED2[17353931];ATM[21150319];ALDH18A1[17314511];RPS21[21150319];TOP2A[17314511];ROBO2[21150319];TENM2[21150319];FASTKD1[21150319];FASTKD2[17353931];FAF2[21150319];SIPA1L3[21150319];GABRR1[21150319];XPO1[17314511];C1QBP[17314511];XPO5[17353931;17314511];CDV3[21150319];TUBG1[17314511];PALD1[21150319];MATN4[21150319];MYCBP[12223483];AKAP8[17314511;21150319];NOL9[17353931];TRAK1[21150319];RBFA[21150319];PPP2CA[19131971];HIRA[21150319];MTHFD1L[17353931];LMNA[17314511;21150319];SHOC2[17314511];RANBP2[17314511];SUZ12[23079660];PTGES2[17314511];AP3D1[17353931];ERBIN[21150319];XPO7[17353931];SORBS1[20195357];ATP5F1C[17314511;21150319];MLH3[21150319];LBX2[21150319];XPOT[17314511];MARS[17353931;17314511];ATP5PO[21150319];COPG2[17314511];TRIP12[20208519];COPG1[17353931;17314511];ZNF354B[21150319];KDM1A[23455924];ARID4B[21150319];EFTUD2[17353931;17314511];HOXA10[21150319];FBL[17314511];CHCHD3[21150319];SACS[21150319];HIST1H2AE[21150319];MAGEB10[21150319];ARID5B[21150319];LMO7[21150319];CDYL[21150319];TUFM[21150319];DPM1[17314511;21150319];SGO2[21150319];PRPF6[17353931;17314511;21150319];MYCN[25609649];LOX[21150319];FANCD2[17314511];ILVBL[17314511];KIAA2026[21150319];MATR3[17353931];COPB2[17353931];ADIPOR1[21150319];PRPF8[17353931];EFNB1[21988832];PDZD2[21150319];NPC1L1[21150319];UBC[16376880;16996503;19131971;21150319];EP400[17314511;21150319;18413597];ATP6V1H[17353931];ZC3H18[21150319];ATP6V1D[21150319];ATP5MF[17314511;21150319];BPTF[21150319];HSPA8[21150319];CPSF1[17353931];NONO[17314511;21150319];CPSF2[21150319];LRP1B[21150319];DIAPH3[17353931];MRGBP[21150319];SKIV2L[17353931];DYNLRB1[21150319];BRWD1[21150319];USP36[21150319];DOCK7[21150319];HSPB1[17314511;21150319];YBX1[21150319];CHTF18[17314511];HK1[21150319];ZC3H7B[21150319];SPEG[21150319];POLE[17353931;17314511];HIST1H1A[21150319];POLG[21150319];KLF10[21150319];TMPRSS11A[21150319];USP48[21150319];H2AFZ[21150319];AXIN1[19131971];IQCE[21150319];PPP2R5A[19131971];CTPS1[17353931;21150319];CKAP4[21150319];DNM2[17353931];LATS1[20195357];EHHADH[21150319];PFDN2[21150319];MCTP2[21150319];PFDN5[17728244];B4GALT7[26496610];RBMS2[21150319];HIST1H2BM[21150319];CAMK2D[21150319];USP10[21150319];HIST1H2BL[17314511];NRXN3[21150319];ATP1A1[17314511];HSPD1[17314511];BICRA[21150319];ALDH1B1[17314511];BUB1[21150319];QPCTL[21150319];NAP1L1[20195357];PPP2R3B[21150319];SCD[20195357];SSBP1[21150319];
32328	chr14	105238735	G	A	chr14:105238735	AKT1	AKT serine/threonine kinase 1	379.0	SNV	0/1	0.37	19_11	30	99	False	rs141303557	EXONIC	YES	NM_001382433.1	Transcript	protein_coding	synonymous_variant		14/16	NM_001382433.1:c.1227C>T	NP_001369362.1:p.Ala409%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	Cowden_syndrome_6	Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3); Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)	Cowden syndrome;Proteus syndrome	Disease-causing germline mutation(s) (gain of function) in;Disease-causing somatic mutation(s) in	Somatic mutation;Autosomal dominant inheritance;Heterogeneous;Breast carcinoma;Melanocytic nevus;Hip dislocation;Clinodactyly of the 5th finger;Joint stiffness;Strabismus;Round face;Enlarged polycystic ovaries;Disproportionate tall stature;Retinal hamartoma;Myopia;Sirenomelia;Asymmetry of the thorax;Macrotia;Intellectual disability;Calvarial hyperostosis;Cachexia;Abnormality of the metacarpal bones;Facial asymmetry;Seizure;Meningioma;Metatarsus valgus;Macroorchidism;Anteverted nares;Downslanted palpebral fissures;Abnormality of the neck;Long penis;Buphthalmos;Neoplasm of the lung;Abnormality of dental enamel;Lymphangioma;Abnormal subcutaneous fat tissue distribution;Narrow internal auditory canal;Craniosynostosis;Hallux valgus;Generalized hirsutism;Abnormal form of the vertebral bodies;Abnormality of the nail;Testicular neoplasm;Thymus hyperplasia;Proptosis;Lymphedema;Macrocephaly;Reduced number of teeth;Cataract;Dolichocephaly;Hypertelorism;Gray matter heterotopia;Ptosis;Skeletal dysplasia;Abnormality of the wrist;Recurrent infections;Upper limb asymmetry;Lower limb asymmetry;Splenomegaly;Myofibrillar myopathy;Visceral angiomatosis;Generalized hyperkeratosis;Irregular hyperpigmentation;Thick nasal alae;Abnormality of retinal pigmentation;Lipoma;Long face;Capillary hemangioma;Generalized hyperpigmentation;Chorioretinal coloboma;Neoplasm of the thymus;Subcutaneous nodule;Depressed nasal bridge;Diabetes insipidus;Decreased muscle mass;Thrombophlebitis;Central heterochromia;Sudden cardiac death;Macrodactyly;Vascular skin abnormality;Exostoses;Renal cyst;Ovarian neoplasm;Scoliosis;Kyphosis;Arterial thrombosis;Pulmonary embolism;Finger syndactyly;Arteriovenous malformation;Bronchogenic cyst;Low-set ears;Retinal nonattachment;Abnormal lung lobation;Multiple cafe-au-lait spots;Epidermal nevus;Carious teeth;Endometrial carcinoma;Brachydactyly;Global developmental delay;Hypopigmented skin patches;Conjunctival hamartoma;Bone cyst;Hearing impairment;Abnormal cerebellum morphology;Melanoma;Cavernous hemangioma;Short stature;Generalized hyperkeratosis;Kyphosis;Adenoma sebaceum;Seizure;Mucosal telangiectasiae;Multiple cafe-au-lait spots;Gynecomastia;Lipoma;Cognitive impairment;Melanocytic nevus;Cellular immunodeficiency;Renal cell carcinoma;Papule;Colorectal polyposis;Pectus excavatum;Furrowed tongue;Palmoplantar keratoderma;High palate;Intellectual disability;Increased intracranial pressure;Myopia;Macrocephaly;Papilloma;Cataract;Abnormality of the penis;Autism;Macule;Macroglossia;Breast carcinoma;Follicular thyroid carcinoma;Failure to thrive;Goiter;Subcutaneous nodule;Meningioma;Enlarged polycystic ovaries;Scoliosis;Ataxia;Hamartomatous polyposis;Abnormality of metabolism/homeostasis;Breast carcinoma;Somatic mutation;Autosomal dominant inheritance;Ovarian papillary adenocarcinoma;Dysgerminoma;Open mouth;Mandibular hyperostosis;Downslanted palpebral fissures;Epidermal acanthosis;Hemangioma;Lipoma;Nevus;Spinal cord compression;Hyperkeratosis;Depigmentation/hyperpigmentation of skin;Depressed nasal bridge;Somatic mutation;Intellectual disability, moderate;Infantile onset;Lymphangioma;Venous malformation;Hypertrophy of skin of soles;Dolichocephaly;Spinal canal stenosis;Deep venous thrombosis;Limbal dermoid;Calvarial hyperostosis;Epidermal nevus;Thin bony cortex;Long face;Splenomegaly;Ptosis;Kyphoscoliosis;Macrocephaly;Progressive;Multiple lipomas;Sporadic;Facial hyperostosis;Hemihypertrophy;Colonic diverticula;Transitional cell carcinoma of the bladder;Goiter;Angioid streaks of the fundus;Breast carcinoma;Hamartomatous polyposis;Intellectual disability, mild;Fibroadenoma of the breast;Cataract;Narrow mouth;Meningioma;Varicocele;Hypoplasia of the maxilla;Hearing impairment;Hyperthyroidism;Intellectual disability;Autosomal dominant inheritance;Adult onset;Thyroiditis;Micrognathia;Palmoplantar hyperkeratosis;Myopia;Abnormality of the cardiovascular system;Skin tags;Furrowed tongue;Seizure;Intention tremor;Kyphosis;High palate;Ovarian cyst;Hydrocele testis;Thyroid adenoma;Subcutaneous lipoma;Gynecomastia;Hypothyroidism;Progressive macrocephaly;Scoliosis;Pectus excavatum		0.000190484	29.0	152244.0	0.0	33	0.98	PASS	afr	0.000578732	24.0	5.87855e-05	4.0	7.16464e-05	18.0	251234.0	0.0	82	1.0	PASS	afr	0.000677757	11.0	5.28132e-05	6.0	0.0000579	9			9e-05	1.0		10.89	0.668999		0	0	0			AKT1	0.0	0.0	0.0	0.01	-16.0	35.0	-31.0	-1.0						0.357	0.98	55.458327287			muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); neoplasm; endocrine/exocrine gland phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; 			liver;heart;	MAPK signaling pathway;ErbB signaling pathway;mTOR signaling pathway;Apoptosis;VEGF signaling pathway;Focal adhesion;Tight junction;Toll-like receptor signaling pathway;Jak-STAT signaling pathway;T cell receptor signaling pathway;B cell receptor signaling pathway;Fc epsilon RI signaling pathway;Insulin signaling pathway;Adipocytokine signaling pathway;Colorectal cancer;Renal cell carcinoma;Pancreatic cancer;Endometrial cancer;Glioma;Prostate cancer;Melanoma;Chronic myeloid leukemia;Acute myeloid leukemia;Small cell lung cancer;Non-small cell lung cancer	obsolete protein import into nucleus, translocation;osteoblast differentiation;maternal placenta development;positive regulation of protein phosphorylation;positive regulation of endothelial cell proliferation;cell migration involved in sprouting angiogenesis;glycogen biosynthetic process;regulation of glycogen biosynthetic process;glucose metabolic process;translation;regulation of translation;cellular protein modification process;protein phosphorylation;negative regulation of protein kinase activity;nitric oxide biosynthetic process;activation-induced cell death of T cells;inflammatory response;cellular response to DNA damage stimulus;response to oxidative stress;signal transduction;epidermal growth factor receptor signaling pathway;G protein-coupled receptor signaling pathway;I-kappaB kinase/NF-kappaB signaling;germ cell development;aging;cell population proliferation;positive regulation of cell population proliferation;insulin receptor signaling pathway;apoptotic mitochondrial changes;carbohydrate transport;response to heat;negative regulation of autophagy;positive regulation of gene expression;negative regulation of gene expression;negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of fibroblast migration;positive regulation of sodium ion transport;positive regulation of glucose metabolic process;positive regulation of mitochondrial membrane potential;negative regulation of endopeptidase activity;regulation of neuron projection development;phosphatidylinositol 3-kinase signaling;negative regulation of macroautophagy;phosphorylation;protein ubiquitination;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;cytokine-mediated signaling pathway;spinal cord development;cell projection organization;cell differentiation;protein catabolic process;hyaluronan metabolic process;positive regulation of cell growth;regulation of cell migration;endocrine pancreas development;T cell costimulation;negative regulation of protein ubiquitination;regulation of myelination;lipopolysaccharide-mediated signaling pathway;TOR signaling;negative regulation of fatty acid beta-oxidation;positive regulation of endodeoxyribonuclease activity;negative regulation of protein binding;response to food;activation of protein kinase B activity;positive regulation of cellular protein metabolic process;peripheral nervous system myelin maintenance;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;cellular response to insulin stimulus;positive regulation of peptidyl-serine phosphorylation;response to fluid shear stress;cellular response to reactive oxygen species;intracellular signal transduction;interleukin-18-mediated signaling pathway;cellular response to vascular endothelial growth factor stimulus;NIK/NF-kappaB signaling;glucose homeostasis;regulation of apoptotic process;positive regulation of apoptotic process;negative regulation of apoptotic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;anoikis;regulation of mRNA stability;protein kinase B signaling;positive regulation of blood vessel endothelial cell migration;positive regulation of nitric oxide biosynthetic process;positive regulation of fat cell differentiation;positive regulation of glycogen biosynthetic process;positive regulation of epidermal growth factor receptor signaling pathway;negative regulation of Notch signaling pathway;negative regulation of cell size;negative regulation of proteolysis;positive regulation of transcription, DNA-templated;positive regulation of vasoconstriction;positive regulation of transcription by RNA polymerase II;positive regulation of glucose import;negative regulation of JNK cascade;positive regulation of organ growth;protein autophosphorylation;positive regulation of lipid biosynthetic process;insulin-like growth factor receptor signaling pathway;positive regulation of smooth muscle cell proliferation;regulation of nitric-oxide synthase activity;positive regulation of nitric-oxide synthase activity;positive regulation of DNA-binding transcription factor activity;striated muscle cell differentiation;cofactor metabolic process;negative regulation of protein kinase B signaling;excitatory postsynaptic potential;response to growth hormone;mammary gland epithelial cell differentiation;glycogen cell differentiation involved in embryonic placenta development;labyrinthine layer blood vessel development;response to UV-A;cellular response to mechanical stimulus;cellular response to cadmium ion;cellular response to tumor necrosis factor;cellular response to epidermal growth factor stimulus;cellular response to prostaglandin E stimulus;cellular response to organic cyclic compound;cellular response to hypoxia;negative regulation of protein serine/threonine kinase activity;establishment of protein localization to mitochondrion;maintenance of protein location in mitochondrion;negative regulation of release of cytochrome c from mitochondria;cellular response to granulocyte macrophage colony-stimulating factor stimulus;execution phase of apoptosis;negative regulation of protein kinase activity by protein phosphorylation;cellular response to oxidised low-density lipoprotein particle stimulus;positive regulation of protein localization to nucleus;negative regulation of neuron death;regulation of signal transduction by p53 class mediator;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;negative regulation of leukocyte cell-cell adhesion;positive regulation of protein localization to plasma membrane;positive regulation of I-kappaB phosphorylation;cellular response to nerve growth factor stimulus;response to insulin-like growth factor stimulus;positive regulation of protein localization to cell surface;negative regulation of lymphocyte migration;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	nucleus;nucleoplasm;cytoplasm;mitochondrion;spindle;cytosol;plasma membrane;cell-cell junction;microtubule cytoskeleton;vesicle;protein-containing complex;ciliary basal body;postsynapse	protein kinase activity;protein serine/threonine kinase activity;protein serine/threonine/tyrosine kinase activity;protein kinase C binding;protein binding;ATP binding;phosphatidylinositol-3,4,5-trisphosphate binding;kinase activity;enzyme binding;nitric-oxide synthase regulator activity;GTPase activating protein binding;identical protein binding;protein homodimerization activity;phosphatidylinositol-3,4-bisphosphate binding;protein phosphatase 2A binding;14-3-3 protein binding	PI4K2B[18624398];ZNF691[25640309];CCNI[25640309];CASC3[25640309];NR3C1[24291004];ENO2[25640309];ACTB[20856200];STK11[24412244];TCL1A[25416956;26871637;25910212;29997244];PPP2R1A[16044149];CDH1[24412244];PEBP4[19197339];FAM110C[19698782];KHSRP[19198587];EPSTI1[25640309];AKT1[7891724;17554339];EP300[21775285];PTGDS[25640309];IL13RA2[25640309];MAP3K5[11154276];PDK1[27505672];TPM4[20856200];FBXW7[24412244];PRKCB[25640309];TPM2[20856200];MTUS2[26871637];PIAS2[25241761];LTB4R2[22044535];MSH2[24412244];SOAT2[25640309];CDC37[12176997];MAPKAPK2[25241761];RAF1[19197339;25241761];CARD11[24548923];DDX5[20856200];DNMT1[21151116];MAPKAP1[24670654];ITPR1[24947355;18250332];CSF2RB[16437163];BCL10[16280327;24412244];FOXO3[10102273;25241761;21621563];STK4[17932490];PPL[12244133;18624398];PRKCZ[18650932];TRHDE[20856200];FOXO1[25241761;18786403];GRIN2A[25640309];BCL2L11[16282323];TERT[18775701];APOH[18624398];EIF4EBP1[25241761];THEM4[22309289;19541650;24670654];SFN[20005908];PLCG1[16525023];S100A14[25640309];CEP76[unassigned1304];HSPA9[20856200];SMAD2[24412244];CREBBP[23434580];SMAD4[23397142];ST14[25640309];SMAD3[25241761];SETDB1[17577629];HSPA5[21445305];RASL10B[25640309];ALYREF[18562279];OSGIN1[25640309];DDIT4L[unassigned1304];BRAF[25241761];GFAP[25640309];RGCC[19162005];FASN[25640309];MDM2[15527798;19166854;20856200;25241761;23397142];TMCC2[26871637];XAF1[unassigned1304];MXD1[18451027];GSK3B[16282323;20856200;23010592;18505846];CDKN1A[25241761];CDKN1B[12042314;25241761];LRRK2[21658387];IL24[25640309];HSPB1[23397142];BRCA1[21242970];ARRB2[19122674];SH3RF1[17535800];IKBKB[25241761];MRC2[25640309];UCHL1[25640309];CASP3[17544405];TOPBP1[17006541];IKBKG[20098747];SULT4A1[25640309];APPL1[25241761;25814554];GET4[25640309];CHUK[25241761];PDPK1[11438723;21775285;23397142;26256536];AHSG[18624398];NCOA4[18624398];COMMD1[18624398];BPGM[18624398];SIRT1[21775285];ZHX1[21900206];SERPINB5[25640309];EEF1G[21900206];CCNA2[24670654];KAT2B[21775285];PPM1A[25241761];PKM[24606918];RARA[23693014];PICK1[25640309];TERF2IP[21044950];TFF1[25640309];MAPT[17512525;18292230];TLR2[24412244];PHLPP2[24670654];BECN1[23112296];DCTN1[21900206];SRC[25241761];FAM129A[22510990];XIAP[25241761];PDHB[25640309];MESD[unassigned1304];EGFR[24658140];AURKA[24412244];PPP2CA[16044149;11839802;26256536];NSD3[25640309];DNAJB1[18624398];PAK1[23397142];NRAS[24412244];SRR[25640309];SERTAD4[20368287];TCOF1[26496610];CTNNA1[24412244];PMS2[24412244];AGR3[25640309];RICTOR[25241761];SNCB[25640309];BUB1[24412244];MTA3[25640309];CLASP2[25640309];NOS3[25241761;23397142];BAD[25241761];SORBS2[15784622];TUBB4B[20856200];MAPK14[23397142];MTOR[11438723;25241761;24670654];MLH3[24412244];PPP1CA[20186153];ASXL1[18624398];PSMC5[25640309];RPS6KB1[11438723;25241761];PLP1[25640309];BAX[26763134];THRSP[25640309];STUB1[18292230];VIM[20856200];PKN1[23223530];PTPN3[25640309];
32945	chr21	46914492	C	T	chr21:46914492	COL18A1	collagen type XVIII alpha 1 chain	408.0	SNV	0/1	0.34	25_13	38	99	False	rs202100967	SPLICING	YES	NM_130444.3	Transcript	protein_coding	splice_region_variant,intron_variant	26/40		NM_130444.3:c.3624+7C>T			1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Knobloch_syndrome_1|not_provided	Knobloch syndrome, type 1, 267750 (3), Autosomal recessive; Glaucoma, primary closed-angle, 618880 (3), Autosomal dominant	Knobloch syndrome	Disease-causing germline mutation(s) in	Mental deterioration;Cerebellar atrophy;Autosomal recessive inheritance;Nystagmus;Cerebral atrophy;Macular hypoplasia;Visual loss;Occipital encephalocele;High myopia;Alopecia;Retinal detachment;Polymicrogyria;Band keratopathy;Vitreoretinopathy;Peripapillary atrophy;Phthisis bulbi;Developmental cataract;Ventriculomegaly;Seizure;Ataxia;Nystagmus;Epicanthus;Lymphangioma;Strabismus;Myopia;Cataract;Patent ductus arteriosus;Abnormal hair morphology;Macular degeneration;Ectopia lentis;Midface retrusion;Occipital encephalocele;Calvarial skull defect;Dextrocardia;Joint hyperflexibility;Seizure;Pyloric stenosis;Depressed nasal bridge;Vitreoretinopathy;Hydrocephalus;Progressive visual loss;Retinal detachment;Vesicoureteral reflux;Bifid ureter		0.00365899	557.0	152228.0	3.0	34	0.98	PASS	nfe	0.0040127	273.0	0.0040127	273.0	0.00392343	974.0	248252.0	8.0	100	1.0	PASS	nfe	0.00376737	423.0	0.00376737	423.0	0.0032668	508	0.002	8.0	0.00316	36.0		0.84	-0.176553		0	0	0			COL18A1	0.01	0.0	0.0	0.0	-29.0	48.0	-1.0	1.0						0.155	0.0				homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; vision/eye phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			liver;trigeminal ganglion;	.	angiogenesis;endothelial cell morphogenesis;cell adhesion;visual perception;positive regulation of cell population proliferation;negative regulation of cell population proliferation;animal organ morphogenesis;extracellular matrix organization;positive regulation of cell migration;response to drug;response to hydrostatic pressure;positive regulation of endothelial cell apoptotic process	extracellular region;collagen trimer;basement membrane;extracellular space;endoplasmic reticulum lumen;extracellular matrix;collagen-containing extracellular matrix;extracellular exosome	extracellular matrix structural constituent;extracellular matrix structural constituent conferring tensile strength;metal ion binding	ITGB1[17615292];COL18A1[16269408;11956183];APP[19542224;28106549];MMP2[17615292];PYHIN1[25665578];TPM1[17615292];PCOLCE[24117177];HSCB[28380382];THBS1[19542224];AHI1[22623184];NCL[19877579;17615292];ITGA5[17615292];TECPR1[20562859];TGM2[19542224];
33275	chr9	19082890	A	G	chr9:19082890	HAUS6	HAUS augmin like complex subunit 6	415.0	SNV	0/1	0.45	18_15	33	99	False	rs138226659	EXONIC	YES	NM_017645.5	Transcript	protein_coding	missense_variant		8/17	NM_017645.5:c.851T>C	NP_060115.3:p.Ile284Thr		-1.0	.,.					.	.	.		0.000197122	30.0	152190.0	0.0	32	0.96	PASS	sas	0.000413907	2.0	0.000293979	20.0	0.000147345	27.0	183244.0	0.0	17	0.43	PASS	sas	0.00020286	4.0	0.00013083	12.0	0.0001543	24	0.002	5.0				24.5	3.359959	0.642	7	13	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,MutationAssessor_pred,PROVEAN_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	HAUS6	0.01	0.0	0.0	0.0	17.0	-5.0	-19.0	2.0						0.942	0.0	0.0	0.997	1.295	embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype; 			.	.	G2/M transition of mitotic cell cycle;centrosome cycle;regulation of G2/M transition of mitotic cell cycle;spindle assembly;cell division;ciliary basal body-plasma membrane docking	centrosome;microtubule organizing center;spindle;cytosol;microtubule;nuclear speck;HAUS complex	molecular_function;protein binding	KDM1A[23455924;unassigned1312];CEP120[26638075];CCP110[26638075];YEATS4[unassigned1312];HSCB[28380382];YBX3[19369198];CEP128[26638075];EEA1[29568061];PSMD9[unassigned1312];RABGEF1[unassigned1312];PCM1[26638075];GOLGA5[unassigned1312];CNTRL[26638075];NUF2[unassigned1312];CEP170[26638075];OIP5[unassigned1312];HMG20A[unassigned1312];CCHCR1[unassigned1312];RBM7[19369198];CEP290[26638075];NINL[26638075];CCDC93[unassigned1312];OFD1[26638075];GRIPAP1[unassigned1312];CEP135[26638075];PARP2[21812934];HAUS4[20360068;19369198];SPICE1[26638075];HAUS3[20360068;19369198];HAUS5[20360068;19369198];RPGRIP1L[26638075];HAUS2[20360068;26496610;19369198;25173975];NIPSNAP1[26496610];HAUS1[20360068;19369198;25173975];POC5[26638075];KATNAL2[26929214];CEP63[26638075];PHLDB3[unassigned1312];EZR[29568061];SSX2IP[26638075];CLOCK[unassigned1312];CEP104[26638075];NLRX1[21903422];DCTN1[26638075];PKN3[unassigned1312];MAX[unassigned1312];TUFT1[unassigned1312];TAF9[20195357];FBF1[26638075];PHF21A[unassigned1312];ARNTL[unassigned1312];TFPT[unassigned1312];HAUS8[20360068;19369198;25173975];VPS51[unassigned1312];HAUS7[20360068;19369198];VPS50[unassigned1312];VPS53[unassigned1312];KIAA0753[26638075];RPRD1A[unassigned1312];UVRAG[20562859];GIT2[unassigned1312];JUN[unassigned1312];RABGAP1L[unassigned1312];CAVIN1[unassigned1312];ODF2[26638075];CEP152[26638075];NCKAP5L[unassigned1312];LCA5[26638075];THAP11[unassigned1312];RPGRIP1[26638075];NEDD1[19369198];NIN[26638075];H1F0[30021884];CENPJ[26638075];SASS6[26638075];CEP162[26638075];CEP44[26638075];DZIP3[unassigned1312];RCOR1[unassigned1312];CEP89[26638075];
33724	chr12	40697943	C	T	chr12:40697943	LRRK2	leucine rich repeat kinase 2	428.0	SNV	0/1	0.42	22_16	38	99	False	rs41286480	SPLICING	YES	NM_198578.4	Transcript	protein_coding	splice_region_variant,intron_variant	27/50		NM_198578.4:c.3777+7C>T			1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Parkinson_disease_8,_autosomal_dominant|not_specified	{Parkinson disease 8}, 607060 (3), Autosomal dominant	Young-onset Parkinson disease;Hereditary late-onset Parkinson disease	Candidate gene tested in;Disease-causing germline mutation(s) (gain of function) in	Chronic constipation;Rigidity;Dyskinesia;Orthostatic hypotension due to autonomic dysfunction;Impulsivity;Schizophrenia;Hypomimic face;Visual hallucinations;Muscle spasm;Resting tremor;Frequent falls;Low frustration tolerance;Depressivity;Gliosis;Bradykinesia;Lewy bodies;Weight loss;Dysphagia;Hyposmia;Dystonia;Postural instability;Parkinsonism with favorable response to dopaminergic medication;Cerebral cortical atrophy;Dementia;Sleep disturbance;Monotonic speech;Agitation;Apathy;Akinesia;Shuffling gait;Spastic/hyperactive bladder;Diplopia;Abnormal autonomic nervous system physiology;Male sexual dysfunction;Hallucinations;Tremor;Insomnia;Short attention span;Postural instability;Rigidity;Dyskinesia;Constipation;Impulsivity;Frontal lobe dementia;Gastroparesis;Impaired social interactions;Nausea;Anxiety;Hyposmia;Female sexual dysfunction;Dystonia;Color vision defect;Hyperreflexia;Diarrhea;Gait imbalance;Apathy;Bradykinesia;Restless legs;Diplopia;Spasticity;Muscle spasm;Agitation;Panic attack;Depressivity;Lewy bodies;Rigidity;Resting tremor;Dementia;Hyposmia;Postural instability;Substantia nigra gliosis;Autosomal dominant inheritance;Bradykinesia;Parkinsonism with favorable response to dopaminergic medication;Slow progression;Incomplete penetrance		0.000947668	144.0	151952.0	0.0	32	0.97	PASS	nfe	0.00163432	111.0	0.00163432	111.0	0.000962217	240.0	249424.0	0.0	42	0.95	PASS	nfe	0.00161522	182.0	0.00161522	182.0	0.0011447	178	0.001	3.0	0.00088	10.0		0.335	-0.312637		0	0	0			LRRK2	0.0	0.0	0.0	0.0	-46.0	-7.0	-2.0	-7.0	0.0001020235246039	0.26				0.869	0.0	0.0			pigmentation phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; 			dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;whole blood;skeletal muscle;	Neurodegenerative Diseases	MAPK cascade;activation of MAPKK activity;activation of MAPK activity;negative regulation of protein phosphorylation;positive regulation of protein phosphorylation;protein phosphorylation;endocytosis;autophagy;response to oxidative stress;mitochondrion organization;endoplasmic reticulum organization;Golgi organization;lysosome organization;spermatogenesis;neuromuscular junction development;determination of adult lifespan;cellular response to starvation;regulation of autophagy;positive regulation of autophagy;regulation of protein kinase A signaling;negative regulation of protein processing;negative regulation of neuron projection development;regulation of neuron maturation;negative regulation of macroautophagy;phosphorylation;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;calcium-mediated signaling;striatum development;olfactory bulb development;tangential migration from the subventricular zone to the olfactory bulb;positive regulation of protein ubiquitination;negative regulation of protein binding;positive regulation of protein binding;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;obsolete positive regulation of protein import into nucleus, translocation;negative regulation of GTPase activity;cellular response to oxidative stress;cellular protein localization;intracellular signal transduction;regulation of kidney size;exploration behavior;locomotory exploration behavior;regulation of lysosomal lumen pH;regulation of locomotion;regulation of membrane potential;positive regulation of programmed cell death;positive regulation of MAP kinase activity;positive regulation of GTPase activity;GTP metabolic process;protein autophosphorylation;intracellular distribution of mitochondria;neuron projection morphogenesis;mitochondrion localization;positive regulation of nitric-oxide synthase biosynthetic process;regulation of mitochondrial depolarization;regulation of synaptic transmission, glutamatergic;canonical Wnt signaling pathway;excitatory postsynaptic potential;regulation of dopamine receptor signaling pathway;positive regulation of dopamine receptor signaling pathway;regulation of ER to Golgi vesicle-mediated transport;regulation of canonical Wnt signaling pathway;regulation of dendritic spine morphogenesis;protein localization to mitochondrion;protein localization to endoplasmic reticulum exit site;neuron death;cellular response to manganese ion;reactive oxygen species metabolic process;regulation of mitochondrial fission;positive regulation of canonical Wnt signaling pathway;negative regulation of excitatory postsynaptic potential;neuron projection arborization;positive regulation of synaptic vesicle endocytosis;regulation of neuron death;negative regulation of neuron death;positive regulation of histone deacetylase activity;negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;positive regulation of protein autoubiquitination;regulation of neuroblast proliferation;regulation of synaptic vesicle transport;negative regulation of late endosome to lysosome transport;negative regulation of autophagosome assembly;negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation;negative regulation of hydrogen peroxide-induced cell death;negative regulation of protein targeting to mitochondrion;negative regulation of protein processing involved in protein targeting to mitochondrion;cellular response to dopamine;positive regulation of microglial cell activation;positive regulation of tumor necrosis factor secretion;Wnt signalosome assembly;regulation of retrograde transport, endosome to Golgi;regulation of CAMKK-AMPK signaling cascade;regulation of branching morphogenesis of a nerve;regulation of synaptic vesicle exocytosis	extracellular space;nucleus;cytoplasm;mitochondrion;mitochondrial outer membrane;mitochondrial inner membrane;mitochondrial matrix;lysosome;endosome;endoplasmic reticulum;Golgi apparatus;Golgi-associated vesicle;trans-Golgi network;cytosol;plasma membrane;microvillus;inclusion body;cell junction;axon;dendrite;growth cone;synaptic vesicle membrane;cytoplasmic vesicle;mitochondrial membrane;cytoplasmic side of mitochondrial outer membrane;dendrite cytoplasm;neuron projection;neuronal cell body;terminal bouton;perikaryon;intracellular membrane-bounded organelle;amphisome;autolysosome;membrane raft;extracellular exosome;endoplasmic reticulum exit site;multivesicular body, internal vesicle;postsynapse;glutamatergic synapse;caveola neck;presynaptic cytosol;ribonucleoprotein complex;Wnt signalosome	SNARE binding;actin binding;GTPase activity;protein kinase activity;protein serine/threonine kinase activity;MAP kinase kinase activity;GTPase activator activity;protein binding;ATP binding;GTP binding;microtubule binding;tubulin binding;kinase activity;Rho GTPase binding;syntaxin-1 binding;receptor signaling complex scaffold activity;clathrin binding;GTP-dependent protein kinase activity;peroxidase inhibitor activity;co-receptor binding;identical protein binding;protein homodimerization activity;ion channel binding;protein kinase A binding;beta-catenin destruction complex binding	CYFIP2[24725412];CYFIP1[24725412];RPL30[24725412];NUP107[24725412];RPL3[24725412];WIPF1[24510904];RPL34[24725412];HNRNPR[24725412];EPRS[17400507];RPL9[24725412];PSMD6[24725412];PSMD5[24725412];PSMD2[24725412];AKT2[24947832];DPYSL3[24947832];AKT1[21658387];PRKACA[24351927;24464040];RPL39[24725412];CHGB[24510904;24947832;29513927];WSB1[27273569];RPL21[24725412];DAPK1[19712061];RPL23[24725412];HOGA1[24947832];MYL6[24725412];MYL1[24725412];MTHFD2[24725412];MAP1B[24754922];CLNS1A[24947832];DDIT4[29513927];YME1L1[24725412];RPL24[24725412];ZSCAN26[24947832];PADI4[24510904];MYL9[24510904];GTSF1[29513927];RHNO1[24947832];PRKDC[17400507];MRPL19[29513927];RNF219[24947832];IQGAP1[21983832];HACD3[24725412];RPS4Y1[24725412];SKA3[29513927];IQGAP3[24725412];PRDX3[21850687;24459295];LDHB[24725412];LDHA[24725412];PRPSAP2[24947832];CEP72[24947832];SFN[24510904];IGHA1[24725412];SNAPIN[23949442];FZD5[22899650];PLK1[24510904];TEX33[24947832];NFATC2[21983832];LARP7[29513927];MRPL28[29513927];LARP4[29513927];LAS1L[24725412];AGO1[17400507];AGO2[17400507;20671708];MMS19[24725412];SFXN1[24725412];PSMG1[24947832];FARSA[24725412];HIST2H2AA3[24725412];PYGB[24725412];TCF25[24947832];CLTC[17400507];RPLP0[24725412];TAF7L[24947832];TUBA1C[24275654];TUBA1B[24275654];TUBA1A[24275654;24725412];AIFM1[24725412];C17orf53[26496610];NKRF[24947832];RACK1[24725412];SPIN1[24947832];TK1[26496610];EMD[23075850];LRRC47[24725412];HELLS[24725412];DFFB[24947832];DFFA[23075850];SSR4[24725412];POU5F1[29513927];DDB1[24725412];PHF20L1[29513927];TUBB2B[24275654];TUBB2A[24275654];TGIF2LX[29513927];CDC42EP3[24947832;29513927];VN1R1[29513927];SMTNL2[29513927];RAPGEF4[29513927];SF3B2[24725412];ECHS1[24510904;24947832];SF3B3[24725412];AHNAK[30021884];RPL12[24725412];RPL11[24725412];PTGS2[24725412];RPS15A[24725412];TP53TG3[24947832];PPP1R8[24510904];RPL14[24725412];RPS3[24725412];MFN2[24282027];RPL13[24725412];RPS2[24725412];SF3B1[24725412];RPL17[24725412];RPL19[24725412];CCL21[24947832];CSNK1A1[25500533];APEX2[29513927];TUBB4B[24275654];TUBB4A[24275654];CENPF[23075850];PSMC6[24725412];TTLL1[29513927];ANKS4B[24947832;29513927];COQ8A[24725412];LIMS2[24947832];RIF1[23075850];RASL11B[29513927];IRS1[24947832];CSE1L[21983832];FAM107A[24947832];RPL10A[24725412];IPO5[24725412];PPP1CB[23937259];PPP1CC[23937259];TUBB6[24275654];TUBB3[24275654];RUVBL2[23075850];LAMP2[23455607];TUBB1[24275654];NEK1[24510904;24947832];HMGN2[24947832];C18orf25[29513927];AP2M1[24725412];GTF2I[24725412];NOMO2[24725412];MAP2K3[20067578;20173330];CSNK1G3[25500533];CDKL3[29513927];SERF1A[29513927];RPS7[24725412];RPS8[24725412];RPS5[24725412];VASH2[24510904];THOC1[24725412];RPSA[24947832];CHD1L[26496610];CDC25A[24947832];ENKUR[24510904];RAB32[25360523];ACLY[24725412];MSH2[24725412];NCL[23075850;24725412];MSH5[24725412];ERG[24947832];KPNB1[24725412];CSNK1G2[25500533];CSNK1G1[25500533];RAB5B[18445495;25605758;27314038];CNP[24725412];UQCRB[29513927];PHB[24725412];NTPCR[24725412];RAD51AP1[29513927];STIP1[24510904];STK33[24947832];BAG5[24510904;24947832];KLC2[29513927];BAG2[24510904;29513927];BAG3[24510904];DVL1[19625296];TPR[23075850];BAG1[24510904];DVL2[19625296];SAFB2[23075850];ABL1[24947832];DVL3[19625296];ABL2[24947832];MAP2K7[20067578];MDN1[17400507];MAP2K6[20067578];FANCM[29513927];NEK4[25798074];SEC16A[25201882];PYM1[24947832];ESRRG[29513927];EEF2[24725412];CHERP[24947832];FAM90A1[29513927];CXCL11[24510904];IRAK1BP1[24947832];CDK2[24725412];BCL2[25446991];PDCL[29513927];SLC25A1[24725412];TCP10L[29513927];DIDO1[29513927];HSP90AB1[20642453;17400507;23075850;24947832];NUMA1[23075850];LRRK2[22363216;18397888;22952686;19712061;20515039;23220480;23241358;19733152;21073465;16321986;24275654;24591621;24904275;26824392;27357661;27013965;18230735];TRADD[19176810];LRRK1[19712061;20144646];OPA1[24282027];AP1G2[24725412];PGM3[24725412];WDR5[24725412];TNPO1[21983832];DNM1L[22639965;22228096;23813973;24282027];LBR[24725412];HSP90AA1[20642453;17400507;23075850;24947832];DIS3[24725412];ATRX[26496610];ARFGAP1[22363216;29513927];PKM[24725412];FAM27E3[24947832];MCM3[24725412];CCDC43[24510904];SLC25A5[21370995;24725412];SLC25A4[21370995;24725412];SLC25A11[24725412];AHDC1[29513927];SLC25A6[21370995;24725412];RAB1A[26824392];NDUFB4[24725412];RAB1B[26824392];VPS4A[24725412];RPL36A[24725412];TTK[24947832];MLLT3[24510904];NSL1[24510904];LRP6[22899650;27013965];CDC42[21454543;21048939];ABLIM1[29513927];NCLN[24725412];RBBP4[23075850];RAB29[24510904];RBBP8[24947832];XIRP2[24510904];RBBP6[23075850];RBBP7[23075850];E2F4[29513927];WASF1[24725412];SLC25A22[24725412];WASF2[24725412];EIF4B[24947832];POLR2M[29513927];ADRM1[24947832];RPL23A[24725412];PML[23075850];MYO1D[24725412];DNAJA1[24725412];RAB10[26824392];MYO1B[24725412];MYO1C[24725412];EIF3L[24725412];RAB12[26824392];EIF3J[24947832];PDCD4[24947832];STUB1[24510904;19196961;29513927];ALDH8A1[24725412];SMAP1[24725412];PFKP[24725412];CMAS[24947832];AHCYL1[29513927];CALML5[24725412];CBLB[29513927];MKI67[23075850];RPS15[24725412;24947832;26824392];RPS14[24725412];RPS16[24725412];RPS19[24725412];PPP2R1A[21983832];RPS18[24725412];SPATA24[24947832];LGALS8[24510904;29513927];RPS11[24725412];RPS13[24725412];TBC1D22B[29513927];TMPO[23075850];ACSL5[24725412];MOGS[24725412];CSNK1D[25500533];CSNK1E[25500533];MAPK8IP2[20173330];AFG3L2[24725412];CDC37[20642453;22612223;16321986;18367605;23075850];CD2BP2[24947832];VDAC1[21370995];TP53[24725412];TRIB2[24947832];KCTD18[29513927];SUPT4H1[29513927];PIK3R1[29513927];RPAP3[24510904];SCFD1[17400507];MRNIP[24947832];SNX9[24947832];FAM192A[29513927];FADD[19176810];TP53BP1[23075850];RAB11FIP2[24510904];FIS1[22639965];TRAP1[24725412];ZRANB2[23075850;29513927];STAC[24510904];PYCR1[24725412];SRPK1[17400507];RPS27[24725412];ZZZ3[24947832];NDUFAF7[24510904;29513927];RPS20[24725412;24947832];MAGED2[24725412];LDHAL6A[24725412];RPS23[24725412];TAS2R60[29513927];WT1-AS[29513927];CETN3[29513927];SPTLC1[24725412];ACTR1B[24725412];ZMYM5[29513927];UFD1[24510904];DHX16[24725412];RAC1[21454543];RAB8A[26824392];CCT3[24725412];TUBB[24275654;24947832];AP3B1[24725412];TUBG1[24725412];RHOA[21454543];GAK[24510904;24947832;29513927];KIF2A[24725412];MAPT[22303461;24113872];HNRNPH3[24725412];ARHGEF7[21048939;25500533];STK40[24510904];VGLL4[29513927];PRKN[16352719];SP100[24947832];PCNA[24725412];FAM47B[24510904];AKAP8[17400507];FAAP24[24947832];SCEL[29513927];PAK1[21454543];ATP5F1A[24725412];IGKC[24725412];FAM184A[29513927];LMNA[23075850];PAK6[24510904;24947832];GPBP1L1[24947832];JHY[29513927];CCT5[24725412];RANBP2[23075850];RANBP1[23075850];NPM1[23075850];COX6C[24725412];PPP1CA[23937259];RIT1[29513927];ATP5PO[24725412];TCEA2[29513927];COPG2[24725412];SH3GL3[22998870];UBE3C[24725412];ZFAND5[24510904];DUX3[24510904];GIMAP8[24947832];ACTG1[24725412];EFTUD2[24725412];RGS2[24794857];RGS1[24947832];KHSRP[24725412];SH3GL2[22998870;25501810];SH3GL1[22998870];MATK[24510904;24947832];PPP4R3A[24947832];TUFM[24725412];DPM3[24725412];PRPF6[24725412];EEF1A2[19559761];EOGT[24947832];MATR3[23075850];HIST1H2BB[24725412];GEMIN8[24947832];DDX5[24725412];PSMD11[21983832];TOR1AIP2[24947832];DAPP1[24947832];TOR1AIP1[24725412];NUP160[24725412];RIPK1[19176810];SUDS3[24947832];HSPA9[17400507];HSPA8[17400507;23455607;24510904;24947832];CBX3[23075850];RHBDD1[29513927];MSN[22363216;20642453;22952686;23241358;24351927;24695735;24904275;25009464;26824392;27357661];NUP153[23075850];CWC15[24947832];DIAPH1[24725412];MRGBP[24510904];NAT1[24725412];UBXN10[29513927];COPE[24725412];YWHAE[20642453;23075850;24725412;24947832];GSK3B[24165324];DDX3X[24725412];DYRK2[29513927];YWHAB[20642453;24510904;24947832];HSPB1[24725412];ATP2A2[24725412];USP39[29513927];AFF4[29513927];LMNB2[23075850];TTC27[29513927];LMNB1[23075850];HK1[24725412];YWHAQ[20642453;23075850;24351927;24947832];NUP62[23075850];CYREN[29513927];POLE[24947832];YWHAG[20642453;23075850;24947832];YWHAH[20642453;23075850];CAMK1D[24510904];NUP133[24725412;24947832];C1orf87[29513927];SPATS2[29513927];RPS3A[24725412];SAFB[23075850];YWHAZ[20642453;23075850;24351927;24510904;24947832];SENP3[24725412];CKAP5[24725412];DNM1[24282027];ETV5[24947832];C8orf59[24510904];EEF1G[24725412];LATS1[29513927];FCHSD1[29513927];ACTA1[24725412];ZAP70[29513927];VGF[24947832];EEF1D[24947832];NUP50[23075850];CPTP[24947832];NCBP3[29513927];CUEDC1[24510904;29513927];ITGB3BP[29513927];SLFN5[24725412];POLDIP3[24947832];DBF4B[24510904];SAMHD1[24725412];TROVE2[24725412];AURKC[24947832];AURKB[29513927];MTA1[24510904];POLD1[24725412];MKNK2[24947832];EPS8L2[24947832];CAMK2G[24725412];CFAP20[24947832];SNCA[23183827];PTCD3[24725412];RBM39[24725412];STN1[29513927];KDM4D[29513927];QPCTL[24947832];NAP1L4[23075850];RPS6KB2[29513927];ACIN1[23075850];VIM[17400507];TAF4[23075850];ABCE1[24725412];
35630	chr6	47763260	G	T	chr6:47763260	OPN5	opsin 5	477.0	SNV	0/1	0.54	11_13	24	99	False	rs138699473	EXONIC	YES	NM_181744.3	Transcript	protein_coding	synonymous_variant		4/7	NM_181744.3:c.717G>T	NP_859528.1:p.Arg239%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.001656	252.0	152174.0	1.0	32	0.96	PASS	sas	0.00372208	18.0	0.0026609	181.0	0.00207854	522.0	251138.0	1.0	75	1.0	PASS	sas	0.00320136	98.0	0.00259926	295.0	0.0018713	291	0.002	6.0				12.18	0.82979		0	0	0			OPN5	0.0	0.0	0.0	0.0	9.0	-41.0	-42.0	39.0						0.346	0.95	80.824732823			vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			ciliary ganglion;superior cervical ganglion;skeletal muscle;	.	G protein-coupled receptor signaling pathway;visual perception;phototransduction;detection of visible light;protein-chromophore linkage;cellular response to light stimulus	integral component of plasma membrane	11-cis retinal binding;G protein-coupled photoreceptor activity	.
36421	chr10	102054830	C	T	chr10:102054830	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	504.0	SNV	0/1	0.55	13_16	29	99	False	rs531470373,COSV58395561	EXONIC	YES	NM_016112.3	Transcript	protein_coding	synonymous_variant		8/16	NM_016112.3:c.1407G>A	NP_057196.2:p.Thr469%3D		-1.0						.	.	.		7.23323e-05	11.0	152076.0	0.0	31	0.95	PASS	eas	0.000384615	2.0	7.35056e-05	5.0	0.000103407	26.0	251434.0	0.0	72	1.0	PASS	eas	0.000924214	17.0	8.79368e-06	1.0	0.0000772	12						2.386	-0.016223		0	0	0			PKD2L1	0.0	0.01	0.0	0.0	-19.0	50.0	43.0	-41.0						0.632	0.0	2.479659119			nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); taste/olfaction phenotype; 			skeletal muscle;	.	detection of chemical stimulus involved in sensory perception of sour taste;cation transport;smoothened signaling pathway;response to water;sodium ion transmembrane transport;detection of chemical stimulus involved in sensory perception of taste;sensory perception of sour taste;detection of mechanical stimulus;protein homotetramerization;calcium ion transmembrane transport;cellular response to acidic pH;potassium ion transmembrane transport;inorganic cation transmembrane transport	endoplasmic reticulum;plasma membrane;integral component of plasma membrane;cell surface;membrane;integral component of membrane;calcium channel complex;intracellular membrane-bounded organelle;receptor complex;ciliary membrane;non-motile cilium	calcium activated cation channel activity;cation channel activity;calcium channel activity;sodium channel activity;calcium ion binding;protein binding;cytoskeletal protein binding;cation transmembrane transporter activity;calcium-activated potassium channel activity;sour taste receptor activity;identical protein binding;muscle alpha-actinin binding;alpha-actinin binding	CLDN19[25910212];PKD1L3[18535624];
36450	chr17	7096390	G	A	chr17:7096390	DLG4	discs large MAGUK scaffold protein 4	506.0	SNV	0/1	0.44	14_11	25	99	False	rs35441057	EXONIC	YES	NM_001365.4	Transcript	protein_coding	synonymous_variant		19/22	NM_001365.4:c.1869C>T	NP_001356.1:p.Tyr623%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided	Intellectual developmental disorder 62, 618793 (3), Autosomal dominant	.	.	.		0.00380686	579.0	152094.0	1.0	31	0.95	PASS	nfe	0.00592612	403.0	0.00592612	403.0	0.00406439	1008.0	248008.0	3.0	84	1.0	PASS	nfe	0.00599188	670.0	0.00599188	670.0	0.0036977	575	0.009	28.0	0.00693	66.0		10.54	0.626375		0	0	0			DLG4	0.16	0.01	0.0	0.0	-22.0	46.0	-23.0	18.0						0.424	1.0	75.529919781			nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; 			caudate nucleus;pons;ciliary ganglion;temporal lobe;amygdala;prefrontal cortex;superior cervical ganglion;cingulate cortex;trigeminal ganglion;parietal lobe;medulla oblongata;cerebellum;	Tight junction	MAPK cascade;negative regulation of receptor internalization;signal transduction;positive regulation of cytosolic calcium ion concentration;chemical synaptic transmission;nervous system development;learning;synaptic vesicle maturation;protein localization to synapse;cellular response to potassium ion;receptor clustering;establishment of protein localization;regulation of long-term neuronal synaptic plasticity;positive regulation of synaptic transmission;dendritic spine morphogenesis;positive regulation of protein tyrosine kinase activity;protein-containing complex assembly;AMPA glutamate receptor clustering;receptor localization to synapse;cell-cell adhesion;postsynaptic neurotransmitter receptor diffusion trapping;positive regulation of neuron projection arborization;regulation of NMDA receptor activity;positive regulation of excitatory postsynaptic potential	cytoplasm;endoplasmic reticulum;cytosol;plasma membrane;synaptic vesicle;voltage-gated potassium channel complex;ionotropic glutamate receptor complex;postsynaptic density;cell junction;endocytic vesicle membrane;cortical cytoskeleton;extrinsic component of cytoplasmic side of plasma membrane;neuromuscular junction;AMPA glutamate receptor complex;dendrite cytoplasm;neuron projection;dendritic spine;juxtaparanode region of axon;neuron projection terminus;neuron spine;synapse;postsynaptic membrane;excitatory synapse;postsynaptic density membrane	Ras guanyl-nucleotide exchange factor activity;protein binding;protein C-terminus binding;kinase binding;protein phosphatase binding;PDZ domain binding;beta-1 adrenergic receptor binding;D1 dopamine receptor binding;P2Y1 nucleotide receptor binding;acetylcholine receptor binding;ionotropic glutamate receptor binding;protein-containing complex binding;neuroligin family protein binding;scaffold protein binding	APP[20573181];NLGN1[11937501];LRP1[17360663];FRMPD4[30126976];KCNA1[11937501];CTNND2[30126976];KCNA4[11937501];HSPD1[30021884];GRIN2A[11937501;17360663];SIPA1L1[22117215];CYSLTR2[30126976];ERBB4[10725395;16767099];KIF13B[10859302];KIF1B[12097473];DLGAP1[22117215];SPRR2A[18155796];NTRK2[23424281];GUCY1A2[30126976];RALBP1[30126976];CRIPT[11937501;20018661];CDC5L[30126976];GRIN2C[11937501];GRIN2B[11937501;20018661];GRIN1[11937501];GRIN2D[11937501];MED28[16964398];NET1[30126976];TANC1[30126976];ARC[23424281];MDM2[23260144];GRB2[17474147];PKP4[30126976];
42431	chr1	93701881	G	A	chr1:93701881	CCDC18	coiled-coil domain containing 18	550.0	SNV	0/1	0.44	15_12	27	99	False	rs1200156739	EXONIC	YES	NM_001378204.1	Transcript	protein_coding	missense_variant		19/29	NM_001378204.1:c.2537G>A	NP_001365133.1:p.Cys846Tyr		1.0	.,.,.					.	.	.		1.31397e-05	2.0	152210.0	0.0	31	0.97	PASS	amr	0.000130822	2.0	0.0	0.0					41	0.61														21.0	2.144773	0.158	1	16	17	fathmm-MKL_coding_pred	LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	CCDC18	0.0	0.0	0.0	0.0	-7.0	-30.0	-41.0	-1.0								60.509008112	1.0	0.245	.			ciliary ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;globus pallidus;	.	.	.	.	OFD1[26496610;26638075];PCM1[26638075];CEP135[26496610;26638075];POC5[26638075];CCDC13[24816561];ODF2[26638075];CCDC14[26496610];FGFR1OP[26496610];CEP63[26638075];DYNLL1[26496610];KIF7[26496610];CEP128[26638075];
42468	chr22	23438569	C	T	chr22:23438569	GNAZ	G protein subunit alpha z	552.0	SNV	0/1	0.59	11_16	27	99	False	rs17853740	EXONIC	YES	NM_002073.4	Transcript	protein_coding	synonymous_variant		2/3	NM_002073.4:c.687C>T	NP_002064.1:p.Ser229%3D		1.0						.	.	.		0.00262417	399.0	152048.0	1.0	33	0.98	PASS	nfe	0.00401412	273.0	0.00401412	273.0	0.00289451	722.0	249438.0	3.0	81	0.99	PASS	nfe	0.00368412	418.0	0.00368412	418.0	0.0027523	428	0.011	34.0				7.472	0.320297		0	0	0			GNAZ	0.0	0.0	0.0	0.0	-5.0	25.0	40.0	36.0						0.0239	0.89	71.137840417			homeostasis/metabolism phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			amygdala;prefrontal cortex;trigeminal ganglion;cingulate cortex;superior cervical ganglion;cerebellum peduncles;cerebellum;pons;occipital lobe;fetal brain;subthalamic nucleus;whole brain;parietal lobe;globus pallidus;medulla oblongata;thalamus;	Long-term depression	protein folding;G protein-coupled receptor signaling pathway;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	nuclear envelope;endoplasmic reticulum;cytosol;heterotrimeric G-protein complex;plasma membrane;dendrite;cell body	G protein-coupled receptor binding;GTPase activity;protein binding;GTP binding;G-protein beta/gamma-subunit complex binding;G protein-coupled serotonin receptor binding;metal ion binding	STIP1[25036637];GNAZ[25416956];NUDCD3[25036637];FKBPL[25036637];PSMD2[25036637];LRRK1[24947832];HTT[17500595];CACYBP[25036637];AARSD1[25036637];MLF1[25036637];
44566	chr15	42858899	C	T	chr15:42858899	HAUS2	HAUS augmin like complex subunit 2	575.0	SNV	0/1	0.45	17_14	31	99	False	rs189692778,COSV53000904	EXONIC	YES	NM_018097.3	Transcript	protein_coding	missense_variant		6/6	NM_018097.3:c.593C>T	NP_060567.1:p.Ser198Leu		1.0	.,.					.	.	.		1.31435e-05	2.0	152166.0	0.0	32	0.97	PASS	amr	0.00013089	2.0	0.0	0.0	3.9794e-05	10.0	251294.0	0.0	56	1.0	PASS	sas	0.000163356	5.0	8.80127e-06	1.0	0.0000386	6						22.0	2.300126	0.088	6	13	19	PolyPhen,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	HAUS2	0.0	0.0	0.01	0.0	24.0	5.0	5.0	-5.0						0.852	0.0	0.000000000	0.189	0.129	.			ciliary ganglion;pons;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;atrioventricular node;skin;superior cervical ganglion;parietal lobe;globus pallidus;	.	G2/M transition of mitotic cell cycle;centrosome cycle;regulation of G2/M transition of mitotic cell cycle;spindle assembly;cell division;ciliary basal body-plasma membrane docking	centrosome;cytosol;spindle microtubule;HAUS complex	molecular_function;protein binding	FAF2[26496610];CEP120[26638075];TRIOBP[26496610];CEP128[26638075];PCM1[26496610;26638075];PDF[26496610];HAUS8[20360068;26496610;25173975];HAUS7[20360068;26496610;25173975];KIAA0753[26638075];CNTRL[26638075];CEP72[26496610];KIF21B[26496610];MAPK6[21900206];NINL[26638075];HEXIM1[26496610];OFD1[26638075];XRCC4[unassigned1304];CEP152[26638075];SQOR[26496610];CEP131[26496610];HAUS4[20360068;26496610];SPICE1[26638075];HAUS3[20360068;26496610];HAUS6[20360068;26496610;19369198;25173975];HAUS5[20360068;26496610];ACSF3[26496610];SCAMP3[26496610];HAUS1[20360068;26496610;19369198;25173975];NEMF[26496610];POC5[26638075];UQCRQ[26496610];STT3A[26496610];SASS6[26638075];CEP162[26638075];FXYD6[16169070];CEP89[26638075];
44711	chr9	35304702	G	A	chr9:35304702	UNC13B	unc-13 homolog B	576.0	SNV	0|1	0.38	15_9	24	99	False	rs186398141	EXONIC	YES	NM_001371189.2	Transcript	protein_coding	synonymous_variant		9/40	NM_001371189.2:c.5301G>A	NP_001358118.1:p.Lys1767%3D		1.0						.	.	.		0.00214259	326.0	152152.0	1.0	32	0.95	PASS	amr	0.00451866	69.0	0.00294048	200.0					0	0.0							0.0004373	68	0.001	3.0				15.88	1.430119		0	0	0			UNC13B	0.0	0.0	0.0	0.0	-14.0	-16.0	-14.0	-1.0						0.183	0.0				mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	.	chemical synaptic transmission;neuromuscular junction development;positive regulation of synaptic vesicle priming;synaptic vesicle docking;synaptic vesicle priming;synaptic vesicle maturation;negative regulation of synaptic plasticity;synaptic transmission, glutamatergic;intracellular signal transduction;positive regulation of apoptotic process;regulation of short-term neuronal synaptic plasticity;positive regulation of protein secretion;innervation;dense core granule priming;cellular response to glucose stimulus;phagosome maturation;positive regulation of inhibitory postsynaptic potential;presynaptic dense core vesicle exocytosis;positive regulation of defense response to bacterium	Golgi apparatus;cytosol;plasma membrane;membrane;cell junction;synaptic vesicle membrane;neuromuscular junction;early phagosome;presynaptic membrane;terminal bouton;calyx of Held;presynaptic active zone;ribbon synapse;hippocampal mossy fiber to CA3 synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse	calcium ion binding;protein binding;calmodulin binding;phospholipid binding;syntaxin-1 binding;Rab GTPase binding;diacylglycerol binding;GTP-dependent protein binding	TOE1[16169070];WDR48[19615732];ECH1[29426014];
44968	chr2	187541988	A	G	chr2:187541988	ITGAV	integrin subunit alpha V	578.0	SNV	0/1	0.69	11_24	35	99	False	rs201434983	EXONIC	YES	NM_002210.5	Transcript	protein_coding	missense_variant		30/30	NM_002210.5:c.3116A>G	NP_002201.2:p.His1039Arg		1.0	.,.,.					.	.	.		5.91351e-05	9.0	152194.0	0.0	32	0.97	PASS	nfe	5.8808e-05	4.0	5.8808e-05	4.0	0.000139516	35.0	250868.0	0.0	47	0.95	PASS	amr	0.000202934	7.0	7.05617e-05	8.0	0.0000900	14						23.3	2.888818	0.198	9	10	19	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	ITGAV	0.0	0.0	0.0	0.0	-30.0	-17.0	5.0	8.0						0.178	0.48	0.000000000	1.0	1.312	endocrine/exocrine gland phenotype; growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; cellular phenotype; immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; renal/urinary system phenotype; 			caudate nucleus;	Focal adhesion;ECM-receptor interaction;Cell adhesion molecules (CAMs);Regulation of actin cytoskeleton;Small cell lung cancer	angiogenesis;vasculogenesis;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;cell adhesion;cell-matrix adhesion;positive regulation of cytosolic calcium ion concentration;integrin-mediated signaling pathway;positive regulation of cell population proliferation;negative regulation of macrophage derived foam cell differentiation;negative regulation of lipid storage;extracellular matrix organization;positive regulation of cell migration;cell-substrate adhesion;negative regulation of lipid transport;cell adhesion mediated by integrin;positive regulation of osteoblast proliferation;heterotypic cell-cell adhesion;substrate adhesion-dependent cell spreading;endodermal cell differentiation;apolipoprotein A-I-mediated signaling pathway;transforming growth factor-beta secretion;apoptotic cell clearance;neutrophil degranulation;negative regulation of low-density lipoprotein particle receptor biosynthetic process;positive regulation of cell adhesion;viral entry into host cell;vascular endothelial growth factor receptor signaling pathway;negative regulation of lipoprotein metabolic process;regulation of phagocytosis;leukocyte migration;negative chemotaxis;entry of symbiont into host cell by promotion of host phagocytosis;ERK1 and ERK2 cascade;calcium ion transmembrane transport;extrinsic apoptotic signaling pathway in absence of ligand;regulation of transforming growth factor beta activation;negative regulation of entry of bacterium into host cell;negative regulation of extrinsic apoptotic signaling pathway	cytosol;plasma membrane;integral component of plasma membrane;focal adhesion;integrin complex;external side of plasma membrane;cell surface;membrane;lamellipodium membrane;filopodium membrane;microvillus membrane;ruffle membrane;integrin alphav-beta3 complex;integrin alphav-beta5 complex;integrin alphav-beta6 complex;integrin alphav-beta8 complex;specific granule membrane;alphav-beta3 integrin-PKCalpha complex;alphav-beta3 integrin-IGF-1-IGF1R complex;alphav-beta3 integrin-HMGB1 complex;phagocytic vesicle;extracellular exosome	virus receptor activity;opsonin binding;fibronectin binding;protease binding;protein kinase C binding;integrin binding;voltage-gated calcium channel activity;protein binding;coreceptor activity;fibroblast growth factor binding;C-X3-C chemokine binding;insulin-like growth factor I binding;neuregulin binding;metal ion binding;transforming growth factor beta binding;extracellular matrix binding;extracellular matrix protein binding	ITGB1[22178926];TGFB1[21677751];ITGB5[1694173];VWF[1694173];TGFB3[25383667];ITGB3[11546839;11884718;15299032;1694173;20639902;16099422;22178926;24658351];FGG[24789099];FN1[1694173;19738201;24658351];PTK2[23397142];AGMAT[unassigned1312];VTN[1694173];PTPRZ1[20639902];LAMP1[29568061];ANGPTL3[11877390];ITGB8[1918072];ITGB6[21677751;25383667];PLPP3[16099422];
46422	chr11	75277974	C	A	chr11:75277974	SERPINH1	serpin family H member 1	605.0	SNV	0/1	0.59	17_24	41	99	False	rs141721173,COSV63997750	EXONIC	YES	NM_001207014.3	Transcript	protein_coding	missense_variant		3/6	NM_001207014.3:c.580C>A	NP_001193943.1:p.Arg194Ser		1.0	Serpin domain&Serpin domain&Serpin H1 inhibitory domain,Serpin domain&Serpin domain&Serpin H1 inhibitory domain,Serpin domain&Serpin domain,Serpin domain&Serpin domain,Serpin domain&Serpin domain,Serpin domain&Serpin domain&Serpin H1 inhibitory domain,Serpin domain&Serpin domain,Serpin domain	Uncertain_significance	criteria_provided,_multiple_submitters,_no_conflicts	Preterm_premature_rupture_of_membranes|Osteogenesis_imperfecta_type_10|not_provided	{Preterm premature rupture of the membranes, susceptibility to}, 610504 (3); Osteogenesis imperfecta, type X, 613848 (3), Autosomal recessive	Osteogenesis imperfecta type 3	Disease-causing germline mutation(s) in	Broad ribs;Inguinal hernia;Short stature;Autosomal recessive inheritance;Narrow forehead;Midface retrusion;Narrow chest;High forehead;Generalized hypotonia;Nephrolithiasis;Platyspondyly;Triangular face;Generalized joint laxity;Micrognathia;Scoliosis;Vertebral compression fractures;Prominent forehead;Pyloric stenosis;Osteopenia;Blue sclerae;Thin ribs;Chronic lung disease;Relative macrocephaly;Shallow orbits;Micromelia;Dentinogenesis imperfecta;Malar flattening;Genu valgum;High pitched voice;Premature rupture of membranes;Polygenic inheritance		0.000958924	146.0	152254.0	0.0	34	0.98	PASS	nfe	0.0014111	96.0	0.0014111	96.0	0.000730098	175.0	239694.0	0.0	70	0.98	PASS	nfe	0.00115521	128.0	0.00115521	128.0	0.0007074	110	0.002	8.0	0.00167	19.0		19.9	2.020855	0.102	5	13	18	M-CAP_pred,MutationTaster_pred,FATHMM_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	SERPINH1	0.0	0.0	0.0	0.0	-42.0	22.0	46.0	40.0						0.12	0.17	0.000000000	0.996	1.026	skeleton phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; embryo phenotype; craniofacial phenotype; growth/size/body region phenotype; 			lung;uterus;smooth muscle;adipose tissue;uterus corpus;placenta;fetal lung;heart;	.	chondrocyte development involved in endochondral bone morphogenesis;response to unfolded protein;negative regulation of endopeptidase activity;collagen fibril organization;collagen biosynthetic process;protein maturation	extracellular space;endoplasmic reticulum;endoplasmic reticulum lumen;endoplasmic reticulum-Golgi intermediate compartment;membrane raft;collagen-containing extracellular matrix	RNA binding;serine-type endopeptidase inhibitor activity;collagen binding;unfolded protein binding	SLC35F6[16169070];ATF2[22304920];YBX1[22118625];METTL14[29507755];TUBA1A[29568061];NUDCD1[29021621];AIFM1[29568061];MYC[21150319];TCTN1[26638075];IQCB1[21565611];PDIA3[30021884];GABARAPL2[20562859];PRMT8[30021884];TSC22D1[17353931];AARSD1[25036637];H1FX-AS1[30021884];SDHA[29128334];BANK1[30021884];FEZ1[21900206];VDAC1[29128334];CRELD2[21900206];PPIB[30021884];PIGG[30021884];DLD[29128334];FKBP5[30021884];COX15[29128334];UBR4[30021884];DLST[29128334];FURIN[30021884];HSD17B10[29128334];TGOLN2[29568061];ADAMTS16[30021884];CEP70[21900206];BSND[30021884];JUN[25609649];NOP58[30021884];PDHA1[29128334];ERVK-19[30021884];RRP1B[20926688];ESR1[21182205];PLEKHA7[28877994];RAB11A[29568061];SOD1[29128334];NSG2[21900206];JMY[30021884];RAB9A[29568061];GRB2[12577067];CALR[30021884];BET1[29568061];
46945	chr5	16779748	T	C	chr5:16779748	MYO10	myosin X	615.0	SNV	0/1	0.57	10_13	23	99	False	rs191119959	EXONIC	YES	NM_012334.3	Transcript	protein_coding	missense_variant		9/41	NM_012334.3:c.836A>G	NP_036466.2:p.Tyr279Cys		-1.0	Myosin head, motor domain&Myosin head, motor domain&Myosin head, motor domain&Class X myosin, motor domain,Myosin head, motor domain&Myosin head, motor domain&Myosin head, motor domain&Class X myosin, motor domain,Myosin head, motor domain&Myosin head, motor domain&Myosin head, motor domain&Class X myosin, motor domain					.	.	.		0.000144623	22.0	152120.0	0.0	32	0.96	PASS	amr	0.00137507	21.0	0.0	0.0	9.00885e-05	21.0	233104.0	0.0	20	0.51	PASS	amr	0.000589237	18.0	9.30042e-06	1.0	0.0000064,0.0000450	1,7	0.001	3.0				23.1	2.759258	0.234	4	14	18	MutationTaster_pred,FATHMM_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	MYO10	0.02	0.0	0.0	0.0	6.0	12.0	6.0	16.0							0.0	0.000000000	1.0	1.13	craniofacial phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; pigmentation phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; vision/eye phenotype; immune system phenotype; skeleton phenotype; embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; 			caudate nucleus;amygdala;appendix;occipital lobe;prefrontal cortex;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;	.	regulation of cell shape;positive regulation of cell-cell adhesion;cytoskeleton-dependent intracellular transport;Fc-gamma receptor signaling pathway involved in phagocytosis;regulation of filopodium assembly	ruffle;nucleolus;cytosol;plasma membrane;cell cortex;myosin complex;lamellipodium;filopodium membrane;filopodium tip;neuron projection;neuronal cell body	motor activity;protein binding;calmodulin binding;ATP binding;phosphatidylinositol-3,4,5-trisphosphate binding;spectrin binding;actin-dependent ATPase activity;actin filament binding;plus-end directed microfilament motor activity	VASP[15158464];PRKCI[14676191];ITGB5[21642953];FBXW11[19615732];DCC[21642953];CALML3[18570893;25416956];MYO19[26496610];HSP90B1[30021884];ENAH[15158464];TUBB2B[21642953];PARD6B[26496610];TUBA1A[21642953];PLA2G10[16169070];FSCN1[18599451];CALM1[18570893];
47408	chr22	46929838	G	A	chr22:46929838	CELSR1	cadherin EGF LAG seven-pass G-type receptor 1	620.0	SNV	0/1	0.5	12_12	24	99	False	rs142438731	EXONIC	YES	NM_001378328.1	Transcript	protein_coding	missense_variant		1/35	NM_001378328.1:c.3230C>T	NP_001365257.1:p.Thr1077Met		-1.0	Cadherin-like&Cadherin-like	Uncertain_significance	criteria_provided,_single_submitter	not_provided	Lymphatic malformation 9, 619319 (3), Autosomal dominant	.	.	.		0.00111683	170.0	152216.0	0.0	33	0.97	PASS	nfe	0.0019696	134.0	0.0019696	134.0	0.00116179	291.0	250476.0	2.0	100	1.0	PASS	nfe	0.00227883	258.0	0.00227883	258.0	0.0012668	197	0.0	1.0	0.00044	5.0		25.4	3.625087	0.747	9	11	20	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	CELSR1	0.0	0.0	0.0	0.0	-19.0	4.0	35.0	-13.0						0.157	1.0	0.000000000	0.828	1.176	integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; vision/eye phenotype; craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; immune system phenotype; skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; 			lung;kidney;appendix;thyroid;tongue;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Pyruvate metabolism	establishment of planar polarity;neuron migration;neural tube closure;hair follicle development;homophilic cell adhesion via plasma membrane adhesion molecules;G protein-coupled receptor signaling pathway;Rho protein signal transduction;central nervous system development;locomotory behavior;anterior/posterior pattern specification;regulation of actin cytoskeleton organization;wound healing;establishment of planar polarity of embryonic epithelium;inner ear morphogenesis;apical protein localization;establishment of body hair planar orientation;Wnt signaling pathway, planar cell polarity pathway;orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis;planar dichotomous subdivision of terminal units involved in lung branching morphogenesis;lateral sprouting involved in lung morphogenesis;planar cell polarity pathway involved in neural tube closure;protein localization involved in establishment of planar polarity	nucleoplasm;plasma membrane;integral component of plasma membrane;integral component of membrane	transmembrane signaling receptor activity;G protein-coupled receptor activity;calcium ion binding;protein dimerization activity	PSAP[16169070];HSCB[28380382];
52898	chr19	12774196	G	A	chr19:12774196	MAN2B1	mannosidase alpha class 2B member 1	650.0	SNV	0/1	0.52	11_12	23	99	False	rs45576136	EXONIC	YES	NM_000528.4	Transcript	protein_coding	missense_variant		6/24	NM_000528.4:c.844C>T	NP_000519.2:p.Pro282Ser		-1.0	Glycoside hydrolase family 38, N-terminal domain,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Deficiency_of_alpha-mannosidase|not_provided	Mannosidosis, alpha-, types I and II, 248500 (3), Autosomal recessive	Alpha-mannosidosis, infantile form;Alpha-mannosidosis, adult form	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Mandibular prognathia;Spasticity;Vacuolated lymphocytes;Epicanthus;Dysostosis multiplex;Inguinal hernia;Midface retrusion;Generalized hypotonia;Depressed nasal ridge;Gait ataxia;Malar flattening;Widely spaced teeth;Dysarthria;Frontal bossing;Flat occiput;Abnormality of the rib cage;Delayed myelination;Cerebellar atrophy;Retinal degeneration;Growth delay;Macrocephaly;Hypertrichosis;Thick eyebrow;Increased vertebral height;Intellectual disability;Muscular hypotonia;Nystagmus;Hepatomegaly;Hyperreflexia;Babinski sign;Autosomal recessive inheritance;Coarse facial features;Cerebral atrophy;Decreased circulating antibody level;Impaired smooth pursuit;Macrotia;Thickened calvaria;Broad forehead;Thoracolumbar kyphosis;Femoral bowing;Spondylolisthesis;Recurrent bacterial infections;Splenomegaly;Macroglossia;Pectus carinatum;Sensorineural hearing impairment;Gliosis;Spinocerebellar tract disease in lower limbs;Low anterior hairline;Global developmental delay;Limb ataxia;Gingival overgrowth;Umbilical hernia;Cataract;Mitral regurgitation;Abnormality of the sella turcica;Abnormal enzyme/coenzyme activity;Strabismus;Delayed speech and language development;Subcortical cerebral atrophy;Optic disc pallor;Craniosynostosis;Clumsiness;Pectus carinatum;Depressed nasal bridge;Prominent forehead;Short attention span;Pancytopenia;Immunodeficiency;Aortic regurgitation;Astigmatism;Widely spaced teeth;Joint stiffness;Joint laxity;Myopathy;Cortical thickening of long bone diaphyses;Mandibular prognathia;Highly arched eyebrow;Osteopenia;Hypertelorism;Talipes valgus;Corneal opacity;Dysostosis multiplex;Cerebral cortical atrophy;Facial hypotonia;Specific learning disability;Bilateral talipes equinovarus;Short neck;Ataxia;Genu valgum;Otitis media;Pectus excavatum;Hypoplastic inferior ilia;Soft skin;Thickened ribs;Oligosacchariduria;Platyspondyly;Avascular necrosis;Confusion;Loss of speech;Disproportionate tall stature;Flat face;Cranial hyperostosis;Abnormality of the sphenoid sinus;Hallucinations;Recurrent urinary tract infections;Bilateral coxa valga;Arnold-Chiari malformation;Proptosis;Intellectual disability, mild;Drowsiness;Cerebellar atrophy;Coarse facial features;Communicating hydrocephalus;Recurrent gastroenteritis;Hypermetropia;Pneumonia;Osteolysis;Depressivity;Mixed hearing impairment;Broad forehead;Thickened calvaria;Anxiety;Facial shape deformation;Macroglossia;Motor delay;Asthenia;Macrocephaly;Hepatosplenomegaly;Brachycephaly;Infantile axial hypotonia;Delusions;Spastic paraplegia;Myopia;Subcortical cerebral atrophy;Hepatosplenomegaly;Delusions;Oligosacchariduria;Clumsiness;Osteopenia;Cataract;Immunodeficiency;Optic disc pallor;Myopia;Anxiety;Asthenia;Macroglossia;Pancytopenia;Intellectual disability, mild;Aortic regurgitation;Hallucinations;Confusion;Ataxia;Mixed hearing impairment;Cerebral cortical atrophy;Depressivity;Cerebellar atrophy;Drowsiness;Pneumonia;Corneal opacity;Recurrent gastroenteritis;Delayed speech and language development	24767253	0.00280899	427.0	152012.0	1.0	32	0.95	PASS	amr	0.00426174	65.0	0.00422084	287.0	0.00259669	653.0	251474.0	1.0	100	1.0	PASS	amr	0.00361355	125.0	0.00352515	401.0	0.0023729	369	0.008	26.0	0.0078	89.0		17.07	1.635317	0.264	9	12	21	PolyPhen,M-CAP_pred,MetaLR_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	MAN2B1	0.0	0.0	0.0	0.0	15.0	49.0	-13.0	-32.0						0.19	0.0	0.0	0.028	0.168	vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; 			white blood cells;superior cervical ganglion;whole blood;	N-Glycan degradation;Glycan structures - degradation	mannose metabolic process;cellular protein modification process;protein deglycosylation;oligosaccharide catabolic process;neutrophil degranulation	extracellular region;extracellular space;vacuolar membrane;azurophil granule lumen;lysosomal lumen;extracellular exosome	alpha-mannosidase activity;carbohydrate binding;metal ion binding	.
53014	chr5	13737379	G	A	chr5:13737379	DNAH5	dynein axonemal heavy chain 5	655.0	SNV	0/1	0.5	22_22	44	99	False	rs140948493,CM147993,COSV54246221,COSV99450222	EXONIC	YES	NM_001369.3	Transcript	protein_coding	missense_variant		66/79	NM_001369.3:c.11437C>T	NP_001360.1:p.Arg3813Trp		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Primary_ciliary_dyskinesia|Ciliary_dyskinesia,_primary,_3|not_specified|not_provided	Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3), Autosomal recessive	Primary ciliary dyskinesia	Disease-causing germline mutation(s) in	Hydrocephalus;Pectus excavatum;Chronic otitis media;Tachypnea;Impaired nasal mucociliary clearance;Delayed speech and language development;Asthma;Atelectasis;Headache;Ectopic pregnancy;Nasal polyposis;Clubbing of fingers;Pulmonary obstruction;Asplenia;Scoliosis;Reduced sperm motility;Respiratory distress;Immotile cilia;Chronic sinusitis;Infertility;Chronic bronchitis;Corneal dystrophy;Glue ear;Pneumonia;Spontaneous abortion;Conductive hearing impairment;Recurrent respiratory infections;Situs inversus totalis;Cough;Bronchiectasis;Ventriculomegaly;Rhinitis;Halitosis;Recurrent respiratory infections;Situs inversus totalis;Autosomal recessive inheritance;Ciliary dyskinesia	24033266,19357118,24498942	0.00107384	163.0	151792.0	0.0	33	0.96	PASS	nfe	0.00167657	114.0	0.00167657	114.0	0.00121809	306.0	251212.0	1.0	100	1.0	PASS	nfe	0.00190235	216.0	0.00190235	216.0	0.0013633	212	0.001	3.0	0.00123	14.0		31.0	4.353385	0.565	16	5	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred	DNAH5	0.0	0.0	0.0	0.05	-18.0	2.0	-15.0	-18.0						0.942	0.0	0.0	1.0	1.176	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; craniofacial phenotype; 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;	.	cilium movement;microtubule-based movement;determination of left/right symmetry;heart development;lateral ventricle development;flagellated sperm motility;outer dynein arm assembly;cilium assembly	microtubule;axoneme;dynein complex;outer dynein arm;9+2 motile cilium	ATP binding;ATP-dependent microtubule motor activity, minus-end-directed;dynein light chain binding;dynein intermediate chain binding;dynein light intermediate chain binding	EIF4A2[17353931];HIST1H2AH[30021884];HIST3H3[30021884];HIST1H2AE[30021884];RRBP1[30021884];HIST1H2BH[30021884];UBA52[30021884];BICD2[30021884];HIST2H2BE[30021884];PATL2[30021884];PLEC[30021884];
55463	chr12	123089876	A	G	chr12:123089876	KNTC1	kinetochore associated 1	694.0	SNV	0/1	0.44	15_12	27	99	False	rs761745919	EXONIC	YES	NM_014708.6	Transcript	protein_coding	missense_variant		51/64	NM_014708.6:c.5410A>G	NP_055523.1:p.Ile1804Val		1.0	RZZ complex, subunit KNTC1/ROD, C-terminal					.	.	.		0.000137956	21.0	152222.0	0.0	32	0.96	PASS	amr	0.0013089	20.0	0.0	0.0	0.000111856	26.0	232442.0	0.0	23	0.57	PASS	amr	0.000737372	24.0	0.0	0.0	0.0000322	5	0.001	2.0				25.3	3.587008	0.437	9	12	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	KNTC1	0.0	0.0	0.0	0.0	-11.0	34.0	-1.0	-23.0						0.998	0.0	0.0	1.0	1.312	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); limbs/digits/tail phenotype; vision/eye phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			testis - seminiferous tubule;tumor;testis - interstitial;superior cervical ganglion;testis;	.	mitotic cell cycle checkpoint;regulation of exit from mitosis;cell division;protein-containing complex assembly	condensed chromosome kinetochore;spindle pole;nucleus;kinetochore microtubule;cytosol;plasma membrane;actin cytoskeleton;RZZ complex	protein binding	PPP6R1[24255178];ZWILCH[20462495];ZW10[15824131;20462495];ACTR5[26496610];VHL[17353931];NIPSNAP1[26496610];
61979	chr11	102713168	C	A	chr11:102713168	MMP3	matrix metallopeptidase 3	757.0	SNV	0|1	0.17	10_2	12	51	False		EXONIC	YES	NM_002422.5	Transcript	protein_coding	missense_variant		3/10	NM_002422.5:c.493G>T	NP_002413.1:p.Val165Phe		-1.0	Peptidase M10, metallopeptidase&Peptidase, metallopeptidase&Peptidase M10A, catalytic domain				{Coronary heart disease, susceptibility to, 6}, 614466 (3)	.	.	.		4.11557e-05	4.0	97192.0	0.0	22	0.56	AS_VQSR	sas	0.000343879	1.0	1.87357e-05	1.0					34	0.77									0.0	0.0				12.04	0.81084	0.069	1	18	19	MutationAssessor_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MMP3	0.0	0.0	0.0	0.0	-5.0	-1.0	-6.0	1.0						0.898	0.0	42.557434366	0.983	1.026	homeostasis/metabolism phenotype; immune system phenotype; hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; 			ciliary ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	.	proteolysis;negative regulation of hydrogen peroxide metabolic process;cytokine-mediated signaling pathway;extracellular matrix disassembly;extracellular matrix organization;collagen catabolic process;positive regulation of protein oligomerization;cellular response to nitric oxide;regulation of neuroinflammatory response;positive regulation of oxidative stress-induced cell death	extracellular region;extracellular space;extracellular matrix	endopeptidase activity;metalloendopeptidase activity;serine-type endopeptidase activity;protein binding;metallopeptidase activity;zinc ion binding	MEOX2[25416956];
62207	chr17	1382994	C	A	chr17:1382994	MYO1C	myosin IC	760.0	SNV	0/1	0.47	19_17	36	99	False		EXONIC	YES	NM_001080779.2	Transcript	protein_coding	synonymous_variant		8/32	NM_001080779.2:c.912G>T	NP_001074248.1:p.Leu304%3D		-1.0						Autosomal dominant non-syndromic sensorineural deafness type DFNA	Disease-causing germline mutation(s) in	.						31	0.94											50	0.78														9.263	0.485244		0	0	0			MYO1C	0.0	0.0	0.0	0.0	-18.0	5.0	-18.0	0.0						0.0331	0.0	52.088969539			skeleton phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; 			ciliary ganglion;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	protein targeting;protein targeting to membrane;vesicle transport along actin filament;positive regulation of cell migration;positive regulation of actin filament polymerization;positive regulation of cell migration by vascular endothelial growth factor signaling pathway;Fc-gamma receptor signaling pathway involved in phagocytosis;positive regulation of gene expression, epigenetic;mRNA transport;cellular response to interferon-gamma;positive regulation of protein targeting to membrane;positive regulation of cellular response to insulin stimulus;positive regulation of vascular endothelial growth factor signaling pathway;regulation of bicellular tight junction assembly	stress fiber;nuclear pore;nucleoplasm;nucleolus;cytoplasm;cytosol;plasma membrane;microvillus;brush border;basal plasma membrane;membrane;lateral plasma membrane;unconventional myosin complex;nuclear body;cytoplasmic vesicle membrane;filamentous actin;ruffle membrane;membrane raft;phagocytic vesicle;stereocilium membrane;extracellular exosome	microfilament motor activity;signaling receptor binding;protein binding;calmodulin binding;ATP binding;protein C-terminus binding;Ral GTPase binding;actin-dependent ATPase activity;actin filament binding	EIF4A2[17353931];TRIR[26496610];DIXDC1[26496610];CCAR1[26496610];ACTG1[26496610];PYCARD[24407287];PPP1CB[26496610];GOLGA2[29568061];FBL[16514417];CHCHD3[26496610];MPRIP[26496610];BASP1[26496610];TUBB3[27291054];CFL2[26496610];CFL1[26496610];BAP18[26496610];SYNPO[26496610];PHLDA3[17353931];TMOD1[26496610];CARD10[26496610];PDGFRA[26496610];PPTC7[28330616];TMOD3[26496610];AFAP1[26496610];OCRL[25107275];ACTN4[26496610];GTF2F1[26496610];CDC25C[28330616];DDX39B[26496610];PPP1R3C[28330616];KCTD10[26496610];SRSF2[26496610];ZSCAN26[26496610];PTPRCAP[28330616];PHLDB2[26496610];HDGFL2[26496610];VCL[26496610];RAI14[26496610];SHC1[19380743];COX15[29128334];FLII[26496610];TWF2[26496610];TWF1[26496610];FBXO46[26496610];IQGAP1[26496610];CIAO1[17353931];CORO1C[26496610];ARHGAP21[26496610];SAFB2[26496610];PNPO[26496610];SPTBN1[26496610];RBM10[26496610];SPTBN2[26496610];SPECC1[26496610];UVRAG[26496610];ITPRID2[26496610];JUN[25609649];NEK6[17353931];DSTN[26496610];MYO5A[26496610];CORO2A[26496610];LARP4[26496610];ESR1[21182205];ESR2[21182203];FBXO30[26496610];SSH1[26496610];CHERP[26496610];ANLN[26496610];ARPC3[26496610];GIPC1[17353931];JMY[26496610];TADA3[26496610];CDK2[26496610];GRB2[12577067];CALM1[26496610];ARHGAP11A[26496610];MCM7[23764002];CCDC127[26496610];WDR1[26496610];LRRK2[24725412];ARPC1B[26496610];DOCK7[26496610];HMGB2[26496610];ARRB1[17620599];ARRB2[17620599];KIF11[26496610];MED16[26496610];SIPA1L3[26496610];MED15[26496610];TRIOBP[26496610];MED12[26496610];TUBA1A[27291054];MYO18A[26496610];IKBKG[14743216];SPTAN1[26496610];RBM5[26496610];RBM33[26496610];TPRN[26496610];ILKAP[28330616];IQCB1[21565611];PLEKHG3[26496610];UNC45A[26496610];SUN2[22555292];RBM17[26496610];PPP1R12A[26496610];TIMM29[26496610];RIPK3[14743216];KSR1[27086506];SPHK1[25216046];COBL[26496610];DUSP7[28330616];GAK[26496610];WRAP73[17353931];PTP4A3[17353931];INF2[26496610];DUSP21[28330616];PSMA1[29568061];PALLD[26496610];POLR1B[16514417];POLR1E[16514417];MYH9[26496610];NCBP3[26496610];NSRP1[26496610];DBN1[26496610];PPP1R15A[29109149];RALA[26496610];SF3B2[26496610];TIMM13[26496610];NEXN[26496610];CSTF2T[26496610];DLST[29128334];CRIP2[26496610];MRM1[26496610];ADD1[26496610];MRPL55[26496610];PCNP[26496610];AP3M1[26496610];LIMA1[26496610];SCAF8[26496610];ABLIM1[26496610];SLX4[19596235];FLNA[26496610];E2F3[22157815];SF3B1[26496610];MISP[26496610];PDLIM7[26496610];CLASP1[26496610];TIMM8B[26496610];MAP3K3[14743216];SVIL[26496610];FARP1[26496610];USP20[19615732];CDKN2A[26496610];RIOK3[26496610];SQOR[26496610];SORBS2[26496610];RRP1B[20926688];OXR1[26496610];MYO19[26496610];U2SURP[26496610];PPP1CA[26496610];TJP1[26496610];MYO1B[26496610];IMPDH1[26496610];IMPDH2[26496610];EIF3I[26496610];CAPZA2[26496610];AGGF1[26496610];CEP162[26496610];SIPA1[26496610];BCAR1[28007913];PTPN2[28330616];EIF3B[26496610];TJP2[26496610];
62539	chr11	64527223	G	A	chr11:64527223	PYGM	glycogen phosphorylase, muscle associated	768.0	SNV	0/1	0.4	21_14	35	99	False	rs116987552,CM930629	EXONIC	YES	NM_005609.4	Transcript	protein_coding	stop_gained		1/20	NM_005609.4:c.148C>T	NP_005600.1:p.Arg50Ter		-1.0	.,.	Pathogenic	criteria_provided,_multiple_submitters,_no_conflicts	Skeletal_muscle_atrophy|Glycogen_storage_disease,_type_V|Inborn_genetic_diseases|not_provided	McArdle disease, 232600 (3), Autosomal recessive	Glycogen storage disease due to muscle glycogen phosphorylase deficiency	Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Exercise-induced rhabdomyolysis;Exercise-induced muscle cramps;Muscle weakness;Myoglobinuria;Elevated serum creatine kinase;Exercise-induced myalgia;Dark urine;Juvenile onset;Exercise-induced muscle cramps;Exercise-induced myalgia;Progressive proximal muscle weakness;Glycogen accumulation in muscle fiber lysosomes;Highly elevated creatine kinase;Dark urine;Hypertrophic cardiomyopathy;Recurrent myoglobinuria;Exercise intolerance;Chronic kidney disease;Dysphagia;Exertional dyspnea;Exercise-induced myoglobinuria;Rhabdomyolysis;Skeletal muscle atrophy;Exercise-induced muscle stiffness;Impaired mastication;Postexertional malaise;Acute kidney injury;Tachycardia	25741868,23757202,17324573,16786513,17221871,21802952,1067063,2391551,3476861,8316268,8401511,9131647,9506549,9674815,11168025,11706962,14748827,17404776,17915571,20301518,22730558,23653251,25914343,29691411	0.00176038	268.0	152240.0	2.0	33	0.98	PASS	nfe	0.00311591	212.0	0.00311591	212.0	0.00145157	365.0	251452.0	0.0	100	1.0	PASS	nfe	0.00245322	279.0	0.00245322	279.0	0.0013569	211	0.002	6.0	0.00281	32.0		33.0	5.345188		6	1	7	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred,fathmm-MKL_coding_pred	fathmm-XF_coding_pred	PYGM	0.0	0.0	0.0	0.0	21.0	-4.0	13.0	-29.0						0.0422	0.0	0.0	0.468	-0.325	renal/urinary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; 			thyroid;tongue;skeletal muscle;	Starch and sucrose metabolism;Insulin signaling pathway	glycogen metabolic process;glycogen catabolic process	cytoplasm;cytosol;extracellular exosome	nucleotide binding;protein binding;glycogen phosphorylase activity;pyridoxal phosphate binding;linear malto-oligosaccharide phosphorylase activity;SHG alpha-glucan phosphorylase activity	PYGB[unassigned1304];POMP[23414517];PYGL[unassigned1304];TTN[23414517];FAM110A[23414517];SRP72[23414517];LMNA[23414517];PACSIN3[17353931];INPP5K[17353931];SGCG[23414517];CLASP2[23414517];IGBP1[23414517];TRAPPC2[23414517];MAP3K3[14743216];PRKAB2[25416956;unassigned1304];AGTPBP1[23414517];PDE4DIP[23414517];WWP1[23414517];WDYHV1[25416956];CDC42BPB[23414517];ARID1B[23414517];DNM2[23414517];NIPSNAP2[23414517];PPP1R3B[23414517];INTS4[23414517];DEGS1[17353931];TRIM54[23414517];TRIM55[23414517];
71609	chr8	131848572	C	T	chr8:131848572	ADCY8	adenylate cyclase 8	812.0	SNV	0/1	0.62	11_18	29	99	False	rs142382471,COSV53904700	EXONIC	YES	NM_001115.3	Transcript	protein_coding	missense_variant		12/18	NM_001115.3:c.2626G>A	NP_001106.1:p.Val876Ile		-1.0	.,.					.	.	Intellectual disability;Hyposmia;Anosmia;Autosomal recessive inheritance;Obesity;Hyperlipidemia;Insulin resistance		9.8631e-05	15.0	152082.0	0.0	32	0.95	PASS	amr	0.000262158	4.0	8.82094e-05	6.0	0.000143546	36.0	250790.0	0.0	53	0.99	PASS	amr	0.000694244	24.0	7.06939e-05	8.0	0.0001415	22						4.013	0.085129	0.031	1	18	19	M-CAP_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ADCY8	0.0	0.0	0.0	0.0	-10.0	3.0	-42.0	-49.0						0.288	0.0	0.0	0.267	-2.255	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;dorsal root ganglion;superior cervical ganglion;skeletal muscle;	Purine metabolism;Calcium signaling pathway;Gap junction;Long-term potentiation;Taste transduction;GnRH signaling pathway;Melanogenesis	renal water homeostasis;cAMP biosynthetic process;signal transduction;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;learning or memory;memory;long-term memory;locomotory behavior;glucose mediated signaling pathway;positive regulation of synaptic plasticity;positive regulation of CREB transcription factor activity;activation of protein kinase A activity;positive regulation of insulin secretion involved in cellular response to glucose stimulus;opioid receptor signaling pathway;glucose homeostasis;protein complex oligomerization;protein homooligomerization;regulation of cytosolic calcium ion concentration;cellular response to calcium ion;cellular response to morphine;cellular response to glucose stimulus;cellular response to glucagon stimulus;regulation of cellular response to stress;neuroinflammatory response;positive regulation of long-term synaptic potentiation;positive regulation of long-term synaptic depression;cellular response to forskolin	plasma membrane;integral component of plasma membrane;caveola;clathrin-coated pit;postsynaptic density;actin cytoskeleton;membrane;basolateral plasma membrane;apical plasma membrane;axon;dendrite;neuronal cell body membrane;plasma membrane raft;membrane raft;presynaptic active zone;excitatory synapse;Schaffer collateral - CA1 synapse;hippocampal mossy fiber to CA3 synapse;glutamatergic synapse;integral component of presynaptic membrane	actin binding;adenylate cyclase activity;calmodulin binding;ATP binding;calcium- and calmodulin-responsive adenylate cyclase activity;protein homodimerization activity;metal ion binding;protein heterodimerization activity;protein dimerization activity;protein phosphatase 2A binding	CFTR[17110338];
77305	chr8	124121759	T	A	chr8:124121759	TBC1D31	TBC1 domain family member 31	843.0	SNV	0/1	0.31	22_10	32	99	False	rs143468472,COSV104381162	EXONIC	YES	NM_145647.4	Transcript	protein_coding	synonymous_variant		10/22	NM_145647.4:c.1335T>A	NP_663622.2:p.Thr445%3D		1.0						.	.	.		0.00157722	240.0	152166.0	0.0	32	0.96	PASS	afr	0.00518797	215.0	0.000132283	9.0	0.000517685	130.0	251118.0	0.0	87	0.98	PASS	afr	0.00529296	86.0	0.000167295	19.0	0.0005145	80	0.001	2.0				12.57	0.880756		0	0	0			TBC1D31	0.02	0.09	0.0	0.0	2.0	9.0	2.0	9.0							0.0	53.289051097			.			.	.	.	centrosome	.	OFD1[26496610];CEP135[26496610;26638075];ODF2[26638075];CCDC14[26496610];CEP120[26638075];LCA5[26638075];SPICE1[26638075];KIF7[26496610];TANK[unassigned1774];CEP128[26638075];PCM1[26638075];KIAA0753[26638075];CNTRL[26638075];FGFR1OP[26496610];CEP162[26638075];MYH11[26496610];CEP63[26638075];MAPRE1[26496610];CEP290[26638075];SSX2IP[26638075];CEP89[26638075];
77697	chr8	124138786	A	G	chr8:124138786	TBC1D31	TBC1 domain family member 31	843.0	SNV	0/1	0.52	12_13	25	99	False	rs369621325	EXONIC	YES	NM_145647.4	Transcript	protein_coding	synonymous_variant		13/22	NM_145647.4:c.1743A>G	NP_663622.2:p.Glu581%3D		1.0						.	.	.		0.000144592	22.0	152152.0	0.0	32	0.96	PASS	amr	0.00065548	10.0	0.00010289	7.0	0.000139226	35.0	251390.0	0.0	50	0.99	PASS	amr	0.000347001	12.0	0.000158303	18.0	0.0001093	17	0.001	2.0				8.75	0.433444		0	0	0			TBC1D31	0.0	0.0	0.0	0.0	-1.0	-38.0	0.0	29.0							0.0	65.017561937			.			.	.	.	centrosome	.	OFD1[26496610];CEP135[26496610;26638075];ODF2[26638075];CCDC14[26496610];CEP120[26638075];LCA5[26638075];SPICE1[26638075];KIF7[26496610];TANK[unassigned1774];CEP128[26638075];PCM1[26638075];KIAA0753[26638075];CNTRL[26638075];FGFR1OP[26496610];CEP162[26638075];MYH11[26496610];CEP63[26638075];MAPRE1[26496610];CEP290[26638075];SSX2IP[26638075];CEP89[26638075];
78131	chr3	58135716	C	T	chr3:58135716	FLNB	filamin B	849.0	SNV	0/1	0.42	20_15	36	99	False	rs145280904	EXONIC	YES	NM_001164317.2	Transcript	protein_coding	synonymous_variant		38/47	NM_001164317.2:c.6324C>T	NP_001157789.1:p.Asp2108%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|FLNB-Related_Spectrum_Disorders|not_provided	Larsen syndrome, 150250 (3), Autosomal dominant; Atelosteogenesis, type I, 108720 (3), Autosomal dominant; Atelosteogenesis, type III, 108721 (3), Autosomal dominant; Spondylocarpotarsal synostosis syndrome, 272460 (3), Autosomal recessive; Boomerang dysplasia, 112310 (3), Autosomal dominant	Boomerang dysplasia;Atelosteogenesis type I;Spondylocarpotarsal synostosis;Larsen syndrome;Atelosteogenesis type III	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Respiratory insufficiency;Flat face;Large joint dislocations;Conductive hearing impairment;Prominent forehead;Hypertelorism;Short nail;Joint hyperflexibility;Depressed nasal bridge;Craniosynostosis;Abnormality of epiphysis morphology;Cryptorchidism;Intellectual disability;Malar flattening;Laryngotracheomalacia;Broad distal phalanx of finger;Short distal phalanx of finger;Vertebral segmentation defect;Accessory carpal bones;Brachydactyly;Broad thumb;Abnormality of the cervical spine;Cleft palate;Abnormality of the cardiovascular system;Scoliosis;Short stature;Finger syndactyly;Wide nasal bridge;Hypoplastic iliac body;Absent radius;Fibular aplasia;Neonatal death;Severe short stature;Autosomal dominant inheritance;Hypoplastic nasal septum;Underdeveloped nasal alae;Patellar dislocation;Short tubular bones of the hand;Absent radius;Laryngotracheomalacia;Hand clenching;Abnormal cervical curvature;Thoracolumbar kyphosis;Ulnar deviation of the wrist;Thoracic hypoplasia;Fibular aplasia;Micrognathia;Hip dislocation;Elbow dislocation;Absent humerus;Global developmental delay;Epiphyseal stippling of the humerus;Distal tapering femur;Respiratory insufficiency;Club-shaped distal femur;Vertebral hypoplasia;Polyhydramnios;Talipes equinovarus;Coronal cleft vertebrae;High palate;Short tibia;Knee dislocation;Talipes equinovarus;Autosomal dominant inheritance;Cleft palate;Hitchhiker thumb;Tibial bowing;Scoliosis;Radial bowing;Widened distal phalanges;Hypoplasia of the maxilla;Flat acetabular roof;Micrognathia;Frontal bossing;Elbow dislocation;Horizontal sacrum;Cervical kyphosis;Malar flattening;Midface retrusion;Short neck;Cervical segmentation defect;Tombstone-shaped proximal phalanges;Sandal gap;Rhizomelia;Prominent occiput;Depressed nasal bridge;Knee dislocation;Pectus carinatum;Tracheomalacia;Depressed nasal bridge;Autosomal dominant inheritance;Intellectual disability;Flat face;Scoliosis;Aortic aneurysm;Multiple carpal ossification centers;Talipes equinovalgus;Talipes equinovarus;Ventricular septal defect;Spondylolysis;Knee dislocation;Shallow orbits;Hypertelorism;Short metatarsal;Short stature;Intrauterine growth retardation;Cleft palate;Short metacarpal;Cryptorchidism;Conductive hearing impairment;Cleft upper lip;Spinal cord compression;Beaking of vertebral bodies;Bipartite calcaneus;Prominent forehead;Hypoplastic cervical vertebrae;Malar flattening;Atrial septal defect;Frontal bossing;Hypodontia;Tracheal stenosis;Pectus excavatum;Cervical kyphosis;Accessory carpal bones;Dislocated wrist;Joint laxity;Spina bifida occulta;Bronchomalacia;Spatulate thumbs;Short nail;Corneal opacity;Hip dislocation;Elbow dislocation;Abnormality of fibula morphology;Neonatal short-trunk short stature;Abnormal ossification involving the femoral head and neck;Joint dislocation;Coronal cleft vertebrae;Cleft palate;Malrotation of colon;Multiple renal cysts;Short femur;Brachydactyly;Absent or minimally ossified vertebral bodies;Hypertelorism;Laryngotracheal stenosis;Telecanthus;Narrow chest;Enlarged cisterna magna;Talipes equinovarus;Retinal dysplasia;Micrognathia;Pulmonary hypoplasia;Midface retrusion;Abnormal pancreatic duct morphology;Polyhydramnios;Proptosis;Scoliosis;Low-set ears;Platyspondyly;Rhizomelia;Severe short-limb dwarfism;Abnormality of the metacarpal bones;Growth hormone deficiency;Abnormality of tibia morphology;Aplasia/Hypoplasia of the lungs;Narrow chest;Polyhydramnios;Micromelia;Abnormality of the ulna;Poorly ossified vertebrae;Aplasia/Hypoplasia of the fibula;Abnormality of femur morphology;Aplasia/Hypoplasia of the abdominal wall musculature;Cryptorchidism;Hydrops fetalis;Abnormality of the humerus;Finger syndactyly;Omphalocele;Abnormality of the radius;Broad nasal tip;Coxa vara;Brachydactyly;Clinodactyly of the 5th finger;Preauricular skin tag;Pectus carinatum;Inguinal hernia;Frontal bossing;Short neck;Scapular winging;Cataract;Epiphyseal dysplasia;Pes planus;Broad face;Mixed hearing impairment;Abnormality of pelvic girdle bone morphology;Small foramen magnum;Bowed humerus;Restrictive ventilatory defect;Short nose;Carpal synostosis;Scoliosis;Hypoplasia of the odontoid process;Abnormality of retinal pigmentation;Talipes equinovarus;Tarsal synostosis;Platybasia;C2-C3 subluxation;Hypoplasia of dental enamel;Hypertelorism;Capitate-hamate fusion;Limited elbow extension;Sensorineural hearing impairment;Delayed skeletal maturation;Cleft palate;Disproportionate short-trunk short stature;Hyperlordosis;Failure of eruption of permanent teeth;Short metacarpal;Autosomal recessive inheritance;Renal cyst;Block vertebrae;Encephalocele;Depressed nasal bridge;Cleft palate;Laryngeal stenosis;Brachydactyly;Short femur;Short nose;Sporadic;Short metatarsal;Elbow dislocation;Aplasia/Hypoplasia of the ulna;Cryptorchidism;Premature birth;Autosomal dominant inheritance;Polyhydramnios;Fused cervical vertebrae;Thoracic platyspondyly;Distal tapering femur;Short metacarpal;Radial bowing;Clubbing;Coronal cleft vertebrae;11 pairs of ribs;Stillbirth;Malar flattening;Talipes equinovarus;Club-shaped proximal femur;Narrow chest;Fibular aplasia;Frontal bossing;Rhizomelia;Multinucleated giant chondrocytes in epiphyseal cartilage;Proptosis;Tibial bowing;Short humerus;Neonatal death;Micrognathia;Midface retrusion;Short neck		0.00199658	304.0	152260.0	0.0	33	0.98	PASS	sas	0.00434243	21.0	0.00339426	231.0	0.00257263	647.0	251494.0	3.0	100	1.0	PASS	nfe	0.00384115	437.0	0.00384115	437.0	0.0025723	400	0.006	20.0	0.00517	59.0		0.186	-0.396543		0	0	0			FLNB	0.0	0.0	0.0	0.0	39.0	4.0	-30.0	38.0						0.00269	0.0	21.873700008			growth/size/body region phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; skeleton phenotype; 			lung;dorsal root ganglion;superior cervical ganglion;placenta;skeletal muscle;	MAPK signaling pathway;Focal adhesion	keratinocyte development;epithelial cell morphogenesis;cytoskeletal anchoring at plasma membrane;signal transduction;skeletal muscle tissue development;actin cytoskeleton organization;cellular response to interferon-gamma	stress fiber;cytoplasm;cytosol;plasma membrane;brush border;focal adhesion;cell cortex;actin cytoskeleton;integral component of membrane;Z disc;phagocytic vesicle;extracellular exosome	RNA binding;actin binding;protein binding;identical protein binding;cadherin binding	RALA[26496610];CAMK2D[29426014];PSEN2[9437013];HSPB1[25277244];UBE2L6[19270716];PSEN1[9437013];PIK3R1[17474147];IQGAP1[26496610];PPP1CB[26496610];LIMA1[26496610];MAPK8[19270716];MAP1LC3B[20562859];TUBA1A[27291054];TUBB3[27291054];G3BP1[19615732];MYO18A[26496610];FLNA[12393796;26496610];FLNB[12393796];PLCG1[17474147];RAC1[19270716];SYNPO[26496610];MAP3K4[19270716];NCK1[17474147];ATF7IP[15231748];GABARAPL1[20562859];MAP3K1[19270716];MYBPC2[23414517];VCAM1[22623428;19738201];SMURF2[15231748];KSR1[27086506];FN1[19738201];ISG15[19270716];MLH1[20706999];ESR1[21182205];MYO19[26496610];ESR2[21182203];ANLN[26496610];CAPZA2[26496610];MYH9[26496610];GRB2[12577067;17474147];PLEKHO1[18624398];CD247[24502978];CRK[17474147];OTUD1[19615732];DBN1[26496610];ITGB3BP[26496610];BCAR1[28007913];
80666	chr11	32456748	G	A	chr11:32456748	WT1	Wilms tumor 1	905.0	SNV	0/1	0.44	17_18	41	99	False	rs1021307133	EXONIC	YES	NM_024426.6	Transcript	protein_coding	synonymous_variant		1/10	NM_024426.6:c.159C>T	NP_077744.4:p.Ala53%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	Frasier_syndrome|Wilms_tumor_1|11p_partial_monosomy_syndrome|Drash_syndrome	Mesothelioma, somatic, 156240 (3); Meacham syndrome, 608978 (3), Autosomal dominant; Frasier syndrome, 136680 (3), Somatic mutation, Autosomal dominant; Nephrotic syndrome, type 4, 256370 (3), Autosomal dominant; Denys-Drash syndrome, 194080 (3), Somatic mutation, Autosomal dominant; Wilms tumor, type 1, 194070 (3), Somatic mutation, Autosomal dominant	WAGR syndrome;Nephroblastoma;Nephroblastoma;46,XY complete gonadal dysgenesis;46,XY partial gonadal dysgenesis;Meacham syndrome;Denys-Drash syndrome;Frasier syndrome;Sporadic idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;Desmoplastic small round cell tumor	Role in the phenotype of;Disease-causing somatic mutation(s) in;Major susceptibility factor in;Candidate gene tested in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Part of a fusion gene in	Tetralogy of Fallot;Hydrometrocolpos;Horseshoe kidney;Transposition of the great arteries;Atrial septal defect;Patent ductus arteriosus;Crossed fused renal ectopia;Congenital diaphragmatic hernia;Coarctation of aorta;Aplasia/Hypoplasia of the lungs;Ambiguous genitalia;Hypoplasia of penis;Vaginal atresia;Cryptorchidism;Aortic valve stenosis;Hypoplastic left heart;Abnormality of the spleen;Pulmonary sequestration;Situs inversus totalis;Anomalous pulmonary venous return;Ventricular septal defect;Abnormal fallopian tube morphology;Nephrotic syndrome;Autosomal dominant inheritance;Autosomal recessive inheritance;Nephroblastoma;Childhood onset;Focal segmental glomerulosclerosis;Progressive;Renal insufficiency;Diffuse mesangial sclerosis;Primary amenorrhea;Abnormal sex determination;Azoospermia;Ambiguous genitalia;Sparse axillary hair;Elevated circulating follicle stimulating hormone level;Urogenital sinus anomaly;Streak ovary;Female external genitalia in individual with 46,XY karyotype;Decreased testicular size;Clitoral hypertrophy;Micropenis;Testicular gonadoblastoma;Decreased fertility in females;Male infertility;Vanishing testis;Elevated circulating luteinizing hormone level;Nephrotic syndrome;Delayed puberty;Absence of secondary sex characteristics;Abnormality of cardiovascular system morphology;Abnormality of the scrotum;Hypergonadotropic hypogonadism;Hypoplasia of the vagina;Hypospadias;Gonadal dysgenesis;Sparse pubic hair;Adrenal insufficiency;Decreased serum testosterone level;Osteoporosis;Primary gonadal insufficiency;Gynecomastia;Ovarian gonadoblastoma;Decreased serum estradiol;Delayed skeletal maturation;Abnormality of the labia;Cryptorchidism;Nephroblastoma;Hematuria;Neoplasm of the liver;Hypertension;Abdominal pain;Nephroblastoma;Neoplasm of the lung;Weight loss;Lymphadenopathy;Fever;Aniridia;Hematuria;Neoplasm of the liver;Hypertension;Abdominal pain;Nephroblastoma;Neoplasm of the lung;Weight loss;Lymphadenopathy;Fever;Aniridia;Somatic mutation;Stage 5 chronic kidney disease;Focal segmental glomerulosclerosis;Nephroblastoma;True hermaphroditism;Ambiguous genitalia, male;Nephropathy;Congenital diaphragmatic hernia;Gonadal tissue inappropriate for external genitalia or chromosomal sex;Autosomal dominant inheritance;Ovarian gonadoblastoma;Gonadal dysgenesis;Nephrotic syndrome;Male pseudohermaphroditism;Hypertension;Ambiguous genitalia, female;Diffuse mesangial sclerosis;Aplasia/Hypoplasia of the iris;Cryptorchidism;Displacement of the urethral meatus;Ptosis;Glaucoma;Hearing abnormality;Everted lower lip vermilion;Short stature;Dysfunction of lateral corticospinal tracts;Micrognathia;Nystagmus;Microcephaly;Visual impairment;Ambiguous genitalia;Cataract;Scoliosis;Intellectual disability;Obesity;Glomerulopathy;Nephroblastoma;Increased circulating gonadotropin level;Hypergonadotropic hypogonadism;Hypertension;Streak ovary;Proteinuria;Decreased serum estradiol;Nephrotic syndrome;Gonadoblastoma;Focal segmental glomerulosclerosis;Male pseudohermaphroditism;Renal insufficiency;Ambiguous genitalia, male;Primary amenorrhea;Gonadal dysgenesis with female appearance, male;Somatic mutation;Malignant mesothelioma;Stage 5 chronic kidney disease;Somatic mutation;Focal segmental glomerulosclerosis;Male pseudohermaphroditism;Nephrotic syndrome;Primary amenorrhea;Autosomal dominant inheritance;Ovarian gonadoblastoma;Gonadal dysgenesis;Male pseudohermaphroditism;Testicular dysgenesis;Polycystic ovaries;Hypogonadotropic hypogonadism;Hypoplasia of the fovea;Polymicrogyria;Cataract;Nystagmus;Optic nerve hypoplasia;Aniridia;Hypoplasia of the corpus callosum;Glaucoma;Glucose intolerance;Opacification of the corneal stroma;Autosomal dominant inheritance;Increased proinsulin:insulin ratio;Hypertension;Nephropathy;Male pseudohermaphroditism;Nephroblastoma;Gonadal dysgenesis;Proteinuria;Nephrotic syndrome;Abdominal distention;Mediastinal lymphadenopathy;Sarcoma;Cachexia;Ovarian neoplasm;Ileus;Hepatomegaly;Neoplasm of the lung;Abdominal pain;Anemia;Neoplasm of the pancreas;Nausea and vomiting;Testicular neoplasm;Abnormality of the peritoneum;Neoplasm of the central nervous system;Ascites;Nephroblastoma;Somatic mutation;Autosomal dominant inheritance;Heterogeneous;Gonadoblastoma;Intellectual disability;Abnormal vagina morphology;Autosomal dominant inheritance;Nephroblastoma;Renal insufficiency;Nephropathy;Streak ovary;Hypospadias;Somatic mutation;Obesity;Cryptorchidism;Contiguous gene syndrome;Abnormality of the uterus;Aniridia						30	0.92							2.30482e-05	3.0	130162.0	0.0	18	0.47	PASS	nfe	4.0853e-05	2.0	4.0853e-05	2.0								4.683	0.125545		0	0	0			WT1	0.0	0.0	0.0	0.0	-19.0	13.0	19.0	-44.0								8.427223213			immune system phenotype; renal/urinary system phenotype; embryo phenotype; respiratory system phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; endocrine/exocrine gland phenotype; neoplasm; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			kidney;ovary;uterus;testis - seminiferous tubule;testis - interstitial;uterus corpus;superior cervical ganglion;trigeminal ganglion;placenta;testis;skeletal muscle;	.	negative regulation of transcription by RNA polymerase II;vasculogenesis;ureteric bud development;branching involved in ureteric bud morphogenesis;kidney development;regulation of animal organ formation;regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;germ cell development;thorax and anterior abdomen determination;heart development;sex determination;negative regulation of cell population proliferation;RNA splicing;gonad development;male gonad development;tissue development;positive regulation of gene expression;negative regulation of cell growth;adrenal gland development;male genitalia development;epithelial cell differentiation;glomerulus development;glomerular basement membrane development;adrenal cortex formation;camera-type eye development;negative regulation of apoptotic process;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;mesenchymal to epithelial transition;positive regulation of heart growth;diaphragm development;cardiac muscle cell fate commitment;visceral serous pericardium development;cellular response to cAMP;cellular response to gonadotropin stimulus;metanephric mesenchyme development;glomerular visceral epithelial cell differentiation;posterior mesonephric tubule development;metanephric epithelium development;metanephric S-shaped body morphogenesis;negative regulation of metanephric glomerular mesangial cell proliferation;positive regulation of pri-miRNA transcription by RNA polymerase II;positive regulation of DNA methylation;positive regulation of male gonad development;negative regulation of female gonad development;positive regulation of metanephric ureteric bud development	nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol;nuclear speck	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;RNA binding;protein binding;zinc ion binding;double-stranded methylated DNA binding;sequence-specific DNA binding;transcription regulatory region DNA binding;hemi-methylated DNA-binding;C2H2 zinc finger domain binding	DIRAS3[25640309];CASZ1[25640309];ZRANB1[unassigned1304];WTAP[unassigned1304];KRTAP10-7[unassigned1304];KRTAP10-6[unassigned1304];OSBPL3[unassigned1304];KRTAP10-8[25416956];NPM3[21900206];KLK7[25640309];KRT40[25416956];HMBOX1[unassigned1304];IPO8[unassigned1304];CYSRT1[unassigned1304];NAT2[25640309];TAOK1[21900206];CCL5[25640309];BHLHE40[unassigned1304];MDM2[21988832];DVL2[27107012];DVL3[19447967;21900206];PICK1[unassigned1304];ZNF205[21900206];THRSP[25640309];
80896	chr9	14859465	G	C	chr9:14859465	FREM1	FRAS1 related extracellular matrix 1	907.0	SNV	0/1	0.67	11_22	33	99	False	rs747949999	EXONIC	YES	NM_144966.7	Transcript	protein_coding	missense_variant		5/38	NM_144966.7:c.347C>G	NP_659403.4:p.Thr116Ser		-1.0	.,.	Uncertain_significance	criteria_provided,_single_submitter	not_provided	Manitoba oculotrichoanal syndrome, 248450 (3), Autosomal recessive; Bifid nose with or without anorectal and renal anomalies, 608980 (3), Autosomal recessive; Trigonocephaly 2, 614485 (3), Autosomal dominant	Oculotrichoanal syndrome;Isolated trigonocephaly;BNAR syndrome;Renal agenesis, unilateral	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Prominent supraorbital ridges;Hypotelorism;Trigonocephaly;Synophrys;Wide nasal bridge;Omphalocele;Nasolacrimal duct obstruction;Bifid nasal tip;Abnormal hair pattern;Anal stenosis;Anteriorly placed anus;Cryptophthalmos;Hypertelorism;Anophthalmia;Microphthalmia;Upper eyelid coloboma;Microcephaly;Autosomal dominant inheritance;Hypertelorism;Metopic synostosis;Trigonocephaly;Autosomal recessive inheritance;Anophthalmia;Nasolacrimal duct obstruction;Eyelid coloboma;Anteriorly placed anus;Hypertelorism;Microphthalmia;Abnormal hair morphology;Anal stenosis;Omphalocele;Bifid nose;Renal agenesis;Short lingual frenulum;Anteriorly placed anus;Anal stenosis;Abnormal respiratory system morphology;Abnormality of the 5th toe;Abnormality of the kidney;Bulbous nose;Autosomal recessive inheritance;Rectovaginal fistula;Short philtrum;Anteriorly placed anus;Bifid nose		6.57186e-06	1.0	152164.0	0.0	32	0.97	PASS	nfe	1.46968e-05	1.0	1.46968e-05	1.0	1.61385e-05	4.0	247854.0	0.0	39	0.94	PASS	nfe	3.56513e-05	4.0	3.56513e-05	4.0	0.0000257	4			9e-05	1.0		27.2	3.934108	0.574	14	7	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,BayesDel_addAF_pred,LIST-S2_pred	FREM1	0.0	0.02	0.0	0.0	-45.0	17.0	17.0	-21.0						0.995		0.0	1.0	1.176	liver/biliary system phenotype; respiratory system phenotype; reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; skeleton phenotype; renal/urinary system phenotype; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; 			.	.	cell communication;cell-matrix adhesion;craniofacial suture morphogenesis	basement membrane;integral component of membrane	carbohydrate binding;metal ion binding	.
82033	chr15	39883540	T	A	chr15:39883540	THBS1	thrombospondin 1	914.0	SNV	0/1	0.48	12_11	23	99	False	rs199786923	EXONIC	YES	NM_003246.4	Transcript	protein_coding	missense_variant		15/22	NM_003246.4:c.2402T>A	NP_003237.2:p.Ile801Asn		1.0						.	.	.		6.57229e-05	10.0	152154.0	0.0	33	0.98	PASS	nfe	0.000132306	9.0	0.000132306	9.0	5.58615e-05	14.0	250620.0	0.0	53	0.97	PASS	nfe	0.000114851	13.0	0.000114851	13.0	0.0000450	7			9e-05	1.0		28.5	4.092466	0.765	19	2	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,PrimateAI_pred	THBS1	0.0	0.0	0.0	0.0	-21.0	-18.0	2.0	16.0						0.104	1.0	0.0	0.3	1.138	endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; limbs/digits/tail phenotype; digestive/alimentary phenotype; muscle phenotype; neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype; respiratory system phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; 			ciliary ganglion;appendix;trachea;adipose tissue;superior cervical ganglion;trigeminal ganglion;smooth muscle;fetal lung;heart;lung;uterus;dorsal root ganglion;atrioventricular node;uterus corpus;placenta;skeletal muscle;	Cell Communication;p53 signaling pathway;TGF-beta signaling pathway;Focal adhesion;ECM-receptor interaction;Bladder cancer	activation of MAPK activity;response to hypoxia;negative regulation of endothelial cell proliferation;negative regulation of cell-matrix adhesion;sprouting angiogenesis;chronic inflammatory response;platelet degranulation;negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II;negative regulation of dendritic cell antigen processing and presentation;inflammatory response;immune response;response to unfolded protein;cell cycle arrest;cell adhesion;positive regulation of cell population proliferation;response to mechanical stimulus;response to glucose;positive regulation of endothelial cell migration;negative regulation of endothelial cell migration;negative regulation of plasma membrane long-chain fatty acid transport;negative regulation of nitric oxide mediated signal transduction;negative regulation of cGMP-mediated signaling;negative regulation of plasminogen activation;positive regulation of macrophage chemotaxis;positive regulation of fibroblast migration;cell migration;negative regulation of angiogenesis;peptide cross-linking;positive regulation of blood coagulation;extracellular matrix organization;positive regulation of cell migration;positive regulation of transforming growth factor beta receptor signaling pathway;response to magnesium ion;response to progesterone;negative regulation of interleukin-12 production;positive regulation of transforming growth factor beta1 production;response to testosterone;cellular response to heat;response to endoplasmic reticulum stress;negative regulation of fibroblast growth factor receptor signaling pathway;positive regulation of phosphorylation;response to drug;positive regulation of tumor necrosis factor biosynthetic process;positive regulation of macrophage activation;negative regulation of apoptotic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of blood vessel endothelial cell migration;negative regulation of blood vessel endothelial cell migration;engulfment of apoptotic cell;regulation of megakaryocyte differentiation;positive regulation of translation;positive regulation of angiogenesis;behavioral response to pain;positive regulation of smooth muscle cell proliferation;positive regulation of chemotaxis;response to calcium ion;negative regulation of focal adhesion assembly;positive regulation of protein kinase B signaling;negative regulation of fibrinolysis;cellular response to tumor necrosis factor;cellular response to growth factor stimulus;negative regulation of cell migration involved in sprouting angiogenesis;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis;negative regulation of sprouting angiogenesis;positive regulation of endothelial cell apoptotic process;positive regulation of reactive oxygen species metabolic process;negative regulation of endothelial cell chemotaxis;negative regulation of extrinsic apoptotic signaling pathway	extracellular region;fibrinogen complex;extracellular space;endoplasmic reticulum;endoplasmic reticulum lumen;external side of plasma membrane;cell surface;sarcoplasmic reticulum;secretory granule;extracellular matrix;platelet alpha granule;platelet alpha granule lumen;collagen-containing extracellular matrix;extracellular exosome	phosphatidylserine binding;fibronectin binding;integrin binding;extracellular matrix structural constituent;calcium ion binding;protein binding;heparin binding;fibroblast growth factor binding;low-density lipoprotein particle binding;identical protein binding;laminin binding;proteoglycan binding;transforming growth factor beta binding;fibrinogen binding;collagen V binding	IQCB1[21565611];COL18A1[19542224];APP[19542224];TGFB1[15864306];TNFAIP6[18042364];NEK4[25798074];PLEK[19722192];FN1[19542224;18042364];PCOLCE[24117177];VEGFA[19805200];HIST1H3A[29568061];TUBA1A[29568061];CD36[23640500];TGM2[19542224];
82626	chr1	120611964	G	C	chr1:120611964	NOTCH2	notch 2	925.0	SNV	0/1	0.48	43_40	84	99	False	rs11810554,COSV56680365	EXONIC	YES	NM_024408.4	Transcript	protein_coding	missense_variant		1/34	NM_024408.4:c.57C>G	NP_077719.2:p.Cys19Trp		-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Hajdu-Cheney_syndrome|not_specified	Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant	Acroosteolysis dominant type;Alagille syndrome due to a NOTCH2 point mutation	Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in	Wide nose;Hypospadias;Short neck;Crowded carpal bones;Dental malocclusion;Osteoporosis;Long philtrum;Dislocated radial head;Vertebral compression fractures;Synophrys;Low-set ears;High palate;Inguinal hernia;Foot acroosteolysis;Tall lumbar vertebral bodies;Cryptorchidism;Elongated sella turcica;Short nail;Autosomal dominant inheritance;Hydrocephalus;Coarse facial features;Pathologic fracture;Full cheeks;Downslanted palpebral fissures;Intestinal malrotation;Large earlobe;Osteolytic defects of the phalanges of the hand;Long eyelashes;Hirsutism;Umbilical hernia;Cervical instability;Osteopenia;Short stature;Conductive hearing impairment;Renal cyst;Abnormal cardiac septum morphology;Basilar impression;Wormian bones;Absent frontal sinuses;Telecanthus;Joint laxity;Failure to thrive;Genu valgum;Biconcave vertebral bodies;Thick eyebrow;Anteverted nares;Premature loss of teeth;Micrognathia;Kyphoscoliosis;Patent ductus arteriosus;Epicanthus;Hydrocephalus;Open bite;Wide nose;Micrognathia;Joint hyperflexibility;Hypospadias;Splenomegaly;Recurrent respiratory infections;Ventricular septal defect;Arnold-Chiari malformation;Wormian bones;Bone pain;Peripheral neuropathy;Hypertelorism;Kyphosis;Thickened skin;Hepatomegaly;Osteoporosis;Biconcave vertebral bodies;Brachydactyly;Wide nasal bridge;Dry skin;Abnormality of the voice;Decreased skull ossification;Coarse facial features;Hypoplasia of the zygomatic bone;Aortic valve stenosis;Coarse hair;Thin vermilion border;Macrocephaly;Osteopenia;Rough bone trabeculation;Syringomyelia;Generalized hirsutism;Inguinal hernia;Low anterior hairline;Telecanthus;Patellar dislocation;Headache;Multiple renal cysts;Cleft palate;Short neck;Myopia;Full cheeks;Scoliosis;Pectus carinatum;Periodontitis;Synophrys;Skin ulcer;Downturned corners of mouth;Bowing of the long bones;Partial absence of toe;Hearing impairment;Umbilical hernia;Thick eyebrow;Iris coloboma;Mitral stenosis;Hypoplastic 5th lumbar vertebrae;Cataract;Long philtrum;Delayed puberty;Recurrent fractures;Short stature;Intestinal malrotation;Skeletal dysplasia;Absent frontal sinuses;Abnormal fingernail morphology;Osteolysis;Low-set ears;Short distal phalanx of finger;Dolichocephaly;Arthralgia;Failure to thrive;Anteverted nares;Downslanted palpebral fissures;Narrow mouth;Short toe;Patent ductus arteriosus;Platybasia;Prominent occiput;Pointed chin;Posterior embryotoxon;Proteinuria;Autosomal dominant inheritance;Renal cyst;Pulmonic stenosis;Peripheral pulmonary artery stenosis;Hematuria;Tetralogy of Fallot;Renal insufficiency;Atrial septal defect;Hypertension;Triangular face;Broad forehead;Cholestatic liver disease;Renal tubular acidosis;Renal hypoplasia;Long nose		5.92995e-05	9.0	151772.0	0.0	29	0.93	PASS	sas	0.000429	2.0	0.000103029	7.0	0.443417	90254.0	203542.0	5.0	37	0.79	InbreedingCoeff	eas	0.466803	7326.0	0.4595	43341.0	0.0209770	3262	0.047	154.0	0.41518	4249.0		21.3	2.18526	0.141	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NOTCH2	0.0	0.0	0.0	0.0	-4.0	9.0	31.0	-16.0						0.0156	1.0		0.979	1.068	cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; muscle phenotype; endocrine/exocrine gland phenotype; taste/olfaction phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; embryo phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; neoplasm; pigmentation phenotype; reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype; respiratory system phenotype; 			ciliary ganglion;testis - seminiferous tubule;trigeminal ganglion;atrioventricular node;superior cervical ganglion;placenta;testis;skeletal muscle;	Notch signaling pathway	cell fate determination;marginal zone B cell differentiation;pulmonary valve morphogenesis;regulation of transcription, DNA-templated;transcription initiation from RNA polymerase II promoter;apoptotic process;cell cycle arrest;Notch signaling pathway;multicellular organism development;nervous system development;animal organ morphogenesis;negative regulation of gene expression;stem cell population maintenance;hemopoiesis;negative regulation of apoptotic process;negative regulation of growth rate;positive regulation of Ras protein signal transduction;bone remodeling;atrial septum morphogenesis;Notch signaling involved in heart development;positive regulation of ERK1 and ERK2 cascade;regulation of osteoclast development	Golgi membrane;extracellular region;nucleus;nucleoplasm;endoplasmic reticulum membrane;plasma membrane;integral component of plasma membrane;cell surface;membrane;receptor complex	calcium ion binding;protein binding;signaling receptor activity	ITIH5[25640309];NOTCH1[23022380];IL24[25640309];KLK5[25640309];HSCB[28380382];RBPJ[25609649;26496610];CST6[25640309];CRKL[18654987];PSMC3IP[25640309];TGOLN2[29568061];LAMP1[29568061];EPSTI1[25640309];HIF1AN[26972000];IL13RA2[25640309];MTA3[25640309];CCR2[28298427];ANKRD28[23414517;24255178];SMAD1[15231748];ST14[25640309];EGLN3[26972000];GOLM1[27569582];TMEM17[26638075];EZR[29568061];FAM84B[25640309];BET1[29568061];
83999	chr8	24811106	A	G	chr8:24811106	NEFL	neurofilament light	946.0	SNV	0/1	0.43	16_12	28	99	False	rs372034119	EXONIC	YES	NM_006158.5	Transcript	protein_coding	missense_variant		3/5	NM_006158.5:c.1373T>C	NP_006149.2:p.Ile458Thr		-1.0		Uncertain_significance	criteria_provided,_multiple_submitters,_no_conflicts	Charcot-Marie-Tooth_disease_type_2E|not_provided	Charcot-Marie-Tooth disease, type 1F, 607734 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate G, 617882 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2E, 607684 (3), Autosomal dominant	Charcot-Marie-Tooth disease type 2B5;Charcot-Marie-Tooth disease type 1F;Autosomal dominant Charcot-Marie-Tooth disease type 2E	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Autosomal dominant inheritance;Pes cavus;Autosomal recessive inheritance;Heterogeneous;Myelin outfoldings;Hyporeflexia;Clusters of axonal regeneration;Variable expressivity;Areflexia;Decreased number of peripheral myelinated nerve fibers;Decreased motor nerve conduction velocity;Juvenile onset;Distal muscle weakness;Distal sensory impairment;Distal amyotrophy;Segmental peripheral demyelination/remyelination;Motor delay;Onion bulb formation;Split hand;Distal muscle weakness;Autosomal dominant inheritance;Hyporeflexia;Motor delay;Facial palsy;High palate;Foot dorsiflexor weakness;Pes cavus;Distal sensory impairment;Ulnar claw;Hypotrophy of the small hand muscles;Flexion contracture;Areflexia;Hammertoe;Decreased motor nerve conduction velocity;Distal amyotrophy;Nemaline bodies;Increased connective tissue;Scoliosis;Steppage gait;Ptosis;Variable expressivity;Babinski sign;Ataxia;Elevated serum creatine kinase;Sensorineural hearing impairment;Gowers sign;Slow progression;Nystagmus;Spasticity;Distal muscle weakness;Split hand;Areflexia;Autosomal dominant inheritance;Steppage gait;Sensorimotor neuropathy;Waddling gait;Pes cavus;Hyporeflexia;Distal sensory impairment;Motor delay		3.28779e-05	5.0	152078.0	0.0	32	0.97	PASS	sas	0.000207727	1.0	1.47029e-05	1.0	4.01152e-06	1.0	249282.0	0.0	100	1.0	PASS	eas	5.56297e-05	1.0	0.0	0.0	0.0000064	1						16.38	1.519483	0.225	5	5	10	SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,PrimateAI_pred,DEOGEN2_pred,LIST-S2_pred	NEFL	0.01	0.0	0.0	0.0	38.0	-49.0	-18.0	38.0									0.998	1.233	nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; 			ciliary ganglion;caudate nucleus;amygdala;temporal lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;cingulate cortex;cerebellum;pons;occipital lobe;fetal brain;subthalamic nucleus;whole brain;dorsal root ganglion;parietal lobe;spinal cord;skeletal muscle;globus pallidus;hypothalamus;medulla oblongata;thalamus;	Amyotrophic lateral sclerosis (ALS)	MAPK cascade;microtubule cytoskeleton organization;anterograde axonal transport;retrograde axonal transport;peripheral nervous system axon regeneration;axonal transport of mitochondrion;spinal cord development;hippocampus development;cerebral cortex development;regulation of axon diameter;neurofilament bundle assembly;locomotion;response to peptide hormone;negative regulation of neuron apoptotic process;intermediate filament polymerization or depolymerization;intermediate filament organization;neuron projection morphogenesis;positive regulation of axonogenesis;neuromuscular process controlling balance;protein polymerization;response to corticosterone;neurofilament cytoskeleton organization;synapse maturation;postsynaptic intermediate filament cytoskeleton organization;response to sodium arsenite;response to acrylamide	cytoplasm;cytosol;neurofilament;axon;growth cone;neuromuscular junction;myelin sheath;Schaffer collateral - CA1 synapse;cholinergic synapse;postsynaptic intermediate filament cytoskeleton;presynaptic intermediate filament cytoskeleton;axon cytoplasm	Ras guanyl-nucleotide exchange factor activity;structural constituent of cytoskeleton;protein binding;protein C-terminus binding;protein domain specific binding;protein binding, bridging;identical protein binding;phospholipase binding;protein heterodimerization activity;structural constituent of postsynaptic intermediate filament cytoskeleton	APP[16049941;25241761];MTMR2[12837694];PHLPP1[23455924];SCHIP1[20195357];USHBP1[26871637];CCNC[25416956];CHD3[15383276];HSPB3[16169070];TNF[20195357];PPP1R18[25416956];GOLGA2[26871637];KLC3[26871637];SMYD1[unassigned1304];NEFM[unassigned1304];BRD7[15383276];SKIL[26871637];YWHAG[15324660];CDK5RAP2[16169070];ENKD1[25416956];PIAS4[15383276];PRMT6[23455924];PPP1R16B[25416956];KSR1[27086506];CCDC13[unassigned1304];NEK6[unassigned1304];TEX11[25416956;26871637];USP2[25416956;unassigned1304];KRT13[26871637];MTUS2[26871637];TERF1[21044950];GFAP[26871637;unassigned1304];DES[26871637;27107012;unassigned1304];KRT18[26871637];TXLNB[25416956];NME7[25416956;unassigned1304];HGS[26871637];CEP57L1[26871637];KRT15[25416956;26871637];GORASP1[26871637];VIM[15383276;27173435;unassigned1312];KIFC3[25416956;26871637];RCOR3[unassigned1304];RAN[16169070];CCDC172[26871637];
85306	chr4	55972029	C	T	chr4:55972029	KDR	kinase insert domain receptor	971.0	SNV	0/1	0.64	9_16	25	99	False	rs55716939,COSV55766446,COSV99818682	EXONIC	YES	NM_002253.3	Transcript	protein_coding	missense_variant		12/30	NM_002253.3:c.1615G>A	NP_002244.1:p.Gly539Arg		-1.0	Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin-like domain&Immunoglobulin subtype	Likely_benign	criteria_provided,_single_submitter	not_specified|not_provided	{Hemangioma, capillary infantile, susceptibility to}, 602089 (3), Autosomal dominant; Hemangioma, capillary infantile, somatic, 602089 (3)	.	.	Autosomal dominant inheritance;Capillary hemangioma	24728327	0.00153747	234.0	152198.0	1.0	32	0.97	PASS	nfe	0.00286562	195.0	0.00286562	195.0	0.00150795	379.0	251334.0	1.0	100	1.0	PASS	nfe	0.00281621	320.0	0.00281621	320.0	0.0015498	241	0.002	8.0	0.00149	17.0		23.3	2.901879	0.191	6	13	19	SIFT,LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	KDR	0.0	0.0	0.0	0.0	20.0	-1.0	-30.0	-50.0						0.196	0.98	0.0	0.997	1.0	vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; respiratory system phenotype; liver/biliary system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; craniofacial phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;placenta;	Cytokine-cytokine receptor interaction;VEGF signaling pathway;Focal adhesion	angiogenesis;vasculogenesis;positive regulation of protein phosphorylation;positive regulation of endothelial cell proliferation;sprouting angiogenesis;cell migration involved in sprouting angiogenesis;endothelium development;transmembrane receptor protein tyrosine kinase signaling pathway;positive regulation of cell population proliferation;regulation of cell shape;positive regulation of endothelial cell migration;negative regulation of gene expression;positive regulation of phosphatidylinositol 3-kinase signaling;viral process;positive regulation of macroautophagy;cell migration;peptidyl-tyrosine phosphorylation;extracellular matrix organization;positive regulation of cell migration;embryonic hemopoiesis;calcium-mediated signaling using intracellular calcium source;cellular response to vascular endothelial growth factor stimulus;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;peptidyl-tyrosine autophosphorylation;negative regulation of apoptotic process;positive regulation of MAPK cascade;protein kinase B signaling;positive regulation of blood vessel endothelial cell migration;endothelial cell differentiation;positive regulation of angiogenesis;protein autophosphorylation;vascular endothelial growth factor receptor signaling pathway;positive regulation of positive chemotaxis;positive regulation of nitric-oxide synthase biosynthetic process;positive regulation of focal adhesion assembly;positive regulation of mitochondrial depolarization;ERK1 and ERK2 cascade;positive regulation of ERK1 and ERK2 cascade;positive regulation of cell migration involved in sprouting angiogenesis;positive regulation of mitochondrial fission;cellular response to hydrogen sulfide;negative regulation of endothelial cell apoptotic process;positive regulation of vasculogenesis	extracellular region;nucleus;endosome;early endosome;endoplasmic reticulum;Golgi apparatus;plasma membrane;integral component of plasma membrane;cell junction;receptor complex;membrane raft;sorting endosome	protein tyrosine kinase activity;transmembrane receptor protein tyrosine kinase activity;vascular endothelial growth factor-activated receptor activity;integrin binding;protein binding;ATP binding;growth factor binding;vascular endothelial growth factor binding;identical protein binding;Hsp90 protein binding	NRP1[16763549;17222790];APP[28106549];TUT7[26496610];SHC1[11950700;12214271];SRC[18377662;18662404;12509223];FLT4[16530705;20224550;21130043];PDCD6[21893193];PTPRJ[18936167];SHB[15026417];LRP8[30139844];HSPD1[30021884];EEA1[23799140];CDH5[11950700;18662404];ATP5F1A[30021884];LGALS1[24529377];KDR[20660291;17293873;20080685];FYN[16966330];PLCG1[12598525];RALGDS[23175184];YWHAG[26496610];AAR2[26496610];NCK1[16966330];PDGFRB[18997771];FBXW11[21900206];ITGA2[21596751];NCOA4[26496610];GATC[26496610];VEGFC[20145116];HSPG2[23374253;21596751];VEGFA[16763549;22897854;23374253;21596751;1417831;20660291;23583373;20145116];GREM1[20660291];AIMP2[21900206];PKM[24606918];PALLD[26496610];ZSCAN21[26496610];GRB2[16966330];PTPN6[18377662];NAXD[26496610];MET[22789536];CRK[23397142];
85814	chr12	125398297	A	G	chr12:125398297	UBC	ubiquitin C	975.0	SNV	0/1	0.47	9_8	17	99	False	rs779546151,COSV60058208	EXONIC	YES	NM_021009.7	Transcript	protein_coding	synonymous_variant		2/2	NM_021009.7:c.21T>C	NP_066289.3:p.Thr7%3D		-1.0						.	.	.		0.000342177	52.0	151968.0	0.0	33	0.97	PASS	amr	0.00118095	18.0	7.35316e-05	5.0	0.000306394	77.0	251310.0	0.0	100	1.0	PASS	amr	0.00144709	50.0	9.6768e-05	11.0	0.0002122	33	0.006	19.0				10.76	0.65298		0	0	0			UBC	0.0	0.0	0.0	0.0	23.0	14.0	14.0	-7.0						0.663	0.7	80.709802837			cellular phenotype; growth/size/body region phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; embryo phenotype; 			ciliary ganglion;temporal lobe;olfactory bulb;testis - seminiferous tubule;trigeminal ganglion;superior cervical ganglion;testis;pons;testis - interstitial;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;thalamus;	PPAR signaling pathway	negative regulation of transcription by RNA polymerase II;activation of MAPK activity;protein polyubiquitination;nucleotide-excision repair, DNA damage recognition;MyD88-dependent toll-like receptor signaling pathway;transcription-coupled nucleotide-excision repair;nucleotide-excision repair, preincision complex assembly;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA gap filling;protein targeting to peroxisome;transforming growth factor beta receptor signaling pathway;I-kappaB kinase/NF-kappaB signaling;JNK cascade;Wnt signaling pathway;endosomal transport;protein ubiquitination;protein deubiquitination;viral life cycle;virion assembly;cytokine-mediated signaling pathway;modification-dependent protein catabolic process;translesion synthesis;negative regulation of transforming growth factor beta receptor signaling pathway;anaphase-promoting complex-dependent catabolic process;nucleotide-excision repair, DNA incision;TRIF-dependent toll-like receptor signaling pathway;interstrand cross-link repair;error-prone translesion synthesis;DNA damage response, detection of DNA damage;positive regulation of apoptotic process;negative regulation of apoptotic process;regulation of mRNA stability;cellular protein metabolic process;positive regulation of transcription by RNA polymerase II;positive regulation of NF-kappaB transcription factor activity;stress-activated MAPK cascade;transmembrane transport;membrane organization;regulation of transcription from RNA polymerase II promoter in response to hypoxia;nucleotide-binding oligomerization domain containing signaling pathway;interleukin-1-mediated signaling pathway;global genome nucleotide-excision repair;error-free translesion synthesis;intracellular transport of virus	extracellular space;nucleus;nucleoplasm;cytoplasm;mitochondrial outer membrane;endoplasmic reticulum membrane;cytosol;plasma membrane;endosome membrane;endocytic vesicle membrane;vesicle;myelin sheath;host cell;extracellular exosome	protease binding;RNA binding;protein binding;protein tag;ubiquitin protein ligase binding	CSF3R[17363902];PLEKHB2[unassigned1304];ZFAND5[16424905];UBE2D3[24446487];BUB1B[19407811];UBE3A[unassigned1304];ICAM1[17174307];RABGEF1[25416956];HERC3[11163799];RGS2[21900206];TBK1[18636086];PSMD4[8570649;9488668;19796170;19798103;20059542];UBASH3B[17599067];MYC[16376880;16996503;19131971;21150319];FTH1[17082767];LEPR[16482222];DENR[16874301;16936636];UBASH3A[17599067];HIST1H2AA[20075863];MAP3K7[16845370;19820695];JUNB[19343052];MAP3K4[16256071];TGM2[19183553];DAXX[16810318;20936779];RALBP1[17703191];SLC38A1[25561175];USP5[19373254];DAPK1[20389280];FBXW11[17510365];UBE2E3[19549727];USP2[19373254];METTL3[29507755];MUL1[19407830];PRKCA[18566587];YOD1[unassigned1304];MTURN[unassigned1304];ADAM19[12463424];ERN1[18369366];HGS[11916981;12230472;12750381;12207904];DDIT4[19557001];CDIP1[unassigned1304];STAMBP[19373254];SQSTM1[12857745;8702753;19427866;21900206];STAM2[12750381];TP53[17139261;17170702;17159902;17268548;17290220;17568776;18309296;18388957;18566590;19098711;19619542;19536131;19798103];VPS28[11916981];OPTN[23414517];ABCG2[19909340];TSG101[11916981];DTX1[17028573];NEDD4L[19343052];BRCC3[19214193];ADRB2[19424180];PHB[20134482];GATA1[16858405];BCL2L12[19376117];ATXN3[14559776;19153604];GRK2[17006543];ZNHIT1[17380123];IRAK1[16884718];RDH12[20006610];UBC[19373254];SNX9[20491914];SMAD2[22045334];BRAP[25820252];FIS1[16874301];JUN[19343052;20936779];ZRANB1[19373254];SMAD4[22045334];SMAD3[22045334];UBE2B[10388568];SMURF2[19343052];NBEAL2[29187380];STAM[12750381;19111546;20150893];MARCH5[16874301];UBAC1[unassigned1304];NFATC4[19026640];NFKB2[18617892];NFKBIA[17318178;18539148];SEM1[24811749];SETX[24244371];CYLD[19373254];NPLOC4[17070805];COPS5[19214193];AGO1[17932509];AGO2[17932509];MKRN1[19536131];MDM2[17290220;18566590;19166840;19098711];SPDYA[19622356];SNAI1[20385133];CDK1[20395957];MDM4[17110929];TAB2[19373254];GRB2[20936779];TAB1[16845370];TP73[15678106];DAZAP2[16189514;25416956;unassigned1304];RNF11[15231748];CDKN1A[19536131];YWHAB[15324660];SH3KBP1[19111555;18680311];CALCOCO2[25416956];TNFAIP3[19373254];ARRB1[17620599];YBX1[16797541];ARRB2[17620599];BMI1[19233177;20601937];MED15[16904669];ING1[18388957];ELAVL1[19322201];SH3RF1[20696164];ING2[20621832];METTL14[29507755];NCK2[18539162];DNMT3B[24001151];POLI[16763556];POLL[18688254];IKBKG[16874300;17363905;19373254];TOPBP1[18923429];RAC1[20936779];IKBKE[18636086];YWHAG[15324660];POLH[16763556;17304240];PSD[20339350];SLC36A1[25561175];PARP1[19779455];RING1[20601937];DESI1[unassigned1304];DDX58[18636086];AXIN1[17510365];COMMD1[17183367];YWHAZ[15324660];RAD23B[20059542;unassigned1304];SENP3[19680224];RHOA[15710384];EPN2[unassigned1304];LCK[18539162];TRAF6[17703191;18239685;19820695];PLSCR4[unassigned1304];TAX1BP1[18239685;unassigned1304];DUX4L9[26816005];BIRC2[19373254];OTUB1[11689694];AMER1[17510365];USP15[19373254];PCNA[16763556];SRC[17936276];XIAP[17318174];ASAP1[17255943];NEDD8[18274552;19782077];ASAP2[17255943];RCHY1[17568776];HDAC6[12354939];RELA[17183367;19322197;19262565];MALT1[17948050];CDC42[20936779];WRN[18588880];FAM168A[unassigned1304];UBQLN1[19798103;25416956];UBQLN2[unassigned1304];MAP3K2[20588253];NPM1[18259216];MAP3K1[16845370];WTAP[29507755];PCGF2[20601937];ADRM1[20059542];WWP1[19343052];WWP2[19343052];UBE2G2[unassigned1304];KLF1[16579989];SH3RF3[20696164];ITCH[19343052];RYBP[17070805];KLF5[17320083];TNIP2[19373254];NEDD4[19343052];NBR1[19427866;24879152];PDCD2[19146857];EIF3F[18354498];
88322	chr9	140777306	C	G	chr9:140777306	CACNA1B	calcium voltage-gated channel subunit alpha1 B	1029.0	SNV	0/1	0.51	24_25	49	99	False	rs4422842,COSV53112319	EXONIC	YES	NM_000718.4	Transcript	protein_coding	missense_variant		3/47	NM_000718.4:c.501C>G	NP_000709.1:p.Asn167Lys		1.0	.,Ion transport domain,Ion transport domain,Ion transport domain,Ion transport domain,Ion transport domain	Benign	criteria_provided,_multiple_submitters,_no_conflicts	Neurodevelopmental_disorder_with_seizures_and_nonepileptic_hyperkinetic_movements|not_provided	Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements, 618497 (3), Autosomal recessive	.	.	Tremor;Retinal degeneration;Ataxia;High forehead;Spasticity;Global developmental delay;Cerebral atrophy;Microcephaly;Encephalopathy;Decreased fetal movement;Delayed speech and language development;Generalized hypotonia;Developmental regression;Short stature;Downslanted palpebral fissures;Abnormal myelination;Intellectual disability;Failure to thrive;Dyskinesia;Feeding difficulties;Autism;Unsteady gait;EEG with multifocal slow activity;Abnormal corpus callosum morphology;Hyporeflexia;Impulsivity;Abnormality of vision;Status epilepticus;Difficulty walking;Rigidity;Myoclonus;Hypsarrhythmia;Optic atrophy;Gastroesophageal reflux;Ptosis;Mental deterioration;Attention deficit hyperactivity disorder;Nystagmus;Poor head control;Limb hypertonia;Hypodontia;Central hypotonia;Cerebral visual impairment;Epileptic encephalopathy;Inability to walk;Choreoathetosis;Myoclonus;Autosomal recessive inheritance;Global developmental delay;Developmental regression;Absent speech;Cerebral atrophy;Dystonia;Strabismus;Recurrent respiratory infections;Nystagmus;Hyperkinetic movements;Postnatal microcephaly;Seizure	20352079,29396286,19503611					32	0.96							0.499956	124620.0	249262.0	1.0	100	1.0	InbreedingCoeff	amr	0.500029	17265.0	0.5	56519.0	0.0029002,0.0338512	451,5264	0.161	500.0				16.35	1.514016	0.639	14	6	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CACNA1B	0.0	0.04	0.01	0.06	29.0	-26.0	0.0	29.0							0.98	32.616318093	0.941	-1.553	integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			kidney;atrioventricular node;parietal lobe;	MAPK signaling pathway;Calcium signaling pathway;Taste transduction;Type II diabetes mellitus	calcium ion transport;chemical synaptic transmission;neurotransmitter secretion;locomotory behavior;regulation of heart contraction;regulation of blood pressure;regulation of ion transmembrane transport;response to pain;modulation of chemical synaptic transmission;membrane depolarization;regulation of calcium ion transport;calcium ion import;calcium ion transmembrane transport;response to amyloid-beta	plasma membrane;voltage-gated calcium channel complex;dendrite;neuronal cell body;presynapse	amyloid-beta binding;voltage-gated calcium channel activity;calcium channel activity;calcium ion binding;protein binding;ATP binding;protein C-terminus binding;high voltage-gated calcium channel activity	RXRB[20195357];MTNR1A[26514267];MRFAP1[17353931];APBA1[16007100];
88454	chr9	140811748	C	T	chr9:140811748	CACNA1B	calcium voltage-gated channel subunit alpha1 B	1029.0	SNV	0/1	0.54	17_20	37	99	False	rs778540767,COSV99500558	EXONIC	YES	NM_000718.4	Transcript	protein_coding	synonymous_variant		6/47	NM_000718.4:c.831C>T	NP_000709.1:p.Cys277%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided	Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements, 618497 (3), Autosomal recessive	.	.	Tremor;Retinal degeneration;Ataxia;High forehead;Spasticity;Global developmental delay;Cerebral atrophy;Microcephaly;Encephalopathy;Decreased fetal movement;Delayed speech and language development;Generalized hypotonia;Developmental regression;Short stature;Downslanted palpebral fissures;Abnormal myelination;Intellectual disability;Failure to thrive;Dyskinesia;Feeding difficulties;Autism;Unsteady gait;EEG with multifocal slow activity;Abnormal corpus callosum morphology;Hyporeflexia;Impulsivity;Abnormality of vision;Status epilepticus;Difficulty walking;Rigidity;Myoclonus;Hypsarrhythmia;Optic atrophy;Gastroesophageal reflux;Ptosis;Mental deterioration;Attention deficit hyperactivity disorder;Nystagmus;Poor head control;Limb hypertonia;Hypodontia;Central hypotonia;Cerebral visual impairment;Epileptic encephalopathy;Inability to walk;Choreoathetosis;Myoclonus;Autosomal recessive inheritance;Global developmental delay;Developmental regression;Absent speech;Cerebral atrophy;Dystonia;Strabismus;Recurrent respiratory infections;Nystagmus;Hyperkinetic movements;Postnatal microcephaly;Seizure		7.22771e-05	11.0	152192.0	0.0	32	0.97	PASS	amr	0.000523218	8.0	4.40995e-05	3.0	0.000538274	134.0	248944.0	0.0	53	0.99	PASS	amr	0.00373913	129.0	2.66075e-05	3.0	0.0003666	57						9.443	0.504276		0	0	0			CACNA1B	0.0	0.0	0.0	0.0	35.0	-20.0	-2.0	-4.0							0.98	32.616318093			integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			kidney;atrioventricular node;parietal lobe;	MAPK signaling pathway;Calcium signaling pathway;Taste transduction;Type II diabetes mellitus	calcium ion transport;chemical synaptic transmission;neurotransmitter secretion;locomotory behavior;regulation of heart contraction;regulation of blood pressure;regulation of ion transmembrane transport;response to pain;modulation of chemical synaptic transmission;membrane depolarization;regulation of calcium ion transport;calcium ion import;calcium ion transmembrane transport;response to amyloid-beta	plasma membrane;voltage-gated calcium channel complex;dendrite;neuronal cell body;presynapse	amyloid-beta binding;voltage-gated calcium channel activity;calcium channel activity;calcium ion binding;protein binding;ATP binding;protein C-terminus binding;high voltage-gated calcium channel activity	RXRB[20195357];MTNR1A[26514267];MRFAP1[17353931];APBA1[16007100];
89036	chr7	117188841	TTG		chr7:117188841-117188843	CFTR	cystic fibrosis transmembrane conductance regulator	1047.0	deletion	0/1	0.15	23_4	27	99	False	rs397508194	EXONIC	YES	NM_000492.4	Transcript	protein_coding	inframe_deletion		10/27	NM_000492.4:c.1360_1362del	NP_000483.3:p.Leu454del		1.0		Likely_benign	criteria_provided,_single_submitter	not_specified	Cystic fibrosis, 219700 (3), Autosomal recessive; Sweat chloride elevation without CF (3); Congenital bilateral absence of vas deferens, 277180 (3), Autosomal recessive; {Pancreatitis, hereditary}, 167800 (3), Autosomal dominant; {Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3), Autosomal dominant; {Hypertrypsinemia, neonatal} (3)	Cystic fibrosis;Hereditary chronic pancreatitis;Congenital bilateral absence of vas deferens;Male infertility with azoospermia or oligozoospermia due to single gene mutation;Aquagenic palmoplantar keratoderma;Idiopathic bronchiectasis	Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Candidate gene tested in;Candidate gene tested in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Obstructive azoospermia;Male infertility;Oligospermia;Abnormal renal morphology;Absent vas deferens;Azoospermia;Autosomal recessive inheritance;Heterogeneous;Myocardial infarction;Emphysema;Clubbing;Fever;Recurrent lower respiratory tract infections;Chest pain;Halitosis;Hemoptysis;Cachexia;Bronchiectasis;Dyspnea;Wheezing;Reduced FEV1/FVC ratio;Productive cough;Recurrent Haemophilus influenzae infections;Crackles;Decreased pulmonary function;Acute infectious pneumonia;Dehydration;Bronchiectasis;Biliary cirrhosis;Hypercalciuria;Rectal prolapse;Meconium ileus;Recurrent pneumonia;Exocrine pancreatic insufficiency;Male infertility;Elevated sweat chloride;Failure to thrive;Chronic lung disease;Cor pulmonale;Asthma;Recurrent bronchopulmonary infections;Autosomal recessive inheritance;Decreased testicular size;Increased circulating gonadotropin level;Obstructive azoospermia;Non-obstructive azoospermia;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification;Pulmonary fibrosis;Hepatomegaly;Decreased circulating antibody level;Recurrent respiratory infections;Immunodeficiency;Malabsorption;Biliary cirrhosis;Exocrine pancreatic insufficiency;Chronic bronchitis;Autosomal dominant inheritance;Bronchiectasis;Elevated sweat chloride	9383031	0.00232609	295.0	126822.0	0.0	32	0.85	AS_VQSR	amr	0.00320566	39.0	0.00186778	109.0	4.15376e-06	1.0	240746.0	0.0	64	0.75	RF	nfe	9.30146e-06	1.0	9.30146e-06	1.0	0.0015948	248	0.001	2.0	0.00031	3.0		19.96	2.028398		0	0	0			CFTR	0.01	0.0	0.01	0.0	-27.0	-9.0	32.0	-46.0						0.0235	0.0	37.013649482			homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			salivary gland;ciliary ganglion;beta cell islets;pancreas;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	ABC transporters;Vibrio cholerae infection	cholesterol biosynthetic process;vesicle docking involved in exocytosis;bicarbonate transport;protein deubiquitination;cholesterol transport;response to endoplasmic reticulum stress;transepithelial water transport;positive regulation of insulin secretion involved in cellular response to glucose stimulus;positive regulation of exocytosis;sperm capacitation;multicellular organismal water homeostasis;intracellular pH elevation;transmembrane transport;membrane hyperpolarization;membrane organization;cellular response to cAMP;ATP hydrolysis coupled anion transmembrane transport;positive regulation of cyclic nucleotide-gated ion channel activity;chloride transmembrane transport;positive regulation of voltage-gated chloride channel activity;cellular response to forskolin	nucleus;cytoplasm;lysosomal membrane;early endosome;endoplasmic reticulum membrane;cytosol;plasma membrane;integral component of plasma membrane;cell surface;endosome membrane;membrane;integral component of membrane;apical plasma membrane;Golgi-associated vesicle membrane;clathrin-coated vesicle membrane;early endosome membrane;protein-containing complex;chloride channel complex;recycling endosome;recycling endosome membrane	chloride channel activity;intracellularly ATP-gated chloride channel activity;protein binding;ATP binding;bicarbonate transmembrane transporter activity;chloride transmembrane transporter activity;ATPase activity;chloride channel regulator activity;chloride channel inhibitor activity;enzyme binding;PDZ domain binding;ATPase activity, coupled to transmembrane movement of substances;ATPase-coupled anion transmembrane transporter activity;chaperone binding;Sec61 translocon complex binding	CSE1L[17110338];PDCD6[17110338];UBE3A[17110338];IPO7[17110338];ACTB[22038833];LGALS4[17110338];EPS8[17110338];LGALS3[17110338];PCMT1[17110338];TFG[17110338];CAPNS1[17110338];PPP2R1A[15936019;17110338];CDH1[17110338];PSMD2[17110338];WSB1[17110338];TPM3[17110338];TMOD3[17110338];AP1B1[17110338];KRT8[22038833];LMO7[17110338];PDZK1[12471024;11051556];ATAD3A[17110338];KRT9[22038833];BCR[15494376;17110338];SLC9A2[16203867];ATXN2L[17110338];TIAM1[17110338];PSME2[17110338];S100A9[17110338];CFTR[11051556];KPNB1[17110338];S100A7[17110338];VCP[17110338];PRKDC[17110338];COPB1[17110338];LPAR2[16203867];LIN7C[17110338];PLD2[17110338];SLC9A3R2[12369822;16203867;17110338];SLC9A3R1[12471024;9671706;17110338;17244609;19446522];SNX4[17110338];STIP1[20534503];UBB[17110338];CLTCL1[17110338];PSAP[17110338];CLCA1[17110338];SNX9[17110338];THEM6[17110338];KCNN4[27092946];HSPA9[17110338];XRCC6[22038833];HSPA5[17110338;22038833];WFS1[17110338];HSPA7[17110338];HSPA2[17110338];DAB2[17110338];CAPRIN1[17110338];CALU[17110338];SFXN3[17110338];FAT1[17110338];SLC26A8[22121115];RAB5A[21455491];RYR2[17110338];MS4A5[17110338];HSP90AB1[17110338];ATP2A3[17110338];PRKAG1[27092946];ATP2A2[17110338];HSPB1[17110338];CLTA[17110338];C6orf48[17110338];CLINT1[17110338];SEC61A2[17110338];SEC61A1[17110338];CASP14[22038833];XPO1[17110338];SPTLC1[17110338];AIFM1[17110338];TMEM43[17110338];EXO1[17110338];RACK1[17110338];MUC13[17110338];FLOT2[17110338];SH3BGRL2[17110338];ELOB[17110338];CEP170[17110338];LRRFIP2[17110338];ELOC[17110338];EMD[17110338];APOA2[17110338];AHSA1[17110338];ANO1[22178883];B3GNT9[17110338];RCN1[17110338];RCN2[17110338];HAX1[17110338];GORASP2[21884936];CANX[12208510;16546175;17110338];IL1RAPL1[17110338];TCP1[22038833];HCLS1[17110338];DSG1[22038833];MYH9[22038833];RAB7A[21455491];CSTB[17110338];GRN[17110338];USP10[21455491];VPS4A[17110338];DERL1[16901789];ADCY8[17110338];RNF5[16901789];USP19[19465887];HSPD1[17110338];GNAI2[17110338];DNAJB1[17110338];LIMA1[17110338];MUC2[17110338];EPCAM[17110338];GNA11[17110338];LMNA[17110338];FAM120A[17110338];CD59[17110338];REPS1[17110338];BCAP31[18555783];SVIL[17110338];HSPA1L[17110338];RYK[17110338];SQOR[17110338];PLEKHA6[17110338];KRT10[22038833];SORL1[17110338];RAB11A[21455491];DNAJA1[17110338];TJP1[17110338];KRT18[22038833];KRT17[22038833];XPNPEP3[17110338];DNAJA2[17110338];GOPC[12471024];TRIP12[17110338];VIM[22038833];TJP3[17110338];HSPA1A[17110338;22038833];
95709	chr4	110897202	C	T	chr4:110897202	EGF	epidermal growth factor	1104.0	SNV	0/1	0.58	14_19	33	99	False	rs759896124	EXONIC	YES	NM_001963.6	Transcript	protein_coding	stop_gained		13/24	NM_001963.6:c.1864C>T	NP_001954.2:p.Arg622Ter		1.0	.,.,.	Uncertain_significance	criteria_provided,_single_submitter	not_provided	?Hypomagnesemia 4, renal, 611718 (3), Autosomal recessive	Adult hepatocellular carcinoma;Familial primary hypomagnesemia with normocalciuria and normocalcemia	Major susceptibility factor in;Disease-causing germline mutation(s) in	Vertigo;Autistic behavior;Headache;Poor speech;Moderate global developmental delay;Ventriculomegaly;Intellectual disability, moderate;Seizure;Hypomagnesemia;Generalized muscle weakness;Obesity;Hypermagnesiuria;Microcephaly;Hyperactive deep tendon reflexes;Abnormal myelination;Intellectual disability, moderate;Autosomal recessive inheritance;Global developmental delay;Seizure;Hypomagnesemia		4.59933e-05	7.0	152196.0	0.0	33	0.98	PASS	amr	0.000130856	2.0	2.93971e-05	2.0	4.77798e-05	12.0	251152.0	0.0	100	1.0	PASS	amr	0.000173451	6.0	2.64452e-05	3.0	0.0000257	4			9e-05	1.0		36.0	6.674361		5	2	7	MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred,fathmm-MKL_coding_pred	LRT_pred,fathmm-XF_coding_pred	EGF	0.23	0.2	0.0	0.0	25.0	-11.0	-34.0	-11.0						0.0495	0.0	0.0	0.998	0.091	reproductive system phenotype; normal phenotype; immune system phenotype; vision/eye phenotype; digestive/alimentary phenotype; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; 			ciliary ganglion;kidney;atrioventricular node;superior cervical ganglion;trigeminal ganglion;	MAPK signaling pathway;ErbB signaling pathway;Cytokine-cytokine receptor interaction;Focal adhesion;Gap junction;Regulation of actin cytoskeleton;Pancreatic cancer;Endometrial cancer;Glioma;Prostate cancer;Melanoma;Bladder cancer;Non-small cell lung cancer	MAPK cascade;activation of MAPKK activity;activation of MAPK activity;angiogenesis;positive regulation of receptor internalization;platelet degranulation;signal transduction;activation of transmembrane receptor protein tyrosine kinase activity;epidermal growth factor receptor signaling pathway;positive regulation of cell population proliferation;positive regulation of gene expression;positive regulation of peptidyl-threonine phosphorylation;peptidyl-tyrosine phosphorylation;positive regulation of cerebellar granule cell precursor proliferation;positive regulation of cell migration;ERBB2 signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;positive regulation of phosphorylation;positive regulation of DNA binding;positive regulation of MAP kinase activity;positive regulation of epidermal growth factor-activated receptor activity;negative regulation of Notch signaling pathway;positive regulation of mitotic nuclear division;positive regulation of transcription, DNA-templated;regulation of JAK-STAT cascade;phosphatidylinositol phosphorylation;branching morphogenesis of an epithelial tube;negative regulation of secretion;positive regulation of protein kinase B signaling;canonical Wnt signaling pathway;mammary gland alveolus development;membrane organization;ERK1 and ERK2 cascade;positive regulation of canonical Wnt signaling pathway;regulation of calcium ion import;negative regulation of cholesterol efflux;positive regulation of hyaluronan biosynthetic process;negative regulation of ERBB signaling pathway;regulation of protein localization to cell surface;positive regulation of ubiquitin-dependent protein catabolic process;regulation of cell motility	extracellular region;extracellular space;lysosomal membrane;plasma membrane;integral component of membrane;clathrin-coated vesicle membrane;platelet alpha granule lumen;receptor complex;extracellular exosome	protein tyrosine kinase activity;Ras guanyl-nucleotide exchange factor activity;epidermal growth factor receptor binding;calcium ion binding;protein binding;growth factor activity;Wnt-protein binding;transmembrane receptor protein tyrosine kinase activator activity;Wnt-activated receptor activity;phosphatidylinositol-4,5-bisphosphate 3-kinase activity	FGF5[25241761];APP[28106549];RPS6KA5[25241761];LOX[30082873];MGST1[unassigned1304];S100A4[19740107];PCOLCE[24117177];EGFR[2790960;12297050;12620237;21439278;25241761;23597562;17697999;21822280;26280537];HDAC6[20029029];
97322	chrX	153008476	T	C	chrX:153008476	ABCD1	ATP binding cassette subfamily D member 1	1154.0	SNV	0|1	0.13	20_3	23	66	False	rs201774661,CM960043,COSV54383418	EXONIC	YES	NM_000033.4	Transcript	protein_coding	missense_variant		8/10	NM_000033.4:c.1816T>C	NP_000024.2:p.Ser606Pro		1.0	ABC transporter-like&ABC transporter, conserved site&ABC transporter-like&AAA+ ATPase domain	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	X-linked_cerebral_adrenoleukodystrophy|Adrenoleukodystrophy|not_specified|not_provided	Adrenoleukodystrophy, 300100 (3), X-linked recessive; Adrenomyeloneuropathy, adult, 300100 (3), X-linked recessive	X-linked cerebral adrenoleukodystrophy;Adrenomyeloneuropathy;CADDS	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Role in the phenotype of	Hyperpigmentation of the skin;Impotence;Paraparesis;Hearing impairment;Progressive;Loss of speech;Visual loss;X-linked recessive inheritance;Neurodegeneration;Urinary incontinence;Slurred speech;Abnormality of the cerebral white matter;Bowel incontinence;Dementia;Limb ataxia;Primary adrenal insufficiency;Psychosis;Polyneuropathy;Alopecia;Attention deficit hyperactivity disorder;Truncal ataxia;Incoordination;Impaired vibration sensation at ankles;Hypogonadism;Blindness;Spastic paraplegia;Elevated circulating long chain fatty acid concentration;Seizure;Urinary bladder sphincter dysfunction;Lower limb muscle weakness;Bulbar palsy	21966424,8651290,17542813,21700483,21889498,22479560,23566833					25	0.62							0.000380507	57.0	149800.0	0.0	80	0.63	PASS	afr	0.000771903	8.0	0.000422548	27.0	0.0001801	28	0.007	21.0	0.0078	89.0		25.0	3.517978	0.941	15	4	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HVAR_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred	ABCD1	0.0	0.0	0.0	0.0	15.0	50.0	49.0	-36.0						0.0188	0.98		0.994	1.137	hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; 			superior cervical ganglion;skeletal muscle;	ABC transporters	regulation of oxidative phosphorylation;fatty acid beta-oxidation;peroxisome organization;peroxisomal long-chain fatty acid import;fatty-acyl-CoA transport;peroxisomal membrane transport;fatty acid elongation;regulation of fatty acid beta-oxidation;positive regulation of fatty acid beta-oxidation;fatty acid beta-oxidation using acyl-CoA oxidase;alpha-linolenic acid metabolic process;very long-chain fatty-acyl-CoA catabolic process;long-chain fatty acid catabolic process;very long-chain fatty acid catabolic process;myelin maintenance;linoleic acid metabolic process;regulation of mitochondrial depolarization;transmembrane transport;fatty acid homeostasis;sterol homeostasis;negative regulation of cytokine production involved in inflammatory response;regulation of cellular response to oxidative stress;negative regulation of reactive oxygen species biosynthetic process;neuron projection maintenance;positive regulation of unsaturated fatty acid biosynthetic process	cytoplasm;lysosomal membrane;peroxisome;peroxisomal membrane;integral component of peroxisomal membrane;endoplasmic reticulum membrane;cytosol;membrane;mitochondrial membrane;perinuclear region of cytoplasm	transporter activity;long-chain fatty acid transporter activity;protein binding;ATP binding;fatty-acyl-CoA transmembrane transporter activity;ATPase activity;enzyme binding;ATPase activity, coupled to transmembrane movement of substances;identical protein binding;protein homodimerization activity;ADP binding	ABCD2[24658140];ABCD3[10551832];PEX19[20531392];VAPA[26496610];RPSA[21988832];VPS26B[26496610];ABCD1[10551832];HNRNPAB[30021884];RAB7A[26496610];
97323	chrX	153008483	G	A	chrX:153008483	ABCD1	ATP binding cassette subfamily D member 1	1154.0	SNV	0|1	0.13	20_3	23	66	False	rs78993751,CM012040,COSV54383323	EXONIC	YES	NM_000033.4	Transcript	protein_coding	missense_variant		8/10	NM_000033.4:c.1823G>A	NP_000024.2:p.Gly608Asp		1.0	ABC transporter-like&ABC transporter, conserved site&ABC transporter-like&AAA+ ATPase domain	Benign	criteria_provided,_multiple_submitters,_no_conflicts	Adrenoleukodystrophy|not_specified|not_provided	Adrenoleukodystrophy, 300100 (3), X-linked recessive; Adrenomyeloneuropathy, adult, 300100 (3), X-linked recessive	X-linked cerebral adrenoleukodystrophy;Adrenomyeloneuropathy;CADDS	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Role in the phenotype of	Hyperpigmentation of the skin;Impotence;Paraparesis;Hearing impairment;Progressive;Loss of speech;Visual loss;X-linked recessive inheritance;Neurodegeneration;Urinary incontinence;Slurred speech;Abnormality of the cerebral white matter;Bowel incontinence;Dementia;Limb ataxia;Primary adrenal insufficiency;Psychosis;Polyneuropathy;Alopecia;Attention deficit hyperactivity disorder;Truncal ataxia;Incoordination;Impaired vibration sensation at ankles;Hypogonadism;Blindness;Spastic paraplegia;Elevated circulating long chain fatty acid concentration;Seizure;Urinary bladder sphincter dysfunction;Lower limb muscle weakness;Bulbar palsy						25	0.62							0.000409434	61.0	148986.0	0.0	79	0.63	RF	afr	0.000867888	9.0	0.000440848	28.0	0.0063535	988	0.014	43.0	0.0078	89.0		26.4	3.823438	1.0	15	4	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred	ABCD1	0.0	0.0	0.0	0.0	-42.0	-41.0	42.0	-43.0						0.0188	0.98		0.977	1.175	hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; 			superior cervical ganglion;skeletal muscle;	ABC transporters	regulation of oxidative phosphorylation;fatty acid beta-oxidation;peroxisome organization;peroxisomal long-chain fatty acid import;fatty-acyl-CoA transport;peroxisomal membrane transport;fatty acid elongation;regulation of fatty acid beta-oxidation;positive regulation of fatty acid beta-oxidation;fatty acid beta-oxidation using acyl-CoA oxidase;alpha-linolenic acid metabolic process;very long-chain fatty-acyl-CoA catabolic process;long-chain fatty acid catabolic process;very long-chain fatty acid catabolic process;myelin maintenance;linoleic acid metabolic process;regulation of mitochondrial depolarization;transmembrane transport;fatty acid homeostasis;sterol homeostasis;negative regulation of cytokine production involved in inflammatory response;regulation of cellular response to oxidative stress;negative regulation of reactive oxygen species biosynthetic process;neuron projection maintenance;positive regulation of unsaturated fatty acid biosynthetic process	cytoplasm;lysosomal membrane;peroxisome;peroxisomal membrane;integral component of peroxisomal membrane;endoplasmic reticulum membrane;cytosol;membrane;mitochondrial membrane;perinuclear region of cytoplasm	transporter activity;long-chain fatty acid transporter activity;protein binding;ATP binding;fatty-acyl-CoA transmembrane transporter activity;ATPase activity;enzyme binding;ATPase activity, coupled to transmembrane movement of substances;identical protein binding;protein homodimerization activity;ADP binding	ABCD2[24658140];ABCD3[10551832];PEX19[20531392];VAPA[26496610];RPSA[21988832];VPS26B[26496610];ABCD1[10551832];HNRNPAB[30021884];RAB7A[26496610];
97441	chr7	150692387	C	T	chr7:150692387	NOS3	nitric oxide synthase 3	1157.0	SNV	0/1	0.52	15_16	31	99	False	rs572649815	EXONIC	YES	NM_000603.5	Transcript	protein_coding	synonymous_variant		3/27	NM_000603.5:c.255C>T	NP_000594.2:p.Ser85%3D		1.0					{Coronary artery spasm 1, susceptibility to} (3); {Hypertension, susceptibility to}, 145500 (3), Multifactorial; {Placental abruption} (3); {Alzheimer disease, late-onset, susceptibility to}, 104300 (3), Autosomal dominant; {Hypertension, pregnancy-induced}, 189800 (3), Autosomal dominant; {Ischemic stroke, susceptibility to}, 601367 (3), Multifactorial	.	.	Autosomal dominant inheritance;Proteinuria;Hypertension;Edema;Thrombocytopenia;Maternal hypertension;Eclampsia;Seizure;Intrauterine growth retardation;Elevated hepatic transaminase;Preeclampsia;Stroke;Elevated mean arterial pressure;Multifactorial inheritance;Elevated systolic blood pressure;Elevated diastolic blood pressure;Autosomal dominant inheritance;Neurofibrillary tangles;Long-tract signs;Decreased level of GABA in serum;Dementia;Heterogeneous;Parkinsonism;Alzheimer disease		6.57436e-05	10.0	152106.0	0.0	33	0.98	PASS	amr	0.000458115	7.0	2.941e-05	2.0	5.24274e-05	13.0	247962.0	0.0	33	0.9	PASS	amr	0.000204153	7.0	3.58732e-05	4.0	0.0000450	7			0.00026	3.0		10.99	0.680811		0	0	0			NOS3	0.0	0.0	0.0	0.02	15.0	0.0	-30.0	15.0						0.817	0.0	60.04807523			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; respiratory system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; muscle phenotype; 			placenta;testis;parietal lobe;	Arginine and proline metabolism;Calcium signaling pathway;VEGF signaling pathway;Long-term depression;Small cell lung cancer	angiogenesis;ovulation from ovarian follicle;in utero embryonic development;blood vessel remodeling;regulation of sodium ion transport;regulation of the force of heart contraction by chemical signal;regulation of systemic arterial blood pressure by endothelin;aortic valve morphogenesis;pulmonary valve morphogenesis;endocardial cushion morphogenesis;arginine catabolic process;nitric oxide biosynthetic process;mitochondrion organization;nitric oxide mediated signal transduction;regulation of blood pressure;negative regulation of cell population proliferation;response to heat;response to hormone;negative regulation of platelet activation;positive regulation of gene expression;negative regulation of muscle hyperplasia;smooth muscle hyperplasia;removal of superoxide radicals;lung development;positive regulation of guanylate cyclase activity;lipopolysaccharide-mediated signaling pathway;response to lipopolysaccharide;response to fluid shear stress;vasodilation;negative regulation of potassium ion transport;positive regulation of blood vessel endothelial cell migration;endothelial cell migration;cell redox homeostasis;positive regulation of angiogenesis;negative regulation of blood pressure;homeostasis of number of cells within a tissue;regulation of blood vessel size;regulation of nitric-oxide synthase activity;cofactor metabolic process;negative regulation of hydrolase activity;negative regulation of calcium ion transport;oxidation-reduction process;ventricular septum morphogenesis;negative regulation of biomineral tissue development;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	Golgi membrane;nucleus;cytoplasm;Golgi apparatus;cytosol;cytoskeleton;plasma membrane;caveola;vesicle membrane;endocytic vesicle membrane	actin monomer binding;NADPH-hemoprotein reductase activity;nitric-oxide synthase activity;protein binding;calmodulin binding;FMN binding;oxidoreductase activity;heme binding;tetrahydrobiopterin binding;arginine binding;cadmium ion binding;flavin adenine dinucleotide binding;NADP binding;scaffold protein binding	RNF31[21163940];KANK2[21163940];GCDH[21163940];RNF32[21163940];MAST1[21163940];HTRA1[21163940];TXNDC11[21163940];ELAVL1[21163940];IKZF3[unassigned1304];ACTB[17502619];ELAVL3[21163940];GOLGA2[25416956;unassigned1304];EFEMP2[21163940];EFEMP1[21163940];MPRIP[21163940];AKT1[25241761;23397142];A2M[21163940];MAGEA11[25416956];FIS1[21163940];ST13[21163940];ACTN2[21163940];CAV1[17502619];H3F3A[21163940];IMMT[21163940];ACTN4[21163940];HBA1[23123858];ESR1[17921256];SIRT1[20479254];DNM1[16432212];CDC37[21163940];NOSTRIN[12446846;16234328];CTNNB1[25062958];EXOC6[21163940];CALM1[11397791];UMPS[21163940];PI4K2A[21163940];
98477	chr12	112036781	GTTGCTGCTGC		chr12:112036781-112036791	ATXN2	ataxin 2	1166.0	deletion	0|1	0.32	11_6	19	99	False	rs752859349	EXONIC	YES	NM_001372574.1	Transcript	protein_coding	frameshift_variant		1/25	NM_001372574.1:c.48_58del	NP_001359503.1:p.Gln17AlafsTer69		-1.0					{Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3), Autosomal dominant; Spinocerebellar ataxia 2, 183090 (3), Autosomal dominant; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial	Amyotrophic lateral sclerosis;Spinocerebellar ataxia type 2	Major susceptibility factor in;Disease-causing germline mutation(s) in	Laryngospasm;Nausea and vomiting;Dyspnea;Anxiety;Pain;Paralysis;Agitation;Generalized muscle weakness;Depressivity;Amyotrophic lateral sclerosis;Xerostomia;Fatigable weakness of respiratory muscles;Muscle spasm;Fatigable weakness of swallowing muscles;Skeletal muscle atrophy;Neurodegeneration;Emotional lability;Spasticity;Respiratory failure;Fatigue;Supranuclear ophthalmoplegia;Gait ataxia;Hyperactive deep tendon reflexes;Olivopontocerebellar hypoplasia;Nystagmus;Dystonia;Progressive cerebellar ataxia;Postural tremor;Chorea;Dysarthria;Abnormality of the substantia nigra;Hyporeflexia;Dementia;Cerebral cortical atrophy;Cerebellar Purkinje layer atrophy;Muscle spasm;Abnormal cell morphology;Generalized hypotonia;Spinal cord posterior columns myelin loss;Slow saccadic eye movements;Abnormality of the spinocerebellar tracts;Fasciculations;Kinetic tremor;Parkinsonism;Abnormal cortical gyration;Cerebral white matter atrophy;Urinary bladder sphincter dysfunction;Limb ataxia;Spinocerebellar tract degeneration;Generalized hypotonia;Dysmetric saccades;Postural instability;Spasticity;Slow saccadic eye movements;Muscular hypotonia;Olivopontocerebellar atrophy;Dilated fourth ventricle;Fasciculations;Dysarthria;Dysdiadochokinesis;Dementia;Rigidity;Ophthalmoplegia;Rod-cone dystrophy;Hyporeflexia;Impaired vibratory sensation;Postural tremor;Progressive cerebellar ataxia;Genetic anticipation;Autosomal dominant inheritance;Dysmetria;Bradykinesia;Gaze-evoked nystagmus;Distal amyotrophy;Oculomotor apraxia;Dysphagia;Parkinsonism;Impaired horizontal smooth pursuit;Myoclonus;Rigidity;Sporadic;Constipation;Sleep disturbance;Depressivity;Dementia;Bradykinesia;Abnormal autonomic nervous system physiology;Substantia nigra gliosis;Resting tremor;Dysarthria;Mask-like facies;Parkinsonism;Insidious onset;Hallucinations;Postural instability;Micrographia;Dysphagia;Dystonia;Tremor;Autosomal dominant inheritance;Personality changes;Neuronal loss in central nervous system;Urinary urgency;Weak voice;Progressive;Short stepped shuffling gait;Lewy bodies		0.00195196	287.0	147032.0	1.0	32	0.86	PASS	nfe	0.00287776	193.0	0.00287776	193.0	0.000397184	44.0	110780.0	0.0	6	0.35	RF	sas	0.000507151	10.0	0.000464889	19.0	0.0000064	1			0.00252	24.0		16.36	1.515303		0	0	0																	0.374	1.0				adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	.	negative regulation of receptor internalization;regulation of translation;regulation of cytoplasmic mRNA processing body assembly;RNA metabolic process;cytoplasmic mRNA processing body assembly;stress granule assembly;RNA transport	cytoplasm;Golgi apparatus;trans-Golgi network;cytosol;polysome;cytoplasmic stress granule;membrane;perinuclear region of cytoplasm;ribonucleoprotein complex	RNA binding;epidermal growth factor receptor binding;protein binding;protein C-terminus binding	SH3GL3[16115810;16713569;18602463];DDX6[17392519];RPL10[26496610];YEATS4[26496610];BAG6[16713569];ZNRD1[16713569];ATXN1[16713569];SUMO3[17000644];G3BP1[23209657];IDH3B[16713569];PLS3[16115810];VHL[17353931];HIF1AN[29426014];SH3GL2[16115810;16713569;18602463];CHGB[16169070];HSPA8[29568061];RBFOX1[16713569];JUN[25609649];ACTN2[16713569];ACTN1[16713569];SEC16A[26496610];NCOA4[16713569];TDRD7[16713569];NBEAL2[29187380];DICER1[21858095];ATXN2L[23209657];GFI1B[16713569];KIF1BP[16713569];MNDA[25665578];LCP1[16115810];PABPC1[15663938;17392519;20181956];TARDBP[20740007];
98490	chr17	71384151	C	T	chr17:71384151	SDK2	sidekick cell adhesion molecule 2	1167.0	SNV	0/1	0.46	14_12	26	99	False	rs147384840,COSV66184615	EXONIC	YES	NM_001144952.2	Transcript	protein_coding	synonymous_variant		30/45	NM_001144952.2:c.4218G>A	NP_001138424.1:p.Pro1406%3D		-1.0						.	.	.		0.00536327	816.0	152146.0	3.0	33	0.97	PASS	amr	0.00896714	137.0	0.00765974	521.0	0.00558221	1003.0	179678.0	6.0	33	0.57	PASS	nfe	0.0076271	574.0	0.0076271	574.0	0.0041349	643	0.007	21.0				0.011	-0.779389		0	0	0			SDK2	0.0	0.0	0.0	0.0	-13.0	14.0	-10.0	-18.0							0.03	93.933952010			vision/eye phenotype; 			ciliary ganglion;kidney;testis - seminiferous tubule;subthalamic nucleus;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	.	homophilic cell adhesion via plasma membrane adhesion molecules;synapse assembly;retina layer formation;cell-cell junction organization;camera-type eye photoreceptor cell differentiation	plasma membrane;integral component of membrane;cell junction;synapse	.	VMAC[unassigned1304];TNFAIP3[unassigned1774];PDZK1[30126976];FADD[unassigned1774];TANK[unassigned1774];
98615	chr12	39716500	G	C	chr12:39716500	KIF21A	kinesin family member 21A	1172.0	SNV	0/1	0.59	12_17	29	99	False	rs149075970	EXONIC	YES	NM_001378439.1	Transcript	protein_coding	missense_variant		27/38	NM_001378439.1:c.3641C>G	NP_001365368.1:p.Pro1214Arg		-1.0	.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	Fibrosis_of_extraocular_muscles,_congenital,_1	Fibrosis of extraocular muscles, congenital, 3B, 135700 (3), Autosomal dominant; Fibrosis of extraocular muscles, congenital, 1, 135700 (3), Autosomal dominant	Congenital fibrosis of extraocular muscles	Disease-causing germline mutation(s) in	Esotropia;Sensory exotropia;Restrictive external ophthalmoplegia;Compensatory chin elevation;Exotropia;Autosomal dominant inheritance;Congenital fibrosis of extraocular muscles;Levator palpebrae superioris atrophy;Bilateral ptosis;Secondary esotropia;Superior rectus atrophy		0.0009794	149.0	152134.0	1.0	32	0.97	PASS	nfe	0.00179354	122.0	0.00179354	122.0	0.00084737	213.0	251366.0	0.0	94	1.0	PASS	nfe	0.00142498	162.0	0.00142498	162.0	0.0008810	137	0.001	2.0	0.00096	11.0		22.6	2.519457	0.11	6	11	17	M-CAP_pred,MutationTaster_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	KIF21A	0.0	0.0	0.01	0.05	20.0	-24.0	-30.0	34.0						0.856	0.0	0.000000000	0.999	1.176	cellular phenotype; muscle phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			ciliary ganglion;amygdala;occipital lobe;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;cingulate cortex;parietal lobe;globus pallidus;hypothalamus;	.	microtubule-based movement	cytosol;kinesin complex;microtubule;plasma membrane	microtubule motor activity;protein binding;ATP binding;microtubule binding;ATPase activity	KANK2[26496610];KANK1[19559006;26496610;22084092];NVL[26496610];HIST1H2BL[30021884];ENDOD1[26496610];NOL8[26496610];NOLC1[26496610];CD99L2[26496610];MSI2[26496610];ZNF24[20195357];PHRF1[26496610];RBM4[26496610];FIP1L1[26496610];ZNF668[26496610];KIF21A[19559006];ZNF106[26496610];KIF21B[26496610];CCT8[26496610];RAB11FIP2[26496610];CCT7[26496610];CCT5[26496610];MAP3K4[26496610];PLXNA3[26496610];CCT4[26496610];ARFGEF1[19020088;22084092];CCT3[26496610];UBL4A[26496610];CCT2[26496610];NCOA4[26496610];CDC5L[20467437];TTC9C[26496610];DYNLL1[26496610];TBX3[26496610];CCT6A[26496610];RNF123[26496610];PPFIBP1[26496610];SNW1[20467437];RAD51[26496610];TCP1[26496610];HIST3H3[30021884];PFDN1[26496610];C6orf136[26496610];PFDN2[26496610];TACC2[26496610];DGKH[26496610];
99645	chr5	112128202	A	G	chr5:112128202	APC	APC, WNT signaling pathway regulator	1196.0	SNV	0/1	0.61	9_14	23	99	False	rs147036141,COSV104567389	EXONIC	YES	NM_001354896.2	Transcript	protein_coding	synonymous_variant		7/17	NM_001354896.2:c.705A>G	NP_001341825.1:p.Leu235%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Carcinoma_of_colon|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified|APC-Associated_Polyposis_Disorders|not_provided	Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant	APC-related attenuated familial adenomatous polyposis;Familial adenomatous polyposis due to 5q22.2 microdeletion;Cenani-Lenz syndrome;Gastric adenocarcinoma and proximal polyposis of the stomach;Desmoid tumor;Gardner syndrome;Turcot syndrome with polyposis	Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Nausea;Hepatoblastoma;Headache;Hematochezia;Increased intracranial pressure;Lymphoma;Cafe-au-lait spot;Glioblastoma multiforme;Desmoid tumors;Alternating esotropia;Melena;Leukemia;Spinal cord compression;Abdominal pain;Cerebellar medulloblastoma;Basal cell carcinoma;Hyperpigmentation of the fundus;Constipation;Ependymoma;Hearing impairment;Epidermoid cyst;Visual acuity no light perception;Papilledema;Brain neoplasm;Colon cancer;Vomiting;Ataxia;Epiretinal membrane;Pituitary adenoma;Papillary thyroid carcinoma;Adenomatous colonic polyposis;Soft tissue neoplasm;Pilomatrixoma;Astrocytoma;Small intestine carcinoid;Desmoid tumors;Increased number of teeth;Epidermoid cyst;Variable expressivity;Keloids;Hepatoblastoma;Adrenocortical adenoma;Congenital hypertrophy of retinal pigment epithelium;Multiple lipomas;Papillary thyroid carcinoma;Duodenal adenocarcinoma;Odontoma;Unerupted tooth;Autosomal dominant inheritance;Colon cancer;Duodenal polyposis;Carcinoma;Hyperpigmentation of the skin;Astrocytoma;Osteoma;Carious teeth;Adenomatous colonic polyposis;Adrenocortical carcinoma;Fibroadenoma of the breast;Multiple gastric polyps;Medulloblastoma;Small intestine carcinoid;Desmoid tumors;Increased number of teeth;Epidermoid cyst;Variable expressivity;Keloids;Hepatoblastoma;Adrenocortical adenoma;Congenital hypertrophy of retinal pigment epithelium;Multiple lipomas;Papillary thyroid carcinoma;Duodenal adenocarcinoma;Odontoma;Unerupted tooth;Autosomal dominant inheritance;Colon cancer;Duodenal polyposis;Carcinoma;Hyperpigmentation of the skin;Astrocytoma;Osteoma;Carious teeth;Adenomatous colonic polyposis;Adrenocortical carcinoma;Fibroadenoma of the breast;Multiple gastric polyps;Medulloblastoma;Gastrointestinal carcinoma;Neoplasm of the pancreas;Thyroid nodule;Ampulla of Vater carcinoma;Osteoma;Epidermoid cyst;Increased number of teeth;Prostate cancer;Abnormality of skin pigmentation;Multiple unerupted teeth;Medulloblastoma;Duodenal polyposis;Multiple gastric polyps;Odontoma;Hepatoblastoma;Astrocytoma;Pilomatrixoma;Adenomatous colonic polyposis;Papillary thyroid carcinoma;Small intestine carcinoid;Lipoma;Adrenocortical carcinoma;Adrenocortical adenoma;Keloids;Esophageal carcinoma;Congenital hypertrophy of retinal pigment epithelium;Breast carcinoma;Brain neoplasm;Desmoid tumors;Colon cancer;Intellectual disability, moderate;Hepatocellular carcinoma;Micronodular cirrhosis;Somatic mutation;Autosomal dominant inheritance;Subacute progressive viral hepatitis;Heterogeneous;Stomach cancer;Somatic mutation;Increased level of L-fucose in urine;Autosomal dominant inheritance;Colon cancer;Desmoid tumors;Epidermoid cyst;Proptosis;Absent fingernail;High, narrow palate;Scoliosis;Ptosis;Micromelia;Synostosis of carpal bones;Nystagmus;Toe syndactyly;Short philtrum;Finger syndactyly;Hypothyroidism;Malar flattening;Protruding ear;Convex nasal ridge;Renal hypoplasia/aplasia;Laryngomalacia;Abnormal form of the vertebral bodies;Radioulnar synostosis;Short thumb;Foot oligodactyly;Hypoplasia of the radius;Crossed fused renal ectopia;Abnormal dermatoglyphics;Downslanted palpebral fissures;Ectropion;Hypodontia;Abnormality of the metacarpal bones;Hypertelorism;Elbow dislocation;Frontal bossing;Hypoplasia of the ulna;Absent toenail;Cataract;Hip dislocation;Abnormality of dental enamel;Short nose;Abnormality of the ribs;Hearing impairment;Duodenal adenocarcinoma;Medulloblastoma;Lipoma;Esophageal carcinoma;Osteoma;Papillary thyroid carcinoma;Multiple gastric polyps;Neoplasm of the pancreas;Fibroadenoma of the breast;Breast carcinoma;Astrocytoma;Thyroid nodule;Pilomatrixoma;Desmoid tumors;Congenital hypertrophy of retinal pigment epithelium;Epidermoid cyst;Colon cancer;Adrenocortical adenoma;Duodenal polyposis;Adenomatous colonic polyposis;Adrenocortical carcinoma;Odontoma;Increased number of teeth;Subcutaneous nodule;Myalgia;Chest pain;Sepsis;Neoplasm of the skin;Arthralgia;Desmoid tumors;Osteolysis;Intestinal obstruction;Hydronephrosis;Malabsorption;Abnormality of the abdominal wall;Abdominal pain;Abnormality of retinal pigmentation;Intestinal polyposis;Limitation of joint mobility;Abnormality of the musculature;Gastrointestinal hemorrhage;Spastic gait;Relative macrocephaly;Mandibular prognathia;Abnormality of canine;Micrognathia;Duodenal polyposis;Low posterior hairline;Hepatoblastoma;Abnormality of the kidney;Congenital hypertrophy of retinal pigment epithelium;Desmoid tumors;Pulmonary obstruction;Epidermoid cyst;Broad nasal tip;Intellectual disability, mild;Thick upper lip vermilion;Hypertelorism;Single transverse palmar crease;Short neck;Long philtrum;Long face;Adenomatous colonic polyposis;Colon cancer;High forehead;Iron deficiency anemia;High palate;Optic disc hypoplasia;Narrow mouth;Downslanted palpebral fissures;Generalized hypotonia;Posterior polar cataract;Early balding;Intestinal bleeding;Dyslexia;Osteoma	25741868,23757202	0.00211497	322.0	152248.0	3.0	32	0.97	PASS	nfe	0.00333608	227.0	0.00333608	227.0	0.00228096	573.0	251210.0	3.0	52	0.99	PASS	nfe	0.00372359	423.0	0.00372359	423.0	0.0022507	350	0.003	9.0	0.00334	38.0		10.55	0.627578		0	0	0			APC	0.0	0.0	0.0	0.0	-5.0	-49.0	28.0	25.0						0.00386	1.0	27.998062047			homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; vision/eye phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; pigmentation phenotype; neoplasm; embryo phenotype; 			ciliary ganglion;temporal lobe;amygdala;prefrontal cortex;cingulate cortex;superior cervical ganglion;trigeminal ganglion;fetal brain;occipital lobe;subthalamic nucleus;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;thalamus;	Wnt signaling pathway;Regulation of actin cytoskeleton;Colorectal cancer;Endometrial cancer;Basal cell carcinoma	mitotic cytokinesis;cell fate specification;cellular response to DNA damage stimulus;negative regulation of microtubule depolymerization;cell cycle arrest;mitotic spindle assembly checkpoint;cell adhesion;pattern specification process;negative regulation of cell population proliferation;insulin receptor signaling pathway;positive regulation of cell death;Wnt signaling pathway;cell migration;protein deubiquitination;positive regulation of cell migration;positive regulation of pseudopodium assembly;regulation of microtubule-based process;positive regulation of apoptotic process;regulation of cell differentiation;positive regulation of protein catabolic process;negative regulation of cyclin-dependent protein serine/threonine kinase activity;protein homooligomerization;regulation of attachment of spindle microtubules to kinetochore;protein-containing complex assembly;bicellular tight junction assembly;negative regulation of canonical Wnt signaling pathway;positive regulation of cold-induced thermogenesis;positive regulation of protein localization to centrosome;beta-catenin destruction complex assembly;beta-catenin destruction complex disassembly	kinetochore;nucleus;nucleoplasm;cytoplasm;centrosome;cytosol;microtubule;cytoplasmic microtubule;plasma membrane;cell-cell adherens junction;bicellular tight junction;lateral plasma membrane;catenin complex;lamellipodium;beta-catenin destruction complex;ruffle membrane;perinuclear region of cytoplasm;Wnt signalosome	protein binding;beta-catenin binding;microtubule binding;protein kinase regulator activity;protein kinase binding;ubiquitin protein ligase binding;identical protein binding;gamma-catenin binding;cadherin binding;microtubule plus-end binding;dynein complex binding	FHOD1[20936779];CASC3[25640309];SMC3[20936779];TOMM20[29568061];CEP128[26638075];GOLGA2[20936779];C4A[20936779];HNRPM[20936779];TRIM28[16212417];KIF5B[20936779];PSMD1[20936779];TRIM25[25640309];BBX[26496610];BTRC[19615732];SYNPO[26496610];NCKAP5[20936779];TRIM21[20936779];AGFG1[20936779];NUP214[20936779];TMOD1[24412244];PNISR[20936779];MAP2K1[24412244];RBFOX2[26496610];CSNK2A1[25241761];COG5[20936779];TSTD2[24412244];ACTN1[20936779];COG4[20936779];KRT1[16212417];CTNNBIP1[15327768];SCRIB[16611247;30126976];CSNK1E[17218255;25241761;11425858];KRT5[20936779];RPGRIP1L[26638075];KRT9[16212417];DKK3[25640309];PROCR[19116273];HGS[20936779];SPECC1L[20936779];SPATA13[17599059;17145773];PKP2[26496610];NUP98[20936779];TELO2[26496610];MAD1L1[26496610];ND4[20936779];ANKRD17[20936779];MACF1[20936779];KHDRBS1[22000517];POM121[20936779];EPAS1[20936779];CTBP1[26496610];MRPL18[26496610];PXN[20224554];NOLC1[30021884];GIGYF2[20936779];SAV1[26496610];ARHGAP21[26496610];PPP3R2[24412244];POM121C[20936779];DVL1[20224554;11425858];MYO6[20936779];TPR[20936779];DVL2[20224554;26496610];SFN[15778465];MYH11[20936779];IGHA1[16212417];MYH10[20936779];SPTBN1[20936779];MARK2[26496610];FAM83B[26496610];SEC31A[20936779];SPTBN2[20936779];EXPH5[20936779];HOXC6[25640309];ASCC3L1[20936779];ANKRD28[24255178];SMAD1[24412244];CREBBP[20936779];ST14[25640309];TGFB1[24412244];HSPA5[20936779];JUP[20936779;25241761;26496610];SETDB1[20936779];SIAH1[25241761];NUP153[20936779];NEB[20936779];FANCC[24412244];FBXO30[20936779];PTK2[25241761];DVL1P1[20224554];DLG1[30126976];RPS27[20936779];NAT2[25640309];NOSTRIN[20936779];SASS6[26638075];ANP32B[24412244];DIRAS3[25640309];GSK3B[23602568;21118991;8638126;29568061];PPP1R13B[20936779];IL24[25640309];KRT23[20936779];CTSV[24412244];SYNE1[20936779];ING5[20936779];AKAP13[26496610];ANXA7[20936779];RAC1[21311754];NANS[24412244];CGNL1[20936779];DST[20936779];AXIN1[19131971;22682247;26496610;17510365];NAV1[20936779];NAV2[20936779];BAAT[24412244];KIF7[26496610];YWHAZ[15161933];PTBP3[22575643];SENP1[26496610];DDB1[16212417];TMEFF1[24412244];NAV3[20936779];EEF1D[26496610];RASA1[24412244];FAM20C[22582013];ARHGEF4[17145773;10947987;22000517];MCM5[16212417];NUP54[20936779];TFF1[25640309];MAPRE1[11943150;19632184;26496610];FBP1[24412244];ZNF510[24412244];NUP58[20936779];AMER1[24251807;26496610;17510365];AMER2[24251807];SEC23A[16212417];AMER3[24251807];LAMA4[20936779];LAMA3[20936779];RBM4B[20936779];WIZ[26496610];ASAP1[20509626];FAM214A[20936779];LRP8[19116273];STRN3[24255178];CYP17A1[25640309];CDC42[17145773;21311754];CYTH2[20936779];KIAA1328[20936779];PDLIM2[25640309];CCL5[25640309];CTNNA1[20936779;25241761;26496610];FLNA[20936779];AGR3[25640309];ZNF106[20936779];BUB1[25241761];RANBP2[20936779];MBD4[26496610];MBD5[20936779];EGLN3[26972000];NCKAP5L[20936779];ERBIN[20936779];KRT13[20936779];RANBP9[20936779];AP2B1[20936779];PTPN13[17240990];KRT19[20936779];MCM3AP[20936779];KRT17[20936779;26496610];KRT15[20936779];CAPZA2[16212417];KRT14[20936779];CTNNB1[16212417;15327768;15327769;17318191;22682247;25241761;9707618;8638126;26496610;17510365;22056988];ADGRL1[20936779];NUPL2[20936779];TAF1[20936779];
100542	chr16	86601049	C	T	chr16:86601049	FOXC2	forkhead box C2	1226.0	SNV	0/1	0.43	17_13	30	99	False	rs138318843	EXONIC	YES	NM_005251.3	Transcript	protein_coding	synonymous_variant		1/1	NM_005251.3:c.108C>T	NP_005242.1:p.Ser36%3D		1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Lymphedema-distichiasis syndrome, 153400 (3), Autosomal dominant; Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3), Autosomal dominant	Lymphedema-distichiasis syndrome	Disease-causing germline mutation(s) in	Corneal erosion;Glomerulopathy;Cleft upper lip;Recurrent urinary tract infections;Patent ductus arteriosus;Ectropion;Cataract;Conjunctivitis;Renal duplication;Muscle weakness;Photophobia;Abnormality of the pulmonary vasculature;Distichiasis;Webbed neck;Predominantly lower limb lymphedema;Spinalarachnoid cyst;Fibrosarcoma;Diabetes mellitus;Arrhythmia;Recurrent skin infections;Proteinuria;Cleft palate;Tubulointerstitial nephritis;Varicose veins;Ptosis;Autosomal dominant inheritance;Yellow nails;Arrhythmia;Ventricular septal defect;Tetralogy of Fallot;Photophobia;Cleft palate;Patent ductus arteriosus;Ptosis;Corneal ulceration;Conjunctivitis;Predominantly lower limb lymphedema;Distichiasis;Recurrent corneal erosions;Lymphedema;Abnormality of the musculature;Varicose veins;Cleft upper lip;Cellulitis	25741868	0.00640722	975.0	152172.0	4.0	33	0.98	PASS	nfe	0.00986417	671.0	0.00986417	671.0	0.00678463	1694.0	249682.0	7.0	100	0.99	PASS	nfe	0.0112641	1268.0	0.0112641	1268.0	0.0069709	1084	0.011	34.0	0.00938	107.0		13.76	1.050265		0	0	0			FOXC2	0.0	0.0	0.0	0.0	-41.0	0.0	-6.0	32.0								1.993088756			homeostasis/metabolism phenotype; craniofacial phenotype; muscle phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; liver/biliary system phenotype; embryo phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; respiratory system phenotype; 			superior cervical ganglion;	.	negative regulation of transcription by RNA polymerase II;lymphangiogenesis;regulation of transcription by RNA polymerase II;mesoderm development;heart development;insulin receptor signaling pathway;anatomical structure morphogenesis;response to hormone;positive regulation of endothelial cell migration;cell differentiation;positive regulation of cell adhesion mediated by integrin;positive regulation of vascular wound healing;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of cell migration involved in sprouting angiogenesis;negative regulation of cold-induced thermogenesis	nucleus;nucleoplasm;nuclear body	RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;chromatin DNA binding;identical protein binding;sequence-specific DNA binding;transcription regulatory region DNA binding;promoter-specific chromatin binding	FOXC2[25609649];FOXC1[25609649];HDAC2[25609649];RIF1[25609649];DLX5[25609649];SATB1[25609649];SATB2[25609649];AKAP8[25609649];UBP1[25609649];PPP2R2A[23878394;26496610];HOXD13[25609649];HOXC13[25609649];HOXB13[25609649];C5orf24[25609649];GOLGA2[unassigned1304];SALL1[25609649];PPP2R1A[26496610];MYC[21150319];KRTAP3-3[unassigned1304];TRIM27[25416956];PITX2[25609649];LYAR[30021884];POU2F1[25609649];RBPMS[25416956];DSCR10[unassigned1304];NR2F1[25609649];SMARCA5[25609649];EBF3[25609649];ZBTB34[25609649];POU2F2[25609649];HOXB9[25609649];CREB1[25609649];TFCP2[25609649];NFIA[25609649];TAX1BP1[25416956];PIN1[23878394];ZNF536[25609649];METTL27[unassigned1304];
101867	chr3	48696411	C	T	chr3:48696411	CELSR3	cadherin EGF LAG seven-pass G-type receptor 3	1260.0	SNV	0/1	0.47	18_16	34	99	False	rs746479389	EXONIC	YES	NM_001407.3	Transcript	protein_coding	synonymous_variant		1/35	NM_001407.3:c.3657G>A	NP_001398.2:p.Leu1219%3D		-1.0						.	.	.		6.56996e-06	1.0	152208.0	0.0	32	0.97	PASS	nfe	1.46959e-05	1.0	1.46959e-05	1.0	3.18256e-05	8.0	251370.0	0.0	100	1.0	PASS	amr	0.000144609	5.0	1.75911e-05	2.0	0.0000257	4						10.34	0.603019		0	0	0			CELSR3	0.0	0.0	0.0	0.01	-2.0	23.0	-49.0	0.0						0.385	1.0	44.884760513			digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			.	.	neuron migration;regulation of protein phosphorylation;homophilic cell adhesion via plasma membrane adhesion molecules;G protein-coupled receptor signaling pathway;axonal fasciculation;regulation of protein localization;dopaminergic neuron axon guidance;serotonergic neuron axon guidance;Wnt signaling pathway, planar cell polarity pathway;cilium assembly;planar cell polarity pathway involved in axon guidance	plasma membrane;integral component of membrane	G protein-coupled receptor activity;calcium ion binding;protein binding	PPP1R26[unassigned5];SPTBN4[unassigned5];CLUH[unassigned5];DST[12421765];NEK4[25798074];IFT140[unassigned5];SWAP70[12421765];UACA[unassigned5];MCM3AP[unassigned5];RACGAP1[unassigned5];SGSM2[16169070];ABL1[17474147];TRIP12[unassigned5];FYN[17474147];GRB2[17474147];SCAPER[unassigned5];TSPYL4[unassigned5];SPTBN2[unassigned5];NCK1[17474147];
102308	chr8	110477240	G	T	chr8:110477240	PKHD1L1	PKHD1 like 1	1279.0	SNV	0/1	0.47	9_8	17	99	False	rs930075690	EXONIC	YES	NM_177531.6	Transcript	protein_coding	missense_variant		49/78	NM_177531.6:c.8179G>T	NP_803875.2:p.Gly2727Cys		1.0						.	.	.		1.31444e-05	2.0	152156.0	0.0	32	0.96	PASS	amr	6.54622e-05	1.0	1.47003e-05	1.0	4.01513e-06	1.0	249058.0	0.0	100	1.0	PASS	nfe	8.85865e-06	1.0	8.85865e-06	1.0								29.9	4.2527	0.886	18	3	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PrimateAI_pred,DEOGEN2_pred,LIST-S2_pred	PKHD1L1	0.0	0.0	0.0	0.0	20.0	-5.0	-23.0	0.0						0.053	0.0	0.000000000	0.989	1.176	.			.	.	immune response	extracellular space;cytosol;cilium;integral component of membrane	signaling receptor activity	.
102312	chr8	110502266	G	A	chr8:110502266	PKHD1L1	PKHD1 like 1	1279.0	SNV	0/1	0.53	14_16	30	99	False	rs199629163,COSV65747271	EXONIC	YES	NM_177531.6	Transcript	protein_coding	synonymous_variant		60/78	NM_177531.6:c.9966G>A	NP_803875.2:p.Thr3322%3D		1.0						.	.	.		0.000434863	66.0	151772.0	0.0	32	0.95	PASS	sas	0.00228216	11.0	0.000279988	19.0	0.00067911	167.0	245910.0	1.0	30	0.86	PASS	sas	0.00142981	43.0	0.000278072	31.0	0.0006688	104	0.0	1.0				7.601	0.330603		0	0	0			PKHD1L1	0.0	0.01	0.0	0.02	18.0	-48.0	-13.0	18.0						0.053	0.0	60.596865305			.			.	.	immune response	extracellular space;cytosol;cilium;integral component of membrane	signaling receptor activity	.
104422	chr2	239009282	G	A	chr2:239009282	ESPNL	espin like	1326.0	SNV	0/1	0.46	14_12	26	99	False	rs768422822	EXONIC	YES	NM_194312.4	Transcript	protein_coding	synonymous_variant		1/9	NM_194312.4:c.222G>A	NP_919288.2:p.Ala74%3D		1.0						.	.	.		7.88219e-05	12.0	152242.0	0.0	33	0.98	PASS	amr	0.00013077	2.0	0.000102893	7.0	0.00023043	14.0	60756.0	0.0	7	0.07	PASS	amr	0.000875964	10.0	0.000117435	3.0	0.0001158	18	0.0	1.0				2.746	0.008065		0	0	0			ESPNL	0.0	0.0	0.0	0.0	2.0	-50.0	1.0	45.0							0.0				homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hearing/vestibular/ear phenotype; 			ciliary ganglion;superior cervical ganglion;trigeminal ganglion;	.	sensory perception of sound;actin filament bundle assembly	cytoplasm;filamentous actin;stereocilium tip	actin filament binding	SERTAD2[unassigned1304];LDLRAP1[unassigned1304];PFDN5[unassigned1304];
104449	chr19	48814825	G	A	chr19:48814825	CCDC114	coiled-coil domain containing 114	1330.0	SNV	0/1	0.38	21_13	34	99	False	rs190978775	EXONIC	YES	NM_001364171.2	Transcript	protein_coding	synonymous_variant		7/16	NM_001364171.2:c.582C>T	NP_001351100.1:p.Asp194%3D		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Primary_ciliary_dyskinesia|not_specified		Primary ciliary dyskinesia	Disease-causing germline mutation(s) (loss of function) in	Hydrocephalus;Pectus excavatum;Chronic otitis media;Tachypnea;Impaired nasal mucociliary clearance;Delayed speech and language development;Asthma;Atelectasis;Headache;Ectopic pregnancy;Nasal polyposis;Clubbing of fingers;Pulmonary obstruction;Asplenia;Scoliosis;Reduced sperm motility;Respiratory distress;Immotile cilia;Chronic sinusitis;Infertility;Chronic bronchitis;Corneal dystrophy;Glue ear;Pneumonia;Spontaneous abortion;Conductive hearing impairment;Recurrent respiratory infections;Situs inversus totalis;Cough;Bronchiectasis;Ventriculomegaly;Rhinitis;Halitosis;Ciliary dyskinesia;Autosomal recessive inheritance;Recurrent sinusitis;Situs inversus totalis;Respiratory insufficiency due to defective ciliary clearance;Bronchiectasis;Absent outer dynein arms;Cough;Recurrent pneumonia;Rhinorrhea;Recurrent otitis media;Atelectasis	25741868	0.00145991	222.0	152064.0	1.0	31	0.95	PASS	nfe	0.00239642	163.0	0.00239642	163.0	0.00163631	256.0	156450.0	1.0	48	0.59	PASS	nfe	0.0028596	173.0	0.0028596	173.0	0.0005273	82	0.006	18.0				6.027	0.212649		0	0	0			CCDC114	0.0	0.0	0.0	0.0	-7.0	21.0	-15.0	-1.0						0.693	0.0	12.649284958			.			ciliary ganglion;temporal lobe;dorsal root ganglion;skin;trigeminal ganglion;atrioventricular node;skeletal muscle;	.	cilium movement;outer dynein arm assembly	cilium;axoneme;outer dynein arm	protein binding	HGS[25416956;26871637;unassigned1304];TPM3[25416956];LNX1[25416956];KLC1[25416956];CCDC151[25416956];C1orf216[25416956;unassigned1304];HAUS1[25416956];TXN2[25416956];
105238	chr7	142583330	C	C	chr7:142583330	TRPV6	transient receptor potential cation channel subfamily V member 6	1341.0	SNV	1/1	0.97	0_34	35	99	False	rs17881456	EXONIC	YES	NM_018646.6	Transcript	protein_coding	synonymous_variant		1/15	NM_018646.6:c.52T>G	NP_061116.5:p.Ala18%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided	Hyperparathyroidism, transient neonatal, 618188 (3), Autosomal recessive	Neonatal severe primary hyperparathyroidism	Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Feeding difficulties;Delayed speech and language development;Polyhydramnios;Femoral bowing;Elevated alkaline phosphatase;Short ribs;Osteopenia;Motor delay;Respiratory distress;Narrow chest;Thin ribs						0	0.0											0	0.0							0.1718927,0.0000379	26730,1	0.254	674.0				15.79	1.414152	0.499	0	0	0			TRPV6	0.0	0.0	0.0	0.0	-23.0	-8.0	-23.0	30.0						0.351	0.0				cellular phenotype; reproductive system phenotype; 			ciliary ganglion;subthalamic nucleus;placenta;globus pallidus;	.	calcium ion transport;regulation of calcium ion-dependent exocytosis;response to calcium ion;calcium ion homeostasis;calcium ion transmembrane transport;calcium ion import across plasma membrane	plasma membrane;integral component of plasma membrane	ion channel activity;calcium channel activity;protein binding;calmodulin binding;metal ion binding	PTPN1[17197020;15894168];CALB1[16763551];
105491	chr11	3688709	GTAG		chr11:3688709-3688712	CHRNA10	cholinergic receptor nicotinic alpha 10 subunit	1346.0	deletion	0/1	0.67	5_10	15	99	False	rs1232732814	EXONIC	YES	NM_020402.4	Transcript	protein_coding	frameshift_variant		4/5	NM_020402.4:c.645_648del	NP_065135.2:p.Tyr216AlafsTer90		-1.0						.	.	.		1.31563e-05	2.0	152018.0	0.0	33	0.98	PASS	amr	0.00013089	2.0	0.0	0.0	4.66962e-06	1.0	214150.0	0.0	25	0.69	PASS	amr	3.02883e-05	1.0	0.0	0.0											0	0	0			CHRNA10	0.0	0.0	0.0	0.0	45.0	-15.0	44.0	17.0						0.278	0.0	8.014092245,0.000000000			hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;	.	signal transduction;positive regulation of cytosolic calcium ion concentration;chemical synaptic transmission;synaptic transmission, cholinergic;ion transmembrane transport;regulation of cell population proliferation;regulation of membrane potential;inner ear morphogenesis;nervous system process;detection of mechanical stimulus involved in sensory perception of sound;excitatory postsynaptic potential;negative regulation of ERK1 and ERK2 cascade;calcium ion transmembrane transport	integral component of plasma membrane;membrane;cell junction;axon;neuron projection;perikaryon;synapse;cholinergic synapse;integral component of postsynaptic specialization membrane	transmembrane signaling receptor activity;signaling receptor binding;extracellular ligand-gated ion channel activity;calcium channel activity;acetylcholine-gated cation-selective channel activity	.
105509	chr16	66426144	G	A	chr16:66426144	CDH5	cadherin 5	1350.0	SNV	0/1	0.52	12_13	25	99	False	rs146820626	EXONIC	YES	NM_001795.5	Transcript	protein_coding	missense_variant		7/12	NM_001795.5:c.1075G>A	NP_001786.2:p.Val359Ile		1.0	.,Cadherin-like&Cadherin-like,Cadherin-like&Cadherin-like,Cadherin-like&Cadherin-like					.	.	.		0.00113144	172.0	152018.0	1.0	32	0.96	PASS	sas	0.00271059	13.0	0.00157302	107.0	0.00137583	346.0	251484.0	0.0	100	1.0	PASS	sas	0.00209041	64.0	0.0014944	170.0	0.0013247	206	0.002	8.0	0.0021	24.0		13.72	1.044548	0.067	2	16	18	MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	CDH5	0.0	0.0	0.0	0.21	19.0	45.0	20.0	-1.0						0.498	0.15	0.000000000	0.394	1.176	reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype; liver/biliary system phenotype; immune system phenotype; vision/eye phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			placenta;fetal lung;heart;	Cell adhesion molecules (CAMs);Leukocyte transendothelial migration	cell morphogenesis;blood vessel maturation;cell-cell junction assembly;homophilic cell adhesion via plasma membrane adhesion molecules;transforming growth factor beta receptor signaling pathway;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;adherens junction organization;cell-cell adhesion mediated by cadherin;positive regulation of angiogenesis;negative regulation of inflammatory response;cell-cell adhesion;positive regulation of establishment of endothelial barrier;regulation of establishment of cell polarity	plasma membrane;cell-cell junction;cell-cell adherens junction;bicellular tight junction;cell surface;membrane;integral component of membrane;catenin complex;cell junction	signaling receptor binding;calcium ion binding;protein binding;beta-catenin binding;cytoskeletal protein binding;protein homodimerization activity;ion channel binding;cadherin binding	TJP1[18662404];PARD6A[17057644];MYCN[27728805];WARS[20010843];SHC1[11950700];SRC[16909109];PARD3[17057644];CTNNBIP1[18287330];KDR[11950700;18662404];CTNNA1[17057644];CTNNB1[17057644;18662404;18287330;20123964];PARD6G[17057644];
105738	chr22	26862194	T	C	chr22:26862194	HPS4	HPS4, biogenesis of lysosomal organelles complex 3 subunit 2	1356.0	SNV	0/1	0.35	22_12	34	99	False	rs150166679	SPLICING	YES	NM_001349900.2	Transcript	protein_coding	missense_variant,splice_region_variant		9/15	NM_001349900.2:c.704A>G	NP_001336829.1:p.His235Arg		-1.0	.,.,.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Hermansky-Pudlak_syndrome_4|not_provided	Hermansky-Pudlak syndrome 4, 614073 (3), Autosomal recessive	Hermansky-Pudlak syndrome with pulmonary fibrosis	Disease-causing germline mutation(s) in	Reduced visual acuity;Abnormal platelet granules;Autosomal recessive inheritance;Bruising susceptibility;Horizontal nystagmus;Hypoplasia of the fovea;Ocular albinism;Restrictive ventilatory defect;Epistaxis;Pulmonary fibrosis;Menorrhagia;Albinism		0.000433572	66.0	152224.0	0.0	33	0.95	PASS	nfe	0.000264566	18.0	0.000264566	18.0	0.000636213	160.0	251488.0	0.0	100	1.0	PASS	sas	0.00048994	15.0	0.000413121	47.0	0.0005145	80	0.002	5.0	0.00062	7.0		0.003	-0.971134	0.013	1	16	17	FATHMM_pred	LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HPS4	0.0	0.01	0.0	0.0	16.0	32.0	1.0	-2.0	4.28281329232891e-05	0.0	10.355	0.658	11.013	0.125	0.0	0.000000000	0.003	-0.671	pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; renal/urinary system phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; 			trigeminal ganglion;skeletal muscle;	Glycosphingolipid biosynthesis - lactoseries;Glycosphingolipid biosynthesis - neo-lactoseries;Glycan structures - biosynthesis 2	protein targeting;lysosome organization;blood coagulation;hemostasis;melanocyte differentiation;positive regulation of eye pigmentation;protein stabilization;melanosome assembly;positive regulation of protein targeting to mitochondrion	cytoplasm;lysosome;cytosol;membrane;BLOC-3 complex;melanosome;platelet dense granule	guanyl-nucleotide exchange factor activity;protein binding;Rab GTPase binding;protein homodimerization activity;protein dimerization activity	HPS1[12756248];RAC1[20936779];
106513	chr15	59523910	G	A	chr15:59523910	MYO1E	myosin IE	1378.0	SNV	0/1	0.52	12_13	25	99	False	rs1281453686	EXONIC	YES	NM_004998.4	Transcript	protein_coding	synonymous_variant		6/28	NM_004998.4:c.501C>T	NP_004989.2:p.Ser167%3D		-1.0					Glomerulosclerosis, focal segmental, 6, 614131 (3), Autosomal recessive	Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis	Disease-causing germline mutation(s) in	Chronic kidney disease;Autosomal recessive inheritance;Focal segmental glomerulosclerosis;Proteinuria;Progressive;Hypoalbuminemia;Nephrotic syndrome;Edema;Hematuria;Renal tubular atrophy		1.31418e-05	2.0	152186.0	0.0	32	0.96	PASS	eas	0.000192382	1.0	0.0	0.0	1.5907e-05	4.0	251462.0	0.0	99	1.0	PASS	eas	5.43656e-05	1.0	2.63759e-05	3.0					9e-05	1.0		12.8	0.910917		0	0	0			MYO1E	0.0	0.0	0.0	0.02	-9.0	20.0	-7.0	-9.0						0.0965	0.05	74.536482548			mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); renal/urinary system phenotype; homeostasis/metabolism phenotype; muscle phenotype; 			trigeminal ganglion;atrioventricular node;superior cervical ganglion;fetal liver;bone marrow;	.	vasculogenesis;in utero embryonic development;glomerular filtration;nitrogen compound metabolic process;endocytosis;actin filament-based movement;glomerular basement membrane development;post-embryonic hemopoiesis;platelet-derived growth factor receptor signaling pathway;glomerular visceral epithelial cell development	cytoplasm;cytoskeleton;brush border;cell-cell junction;adherens junction;actin cytoskeleton;myosin complex;clathrin-coated endocytic vesicle;extracellular exosome	microfilament motor activity;motor activity;protein binding;calmodulin binding;ATP binding;phosphatidylinositol binding;ATPase activity, coupled;actin filament binding	PDGFRB[26496610];ARL14EP[21458045];SLC33A1[26496610];OCRL[25107275];IQGAP1[26496610];MYO19[26496610];DNM1[17257598];DNM2[17257598];PPP1CB[26496610];ANLN[26496610];LIMA1[26496610];SYNJ1[17257598];LTB4R2[28298427];MYO5C[26496610];CAPZA2[26496610];MYO18A[26496610];MYH9[26496610];FLNA[26496610];RAC1[unassigned1312];SYNPO[26496610];MAPRE1[26496610];DBN1[26496610];PDLIM7[26496610];
107328	chr3	87276714	C	T	chr3:87276714	CHMP2B	charged multivesicular body protein 2B	1391.0	SNV	0/1	0.48	17_16	33	99	False	rs35413339	SPLICING	YES	NM_014043.4	Transcript	protein_coding	splice_region_variant,intron_variant	1/5		NM_014043.4:c.34+8C>T			1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Frontotemporal_dementia_and/or_amyotrophic_lateral_sclerosis_7|not_specified|not_provided	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7, 600795 (3), Autosomal dominant	Amyotrophic lateral sclerosis;Behavioral variant of frontotemporal dementia;Semantic dementia;Progressive non-fluent aphasia	Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in;Major susceptibility factor in	Laryngospasm;Nausea and vomiting;Dyspnea;Anxiety;Pain;Paralysis;Agitation;Generalized muscle weakness;Depressivity;Amyotrophic lateral sclerosis;Xerostomia;Fatigable weakness of respiratory muscles;Muscle spasm;Fatigable weakness of swallowing muscles;Skeletal muscle atrophy;Neurodegeneration;Emotional lability;Spasticity;Respiratory failure;Fatigue;Aphasia;Abulia;Visual agnosia;Dysgraphia;Dementia;Anomia;Dyslexia;Alexia;Brain atrophy;Memory impairment;Mutism;Lack of insight;Aggressive behavior;Babinski sign;Frontal release signs;Neuronal loss in central nervous system;Disinhibition;Restlessness;Autosomal dominant inheritance;Hyperreflexia;Rigidity;Stereotypy;Frontotemporal dementia;Dyscalculia;Apathy;Personality changes;Orofacial dyskinesia;Cerebral cortical atrophy;Urinary incontinence;Astrocytosis;Dystonia;Inappropriate behavior;Hyperorality;Myoclonus;Gait disturbance;Loss of speech;Frontotemporal cerebral atrophy;Perseveration;Frontotemporal dementia;Parkinsonism;Thickened nuchal skin fold;Abnormality of the cerebral white matter;Senile plaques;Anxiety;Personality changes;Dysphasia;Grammar-specific speech disorder;Restlessness;Depressivity;Alexia;Dysgraphia;EEG with continuous slow activity;Apraxia;Abnormal brain FDG positron emission tomography;Mutism;Abnormal lower motor neuron morphology;Memory impairment;Astrocytosis;Temporal cortical atrophy;Spoken Word Recognition Deficit;Motor aphasia;Hyporeflexia;Fasciculations;Dysarthria;Bulbar signs;Areflexia;Brisk reflexes;Dysphagia;Babinski sign;Adult onset;Autosomal dominant inheritance;Amyotrophic lateral sclerosis;Frontotemporal dementia;Respiratory insufficiency due to muscle weakness;Skeletal muscle atrophy;Rapidly progressive;Hyperorality;Collectionism;Fasciculations;Frontotemporal cerebral atrophy;Upper motor neuron dysfunction;Inappropriate behavior;Astrocytosis;Apathy;Dysgraphia;Dysphasia;Mutism;Stereotypy;Thickened nuchal skin fold;Irritability;Psychosis;Loss of speech;Echolalia;Restrictive behavior;Dyscalculia;Poor speech;Bilateral tonic-clonic seizure;Abnormal brain FDG positron emission tomography;EEG with continuous slow activity;Emotional blunting;Restlessness;Gait disturbance;Perseveration;Frontotemporal dementia;Abnormality of the cerebral white matter;Dyslexia;Aggressive behavior;Abnormality of extrapyramidal motor function;Personality changes;Hyperreflexia;Disinhibition;Abulia;Lack of insight;Memory impairment		0.00289826	441.0	152160.0	1.0	32	0.97	PASS	nfe	0.0054979	374.0	0.0054979	374.0	0.00272922	682.0	249888.0	3.0	99	1.0	PASS	nfe	0.00487557	547.0	0.00487557	547.0	0.0028424	442	0.005	18.0	0.00421	48.0		11.28	0.716216		0	0	0			CHMP2B	0.0	0.0	0.0	0.0	4.0	-23.0	-8.0	50.0	3.95325342239304e-05	0.004				0.591	0.01				nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			amygdala;thyroid;dorsal root ganglion;superior cervical ganglion;	.	autophagy;nucleus organization;endosome organization;mitotic metaphase plate congression;regulation of centrosome duplication;protein transport;endosomal transport;macroautophagy;viral life cycle;endosome transport via multivesicular body sorting pathway;multivesicular body assembly;viral budding via host ESCRT complex;late endosome to vacuole transport;cognition;multivesicular body-lysosome fusion;midbody abscission;neuron cellular homeostasis;regulation of modification of postsynaptic structure;regulation of postsynapse organization;regulation of mitotic spindle assembly;positive regulation of viral release from host cell;ESCRT III complex disassembly	ESCRT III complex;cytoplasm;lysosome;endosome;late endosome;multivesicular body;cytosol;plasma membrane;postsynaptic density;late endosome membrane;extracellular exosome;glutamatergic synapse	protein binding;protein domain specific binding;cadherin binding	ATP6V1A[21674799];RAB5C[26496610];GOLT1B[26496610];USP54[19302785];VPS4B[17928862];VPS4A[17928862];LTN1[26496610];DPY30[16730941];MALSU1[16730941];PNMA1[16730941];MYH14[26496610];PHGDH[16730941];VHL[17353931];ATP5ME[30021884];USP8[19302785];ATP6AP2[26496610];TRAF2[16189514];ATP5F1C[16169070];SGO1[26496610];NR4A1[20195357];CENPF[16730941];CHMP2B[16730941];CHMP4B[26496610;23051622];TERF2IP[21044950];CHMP3[23051622;16730941];RAB7A[26496610];MAD2L1[26496610];
107569	chr1	6111718	G	A	chr1:6111718	KCNAB2	potassium voltage-gated channel subfamily A regulatory beta subunit 2	1404.0	SNV	0/1	0.57	15_20	35	99	False	rs530635823,COSV51240164	EXONIC	YES	NM_001199862.2	Transcript	protein_coding	missense_variant		2/16	NM_001199862.2:c.122G>A	NP_001186791.1:p.Arg41Gln		1.0						1p36 deletion syndrome	Role in the phenotype of	Abnormal intestine morphology;Narrow mouth;Cataract;Stereotypy;Epicanthus;Short stature;Hemiplegia/hemiparesis;Nystagmus;Spinal canal stenosis;Rib fusion;Brachydactyly;Long philtrum;Strabismus;11 pairs of ribs;Polyphagia;Low-set, posteriorly rotated ears;Wide nasal bridge;Myopathy;Annular pancreas;Hypospadias;Camptodactyly of finger;Pointed chin;Optic atrophy;Telangiectasia;Hip dysplasia;Gastroesophageal reflux;Aortic arch aneurysm;Horizontal eyebrow;Brachycephaly;Scoliosis;Frontal bossing;Feeding difficulties in infancy;Kyphosis;Abnormal blistering of the skin;Lower limb asymmetry;Renal cyst;Bifid ribs;Patent ductus arteriosus;Muscular hypotonia;Failure to thrive;Obesity;Sensorineural hearing impairment;Joint stiffness;Poor speech;Self-injurious behavior;Depressed nasal ridge;Microtia;Dilated cardiomyopathy;Depressed nasal bridge;High hypermetropia;Seizure;Agenesis of corpus callosum;Pyloric stenosis;Microcephaly;Absent speech;Short foot;Delayed cranial suture closure;Abnormality of the neck;Abnormality of the anus;Cranial nerve paralysis;Abnormal heart valve morphology;Visual impairment;Autism;Hepatic steatosis;Abnormal cardiac septum morphology;Hypogonadism;Hypoplasia of penis;Intellectual disability;Abnormality of female external genitalia;Hydronephrosis;Hypothyroidism;Abnormality of the spleen;Generalized hirsutism;Neuroblastoma;Clinodactyly of the 5th finger;Gait disturbance;EEG abnormality;Foot polydactyly;Constipation;Ventriculomegaly;Deeply set eye;Cerebral cortical atrophy;Global developmental delay;Cryptorchidism;Conductive hearing impairment;Midface retrusion;Ocular albinism;Dysphagia;Tetralogy of Fallot;Macule		0.00101156	154.0	152240.0	0.0	33	0.99	PASS	amr	0.00457935	70.0	0.000823021	56.0	0.00155449	205.0	131876.0	0.0	40	0.56	PASS	sas	0.00342832	77.0	0.00112764	57.0	0.0003408	53	0.001	3.0	0.00263	30.0		23.1	2.801352	0.184	6	12	18	LRT_pred,M-CAP_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	KCNAB2	0.0	0.0	0.0	0.0	-37.0	14.0	13.0	-5.0						0.498	0.84	0.0	0.986	1.176	nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype; 			ciliary ganglion;caudate nucleus;temporal lobe;amygdala;prefrontal cortex;cingulate cortex;trigeminal ganglion;superior cervical ganglion;pons;occipital lobe;subthalamic nucleus;whole brain;dorsal root ganglion;parietal lobe;globus pallidus;medulla oblongata;thalamus;	.	hematopoietic progenitor cell differentiation;neutrophil degranulation;neuromuscular process;oxidation-reduction process;NADPH oxidation;potassium ion transmembrane transport;regulation of potassium ion transmembrane transport;regulation of protein localization to cell surface	cytosol;microtubule;plasma membrane;voltage-gated potassium channel complex;postsynaptic density;membrane;cell junction;extrinsic component of cytoplasmic side of plasma membrane;specific granule membrane;axon terminus;juxtaparanode region of axon;tertiary granule membrane;pinceau fiber	aldo-keto reductase (NADP) activity;voltage-gated potassium channel activity;potassium channel regulator activity	SNX3[26496610];BAG6[26496610];GRIA2[26496610];MRPL50[26496610];ATXN1[16713569];NASP[26496610];ZNF281[26496610];KCNAB2[25416956];BCOR[26496610];
108327	chr17	16068340	C	T	chr17:16068340	NCOR1	nuclear receptor corepressor 1	1410.0	SNV	0|1	0.45	21_20	44	99	False	rs76780359,COSV51959636	EXONIC	YES	NM_006311.4	Transcript	protein_coding	missense_variant		5/46	NM_006311.4:c.571G>A	NP_006302.2:p.Glu191Lys		-1.0	N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,.,.,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain					.	.	.		0.0	0.0	151178.0	0.0	31	0.94	AC0_AS_VQSR				0.0	0.0	0.259957	28144.0	108264.0	0.0	35	0.64	InbreedingCoeff	sas	0.330115	4753.0	0.265616	12663.0	0.0002058	32	0.013	39.0				25.9	3.738267	0.615	14	6	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,ClinPred_pred	NCOR1	0.0	0.0	0.03	0.0	-47.0	5.0	21.0	-47.0						0.467	1.0		1.0	1.026	embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;prefrontal cortex;skin;superior cervical ganglion;trigeminal ganglion;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	Huntington's disease	negative regulation of transcription by RNA polymerase II;chromatin organization;transcription by RNA polymerase II;circadian rhythm;regulation of lipid metabolic process;negative regulation of transcription, DNA-templated;negative regulation of JNK cascade;spindle assembly;negative regulation of androgen receptor signaling pathway;regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;negative regulation of production of miRNAs involved in gene silencing by miRNA;regulation of fatty acid transport	histone deacetylase complex;nuclear chromatin;nucleus;nucleoplasm;cytosol;membrane;Sin3 complex;transcriptional repressor complex;mitotic spindle	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II regulatory region DNA binding;RNA polymerase II activating transcription factor binding;chromatin binding;transcription corepressor activity;protein binding;nuclear hormone receptor binding;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;thyroid hormone receptor binding	YWHAE[17630505];LIN54[17531812];KDM5C[17468742];SMARCB1[11013263];THRB[20956942];ENO1[23414517];HSCB[24606901];HK1[26120082];GOLGA2[29568061];DACH1[14525983];TRIM28[11013263];MYC[21150319];KIF5B[26496610];MYB[20195357];NINL[26638075];NELFE[14667819];KPNA1[26496610];SREBF1[26120082];SMARCC1[11013263];SMARCC2[11013263];TCF12[17572682];UGT2B17[26175416];SIRT1[15175761];PTBP3[22575643];NCOR2[11013263];SGO1[26496610];AR[23518348];TBL1XR1[21258344];RARA[21988832;16606617;25303530;27107012;20543827];PPARG[22078880;21775429];ZMYND11[10734313];PPARA[19955185;21775429];PPARD[21775429];HDAC4[23752268;17956988];HDAC5[23752268];PFKFB1[26120082];HDAC3[11013263;21258344;23752268;16980585];SF3B3[11013263];SRCAP[11013263];AKAP8[16980585];TULP3[23414517];HTT[17500595];FOXK2[25609649];FOXK1[25609649];HDAC9[12590135];HDAC7[23752268];ATXN1[16713569];BAG1[19595997];SKIL[15231748];EXOSC1[26496610];RUNX1T1[17572682;18952841];SF3A1[11013263];EGLN3[26972000];SIAH2[23518348];NR1H2[26120082];CDC5L[20467437];NR1H3[26120082];NBEAL2[29187380];NR1D1[20581824];ESR1[21182203];SMARCA4[11013263];SKI[14525983;10049357;19032343];KIF18A[26496610];REST[17468742];SNW1[20467437];FGFR1OP[26638075];RAB5A[26496610];
108330	chr17	16068343	G	A	chr17:16068343	NCOR1	nuclear receptor corepressor 1	1410.0	SNV	0|1	0.48	20_21	44	99	False	rs78230791,COSV51959653	EXONIC	YES	NM_006311.4	Transcript	protein_coding	stop_gained		5/46	NM_006311.4:c.568C>T	NP_006302.2:p.Arg190Ter		-1.0	N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,.,.,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain					.	.	.						32	0.95							0.25638	27689.0	108000.0	0.0	37	0.66	InbreedingCoeff_RF	sas	0.320295	4520.0	0.262251	12319.0	0.0000707	11	0.012	36.0				33.0	5.348793		6	1	7	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred,fathmm-MKL_coding_pred	fathmm-XF_coding_pred	NCOR1	0.0	0.0	0.07	0.04	-50.0	33.0	18.0	-50.0						0.467	1.0		1.0	1.176	embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;prefrontal cortex;skin;superior cervical ganglion;trigeminal ganglion;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	Huntington's disease	negative regulation of transcription by RNA polymerase II;chromatin organization;transcription by RNA polymerase II;circadian rhythm;regulation of lipid metabolic process;negative regulation of transcription, DNA-templated;negative regulation of JNK cascade;spindle assembly;negative regulation of androgen receptor signaling pathway;regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;negative regulation of production of miRNAs involved in gene silencing by miRNA;regulation of fatty acid transport	histone deacetylase complex;nuclear chromatin;nucleus;nucleoplasm;cytosol;membrane;Sin3 complex;transcriptional repressor complex;mitotic spindle	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II regulatory region DNA binding;RNA polymerase II activating transcription factor binding;chromatin binding;transcription corepressor activity;protein binding;nuclear hormone receptor binding;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;thyroid hormone receptor binding	YWHAE[17630505];LIN54[17531812];KDM5C[17468742];SMARCB1[11013263];THRB[20956942];ENO1[23414517];HSCB[24606901];HK1[26120082];GOLGA2[29568061];DACH1[14525983];TRIM28[11013263];MYC[21150319];KIF5B[26496610];MYB[20195357];NINL[26638075];NELFE[14667819];KPNA1[26496610];SREBF1[26120082];SMARCC1[11013263];SMARCC2[11013263];TCF12[17572682];UGT2B17[26175416];SIRT1[15175761];PTBP3[22575643];NCOR2[11013263];SGO1[26496610];AR[23518348];TBL1XR1[21258344];RARA[21988832;16606617;25303530;27107012;20543827];PPARG[22078880;21775429];ZMYND11[10734313];PPARA[19955185;21775429];PPARD[21775429];HDAC4[23752268;17956988];HDAC5[23752268];PFKFB1[26120082];HDAC3[11013263;21258344;23752268;16980585];SF3B3[11013263];SRCAP[11013263];AKAP8[16980585];TULP3[23414517];HTT[17500595];FOXK2[25609649];FOXK1[25609649];HDAC9[12590135];HDAC7[23752268];ATXN1[16713569];BAG1[19595997];SKIL[15231748];EXOSC1[26496610];RUNX1T1[17572682;18952841];SF3A1[11013263];EGLN3[26972000];SIAH2[23518348];NR1H2[26120082];CDC5L[20467437];NR1H3[26120082];NBEAL2[29187380];NR1D1[20581824];ESR1[21182203];SMARCA4[11013263];SKI[14525983;10049357;19032343];KIF18A[26496610];REST[17468742];SNW1[20467437];FGFR1OP[26638075];RAB5A[26496610];
108333	chr17	16068362	C	T	chr17:16068362	NCOR1	nuclear receptor corepressor 1	1410.0	SNV	0/1	0.46	24_23	50	99	False	rs76375524,COSV51960926	EXONIC	YES	NM_006311.4	Transcript	protein_coding	synonymous_variant		5/46	NM_006311.4:c.549G>A	NP_006302.2:p.Gln183%3D		-1.0						.	.	.						32	0.96							0.274906	32595.0	118568.0	0.0	47	0.76	InbreedingCoeff_RF	sas	0.308404	4565.0	0.281997	14480.0	0.0001029	16	0.006	19.0				12.05	0.812933		0	0	0			NCOR1	0.0	0.0	0.13	0.0	-3.0	-1.0	-1.0	-33.0						0.467	1.0				embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;prefrontal cortex;skin;superior cervical ganglion;trigeminal ganglion;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	Huntington's disease	negative regulation of transcription by RNA polymerase II;chromatin organization;transcription by RNA polymerase II;circadian rhythm;regulation of lipid metabolic process;negative regulation of transcription, DNA-templated;negative regulation of JNK cascade;spindle assembly;negative regulation of androgen receptor signaling pathway;regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;negative regulation of production of miRNAs involved in gene silencing by miRNA;regulation of fatty acid transport	histone deacetylase complex;nuclear chromatin;nucleus;nucleoplasm;cytosol;membrane;Sin3 complex;transcriptional repressor complex;mitotic spindle	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II regulatory region DNA binding;RNA polymerase II activating transcription factor binding;chromatin binding;transcription corepressor activity;protein binding;nuclear hormone receptor binding;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;thyroid hormone receptor binding	YWHAE[17630505];LIN54[17531812];KDM5C[17468742];SMARCB1[11013263];THRB[20956942];ENO1[23414517];HSCB[24606901];HK1[26120082];GOLGA2[29568061];DACH1[14525983];TRIM28[11013263];MYC[21150319];KIF5B[26496610];MYB[20195357];NINL[26638075];NELFE[14667819];KPNA1[26496610];SREBF1[26120082];SMARCC1[11013263];SMARCC2[11013263];TCF12[17572682];UGT2B17[26175416];SIRT1[15175761];PTBP3[22575643];NCOR2[11013263];SGO1[26496610];AR[23518348];TBL1XR1[21258344];RARA[21988832;16606617;25303530;27107012;20543827];PPARG[22078880;21775429];ZMYND11[10734313];PPARA[19955185;21775429];PPARD[21775429];HDAC4[23752268;17956988];HDAC5[23752268];PFKFB1[26120082];HDAC3[11013263;21258344;23752268;16980585];SF3B3[11013263];SRCAP[11013263];AKAP8[16980585];TULP3[23414517];HTT[17500595];FOXK2[25609649];FOXK1[25609649];HDAC9[12590135];HDAC7[23752268];ATXN1[16713569];BAG1[19595997];SKIL[15231748];EXOSC1[26496610];RUNX1T1[17572682;18952841];SF3A1[11013263];EGLN3[26972000];SIAH2[23518348];NR1H2[26120082];CDC5L[20467437];NR1H3[26120082];NBEAL2[29187380];NR1D1[20581824];ESR1[21182203];SMARCA4[11013263];SKI[14525983;10049357;19032343];KIF18A[26496610];REST[17468742];SNW1[20467437];FGFR1OP[26638075];RAB5A[26496610];
108336	chr17	16068377	C	G	chr17:16068377	NCOR1	nuclear receptor corepressor 1	1410.0	SNV	0|1	0.46	24_23	50	99	False	rs200020868,COSV51959222	EXONIC	YES	NM_006311.4	Transcript	protein_coding	missense_variant		5/46	NM_006311.4:c.534G>C	NP_006302.2:p.Lys178Asn		-1.0	N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,.,.,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain					.	.	.						32	0.96							0.190681	18993.0	99606.0	0.0	53	0.86	InbreedingCoeff	nfe	0.198097	8038.0	0.198097	8038.0	0.0000836	13	0.006	18.0				23.5	2.96789	0.611	10	10	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	NCOR1	0.0	0.0	0.0	0.01	-16.0	-1.0	-48.0	-16.0						0.467	1.0		0.997	-0.23	embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;prefrontal cortex;skin;superior cervical ganglion;trigeminal ganglion;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	Huntington's disease	negative regulation of transcription by RNA polymerase II;chromatin organization;transcription by RNA polymerase II;circadian rhythm;regulation of lipid metabolic process;negative regulation of transcription, DNA-templated;negative regulation of JNK cascade;spindle assembly;negative regulation of androgen receptor signaling pathway;regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;negative regulation of production of miRNAs involved in gene silencing by miRNA;regulation of fatty acid transport	histone deacetylase complex;nuclear chromatin;nucleus;nucleoplasm;cytosol;membrane;Sin3 complex;transcriptional repressor complex;mitotic spindle	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II regulatory region DNA binding;RNA polymerase II activating transcription factor binding;chromatin binding;transcription corepressor activity;protein binding;nuclear hormone receptor binding;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;thyroid hormone receptor binding	YWHAE[17630505];LIN54[17531812];KDM5C[17468742];SMARCB1[11013263];THRB[20956942];ENO1[23414517];HSCB[24606901];HK1[26120082];GOLGA2[29568061];DACH1[14525983];TRIM28[11013263];MYC[21150319];KIF5B[26496610];MYB[20195357];NINL[26638075];NELFE[14667819];KPNA1[26496610];SREBF1[26120082];SMARCC1[11013263];SMARCC2[11013263];TCF12[17572682];UGT2B17[26175416];SIRT1[15175761];PTBP3[22575643];NCOR2[11013263];SGO1[26496610];AR[23518348];TBL1XR1[21258344];RARA[21988832;16606617;25303530;27107012;20543827];PPARG[22078880;21775429];ZMYND11[10734313];PPARA[19955185;21775429];PPARD[21775429];HDAC4[23752268;17956988];HDAC5[23752268];PFKFB1[26120082];HDAC3[11013263;21258344;23752268;16980585];SF3B3[11013263];SRCAP[11013263];AKAP8[16980585];TULP3[23414517];HTT[17500595];FOXK2[25609649];FOXK1[25609649];HDAC9[12590135];HDAC7[23752268];ATXN1[16713569];BAG1[19595997];SKIL[15231748];EXOSC1[26496610];RUNX1T1[17572682;18952841];SF3A1[11013263];EGLN3[26972000];SIAH2[23518348];NR1H2[26120082];CDC5L[20467437];NR1H3[26120082];NBEAL2[29187380];NR1D1[20581824];ESR1[21182203];SMARCA4[11013263];SKI[14525983;10049357;19032343];KIF18A[26496610];REST[17468742];SNW1[20467437];FGFR1OP[26638075];RAB5A[26496610];
108339	chr17	16068383	G	A	chr17:16068383	NCOR1	nuclear receptor corepressor 1	1410.0	SNV	0|1	0.45	25_23	51	99	False	rs199892481,COSV51969699	EXONIC	YES	NM_006311.4	Transcript	protein_coding	synonymous_variant		5/46	NM_006311.4:c.528C>T	NP_006302.2:p.Leu176%3D		-1.0						.	.	.						32	0.96							0.207173	21703.0	104758.0	0.0	55	0.86	InbreedingCoeff_RF	nfe	0.224195	9635.0	0.224195	9635.0	0.0000772	12	0.008	26.0				10.17	0.584406		0	0	0			NCOR1	0.0	0.0	0.0	0.01	-7.0	6.0	-24.0	-22.0						0.467	1.0				embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;prefrontal cortex;skin;superior cervical ganglion;trigeminal ganglion;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	Huntington's disease	negative regulation of transcription by RNA polymerase II;chromatin organization;transcription by RNA polymerase II;circadian rhythm;regulation of lipid metabolic process;negative regulation of transcription, DNA-templated;negative regulation of JNK cascade;spindle assembly;negative regulation of androgen receptor signaling pathway;regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;negative regulation of production of miRNAs involved in gene silencing by miRNA;regulation of fatty acid transport	histone deacetylase complex;nuclear chromatin;nucleus;nucleoplasm;cytosol;membrane;Sin3 complex;transcriptional repressor complex;mitotic spindle	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II regulatory region DNA binding;RNA polymerase II activating transcription factor binding;chromatin binding;transcription corepressor activity;protein binding;nuclear hormone receptor binding;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;thyroid hormone receptor binding	YWHAE[17630505];LIN54[17531812];KDM5C[17468742];SMARCB1[11013263];THRB[20956942];ENO1[23414517];HSCB[24606901];HK1[26120082];GOLGA2[29568061];DACH1[14525983];TRIM28[11013263];MYC[21150319];KIF5B[26496610];MYB[20195357];NINL[26638075];NELFE[14667819];KPNA1[26496610];SREBF1[26120082];SMARCC1[11013263];SMARCC2[11013263];TCF12[17572682];UGT2B17[26175416];SIRT1[15175761];PTBP3[22575643];NCOR2[11013263];SGO1[26496610];AR[23518348];TBL1XR1[21258344];RARA[21988832;16606617;25303530;27107012;20543827];PPARG[22078880;21775429];ZMYND11[10734313];PPARA[19955185;21775429];PPARD[21775429];HDAC4[23752268;17956988];HDAC5[23752268];PFKFB1[26120082];HDAC3[11013263;21258344;23752268;16980585];SF3B3[11013263];SRCAP[11013263];AKAP8[16980585];TULP3[23414517];HTT[17500595];FOXK2[25609649];FOXK1[25609649];HDAC9[12590135];HDAC7[23752268];ATXN1[16713569];BAG1[19595997];SKIL[15231748];EXOSC1[26496610];RUNX1T1[17572682;18952841];SF3A1[11013263];EGLN3[26972000];SIAH2[23518348];NR1H2[26120082];CDC5L[20467437];NR1H3[26120082];NBEAL2[29187380];NR1D1[20581824];ESR1[21182203];SMARCA4[11013263];SKI[14525983;10049357;19032343];KIF18A[26496610];REST[17468742];SNW1[20467437];FGFR1OP[26638075];RAB5A[26496610];
108342	chr17	16068396	G	A	chr17:16068396	NCOR1	nuclear receptor corepressor 1	1410.0	SNV	0/1	0.48	26_28	58	99	False	rs150910818,COSV51959131	EXONIC	YES	NM_006311.4	Transcript	protein_coding	missense_variant		5/46	NM_006311.4:c.515C>T	NP_006302.2:p.Ser172Leu		-1.0	N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,.,.,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain					.	.	.						32	0.96							0.365091	57220.0	156728.0	0.0	65	0.85	InbreedingCoeff_RF	nfe	0.393955	28115.0	0.393955	28115.0	0.0050159	780	0.015	48.0				22.9	2.66933	0.125	8	12	20	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	NCOR1	0.0	0.0	0.0	0.01	-20.0	-35.0	-24.0	-35.0						0.467	1.0		1.0	1.176	embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;prefrontal cortex;skin;superior cervical ganglion;trigeminal ganglion;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	Huntington's disease	negative regulation of transcription by RNA polymerase II;chromatin organization;transcription by RNA polymerase II;circadian rhythm;regulation of lipid metabolic process;negative regulation of transcription, DNA-templated;negative regulation of JNK cascade;spindle assembly;negative regulation of androgen receptor signaling pathway;regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;negative regulation of production of miRNAs involved in gene silencing by miRNA;regulation of fatty acid transport	histone deacetylase complex;nuclear chromatin;nucleus;nucleoplasm;cytosol;membrane;Sin3 complex;transcriptional repressor complex;mitotic spindle	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II regulatory region DNA binding;RNA polymerase II activating transcription factor binding;chromatin binding;transcription corepressor activity;protein binding;nuclear hormone receptor binding;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;thyroid hormone receptor binding	YWHAE[17630505];LIN54[17531812];KDM5C[17468742];SMARCB1[11013263];THRB[20956942];ENO1[23414517];HSCB[24606901];HK1[26120082];GOLGA2[29568061];DACH1[14525983];TRIM28[11013263];MYC[21150319];KIF5B[26496610];MYB[20195357];NINL[26638075];NELFE[14667819];KPNA1[26496610];SREBF1[26120082];SMARCC1[11013263];SMARCC2[11013263];TCF12[17572682];UGT2B17[26175416];SIRT1[15175761];PTBP3[22575643];NCOR2[11013263];SGO1[26496610];AR[23518348];TBL1XR1[21258344];RARA[21988832;16606617;25303530;27107012;20543827];PPARG[22078880;21775429];ZMYND11[10734313];PPARA[19955185;21775429];PPARD[21775429];HDAC4[23752268;17956988];HDAC5[23752268];PFKFB1[26120082];HDAC3[11013263;21258344;23752268;16980585];SF3B3[11013263];SRCAP[11013263];AKAP8[16980585];TULP3[23414517];HTT[17500595];FOXK2[25609649];FOXK1[25609649];HDAC9[12590135];HDAC7[23752268];ATXN1[16713569];BAG1[19595997];SKIL[15231748];EXOSC1[26496610];RUNX1T1[17572682;18952841];SF3A1[11013263];EGLN3[26972000];SIAH2[23518348];NR1H2[26120082];CDC5L[20467437];NR1H3[26120082];NBEAL2[29187380];NR1D1[20581824];ESR1[21182203];SMARCA4[11013263];SKI[14525983;10049357;19032343];KIF18A[26496610];REST[17468742];SNW1[20467437];FGFR1OP[26638075];RAB5A[26496610];
109323	chr3	48627096	G	A	chr3:48627096	COL7A1	collagen type VII alpha 1 chain	1431.0	SNV	0/1	0.52	13_14	27	99	False	rs75551775	EXONIC	YES	NM_000094.4	Transcript	protein_coding	synonymous_variant		17/119	NM_000094.4:c.2106C>T	NP_000085.1:p.Val702%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Epidermolysis_bullosa_dystrophica|Epidermolysis_bullosa_dystrophica_inversa,_autosomal_recessive|not_provided	EBD, localisata variant (3); Epidermolysis bullosa, pretibial, 131850 (3), Autosomal recessive, Autosomal dominant; Transient bullous of the newborn, 131705 (3), Autosomal recessive, Autosomal dominant; EBD, Bart type, 132000 (3), Autosomal dominant; Epidermolysis bullosa dystrophica, AD, 131750 (3), Autosomal dominant; Epidermolysis bullosa pruriginosa, 604129 (3), Autosomal recessive, Autosomal dominant; EBD inversa, 226600 (3), Autosomal recessive; Epidermolysis bullosa dystrophica, AR, 226600 (3), Autosomal recessive; Toenail dystrophy, isolated, 607523 (3), Autosomal dominant	Dominant dystrophic epidermolysis bullosa, nails only;Acral dystrophic epidermolysis bullosa;Generalized dominant dystrophic epidermolysis bullosa;Dystrophic epidermolysis bullosa pruriginosa;Recessive dystrophic epidermolysis bullosa, generalized intermediate;Centripetalis recessive dystrophic epidermolysis bullosa;Epidermolysis bullosa simplex superficialis;Recessive dystrophic epidermolysis bullosa inversa;Severe generalized recessive dystrophic epidermolysis bullosa;Transient bullous dermolysis of the newborn;Pretibial dystrophic epidermolysis bullosa	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Autosomal dominant inheritance;Nail dystrophy;Nail dysplasia;Fragile skin;Congenital localized absence of skin;Fragile skin;Skin vesicle;Atrophic scars;Nail dystrophy;Milia;Atrophic scars;Dysphagia;Abnormal toenail morphology;Anemia;Carious teeth;Hypopigmented skin patches;Cheilitis;Esophageal stricture;Urethral stricture;Skin vesicle;Urinary retention;Corneal erosion;Abnormal fingernail morphology;Milia;Milia;Fragile skin;Nail dysplasia;Autosomal dominant inheritance;Autosomal recessive inheritance;Nail dystrophy;Hyperkeratosis;Autosomal recessive inheritance;Pruritus;Autosomal dominant inheritance;Nail dystrophy;Pretibial blistering;Abnormality of the skin;Atypical scarring of skin;Pruritus;Dystrophic fingernails;Milia;Dystrophic toenail;Hypopigmented skin patches;Milia;Nail dystrophy;Atrophic scars;Oral mucosal blisters;Dysphagia;Mitten deformity;Dilated cardiomyopathy;Delayed puberty;Osteoporosis;Flexion contracture;Esophageal stricture;Abnormality of the anus;Refractory anemia;Squamous cell carcinoma of the skin;Ectropion;Pruritus;Narrow mouth;Absent toenail;Milia;Scarring alopecia of scalp;Ankyloglossia;Blepharitis;Constipation;Loss of eyelashes;Osteopenia;Abnormal blistering of the skin;Hypoalbuminemia;Progressive visual loss;Absent fingernail;Carious teeth;Dermal atrophy;Corneal erosion;Milia;Growth delay;Dysphagia;Abnormal blistering of the skin;Conjunctivitis;Constipation;Spontaneous esophageal perforation;Fragile skin;Nail dysplasia;Autosomal recessive inheritance;Squamous cell carcinoma;Flexion contracture;Atrophic scars;Narrow mouth;Cataract;Anemia;Esophageal stricture;Nail dystrophy;Corneal scarring;Mitten deformity;Hypoplasia of dental enamel;Malnutrition;Congenital onset;Alopecia;Abnormality of metabolism/homeostasis;Atrophic scars;Autosomal dominant inheritance;Abnormal blistering of the skin;Autosomal recessive inheritance;Fragile skin;Milia;Congenital onset;Nail dystrophy;Flexion contracture;Narrow mouth;Constipation;Hearing impairment;Skin erosion;Renal insufficiency;Abnormal vagina morphology;Recurrent skin infections;Ankyloglossia;Corneal erosion;Growth delay;Nephropathy;Squamous cell carcinoma of the skin;Oral mucosal blisters;Anemia;Milia;Abnormality of the anus;Tongue atrophy;Esophageal stricture;Microglossia;Atrophic scars;Nail dystrophy;Dysphagia;Keratitis;Dilated cardiomyopathy;Cataract;Stenosis of the external auditory canal;Dystrophic toenail;Autosomal dominant inheritance;Skin vesicle;Milia;Delayed puberty;Alopecia;Dysphagia;Aplasia cutis congenita;Atrophic scars;Ankyloglossia;Narrow mouth;Esophageal stricture;Mitten deformity;Constipation;Carious teeth;Visual loss;Oral mucosal blisters;Abnormality of the anus;Squamous cell carcinoma;Nail dystrophy;Feeding difficulties;Failure to thrive;Corneal erosion;Fragile skin;Anemia;Atrophic scars;Fragile skin;Milia;Hypoplasia of dental enamel;Skin erosion;Absent toenail;Dystrophic toenail;Fragile skin;Skin nodule;Thin skin;Milia;Atrophic scars;Abnormal blistering of the skin;Skin vesicle;Papule;Pruritus;Nail dystrophy;Atrophic scars;Nail dystrophy;Milia;Milia;Congenital onset;Autosomal dominant inheritance;Nail dysplasia;Nail dystrophy;Atrophic scars;Abnormal blistering of the skin		0.000400978	61.0	152128.0	0.0	32	0.95	PASS	nfe	0.000587993	40.0	0.000587993	40.0	0.000382026	96.0	251292.0	0.0	100	1.0	PASS	amr	0.000520412	18.0	0.000519403	59.0	0.0003858	60	0.001	3.0	0.00088	10.0		12.35	0.851621		0	0	0			COL7A1	0.0	0.0	0.0	0.01	9.0	-18.0	18.0	-42.0						0.0371	0.0	49.34736822			craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); skeleton phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; 			trigeminal ganglion;skin;cingulate cortex;	.	growth plate cartilage chondrocyte morphogenesis;endoplasmic reticulum to Golgi vesicle-mediated transport;cell adhesion;epidermis development;negative regulation of endopeptidase activity;extracellular matrix organization;endodermal cell differentiation;COPII vesicle coating	Golgi membrane;extracellular region;collagen type VII trimer;basement membrane;extracellular space;endoplasmic reticulum lumen;COPII-coated ER to Golgi transport vesicle;extracellular matrix;endoplasmic reticulum-Golgi intermediate compartment membrane;collagen-containing extracellular matrix	serine-type endopeptidase inhibitor activity;protein binding;extracellular matrix structural constituent conferring tensile strength	NFKBIA[26496610];HSPA8[16169070];ZC3H7A[16169070];CBFB[20195357];SHKBP1[16169070];MIA3[19269366];FBXL2[16169070];SNCA[26496610];
109753	chr12	1755098	G	A	chr12:1755098	WNT5B	Wnt family member 5B	1445.0	SNV	0/1	0.38	28_17	45	99	False	rs774388139	EXONIC	YES	NM_032642.3	Transcript	protein_coding	missense_variant		5/5	NM_032642.3:c.760G>A	NP_116031.1:p.Ala254Thr		1.0	.,.,.					.	.	.						33	0.99							1.22435e-05	3.0	245028.0	0.0	56	0.98	PASS	amr	5.80417e-05	2.0	0.0	0.0	0.0000064	1						22.4	2.416902	0.36	8	12	20	LRT_pred,M-CAP_pred,MutationTaster_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	WNT5B	0.0	0.0	0.0	0.0	21.0	44.0	2.0	-17.0						0.41	0.84	0.0	0.963	1.175	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; 			trigeminal ganglion;adipose tissue;atrioventricular node;superior cervical ganglion;uterus corpus;prostate;skeletal muscle;	Wnt signaling pathway;Hedgehog signaling pathway;Melanogenesis;Basal cell carcinoma	chondrocyte differentiation;Wnt signaling pathway;neuron differentiation;positive regulation of cell migration;wound healing;cell fate commitment;fat cell differentiation;positive regulation of fat cell differentiation;lens fiber cell development;cellular response to retinoic acid;negative regulation of canonical Wnt signaling pathway	extracellular region;extracellular space;endoplasmic reticulum lumen;Golgi lumen;plasma membrane;cell surface;endocytic vesicle membrane;collagen-containing extracellular matrix;extracellular exosome	signaling receptor binding;frizzled binding	APPBP2[16189514];
113692	chr4	114067061	G	T	chr4:114067061	ANK2	ankyrin 2	1470.0	SNV	0/1	0.38	20_12	32	99	False	rs55847200	EXONIC	YES	NM_001386174.1	Transcript	protein_coding	missense_variant		1/51	NM_001386174.1:c.37G>T	NP_001373103.1:p.Asp13Tyr		1.0					Long QT syndrome 4, 600919 (3), Autosomal dominant; Cardiac arrhythmia, ankyrin-B-related, 600919 (3), Autosomal dominant	Romano-Ward syndrome	Disease-causing germline mutation(s) (loss of function) in	Heterogeneous;Prolonged QT interval;Syncope;Atrial fibrillation;Sinus bradycardia;Sudden cardiac death;Autosomal dominant inheritance;Abnormality of prenatal development or birth;Syncope;Torsade de pointes;Abnormal cardiac exercise stress test;Hypokalemia;Abnormal T-wave;Sudden cardiac death;Sinus bradycardia;Prolonged QTc interval;Abnormal autonomic nervous system physiology;Seizure		0.00397467	605.0	152214.0	3.0	32	0.96	PASS	nfe	0.00642326	437.0	0.00642326	437.0	0.0041193	553.0	134246.0	4.0	47	0.57	PASS	nfe	0.00633875	333.0	0.00633875	333.0	0.0011768	183	0.005	16.0				13.64	1.03091		0	13	13		MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANK2	0.0	0.0	0.0	0.0	6.0	-23.0	-2.0	0.0						0.363	1.0	0.0	0.933	1.146	nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			caudate nucleus;ciliary ganglion;temporal lobe;amygdala;prefrontal cortex;cingulate cortex;superior cervical ganglion;trigeminal ganglion;cerebellum peduncles;cerebellum;pons;occipital lobe;fetal brain;subthalamic nucleus;whole brain;dorsal root ganglion;spinal cord;parietal lobe;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	regulation of heart rate;atrial septum development;cellular calcium ion homeostasis;endoplasmic reticulum to Golgi vesicle-mediated transport;endocytosis;cytoskeleton organization;positive regulation of gene expression;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;regulation of cardiac muscle contraction by calcium ion signaling;protein transport;paranodal junction assembly;regulation of protein stability;T-tubule organization;protein localization to organelle;protein localization to cell surface;cellular protein localization;protein localization to M-band;protein localization to T-tubule;positive regulation of potassium ion transport;protein stabilization;regulation of release of sequestered calcium ion into cytosol;response to methylmercury;regulation of calcium ion transport;positive regulation of calcium ion transport;regulation of cardiac muscle contraction;regulation of ventricular cardiac muscle cell membrane repolarization;sarcoplasmic reticulum calcium ion transport;protein localization to endoplasmic reticulum;protein localization to plasma membrane;regulation of cardiac muscle cell contraction;ventricular cardiac muscle cell action potential;atrial cardiac muscle cell action potential;SA node cell action potential;membrane depolarization during SA node cell action potential;atrial cardiac muscle cell to AV node cell communication;SA node cell to atrial cardiac muscle cell communication;regulation of heart rate by cardiac conduction;regulation of SA node cell action potential;regulation of atrial cardiac muscle cell action potential;positive regulation of potassium ion transmembrane transporter activity;regulation of calcium ion transmembrane transporter activity;positive regulation of calcium ion transmembrane transporter activity;positive regulation of cation channel activity	mitochondrion;lysosome;early endosome;cytosol;cytoskeleton;plasma membrane;intercalated disc;membrane;basolateral plasma membrane;apical plasma membrane;Z disc;T-tubule;M band;A band;sarcolemma;costamere;axon initial segment;membrane raft;postsynaptic membrane;recycling endosome	structural constituent of cytoskeleton;protein binding;enzyme binding;protein kinase binding;spectrin binding;protein binding, bridging;ion channel binding;ATPase binding;phosphorylation-dependent protein binding	MDC1[29656893];DCTN4[19109891];TAF9[20195357];CEP120[26638075];RRBP1[30021884];SLC8A1[16292983];DNAJB5[23414517];DMD[19109891];MTERF1[20195357];NCK1[17474147];HIST1H1C[30021884];ANKRD28[23414517];GABARAPL2[20562859];GABARAPL1[20562859];KCNJ11[19805355];ABCC8[19805355];EHD1[20489164];EHD2[20489164];EHD3[20489164];OBSCN[12527750];EHD4[20489164];GRB2[17474147];TNIK[17043677];EZR[29568061];TP53[20195357];
127087	chr18	39570440	T	G	chr18:39570440	PIK3C3	phosphatidylinositol 3-kinase catalytic subunit type 3	1476.0	SNV	0/1	0.52	12_13	25	99	False	rs144017818	EXONIC	YES	NM_002647.4	Transcript	protein_coding	synonymous_variant		6/25	NM_002647.4:c.636T>G	NP_002638.2:p.Ser212%3D		1.0						.	.	.		0.0013537	206.0	152176.0	0.0	32	0.96	PASS	afr	0.00439041	182.0	0.000117626	8.0	0.00057778	144.0	249230.0	0.0	35	0.9	PASS	afr	0.00506861	82.0	0.000239527	27.0	0.0005916	92	0.001	2.0	0.00164	3.0		11.33	0.722364		0	0	0			PIK3C3	0.0	0.0	0.0	0.0	-17.0	40.0	8.0	-17.0						0.481	0.08	60.73939369			growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; immune system phenotype; vision/eye phenotype; 			testis - seminiferous tubule;testis - interstitial;	Inositol phosphate metabolism;Phosphatidylinositol signaling system;Regulation of autophagy	autophagosome assembly;protein phosphorylation;protein lipidation;endocytosis;autophagy;endosome organization;cell cycle;macroautophagy;protein processing;autophagy of peroxisome;regulation of cytokinesis;toll-like receptor 9 signaling pathway;protein localization to phagophore assembly site;phosphatidylinositol-3-phosphate biosynthetic process;cellular response to glucose starvation;response to leucine;early endosome to late endosome transport;phosphatidylinositol phosphorylation;phosphatidylinositol-mediated signaling;regulation of protein secretion;cell division	phagophore assembly site;cytoplasm;endosome;late endosome;peroxisome;cytosol;axoneme;membrane;midbody;phagocytic vesicle membrane;phosphatidylinositol 3-kinase complex, class III, type I;phosphatidylinositol 3-kinase complex, class III, type II;phosphatidylinositol 3-kinase complex, class III;autolysosome	protein kinase activity;protein binding;ATP binding;kinase activity;1-phosphatidylinositol-3-kinase activity	HSPA9[24785657];SH3GLB1[24056303];UVRAG[20562859;25490155;24849286;24785657;22493499;24056303];BECN1[20562859;23332761;23954414;24034250;24472739;25490155;25594178;26496610;24785657;23316280;19050071;23364696;24056303];RUBCN[20562859;21062745];USP11[20562859];BECN2[23954414];PIK3R4[20562859;24849286;24785657];RAB39A[24349490];ATG14[20562859;23332761;25490155;24785657;22493499;19050071];VMP1[23316280];TGOLN2[29568061];H1F0[30021884];MAP1LC3C[20562859];PIK3C3[20562859];NRBF2[20562859;24849286;24785657];CLPTM1L[20562859];YWHAG[15324660;17353931];SLAMF1[22493499];
128311	chr9	116930862	G	A	chr9:116930862	COL27A1	collagen type XXVII alpha 1 chain	1491.0	SNV	0/1	0.46	19_16	35	99	False	rs755477387	EXONIC	YES	NM_032888.4	Transcript	protein_coding	missense_variant		3/61	NM_032888.4:c.1027G>A	NP_116277.2:p.Gly343Ser		1.0	.,.				Steel syndrome, 615155 (3), Autosomal recessive	Steel syndrome	Disease-causing germline mutation(s) in	Hypertelorism;Global developmental delay;Short stature;Prominent forehead;Autosomal recessive inheritance;Dislocated radial head;Sensorineural hearing impairment;Wide nasal bridge;Scoliosis		6.57523e-06	1.0	152086.0	0.0	33	0.97	PASS	sas	0.000207555	1.0	0.0	0.0	7.96014e-06	2.0	251252.0	0.0	78	1.0	PASS	eas	5.43715e-05	1.0	8.80437e-06	1.0	0.0000129	2						0.001	-1.243364	0.01	2	16	18	M-CAP_pred,FATHMM_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	COL27A1	0.0	0.0	0.0	0.0	-11.0	11.0	2.0	11.0						0.0176	1.0	0.0	0.0	-4.198	growth/size/body region phenotype; craniofacial phenotype; respiratory system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; skeleton phenotype; 			ciliary ganglion;olfactory bulb;trigeminal ganglion;superior cervical ganglion;cerebellum peduncles;cerebellum;pons;kidney;subthalamic nucleus;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	growth plate cartilage chondrocyte development;extracellular matrix organization	extracellular region;fibrillar collagen trimer;extracellular space;endoplasmic reticulum lumen;extracellular matrix;collagen-containing extracellular matrix	extracellular matrix structural constituent;extracellular matrix structural constituent conferring tensile strength;metal ion binding	.
128336	chr17	17700774	G	T	chr17:17700774	RAI1	retinoic acid induced 1	1494.0	SNV	0/1	0.5	13_13	26	99	False	rs117995220	EXONIC	YES	NM_030665.4	Transcript	protein_coding	synonymous_variant		3/6	NM_030665.4:c.4512G>T	NP_109590.3:p.Leu1504%3D		1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Smith-Magenis_syndrome|History_of_neurodevelopmental_disorder|not_specified|not_provided	Smith-Magenis syndrome, 182290 (3), Isolated cases, Autosomal dominant	Smith-Magenis syndrome;Smith-Magenis syndrome;17p11.2 microduplication syndrome;PMP22-RAI1 contiguous gene duplication syndrome	Disease-causing germline mutation(s) in;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of	Morphological abnormality of the middle ear;Abnormality of the thyroid gland;Short palm;Deeply set eye;Midface retrusion;Onychotillomania;Increased body weight;Abnormality of the dentition;Areflexia;EEG abnormality;Hearing impairment;Constipation;Brachydactyly;Abnormality of the urinary system;Ventriculomegaly;Stereotypy;Hoarse voice;Velopharyngeal insufficiency;Abnormality of the forearm;Sporadic;Self-mutilation;Abnormal tracheobronchial morphology;Head-banging;Sleep-wake inversion;Hoarse voice;Broad palm;Hypercholesterolemia;Abnormality of cardiovascular system morphology;Brachycephaly;Abnormal renal morphology;Abnormality of the outer ear;Autosomal dominant inheritance;Broad face;Seizure;Stereotypy;Retinal detachment;Delayed speech and language development;Pes planus;Short stature;Hypertriglyceridemia;Hyperacusis;Impaired pain sensation;Abnormality of the immune system;Hyporeflexia;Oral cleft;Everted upper lip vermilion;Global developmental delay;Abnormal heart morphology;Polyembolokoilamania;Generalized hypotonia;Wide nasal bridge;Mandibular prognathia;Hyperactivity;Abnormality of the larynx;Intellectual disability;Scoliosis;Synophrys;Self hugging;Malar flattening;Sleep disturbance;Downslanted palpebral fissures;Double outlet right ventricle;Smooth philtrum;Foot dorsiflexor weakness;Syringomyelia;Pes valgus;Joint laxity;Pes planus;Failure to thrive in infancy;Delayed speech and language development;Sensory neuropathy;Aortic aneurysm;Abnormality of the pinna;Persistent left superior vena cava;Triangular face;Thin upper lip vermilion;Long philtrum;Broad-based gait;Decreased number of peripheral myelinated nerve fibers;Sandal gap;Delayed ability to walk;Brain imaging abnormality;Ventricular septal defect;Feeding difficulties in infancy;Bicuspid aortic valve;Decreased/absent ankle reflexes;Global developmental delay;Distal sensory impairment;Strabismus;Chronic constipation;Decreased nerve conduction velocity;Abnormal renal morphology;Wide nose;2-3 toe syndactyly;Talipes equinovarus;Distal amyotrophy;Infantile muscular hypotonia;Patent foramen ovale;Distal muscle weakness;Overriding aorta;Autism;Intellectual disability, mild;Low-set, posteriorly rotated ears;Oral-pharyngeal dysphagia;Dysarthria;Muscular hypotonia;Abnormality of chromosome segregation;Triangular face;Failure to thrive;Poor fine motor coordination;High hypermetropia;Hypertelorism;Hypoplasia of the corpus callosum;Global developmental delay;Short stature;Dysphasia;Hearing impairment;Scoliosis;Attention deficit hyperactivity disorder;Micrognathia;Downslanted palpebral fissures;Microcephaly;Anxiety;Broad forehead;Abnormality of cardiovascular system morphology;EEG abnormality;Echolalia;Gastroesophageal reflux;Open bite;Abnormality of dental morphology;Speech apraxia;Wide mouth;Expressive language delay;Sleep apnea;Precocious puberty;Renal hypoplasia/aplasia;Neurological speech impairment;Hand polydactyly;Strabismus;Global developmental delay;Sleep disturbance;Short nose;Broad forehead;Wide nasal bridge;Hyperacusis;Muscular hypotonia;Aplasia/Hypoplasia of the corpus callosum;Gait disturbance;Short philtrum;Anteverted nares;Synophrys;Open mouth;Deeply set eye;Upslanted palpebral fissure;Hypercholesterolemia;Micrognathia;Taurodontia;EEG abnormality;Conductive hearing impairment;Failure to thrive in infancy;Brachycephaly;Hyporeflexia;Delayed puberty;Hypertelorism;Abnormal form of the vertebral bodies;Anxiety;Abnormality of cardiovascular system morphology;Stereotypy;Joint stiffness;Abnormality of the ureter;Cleft palate;Pes planus;Midface retrusion;Clinodactyly of the 5th finger;Feeding difficulties in infancy;Brachydactyly;Hoarse voice;Ventriculomegaly;Corticospinal tract hypoplasia;Mandibular prognathia;Tented upper lip vermilion;Delayed eruption of primary teeth;Large face;Intellectual disability;Constipation;Hypertriglyceridemia;Seizure;Short stature;Cleft upper lip;Toe syndactyly;Frontal bossing;Abnormal localization of kidney;Self-injurious behavior;Retinal detachment;Delayed speech and language development;Depressed nasal bridge;Attention deficit hyperactivity disorder;Decreased fetal movement;Abnormal tracheobronchial morphology;Microcephaly;Myopia;Scoliosis;Gastroesophageal reflux;Microcornea;Chronic otitis media;Hypothyroidism;Obesity;Impaired pain sensation;Precocious puberty;Renal hypoplasia/aplasia;Neurological speech impairment;Hand polydactyly;Strabismus;Global developmental delay;Sleep disturbance;Short nose;Broad forehead;Wide nasal bridge;Hyperacusis;Muscular hypotonia;Aplasia/Hypoplasia of the corpus callosum;Gait disturbance;Short philtrum;Anteverted nares;Synophrys;Open mouth;Deeply set eye;Upslanted palpebral fissure;Hypercholesterolemia;Micrognathia;Taurodontia;EEG abnormality;Conductive hearing impairment;Failure to thrive in infancy;Brachycephaly;Hyporeflexia;Delayed puberty;Hypertelorism;Abnormal form of the vertebral bodies;Anxiety;Abnormality of cardiovascular system morphology;Stereotypy;Joint stiffness;Abnormality of the ureter;Cleft palate;Pes planus;Midface retrusion;Clinodactyly of the 5th finger;Feeding difficulties in infancy;Brachydactyly;Hoarse voice;Ventriculomegaly;Corticospinal tract hypoplasia;Mandibular prognathia;Tented upper lip vermilion;Delayed eruption of primary teeth;Large face;Intellectual disability;Constipation;Hypertriglyceridemia;Seizure;Short stature;Cleft upper lip;Toe syndactyly;Frontal bossing;Abnormal localization of kidney;Self-injurious behavior;Retinal detachment;Delayed speech and language development;Depressed nasal bridge;Attention deficit hyperactivity disorder;Decreased fetal movement;Abnormal tracheobronchial morphology;Microcephaly;Myopia;Scoliosis;Gastroesophageal reflux;Microcornea;Chronic otitis media;Hypothyroidism;Obesity;Impaired pain sensation	23757202	0.00545866	830.0	152052.0	3.0	33	0.97	PASS	amr	0.00889936	136.0	0.00745786	507.0	0.00573952	1431.0	249324.0	8.0	51	0.98	PASS	nfe	0.00816932	919.0	0.00816932	919.0	0.0054468	847	0.007	20.0	0.00938	107.0		9.736	0.536048		0	0	0			RAI1	0.0	0.0	0.0	0.0	16.0	40.0	29.0	-26.0						0.202	1.0	76.530214162			homeostasis/metabolism phenotype; craniofacial phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; respiratory system phenotype; skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			pons;trigeminal ganglion;superior cervical ganglion;skeletal muscle;globus pallidus;	Urea cycle and metabolism of amino groups;beta-Alanine metabolism;Glutathione metabolism	skeletal system development;circadian regulation of gene expression;negative regulation of multicellular organism growth;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II	nucleus;nucleoplasm;mitochondrion	DNA-binding transcription factor activity;protein binding;enhancer binding;transcription regulatory region DNA binding;metal ion binding	GSK3B[21900206];CDKN1A[21900206];DAXX[26496610];GADD45A[21900206];TESC[16189514];PYHIN1[25665578];TCF20[26496610];MAPK8IP2[21900206];RPS6KA5[21900206];TTR[21900206];PIN1[16189514;25416956];CASP2[21900206];CDK2AP1[26496610];RPL13[30021884];HMG20A[26496610];HIST1H2BH[30021884];
134923	chr1	247587771	C	T	chr1:247587771	NLRP3	NLR family pyrin domain containing 3	1529.0	SNV	0/1	0.49	20_19	39	99	False	rs41311573,CM045283	EXONIC	YES	NM_004895.5	Transcript	protein_coding	synonymous_variant		4/10	NM_004895.5:c.1026C>T	NP_004886.3:p.Pro342%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Familial_cold_autoinflammatory_syndrome_1|Familial_amyloid_nephropathy_with_urticaria_AND_deafness|Chronic_infantile_neurological,_cutaneous_and_articular_syndrome|Cryopyrin_associated_periodic_syndrome|not_specified|not_provided	CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant	Muckle-Wells syndrome;CINCA syndrome;Familial cold urticaria	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in	Urticaria;Lymphadenopathy;Arthralgia;Arthritis;Headache;Periodic fever;Slow progression;Conjunctivitis;Autosomal dominant inheritance;Variable expressivity;Arthralgia;Elevated erythrocyte sedimentation rate;Renal insufficiency;Infantile onset;Renal amyloidosis;Abnormality of the mouth;Progressive sensorineural hearing impairment;Conjunctivitis;Autosomal dominant inheritance;Hearing impairment;Leukocytosis;Abnormality of the skin;Recurrent aphthous stomatitis;Recurrent fever;Myalgia;Proptosis;Arthritis;Growth delay;Autosomal dominant inheritance;Progressive sensorineural hearing impairment;Meningitis;Skin rash;Fever;Frontal bossing;Conjunctivitis;Urticaria;Arthralgia;Nausea and vomiting;Headache;Arthritis;Erythema;Dehydration;Myalgia;Pruritus;Fever;Dysesthesia;Hyperhidrosis;Polydipsia;Sensorineural hearing impairment;Abdominal pain;Fatigue;Urticaria;Uveitis;Edema;Blindness;Brachydactyly;Pseudopapilledema;Global developmental delay;Migraine;EEG abnormality;Premature birth;Splenomegaly;Proptosis;Fatigue;Meningitis;Leukocytosis;Lymphadenopathy;Myalgia;Anemia;Papule;Delayed closure of the anterior fontanelle;Fever;Nausea and vomiting;Frontal bossing;Macrocephaly;Growth delay;Abnormality of neutrophils;Increased intracranial pressure;Retrobulbar optic neuritis;Elevated C-reactive protein level;Abnormal thrombocyte morphology;Reduced bone mineral density;Hepatomegaly;Joint dislocation;Purpura;Skeletal dysplasia;Arthralgia;Intellectual disability;Sensorineural hearing impairment;Elevated erythrocyte sedimentation rate;Keratitis;Edema;Blurred vision;Epiphora;Conjunctival hyperemia;Autosomal dominant inheritance;Juvenile onset;Opacification of the corneal stroma;Photophobia;Headache;Renal amyloidosis;Infantile onset;Conjunctivitis;Recurrent fever;Myalgia;Autosomal dominant inheritance;Arthralgia;Leukocytosis;Optic atrophy;Hepatomegaly;Abnormality of the nose;Restrictive ventilatory defect;Arthralgia;Myalgia;Glaucoma;Abnormal palate morphology;Uveitis;Urticaria;Pes cavus;Abnormality of the voice;Skin rash;Camptodactyly of finger;Broad foot;Abdominal pain;Nephrotic syndrome;Delayed puberty;Splenomegaly;Conjunctivitis;Ichthyosis;Macrocephaly;Arthritis;Fever;Vasculitis;Abnormality of the genital system;Hernia of the abdominal wall;Progressive sensorineural hearing impairment;Short stature;Episcleritis;Elevated erythrocyte sedimentation rate;Cranial nerve paralysis;Renal amyloidosis;Recurrent aphthous stomatitis;Nephropathy;Anemia	25741868	0.00527609	803.0	152196.0	3.0	32	0.97	PASS	amr	0.00877423	134.0	0.00752565	512.0	0.00520842	1305.0	250556.0	12.0	91	0.99	PASS	nfe	0.00700662	792.0	0.00700662	792.0	0.0048873	760	0.009	29.0	0.00859	98.0		0.545	-0.241315		0	0	0			NLRP3	0.0	0.0	0.0	0.0	27.0	4.0	-9.0	15.0						0.00351	0.45	46.416694015			hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; liver/biliary system phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; 			pons;appendix;subthalamic nucleus;atrioventricular node;superior cervical ganglion;trigeminal ganglion;parietal lobe;skeletal muscle;	.	cytokine secretion involved in immune response;negative regulation of acute inflammatory response;positive regulation of type 2 immune response;apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process;defense response;inflammatory response;signal transduction;detection of biotic stimulus;protein deubiquitination;negative regulation of NF-kappaB transcription factor activity;interleukin-1 beta production;interleukin-18 production;positive regulation of interleukin-13 production;positive regulation of interleukin-4 production;positive regulation of interleukin-5 production;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;NLRP3 inflammasome complex assembly;innate immune response;positive regulation of T-helper 2 cell differentiation;positive regulation of transcription by RNA polymerase II;interleukin-1 secretion;negative regulation of interleukin-1 beta secretion;positive regulation of interleukin-1 beta secretion;negative regulation of inflammatory response;defense response to Gram-positive bacterium;positive regulation of NF-kappaB transcription factor activity;protein complex oligomerization;defense response to virus;cellular response to lipopolysaccharide;cellular response to peptidoglycan;negative regulation of NIK/NF-kappaB signaling;positive regulation of T-helper 17 cell differentiation;positive regulation of T-helper 2 cell cytokine production	extracellular region;nucleus;cytoplasm;endoplasmic reticulum;cytosol;NLRP3 inflammasome complex	protein binding;ATP binding;transcription factor binding;identical protein binding;peptidoglycan binding;sequence-specific DNA binding	MTCH1[26496610];GEMIN2[26496610];FBXO28[26496610];LTBP4[26496610];ZC3H8[26496610];COPS7A[26496610];GPATCH4[26496610];PHRF1[26496610];YBX3[26496610];HSPD1[30021884];PYCARD[11786556;15020601;24630722;19158675];MAP1LC3A[22286270];SPAST[26496610];NLRP5[26496610];NLRP3[23582325;24630722];LUC7L[26496610];RBBP7[26496610];DMAP1[26496610];HIST1H1B[26496610];CBX5[26496610];FEM1A[26496610];SYK[25605870];CBX3[26496610];PCGF5[26496610];CARD8[28137891];NEK7[26814970];SMARCA5[26496610];EIF2AK2[22801494];AP3B1[26496610];KIAA2013[26496610];URB1[26496610];MAVS[23582325;26494172];UQCRQ[26496610];DNAJA2[26496610];PHF14[26496610];LUC7L3[26496610];CCDC86[26496610];TOP1[26496610];HNRNPC[26496610];NECTIN3[26496610];FBXL6[26496610];SNRPB[26496610];
135785	chr3	14444244	T		chr3:14444244	SLC6A6	solute carrier family 6 member 6	1546.0	deletion	1|1	1.0	0_38	38	99	False	rs67046817,COSV62647327	SPLICING	YES	NM_001134367.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,coding_sequence_variant	1/21		NM_001134367.3:c.150+1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0001137,0.0001516,0.0457957,0.0001137,0.0001137,0.7709834	3,4,1208,3,3,20337	0.001	2.0	1.0	8398.0		11.71	0.769889		0	0	0			SLC6A6	0.0	0.0	0.0	0.03	-26.0	42.0	-4.0	20.0						0.301	0.98				cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];
135787	chr3	14444250	T		chr3:14444250	SLC6A6	solute carrier family 6 member 6	1546.0	deletion	1|1	1.0	0_39	39	99	False	rs66528743,COSV62647330	SPLICING	YES	NM_001134367.3	Transcript	protein_coding	splice_region_variant,coding_sequence_variant	2/21		NM_001134367.3:c.155+1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0455683,0.0003033,0.0001896,0.0001137,0.4830541	1202,8,5,3,12742			1.0	8398.0		11.88	0.790884		0	0	0			SLC6A6	0.0	0.0	0.0	0.01	-32.0	1.0	-13.0	14.0						0.301	0.98				cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];
135792	chr3	14444277	C		chr3:14444277	SLC6A6	solute carrier family 6 member 6	1546.0	deletion	1|1	1.0	0_36	36	99	False	rs1574897616	SPLICING	YES	NM_001134367.3	Transcript	protein_coding	splice_acceptor_variant,frameshift_variant		3/22	NM_001134367.3:c.182+1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						32	0.97											0	0.0							0.0002275,0.0001516,0.0001137,0.0004549,0.0003791,0.0000379,0.0001516,0.0000379,0.0330199,0.4781636,0.0001896	6,4,3,12,10,1,4,1,871,12613,5			1.0	8398.0		9.585	0.519468		0	0	0			SLC6A6	0.0	0.0	0.01	0.0	41.0	4.0	-13.0	-37.0						0.301	0.98				cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];
135796	chr3	14444286	C		chr3:14444286	SLC6A6	solute carrier family 6 member 6	1546.0	deletion	1|1	1.0	0_36	36	99	False		SPLICING	YES	NM_001134367.3	Transcript	protein_coding	splice_acceptor_variant,frameshift_variant		4/22	NM_001134367.3:c.190+1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0001516,0.0001896,0.0345743,0.4783153,0.0007582,0.0000379	4,5,912,12617,20,1			1.0	8398.0		9.513	0.511754		0	0	0			SLC6A6	0.0	0.0	0.0	0.01	32.0	-1.0	-49.0	-22.0						0.301	0.98				cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];
135800	chr3	14444309	T		chr3:14444309	SLC6A6	solute carrier family 6 member 6	1546.0	deletion	1|1	1.0	0_39	39	99	False	rs68047955,COSV62647343	EXONIC	YES	NM_001134367.3	Transcript	protein_coding	coding_sequence_variant	5/21		NM_001134367.3:c.211+1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0000379,0.0000379,0.0312761,0.0001516,0.0001516,0.4743726	1,1,825,4,4,12513			1.0	8398.0		7.338	0.309791		0	0	0			SLC6A6	0.0	0.0	0.0	0.03	18.0	9.0	-24.0	-45.0						0.301	0.98				cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];
135803	chr3	14444319	T		chr3:14444319	SLC6A6	solute carrier family 6 member 6	1546.0	deletion	1|1	1.0	0_37	37	99	False	rs67637606,COSV62650056	EXONIC	YES	NM_001134367.3	Transcript	protein_coding	coding_sequence_variant	6/21		NM_001134367.3:c.220+1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0002654,0.0310107,0.4724771	7,818,12463			1.0	8398.0		8.554	0.414607		0	0	0			SLC6A6	0.0	0.0	0.0	0.0	8.0	-1.0	37.0	38.0						0.301	0.98				cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];
135806	chr3	14444327	T		chr3:14444327	SLC6A6	solute carrier family 6 member 6	1546.0	deletion	1|1	1.0	0_37	37	99	False	rs66654032,COSV62651580	SPLICING	YES	NM_001134367.3	Transcript	protein_coding	frameshift_variant,splice_region_variant,splice_polypyrimidine_tract_variant		7/22	NM_001134367.3:c.228del	NP_001127839.2:p.Asp76GlufsTer19		1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0308970,0.1894382	815,4997			1.0	8398.0		9.344	0.4937		0	0	0			SLC6A6	0.0	0.0	0.0	0.0	3.0	-9.0	-42.0	29.0						0.301	0.98				cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];
135812	chr3	14444330	T		chr3:14444330	SLC6A6	solute carrier family 6 member 6	1546.0	deletion	1|1	1.0	0_36	36	99	False	rs67559364,COSV62651585	EXONIC	YES	NM_001134367.3	Transcript	protein_coding	coding_sequence_variant	7/21		NM_001134367.3:c.230-1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0301767,0.0001896,0.0001516,0.0001137,0.1122526	796,5,4,3,2961			1.0	8398.0		8.86	0.444212		0	0	0			SLC6A6	0.0	0.0	0.0	0.0	27.0	49.0	-4.0	26.0						0.301	0.98				cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];
137279	chr9	135144795	G	A	chr9:135144795	SETX	senataxin	1559.0	SNV	0/1	0.5	11_11	22	99	False	rs45490698	EXONIC	YES	NM_001351528.2	Transcript	protein_coding	missense_variant		26/27	NM_001351528.2:c.7369C>T	NP_001338457.1:p.Leu2457Phe		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2, 606002 (3), Autosomal recessive; Amyotrophic lateral sclerosis 4, juvenile, 602433 (3), Autosomal dominant	Amyotrophic lateral sclerosis type 4;Spinocerebellar ataxia with axonal neuropathy type 2	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Elevated serum creatine kinase;Ataxia;Areflexia;Elevated alpha-fetoprotein;Gait imbalance;Hypoalbuminemia;Sensory impairment;Sensorimotor neuropathy;Choreoathetosis;Dystonia;Dysphagia;Postural tremor;Cerebellar vermis atrophy;Strabismus;Oculomotor apraxia;Hypercholesterolemia;Babinski sign;Gaze-evoked nystagmus;Head tremor;Saccadic smooth pursuit;Urinary bladder sphincter dysfunction;Diffuse axonal swelling;Distal muscle weakness;Degeneration of anterior horn cells;Slow progression;Amyotrophic lateral sclerosis;Pallor of dorsal columns of the spinal cord;Abnormal upper motor neuron morphology;Difficulty walking;Clonus;Axonal degeneration;Babinski sign;Peripheral axonal degeneration;Hyperreflexia;Abnormal lower motor neuron morphology;Pes cavus;Autosomal dominant inheritance;Polyneuropathy;Autosomal recessive inheritance;Scoliosis;Saccadic smooth pursuit;Dysphagia;Chronic axonal neuropathy;Dysarthria;Conjunctival telangiectasia;Chorea;Elevated alpha-fetoprotein;Gait ataxia;Variable expressivity;Abnormal pyramidal sign;Limb ataxia;Areflexia;Strabismus;Dystonia;Nystagmus;Impaired distal tactile sensation;Impaired distal vibration sensation;Cerebellar atrophy;Distal amyotrophy;Increased circulating antibody level;Pontocerebellar atrophy;Decreased motor nerve conduction velocity;Progressive gait ataxia;Oculomotor apraxia;Hyporeflexia;Tremor;Head tremor;Progressive;Gaze-evoked nystagmus;Distal muscle weakness;Impaired proprioception;Peripheral axonal neuropathy;Pes cavus;Elevated serum creatine kinase;Pes cavus;Skeletal muscle atrophy;Distal muscle weakness;Babinski sign;Gait disturbance;Sensory impairment;Spastic paraplegia		0.00445426	678.0	152214.0	3.0	33	0.98	PASS	nfe	0.00664296	452.0	0.00664296	452.0	0.00561226	1356.0	241614.0	8.0	34	0.85	PASS	nfe	0.00724489	776.0	0.00724489	776.0	0.0051317	798	0.004	13.0	0.00395	8.0		5.942	0.206854	0.065	1	13	14	FATHMM_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SETX	0.0	0.0	0.03	0.0	28.0	23.0	-5.0	-11.0						0.0245	0.2	0.0	0.146	-0.553	cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; immune system phenotype; reproductive system phenotype; hematopoietic system phenotype; 			testis - seminiferous tubule;testis - interstitial;trigeminal ganglion;superior cervical ganglion;testis;	Neurodegenerative Diseases	MAPK cascade;double-strand break repair;DNA recombination;DNA-templated transcription, termination;termination of RNA polymerase II transcription;mRNA splice site selection;RNA processing;cellular response to DNA damage stimulus;spermatogenesis;circadian rhythm;fibroblast growth factor receptor signaling pathway;positive regulation of neuron projection development;DNA duplex unwinding;positive regulation of RNA splicing;cellular response to oxidative stress;negative regulation of apoptotic process;protein kinase B signaling;cellular response to fibroblast growth factor stimulus;positive regulation of transcription by RNA polymerase II;positive regulation of DNA-templated transcription, termination;cellular response to hydrogen peroxide;cellular response to retinoic acid;positive regulation of DNA-templated transcription, initiation;positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled	nuclear chromosome;chromosome, telomeric region;nucleus;nucleoplasm;nucleolus;cytoplasm;nuclear body;axon;growth cone;intercellular bridge	transcription termination site sequence-specific DNA binding;DNA binding;DNA helicase activity;RNA binding;protein binding;ATP binding;identical protein binding	CHD3[24244371];BRCA1[29656893];CLU[26496610];C14orf178[24244371];SUMO1[24244371];POLR2A[26700805];MYC[21150319];TDG[24244371];EXOSC9[24244371];UBC[24244371];POLR2F[26496610];POLR2G[26496610];SMN1[26700805];TP53BP1[29656893];MEF2A[25609649];PRMT5[26700805];UBE2I[20936779;24244371];APOA1[15174051];CDC5L[20467437];SUPT5H[26496610];TOPORS[24244371];PTBP3[22575643];PIAS1[24244371];HIPK2[24244371];SETX[24244371];TF[15174051];SNW1[20467437];ALB[15174051];UBA2[24244371];CNTROB[26496610];PPIB[30021884];
139486	chr6	160501171	C	T	chr6:160501171	IGF2R	insulin like growth factor 2 receptor	1596.0	SNV	0/1	0.5	18_18	36	99	False	rs143030499	EXONIC	YES	NM_000876.4	Transcript	protein_coding	synonymous_variant		39/48	NM_000876.4:c.5697C>T	NP_000867.3:p.Asp1899%3D		1.0					Hepatocellular carcinoma, somatic, 114550 (3)	.	.	Hepatocellular carcinoma;Micronodular cirrhosis;Somatic mutation;Autosomal dominant inheritance;Subacute progressive viral hepatitis;Heterogeneous		3.94192e-05	6.0	152210.0	0.0	33	0.98	PASS	nfe	8.81912e-05	6.0	8.81912e-05	6.0	3.1856e-05	8.0	251130.0	0.0	51	0.99	PASS	nfe	6.16165e-05	7.0	6.16165e-05	7.0	0.0000322	5						0.002	-1.028927		0	0	0			IGF2R	0.0	0.0	0.0	0.0	-10.0	40.0	-2.0	10.0						0.339	1.0	21.873700008			limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; renal/urinary system phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; endocrine/exocrine gland phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			whole blood;skeletal muscle;	.	liver development;post-Golgi vesicle-mediated transport;receptor-mediated endocytosis;lysosomal transport;signal transduction;G protein-coupled receptor signaling pathway;spermatogenesis;post-embryonic development;animal organ regeneration;response to retinoic acid;positive regulation of apoptotic process;neutrophil degranulation;insulin-like growth factor receptor signaling pathway;membrane organization	nuclear envelope lumen;lysosomal membrane;endosome;early endosome;late endosome;Golgi apparatus;trans-Golgi network;plasma membrane;integral component of plasma membrane;focal adhesion;cell surface;membrane;clathrin coat;transport vesicle;clathrin-coated vesicle;endocytic vesicle;trans-Golgi network transport vesicle;clathrin-coated vesicle membrane;secretory granule membrane;trans-Golgi network membrane;perinuclear region of cytoplasm;extracellular exosome	G-protein alpha-subunit binding;retinoic acid binding;insulin-like growth factor-activated receptor activity;protein binding;insulin-like growth factor binding;mannose binding;enzyme binding;insulin-like growth factor II binding;kringle domain binding;signaling receptor activity;identical protein binding;phosphoprotein binding	RAB5C[26496610];VPS26A[15078903];HSCB[28380382];GGA2[11390366;11387475];EEA1[16977309;29568061];TGOLN2[16977309;29568061];GGA1[11390366;11387475;20676133];GGA3[11387475;16977309];ATXN1[23275563];APOL6[30021884];LAMP1[29568061];USP50[19615732];VPS35[15078903];GTSE1[26496610];RPL19[30021884];HIST1H1C[30021884];VCAM1[22623428];XRCC5[26496610];IGF2[18046459;17850746];FN1[19738201];OCRL[25107275];IGF2R[22681933];TMEM17[26638075];PACS1[16977309];TRAF6[17353931];TMEM216[26638075];CANX[29568061];CHMP4B[26496610];RAB9A[29568061];RAB5A[29568061];BET1[29568061];
140137	chr17	48680475	C	T	chr17:48680475	CACNA1G	calcium voltage-gated channel subunit alpha1 G	1604.0	SNV	0/1	0.44	10_8	18	99	False	rs374849749,COSV61734157	EXONIC	YES	NM_018896.5	Transcript	protein_coding	synonymous_variant		21/38	NM_018896.5:c.4084C>T	NP_061496.2:p.Leu1362%3D		1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	Spinocerebellar ataxia 42, 616795 (3), Autosomal dominant; Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits, 618087 (3), Autosomal dominant	Spinocerebellar ataxia type 42	Disease-causing germline mutation(s) in	Cerebellar atrophy;Resting tremor;Diplopia;Dysarthria;Cerebellar vermis atrophy;Head tremor;Upper limb postural tremor;Depressivity;Alzheimer disease;Spastic gait;Eyelid myokymia;Impaired vibration sensation at ankles;Unsteady gait;Saccadic smooth pursuit;Gait ataxia;Urinary incontinence;Psoriasiform dermatitis;Reduced brain N-acetyl aspartate level by MRS;Hypometric saccades;Neurodevelopmental abnormality;Strabismus;Urinary urgency;Gaze-evoked horizontal nystagmus;Impotence;Babinski sign;Dysphagia;Hyperintensity of cerebral white matter on MRI;Atrophy/Degeneration affecting the brainstem;Vertigo;Scoliosis;Hyperreflexia;Cognitive impairment;Autosomal dominant inheritance;Cerebellar atrophy;Spastic gait;Diplopia;Tremor;Urinary incontinence;Unsteady gait;Eyelid myokymia;Horizontal nystagmus;Urinary urgency;Babinski sign;Loss of Purkinje cells in the cerebellar vermis;Depressivity;Impaired vibration sensation at ankles;Slow progression;Dysphagia;Spastic ataxia;Saccadic smooth pursuit;Dysarthria;Sparse hair;Intellectual disability;Short nose;Dysmetria;Clinodactyly;Autosomal dominant inheritance;Upslanted palpebral fissure;Hypermetropia;Narrow palpebral fissure;Syndactyly;Anteverted ears;Mandibular prognathia;Hirsutism;Strabismus;Microcephaly;Inability to walk;Spasticity;Oculomotor apraxia;Deeply set eye;Cerebellar hypoplasia;Dystonia;Poor head control;Hypertelorism;Hyperreflexia;Global developmental delay;Muscular hypotonia of the trunk		0.00142696	217.0	152072.0	0.0	32	0.95	PASS	nfe	0.00233817	159.0	0.00233817	159.0	0.00151328	377.0	249128.0	0.0	86	1.0	PASS	nfe	0.00241623	273.0	0.00241623	273.0	0.0014276	222	0.001	3.0	0.00272	31.0		11.39	0.729406		0	0	0			CACNA1G	0.06	0.0	0.0	0.0	23.0	-49.0	-25.0	2.0						0.00062	1.0	29.049413061			homeostasis/metabolism phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;cerebellum peduncles;cerebellum;pons;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;thalamus;	MAPK signaling pathway;Calcium signaling pathway;Type II diabetes mellitus	chemical synaptic transmission;response to nickel cation;neuronal action potential;regulation of ion transmembrane transport;regulation of membrane potential;positive regulation of calcium ion-dependent exocytosis;regulation of atrial cardiac muscle cell membrane depolarization;calcium ion import;calcium ion transmembrane transport;cardiac muscle cell action potential involved in contraction;membrane depolarization during action potential;SA node cell action potential;AV node cell action potential;SA node cell to atrial cardiac muscle cell signaling;AV node cell to bundle of His cell signaling;membrane depolarization during AV node cell action potential;membrane depolarization during SA node cell action potential;regulation of heart rate by cardiac conduction	cytoplasm;plasma membrane;voltage-gated calcium channel complex	low voltage-gated calcium channel activity;voltage-gated calcium channel activity involved in AV node cell action potential;voltage-gated calcium channel activity involved SA node cell action potential;scaffold protein binding	MYC[21150319];UBQLN4[16713569];
141652	chr1	150530009	C	T	chr1:150530009	ADAMTSL4	ADAMTS like 4	1624.0	SNV	0/1	0.47	18_16	34	99	False	rs115937511,COSV54996509	EXONIC	YES	NM_001288608.2	Transcript	protein_coding	missense_variant		14/20	NM_001288608.2:c.2156C>T	NP_001275537.1:p.Ser719Leu		1.0	.,.,.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Ectopia_lentis_2,_isolated,_autosomal_recessive|Ectopia_lentis_et_pupillae|not_provided	Ectopia lentis et pupillae, 225200 (3), Autosomal recessive; Ectopia lentis, isolated, autosomal recessive, 225100 (3), Autosomal recessive	Isolated ectopia lentis	Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Ectopia lentis;Cataract;Cognitive impairment;Malar flattening;Amblyopia;Hypertension;Mandibular prognathia;Ectopia lentis;Nystagmus;Joint stiffness;Ectopia pupillae;Autosomal recessive inheritance;Ectopia lentis;Retinal detachment;Cataract;High myopia;Persistent pupillary membrane		0.00278059	423.0	152126.0	2.0	32	0.97	PASS	afr	0.00765109	317.0	0.000720503	49.0	0.00141995	349.0	245784.0	2.0	98	0.83	PASS	afr	0.00963886	150.0	0.00080527	89.0	0.0014726	229	0.004	14.0	0.00596	68.0		28.8	4.126024	0.156	8	11	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	ADAMTSL4	0.0	0.02	0.01	0.0	-3.0	-39.0	-7.0	35.0						0.989	0.0	0.0	0.991	1.026	pigmentation phenotype; vision/eye phenotype; 			ciliary ganglion;tongue;subthalamic nucleus;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;placenta;skeletal muscle;globus pallidus;	.	epithelial cell development;proteolysis;apoptotic process;extracellular matrix organization;positive regulation of apoptotic process	cellular_component;interstitial matrix;endoplasmic reticulum lumen;collagen-containing extracellular matrix	protease binding;protein binding;peptidase activity	MAPKBP1[25416956;unassigned1304];CHIC2[unassigned1304];PID1[25416956];CPNE7[25416956;unassigned1304];SLC23A1[25416956];AQP1[19060904];LCE1A[unassigned1304];LCE1B[25416956;unassigned1304];HOXA1[25416956;unassigned1304];DIP2A[25416956];SMARCC1[25416956;unassigned1304];PRKAB2[unassigned1304];LGALS14[25416956];FRS3[25416956;unassigned1304];LCE1F[unassigned1304];LCE1C[unassigned1304];LCE2B[unassigned1304];LCE2C[unassigned1304];THAP6[unassigned1304];LCE2A[unassigned1304];KRTAP4-12[16189514;25416956];PRR19[unassigned1304];KRTAP4-11[25416956;unassigned1304];BOLA2[unassigned1304];COL8A1[19060904];GNE[25416956;unassigned1304];KRTAP10-11[25416956];GATA2[25416956];SLC6A20[25416956];GMCL2[25416956;unassigned1304];FAM124B[25416956];GUCD1[unassigned1304];PTPMT1[unassigned1304];HOXC8[unassigned1304];HEXIM2[unassigned1304];AMMECR1[25416956;26871637];WDYHV1[unassigned1304];MAGOHB[unassigned1304];NOTCH2NLA[unassigned1304];VASN[unassigned1304];C19orf57[unassigned1304];GNG13[unassigned1304];CYP2S1[21516116;25416956];TRIP6[25416956];RGL2[unassigned1304];QPRT[unassigned1304];PCSK5[unassigned1304];FARS2[25416956];ADAMTSL5[25416956];ADAMTSL4[unassigned1304];DGCR6L[unassigned1304];KRTAP1-5[unassigned1304];KRTAP1-1[unassigned1304];CTSB[16364318];VENTX[unassigned1304];TOP3B[25416956];ApoL6[25416956];TMEM150A[25416956];KRTAP9-4[25416956];KRTAP9-3[unassigned1304];KRTAP9-2[25416956;unassigned1304];JOSD1[unassigned1304];PLSCR1[16189514];SCNM1[unassigned1304];RHOJ[25416956];PLSCR4[unassigned1304];GSTP1[unassigned1304];PTGER3[25416956];LCE2D[25416956;unassigned1304];NTF4[25416956];LCE3C[25416956;unassigned1304];CST2[25416956];LCE3D[unassigned1304];EXOSC5[unassigned1304];LCE3A[unassigned1304];APOL6[unassigned1304];CHRNG[25910212];FLNA[25416956];SUSD6[25416956];ZNF587[25416956];RUNX1T1[unassigned1304];LRRC29[25416956];GLYCTK[unassigned1304];RYDEN[25416956;unassigned1304];FAH[25416956];SORBS3[16189514];LCE3E[25416956;unassigned1304];POU4F2[unassigned1304];LCE4A[25416956;unassigned1304];FKBP1B[25416956];MORN3[25416956];TCEA2[25416956];VWC2[unassigned1304];PKN1[unassigned1304];ZNF330[unassigned1304];KLHL38[unassigned1304];CCER1[unassigned1304];CLEC18A[25416956];CHCHD2[25416956];EFEMP2[unassigned1304];CYSRT1[unassigned1304];SALL2[19060904];STK16[16189514;19060904;unassigned1304];BANF2[unassigned1304];LMO1[25416956];RAB2B[25416956];MYLIP[unassigned1304];SPINK2[25416956];FBXW5[25416956;unassigned1304];LMO4[unassigned1304];HGF[25416956];LMO2[25416956;unassigned1304];FBXO17[unassigned1304];ATG9A[unassigned1304];EPDR1[unassigned1304];MID2[25416956;unassigned1304];KCTD7[unassigned1304];KCTD9[unassigned1304];OLFM3[25416956];ADAM12[unassigned1304];TSSK3[25416956];RPS19BP1[unassigned1304];NATD1[21516116;25416956;unassigned1304];CCDC26[25416956];CHRD[unassigned1304];FBLN1[21988832];SPATA8[25416956];BAG4[unassigned1304];KRTAP4-4[unassigned1304];KRTAP4-2[25416956;unassigned1304];OTX1[21516116;unassigned1304];LONRF1[25416956;unassigned1304];IP6K1[unassigned1304];DSCR8[25416956];TXNDC5[unassigned1304];NEK8[unassigned1304];KRTAP12-3[unassigned1304];VCAM1[22623428];TGFB1[unassigned1304];ZFHX2[unassigned1304];TFAP2D[unassigned1304];CBX3[unassigned1304];ASPSCR1[25416956];CHERP[unassigned1304];LRFN4[unassigned1304];NR4A3[unassigned1304];ALPP[unassigned1304];ZNF417[25416956;unassigned1304];PIN1[25416956];NMUR2[25416956];MKRN3[unassigned1304];ZNF414[unassigned1304];TUBGCP4[19060904];LHX4[26871637];NFKBID[unassigned1304];ITGB4[unassigned1304];ITGB2[unassigned1304];FHL3[16189514];KRTAP5-3[unassigned1304];KRTAP5-2[unassigned1304];KRTAP5-9[25416956;unassigned1304];GLRX3[16189514];KRTAP5-7[unassigned1304];KRTAP5-6[25416956];KRTAP5-4[unassigned1304];KRTAP19-2[unassigned1304];GIP[25416956];POLR1C[unassigned1304];EIF4E2[25416956];CREB5[25416956;unassigned1304];CATSPER1[16189514;unassigned1304];KRTAP21-2[unassigned1304];NUFIP2[unassigned1304];NTN4[16189514];CFAP206[25416956;unassigned1304];RCHY1[25416956];INS[unassigned1304];DNPEP[16189514];POLD1[unassigned1304];SLIT1[unassigned1304];KRTAP6-2[unassigned1304];TRIM42[25416956];SLC13A5[unassigned1304];HSD3B7[unassigned1304];KRTAP10-5[25416956;unassigned1304];USP21[unassigned1304];KRTAP10-9[25416956;unassigned1304];KRTAP10-8[25416956;unassigned1304];HEL-S-182mP[25416956];DLK2[16189514];GOLGA8DP[25416956];ERCC3[unassigned1304];LNX1[unassigned1304];SPRY2[16189514];SPRY1[unassigned1304];R3HDM2[unassigned1304];
142403	chr14	38061859	T	C	chr14:38061859	FOXA1	forkhead box A1	1636.0	SNV	0/1	0.45	18_15	33	99	False	rs753616150	EXONIC	YES	NM_004496.5	Transcript	protein_coding	missense_variant		2/2	NM_004496.5:c.130A>G	NP_004487.2:p.Met44Val		-1.0	Fork-head N-terminal					.	.	.		6.57065e-06	1.0	152192.0	0.0	33	0.98	PASS				0.0	0.0	1.19522e-05	3.0	251000.0	0.0	100	1.0	PASS	amr	8.67303e-05	3.0	0.0	0.0	0.0000064	1			9e-05	1.0		24.8	3.439162	0.273	11	9	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	FOXA1	0.0	0.0	0.0	0.0	34.0	-38.0	1.0	40.0						0.0959		0.0	1.0	1.138	integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; immune system phenotype; digestive/alimentary phenotype; 			.	.	negative regulation of transcription by RNA polymerase II;chromatin remodeling;regulation of transcription by RNA polymerase II;Notch signaling pathway;anatomical structure morphogenesis;negative regulation of epithelial to mesenchymal transition;dorsal/ventral neural tube patterning;cell differentiation;response to estradiol;positive regulation of intracellular estrogen receptor signaling pathway;hormone metabolic process;glucose homeostasis;positive regulation of apoptotic process;positive regulation of neuron differentiation;positive regulation of smoothened signaling pathway;positive regulation of mitotic cell cycle;positive regulation of transcription by RNA polymerase II;anatomical structure formation involved in morphogenesis;neuron fate specification;positive regulation of DNA-binding transcription factor activity;epithelial tube branching involved in lung morphogenesis;lung epithelial cell differentiation;secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development;epithelial-mesenchymal signaling involved in prostate gland development;prostate gland epithelium morphogenesis;prostate gland stromal morphogenesis;epithelial cell maturation involved in prostate gland development;alveolar secondary septum development;dopaminergic neuron differentiation;respiratory basal cell differentiation;positive regulation of cell-cell adhesion mediated by cadherin	fibrillar center;nucleus;nucleoplasm;microvillus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;transcription factor binding;protein domain specific binding;sequence-specific DNA binding;transcription regulatory region DNA binding	FOXA1[25609649];DLX1[25609649];FOXC1[25303530];NFIX[25609649];VARS[25609649];LDB1[25609649];UBA7[25609649];DLX5[25609649];SATB1[25609649];SATB2[25609649];UBP1[25609649];HOXD13[25609649];PLOD2[25609649];GATA3[25303530];LDB2[25609649];SEZ6L2[21988832];NACC1[25609649];NKX2-1[18003659];RCC1[25609649];ALX4[25609649];NKX2-5[25609649];SUMO1P1[unassigned1304];TFAP2A[24835590];MGME1[25609649];TFAP2C[24835590];TBP[19769745];SMAD3[18003659];H2AFY[25609649];GREB1[25303530];RECQL[25609649];HMGA1[25609649];RPA2[25609649];ESR1[25303530];PBX1[25609649];AR[23260764;22722839];CREB1[25609649];HOXB9[25609649];TFAP4[25609649];MSH3[25609649];NFIC[25609649];RARA[25303530];KBTBD7[25609649];FOXA3[25609649];FOXA2[19769745];
142775	chr17	7752284	T	A	chr17:7752284	KDM6B	lysine demethylase 6B	1642.0	SNV	0|1	0.12	14_2	16	42	False		EXONIC	YES	NM_001080424.2	Transcript	protein_coding	missense_variant		11/22	NM_001080424.2:c.2678T>A	NP_001073893.1:p.Met893Lys		1.0	.,.				Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, 618505 (3), Autosomal dominant	.	.	Cryptorchidism;Abnormality of the dentition;Autistic behavior;Wide nasal bridge;Hypoplastic nipples;Exotropia;Hemangioma;Autosomal dominant inheritance;Pectus excavatum;Speech apraxia;Full cheeks;Global developmental delay;Mandibular prognathia;Thick vermilion border;Round face;Seizure;Joint hypermobility;Generalized hypotonia;Dolichocephaly;Wide mouth;Hyperactivity;Macrotia;Depressed nasal bridge;Telecanthus;Cafe-au-lait spot;Esotropia;Hypermelanotic macule;Prominent forehead;Epicanthus;Clinodactyly of the 5th finger		2.04787e-05	3.0	146494.0	0.0	32	0.95	AS_VQSR	sas	0.000238436	1.0	0.0	0.0					17	0.43														7.719	0.340225	0.047	1	18	19	M-CAP_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	KDM6B	0.0	0.0	0.0	0.0	2.0	15.0	46.0	-14.0						0.2	1.0	19.273850792	0.492	-0.678	skeleton phenotype; immune system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; 			pons;ciliary ganglion;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;skin;whole blood;testis;parietal lobe;skeletal muscle;	.	inflammatory response to antigenic stimulus;chromatin remodeling;response to activity;hippocampus development;cell fate commitment;endothelial cell differentiation;positive regulation of transcription by RNA polymerase II;mesodermal cell differentiation;cardiac muscle cell differentiation;oxidation-reduction process;response to fungicide;cellular response to hydrogen peroxide;histone H3-K27 demethylation;positive regulation of cold-induced thermogenesis	nucleus;nucleoplasm;MLL3/4 complex	RNA polymerase II proximal promoter sequence-specific DNA binding;chromatin binding;protein binding;beta-catenin binding;chromatin DNA binding;histone demethylase activity;sequence-specific DNA binding;metal ion binding;dioxygenase activity;histone demethylase activity (H3-K27 specific)	SOX2[22801502];CSNK2B[21900206];TK1[21900206];KLF4[22801502];ESR1[21841772];HIST1H1C[30021884];
143137	chr2	179436481	G	A	chr2:179436481	TTN	titin	1662.0	SNV	0/1	0.38	18_11	29	99	False	rs766741890	EXONIC	YES	NM_001267550.2	Transcript	protein_coding	missense_variant		326/363	NM_001267550.2:c.74378C>T	NP_001254479.2:p.Ser24793Leu		-1.0	.,.,Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype 2&Immunoglobulin subtype,Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype 2&Immunoglobulin subtype,.,Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype 2&Immunoglobulin subtype,Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype 2&Immunoglobulin subtype	Likely_benign	criteria_provided,_single_submitter	not_provided	Muscular dystrophy, limb-girdle, autosomal recessive 10, 608807 (3), Autosomal recessive; Cardiomyopathy, familial hypertrophic, 9, 613765 (3), Autosomal dominant; Tibial muscular dystrophy, tardive, 600334 (3), Autosomal dominant; Salih myopathy, 611705 (3), Autosomal recessive; Cardiomyopathy, dilated, 1G, 604145 (3); Myopathy, myofibrillar, 9, with early respiratory failure, 603689 (3), Autosomal dominant	Autosomal recessive centronuclear myopathy;Familial isolated dilated cardiomyopathy;Hereditary myopathy with early respiratory failure;Autosomal recessive limb-girdle muscular dystrophy type 2J;Classic multiminicore myopathy;Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Early-onset myopathy with fatal cardiomyopathy;Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome;Tibial muscular dystrophy	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Centrally nucleated skeletal muscle fibers;Arrhythmia;Ptosis;Myopathy;Infantile onset;Elevated serum creatine kinase;Congenital onset;Autosomal recessive inheritance;Sudden death;Scoliosis;Calf muscle hypertrophy;Generalized muscle weakness;Facial palsy;Motor delay;Dilated cardiomyopathy;Flexion contracture;Mitochondrial depletion;Elevated serum creatine kinase;Skeletal muscle atrophy;Distal muscle weakness;Elevated serum creatine kinase;Childhood onset;Proximal muscle weakness;Muscular dystrophy;Progressive;Autosomal recessive inheritance;EMG: myopathic abnormalities;Variable expressivity;Tibialis muscle weakness;Internally nucleated skeletal muscle fibers;EMG: myopathic abnormalities;Skeletal muscle atrophy;Elevated serum creatine kinase;Neck flexor weakness;Type 1 muscle fiber predominance;Limited hip movement;Increased variability in muscle fiber diameter;Orthopnea;Rimmed vacuoles;Restrictive ventilatory defect;Falls;Muscle fiber splitting;Reduced vital capacity;Respiratory insufficiency due to muscle weakness;Calf muscle hypertrophy;Foot dorsiflexor weakness;Muscle fiber hypertrophy;Proximal muscle weakness;Necrotizing myopathy;Autosomal dominant inheritance;Adult onset;EMG: myopathic abnormalities;Steppage gait;Slow progression;Incomplete penetrance;Rimmed vacuoles;Muscular dystrophy;Palmoplantar keratoderma;EMG abnormality;Lipoatrophy;Dilated cardiomyopathy;Elevated serum creatine kinase;Abnormality of neutrophils;Sensorineural hearing impairment;Myopathy;Waddling gait;Dysphonia;Talipes equinovarus;Difficulty climbing stairs;Pes cavus;Generalized amyotrophy;Intellectual disability, mild;Motor delay;Narrow mouth;Dysarthria;Scapular winging;Protruding ear;Facial diplegia;Type 1 muscle fiber predominance;Ophthalmoplegia;Areflexia;Bifid uvula;Delayed speech and language development;Respiratory insufficiency;Hyperlordosis;Generalized hypotonia;Difficulty running;Retrognathia;Gowers sign;EMG: decremental response of compound muscle action potential to repetitive nerve stimulation;Long face;Centrally nucleated skeletal muscle fibers;Abnormal heart valve morphology;Left ventricular hypertrophy;Progressive muscle weakness;Long fingers;High palate;Hip contracture;Limited neck flexion;Intermittent episodes of respiratory insufficiency due to muscle weakness;Pes planus;Muscle fiber atrophy;Generalized hypotonia;Poor head control;High palate;Spinal rigidity;Mandibular prognathia;Delayed gross motor development;Right ventricular hypertrophy;Hip dysplasia;Increased muscle lipid content;Right ventricular failure;Congenital muscular dystrophy;Microretrognathia;Multiple joint contractures;Weakness of facial musculature;Scoliosis;Failure to thrive;High pitched voice;Generalized amyotrophy;Nocturnal hypoventilation;Congestive heart failure;Restrictive ventilatory defect;Axial muscle weakness;Short stature;Mitral valve prolapse;Dilated cardiomyopathy;Autosomal dominant inheritance;Hypertrophic cardiomyopathy;Increased variability in muscle fiber diameter;Neck flexor weakness;Frequent falls;Shoulder girdle muscle weakness;Proximal muscle weakness;Variable expressivity;Reduced vital capacity;Elevated serum creatine kinase;Autosomal dominant inheritance;Rimmed vacuoles;Diaphragmatic weakness;Pelvic girdle muscle weakness;Difficulty walking;Foot dorsiflexor weakness;Nocturnal hypoventilation;Adult onset;Respiratory failure;Slow progression;Calf muscle hypertrophy;Muscle fiber splitting;Myofibrillar myopathy;Quadriceps muscle weakness;Rimmed vacuoles;Increased muscle lipid content;Mildly elevated creatine kinase;Ankle weakness;Increased variability in muscle fiber diameter;Foot dorsiflexor weakness;Peroneal muscle atrophy;Steppage gait;Distal upper limb muscle weakness;Centrally nucleated skeletal muscle fibers;EMG: myopathic abnormalities;Clumsiness;Quadriceps muscle weakness;Difficulty walking;Atrioventricular block;Reduced ejection fraction;Atrial fibrillation;Dilated cardiomyopathy;Autosomal dominant inheritance;Ventricular tachycardia;Congestive heart failure;Premature atrial contractions		1.97296e-05	3.0	152056.0	0.0	32	0.97	PASS	amr	6.54965e-05	1.0	1.47098e-05	1.0	3.22523e-05	8.0	248044.0	0.0	95	0.99	PASS	amr	5.80215e-05	2.0	5.35322e-05	6.0	0.0000257	4	0.0	1.0	0.00026	3.0		22.7	2.591483	0.156	5	10	15	M-CAP_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	TTN	0.0	0.0	0.0	0.0	-12.0	49.0	-5.0	-28.0						0.971	0.0	0.0	0.986	0.199	growth/size/body region phenotype; muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype; 			pons;fetal thyroid;thyroid;tongue;trigeminal ganglion;atrioventricular node;superior cervical ganglion;testis;skeletal muscle;globus pallidus;	.	platelet degranulation;cardiac muscle hypertrophy;muscle contraction;striated muscle contraction;mitotic chromosome condensation;positive regulation of gene expression;protein kinase A signaling;peptidyl-tyrosine phosphorylation;muscle filament sliding;skeletal muscle thin filament assembly;skeletal muscle myosin thick filament assembly;detection of muscle stretch;sarcomere organization;regulation of protein kinase activity;cardiac muscle fiber development;sarcomerogenesis;positive regulation of protein secretion;regulation of catalytic activity;response to calcium ion;cardiac myofibril assembly;cardiac muscle tissue morphogenesis;cardiac muscle contraction;striated muscle myosin thick filament assembly	condensed nuclear chromosome;extracellular region;cytosol;striated muscle thin filament;sarcomere;Z disc;M band;I band;extracellular exosome	protease binding;protein serine/threonine kinase activity;protein tyrosine kinase activity;calcium ion binding;protein binding;calmodulin binding;ATP binding;structural constituent of muscle;enzyme binding;protein kinase binding;telethonin binding;identical protein binding;actinin binding;protein self-association;actin filament binding;muscle alpha-actinin binding;structural molecule activity conferring elasticity	ENO1[23414517];ENO3[23414517];AMOT[23414517];IGHG1[15174051];MYC[21150319];HIST1H2AE[30021884];CAPN3[20860623;23414517];SH3GLB1[23414517];ACTN3[23414517];ACTN2[9501083;16902413;23414517;11101506;11846417];HIST1H2AH[30021884];ACTN1[11101506];FNDC3B[23414517];KRT8[30021884];ACTN4[23414517];OBSCN[11448995;20489725;23414517;20133654];SCO1[29568061];PARD3[23414517];CLIP4[23414517];ERP29[30021884];VDAC1[17353931];HIST1H2BH[30021884];OBSL1[20489725;20133654];OPTN[23414517];ASF1B[17353931];SF1[23414517];MYCBP2[23414517];PIK3R4[30021884];GABARAP[23414517];HNRNPDL[30021884];STK38L[30108113];ANKRD28[23414517];SRPK2[23602568];NEK9[23414517];UBE2I[23414517];SMURF2[18157088];FN1[23414517];HMGA1[30021884];NEB[16902413;12482578];H2BFS[30021884];ESR1[25604459];ESR2[25604459];CCT6A[23414517];HNRNPF[30021884];ALB[15174051];CALU[30021884];TAB2[23414517];STT3B[30021884];CALM1[7607248];HNRNPA1L2[30021884];RYR1[23414517];MYOM1[23414517];SYNM[25447537];DYRK2[23602568];ITGB5[23414517];MAST2[23414517];FHL1[23414517];DYSF[23414517];HSPB2[26465331];MED19[15175163];ARRB1[17620599];ASH2L[23414517];PYGM[23414517];CHD4[23414517];C1QTNF9[23414517];KRI1[30021884];JPH1[23414517];MYOM2[23414517];HK1[29568061];MAP1LC3B[20562859];MED10[15175163];ANKRD1[23414517];PHGDH[23414517];NEO1[23414517];SGCG[23414517];HIST1H1B[30021884];HIST1H1C[30021884];SUN2[22555292];DFFA[17353931];MYBPC1[23414517];TRIM63[18157088;23414517];MYBPC2[23414517];DDX56[17353931];MED26[15175163];YWHAZ[20618440];HIST2H2BF[30021884];MED29[15175163];HIST2H2BE[30021884];VAV2[18654987;23414517];ACTA2[9501083];RNF167[23414517];PKM[24606918];ITGB1BP2[23414517];RPL12[23414517];POMP[23414517];FSTL1[20860622];TTN[9804419;23414517;16407954;16962974];ABLIM1[23414517];ABLIM2[23414517];EXOSC10[23414517];UGP2[23414517];ATP5F1B[30021884];PUF60[17353931];DNAJB6[23414517];DNAJB5[23414517];FLNA[16902413];EBLN1[30021884];NPM1[30021884];MCRS1[17353931];MYBPH[23414517];HSPE1[30021884];ATP5F1D[23414517];KTN1[30021884];RSL1D1[30021884];TTC3[23414517];HNRNPA2B1[30021884];TCAP[16962094;23414517;15582318;11846417;16407954;19622741];TARDBP[30021884];LIMS1[23414517];HSPA1A[23414517];
143143	chr2	179440297	G	C	chr2:179440297	TTN	titin	1662.0	SNV	0/1	0.66	10_19	29	99	False	rs775589244	EXONIC	YES	NM_001267550.2	Transcript	protein_coding	missense_variant		326/363	NM_001267550.2:c.70562C>G	NP_001254479.2:p.Thr23521Arg		-1.0	.,.,Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III,.,Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III	Likely_benign	criteria_provided,_single_submitter	not_provided	Muscular dystrophy, limb-girdle, autosomal recessive 10, 608807 (3), Autosomal recessive; Cardiomyopathy, familial hypertrophic, 9, 613765 (3), Autosomal dominant; Tibial muscular dystrophy, tardive, 600334 (3), Autosomal dominant; Salih myopathy, 611705 (3), Autosomal recessive; Cardiomyopathy, dilated, 1G, 604145 (3); Myopathy, myofibrillar, 9, with early respiratory failure, 603689 (3), Autosomal dominant	Autosomal recessive centronuclear myopathy;Familial isolated dilated cardiomyopathy;Hereditary myopathy with early respiratory failure;Autosomal recessive limb-girdle muscular dystrophy type 2J;Classic multiminicore myopathy;Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Early-onset myopathy with fatal cardiomyopathy;Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome;Tibial muscular dystrophy	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Centrally nucleated skeletal muscle fibers;Arrhythmia;Ptosis;Myopathy;Infantile onset;Elevated serum creatine kinase;Congenital onset;Autosomal recessive inheritance;Sudden death;Scoliosis;Calf muscle hypertrophy;Generalized muscle weakness;Facial palsy;Motor delay;Dilated cardiomyopathy;Flexion contracture;Mitochondrial depletion;Elevated serum creatine kinase;Skeletal muscle atrophy;Distal muscle weakness;Elevated serum creatine kinase;Childhood onset;Proximal muscle weakness;Muscular dystrophy;Progressive;Autosomal recessive inheritance;EMG: myopathic abnormalities;Variable expressivity;Tibialis muscle weakness;Internally nucleated skeletal muscle fibers;EMG: myopathic abnormalities;Skeletal muscle atrophy;Elevated serum creatine kinase;Neck flexor weakness;Type 1 muscle fiber predominance;Limited hip movement;Increased variability in muscle fiber diameter;Orthopnea;Rimmed vacuoles;Restrictive ventilatory defect;Falls;Muscle fiber splitting;Reduced vital capacity;Respiratory insufficiency due to muscle weakness;Calf muscle hypertrophy;Foot dorsiflexor weakness;Muscle fiber hypertrophy;Proximal muscle weakness;Necrotizing myopathy;Autosomal dominant inheritance;Adult onset;EMG: myopathic abnormalities;Steppage gait;Slow progression;Incomplete penetrance;Rimmed vacuoles;Muscular dystrophy;Palmoplantar keratoderma;EMG abnormality;Lipoatrophy;Dilated cardiomyopathy;Elevated serum creatine kinase;Abnormality of neutrophils;Sensorineural hearing impairment;Myopathy;Waddling gait;Dysphonia;Talipes equinovarus;Difficulty climbing stairs;Pes cavus;Generalized amyotrophy;Intellectual disability, mild;Motor delay;Narrow mouth;Dysarthria;Scapular winging;Protruding ear;Facial diplegia;Type 1 muscle fiber predominance;Ophthalmoplegia;Areflexia;Bifid uvula;Delayed speech and language development;Respiratory insufficiency;Hyperlordosis;Generalized hypotonia;Difficulty running;Retrognathia;Gowers sign;EMG: decremental response of compound muscle action potential to repetitive nerve stimulation;Long face;Centrally nucleated skeletal muscle fibers;Abnormal heart valve morphology;Left ventricular hypertrophy;Progressive muscle weakness;Long fingers;High palate;Hip contracture;Limited neck flexion;Intermittent episodes of respiratory insufficiency due to muscle weakness;Pes planus;Muscle fiber atrophy;Generalized hypotonia;Poor head control;High palate;Spinal rigidity;Mandibular prognathia;Delayed gross motor development;Right ventricular hypertrophy;Hip dysplasia;Increased muscle lipid content;Right ventricular failure;Congenital muscular dystrophy;Microretrognathia;Multiple joint contractures;Weakness of facial musculature;Scoliosis;Failure to thrive;High pitched voice;Generalized amyotrophy;Nocturnal hypoventilation;Congestive heart failure;Restrictive ventilatory defect;Axial muscle weakness;Short stature;Mitral valve prolapse;Dilated cardiomyopathy;Autosomal dominant inheritance;Hypertrophic cardiomyopathy;Increased variability in muscle fiber diameter;Neck flexor weakness;Frequent falls;Shoulder girdle muscle weakness;Proximal muscle weakness;Variable expressivity;Reduced vital capacity;Elevated serum creatine kinase;Autosomal dominant inheritance;Rimmed vacuoles;Diaphragmatic weakness;Pelvic girdle muscle weakness;Difficulty walking;Foot dorsiflexor weakness;Nocturnal hypoventilation;Adult onset;Respiratory failure;Slow progression;Calf muscle hypertrophy;Muscle fiber splitting;Myofibrillar myopathy;Quadriceps muscle weakness;Rimmed vacuoles;Increased muscle lipid content;Mildly elevated creatine kinase;Ankle weakness;Increased variability in muscle fiber diameter;Foot dorsiflexor weakness;Peroneal muscle atrophy;Steppage gait;Distal upper limb muscle weakness;Centrally nucleated skeletal muscle fibers;EMG: myopathic abnormalities;Clumsiness;Quadriceps muscle weakness;Difficulty walking;Atrioventricular block;Reduced ejection fraction;Atrial fibrillation;Dilated cardiomyopathy;Autosomal dominant inheritance;Ventricular tachycardia;Congestive heart failure;Premature atrial contractions		1.31539e-05	2.0	152046.0	0.0	32	0.97	PASS	amr	6.5548e-05	1.0	1.47072e-05	1.0	3.21877e-05	8.0	248542.0	0.0	100	1.0	PASS	amr	5.79441e-05	2.0	5.33931e-05	6.0	0.0000257	4	0.0	1.0	0.00026	3.0		16.22	1.492079	0.117	2	13	15	PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	TTN	0.0	0.0	0.0	0.0	38.0	-3.0	38.0	10.0						0.971	0.0	0.0	0.708	0.225	growth/size/body region phenotype; muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype; 			pons;fetal thyroid;thyroid;tongue;trigeminal ganglion;atrioventricular node;superior cervical ganglion;testis;skeletal muscle;globus pallidus;	.	platelet degranulation;cardiac muscle hypertrophy;muscle contraction;striated muscle contraction;mitotic chromosome condensation;positive regulation of gene expression;protein kinase A signaling;peptidyl-tyrosine phosphorylation;muscle filament sliding;skeletal muscle thin filament assembly;skeletal muscle myosin thick filament assembly;detection of muscle stretch;sarcomere organization;regulation of protein kinase activity;cardiac muscle fiber development;sarcomerogenesis;positive regulation of protein secretion;regulation of catalytic activity;response to calcium ion;cardiac myofibril assembly;cardiac muscle tissue morphogenesis;cardiac muscle contraction;striated muscle myosin thick filament assembly	condensed nuclear chromosome;extracellular region;cytosol;striated muscle thin filament;sarcomere;Z disc;M band;I band;extracellular exosome	protease binding;protein serine/threonine kinase activity;protein tyrosine kinase activity;calcium ion binding;protein binding;calmodulin binding;ATP binding;structural constituent of muscle;enzyme binding;protein kinase binding;telethonin binding;identical protein binding;actinin binding;protein self-association;actin filament binding;muscle alpha-actinin binding;structural molecule activity conferring elasticity	ENO1[23414517];ENO3[23414517];AMOT[23414517];IGHG1[15174051];MYC[21150319];HIST1H2AE[30021884];CAPN3[20860623;23414517];SH3GLB1[23414517];ACTN3[23414517];ACTN2[9501083;16902413;23414517;11101506;11846417];HIST1H2AH[30021884];ACTN1[11101506];FNDC3B[23414517];KRT8[30021884];ACTN4[23414517];OBSCN[11448995;20489725;23414517;20133654];SCO1[29568061];PARD3[23414517];CLIP4[23414517];ERP29[30021884];VDAC1[17353931];HIST1H2BH[30021884];OBSL1[20489725;20133654];OPTN[23414517];ASF1B[17353931];SF1[23414517];MYCBP2[23414517];PIK3R4[30021884];GABARAP[23414517];HNRNPDL[30021884];STK38L[30108113];ANKRD28[23414517];SRPK2[23602568];NEK9[23414517];UBE2I[23414517];SMURF2[18157088];FN1[23414517];HMGA1[30021884];NEB[16902413;12482578];H2BFS[30021884];ESR1[25604459];ESR2[25604459];CCT6A[23414517];HNRNPF[30021884];ALB[15174051];CALU[30021884];TAB2[23414517];STT3B[30021884];CALM1[7607248];HNRNPA1L2[30021884];RYR1[23414517];MYOM1[23414517];SYNM[25447537];DYRK2[23602568];ITGB5[23414517];MAST2[23414517];FHL1[23414517];DYSF[23414517];HSPB2[26465331];MED19[15175163];ARRB1[17620599];ASH2L[23414517];PYGM[23414517];CHD4[23414517];C1QTNF9[23414517];KRI1[30021884];JPH1[23414517];MYOM2[23414517];HK1[29568061];MAP1LC3B[20562859];MED10[15175163];ANKRD1[23414517];PHGDH[23414517];NEO1[23414517];SGCG[23414517];HIST1H1B[30021884];HIST1H1C[30021884];SUN2[22555292];DFFA[17353931];MYBPC1[23414517];TRIM63[18157088;23414517];MYBPC2[23414517];DDX56[17353931];MED26[15175163];YWHAZ[20618440];HIST2H2BF[30021884];MED29[15175163];HIST2H2BE[30021884];VAV2[18654987;23414517];ACTA2[9501083];RNF167[23414517];PKM[24606918];ITGB1BP2[23414517];RPL12[23414517];POMP[23414517];FSTL1[20860622];TTN[9804419;23414517;16407954;16962974];ABLIM1[23414517];ABLIM2[23414517];EXOSC10[23414517];UGP2[23414517];ATP5F1B[30021884];PUF60[17353931];DNAJB6[23414517];DNAJB5[23414517];FLNA[16902413];EBLN1[30021884];NPM1[30021884];MCRS1[17353931];MYBPH[23414517];HSPE1[30021884];ATP5F1D[23414517];KTN1[30021884];RSL1D1[30021884];TTC3[23414517];HNRNPA2B1[30021884];TCAP[16962094;23414517;15582318;11846417;16407954;19622741];TARDBP[30021884];LIMS1[23414517];HSPA1A[23414517];
143793	chr15	75981185	C	T	chr15:75981185	CSPG4	chondroitin sulfate proteoglycan 4	1675.0	SNV	0/1	0.48	17_16	33	99	False	rs146067513	EXONIC	YES	NM_001897.5	Transcript	protein_coding	missense_variant		3/10	NM_001897.5:c.2221G>A	NP_001888.2:p.Val741Met		-1.0						.	.	.		0.00106415	162.0	152234.0	0.0	33	0.98	PASS	amr	0.0016357	25.0	0.00139648	95.0	0.00106484	266.0	249802.0	0.0	64	0.99	PASS	nfe	0.00113788	128.0	0.00113788	128.0	0.0008874	138	0.003	8.0				20.8	2.116741	0.265	2	18	20	SIFT,MutationAssessor_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CSPG4	0.0	0.0	0.0	0.0	-27.0	6.0	-4.0	1.0						0.654	0.0		0.814	0.933	hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; liver/biliary system phenotype; hematopoietic system phenotype; normal phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	.	activation of MAPK activity;angiogenesis;transmembrane receptor protein tyrosine kinase signaling pathway;cell population proliferation;glial cell migration;chondroitin sulfate biosynthetic process;chondroitin sulfate catabolic process;dermatan sulfate biosynthetic process;intracellular signal transduction;tissue remodeling;positive regulation of peptidyl-tyrosine phosphorylation	extracellular region;Golgi lumen;integral component of plasma membrane;focal adhesion;cell surface;apical plasma membrane;lamellipodium membrane;lysosomal lumen;collagen-containing extracellular matrix;extracellular exosome	protein kinase binding	ATF7IP[15231748];LAMP1[29568061];SORT1[26496610];NEDD9[22984505];ZNF644[26496610];
145709	chr2	182387000	G	T	chr2:182387000	ITGA4	integrin subunit alpha 4	1694.0	SNV	0|1	0.14	12_2	14	47	False		EXONIC	YES	NM_000885.6	Transcript	protein_coding	missense_variant		18/28	NM_000885.6:c.2005G>T	NP_000876.3:p.Asp669Tyr		1.0	Integrin alpha-2					.	.	.						32	0.96											50	0.89														29.4	4.188448	0.904	16	5	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred	ITGA4	0.0	0.0	0.0	0.0	3.0	-2.0	-48.0	35.0						0.697	0.03	54.486023489	0.983	1.176	cellular phenotype; craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; embryo phenotype; immune system phenotype; 			ciliary ganglion;subthalamic nucleus;superior cervical ganglion;atrioventricular node;whole blood;fetal liver;skeletal muscle;globus pallidus;	Focal adhesion;ECM-receptor interaction;Cell adhesion molecules (CAMs);Hematopoietic cell lineage;Leukocyte transendothelial migration;Regulation of actin cytoskeleton	cell-matrix adhesion involved in ameboidal cell migration;leukocyte cell-cell adhesion;cell-matrix adhesion;integrin-mediated signaling pathway;B cell differentiation;extracellular matrix organization;heterotypic cell-cell adhesion;substrate adhesion-dependent cell spreading;endodermal cell differentiation;receptor clustering;regulation of immune response;leukocyte migration;leukocyte tethering or rolling;diapedesis;axonogenesis involved in innervation;cellular response to cytokine stimulus;negative regulation of protein homodimerization activity;positive regulation of leukocyte tethering or rolling;positive regulation of vascular endothelial cell proliferation;neuron projection extension;clathrin-dependent extracellular exosome endocytosis;positive regulation of endothelial cell apoptotic process;positive regulation of T cell migration	plasma membrane;focal adhesion;cell surface;membrane;growth cone;integrin alpha4-beta7 complex;neuronal cell body;extracellular exosome	fibronectin binding;protein binding;coreceptor activity;C-X3-C chemokine binding;metal ion binding;cell adhesion molecule binding;protein antigen binding	ITGB1[14681217;20159608;10604475;1542691];LYN[20159608];CX3CR1[23125415];VCAM1[22623428;19738201];ITGA4[14681217];TGFB1I1[10604475];PXN[10604475;21173240];FN1[19738201;24789099];CX3CL1[23125415];ABI1[21173240];LPXN[10604475];FLNA[10604475];ITGB7[14681217;1542691;22232704];MADCAM1[22232704];CD44[21257905];
145710	chr2	182387001	A	T	chr2:182387001	ITGA4	integrin subunit alpha 4	1694.0	SNV	0|1	0.14	12_2	14	47	False		EXONIC	YES	NM_000885.6	Transcript	protein_coding	missense_variant		18/28	NM_000885.6:c.2006A>T	NP_000876.3:p.Asp669Val		1.0	Integrin alpha-2					.	.	.						32	0.96											50	0.9														27.9	4.019337	0.908	16	5	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred	ITGA4	0.0	0.0	0.0	0.0	21.0	-3.0	-49.0	34.0						0.697	0.03	54.486023489	0.953	1.312	cellular phenotype; craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; embryo phenotype; immune system phenotype; 			ciliary ganglion;subthalamic nucleus;superior cervical ganglion;atrioventricular node;whole blood;fetal liver;skeletal muscle;globus pallidus;	Focal adhesion;ECM-receptor interaction;Cell adhesion molecules (CAMs);Hematopoietic cell lineage;Leukocyte transendothelial migration;Regulation of actin cytoskeleton	cell-matrix adhesion involved in ameboidal cell migration;leukocyte cell-cell adhesion;cell-matrix adhesion;integrin-mediated signaling pathway;B cell differentiation;extracellular matrix organization;heterotypic cell-cell adhesion;substrate adhesion-dependent cell spreading;endodermal cell differentiation;receptor clustering;regulation of immune response;leukocyte migration;leukocyte tethering or rolling;diapedesis;axonogenesis involved in innervation;cellular response to cytokine stimulus;negative regulation of protein homodimerization activity;positive regulation of leukocyte tethering or rolling;positive regulation of vascular endothelial cell proliferation;neuron projection extension;clathrin-dependent extracellular exosome endocytosis;positive regulation of endothelial cell apoptotic process;positive regulation of T cell migration	plasma membrane;focal adhesion;cell surface;membrane;growth cone;integrin alpha4-beta7 complex;neuronal cell body;extracellular exosome	fibronectin binding;protein binding;coreceptor activity;C-X3-C chemokine binding;metal ion binding;cell adhesion molecule binding;protein antigen binding	ITGB1[14681217;20159608;10604475;1542691];LYN[20159608];CX3CR1[23125415];VCAM1[22623428;19738201];ITGA4[14681217];TGFB1I1[10604475];PXN[10604475;21173240];FN1[19738201;24789099];CX3CL1[23125415];ABI1[21173240];LPXN[10604475];FLNA[10604475];ITGB7[14681217;1542691;22232704];MADCAM1[22232704];CD44[21257905];
145711	chr2	182387004	C	A	chr2:182387004	ITGA4	integrin subunit alpha 4	1694.0	SNV	0|1	0.14	12_2	14	47	False		EXONIC	YES	NM_000885.6	Transcript	protein_coding	missense_variant		18/28	NM_000885.6:c.2009C>A	NP_000876.3:p.Ala670Glu		1.0	Integrin alpha-2					.	.	.		0.0	0.0	149182.0	0.0	32	0.96	AC0_AS_VQSR				0.0	0.0					50	0.89														26.0	3.757024	0.78	18	3	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,PrimateAI_pred,DEOGEN2_pred	ITGA4	0.0	0.0	0.0	0.0	-6.0	18.0	31.0	-6.0						0.697	0.03	54.486023489	0.719	1.026	cellular phenotype; craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; embryo phenotype; immune system phenotype; 			ciliary ganglion;subthalamic nucleus;superior cervical ganglion;atrioventricular node;whole blood;fetal liver;skeletal muscle;globus pallidus;	Focal adhesion;ECM-receptor interaction;Cell adhesion molecules (CAMs);Hematopoietic cell lineage;Leukocyte transendothelial migration;Regulation of actin cytoskeleton	cell-matrix adhesion involved in ameboidal cell migration;leukocyte cell-cell adhesion;cell-matrix adhesion;integrin-mediated signaling pathway;B cell differentiation;extracellular matrix organization;heterotypic cell-cell adhesion;substrate adhesion-dependent cell spreading;endodermal cell differentiation;receptor clustering;regulation of immune response;leukocyte migration;leukocyte tethering or rolling;diapedesis;axonogenesis involved in innervation;cellular response to cytokine stimulus;negative regulation of protein homodimerization activity;positive regulation of leukocyte tethering or rolling;positive regulation of vascular endothelial cell proliferation;neuron projection extension;clathrin-dependent extracellular exosome endocytosis;positive regulation of endothelial cell apoptotic process;positive regulation of T cell migration	plasma membrane;focal adhesion;cell surface;membrane;growth cone;integrin alpha4-beta7 complex;neuronal cell body;extracellular exosome	fibronectin binding;protein binding;coreceptor activity;C-X3-C chemokine binding;metal ion binding;cell adhesion molecule binding;protein antigen binding	ITGB1[14681217;20159608;10604475;1542691];LYN[20159608];CX3CR1[23125415];VCAM1[22623428;19738201];ITGA4[14681217];TGFB1I1[10604475];PXN[10604475;21173240];FN1[19738201;24789099];CX3CL1[23125415];ABI1[21173240];LPXN[10604475];FLNA[10604475];ITGB7[14681217;1542691;22232704];MADCAM1[22232704];CD44[21257905];
145712	chr2	182387007	A	T	chr2:182387007	ITGA4	integrin subunit alpha 4	1694.0	SNV	0|1	0.14	12_2	14	47	False		EXONIC	YES	NM_000885.6	Transcript	protein_coding	missense_variant		18/28	NM_000885.6:c.2012A>T	NP_000876.3:p.Tyr671Phe		1.0	Integrin alpha-2					.	.	.						32	0.96											50	0.88														15.23	1.307861	0.073	3	16	19	MutationTaster_pred,MetaRNN_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	ITGA4	0.0	0.0	0.0	0.0	50.0	0.0	28.0	-3.0						0.697	0.03	0.0	0.449	1.312	cellular phenotype; craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; embryo phenotype; immune system phenotype; 			ciliary ganglion;subthalamic nucleus;superior cervical ganglion;atrioventricular node;whole blood;fetal liver;skeletal muscle;globus pallidus;	Focal adhesion;ECM-receptor interaction;Cell adhesion molecules (CAMs);Hematopoietic cell lineage;Leukocyte transendothelial migration;Regulation of actin cytoskeleton	cell-matrix adhesion involved in ameboidal cell migration;leukocyte cell-cell adhesion;cell-matrix adhesion;integrin-mediated signaling pathway;B cell differentiation;extracellular matrix organization;heterotypic cell-cell adhesion;substrate adhesion-dependent cell spreading;endodermal cell differentiation;receptor clustering;regulation of immune response;leukocyte migration;leukocyte tethering or rolling;diapedesis;axonogenesis involved in innervation;cellular response to cytokine stimulus;negative regulation of protein homodimerization activity;positive regulation of leukocyte tethering or rolling;positive regulation of vascular endothelial cell proliferation;neuron projection extension;clathrin-dependent extracellular exosome endocytosis;positive regulation of endothelial cell apoptotic process;positive regulation of T cell migration	plasma membrane;focal adhesion;cell surface;membrane;growth cone;integrin alpha4-beta7 complex;neuronal cell body;extracellular exosome	fibronectin binding;protein binding;coreceptor activity;C-X3-C chemokine binding;metal ion binding;cell adhesion molecule binding;protein antigen binding	ITGB1[14681217;20159608;10604475;1542691];LYN[20159608];CX3CR1[23125415];VCAM1[22623428;19738201];ITGA4[14681217];TGFB1I1[10604475];PXN[10604475;21173240];FN1[19738201;24789099];CX3CL1[23125415];ABI1[21173240];LPXN[10604475];FLNA[10604475];ITGB7[14681217;1542691;22232704];MADCAM1[22232704];CD44[21257905];
145713	chr2	182387009	G	T	chr2:182387009	ITGA4	integrin subunit alpha 4	1694.0	SNV	0|1	0.14	12_2	14	47	False		EXONIC	YES	NM_000885.6	Transcript	protein_coding	stop_gained		18/28	NM_000885.6:c.2014G>T	NP_000876.3:p.Glu672Ter		1.0	Integrin alpha-2					.	.	.						32	0.96											50	0.87														37.0	7.231188		5	2	7	MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred,fathmm-MKL_coding_pred	LRT_pred,fathmm-XF_coding_pred	ITGA4	0.0	0.0	0.0	0.0	48.0	-11.0	26.0	-17.0						0.697	0.03	22.908947238	0.365	1.176	cellular phenotype; craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; embryo phenotype; immune system phenotype; 			ciliary ganglion;subthalamic nucleus;superior cervical ganglion;atrioventricular node;whole blood;fetal liver;skeletal muscle;globus pallidus;	Focal adhesion;ECM-receptor interaction;Cell adhesion molecules (CAMs);Hematopoietic cell lineage;Leukocyte transendothelial migration;Regulation of actin cytoskeleton	cell-matrix adhesion involved in ameboidal cell migration;leukocyte cell-cell adhesion;cell-matrix adhesion;integrin-mediated signaling pathway;B cell differentiation;extracellular matrix organization;heterotypic cell-cell adhesion;substrate adhesion-dependent cell spreading;endodermal cell differentiation;receptor clustering;regulation of immune response;leukocyte migration;leukocyte tethering or rolling;diapedesis;axonogenesis involved in innervation;cellular response to cytokine stimulus;negative regulation of protein homodimerization activity;positive regulation of leukocyte tethering or rolling;positive regulation of vascular endothelial cell proliferation;neuron projection extension;clathrin-dependent extracellular exosome endocytosis;positive regulation of endothelial cell apoptotic process;positive regulation of T cell migration	plasma membrane;focal adhesion;cell surface;membrane;growth cone;integrin alpha4-beta7 complex;neuronal cell body;extracellular exosome	fibronectin binding;protein binding;coreceptor activity;C-X3-C chemokine binding;metal ion binding;cell adhesion molecule binding;protein antigen binding	ITGB1[14681217;20159608;10604475;1542691];LYN[20159608];CX3CR1[23125415];VCAM1[22623428;19738201];ITGA4[14681217];TGFB1I1[10604475];PXN[10604475;21173240];FN1[19738201;24789099];CX3CL1[23125415];ABI1[21173240];LPXN[10604475];FLNA[10604475];ITGB7[14681217;1542691;22232704];MADCAM1[22232704];CD44[21257905];
146219	chr9	18905795	A	G	chr9:18905795	ADAMTSL1	ADAMTS like 1	1703.0	SNV	0/1	0.52	13_14	27	99	False	rs149316235	EXONIC	YES	NM_001040272.6	Transcript	protein_coding	missense_variant		27/29	NM_001040272.6:c.4867A>G	NP_001035362.3:p.Ile1623Val		1.0	.,.					Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome	Disease-causing germline mutation(s) in	Bilateral sensorineural hearing impairment;Delayed myelination;Prominent metopic ridge;Vertebrobasilar dolichoectasia;Microcephaly;Nephrolithiasis;Migraine;Thyroid hypoplasia;Congenital hypothyroidism;Short philtrum;Tapered finger;Primary congenital glaucoma;Mandibular prognathia;Tented upper lip vermilion;Delayed eruption of permanent teeth;Buphthalmos;Brachycephaly;Rieger anomaly;Macrotia;Square face;Wide nasal bridge;Myopia;Abnormality of the palmar creases;Retinal detachment;Calcaneovalgus deformity		0.00373193	568.0	152200.0	0.0	32	0.97	PASS	amr	0.00549522	84.0	0.00408655	278.0	0.00339292	842.0	248164.0	3.0	48	0.89	PASS	nfe	0.00373956	421.0	0.00373956	421.0	0.0030031	467	0.006	20.0				16.63	1.562017	0.026	1	17	18	fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	ADAMTSL1	0.0	0.0	0.0	0.0	-15.0	-37.0	-1.0	-42.0						0.673	0.0	0.0	1.0	1.308	.			ciliary ganglion;pons;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;	.	proteolysis	extracellular region;endoplasmic reticulum lumen	peptidase activity	.
148868	chr9	6553445	C	T	chr9:6553445	GLDC	glycine decarboxylase	1722.0	SNV	0/1	0.52	15_16	31	99	False	rs141933811,COSV58686335	EXONIC	YES	NM_000170.3	Transcript	protein_coding	missense_variant		20/25	NM_000170.3:c.2380G>A	NP_000161.2:p.Ala794Thr		-1.0	.,.,.,.	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Non-ketotic_hyperglycinemia|not_specified|not_provided	Glycine encephalopathy, 605899 (3), Autosomal recessive	Atypical glycine encephalopathy;Neonatal glycine encephalopathy;Infantile glycine encephalopathy	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Agenesis of corpus callosum;Hyperglycinemia;Hyporeflexia;Muscular hypotonia;Myoclonus;Aggressive behavior;Lethargy;Intellectual disability;Seizure;Generalized hypotonia;Hyperactivity;Hyperreflexia;Restlessness;Recurrent singultus;Death in infancy;Irritability;Encephalopathy;Impulsivity;Autosomal recessive inheritance;Hyperglycinuria	25741868	0.0071253	1084.0	152134.0	8.0	32	0.95	PASS	amr	0.0097011	148.0	0.00956875	651.0	0.00693113	1743.0	251474.0	6.0	100	1.0	PASS	nfe	0.00903657	1028.0	0.00903657	1028.0	0.0066751	1038	0.018	60.0	0.01526	174.0		2.301	-0.022265	0.129	2	16	18	MetaLR_pred,FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GLDC	0.0	0.0	0.0	0.0	17.0	12.0	-17.0	-21.0						0.0943	0.0	0.0	0.0	-2.819	renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; 			.	Glycine, serine and threonine metabolism	glycine catabolic process;glycine decarboxylation via glycine cleavage system;electron transport chain;response to methylamine;response to lipoic acid;cellular response to leukemia inhibitory factor	nucleus;mitochondrion;mitochondrial matrix;plasma membrane;glycine cleavage complex	glycine dehydrogenase (decarboxylating) activity;electron transfer activity;glycine binding;lyase activity;enzyme binding;pyridoxal phosphate binding;protein homodimerization activity;pyridoxal binding	JUN[25609649];TNIP3[19615732];ULK2[20562859];MRPL58[20186120];HSCB[28380382];PLEKHA7[28877994];
149664	chr20	8696935	G	A	chr20:8696935	PLCB1	phospholipase C beta 1	1733.0	SNV	0/1	0.75	5_15	20	84	False	rs143366963,COSV100569327,COSV62050515	EXONIC	YES	NM_015192.4	Transcript	protein_coding	synonymous_variant		13/32	NM_015192.4:c.1275G>A	NP_056007.1:p.Ala425%3D		1.0		Likely_benign	criteria_provided,_single_submitter	Early_infantile_epileptic_encephalopathy_12	Developmental and epileptic encephalopathy 12, 613722 (3), Autosomal recessive	West syndrome;Malignant migrating partial seizures of infancy	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Myoclonus;Infantile spasms;Developmental regression;Hypsarrhythmia;Abnormality of skin morphology;Hyperreflexia;Muscular hypotonia of the trunk;Autosomal recessive inheritance;Hypsarrhythmia;Spasticity;Generalized-onset seizure;Focal-onset seizure;Epileptic encephalopathy		6.57108e-05	10.0	152182.0	0.0	33	0.97	PASS	nfe	0.000117578	8.0	0.000117578	8.0	7.96033e-05	20.0	251246.0	0.0	55	1.0	PASS	nfe	0.000149672	17.0	0.000149672	17.0	0.0000836	13	0.0	1.0	9e-05	1.0		7.432	0.317151		0	0	0			PLCB1	0.0	0.05	0.0	0.0	2.0	-24.0	2.0	-14.0						0.581	0.98	80.676806861			craniofacial phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			caudate nucleus;temporal lobe;amygdala;prefrontal cortex;superior cervical ganglion;cingulate cortex;trigeminal ganglion;pons;occipital lobe;subthalamic nucleus;whole brain;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	Inositol phosphate metabolism;Calcium signaling pathway;Phosphatidylinositol signaling system;Wnt signaling pathway;Gap junction;Long-term potentiation;Long-term depression;GnRH signaling pathway;Melanogenesis	G2/M transition of mitotic cell cycle;signal transduction;G protein-coupled receptor signaling pathway;G protein-coupled acetylcholine receptor signaling pathway;glutamate receptor signaling pathway;Wnt signaling pathway, calcium modulating pathway;memory;regulation of G protein-coupled receptor signaling pathway;lipid catabolic process;cerebral cortex development;positive regulation of interleukin-12 production;inositol trisphosphate biosynthetic process;intracellular signal transduction;interleukin-12-mediated signaling pathway;interleukin-15-mediated signaling pathway;positive regulation of embryonic development;positive regulation of GTPase activity;inositol phosphate metabolic process;fat cell differentiation;positive regulation of myoblast differentiation;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of JNK cascade;phosphatidylinositol metabolic process;insulin-like growth factor receptor signaling pathway;phosphatidylinositol-mediated signaling;positive regulation of developmental growth;release of sequestered calcium ion into cytosol;activation of meiosis involved in egg activation;interleukin-1-mediated signaling pathway;regulation of fertilization;postsynaptic modulation of chemical synaptic transmission;regulation of retrograde trans-synaptic signaling by endocanabinoid;positive regulation of G1/S transition of mitotic cell cycle;positive regulation of acrosome reaction;negative regulation of monocyte extravasation;positive regulation of CD24 biosynthetic process	nuclear chromatin;nucleus;cytoplasm;cytosol;nuclear speck;nuclear membrane;myelin sheath;extracellular exosome;postsynapse;glutamatergic synapse;GABA-ergic synapse	phosphatidylinositol phospholipase C activity;phospholipase C activity;GTPase activator activity;calcium ion binding;protein binding;calmodulin binding;lamin binding;phosphatidylinositol-4,5-bisphosphate binding;enzyme binding;protein homodimerization activity	TFCP2[25416956];CTBP2[25416956];LAMP1[29568061];CTBP1[25416956];CEP76[25416956];PHB2[30021884];HIST1H1A[30021884];SPTBN1[20936779];
151366	chr13	28537450	CTT		chr13:28537450-28537452	CDX2	caudal type homeobox 2	1767.0	deletion	0/1	0.6	10_15	25	99	False	rs553066746	EXONIC	YES	NM_001265.6	Transcript	protein_coding	inframe_deletion		3/3	NM_001265.6:c.742_744del	NP_001256.4:p.Lys248del		-1.0						.	.	.		0.000374537	57.0	152188.0	0.0	33	0.96	PASS	afr	0.00108606	45.0	8.81912e-05	6.0	0.000172639	43.0	249074.0	0.0	38	0.93	PASS	afr	0.000995768	16.0	8.90678e-05	10.0	0.0001415,0.0000386	22,6	0.0	1.0	0.00031	3.0		21.4	2.191796		0	0	0			CDX2	0.0	0.02	0.0	0.0	31.0	39.0	39.0	2.0							0.55	0.0			homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; neoplasm; digestive/alimentary phenotype; limbs/digits/tail phenotype; skeleton phenotype; embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; 			.	.	negative regulation of transcription by RNA polymerase II;blood vessel development;trophectodermal cell differentiation;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;positive regulation of cell population proliferation;endosome to lysosome transport;animal organ morphogenesis;anterior/posterior axis specification;anterior/posterior pattern specification;regulation of somitogenesis;cell differentiation;somatic stem cell population maintenance;establishment or maintenance of epithelial cell apical/basal polarity;positive regulation of cell differentiation;positive regulation of transcription, DNA-templated;intestinal epithelial cell differentiation;labyrinthine layer development	condensed nuclear chromosome;nucleus;nucleoplasm;transcriptional repressor complex	RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;transcription corepressor activity;methyl-CpG binding	FOXE1[25609649];MEP1A[22326557];KRTAP4-12[unassigned1304];CFAP206[unassigned1304];HIST1H1B[30021884];
152249	chr12	2968582	G	A	chr12:2968582	FOXM1	forkhead box M1	1800.0	SNV	0/1	0.35	13_7	20	99	False	rs149215740,COSV100700834	EXONIC	YES	NM_202002.3	Transcript	protein_coding	missense_variant		10/10	NM_202002.3:c.1628C>T	NP_973731.1:p.Ser543Leu		-1.0	.,.,.,.					.	.	.		0.00146629	223.0	152084.0	0.0	32	0.95	PASS	afr	0.00487923	202.0	5.88097e-05	4.0	0.000409911	103.0	251274.0	0.0	100	1.0	PASS	afr	0.00443787	72.0	5.27667e-05	6.0	0.0004244	66			0.00053	5.0		16.3	1.506351	0.031	5	15	20	SIFT,M-CAP_pred,MetaLR_pred,MutationAssessor_pred,FATHMM_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FOXM1	0.0	0.0	0.0	0.0	-22.0	-49.0	21.0	-48.0						0.0154	0.8	0.0	0.009	-0.138	digestive/alimentary phenotype; immune system phenotype; liver/biliary system phenotype; respiratory system phenotype; neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; 			testis - seminiferous tubule;testis - interstitial;tumor;testis;	.	G2/M transition of mitotic cell cycle;negative regulation of transcription by RNA polymerase II;DNA repair;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of cell population proliferation;negative regulation of stress-activated MAPK cascade;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;regulation of Ras protein signal transduction;regulation of cell cycle;regulation of cell cycle arrest;negative regulation of cell aging;regulation of reactive oxygen species metabolic process;positive regulation of double-strand break repair	nucleoplasm	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;protein binding;protein kinase binding	TOP2A[15965487];LIN54[25609649];HSP90AB1[22939624];PARS2[25609649];FOXM1[25609649];SMC2[25609649];HERC5[25609649];SART1[25609649];MYBL2[25609649];MEN1[25609649];KIF22[25609649];DDX52[25609649];ZBTB33[26496610];TERF1[26496610];CCNE1[16504183];GORASP2[23241949];CDC37[22939624];ZC3H11A[25609649];DEPDC1[25609649];DNAJC9[25609649];SNRNP200[25609649];RNASEH2B[26496610];GTF3C4[25609649];LIN37[25609649];ANKRD12[22094256];LIN9[25609649];FOXO3[16809346];PRPF8[25609649];PARD6B[26496610];OS9[21988832];LARS[25609649];PES1[25609649];BMS1[25609649];ORC2[25609649];IARS2[25609649];ECT2[25609649];TRMT1L[25609649];BANP[21988832;26871637];TCF7L2[22014570];DARS[25609649];SMARCA5[25609649];LRWD1[25609649];KIF18A[26496610];CDK6[22094256];QARS[25609649];CDK4[22094256];PRC1[25609649];CTNNB1[22014570];IARS[25609649];FBXL2[26790640];RBMX[25609649];
157394	chr17	17717998	C	T	chr17:17717998	SREBF1	sterol regulatory element binding transcription factor 1	1854.0	SNV	0/1	0.48	12_11	23	99	False	rs764217259,COSV55396126	EXONIC	YES	NM_001005291.3	Transcript	protein_coding	missense_variant		16/20	NM_001005291.3:c.2756G>A	NP_001005291.1:p.Arg919Gln		-1.0	.,.,.				Ichthyosis, follicular, with atrichia and photophobia syndrome 2, 619016 (3), Autosomal dominant; Mucoepithelial dysplasia, hereditary, 158310 (3), Autosomal dominant	.	.	.		6.56944e-06	1.0	152220.0	0.0	33	0.98	PASS	afr	2.41208e-05	1.0	0.0	0.0	9.25472e-06	2.0	216106.0	0.0	100	0.61	PASS	afr	7.74954e-05	1.0	1.03146e-05	1.0	0.0000064	1						22.2	2.346506	0.058	2	17	19	LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	SREBF1	0.1	0.03	0.0	0.0	-2.0	24.0	-2.0	-34.0						0.388	0.99	12.79425135	0.996	1.022	liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; 			caudate nucleus;testis - seminiferous tubule;adipose tissue;adrenal gland;testis;adrenal cortex;	Insulin signaling pathway	negative regulation of transcription by RNA polymerase II;regulation of heart rate by chemical signal;regulation of transcription by RNA polymerase II;lipid metabolic process;aging;circadian rhythm;cholesterol metabolic process;insulin receptor signaling pathway;lipid biosynthetic process;cellular response to starvation;response to glucose;positive regulation of triglyceride biosynthetic process;regulation of fatty acid metabolic process;lung development;intracellular receptor signaling pathway;positive regulation of histone deacetylation;regulation of protein stability;response to food;response to retinoic acid;response to progesterone;response to glucagon;mRNA transcription by RNA polymerase II;positive regulation of catalytic activity;fat cell differentiation;regulation of cholesterol biosynthetic process;positive regulation of cholesterol biosynthetic process;positive regulation of transcription by RNA polymerase II;negative regulation of insulin secretion;response to cAMP;cellular response to fatty acid;regulation of autophagy of mitochondrion;regulation of protein targeting to mitochondrion	Golgi membrane;nucleus;nuclear envelope;nucleoplasm;cytoplasm;endoplasmic reticulum membrane;cytosol;ER to Golgi transport vesicle membrane;integral component of membrane;protein-containing complex	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;chromatin binding;DNA-binding transcription factor activity;nuclear receptor activity;protein binding;enzyme activator activity;protein kinase binding;sterol response element binding;protein-containing complex binding;protein dimerization activity	MED1[16799563];CREBBP[16799563];HSP90AB1[22939624];NR1H2[26120082];NR1H3[26120082];SIRT1[20817729];MED15[16799563;18385733];USF1[19303849];MED6[16799563];CDK8[16799563];ATXN1[16713569];NCOR1[26120082];MTNR1B[26514267];TP53[22265415];MEN1[25962847];
158397	chr22	44369168	C	T	chr22:44369168	SAMM50	SAMM50 sorting and assembly machinery component	1861.0	SNV	0/1	0.32	15_7	22	99	False	rs150292452	EXONIC	YES	NM_015380.5	Transcript	protein_coding	missense_variant		7/15	NM_015380.5:c.613C>T	NP_056195.3:p.Arg205Trp		1.0	Bacterial surface antigen (D15)					.	.	.		3.94115e-05	6.0	152240.0	0.0	33	0.98	PASS	eas	0.000192382	1.0	7.34905e-05	5.0	4.37567e-05	11.0	251390.0	0.0	59	0.99	PASS	sas	0.000163409	5.0	3.51753e-05	4.0	0.0000643	10						32.0	4.443082	0.562	13	8	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred	SAMM50	0.0	0.0	0.0	0.12	-23.0	-29.0	-31.0	35.0						0.709	0.0	0.0	0.998	1.015	.			fetal liver;adrenal gland;testis;skeletal muscle;	.	mitochondrial respiratory chain complex assembly;cristae formation;protein insertion into mitochondrial outer membrane	mitochondrial sorting and assembly machinery complex;mitochondrion;mitochondrial outer membrane;integral component of membrane;extracellular exosome	protein binding	TIMMDC1[24344204];MTX1[17510655];PLGRKT[29568061];MTX2[26496610];COX4I1[29568061];IMMT[17624330];MEOX2[16189514];TOMM22[29568061];ATP5F1A[27499296];NDUFAF8[27499296];CHCHD3[25416956;unassigned1304];AIFM1[29568061];SCO1[29568061];CHCHD6[unassigned1304];NDUFAF4[27499296];MFN2[27059175];COX14[29568061];SFXN1[29568061];DNM1L[27059175];RAB8A[27173435;unassigned1312];PRELID3B[27499296];
158437	chr3	189689689	G	T	chr3:189689689	P3H2	prolyl 3-hydroxylase 2	1864.0	SNV	0/1	0.52	16_17	33	99	False	rs35067805,COSV60022131,COSV60025565	EXONIC	YES	NM_018192.4	Transcript	protein_coding	synonymous_variant		12/15	NM_018192.4:c.1807C>A	NP_060662.2:p.Arg603%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided	Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3), Autosomal recessive	Rare isolated myopia	Disease-causing germline mutation(s) in	Lens subluxation;Retinal detachment;High myopia;Cataract;Autosomal recessive inheritance;Peripheral vitreoretinal degeneration		0.00331291	504.0	152132.0	4.0	32	0.97	PASS	nfe	0.00513039	349.0	0.00513039	349.0	0.00331318	833.0	251420.0	1.0	91	1.0	PASS	nfe	0.00536415	610.0	0.00536415	610.0	0.0034533	537	0.005	16.0	0.0036	41.0		14.07	1.099989		0	0	0			P3H2	0.0	0.0	0.0	0.13	-10.0	41.0	-6.0	-10.0								0.0			mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; homeostasis/metabolism phenotype; 			.	.	negative regulation of cell population proliferation;peptidyl-proline hydroxylation;collagen metabolic process;oxidation-reduction process	basement membrane;endoplasmic reticulum;endoplasmic reticulum lumen;Golgi apparatus;sarcoplasmic reticulum	iron ion binding;procollagen-proline 3-dioxygenase activity;L-ascorbic acid binding	CCNA2[26496610];NUDT21[26496610];MYH13[26496610];ATM[26496610];RNPS1[26496610];
164828	chr8	121267490	G	A	chr8:121267490	COL14A1	collagen type XIV alpha 1 chain	1931.0	SNV	0/1	0.44	23_18	41	99	False	rs11774228	EXONIC	YES	NM_021110.4	Transcript	protein_coding	missense_variant		23/48	NM_021110.4:c.2764G>A	NP_066933.1:p.Val922Ile		1.0	.,Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III	Likely_benign	criteria_provided,_single_submitter	not_provided		Punctate palmoplantar keratoderma type 1	Disease-causing germline mutation(s) in	Breast carcinoma;Colon cancer;Renal cell carcinoma;Hodgkin lymphoma;Abnormality of the nail;Palmoplantar keratoderma;Transitional cell carcinoma of the bladder;Neoplasm of the pancreas		0.0053885	820.0	152176.0	4.0	32	0.97	PASS	nfe	0.00906873	617.0	0.00906873	617.0	0.00532528	1339.0	251442.0	10.0	72	1.0	PASS	nfe	0.00859916	978.0	0.00859916	978.0	0.0054082	841	0.009	27.0				19.65	1.989637	0.062	5	15	20	MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	COL14A1	0.0	0.03	0.0	0.0	38.0	-11.0	-3.0	-1.0						0.172	0.0	0.0	0.717	1.176	skeleton phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;pons;olfactory bulb;uterus;thyroid;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	growth plate cartilage chondrocyte morphogenesis;extracellular matrix organization;collagen fibril organization;cell-cell adhesion	extracellular region;collagen trimer;collagen type XIV trimer;extracellular space;endoplasmic reticulum lumen;extracellular matrix;collagen-containing extracellular matrix	RNA binding;extracellular matrix structural constituent;collagen binding;extracellular matrix structural constituent conferring tensile strength;protein binding, bridging	PRDX2[27173435;unassigned1312];METTL14[29507755];HDAC2[30021884];WTAP[29507755];CD81[26212323];ILVBL[30021884];METTL3[29507755];ENO1[23414517];
166289	chr14	20903564	C	G	chr14:20903564	KLHL33	kelch like family member 33	1940.0	SNV	0/1	0.43	28_21	49	99	False		EXONIC	YES	NM_001365790.2	Transcript	protein_coding	missense_variant		2/5	NM_001365790.2:c.407G>C	NP_001352719.1:p.Ser136Thr		-1.0	BTB/POZ domain&BTB/POZ domain&BTB/POZ domain,BTB/POZ domain&BTB/POZ domain&BTB/POZ domain					.	.	.		6.56892e-06	1.0	152232.0	0.0	33	0.98	PASS	amr	6.54279e-05	1.0	0.0	0.0					0	0.0														18.76	1.873692		2	5	7	PolyPhen,MutationTaster_pred	SIFT,MetaRNN_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred	KLHL33	0.0	0.0	0.0	0.0	-16.0	-1.0	41.0	-32.0									0.998	0.952	.			.	.	.	.	.	NUDCD3[25036637];
166465	chr14	24787949	C	G	chr14:24787949	ADCY4	adenylate cyclase 4	1955.0	SNV	0/1	0.54	16_19	35	99	False	rs756898834	EXONIC	YES	NM_001198568.2	Transcript	protein_coding	missense_variant		24/25	NM_001198568.2:c.2992G>C	NP_001185497.1:p.Gly998Arg		-1.0	Adenylyl cyclase class-3/4/guanylyl cyclase&Adenylyl cyclase class-4/guanylyl cyclase, conserved site&Adenylyl cyclase class-3/4/guanylyl cyclase&Adenylyl cyclase class-3/4/guanylyl cyclase,Adenylyl cyclase class-3/4/guanylyl cyclase&Adenylyl cyclase class-4/guanylyl cyclase, conserved site&Adenylyl cyclase class-3/4/guanylyl cyclase&Adenylyl cyclase class-3/4/guanylyl cyclase,Adenylyl cyclase class-3/4/guanylyl cyclase&Adenylyl cyclase class-4/guanylyl cyclase, conserved site&Adenylyl cyclase class-3/4/guanylyl cyclase&Adenylyl cyclase class-3/4/guanylyl cyclase					.	.	.						32	0.97											98	1.0							0.0000064	1	0.0	1.0				29.6	4.222168	0.772	19	1	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred	ADCY4	0.08	0.0	0.0	0.0	35.0	-40.0	-38.0	35.0						0.37	0.0	24.151647419	1.0	1.026	normal phenotype; 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	Purine metabolism;Calcium signaling pathway;Gap junction;Taste transduction;GnRH signaling pathway;Melanogenesis	renal water homeostasis;cAMP biosynthetic process;G protein-coupled receptor signaling pathway;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;cellular response to glucagon stimulus	cytoplasm;plasma membrane;integral component of plasma membrane;membrane;dendrite	adenylate cyclase activity;protein kinase C binding;protein binding;ATP binding;metal ion binding	C1orf50[unassigned1304];ESRRG[unassigned1304];PPARG[unassigned1304];TRIM54[25416956];GLYR1[unassigned1304];
166545	chr1	145541479	G	T	chr1:145541479	ITGA10	integrin subunit alpha 10	1958.0	SNV	0/1	0.6	12_18	30	99	False	rs142193785	EXONIC	YES	NM_003637.5	Transcript	protein_coding	missense_variant		28/30	NM_003637.5:c.3267G>T	NP_003628.2:p.Glu1089Asp		1.0						.	.	.		0.00113722	173.0	152126.0	1.0	31	0.96	PASS	amr	0.00255302	39.0	0.00148494	101.0	0.00140052	350.0	249908.0	1.0	50	0.86	PASS	amr	0.00345408	119.0	0.0015476	175.0	0.0014855	231	0.002	6.0				15.81	1.41736		0	2	2		SIFT,PolyPhen	ITGA10	0.0	0.0	0.0	0.0	-38.0	1.0	-15.0	-34.0						0.788	0.0	0.0			skeleton phenotype; limbs/digits/tail phenotype; 			.	Focal adhesion;ECM-receptor interaction;Regulation of actin cytoskeleton	cell-matrix adhesion;integrin-mediated signaling pathway;extracellular matrix organization	plasma membrane;integrin complex;integrin alpha10-beta1 complex	collagen binding;metal ion binding;collagen binding involved in cell-matrix adhesion	.
166694	chr1	109803697	G	A	chr1:109803697	CELSR2	cadherin EGF LAG seven-pass G-type receptor 2	1966.0	SNV	0/1	0.48	14_13	27	99	False	rs115077620,COSV54776649	EXONIC	YES	NM_001408.3	Transcript	protein_coding	missense_variant		3/34	NM_001408.3:c.3992G>A	NP_001399.1:p.Arg1331His		1.0	EGF-like domain&Laminin EGF domain&EGF-like domain	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00126832	193.0	152170.0	0.0	32	0.97	PASS	amr	0.00229058	35.0	0.00186693	127.0	0.00124233	312.0	251140.0	1.0	73	0.99	PASS	nfe	0.00195464	222.0	0.00195464	222.0	0.0012154	189	0.006	18.0	0.0042	40.0		31.0	4.364849	0.683	10	10	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	CELSR2	0.0	0.0	0.0	0.0	-28.0	-33.0	-34.0	-20.0						0.228	1.0	0.0	1.0	1.176	nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			caudate nucleus;ciliary ganglion;amygdala;temporal lobe;prefrontal cortex;trigeminal ganglion;superior cervical ganglion;cingulate cortex;cerebellum;pons;fetal brain;occipital lobe;subthalamic nucleus;whole brain;spinal cord;parietal lobe;globus pallidus;medulla oblongata;thalamus;	.	regulation of transcription, DNA-templated;homophilic cell adhesion via plasma membrane adhesion molecules;G protein-coupled receptor signaling pathway;Wnt signaling pathway;neural plate anterior/posterior regionalization;regulation of cell-cell adhesion;dendrite morphogenesis;Wnt signaling pathway, planar cell polarity pathway	cytoplasm;plasma membrane;integral component of membrane	G protein-coupled receptor activity;calcium ion binding	KLF6[16169070];PHF10[16169070];SRC[17474147];LCA5[26638075];GARS[16169070];CRK[17474147];NCK1[17474147];
166696	chr1	109815465	G	A	chr1:109815465	CELSR2	cadherin EGF LAG seven-pass G-type receptor 2	1966.0	SNV	0/1	0.5	13_13	26	99	False	rs41279718,COSV54768439	EXONIC	YES	NM_001408.3	Transcript	protein_coding	synonymous_variant		31/34	NM_001408.3:c.8154G>A	NP_001399.1:p.Thr2718%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00217717	331.0	152032.0	1.0	33	0.96	PASS	amr	0.00327525	50.0	0.00298538	203.0	0.00242516	604.0	249056.0	4.0	77	0.97	PASS	nfe	0.00320697	358.0	0.00320697	358.0	0.0023151	360	0.007	21.0	0.0061	58.0		2.599	-0.001651		0	0	0			CELSR2	0.18	0.09	0.0	0.0	2.0	12.0	2.0	37.0						0.228	1.0	4.447348938			nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			caudate nucleus;ciliary ganglion;amygdala;temporal lobe;prefrontal cortex;trigeminal ganglion;superior cervical ganglion;cingulate cortex;cerebellum;pons;fetal brain;occipital lobe;subthalamic nucleus;whole brain;spinal cord;parietal lobe;globus pallidus;medulla oblongata;thalamus;	.	regulation of transcription, DNA-templated;homophilic cell adhesion via plasma membrane adhesion molecules;G protein-coupled receptor signaling pathway;Wnt signaling pathway;neural plate anterior/posterior regionalization;regulation of cell-cell adhesion;dendrite morphogenesis;Wnt signaling pathway, planar cell polarity pathway	cytoplasm;plasma membrane;integral component of membrane	G protein-coupled receptor activity;calcium ion binding	KLF6[16169070];PHF10[16169070];SRC[17474147];LCA5[26638075];GARS[16169070];CRK[17474147];NCK1[17474147];
167094	chr16	4390914	C	A	chr16:4390914	PAM16	presequence translocase associated motor 16	1985.0	SNV	0/1	0.46	19_16	35	99	False	rs142976385	SPLICING	YES	NM_016069.11	Transcript	protein_coding	splice_region_variant,intron_variant	4/4		NM_016069.11:c.291+7G>T			-1.0		Benign	criteria_provided,_single_submitter	not_provided	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3), Autosomal recessive	Autosomal recessive spondylometaphyseal dysplasia, M�garban� type	Disease-causing germline mutation(s) in	Low-set ears;Spondylometaphyseal dysplasia;Round face;Autosomal recessive inheritance;Short nose;Short long bone;Anteverted nares;Delayed skeletal maturation;Short neck;Muscular hypotonia of the trunk;Large fontanelles;Wormian bones;Global developmental delay;Pulmonary arterial hypertension;Hypoplastic ischia;Prominent forehead;Wide nose;Short stature;Small for gestational age;Short ribs;Squared iliac bones;Tachypnea;Bell-shaped thorax;Microtia;Iliac crest serration;Deep philtrum;Micromelia;Narrow chest;Dilatation;Dysplastic sacrum;Hypertension;Depressed nasal bridge;Hypokinesia;Frontal bossing;Cardiomegaly;Metaphyseal cupping;Severe platyspondyly		0.00423422	644.0	152094.0	1.0	33	0.97	PASS	nfe	0.0071771	488.0	0.0071771	488.0	0.00390111	979.0	250954.0	3.0	100	1.0	PASS	nfe	0.00598253	678.0	0.00598253	678.0	0.0038777	603	0.003	8.0				12.4	0.857591		0	0	0			PAM16	0.0	0.0	0.0	0.0	-18.0	12.0	7.0	8.0	0.0008855183511974	0.026					0.14				mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			caudate nucleus;ciliary ganglion;testis - seminiferous tubule;dorsal root ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;globus pallidus;	.	ossification;protein import into mitochondrial matrix;negative regulation of ATPase activity;negative regulation of release of cytochrome c from mitochondria;negative regulation of apoptotic DNA fragmentation	PAM complex, Tim23 associated import motor;TIM23 mitochondrial import inner membrane translocase complex;mitochondrial matrix;extrinsic component of mitochondrial inner membrane;protein-containing complex	protein binding	GPM6A[21900206];ARL6IP1[25416956];MRFAP1[21900206];TFB2M[unassigned1312];HDHD5[27499296];MEOX2[unassigned1304];DNAJC15[23263864];COX6B1[27499296];GH1[17353931];PGRMC1[21900206];SLC25A29[unassigned1312];FEZ1[16169070;21900206];BLOC1S2[21900206];NDUFAF4[27499296];CEP70[21900206];MARC1[unassigned1312];DNMT3B[21900206];TIMM17B[23263864];
167268	chr9	84235404	G	A	chr9:84235404	TLE1	transducin like enhancer of split 1	1993.0	SNV	0/1	0.49	21_20	41	99	False	rs147867092	EXONIC	YES	NM_001303103.2	Transcript	protein_coding	synonymous_variant		9/20	NM_001303103.2:c.693C>T	NP_001290032.1:p.Ser231%3D		-1.0						.	.	.		0.000236702	36.0	152090.0	0.0	33	0.97	PASS	amr	0.000785649	12.0	0.000338146	23.0	0.000194981	49.0	251306.0	0.0	48	0.98	PASS	amr	0.000405093	14.0	0.000281581	32.0	0.0001608	25	0.001	2.0				12.19	0.830014		0	0	0			TLE1	0.0	0.0	0.0	0.0	-18.0	46.0	-46.0	-48.0						0.215	0.96	4.533184568			.			ciliary ganglion;pons;appendix;dorsal root ganglion;atrioventricular node;skin;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	signal transduction;multicellular organism development;animal organ morphogenesis;positive regulation of gene expression;Wnt signaling pathway;negative regulation of Wnt signaling pathway;negative regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of transcription, DNA-templated;negative regulation of canonical Wnt signaling pathway;beta-catenin-TCF complex assembly;negative regulation of anoikis	nucleus;nucleoplasm;transcription factor complex;cytosol;beta-catenin-TCF complex	transcription corepressor activity;protein binding;transcription factor binding;identical protein binding;repressing transcription factor binding	RERE[16169070];RNF10[16169070];DAZAP2[16169070;21900206];GSK3B[21900206];ATF2[22439931];CDKN1A[21900206];CELF3[16169070];SAT1[16169070];POLB[16169070];GOLGA2[29568061];TMSB4X[16169070];DLEU1[16169070];UBTF[20160071];ANXA7[21900206];RCC1[21900206];TK1[16169070;21900206];TLE1[24596249];TSC22D1[21900206];EED[22439931];SERPINB9[16169070];PEX2[16169070];RUNX3[9751710];SIRT1[17680780];RUNX2[20160071];RUNX1[9751710];AES[17353931];ARL4D[16169070];CSNK2B[21900206];SNRPG[16169070];ERH[16169070];PFN1[16169070];PAFAH1B3[16169070];KIAA0408[21900206];GRB7[21900206];PSMD11[16169070];HDAC3[21251616];HDAC1[22439931];ARL3[16169070];CRCT1[16169070];LEF1[9751710];NOD2[21699783];APH1A[21988832];RAP1B[21900206];BTBD2[16169070];PCDHA4[16169070];VHL[17353931];SMN1[21900206];CCL18[16169070];BID[21900206];HLA-DQA1[16169070];GSTM4[16169070];SUZ12[22439931];FOXB1[25609649];CDKN2C[16169070];GADD45A[21900206];RPA2[16169070];EIF2S2[16169070];HSPE1[16169070];HIPK2[15896780];NUDT21[21900206];HIST1H4A[24596249];FUBP1[16169070];POLE2[16169070];ZFP64[16169070];FXYD6[16169070];TCF4[24596249];SYT-SSX1[22439931];SYT-SSX2[22439931];MPHOSPH6[16169070];CUL4B[17041588];BCL2L1[21900206];EZH2[22439931];
169181	chr6	24570151	G	A	chr6:24570151	KIAA0319	KIAA0319	2031.0	SNV	0/1	0.45	16_13	29	99	False	rs41271797,COSV65500295	EXONIC	YES	NM_001168375.2	Transcript	protein_coding	synonymous_variant		12/21	NM_001168375.2:c.1971C>T	NP_001161847.1:p.Phe657%3D		-1.0						.	.	.		0.000781732	119.0	152226.0	0.0	32	0.97	PASS	nfe	0.00141081	96.0	0.00141081	96.0	0.000768312	193.0	251200.0	2.0	49	1.0	PASS	nfe	0.00121554	138.0	0.00121554	138.0	0.0009325	145	0.001	3.0	9e-05	1.0		11.78	0.77807		0	0	0			KIAA0319	0.0	0.0	0.01	0.01	-20.0	48.0	-45.0	-20.0						0.943	0.0	10.328767441			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	.	neuron migration;membrane organization;negative regulation of dendrite development	early endosome;plasma membrane;integral component of membrane;clathrin-coated vesicle membrane;cytoplasmic vesicle;early endosome membrane;intracellular membrane-bounded organelle	protein binding	APP[26960425];FEM1B[12421765];MYC[21150319];SH2B1[12421765];
170172	chr2	28975017	C	T	chr2:28975017	PPP1CB	protein phosphatase 1 catalytic subunit beta	2037.0	SNV	0/1	0.42	23_17	40	99	False	rs141050112	EXONIC	YES	NM_206876.2	Transcript	protein_coding	synonymous_variant		2/9	NM_206876.2:c.27C>T	NP_996759.1:p.Asp9%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	Noonan syndrome-like disorder with loose anagen hair 2, 617506 (3), Autosomal dominant	Noonan syndrome-like disorder with loose anagen hair	Disease-causing germline mutation(s) in	Hypertelorism;Hypertrophic cardiomyopathy;Low posterior hairline;Hearing impairment;Intellectual disability;Sparse scalp hair;Anteverted nares;Thin vermilion border;Webbed neck;Pectus excavatum;Cryptorchidism;Aplasia/Hypoplasia of the eyebrow;Carious teeth;Short stature;Hydrocephalus;Abnormal fingernail morphology;Short nose;Macrotia;Deep philtrum;Hypoplastic toenails;Abnormal palate morphology;Brachydactyly;Pulmonic stenosis;Abnormality of the intervertebral disk;Epicanthus;Low-set, posteriorly rotated ears;Abnormality of the elbow;Delayed skeletal maturation;Thick lower lip vermilion;Generalized hypotonia;Pectus excavatum;Cafe-au-lait spot;Broad neck;Dermal translucency;Ptosis;Patent foramen ovale;Arnold-Chiari type I malformation;Coarctation of aorta;Hypertelorism;Posteriorly rotated ears;Freckling;Delayed speech and language development;Overfolded helix;Pectus carinatum;Optic nerve hypoplasia;Low-set ears;Macrocephaly;Craniosynostosis;Craniosynostosis;Joint hypermobility;Prominent forehead;Sparse hair;Short neck;Pulmonic stenosis;Mitral regurgitation;Delayed skeletal maturation;Thin skin;Ventricular septal defect;Webbed neck;Short stature;High palate;Dandy-Walker malformation;Failure to thrive;Patent ductus arteriosus;Autosomal dominant inheritance;Cryptorchidism;Thickened helices;Peripheral pulmonary artery stenosis;Downslanted palpebral fissures;Right bundle branch block;Slow-growing hair;Global developmental delay		0.00134767	205.0	152114.0	1.0	30	0.93	PASS	nfe	0.00236751	161.0	0.00236751	161.0	0.00124199	185.0	148954.0	0.0	18	0.49	PASS	nfe	0.00241897	133.0	0.00241897	133.0	0.0005337	83	0.002	6.0				13.42	0.998202		0	0	0			PPP1CB	0.0	0.0	0.0	0.0	-4.0	-45.0	-6.0	25.0						0.222	1.0	98.092241482			mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			globus pallidus;	Focal adhesion;Long-term potentiation;Regulation of actin cytoskeleton;Insulin signaling pathway	glycogen metabolic process;protein dephosphorylation;cell cycle;regulation of cell adhesion;circadian regulation of gene expression;regulation of circadian rhythm;entrainment of circadian clock by photoperiod;cell division	protein phosphatase type 1 complex;nuclear chromosome, telomeric region;nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol;plasma membrane;focal adhesion;extracellular exosome;PTW/PP1 phosphatase complex	protein serine/threonine phosphatase activity;protein binding;phosphatase activity;myosin phosphatase activity;protein kinase binding;metal ion binding;myosin-light-chain-phosphatase activity	TES[26496610];ZFYVE9[15231748];ZDHHC5[26496610];CALML3[26496610];ACTB[26496610];DCAF7[27173435;unassigned1312];MYLK[26496610];UXT[27173435;unassigned1312];MPRIP[26496610];WDR92[26496610;27173435;unassigned1312];SYNPO[26496610];LIMCH1[26496610];ACTN2[25910212];ACTN1[26496610];PIH1D1[26496610];DAPK3[26496610];ECH1[29426014];AFAP1[26496610];ACTN4[26496610];MYL6[15545284];CDC34[17274640];PPP1R3C[25416956;unassigned1304;28330616];PPP1R3B[23414517];WDR82[28330616];CSNK2B[23555304];ASF1A[26496610];PPP1R37[28330616];URI1[26496610;27173435;unassigned1312];CDCA2[26496610];INTU[27173435;unassigned1312];DHX9[26496610];FLII[26496610];TWF1[26496610];IQGAP1[26496610];RPAP3[27173435;unassigned1312];PPP1R2B[25416956;unassigned1304];RACGAP1[26496610];EPB41L1[26575790];MYO6[26496610];PPP1R2C[unassigned1304];TP53BP2[24366813;25416956;unassigned1304;28330616];SPTBN1[26496610];SPTBN2[26496610];JUN[25609649];YES1[26496610];PPP1R27[unassigned1304];C20orf27[27173435;unassigned1312];RASSF7[24366813];RASSF8[24366813];MYO5A[26496610];RASSF9[24366813];ANLN[26496610];MYO5B[26496610];MYO5C[26496610];GRB2[12577067];CALM1[26496610];APOBEC3B[26496610];CSRNP1[unassigned1304];CSRNP2[25416956;unassigned1304];PPP1R11[17353931;26496610;27173435;unassigned1304;unassigned1312;28330616];PPP1R10[26496610;28330616];CLTB[26496610];CLTA[26496610];AP2A1[26496610];SPATC1L[unassigned1304];BRCA1[17511879];STON2[26496610];MEOX2[unassigned1304];CLINT1[26496610];SIPA1L3[26496610];TRIOBP[26496610;28330616];PQBP1[27173435;unassigned1312];GYS1[28330616];TUBA1A[27291054];IKBKG[14743216];SPTAN1[26496610];RIPK3[14743216];NCOA5[26496610];ANXA2[26496610];DYNLL2[27173435;unassigned1312];SIRT2[26496610];PDRG1[26496610];TOX4[26496610;28330616];INF2[26496610];CTTN[26496610];TMEM33[17353931];PACS1[unassigned1312];RBM12B[26496610];HNRNPH3[26496610];DBN1[26496610];ACTRT1[26496610];KANK2[unassigned1304];NRAC[unassigned1304];NEXN[26496610];AKAP2[26496610];PPP1R2[17353931;28330616];LIMA1[26496610];PPP1R7[17353931;23414517;26496610;27173435;unassigned1304;unassigned1312;28330616];PPP1R8[17353931;26496610;28330616];FLNA[26496610];ZNF106[26496610];FLNB[26496610];CCT8[26496610];EPS15[26496610];MISP[26496610];SVIL[26496610];CDKN2A[17274640];YLPM1[26496610;28330616];SORBS2[26496610];RRP1B[27173435;unassigned1312;20926688];PLEKHA7[28877994];PPP1CA[26496610;unassigned1312];TJP1[26496610];CAPZA1[26496610];HNRNPA2B1[26496610];CAPZA2[26496610];SIPA1[26496610];RIF1[26496610;27173435;unassigned1312;28330616];UBXN2A[26496610];RORC[23555304];ACTG1[26496610];PPP1CC[24366813];CCND3[17274640];CYSRT1[unassigned1304];CHCHD3[unassigned1304];CCND1[17274640];BASP1[26496610];TUBB3[27291054];CFL2[26496610];CFL1[26496610];ZNF326[26496610];TMOD1[26496610];PPP1R16B[27107012;28330616];GAS2L3[26496610];TPM4[26496610];TPM3[26496610];TPM2[26496610];TMOD3[26496610];PPP1R16A[21516116;25416956;unassigned1304;28330616];TPM1[26496610];LMO7[26496610];WBP11[27173435;unassigned1312];MINPP1[28330616];ILF3[26496610];RBMXL1[26496610];NCL[12185196];SPECC1L[26496610];MATR3[26496610];KPNB1[28330616];RAI14[26496610;28330616];KHDRBS1[26496610];MAX[17274640];CORO1B[26496610];CORO1C[26496610];ARHGAP21[26496610];SAFB2[26496610];GAS2L1[26496610];SPECC1[26496610];ITPRID2[26496610];VCAM1[22623428];SEC16A[26496610];DSTN[26496610];ARPC4[26496610];SSH2[26496610];DAB2[26496610];KIF18A[27173435;unassigned1312];KIF18B[26496610];ARPC2[26496610];BHLHE40[23555304];CDK2[26496610];BCL2[17274640];ARHGAP11A[26496610];PPP1R13B[24366813;28330616];DDX3X[26496610];SH2D4A[17353931;25416956;26496610;27107012;27173435;unassigned1304;unassigned1312;28330616];WDR1[26496610];LRRK2[23937259];KIAA1671[26496610];TNFAIP1[26496610];PIK3C2A[26496610];PPP1R9B[26496610;25785436];CAPZB[26496610];PPP1R13L[21998301;26496610;27173435;unassigned1312;28330616];MYO18A[26496610];PHACTR3[unassigned1304];TLK1[27173435;unassigned1312];TPRN[26496610];RBM6[26496610];METTL17[26496610];PLEKHG3[26496610];ACTR3[26496610];ACTR2[26496610];PPP1R12A[17353931;26496610;27173435;unassigned1312;28330616];DST[26496610];COBL[26496610];PPP2R5C[25487150];SAFB[26496610];ZNF638[26496610];BMP2K[26496610];MYH9[26496610];DUX4L9[26816005];PPP1R12B[26496610;26871637;28330616];PPP1R12C[26496610;28330616];PLEC[26496610];PPP1R15A[29109149];PPP1R15B[26496610];LUZP1[26496610];UACA[26496610;28330616];ABLIM1[26496610];CCDC85C[27173435;unassigned1312;28330616];POLR2E[27173435;unassigned1312];TAF15[26496610];MYO19[26496610];MYO1E[26496610];MYO1B[26496610];MYO1C[26496610];ACTC1[26496610];ST5[26496610];MNDA[25665578];RBMX[26496610];
171252	chr19	8191359	G	A	chr19:8191359	FBN3	fibrillin 3	2049.0	SNV	0/1	0.62	8_13	21	99	False	rs377489898,COSV54467607	EXONIC	YES	NM_032447.5	Transcript	protein_coding	synonymous_variant		20/64	NM_032447.5:c.2547C>T	NP_115823.3:p.Cys849%3D		-1.0						.	.	.		1.31399e-05	2.0	152208.0	0.0	34	0.97	PASS	amr	6.54022e-05	1.0	1.47007e-05	1.0	2.45865e-05	6.0	244036.0	0.0	32	0.81	PASS	amr	5.85995e-05	2.0	2.74504e-05	3.0	0.0000129	2	0.0	1.0				9.18	0.476606		0	0	0			FBN3	0.0	0.0	0.48	0.23	2.0	-12.0	2.0	-10.0						0.0141	0.0	0.0			.			ciliary ganglion;superior cervical ganglion;	.	.	extracellular matrix;collagen-containing extracellular matrix	extracellular matrix structural constituent;calcium ion binding	DAZAP2[21900206];GSK3B[21900206];CDKN1A[21900206];RPN2[21900206];TSC22D1[21900206];GADD45A[21900206];FN1[25034023];PIK3R3[21900206];SMAP[21900206];NUDT21[21900206];RPS6KA6[21900206];ANXA7[21900206];TK1[21900206];BID[21900206];
172046	chr6	1610761	CGGCGGCCG		chr6:1610761-1610769	FOXC1	forkhead box C1	2064.0	deletion	0/1	0.53	8_10	19	99	False	rs756196843	EXONIC	YES	NM_001453.3	Transcript	protein_coding	inframe_deletion		1/1	NM_001453.3:c.92_100del	NP_001444.2:p.Ala31_Ala33del		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Axenfeld-Rieger_syndrome_type_3|not_specified|not_provided	Axenfeld-Rieger syndrome, type 3, 602482 (3), Autosomal dominant; Anterior segment dysgenesis 3, multiple subtypes, 601631 (3), Autosomal dominant	Isolated aniridia;Peters anomaly;Axenfeld-Rieger syndrome;Rieger anomaly;Axenfeld anomaly	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Concave nasal ridge;Sensorineural hearing impairment;Posterior embryotoxon;Cerebellar vermis hypoplasia;Hypodontia;Hypertelorism;Midface retrusion;Ectopia pupillae;Microdontia;Atrial septal defect;Hypoplasia of the iris;Glaucoma;Proptosis;Malar flattening;Heterogeneous;Patent ductus arteriosus;Autosomal dominant inheritance;Autosomal dominant inheritance;Rieger anomaly;Peters anomaly;Enlarged cisterna magna;Glaucoma;Posterior embryotoxon;Ectopia pupillae;Axenfeld anomaly;Hypoplastic iris stroma;Abnormal iris vasculature;Cerebellar vermis hypoplasia;Posterior embryotoxon;Redundant skin;Hypertelorism;Depressed nasal bridge;Hearing impairment;Hypospadias;Hypoplasia of the maxilla;Glaucoma;Aplasia/Hypoplasia of the iris;Abnormality of cardiovascular system morphology;Microdontia;Growth delay;Everted lower lip vermilion;Telecanthus;Wide nasal bridge;Abnormality of the hypothalamus-pituitary axis;Midface retrusion;Abnormal anterior chamber morphology;Hypodontia;Prominent forehead;Anal stenosis;Nystagmus;Peters anomaly;Visual loss;Cataract;Aplasia/Hypoplasia of the macula;Glaucoma;Aniridia;Subcapsular cataract;Developmental glaucoma;Nystagmus;Anterior synechiae of the anterior chamber;Strabismus;Thinning of Descemet membrane;Peters anomaly;Central opacification of the cornea		0.00107469	163.0	151672.0	1.0	31	0.93	PASS	sas	0.00331538	16.0	0.000884199	60.0	0.00108468	140.0	129070.0	1.0	11	0.4	PASS	sas	0.00347933	68.0	0.00105699	49.0	0.0000579	9			0.00027	3.0		21.7	2.25154		0	0	0																			0.0			endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; respiratory system phenotype; liver/biliary system phenotype; embryo phenotype; pigmentation phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; 			.	.	negative regulation of transcription by RNA polymerase II;angiogenesis;ovarian follicle development;eye development;ureteric bud development;in utero embryonic development;somitogenesis;kidney development;lymph vessel development;endochondral ossification;blood vessel remodeling;regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;Notch signaling pathway;heart development;cell population proliferation;germ cell migration;anatomical structure morphogenesis;positive regulation of epithelial to mesenchymal transition;mesenchymal cell development;neural crest cell development;cell migration;negative regulation of angiogenesis;cerebellum development;cell differentiation;collagen fibril organization;glycosaminoglycan metabolic process;lacrimal gland development;embryonic heart tube development;maintenance of lens transparency;vascular endothelial growth factor signaling pathway;odontogenesis of dentin-containing tooth;camera-type eye development;positive regulation of DNA binding;positive regulation of keratinocyte differentiation;positive regulation of transcription, DNA-templated;negative regulation of mitotic cell cycle;positive regulation of transcription by RNA polymerase II;regulation of organ growth;vascular endothelial growth factor receptor signaling pathway;paraxial mesoderm formation;artery morphogenesis;regulation of blood vessel size;ventricular cardiac muscle tissue morphogenesis;cardiac muscle cell proliferation;chemokine-mediated signaling pathway;cellular response to epidermal growth factor stimulus;glomerular epithelium development;negative regulation of lymphangiogenesis;positive regulation of hematopoietic progenitor cell differentiation;positive regulation of hematopoietic stem cell differentiation;negative regulation of apoptotic process involved in outflow tract morphogenesis;positive regulation of core promoter binding;cellular response to chemokine	nucleus;nucleoplasm;nuclear heterochromatin;cytosol	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription coactivator binding;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transcription coactivator activity;protein binding;transcription factor binding;DNA binding, bending;sequence-specific DNA binding;transcription regulatory region DNA binding;promoter-specific chromatin binding	FOXA1[25303530];RARG[25303530];VARS[25609649];LDB1[25609649];NDUFA11[25609649];UBP1[25609649];PPP2R2A[26496610;28330616];HOXC13[25609649];MECP2[25609649];SALL1[25609649];PPP2R1A[26496610];C1QBP[18676636];PITX2[16449236];FOXD4[25609649];RECQL[25609649];FOS[25303530];AIM2[25665578];DDX39A[25609649];HOXB9[25609649];CREB1[25609649];RARA[25303530];TP53[25609649];FOXC2[25609649];FOXC1[25609649];NFIX[25609649];DLX5[25609649];SATB1[25609649];SATB2[25609649];HOXD13[25609649];GATA3[25303530];C5orf24[25609649];FOXS1[25609649];FLNA[15684392];EGLN3[26972000];TFAP2C[25303530];JUN[25303530];POU2F1[25609649];PYHIN1[25665578];SMARCA5[25609649];FOXJ2[25609649];PBX2[25609649];SMARCA1[25609649];ESR1[25303530];PBX1[15684392;25609649];GATAD2B[25609649];MEIS1[25609649];TFCP2[25609649];NFIC[25609649];PPP2R2D[28330616];BCOR[27505670];
173480	chr2	136872715	G	A	chr2:136872715	CXCR4	C-X-C motif chemokine receptor 4	2081.0	SNV	0/1	0.48	15_14	29	99	False	rs148279552,COSV54010958	EXONIC	YES	NM_001348056.2	Transcript	protein_coding	synonymous_variant		3/3	NM_001348056.2:c.996C>T	NP_001334985.1:p.Ile332%3D		-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Warts,_hypogammaglobulinemia,_infections,_and_myelokathexis|not_specified|not_provided	WHIM syndrome 1, 193670 (3), Autosomal dominant; Myelokathexis, isolated, 193670 (3), Autosomal dominant	WHIM syndrome	Disease-causing germline mutation(s) (gain of function) in	Myelokathexis;Meningitis;Pharyngitis;Limb ataxia;Neurological speech impairment;Cellulitis;Postural instability;Abnormality of neutrophil morphology;Vitiligo;Lymphadenitis;Seizure;Sinusitis;Bronchiectasis;Decreased circulating antibody level;Atelectasis;Parotitis;Tetralogy of Fallot;Abnormality of the small intestine;Recurrent upper respiratory tract infections;Recurrent bacterial infections;Otitis media;Bone marrow hypercellularity;Sepsis;Lymphopenia;Neutropenia;Verrucae;Cervix cancer;Recurrent pneumonia;Cutaneous melanoma;Severe periodontitis;Poor fine motor coordination;Abnormal morphology of female internal genitalia;Autosomal dominant inheritance;Bronchiectasis;Recurrent bacterial infections;Bone marrow hypercellularity;Myelokathexis;Infantile onset;Abnormality of female external genitalia;Decreased circulating antibody level;Recurrent upper respiratory tract infections;Abnormality of bone marrow cell morphology;Neutropenia;Decreased circulating IgG level;Verrucae	25741868,27005825	0.00244438	372.0	152186.0	1.0	32	0.97	PASS	nfe	0.00355705	242.0	0.00355705	242.0	0.00274	689.0	251460.0	1.0	100	1.0	PASS	nfe	0.0039386	448.0	0.0039386	448.0	0.0026687	415	0.003	10.0	0.00307	35.0		9.252	0.484091		0	0	0			CXCR4	0.0	0.0	0.0	0.01	-35.0	3.0	-36.0	-35.0						0.329	0.43	83.542972943			craniofacial phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; respiratory system phenotype; neoplasm; 			tonsil;thymus;olfactory bulb;white blood cells;lymph node;trigeminal ganglion;superior cervical ganglion;whole blood;adrenal gland;adrenal cortex;bone marrow;	Cytokine-cytokine receptor interaction;Axon guidance;Leukocyte transendothelial migration	activation of MAPK activity;response to hypoxia;dendritic cell chemotaxis;apoptotic process;chemotaxis;inflammatory response;immune response;G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;axon guidance;brain development;response to virus;fusion of virus membrane with host plasma membrane;calcium-mediated signaling;neurogenesis;entry into host cell;CXCL12-activated CXCR4 signaling pathway;myelin maintenance;positive regulation of oligodendrocyte differentiation;regulation of chemotaxis;cell chemotaxis;cellular response to cytokine stimulus;positive regulation of cold-induced thermogenesis	cytoplasm;lysosome;early endosome;late endosome;plasma membrane;external side of plasma membrane;cell surface;integral component of membrane;cell junction;cell leading edge;cytoplasmic vesicle;protein-containing complex;extracellular exosome	virus receptor activity;actin binding;G protein-coupled receptor activity;protein binding;coreceptor activity;C-C chemokine receptor activity;C-X-C chemokine receptor activity;chemokine binding;C-C chemokine binding;ubiquitin protein ligase binding;myosin light chain binding;C-X-C motif chemokine 12 receptor activity;ubiquitin binding	CD74[19665027];CD164[24094005];TMEM63B[26496610];GOLT1B[26496610];PAUF[20802527];SLC1A1[unassigned1312];CXCR5[23773523];CXCL14[23669361];GNA13[23773523];CD4[10816381];PECAM1[24497640];MYH9[12421915];MYBL2[21988832];ATP13A2[22645275];CCR5[15660419;18632580];DBN1[23926103;20215400];TLR2[20802527;18765807];
173548	chr1	208383748	T	C	chr1:208383748	PLXNA2	plexin A2	2083.0	SNV	0/1	0.59	15_22	37	99	False	rs139127977	EXONIC	YES	NM_025179.4	Transcript	protein_coding	synonymous_variant		3/32	NM_025179.4:c.1248A>G	NP_079455.3:p.Ser416%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.000762877	116.0	152056.0	1.0	31	0.94	PASS	afr	0.00248756	103.0	0.0	0.0	0.000278738	70.0	251132.0	0.0	53	0.97	PASS	afr	0.00277025	45.0	3.52262e-05	4.0	0.0003022	47						3.26	0.040084		0	0	0			PLXNA2	0.0	0.0	0.0	0.0	14.0	-39.0	-23.0	44.0						0.424	0.99	17.887712523			immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; growth/size/body region phenotype; 			.	Axon guidance	somitogenesis;negative regulation of cell adhesion;regulation of cell shape;neural tube development;cerebellar granule cell precursor tangential migration;regulation of cell migration;regulation of GTPase activity;positive regulation of axonogenesis;centrosome localization;pharyngeal system development;limb bud formation;semaphorin-plexin signaling pathway;semaphorin-plexin signaling pathway involved in axon guidance	semaphorin receptor complex;plasma membrane;integral component of plasma membrane	protein binding;semaphorin receptor activity;identical protein binding	FNBP4[12421765];NRP1[19243221];CEMIP[12421765];PDCD6IP[12421765];HACE1[unassigned5];DHX37[unassigned5];UBAP2L[12421765];
173551	chr1	208391177	G	A	chr1:208391177	PLXNA2	plexin A2	2083.0	SNV	0/1	0.38	23_14	37	99	False	rs149664316	EXONIC	YES	NM_025179.4	Transcript	protein_coding	missense_variant		2/32	NM_025179.4:c.91C>T	NP_079455.3:p.Pro31Ser		-1.0	Sema domain	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.000782277	119.0	152120.0	0.0	32	0.96	PASS	afr	0.00255816	106.0	0.0	0.0	0.000291655	73.0	250296.0	0.0	90	0.99	PASS	afr	0.00287572	46.0	4.42337e-05	5.0	0.0003022	47						0.001	-1.751095	0.025	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PLXNA2	0.0	0.0	0.0	0.0	-21.0	-42.0	-45.0	16.0						0.424	0.99	0.0	0.0	-3.968	immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; growth/size/body region phenotype; 			.	Axon guidance	somitogenesis;negative regulation of cell adhesion;regulation of cell shape;neural tube development;cerebellar granule cell precursor tangential migration;regulation of cell migration;regulation of GTPase activity;positive regulation of axonogenesis;centrosome localization;pharyngeal system development;limb bud formation;semaphorin-plexin signaling pathway;semaphorin-plexin signaling pathway involved in axon guidance	semaphorin receptor complex;plasma membrane;integral component of plasma membrane	protein binding;semaphorin receptor activity;identical protein binding	FNBP4[12421765];NRP1[19243221];CEMIP[12421765];PDCD6IP[12421765];HACE1[unassigned5];DHX37[unassigned5];UBAP2L[12421765];
174316	chr14	70633677	C	A	chr14:70633677	SLC8A3	solute carrier family 8 member A3	2100.0	SNV	0/1	0.61	11_17	28	99	False	rs774270009,COSV63519972,COSV63520152	EXONIC	YES	NM_183002.3	Transcript	protein_coding	missense_variant		2/8	NM_183002.3:c.1463G>T	NP_892114.1:p.Arg488Leu		-1.0	.,.,.,.,.					.	.	.		5.25693e-05	8.0	152180.0	0.0	32	0.97	PASS	amr	0.000523423	8.0	0.0	0.0	3.98035e-06	1.0	251234.0	0.0	100	1.0	PASS	amr	2.89118e-05	1.0	0.0	0.0	0.0000064	1						25.2	3.557779	0.588	16	5	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,PrimateAI_pred	SLC8A3	0.0	0.0	0.0	0.0	-6.0	14.0	15.0	5.0						0.388	0.62	0.0	0.851	1.026	homeostasis/metabolism phenotype; muscle phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			pons;subthalamic nucleus;trigeminal ganglion;superior cervical ganglion;	Calcium signaling pathway	hematopoietic progenitor cell differentiation;ion transport;mitochondrial calcium ion transmembrane transport;cellular calcium ion homeostasis;cell communication;learning;memory;regulation of skeletal muscle contraction;telencephalon development;sodium ion transmembrane transport;myelination;oligodendrocyte differentiation;mitochondrial calcium ion homeostasis;regulation of postsynaptic membrane potential;long-term synaptic potentiation;calcium ion transmembrane transport;cellular response to cAMP;cellular response to hypoxia;calcium ion import across plasma membrane;regulation of cardiac conduction;calcium ion export across plasma membrane	mitochondrial outer membrane;endoplasmic reticulum membrane;microtubule;plasma membrane;integral component of plasma membrane;sarcoplasm;cell junction;intrinsic component of plasma membrane;neuromuscular junction;sarcolemma;dendritic spine;perikaryon;perinuclear region of cytoplasm;integral component of postsynaptic membrane	calcium:sodium antiporter activity;calmodulin binding;metal ion binding;ion antiporter activity involved in regulation of postsynaptic membrane potential	GJA8[unassigned1304];
185141	chr16	75512684	A	C	chr16:75512684	CHST6	carbohydrate sulfotransferase 6	2175.0	SNV	0/1	0.73	9_24	33	99	False	rs189849720	EXONIC	YES	NM_021615.5	Transcript	protein_coding	missense_variant		3/3	NM_021615.5:c.1043T>G	NP_067628.1:p.Leu348Arg		-1.0	Sulfotransferase domain,Sulfotransferase domain,Sulfotransferase domain	Uncertain_significance	criteria_provided,_single_submitter	Macular_corneal_dystrophy	Macular corneal dystrophy, 217800 (3), Autosomal recessive	Macular corneal dystrophy	Disease-causing germline mutation(s) (loss of function) in	Recurrent corneal erosions;Photophobia;Corneal crystals;Abnormality of metabolism/homeostasis;Ocular pain;Punctate opacification of the cornea;Severely reduced visual acuity;Decreased corneal thickness;Decreased corneal sensation;Hyperopic astigmatism;Juvenile onset;Autosomal recessive inheritance;Punctate opacification of the cornea;Macular dystrophy;Corneal dystrophy;Recurrent corneal erosions;Photophobia;Abnormality of metabolism/homeostasis		0.000551681	84.0	152262.0	0.0	33	0.99	PASS	amr	0.00189691	29.0	0.000440878	30.0	0.000386889	97.0	250718.0	0.0	100	1.0	PASS	amr	0.00135964	47.0	0.000362338	41.0	0.0003215	50	0.004	12.0	0.00352	40.0		25.1	3.541309	0.576	10	11	21	SIFT,PolyPhen,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred	CHST6	0.0	0.0	0.01	0.0	4.0	-20.0	0.0	-8.0						0.15	0.0		0.838	0.323	vision/eye phenotype; 			.	Keratan sulfate biosynthesis;Glycan structures - biosynthesis 1	carbohydrate metabolic process;N-acetylglucosamine metabolic process;sulfur compound metabolic process;keratan sulfate biosynthetic process	Golgi membrane;Golgi apparatus;trans-Golgi network;integral component of membrane	N-acetylglucosamine 6-O-sulfotransferase activity	.
190683	chr7	150768367	A	G	chr7:150768367	SLC4A2	solute carrier family 4 member 2	2227.0	SNV	0/1	0.55	14_17	31	99	False	rs1341073925	EXONIC	YES	NM_001199692.3	Transcript	protein_coding	missense_variant		13/23	NM_001199692.3:c.1958A>G	NP_001186621.1:p.Lys653Arg		1.0	.,.,.,.					.	.	.						33	0.98											34	0.57														23.8	3.094367	0.073	7	14	21	PolyPhen,LRT_pred,M-CAP_pred,MutationTaster_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred	SLC4A2	0.0	0.0	0.0	0.0	1.0	-18.0	17.0	-25.0						0.0699	1.0	46.604068787	0.993	1.312	growth/size/body region phenotype; endocrine/exocrine gland phenotype; craniofacial phenotype; cellular phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; immune system phenotype; 			placenta;skeletal muscle;	.	anion transport;spermatogenesis;inorganic anion transport;bicarbonate transport;digestive tract development;regulation of intracellular pH;anion transmembrane transport	plasma membrane;integral component of plasma membrane;focal adhesion;membrane;basolateral plasma membrane;apical plasma membrane	inorganic anion exchanger activity;anion transmembrane transporter activity;anion:anion antiporter activity;enzyme binding	LIN54[17531812];ATXN1[23275563];ATL3[26496610];THOC2[26496610];ELL2[26496610];
191375	chr4	108853107	C	T	chr4:108853107	CYP2U1	cytochrome P450 family 2 subfamily U member 1	2245.0	SNV	0/1	0.53	21_24	45	99	False	rs147506864	EXONIC	YES	NM_183075.3	Transcript	protein_coding	missense_variant		1/5	NM_183075.3:c.308C>T	NP_898898.1:p.Pro103Leu		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Spastic_paraplegia|Spastic_paraplegia_56,_autosomal_recessive|Hereditary_spastic_paraplegia	Spastic paraplegia 56, autosomal recessive, 615030 (3), Autosomal recessive	Autosomal recessive spastic paraplegia type 56	Disease-causing germline mutation(s) in	Lower limb hyperreflexia;Hypoplasia of the corpus callosum;Peripheral axonal neuropathy;Babinski sign;Spastic paraplegia;Intellectual disability;Unsteady gait;Abnormal globus pallidus morphology;Dystonia;Cognitive impairment;Spastic gait;Global developmental delay;Toe walking;Unsteady gait;Variable expressivity;Cognitive impairment;Hypoplasia of the corpus callosum;Toe walking;Lower limb hyperreflexia;Autosomal recessive inheritance;Spastic paraplegia;Motor delay;Basal ganglia calcification;Babinski sign		0.00121549	185.0	152202.0	1.0	33	0.99	PASS	amr	0.00222484	34.0	0.00142593	97.0	0.00120349	187.0	155382.0	0.0	43	0.58	PASS	amr	0.00327431	81.0	0.00142022	85.0	0.0005852	91	0.005	17.0	0.00409	39.0		14.12	1.107296	0.05	2	17	19	M-CAP_pred,PROVEAN_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CYP2U1	0.0	0.0	0.0	0.0	24.0	-3.0	4.0	-3.0						0.272	0.08	0.0	0.018	0.056	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			.	Arachidonic acid metabolism	organic acid metabolic process;xenobiotic metabolic process;exogenous drug catabolic process;oxidation-reduction process;omega-hydroxylase P450 pathway	cytoplasm;endoplasmic reticulum membrane;integral component of membrane;organelle membrane;intracellular membrane-bounded organelle	monooxygenase activity;iron ion binding;steroid hydroxylase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;heme binding;aromatase activity	MYC[21150319];
195525	chr15	42379640	A	G	chr15:42379640	PLA2G4D	phospholipase A2 group IVD	2308.0	SNV	0/1	0.5	17_17	34	99	False	rs184535005	SPLICING	YES	NM_178034.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/19		NM_178034.4:c.119-6T>C			-1.0						.	.	.		0.00339317	516.0	152070.0	1.0	32	0.97	PASS	nfe	0.00560377	381.0	0.00560377	381.0	0.00313471	787.0	251060.0	2.0	82	1.0	PASS	nfe	0.00497806	565.0	0.00497806	565.0	0.0031961	497	0.006	20.0				8.405	0.400668		0	0	0			PLA2G4D	0.0	0.06	0.0	0.0	-3.0	-6.0	-4.0	-6.0	8.32506101721022e-05	0.032	3.279	0.46	3.739	0.952	0.0				.			superior cervical ganglion;atrioventricular node;skeletal muscle;	.	phospholipid metabolic process;phosphatidic acid biosynthetic process;phosphatidylglycerol acyl-chain remodeling;phosphatidylinositol acyl-chain remodeling;phosphatidylserine acyl-chain remodeling;phosphatidylcholine acyl-chain remodeling;phosphatidylethanolamine acyl-chain remodeling;glycerophospholipid catabolic process	cytoplasm;cytosol;membrane	lysophospholipase activity;phospholipase A2 activity;calcium ion binding;calcium-dependent phospholipid binding;phospholipase A1 activity;calcium-dependent phospholipase A2 activity;phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine);phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)	.
196759	chr1	12336504	G	A	chr1:12336504	VPS13D	vacuolar protein sorting 13 homolog D	2331.0	SNV	0/1	0.55	13_16	29	99	False	rs139222925,COSV99166152	EXONIC	YES	NM_015378.4	Transcript	protein_coding	synonymous_variant		19/70	NM_015378.4:c.2859G>A	NP_056193.2:p.Gln953%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided	Spinocerebellar ataxia, autosomal recessive 4, 607317 (3), Autosomal recessive	.	.	Abnormality of the cerebral white matter;Pes cavus;Babinski sign;Macrosaccadic oscillations;Dysarthria;Peripheral axonal neuropathy;Nystagmus;Spasticity;Hyperreflexia;Microcephaly;Tremor;Frequent falls;Variable expressivity;Autosomal recessive inheritance;Distal amyotrophy;Intellectual disability, mild;Myoclonus;Adult onset;Muscular hypotonia of the trunk;Gait ataxia;Ataxia;Dystonia;Hypermetric saccades;Fasciculations;Distal muscle weakness;Motor delay		0.00501307	763.0	152202.0	4.0	32	0.96	PASS	nfe	0.00774476	527.0	0.00774476	527.0	0.00626264	1573.0	251172.0	9.0	84	1.0	PASS	nfe	0.0085458	970.0	0.0085458	970.0	0.0060256	937	0.01	33.0				10.13	0.579583		0	0	0			VPS13D	0.0	0.0	0.0	0.0	-50.0	1.0	-12.0	28.0						0.655	1.0	51.152212932			mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;amygdala;prefrontal cortex;subthalamic nucleus;superior cervical ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;skeletal muscle;globus pallidus;	.	protein targeting to vacuole;mitochondrion organization;protein retention in Golgi apparatus;positive regulation of mitophagy	cell;extrinsic component of membrane;extracellular exosome	.	GSK3B[29568061];PLGRKT[29568061];P4HA2[30021884];MGST3[29568061];MADD[12421765];ESR1[21182205];TOMM20[29568061];TOMM22[29568061];
196962	chr16	87723535	C	T	chr16:87723535	JPH3	junctophilin 3	2333.0	SNV	0/1	0.63	13_22	35	99	False	rs190793959	EXONIC	YES	NM_020655.4	Transcript	protein_coding	synonymous_variant		4/5	NM_020655.4:c.1569C>T	NP_065706.2:p.Ala523%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided	Huntington disease-like 2, 606438 (3), Autosomal dominant	Huntington disease-like 2	Disease-causing germline mutation(s) in	Memory impairment;Weight loss;Parkinsonism;Chorea;Functional motor deficit;Caudate atrophy;Hyperreflexia;Dystonia;Cerebral cortical atrophy;Primitive reflex;Dementia;Personality changes;Gait disturbance;Dysarthria;Hyperreflexia;Weight loss;Apathy;Irritability;Bradykinesia;Chorea;Delusions;Rigidity;Action tremor;Autosomal dominant inheritance;Anxiety;Dementia;Dystonia;Hallucinations;Depressivity		0.00362095	551.0	152170.0	0.0	33	0.98	PASS	sas	0.00704517	34.0	0.00598494	407.0	0.00351554	217.0	61726.0	2.0	3	0.19	PASS	nfe	0.00601471	139.0	0.00601471	139.0	0.0012990	202	0.003	10.0	0.00352	40.0		3.604	0.060763		0	0	0			JPH3	0.0	0.0	0.0	0.0	21.0	-20.0	-2.0	25.0							0.99				growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 			amygdala;	.	learning;memory;exploration behavior;locomotion;regulation of synaptic plasticity;regulation of neuronal synaptic plasticity;neuromuscular process controlling balance;release of sequestered calcium ion into cytosol;regulation of ryanodine-sensitive calcium-release channel activity;calcium ion transport into cytosol	endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;junctional sarcoplasmic reticulum membrane;integral component of membrane;junctional membrane complex	molecular_function;calcium-release channel activity	STK24[17353931];SMO[28298427];KRTAP10-8[unassigned1304];TSHR[28298427];PPP1CA[22321011];CCR2[28298427];
200972	chr16	31226238	C	A	chr16:31226238	TRIM72	tripartite motif containing 72	2355.0	SNV	0/1	0.46	21_18	39	99	False	rs1017497201	EXONIC	YES	NM_001008274.4	Transcript	protein_coding	missense_variant		2/7	NM_001008274.4:c.179C>A	NP_001008275.2:p.Thr60Lys		1.0	.,.					.	.	.						32	0.99							4.76317e-05	5.0	104972.0	0.0	8	0.26	PASS	amr	0.000140463	3.0	2.54959e-05	1.0								24.9	3.486183	0.244	12	9	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred	Polyphen2_HVAR_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TRIM72	0.01	0.0	0.0	0.0	-7.0	11.0	2.0	10.0							0.0		0.518	0.95	muscle phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			ciliary ganglion;kidney;subthalamic nucleus;atrioventricular node;skeletal muscle;	.	plasma membrane repair;muscle system process;exocytosis;muscle contraction;muscle organ development;negative regulation of myotube differentiation;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;negative regulation of insulin-like growth factor receptor signaling pathway;negative regulation of insulin receptor signaling pathway;protein homooligomerization	cytoplasmic vesicle membrane;sarcolemma	phosphatidylserine binding;protein binding;zinc ion binding;ubiquitin conjugating enzyme binding;ubiquitin protein ligase activity	TRIM72[unassigned1304];SMARCD1[unassigned1304];UBE2I[19549727];ABI2[unassigned1304];TCF12[25416956;unassigned1304];DDIT4L[unassigned1304];NMI[unassigned1304];ZNF655[unassigned1304];C1orf216[unassigned1304];NFKB1[25609649];
201627	chr17	35620797	C	A	chr17:35620797	ACACA	acetyl-CoA carboxylase alpha	2356.0	SNV	0/1	0.47	17_15	32	99	False		SPLICING	YES	NM_198834.3	Transcript	protein_coding	missense_variant,splice_region_variant		11/56	NM_198834.3:c.1120G>T	NP_942131.1:p.Val374Phe		-1.0	.,.,Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain&ATP-grasp fold&Biotin carboxylation domain,.				Acetyl-CoA carboxylase deficiency, 613933 (1), Autosomal recessive	.	.	Growth delay;Myopathy;Generalized hypotonia;Autosomal recessive inheritance						32	0.96											61	0.99														33.0	5.109671	0.837	17	1	18	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PrimateAI_pred	ACACA	0.0	0.01	0.0	0.0	-7.0	0.0	0.0	1.0	0.999736133430825	0.96	8.371	2.034	10.406	0.0461	1.0	91.653501902	0.997	1.026	growth/size/body region phenotype; homeostasis/metabolism phenotype; embryo phenotype; liver/biliary system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; 			occipital lobe;prefrontal cortex;subthalamic nucleus;superior cervical ganglion;atrioventricular node;cingulate cortex;adipose tissue;prostate;cerebellum peduncles;hypothalamus;thalamus;	Fatty acid biosynthesis;Pyruvate metabolism;Propanoate metabolism;Insulin signaling pathway	tissue homeostasis;acetyl-CoA metabolic process;fatty acid biosynthetic process;carnitine shuttle;protein metabolic process;positive regulation of cellular metabolic process;regulation of cholesterol biosynthetic process;fatty-acyl-CoA biosynthetic process;protein homotetramerization;lipid homeostasis;cellular response to prostaglandin E stimulus;malonyl-CoA biosynthetic process	fibrillar center;cytosol;actin cytoskeleton	acetyl-CoA carboxylase activity;biotin carboxylase activity;protein binding;ATP binding;identical protein binding;metal ion binding	PRKAA1[23455922];ILK[17353931;23455922];ARRB1[17620599];BRCA1[16326698;29899443];IFIT1[21642987];STK4[23386615];GABARAP[20562859];ACACA[20457939;29899443];CIAO1[17353931];STK3[23455922];ATXN1[16713569];EEF2K[23455922];GRK2[23455922];NUDCD1[29021621];MYC[17353931;21150319];PHKG2[23455922];RPS6KA1[23455922];RIOK2[23455922];CHGB[16169070];EGLN3[26972000];CSNK1A1[23455922];SPHK1[25216046];FN1[19738201];CSNK1E[23455922];MCC[17353931];SIRT1[19343720];NFKB1[25609649];NDUFAF8[27499296];AKR1B10[18056116];FGF14[unassigned1304];PPP2R2B[19156129];STK25[23455922];NDUFAF4[27499296];RPL27A[30021884];APOC1[unassigned1304];SIK2[27478041];MAPT[26402096];
204829	chr11	69588861	C	T	chr11:69588861	FGF4	fibroblast growth factor 4	2414.0	SNV	0/1	0.68	10_21	31	99	False	rs773814677	EXONIC	YES	NM_002007.4	Transcript	protein_coding	synonymous_variant		2/3	NM_002007.4:c.375G>A	NP_001998.1:p.Val125%3D		-1.0						.	.	.						34	0.98							4.03656e-06	1.0	247736.0	0.0	46	0.96	PASS	sas	3.27225e-05	1.0	0.0	0.0	0.0000064	1						1.272	-0.115046		0	0	0			FGF4	0.0	0.0	0.0	0.0	-2.0	34.0	-26.0	0.0							0.75	2.873188997			cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; limbs/digits/tail phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; embryo phenotype; 			.	MAPK signaling pathway;Regulation of actin cytoskeleton;Melanoma	MAPK cascade;cartilage condensation;signal transduction;cell-cell signaling;positive regulation of cell population proliferation;fibroblast growth factor receptor signaling pathway;mesenchymal cell proliferation;regulation of signaling receptor activity;peptidyl-tyrosine phosphorylation;stem cell population maintenance;embryonic hindlimb morphogenesis;phosphatidylinositol-3-phosphate biosynthetic process;odontogenesis of dentin-containing tooth;negative regulation of apoptotic process;positive regulation of transcription by RNA polymerase II;phosphatidylinositol phosphorylation;positive regulation of cell division;positive regulation of protein kinase B signaling;cranial suture morphogenesis;apoptotic process involved in morphogenesis;chondroblast differentiation;positive regulation of ERK1 and ERK2 cascade;cellular response to leukemia inhibitory factor;regulation of endothelial cell chemotaxis to fibroblast growth factor	extracellular region	protein tyrosine kinase activity;Ras guanyl-nucleotide exchange factor activity;fibroblast growth factor receptor binding;growth factor activity;heparin binding;1-phosphatidylinositol-3-kinase activity;phosphatidylinositol-4,5-bisphosphate 3-kinase activity	.
205062	chr19	3637456	C	T	chr19:3637456	PIP5K1C	phosphatidylinositol-4-phosphate 5-kinase type 1 gamma	2424.0	SNV	0/1	0.5	16_16	32	99	False	rs150414663	EXONIC	YES	NM_001300849.2	Transcript	protein_coding	synonymous_variant		17/17	NM_001300849.2:c.2076G>A	NP_001287778.1:p.Pro692%3D		-1.0					Lethal congenital contractural syndrome 3, 611369 (3), Autosomal recessive	Lethal congenital contracture syndrome type 3	Disease-causing germline mutation(s) in	Arthrogryposis multiplex congenita;Neonatal death;Multiple joint contractures;Autosomal recessive inheritance;Skeletal muscle atrophy;Respiratory insufficiency		0.00316061	481.0	152186.0	3.0	31	0.95	PASS	nfe	0.00513039	349.0	0.00513039	349.0	0.004086	542.0	132648.0	1.0	41	0.56	PASS	nfe	0.00548229	281.0	0.00548229	281.0	0.0010032,0.0000129	156,2	0.002	5.0	0.0031	26.0		0.163	-0.415593		0	0	0			PIP5K1C	0.0	0.01	0.0	0.0	-23.0	-34.0	11.0	-44.0						0.269	0.86	7.977934542			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; growth/size/body region phenotype; 			.	Inositol phosphate metabolism;Phosphatidylinositol signaling system;Focal adhesion;Regulation of actin cytoskeleton	phosphatidylinositol biosynthetic process;phagocytosis;regulation of phosphatidylinositol 3-kinase signaling;synaptic vesicle exocytosis;actin cytoskeleton organization;neutrophil chemotaxis;adherens junction assembly;phosphatidylinositol phosphorylation;synaptic vesicle endocytosis;membrane organization;clathrin-dependent endocytosis;cell-cell adhesion	phagocytic cup;uropod;nucleoplasm;cytosol;focal adhesion;endosome membrane;ruffle membrane;presynapse	protein binding;ATP binding;1-phosphatidylinositol-4-phosphate 5-kinase activity;1-phosphatidylinositol-3-phosphate 4-kinase activity;phosphatidylinositol-3,4-bisphosphate 5-kinase activity	COQ2[29128334];SOAT1[29128334];VDAC1[29128334];IQGAP1[23982733];
207532	chr11	116693893	G	A	chr11:116693893	APOA4	apolipoprotein A4	2445.0	SNV	0/1	0.46	13_11	24	99	False	rs370537175	EXONIC	YES	NM_000482.4	Transcript	protein_coding	synonymous_variant		1/3	NM_000482.4:c.15C>T	NP_000473.2:p.Ala5%3D		-1.0						.	.	.		9.20072e-05	14.0	152162.0	0.0	33	0.97	PASS	amr	0.000458175	7.0	8.82145e-05	6.0	0.000103456	26.0	251314.0	0.0	100	1.0	PASS	amr	0.000607077	21.0	1.76053e-05	2.0	0.0000386	6	0.001	2.0	0.00044	5.0		11.03	0.684919		0	0	0			APOA4	0.0	0.0	0.0	0.0	-43.0	2.0	-35.0	-34.0						0.722	0.0	7.45005553			mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			trigeminal ganglion;	.	retinoid metabolic process;innate immune response in mucosa;cholesterol biosynthetic process;lipid transport;response to lipid hydroperoxide;leukocyte cell-cell adhesion;cholesterol metabolic process;positive regulation of cholesterol esterification;positive regulation of triglyceride catabolic process;lipid catabolic process;removal of superoxide radicals;triglyceride catabolic process;regulation of intestinal cholesterol absorption;regulation of cholesterol transport;cholesterol efflux;phospholipid efflux;chylomicron remodeling;very-low-density lipoprotein particle remodeling;high-density lipoprotein particle remodeling;chylomicron assembly;high-density lipoprotein particle assembly;negative regulation of plasma lipoprotein oxidation;response to stilbenoid;lipoprotein metabolic process;cholesterol homeostasis;hydrogen peroxide catabolic process;reverse cholesterol transport;cellular protein metabolic process;positive regulation of fatty acid biosynthetic process;phosphatidylcholine metabolic process;positive regulation of lipid biosynthetic process;positive regulation of lipoprotein lipase activity;lipid homeostasis;protein-lipid complex assembly;triglyceride homeostasis	extracellular region;extracellular space;early endosome;endoplasmic reticulum lumen;cytosol;cell surface;very-low-density lipoprotein particle;high-density lipoprotein particle;chylomicron;collagen-containing extracellular matrix;extracellular exosome;blood microparticle	lipid transporter activity;copper ion binding;protein binding;phospholipid binding;lipid binding;cholesterol binding;antioxidant activity;cholesterol transporter activity;phosphatidylcholine binding;identical protein binding;protein homodimerization activity;phosphatidylcholine-sterol O-acyltransferase activator activity	CMTM4[unassigned1304];CMTM5[unassigned1304];ALB[15174051];AGTRAP[unassigned1304];APOA4[22579246];NR1D1[24311788];MAGEA6[unassigned1304];
207574	chr6	56420274	T	C	chr6:56420274	DST	dystonin	2446.0	SNV	0/1	0.61	9_14	23	99	False	rs1220522300	EXONIC	YES	NM_001374736.1	Transcript	protein_coding	missense_variant		60/104	NM_001374736.1:c.15005A>G	NP_001361665.1:p.Lys5002Arg		-1.0	.,.,.,.,.				?Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3), Autosomal recessive; Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiency, 615425 (3), Autosomal recessive	Hereditary sensory and autonomic neuropathy type 6;Epidermolysis bullosa simplex due to BP230 deficiency	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Atrophic scars;Nail dystrophy;Autosomal recessive inheritance;Fever;Feeding difficulties;High palate;Hyperhidrosis;Respiratory insufficiency;Short chin;Autosomal recessive inheritance;Flexion contracture;Blotching pigmentation of the skin;Talipes equinovarus;Open mouth;Corneal scarring;Hand clenching;Tachycardia;Low-set ears;Apnea;Growth delay;Bradycardia;Alacrima;Sensory neuropathy;Areflexia;Neonatal hypotonia;Limited hip extension						32	0.97											89	1.0														19.24	1.937405	0.035	2	13	15	LIST-S2_pred,fathmm-MKL_coding_pred	LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	DST	0.0	0.0	0.0	0.01	-20.0	46.0	0.0	-26.0						0.554	1.0	68.425167686	0.509	0.142	vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); pigmentation phenotype; growth/size/body region phenotype; hematopoietic system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; taste/olfaction phenotype; 			caudate nucleus;ciliary ganglion;amygdala;tongue;prefrontal cortex;skin;superior cervical ganglion;trigeminal ganglion;cingulate cortex;pons;uterus;occipital lobe;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;spinal cord;skeletal muscle;globus pallidus;medulla oblongata;hypothalamus;thalamus;	.	cytoskeleton organization;cell adhesion;integrin-mediated signaling pathway;retrograde axonal transport;response to wounding;maintenance of cell polarity;cytoplasmic microtubule organization;hemidesmosome assembly;wound healing;intermediate filament cytoskeleton organization;cell motility	basement membrane;nucleus;nuclear envelope;cytoplasm;endoplasmic reticulum membrane;cytosol;intermediate filament;focal adhesion;cell cortex;basal plasma membrane;microtubule cytoskeleton;membrane;integral component of membrane;Z disc;hemidesmosome;cell leading edge;cytoplasmic vesicle;H zone;microtubule plus-end;axon cytoplasm	actin binding;integrin binding;structural molecule activity;calcium ion binding;protein binding;microtubule binding;protein C-terminus binding;microtubule plus-end binding	GSK3B[29568061];TRAF3IP1[17043677];SNAP23[26359495];AKR1B1[17353931];C1QTNF9[23414517];MKI67[26949251];TOMM20[29568061];CELSR3[12421765];RPL6[30021884];TOMM22[29568061];PPP1CB[26496610];KIAA1549[12421765];LAMP1[29568061];ANKRD1[23414517];MYO18A[26496610];APPL1[23414517];MYBPC2[23414517];TCTE1[26638075];MTNR1B[26514267];CLIP4[23414517];MYH9[26496610];PRKD2[15231748];TNIK[17043677];MAPRE1[19632184;26496610];EZR[29568061];OPTN[23414517];DBN1[26496610];EXOC1[17043677];PTGER4[28298427];CBFB[20195357];CSTF3[30021884];TULP3[23414517];ATP1A2[30021884];IQGAP1[26496610];ADD1[26496610];STK3[23455922];TGOLN2[29568061];LIMA1[26496610];PUF60[17353931];DISC1[17043677];MAPK6[20936779];PAK2[20936779];SNAPIN[23414517];SSB[30021884];NEK4[25798074];NFYC[20936779];DTNBP1[17043677];SMAD9[15231748];NFKB1[20195357];MOB1B[24255178];MOB1A[24255178];ANLN[26496610];RSL1D1[30021884];TMEM17[26638075];APC[20936779];ABI1[23414517];CAPZA2[26496610];RAB9A[29568061];GRB2[12577067];RNPS1[17353931];BET1[29568061];
212666	chr17	72889677		GGCTCCGTAGGTTCCATGGGCTCCGTAGGTTCCATGGGCTCCGTAGGTTCCATGGGCTCCGTAGGTTCCATGGGCTCCGTAGGTTCCATC	chr17:72889676-72889677	FADS6	fatty acid desaturase 6	2480.0	insertion	1/2	0.5	0_10_17	34	99	False		EXONIC	YES	NM_178128.6	Transcript	protein_coding	inframe_insertion		1/6	NM_178128.6:c.71_72insGATGGAACCTACGGAGCCCATGGAACCTACGGAGCCCATGGAACCTACGGAGCC	NP_835229.3:p.Thr16_Glu33insThrGluProMetGluProThrGluProMetGluProThrGluProMetGluProThrGluProMetGluProThrGluProMetGluPro		-1.0						.	.	.						34	0.88											18	0.47																	0	0	0																	0.595	0.0	18.481425805			.			.	.	fatty acid biosynthetic process;oxidation-reduction process	integral component of membrane	oxidoreductase activity	MTERF3[unassigned1304];KRTAP10-7[unassigned1304];DIABLO[unassigned1304];PNKP[unassigned1304];KRTAP10-8[unassigned1304];PBX3[unassigned1304];FHL3[unassigned1304];GAD2[unassigned1304];RCHY1[21988832];CYSRT1[unassigned1304];TTPA[unassigned1304];ARFIP2[unassigned1304];INPP5K[unassigned1304];KRTAP3-3[unassigned1304];KRTAP5-1[unassigned1304];UBASH3A[unassigned1304];TRIM32[unassigned1304];MDFI[unassigned1304];TMEM14B[unassigned1304];
212667	chr17	72889677		GGCTCCGTAGGTTCCATGGGCTCCGTAGGTTCCATGGGCTCCGTAGGTTCCATC	chr17:72889676-72889677	FADS6	fatty acid desaturase 6	2480.0	insertion	1/2	0.29	0_10_17	34	99	False	rs1598567899,rs1598567993	EXONIC	YES	NM_178128.6	Transcript	protein_coding	inframe_insertion		1/6	NM_178128.6:c.71_72insGATGGAACCTACGGAGCCCATGGAACCTACGGAGCCCATGGAACCTACGGAGCC	NP_835229.3:p.Thr16_Glu33insThrGluProMetGluProThrGluProMetGluProThrGluProMetGluPro		-1.0						.	.	.						34	0.88											18	0.47							0.0024823	386						13.14	0.957974		0	0	0																	0.595	0.0	18.481425805			.			.	.	fatty acid biosynthetic process;oxidation-reduction process	integral component of membrane	oxidoreductase activity	MTERF3[unassigned1304];KRTAP10-7[unassigned1304];DIABLO[unassigned1304];PNKP[unassigned1304];KRTAP10-8[unassigned1304];PBX3[unassigned1304];FHL3[unassigned1304];GAD2[unassigned1304];RCHY1[21988832];CYSRT1[unassigned1304];TTPA[unassigned1304];ARFIP2[unassigned1304];INPP5K[unassigned1304];KRTAP3-3[unassigned1304];KRTAP5-1[unassigned1304];UBASH3A[unassigned1304];TRIM32[unassigned1304];MDFI[unassigned1304];TMEM14B[unassigned1304];
214244	chr10	27356107	C	T	chr10:27356107	ANKRD26	ankyrin repeat domain 26	2499.0	SNV	0/1	0.6	8_12	20	99	False		EXONIC	YES	NM_014915.3	Transcript	protein_coding	missense_variant		10/34	NM_014915.3:c.1186G>A	NP_055730.2:p.Val396Met		-1.0	.,.				Thrombocytopenia 2, 188000 (3), Autosomal dominant	Hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome	Disease-causing germline mutation(s) in	Autosomal dominant inheritance;Thrombocytopenia;Bruising susceptibility						31	0.96											72	1.0														5.558	0.18125	0.04	0	19	19		SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD26	0.0	0.0	0.0	0.01	-17.0	-1.0	-25.0	-21.0						0.985	0.0	41.766699407	0.016	-0.401	renal/urinary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			.	.	negative regulation of fat cell differentiation	centrosome	protein binding	ANKRD28[23414517];BBS1[27107012];JUN[25609649];RBM26[30021884];AHNAK[30021884];CBX2[21282530];AMOT[24255178];CEP128[26638075];CORO1C[30021884];PCM1[26638075];CNTRL[26638075];CANX[30021884];HIST1H1B[30021884];CEP89[26638075];
215095	chr7	121651491	G	A	chr7:121651491	PTPRZ1	protein tyrosine phosphatase, receptor type Z1	2521.0	SNV	0/1	0.39	20_13	33	99	False	rs61758737,COSV66437406	EXONIC	YES	NM_002851.3	Transcript	protein_coding	synonymous_variant		12/30	NM_002851.3:c.2391G>A	NP_002842.2:p.Thr797%3D		1.0						.	.	.		0.000835208	127.0	152058.0	0.0	32	0.97	PASS	amr	0.00216308	33.0	0.00120563	82.0	0.000640679	161.0	251296.0	0.0	100	1.0	PASS	amr	0.00127204	44.0	0.000932606	106.0	0.0006752	105	0.002	7.0				10.32	0.601301		0	0	0			PTPRZ1	0.0	0.0	0.0	0.0	15.0	-21.0	20.0	3.0						0.535	0.99	0.0			integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	Epithelial cell signaling in Helicobacter pylori infection	hematopoietic progenitor cell differentiation;protein dephosphorylation;axonogenesis;central nervous system development;learning or memory;cytokine-mediated signaling pathway;peptidyl-tyrosine dephosphorylation;oligodendrocyte differentiation;regulation of oligodendrocyte progenitor proliferation	plasma membrane;integral component of plasma membrane;intrinsic component of plasma membrane;synapse;perineuronal net	protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding	ALK[17681947];PTPRZ1[15978577];LCK[19167335];ITGB3[20639902];PXN[19167335];ERBB2[19167335];WAS[19167335];CNTN1[21969550];CSK[19167335];ITGAV[20639902];TNF[20195357];
219743	chr19	17283642	C	T	chr19:17283642	MYO9B	myosin IXB	2589.0	SNV	0/1	0.59	12_17	29	99	False	rs747562657,COSV68278162	EXONIC	YES	NM_004145.4	Transcript	protein_coding	synonymous_variant		13/40	NM_004145.4:c.2010C>T	NP_004136.2:p.Tyr670%3D		1.0					{Celiac disease, susceptibility to, 4}, 609753 (3)	.	.	.		9.85662e-05	15.0	152182.0	0.0	32	0.96	PASS	amr	0.000720367	11.0	4.40982e-05	3.0	8.1367e-05	20.0	245800.0	0.0	100	0.99	PASS	amr	0.000289956	10.0	6.28231e-05	7.0	0.0000386	6	0.0	1.0	0.00061	7.0	1.0	0.524	-0.24712		0	0	0			MYO9B	0.0	0.0	0.0	0.0	-37.0	-12.0	0.0	16.0						0.0526	1.0	82.656613938			normal phenotype; hematopoietic system phenotype; immune system phenotype; cellular phenotype; 			ciliary ganglion;pons;testis - seminiferous tubule;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;whole blood;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	.	Rho protein signal transduction;actin filament-based movement;ARF protein signal transduction;regulation of Rho protein signal transduction;Roundabout signaling pathway;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction	cytoplasm;cytosol;actin filament;cell cortex;actin cytoskeleton;membrane;myosin complex;perinuclear region of cytoplasm	microfilament motor activity;actin binding;GTPase activator activity;protein binding;calmodulin binding;ATP binding;ATPase activity;Rho GTPase binding;protein homodimerization activity;ADP binding;metal ion binding;Roundabout binding	ARFGEF1[15644318];FOXG1[25609649];FOXL1[25609649];LRRC41[16169070];RHOA[15644318];MOB4[16169070];NEURL4[29426014];RCN1[30021884];MYC[17314511];PKN2[21900206];HMGN3[30021884];NOMO1[30021884];HIST1H1B[30021884];HIST1H1C[30021884];
221650	chr2	27247103	C	T	chr2:27247103	MAPRE3	microtubule associated protein RP/EB family member 3	2622.0	SNV	0/1	0.43	20_15	35	99	False	rs761152460	EXONIC	YES	NM_001303050.2	Transcript	protein_coding	missense_variant		4/7	NM_001303050.2:c.407C>T	NP_001289979.1:p.Ala136Val		1.0	.,.,.,.,.					.	.	.		1.31354e-05	2.0	152260.0	0.0	33	0.99	PASS	amr	0.000130787	2.0	0.0	0.0	1.98875e-05	5.0	251414.0	0.0	60	1.0	PASS	amr	0.000144576	5.0	0.0	0.0	0.0000129	2						12.22	0.834173	0.181	2	17	19	MutationAssessor_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	MAPRE3	0.0	0.02	0.0	0.07	26.0	-13.0	-5.0	17.0							0.8	0.0	1.0	0.947	hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			ciliary ganglion;amygdala;temporal lobe;testis - seminiferous tubule;prefrontal cortex;skin;testis;cerebellum;pons;occipital lobe;subthalamic nucleus;testis - interstitial;whole brain;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	protein localization;regulation of microtubule polymerization or depolymerization;protein localization to microtubule;positive regulation of cyclin-dependent protein serine/threonine kinase activity;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;spindle assembly;cell division;positive regulation of microtubule plus-end binding;protein localization to microtubule plus-end	cytoplasm;microtubule organizing center;microtubule;cytoplasmic microtubule;midbody;microtubule plus-end;spindle midzone	protein binding;microtubule binding;protein C-terminus binding;protein kinase binding;identical protein binding;microtubule plus-end binding	TEX43[unassigned1304];KLHDC7B[unassigned1304];IKZF1[unassigned1304];MEOX2[unassigned1304];CHRDL2[unassigned1304];TXN2[25416956;unassigned1304];C17orf53[unassigned1304];CRTAC1[unassigned1304];ZNF526[unassigned1304];ANKRD1[unassigned1304];C20orf202[unassigned1304];SPTAN1[22275434];YAF2[unassigned1304];APPL2[25814554];APC2[10644998];LMO2[16189514;21516116;25416956;unassigned1304];KNSTRN[unassigned1304];AES[unassigned1304];TRAIP[unassigned1304];ZC2HC1C[unassigned1304];CLIP1[17563362];PSRC1[unassigned1304];ZC2HC1A[unassigned1304];PSMA1[21516116;25416956];DOK4[25814554];TRIM14[unassigned1304];PICK1[unassigned1304];MAPRE3[27107012;unassigned1304];KIF2C[unassigned1312];FAM161B[unassigned1304];EIF4E2[25416956];MAPRE1[25416956;27107012;27173435;unassigned1304;unassigned1312;29997244];C4orf45[unassigned1304];MAPRE2[16189514;unassigned1304];FOXD4L4[unassigned1304];DBN1[22275434];FOXD4L1[unassigned1304];RAB1A[16169070];DCTN2[27107012];DCTN1[26638075];TROAP[21516116;25416956;unassigned1304];MRPL12[unassigned1304];SDCBP[25416956;unassigned1304];PSMB1[25416956];ZNF547[unassigned1304];GAS2L2[unassigned1304];JUN[20195357];SIAH1[unassigned1304];PDE4DIP[unassigned1304];DDIT4L[unassigned1304];SPDYE6[unassigned1304];MARCH7[unassigned1304];POU4F1[unassigned1304];KIF18B[unassigned1312];TAOK2[unassigned1304];REL[unassigned1304];CCSER1[unassigned1304];LHX4[unassigned1304];
221779	chrX	123654642	AAAA		chrX:123654642-123654645	TENM1	teneurin transmembrane protein 1	2631.0	sequence_alteration	1/2	0.31	0_4_9	13	50	False	rs112813437	SPLICING	YES	NM_001163278.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	17/31		NM_001163278.1:c.3034-11_3034-8del			-1.0						Isolated congenital anosmia	Disease-causing germline mutation(s) in	.		0.00011831	8.0	67619.0	0.0	15	0.37	PASS	nfe	0.000167185	5.0	0.000167185	5.0	0.0146478	850.0	58029.0	0.0	12	0.27	PASS	afr	0.0286106	167.0	0.0121344	307.0	0.0078647,0.0000064	1223,1						0.553	-0.239063		0	0	0			TENM1	0.0	0.02	0.0	0.0	22.0	-16.0	-6.0	-19.0							1.0				.			.	.	regulation of transcription by RNA polymerase III;immune response;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;neuropeptide signaling pathway;nervous system development;negative regulation of cell population proliferation;positive regulation of actin filament polymerization;positive regulation of peptidyl-serine phosphorylation;positive regulation of MAP kinase activity;neuron development;positive regulation of filopodium assembly;positive regulation of intracellular protein transport	extracellular region;nucleus;cytoplasm;endoplasmic reticulum;Golgi apparatus;cytoskeleton;plasma membrane;integral component of plasma membrane;nuclear matrix;nuclear speck;neuron projection;perinuclear region of cytoplasm	heparin binding;protein homodimerization activity;protein heterodimerization activity;cell adhesion molecule binding	NEK4[25798074];HIST2H2BE[30021884];
222312	chr5	176308829	C	T	chr5:176308829	HK3	hexokinase 3	2641.0	SNV	0/1	0.38	16_10	26	99	False	rs200997168	EXONIC	YES	NM_002115.3	Transcript	protein_coding	missense_variant		17/19	NM_002115.3:c.2257G>A	NP_002106.2:p.Gly753Ser		-1.0	Hexokinase, C-terminal					.	.	.		8.54914e-05	13.0	152062.0	0.0	33	0.98	PASS	nfe	0.000161712	11.0	0.000161712	11.0	9.55155e-05	24.0	251268.0	0.0	70	1.0	PASS	afr	0.000184729	3.0	0.000114418	13.0	0.0000965	15						32.0	4.38582	0.632	21	0	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred		HK3	0.05	0.01	0.0	0.0	-50.0	9.0	-2.0	20.0						0.0604	0.0	0.0	0.999	1.026	.			whole blood;bone marrow;	Glycolysis / Gluconeogenesis;Fructose and mannose metabolism;Galactose metabolism;Starch and sucrose metabolism;Streptomycin biosynthesis;Aminosugars metabolism	cellular glucose homeostasis;glycolytic process;neutrophil degranulation;carbohydrate phosphorylation;glucose 6-phosphate metabolic process;canonical glycolysis	extracellular region;cytosol;secretory granule lumen;ficolin-1-rich granule lumen	glucokinase activity;hexokinase activity;ATP binding;glucose binding;fructokinase activity;mannokinase activity	PPP2CB[21988832];FOXB1[25609649];FOXI2[25609649];MITF[21988832];FOXL1[25609649];MEOX2[unassigned1304];ATF4[21988832];
223118	chr11	19970263	A	G	chr11:19970263	NAV2	neuron navigator 2	2654.0	SNV	0/1	0.5	12_12	24	99	False	rs763080757,COSV104414729	EXONIC	YES	NM_001244963.2	Transcript	protein_coding	missense_variant		11/41	NM_001244963.2:c.2351A>G	NP_001231892.1:p.Asn784Ser		1.0	.,.,.,.,.,.					.	.	.		3.28796e-05	5.0	152070.0	0.0	32	0.95	PASS	eas	0.000193274	1.0	2.94048e-05	2.0	8.20499e-06	2.0	243754.0	0.0	36	0.78	PASS	afr	6.18276e-05	1.0	9.03702e-06	1.0	0.0000129	2						9.468	0.506944	0.028	3	16	19	LRT_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	NAV2	0.0	0.0	0.0	0.0	1.0	-26.0	1.0	-44.0						0.373	1.0	0.0	0.964	0.318	integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; taste/olfaction phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; 			ciliary ganglion;fetal brain;prefrontal cortex;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;cingulate cortex;atrioventricular node;trigeminal ganglion;spinal cord;skeletal muscle;globus pallidus;	.	regulation of systemic arterial blood pressure by baroreceptor feedback;nervous system development;sensory perception of sound;sensory perception of smell;locomotory behavior;optic nerve development;glossopharyngeal nerve development;vagus nerve development;neurogenesis	interstitial matrix;nucleoplasm	helicase activity;protein binding;ATP binding;heparin binding	ING4[25416956];ING5[16189514;25416956];MORF4L1[25416956];RBM15B[25416956];RBM15[25416956];APC[20936779];MYC[21150319];CFAP58[25416956];MKI67[30021884];PIAS2[16189514;25416956];ADAT2[25416956];
223518	chr20	42331285	C	T	chr20:42331285	MYBL2	MYB proto-oncogene like 2	2666.0	SNV	0/1	0.56	12_15	27	99	False	rs181688716	EXONIC	YES	NM_002466.4	Transcript	protein_coding	synonymous_variant		8/14	NM_002466.4:c.1107C>T	NP_002457.1:p.Thr369%3D		1.0						.	.	.		2.62829e-05	4.0	152190.0	0.0	32	0.97	PASS	amr	0.000130907	2.0	2.93945e-05	2.0	6.36958e-05	16.0	251194.0	0.0	100	1.0	PASS	amr	0.00011564	4.0	7.92086e-05	9.0	0.0000643	10						9.448	0.504815		0	0	0			MYBL2	0.0	0.0	0.0	0.0	32.0	-26.0	2.0	24.0							0.99	15.808990294			cellular phenotype; neoplasm; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; embryo phenotype; immune system phenotype; 			tumor;	.	mitotic cell cycle;regulation of transcription by RNA polymerase II;positive regulation of neuron apoptotic process;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;regulation of cell cycle;mitotic spindle assembly;cellular response to leukemia inhibitory factor	nucleoplasm;Myb complex	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding	LIN54[17531812;19725879];HDAC2[17159899];LIN37[17531812];UBE2D4[21988832];CXCR4[21988832];LIN9[17159899;17531812];TTF2[12927788];CTDSPL2[26496610];FOXM1[25609649];DHRS2[30021884];MAP1LC3B[21900206];RBBP4[27705803];PPP2R3C[26496610];NUF2[26496610];HIST1H1E[30021884];E2F3[17159899];ZSCAN26[26496610];E2F4[17159899];MAPK6[21900206];TEAD2[25609649];HIST1H1B[30021884];LIN52[17531812];
225347	chr16	88788618	G	A	chr16:88788618	PIEZO1	piezo type mechanosensitive ion channel component 1	2695.0	SNV	0/1	0.41	19_13	32	99	False	rs533263001	SPLICING	YES	NM_001142864.4	Transcript	protein_coding	splice_region_variant,intron_variant	36/50		NM_001142864.4:c.4955+8C>T			-1.0		Benign	criteria_provided,_single_submitter	not_provided	Lymphatic malformation 6, 616843 (3), Autosomal recessive; Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3), Autosomal dominant	Dehydrated hereditary stomatocytosis	Disease-causing germline mutation(s) (gain of function) in	Pulmonary venous hypertension;Neonatal hyperbilirubinemia;Increased mean corpuscular hemoglobin concentration;Edema;Schistocytosis;Nonspherocytic hemolytic anemia;Portal vein thrombosis;Episodic fatigue;Reticulocytosis;Macrocytic anemia;Polycythemia;Increased lactate dehydrogenase level;Increased red cell osmotic fragility;Abdominal pain;Congenital hemolytic anemia;Thromboembolism;Intermittent jaundice;Increased serum ferritin;Cholelithiasis;Increased mean corpuscular volume;Splenomegaly;Increased total bilirubin;Abnormal blood potassium concentration;Increased hemoglobin concentration;Prune belly;Hypothyroidism;Short stature;Varicose veins;Chylothorax;Scoliosis;Periorbital edema;Cellulitis;Autosomal recessive inheritance;Hearing impairment;Generalized edema;Epicanthus;Gastroesophageal reflux;Webbed neck;Facial edema;Nonimmune hydrops fetalis;Ascites;Global developmental delay;Cupped ear;Atrial septal defect;Micrognathia;Pectus excavatum;Hydrocele testis;Splenomegaly;Genital edema;Polyhydramnios;Deep venous thrombosis;Lymphedema;Intestinal lymphangiectasia;Autosomal dominant inheritance;Increased mean corpuscular hemoglobin concentration;Exercise-induced hemolysis;Increased serum ferritin;Conjunctival icterus;Hepatomegaly;Cholelithiasis;Hemoglobinuria;Jaundice;Reticulocytosis;Increased red cell hemolysis by shear stress;Splenomegaly;Pallor;Hepatitis		0.000591351	90.0	152194.0	1.0	34	0.98	PASS	amr	0.00143941	22.0	0.000235232	16.0	0.000239061	35.0	146406.0	0.0	21	0.51	PASS	afr	0.000775795	6.0	0.000283537	16.0	0.0001801	28	0.001	2.0				0.028	-0.655075		0	0	0			PIEZO1	0.0	0.07	0.08	0.0	-45.0	45.0	8.0	-16.0	0.0002177929220021	0.018					0.54				homeostasis/metabolism phenotype; growth/size/body region phenotype; embryo phenotype; immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			white blood cells;tumor;prostate;	.	cation transport;positive regulation of integrin activation;positive regulation of cell-cell adhesion mediated by integrin;regulation of membrane potential;detection of mechanical stimulus;cellular response to mechanical stimulus;cation transmembrane transport	endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;integral component of membrane;lamellipodium membrane;endoplasmic reticulum-Golgi intermediate compartment membrane	cation channel activity;mechanosensitive ion channel activity	GJB2[26496610];RAB5C[26496610];VAPA[26496610];GOLT1B[26496610];RAB7A[26496610];
225895	chr21	28216791	C	T	chr21:28216791	ADAMTS1	ADAM metallopeptidase with thrombospondin type 1 motif 1	2709.0	SNV	0/1	0.5	19_19	38	99	False	rs61753557	EXONIC	YES	NM_006988.5	Transcript	protein_coding	synonymous_variant		1/9	NM_006988.5:c.483G>A	NP_008919.3:p.Leu161%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00159629	243.0	152228.0	1.0	33	0.97	PASS	sas	0.00786749	38.0	0.00173427	118.0	0.00323436	637.0	196948.0	1.0	38	0.58	PASS	sas	0.0103461	278.0	0.00242278	203.0	0.0024887	387	0.001	4.0	0.00273	26.0		6.77	0.266056		0	0	0			ADAMTS1	0.0	0.0	0.0	0.0	-12.0	-38.0	3.0	-37.0						0.398	0.59	51.991954658			endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); renal/urinary system phenotype; 			ciliary ganglion;ovary;superior cervical ganglion;atrioventricular node;uterus corpus;trigeminal ganglion;placenta;adrenal cortex;	.	ovulation from ovarian follicle;kidney development;proteolysis;integrin-mediated signaling pathway;negative regulation of cell population proliferation;heart trabecula formation;positive regulation of G1/S transition of mitotic cell cycle;positive regulation of vascular smooth muscle cell proliferation;positive regulation of vascular associated smooth muscle cell migration	basement membrane;cytoplasmic vesicle;collagen-containing extracellular matrix	metalloendopeptidase activity;heparin binding;metallopeptidase activity;zinc ion binding	KRTAP10-8[unassigned1304];KRT40[unassigned1304];USP17L24[19615732];
226690	chr11	108155132	G	A	chr11:108155132	ATM	ATM serine/threonine kinase	2720.0	SNV	0/1	0.64	9_16	25	99	False	rs149711770,COSV53733128,COSV53743932	EXONIC	YES	NM_001351834.2	Transcript	protein_coding	missense_variant		27/64	NM_001351834.2:c.3925G>A	NP_001338763.1:p.Ala1309Thr		1.0	.,.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Hereditary_breast_and_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_specified|Breast_and/or_ovarian_cancer|not_provided	Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)	Ataxia-telangiectasia;Ataxia-telangiectasia variant;B-cell chronic lymphocytic leukemia;Mantle cell lymphoma	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in	Somatic mutation;Autosomal dominant inheritance;Heterogeneous;Breast carcinoma;Weight loss;Abnormality of the gastrointestinal tract;B-cell lymphoma;Lymphadenopathy;Abnormality of bone marrow cell morphology;Anorexia;Fatigue;Splenomegaly;Fever;Autosomal recessive inheritance;Dysarthria;Ataxia;Elevated alpha-fetoprotein;Choreoathetosis;Diabetes mellitus;Seizure;Abnormal spermatogenesis;Leukemia;Decreased proportion of CD4-positive helper T cells;Dystonia;Nystagmus;Hypoplasia of the thymus;Conjunctival telangiectasia;Sinusitis;Decreased circulating IgA level;Female hypogonadism;Abnormal hair morphology;Lymphoma;Tremor;Strabismus;Myoclonus;Short stature;Decreased circulating IgG2 level;Defective B cell differentiation;Recurrent bronchitis;Non-Hodgkin lymphoma;Glucose intolerance;Hodgkin lymphoma;Delayed puberty;Reduced tendon reflexes;Cafe-au-lait spot;Bronchiectasis;Spasticity;Skeletal muscle atrophy;Tremor;Lymphopenia;Type II diabetes mellitus;Hypopigmentation of hair;Aplasia/Hypoplasia of the skin;Gait disturbance;Seizure;Cellular immunodeficiency;Strabismus;Abnormality of chromosome stability;Polycystic ovaries;Dysarthria;Abnormal testis morphology;Nystagmus;Recurrent respiratory infections;Premature graying of hair;Neoplasm;Delayed puberty;Failure to thrive;Multiple cafe-au-lait spots;Elevated hepatic transaminase;Short stature;Cognitive impairment;Mucosal telangiectasiae;Decreased circulating antibody level;Ataxia;Aplasia/Hypoplasia of the thymus;Telangiectasia of the skin	25741868	0.000749438	114.0	152114.0	0.0	32	0.97	PASS	nfe	0.0013672	93.0	0.0013672	93.0	0.00068461	172.0	251238.0	0.0	72	1.0	PASS	nfe	0.00121498	138.0	0.00121498	138.0	0.0006752	105	0.0	1.0	0.00035	4.0		19.79	2.007389	0.235	5	14	19	LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	ATM	0.01	0.0	0.0	0.0	-21.0	47.0	26.0	-21.0						0.782	0.0	0.0	0.719	-0.237	nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); neoplasm; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; 			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;	Cell cycle;p53 signaling pathway;Apoptosis	DNA damage checkpoint;telomere maintenance;DNA double-strand break processing;response to hypoxia;pre-B cell allelic exclusion;DNA replication;double-strand break repair via nonhomologous end joining;protein phosphorylation;cellular response to DNA damage stimulus;DNA damage induced protein phosphorylation;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;cell cycle arrest;mitotic spindle assembly checkpoint;reciprocal meiotic recombination;signal transduction;intrinsic apoptotic signaling pathway in response to DNA damage;response to ionizing radiation;regulation of autophagy;positive regulation of gene expression;histone phosphorylation;peptidyl-serine phosphorylation;positive regulation of cell migration;negative regulation of B cell proliferation;regulation of telomere maintenance via telomerase;positive regulation of telomere maintenance via telomerase;positive regulation of histone phosphorylation;phosphatidylinositol-3-phosphate biosynthetic process;peptidyl-serine autophosphorylation;regulation of apoptotic process;positive regulation of apoptotic process;positive regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neuron apoptotic process;positive regulation of cell adhesion;positive regulation of transcription by RNA polymerase II;protein autophosphorylation;regulation of telomerase activity;histone mRNA catabolic process;cellular response to retinoic acid;cellular response to gamma radiation;cellular response to X-ray;cellular response to nitrosative stress;signal transduction involved in mitotic G2 DNA damage checkpoint;replicative senescence;establishment of RNA localization to telomere;establishment of protein-containing complex localization to telomere;regulation of cellular response to heat;regulation of signal transduction by p53 class mediator;positive regulation of DNA catabolic process;regulation of microglial cell activation;negative regulation of TORC1 signaling;negative regulation of telomere capping;positive regulation of telomere maintenance via telomere lengthening;positive regulation of telomerase catalytic core complex assembly;regulation of cellular response to gamma radiation	chromosome, telomeric region;nuclear chromosome, telomeric region;nucleus;nucleoplasm;nucleolus;cytoplasmic vesicle;DNA repair complex	DNA binding;protein serine/threonine kinase activity;DNA-dependent protein kinase activity;protein binding;ATP binding;1-phosphatidylinositol-3-kinase activity;protein-containing complex binding;protein dimerization activity;protein N-terminus binding	MDC1[12607005;29656893];ERRFI1[25640309];MT-ND4[25640309];MTRR[26496610];IL24[25640309];GMNN[26496610];BHLHE41[26496610];BRCA1[29656893];AATF[17157788];PPP1CC[17274640];ODR4[26496610];MYC[21150319];RUVBL1[20371770];IKBKG[18583959];NBN[25895060];UTP15[26496610];BCAS3[25640309];ZER1[26496610];ATMIN[17525732];ACTL6B[25640309];MAP1S[25640309];H2AFX[16858402;22451927];MINK1[26496610];P3H2[26496610];PPP2R5C[21460856];TERF1[11375976;15314656];SMC1A[11877377];TERF2[15314656];YWHAZ[30021884];TTI2[20810650];TTI1[20810650];RRM2B[19015526];PEX5[26344566];TFF1[25640309];TP53[10864201];TELO2[18160036;20801936];SRSF8[26496610];RBM47[26496610];MTMR3[26496610];NOTCH1[25895060];FECH[25640309];BRAT1[16452482];RNF8[18001825];CRX[27107012];NOLC1[26496610];CD99L2[26496610];NREP[25640309];NSD3[25640309];BAG6[26496610];ABL1[11375976;9168117];SFN[20843328];ZNF821[25640309];VHL[17353931];TP53BP1[22621922;29656893];MTA3[25640309];DCAF13[26496610];HSPA8[25640309];NDUFA8[26496610];RRM1[19015526];NRDC[26496610];OSGIN1[25640309];HMGA2[26045162];PPP1CA[17274640];FBXO31[19412162];NR4A1[25640309];SNW1[20467437];PER3[21070773];NAT2[25640309];TDP1[19851285];ALB[15174051];NABP2[18449195];ATM[20360068];TPT1[22451927];TAF1[26496610];
228259	chr16	2813952	C	G	chr16:2813952	SRRM2	serine/arginine repetitive matrix 2	2732.0	SNV	0/1	0.5	19_19	38	99	False	rs72768766,COSV100070675	EXONIC	YES	NM_016333.4	Transcript	protein_coding	missense_variant		11/15	NM_016333.4:c.3423C>G	NP_057417.3:p.Asp1141Glu		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00335094	510.0	152196.0	1.0	32	0.97	PASS	nfe	0.00559965	381.0	0.00559965	381.0	0.00408384	1026.0	251234.0	4.0	100	1.0	PASS	nfe	0.00635239	722.0	0.00635239	722.0	0.0044500	692	0.005	15.0				16.46	1.533776	0.039	3	16	19	LRT_pred,M-CAP_pred,FATHMM_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SRRM2	0.0	0.0	0.0	0.0	-17.0	20.0	-1.0	-13.0						0.174		0.0	0.136	-0.238	.			superior cervical ganglion;cingulate cortex;prostate;skeletal muscle;adrenal cortex;	.	mRNA splicing, via spliceosome	nucleus;nucleoplasm;Cajal body;nuclear speck;U2-type catalytic step 2 spliceosome;catalytic step 2 spliceosome	RNA binding;protein N-terminus binding;C2H2 zinc finger domain binding	YWHAB[15324660;17353931];EIF4A3[23084401];HDAC11[23752268];ILK[25852190];ARRB1[17620599];ARRB2[17620599];DDX41[25920683];OSBPL10[19615732];MAP1LC3B[20562859];MAP1LC3A[20562859];MAGOH[23084401];SNIP1[22365833];HIF1AN[29426014];YWHAG[15324660;17353931];YWHAH[26496610];USP42[19615732];CSNK2A1[22113938;25852190];PRPF4B[23602568];YWHAZ[15161933];PRPF6[22365833];MAGEB2[17353931];SRSF4[22365833];SF1[26420826];PFKFB2[26496610];HDAC2[23752268];RPL10[30021884];GABARAP[20562859];HDAC6[23752268];NUAK1[25852190];RASSF10[24366813];IFI16[25665578];EPB41L3[24366813];SFN[15778465];BAK1[17353931];TTC14[22365833];SRPK2[23602568];SRPK3[23602568];SF3A2[17332742];NEK4[25798074];PYHIN1[25665578];ESR1[21182205];CLK4[23602568];ESR2[21182203;25604459];CLK3[23602568];PLEKHA7[28877994];SRPK1[23602568;25852190];SNW1[20467437];RNPS1[17353931];PTPN4[28330616];PTPN3[28330616];
228545	chr7	123516943	G	A	chr7:123516943	HYAL4	hyaluronidase 4	2737.0	SNV	0/1	0.6	10_15	25	99	False	rs139736892	EXONIC	YES	NM_012269.3	Transcript	protein_coding	missense_variant		5/5	NM_012269.3:c.1180G>A	NP_036401.2:p.Ala394Thr		1.0	.,.					.	.	.		0.00298323	454.0	152184.0	2.0	32	0.97	PASS	nfe	0.00507084	345.0	0.00507084	345.0	0.00274052	689.0	251412.0	3.0	100	1.0	PASS	nfe	0.0046609	530.0	0.0046609	530.0	0.0028938	450	0.004	14.0				5.248	0.161089	0.022	1	18	19	SIFT	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HYAL4	0.0	0.0	0.0	0.0	32.0	-34.0	-23.0	-27.0						0.929	0.0	0.0	0.05	0.218	skeleton phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 			appendix;testis - interstitial;trigeminal ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;globus pallidus;	.	carbohydrate metabolic process;glycosaminoglycan catabolic process;chondroitin sulfate catabolic process	cell surface;integral component of membrane	hyalurononglucosaminidase activity	NEK4[25798074];
238468	chr2	206991447	T	C	chr2:206991447	NDUFS1	NADH:ubiquinone oxidoreductase core subunit S1	2867.0	SNV	0/1	0.55	15_18	33	99	False	rs142716964,COSV51910662	EXONIC	YES	NM_001199984.2	Transcript	protein_coding	missense_variant		17/19	NM_001199984.2:c.2048A>G	NP_001186913.1:p.Asn683Ser		-1.0	NADH-quinone oxidoreductase, chain G, C-terminal,.,.,NADH-quinone oxidoreductase, chain G, C-terminal,.,NADH-quinone oxidoreductase, chain G, C-terminal,.	Uncertain_significance	criteria_provided,_multiple_submitters,_no_conflicts	Leigh_syndrome|Mitochondrial_complex_1_deficiency,_nuclear_type_5|Mitochondrial_complex_I_deficiency,_nuclear_type_1|not_provided	Mitochondrial complex I deficiency, nuclear type 5, 618226 (3), Autosomal recessive	Isolated complex I deficiency;Leigh syndrome with leukodystrophy	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sensorineural hearing impairment;Respiratory insufficiency;Leukoencephalopathy;Paroxysmal involuntary eye movements;Microcephaly;Nystagmus;Lethargy;Hypoglycemia;Increased CSF lactate;Strabismus;Proximal tubulopathy;Hypertrophic cardiomyopathy;Failure to thrive;Abnormal mitochondria in muscle tissue;Mitochondrial myopathy;Lactic acidosis;Ataxia;Focal T2 hyperintense brainstem lesion;Optic disc pallor;Increased serum pyruvate;Feeding difficulties;Blindness;Leukodystrophy;Poor eye contact;Global developmental delay;Encephalopathy;Vomiting;Poor head control;Decreased activity of mitochondrial complex I;Fetal distress;Ptosis;Diabetes mellitus;Intrauterine growth retardation;Muscular hypotonia;Optic neuropathy;Hepatomegaly;Intellectual disability, severe;Increased serum lactate;Ophthalmoplegia;Apnea;Nystagmus;Global developmental delay;Decreased activity of mitochondrial respiratory chain;Emotional lability;Seizure;Hyperreflexia;Ventricular septal defect;Decreased activity of the pyruvate dehydrogenase complex;Focal T2 hyperintense basal ganglia lesion;Failure to thrive;Pigmentary retinopathy;Ptosis;Hypertrichosis;Anemia;Increased CSF lactate;Optic atrophy;Hearing impairment;Muscular hypotonia;Dysarthria;Progressive spastic paraplegia;Progressive cerebellar ataxia;Strabismus;Peripheral neuropathy;Dystonia;Hypertrophic cardiomyopathy;Leukodystrophy;Autosomal recessive inheritance;Cerebellar atrophy;Seizure;Generalized hypotonia;Poor speech;Lethargy;Optic atrophy;Ataxia;Progressive;Leukoencephalopathy;Nystagmus;Failure to thrive;Apnea;Strabismus;Hyperreflexia;Leukodystrophy;Brain atrophy;Dystonia;Ophthalmoplegia;Progressive microcephaly;Dysphagia;Ptosis;Global developmental delay;Babinski sign;Irritability;Infantile onset;Respiratory insufficiency;Lactic acidosis;Developmental regression;Vomiting		0.00016429	25.0	152170.0	0.0	33	0.97	PASS	nfe	0.000323463	22.0	0.000323463	22.0	0.000194943	49.0	251356.0	0.0	100	1.0	PASS	nfe	0.000369562	42.0	0.000369562	42.0	0.0001994	31			0.00026	3.0		10.19	0.586282	0.034	2	16	18	FATHMM_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	NDUFS1	0.0	0.0	0.15	0.0	24.0	13.0	1.0	-13.0						0.208	0.0	0.000000000	0.992	-0.636	vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			amygdala;occipital lobe;subthalamic nucleus;skeletal muscle;globus pallidus;	Oxidative phosphorylation	mitochondrial electron transport, NADH to ubiquinone;apoptotic mitochondrial changes;mitochondrial respiratory chain complex I assembly;cellular respiration;ATP metabolic process;regulation of mitochondrial membrane potential;reactive oxygen species metabolic process	mitochondrion;mitochondrial respiratory chain complex I;mitochondrial intermembrane space;mitochondrial matrix;myelin sheath;plasma membrane respiratory chain complex I	NADH dehydrogenase activity;protein binding;NADH dehydrogenase (ubiquinone) activity;electron transfer activity;metal ion binding;2 iron, 2 sulfur cluster binding;4 iron, 4 sulfur cluster binding	PIGS[unassigned1312];NDUFA13[24344204];NDUFA11[24344204];GOLT1B[26496610];GDI1[unassigned1312];NDUFA12[24344204];GPAA1[unassigned1312];FASTKD3[20869947];COX4I1[29568061];ARRB1[17620599];C1QTNF9[23414517];ECE2[23455924];HSCB[28380382];ECSIT[24344204];AIFM1[29568061];TCTN3[26638075];MYC[17314511];FGFR1OP2[26496610];PDK1[29568061];MMGT1[26496610];HLA-B[17353931];SIRT4[25525879];COQ10A[27499296];COX6B1[27499296];ACAP2[unassigned1312];NDUFS7[24344204];SOAT1[unassigned1312;29128334];SCO1[29568061];NOA1[19103604];NDUFS6[24344204];NDUFS5[24344204];NDUFS4[24344204];BTK[21080425];NDUFS3[24344204];VDAC1[29128334];AURKAIP1[29568061];RAB7A[26496610];RAB5C[26496610];COX15[29128334];MGST3[29568061];HTT[17500595];MRPL58[20186120];HSFY1[25036637];EHBP1[unassigned1312];HSPD1[29568061];STOM[unassigned1312];E2F3[22157815];COX14[29568061];NDUFV2[24344204];NDUFV1[24344204];NDUFA9[24344204;unassigned1312];VCAM1[22623428;19738201];NDUFA6[12611891];NEK4[25798074];MBOAT7[unassigned1312];NDUFA2[19688755];DHRS4[27499296];NDUFAF8[27499296];VAPA[26496610];TNIP3[19615732];NDUFAF4[27499296];SFXN1[29568061];NDUFAF1[24344204];NIT1[27499296];TRMT61B[29568061];
238500	chr12	123481019	C	T	chr12:123481019	PITPNM2	phosphatidylinositol transfer protein membrane associated 2	2869.0	SNV	1/1	1.0	0_33	33	99	True	rs147212495,COSV99758769	EXONIC	YES	NM_001384660.1	Transcript	protein_coding	missense_variant		12/26	NM_001384660.1:c.1768G>A	NP_001371589.1:p.Val590Met		-1.0	.,.,.					.	.	.		0.00481041	732.0	152170.0	6.0	33	0.98	PASS	amr	0.00654536	100.0	0.00635107	432.0	0.00515014	1287.0	249896.0	11.0	55	0.99	PASS	nfe	0.00652962	735.0	0.00652962	735.0	0.0050352	783	0.008	25.0				23.9	3.144729	0.059	4	15	19	Polyphen2_HDIV_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	PITPNM2	0.0	0.01	0.29	0.02	-2.0	46.0	-2.0	-14.0						0.163	1.0	0.000000000	0.997	1.026	normal phenotype; 			pons;appendix;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	phosphatidylinositol biosynthetic process;phospholipid transport;phosphatidylinositol-mediated signaling	cytoplasm;cytosol;endomembrane system;membrane;cell body	calcium ion binding;phosphatidylcholine transporter activity;phosphatidylinositol transporter activity;receptor tyrosine kinase binding;phosphatidylcholine binding;phosphatidylinositol binding	VAPA[26496610];
240239	chr1	119929268	G	A	chr1:119929268	HAO2	hydroxyacid oxidase 2	2897.0	SNV	0/1	0.41	16_11	27	99	False	rs35295280	EXONIC	YES	NM_001005783.3	Transcript	protein_coding	synonymous_variant		6/9	NM_001005783.3:c.624G>A	NP_001005783.2:p.Gln208%3D		1.0						.	.	.		0.00226108	344.0	152140.0	3.0	32	0.97	PASS	nfe	0.00407185	277.0	0.00407185	277.0	0.00273778	686.0	250568.0	1.0	86	1.0	PASS	nfe	0.00479544	542.0	0.00479544	542.0	0.0028295	440	0.006	19.0				2.368	-0.017469		0	0	0			HAO2	0.01	0.13	0.0	0.0	15.0	-23.0	15.0	1.0						0.949	0.0	7.947566600			.			ciliary ganglion;kidney;liver;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	Glyoxylate and dicarboxylate metabolism	protein targeting to peroxisome;fatty acid catabolic process;fatty acid oxidation	peroxisome;peroxisomal matrix;cytosol	(S)-2-hydroxy-acid oxidase activity;signaling receptor binding;FMN binding;very-long-chain-(S)-2-hydroxy-acid oxidase activity;long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity;medium-chain-(S)-2-hydroxy-acid oxidase activity	SEC14L4[unassigned1304];
242978	chr4	85715776	C	T	chr4:85715776	WDFY3	WD repeat and FYVE domain containing 3	2917.0	SNV	0/1	0.37	12_7	19	99	False	rs143975457	EXONIC	YES	NM_014991.6	Transcript	protein_coding	missense_variant		21/68	NM_014991.6:c.3383G>A	NP_055806.2:p.Arg1128Gln		-1.0					?Microcephaly 18, primary, autosomal dominant, 617520 (3), Autosomal dominant	.	.	Autosomal dominant inheritance;Intellectual disability, mild;Intellectual disability, moderate;Microcephaly		1.97571e-05	3.0	151844.0	0.0	32	0.96	PASS	amr	6.56599e-05	1.0	2.94135e-05	2.0	3.18195e-05	8.0	251418.0	0.0	88	1.0	PASS	sas	9.79944e-05	3.0	2.63801e-05	3.0	0.0000129	2			9e-05	1.0		22.9	2.686351	0.218	5	14	19	LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	WDFY3	0.0	0.04	0.0	0.0	-42.0	47.0	26.0	47.0						0.279	1.0	0.000000000	0.964	1.026	cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; 			ciliary ganglion;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;	.	multicellular organism development;aggrephagy	nucleus;nuclear envelope;nucleolus;cytoplasm;autophagosome;cytosol;plasma membrane;inclusion body;PML body;extrinsic component of membrane;axon;nuclear membrane;Atg12-Atg5-Atg16 complex;perikaryon;extrinsic component of autophagosome membrane	beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity;protein binding;1-phosphatidylinositol binding;metal ion binding	RAB5C[26496610];SUV39H1[23455924];HTT[20417604];PIK3R3[25814554];ZBTB44[25416956];GABARAP[20562859;24668264];BAG6[26496610];MAP1LC3B[18083104;20417604;24668264];ATXN1[20417604];EEF2K[23455922];MAP1LC3C[24668264];MYC[21150319];CEP76[25416956];TNS2[25814554];ATG5[20417604];SNCA[20417604];PRMT6[23455924];GABARAPL2[24668264];RTEL1-TNFRSF6B[26496610];RABGAP1L[25814554];GABARAPL1[24668264];DAXX[26496610];SGTB[26496610];PRMT1[23455924];STAT3[25814554];TMEM132A[26496610];NEDD1[26496610];WEE1[26496610];TRIM39[21516116;25416956];TERF2IP[26496610];GRB2[25814554];S100A4[26496610];HIST1H2BH[30021884];SQSTM1[20417604];MDFI[21516116];NFE2L1[26496610];
243162	chr11	62678530	C	T	chr11:62678530	CHRM1	cholinergic receptor muscarinic 1	2924.0	SNV	0/1	0.54	12_14	26	99	False	rs781306085	EXONIC	YES	NM_000738.3	Transcript	protein_coding	missense_variant		2/2	NM_000738.3:c.43G>A	NP_000729.2:p.Val15Ile		-1.0	.,.,.					.	.	.		6.57601e-06	1.0	152068.0	0.0	32	0.97	PASS	nfe	1.47046e-05	1.0	1.47046e-05	1.0	3.97858e-05	10.0	251346.0	0.0	63	1.0	PASS	sas	0.000130676	4.0	5.27742e-05	6.0	0.0000322	5						13.99	1.086614	0.065	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CHRM1	0.0	0.0	0.0	0.0	-13.0	29.0	19.0	-25.0							0.93	0.000000000	0.999	1.011	endocrine/exocrine gland phenotype; immune system phenotype; homeostasis/metabolism phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; 			.	Calcium signaling pathway;Neuroactive ligand-receptor interaction;Regulation of actin cytoskeleton	cellular protein modification process;signal transduction;G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway;protein kinase C-activating G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway;G protein-coupled acetylcholine receptor signaling pathway;chemical synaptic transmission;neuromuscular synaptic transmission;nervous system development;cell population proliferation;positive regulation of cell population proliferation;regulation of locomotion;positive regulation of ion transport;saliva secretion;cognition;regulation of postsynaptic membrane potential;positive regulation of intracellular protein transport;G protein-coupled serotonin receptor signaling pathway	plasma membrane;integral component of plasma membrane;membrane;cell junction;dendrite;axon terminus;Schaffer collateral - CA1 synapse;glutamatergic synapse;cholinergic synapse;integral component of presynaptic membrane;integral component of postsynaptic density membrane	phosphatidylinositol phospholipase C activity;G protein-coupled receptor activity;G protein-coupled serotonin receptor activity;drug binding;G protein-coupled acetylcholine receptor activity;neurotransmitter receptor activity;neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential	ARRB1[24069330];ARRB2[24069330];GPRASP1[15086532];GPRASP2[15086532];
243338	chr14	70237973	G	A	chr14:70237973	SRSF5	serine and arginine rich splicing factor 5	2936.0	SNV	0/1	0.53	14_16	30	99	False	rs141668513,COSV53682615,COSV99384315	EXONIC	YES	NM_001039465.2	Transcript	protein_coding	missense_variant		8/8	NM_001039465.2:c.614G>A	NP_001034554.1:p.Arg205His		1.0	.,.,.,.					.	.	.		6.57454e-05	10.0	152102.0	0.0	33	0.97	PASS	amr	0.000393288	6.0	0.0	0.0	2.78359e-05	7.0	251474.0	0.0	100	1.0	PASS	eas	0.000108731	2.0	2.63718e-05	3.0	0.0000322	5						24.8	3.440448	0.231	7	12	19	SIFT,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	SRSF5	0.01	0.0	0.0	0.0	25.0	-17.0	5.0	-18.0							0.34	0.000000000	1.0	1.176	.			.	.	regulation of alternative mRNA splicing, via spliceosome;mRNA splicing, via spliceosome;mRNA splice site selection;mRNA processing;RNA export from nucleus;mRNA export from nucleus;mRNA 3'-end processing;cellular response to insulin stimulus;positive regulation of RNA splicing;mRNA cis splicing, via spliceosome;regulation of cell cycle;liver regeneration	nucleus;nucleoplasm;nucleolus;cytosol;nuclear speck	RNA binding;protein binding;protein kinase B binding	FLII[26496610];DDX41[25920683];NR3C1[20195357];MKI67[26949251];DUX4[26816005];GABARAP[20562859];PAK1[17389360];RPS6KA1[21900206];CCNL2[18216018];HIF1AN[29426014];MAPK6[21900206];CCNL1[18216018];CCR2[28298427];SMAD2[20195357];SRPK2[23602568];GABARAPL2[20562859];ZRSR2[unassigned1304];GABARAPL1[20562859];JUN[25609649];SF3A2[17332742];PRPF38A[27173435;unassigned1312];TNK2[16169070];MAPK14[18624398];ESR1[21182205];ESR2[21182203;25604459];OLFM2[16169070];SNW1[20467437];SRSF3[unassigned1312];HDGF[21907836];SNRPF[22365833];SRSF6[unassigned1312];CD101[16169070];SF1[26420826];
243855	chr11	57004322	C	T	chr11:57004322	APLNR	apelin receptor	2946.0	SNV	0/1	0.27	32_12	44	99	False	rs145108815,COSV57243481	EXONIC	YES	NM_005161.5	Transcript	protein_coding	missense_variant		1/1	NM_005161.5:c.157G>A	NP_005152.1:p.Val53Met		-1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.000932799	142.0	152230.0	1.0	33	0.98	PASS	amr	0.00555919	85.0	0.000514313	35.0	0.000792153	199.0	251214.0	0.0	75	1.0	PASS	amr	0.00274789	95.0	0.000607619	69.0	0.0007717	120	0.006	20.0	0.0076	14.0		23.3	2.88985	0.085	6	13	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred,fathmm-MKL_coding_pred	LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	APLNR	0.0	0.0	0.0	0.0	-14.0	-1.0	-1.0	50.0							0.43	0.000000000	0.973	1.026	growth/size/body region phenotype; muscle phenotype; homeostasis/metabolism phenotype; renal/urinary system phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			olfactory bulb;amygdala;prefrontal cortex;subthalamic nucleus;superior cervical ganglion;placenta;spinal cord;hypothalamus;thalamus;	Neuroactive ligand-receptor interaction	angiogenesis;vasculogenesis;G protein-coupled receptor signaling pathway;gastrulation;heart development;adult heart development;negative regulation of cAMP-mediated signaling;positive regulation of angiogenesis;regulation of body fluid levels;positive regulation of release of sequestered calcium ion into cytosol;coronary vasculature development;positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis;positive regulation of inhibitory G protein-coupled receptor phosphorylation	plasma membrane;integral component of plasma membrane	G protein-coupled receptor activity;signaling receptor activity	MTCH1[28298427];GJB2[unassigned1304];NDRG4[28298427];SETD3[28298427];LAMP2[28298427];AKR1B1[28298427];MARK4[28298427];
244383	chr8	16859332	A	G	chr8:16859332	FGF20	fibroblast growth factor 20	2960.0	SNV	0|1	0.12	34_5	40	99	False	rs112352647,COSV51662402	EXONIC	YES	NM_019851.3	Transcript	protein_coding	synonymous_variant		1/3	NM_019851.3:c.210T>C	NP_062825.1:p.Tyr70%3D		-1.0					?Renal hypodysplasia/aplasia 2, 615721 (3), Autosomal recessive	Renal agenesis, bilateral	Disease-causing germline mutation(s) (loss of function) in	Potter facies;Redundant skin;Pulmonary hypoplasia;Autosomal recessive inheritance;Epicanthus;Oligohydramnios;Urogenital fistula;Cleft palate;Non-midline cleft lip;Abnormality of cardiovascular system morphology;Low-set ears;Tracheoesophageal fistula;Pulmonary hypoplasia;Abnormal intestine morphology;Hypertelorism;Abnormal morphology of female internal genitalia;Nonketotic hypoglycemia;Abnormal sacrum morphology;Renal agenesis;Depressed nasal ridge;Fetal polyuria;Sirenomelia		6.57549e-06	1.0	152080.0	0.0	33	0.97	PASS	afr	2.41301e-05	1.0	0.0	0.0					12	0.32							0.0000450	7	0.0	0.0				12.87	0.920892		0	0	0			FGF20	0.0	0.0	0.0	0.0	41.0	-25.0	-37.0	-25.0							0.7	74.967803553			hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); 			uterus corpus;skeletal muscle;	MAPK signaling pathway;Regulation of actin cytoskeleton;Melanoma	MAPK cascade;signal transduction;cell-cell signaling;positive regulation of cell population proliferation;fibroblast growth factor receptor signaling pathway;regulation of signaling receptor activity;regulation of dopamine secretion;peptidyl-tyrosine phosphorylation;phosphatidylinositol-3-phosphate biosynthetic process;negative regulation of neuron apoptotic process;phosphatidylinositol phosphorylation;positive regulation of protein kinase B signaling;regulation of cardiac muscle cell proliferation;inner ear receptor cell differentiation;positive regulation of ERK1 and ERK2 cascade;positive regulation of dopaminergic neuron differentiation	extracellular region	protein tyrosine kinase activity;Ras guanyl-nucleotide exchange factor activity;signaling receptor binding;fibroblast growth factor receptor binding;growth factor activity;1-phosphatidylinositol-3-kinase activity;heparan sulfate proteoglycan binding;phosphatidylinositol-4,5-bisphosphate 3-kinase activity;receptor-receptor interaction	.
244384	chr8	16859347	G	C	chr8:16859347	FGF20	fibroblast growth factor 20	2960.0	SNV	0|1	0.12	37_5	43	99	False	rs796448091	EXONIC	YES	NM_019851.3	Transcript	protein_coding	synonymous_variant		1/3	NM_019851.3:c.195C>G	NP_062825.1:p.Arg65%3D		-1.0					?Renal hypodysplasia/aplasia 2, 615721 (3), Autosomal recessive	Renal agenesis, bilateral	Disease-causing germline mutation(s) (loss of function) in	Potter facies;Redundant skin;Pulmonary hypoplasia;Autosomal recessive inheritance;Epicanthus;Oligohydramnios;Urogenital fistula;Cleft palate;Non-midline cleft lip;Abnormality of cardiovascular system morphology;Low-set ears;Tracheoesophageal fistula;Pulmonary hypoplasia;Abnormal intestine morphology;Hypertelorism;Abnormal morphology of female internal genitalia;Nonketotic hypoglycemia;Abnormal sacrum morphology;Renal agenesis;Depressed nasal ridge;Fetal polyuria;Sirenomelia						33	0.97											9	0.28							0.0000064	1						13.76	1.049983		0	0	0			FGF20	0.0	0.0	0.0	0.0	-27.0	-40.0	1.0	-40.0							0.7				hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); 			uterus corpus;skeletal muscle;	MAPK signaling pathway;Regulation of actin cytoskeleton;Melanoma	MAPK cascade;signal transduction;cell-cell signaling;positive regulation of cell population proliferation;fibroblast growth factor receptor signaling pathway;regulation of signaling receptor activity;regulation of dopamine secretion;peptidyl-tyrosine phosphorylation;phosphatidylinositol-3-phosphate biosynthetic process;negative regulation of neuron apoptotic process;phosphatidylinositol phosphorylation;positive regulation of protein kinase B signaling;regulation of cardiac muscle cell proliferation;inner ear receptor cell differentiation;positive regulation of ERK1 and ERK2 cascade;positive regulation of dopaminergic neuron differentiation	extracellular region	protein tyrosine kinase activity;Ras guanyl-nucleotide exchange factor activity;signaling receptor binding;fibroblast growth factor receptor binding;growth factor activity;1-phosphatidylinositol-3-kinase activity;heparan sulfate proteoglycan binding;phosphatidylinositol-4,5-bisphosphate 3-kinase activity;receptor-receptor interaction	.
246490	chr8	144799903	G	A	chr8:144799903	MAPK15	mitogen-activated protein kinase 15	2987.0	SNV	0/1	0.46	13_11	24	99	False	rs45495391,COSV62030049	EXONIC	YES	NM_139021.3	Transcript	protein_coding	missense_variant		2/14	NM_139021.3:c.106G>A	NP_620590.2:p.Gly36Ser		1.0	Protein kinase domain&Protein kinase, ATP binding site&Protein kinase domain,.,.					.	.	.		0.00313403	477.0	152200.0	3.0	32	0.97	PASS	nfe	0.0053803	366.0	0.0053803	366.0	0.00286419	704.0	245794.0	4.0	83	0.79	PASS	nfe	0.00489756	545.0	0.00489756	545.0	0.0029324	456	0.006	19.0				26.1	3.763276	0.333	12	9	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	MAPK15	0.02	0.0	0.0	0.0	41.0	-39.0	5.0	0.0						0.938	0.0	0.0	0.236	1.144	.			.	.	MAPK cascade;regulation of COPII vesicle coating;cellular response to DNA damage stimulus;endoplasmic reticulum organization;positive regulation of cell population proliferation;regulation of gene expression;regulation of autophagy;negative regulation of cell migration;positive regulation of telomere maintenance via telomerase;intracellular signal transduction;protein autophosphorylation;positive regulation of telomerase activity;dopamine uptake;regulation of cilium assembly;positive regulation of telomere capping;protein localization to ciliary transition zone;positive regulation of metaphase/anaphase transition of meiosis I;positive regulation of spindle assembly	extracellular region;nucleus;cytoplasm;autophagosome;Golgi apparatus;centriole;cell-cell junction;bicellular tight junction;axoneme;cytoplasmic vesicle;ciliary basal body;meiotic spindle	chromatin binding;protein kinase activity;MAP kinase activity;protein binding;ATP binding;kinase activity;SH3 domain binding	RBM14[23602568];HSP90AB1[22939624];WDR81[23602568];CDK2[23455922;25852190];ESYT2[23602568];B2M[23602568];CACNA1H[23602568];MAPK12[23602568];LTF[23602568];
247172	chr17	73813515	T	C	chr17:73813515	UNK	unkempt family zinc finger	3004.0	SNV	0/1	0.62	13_21	34	99	False	rs763366409	EXONIC	YES	NM_001080419.3	Transcript	protein_coding	missense_variant		9/16	NM_001080419.3:c.1213T>C	NP_001073888.2:p.Ser405Pro		1.0						.	.	.		5.26046e-05	8.0	152078.0	0.0	32	0.98	PASS	nfe	7.35208e-05	5.0	7.35208e-05	5.0	3.21908e-05	8.0	248518.0	0.0	47	0.98	PASS	amr	8.71384e-05	3.0	3.55492e-05	4.0	0.0000257	4						12.68	0.895487	0.11	0	17	17		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	UNK	0.0	0.0	0.0	0.0	30.0	-40.0	19.0	-2.0							0.99	0.0	1.0	1.138	homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; respiratory system phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			.	.	neuron migration;cell morphogenesis involved in neuron differentiation;negative regulation of cytoplasmic translation	cytoplasm;polysome	RNA binding;metal ion binding;polysome binding;mRNA CDS binding	CAMK2D[29426014];ATXN1[16713569];PAX8[20195357];SAV1[24255178];
248316	chr3	75986717	G	A	chr3:75986717	ROBO2	roundabout guidance receptor 2	3034.0	SNV	0/1	0.31	44_20	65	99	False	rs78834776,COSV72212208	EXONIC	YES	NM_001378191.1	Transcript	protein_coding	missense_variant		2/30	NM_001378191.1:c.73G>A	NP_001365120.1:p.Val25Met		1.0	.,.	Benign	criteria_provided,_single_submitter	Vesicoureteral_reflux_2	Vesicoureteral reflux 2, 610878 (3), Autosomal dominant	Familial vesicoureteral reflux	Disease-causing germline mutation(s) in	Vesicoureteral reflux;Renal hypoplasia;Autosomal dominant inheritance						32	0.93							0.308273	33746.0	109468.0	0.0	40	0.93	InbreedingCoeff	afr	0.423606	3388.0	0.361428	19207.0	0.0024115	375	0.001	4.0	0.11134	935.0		5.758	0.194492		0	11	11		MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.324	1.0		0.007	0.251	muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; renal/urinary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			fetal brain;cingulate cortex;trigeminal ganglion;	Axon guidance	metanephros development;ureteric bud development;outflow tract septum morphogenesis;aortic valve morphogenesis;pulmonary valve morphogenesis;endocardial cushion formation;homophilic cell adhesion via plasma membrane adhesion molecules;axon guidance;central nervous system development;brain development;axon midline choice point recognition;spinal cord development;olfactory bulb interneuron development;retinal ganglion cell axon guidance;cellular response to hormone stimulus;Roundabout signaling pathway;positive regulation of Notch signaling pathway involved in heart induction;aorta development;positive regulation of axonogenesis;negative regulation of negative chemotaxis;negative regulation of synapse assembly;ventricular septum morphogenesis;apoptotic process involved in luteolysis	plasma membrane;cell surface;integral component of membrane;axolemma;extracellular exosome	protein binding;axon guidance receptor activity;identical protein binding	ROBO2[12504588];ROBO1[12504588];GPR152[unassigned1304];PARD6B[26496610];RPS6KA5[21900206];RDH11[21900206];TMEM248[26496610];MYC[21150319];KIF1C[26496610];FADD[unassigned1774];UBQLN4[16713569];BNIP3L[21900206];CENPU[21900206];OR1D4[unassigned1304];NR1H2[21900206];METTL3[26496610];SSRP1[16169070];KCNRG[21900206];NR4A1[21900206];OLFM2[16169070];KIF2A[26496610];VAPA[26496610];TMEM237[unassigned1304];PPP1R1B[16169070];HLA-DPB1[21900206];CPE[16169070];
251896	chr9	139581620	G	A	chr9:139581620	AGPAT2	1-acylglycerol-3-phosphate O-acyltransferase 2	3052.0	SNV	0/1	0.45	17_14	31	99	False	rs199860398	SPLICING	YES	NM_006412.4	Transcript	protein_coding	splice_region_variant,intron_variant	1/5		NM_006412.4:c.182+8C>T			-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Congenital_generalized_lipodystrophy_type_1|not_provided	Lipodystrophy, congenital generalized, type 1, 608594 (3), Autosomal recessive	Berardinelli-Seip congenital lipodystrophy	Disease-causing germline mutation(s) in	Hepatomegaly;Intellectual disability;Broad foot;Abnormal circulating creatine kinase concentration;Lipoatrophy;Acanthosis nigricans;Decreased circulating IgA level;Recurrent infections;Precocious puberty;Secondary amenorrhea;Generalized hirsutism;Spinal rigidity;Diabetes mellitus;Mandibular prognathia;Loss of subcutaneous adipose tissue in limbs;Prolonged QTc interval;Hepatic steatosis;Dysmenorrhea;Hyperlordosis;Abnormality of skin pigmentation;Failure to thrive;Scoliosis;Hyperinsulinemia;Delayed skeletal maturation;Osteopenia;Large hands;Bone cyst;Glomerulopathy;Myocardial infarction;Bradycardia;Abnormal oral cavity morphology;Accelerated skeletal maturation;Atherosclerosis;Nephropathy;Ventriculomegaly;Atlantoaxial dislocation;Pancreatitis;Ventricular hypertrophy;Oligomenorrhea;Pulmonary arterial hypertension;Hypertriglyceridemia;Elevated hepatic transaminase;Arterial stenosis;Growth hormone excess;Myopathy;Polycystic ovaries;Immunodeficiency;Progressive proximal muscle weakness;Renal insufficiency;Congestive heart failure;Atrial fibrillation;Palpitations;Hyperhidrosis;Splenomegaly;Skeletal muscle hypertrophy;Prominent supraorbital ridges;Growth hormone deficiency;Flexion contracture;Insulin resistance;Exercise-induced myalgia;Peripheral neuropathy;Abnormality of skeletal muscle fiber size;Osteoporosis;Hypertrophic cardiomyopathy;Pyloric stenosis;Recurrent fractures;Muscle stiffness;Cirrhosis;Hepatic failure;Autosomal recessive inheritance;Splenomegaly;Triangular face;Reduced intraabdominal adipose tissue;Hypertriglyceridemia;Cystic angiomatosis of bone;Large hands;Cirrhosis;Generalized muscular appearance from birth;Nephrolithiasis;Hirsutism;Umbilical hernia;Tall stature;Decreased serum leptin;Long foot;Acanthosis nigricans;Decreased fertility in females;Macrotia;Lipodystrophy;Hepatomegaly;Polyphagia;Elevated hepatic transaminase;Cardiomyopathy;Clitoral hypertrophy;Insulin-resistant diabetes mellitus at puberty;Heterogeneous;Acute pancreatitis;Decreased fertility in females;Hepatic steatosis;Reduced intrathoracic adipose tissue;Prominent umbilicus;Reduced subcutaneous adipose tissue;Polycystic ovaries;Hyperinsulinemia;Mandibular prognathia;Labial hypertrophy;Accelerated skeletal maturation		0.00205856	313.0	152048.0	0.0	33	0.98	PASS	nfe	0.00360474	245.0	0.00360474	245.0	0.00197846	392.0	198134.0	0.0	22	0.57	PASS	nfe	0.00378591	335.0	0.00378591	335.0	0.0014919	232	0.002	6.0	0.00255	29.0		1.39	-0.101791		0	0	0			AGPAT2	0.0	0.0	0.01	0.0	13.0	22.0	8.0	3.0						0.108	0.0				homeostasis/metabolism phenotype; craniofacial phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; limbs/digits/tail phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; 			.	Glycerolipid metabolism;Glycerophospholipid metabolism;Ether lipid metabolism	positive regulation of cytokine production;positive regulation of cytokine-mediated signaling pathway;phospholipid metabolic process;phosphatidic acid biosynthetic process;epidermis development;CDP-diacylglycerol biosynthetic process;response to drug;neutrophil degranulation	endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;integral component of membrane;specific granule membrane	1-acylglycerol-3-phosphate O-acyltransferase activity	ANKRD28[21988832];SLC23A2[21988832];ABCG8[21988832];INTU[unassigned1312];PHF11[21988832];GMPS[21988832];PHRF1[21988832];TMEM173[29251827];
253879	chr12	21526294	C	T	chr12:21526294	IAPP	islet amyloid polypeptide	3105.0	SNV	0/1	0.57	14_20	35	99	False	rs145555931	EXONIC	YES	NM_000415.3	Transcript	protein_coding	synonymous_variant		2/3	NM_000415.3:c.9C>T	NP_000406.1:p.Ile3%3D		1.0						.	.	.		0.000460169	70.0	152118.0	0.0	32	0.97	PASS	amr	0.00150583	23.0	0.0	0.0	0.00013541	34.0	251090.0	0.0	67	1.0	PASS	afr	0.00135368	22.0	2.64289e-05	3.0	0.0001865	29	0.0	1.0	0.00044	5.0		0.377	-0.295604		0	0	0			IAPP	0.01	0.01	0.0	0.0	-43.0	-23.0	-43.0	12.0						0.416	0.17	59.17925532			immune system phenotype; skeleton phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			beta cell islets;pancreas;trigeminal ganglion;superior cervical ganglion;	Maturity onset diabetes of the young	apoptotic process;signal transduction;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;cell-cell signaling;regulation of signaling receptor activity;positive regulation of protein kinase A signaling;negative regulation of mitochondrion organization;sensory perception of pain;negative regulation of protein homooligomerization;eating behavior;positive regulation of apoptotic process;positive regulation of MAPK cascade;cellular protein metabolic process;negative regulation of cell differentiation;negative regulation of bone resorption;protein homooligomerization;positive regulation of protein kinase B signaling;amylin receptor signaling pathway;negative regulation of amyloid fibril formation	extracellular region;extracellular space;neuronal cell body	amyloid-beta binding;signaling receptor binding;hormone activity;protein binding;identical protein binding	IAPP[21130765;24042052;24561193;17640888;18408164];IDE[17051221];
258392	chr17	7321001	ACCG		chr17:7321001-7321004	NLGN2	neuroligin 2	3133.0	deletion	0|1	0.17	10_2	12	54	False		EXONIC	YES	NM_020795.4	Transcript	protein_coding	frameshift_variant		7/7	NM_020795.4:c.2391_2394del	NP_065846.1:p.Pro798HisfsTer106		1.0						.	.	.		8.66805e-05	13.0	149976.0	0.0	26	0.69	AS_VQSR	eas	0.000201126	1.0	7.43893e-05	5.0					3	0.0														32.0	4.429837		0	0	0			NLGN2	0.0	0.0	0.0	0.0	-13.0	35.0	-13.0	49.0							0.99				growth/size/body region phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	Cell adhesion molecules (CAMs)	regulation of respiratory gaseous exchange by neurological system process;neuron cell-cell adhesion;synapse assembly;sensory perception of pain;positive regulation of insulin secretion;positive regulation of synaptic transmission, GABAergic;protein localization to synapse;locomotory exploration behavior;cell-cell junction maintenance;synaptic vesicle endocytosis;modulation of chemical synaptic transmission;synapse organization;neuromuscular process controlling balance;positive regulation of synapse assembly;positive regulation of synaptic transmission, glutamatergic;terminal button organization;postsynaptic membrane assembly;presynaptic membrane assembly;gephyrin clustering involved in postsynaptic density assembly;postsynaptic density protein 95 clustering;positive regulation of inhibitory postsynaptic potential;cell-cell adhesion;presynapse assembly;positive regulation of protein localization to synapse;inhibitory synapse assembly;regulation of AMPA receptor activity;positive regulation of excitatory postsynaptic potential;positive regulation of synaptic vesicle clustering	plasma membrane;integral component of plasma membrane;cell surface;membrane;cell junction;presynaptic membrane;synapse;postsynaptic membrane;inhibitory synapse;spanning component of membrane;glycinergic synapse;dopaminergic synapse;symmetric, GABA-ergic, inhibitory synapse;integral component of postsynaptic membrane;integral component of postsynaptic specialization membrane	signaling receptor activity;neurexin family protein binding;identical protein binding;cell adhesion molecule binding	.
258512	chr21	45732999	T	C	chr21:45732999	PFKL	phosphofructokinase, liver type	3140.0	SNV	0/1	0.39	14_9	23	99	False	rs145436051	EXONIC	YES	NM_001002021.3	Transcript	protein_coding	missense_variant		8/25	NM_001002021.3:c.716T>C	NP_001002021.2:p.Ile239Thr		1.0	Phosphofructokinase domain				Hemolytic anemia due to phosphofructokinase deficiency (1)	.	.	.		0.000197197	30.0	152132.0	0.0	33	0.98	PASS	nfe	0.000308878	21.0	0.000308878	21.0	0.000271707	68.0	250270.0	0.0	75	1.0	PASS	nfe	0.000381037	43.0	0.000381037	43.0	0.0001736	27						25.8	3.716432	0.609	18	3	21	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,ClinPred_pred	PFKL	0.0	0.0	0.0	0.0	-4.0	-5.0	26.0	-5.0						0.507	0.0	0.0	0.995	0.996	.			ciliary ganglion;kidney;liver;subthalamic nucleus;atrioventricular node;superior cervical ganglion;cingulate cortex;skeletal muscle;	Glycolysis / Gluconeogenesis;Pentose phosphate pathway;Fructose and mannose metabolism;Galactose metabolism;Insulin signaling pathway	fructose 6-phosphate metabolic process;glucose catabolic process;glycolytic process;response to glucose;fructose 1,6-bisphosphate metabolic process;neutrophil degranulation;negative regulation of insulin secretion;protein complex oligomerization;protein homotetramerization;canonical glycolysis	extracellular region;cytosol;6-phosphofructokinase complex;membrane;secretory granule lumen;extracellular exosome;ficolin-1-rich granule lumen	6-phosphofructokinase activity;protein binding;ATP binding;AMP binding;kinase binding;identical protein binding;metal ion binding;monosaccharide binding;fructose binding;fructose-6-phosphate binding	SMARCB1[30108113];ATN1[16713569];TESK1[21988832];DUSP16[28330616];RELB[14743216];TUBA1A[29568061];MAP3K8[14743216];IKBKE[14743216];TSNAX[26496610];MAP3K3[14743216];KRTAP5-9[25416956];VCAM1[22623428];KRTAP10-7[25416956];NEK4[25798074];STAT1[26966684];HLA-B[17353931];FN1[19738201];TRAF2[14743216];PRPF40A[15231748];FOXP4[25609649];NFKB2[14743216];TNFRSF1A[14743216];GTPBP3[25416956];PFKL[6444721;25416956];COPS6[16169070];SNW1[12840015];KRTAP4-12[16189514];CEP162[26638075];TAB2[14743216];ANG[28777577];PFKM[6444721;21988832];MYD88[21988832];
259890	chr19	45864903		GGCGGGGAGGAGAGACGGG	chr19:45864902-45864903	ERCC2	ERCC excision repair 2, TFIIH core complex helicase subunit	3191.0	insertion	0/1	0.32	18_9	28	99	False		SPLICING	YES	NM_000400.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	11/22		NM_000400.4:c.1119-21_1119-3dup			-1.0					Xeroderma pigmentosum, group D, 278730 (3), Autosomal recessive; Trichothiodystrophy 1, photosensitive, 601675 (3), Autosomal recessive; ?Cerebrooculofacioskeletal syndrome 2, 610756 (3), Autosomal recessive	COFS syndrome;Xeroderma pigmentosum;Xeroderma pigmentosum-Cockayne syndrome complex;Trichothiodystrophy	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Skin rash;Short stature;Hearing impairment;Hydrocephalus;Confusion;Abnormality of amino acid metabolism;Urticaria;Poikiloderma;Dry skin;Arteriosclerosis;Global developmental delay;Nystagmus;Cachexia;Demyelinating peripheral neuropathy;Optic atrophy;Intellectual disability;Numerous pigmented freckles;Prematurely aged appearance;Ataxia;Melanoma;Dermal atrophy;Cutaneous photosensitivity;Retinopathy;Diplopia;Spasticity;Dysarthria;Basal cell carcinoma;Microcephaly;Squamous cell carcinoma of the skin;Cataract;Keratoconjunctivitis sicca;Choreoathetosis;Mental deterioration;Ataxia;Entropion;Dermal atrophy;Hyporeflexia;Defective DNA repair after ultraviolet radiation damage;Telangiectasia;Cutaneous photosensitivity;Spasticity;Autosomal recessive inheritance;Photophobia;Keratitis;Conjunctivitis;Microphthalmia;Corneal neovascularization;Ectropion;Microcephaly;Poikiloderma;Melanoma;Sensorineural hearing impairment;Intellectual disability;Hypoplasia of dental enamel;Intention tremor;Low-set nipples;Tiger tail banding;Aplasia/Hypoplasia of the nails;Hypoplasia of mandible relative to maxilla;Microcephaly;Nystagmus;Prematurely aged appearance;Psychomotor retardation;Cardiomyopathy;Dry skin;Dystrophic fingernails;Diffuse cerebellar atrophy;Concave nail;Dysarthria;Gait ataxia;Panhypogammaglobulinemia;Clubbing;Generalized hypotonia;Dysphonia;Generalized hyperreflexia;Ventriculomegaly;Cutaneous photosensitivity;Thoracic kyphosis;Neutropenia;Ventricular septal defect;Fragile nails;Absence of subcutaneous fat;Numerous pigmented freckles;Epicanthus;Spasticity;Increased mean corpuscular hemoglobin concentration;Partial agenesis of the corpus callosum;Peripheral neuropathy;Ridged nail;Periventricular leukomalacia;Brittle hair;Bird-like facies;Macular degeneration;Paraplegia/paraparesis;Craniosynostosis;Developmental cataract;Carious teeth;Anemia;Generalized-onset seizure;Bronchospasm;Hypotelorism;Eczema;Cryptorchidism;Hyporeflexia;Cerebral cortical atrophy;Photophobia;Intrauterine growth retardation;Squamous cell carcinoma;Ectropion;Coarse facial features;Abnormality of prenatal development or birth;Bilateral sensorineural hearing impairment;Esotropia;High, narrow palate;Osteopenia;Alopecia of scalp;Congenital exfoliative erythroderma;Joint dislocation;Delayed skeletal maturation;Impaired social reciprocity;Microcornea;Global developmental delay;Sparse scalp hair;Abnormal pyramidal sign;Astigmatism;Multiple joint contractures;Defective DNA repair after ultraviolet radiation damage;Protruding ear;Hypertelorism;Ichthyosis;Increased bone mineral density;Gonadal dysgenesis;Recurrent bronchopulmonary infections;Retrognathia;Umbilical hernia;Cerebral dysmyelination;Bilateral microphthalmos;Myopia;Keratoconjunctivitis sicca;Split nail;Flat nasal alae;Short stature;Ectropion;Abnormality of the dentition;Cataract;Freckling;Delayed skeletal maturation;Peripheral neuropathy;Reduced tendon reflexes;Intellectual disability, progressive;Hypopigmented skin patches;Fatigue;Melanocytic nevus;Poikiloderma;Strabismus;Ataxia;Abnormality of extrapyramidal motor function;EEG abnormality;Alopecia;Pterygium;Fever;Cognitive impairment;Hyperkeratosis;Thin skin;Cerebral cortical atrophy;Cutaneous photosensitivity;Arthralgia;Spasticity;Neoplasm of the eye;Keratitis;Telangiectasia of the skin;Dermal atrophy;Blepharitis;Craniofacial hyperostosis;Decreased testicular size;Hypogonadism;Optic atrophy;Developmental regression;Melanoma;Hypermelanotic macule;Entropion;Sensorineural hearing impairment;Failure to thrive;Conjunctival telangiectasia;Aminoaciduria;Opacification of the corneal stroma;Erythema;Dry skin;Microcephaly;Ankyloblepharon;Seizure;Cryptorchidism;Photophobia;Papilloma;Death in childhood;Large beaked nose;Sparse hair;Developmental cataract;Cutaneous photosensitivity;Autosomal recessive inheritance;Global developmental delay;Camptodactyly of finger;Micropenis;Micrognathia;Microphthalmia;Kyphoscoliosis;Microcephaly;Intrauterine growth retardation;Convex nasal ridge;Cataract;Hearing impairment;Small for gestational age;Scrotal hypoplasia;Rocker bottom foot;Death in infancy;Deeply set eye;Cataract;Abnormality of the thorax;Asthma;Abnormality of hair texture;Hypogonadism;Intellectual disability;Basal cell carcinoma;Telangiectasia;Intestinal obstruction;Erythroderma;Absence of subcutaneous fat;Small for gestational age;Fine hair;Brittle hair;Photophobia;Strabismus;Decreased circulating IgG level;Microcornea;Microcephaly;Protruding ear;Keratoconjunctivitis sicca;Chronic diarrhea;Nail dystrophy;Short stature;Tiger tail banding;Sparse hair;Fragile nails;Malabsorption;Hyperkeratosis;Recurrent infections;Small nail;Squamous cell carcinoma;Trichorrhexis nodosa;Congenital nonbullous ichthyosiform erythroderma;Cutaneous photosensitivity;Flexion contracture;Nystagmus;Freckling;Triangular mouth;Delayed speech and language development;Erythroderma;Autosomal recessive inheritance;Microphthalmia;Dry skin;Retrognathia;Short neck;Visual impairment;Arthrogryposis multiplex congenita;Aplasia/Hypoplasia of the cerebellum;Intrauterine growth retardation;Microcephaly;Feeding difficulties in infancy;Cataract;Death in infancy;Cutaneous photosensitivity;Talipes;Joint stiffness;Micrognathia;Sensorineural hearing impairment;Abnormal nasal morphology;Peripheral neuropathy;Prominent metopic ridge;Abnormality of retinal pigmentation;Seizure;Wide nasal bridge;Abnormality of immune system physiology;Muscular hypotonia;Hypogonadism;Severe global developmental delay;Reduced tendon reflexes;Camptodactyly of finger;Hypertonia;Everted lower lip vermilion;Microphthalmia;Cerebral cortical atrophy;Optic atrophy;Cerebral calcification;Short stature						31	0.95											64	0.99																	0	0	0																	0.408	0.0				nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; neoplasm; pigmentation phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; 			.	Nucleotide excision repair	regulation of mitotic recombination;nucleotide-excision repair, DNA duplex unwinding;response to hypoxia;in utero embryonic development;transcription-coupled nucleotide-excision repair;nucleotide-excision repair;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, preincision complex assembly;nucleotide-excision repair, DNA incision, 5'-to lesion;transcription initiation from RNA polymerase I promoter;termination of RNA polymerase I transcription;transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;transcription elongation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;apoptotic process;response to oxidative stress;chromosome segregation;aging;cell population proliferation;response to UV;UV protection;post-embryonic development;viral process;spinal cord development;extracellular matrix organization;bone mineralization;central nervous system myelin formation;nucleotide-excision repair, DNA incision;multicellular organism growth;hair cell differentiation;embryonic cleavage;erythrocyte maturation;positive regulation of DNA binding;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of mitotic recombination;embryonic organ development;hair follicle maturation;hematopoietic stem cell differentiation;global genome nucleotide-excision repair;regulation of mitotic cell cycle phase transition	transcription factor TFIIH core complex;nucleus;nucleoplasm;transcription factor TFIID complex;transcription factor TFIIH holo complex;cytoplasm;spindle;cytosol;CAK-ERCC2 complex;MMXD complex	damaged DNA binding;ATP-dependent DNA helicase activity;protein kinase activity;protein binding;ATP binding;protein C-terminus binding;DNA-dependent ATPase activity;RNA polymerase II CTD heptapeptide repeat kinase activity;protein binding, bridging;5'-3' DNA helicase activity;ATP-dependent 5'-3' DNA helicase activity;metal ion binding;protein N-terminus binding;4 iron, 4 sulfur cluster binding	GTF2A1[27193682];GTF2A2[27193682];HSP90AB1[25036637];GTF2H2C[25416956];CCNH[26340423];GTF2B[27193682];HSCB[28380382];GTF2E1[27193682];EGFR[24780295];GTF2E2[27193682];CIAO1[28178521];STIP1[25036637];NUDCD3[25036637];POLR2A[27193682];POLR2B[27193682];HSF2[25036637];POLR2C[27193682];POLR2D[27193682];POLR2E[27193682];POLR2F[27193682];POLR2G[27193682];POLR2H[27193682];CIAO2B[28178521];POLR2I[27193682];POLR2J[27193682];POLR2K[27193682];POLR2L[27193682];TBP[27193682];CACYBP[25036637];GTF2H1[26340423];AARSD1[25036637];GTF2H2[27193682];GTF2F1[27193682];GTF2H3[27193682];GTF2H4[19172752;27193682];GTF2F2[27193682];GTF2H5[26496610;19172752;27193682];CDK7[23602568;29568061];PPP5C[25036637];ERCC3[16669699;27193682];TCEA1[27193682];MMS19[28178521];
260215	chr3	61989122	G	T	chr3:61989122	PTPRG	protein tyrosine phosphatase, receptor type G	3196.0	SNV	0/1	0.54	19_22	41	99	False	rs757115800,COSV55641469	EXONIC	YES	NM_002841.4	Transcript	protein_coding	missense_variant		4/30	NM_002841.4:c.470G>T	NP_002832.3:p.Gly157Val		1.0	.,Alpha carbonic anhydrase domain&Alpha carbonic anhydrase domain&Alpha carbonic anhydrase domain					.	.	.		6.57471e-06	1.0	152098.0	0.0	32	0.97	PASS	afr	2.41429e-05	1.0	0.0	0.0	7.95836e-06	2.0	251308.0	0.0	61	1.0	PASS	nfe	1.76044e-05	2.0	1.76044e-05	2.0	0.0000064	1	0.0	1.0				27.2	3.936902	0.356	13	8	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred	PTPRG	0.0	0.0	0.0	0.0	50.0	-44.0	-29.0	49.0						0.417	0.0	15.433169321	0.998	1.176	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); 			amygdala;superior cervical ganglion;adipose tissue;	.	transmembrane receptor protein tyrosine kinase signaling pathway;brain development;negative regulation of epithelial cell migration;negative regulation of neuron projection development;peptidyl-tyrosine dephosphorylation;regulation of homophilic cell adhesion	integral component of plasma membrane;extracellular exosome	protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding;identical protein binding	ALK[19167335];PXN[19167335];WAS[19167335];CBL[19167335];EGFR[25970784];PTPRG[15978577;19167335];CDH2[19167335];ERBB2[19167335];CSK[19167335];MAPK3[19167335];PDGFRB[19167335];NTRK1[19167335];NSF[19167335];PDPK1[19167335];INSR[19167335];TIE1[19167335];GAB1[19167335];GRIN2B[19167335];EPOR[19167335];TEC[19167335];LCK[19167335];PACS1[27173435;unassigned1312];CTNNB1[19167335;21112398];TEK[19167335];VIM[30021884];MET[19167335];
260893	chr7	128491324	C	T	chr7:128491324	FLNC	filamin C	3200.0	SNV	0/1	0.41	23_16	39	99	False	rs181067717,CM1618129	EXONIC	YES	NM_001458.5	Transcript	protein_coding	missense_variant		34/48	NM_001458.5:c.5578C>T	NP_001449.3:p.Arg1860Cys		1.0	.,.	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Myofibrillar_myopathy,_filamin_C-related|Myopathy,_distal,_4|Cardiomyopathy,_familial_hypertrophic,_26|not_specified|Dilated_Cardiomyopathy,_Dominant|not_provided	Cardiomyopathy, familial hypertrophic, 26, 617047 (3), Autosomal dominant; Cardiomyopathy, familial restrictive 5, 617047 (3), Autosomal dominant; Myopathy, distal, 4, 614065 (3), Autosomal dominant; Myopathy, myofibrillar, 5, 609524 (3), Autosomal dominant	Muscle filaminopathy;Distal myopathy with posterior leg and anterior hand involvement;Familial isolated restrictive cardiomyopathy	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Difficulty climbing stairs;Abnormal peripheral nervous system morphology;Myofibrillar myopathy;Respiratory insufficiency;Slow progression;Elevated serum creatine kinase;Proximal muscle weakness;Muscle fiber cytoplasmatic inclusion bodies;Waddling gait;Autosomal dominant inheritance;Adult onset;Muscle fiber splitting;Left atrial enlargement;Dyspnea;Mitral regurgitation;Congestive heart failure;Autosomal dominant inheritance;Atrial fibrillation;Hepatomegaly;Pulmonary venous hypertension;Orthopnea;Tricuspid regurgitation;Hypertrophic cardiomyopathy;Atrial fibrillation;Interstitial cardiac fibrosis;Thromboembolism;Peripheral edema;Mitral regurgitation;Stroke;Left atrial enlargement;Postnatal growth retardation;Left ventricular dysfunction;Syncope;Right atrial enlargement;Pulmonary edema;Recurrent respiratory infections;Proximal muscle weakness;Autosomal dominant inheritance;Slow progression;Muscle weakness;Myopathy;Cardiomyopathy;Abnormality of the calf musculature;Distal lower limb amyotrophy;Hyporeflexia;Distal upper limb amyotrophy;Mildly elevated creatine kinase;Hip flexor weakness;Decreased finger mobility;Intrinsic hand muscle atrophy;Limited knee flexion;Exercise-induced myalgia;Distal upper limb muscle weakness;Difficulty running;Hyporeflexia of lower limbs;Inability to walk;Proximal muscle weakness in lower limbs;Foot dorsiflexor weakness;Fatiguable weakness of proximal limb muscles;Weakness of facial musculature;Gait imbalance;Cardiomyopathy;Distal lower limb muscle weakness;Finger flexor weakness;Difficulty walking	25741868,28866788	0.0052184	794.0	152154.0	2.0	33	0.98	PASS	amr	0.00962168	147.0	0.00805622	548.0	0.0053551	1336.0	249482.0	9.0	100	1.0	PASS	nfe	0.00843446	955.0	0.00843446	955.0	0.0050610	787	0.01	34.0	0.01341	153.0		27.3	3.948619	0.44	8	13	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationTaster_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	FLNC	0.0	0.0	0.0	0.0	-1.0	-38.0	5.0	9.0						0.00661	1.0	0.0	1.0	1.026	homeostasis/metabolism phenotype; muscle phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			fetal thyroid;tongue;trigeminal ganglion;skeletal muscle;heart;	MAPK signaling pathway;Focal adhesion	cell junction assembly;muscle fiber development	cytoplasm;cytosol;cytoskeleton;plasma membrane;focal adhesion;sarcoplasm;Z disc;sarcolemma;costamere	protein binding;cytoskeletal protein binding;ankyrin binding;actin filament binding	OTUD4[19615732];DOCK6[30021884];TNFAIP8[17353931];SYNM[25447537];RPL30[30021884];DYSF[23414517];HSPB2[26465331];ADRA1D[15525470];ENO1[23414517];ADRA1B[15525470];ADRA1A[15525470];MAP1LC3B[20562859];SGCD[10629222];MAP1LC3A[20562859];TUBA1A[27291054];TUBB3[27291054];RASSF5[20562859];RPS6KA2[21988832];HIST1H2AE[30021884];MYOZ1[10984498];SGCG[10629222];TP63[20085233];NCK1[17474147];SH3GLB1[20562859];IQCB1[21565611];MYBPC3[21569246];TRIM63[18157088];MYBPC2[23414517];WIPI2[20562859];ANK3[21223964];HIST2H2BF[30021884];MYOT[11038172];PPIB[30021884];CRK[17474147];FLG[30021884];USP53[19615732];PIK3R1[17474147];CAMKK2[20562859];ABL1[17474147];XIRP1[16631741];FYN[17474147];PLCG1[17474147];FLNC[15642266];REPS1[23414517];JUN[25609649];UBE2I[20936779];VCAM1[22623428];SMURF2[18157088];FOXF1[25609649];RRP1B[20926688];MLH1[20706999];ESR2[21182203];ATG2A[20562859];GRB2[17474147];OTUD1[19615732];
261306	chr11	67759032	C	T	chr11:67759032	UNC93B1	unc-93 homolog B1, TLR signaling regulator	3210.0	SNV	0/1	0.52	16_17	33	99	False	rs2375183	EXONIC	YES	NM_030930.4	Transcript	protein_coding	synonymous_variant		12/12	NM_030930.4:c.1776G>A	NP_112192.2:p.Gly592%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	Herpes_simplex_encephalitis_1	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}, 610551 (3)	Herpes simplex virus encephalitis	Major susceptibility factor in	Recurrent herpes;Autosomal recessive inheritance;Herpes simplex encephalitis;Cerebral edema;Focal impaired awareness seizure;Excessive daytime somnolence;Nuchal rigidity;Immunodeficiency;Alcoholism;Hyperreflexia;Elevated C-reactive protein level;Increased CSF protein;Headache;EEG abnormality;Hyponatremia;Loss of consciousness;Leukocytosis;Status epilepticus;Hypoglycorrhachia;Coma;Fever;Neutrophilia;Fatigue;CSF lymphocytic pleiocytosis;Nausea and vomiting;Functional motor deficit;Respiratory failure requiring assisted ventilation;Neurological speech impairment;Focal aware seizure;Chills		0.000520011	79.0	151920.0	0.0	33	0.97	PASS	afr	0.00166699	69.0	7.36485e-05	5.0	4.83325e-05	4.0	82760.0	0.0	4	0.07	PASS	afr	0.00143266	2.0	0.0	0.0	0.0000064	1			0.0001	1.0		0.361	-0.30171		0	0	0			UNC93B1	0.0	0.0	0.0	0.0	17.0	28.0	-11.0	28.0							0.51				mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; liver/biliary system phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; homeostasis/metabolism phenotype; 			.	.	toll-like receptor signaling pathway;adaptive immune response;intracellular protein transport;toll-like receptor 3 signaling pathway;toll-like receptor 7 signaling pathway;toll-like receptor 9 signaling pathway;innate immune response;defense response to virus	Golgi membrane;lysosome;endosome;endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane;early phagosome	protein transporter activity;Toll-like receptor binding	HHLA2[unassigned1304];LDLRAD1[unassigned1304];CCDC107[unassigned1304];MFF[unassigned1304];BEST2[unassigned1304];LEUTX[unassigned1304];CD79A[unassigned1304];EBP[unassigned1304];TCTN3[26638075];CREB3L1[unassigned1304];SYNDIG1[unassigned1304];FFAR3[unassigned1304];KLRC1[unassigned1304];TM4SF18[unassigned1304];SLC35C2[unassigned1304];GPR37L1[unassigned1304];LIME1[unassigned1304];REEP1[unassigned1304];TMEM237[unassigned1304];CLDN7[unassigned1304];TLR9[21903422];TLR8[22164301];ERGIC3[unassigned1304];GPR101[unassigned1304];GPRC5D[unassigned1304];FATE1[unassigned1304];TLR3[22164301];
264678	chr16	31418931	A	G	chr16:31418931	ITGAD	integrin subunit alpha D	3255.0	SNV	0/1	0.4	15_10	25	99	False	rs989645256	EXONIC	YES	NM_001318185.2	Transcript	protein_coding	missense_variant		8/30	NM_001318185.2:c.800A>G	NP_001305114.1:p.Glu267Gly		1.0	von Willebrand factor, type A&von Willebrand factor, type A&von Willebrand factor, type A					.	.	.						32	0.97							1.59425e-05	4.0	250902.0	0.0	54	0.99	PASS	amr	8.67453e-05	3.0	0.0	0.0								14.47	1.167031	0.143	1	17	18	PROVEAN_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ITGAD	0.0	0.0	0.0	0.0	50.0	-27.0	-18.0	5.0						0.604	0.0	0.0	0.014	0.309	homeostasis/metabolism phenotype; immune system phenotype; hematopoietic system phenotype; 			.	Regulation of actin cytoskeleton	immune response;integrin-mediated signaling pathway;extracellular matrix organization;heterotypic cell-cell adhesion	plasma membrane;integrin complex;cell surface	metal ion binding	RRP1B[19710015];
266140	chr13	102235608	C	T	chr13:102235608	ITGBL1	integrin subunit beta like 1	3291.0	SNV	0/1	0.63	11_19	30	99	False	rs140688507,COSV101095894	EXONIC	YES	NM_004791.3	Transcript	protein_coding	missense_variant		6/11	NM_004791.3:c.770C>T	NP_004782.1:p.Pro257Leu		1.0	EGF-like domain,EGF-like domain,EGF-like domain,.,.					.	.	.		0.00219631	333.0	151618.0	7.0	31	0.93	PASS	nfe	0.0023689	161.0	0.0023689	161.0	0.00186279	468.0	251236.0	1.0	57	0.95	PASS	nfe	0.00228001	259.0	0.00228001	259.0	0.0016977	264	0.001	4.0				24.4	3.325606	0.26	12	7	19	SIFT,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	ITGBL1	0.0	0.0	0.0	0.0	-40.0	-42.0	-28.0	-22.0							0.17	0.0	0.985	0.966	.			.	.	cell adhesion;cell-matrix adhesion;integrin-mediated signaling pathway;cell migration;cell adhesion mediated by integrin	extracellular region;plasma membrane;focal adhesion;integrin complex;cell surface	integrin binding	.
266582	chr5	64273045	A	T	chr5:64273045	CWC27	CWC27 spliceosome associated protein homolog	3298.0	SNV	0/1	0.56	12_15	27	99	False	rs150642131	EXONIC	YES	NM_005869.4	Transcript	protein_coding	missense_variant		13/14	NM_005869.4:c.1236A>T	NP_005860.2:p.Glu412Asp		1.0		Uncertain_significance	criteria_provided,_single_submitter	not_provided	Retinitis pigmentosa with or without skeletal anomalies, 250410 (3), Autosomal recessive	Brachydactyly-short stature-retinitis pigmentosa syndrome	Disease-causing germline mutation(s) in	Downslanted palpebral fissures;Delayed ability to walk;Cafe-au-lait spot;Feeding difficulties;Nyctalopia;Macrotia;Horseshoe kidney;Underdeveloped nasal alae;Micrognathia;Sparse eyelashes;Autosomal recessive inheritance;Intellectual disability;Macrocephaly;Craniosynostosis;Short metacarpal;Short stature;Sparse eyebrow;Metaphyseal chondrodysplasia;Sparse hair;Ventricular septal defect;Frontal bossing;Small nail;Broad columella;Psychomotor retardation;Global developmental delay;Renal cyst;High anterior hairline;Peripheral visual field loss;Brachydactyly;Short distal phalanx of finger;Retinal degeneration;Delayed speech and language development;Hypoautofluorescent retinal lesion;Low-set ears;Thick vermilion border;Rod-cone dystrophy		7.22686e-05	11.0	152210.0	0.0	32	0.96	PASS	amr	0.000130856	2.0	5.87941e-05	4.0	5.9931e-05	15.0	250288.0	0.0	31	0.88	PASS	afr	0.000369731	6.0	7.93231e-05	9.0	0.0000386	6						17.76	1.74038	0.102	2	17	19	LRT_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	CWC27	0.0	0.0	0.0	0.01	-1.0	-40.0	17.0	20.0						0.843	0.0	0.0	0.998	1.312	reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			.	.	mRNA splicing, via spliceosome;protein peptidyl-prolyl isomerization;protein folding	nucleus;nucleoplasm;catalytic step 1 spliceosome;catalytic step 2 spliceosome	peptidyl-prolyl cis-trans isomerase activity;cyclosporin A binding	MORF4L1[unassigned1304];EPB41L3[24366813];LMNA[29568061];HMGA1[18850631];E2F1[20195357];YWHAZ[26496610];ESR2[21182203];FRA10AC1[22365833];
266893	chr21	47615646	G	A	chr21:47615646	LSS	lanosterol synthase	3314.0	SNV	0/1	0.41	19_13	32	99	False	rs767928866	EXONIC	YES	NM_002340.6	Transcript	protein_coding	synonymous_variant		19/22	NM_002340.6:c.1761C>T	NP_002331.3:p.Tyr587%3D		-1.0					Hypotrichosis 14, 618275 (3), Autosomal recessive; Cataract 44, 616509 (3), Autosomal recessive; Alopecia-intellectual disability syndrome 4, 618840 (3), Autosomal recessive	Total early-onset cataract	Disease-causing germline mutation(s) in	Developmental cataract;Autosomal recessive inheritance;Visual loss;Sparse and thin eyebrow;Sparse eyelashes;Sparse scalp hair;Sparse body hair;Alopecia;Autosomal recessive inheritance;Sparse body hair;Alopecia;Macrotia;Sparse scalp hair;Delayed skeletal maturation;Hearing impairment;Abnormal nasal morphology;Intellectual disability;Brachydactyly;EEG abnormality;Microcephaly;Hypergonadotropic hypogonadism;Split hand;Short stature;Sparse body hair;Aplasia/Hypoplasia of the eyebrow;Muscular hypotonia;Photophobia;Seizure;Scoliosis;Ichthyosis;Flexion contracture;Short corpus callosum		0.000105108	16.0	152224.0	0.0	33	0.98	PASS	eas	0.000578704	3.0	2.93945e-05	2.0	0.000175383	44.0	250880.0	0.0	82	1.0	PASS	eas	0.000543715	10.0	7.05393e-05	8.0	0.0001350	21						7.347	0.310538		0	0	0			LSS	0.0	0.03	0.0	0.0	-22.0	24.0	24.0	-31.0						0.798	0.0	1.597133001			mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; 			atrioventricular node;	Biosynthesis of steroids	steroid biosynthetic process;cholesterol biosynthetic process;regulation of protein stability;regulation of cholesterol biosynthetic process	endoplasmic reticulum membrane;lipid droplet;membrane	lanosterol synthase activity	APP[26045787];SLC10A6[unassigned1304];TMEM86B[unassigned1304];TMEM167B[unassigned1304];SLC10A1[unassigned1304];GPR35[28298427];AQP6[unassigned1304];CIB1[unassigned1304];YIF1A[unassigned1304];NR4A1[21988832];FIP1L1[26496610];MYO5C[26496610];MYH9[26496610];
266959	chr2	163055268	G	A	chr2:163055268	FAP	fibroblast activation protein alpha	3315.0	SNV	0/1	0.47	17_15	32	99	False	rs376503598,COSV99502032	SPLICING	YES	NM_004460.5	Transcript	protein_coding	splice_region_variant,synonymous_variant		16/26	NM_004460.5:c.1401C>T	NP_004451.2:p.Tyr467%3D		-1.0						.	.	.		5.25762e-05	8.0	152160.0	0.0	32	0.97	PASS	nfe	8.82016e-05	6.0	8.82016e-05	6.0	1.59162e-05	4.0	251316.0	0.0	57	1.0	PASS	amr	5.78637e-05	2.0	8.79848e-06	1.0	0.0000257	4	0.0	1.0				8.628	0.421677		0	0	0			FAP	0.0	0.0	0.0	0.01	-6.0	43.0	22.0	-1.0	0.001176209411766	0.084	8.601	1.553	10.154	0.471	0.0	0.0			normal phenotype; 			appendix;skin;trigeminal ganglion;uterus corpus;adipose tissue;smooth muscle;atrioventricular node;superior cervical ganglion;	.	angiogenesis;proteolysis;cell adhesion;regulation of collagen catabolic process;negative regulation of extracellular matrix disassembly;endothelial cell migration;proteolysis involved in cellular protein catabolic process;regulation of fibrinolysis;negative regulation of cell proliferation involved in contact inhibition;positive regulation of cell cycle arrest;mitotic cell cycle arrest;melanocyte proliferation;positive regulation of execution phase of apoptosis;melanocyte apoptotic process;negative regulation of extracellular matrix organization	extracellular space;cytoplasm;plasma membrane;focal adhesion;cell surface;integral component of membrane;lamellipodium;lamellipodium membrane;ruffle membrane;apical part of cell;basal part of cell;invadopodium membrane	protease binding;endopeptidase activity;metalloendopeptidase activity;serine-type endopeptidase activity;integrin binding;protein binding;peptidase activity;serine-type peptidase activity;dipeptidyl-peptidase activity;protein homodimerization activity;protein dimerization activity	NPPB[21314817];PYY[21314817];ADCYAP1[21314817];GHRH[21314817];NPY[21314817];GCG[21314817];VIP[21314817];TAC1[21314817];GIP[21314817];
267536	chr6	131225624	A	G	chr6:131225624	EPB41L2	erythrocyte membrane protein band 4.1 like 2	3332.0	SNV	0/1	0.6	10_15	25	99	False	rs372509765	EXONIC	YES	NM_001350299.2	Transcript	protein_coding	synonymous_variant		6/22	NM_001350299.2:c.910T>C	NP_001337228.1:p.Leu304%3D		-1.0						.	.	.		0.000203744	31.0	152152.0	0.0	33	0.97	PASS	sas	0.00372517	18.0	4.41138e-05	3.0	0.000652198	163.0	249924.0	3.0	43	0.81	PASS	sas	0.00497136	151.0	6.18462e-05	7.0	0.0006688	104	0.0	1.0				10.09	0.575042		0	0	0			EPB41L2	0.0	0.0	0.09	0.0	-10.0	-19.0	-19.0	31.0						0.0229	0.99	0.0			endocrine/exocrine gland phenotype; normal phenotype; reproductive system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			pons;olfactory bulb;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;testis;	Tight junction	cell cycle;cortical actin cytoskeleton organization;actomyosin structure organization;cell division;positive regulation of protein localization to cell cortex	nucleus;nucleoplasm;cytosol;plasma membrane;focal adhesion;spectrin;COP9 signalosome;cell junction;extracellular exosome;cell cortex region	actin binding;structural molecule activity;protein binding;spectrin binding;PH domain binding	KSR1[27086506];YWHAB[17353931];WWC1[24366813];HSPB1[25277244];ARID5B[30021884];LIN7A[24366813];PAX6[26496610];NR3C1[20195357];PLEKHA7[28877994];KLC4[26496610];SNRNP40[30021884];COPS5[18850735];TUBA1A[27291054];YWHAQ[17353931];WNK1[20936779];TUBB3[27291054];PRC1[30021884];EPB41L3[24366813];ZNF736[30021884];YWHAG[17353931;20936779];NSMAF[26496610];
269027	chr2	27459307	C	T	chr2:27459307	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	3366.0	SNV	0/1	0.48	13_13	27	99	False	rs147653891,COSV53026917	EXONIC	YES	NM_004341.5	Transcript	protein_coding	synonymous_variant		26/44	NM_004341.5:c.4230C>T	NP_004332.2:p.Thr1410%3D		1.0		Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	Developmental and epileptic encephalopathy 50, 616457 (3), Autosomal recessive	CAD-CDG	Disease-causing germline mutation(s) in	Broad-based gait;Schistocytosis;Infantile onset;Anisopoikilocytosis;Epileptic encephalopathy;Renal tubular acidosis;Abnormal glycosylation;Global developmental delay;Generalized hypotonia;Acanthocytosis;Autosomal recessive inheritance;Status epilepticus;Hyperammonemia;Poor speech;Anemia;Progressive;Brain atrophy;Developmental regression		0.000854072	130.0	152212.0	0.0	32	0.97	PASS	nfe	0.00171973	117.0	0.00171973	117.0	0.000759939	191.0	251336.0	0.0	100	1.0	PASS	nfe	0.00147833	168.0	0.00147833	168.0	0.0007524	117	0.002	6.0				13.93	1.077059		0	0	0			CAD	0.04	0.0	0.0	0.0	4.0	5.0	4.0	5.0							1.0	92.912269477			.			tumor;	Pyrimidine metabolism;Glutamate metabolism;Alanine and aspartate metabolism	liver development;'de novo' pyrimidine nucleobase biosynthetic process;UTP biosynthetic process;glutamine metabolic process;nitrogen compound metabolic process;heart development;female pregnancy;lactation;response to amine;drug metabolic process;peptidyl-threonine phosphorylation;citrulline biosynthetic process;response to caffeine;animal organ regeneration;response to insulin;cellular response to drug;response to starvation;'de novo' UMP biosynthetic process;pyrimidine nucleoside biosynthetic process;protein autophosphorylation;cellular response to epidermal growth factor stimulus	nucleus;nucleoplasm;cytoplasm;cytosol;membrane;nuclear matrix;protein-containing complex;cell projection;neuronal cell body;terminal bouton;extracellular exosome	aspartate carbamoyltransferase activity;carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity;dihydroorotase activity;protein kinase activity;ATP binding;zinc ion binding;enzyme binding;identical protein binding;aspartate binding	LGALS3BP[26496610];SMARCB1[30108113];TRADD[14743216];HDAC11[23752268];ILK[23455922;25852190;26496610];HSCB[28380382];PTPN23[28330616];DUSP16[28330616];TUBA1C[26496610];MAP1LC3B[20562859];MAP1LC3A[20562859];HTR7[19486527];TUBA1A[27291054;29568061];TRIM29[26496610];TUBB3[27291054];IKBKG[14743216];MAP3K7[14743216];TP63[20085233];GABARAPL2[20562859];RPS9[17461779];GABARAPL1[20562859];RIPK3[14743216];RIPK4[26972000];CAD[24332717];METTL3[29507755];TRAF2[14743216];TNFRSF1B[14743216];YWHAZ[15161933];TNFRSF1A[14743216];PTBP3[22575643];DNAJC7[26496610];ERG[21575865];PPEF1[28330616];OTUB1[26752685];SHC1[19380743];RELA[14743216];GABARAP[20562859];RELB[14743216];POC1B[26638075];RIPK1[14743216];MAPK6[26972000];SMAD2[18729074];MAP3K3[14743216];JUN[25609649];MAP3K1[14743216];VCAM1[22623428];HSPA5[26496610];NEK4[25798074];SEC16A[26496610];RRP1B[20926688];MEX3C[22863774];ESR1[25604459];ESR2[25604459];NFKB2[14743216];AHI1[26638075];PPP5C[28330616];LRFN4[22677168];PPP2R2B[19156129];MKS1[26638075];TAB2[14743216];GRB2[19380743];NFKBIE[14743216];MAP3K14[14743216];MAD2L1[26496610];
269191	chr13	37596152	C	G	chr13:37596152	SUPT20H	SPT20 homolog, SAGA complex component	3370.0	SNV	0/1	0.46	21_18	39	99	False	rs74906774	EXONIC	YES	NM_001278480.2	Transcript	protein_coding	missense_variant		20/25	NM_001278480.2:c.1894G>C	NP_001265409.1:p.Val632Leu		-1.0	.,.,.,.,.,.					.	.	.		0.0031693	482.0	152084.0	2.0	32	0.97	PASS	amr	0.00818813	125.0	0.00441112	300.0	0.00266264	620.0	232852.0	3.0	25	0.62	PASS	amr	0.00626714	192.0	0.00347059	370.0	0.0024758	385	0.013	42.0				14.77	1.221978	0.164	5	13	18	LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	SUPT20H	0.0	0.0	0.0	0.0	-10.0	8.0	49.0	-4.0							0.0	0.0	1.0	1.026	growth/size/body region phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	.	regulation of transcription by RNA polymerase II;autophagy;gastrulation;positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter	SAGA complex;fibrillar center;SAGA-type complex	transcription coregulator activity;protein binding	PDIA3[30021884];NPM1[30021884];TRRAP[26496610];USP22[19615732];ATG9A[19893488];STAT3[21988832];SGF29[26496610];MAPK14[16751104;19893488;20936779;21988832];ATXN1[16713569];HIST1H3A[29568061];MAPK1[21988832];RPLP2[30021884];UBQLN4[16713569];KPNA1[26496610];
269973	chr2	162738903	T	C	chr2:162738903	SLC4A10	solute carrier family 4 member 10	3371.0	SNV	0/1	0.55	10_12	22	99	False	rs1172992448	EXONIC	YES	NM_001354440.2	Transcript	protein_coding	synonymous_variant		10/26	NM_001354440.2:c.1143T>C	NP_001341369.1:p.Gly381%3D		1.0						.	.	.		6.58077e-06	1.0	151958.0	0.0	32	0.95	PASS	amr	6.57722e-05	1.0	0.0	0.0					18	0.41									0.0	1.0				10.9	0.66961		0	0	0			SLC4A10	0.0	0.0	0.0	0.0	-36.0	-2.0	48.0	-2.0						0.77	0.0	94.820937699			growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; 			.	.	sodium ion transport;chloride transport;response to light stimulus;post-embryonic development;bicarbonate transport;pyramidal neuron development;multicellular organism growth;locomotory exploration behavior;brain morphogenesis;regulation of intracellular pH;anion transmembrane transport;proton transmembrane transport	plasma membrane;integral component of plasma membrane;integral component of membrane;basolateral plasma membrane;neuronal cell body;apical dendrite;basal dendrite;CA3 pyramidal cell dendrite	inorganic anion exchanger activity;sodium:bicarbonate symporter activity;anion:anion antiporter activity	CBFB[20195357];FOS[20195357];
270565	chrX	118604043	T	C	chrX:118604043	SLC25A5	solute carrier family 25 member 5	3388.0	SNV	0|1	0.6	8_12	20	99	False	rs199547691,COSV58625695,COSV58627387	EXONIC	YES	NM_001152.5	Transcript	protein_coding	synonymous_variant		2/4	NM_001152.5:c.531T>C	NP_001143.2:p.Phe177%3D		1.0						.	.	.		0.000520534	38.0	73002.0	0.0	22	0.57	PASS	amr	0.00111661	7.0	0.000345993	13.0	0.0	0.0	178259.0	0.0	96	0.9	AC0_RF				0.0	0.0	0.0000579	9						13.1	0.952451		0	0	0			SLC25A5	0.0	0.04	0.01	0.0	-17.0	16.0	46.0	-48.0							0.86				cellular phenotype; 			.	Calcium signaling pathway	chromosome segregation;positive regulation of cell population proliferation;adenine transport;ADP transport;ATP transport;viral process;regulation of insulin secretion;transmembrane transport;negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;cellular response to leukemia inhibitory factor	nucleus;mitochondrion;mitochondrial inner membrane;integral component of plasma membrane;membrane;mitochondrial nucleoid;myelin sheath;membrane raft;MMXD complex	RNA binding;ATP:ADP antiporter activity;protein binding;adenine transmembrane transporter activity;ubiquitin protein ligase binding	RNH1[21276451];MT-CO1[23260140];TONSL[21113133];DUX4[26816005];CISD3[27499296];CHCHD2[27499296];HTR7[19486527];CCND1[26496610];TUBB3[27291054];MAGOH[23084401];CHCHD1[27499296];GABARAPL2[20562859];GABARAPL1[20562859];CMC1[23260140];SDHC[24983503];SDHD[24983503];DICER1[21858095];SDHA[24983503;29128334];SDHB[24983503];TUFM[24983503];COX6B1[27499296];IFT88[27173435];SOAT1[29128334];VDAC1[29128334];EZR[29568061];COX15[29128334];PHB[24983503];GABARAP[20562859];NCSTN[26496610];RIPK1[14743216];COX14[23260140];RDH13[23260140];C6orf203[27499296];A2M[17174955];SMAD2[18729074];HSPA9[24983503];SURF1[23260140];JUN[25609649];VCAM1[22623428];CBX4[21282530];NEK4[25798074];ARHGAP28[30021884];ESR1[21182205];MEX3C[22863774];COQ7[27499296];ESR2[25604459];NFKB1[25609649];NFKBIA[14743216];COQ3[27499296];COQ2[29128334];NDUFAF8[27499296];ADCK2[27499296];AGO4[19167051];AGO1[17932509];NDUFAF4[27499296];AGO2[17932509];CDK1[29128334];GRB2[21706016];SLC35F6[19154410];TRADD[14743216];LRRK2[21370995;24725412];FASTKD3[20869947];TUBA1C[26496610];MAP1LC3B[20562859];TMEM223[23260140];METTL14[29507755];MAP1LC3A[20562859];MRPL40[23260140];TUBA1A[29568061];OPA3[27499296];NCK2[23322602];FLOT1[24983503];FLOT2[24983503];IKBKG[14743216];RIPK3[14743216];RIPK4[26972000];SIRT4[17715127];TRAF2[14743216];TRAF1[14743216];MRPL48[23260140];TIMM21[23260140];TNFRSF1B[14743216];MRPL46[23260140];COQ10A[27499296];TNFRSF1A[14743216];BDP1[30021884];SMIM20[23260140];SLC25A6[23260140];OTUB1[26752685];PRKAA1[16306228];DLST[29128334];MRPL58[20186120];RELA[14743216];EGFR[15657067];HSPD1[24983503];ATP5F1A[24983503;27499296];ATP5F1B[24983503];C21orf33[27499296];MIC13[27499296];E2F3[22157815];OXCT2[27499296];MAPK6[26972000];PAK5[27499296];MAP3K3[14743216];MAP3K1[14743216];SPRYD4[27499296];RRP1B[20926688];GPAM[27499296];XPNPEP3[27499296];HDGF[21907836];CD247[24502978];COQ8A[27499296];PMFBP1[30021884];
270566	chrX	118604060	G	T	chrX:118604060	SLC25A5	solute carrier family 25 member 5	3388.0	SNV	0|1	0.55	10_12	22	99	False	rs200974395,COSV58624651	EXONIC	YES	NM_001152.5	Transcript	protein_coding	missense_variant		2/4	NM_001152.5:c.548G>T	NP_001143.2:p.Gly183Val		1.0						.	.	.		0.00196356	126.0	64169.0	0.0	20	0.51	PASS	afr	0.00294523	47.0	0.00152518	50.0	4.04064e-05	7.0	173240.0	0.0	89	0.84	RF	afr	0.000402609	5.0	2.56374e-05	2.0	0.0005145	80	0.0	1.0				27.3	3.951689	0.714	17	2	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	FATHMM_pred,MetaRNN_pred	SLC25A5	0.09	0.0	0.01	0.0	-1.0	-34.0	-2.0	50.0							0.86		0.993	0.214	cellular phenotype; 			.	Calcium signaling pathway	chromosome segregation;positive regulation of cell population proliferation;adenine transport;ADP transport;ATP transport;viral process;regulation of insulin secretion;transmembrane transport;negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;cellular response to leukemia inhibitory factor	nucleus;mitochondrion;mitochondrial inner membrane;integral component of plasma membrane;membrane;mitochondrial nucleoid;myelin sheath;membrane raft;MMXD complex	RNA binding;ATP:ADP antiporter activity;protein binding;adenine transmembrane transporter activity;ubiquitin protein ligase binding	RNH1[21276451];MT-CO1[23260140];TONSL[21113133];DUX4[26816005];CISD3[27499296];CHCHD2[27499296];HTR7[19486527];CCND1[26496610];TUBB3[27291054];MAGOH[23084401];CHCHD1[27499296];GABARAPL2[20562859];GABARAPL1[20562859];CMC1[23260140];SDHC[24983503];SDHD[24983503];DICER1[21858095];SDHA[24983503;29128334];SDHB[24983503];TUFM[24983503];COX6B1[27499296];IFT88[27173435];SOAT1[29128334];VDAC1[29128334];EZR[29568061];COX15[29128334];PHB[24983503];GABARAP[20562859];NCSTN[26496610];RIPK1[14743216];COX14[23260140];RDH13[23260140];C6orf203[27499296];A2M[17174955];SMAD2[18729074];HSPA9[24983503];SURF1[23260140];JUN[25609649];VCAM1[22623428];CBX4[21282530];NEK4[25798074];ARHGAP28[30021884];ESR1[21182205];MEX3C[22863774];COQ7[27499296];ESR2[25604459];NFKB1[25609649];NFKBIA[14743216];COQ3[27499296];COQ2[29128334];NDUFAF8[27499296];ADCK2[27499296];AGO4[19167051];AGO1[17932509];NDUFAF4[27499296];AGO2[17932509];CDK1[29128334];GRB2[21706016];SLC35F6[19154410];TRADD[14743216];LRRK2[21370995;24725412];FASTKD3[20869947];TUBA1C[26496610];MAP1LC3B[20562859];TMEM223[23260140];METTL14[29507755];MAP1LC3A[20562859];MRPL40[23260140];TUBA1A[29568061];OPA3[27499296];NCK2[23322602];FLOT1[24983503];FLOT2[24983503];IKBKG[14743216];RIPK3[14743216];RIPK4[26972000];SIRT4[17715127];TRAF2[14743216];TRAF1[14743216];MRPL48[23260140];TIMM21[23260140];TNFRSF1B[14743216];MRPL46[23260140];COQ10A[27499296];TNFRSF1A[14743216];BDP1[30021884];SMIM20[23260140];SLC25A6[23260140];OTUB1[26752685];PRKAA1[16306228];DLST[29128334];MRPL58[20186120];RELA[14743216];EGFR[15657067];HSPD1[24983503];ATP5F1A[24983503;27499296];ATP5F1B[24983503];C21orf33[27499296];MIC13[27499296];E2F3[22157815];OXCT2[27499296];MAPK6[26972000];PAK5[27499296];MAP3K3[14743216];MAP3K1[14743216];SPRYD4[27499296];RRP1B[20926688];GPAM[27499296];XPNPEP3[27499296];HDGF[21907836];CD247[24502978];COQ8A[27499296];PMFBP1[30021884];
270567	chrX	118604079	C	T	chrX:118604079	SLC25A5	solute carrier family 25 member 5	3388.0	SNV	0|1	0.47	9_8	17	99	False	rs769645446,COSV58625133	EXONIC	YES	NM_001152.5	Transcript	protein_coding	synonymous_variant		2/4	NM_001152.5:c.567C>T	NP_001143.2:p.Ala189%3D		1.0						.	.	.		0.000309798	22.0	71014.0	0.0	20	0.52	AS_VQSR	amr	0.000622374	4.0	0.00019337	7.0	3.60586e-05	6.0	166396.0	0.0	69	0.75	RF	eas	0.000149734	2.0	2.65432e-05	2.0	0.0005595	87	0.0	1.0				10.43	0.613771		0	0	0			SLC25A5	0.0	0.02	0.0	0.0	31.0	-20.0	-31.0	10.0							0.86				cellular phenotype; 			.	Calcium signaling pathway	chromosome segregation;positive regulation of cell population proliferation;adenine transport;ADP transport;ATP transport;viral process;regulation of insulin secretion;transmembrane transport;negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;cellular response to leukemia inhibitory factor	nucleus;mitochondrion;mitochondrial inner membrane;integral component of plasma membrane;membrane;mitochondrial nucleoid;myelin sheath;membrane raft;MMXD complex	RNA binding;ATP:ADP antiporter activity;protein binding;adenine transmembrane transporter activity;ubiquitin protein ligase binding	RNH1[21276451];MT-CO1[23260140];TONSL[21113133];DUX4[26816005];CISD3[27499296];CHCHD2[27499296];HTR7[19486527];CCND1[26496610];TUBB3[27291054];MAGOH[23084401];CHCHD1[27499296];GABARAPL2[20562859];GABARAPL1[20562859];CMC1[23260140];SDHC[24983503];SDHD[24983503];DICER1[21858095];SDHA[24983503;29128334];SDHB[24983503];TUFM[24983503];COX6B1[27499296];IFT88[27173435];SOAT1[29128334];VDAC1[29128334];EZR[29568061];COX15[29128334];PHB[24983503];GABARAP[20562859];NCSTN[26496610];RIPK1[14743216];COX14[23260140];RDH13[23260140];C6orf203[27499296];A2M[17174955];SMAD2[18729074];HSPA9[24983503];SURF1[23260140];JUN[25609649];VCAM1[22623428];CBX4[21282530];NEK4[25798074];ARHGAP28[30021884];ESR1[21182205];MEX3C[22863774];COQ7[27499296];ESR2[25604459];NFKB1[25609649];NFKBIA[14743216];COQ3[27499296];COQ2[29128334];NDUFAF8[27499296];ADCK2[27499296];AGO4[19167051];AGO1[17932509];NDUFAF4[27499296];AGO2[17932509];CDK1[29128334];GRB2[21706016];SLC35F6[19154410];TRADD[14743216];LRRK2[21370995;24725412];FASTKD3[20869947];TUBA1C[26496610];MAP1LC3B[20562859];TMEM223[23260140];METTL14[29507755];MAP1LC3A[20562859];MRPL40[23260140];TUBA1A[29568061];OPA3[27499296];NCK2[23322602];FLOT1[24983503];FLOT2[24983503];IKBKG[14743216];RIPK3[14743216];RIPK4[26972000];SIRT4[17715127];TRAF2[14743216];TRAF1[14743216];MRPL48[23260140];TIMM21[23260140];TNFRSF1B[14743216];MRPL46[23260140];COQ10A[27499296];TNFRSF1A[14743216];BDP1[30021884];SMIM20[23260140];SLC25A6[23260140];OTUB1[26752685];PRKAA1[16306228];DLST[29128334];MRPL58[20186120];RELA[14743216];EGFR[15657067];HSPD1[24983503];ATP5F1A[24983503;27499296];ATP5F1B[24983503];C21orf33[27499296];MIC13[27499296];E2F3[22157815];OXCT2[27499296];MAPK6[26972000];PAK5[27499296];MAP3K3[14743216];MAP3K1[14743216];SPRYD4[27499296];RRP1B[20926688];GPAM[27499296];XPNPEP3[27499296];HDGF[21907836];CD247[24502978];COQ8A[27499296];PMFBP1[30021884];
270568	chrX	118604109	G	T	chrX:118604109	SLC25A5	solute carrier family 25 member 5	3388.0	SNV	0|1	0.21	11_3	14	93	False	rs747817510,COSV58627434	SPLICING	YES	NM_001152.5	Transcript	protein_coding	missense_variant,splice_region_variant		2/4	NM_001152.5:c.597G>T	NP_001143.2:p.Lys199Asn		1.0						.	.	.		3.50022e-05	3.0	85709.0	0.0	21	0.57	AS_VQSR	amr	0.000257533	2.0	0.0	0.0					70	0.68														24.6	3.377609	0.513	17	3	20	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,BayesDel_noAF_pred	SLC25A5	0.0	0.0	0.0	0.0	-50.0	1.0	1.0	-20.0	0.0001906016908989	0.13	11.013	-0.563	10.451		0.86		0.999	0.196	cellular phenotype; 			.	Calcium signaling pathway	chromosome segregation;positive regulation of cell population proliferation;adenine transport;ADP transport;ATP transport;viral process;regulation of insulin secretion;transmembrane transport;negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;cellular response to leukemia inhibitory factor	nucleus;mitochondrion;mitochondrial inner membrane;integral component of plasma membrane;membrane;mitochondrial nucleoid;myelin sheath;membrane raft;MMXD complex	RNA binding;ATP:ADP antiporter activity;protein binding;adenine transmembrane transporter activity;ubiquitin protein ligase binding	RNH1[21276451];MT-CO1[23260140];TONSL[21113133];DUX4[26816005];CISD3[27499296];CHCHD2[27499296];HTR7[19486527];CCND1[26496610];TUBB3[27291054];MAGOH[23084401];CHCHD1[27499296];GABARAPL2[20562859];GABARAPL1[20562859];CMC1[23260140];SDHC[24983503];SDHD[24983503];DICER1[21858095];SDHA[24983503;29128334];SDHB[24983503];TUFM[24983503];COX6B1[27499296];IFT88[27173435];SOAT1[29128334];VDAC1[29128334];EZR[29568061];COX15[29128334];PHB[24983503];GABARAP[20562859];NCSTN[26496610];RIPK1[14743216];COX14[23260140];RDH13[23260140];C6orf203[27499296];A2M[17174955];SMAD2[18729074];HSPA9[24983503];SURF1[23260140];JUN[25609649];VCAM1[22623428];CBX4[21282530];NEK4[25798074];ARHGAP28[30021884];ESR1[21182205];MEX3C[22863774];COQ7[27499296];ESR2[25604459];NFKB1[25609649];NFKBIA[14743216];COQ3[27499296];COQ2[29128334];NDUFAF8[27499296];ADCK2[27499296];AGO4[19167051];AGO1[17932509];NDUFAF4[27499296];AGO2[17932509];CDK1[29128334];GRB2[21706016];SLC35F6[19154410];TRADD[14743216];LRRK2[21370995;24725412];FASTKD3[20869947];TUBA1C[26496610];MAP1LC3B[20562859];TMEM223[23260140];METTL14[29507755];MAP1LC3A[20562859];MRPL40[23260140];TUBA1A[29568061];OPA3[27499296];NCK2[23322602];FLOT1[24983503];FLOT2[24983503];IKBKG[14743216];RIPK3[14743216];RIPK4[26972000];SIRT4[17715127];TRAF2[14743216];TRAF1[14743216];MRPL48[23260140];TIMM21[23260140];TNFRSF1B[14743216];MRPL46[23260140];COQ10A[27499296];TNFRSF1A[14743216];BDP1[30021884];SMIM20[23260140];SLC25A6[23260140];OTUB1[26752685];PRKAA1[16306228];DLST[29128334];MRPL58[20186120];RELA[14743216];EGFR[15657067];HSPD1[24983503];ATP5F1A[24983503;27499296];ATP5F1B[24983503];C21orf33[27499296];MIC13[27499296];E2F3[22157815];OXCT2[27499296];MAPK6[26972000];PAK5[27499296];MAP3K3[14743216];MAP3K1[14743216];SPRYD4[27499296];RRP1B[20926688];GPAM[27499296];XPNPEP3[27499296];HDGF[21907836];CD247[24502978];COQ8A[27499296];PMFBP1[30021884];
270569	chrX	118604112	T		chrX:118604112	SLC25A5	solute carrier family 25 member 5	3388.0	deletion	0|1	0.2	12_3	15	90	False	rs1202916175	SPLICING	YES	NM_001152.5	Transcript	protein_coding	splice_donor_variant	2/3		NM_001152.5:c.598+2del			1.0						.	.	.		0.0	0.0	112040.0	0.0	22	0.57	AC0_AS_VQSR				0.0	0.0					68	0.67														33.0	5.304006		0	0	0			SLC25A5	0.0	0.0	0.52	0.99	36.0	-1.0	-22.0	-1.0							0.86				cellular phenotype; 			.	Calcium signaling pathway	chromosome segregation;positive regulation of cell population proliferation;adenine transport;ADP transport;ATP transport;viral process;regulation of insulin secretion;transmembrane transport;negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;cellular response to leukemia inhibitory factor	nucleus;mitochondrion;mitochondrial inner membrane;integral component of plasma membrane;membrane;mitochondrial nucleoid;myelin sheath;membrane raft;MMXD complex	RNA binding;ATP:ADP antiporter activity;protein binding;adenine transmembrane transporter activity;ubiquitin protein ligase binding	RNH1[21276451];MT-CO1[23260140];TONSL[21113133];DUX4[26816005];CISD3[27499296];CHCHD2[27499296];HTR7[19486527];CCND1[26496610];TUBB3[27291054];MAGOH[23084401];CHCHD1[27499296];GABARAPL2[20562859];GABARAPL1[20562859];CMC1[23260140];SDHC[24983503];SDHD[24983503];DICER1[21858095];SDHA[24983503;29128334];SDHB[24983503];TUFM[24983503];COX6B1[27499296];IFT88[27173435];SOAT1[29128334];VDAC1[29128334];EZR[29568061];COX15[29128334];PHB[24983503];GABARAP[20562859];NCSTN[26496610];RIPK1[14743216];COX14[23260140];RDH13[23260140];C6orf203[27499296];A2M[17174955];SMAD2[18729074];HSPA9[24983503];SURF1[23260140];JUN[25609649];VCAM1[22623428];CBX4[21282530];NEK4[25798074];ARHGAP28[30021884];ESR1[21182205];MEX3C[22863774];COQ7[27499296];ESR2[25604459];NFKB1[25609649];NFKBIA[14743216];COQ3[27499296];COQ2[29128334];NDUFAF8[27499296];ADCK2[27499296];AGO4[19167051];AGO1[17932509];NDUFAF4[27499296];AGO2[17932509];CDK1[29128334];GRB2[21706016];SLC35F6[19154410];TRADD[14743216];LRRK2[21370995;24725412];FASTKD3[20869947];TUBA1C[26496610];MAP1LC3B[20562859];TMEM223[23260140];METTL14[29507755];MAP1LC3A[20562859];MRPL40[23260140];TUBA1A[29568061];OPA3[27499296];NCK2[23322602];FLOT1[24983503];FLOT2[24983503];IKBKG[14743216];RIPK3[14743216];RIPK4[26972000];SIRT4[17715127];TRAF2[14743216];TRAF1[14743216];MRPL48[23260140];TIMM21[23260140];TNFRSF1B[14743216];MRPL46[23260140];COQ10A[27499296];TNFRSF1A[14743216];BDP1[30021884];SMIM20[23260140];SLC25A6[23260140];OTUB1[26752685];PRKAA1[16306228];DLST[29128334];MRPL58[20186120];RELA[14743216];EGFR[15657067];HSPD1[24983503];ATP5F1A[24983503;27499296];ATP5F1B[24983503];C21orf33[27499296];MIC13[27499296];E2F3[22157815];OXCT2[27499296];MAPK6[26972000];PAK5[27499296];MAP3K3[14743216];MAP3K1[14743216];SPRYD4[27499296];RRP1B[20926688];GPAM[27499296];XPNPEP3[27499296];HDGF[21907836];CD247[24502978];COQ8A[27499296];PMFBP1[30021884];
275185	chr3	195306219	G	A	chr3:195306219	APOD	apolipoprotein D	3439.0	SNV	0/1	0.62	14_23	37	99	False	rs5953,COSV100581363	EXONIC	YES	NM_001647.4	Transcript	protein_coding	synonymous_variant		2/5	NM_001647.4:c.114C>T	NP_001638.1:p.Asp38%3D		-1.0						.	.	.		0.00580815	884.0	152200.0	5.0	33	0.98	PASS	nfe	0.00905376	616.0	0.00905376	616.0	0.00575549	1447.0	251412.0	6.0	66	1.0	PASS	nfe	0.00830109	944.0	0.00830109	944.0	0.0054725	851	0.009	29.0	0.00859	98.0		1.067	-0.141162		0	0	0			APOD	0.0	0.0	0.0	0.01	-9.0	11.0	0.0	-9.0						0.776	0.0	61.768774340			nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			caudate nucleus;ciliary ganglion;olfactory bulb;superior cervical ganglion;adipose tissue;trigeminal ganglion;occipital lobe;dorsal root ganglion;atrioventricular node;spinal cord;parietal lobe;skeletal muscle;medulla oblongata;thalamus;	.	response to reactive oxygen species;angiogenesis;glucose metabolic process;lipid metabolic process;lipid transport;brain development;aging;negative regulation of platelet-derived growth factor receptor signaling pathway;peripheral nervous system axon regeneration;tissue regeneration;negative regulation of protein import into nucleus;response to drug;negative regulation of smooth muscle cell proliferation;response to axon injury;negative regulation of focal adhesion assembly;negative regulation of lipoprotein lipid oxidation;negative regulation of monocyte chemotactic protein-1 production;negative regulation of cytokine production involved in inflammatory response;negative regulation of smooth muscle cell-matrix adhesion;negative regulation of T cell migration	extracellular region;extracellular space;cytoplasm;endoplasmic reticulum;cytosolic ribosome;dendrite;neuronal cell body;perinuclear region of cytoplasm;extracellular exosome	lipid transporter activity;protein binding;cholesterol binding	TMEM45B[unassigned1304];GORAB[unassigned1304];CLEC10A[unassigned1304];AQP9[unassigned1304];VSIR[unassigned1304];CREB3L1[unassigned1304];FFAR2[unassigned1304];CD53[unassigned1304];SIGLECL1[unassigned1304];ATP6V0B[unassigned1304];ATP6V0E1[unassigned1304];TMEM52B[unassigned1304];SLC35C2[unassigned1304];GPX8[unassigned1304];CREB3[21516116;25910212];TFDP1[27705803];TMEM79[unassigned1304];CLDN7[unassigned1304];FKBP7[unassigned1304];ERGIC3[unassigned1304];ATF6[25609649];MGST3[unassigned1304];GPR42[unassigned1304];MFF[unassigned1304];KIR2DL3[unassigned1304];CPLX4[unassigned1304];APH1A[unassigned1304];BCL2L13[unassigned1304];CD79A[unassigned1304];GPR151[unassigned1304];A2M[17174955];GRINL1A[16169070];E2F6[27705803];RHBDL1[unassigned1304];CDK19[23602568];JUN[25609649];SLC10A6[unassigned1304];KCNJ6[unassigned1304];BIK[unassigned1304];NCAPH2[unassigned1304];FAM209A[unassigned1304];AIG1[unassigned1304];PDZK1IP1[unassigned1304];ESR1[21182205];GDAP1[unassigned1304];STK24[17353931];VAPA[unassigned1304;25910212];TMEM237[unassigned1304];EVI2B[unassigned1304];
275921	chr10	49393643	C	T	chr10:49393643	FRMPD2	FERM and PDZ domain containing 2	3459.0	SNV	0/1	0.5	13_13	26	99	False	rs141722516,COSV59721903	EXONIC	YES	NM_001018071.4	Transcript	protein_coding	missense_variant		18/29	NM_001018071.4:c.2312G>A	NP_001018081.4:p.Arg771Gln		-1.0	.,.,.					.	.	.		0.0047912	729.0	152154.0	2.0	33	0.97	PASS	nfe	0.00798154	543.0	0.00798154	543.0	0.00488414	1228.0	251426.0	1.0	96	1.0	PASS	nfe	0.00704436	801.0	0.00704436	801.0	0.0047394	737	0.002	7.0				3.072	0.02863	0.009	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FRMPD2	0.0	0.01	0.0	0.03	-47.0	45.0	-7.0	-47.0						0.895	0.0	0.000000000	0.004	-0.785	.			ciliary ganglion;olfactory bulb;testis - seminiferous tubule;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	.	bicellular tight junction assembly	cytoplasm;cytoskeleton;bicellular tight junction;basolateral plasma membrane	protein binding;1-phosphatidylinositol binding	.
275922	chr10	49393688	C	A	chr10:49393688	FRMPD2	FERM and PDZ domain containing 2	3459.0	SNV	0/1	0.42	18_13	31	99	False	rs116266683,COSV100564373	SPLICING	YES	NM_001018071.4	Transcript	protein_coding	missense_variant,splice_region_variant		18/29	NM_001018071.4:c.2267G>T	NP_001018081.4:p.Gly756Val		-1.0	.,.,.					.	.	.		0.00564411	859.0	152194.0	5.0	33	0.97	PASS	amr	0.00994895	152.0	0.00842275	573.0	0.00568539	1429.0	251346.0	8.0	73	1.0	PASS	nfe	0.00804139	914.0	0.00804139	914.0	0.0056783	883	0.017	54.0				24.2	3.265208	0.31	5	14	19	SIFT,Polyphen2_HVAR_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	FRMPD2	0.0	0.78	0.0	0.0	-19.0	0.0	45.0	0.0	0.975676940719179	0.814	7.676	2.044	9.72	0.895	0.0	0.000000000	0.032	0.947	.			ciliary ganglion;olfactory bulb;testis - seminiferous tubule;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	.	bicellular tight junction assembly	cytoplasm;cytoskeleton;bicellular tight junction;basolateral plasma membrane	protein binding;1-phosphatidylinositol binding	.
276051	chr5	137465027	T	C	chr5:137465027	NME5	NME/NM23 family member 5	3474.0	SNV	0/1	0.44	18_14	32	99	False	rs191188008	EXONIC	YES	NM_003551.3	Transcript	protein_coding	missense_variant		3/6	NM_003551.3:c.260A>G	NP_003542.1:p.His87Arg		-1.0	Nucleoside diphosphate kinase-like domain&Nucleoside diphosphate kinase-like domain					.	.	.		0.000190554	29.0	152188.0	0.0	32	0.96	PASS	amr	0.0012446	19.0	8.81834e-05	6.0	0.000174973	44.0	251468.0	0.0	100	1.0	PASS	amr	0.000838344	29.0	6.15363e-05	7.0	0.0001093	17	0.002	5.0	0.0021	20.0		16.76	1.58478	0.063	2	17	19	fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	NME5	0.01	0.0	0.01	0.0	45.0	-6.0	1.0	7.0						0.715	0.57	0.000000000	0.998	1.045	cellular phenotype; craniofacial phenotype; skeleton phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; 			pons;testis - seminiferous tubule;testis - interstitial;trigeminal ganglion;superior cervical ganglion;testis;skeletal muscle;	.	epithelial cilium movement;nucleoside diphosphate phosphorylation;GTP biosynthetic process;UTP biosynthetic process;CTP biosynthetic process;spermatogenesis;spermatid development;nucleoside metabolic process;ventricular system development;cilium assembly;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	cellular_component;sperm flagellum	nucleoside diphosphate kinase activity;protein binding	ZYX[26871637];DYDC2[16189514;19447967];DYDC1[16189514;25416956;unassigned1304];CEP76[26871637];RELA[22325559];
281754	chr3	15686008	C	T	chr3:15686008	BTD	biotinidase	3527.0	SNV	0/1	0.59	9_13	22	99	False	rs145388314	EXONIC	YES	NM_001281723.3	Transcript	protein_coding	synonymous_variant		4/4	NM_001281723.3:c.585C>T	NP_001268652.2:p.Leu195%3D		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Biotinidase_deficiency|not_specified|not_provided	Biotinidase deficiency, 253260 (3), Autosomal recessive	Biotinidase deficiency	Disease-causing germline mutation(s) in	Sensorineural hearing impairment;Feeding difficulties in infancy;Global developmental delay;Diarrhea;Ataxia;Metabolic ketoacidosis;Splenomegaly;Seizure;Lethargy;Visual loss;Seborrheic dermatitis;Tachypnea;Diffuse cerebral atrophy;Generalized hypotonia;Autosomal recessive inheritance;Hyperammonemia;Vomiting;Diffuse cerebellar atrophy;Conjunctivitis;Muscular hypotonia;Optic atrophy;Organic aciduria;Skin rash;Decreased biotinidase level;Alopecia;Recurrent skin infections;Hepatomegaly;Apnea;Hearing impairment;Generalized myoclonic seizure;Global developmental delay;Alopecia;Recurrent fungal infections;Coma;Hypertonia;Hyperventilation;Perioral eczema;Myopia;Lethargy;Muscle weakness;Optic atrophy;Keratoconjunctivitis;Ataxia;Abnormal cerebellum morphology;Muscular hypotonia;Metabolic ketoacidosis;Laryngeal stridor;Desquamation of skin soon after birth;Growth delay;Visual field defect;Apnea;Iris hypopigmentation	23757202,11668630	0.00661137	1006.0	152162.0	6.0	31	0.96	PASS	nfe	0.00996766	678.0	0.00996766	678.0	0.00797684	2006.0	251478.0	12.0	100	1.0	PASS	nfe	0.0111379	1267.0	0.0111379	1267.0	0.0075561	1175	0.009	30.0	0.00701	80.0		3.763	0.070227		0	0	0			BTD	0.0	0.0	0.0	0.0	14.0	-42.0	-14.0	33.0						0.126	0.0	15.574771829			growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); pigmentation phenotype; vision/eye phenotype; renal/urinary system phenotype; skeleton phenotype; 			liver;dorsal root ganglion;trigeminal ganglion;placenta;testis;	Biotin metabolism	biotin metabolic process;central nervous system development	extracellular region;extracellular space;mitochondrial matrix;extracellular exosome	biotinidase activity	SIKE1[26496610];CCND1[26496610];CDCA5[26496610];KIF21B[26496610];
281900	chr21	35821794	C	T	chr21:35821794	KCNE1	potassium voltage-gated channel subfamily E regulatory subunit 1	3534.0	SNV	0/1	0.41	13_9	22	99	False	rs199473353,CM106181,CM990756,COSV61607133	EXONIC	YES	NM_000219.6	Transcript	protein_coding	missense_variant		4/4	NM_000219.6:c.139G>A	NP_000210.2:p.Val47Ile		-1.0	.,.,.,.,.,.,.,.	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Cardiomyopathy|Long_QT_syndrome|not_provided	Jervell and Lange-Nielsen syndrome 2, 612347 (3), Autosomal recessive; Long QT syndrome 5, 613695 (3), Autosomal dominant	Familial atrial fibrillation;Jervell and Lange-Nielsen syndrome;Romano-Ward syndrome	Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Syncope;Seizure;Iron deficiency anemia;Profound sensorineural hearing impairment;Loss of consciousness;Postexertional malaise;Ventricular fibrillation;Bilateral sensorineural hearing impairment;Prolonged QTc interval;Torsade de pointes;Congenital sensorineural hearing impairment;Autosomal recessive inheritance;Torsade de pointes;Heterogeneous;Prolonged QT interval;Sudden cardiac death;Syncope;Autosomal dominant inheritance;Sudden cardiac death;Torsade de pointes;Syncope;Ventricular fibrillation;Heterogeneous;Prolonged QT interval;Abnormality of prenatal development or birth;Syncope;Torsade de pointes;Abnormal cardiac exercise stress test;Hypokalemia;Abnormal T-wave;Sudden cardiac death;Sinus bradycardia;Prolonged QTc interval;Abnormal autonomic nervous system physiology;Seizure	22581653,10400998	0.00052772	55.0	104222.0	9.0	14	0.25	PASS,PASS	amr,amr	0.00530074	49.0	0.000101717	5.0	0.000278405	70.0	251432.0	1.0	100	1.0	PASS	amr	0.00132979	46.0	0.000114316	13.0	0.0001801	28	0.001	2.0	0.00053	6.0		13.34	0.986465	0.04	2	17	19	M-CAP_pred,FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	KCNE1	0.0	0.0	0.0	0.0	25.0	40.0	-8.0	41.0						0.0168	0.0	0.0	0.392	-0.732	hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); digestive/alimentary phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	sensory perception of sound;regulation of ventricular cardiac muscle cell membrane repolarization;cellular response to cAMP;potassium ion transmembrane transport;cardiac muscle cell action potential involved in contraction;ventricular cardiac muscle cell action potential;membrane repolarization;membrane repolarization during action potential;membrane repolarization during cardiac muscle cell action potential;regulation of heart rate by cardiac conduction;negative regulation of protein targeting to membrane;potassium ion export across plasma membrane;membrane repolarization during ventricular cardiac muscle cell action potential;regulation of potassium ion transmembrane transport;positive regulation of potassium ion transmembrane transport;regulation of delayed rectifier potassium channel activity;negative regulation of delayed rectifier potassium channel activity	lysosome;plasma membrane;voltage-gated potassium channel complex;cell surface;apical plasma membrane;Z disc;membrane raft	voltage-gated potassium channel activity;delayed rectifier potassium channel activity;protein binding;potassium channel regulator activity;telethonin binding;ion channel binding;voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization;voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization	TPM3[25416956];KCNQ1[19521339];UBASH3A[25416956];CALM1[19521339];
287722	chr2	135743508	T	C	chr2:135743508	MAP3K19	mitogen-activated protein kinase kinase kinase 19	3649.0	SNV	0/1	0.7	7_16	23	99	False	rs56319025	EXONIC	YES	NM_025052.5	Transcript	protein_coding	synonymous_variant		10/13	NM_025052.5:c.2934A>G	NP_079328.3:p.Leu978%3D		-1.0						.	.	.		0.00480832	732.0	152236.0	3.0	33	0.98	PASS	amr	0.00915631	140.0	0.00611441	416.0	0.0056055	1408.0	251182.0	10.0	51	0.99	PASS	amr	0.00691631	239.0	0.00690469	784.0	0.0053118	826	0.006	19.0				9.539	0.514514		0	0	0			MAP3K19	0.0	0.0	0.0	0.0	22.0	-2.0	13.0	23.0							0.0	65.668610832			.			.	.	signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity	cytoplasm	protein serine/threonine kinase activity;ATP binding	.
288084	chr10	91477375	G	T	chr10:91477375	KIF20B	kinesin family member 20B	3660.0	SNV	0/1	0.43	16_12	28	99	False	rs150319905	EXONIC	YES	NM_001284259.2	Transcript	protein_coding	missense_variant		11/33	NM_001284259.2:c.1167G>T	NP_001271188.1:p.Lys389Asn		1.0	.,Kinesin motor domain&Kinesin motor domain&Kinesin motor domain&Kinesin motor domain					.	.	.		0.00089456	136.0	152030.0	1.0	32	0.97	PASS	sas	0.00227932	11.0	0.00132369	90.0	0.0014639	367.0	250700.0	1.0	55	0.95	PASS	sas	0.00374556	114.0	0.00149014	169.0	0.0002251,0.0012025	35,187	0.002	6.0				24.3	3.290173	0.174	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	KIF20B	0.0	0.15	0.0	0.01	7.0	-13.0	-20.0	13.0						0.989	0.0	0.0	1.0	1.166	limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; 			ciliary ganglion;temporal lobe;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;	.	neural tube closure;microtubule-based movement;cell cycle arrest;regulation of mitotic nuclear division;positive regulation of cell population proliferation;positive regulation of cytokinesis;protein localization to microtubule;neuron projection morphogenesis;cell division;positive regulation of intracellular protein transport;positive regulation of mitotic cytokinetic process;regulation of establishment of cell polarity;positive regulation of neuron migration	nucleus;nucleoplasm;nucleolus;cytoplasm;centrosome;kinesin complex;microtubule;growth cone;midbody;perinuclear region of cytoplasm;spindle midzone;contractile ring;mitotic spindle pole;mitotic spindle midzone	microtubule motor activity;protein binding;ATP binding;microtubule binding;ATP-dependent microtubule motor activity, plus-end-directed;ATPase activity;protein homodimerization activity;WW domain binding	C1orf52[26496610];YWHAB[17353931];BRCA1[29656893];MKI67[26949251];HSP90B1[26496610];VCPIP1[26496610];ASTE1[26496610];MYC[21150319];RUVBL1[17353931];SAP18[30021884];SLC38A2[26496610];HIST1H1C[30021884];CBX8[21282530];CBX6[21282530];KDM2A[26496610];YJU2[26496610];ACSL3[26496610];CMBL[26496610];CDC42BPA[26496610];EEF1G[26496610];STAG1[26496610];IMPACT[26496610];CRY1[26496610];OCIAD2[30021884];VIM[30021884];
290148	chr9	130230060	G	A	chr9:130230060	LRSAM1	leucine rich repeat and sterile alpha motif containing 1	3686.0	SNV	0/1	0.55	17_21	38	99	False	rs545814024	EXONIC	YES	NM_001384142.1	Transcript	protein_coding	synonymous_variant		10/26	NM_001384142.1:c.570G>A	NP_001371071.1:p.Arg190%3D		1.0		Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Charcot-Marie-Tooth_disease_type_2P|not_specified	Charcot-Marie-Tooth disease, axonal, type 2P, 614436 (3), Autosomal recessive, Autosomal dominant	Charcot-Marie-Tooth disease type 2P	Disease-causing germline mutation(s) in	Axonal degeneration/regeneration;Fasciculations;Steppage gait;Autosomal recessive inheritance;Hyporeflexia;Autosomal dominant inheritance;Slow progression;Decreased motor nerve conduction velocity;Foot dorsiflexor weakness;Autosomal recessive inheritance;Axonal degeneration;Pes cavus;Distal sensory impairment;Hammertoe;Areflexia;Toe walking;Distal muscle weakness;Distal amyotrophy;Incomplete penetrance;Impaired distal vibration sensation;Peripheral axonal degeneration		0.000203626	31.0	152240.0	0.0	32	0.98	PASS	amr	0.00117755	18.0	0.000146946	10.0	0.000206153	50.0	242538.0	0.0	100	0.77	PASS	amr	0.00079524	27.0	0.000190628	21.0	0.0001350	21	0.002	8.0	0.00246	28.0		2.078	-0.039014		0	0	0			LRSAM1	0.0	0.0	0.01	0.0	2.0	-41.0	3.0	49.0						0.809	0.0	36.805157448			nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			pons;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	.	protein polyubiquitination;autophagy;protein catabolic process;negative regulation of endocytosis;viral budding;protein autoubiquitination;ubiquitin-dependent endocytosis;positive regulation of xenophagy;positive regulation of autophagosome assembly	cytoplasm;cytosol;membrane	ubiquitin-protein transferase activity;protein binding;metal ion binding;ubiquitin protein ligase activity	HIP2[19549727];TSG101[16189514;19549727;25416956;unassigned1304];TRIM74[22493164];HSP90AB1[22939624];UBE2D4[19549727];GRIK5[16169070];PHF23[16169070];UBE2D2[19549727];UBE2D3[19549727];UBE2D1[19549727];KLC1[16169070];UBE2J1[19690564];FAM178B[16169070];ATXN1[16713569];ATXN7[21078624];ZMAT4[unassigned1304];VPS11[22493164];NINL[16169070];RXRG[16169070];RNF111[22493164];MUTYH[16169070];GABARAPL2[16169070];UBE2H[19549727];UBE2I[unassigned1304];GPR108[16169070];TNFRSF10C[16169070];UBE2E1[19549727];TERF1[21044950];UEVLD[19549727];UBE2W[19549727];TRIM17[22493164];MYL2[16169070];MGAT4B[16169070];UBE2N[19690564;19549727;25260751];CCDC6[unassigned1304];MKRN3[22493164];MDM4[22493164];UBA1[25260751];UBE2V1[25260751];XAF1[unassigned1304];
290767	chr11	4703793	G	A	chr11:4703793	OR51E2	olfactory receptor family 51 subfamily E member 2	3706.0	SNV	0/1	0.36	27_15	42	99	False	rs760468563,COSV104431048	EXONIC	YES	NM_030774.4	Transcript	protein_coding	missense_variant		2/2	NM_030774.4:c.149C>T	NP_110401.1:p.Thr50Met		-1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		6.57445e-06	1.0	152104.0	0.0	33	0.97	PASS	sas	0.000207383	1.0	0.0	0.0	3.97687e-06	1.0	251454.0	0.0	100	1.0	PASS				0.0	0.0	0.0000064	1						4.983	0.144191	0.155	1	18	19	PROVEAN_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR51E2	0.0	0.0	0.0	0.0	2.0	42.0	8.0	4.0						0.654	0.0	0.0	0.543	0.23	taste/olfaction phenotype; growth/size/body region phenotype; craniofacial phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; 			.	Olfactory transduction	G protein-coupled receptor signaling pathway;steroid hormone mediated signaling pathway;positive regulation of blood pressure;detection of chemical stimulus involved in sensory perception of smell;cellular response to fatty acid;positive regulation of renin secretion into blood stream	plasma membrane;integral component of membrane	steroid hormone receptor activity;G protein-coupled receptor activity;olfactory receptor activity;signaling receptor activity	.
291161	chr17	51901651	C	T	chr17:51901651	KIF2B	kinesin family member 2B	3725.0	SNV	0/1	0.39	14_9	23	99	False	rs148923659,COSV52126903	EXONIC	YES	NM_032559.5	Transcript	protein_coding	synonymous_variant		1/1	NM_032559.5:c.1257C>T	NP_115948.4:p.Asn419%3D		1.0						.	.	.		0.00519388	790.0	152102.0	5.0	33	0.94	PASS	nfe	0.00767286	522.0	0.00767286	522.0	0.00568896	1430.0	251364.0	6.0	58	1.0	PASS	nfe	0.00757269	861.0	0.00757269	861.0	0.0055626	865	0.01	31.0				0.034	-0.628492		0	0	0			KIF2B	0.04	0.0	0.0	0.0	15.0	-15.0	33.0	44.0						0.901	0.0	0.0			normal phenotype; 			testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;testis;	.	retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;microtubule-based movement;microtubule depolymerization;antigen processing and presentation of exogenous peptide antigen via MHC class II;cell division;metaphase plate congression;regulation of chromosome segregation	condensed chromosome kinetochore;nucleus;nucleolus;centrosome;cytosol;kinesin complex;microtubule;microtubule cytoskeleton;intercellular bridge;mitotic spindle	microtubule motor activity;ATP binding;microtubule binding;ATPase activity	STAU1[15303970];BICD2[30021884];HIST1H1B[30021884];
292500	chr2	44050041	C	G	chr2:44050041	ABCG5	ATP binding cassette subfamily G member 5	3745.0	SNV	0/1	0.58	13_18	31	99	False	rs778497502	EXONIC	YES	NM_022436.3	Transcript	protein_coding	missense_variant		10/13	NM_022436.3:c.1358G>C	NP_071881.1:p.Ser453Thr		-1.0	ABC-2 type transporter,ABC-2 type transporter	Uncertain_significance	criteria_provided,_single_submitter	not_provided	Sitosterolemia 2, 618666 (3), Autosomal recessive	Sitosterolemia;Homozygous familial hypercholesterolemia	Disease-causing germline mutation(s) in;Candidate gene tested in	Myocardial infarction;Mitral regurgitation;Sudden cardiac death;Aortic atherosclerotic lesion;Coronary artery aneurysm;Hepatic steatosis;Premature coronary artery atherosclerosis;Left ventricular dysfunction;Hyperlipidemia;Dyspnea;Cerebral artery atherosclerosis;Tendon xanthomatosis;Supravalvular aortic stenosis;Premature arteriosclerosis;Abnormal nervous system physiology;Hypertension;Abnormal eye physiology;Precocious atherosclerosis;Hypercholesterolemia;Increased LDL cholesterol concentration;Abnormal internal carotid artery morphology;Angina pectoris;Arthralgia;Myocardial steatosis;Renal steatosis;Heart murmur;Renal artery stenosis;Peripheral arterial stenosis;Calcification of the aorta;Optic neuropathy		1.31416e-05	2.0	152188.0	0.0	31	0.95	PASS	amr	6.54879e-05	1.0	0.0	0.0	4.78e-05	12.0	251046.0	0.0	100	0.97	PASS	amr	0.000318342	11.0	8.81011e-06	1.0	0.0000257	4	0.0	1.0				24.4	3.302389	0.12	11	10	21	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred	ABCG5	0.01	0.0	0.0	0.0	33.0	11.0	-48.0	1.0						0.359	0.0		0.994	1.026	muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; digestive/alimentary phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 			liver;testis - interstitial;fetal liver;	ABC transporters	drug transmembrane transport;response to nutrient;excretion;response to ionizing radiation;negative regulation of intestinal phytosterol absorption;intestinal cholesterol absorption;cholesterol efflux;cholesterol homeostasis;negative regulation of intestinal cholesterol absorption;transmembrane transport	plasma membrane;integral component of plasma membrane;apical plasma membrane;ATP-binding cassette (ABC) transporter complex;receptor complex	protein binding;ATP binding;ATPase activity;cholesterol transporter activity;ATPase activity, coupled to transmembrane movement of substances;metal ion binding;protein heterodimerization activity	ABCG8[16870176;27144356];PIK3R1[17474147];ABCG1[16870176];NCK1[17474147];
296439	chr17	62141416	G	A	chr17:62141416	ERN1	endoplasmic reticulum to nucleus signaling 1	3821.0	SNV	0/1	0.52	14_15	29	99	False	rs56201815	EXONIC	YES	NM_001433.5	Transcript	protein_coding	synonymous_variant		10/22	NM_001433.5:c.1017C>T	NP_001424.3:p.Asp339%3D		-1.0						.	.	.		0.00111701	170.0	152192.0	0.0	32	0.96	PASS	nfe	0.00188136	128.0	0.00188136	128.0	0.00134648	335.0	248796.0	2.0	52	0.96	PASS	sas	0.00222615	68.0	0.00176375	199.0	0.0012025	187	0.003	8.0				5.289	0.163686		0	0	0			ERN1	0.0	0.0	0.0	0.0	-7.0	6.0	25.0	-25.0							0.91				digestive/alimentary phenotype; immune system phenotype; embryo phenotype; liver/biliary system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); 			.	.	endothelial cell proliferation;mRNA cleavage;mRNA catabolic process;protein phosphorylation;cell cycle arrest;activation of JUN kinase activity;regulation of macroautophagy;endoplasmic reticulum unfolded protein response;positive regulation of RNA splicing;cellular response to unfolded protein;response to endoplasmic reticulum stress;cellular response to vascular endothelial growth factor stimulus;peptidyl-serine autophosphorylation;IRE1-mediated unfolded protein response;protein autophosphorylation;mRNA splicing, via endonucleolytic cleavage and ligation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;cellular response to glucose stimulus;RNA phosphodiester bond hydrolysis, endonucleolytic;mRNA cleavage involved in mRNA processing;positive regulation of endoplasmic reticulum unfolded protein response;insulin metabolic process;positive regulation of vascular smooth muscle cell proliferation;peptidyl-serine trans-autophosphorylation	nuclear inner membrane;cytoplasm;mitochondrion;endoplasmic reticulum;endoplasmic reticulum membrane;integral component of endoplasmic reticulum membrane;Ire1 complex;AIP1-IRE1 complex;IRE1-TRAF2-ASK1 complex;IRE1-RACK1-PP2A complex	magnesium ion binding;endoribonuclease activity;protein kinase activity;protein serine/threonine kinase activity;platelet-derived growth factor receptor binding;protein binding;ATP binding;enzyme binding;Hsp70 protein binding;identical protein binding;protein homodimerization activity;ADP binding;unfolded protein binding;Hsp90 protein binding	SRPK2[23602568];SEC24B[25742138];SEC24A[25742138];HSPA5[27238082;26551274];YIPF5[25742138];SEL1L[26551274];SYVN1[18369366;26551274];TRAF2[11278723;25241761];ERN1[12637535;21317875;16973740;20798350];TAOK3[11278723];OS9[26551274];UBC[18369366];BAX[16645094];SEC24D[25742138];SEC24C[25742138];MAP3K5[25241761];HSPA1A[20625543];
297791	chr1	152277159	C	T	chr1:152277159	FLG	filaggrin	3844.0	SNV	0|1	0.16	16_3	19	68	False	rs563764210,COSV64245638	EXONIC	YES	NM_002016.2	Transcript	protein_coding	synonymous_variant		3/3	NM_002016.2:c.10203G>A	NP_002007.1:p.Gly3401%3D		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.000440147	65.0	147678.0	0.0	28	0.84	AS_VQSR	sas	0.000921234	4.0	0.000608791	40.0	0.000108002	27.0	249996.0	6.0	100	1.0	RF	sas	0.000298092	9.0	9.71955e-05	11.0	0.0004952	77	0.002	6.0	0.0063	60.0		0.029	-0.649982		0	0	0			FLG	0.0	0.0	0.0	0.0	35.0	-49.0	-48.0	36.0						0.995					.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];
297800	chr1	152282101	T	C	chr1:152282101	FLG	filaggrin	3844.0	SNV	0|1	0.19	38_9	47	99	False	rs761680413,COSV64239131	EXONIC	YES	NM_002016.2	Transcript	protein_coding	missense_variant		3/3	NM_002016.2:c.5261A>G	NP_002007.1:p.Gln1754Arg		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.00182688	271.0	148340.0	0.0	30	0.92	AS_VQSR	sas	0.00875617	39.0	0.00220331	145.0	6.80218e-05	17.0	249920.0	0.0	100	1.0	PASS	sas	0.000165662	5.0	6.18276e-05	7.0	0.0000064	1			0.00913	87.0		0.032	-0.63782	0.095	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FLG	0.0	0.0	0.0	0.0	-44.0	-2.0	-43.0	-7.0						0.995			0.0	-2.317	.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];
297801	chr1	152282104	C	T	chr1:152282104	FLG	filaggrin	3844.0	SNV	0|1	0.14	37_6	43	99	False	rs762948644	EXONIC	YES	NM_002016.2	Transcript	protein_coding	missense_variant		3/3	NM_002016.2:c.5258G>A	NP_002007.1:p.Gly1753Asp		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.00123959	184.0	148436.0	0.0	30	0.92	AS_VQSR	sas	0.00563317	25.0	0.00153295	101.0	0.0	0.0	250118.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0000064	1			0.00577	55.0		15.94	1.441607	0.147	5	15	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,PROVEAN_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FLG	0.0	0.0	0.0	0.0	40.0	-47.0	-46.0	1.0						0.995			0.0	0.005	.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];
297802	chr1	152282111	T	C	chr1:152282111	FLG	filaggrin	3844.0	SNV	0|1	0.12	37_5	42	99	False	rs577966299,COSV64239135	EXONIC	YES	NM_002016.2	Transcript	protein_coding	missense_variant		3/3	NM_002016.2:c.5251A>G	NP_002007.1:p.Thr1751Ala		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.000645699	96.0	148676.0	0.0	30	0.92	AS_VQSR	sas	0.00224517	10.0	0.000786973	52.0	8.37281e-05	21.0	250812.0	0.0	100	1.0	PASS	afr	0.000184593	3.0	0.000132091	15.0	0.0001415	22			0.00346	33.0		0.001	-1.643312	0.127	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FLG	0.0	0.0	0.0	0.0	15.0	-37.0	-22.0	-23.0						0.995			0.0	-0.553	.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];
297807	chr1	152284541	G	A	chr1:152284541	FLG	filaggrin	3844.0	SNV	0/1	0.16	31_6	37	90	False	rs138002269,COSV64245372,COSV64246254	EXONIC	YES	NM_002016.2	Transcript	protein_coding	missense_variant		3/3	NM_002016.2:c.2821C>T	NP_002007.1:p.Arg941Cys		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.00141924	212.0	149376.0	0.0	31	0.94	PASS	sas	0.00611888	28.0	0.00191542	127.0	0.00041531	101.0	243192.0	0.0	100	1.0	PASS	sas	0.00124043	35.0	0.000436546	48.0	0.0000064	1						21.8	2.255804	0.227	5	14	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FLG	0.0	0.0	0.0	0.0	39.0	7.0	2.0	-14.0						0.995			0.001	0.927	.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];
297813	chr1	152284629	T	C	chr1:152284629	FLG	filaggrin	3844.0	SNV	0|1	0.14	31_5	36	99	False	rs540595062	EXONIC	YES	NM_002016.2	Transcript	protein_coding	synonymous_variant		3/3	NM_002016.2:c.2733A>G	NP_002007.1:p.Ser911%3D		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.00274094	372.0	135720.0	0.0	30	0.89	AS_VQSR	afr	0.00993311	297.0	0.00042328	28.0	0.000230629	58.0	251486.0	0.0	100	1.0	PASS	nfe	0.000395556	45.0	0.000395556	45.0	0.0000193	3			0.00021	2.0		0.003	-0.949513		0	0	0			FLG	0.0	0.0	0.0	0.0	4.0	-39.0	-48.0	-1.0						0.995					.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];
297814	chr1	152284996	C	T	chr1:152284996	FLG	filaggrin	3844.0	SNV	0/1	0.65	12_22	34	99	False	rs147308729	EXONIC	YES	NM_002016.2	Transcript	protein_coding	missense_variant		3/3	NM_002016.2:c.2366G>A	NP_002007.1:p.Arg789His		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.00139882	212.0	151556.0	0.0	29	0.88	PASS	nfe	0.00161974	110.0	0.00161974	110.0	0.00178151	448.0	251472.0	0.0	100	1.0	PASS	amr	0.00187905	65.0	0.00149451	170.0	0.0012733	198	0.008	24.0	0.00546	52.0		1.204	-0.123302	0.11	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FLG	0.0	0.0	0.0	0.0	-23.0	46.0	21.0	-22.0						0.995			0.001	-0.085	.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];
300356	chr4	103947558	T	G	chr4:103947558	SLC9B2	solute carrier family 9 member B2	3857.0	SNV	0/1	0.53	15_17	32	99	False	rs756623440	EXONIC	YES	NM_178833.7	Transcript	protein_coding	missense_variant		12/12	NM_178833.7:c.1583A>C	NP_849155.2:p.Glu528Ala		-1.0	.,.,.					.	.	.		2.62784e-05	4.0	152216.0	0.0	32	0.97	PASS	amr	6.53937e-05	1.0	0.0	0.0	2.78933e-05	7.0	250956.0	0.0	44	0.97	PASS	amr	0.000116212	4.0	0.0	0.0	0.0000129	2						18.19	1.798629	0.084	3	16	19	MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	SLC9B2	0.0	0.0	0.0	0.05	11.0	38.0	26.0	-33.0							0.07	0.0	0.392	0.175	homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; 			ciliary ganglion;kidney;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;globus pallidus;	.	sodium ion transport;flagellated sperm motility;ion transmembrane transport;sodium ion transmembrane transport;regulation of insulin secretion involved in cellular response to glucose stimulus;clathrin-dependent endocytosis;proton transmembrane transport;positive regulation of osteoclast development	mitochondrial inner membrane;plasma membrane;endosome membrane;integral component of membrane;basolateral plasma membrane;apical plasma membrane;cell junction;synaptic vesicle membrane;mitochondrial membrane;sperm principal piece	monovalent cation:proton antiporter activity;lithium:proton antiporter activity;sodium:proton antiporter activity;identical protein binding	PGRMC2[unassigned1304];UBE2N[25260751];UBA1[25260751];UBE2V1[25260751];
300673	chr19	16799021	G	A	chr19:16799021	TMEM38A	transmembrane protein 38A	3860.0	SNV	0/1	0.4	18_12	30	99	False	rs145844119	EXONIC	YES	NM_024074.4	Transcript	protein_coding	missense_variant		6/6	NM_024074.4:c.739G>A	NP_076979.1:p.Val247Met		1.0						.	.	.		0.00146545	223.0	152172.0	0.0	33	0.97	PASS	amr	0.00418903	64.0	0.000573159	39.0	0.00122109	266.0	217838.0	0.0	20	0.51	PASS	afr	0.00251906	37.0	0.000946169	94.0	0.0010997	171	0.004	14.0				12.5	0.870504	0.066	3	14	17	LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	TMEM38A	0.0	0.04	0.0	0.0	2.0	-37.0	24.0	48.0							0.03	0.0	0.591	1.083	muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			.	.	potassium ion transmembrane transport	integral component of membrane;nuclear membrane;sarcoplasmic reticulum membrane;extracellular exosome	potassium channel activity	.
301876	chr18	712357	TACCATGGCGTCCGCGCTTACCATGGCGTCCGCGCT		chr18:712357-712392	ENOSF1	enolase superfamily member 1	3869.0	deletion	1|1	1.0	0_5	5	23	False		SPLICING	YES	NM_001354067.2	Transcript	protein_coding	splice_donor_variant,splice_donor_region_variant,coding_sequence_variant,intron_variant	1/15	1/16	NM_001354067.2:c.196_228+3del			-1.0						.	.	.		0.0	0.0	138810.0	0.0	28	0.78	AC0				0.0	0.0					80	0.57																	0	0	0																	0.981	0.0	0.0			.			.	.	cellular amino acid catabolic process;cellular carbohydrate catabolic process	cellular_component;mitochondrion	magnesium ion binding;isomerase activity;L-fuconate dehydratase activity	.
301938	chr16	31367298	T	G	chr16:31367298	ITGAX	integrin subunit alpha X	3876.0	SNV	0/1	0.53	14_16	30	99	False	rs914831089	EXONIC	YES	NM_001286375.2	Transcript	protein_coding	missense_variant		2/31	NM_001286375.2:c.122T>G	NP_001273304.1:p.Val41Gly		1.0	.,.,.					.	.	.		1.31387e-05	2.0	152222.0	0.0	32	0.97	PASS	amr	6.54365e-05	1.0	0.0	0.0	1.59839e-05	4.0	250252.0	0.0	37	0.9	PASS	amr	8.71738e-05	3.0	0.0	0.0								26.0	3.750334	0.672	15	4	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,PrimateAI_pred,BayesDel_addAF_pred,LIST-S2_pred	ITGAX	0.0	0.0	0.0	0.03	21.0	-48.0	35.0	6.0						0.441	0.0	0.0	0.989	1.082	hematopoietic system phenotype; normal phenotype; immune system phenotype; 			lymph node;whole blood;	Regulation of actin cytoskeleton	cell adhesion;integrin-mediated signaling pathway;animal organ morphogenesis;cytokine-mediated signaling pathway;extracellular matrix organization;heterotypic cell-cell adhesion;neutrophil degranulation;leukocyte migration	plasma membrane;integrin complex;cell surface;membrane;secretory granule membrane;tertiary granule membrane;ficolin-1-rich granule membrane	protein binding;signaling receptor activity;metal ion binding	ITGB2[20033057;20679211];
301941	chr16	31368622	A	G	chr16:31368622	ITGAX	integrin subunit alpha X	3876.0	SNV	0/1	0.55	13_16	29	99	False	rs141436259	EXONIC	YES	NM_001286375.2	Transcript	protein_coding	missense_variant		5/31	NM_001286375.2:c.367A>G	NP_001273304.1:p.Thr123Ala		1.0	.,.					.	.	.		0.000190604	29.0	152148.0	0.0	32	0.97	PASS	amr	0.000785752	12.0	0.000191098	13.0	0.000226017	54.0	238920.0	0.0	30	0.69	PASS	amr	0.000679508	23.0	0.000260611	28.0	0.0001286	20	0.001	3.0				10.3	0.598372	0.049	1	17	18	MutationAssessor_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ITGAX	0.0	0.15	0.0	0.0	-13.0	33.0	-8.0	33.0						0.441	0.0	0.0	0.261	1.199	hematopoietic system phenotype; normal phenotype; immune system phenotype; 			lymph node;whole blood;	Regulation of actin cytoskeleton	cell adhesion;integrin-mediated signaling pathway;animal organ morphogenesis;cytokine-mediated signaling pathway;extracellular matrix organization;heterotypic cell-cell adhesion;neutrophil degranulation;leukocyte migration	plasma membrane;integrin complex;cell surface;membrane;secretory granule membrane;tertiary granule membrane;ficolin-1-rich granule membrane	protein binding;signaling receptor activity;metal ion binding	ITGB2[20033057;20679211];
304811	chr10	91294402	AA		chr10:91294402-91294403	SLC16A12	solute carrier family 16 member 12	3912.0	deletion	1/1	0.83	1_5	6	11	False	rs55935286	SPLICING	YES	NM_213606.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/7		NM_213606.4:c.-186-6_-186-5del			-1.0					Cataract 47, juvenile, with microcornea, 612018 (3), Autosomal dominant	Juvenile cataract-microcornea-renal glucosuria syndrome	Disease-causing germline mutation(s) in	Autosomal dominant inheritance;Glycosuria;Cataract;Microcornea		0.0018362	96.0	52282.0	3.0	0	0.18	PASS	eas	0.00404313	6.0	0.00218805	72.0					0	0.0																	0	0	0			SLC16A12	0.0	0.0	0.0	0.0	-10.0	-4.0	46.0	-10.0						0.726	0.0				.			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;cerebellum;	.	monocarboxylic acid transport;creatine transmembrane transport	plasma membrane;integral component of plasma membrane	creatine transmembrane transporter activity;monocarboxylic acid transmembrane transporter activity;symporter activity	CD79A[unassigned1304];FXYD3[unassigned1304];AQP6[unassigned1304];GJA8[unassigned1304];
304829	chr3	47452631	G	A	chr3:47452631	PTPN23	protein tyrosine phosphatase, non-receptor type 23	3914.0	SNV	0/1	0.54	12_14	26	99	True	rs763104053,COSV55546400	EXONIC	YES	NM_015466.4	Transcript	protein_coding	missense_variant		20/25	NM_015466.4:c.3343G>A	NP_056281.1:p.Ala1115Thr		1.0		Uncertain_significance	criteria_provided,_single_submitter	not_provided	Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, 618890 (3), Autosomal recessive	.	.	.		0.000105165	16.0	152142.0	0.0	32	0.96	PASS	sas	0.000206954	1.0	0.000132365	9.0	8.37755e-05	18.0	214860.0	0.0	26	0.6	PASS	amr	0.000154741	5.0	9.73078e-05	9.0	0.0000322	5						7.231	0.301543	0.018	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PTPN23	0.12	0.02	0.0	0.0	26.0	-32.0	26.0	-32.0						0.516	0.65	0.0	0.186	-0.191	vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			.	.	negative regulation of epithelial cell migration;protein transport;endocytic recycling;peptidyl-tyrosine dephosphorylation;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;early endosome to late endosome transport;cilium assembly;positive regulation of Wnt protein secretion;cellular response to cytokine stimulus;positive regulation of homophilic cell adhesion;positive regulation of adherens junction organization;positive regulation of early endosome to late endosome transport	nucleus;nucleoplasm;cytoplasm;endosome;early endosome;cytosol;nuclear body;ciliary basal body;extracellular exosome	protein tyrosine phosphatase activity;protein binding;protein kinase binding	TSG101[17174262];DDX24[16169070];SRC[18835089];SHMT2[28330616];PDCD6[17174262];CEP19[unassigned1304];CLTC[26496610];RPN1[28330616];ARL1[28330616];NTPCR[28330616];EEA1[29568061];TGOLN2[29568061];STIP1[28330616];HSPH1[28330616];GRAP2[21179510];TRIM27[25416956];SH3GL2[17174262];CEP55[25416956];VCAM1[22623428];HSPA4[28330616];CAD[28330616];NME2[28330616];NOTCH2NLA[25416956];TUBB4A[28330616];ESR2[21182203];PTK2[18835089];GLUD1[28330616];PSMA3[25416956];CHMP4B[17174262;18434552];GRB2[20936779;21179510];KIF20A[26496610];CALR[28330616];
309040	chr7	44266179	G	A	chr7:44266179	CAMK2B	calcium/calmodulin dependent protein kinase II beta	3939.0	SNV	0/1	0.48	13_12	25	99	False	rs746905305	EXONIC	YES	NM_001220.5	Transcript	protein_coding	synonymous_variant		20/24	NM_001220.5:c.1533C>T	NP_001211.3:p.Gly511%3D		-1.0					Mental retardation, autosomal dominant 54, 617799 (3), Autosomal dominant	Autosomal dominant non-syndromic intellectual disability	Disease-causing germline mutation(s) in	Gastroesophageal reflux;Inability to walk;Intellectual disability;Strabismus;Generalized hypotonia;Absent speech;Seizure;Autosomal dominant inheritance;Visual impairment;Constipation;Feeding difficulties;Microcephaly		1.31799e-05	2.0	151746.0	0.0	27	0.86	PASS	nfe	2.94386e-05	2.0	2.94386e-05	2.0	4.98086e-05	7.0	140538.0	0.0	11	0.34	PASS	nfe	8.8697e-05	6.0	8.8697e-05	6.0	0.0000386	6						9.973	0.562483		0	0	0			CAMK2B	0.0	0.0	0.0	0.0	-11.0	32.0	2.0	36.0						0.575	0.47	0.379585126			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 			caudate nucleus;ciliary ganglion;temporal lobe;amygdala;prefrontal cortex;cingulate cortex;trigeminal ganglion;superior cervical ganglion;cerebellum peduncles;cerebellum;pons;occipital lobe;fetal brain;subthalamic nucleus;dorsal root ganglion;whole brain;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;hypothalamus;thalamus;	ErbB signaling pathway;Calcium signaling pathway;Wnt signaling pathway;Long-term potentiation;Olfactory transduction;GnRH signaling pathway;Melanogenesis;Glioma	MAPK cascade;protein phosphorylation;signal transduction;positive regulation of neuron projection development;regulation of skeletal muscle adaptation;protein autophosphorylation;regulation of long-term neuronal synaptic plasticity;regulation of synapse structural plasticity;regulation of calcium ion transport;interferon-gamma-mediated signaling pathway;regulation of dendritic spine development;positive regulation of dendritic spine morphogenesis;positive regulation of synapse maturation;regulation of neuron migration	nucleoplasm;cytoplasm;microtubule organizing center;cytosol;plasma membrane;cell junction;endocytic vesicle membrane;sarcoplasmic reticulum membrane;neuron projection;synapse	actin binding;protein serine/threonine kinase activity;calmodulin-dependent protein kinase activity;Ras guanyl-nucleotide exchange factor activity;protein binding;calmodulin binding;ATP binding;identical protein binding;protein homodimerization activity	CAMK2B[25416956;unassigned1304;20668654];POP5[25416956];CAMK2D[unassigned1304;20668654;29426014];HSP90AB1[22939624];KRTAP10-11[25416956];PNKP[unassigned1304];CAMK2A[17353931;27173435;unassigned1304;unassigned1312;29426014];RPL11[25416956];CCM2L[unassigned1304];KRT86[unassigned1304];RNF4[unassigned1304];MEOX2[unassigned1304];TANK[unassigned1774];MED18[25416956];MRPL11[25416956;unassigned1304];FAM171A2[25416956];ATXN1[23275563];KRTAP6-2[unassigned1304];SMYD3[21988832];SUMO1P1[unassigned1304];NINL[26638075];CAMK2G[unassigned1304];TNPO2[unassigned1304];TNPO3[unassigned1304];KRTAP1-1[unassigned1304];ARSA[unassigned1304];ACOT7[25416956];RBFOX2[25416956];RBPMS[25416956];SPRYD7[25416956];ZBTB32[26871637];PHKB[25416956];SEMA4G[25416956];KRTAP19-3[unassigned1304];AP5B1[25416956];KRTAP19-5[25416956];KRTAP19-7[25416956];MAD2L2[25416956];MORF4L1[25416956;unassigned1304];PPP5C[25036637];PKM[24606918];RAP2B[25416956;unassigned1304];TTC5[25416956;unassigned1304];POLR3C[unassigned1304];CDC37[unassigned1304];MORF4L2[unassigned1304];DUS1L[unassigned1304];CALM1[20668654];
309760	chr9	124522400	G	A	chr9:124522400	DAB2IP	DAB2 interacting protein	3956.0	SNV	0/1	0.55	14_17	31	99	False	rs34839326	EXONIC	YES	NM_032552.4	Transcript	protein_coding	synonymous_variant		6/17	NM_032552.4:c.768G>A	NP_115941.2:p.Lys256%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00235939	359.0	152158.0	1.0	33	0.97	PASS	amr	0.00359901	55.0	0.00349856	238.0	0.00255297	641.0	251080.0	2.0	100	1.0	PASS	sas	0.00336425	103.0	0.00334015	379.0	0.0023858	371	0.009	26.0				11.3	0.718356		0	0	0			DAB2IP	0.0	0.0	0.0	0.02	-42.0	-8.0	-42.0	27.0						0.00482	1.0	79.697520579			homeostasis/metabolism phenotype; cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;cerebellum peduncles;globus pallidus;cerebellum;	.	negative regulation of transcription by RNA polymerase II;MAPK cascade;activation of MAPKKK activity;angiogenesis;negative regulation of protein phosphorylation;inflammatory response;cell cycle;I-kappaB phosphorylation;activation of JUN kinase activity;negative regulation of cell population proliferation;extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of endothelial cell migration;negative regulation of epithelial cell migration;negative regulation of epithelial to mesenchymal transition;positive regulation of neuron projection development;negative regulation of phosphatidylinositol 3-kinase signaling;negative regulation of angiogenesis;cell motility involved in cerebral cortex radial glia guided migration;layer formation in cerebral cortex;negative regulation of vascular endothelial growth factor receptor signaling pathway;negative regulation of NF-kappaB transcription factor activity;negative regulation of toll-like receptor 4 signaling pathway;negative regulation of GTPase activity;cellular response to unfolded protein;tube formation;cellular response to vascular endothelial growth factor stimulus;vascular endothelial growth factor receptor-2 signaling pathway;reelin-mediated signaling pathway;regulation of growth;negative regulation of epidermal growth factor receptor signaling pathway;positive regulation of apoptotic process;regulation of GTPase activity;regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of I-kappaB kinase/NF-kappaB signaling;regulation of protein complex assembly;negative regulation of MAP kinase activity;positive regulation of MAPK cascade;regulation of protein heterodimerization activity;positive regulation of JUN kinase activity;positive regulation of GTPase activity;negative regulation of phosphatidylinositol 3-kinase activity;cellular protein catabolic process;innate immune response;positive regulation of protein catabolic process;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of JNK cascade;negative regulation of Ras protein signal transduction;negative regulation of fibroblast proliferation;neuron projection morphogenesis;negative regulation of epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;negative regulation of G0 to G1 transition;negative regulation of ERK1 and ERK2 cascade;positive regulation of cell cycle arrest;cellular response to lipopolysaccharide;cellular response to interleukin-1;cellular response to tumor necrosis factor;cellular response to epidermal growth factor stimulus;negative regulation of protein serine/threonine kinase activity;positive regulation of protein serine/threonine kinase activity;endothelial cell apoptotic process;negative regulation of canonical Wnt signaling pathway;positive regulation of synapse maturation;positive regulation of dendrite development;regulation of p38MAPK cascade;negative regulation of vascular endothelial growth factor signaling pathway;positive regulation of proteasomal protein catabolic process;negative regulation of cellular protein catabolic process;positive regulation of IRE1-mediated unfolded protein response;positive regulation of neuron migration;positive regulation of apoptotic signaling pathway	cytoplasm;cytosol;plasma membrane;endocytic vesicle;axon;dendrite;neuronal cell body membrane;neuronal cell body;cerebellar mossy fiber;climbing fiber;parallel fiber;AIP1-IRE1 complex	GTPase activator activity;death receptor binding;protein binding;SH3 domain binding;kinase binding;protein kinase binding;mitogen-activated protein kinase kinase binding;mitogen-activated protein kinase kinase kinase binding;phosphatidylinositol-3-phosphate binding;signaling adaptor activity;Toll-like receptor 4 binding;phosphatidylinositol 3-kinase regulatory subunit binding;identical protein binding;protein homodimerization activity;vascular endothelial growth factor receptor 2 binding;phosphatidylinositol 3-kinase binding;protein-containing complex binding;cadherin binding;protein phosphatase 2A binding;phosphatidylinositol-4-phosphate binding;14-3-3 protein binding	GSK3B[20080667];RNASEH2B[26496610];RAB4B[26496610];EXOSC9[26496610];DAB2IP[12813029];CBY1[unassigned1312];AXIN1[20080667];ANKS1A[unassigned1304];UGGT1[26496610];IWS1[26496610];MAP3K5[12813029];
310580	chr14	73717721	C	T	chr14:73717721	PAPLN	papilin, proteoglycan like sulfated glycoprotein	3987.0	SNV	0/1	0.42	22_16	38	99	False	rs146070218	EXONIC	YES	NM_001365906.3	Transcript	protein_coding	missense_variant		7/27	NM_001365906.3:c.572C>T	NP_001352835.1:p.Ala191Val		1.0	ADAM-TS Spacer 1,.,ADAM-TS Spacer 1,.					.	.	.		0.000564927	86.0	152232.0	0.0	33	0.98	PASS	afr	0.00154358	64.0	0.00014699	10.0	0.000304373	76.0	249694.0	0.0	38	0.9	PASS	afr	0.00191169	31.0	0.000150704	17.0	0.0002958	46	0.001	4.0				16.81	1.592905	0.009	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PAPLN	0.0	0.0	0.08	0.0	-12.0	14.0	-2.0	17.0						0.97	0.0	0.0	0.893	0.032	homeostasis/metabolism phenotype; 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	proteolysis;negative regulation of endopeptidase activity	extracellular region	serine-type endopeptidase inhibitor activity;peptidase activity	TFAP2C[24835590];
310584	chr14	73729347	C	T	chr14:73729347	PAPLN	papilin, proteoglycan like sulfated glycoprotein	3987.0	SNV	0/1	0.4	25_17	42	99	False	rs373606990,COSV99389727	EXONIC	YES	NM_001365906.3	Transcript	protein_coding	synonymous_variant		19/27	NM_001365906.3:c.2535C>T	NP_001352835.1:p.Ala845%3D		1.0						.	.	.		0.000499245	76.0	152230.0	0.0	33	0.99	PASS	afr	0.00132645	55.0	0.000117581	8.0	0.000365808	49.0	133950.0	0.0	10	0.24	PASS	afr	0.00217978	21.0	0.00016325	9.0	0.0002315	36	0.0	1.0				0.207	-0.38193		0	0	0			PAPLN	0.0	0.0	0.0	0.0	10.0	-42.0	-35.0	28.0						0.97	0.0	0.0			homeostasis/metabolism phenotype; 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	proteolysis;negative regulation of endopeptidase activity	extracellular region	serine-type endopeptidase inhibitor activity;peptidase activity	TFAP2C[24835590];
311169	chr17	80881596	T	C	chr17:80881596	TBCD	tubulin folding cofactor D	3997.0	SNV	0/1	0.52	16_17	33	99	False	rs749237672	EXONIC	YES	NM_005993.5	Transcript	protein_coding	synonymous_variant		26/39	NM_005993.5:c.2247T>C	NP_005984.3:p.Asp749%3D		1.0					Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum, 617193 (3), Autosomal recessive	Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome	Disease-causing germline mutation(s) (loss of function) in	Respiratory failure;Widely spaced teeth;Muscle weakness;Fasciculations;Arthrogryposis multiplex congenita;Infantile muscular hypotonia;Intellectual disability, profound;Postnatal microcephaly;Pectus excavatum;Cerebellar atrophy;Urinary incontinence;Macrotia;Progressive spasticity;Dysphagia;Cerebral hypomyelination;Cerebral cortical atrophy;Plagiocephaly;Skeletal muscle atrophy;Tetraplegia;Hirsutism;Respiratory failure requiring assisted ventilation;Dystonia;Growth delay;Congenital microcephaly;Congenital hip dislocation;Hypertelorism;Absent smooth pursuit;Feeding difficulties;Chronic constipation;Stereotypy;Generalized tonic seizure;Absent speech;Micrognathia;Recurrent pneumonia;Motor axonal neuropathy;Upslanted palpebral fissure;Neurogenic bladder;Developmental regression;Pectus carinatum;Poor speech;Scoliosis;Bowel incontinence;Optic atrophy;Hypoplasia of the corpus callosum;Polyhydramnios;Febrile seizure (within the age range of 3 months to 6 years);Intellectual disability, moderate;Elevated serum creatine kinase;Bilateral tonic-clonic seizure;Ataxia;Sparse eyebrow;Global developmental delay;Areflexia;Fractures of the long bones;Cataplexy;Postnatal microcephaly;Seizure;CNS hypomyelination;Intellectual disability;Global developmental delay;Tongue fasciculations;Neuronal loss in central nervous system;Feeding difficulties;Optic atrophy;Cerebellar atrophy;Developmental regression;Muscle weakness;Arthrogryposis multiplex congenita;Respiratory insufficiency;Facial hypotonia;Severe muscular hypotonia;Constipation;Upslanted palpebral fissure;Widely spaced teeth;Ventriculomegaly;Diffuse cerebral atrophy;Skeletal muscle atrophy;Hypertelorism;Sparse eyebrow;Atrophy/Degeneration affecting the brainstem;Encephalopathy;Absent speech;Scoliosis;Gliosis;Autosomal recessive inheritance;Spastic tetraplegia;Variable expressivity;Hypoplasia of the corpus callosum;Micrognathia						32	0.97											21	0.54							0.0000064	1						0.183	-0.399131		0	0	0			TBCD	0.0	0.0	0.0	0.0	40.0	13.0	-35.0	13.0						0.799	0.0	75.332914276			.			caudate nucleus;thymus;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	microtubule cytoskeleton organization;mitotic cell cycle;protein folding;tubulin complex assembly;post-chaperonin tubulin folding pathway;negative regulation of cell-substrate adhesion;negative regulation of microtubule polymerization;adherens junction assembly;positive regulation of GTPase activity;cell morphogenesis involved in neuron differentiation;bicellular tight junction assembly	cytoplasm;centrosome;microtubule;adherens junction;bicellular tight junction;lateral plasma membrane	GTPase activator activity;protein binding;beta-tubulin binding;chaperone binding	XRCC6[16169070];ACD[21044950];ARL3[18588884];SMAD9[15231748];ARL2[18588884];TERF1[21044950];DEXI[16169070];HIST1H4A[30021884];MTNR1B[26514267];ZNF836[unassigned1312];TCP11L1[unassigned1312];POT1[21044950];IKBKG[14743216];POLR2I[21988832];ZNF146[unassigned1312];
313456	chr16	46958348	G	A	chr16:46958348	GPT2	glutamic--pyruvic transaminase 2	4056.0	SNV	0/1	0.58	13_18	31	99	False	rs115072332,COSV60839903	EXONIC	YES	NM_133443.4	Transcript	protein_coding	synonymous_variant		10/12	NM_133443.4:c.1260G>A	NP_597700.1:p.Thr420%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	Neurodevelopmental disorder with microcephaly and spastic paraplegia, 616281 (3), Autosomal recessive	Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome	Disease-causing germline mutation(s) in	Nasogastric tube feeding in infancy;Dysarthria;Drooling;Intellectual disability;Babinski sign;Febrile seizure (within the age range of 3 months to 6 years);Hyperreflexia;Low-set ears;Difficulty walking;Microcephaly;Global developmental delay;Spastic paraplegia;Delayed speech and language development;Abnormal CNS myelination;Broad-based gait;Severe muscular hypotonia;Hypotelorism;Tremor;Failure to thrive;Narrow forehead;Hypoplasia of the corpus callosum;Absent speech;Hypoplasia of the corpus callosum;Intellectual disability;Global developmental delay;Dysarthria;Postnatal microcephaly;Failure to thrive;Encephalopathy;Microcephaly;Drooling;Spasticity;Autosomal recessive inheritance;Hyperreflexia;Bilateral tonic-clonic seizure;Generalized hypotonia;Progressive		0.00593298	903.0	152200.0	7.0	33	0.98	PASS	nfe	0.00981977	668.0	0.00981977	668.0	0.00489892	1232.0	251484.0	5.0	100	1.0	PASS	nfe	0.00828953	943.0	0.00828953	943.0	0.0050674	788	0.01	32.0				10.88	0.667888		0	0	0			GPT2	0.0	0.05	0.0	0.0	-44.0	-47.0	-47.0	-29.0						0.243	0.0	16.688799429			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; 			.	Glutamate metabolism;Alanine and aspartate metabolism;Carbon fixation	2-oxoglutarate metabolic process;cellular amino acid biosynthetic process;L-alanine metabolic process;L-alanine catabolic process	mitochondrial matrix	L-alanine:2-oxoglutarate aminotransferase activity;pyridoxal phosphate binding	BABAM1[19615732];SLC10A6[30021884];USP20[19615732];SIRT4[25525879];DDIT4L[unassigned1304];
315921	chr4	68562401	C	T	chr4:68562401	UBA6	ubiquitin like modifier activating enzyme 6	4104.0	SNV	0/1	0.44	14_11	25	99	False	rs142985596	EXONIC	YES	NM_018227.6	Transcript	protein_coding	missense_variant		2/33	NM_018227.6:c.96G>A	NP_060697.4:p.Met32Ile		-1.0	.,.					.	.	.		0.000461315	70.0	151740.0	0.0	32	0.95	PASS	nfe	0.00078033	53.0	0.00078033	53.0	0.000315823	78.0	246974.0	0.0	35	0.77	PASS	nfe	0.000578611	65.0	0.000578611	65.0	0.0002765	43						22.9	2.658315	0.112	5	14	19	SIFT,LRT_pred,M-CAP_pred,MutationTaster_pred,fathmm-MKL_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	UBA6	0.0	0.01	0.0	0.0	-12.0	-8.0	12.0	-38.0						0.658	0.93	0.0	0.955	1.026	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype; 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;globus pallidus;	Ubiquitin mediated proteolysis	ubiquitin-dependent protein catabolic process;learning;locomotory behavior;protein ubiquitination;amygdala development;hippocampus development;protein modification by small protein conjugation;dendritic spine development	cytoplasm;cytosol	ubiquitin activating enzyme activity;protein binding;ATP binding;FAT10 activating enzyme activity	FXR1[26496610];HMBOX1[25416956];FMR1[26496610];EIF4A3[26496610];SMAD9[15231748];
322433	chr12	45059310	G	C	chr12:45059310	NELL2	neural EGFL like 2	4251.0	SNV	0/1	0.56	12_15	27	99	False	rs138454729	EXONIC	YES	NM_001145107.2	Transcript	protein_coding	missense_variant		14/21	NM_001145107.2:c.1551C>G	NP_001138579.1:p.Ile517Met		-1.0	.,EGF-like calcium-binding domain&EGF-like, conserved site&EGF-like domain&EGF-like calcium-binding domain&EGF-like domain,EGF-like calcium-binding domain&EGF-like, conserved site&EGF-like domain&EGF-like calcium-binding domain&EGF-like domain,EGF-like calcium-binding domain&EGF-like, conserved site&EGF-like domain&EGF-like calcium-binding domain&EGF-like domain,.,.,.					.	.	.		0.00143912	219.0	152176.0	0.0	32	0.97	PASS	amr	0.00419342	64.0	0.00149934	102.0	0.00158533	398.0	251052.0	0.0	48	0.99	PASS	amr	0.00361648	125.0	0.00167525	190.0	0.0013247	206	0.007	22.0				22.9	2.680035	0.136	7	14	21	PolyPhen,LRT_pred,M-CAP_pred,MutationTaster_pred,FATHMM_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	NELL2	0.0	0.0	0.0	0.0	-43.0	-21.0	34.0	-43.0						0.0196	1.0	0.0	1.0	0.228	nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			amygdala;temporal lobe;occipital lobe;fetal brain;prefrontal cortex;subthalamic nucleus;whole brain;trigeminal ganglion;cingulate cortex;parietal lobe;globus pallidus;medulla oblongata;	.	neuron cellular homeostasis	extracellular region;cell	calcium ion binding;protein binding	ROBO3[26586761];GFI1B[16713569];ATXN7[21078624];PRKAR1A[21900206];ATN1[16713569];CACNA1A[21078624];HOXA1[unassigned1304];
324693	chr2	96780987		TCCTCCTCT	chr2:96780986-96780987	ADRA2B	adrenoceptor alpha 2B	4332.0	insertion	1/1	1.0	0_32	32	96	False	rs1204257059,rs4066772	EXONIC	YES	NM_000682.7	Transcript	protein_coding	inframe_insertion		1/1	NM_000682.7:c.903_911dup	NP_000673.2:p.Glu304_Glu306dup		-1.0						Benign adult familial myoclonic epilepsy	Disease-causing germline mutation(s) (gain of function) in	EEG abnormality;Amaurosis fugax;Hand tremor;Focal-onset seizure;Intellectual disability;Headache;Generalized-onset seizure;Myoclonus	20051907					28	0.73											18	0.49							0.0209448,0.5142826	3257,79973			0.68086	7740.0		16.79	1.590496		0	0	0																	0.761	0.0	43.832499795			respiratory system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; muscle phenotype; 			.	Neuroactive ligand-receptor interaction	activation of MAPK activity;regulation of vascular smooth muscle contraction;G protein-coupled receptor signaling pathway;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;cell-cell signaling;female pregnancy;negative regulation of norepinephrine secretion;platelet activation;activation of protein kinase B activity;negative regulation of epinephrine secretion;receptor transactivation;positive regulation of MAPK cascade;positive regulation of neuron differentiation;positive regulation of blood pressure;positive regulation of uterine smooth muscle contraction;adrenergic receptor signaling pathway;adenylate cyclase-activating adrenergic receptor signaling pathway	plasma membrane;integral component of plasma membrane;cell surface	adrenergic receptor activity;alpha2-adrenergic receptor activity;protein binding;epinephrine binding	RAB26[23105096];SH3GL2[25517094];SH3GL1[25517094];
326514	chr9	135862813	C	T	chr9:135862813	GFI1B	growth factor independent 1B transcriptional repressor	4372.0	SNV	0/1	0.56	23_29	52	99	False	rs11793702	SPLICING	YES	NM_001371908.1	Transcript	protein_coding	splice_region_variant,intron_variant	3/6		NM_001371908.1:c.238+7C>T			1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Bleeding disorder, platelet-type, 17, 187900 (3), Autosomal recessive, Autosomal dominant	Autosomal dominant macrothrombocytopenia;Alpha delta granule deficiency;Gray platelet syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Infantile onset;Petechiae;Epistaxis;Prolonged bleeding time;Autosomal dominant inheritance;Bruising susceptibility;Ecchymosis;Myelofibrosis;Autosomal recessive inheritance;Reduced prothrombin consumption;Gastrointestinal hemorrhage;Variable expressivity;Absence of alpha granules;Thrombocytopenia;Splenomegaly;Epistaxis;Abnormality of the menstrual cycle;Myelodysplasia;Thrombocytopenia;Bruising susceptibility		0.00535961	816.0	152250.0	3.0	33	0.98	PASS	nfe	0.00905376	616.0	0.00905376	616.0	0.0053961	1354.0	250922.0	3.0	100	0.99	PASS	nfe	0.00846755	960.0	0.00846755	960.0	0.0055497	863	0.004	12.0	0.00412	47.0		4.528	0.116075		0	0	0			GFI1B	0.0	0.0	0.0	0.0	-34.0	26.0	-7.0	-6.0	9.74357842205131e-05	0.006				0.626	0.01				embryo phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); 			.	.	negative regulation of transcription by RNA polymerase II;chromatin organization;transcription by RNA polymerase II;multicellular organism development;cell population proliferation	nucleus;transcription factor complex;nuclear matrix	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II transcription factor binding;DNA binding;protein binding;metal ion binding	TXNDC11[16713569];BRCA1[16713569];KIF17[16713569];BABAM2[16713569];EFEMP2[16713569];ZNRD1[16713569];EFEMP1[16713569];TRIM27[16713569];LZTS2[16713569];TNS2[16713569];TSPYL2[16713569];EGFL7[16713569];ACTN1[16713569];TRAF1[16713569];HSPG2[16713569];RUNDC3A[16713569];GRIP2[16713569];MID2[16713569];AES[16713569];RINT1[16713569];PSMA3[16713569];VSNL1[16713569];HGS[16713569];HECW1[16713569];PICK1[16713569];MATR3[16713569];NSMF[16713569];AJUBA[16713569];RNF31[16713569];BECN1[16713569];MEGF6[16713569];GRN[16713569];NOTCH1[16713569];TMF1[16713569];USHBP1[16713569];ANKS3[16713569];LTBP4[16713569];FBLN1[16713569];RCHY1[16713569];KALRN[16713569];CENPB[16713569];FBLN5[16713569];BEGAIN[16713569];PDZD4[16713569];ATXN2[16713569];ZNRF3[16713569];CCDC85B[16713569];DZANK1[16713569];MYH14[16713569];PDLIM5[16713569];BEND5[16713569];RAB11FIP4[16713569];JAG2[16713569];PHC2[16713569];DTNA[16713569];CCDC136[16713569];DKFZp586M1819[16713569];PDE4DIP[16713569];LAMB1[16713569];IFFO1[16713569];NELL2[16713569];NELL1[16713569];COPS5[16713569];HNRNPK[16713569];CENPJ[16713569];DNAJA3[16713569];TRIP6[16713569];AGRN[16713569];MEGF8[16713569];MON1A[16713569];TAF1[16713569];
326998	chr2	201457918	G	A	chr2:201457918	AOX1	aldehyde oxidase 1	4403.0	SNV	0/1	0.41	19_13	32	99	False	rs142145534	EXONIC	YES	NM_001159.4	Transcript	protein_coding	missense_variant		2/35	NM_001159.4:c.95G>A	NP_001150.3:p.Arg32Lys		1.0	2Fe-2S ferredoxin-type iron-sulfur binding domain&2Fe-2S ferredoxin-type iron-sulfur binding domain,2Fe-2S ferredoxin-type iron-sulfur binding domain&2Fe-2S ferredoxin-type iron-sulfur binding domain					.	.	.		1.31422e-05	2.0	152182.0	0.0	32	0.97	PASS	nfe	2.93971e-05	2.0	2.93971e-05	2.0	0.0	0.0	251236.0	0.0	58	1.0	AC0				0.0	0.0	0.0000129	2						27.8	4.012196	0.474	17	3	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,PrimateAI_pred,BayesDel_noAF_pred	AOX1	0.2	0.0	0.27	0.0	-49.0	1.0	8.0	-49.0						0.979	0.0	65.668610832	0.952	1.176	.			ciliary ganglion;kidney;superior cervical ganglion;trigeminal ganglion;adipose tissue;atrioventricular node;adrenal gland;adrenal cortex;skeletal muscle;	Valine, leucine and isoleucine degradation;Tyrosine metabolism;Tryptophan metabolism;Vitamin B6 metabolism;Nicotinate and nicotinamide metabolism;Drug metabolism - cytochrome P450	xanthine catabolic process;drug metabolic process;electron transport chain;vitamin B6 metabolic process;oxidation-reduction process	cytosol;extracellular exosome	aldehyde oxidase activity;xanthine dehydrogenase activity;iron ion binding;electron transfer activity;identical protein binding;protein homodimerization activity;molybdopterin cofactor binding;flavin adenine dinucleotide binding;NAD binding;2 iron, 2 sulfur cluster binding;FAD binding;geranial:oxygen oxidoreductase activity;heptaldehyde:oxygen oxidoreductase activity	RBL1[21988832];GK[21988832];AOX1[26322824];RCHY1[21988832];CRKL[21988832];
331329	chr6	90458979	T	C	chr6:90458979	MDN1	midasin AAA ATPase 1	4468.0	SNV	0/1	0.7	8_19	27	99	False	rs116229207	EXONIC	YES	NM_014611.3	Transcript	protein_coding	missense_variant		26/102	NM_014611.3:c.3725A>G	NP_055426.1:p.Tyr1242Cys		-1.0	.,.,.					.	.	.		0.00292682	445.0	152042.0	0.0	32	0.96	PASS	amr	0.00340894	52.0	0.00322049	219.0	0.00298306	750.0	251420.0	6.0	53	1.0	PASS	nfe	0.00334125	380.0	0.00334125	380.0	0.0027395	426	0.002	8.0	0.00254	29.0		24.6	3.370887	0.708	14	7	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	MDN1	0.0	0.0	0.0	0.0	50.0	-7.0	-13.0	-37.0						0.695	1.0	0.0	0.995	1.138	.			.	.	ribosomal large subunit assembly;rRNA processing;protein-containing complex assembly	nucleus;nucleoplasm;nucleolus;cytosol;membrane;intermediate filament cytoskeleton	protein binding;ATP binding;ATPase activity;unfolded protein binding	BECN1[26496610];GSK3A[26496610];VCAM1[22623428];NOTCH1[23022380];LRRK2[17400507];HDAC11[23752268];RIPK4[26972000];FN1[19738201];CDC5L[20467437];FOXL1[25609649];HSCB[28380382];RRP1B[20926688];FTSJ1[17353931];PTP4A3[17353931];SNW1[20467437];MYC[17353931];STK17B[26496610];CASP4[17353931];TP53BP1[29656893];MAPT[26402096];PELP1[21326211];
333217	chr15	28517436	T	C	chr15:28517436	HERC2	HECT and RLD domain containing E3 ubiquitin protein ligase 2	4522.0	SNV	0/1	0.33	27_16	49	99	False	rs75181529,COSV55308410	EXONIC	YES	NM_004667.6	Transcript	protein_coding	synonymous_variant		9/93	NM_004667.6:c.1008A>G	NP_004658.3:p.Pro336%3D		-1.0					Intellectual developmental disorder, autosomal recessive 38, 615516 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive	Developmental delay with autism spectrum disorder and gait instability	Disease-causing germline mutation(s) (loss of function) in	Autosomal dominant inheritance;Autism;Short stature;Hypermetropia;Delayed speech and language development;Scrotal hypoplasia;Almond-shaped palpebral fissure;Decreased fetal movement;Poor fine motor coordination;Poor gross motor coordination;Syndactyly;Frontal upsweep of hair;Short palm;Delayed puberty;Seizure;Impaired pain sensation;Osteoporosis;Dolichocephaly;Hyperinsulinemia;Decreased muscle mass;Oligomenorrhea;Iris hypopigmentation;Small hand;Hypopigmentation of hair;Micropenis;Clitoral hypoplasia;Cryptorchidism;Thin upper lip vermilion;Primary amenorrhea;Infertility;Type II diabetes mellitus;Hypoplastic labia minora;Hypoventilation;Clinodactyly;Narrow nasal bridge;Short foot;Failure to thrive in infancy;Narrow forehead;Poor suck;Thin upper lip vermilion;Recurrent respiratory infections;Myopia;Global developmental delay;Upslanted palpebral fissure;Kyphosis;Psychosis;Motor delay;Radial deviation of finger;Attention deficit hyperactivity disorder;Narrow palm;Temperature instability;Esotropia;Growth hormone deficiency;Genu valgum;Specific learning disability;Downturned corners of mouth;Neonatal hypotonia;Generalized hypotonia;Sleep apnea;Hypogonadotropic hypogonadism;Cutaneous photosensitivity;Carious teeth;Scoliosis;Hip dysplasia;Polyphagia;Nasal speech;Osteopenia;Generalized hypopigmentation;Adrenal insufficiency;Sporadic;Abdominal obesity;Acromicria;Ventriculomegaly;Precocious puberty;Delayed ability to walk;Aggressive behavior;Sandal gap;Hyperactivity;Self-mutilation;Neonatal hypotonia;Echolalia;Autistic behavior;Infantile onset;Diminished ability to concentrate;Global developmental delay;Unsteady gait;Recurrent hand flapping;Febrile seizure (within the age range of 3 months to 6 years);Mandibular prognathia;Delayed speech and language development;Generalized hypotonia;Seizure;Autosomal recessive inheritance;Intellectual disability;Strabismus;Blue irides;Narrow palate;Plagiocephaly						33	0.97							0.49154	117834.0	239724.0	0.0	53	0.99	InbreedingCoeff	eas	0.499278	8985.0	0.489322	53068.0	0.0207840	3232	0.16	505.0	0.47614	878.0		0.7	-0.203807		0	0	0			HERC2	0.01	0.0	0.0	0.0	14.0	-21.0	14.0	-20.0						0.307	1.0				mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			pons;caudate nucleus;amygdala;prefrontal cortex;whole brain;superior cervical ganglion;trigeminal ganglion;cingulate cortex;medulla oblongata;thalamus;	Ubiquitin mediated proteolysis	double-strand break repair via nonhomologous end joining;intracellular protein transport;cellular response to DNA damage stimulus;spermatogenesis;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process	nucleus;nucleoplasm;cytoplasm;centriole;membrane	ubiquitin-protein transferase activity;guanyl-nucleotide exchange factor activity;protein binding;zinc ion binding;ubiquitin protein ligase binding;SUMO binding	WDR48[29426014];ECI2[29426014];UBE3A[29426014];SMC3[26496610];MKI67[29426014];MAP1LC3B[20562859];PCM1[26638075;29426014];TUBB6[29426014];NUDCD2[29426014];CHCHD3[29426014];EME1[29426014];TUBB3[29426014];FTH1[29426014];BDKRB2[28298427];CEP170[29426014];GTSE1[26496610];CEP290[26638075];KRT6C[29426014];KRT6B[29426014];DBNL[17353931];USP42[19615732];MIOS[29426014];NCOA4[29426014];KRT77[29426014];OCRL[29426014];PHKA1[29426014];PHKA2[29426014];SIRT3[19343720];SELENOO[29426014];CHMP4B[26496610];KIF20A[26496610];KIFC3[26496610];PFDN4[29426014];TP53[22653443];FTL[29426014];CEP104[26638075];COPB2[29426014];COPA[29426014];USP16[19615732];SET[29426014];SEH1L[29426014];C5AR2[28298427];XPA[20304803];RNF8[26503038];DPT[29426014];WDR20[29426014];ZBTB5[29426014];WDR24[29426014];USP19[19615732];CAMSAP1[29426014];CDC42[20936779];PHKG2[29426014];LMNA[29426014];CTNNA1[29426014];CCDC180[29426014];FLNA[29426014];RPL13[30021884];DISC1[17043677];MAPK6[23602568;26972000;29426014];MARK2[26496610];GCN1[29426014];MPDU1[17353931];ZRANB1[19615732];WDR59[29426014];USP20[19615732;29426014];NEK4[25798074];PHKB[29426014];LRPPRC[29426014];CDK8[23602568];NEURL4[29426014];EIF3M[29426014];KRT17[29426014];EIF3K[29426014];EIF3L[29426014];PSMC1[26496610];EIF3I[29426014];GNAS[29426014];EIF3G[29426014];CEP162[26638075];EIF3H[29426014];EIF3E[29426014];EIF3F[29426014];EIF3C[29426014];EIF3D[29426014];EIF3A[29426014];EIF4G1[29426014];EIF3B[29426014];
333218	chr15	28517539	G	A	chr15:28517539	HERC2	HECT and RLD domain containing E3 ubiquitin protein ligase 2	4522.0	SNV	0|1	0.14	32_6	43	99	False	rs80340439,COSV55308431	SPLICING	YES	NM_004667.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	8/92		NM_004667.6:c.912-7C>T			-1.0					Intellectual developmental disorder, autosomal recessive 38, 615516 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive	Developmental delay with autism spectrum disorder and gait instability	Disease-causing germline mutation(s) (loss of function) in	Autosomal dominant inheritance;Autism;Short stature;Hypermetropia;Delayed speech and language development;Scrotal hypoplasia;Almond-shaped palpebral fissure;Decreased fetal movement;Poor fine motor coordination;Poor gross motor coordination;Syndactyly;Frontal upsweep of hair;Short palm;Delayed puberty;Seizure;Impaired pain sensation;Osteoporosis;Dolichocephaly;Hyperinsulinemia;Decreased muscle mass;Oligomenorrhea;Iris hypopigmentation;Small hand;Hypopigmentation of hair;Micropenis;Clitoral hypoplasia;Cryptorchidism;Thin upper lip vermilion;Primary amenorrhea;Infertility;Type II diabetes mellitus;Hypoplastic labia minora;Hypoventilation;Clinodactyly;Narrow nasal bridge;Short foot;Failure to thrive in infancy;Narrow forehead;Poor suck;Thin upper lip vermilion;Recurrent respiratory infections;Myopia;Global developmental delay;Upslanted palpebral fissure;Kyphosis;Psychosis;Motor delay;Radial deviation of finger;Attention deficit hyperactivity disorder;Narrow palm;Temperature instability;Esotropia;Growth hormone deficiency;Genu valgum;Specific learning disability;Downturned corners of mouth;Neonatal hypotonia;Generalized hypotonia;Sleep apnea;Hypogonadotropic hypogonadism;Cutaneous photosensitivity;Carious teeth;Scoliosis;Hip dysplasia;Polyphagia;Nasal speech;Osteopenia;Generalized hypopigmentation;Adrenal insufficiency;Sporadic;Abdominal obesity;Acromicria;Ventriculomegaly;Precocious puberty;Delayed ability to walk;Aggressive behavior;Sandal gap;Hyperactivity;Self-mutilation;Neonatal hypotonia;Echolalia;Autistic behavior;Infantile onset;Diminished ability to concentrate;Global developmental delay;Unsteady gait;Recurrent hand flapping;Febrile seizure (within the age range of 3 months to 6 years);Mandibular prognathia;Delayed speech and language development;Generalized hypotonia;Seizure;Autosomal recessive inheritance;Intellectual disability;Strabismus;Blue irides;Narrow palate;Plagiocephaly		6.57039e-06	1.0	152198.0	0.0	33	0.97	PASS	nfe	1.46985e-05	1.0	1.46985e-05	1.0	0.46538	75642.0	162538.0	0.0	34	0.87	InbreedingCoeff	afr	0.476195	4841.0	0.462888	34599.0	0.0030160	469	0.043	131.0	0.27169	501.0		9.197	0.478404		0	0	0			HERC2	0.0	0.02	0.0	0.0	11.0	-41.0	-41.0	-7.0	1.816944460928e-05	0.042	6.168	0.291	6.458	0.307	1.0				mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			pons;caudate nucleus;amygdala;prefrontal cortex;whole brain;superior cervical ganglion;trigeminal ganglion;cingulate cortex;medulla oblongata;thalamus;	Ubiquitin mediated proteolysis	double-strand break repair via nonhomologous end joining;intracellular protein transport;cellular response to DNA damage stimulus;spermatogenesis;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process	nucleus;nucleoplasm;cytoplasm;centriole;membrane	ubiquitin-protein transferase activity;guanyl-nucleotide exchange factor activity;protein binding;zinc ion binding;ubiquitin protein ligase binding;SUMO binding	WDR48[29426014];ECI2[29426014];UBE3A[29426014];SMC3[26496610];MKI67[29426014];MAP1LC3B[20562859];PCM1[26638075;29426014];TUBB6[29426014];NUDCD2[29426014];CHCHD3[29426014];EME1[29426014];TUBB3[29426014];FTH1[29426014];BDKRB2[28298427];CEP170[29426014];GTSE1[26496610];CEP290[26638075];KRT6C[29426014];KRT6B[29426014];DBNL[17353931];USP42[19615732];MIOS[29426014];NCOA4[29426014];KRT77[29426014];OCRL[29426014];PHKA1[29426014];PHKA2[29426014];SIRT3[19343720];SELENOO[29426014];CHMP4B[26496610];KIF20A[26496610];KIFC3[26496610];PFDN4[29426014];TP53[22653443];FTL[29426014];CEP104[26638075];COPB2[29426014];COPA[29426014];USP16[19615732];SET[29426014];SEH1L[29426014];C5AR2[28298427];XPA[20304803];RNF8[26503038];DPT[29426014];WDR20[29426014];ZBTB5[29426014];WDR24[29426014];USP19[19615732];CAMSAP1[29426014];CDC42[20936779];PHKG2[29426014];LMNA[29426014];CTNNA1[29426014];CCDC180[29426014];FLNA[29426014];RPL13[30021884];DISC1[17043677];MAPK6[23602568;26972000;29426014];MARK2[26496610];GCN1[29426014];MPDU1[17353931];ZRANB1[19615732];WDR59[29426014];USP20[19615732;29426014];NEK4[25798074];PHKB[29426014];LRPPRC[29426014];CDK8[23602568];NEURL4[29426014];EIF3M[29426014];KRT17[29426014];EIF3K[29426014];EIF3L[29426014];PSMC1[26496610];EIF3I[29426014];GNAS[29426014];EIF3G[29426014];CEP162[26638075];EIF3H[29426014];EIF3E[29426014];EIF3F[29426014];EIF3C[29426014];EIF3D[29426014];EIF3A[29426014];EIF4G1[29426014];EIF3B[29426014];
333231	chr15	28518112	C	A	chr15:28518112	HERC2	HECT and RLD domain containing E3 ubiquitin protein ligase 2	4522.0	SNV	0|1	0.12	29_4	33	81	False	rs200859595,COSV55316122,COSV55323940	EXONIC	YES	NM_004667.6	Transcript	protein_coding	missense_variant		8/93	NM_004667.6:c.839G>T	NP_004658.3:p.Ser280Ile		-1.0					Intellectual developmental disorder, autosomal recessive 38, 615516 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive	Developmental delay with autism spectrum disorder and gait instability	Disease-causing germline mutation(s) (loss of function) in	Autosomal dominant inheritance;Autism;Short stature;Hypermetropia;Delayed speech and language development;Scrotal hypoplasia;Almond-shaped palpebral fissure;Decreased fetal movement;Poor fine motor coordination;Poor gross motor coordination;Syndactyly;Frontal upsweep of hair;Short palm;Delayed puberty;Seizure;Impaired pain sensation;Osteoporosis;Dolichocephaly;Hyperinsulinemia;Decreased muscle mass;Oligomenorrhea;Iris hypopigmentation;Small hand;Hypopigmentation of hair;Micropenis;Clitoral hypoplasia;Cryptorchidism;Thin upper lip vermilion;Primary amenorrhea;Infertility;Type II diabetes mellitus;Hypoplastic labia minora;Hypoventilation;Clinodactyly;Narrow nasal bridge;Short foot;Failure to thrive in infancy;Narrow forehead;Poor suck;Thin upper lip vermilion;Recurrent respiratory infections;Myopia;Global developmental delay;Upslanted palpebral fissure;Kyphosis;Psychosis;Motor delay;Radial deviation of finger;Attention deficit hyperactivity disorder;Narrow palm;Temperature instability;Esotropia;Growth hormone deficiency;Genu valgum;Specific learning disability;Downturned corners of mouth;Neonatal hypotonia;Generalized hypotonia;Sleep apnea;Hypogonadotropic hypogonadism;Cutaneous photosensitivity;Carious teeth;Scoliosis;Hip dysplasia;Polyphagia;Nasal speech;Osteopenia;Generalized hypopigmentation;Adrenal insufficiency;Sporadic;Abdominal obesity;Acromicria;Ventriculomegaly;Precocious puberty;Delayed ability to walk;Aggressive behavior;Sandal gap;Hyperactivity;Self-mutilation;Neonatal hypotonia;Echolalia;Autistic behavior;Infantile onset;Diminished ability to concentrate;Global developmental delay;Unsteady gait;Recurrent hand flapping;Febrile seizure (within the age range of 3 months to 6 years);Mandibular prognathia;Delayed speech and language development;Generalized hypotonia;Seizure;Autosomal recessive inheritance;Intellectual disability;Strabismus;Blue irides;Narrow palate;Plagiocephaly						33	0.98							0.0114557	1860.0	162364.0	0.0	56	0.99	PASS	amr	0.029692	592.0	0.00758746	560.0	0.0011640	181	0.002	5.0	0.00651	12.0		22.1	2.328751	0.076	3	15	18	LRT_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	HERC2	0.01	0.0	0.0	0.0	-14.0	-1.0	-14.0	38.0						0.307	1.0		0.985	0.119	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			pons;caudate nucleus;amygdala;prefrontal cortex;whole brain;superior cervical ganglion;trigeminal ganglion;cingulate cortex;medulla oblongata;thalamus;	Ubiquitin mediated proteolysis	double-strand break repair via nonhomologous end joining;intracellular protein transport;cellular response to DNA damage stimulus;spermatogenesis;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process	nucleus;nucleoplasm;cytoplasm;centriole;membrane	ubiquitin-protein transferase activity;guanyl-nucleotide exchange factor activity;protein binding;zinc ion binding;ubiquitin protein ligase binding;SUMO binding	WDR48[29426014];ECI2[29426014];UBE3A[29426014];SMC3[26496610];MKI67[29426014];MAP1LC3B[20562859];PCM1[26638075;29426014];TUBB6[29426014];NUDCD2[29426014];CHCHD3[29426014];EME1[29426014];TUBB3[29426014];FTH1[29426014];BDKRB2[28298427];CEP170[29426014];GTSE1[26496610];CEP290[26638075];KRT6C[29426014];KRT6B[29426014];DBNL[17353931];USP42[19615732];MIOS[29426014];NCOA4[29426014];KRT77[29426014];OCRL[29426014];PHKA1[29426014];PHKA2[29426014];SIRT3[19343720];SELENOO[29426014];CHMP4B[26496610];KIF20A[26496610];KIFC3[26496610];PFDN4[29426014];TP53[22653443];FTL[29426014];CEP104[26638075];COPB2[29426014];COPA[29426014];USP16[19615732];SET[29426014];SEH1L[29426014];C5AR2[28298427];XPA[20304803];RNF8[26503038];DPT[29426014];WDR20[29426014];ZBTB5[29426014];WDR24[29426014];USP19[19615732];CAMSAP1[29426014];CDC42[20936779];PHKG2[29426014];LMNA[29426014];CTNNA1[29426014];CCDC180[29426014];FLNA[29426014];RPL13[30021884];DISC1[17043677];MAPK6[23602568;26972000;29426014];MARK2[26496610];GCN1[29426014];MPDU1[17353931];ZRANB1[19615732];WDR59[29426014];USP20[19615732;29426014];NEK4[25798074];PHKB[29426014];LRPPRC[29426014];CDK8[23602568];NEURL4[29426014];EIF3M[29426014];KRT17[29426014];EIF3K[29426014];EIF3L[29426014];PSMC1[26496610];EIF3I[29426014];GNAS[29426014];EIF3G[29426014];CEP162[26638075];EIF3H[29426014];EIF3E[29426014];EIF3F[29426014];EIF3C[29426014];EIF3D[29426014];EIF3A[29426014];EIF4G1[29426014];EIF3B[29426014];
333232	chr15	28518115	C		chr15:28518115	HERC2	HECT and RLD domain containing E3 ubiquitin protein ligase 2	4522.0	deletion	0|1	0.12	29_4	33	81	False	rs756835034,COSV55353505	EXONIC	YES	NM_004667.6	Transcript	protein_coding	frameshift_variant		8/93	NM_004667.6:c.836del	NP_004658.3:p.Gly279GlufsTer25		-1.0		Benign	criteria_provided,_single_submitter	not_specified	Intellectual developmental disorder, autosomal recessive 38, 615516 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive	Developmental delay with autism spectrum disorder and gait instability	Disease-causing germline mutation(s) (loss of function) in	Autosomal dominant inheritance;Autism;Short stature;Hypermetropia;Delayed speech and language development;Scrotal hypoplasia;Almond-shaped palpebral fissure;Decreased fetal movement;Poor fine motor coordination;Poor gross motor coordination;Syndactyly;Frontal upsweep of hair;Short palm;Delayed puberty;Seizure;Impaired pain sensation;Osteoporosis;Dolichocephaly;Hyperinsulinemia;Decreased muscle mass;Oligomenorrhea;Iris hypopigmentation;Small hand;Hypopigmentation of hair;Micropenis;Clitoral hypoplasia;Cryptorchidism;Thin upper lip vermilion;Primary amenorrhea;Infertility;Type II diabetes mellitus;Hypoplastic labia minora;Hypoventilation;Clinodactyly;Narrow nasal bridge;Short foot;Failure to thrive in infancy;Narrow forehead;Poor suck;Thin upper lip vermilion;Recurrent respiratory infections;Myopia;Global developmental delay;Upslanted palpebral fissure;Kyphosis;Psychosis;Motor delay;Radial deviation of finger;Attention deficit hyperactivity disorder;Narrow palm;Temperature instability;Esotropia;Growth hormone deficiency;Genu valgum;Specific learning disability;Downturned corners of mouth;Neonatal hypotonia;Generalized hypotonia;Sleep apnea;Hypogonadotropic hypogonadism;Cutaneous photosensitivity;Carious teeth;Scoliosis;Hip dysplasia;Polyphagia;Nasal speech;Osteopenia;Generalized hypopigmentation;Adrenal insufficiency;Sporadic;Abdominal obesity;Acromicria;Ventriculomegaly;Precocious puberty;Delayed ability to walk;Aggressive behavior;Sandal gap;Hyperactivity;Self-mutilation;Neonatal hypotonia;Echolalia;Autistic behavior;Infantile onset;Diminished ability to concentrate;Global developmental delay;Unsteady gait;Recurrent hand flapping;Febrile seizure (within the age range of 3 months to 6 years);Mandibular prognathia;Delayed speech and language development;Generalized hypotonia;Seizure;Autosomal recessive inheritance;Intellectual disability;Strabismus;Blue irides;Narrow palate;Plagiocephaly	24033266					33	0.98							0.00568835	1068.0	187752.0	0.0	53	0.99	RF	amr	0.0156182	361.0	0.0033307	287.0	0.0011189	174			0.00869	16.0		32.0	4.673767		0	0	0			HERC2	0.0	0.0	0.0	0.0	36.0	16.0	27.0	26.0						0.307	1.0				mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			pons;caudate nucleus;amygdala;prefrontal cortex;whole brain;superior cervical ganglion;trigeminal ganglion;cingulate cortex;medulla oblongata;thalamus;	Ubiquitin mediated proteolysis	double-strand break repair via nonhomologous end joining;intracellular protein transport;cellular response to DNA damage stimulus;spermatogenesis;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process	nucleus;nucleoplasm;cytoplasm;centriole;membrane	ubiquitin-protein transferase activity;guanyl-nucleotide exchange factor activity;protein binding;zinc ion binding;ubiquitin protein ligase binding;SUMO binding	WDR48[29426014];ECI2[29426014];UBE3A[29426014];SMC3[26496610];MKI67[29426014];MAP1LC3B[20562859];PCM1[26638075;29426014];TUBB6[29426014];NUDCD2[29426014];CHCHD3[29426014];EME1[29426014];TUBB3[29426014];FTH1[29426014];BDKRB2[28298427];CEP170[29426014];GTSE1[26496610];CEP290[26638075];KRT6C[29426014];KRT6B[29426014];DBNL[17353931];USP42[19615732];MIOS[29426014];NCOA4[29426014];KRT77[29426014];OCRL[29426014];PHKA1[29426014];PHKA2[29426014];SIRT3[19343720];SELENOO[29426014];CHMP4B[26496610];KIF20A[26496610];KIFC3[26496610];PFDN4[29426014];TP53[22653443];FTL[29426014];CEP104[26638075];COPB2[29426014];COPA[29426014];USP16[19615732];SET[29426014];SEH1L[29426014];C5AR2[28298427];XPA[20304803];RNF8[26503038];DPT[29426014];WDR20[29426014];ZBTB5[29426014];WDR24[29426014];USP19[19615732];CAMSAP1[29426014];CDC42[20936779];PHKG2[29426014];LMNA[29426014];CTNNA1[29426014];CCDC180[29426014];FLNA[29426014];RPL13[30021884];DISC1[17043677];MAPK6[23602568;26972000;29426014];MARK2[26496610];GCN1[29426014];MPDU1[17353931];ZRANB1[19615732];WDR59[29426014];USP20[19615732;29426014];NEK4[25798074];PHKB[29426014];LRPPRC[29426014];CDK8[23602568];NEURL4[29426014];EIF3M[29426014];KRT17[29426014];EIF3K[29426014];EIF3L[29426014];PSMC1[26496610];EIF3I[29426014];GNAS[29426014];EIF3G[29426014];CEP162[26638075];EIF3H[29426014];EIF3E[29426014];EIF3F[29426014];EIF3C[29426014];EIF3D[29426014];EIF3A[29426014];EIF4G1[29426014];EIF3B[29426014];
333256	chr15	28566548	T	C	chr15:28566548	HERC2	HECT and RLD domain containing E3 ubiquitin protein ligase 2	4522.0	SNV	0/1	0.2	20_5	25	59	False	rs201990459,COSV55305623	EXONIC	YES	NM_004667.6	Transcript	protein_coding	missense_variant		2/93	NM_004667.6:c.32A>G	NP_004658.3:p.Gln11Arg		-1.0					Intellectual developmental disorder, autosomal recessive 38, 615516 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive	Developmental delay with autism spectrum disorder and gait instability	Disease-causing germline mutation(s) (loss of function) in	Autosomal dominant inheritance;Autism;Short stature;Hypermetropia;Delayed speech and language development;Scrotal hypoplasia;Almond-shaped palpebral fissure;Decreased fetal movement;Poor fine motor coordination;Poor gross motor coordination;Syndactyly;Frontal upsweep of hair;Short palm;Delayed puberty;Seizure;Impaired pain sensation;Osteoporosis;Dolichocephaly;Hyperinsulinemia;Decreased muscle mass;Oligomenorrhea;Iris hypopigmentation;Small hand;Hypopigmentation of hair;Micropenis;Clitoral hypoplasia;Cryptorchidism;Thin upper lip vermilion;Primary amenorrhea;Infertility;Type II diabetes mellitus;Hypoplastic labia minora;Hypoventilation;Clinodactyly;Narrow nasal bridge;Short foot;Failure to thrive in infancy;Narrow forehead;Poor suck;Thin upper lip vermilion;Recurrent respiratory infections;Myopia;Global developmental delay;Upslanted palpebral fissure;Kyphosis;Psychosis;Motor delay;Radial deviation of finger;Attention deficit hyperactivity disorder;Narrow palm;Temperature instability;Esotropia;Growth hormone deficiency;Genu valgum;Specific learning disability;Downturned corners of mouth;Neonatal hypotonia;Generalized hypotonia;Sleep apnea;Hypogonadotropic hypogonadism;Cutaneous photosensitivity;Carious teeth;Scoliosis;Hip dysplasia;Polyphagia;Nasal speech;Osteopenia;Generalized hypopigmentation;Adrenal insufficiency;Sporadic;Abdominal obesity;Acromicria;Ventriculomegaly;Precocious puberty;Delayed ability to walk;Aggressive behavior;Sandal gap;Hyperactivity;Self-mutilation;Neonatal hypotonia;Echolalia;Autistic behavior;Infantile onset;Diminished ability to concentrate;Global developmental delay;Unsteady gait;Recurrent hand flapping;Febrile seizure (within the age range of 3 months to 6 years);Mandibular prognathia;Delayed speech and language development;Generalized hypotonia;Seizure;Autosomal recessive inheritance;Intellectual disability;Strabismus;Blue irides;Narrow palate;Plagiocephaly		1.33348e-05	2.0	149984.0	0.0	28	0.81	PASS	nfe	2.95125e-05	2.0	2.95125e-05	2.0	0.441602	53523.0	121202.0	1.0	18	0.45	InbreedingCoeff_RF	afr	0.469307	3318.0	0.432293	23745.0	0.0006045	94	0.001	4.0	0.0354	65.0		23.0	2.715813	0.067	4	15	19	PolyPhen,Polyphen2_HDIV_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	HERC2	0.0	0.02	0.0	0.0	-33.0	-2.0	-40.0	-21.0						0.307	1.0		0.999	0.981	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			pons;caudate nucleus;amygdala;prefrontal cortex;whole brain;superior cervical ganglion;trigeminal ganglion;cingulate cortex;medulla oblongata;thalamus;	Ubiquitin mediated proteolysis	double-strand break repair via nonhomologous end joining;intracellular protein transport;cellular response to DNA damage stimulus;spermatogenesis;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process	nucleus;nucleoplasm;cytoplasm;centriole;membrane	ubiquitin-protein transferase activity;guanyl-nucleotide exchange factor activity;protein binding;zinc ion binding;ubiquitin protein ligase binding;SUMO binding	WDR48[29426014];ECI2[29426014];UBE3A[29426014];SMC3[26496610];MKI67[29426014];MAP1LC3B[20562859];PCM1[26638075;29426014];TUBB6[29426014];NUDCD2[29426014];CHCHD3[29426014];EME1[29426014];TUBB3[29426014];FTH1[29426014];BDKRB2[28298427];CEP170[29426014];GTSE1[26496610];CEP290[26638075];KRT6C[29426014];KRT6B[29426014];DBNL[17353931];USP42[19615732];MIOS[29426014];NCOA4[29426014];KRT77[29426014];OCRL[29426014];PHKA1[29426014];PHKA2[29426014];SIRT3[19343720];SELENOO[29426014];CHMP4B[26496610];KIF20A[26496610];KIFC3[26496610];PFDN4[29426014];TP53[22653443];FTL[29426014];CEP104[26638075];COPB2[29426014];COPA[29426014];USP16[19615732];SET[29426014];SEH1L[29426014];C5AR2[28298427];XPA[20304803];RNF8[26503038];DPT[29426014];WDR20[29426014];ZBTB5[29426014];WDR24[29426014];USP19[19615732];CAMSAP1[29426014];CDC42[20936779];PHKG2[29426014];LMNA[29426014];CTNNA1[29426014];CCDC180[29426014];FLNA[29426014];RPL13[30021884];DISC1[17043677];MAPK6[23602568;26972000;29426014];MARK2[26496610];GCN1[29426014];MPDU1[17353931];ZRANB1[19615732];WDR59[29426014];USP20[19615732;29426014];NEK4[25798074];PHKB[29426014];LRPPRC[29426014];CDK8[23602568];NEURL4[29426014];EIF3M[29426014];KRT17[29426014];EIF3K[29426014];EIF3L[29426014];PSMC1[26496610];EIF3I[29426014];GNAS[29426014];EIF3G[29426014];CEP162[26638075];EIF3H[29426014];EIF3E[29426014];EIF3F[29426014];EIF3C[29426014];EIF3D[29426014];EIF3A[29426014];EIF4G1[29426014];EIF3B[29426014];
333257	chr15	28566562	G	C	chr15:28566562	HERC2	HECT and RLD domain containing E3 ubiquitin protein ligase 2	4522.0	SNV	0/1	0.2	20_5	25	83	False	rs200084694,COSV55308920	EXONIC	YES	NM_004667.6	Transcript	protein_coding	missense_variant		2/93	NM_004667.6:c.18C>G	NP_004658.3:p.Phe6Leu		-1.0					Intellectual developmental disorder, autosomal recessive 38, 615516 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive	Developmental delay with autism spectrum disorder and gait instability	Disease-causing germline mutation(s) (loss of function) in	Autosomal dominant inheritance;Autism;Short stature;Hypermetropia;Delayed speech and language development;Scrotal hypoplasia;Almond-shaped palpebral fissure;Decreased fetal movement;Poor fine motor coordination;Poor gross motor coordination;Syndactyly;Frontal upsweep of hair;Short palm;Delayed puberty;Seizure;Impaired pain sensation;Osteoporosis;Dolichocephaly;Hyperinsulinemia;Decreased muscle mass;Oligomenorrhea;Iris hypopigmentation;Small hand;Hypopigmentation of hair;Micropenis;Clitoral hypoplasia;Cryptorchidism;Thin upper lip vermilion;Primary amenorrhea;Infertility;Type II diabetes mellitus;Hypoplastic labia minora;Hypoventilation;Clinodactyly;Narrow nasal bridge;Short foot;Failure to thrive in infancy;Narrow forehead;Poor suck;Thin upper lip vermilion;Recurrent respiratory infections;Myopia;Global developmental delay;Upslanted palpebral fissure;Kyphosis;Psychosis;Motor delay;Radial deviation of finger;Attention deficit hyperactivity disorder;Narrow palm;Temperature instability;Esotropia;Growth hormone deficiency;Genu valgum;Specific learning disability;Downturned corners of mouth;Neonatal hypotonia;Generalized hypotonia;Sleep apnea;Hypogonadotropic hypogonadism;Cutaneous photosensitivity;Carious teeth;Scoliosis;Hip dysplasia;Polyphagia;Nasal speech;Osteopenia;Generalized hypopigmentation;Adrenal insufficiency;Sporadic;Abdominal obesity;Acromicria;Ventriculomegaly;Precocious puberty;Delayed ability to walk;Aggressive behavior;Sandal gap;Hyperactivity;Self-mutilation;Neonatal hypotonia;Echolalia;Autistic behavior;Infantile onset;Diminished ability to concentrate;Global developmental delay;Unsteady gait;Recurrent hand flapping;Febrile seizure (within the age range of 3 months to 6 years);Mandibular prognathia;Delayed speech and language development;Generalized hypotonia;Seizure;Autosomal recessive inheritance;Intellectual disability;Strabismus;Blue irides;Narrow palate;Plagiocephaly		0.00125885	186.0	147754.0	0.0	28	0.81	PASS	sas	0.00367309	16.0	0.00146059	98.0	0.457725	52004.0	113614.0	1.0	15	0.39	InbreedingCoeff	afr	0.479677	3210.0	0.447748	22468.0	0.0010161	158	0.002	5.0	0.05016	92.0		19.43	1.960956	0.12	4	14	18	MutationTaster_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	HERC2	0.0	0.01	0.0	0.0	32.0	-16.0	48.0	-35.0						0.307	1.0		0.999	1.012	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			pons;caudate nucleus;amygdala;prefrontal cortex;whole brain;superior cervical ganglion;trigeminal ganglion;cingulate cortex;medulla oblongata;thalamus;	Ubiquitin mediated proteolysis	double-strand break repair via nonhomologous end joining;intracellular protein transport;cellular response to DNA damage stimulus;spermatogenesis;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process	nucleus;nucleoplasm;cytoplasm;centriole;membrane	ubiquitin-protein transferase activity;guanyl-nucleotide exchange factor activity;protein binding;zinc ion binding;ubiquitin protein ligase binding;SUMO binding	WDR48[29426014];ECI2[29426014];UBE3A[29426014];SMC3[26496610];MKI67[29426014];MAP1LC3B[20562859];PCM1[26638075;29426014];TUBB6[29426014];NUDCD2[29426014];CHCHD3[29426014];EME1[29426014];TUBB3[29426014];FTH1[29426014];BDKRB2[28298427];CEP170[29426014];GTSE1[26496610];CEP290[26638075];KRT6C[29426014];KRT6B[29426014];DBNL[17353931];USP42[19615732];MIOS[29426014];NCOA4[29426014];KRT77[29426014];OCRL[29426014];PHKA1[29426014];PHKA2[29426014];SIRT3[19343720];SELENOO[29426014];CHMP4B[26496610];KIF20A[26496610];KIFC3[26496610];PFDN4[29426014];TP53[22653443];FTL[29426014];CEP104[26638075];COPB2[29426014];COPA[29426014];USP16[19615732];SET[29426014];SEH1L[29426014];C5AR2[28298427];XPA[20304803];RNF8[26503038];DPT[29426014];WDR20[29426014];ZBTB5[29426014];WDR24[29426014];USP19[19615732];CAMSAP1[29426014];CDC42[20936779];PHKG2[29426014];LMNA[29426014];CTNNA1[29426014];CCDC180[29426014];FLNA[29426014];RPL13[30021884];DISC1[17043677];MAPK6[23602568;26972000;29426014];MARK2[26496610];GCN1[29426014];MPDU1[17353931];ZRANB1[19615732];WDR59[29426014];USP20[19615732;29426014];NEK4[25798074];PHKB[29426014];LRPPRC[29426014];CDK8[23602568];NEURL4[29426014];EIF3M[29426014];KRT17[29426014];EIF3K[29426014];EIF3L[29426014];PSMC1[26496610];EIF3I[29426014];GNAS[29426014];EIF3G[29426014];CEP162[26638075];EIF3H[29426014];EIF3E[29426014];EIF3F[29426014];EIF3C[29426014];EIF3D[29426014];EIF3A[29426014];EIF4G1[29426014];EIF3B[29426014];
338317	chr7	111372325	G	A	chr7:111372325	DOCK4	dedicator of cytokinesis 4	4571.0	SNV	0/1	0.38	24_15	39	99	False	rs201119594,COSV70242611	EXONIC	YES	NM_001363540.2	Transcript	protein_coding	missense_variant		52/53	NM_001363540.2:c.5438C>T	NP_001350469.1:p.Thr1813Met		-1.0	.,.					.	.	.		5.91288e-05	9.0	152210.0	0.0	33	0.96	PASS	afr	7.23764e-05	3.0	4.4093e-05	3.0	0.000140428	35.0	249238.0	0.0	49	0.99	PASS	sas	0.000163473	5.0	8.84846e-05	10.0	0.0001415	22	0.0	1.0	9e-05	1.0		22.5	2.465902	0.068	2	17	19	LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	DOCK4	0.0	0.02	0.0	0.02	9.0	18.0	18.0	-43.0						0.717	1.0	0.0	0.973	1.176	neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			ciliary ganglion;caudate nucleus;amygdala;appendix;occipital lobe;prefrontal cortex;whole brain;trigeminal ganglion;atrioventricular node;superior cervical ganglion;cingulate cortex;medulla oblongata;	.	small GTPase mediated signal transduction;positive regulation of GTPase activity;cell chemotaxis;negative regulation of vascular smooth muscle contraction;positive regulation of vascular associated smooth muscle cell migration	nucleolus;Golgi apparatus;cytosol;plasma membrane;membrane;stereocilium;stereocilium bundle	guanyl-nucleotide exchange factor activity;GTPase activator activity;protein binding;SH3 domain binding;PDZ domain binding;receptor tyrosine kinase binding;Rac GTPase binding	HNRNPL[17353931];YWHAB[15324660];DHX15[29021621];ELMO2[unassigned1304];FASLG[19807924];GRB2[21988832;21706016];HSCB[28380382];HSPD1[30021884];
339944	chr7	4285303	C	T	chr7:4285303	SDK1	sidekick cell adhesion molecule 1	4593.0	SNV	0/1	0.5	21_21	42	99	False	rs149321114	SPLICING	YES	NM_152744.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	43/44		NM_152744.4:c.6252-5C>T			1.0						.	.	.		0.00352256	536.0	152162.0	4.0	32	0.97	PASS	sas	0.00869205	42.0	0.00464556	316.0	0.00476471	1195.0	250802.0	8.0	47	0.99	PASS	sas	0.0101927	312.0	0.00465433	527.0	0.0044758	696	0.005	16.0				0.823	-0.179569		0	0	0			SDK1	0.04	0.22	0.0	0.0	5.0	23.0	23.0	5.0	4.3753860507477e-05	0.0	7.687	-1.738	5.95	0.433	0.01				.			.	.	homophilic cell adhesion via plasma membrane adhesion molecules;synapse assembly;retina layer formation;cell-cell junction organization;behavioral response to cocaine;regulation of dendritic spine development	plasma membrane;integral component of membrane;cell junction;synapse	identical protein binding	MYC[21150319];PRPF40A[15231748];
342523	chr19	44273625	G	T	chr19:44273625	KCNN4	potassium calcium-activated channel subfamily N member 4	4650.0	SNV	0/1	0.53	14_16	30	99	False	rs76935412	EXONIC	YES	NM_002250.3	Transcript	protein_coding	missense_variant		6/9	NM_002250.3:c.1018C>A	NP_002241.1:p.His340Asn		-1.0	Calmodulin-binding domain&Calmodulin-binding domain,Calmodulin-binding domain&Calmodulin-binding domain,Calmodulin-binding domain&Calmodulin-binding domain				Dehydrated hereditary stomatocytosis 2, 616689 (3), Autosomal dominant	Dehydrated hereditary stomatocytosis	Disease-causing germline mutation(s) in	Reticulocytosis;Bite cells;Increased mean corpuscular hemoglobin concentration;Splenomegaly;Hepatomegaly;Increased mean corpuscular volume;Anisopoikilocytosis;Hyperbilirubinemia;Jaundice;Autosomal dominant inheritance;Hemolytic anemia;Acanthocytosis;Pulmonary venous hypertension;Neonatal hyperbilirubinemia;Increased mean corpuscular hemoglobin concentration;Edema;Schistocytosis;Nonspherocytic hemolytic anemia;Portal vein thrombosis;Episodic fatigue;Reticulocytosis;Macrocytic anemia;Polycythemia;Increased lactate dehydrogenase level;Increased red cell osmotic fragility;Abdominal pain;Congenital hemolytic anemia;Thromboembolism;Intermittent jaundice;Increased serum ferritin;Cholelithiasis;Increased mean corpuscular volume;Splenomegaly;Increased total bilirubin;Abnormal blood potassium concentration;Increased hemoglobin concentration		0.000965492	147.0	152254.0	0.0	32	0.97	PASS	amr	0.00150425	23.0	0.0012198	83.0	0.00153926	387.0	251420.0	0.0	84	1.0	PASS	amr	0.0021108	73.0	0.00145093	165.0	0.0013183	205	0.002	5.0				28.1	4.042644	0.891	17	4	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred	KCNN4	0.02	0.0	0.15	0.0	25.0	-31.0	-31.0	2.0						0.152	0.0	0.0	0.998	1.176	hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); immune system phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; muscle phenotype; 			ciliary ganglion;trachea;placenta;	.	immune system process;potassium ion transport;calcium ion transport;cell volume homeostasis;defense response;stabilization of membrane potential;phospholipid translocation;saliva secretion;positive regulation of protein secretion;positive regulation of T cell receptor signaling pathway;potassium ion transmembrane transport	plasma membrane;voltage-gated potassium channel complex;vesicle;neuron projection;neuronal cell body	potassium channel activity;protein binding;calmodulin binding;calcium-activated potassium channel activity;small conductance calcium-activated potassium channel activity;protein phosphatase binding;Intermediate conductance calcium-activated potassium channel activity	GPR152[unassigned1304];BIK[unassigned1304];FXYD3[unassigned1304];SLC30A2[unassigned1304];PRKAG1[27092946];ISG15[26259872];CALM1[10880439;29724949];PHPT1[18796614];CNIH3[unassigned1304];CFTR[27092946];
342963	chr16	88501431	C	A	chr16:88501431	ZNF469	zinc finger protein 469	4672.0	SNV	0/1	0.4	15_10	25	99	False	rs201943633	EXONIC	YES	NM_001367624.2	Transcript	protein_coding	missense_variant		3/3	NM_001367624.2:c.7553C>A	NP_001354553.1:p.Pro2518His		1.0	.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Brittle_cornea_syndrome_1|not_provided	Brittle cornea syndrome 1, 229200 (3), Autosomal recessive	Brittle cornea syndrome	Disease-causing germline mutation(s) in	Visual loss;Myalgia;Scoliosis;Hyperextensible skin;Mitral valve prolapse;Sensorineural hearing impairment;Blue sclerae;Joint hyperflexibility;High myopia;Hernia;Abnormality of hair pigmentation;Corneal scarring;Glaucoma;Retinal detachment;Bruising susceptibility;Hallux valgus;Corneal erosion;Neonatal hypotonia;Conductive hearing impairment;Corneal dystrophy;Abnormality of epiphysis morphology;Pulmonic stenosis;Arachnodactyly;Hip dysplasia;Keratoglobus;Cleft palate;Soft skin;Camptodactyly;Osteoporosis;Gait disturbance;Increased susceptibility to fractures;Abnormality of the dentition;Pes planus;Dentinogenesis imperfecta;Keratoglobus;Decreased corneal thickness;Autosomal recessive inheritance;Blue sclerae;Keratoconus;Spondylolisthesis;Disproportionate tall stature;Scoliosis;Congenital hip dislocation;Red hair;Myopia;Molluscoid pseudotumors;Mitral valve prolapse;Epicanthus;Visual loss;Atypical scarring of skin;Palmoplantar cutis laxa;Joint laxity;Hearing impairment;Macrocephaly		0.00188531	287.0	152230.0	1.0	33	0.98	PASS	nfe	0.00321841	219.0	0.00321841	219.0	0.00173065	265.0	153122.0	0.0	100	0.57	PASS	nfe	0.00376616	222.0	0.00376616	222.0	0.0006366	99	0.003	9.0	0.00228	26.0		16.43	1.52769	0.074	2	15	17	PolyPhen,M-CAP_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF469	0.0	0.0	0.0	0.0	-30.0	6.0	43.0	40.0								0.0	0.0	-0.01	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	HIST1H2BL[30021884];RIPK4[26972000];HIST1H2BH[30021884];
346829	chr16	8620007	G	A	chr16:8620007	TMEM114	transmembrane protein 114	4753.0	SNV	0/1	0.47	10_9	19	99	False	rs141472774	SPLICING	YES	NM_001146336.1	Transcript	protein_coding	missense_variant,splice_region_variant		2/2	NM_001146336.1:c.137C>T	NP_001139808.1:p.Ala46Val		-1.0	.,.					.	.	.		0.00400788	610.0	152200.0	1.0	33	0.96	PASS	sas	0.00703351	34.0	0.00598336	407.0	0.00490693	707.0	144082.0	6.0	27	0.56	PASS	sas	0.00853106	192.0	0.00627477	323.0	0.0016527	257	0.003	9.0	0.00377	43.0		24.7	3.415831		6	8	14	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	TMEM114	0.0	0.0	0.0	0.0	-25.0	28.0	-25.0	-10.0			10.115	0.652	10.767			0.0	0.612	1.171	homeostasis/metabolism phenotype; 			.	.	.	integral component of membrane;apical plasma membrane;apicolateral plasma membrane	.	EMP1[unassigned1304];
346922	chr8	144942300	C	T	chr8:144942300	EPPK1	epiplakin 1	4756.0	SNV	0/1	0.34	19_10	29	99	False	rs191533123,COSV73261024	EXONIC	YES	NM_031308.4	Transcript	protein_coding	missense_variant		2/3	NM_031308.4:c.5122G>A	NP_112598.3:p.Gly1708Ser		-1.0	.,.					.	.	.		0.00444786	677.0	152208.0	3.0	33	0.98	PASS	nfe	0.00653989	445.0	0.00653989	445.0	0.00410894	1022.0	248726.0	7.0	100	1.0	PASS	nfe	0.00584058	658.0	0.00584058	658.0	0.0038841	604	0.004	12.0				24.6	3.38632	0.525	10	5	15	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	EPPK1	0.0	0.0	0.0	0.0	-2.0	-15.0	-2.0	43.0							0.0	0.0	0.485	1.026	normal phenotype; homeostasis/metabolism phenotype; cellular phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); 			.	.	negative regulation of keratinocyte proliferation;negative regulation of cell migration;wound healing;intermediate filament cytoskeleton organization;intermediate filament organization;intermediate filament bundle assembly;negative regulation of epithelial cell proliferation;negative regulation of keratinocyte migration;negative regulation of wound healing;regulation of epithelium regeneration	cytoplasm;cytoskeleton;intermediate filament;bicellular tight junction;membrane;basolateral plasma membrane;apicolateral plasma membrane;hemidesmosome;cell projection;keratin filament;cell periphery;perinucleolar compartment	RNA binding;structural molecule activity;cytoskeletal protein binding;intermediate filament binding;keratin filament binding	SMARCB1[30108113];PINX1[17353931];CEP120[26638075];STK4[23386615];PHB2[17353931];NUDCD1[29021621];MYC[17353931];INPP5K[17353931];MAP3K8[14743216];IKBKG[14743216];TRDMT1[17353931];YWHAH[26496610];MAP3K3[14743216];GSTK1[17353931];GABARAPL2[17353931];GABARAPL1[20562859];MAP3K1[14743216];TSC22D1[17353931];NME2[17353931];CDC5L[20467437];CFLAR[17353931];RPGRIP1L[26638075];TNFRSF1B[14743216];ESR1[21182205];NFKB2[14743216];TNFRSF1A[14743216];WRAP73[17353931];PTP4A3[17353931];SNW1[20467437];POC5[26638075];TRAF6[17353931];GRB2[12577067];CNTROB[26638075];SQSTM1[20562859];ARF6[17353931];
350214	chr17	10432788	G	A	chr17:10432788	MYH2	myosin heavy chain 2	4795.0	SNV	0/1	0.64	10_18	28	99	False	rs200217946	EXONIC	YES	NM_001100112.2	Transcript	protein_coding	missense_variant		25/40	NM_001100112.2:c.3128C>T	NP_001093582.1:p.Ser1043Phe		-1.0	Myosin tail,Myosin tail	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Inclusion_Body_Myopathy,_Dominant|not_provided	Proximal myopathy and ophthalmoplegia, 605637 (3), Autosomal recessive, Autosomal dominant	Childhood-onset autosomal recessive myopathy with external ophthalmoplegia;Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Neck muscle weakness;Ptosis;Scapular winging;Muscle fiber inclusion bodies;Myopathy;Myopathic facies;Congenital contracture;Autosomal recessive inheritance;Scoliosis;Waddling gait;Generalized muscle weakness;Ophthalmoplegia;Distal muscle weakness;Autosomal dominant inheritance;High palate;Variable expressivity;Proximal muscle weakness		0.000262912	40.0	152142.0	0.0	32	0.97	PASS	amr	0.00091671	14.0	0.000279313	19.0	0.000624622	157.0	251352.0	1.0	100	1.0	PASS	amr	0.00326722	113.0	0.000246353	28.0	0.0005080	79	0.003	9.0	0.00483	55.0		27.6	3.990718	0.614	15	5	20	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaRNN_pred,ClinPred_pred,LIST-S2_pred	MYH2	0.0	0.0	0.0	0.0	-8.0	10.0	-16.0	-39.0						0.036	0.0	0.0	1.0	1.106	.			fetal thyroid;thyroid;tongue;skeletal muscle;	Tight junction	muscle contraction;muscle filament sliding;Fc-gamma receptor signaling pathway involved in phagocytosis	cytosol;muscle myosin complex;myofibril;sarcomere;myosin filament;protein-containing complex	microfilament motor activity;protein binding;calmodulin binding;ATP binding;actin filament binding	USP15[19615732];ATG101[20562859];LRRC39[20847312];DUX4L9[26816005];HIST1H2BH[30021884];YWHAZ[20618440];UBAC1[17353931];PTBP3[22575643];
351051	chr6	33695951	G	A	chr6:33695951	IP6K3	inositol hexakisphosphate kinase 3	4809.0	SNV	0/1	0.53	9_10	19	99	False	rs150896095,COSV53391978	EXONIC	YES	NM_001142883.2	Transcript	protein_coding	missense_variant		4/7	NM_001142883.2:c.326C>T	NP_001136355.1:p.Thr109Met		-1.0	.,.					.	.	.		0.00311522	474.0	152156.0	1.0	32	0.98	PASS	afr	0.0059633	247.0	0.00180792	123.0	0.00225017	564.0	250648.0	2.0	82	0.99	PASS	afr	0.00554324	90.0	0.00179622	204.0	0.0021414	333	0.004	13.0				18.67	1.862424	0.166	5	16	21	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MutationAssessor_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	IP6K3	0.0	0.0	0.0	0.0	1.0	27.0	38.0	27.0						0.718	0.05	0.0	0.0	0.227	reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	.	protein phosphorylation;inositol phosphate biosynthetic process;inositol phosphate metabolic process;phosphatidylinositol metabolic process	nucleus;cytoplasm;cytosol	inositol-1,3,4,5,6-pentakisphosphate kinase activity;inositol hexakisphosphate kinase activity;inositol heptakisphosphate kinase activity;inositol hexakisphosphate 6-kinase activity;inositol hexakisphosphate 5-kinase activity;ATP binding;inositol hexakisphosphate 1-kinase activity;inositol hexakisphosphate 3-kinase activity;inositol 5-diphosphate pentakisphosphate 5-kinase activity;inositol diphosphate tetrakisphosphate kinase activity	NUP107[26496610];SRRT[26496610];FHL5[unassigned1304];MEOX2[unassigned1304];PHF21A[26496610];BAG6[26496610];BAIAP2L1[26496610];POLR2E[unassigned1304];NOTO[unassigned1304];TRIM27[unassigned1304];MAPK3[26496610];UBL4A[26496610];MAP3K3[26496610];ZRANB1[unassigned1304];KRTAP10-8[unassigned1304];ELP3[26496610];TRAF2[unassigned1304];MED4[unassigned1304];NIF3L1[unassigned1304];PCCA[26496610];TRAF3[unassigned1304];TRIP6[unassigned1304];LNX1[unassigned1304];ZNF655[unassigned1304];TARDBP[26496610];GLYR1[unassigned1304];
352442	chr1	172547517	G	A	chr1:172547517	SUCO	SUN domain containing ossification factor	4838.0	SNV	0/1	0.45	16_13	29	99	False	rs754473185	EXONIC	YES	NM_016227.4	Transcript	protein_coding	missense_variant		13/23	NM_016227.4:c.1873G>A	NP_057311.3:p.Asp625Asn		1.0	.,.,.,.					.	.	.		3.94914e-05	6.0	151932.0	0.0	32	0.96	PASS	amr	6.55566e-05	1.0	4.42413e-05	3.0	1.99184e-05	5.0	251024.0	0.0	46	0.99	PASS	amr	5.78804e-05	2.0	2.64448e-05	3.0	0.0000257	4			0.00021	2.0		32.0	4.387444	0.641	12	7	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	SUCO	0.0	0.0	0.0	0.0	-14.0	-17.0	9.0	41.0							0.3	0.0	1.0	1.176	cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; 			.	.	ossification;multicellular organism development;positive regulation of collagen biosynthetic process;protein folding in endoplasmic reticulum;positive regulation of osteoblast differentiation;regulation of bone remodeling	cytoplasm;rough endoplasmic reticulum;membrane;integral component of membrane;rough endoplasmic reticulum membrane	.	SLC35F6[26496610];PSMD11[26496610];RPL10[26496610];LAMA1[26496610];NDUFB11[26496610];ELOVL5[26496610];PREP[26496610];ISG20L2[26496610];TIMM23[26496610];GMCL1[26496610];PSTPIP1[17353931];NIPBL[26496610];HIST1H4A[30021884];MED24[26496610];BAP18[26496610];CALU[26496610];P4HB[26496610];PHLDA2[26496610];TNPO1[26496610];TAPT1[26496610];
353086	chr5	176079738	C	G	chr5:176079738	TSPAN17	tetraspanin 17	4860.0	SNV	0/1	0.29	15_6	21	99	False	rs191378931	SPLICING	YES	NM_001366491.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/7		NM_001366491.2:c.286-6C>G			1.0						.	.	.		0.00341057	519.0	152174.0	1.0	32	0.97	PASS	nfe	0.00454305	309.0	0.00454305	309.0	0.00354881	892.0	251352.0	6.0	72	0.99	PASS	nfe	0.00488101	555.0	0.00488101	555.0	0.0032604	507	0.003	9.0	0.00326	37.0		19.75	2.001754		0	0	0			TSPAN17	0.82	0.23	0.0	0.0	1.0	6.0	-11.0	42.0	0.999979035921536	0.916	-2.211	6.065	3.854	0.589	0.0				.			ciliary ganglion;pons;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;globus pallidus;	.	cell surface receptor signaling pathway;protein ubiquitination;establishment of protein localization to organelle	ubiquitin ligase complex;integral component of plasma membrane	ubiquitin-protein transferase activity;enzyme binding	UBE2N[25260751];UBA1[25260751];UBE2V1[25260751];HACD3[17353931];
353488	chr1	165712556		A	chr1:165712555-165712556	TMCO1	transmembrane and coiled-coil domains 1	4873.0	insertion	0/1	0.25	14_6	24	76	False	rs751227407	SPLICING	YES	NM_001256164.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/6		NM_001256164.1:c.375-8dup			-1.0		Benign	criteria_provided,_single_submitter	not_provided	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome, 213980 (3), Autosomal recessive	Cerebrofaciothoracic dysplasia	Disease-causing germline mutation(s) (loss of function) in	Narrow chest;Low-set, posteriorly rotated ears;Brachycephaly;Polyhydramnios;Cerebral cortical atrophy;Downslanted palpebral fissures;Wide mouth;Hypoplasia of the corpus callosum;Bifid ribs;Cleft palate;Cerebellar vermis hypoplasia;Cleft upper lip;Rib fusion;Hypertelorism;Midface retrusion;Hemivertebrae;Scoliosis;Ventriculomegaly;Thick eyebrow;Strabismus;Sprengel anomaly;Epicanthus;Short stature;Wide nose;Synophrys;Intellectual disability;Low posterior hairline;Hernia;Short nose;Coarse hair;Macrocephaly;Broad philtrum;Short neck;Cleft palate;Self-mutilation;Highly arched eyebrow;Sparse and thin eyebrow;Muscular hypotonia;Micrognathia;Inguinal hernia;Ptosis;Short neck;Sparse eyelashes;Low-set, posteriorly rotated ears;Microcephaly;Attention deficit hyperactivity disorder;Narrow forehead;Scoliosis;Low posterior hairline;Decreased fetal movement;Shawl scrotum;Overlapping toe;Postnatal growth retardation;Short stature;Polyhydramnios;Short nose;Gingival overgrowth;Wide nose;Abnormality of the kidney;Joint hypermobility;Autosomal recessive inheritance;Rib fusion;Hypertelorism;Long eyelashes;Posteriorly rotated ears;Strabismus;Sacral dimple;Growth hormone deficiency;Synophrys;Microdontia of primary teeth;Hypoplasia of the maxilla;Low anterior hairline;Bifid ribs;Anxiety;Bull's eye maculopathy;Hypoplasia of the corpus callosum;Cleft upper lip;Absent speech;Poliosis;Wide intermamillary distance;Thick eyebrow;Craniosynostosis;Postaxial hand polydactyly;Motor delay;Pes planus;Narrow chest;Atrial septal defect;Macrocephaly;Intellectual disability;Hemivertebrae;Flat face;Talipes equinovarus;Beaking of vertebral bodies;Epicanthus;Upslanted palpebral fissure;Low-set ears;Large for gestational age;High palate;Feeding difficulties;Brachycephaly;Supernumerary nipple;Neonatal hypotonia;Patent ductus arteriosus		0.00341111	326.0	95570.0	0.0	30	0.77	AS_VQSR	sas	0.00703364	23.0	0.00187086	82.0	0.0848718	13047.0	153726.0	0.0	44	0.89	InbreedingCoeff	eas	0.110033	1202.0	0.0792219	5498.0	0.0003087,0.0000579,0.0004116,0.0000129	48,9,64,2			0.00424	48.0		0.726	-0.198312		0	0	0			TMCO1	0.0	0.0	0.0	0.0	-19.0	-7.0	-19.0	26.0							0.0				homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			.	.	ER overload response;endoplasmic reticulum calcium ion homeostasis;calcium ion transmembrane transport	Golgi membrane;endoplasmic reticulum;integral component of endoplasmic reticulum membrane	calcium channel activity	GSTK1[17353931];JUN[25609649];TMEM63B[26496610];KMT2A[30021884];YIPF5[26496610];KIF14[26496610];HSCB[28380382];KNL1[30021884];CENPA[26496610];FAM177B[30021884];GH1[17353931];ATXN3[26496610];MPHOSPH9[30021884];TMBIM4[17353931];TCTN3[26638075];TCTN2[26638075];VHL[17353931];HIF1AN[26972000];MAPK6[26972000];
355332	chr4	41747993	GCCGCCGCTGCCGCTGCCGCC		chr4:41747993-41748013	PHOX2B	paired like homeobox 2B	4896.0	deletion	0/1	0.67	4_8	12	99	False	rs17879189	EXONIC	YES	NM_003924.4	Transcript	protein_coding	inframe_deletion		3/3	NM_003924.4:c.756_776del	NP_003915.2:p.Ala254_Ala260del		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Hereditary_cancer-predisposing_syndrome|Haddad_syndrome|not_specified|not_provided	{Neuroblastoma, susceptibility to, 2}, 613013 (3); Neuroblastoma with Hirschsprung disease, 613013 (3); Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease, 209880 (3), Autosomal dominant	Neuroblastoma;Ondine syndrome;Hirschsprung disease-ganglioneuroblastoma syndrome;Haddad syndrome	Major susceptibility factor in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in	Elevated urinary catecholamines;Neoplasm of the nervous system;Hyperhidrosis;Abnormal pupil morphology;Ganglioneuroblastoma;Seizure;Arrhythmia;Prolonged QT interval;Aganglionic megacolon;Aganglionic megacolon;Muscular hypotonia;Cognitive impairment;Respiratory insufficiency;Ganglioneuroma;Seizure;Ganglioneuroblastoma;Central sleep apnea;Muscular hypotonia;Oligohydramnios;Central hypoventilation;Failure to thrive;Decreased fetal movement;Small for gestational age;Polyhydramnios;Sensorineural hearing impairment;Seizure;Neuroblastoma;Intellectual disability;Abnormal autonomic nervous system physiology;Aganglionic megacolon;Gastroesophageal reflux;Breathing dysregulation;Strabismus;Death in infancy;Ganglioneuroma;Hyperhidrosis;Autosomal dominant inheritance;Low-set ears;Posteriorly rotated ears;Hypoventilation;Abnormality of temperature regulation;Abnormality of the mouth;Hypercapnia;Ganglioneuroma;Ganglioneuroblastoma;Constipation;Apnea;Abnormality of the cardiovascular system;Feeding difficulties;Hypoxemia;Downslanted palpebral fissures;Aganglionic megacolon;Central hypoventilation;Ganglioneuroblastoma;Autosomal dominant inheritance;Aganglionic megacolon;Ganglioneuroma		0.00188855	279.0	147732.0	3.0	32	0.93	PASS	amr	0.00870613	130.0	0.000872994	58.0	0.0082507	421.0	51026.0	9.0	4	0.06	PASS	eas	0.0436198	67.0	0.00366459	93.0	0.0001479,0.0065272	23,1015			0.0029	28.0		14.51	1.174125		0	0	0																	0.0467	0.85				vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; embryo phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			ciliary ganglion;pons;appendix;dorsal root ganglion;skin;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	neuron migration;regulation of respiratory gaseous exchange by neurological system process;noradrenergic neuron differentiation;noradrenergic neuron development;brainstem development;nervous system development;negative regulation of cell population proliferation;glial cell differentiation;regulation of gene expression;positive regulation of G2/M transition of mitotic cell cycle;cell differentiation in hindbrain;medullary reticular formation development;hindbrain tangential cell migration;skeletal muscle cell differentiation;negative regulation of neuron differentiation;positive regulation of neuron differentiation;positive regulation of transcription by RNA polymerase II;autonomic nervous system development;enteric nervous system development;sympathetic nervous system development;parasympathetic nervous system development;inner ear development;efferent axon development in a lateral line nerve;respiratory system development;retrotrapezoid nucleus neuron differentiation;sympathetic ganglion development;negative regulation of cell cycle arrest;dopaminergic neuron differentiation;cellular response to BMP stimulus;positive regulation of cold-induced thermogenesis;neural crest cell migration involved in autonomic nervous system development	nuclear chromatin;nucleus;nucleoplasm	RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific	.
358711	chr11	68562288	C	T	chr11:68562288	CPT1A	carnitine palmitoyltransferase 1A	4936.0	SNV	0/1	0.39	19_12	31	99	False	rs140958507,COSV99039713	EXONIC	YES	NM_001876.4	Transcript	protein_coding	missense_variant		8/19	NM_001876.4:c.863G>A	NP_001867.2:p.Arg288Gln		-1.0	.,.,Choline/carnitine acyltransferase domain,Choline/carnitine acyltransferase domain,Choline/carnitine acyltransferase domain	Benign	criteria_provided,_multiple_submitters,_no_conflicts	Carnitine_palmitoyltransferase_1A_deficiency|not_specified	CPT deficiency, hepatic, type IA, 255120 (3), Autosomal recessive	Carnitine palmitoyl transferase 1A deficiency	Disease-causing germline mutation(s) (loss of function) in	Coma;Lethargy;Hypertrophic cardiomyopathy;Fatigue;Reduced tendon reflexes;Muscular hypotonia;Hypoglycemia;Transient hyperlipidemia;Renal tubular acidosis;Behavioral abnormality;Hepatomegaly;Neurological speech impairment;Skeletal muscle atrophy;Hepatic failure;Elevated hepatic transaminase;Sudden cardiac death;Loss of consciousness;Hemiplegia/hemiparesis;Seizure;Recurrent encephalopathy;Elevated serum creatine kinase;Hepatomegaly;Hepatic steatosis;Prenatal maternal abnormality;Autosomal recessive inheritance;Hyperammonemia;Coma;Generalized hypotonia;Elevated hepatic transaminase;Muscular hypotonia;Arrhythmia;Seizure;Cardiomegaly;Hypoketotic hypoglycemia;Diarrhea;Transient hyperlipidemia;Lethargy;Renal tubular acidosis;Feeding difficulties in infancy		0.00473155	720.0	152170.0	2.0	33	0.98	PASS	nfe	0.00825936	562.0	0.00825936	562.0	0.00530443	1334.0	251488.0	6.0	100	1.0	PASS	nfe	0.00956349	1088.0	0.00956349	1088.0	0.0056269	875	0.004	14.0	0.00342	39.0		23.5	2.962419	0.671	12	8	20	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	CPT1A	0.0	0.0	0.0	0.0	14.0	-16.0	-20.0	15.0						0.0338	0.94	0.0	0.984	0.966	cellular phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; 			superior cervical ganglion;trigeminal ganglion;atrioventricular node;testis;skeletal muscle;	Fatty acid metabolism;PPAR signaling pathway;Adipocytokine signaling pathway	long-chain fatty acid metabolic process;glucose metabolic process;fatty acid beta-oxidation;triglyceride metabolic process;carnitine shuttle;circadian rhythm;carnitine metabolic process;response to organic cyclic compound;regulation of lipid metabolic process;epithelial cell differentiation;positive regulation of fatty acid beta-oxidation;response to drug;eating behavior;regulation of insulin secretion;protein homooligomerization;cellular response to fatty acid	mitochondrion;mitochondrial outer membrane;membrane;integral component of mitochondrial outer membrane	carnitine O-palmitoyltransferase activity;identical protein binding;palmitoleoyltransferase activity	NPDC1[21988832];PDHA1[29128334];HSPA5[21988832];HDAC11[23752268];HUWE1[26496610];CYBA[21988832];CACYBP[25036637];TUBG1[26496610];SDHA[29128334];ESR2[21182203];HDAC6[26496610];COX6B1[27499296];NR4A1[21988832];NEURL4[29426014];NDUFAF4[27499296];E2F3[22157815];KBTBD7[21988832];CLIC1[21988832];RAB7A[26496610];
358981	chr6	38862507	C	A	chr6:38862507	DNAH8	dynein axonemal heavy chain 8	4944.0	SNV	0/1	0.52	10_11	21	99	False	rs370299465,COSV59479793	EXONIC	YES	NM_001206927.2	Transcript	protein_coding	missense_variant		59/93	NM_001206927.2:c.8614C>A	NP_001193856.1:p.His2872Asn		1.0	.,.,.				Spermatogenic failure 46, 619095 (3), Autosomal recessive	.	.	.		4.60217e-05	7.0	152102.0	0.0	32	0.97	PASS	nfe	0.000102914	7.0	0.000102914	7.0	5.17895e-05	13.0	251016.0	0.0	45	0.99	PASS	nfe	0.000114614	13.0	0.000114614	13.0	0.0000643	10						28.1	4.04623	0.907	16	5	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	DNAH8	0.01	0.0	0.0	0.0	22.0	-30.0	-31.0	37.0							0.0	0.0	1.0	1.026	.			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;atrioventricular node;trigeminal ganglion;testis;	.	microtubule-based movement;outer dynein arm assembly;cilium-dependent cell motility	axonemal dynein complex;microtubule;dynein complex;outer dynein arm	microtubule motor activity;ATP binding;ATP-dependent microtubule motor activity, minus-end-directed;dynein light chain binding;dynein intermediate chain binding;dynein light intermediate chain binding	RNF31[unassigned1774];ITGB1[30021884];MYC[21150319];
359263	chr3	81720013	G	A	chr3:81720013	GBE1	1,4-alpha-glucan branching enzyme 1	4960.0	SNV	0/1	0.59	12_17	29	99	False	rs139882066,COSV70099089	EXONIC	YES	NM_000158.4	Transcript	protein_coding	synonymous_variant		3/16	NM_000158.4:c.405C>T	NP_000149.4:p.Leu135%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Glycogen_storage_disease,_type_IV|Adult_polyglucosan_body_disease|Glycogen_storage_disease_IV,_classic_hepatic|not_specified|not_provided	Glycogen storage disease IV, 232500 (3), Autosomal recessive; Polyglucosan body disease, adult form, 263570 (3), Autosomal recessive	Adult polyglucosan body disease;Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form;Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form;Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form;Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form;Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form;Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form;Glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Failure to thrive;Muscular hypotonia;Edema;Decreased fetal movement;Arthrogryposis multiplex congenita;Generalized hypotonia;Ascites;Portal hypertension;Tubulointerstitial fibrosis;Reduced tendon reflexes;Hepatic failure;Polyhydramnios;Hydrops fetalis;Hepatosplenomegaly;Autosomal recessive inheritance;Esophageal varix;Cirrhosis;Cardiomyopathy;Muscle weakness;Skeletal muscle atrophy;Gait disturbance;Spastic paraplegia;Adult onset;Peripheral axonal neuropathy;Abnormality of the cerebral white matter;Slow progression;Neurogenic bladder;Abnormality of metabolism/homeostasis;Orthostatic hypotension;Neurogenic bladder;Autosomal recessive inheritance;Cognitive impairment;Paresthesia;Distal sensory impairment;Abnormal upper motor neuron morphology;Tetraparesis;Urinary bladder sphincter dysfunction;EMG abnormality;Hemiparesis;Intellectual disability;Gait disturbance;Spasticity;Abnormality of extrapyramidal motor function;Muscle weakness;Distal sensory impairment;Urinary incontinence;Limitation of joint mobility;Dementia;Neurogenic bladder;Behavioral abnormality;Abnormal pyramidal sign;Ataxia;Skin ulcer		0.00261591	398.0	152146.0	2.0	32	0.97	PASS	nfe	0.00398447	271.0	0.00398447	271.0	0.00287233	589.0	205060.0	2.0	14	0.31	PASS	nfe	0.00426884	415.0	0.00426884	415.0	0.0030932	481	0.005	18.0	0.005	57.0		0.518	-0.248927		0	0	0			GBE1	0.0	0.0	0.0	0.0	-25.0	-1.0	6.0	-24.0						0.116	0.0	89.175989684			homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; respiratory system phenotype; 			smooth muscle;adipose tissue;	Starch and sucrose metabolism	carbohydrate metabolic process;glycogen metabolic process;glycogen biosynthetic process;generation of precursor metabolites and energy	cytosol;extracellular exosome	1,4-alpha-glucan branching enzyme activity;hydrolase activity, hydrolyzing O-glycosyl compounds;protein binding;cation binding;1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis)	PRMT6[23455924];SETD4[26496610];VAPA[26496610];PRICKLE3[26496610];PGD[16169070];KIFAP3[26496610];OAZ1[26496610];TRDMT1[21988832];EPHB3[21988832];
363044	chr2	172928555	C	T	chr2:172928555	METAP1D	methionyl aminopeptidase type 1D, mitochondrial	5007.0	SNV	0/1	0.53	9_10	19	99	False		EXONIC	YES	NM_199227.3	Transcript	protein_coding	synonymous_variant		3/10	NM_199227.3:c.315C>T	NP_954697.1:p.Arg105%3D		1.0						.	.	.						32	0.97											41	0.91														10.58	0.63165		0	0	0			METAP1D	0.0	0.0	0.0	0.07	25.0	33.0	-14.0	33.0							0.0	1.772665448			.			ciliary ganglion;pons;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;globus pallidus;	.	proteolysis;peptidyl-methionine modification;N-terminal protein amino acid modification;protein initiator methionine removal	mitochondrion;intracellular membrane-bounded organelle	aminopeptidase activity;metalloexopeptidase activity;metal ion binding;metalloaminopeptidase activity	.
368987	chr9	100777705	G	A	chr9:100777705	ANP32B	acidic nuclear phosphoprotein 32 family member B	5059.0	SNV	0|1	0.33	29_14	43	99	False	rs76167314,COSV59586079,COSV59586893	EXONIC	YES	NM_006401.3	Transcript	protein_coding	missense_variant		7/7	NM_006401.3:c.748G>A	NP_006392.1:p.Asp250Asn		1.0						.	.	.						32	0.95							8.15599e-05	13.0	159392.0	0.0	36	0.6	RF	nfe	0.000210799	13.0	0.000210799	13.0	0.0000064	1						25.3	3.599491	0.247	6	15	21	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	ANP32B	0.0	0.0	0.0	0.0	10.0	-50.0	37.0	-47.0							0.96	12.626032923	1.0	1.176	growth/size/body region phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; respiratory system phenotype; neoplasm; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; skeleton phenotype; renal/urinary system phenotype; 			thymus;white blood cells;tumor;fetal liver;spinal cord;bone marrow;	.	vasculature development;nucleosome assembly;activation of cysteine-type endopeptidase activity involved in apoptotic process;ventricular system development;negative regulation of cell differentiation;positive regulation of protein export from nucleus;inner ear development;roof of mouth development	nucleus;nucleolus;cytoplasm;extracellular exosome	protein binding;histone binding;RNA polymerase binding	SMARCD1[21988832];PTEN[24412244];MYNN[unassigned1304];PTPRJ[24412244];PHB[20195357];BCL10[24412244];MEOX2[25416956];AURKA[24412244];SDCBP[25416956;unassigned1304];STK11[24412244];HIST1H3A[29568061];CDH1[16212417];HNF4A[21988832];KPNA6[unassigned1304];PMS2[24412244];KPNA5[25416956];TP53BP1[29656893];BEND7[unassigned1304];BUB1[24412244];YAF2[unassigned1304];KPNA1[21988832;25416956;unassigned1304];SMAD2[20195357];JUN[25609649];VCAM1[22623428;19738201];CSNK2A1[22113938];DCC[24412244];FBXW7[24412244];FN1[19738201];DNTTIP1[unassigned1304];PTPN12[24412244];MCC[24412244];MLH3[24412244];FAM217B[unassigned1304];APC[24412244];PRKAR1A[20195357];BAX[24412244];ANG[28777577];TLR2[24412244];OTUB1[26752685];
368988	chr9	100777710	T	A	chr9:100777710	ANP32B	acidic nuclear phosphoprotein 32 family member B	5059.0	SNV	0|1	0.33	28_14	42	99	False	rs112073824,COSV59586091	EXONIC	YES	NM_006401.3	Transcript	protein_coding	missense_variant		7/7	NM_006401.3:c.753T>A	NP_006392.1:p.Asp251Glu		1.0						.	.	.						32	0.95							6.26959e-05	10.0	159500.0	0.0	36	0.6	PASS	nfe	0.000161991	10.0	0.000161991	10.0	0.0000064	1						22.3	2.366238	0.098	4	16	20	SIFT,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	ANP32B	0.0	0.0	0.0	0.0	32.0	23.0	37.0	32.0							0.96	0.0	0.994	0.205	growth/size/body region phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; respiratory system phenotype; neoplasm; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; skeleton phenotype; renal/urinary system phenotype; 			thymus;white blood cells;tumor;fetal liver;spinal cord;bone marrow;	.	vasculature development;nucleosome assembly;activation of cysteine-type endopeptidase activity involved in apoptotic process;ventricular system development;negative regulation of cell differentiation;positive regulation of protein export from nucleus;inner ear development;roof of mouth development	nucleus;nucleolus;cytoplasm;extracellular exosome	protein binding;histone binding;RNA polymerase binding	SMARCD1[21988832];PTEN[24412244];MYNN[unassigned1304];PTPRJ[24412244];PHB[20195357];BCL10[24412244];MEOX2[25416956];AURKA[24412244];SDCBP[25416956;unassigned1304];STK11[24412244];HIST1H3A[29568061];CDH1[16212417];HNF4A[21988832];KPNA6[unassigned1304];PMS2[24412244];KPNA5[25416956];TP53BP1[29656893];BEND7[unassigned1304];BUB1[24412244];YAF2[unassigned1304];KPNA1[21988832;25416956;unassigned1304];SMAD2[20195357];JUN[25609649];VCAM1[22623428;19738201];CSNK2A1[22113938];DCC[24412244];FBXW7[24412244];FN1[19738201];DNTTIP1[unassigned1304];PTPN12[24412244];MCC[24412244];MLH3[24412244];FAM217B[unassigned1304];APC[24412244];PRKAR1A[20195357];BAX[24412244];ANG[28777577];TLR2[24412244];OTUB1[26752685];
369134	chr1	233122016	A	G	chr1:233122016	PCNX2	pecanex 2	5062.0	SNV	0/1	0.62	18_29	47	99	False	rs201952935	EXONIC	YES	NM_014801.4	Transcript	protein_coding	missense_variant		33/34	NM_014801.4:c.6062T>C	NP_055616.3:p.Leu2021Pro		-1.0	.,.					.	.	.		0.00155033	236.0	152226.0	1.0	33	0.98	PASS	nfe	0.00230787	157.0	0.00230787	157.0	0.00159709	270.0	169058.0	1.0	60	0.58	PASS	nfe	0.00173822	120.0	0.00173822	120.0	0.0008360	130	0.001	4.0				27.3	3.951525	0.603	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	PCNXL2	0.0	0.0	0.0	0.0	8.0	-16.0	9.0	34.0								0.0	0.999	1.312	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	.	biological_process	cellular_component;integral component of membrane	molecular_function	SLC30A2[unassigned1304];ORMDL1[unassigned1304];
376906	chr5	162939175	A	G	chr5:162939175	MAT2B	methionine adenosyltransferase 2B	5181.0	SNV	0/1	0.46	19_16	35	99	False	rs143459228	EXONIC	YES	NM_013283.5	Transcript	protein_coding	synonymous_variant		2/7	NM_013283.5:c.231A>G	NP_037415.1:p.Ala77%3D		1.0						.	.	.		0.000177331	27.0	152258.0	0.0	33	0.97	PASS	amr	0.000784724	12.0	0.000220452	15.0	0.000123388	31.0	251240.0	0.0	70	1.0	PASS	amr	0.000289218	10.0	0.000176131	20.0	0.0001415	22	0.003	11.0				11.95	0.799577		0	0	0			MAT2B	0.0	0.0	0.01	0.02	-23.0	2.0	27.0	-24.0						0.397	0.25	58.035830129			.			kidney;occipital lobe;superior cervical ganglion;whole blood;parietal lobe;globus pallidus;	Methionine metabolism;Selenoamino acid metabolism	S-adenosylmethionine biosynthetic process;one-carbon metabolic process;regulation of catalytic activity	nucleus;cytosol;methionine adenosyltransferase complex;extracellular exosome	protein binding;enzyme binding;methionine adenosyltransferase regulator activity	TEPSIN[unassigned1304];HRH1[28298427];RABEP1[unassigned1304];MAT2A[25416956];KPNA4[25416956];TRIM27[25416956];HSCB[28380382];PLA2G6[unassigned1304];KPNA3[25416956;unassigned1304];
377433	chr5	31526792	G	A	chr5:31526792	DROSHA	drosha ribonuclease III	5203.0	SNV	0/1	0.57	6_8	14	99	False	rs149389256	EXONIC	YES	NM_001382508.1	Transcript	protein_coding	missense_variant		5/36	NM_001382508.1:c.248C>T	NP_001369437.1:p.Pro83Leu		-1.0	.,.,.,.,.	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00393851	597.0	151580.0	4.0	30	0.88	PASS	nfe	0.00686404	466.0	0.00686404	466.0	0.00437303	777.0	177680.0	5.0	23	0.58	PASS	nfe	0.00775238	673.0	0.00775238	673.0	0.0045980	715	0.002	6.0	0.00129	1.0		26.3	3.805874	0.239	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	DROSHA	0.0	0.0	0.0	0.0	37.0	18.0	14.0	-12.0							1.0	0.0	0.706	1.176	integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cellular phenotype; muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype; immune system phenotype; digestive/alimentary phenotype; 			ciliary ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	RNA processing;miRNA metabolic process;positive regulation of gene expression;rRNA catabolic process;production of siRNA involved in RNA interference;primary miRNA processing;pre-miRNA processing;ribosome biogenesis;regulation of regulatory T cell differentiation;regulation of inflammatory response;defense response to Gram-negative bacterium;defense response to Gram-positive bacterium;RNA phosphodiester bond hydrolysis, endonucleolytic;regulation of miRNA metabolic process	nucleus;nucleoplasm;nucleolus;postsynaptic density;microprocessor complex	lipopolysaccharide binding;RNA binding;double-stranded RNA binding;ribonuclease III activity;protein binding;DEAD/H-box RNA helicase binding;protein homodimerization activity;SMAD binding;metal ion binding;R-SMAD binding;primary miRNA binding	ZNF512B[15231748];HDAC2[22222205];DDX5[22222205;18548003;19626115];HDAC1[22222205];EPAS1[26766590];TULP3[23414517];HIF1A[26766590];KHSRP[19458619];DGCR8[15574589;22222205;24581491;26496610;19626115;22796965;23995758];DROSHA[15574589];SNIP1[18632581];NCK1[17474147;26496610];DDX17[22222205;24581491;19626115];SRPK2[23602568];SMAD1[18548003];EGLN3[26972000];SMAD3[18548003];FUS[23232809];RPA1[26496610];LNPEP[26496610];SMAD5[18548003];SRPK1[23602568];SGO1[26496610];ZNFX1[26496610];BCL6[16147992];SP1[10976766];GRB2[17474147];TP53[24219989;19626115];
377795	chr17	68096908	A	G	chr17:68096908	KCNJ16	potassium voltage-gated channel subfamily J member 16	5210.0	SNV	0/1	0.5	17_17	34	99	False	rs7226242	SPLICING	YES	NM_001270422.2	Transcript	protein_coding	splice_donor_variant	2/5		NM_001270422.2:c.-400+1A>G			1.0		Benign	criteria_provided,_single_submitter	not_specified	Hypokalemic tubulopathy and deafness, 619406 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.8466525	22333						3.549	0.05747		0	0	0			KCNJ16	0.0	0.0	0.89	0.0	0.0	34.0	-1.0	-2.0			10.567	-8.182	2.385		0.0				nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			fetal thyroid;kidney;thyroid;superior cervical ganglion;	.	potassium ion transport;regulation of ion transmembrane transport;potassium ion import across plasma membrane	plasma membrane;voltage-gated potassium channel complex;basolateral plasma membrane	inward rectifier potassium channel activity;G-protein activated inward rectifier potassium channel activity	KCNJ10[24561201];
378008	chr19	16640581	TGC		chr19:16640581-16640583	CHERP	calcium homeostasis endoplasmic reticulum protein	5215.0	deletion	0/1	0.15	22_4	26	76	False	rs751586190	EXONIC	YES	NM_006387.6	Transcript	protein_coding	inframe_deletion		8/17	NM_006387.6:c.1005_1007del	NP_006378.3:p.Gln341del		-1.0						.	.	.		0.0	0.0	151776.0	0.0	33	0.96	AC0				0.0	0.0	0.001064	227.0	213346.0	0.0	100	0.97	RF	nfe	0.000966974	91.0	0.000966974	91.0	0.0000386	6	0.001	3.0				17.31	1.6734		0	0	0			CHERP	0.0	0.0	0.0	0.0	47.0	27.0	-48.0	-42.0						0.14	1.0	0.0			.			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	mRNA splicing, via spliceosome;cellular calcium ion homeostasis;nervous system development;negative regulation of cell population proliferation;release of sequestered calcium ion into cytosol;positive regulation of calcineurin-NFAT signaling cascade	nucleoplasm;cytoplasm;membrane;sarcoplasmic reticulum membrane;perinuclear region of cytoplasm	RNA binding;protein binding;ion channel binding	"C1orf94[unassigned1304];LRRK2[24947832];ZMYND8[26496610];DDX41[25920683];CCAR1[22365833];SART1[22365833];LASP1[unassigned1304];SNRNP70[22365833];ADAMTSL4[unassigned1304];FASTK[unassigned1304];RACK1[22365833];DHX15[24304693;29021621];LUC7L[22365833];SNIP1[22365833];TRIM26[26496610];RBM7[22365833];KRTAP11-1[unassigned1304];TLE3[unassigned1304];RBFOX2[unassigned1304];PRPF40A[22365833];EWSR1[21988832];SNRNP27[22365833];HNRNPH3[22365833];RBM23[22365833];SAXO1[unassigned1304];CD44[26496610];SF1[26420826];SF3B4[22365833];DHX8[22365833];MAGED1[unassigned1304];USP54[unassigned1304];WBP4[16055720];U2AF1[22365833];FIGN[unassigned1304];U2AF2[22365833];EMC2[26496610];ARGLU1[22365833];TTC14[22365833];SRPK2[23602568];RBM39[22365833];PRPF38A[22365833];XRCC3[26496610];CDC5L[20467437];""Em[unassigned1304];NBEAL2[29187380];SORBS3[unassigned1304];U2SURP[30021884];SRPK1[23602568];PPP1CA[28330616];SNW1[20467437];MYO1C[26496610];AGGF1[22365833];RNPS1[22365833];PPIL4[22365833];FRA10AC1[22365833];"
378517	chr9	109689486		GGCCCCCCCCCC	chr9:109689485-109689486	ZNF462	zinc finger protein 462	5226.0	insertion	0/1	0.05	19_1	22	62	False		EXONIC	YES	NM_021224.6	Transcript	protein_coding	protein_altering_variant		3/13	NM_021224.6:c.3292_3293insGGCCCCCCCCCC	NP_067047.4:p.Ser1098delinsTrpProProProPro		1.0					Weiss-Kruszka syndrome, 618619 (3), Autosomal dominant	Metopic ridging-ptosis-facial dysmorphism syndrome	Disease-causing germline mutation(s) in	.		7.02119e-06	1.0	142426.0	0.0	31	0.9	AS_VQSR	eas	0.000224719	1.0	0.0	0.0					34	0.91																	0	0	0																	0.413	1.0	31.513122036			integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;pons;testis - interstitial;superior cervical ganglion;trigeminal ganglion;atrioventricular node;parietal lobe;testis;skeletal muscle;globus pallidus;	.	chromatin organization;regulation of gene expression;negative regulation of DNA binding;positive regulation of transcription by RNA polymerase II	nucleus;histone methyltransferase complex	RNA polymerase II core promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding	CBX5[20562864;27705803];NEK4[25798074];CBX3[27705803];EHMT2[27705803;unassigned1304];CBX1[27705803];KLHL21[27705803];TULP3[23414517];EHMT1[27705803];WIZ[27705803];DPY30[23995757];RCN2[27705803];SUMO1[17000644];TRIM28[27705803];AIFM1[27705803];TCOF1[30021884];RUVBL2[27705803];SCGB2A1[27705803];DNAJB11[27705803];CALU[27705803];D2HGDH[27705803];ZNF644[27705803];
379721	chr11	118250371	A	G	chr11:118250371	UBE4A	ubiquitination factor E4A	5238.0	SNV	0/1	0.53	17_19	36	99	False	rs143573037	EXONIC	YES	NM_004788.4	Transcript	protein_coding	synonymous_variant		11/20	NM_004788.4:c.1803A>G	NP_004779.2:p.Leu601%3D		1.0					Neurodevelopmental disorder with hypotonia and gross motor and seech delay, 619639 (3), Autosomal recessive	.	.	.		0.00114292	174.0	152242.0	0.0	32	0.98	PASS	amr	0.00209287	32.0	0.00132279	90.0	0.00109072	274.0	251210.0	1.0	94	1.0	PASS	nfe	0.00138297	157.0	0.00138297	157.0	0.0011189	174	0.001	3.0				6.472	0.244102		0	0	0			UBE4A	0.01	0.0	0.0	0.0	-17.0	-18.0	-17.0	-18.0						0.6	0.94	74.6056524			.			occipital lobe;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;cingulate cortex;parietal lobe;	Ubiquitin mediated proteolysis	protein polyubiquitination;ubiquitin-dependent protein catabolic process;ubiquitin-dependent ERAD pathway	ubiquitin ligase complex;nucleus;cytoplasm	protein binding;ubiquitin-ubiquitin ligase activity	CBX7[21282530];FOXB1[25609649];UBE2D4[19690564];UBE2D2[19690564];UBE2D3[19690564];FOXI2[25609649];UBE2D1[19690564];FOXL2[25609649];CWC25[30021884];FOXL1[25609649];FOXQ1[25609649];PTP4A3[17353931];MAVS[21903422];CANX[29568061];IP6K1[unassigned1304];
380713	chr15	64067391	A	G	chr15:64067391	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	5270.0	SNV	0/1	0.48	15_14	29	99	False	rs371404887	EXONIC	YES	NM_003922.4	Transcript	protein_coding	synonymous_variant		2/78	NM_003922.4:c.432T>C	NP_003913.3:p.His144%3D		-1.0					Macrocephaly, dysmorphic facies, and psychomotor retardation, 617011 (3), Autosomal recessive	Megalencephaly-severe kyphoscoliosis-overgrowth syndrome	Disease-causing germline mutation(s) (loss of function) in	Large hands;Low-set ears;Cerebellar atrophy;Frontal bossing;Long neck;Pes planus;Absent speech;Hydrocephalus;Intellectual disability;Malar flattening;Macrotia;Ventriculomegaly;High palate;Long face;Thick corpus callosum;Megalencephaly;Proptosis;Arachnodactyly;Mandibular prognathia;Posteriorly rotated ears;Hypertelorism;Global developmental delay;Triangular face;Downslanted palpebral fissures;Generalized hypotonia;Cerebral cortical atrophy;Kyphosis;Upslanted palpebral fissure;Long foot;Scoliosis;Congenital onset;Sparse eyebrow;Prominent nasal bridge;Prominent forehead;Seizure;Joint laxity;Autosomal recessive inheritance;Tall stature;Macrocephaly;Gait ataxia;Hyperlordosis;Drooling;Megalencephaly;Long neck;Absent speech;Arachnodactyly;Prominent forehead;Large for gestational age;Gait ataxia;Intellectual disability, severe;Low-set, posteriorly rotated ears;Mandibular prognathia;Triangular face;Global developmental delay;Downslanted palpebral fissures;High myopia;Macrocephaly;Thick corpus callosum;Shallow orbits;Neonatal hypoglycemia;Long foot;Diffuse white matter abnormalities;Broad eyebrow;Ventriculomegaly;Bilateral tonic-clonic seizure;Pes planus;Metopic synostosis;Lumbar hyperlordosis;Cerebral cortical atrophy;Kyphoscoliosis;Difficulty walking;Communicating hydrocephalus;Limitation of joint mobility;Slender build;High palate;Hypertelorism;Severe expressive language delay;Asymmetry of the thorax;Impaired social interactions;Upslanted palpebral fissure;Overgrowth;Prominent nasal bridge;Malar flattening;Facial hypotonia;Long face;Macrotia;Cerebellar hypoplasia;Disproportionate tall stature;Sparse eyebrow;Micropenis;Joint laxity		0.000190526	29.0	152210.0	0.0	32	0.97	PASS	amr	6.54365e-05	1.0	2.93971e-05	2.0	0.000196688	49.0	249126.0	0.0	100	1.0	PASS	amr	5.79307e-05	2.0	8.85551e-06	1.0	0.0000514	8						10.72	0.647836		0	0	0			HERC1	0.0	0.0	0.0	0.0	7.0	-9.0	-20.0	-3.0						0.652	1.0	41.356491622			nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			.	Ubiquitin mediated proteolysis	negative regulation of autophagy;protein ubiquitination;cerebellar Purkinje cell differentiation;neuron projection development;neuromuscular process controlling balance	cytoplasm;Golgi apparatus;cytosol;membrane	ubiquitin-protein transferase activity;ARF guanyl-nucleotide exchange factor activity	JUN[20195357];SCHIP1[20195357];CANX[30021884];PPEF1[28330616];HMGN2[30021884];PTBP3[22575643];
380755	chr6	111697863	A	G	chr6:111697863	REV3L	REV3 like, DNA directed polymerase zeta catalytic subunit	5271.0	SNV	0/1	0.57	13_17	30	99	False	rs143341805	EXONIC	YES	NM_002912.5	Transcript	protein_coding	synonymous_variant		14/33	NM_002912.5:c.1695T>C	NP_002903.3:p.Ala565%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided		Moebius syndrome	Disease-causing germline mutation(s) in	Aplasia/Hypoplasia of the radius;Facial palsy;Ophthalmoplegia;Talipes equinovarus;Corneal opacity;Visual impairment;Motor delay;Skeletal muscle atrophy;Feeding difficulties in infancy;Autism;Aplasia of the pectoralis major muscle;Abnormality of the voice;Absent hand;Aplasia/Hypoplasia involving the metacarpal bones;Hearing impairment;Open mouth;Reduced number of teeth;Aplasia/Hypoplasia of the thumb;Abnormality of the sense of smell;Abnormality of the ulna;Hypogonadotropic hypogonadism;Micrognathia;Dysphagia;Epicanthus;Cleft palate;Clinodactyly of the 5th finger;High palate;Muscular hypotonia;Death in infancy;Brachydactyly;Aplasia/Hypoplasia of the tongue;Blepharitis;Arthrogryposis multiplex congenita;Breast aplasia;Microdontia;Ptosis;Mask-like facies;Finger syndactyly;Everted lower lip vermilion;Strabismus;Multiple cafe-au-lait spots		0.00139245	212.0	152250.0	0.0	32	0.98	PASS	nfe	0.00235177	160.0	0.00235177	160.0	0.00127623	318.0	249172.0	0.0	57	0.98	PASS	nfe	0.00234821	266.0	0.00234821	266.0	0.0014791	230	0.003	10.0	0.00326	6.0		11.4	0.73129		0	0	0			REV3L	0.0	0.0	0.0	0.0	7.0	-28.0	-5.0	-40.0						0.218	1.0	64.11358702			nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; neoplasm; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			amygdala;uterus;fetal brain;prefrontal cortex;skin;adipose tissue;globus pallidus;	.	DNA-dependent DNA replication;error-prone translesion synthesis;nucleic acid phosphodiester bond hydrolysis	nucleoplasm;nucleolus;zeta DNA polymerase complex	nucleotide binding;DNA binding;DNA-directed DNA polymerase activity;protein binding;3'-5' exonuclease activity;metal ion binding;4 iron, 4 sulfur cluster binding	MAD2L2[22828282];MEF2A[25609649];CCND1[26496610];SLTM[30021884];STK17B[26496610];H3F3A[30021884];HIST1H1A[30021884];HIST1H1B[30021884];HIST1H1C[30021884];
380853	chr10	95263065	G	A	chr10:95263065	CEP55	centrosomal protein 55	5273.0	SNV	0/1	0.71	6_15	21	99	False	rs199894468,COSV65185732,COSV65185835	EXONIC	YES	NM_018131.5	Transcript	protein_coding	missense_variant		3/9	NM_018131.5:c.379G>A	NP_060601.4:p.Val127Ile		1.0					Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly, 236500 (3), Autosomal recessive	Meckel syndrome;Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Talipes;Cataract;Anophthalmia;Situs inversus totalis;Hypertelorism;Microphthalmia;Preaxial hand polydactyly;Accessory spleen;Aplasia/Hypoplasia of the corpus callosum;Hydrocephalus;Pancreatic cysts;Multicystic kidney dysplasia;Aplasia/Hypoplasia of the iris;Urethral atresia;Dandy-Walker malformation;Microcornea;Anencephaly;Optic atrophy;Furrowed tongue;Cryptorchidism;Congenital hepatic fibrosis;Cystic liver disease;Asplenia;Pancreatic fibrosis;Sclerocornea;Ureteral duplication;Microcephaly;Lobar holoprosencephaly;Postaxial hand polydactyly;True hermaphroditism;Bowing of the long bones;Encephalocele;Micrognathia;Male pseudohermaphroditism;Sloping forehead;Abnormal chorioretinal morphology;Aplasia/Hypoplasia of the tongue;Cleft palate;Oligohydramnios;Full cheeks;Postaxial foot polydactyly;Depressed nasal ridge;Low-set, posteriorly rotated ears;Renal dysplasia;Narrow nasal ridge;Talipes equinovarus;Renal cyst;Potter facies;Hypoplasia of the brainstem;Renal agenesis;Pulmonary hypoplasia;Oligohydramnios;Microretrognathia;Renal hypoplasia;Arthrogryposis multiplex congenita;Hydranencephaly;Redundant neck skin;Autosomal recessive inheritance;Single transverse palmar crease;Clinodactyly of the 5th finger;Cerebellar hypoplasia;Cystic hygroma;2-3 toe syndactyly		0.000473174	72.0	152164.0	0.0	32	0.96	PASS	nfe	0.000705675	48.0	0.000705675	48.0	0.000568742	143.0	251432.0	1.0	68	1.0	PASS	amr	0.000867353	30.0	0.000844134	96.0	0.0004759	74	0.002	6.0				0.734	-0.19675	0.054	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CEP55	0.0	0.0	0.02	0.01	-31.0	-2.0	-31.0	-1.0						0.872	0.0	0.0	0.966	0.225	.			testis - seminiferous tubule;tumor;testis - interstitial;trigeminal ganglion;testis;heart;	.	mitotic cytokinesis;nucleus organization;mitotic metaphase plate congression;regulation of phosphatidylinositol 3-kinase signaling;establishment of protein localization;midbody abscission;renal system development;cranial skeletal system development	centrosome;centriole;microtubule organizing center;plasma membrane;membrane;midbody;cleavage furrow;intercellular bridge;Flemming body	protein binding	CCDC120[unassigned1304];RAB3D[21163940];CEP120[26638075];MUM1[25416956];MIA3[25416956];HSF2BP[unassigned1304];PTPN23[25416956];ECSIT[21163940];ZNF48[unassigned1304];CEP128[26638075];GOLGA2[27107012];LGALS4[unassigned1304];SYNCRIP[26496610];TCL1A[25416956;27107012];PCM1[26638075];TFG[25416956;unassigned1304];MYC[21150319];CCHCR1[25416956;unassigned1304];NINL[26638075];CEP55[17853893;25416956];WASHC3[25416956;unassigned1304];TEAD4[21516116;25416956;unassigned1304];MAPK1IP1L[25416956];PPP1R16B[25416956;27107012];OFD1[26638075];CCBE1[25416956;unassigned1304];RBM17[25416956;unassigned1304];PDCD6IP[17853893;20176808;25416956;18940611];CEP135[26638075];ARHGEF15[25416956;26871637;unassigned1304];KSR1[27086506];PLEKHG6[25416956;unassigned1304];VPS37C[17853893;25416956;unassigned1304];SPICE1[26638075];VPS37D[17853893];ANXA11[25416956;unassigned1304;25910212];TEX14[20176808];KIF23[26496610];VPS37B[17853893];TUBG1[17853893];PTBP3[22575643];HAUS1[25416956;27107012];HGS[17853893;unassigned1304];CEP57L1[21516116;25416956];MORF4L2[25416956;unassigned1304];CDC37[unassigned1304];COL8A1[unassigned1304];KIFC3[25416956;unassigned1304];CEP63[26638075];FAM161B[unassigned1304];SSX2IP[25416956;26638075];C1orf216[unassigned1304];VPS28[17853893];KPNB1[26496610];SNRPB[25416956];RBM22[25416956;unassigned1304];KANK2[unassigned1304];POM121[16189514];RALA[26496610];TSG101[16189514;17853893;19549727;20176808;25416956;27107012;unassigned1304];PEF1[25416956;unassigned1304];FBF1[25416956];PIK3R4[30021884];RRBP1[30021884];BAG6[26496610];SDCBP[25416956;unassigned1304];EIF1AD[25416956];CDC45[25416956;unassigned1304];FXR2[25416956];KIAA0753[26638075];TP53BP2[unassigned1304];C1orf109[25416956;unassigned1304];ENKD1[unassigned1304];LRRC23[unassigned1304];DTNB[25416956;unassigned1304];POLM[25416956;unassigned1304];ODF2[26638075];SS18L1[unassigned1304];TMEM132A[26496610];WDYHV1[27107012;unassigned1304];SUPT5H[27107012];FAM90A1[25416956;unassigned1304];SOD1[26496610];GOLGA8DP[25416956;unassigned1304];NEURL4[29426014];SNW1[25416956];MFAP1[25416956;unassigned1304];TACC3[27107012];PIN1[25416956];CEP162[26638075];RCOR3[25416956];SPERT[unassigned1304];CEP89[26638075];
381032	chr4	76734387	G	A	chr4:76734387	USO1	USO1 vesicle transport factor	5282.0	SNV	0/1	0.38	16_10	26	99	False	rs749343905	EXONIC	YES	NM_001290049.2	Transcript	protein_coding	missense_variant		26/26	NM_001290049.2:c.2738G>A	NP_001276978.1:p.Gly913Glu		1.0	Uso1/p115-like vesicle tethering protein, C-terminal,.					.	.	.		1.31487e-05	2.0	152106.0	0.0	32	0.96	PASS	nfe	2.93979e-05	2.0	2.93979e-05	2.0	2.03827e-05	5.0	245306.0	0.0	34	0.74	PASS	amr	8.95202e-05	3.0	1.78856e-05	2.0	0.0000257	4						20.5	2.082386		2	14	16	MutationAssessor_pred,fathmm-MKL_coding_pred	Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	USO1	0.0	0.0	0.0	0.0	-18.0	11.0	26.0	-18.0							0.92	0.0	1.0	1.172	cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			white blood cells;smooth muscle;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	intracellular protein transport;endoplasmic reticulum to Golgi vesicle-mediated transport;Golgi organization;transcytosis;COPII vesicle coating;Golgi vesicle docking;vesicle fusion with Golgi apparatus;membrane fusion	Golgi membrane;fibrillar center;endoplasmic reticulum;Golgi apparatus;Golgi stack;cytosol;ER to Golgi transport vesicle membrane;membrane;transport vesicle;perinuclear region of cytoplasm	RNA binding;protein binding;protein transporter activity;cadherin binding	C1orf94[16189514];RAB1A[22228731];USO1[25416956];CLTC[26496610];GABPB1[16189514];FOXQ1[25609649];GOLGA2[29568061];TGOLN2[29568061];DUSP12[25416956];IKBKG[14743216];GTSE1[26496610];CEP290[26638075];GSTK1[17353931];PDHA1[29128334];PHYKPL[25416956];SEC16A[26496610];GBF1[12634853];ERLIN1[30021884];CDC5L[20467437];XPO7[25416956];GAK[16189514];ERP44[17805346];PTP4A3[17353931];TMEM17[26638075];TRAF3[21903422];AKAP9[25416956];ARF6[17353931];BET1[29568061];
387976	chr1	33360426	AGCTGGTGCAGCTC		chr1:33360426-33360439	TMEM54	transmembrane protein 54	5357.0	deletion	0/1	0.48	12_11	23	99	False	rs527445029	EXONIC	YES	NM_001329722.2	Transcript	protein_coding	frameshift_variant		6/6	NM_001329722.2:c.690_703del	NP_001316651.1:p.Ser231Ter		-1.0						.	.	.		0.00166266	253.0	152166.0	2.0	32	0.97	PASS	nfe	0.0025727	175.0	0.0025727	175.0	0.00166379	418.0	251234.0	0.0	66	1.0	PASS	nfe	0.00260582	296.0	0.00260582	296.0	0.0000965,0.0003151	15,49	0.001	4.0				33.0	4.873452		0	0	0																	0.696	0.16	0.0			.			.	.	biological_process	cellular_component;integral component of membrane	molecular_function	KCNK5[unassigned1304];PEX19[21988832];TIMMDC1[unassigned1304];TMEM52B[unassigned1304];KCNJ8[unassigned1304];CLSTN3[unassigned1304];NRG1[unassigned1304];CD3G[unassigned1304];PVR[unassigned1304];GPR152[unassigned1304];UPK1B[unassigned1304];TSPO2[unassigned1304];ARL13B[unassigned1304];RBBP8[21988832];MS4A14[unassigned1304];FKBP7[unassigned1304];KLRC1[unassigned1304];SLC39A2[unassigned1304];SLC12A7[unassigned1304];
388053	chr19	9921880	G	A	chr19:9921880	FBXL12	F-box and leucine rich repeat protein 12	5361.0	SNV	0/1	0.41	34_24	58	99	False	rs140944467	EXONIC	YES	NM_017703.3	Transcript	protein_coding	missense_variant		3/3	NM_017703.3:c.673C>T	NP_060173.1:p.Arg225Cys		-1.0	.,.,.					.	.	.		0.00128842	196.0	152124.0	0.0	32	0.97	PASS	nfe	0.00195531	133.0	0.00195531	133.0	0.00159422	397.0	249024.0	0.0	48	0.97	PASS	sas	0.00235433	72.0	0.00221306	248.0	0.0014919	232	0.002	5.0				24.8	3.4458	0.091	5	16	21	PolyPhen,Polyphen2_HDIV_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	FBXL12	0.0	0.0	0.0	0.0	1.0	19.0	49.0	-3.0						0.646	0.01	0.0	1.0	1.176	embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; 			pons;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;	.	G2/M transition of mitotic cell cycle;protein polyubiquitination;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;post-translational protein modification;regulation of cell cycle	nucleus;cytosol;SCF ubiquitin ligase complex	ubiquitin-protein transferase activity;protein binding;ubiquitin protein ligase activity	CDKN1C[18660753];RNF32[21163940];HSP90AB1[22939624];DOCK8[25416956];MAST1[21163940];CUL1[18660753];PSEN2[21163940];RBX1[18660753];FXYD3[16169070];CDC37[21163940];LNX1[25416956];GEMIN4[unassigned1304];SKP1[18660753;27705803;unassigned1304];
388472	chr4	3441354	C	T	chr4:3441354	RGS12	regulator of G protein signaling 12	5372.0	SNV	0/1	0.56	17_22	39	99	False	rs148872141,COSV100122575	EXONIC	YES	NM_198229.2	Transcript	protein_coding	synonymous_variant		18/18	NM_198229.2:c.4287C>T	NP_937872.1:p.Pro1429%3D		1.0						.	.	.		0.00109727	167.0	152196.0	0.0	33	0.99	PASS	amr	0.00261677	40.0	0.0014555	99.0	0.0011101	254.0	228808.0	0.0	23	0.61	PASS	nfe	0.00170568	173.0	0.00170568	173.0	0.0009003	140	0.001	3.0				0.528	-0.246008		0	0	0			RGS12	0.0	0.0	0.0	0.0	13.0	-19.0	-38.0	7.0						0.604	0.0	63.353802213			hematopoietic system phenotype; normal phenotype; immune system phenotype; skeleton phenotype; 			ciliary ganglion;cingulate cortex;atrioventricular node;superior cervical ganglion;trigeminal ganglion;parietal lobe;skeletal muscle;globus pallidus;	.	signal transduction;regulation of G protein-coupled receptor signaling pathway;negative regulation of signal transduction;positive regulation of GTPase activity	condensed nuclear chromosome;nucleus;nucleolus;cytoplasm;cytosol;nuclear matrix;cell junction;dendrite;synapse	GTPase activator activity;GTPase regulator activity	BCR[15494376];PM20D2[unassigned1304];MTNR1A[26514267];ITGB3[12606711];
389471	chr11	65715203	C	T	chr11:65715203	TSGA10IP	testis specific 10 interacting protein	5401.0	SNV	0/1	0.52	15_16	31	99	False	rs117506262	EXONIC	YES	NM_152762.2	Transcript	protein_coding	stop_gained		3/8	NM_152762.2:c.907C>T	NP_689975.2:p.Arg303Ter		1.0						.	.	.		0.00222193	338.0	152120.0	4.0	32	0.97	PASS	nfe	0.00310176	211.0	0.00310176	211.0	0.00191019	403.0	210974.0	2.0	57	0.6	PASS	nfe	0.00338965	317.0	0.00338965	317.0	0.0019935	310	0.004	14.0				1.427	-0.097745		0	4	4		BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TSGA10IP	0.01	0.0	0.0	0.0	5.0	-44.0	5.0	9.0									0.0	-0.306	.			.	.	cilium organization	photoreceptor connecting cilium;ciliary basal body	protein binding	PRDM6[unassigned1304];NAB2[unassigned1304];CIB1[unassigned1304];HSF2BP[unassigned1304];RORB[unassigned1304];IKZF3[unassigned1304];CCDC102B[unassigned1304];MBD3L1[unassigned1304];GOLGA2[unassigned1304];LIPE[unassigned1304];CYSRT1[unassigned1304];GOLGA6L9[unassigned1304];TEKT1[unassigned1304];CFL1[30021884];TRIM27[25416956];LZTS1[unassigned1304];LMO2[unassigned1304];AP1B1[unassigned1304];MTUS2[25416956;unassigned1304];TSC1[unassigned1304];LDOC1[unassigned1304];RUNDC3A[unassigned1304];FRS3[unassigned1304];UHMK1[unassigned1304];PRKAR1B[unassigned1304];DYDC1[unassigned1304];STX1A[unassigned1304];ROPN1[unassigned1304];KHDRBS3[unassigned1304];BHLHB9[unassigned1304];MAGED1[unassigned1304];KRT40[25416956];GMCL2[unassigned1304];HMBOX1[unassigned1304];CRACR2B[unassigned1304];CEP70[25416956;unassigned1304];DMAP1[unassigned1304];SMN1[unassigned1304];CDR2[unassigned1304];ZRANB1[unassigned1304];KRTAP12-2[unassigned1304];YES1[unassigned1304];RBPMS[unassigned1304];CCDC13[unassigned1304];CCDC88B[unassigned1304];GOLGA6A[unassigned1304];HOOK2[unassigned1304];PARVG[unassigned1304];TRIP6[unassigned1304];MKRN3[unassigned1304];AMOTL2[unassigned1304];SPERT[unassigned1304];TTC23[unassigned1304];CCDC120[unassigned1304];CALCOCO2[unassigned1304];CCDC125[unassigned1304];AKAP8L[unassigned1304];KRT24[unassigned1304];FHL3[unassigned1304];BICDL2[unassigned1304];MEOX2[unassigned1304];BICD2[unassigned1304];LMNB2[unassigned1304];PSTPIP1[unassigned1304];TRIM5[unassigned1304];RASGEF1B[unassigned1304];TTC23L[unassigned1304];GRIPAP1[unassigned1304];TFIP11[unassigned1304];TRAF2[unassigned1304];MSS51[unassigned1304];AES[unassigned1304];LCA5L[unassigned1304];TBC1D1[unassigned1304];ARHGEF9[unassigned1304];FCHSD2[unassigned1304];TRAF4[unassigned1304];KRT36[unassigned1304];EFHC1[unassigned1304];PICK1[unassigned1304];CEP63[unassigned1304];BIRC7[unassigned1304];KIFC3[unassigned1304];SSX2IP[unassigned1304];MDFI[unassigned1304];GAS8[unassigned1304];KANK2[unassigned1304];TRIM50[unassigned1304];RBM4B[unassigned1304];JAKMIP1[unassigned1304];KRT86[unassigned1304];STX11[unassigned1304];MIPOL1[unassigned1304];CTAG1A[unassigned1304];KRTAP6-2[unassigned1304];FSD2[unassigned1304];C1orf109[unassigned1304];PDLIM7[unassigned1304];CDKN2D[unassigned1304];WWOX[unassigned1304];CAVIN1[unassigned1304];CCDC57[25416956;unassigned1304];CARD9[unassigned1304];MEIS3[unassigned1304];SORBS3[unassigned1304];GOLGA8DP[unassigned1304];MIS18A[unassigned1304];CDR2L[unassigned1304];SPG21[unassigned1304];
389665	chr14	50159928	TCTGT		chr14:50159928-50159932	KLHDC1	kelch domain containing 1	5411.0	deletion	0/1	0.68	10_21	31	99	False		EXONIC	YES	NM_172193.3	Transcript	protein_coding	frameshift_variant		1/13	NM_172193.3:c.20_24del	NP_751943.1:p.Phe7CysfsTer27		1.0						.	.	.						32	0.98											22	0.59																	0	0	0																		0.0	89.709759535			.			.	.	.	cytosol	.	NUDCD3[25036637];NUDC[25036637];
393752	chr10	70406520	C	T	chr10:70406520	TET1	tet methylcytosine dioxygenase 1	5454.0	SNV	0/1	0.52	13_14	27	99	False	rs150543016,COSV104684853	EXONIC	YES	NM_030625.3	Transcript	protein_coding	missense_variant		4/12	NM_030625.3:c.4034C>T	NP_085128.2:p.Pro1345Leu		1.0						.	.	.		0.000710059	108.0	152100.0	0.0	32	0.96	PASS	nfe	0.00120549	82.0	0.00120549	82.0	0.000763504	192.0	251472.0	0.0	100	1.0	PASS	nfe	0.00119552	136.0	0.00119552	136.0	0.0007781	121	0.002	6.0	0.00096	11.0		14.61	1.19318	0.108	1	18	19	PROVEAN_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TET1	0.0	0.0	0.0	0.0	42.0	-37.0	-19.0	31.0						0.247	1.0	0.0	0.576	0.138	embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; neoplasm; pigmentation phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype; skeleton phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			.	.	inner cell mass cell differentiation;5-methylcytosine catabolic process;chromatin organization;protein O-linked glycosylation;positive regulation of cell population proliferation;stem cell population maintenance;positive regulation of histone methylation;positive regulation of transcription by RNA polymerase II;oxidation-reduction process;oxidative demethylation;DNA demethylation;negative regulation of methylation-dependent chromatin silencing	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;iron ion binding;zinc ion binding;methylcytosine dioxygenase activity	SIN3A[23353889];OGT[27705803;23353889];
395869	chr1	8384565		GCCC	chr1:8384564-8384565	SLC45A1	solute carrier family 45 member 1	5485.0	insertion	0/1	0.15	11_2	13	51	False		EXONIC	YES	NM_001379614.1	Transcript	protein_coding	frameshift_variant		2/9	NM_001379614.1:c.175_176insGCCC	NP_001366543.1:p.Ser59CysfsTer14		1.0					Intellectual developmental disorder with neuropsychiatric features, 617532 (3), Autosomal recessive	Autosomal recessive non-syndromic intellectual disability	Disease-causing germline mutation(s) in	Dystonia;Cerebral atrophy;Cerebral visual impairment;Autistic behavior;Intellectual disability, mild;Generalized hypotonia;Hypoplasia of the corpus callosum;Poor speech;Multifocal epileptiform discharges;Large basal ganglia;Stereotypy;Hypsarrhythmia;Microcephaly;Motor delay;Hyperactivity;Absent septum pellucidum;Delayed speech and language development;Intellectual disability, moderate;Chorea;Nasogastric tube feeding;Impulsivity;Sleep disturbance;Epileptic spasm;Short attention span;Global developmental delay;Depressivity;Intellectual disability, severe;Cortical dysplasia;Polymicrogyria;Abnormal facial shape;Generalized-onset seizure;Dyskinesia;Focal-onset seizure;Spasticity;Autosomal recessive inheritance;Smooth philtrum;Generalized hypotonia;Downslanted palpebral fissures;Obsessive-compulsive trait;Depressed nasal bridge;Thin vermilion border;Highly arched eyebrow;Anxiety;Seizure;Intellectual disability, moderate;Global developmental delay;Hypertelorism;Triangular face		6.09079e-05	9.0	147764.0	0.0	30	0.9	AS_VQSR	sas	0.000444444	2.0	1.49889e-05	1.0					78	0.99																	0	0	0																	0.184	0.05	32.137179001			.			pons;cingulate cortex;cerebellum;	.	glucose transmembrane transport	membrane;integral component of membrane	sucrose:proton symporter activity;symporter activity	PPP1CA[22321011];
395884	chr1	8384582	AA		chr1:8384582-8384583	SLC45A1	solute carrier family 45 member 1	5485.0	deletion	0|1	0.14	12_2	14	48	False		EXONIC	YES	NM_001379614.1	Transcript	protein_coding	frameshift_variant		2/9	NM_001379614.1:c.193_194del	NP_001366543.1:p.Asn65HisfsTer6		1.0					Intellectual developmental disorder with neuropsychiatric features, 617532 (3), Autosomal recessive	Autosomal recessive non-syndromic intellectual disability	Disease-causing germline mutation(s) in	Dystonia;Cerebral atrophy;Cerebral visual impairment;Autistic behavior;Intellectual disability, mild;Generalized hypotonia;Hypoplasia of the corpus callosum;Poor speech;Multifocal epileptiform discharges;Large basal ganglia;Stereotypy;Hypsarrhythmia;Microcephaly;Motor delay;Hyperactivity;Absent septum pellucidum;Delayed speech and language development;Intellectual disability, moderate;Chorea;Nasogastric tube feeding;Impulsivity;Sleep disturbance;Epileptic spasm;Short attention span;Global developmental delay;Depressivity;Intellectual disability, severe;Cortical dysplasia;Polymicrogyria;Abnormal facial shape;Generalized-onset seizure;Dyskinesia;Focal-onset seizure;Spasticity;Autosomal recessive inheritance;Smooth philtrum;Generalized hypotonia;Downslanted palpebral fissures;Obsessive-compulsive trait;Depressed nasal bridge;Thin vermilion border;Highly arched eyebrow;Anxiety;Seizure;Intellectual disability, moderate;Global developmental delay;Hypertelorism;Triangular face		6.59544e-06	1.0	151620.0	0.0	24	0.66	AS_VQSR	eas	0.000195084	1.0	0.0	0.0	0.0	0.0	245272.0	0.0	64	0.97	AC0_RF				0.0	0.0											0	0	0			SLC45A1	0.0	0.0	0.0	0.0	-33.0	22.0	24.0	-31.0						0.184	0.05	64.262964465			.			pons;cingulate cortex;cerebellum;	.	glucose transmembrane transport	membrane;integral component of membrane	sucrose:proton symporter activity;symporter activity	PPP1CA[22321011];
395891	chr1	8384585	A	C	chr1:8384585	SLC45A1	solute carrier family 45 member 1	5485.0	SNV	0|1	0.14	12_2	14	48	False	rs1418923052	EXONIC	YES	NM_001379614.1	Transcript	protein_coding	missense_variant		2/9	NM_001379614.1:c.196A>C	NP_001366543.1:p.Thr66Pro		1.0	.,.				Intellectual developmental disorder with neuropsychiatric features, 617532 (3), Autosomal recessive	Autosomal recessive non-syndromic intellectual disability	Disease-causing germline mutation(s) in	Dystonia;Cerebral atrophy;Cerebral visual impairment;Autistic behavior;Intellectual disability, mild;Generalized hypotonia;Hypoplasia of the corpus callosum;Poor speech;Multifocal epileptiform discharges;Large basal ganglia;Stereotypy;Hypsarrhythmia;Microcephaly;Motor delay;Hyperactivity;Absent septum pellucidum;Delayed speech and language development;Intellectual disability, moderate;Chorea;Nasogastric tube feeding;Impulsivity;Sleep disturbance;Epileptic spasm;Short attention span;Global developmental delay;Depressivity;Intellectual disability, severe;Cortical dysplasia;Polymicrogyria;Abnormal facial shape;Generalized-onset seizure;Dyskinesia;Focal-onset seizure;Spasticity;Autosomal recessive inheritance;Smooth philtrum;Generalized hypotonia;Downslanted palpebral fissures;Obsessive-compulsive trait;Depressed nasal bridge;Thin vermilion border;Highly arched eyebrow;Anxiety;Seizure;Intellectual disability, moderate;Global developmental delay;Hypertelorism;Triangular face		0.000302668	38.0	125550.0	0.0	28	0.81	AS_VQSR	amr	0.00072969	9.0	0.000236112	14.0	0.0	0.0	244742.0	0.0	63	0.96	AC0_RF				0.0	0.0								25.4	3.612147	0.438	6	9	15	LRT_pred,M-CAP_pred,MutationTaster_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred	SLC45A1	0.0	0.0	0.0	0.0	48.0	-42.0	-35.0	49.0						0.184	0.05	64.262964465	0.976	1.312	.			pons;cingulate cortex;cerebellum;	.	glucose transmembrane transport	membrane;integral component of membrane	sucrose:proton symporter activity;symporter activity	PPP1CA[22321011];
395899	chr1	8390367	T	C	chr1:8390367	SLC45A1	solute carrier family 45 member 1	5485.0	SNV	0/1	0.44	23_18	41	99	False	rs200094048	EXONIC	YES	NM_001379614.1	Transcript	protein_coding	missense_variant		5/9	NM_001379614.1:c.814T>C	NP_001366543.1:p.Phe272Leu		1.0	.,.	Uncertain_significance	criteria_provided,_single_submitter	Intellectual_developmental_disorder_with_neuropsychiatric_features	Intellectual developmental disorder with neuropsychiatric features, 617532 (3), Autosomal recessive	Autosomal recessive non-syndromic intellectual disability	Disease-causing germline mutation(s) in	Dystonia;Cerebral atrophy;Cerebral visual impairment;Autistic behavior;Intellectual disability, mild;Generalized hypotonia;Hypoplasia of the corpus callosum;Poor speech;Multifocal epileptiform discharges;Large basal ganglia;Stereotypy;Hypsarrhythmia;Microcephaly;Motor delay;Hyperactivity;Absent septum pellucidum;Delayed speech and language development;Intellectual disability, moderate;Chorea;Nasogastric tube feeding;Impulsivity;Sleep disturbance;Epileptic spasm;Short attention span;Global developmental delay;Depressivity;Intellectual disability, severe;Cortical dysplasia;Polymicrogyria;Abnormal facial shape;Generalized-onset seizure;Dyskinesia;Focal-onset seizure;Spasticity;Autosomal recessive inheritance;Smooth philtrum;Generalized hypotonia;Downslanted palpebral fissures;Obsessive-compulsive trait;Depressed nasal bridge;Thin vermilion border;Highly arched eyebrow;Anxiety;Seizure;Intellectual disability, moderate;Global developmental delay;Hypertelorism;Triangular face		0.000111842	17.0	152000.0	0.0	31	0.94	PASS	nfe	0.000235322	16.0	0.000235322	16.0	9.54775e-05	24.0	251368.0	0.0	100	1.0	PASS	nfe	0.000202337	23.0	0.000202337	23.0	0.0000707	11	0.0	1.0				21.9	2.269765	0.428	12	3	15	LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,ClinPred_pred	SLC45A1	0.0	0.0	0.0	0.0	47.0	20.0	8.0	41.0						0.184	0.05	0.0	0.69	1.049	.			pons;cingulate cortex;cerebellum;	.	glucose transmembrane transport	membrane;integral component of membrane	sucrose:proton symporter activity;symporter activity	PPP1CA[22321011];
396635	chr19	42599995	G	A	chr19:42599995	POU2F2	POU class 2 homeobox 2	5501.0	SNV	0/1	0.48	25_23	48	99	False	rs138243265	EXONIC	YES	NM_001207025.3	Transcript	protein_coding	synonymous_variant		9/14	NM_001207025.3:c.750C>T	NP_001193954.1:p.Ser250%3D		-1.0						.	.	.		0.00102503	156.0	152190.0	0.0	32	0.98	PASS	nfe	0.00195548	133.0	0.00195548	133.0	0.00118913	299.0	251444.0	0.0	95	1.0	PASS	nfe	0.00235604	268.0	0.00235604	268.0	0.0014598	227	0.002	7.0				14.46	1.165031		0	0	0			POU2F2	0.0	0.0	0.0	0.0	35.0	14.0	6.0	-11.0						0.185	0.97	97.693475752			growth/size/body region phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; 			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;globus pallidus;	.	mature B cell differentiation;immunoglobulin secretion involved in immune response;transcription by RNA polymerase II;humoral immune response;snRNA transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;cell maturation	nucleus;nucleoplasm;cytoplasm;intracellular membrane-bounded organelle	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein domain specific binding;sequence-specific DNA binding	FOXC2[25609649];FOXS1[25609649];MSX2[unassigned1304];FOXJ2[25609649];TEAD2[25609649];
397071	chr8	52733128	T	G	chr8:52733128	PCMTD1	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1	5510.0	SNV	0/1	0.16	30_8	49	99	False	rs62506083,COSV62119079	EXONIC	YES	NM_052937.4	Transcript	protein_coding	missense_variant		6/6	NM_052937.4:c.857A>C	NP_443169.2:p.Asn286Thr		-1.0	.,.,.					.	.	.		0.0	0.0	152064.0	0.0	33	0.96	AC0				0.0	0.0	0.499884	120555.0	241166.0	139.0	68	1.0	InbreedingCoeff	amr	0.50054	16684.0	0.500156	54624.0	0.0077876	1211	0.108	323.0				21.1	2.15931	0.119	6	14	20	Polyphen2_HDIV_pred,LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	PCMTD1	0.0	0.01	0.0	0.0	-45.0	-26.0	-17.0	-7.0						0.848	0.0		0.998	1.138	.			.	.	protein methylation	cytoplasm;membrane	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity	JUN[25609649];SCHIP1[20195357];
401527	chr14	19553642	A	G	chr14:19553642	POTEG	POTE ankyrin domain family member G	5534.0	SNV	0/1	0.58	11_15	26	99	False	rs57000026,COSV69152662	EXONIC	YES	NM_001005356.3	Transcript	protein_coding	missense_variant		1/11	NM_001005356.3:c.226A>G	NP_001005356.1:p.Ser76Gly		1.0						.	.	.						0	0.0							0.00296192	603.0	203584.0	63.0	100	0.81	PASS	afr	0.00563818	69.0	0.00225297	211.0	0.0020257	315						0.004	-0.931677		0	2	2		SIFT,PolyPhen	POTEG	0.0	0.0	0.0	0.0	28.0	2.0	-42.0	-7.0											.			.	.	.	.	.	.
401726	chr14	65262093	C	T	chr14:65262093	SPTB	spectrin beta, erythrocytic	5539.0	SNV	0/1	0.39	22_14	36	99	False	rs145675502	EXONIC	YES	NM_001024858.4	Transcript	protein_coding	missense_variant		11/35	NM_001024858.4:c.1606G>A	NP_001020029.1:p.Asp536Asn		-1.0	.,.,.,.,.	Uncertain_significance	criteria_provided,_multiple_submitters,_no_conflicts	Elliptocytosis|Elliptocytosis_3|Spherocytosis,_Dominant|not_provided	Anemia, neonatal hemolytic, fatal or near-fatal, 617948 (3); Elliptocytosis-3, 617948 (3); Spherocytosis, type 2, 616649 (3), Autosomal dominant	Hereditary spherocytosis;Hereditary elliptocytosis	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hyperbilirubinemia;Jaundice;Increased red cell osmotic fragility;Autosomal dominant inheritance;Reticulocytosis;Spherocytosis;Splenomegaly;Acanthocytosis;Hemolytic anemia;Fever;Cholelithiasis;Postnatal growth retardation;Hydrops fetalis;Abdominal pain;Reticulocytosis;Frontal bossing;Stomatocytosis;Splenomegaly;Prolonged neonatal jaundice;Neonatal hyperbilirubinemia;Chills;Congenital hemolytic anemia;Elliptocytosis;Increased red cell osmotic fragility;Restrictive cardiomyopathy;Pallor;Abdominal pain;Fever;Hypercoagulability;Growth delay;Reticulocytosis;Extramedullary hematopoiesis;Spherocytosis;Chills;Jaundice;Hepatomegaly;Abdominal distention;Ataxia;Myalgia;Gout;Splenomegaly;Hypofibrinogenemia;Muscle weakness;Maculopapular exanthema;Cholelithiasis;Spontaneous hemolytic crises;Increased red cell osmotic fragility;Increased mean corpuscular hemoglobin concentration;Skin ulcer;Hyperbilirubinemia		0.000683267	104.0	152210.0	1.0	32	0.98	PASS	amr	0.00170068	26.0	0.000735035	50.0	0.000675502	168.0	248704.0	0.0	63	1.0	PASS	amr	0.000954474	33.0	0.000671874	75.0	0.0005530	86	0.003	9.0	0.0029	33.0		29.8	4.244009	0.773	13	8	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	SPTB	0.0	0.0	0.0	0.0	39.0	12.0	-40.0	-38.0						0.144	1.0	0.0	1.0	1.026	reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype; renal/urinary system phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;caudate nucleus;subthalamic nucleus;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;globus pallidus;cerebellum peduncles;cerebellum;	.	MAPK cascade;endoplasmic reticulum to Golgi vesicle-mediated transport;cytoskeleton organization;axon guidance;actin filament capping	Golgi apparatus;cytosol;spectrin;spectrin-associated cytoskeleton;actin cytoskeleton;intrinsic component of the cytoplasmic side of the plasma membrane;protein-containing complex	actin binding;Ras guanyl-nucleotide exchange factor activity;structural constituent of cytoskeleton;protein binding;ankyrin binding;actin filament binding	SPTA1[12820899;20197550];RPL30[30021884];SNAPIN[23414517];STAT1[25814554];SH2D2A[25814554];HUWE1[30021884];TULP3[23414517];SLC4A1[23219802];SPTAN1[12820899];ENO3[23414517];
403219	chr18	14542867	C	T	chr18:14542867	POTEC	POTE ankyrin domain family member C	5596.0	SNV	0|1	0.32	28_13	41	99	False	rs200779556,COSV62801324	EXONIC	YES	NM_001137671.2	Transcript	protein_coding	synonymous_variant		1/11	NM_001137671.2:c.279G>A	NP_001131143.1:p.Thr93%3D		-1.0						.	.	.		0.000139823	21.0	150190.0	0.0	30	0.91	PASS	amr	0.00132031	20.0	0.0	0.0	0.428978	66157.0	154220.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.48365	6508.0	0.442949	31934.0	0.0003537	55	0.004	14.0				0.037	-0.61938		0	0	0			POTEC	0.0	0.0	0.0	0.0	-6.0	25.0	42.0	-16.0							0.16				.			.	.	.	.	.	.
403220	chr18	14542909	G	A	chr18:14542909	POTEC	POTE ankyrin domain family member C	5596.0	SNV	0|1	0.35	29_17	48	99	False	rs370268513,COSV62800580	EXONIC	YES	NM_001137671.2	Transcript	protein_coding	synonymous_variant		1/11	NM_001137671.2:c.237C>T	NP_001131143.1:p.Asn79%3D		-1.0						.	.	.		6.59152e-06	1.0	151710.0	0.0	30	0.91	PASS	nfe	1.47158e-05	1.0	1.47158e-05	1.0	0.480797	104509.0	217366.0	0.0	100	1.0	InbreedingCoeff	eas	0.497462	8625.0	0.482632	48130.0	0.0029903	465	0.047	141.0				0.254	-0.352904		0	0	0			POTEC	0.0	0.0	0.0	0.0	18.0	-2.0	0.0	18.0							0.16				.			.	.	.	.	.	.
403223	chr18	14542979	A	G	chr18:14542979	POTEC	POTE ankyrin domain family member C	5596.0	SNV	0/1	0.43	22_18	42	99	False	rs200806970,COSV62800439	EXONIC	YES	NM_001137671.2	Transcript	protein_coding	missense_variant		1/11	NM_001137671.2:c.167T>C	NP_001131143.1:p.Met56Thr		-1.0	.,.					.	.	.						31	0.9							0.486041	116821.0	240352.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.497938	8933.0	0.487421	53433.0	0.0100062	1556	0.089	270.0				0.001	-1.403316	0.011	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	POTEC	0.0	0.0	0.0	0.0	-7.0	1.0	-17.0	2.0							0.16		0.008	-1.098	.			.	.	.	.	.	.
404377	chr5	176885111	G	A	chr5:176885111	DBN1	drebrin 1	5615.0	SNV	0/1	0.58	10_14	24	99	False	rs142417578	EXONIC	YES	NM_001363541.2	Transcript	protein_coding	missense_variant		13/15	NM_001363541.2:c.1862C>T	NP_001350470.2:p.Pro621Leu		-1.0	.,.,.,.					.	.	.		0.00086097	131.0	152154.0	0.0	32	0.95	PASS	nfe	0.00161712	110.0	0.00161712	110.0	0.000747486	187.0	250172.0	0.0	93	0.99	PASS	nfe	0.00131282	148.0	0.00131282	148.0	0.0009325	145	0.002	6.0				14.77	1.222401	0.02	3	16	19	M-CAP_pred,MetaLR_pred,FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	DBN1	0.0	0.02	0.0	0.0	49.0	30.0	-23.0	7.0						0.546	0.96	0.0	0.003	0.195	growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); craniofacial phenotype; homeostasis/metabolism phenotype; skeleton phenotype; embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; 			superior cervical ganglion;	.	actin filament organization;cell communication by chemical coupling;cell communication by electrical coupling;positive regulation of synaptic plasticity;maintenance of protein location in cell;regulation of neuronal synaptic plasticity;regulation of dendrite development;cytoplasmic sequestering of protein;positive regulation of dendritic spine morphogenesis;neural precursor cell proliferation;positive regulation of receptor localization to synapse	cytoplasm;cytoskeleton;gap junction;postsynaptic density;actin cytoskeleton;dendrite;growth cone;cortical cytoskeleton;actomyosin;postsynaptic membrane;glutamatergic synapse;postsynaptic cytosol	actin binding;protein binding;profilin binding;cadherin binding	ZMYND8[28966017];ZDHHC5[26496610];ARPC5L[26496610];DIXDC1[26496610];NUDT3[21900206];LGALS1[26496610];MPRIP[26496610];HOMER3[26496610];BTRC[21900206];SYNPO[26496610];GTSE1[26496610];ACTN1[26496610];TINF2[21044950];AFAP1[26496610];ACTN4[26496610];PPP1R3C[28330616];KCTD10[26496610];BTK[21080425];ULK2[20562859];SDC4[26496610];FLII[26496610];TWF1[26496610];IQGAP1[26496610];MYO6[26496610];SPTBN1[26496610];RABGAP1L[25814554];JUN[25609649];ACD[21044950];YES1[26496610];JUP[26496610];HOMER1[26496610];ERLIN1[26496610];MYO5A[26496610];CGN[26496610];SNUPN[21900206];ANLN[26496610];MYO5B[26496610];MYO5C[26496610];GRB2[12577067;25814554];CALM1[26496610];ARPC1B[26496610];ARPC1A[26496610];CLTC[26496610];CLTB[26496610];CLTA[26496610];AP2A1[26496610];STON2[26496610];PPP1R18[26496610];CLINT1[26496610];AP2A2[26496610];NIPBL[16169070];MAP1LC3B[21900206];IKBKG[14743216];SPTAN1[26496610];RIPK3[14743216];ANXA2[26496610];SPHK1[25216046];RRAS2[26496610];TERF1[21044950];GAK[26496610];GPRC5A[26496610];INF2[26496610];CTTN[26496610];ITPKA[26496610];POT1[21044950];MAPRE3[22275434];MAPRE1[26496610];ZNF598[16169070];GART[26496610];DBN1[23750010;23979715];CD44[26496610];GRN[25839164];TIMM13[26496610];CXCR4[23926103;20215400];NEXN[26496610];DLST[29128334];AKAP2[26496610];LIMA1[26496610];FLNA[26496610];CD59[26496610];FLNB[26496610];EPS15[26496610];MISP[26496610];RTRAF[26496610];MAP3K3[14743216];SVIL[26496610];GSN[26496610];CAVIN1[26496610];ERBIN[26496610];SORBS2[26496610];AP2B1[26496610];PLEKHA7[28877994];PPP1CA[26496610];NUDT21[21900206];CAPZA2[26496610];SIPA1[26496610];UBE2D3[21900206];PARK7[29128334];ACTG1[26496610];PPP1CB[26496610];PPP1CC[26496610];BASP1[26496610];CFL2[26496610];PALM[26496610];CFL1[26496610];AP2M1[26496610];TMOD1[26496610];CARD10[26496610];TMOD3[26496610];TPM1[26496610];LMO7[26496610];OCRL[25107275];SPECC1L[26496610];FSCN1[26496610];CHMP4B[26496610];XPR1[26496610];ABCG2[26496610];RAI14[26496610];ATP6V1A[26496610];COX15[29128334];CORO1C[26496610];ARHGAP21[26496610];CLTCL1[26496610];PACSIN3[26496610];SPECC1[26496610];ITPRID2[26496610];VCAM1[22623428];PDHA1[29128334];SEC16A[26496610];CAV1[26496610];CYBRD1[26496610];ARPC4[26496610];ARPC5[26496610];SUPT5H[16169070];SSH2[26496610];CORO2A[26496610];MAFA[30021884];ESR1[21182205];ESR2[21182203];AFDN[23750010];DAB2[26496610];CDK5[23979715];ARPC2[26496610];ARPC3[26496610];GNB2[26496610];CDK2[26496610];GNAS[26496610];TAB1[21900206];NF2[26496610];IARS[26496610];LRCH3[24255178];PICALM[26496610];ARHGAP11A[26496610];CPM[26496610];HSP90AB1[26496610];WDR1[26496610];FHL1[21900206];LRRK1[24947832];PTEN[23940795];DUSP19[28330616];ARRB2[17620599];PPP1R9A[26496610];PIK3C2A[26496610];PPP1R9B[26496610];CAPZB[26496610];MYO18A[26496610];FLOT1[26496610];FLOT2[26496610];LRRFIP2[26496610];LRRFIP1[26496610];DNM1L[29128334];TPRN[26496610];ILKAP[28330616];PLEKHG3[26496610];ACTR3[26496610];ACTR2[26496610];PPP1R12A[26496610];DST[26496610];ATP6AP1[26496610];KSR1[27086506];COBL[26496610];DUSP23[21900206];NUMB[26496610];BMP2K[26496610];MYH9[26496610];DSG2[26496610];PPP1R15A[29109149];DCTN5[26496610];RAB1A[26496610];LUZP1[26496610];DCTN2[26496610];UHRF1[26496610];CDC42[26496610];ABLIM1[26496610];PALMD[26496610];FCHO2[26496610];BAK1[21900206];MAPK6[21900206];MEST[21900206];CAMK2G[26496610];NAP1L1[26496610];MYO19[26496610];NAP1L4[26496610];MYO1E[26496610];MYO1B[26496610];MYO1C[26496610];ACTC1[30021884];PPP2R2B[28330616];CDK2AP2[21900206];CEP162[26496610];NECTIN3[23750010];TPT1[21900206];NECTIN2[23750010];PTPN2[28330616];
406137	chr7	150746376	C	T	chr7:150746376	ASIC3	acid sensing ion channel subunit 3	5644.0	SNV	0/1	0.35	13_7	20	99	False	rs762969627	EXONIC	YES	NM_020321.3	Transcript	protein_coding	missense_variant		1/11	NM_020321.3:c.404C>T	NP_064717.1:p.Pro135Leu		1.0	.,.,.					.	.	.		3.28437e-05	5.0	152236.0	0.0	33	0.99	PASS	eas	0.000192308	1.0	4.40956e-05	3.0	3.62086e-05	9.0	248560.0	0.0	61	0.99	PASS	nfe	5.33665e-05	6.0	5.33665e-05	6.0	0.0000386	6	0.0	1.0				3.094	0.029953	0.041	2	17	19	Polyphen2_HVAR_pred,M-CAP_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ASIC3	0.0	0.0	0.0	0.0	6.0	19.0	-42.0	24.0							0.0	0.0	0.001	0.127	homeostasis/metabolism phenotype; cellular phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			.	.	signal transduction;sensory perception;response to heat;response to acidic pH;ion transmembrane transport;sodium ion transmembrane transport;enterobactin transport;sensory perception of sour taste;detection of temperature stimulus involved in sensory perception of pain;detection of mechanical stimulus involved in sensory perception of pain;detection of chemical stimulus involved in sensory perception of pain	plasma membrane;integral component of plasma membrane;perinuclear region of cytoplasm	cation channel activity;sodium channel activity;enterobactin transmembrane transporter activity;acid-sensing ion channel activity	.
407782	chr10	105005898	T	G	chr10:105005898	RPEL1	ribulose-5-phosphate-3-epimerase like 1	5686.0	SNV	0/1	0.43	16_12	28	99	False		EXONIC	YES	NM_001143909.1	Transcript	protein_coding	missense_variant		1/1	NM_001143909.1:c.145T>G	NP_001137381.1:p.Phe49Val		1.0						.	.	.						32	0.97											100	1.0														22.8	2.645884		8	5	13	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred,BayesDel_addAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	M-CAP_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	RPEL1	0.0	0.0	0.0	0.0	1.0	19.0	-1.0	-34.0									0.236	0.348	.			.	.	pentose-phosphate shunt;pentose-phosphate shunt, non-oxidative branch;pentose catabolic process;cellular carbohydrate metabolic process	cytosol	ribulose-phosphate 3-epimerase activity;metal ion binding	.
408099	chr20	62198215	G	A	chr20:62198215	HELZ2	helicase with zinc finger 2	5695.0	SNV	0/1	0.44	19_15	34	99	False	rs1195463213	EXONIC	YES	NM_001037335.2	Transcript	protein_coding	synonymous_variant		7/20	NM_001037335.2:c.2496C>T	NP_001032412.2:p.Val832%3D		-1.0						.	.	.		6.56832e-06	1.0	152246.0	0.0	35	0.98	PASS	nfe	1.46972e-05	1.0	1.46972e-05	1.0	1.25547e-05	3.0	238954.0	0.0	59	0.92	PASS	amr	5.80653e-05	2.0	0.0	0.0								0.095	-0.490588		0	0	0			HELZ2	0.0	0.0	0.03	0.02	-19.0	-2.0	13.0	-18.0							0.0	3.640392945			liver/biliary system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			.	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of lipid metabolic process;positive regulation of transcription by RNA polymerase II;RNA phosphodiester bond hydrolysis	nucleoplasm;cytoplasm;membrane	DNA binding;RNA binding;ATP-dependent RNA helicase activity;ribonuclease activity;protein binding;ATP binding;nuclear receptor transcription coactivator activity;metal ion binding	BCL6[16147992];NUMA1[30021884];
410004	chr17	17910356	C	T	chr17:17910356	DRC3	dynein regulatory complex subunit 3	5746.0	SNV	0/1	0.42	18_14	33	99	False	rs201294810	EXONIC	YES	NM_001130090.1	Transcript	protein_coding	synonymous_variant		13/15	NM_001130090.1:c.1221C>T	NP_001123562.1:p.Asp407%3D		1.0						.	.	.		0.00221699	318.0	143438.0	0.0	31	0.88	PASS	nfe	0.00342225	224.0	0.00342225	224.0	0.00235445	575.0	244218.0	0.0	59	0.97	PASS	nfe	0.00343171	380.0	0.00343171	380.0	0.0022122	344	0.003	9.0				11.27	0.714929		0	0	0			DRC3	0.0	0.03	0.0	0.0	-18.0	-8.0	-2.0	33.0								50.041217679			craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	.	.	cytoplasm;axoneme;motile cilium	.	MFHAS1[29513927];ZNF250[unassigned1304];DDIT4L[unassigned1304];
410961	chr14	91952042	A	G	chr14:91952042	PPP4R3A	protein phosphatase 4 regulatory subunit 3A	5769.0	SNV	0/1	0.55	14_17	31	99	False	rs143007367	EXONIC	YES	NM_001366432.2	Transcript	protein_coding	synonymous_variant		3/15	NM_001366432.2:c.231T>C	NP_001353361.1:p.Asn77%3D		-1.0						.	.	.		5.25755e-05	8.0	152162.0	0.0	32	0.98	PASS	amr	0.000130993	2.0	8.82016e-05	6.0	0.000142177	35.0	246172.0	0.0	43	0.98	PASS	amr	0.000840482	29.0	3.53251e-05	4.0	0.0000900	14	0.002	5.0				11.52	0.745982		0	0	0			PPP4R3A	0.0	0.0	0.0	0.0	32.0	-18.0	-37.0	32.0								99.797734384			.			.	.	.	nucleoplasm;cytoplasm;microtubule organizing center	.	ITSN2[26496610];DOCK5[26496610];USP15[unassigned1312];SLC4A1AP[26496610];LRRK2[24947832];FBXO28[26496610];BUB1B[26496610];PPP4C[17353931;19156129;18715871;16085932;26496610;18614045];PPP4R2[16085932;26496610;18614045;28330616];COBLL1[26496610];DHX38[26496610];HIST1H1A[30021884];HIST1H1B[30021884];HIST1H1C[30021884];SPAG9[unassigned1312];MED1[26496610];COG4[26496610];CASK[21988832];MAPK14[20936779];KNSTRN[26496610];SIRT1[26496610];SCAF4[26496610];CLK1[26496610];NELL1[21723284];NSFL1C[26496610];XAB2[26496610];CDK8[29568061];PTPRA[26496610];HIST3H3[30021884];MCM4[unassigned1312];CACTIN[26496610];NECTIN3[26496610];LRCH3[26496610];MCM2[unassigned1312];
414266	chr22	16287789	C	G	chr22:16287789	POTEH	POTE ankyrin domain family member H	5810.0	SNV	0/1	0.37	19_11	30	99	False	rs201322170,COSV58880052	EXONIC	YES	NM_001136213.1	Transcript	protein_coding	missense_variant		1/11	NM_001136213.1:c.97G>C	NP_001129685.1:p.Ala33Pro		-1.0						.	.	.						0	0.0							0.0467793	9290.0	198592.0	2783.0	100	0.84	PASS	eas	0.0976115	1414.0	0.0338123	3045.0	0.0179224	2787	0.008	24.0				0.091	-0.496527		0	2	2		SIFT,PolyPhen	POTEH	0.0	0.0	0.0	0.0	-11.0	34.0	24.0	-29.0											.			.	.	.	.	.	MME[17342744];
414598	chr10	100159989	C	T	chr10:100159989	PYROXD2	pyridine nucleotide-disulphide oxidoreductase domain 2	5818.0	SNV	0/1	0.46	13_11	24	99	False	rs376182470,COSV65329337	EXONIC	YES	NM_032709.3	Transcript	protein_coding	missense_variant		5/16	NM_032709.3:c.341G>A	NP_116098.2:p.Arg114Gln		-1.0						.	.	.		3.94358e-05	6.0	152146.0	0.0	33	0.97	PASS	amr	6.54622e-05	1.0	2.93988e-05	2.0	8.82344e-05	22.0	249336.0	0.0	38	0.91	PASS	amr	0.000179083	6.0	0.000114527	13.0	0.0001029	16	0.002	5.0				23.7	3.052455	0.428	12	8	20	SIFT,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred	PYROXD2	0.0	0.0	0.0	0.0	-33.0	25.0	25.0	-49.0						0.949	0.0	0.0	0.689	1.026	.			.	.	oxidation-reduction process	.	protein binding;oxidoreductase activity	MYL4[21988832];APPBP2[25416956];CSNK2B[21900206];
421462	chr9	125772713	G	A	chr9:125772713	RABGAP1	RAB GTPase activating protein 1	5883.0	SNV	0/1	0.55	13_16	29	99	False	rs78302239	EXONIC	YES	NM_012197.4	Transcript	protein_coding	synonymous_variant		11/26	NM_012197.4:c.1455G>A	NP_036329.3:p.Arg485%3D		1.0						.	.	.		0.00100549	153.0	152164.0	0.0	32	0.97	PASS	amr	0.00170246	26.0	0.00151422	103.0	0.00110351	277.0	251018.0	1.0	61	0.99	PASS	amr	0.00193978	67.0	0.0013489	153.0	0.0009389	146	0.003	9.0				11.28	0.715871		0	0	0			RABGAP1	0.0	0.0	0.0	0.0	14.0	-34.0	-6.0	38.0						0.265	1.0	32.616318093			.			caudate nucleus;ciliary ganglion;olfactory bulb;temporal lobe;amygdala;prefrontal cortex;cingulate cortex;trigeminal ganglion;superior cervical ganglion;testis;pons;fetal thyroid;thyroid;occipital lobe;fetal brain;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;hypothalamus;medulla oblongata;	.	intracellular protein transport;cell cycle;regulation of GTPase activity;activation of GTPase activity;regulation of cilium assembly	centrosome;cytosol;microtubule associated complex	GTPase activator activity;protein binding;tubulin binding;Rab GTPase binding	ITGB1[12606711];GABARAPL2[20562859];GABARAPL1[20562859];RABGAP1L[20562859];RAB4A[21988832];RABGAP1[20562859];ITGB3[12606711];STAT3[25814554];TWIST1[20195357];GABARAP[20562859];RAB11A[29568061];MAP1LC3B[20562859];MAP1LC3C[20562859];ITGB7[12606711];DISC1[17043677];TP53[22653443];ARF6[17353931];
421969	chr20	3652298	A	G	chr20:3652298	ADAM33	ADAM metallopeptidase domain 33	5894.0	SNV	0/1	0.43	13_10	23	99	False	rs41453444	EXONIC	YES	NM_025220.5	Transcript	protein_coding	missense_variant		16/22	NM_025220.5:c.1835T>C	NP_079496.1:p.Leu612Pro		-1.0	ADAM, cysteine-rich,ADAM, cysteine-rich,ADAM, cysteine-rich,.					.	.	.		0.000243146	37.0	152172.0	0.0	33	0.98	PASS	amr	0.00209397	32.0	7.351e-05	5.0	8.3422e-05	16.0	191796.0	0.0	100	0.59	PASS	amr	0.000282506	8.0	8.67518e-05	7.0	0.0000322	5	0.0	1.0				14.85	1.235945	0.309	3	15	18	SIFT,PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	ADAM33	0.0	0.01	0.0	0.0	24.0	36.0	26.0	-37.0						0.95	0.0	0.0	0.008	1.312	normal phenotype; 			pons;ciliary ganglion;subthalamic nucleus;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;globus pallidus;	.	proteolysis	integral component of membrane	metalloendopeptidase activity;zinc ion binding	STOML3[unassigned1304];HIBADH[unassigned1304];AQP9[unassigned1304];SLC4A1[unassigned1304];CLDN2[unassigned1304];CD3E[unassigned1304];ASGR2[unassigned1304];MUC1[unassigned1304];ATXN7[21078624];CLEC7A[25416956;unassigned1304];SGCB[unassigned1304];CREB3L1[unassigned1304];UBQLN4[16713569];LOC728138[unassigned1304];TMEM14B[unassigned1304];BTNL9[unassigned1304];GGT6[unassigned1304];SLC35E2[unassigned1304];TNFSF14[unassigned1304];SLC30A2[25416956;unassigned1304];OPRM1[unassigned1304];NCR1[unassigned1304];SLC22A23[unassigned1304];EPGN[unassigned1304];FCGR2A[unassigned1304];SPINT1[unassigned1304];TMEM237[unassigned1304];VMA21[unassigned1304];TMEM106C[unassigned1304];PLEKHO1[unassigned1304];
423474	chr2	97820430	C	T	chr2:97820430	ANKRD36	ankyrin repeat domain 36	5937.0	SNV	0|1	0.14	24_4	28	96	False	rs776281681,COSV70742939	EXONIC	YES	NM_001354587.1	Transcript	protein_coding	synonymous_variant		15/76	NM_001354587.1:c.1212C>T	NP_001341516.1:p.Asp404%3D		1.0						.	.	.		0.006774	621.0	91674.0	2.0	26	0.65	PASS	nfe	0.00784482	330.0	0.00784482	330.0	0.000901641	123.0	136418.0	30.0	20	0.51	RF	nfe	0.00201087	108.0	0.00201087	108.0	0.0000064	1	0.002	7.0				0.162	-0.415883		0	0	0			ANKRD36	0.0	0.0	0.0	0.0	13.0	-18.0	-4.0	48.0							0.0				.			.	.	.	.	.	GOLGA2[unassigned1304];HMBOX1[unassigned1304];STAC3[unassigned1304];EVI5L[unassigned1304];IKZF1[unassigned1304];CEP76[unassigned1304];
423475	chr2	97820431	C	A	chr2:97820431	ANKRD36	ankyrin repeat domain 36	5937.0	SNV	0|1	0.14	24_4	28	96	False	rs759218807	EXONIC	YES	NM_001354587.1	Transcript	protein_coding	missense_variant		15/76	NM_001354587.1:c.1213C>A	NP_001341516.1:p.Arg405Ser		1.0	.,.					.	.	.		0.00663816	621.0	93550.0	2.0	27	0.66	PASS	eas	0.00785024	26.0	0.00766971	329.0	0.000938898	128.0	136330.0	31.0	20	0.51	RF	nfe	0.00208971	112.0	0.00208971	112.0	0.0000064	1	0.002	7.0				0.167	-0.41225	0.024	1	16	17	PolyPhen	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36	0.0	0.0	0.0	0.0	2.0	-19.0	2.0	47.0							0.0		0.0	-2.433	.			.	.	.	.	.	GOLGA2[unassigned1304];HMBOX1[unassigned1304];STAC3[unassigned1304];EVI5L[unassigned1304];IKZF1[unassigned1304];CEP76[unassigned1304];
423476	chr2	97820434	T	G	chr2:97820434	ANKRD36	ankyrin repeat domain 36	5937.0	SNV	0|1	0.15	23_4	27	99	False	rs200122064	EXONIC	YES	NM_001354587.1	Transcript	protein_coding	missense_variant		15/76	NM_001354587.1:c.1216T>G	NP_001341516.1:p.Phe406Val		1.0	.,.					.	.	.		0.00649526	625.0	96224.0	2.0	27	0.67	PASS	eas	0.00768776	26.0	0.00746098	327.0	0.00096233	131.0	136128.0	31.0	21	0.51	RF	nfe	0.00211357	113.0	0.00211357	113.0	0.0002508	39	0.003	9.0				0.001	-1.315288	0.012	1	16	17	PolyPhen	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36	0.0	0.0	0.0	0.0	-22.0	9.0	44.0	49.0							0.0		0.0	-1.589	.			.	.	.	.	.	GOLGA2[unassigned1304];HMBOX1[unassigned1304];STAC3[unassigned1304];EVI5L[unassigned1304];IKZF1[unassigned1304];CEP76[unassigned1304];
428063	chr1	11134035	C	T	chr1:11134035	EXOSC10	exosome component 10	5973.0	SNV	0/1	0.46	14_12	26	99	False	rs752855218,COSV58667774	EXONIC	YES	NM_001001998.3	Transcript	protein_coding	missense_variant		19/25	NM_001001998.3:c.2113G>A	NP_001001998.1:p.Val705Ile		-1.0						.	.	.		1.32284e-05	2.0	151190.0	0.0	30	0.92	PASS	nfe	2.94282e-05	2.0	2.94282e-05	2.0	1.98829e-05	5.0	251472.0	0.0	67	1.0	PASS	nfe	3.51642e-05	4.0	3.51642e-05	4.0	0.0000322	5						2.987	0.023346	0.013	1	17	18	MutationTaster_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	EXOSC10	0.0	0.03	0.0	0.02	-13.0	30.0	30.0	-44.0						0.0801	0.0	0.000000000	0.065	-2.523	normal phenotype; 			testis - seminiferous tubule;subthalamic nucleus;testis - interstitial;prefrontal cortex;cingulate cortex;testis;hypothalamus;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;maturation of 5.8S rRNA;nuclear-transcribed mRNA catabolic process;rRNA processing;dosage compensation by inactivation of X chromosome;negative regulation of telomere maintenance via telomerase;nuclear mRNA surveillance;CUT catabolic process;nuclear polyadenylation-dependent rRNA catabolic process;histone mRNA catabolic process;nuclear retention of unspliced pre-mRNA at the site of transcription;RNA phosphodiester bond hydrolysis, exonucleolytic;regulation of telomerase RNA localization to Cajal body	nuclear exosome (RNase complex);exosome (RNase complex);nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol;membrane;transcriptionally active chromatin	nucleotide binding;3'-5'-exoribonuclease activity;RNA binding;exoribonuclease activity;protein binding;telomerase RNA binding	CHPF[15231747];DIS3L[20531386;26496610];HNRNPU[26496610];CIB1[15231747];FBL[29568061];RUVBL2[15231747];MTREX[17412707];RBM7[26496610];NOMO1[15231747];UPF2[15231747];DIS3[15231747;20531386;21255825;23756462];RPS6[29568061];SCRIB[15231747];OCRL[25107275];XRN2[15231747];C1D[17412707];DXO[15231747];DDX5[23143267];RPE[15231747];FOXRED1[15231747];GABARAP[20562859];TTN[23414517];EXOSC7[15231747;11812149;21255825];EXOSC6[21255825];EXOSC5[15231747;11812149;21255825;26496610];EXOSC4[15231747;20531386;21255825;26496610];EXOSC10[15231747;21255825];HIST1H3A[29568061];IFI16[25665578];EXOSC9[12788944;17412707;26496610];EXOSC8[15231747;21255825];EXOSC3[20531389;20531386;21255825];EXOSC2[11719186;21255825;17545563;16396833;26496610];EXOSC1[11812149;21255825;26496610;25043052];JUN[25609649];NPM1[26496610];PTGES2[15231747];USP21[15231747];CDC5L[20467437];SSRP1[15231747];RRP1B[20926688];ESR1[21182205];ESR2[21182203];LSM2[15231747];LSM8[15231747];MFSD14B[15231747];EIF3M[15231747];SNW1[20467437];SP1[20195357];SKIV2L[15231747];B9D1[15231747];HDGF[21907836];MNDA[25665578];TARDBP[15231747];MAP3K14[14743216];MPHOSPH6[15231747;17412707;16396833];FERMT3[15231747];
428278	chr19	17627068	C	G	chr19:17627068	PGLS	6-phosphogluconolactonase	5982.0	SNV	0/1	0.52	15_16	31	99	False	rs45597532	EXONIC	YES	NM_012088.3	Transcript	protein_coding	missense_variant		2/5	NM_012088.3:c.375C>G	NP_036220.1:p.Asp125Glu		1.0	Glucosamine/galactosamine-6-phosphate isomerase&6-phosphogluconolactonase, DevB-type&6-phosphogluconolactonase, DevB-type,Glucosamine/galactosamine-6-phosphate isomerase&6-phosphogluconolactonase, DevB-type&6-phosphogluconolactonase, DevB-type,Glucosamine/galactosamine-6-phosphate isomerase&6-phosphogluconolactonase, DevB-type&6-phosphogluconolactonase, DevB-type					.	.	.		0.00123489	188.0	152240.0	0.0	32	0.97	PASS	nfe	0.00205737	140.0	0.00205737	140.0	0.00132938	333.0	250492.0	0.0	59	0.98	PASS	nfe	0.00234418	265.0	0.00234418	265.0	0.0013955	217	0.001	4.0				22.6	2.54309	0.407	9	12	21	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	PGLS	0.0	0.0	0.0	0.0	-14.0	22.0	-48.0	21.0							0.04		0.988	0.077	.			lung;thyroid;liver;whole blood;heart;	Pentose phosphate pathway	carbohydrate metabolic process;pentose-phosphate shunt;pentose-phosphate shunt, oxidative branch	cytosol;extracellular exosome	protein binding;6-phosphogluconolactonase activity	KSR1[27086506];TERF2IP[21044950];POT1[21044950];DDIT4L[unassigned1304];BLMH[unassigned1304];TERF1[21044950];GLYR1[unassigned1304];
428352	chr8	31012237	C	G	chr8:31012237	WRN	Werner syndrome RecQ like helicase	5987.0	SNV	0/1	0.61	13_20	33	99	False	rs78488552,CM1512768,COSV99988182	EXONIC	YES	NM_000553.6	Transcript	protein_coding	missense_variant		32/35	NM_000553.6:c.3785C>G	NP_000544.2:p.Thr1262Arg		1.0	Helicase Helix-turn-helix domain	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Werner_syndrome|not_specified|not_provided	Werner syndrome, 277700 (3), Autosomal recessive	Werner syndrome	Disease-causing germline mutation(s) in	Meningioma;Progeroid facial appearance;Scleroderma;Convex nasal ridge;Osteoporosis;Short stature;Abnormal hair morphology;Diabetes mellitus;Osteosarcoma;Retinal degeneration;Premature arteriosclerosis;Hypogonadism;Cataract;Subcutaneous calcification;Autosomal recessive inheritance;Slender build;Neoplasm of the small intestine;Chondrocalcinosis;Congestive heart failure;Hyperkeratosis;Squamous cell carcinoma;Gastrointestinal carcinoma;Telangiectasia of the skin;Sparse scalp hair;Spontaneous abortion;Pulmonary artery stenosis;Type II diabetes mellitus;Osteoporosis;Convex nasal ridge;Atherosclerosis;Decreased fertility;Small hand;Neoplasm of the lung;Aplasia/Hypoplasia of the testes;Laryngomalacia;White forelock;Skeletal muscle atrophy;Pili torti;Short stature;Renal neoplasm;Rocker bottom foot;Increased bone mineral density;Cataract;Lack of skin elasticity;Breast carcinoma;Abnormality of the cerebral vasculature;Meningioma;Abnormal hair whorl;Hypertension;Aplasia/Hypoplasia of the skin;Acral lentiginous melanoma;Hypogonadism;Thyroid carcinoma;Abnormality of retinal pigmentation;Secondary amenorrhea;Premature graying of hair;Subcutaneous calcification;Insulin resistance;Myocardial infarction;Sarcoma;Joint stiffness;Lipoatrophy;Ovarian neoplasm;Skin ulcer;Abnormality of the voice;Abnormality of the thorax;Neoplasm of the oral cavity;Narrow face	24728327	0.00273461	416.0	152124.0	3.0	33	0.97	PASS	nfe	0.00482325	328.0	0.00482325	328.0	0.00272926	686.0	251350.0	6.0	63	1.0	PASS	nfe	0.00525186	597.0	0.00525186	597.0	0.0030096	468	0.004	13.0	0.00368	42.0		25.2	3.556451	0.422	12	9	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-XF_coding_pred	WRN	0.0	0.0	0.0	0.0	-13.0	23.0	34.0	40.0						0.988	0.0	0.000000000	0.485	1.026	neoplasm; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype; 			skeletal muscle;	.	telomere maintenance;double-strand break repair via homologous recombination;DNA synthesis involved in DNA repair;replicative cell aging;DNA metabolic process;DNA replication;DNA repair;base-excision repair;double-strand break repair;DNA recombination;cellular response to DNA damage stimulus;response to oxidative stress;brain development;aging;cell aging;determination of adult lifespan;cellular response to starvation;response to UV-C;multicellular organism aging;replication fork processing;DNA duplex unwinding;regulation of growth rate;regulation of apoptotic process;G-quadruplex DNA unwinding;positive regulation of hydrolase activity;telomeric D-loop disassembly;cellular response to gamma radiation;nucleic acid phosphodiester bond hydrolysis;t-circle formation;positive regulation of strand invasion;protein localization to nucleolus	chromosome, telomeric region;nucleus;nucleoplasm;replication fork;DNA replication factor A complex;chromosome;nucleolus;cytoplasm;centrosome;nuclear speck;site of double-strand break;neuron projection	magnesium ion binding;four-way junction DNA binding;Y-form DNA binding;bubble DNA binding;DNA binding;DNA helicase activity;chromatin binding;ATP-dependent DNA helicase activity;helicase activity;exonuclease activity;protein binding;ATP binding;3'-5' exonuclease activity;four-way junction helicase activity;ATPase activity;manganese ion binding;MutLalpha complex binding;protein homodimerization activity;3'-5' DNA helicase activity;ATP-dependent 3'-5' DNA helicase activity;protein-containing complex binding;G-quadruplex DNA binding;forked DNA-dependent helicase activity;telomeric D-loop binding;telomeric G-quadruplex DNA binding;3'-flap-structured DNA binding;8-hydroxy-2'-deoxyguanosine DNA binding	VCP[15037256];BLM[11919194];FEN1[11598021;14688284;14657243];WDR48[19615732];ARL3[27173435;unassigned1312];SUV39H1[25931448];BRCA1[29656893];WRN[10783163];UBC[18588880];NLRP2[15733840];E2F3[22157815];POLL[27173435;unassigned1312];CTNNBL1[30021884];TMPO[25931448];XRCC6[10783163;14734561;11328876;26496610];CREBBP[18203716];SUPT16H[unassigned1312];CBX5[25931448];PARP1[14734561;14596914];XRCC5[10783163;14734561;11328876;21679440;26496610];H2AFX[15733840;20802463];TINF2[26496610];RPA1[10373438;15965237;15735006;24126761];RPA2[20802463;24126761];TERF2[12181313];SIRT1[19343720;18203716];RAD52[12750383];RAD51[18562274];RPA3[24126761;unassigned1312];TP53[11427532;15735006];
428719	chr3	16926540	T		chr3:16926540	PLCL2	phospholipase C like 2	5995.0	deletion	1|1	1.0	0_17	17	51	False	rs587725102,COSV67620418	EXONIC	YES	NM_001144382.2	Transcript	protein_coding	coding_sequence_variant	1/8		NM_001144382.2:c.5+1del			1.0						.	.	.						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0000064,0.0043279,0.0498444	1,673,7751	0.029	90.0				15.42	1.344508		0	0	0																		1.0				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skin;cingulate cortex;cerebellum;occipital lobe;fetal brain;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	B cell proliferation involved in immune response;B-1a B cell differentiation;lipid metabolic process;gamma-aminobutyric acid signaling pathway;regulation of synaptic transmission, GABAergic;inositol trisphosphate biosynthetic process;regulation of peptidyl-serine phosphorylation;intracellular signal transduction;negative regulation of B cell receptor signaling pathway;negative regulation of cold-induced thermogenesis;positive regulation of receptor binding	cytoplasm	phosphatidylinositol phospholipase C activity;GABA receptor binding;inositol 1,4,5 trisphosphate binding	SLC35F5[unassigned1312];SHOC2[unassigned1312];DSCAML1[12421765];PPP1CA[15231748];
428720	chr3	16926544	T	G	chr3:16926544	PLCL2	phospholipase C like 2	5995.0	SNV	1|1	1.0	0_18	18	54	False	rs368284573,COSV67620674	EXONIC	YES	NM_001144382.2	Transcript	protein_coding	splice_donor_5th_base_variant,missense_variant		2/9	NM_001144382.2:c.9T>G	NP_001137854.1:p.Asp3Glu		1.0						.	.	.						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0222502,0.0000257	3460,4						16.58	1.554116		0	2	2		SIFT,PolyPhen																1.0				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skin;cingulate cortex;cerebellum;occipital lobe;fetal brain;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	B cell proliferation involved in immune response;B-1a B cell differentiation;lipid metabolic process;gamma-aminobutyric acid signaling pathway;regulation of synaptic transmission, GABAergic;inositol trisphosphate biosynthetic process;regulation of peptidyl-serine phosphorylation;intracellular signal transduction;negative regulation of B cell receptor signaling pathway;negative regulation of cold-induced thermogenesis;positive regulation of receptor binding	cytoplasm	phosphatidylinositol phospholipase C activity;GABA receptor binding;inositol 1,4,5 trisphosphate binding	SLC35F5[unassigned1312];SHOC2[unassigned1312];DSCAML1[12421765];PPP1CA[15231748];
428721	chr3	16926549	T		chr3:16926549	PLCL2	phospholipase C like 2	5995.0	deletion	1|1	1.0	0_17	17	51	False	rs587740988	SPLICING	YES	NM_001144382.2	Transcript	protein_coding	frameshift_variant,splice_region_variant,splice_polypyrimidine_tract_variant		2/9	NM_001144382.2:c.14del	NP_001137854.1:p.Val5GlyfsTer24		1.0						.	.	.						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0000450,0.0033890,0.0469506	7,527,7301	0.051	160.0				15.83	1.4217		0	0	0																		1.0				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skin;cingulate cortex;cerebellum;occipital lobe;fetal brain;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	B cell proliferation involved in immune response;B-1a B cell differentiation;lipid metabolic process;gamma-aminobutyric acid signaling pathway;regulation of synaptic transmission, GABAergic;inositol trisphosphate biosynthetic process;regulation of peptidyl-serine phosphorylation;intracellular signal transduction;negative regulation of B cell receptor signaling pathway;negative regulation of cold-induced thermogenesis;positive regulation of receptor binding	cytoplasm	phosphatidylinositol phospholipase C activity;GABA receptor binding;inositol 1,4,5 trisphosphate binding	SLC35F5[unassigned1312];SHOC2[unassigned1312];DSCAML1[12421765];PPP1CA[15231748];
428722	chr3	16926552	G		chr3:16926552	PLCL2	phospholipase C like 2	5995.0	deletion	1|1	1.0	0_17	17	51	False	rs587730619	EXONIC	YES	NM_001144382.2	Transcript	protein_coding	coding_sequence_variant	2/8		NM_001144382.2:c.16+1del			1.0						.	.	.						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0357097	5553						16.62	1.561375		0	0	0																		1.0				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skin;cingulate cortex;cerebellum;occipital lobe;fetal brain;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	B cell proliferation involved in immune response;B-1a B cell differentiation;lipid metabolic process;gamma-aminobutyric acid signaling pathway;regulation of synaptic transmission, GABAergic;inositol trisphosphate biosynthetic process;regulation of peptidyl-serine phosphorylation;intracellular signal transduction;negative regulation of B cell receptor signaling pathway;negative regulation of cold-induced thermogenesis;positive regulation of receptor binding	cytoplasm	phosphatidylinositol phospholipase C activity;GABA receptor binding;inositol 1,4,5 trisphosphate binding	SLC35F5[unassigned1312];SHOC2[unassigned1312];DSCAML1[12421765];PPP1CA[15231748];
428723	chr3	16926553	T	C	chr3:16926553	PLCL2	phospholipase C like 2	5995.0	SNV	1|1	1.0	0_17	17	51	False	rs549925423	EXONIC	YES	NM_001144382.2	Transcript	protein_coding	coding_sequence_variant	2/8		NM_001144382.2:c.17-1T>C			1.0						.	.	.						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0357740	5563						16.22	1.49122		0	0	0														-7.837	7.754	-0.083		1.0				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skin;cingulate cortex;cerebellum;occipital lobe;fetal brain;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	B cell proliferation involved in immune response;B-1a B cell differentiation;lipid metabolic process;gamma-aminobutyric acid signaling pathway;regulation of synaptic transmission, GABAergic;inositol trisphosphate biosynthetic process;regulation of peptidyl-serine phosphorylation;intracellular signal transduction;negative regulation of B cell receptor signaling pathway;negative regulation of cold-induced thermogenesis;positive regulation of receptor binding	cytoplasm	phosphatidylinositol phospholipase C activity;GABA receptor binding;inositol 1,4,5 trisphosphate binding	SLC35F5[unassigned1312];SHOC2[unassigned1312];DSCAML1[12421765];PPP1CA[15231748];
428724	chr3	16926557	T	G	chr3:16926557	PLCL2	phospholipase C like 2	5995.0	SNV	1|1	1.0	0_18	18	54	False	rs372006934	EXONIC	YES	NM_001144382.2	Transcript	protein_coding	missense_variant,splice_donor_region_variant		3/9	NM_001144382.2:c.20T>G	NP_001137854.1:p.Val7Gly		1.0						.	.	.						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0000322,0.0000064,0.0000064,0.0510726,0.0002058	5,1,1,7942,32						15.42	1.344473		0	2	2		SIFT,PolyPhen																1.0				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skin;cingulate cortex;cerebellum;occipital lobe;fetal brain;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	B cell proliferation involved in immune response;B-1a B cell differentiation;lipid metabolic process;gamma-aminobutyric acid signaling pathway;regulation of synaptic transmission, GABAergic;inositol trisphosphate biosynthetic process;regulation of peptidyl-serine phosphorylation;intracellular signal transduction;negative regulation of B cell receptor signaling pathway;negative regulation of cold-induced thermogenesis;positive regulation of receptor binding	cytoplasm	phosphatidylinositol phospholipase C activity;GABA receptor binding;inositol 1,4,5 trisphosphate binding	SLC35F5[unassigned1312];SHOC2[unassigned1312];DSCAML1[12421765];PPP1CA[15231748];
429375	chr17	21318698	C	T	chr17:21318698	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0/1	0.29	77_31	108	99	False	rs1657738,COSV59162518	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.44C>T	NP_066292.2:p.Ser15Leu		1.0	Potassium channel, inwardly rectifying, Kir, N-terminal,Potassium channel, inwardly rectifying, Kir, N-terminal					.	.	.		6.56659e-05	10.0	152286.0	0.0	68	1.0	PASS	sas	0.000206697	1.0	7.34711e-05	5.0	0.499594	121776.0	243750.0	1.0	100	1.0	InbreedingCoeff	amr	0.499853	17018.0	0.499719	55097.0	0.0317162	4932	0.153	444.0	0.49507	4716.0		23.1	2.799047	0.206	5	14	19	SIFT,LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	5.0	-11.0	-6.0	22.0						0.0599	0.0	74.840780568	0.359	1.021	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429376	chr17	21318770	G	A	chr17:21318770	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0|1	0.18	88_19	107	99	False	rs3752033,COSV59162676	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.116G>A	NP_066292.2:p.Arg39Gln		1.0	Potassium channel, inwardly rectifying, Kir, N-terminal,Potassium channel, inwardly rectifying, Kir, N-terminal					.	.	.		0.000132317	20.0	151152.0	0.0	50	0.98	PASS,PASS	afr,eas	0.00033859	14.0	2.96402e-05	2.0	0.293368	48452.0	165158.0	0.0	100	1.0	InbreedingCoeff	eas	0.478866	6911.0	0.26834	19555.0	0.0247582	3850	0.108	321.0	0.34086	3247.0		23.8	3.112377	0.338	4	14	18	MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	2.0	7.0	6.0	-11.0						0.0599	0.0	6.586176324	0.972	1.17	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429377	chr17	21318773	G	A	chr17:21318773	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0|1	0.18	86_19	105	99	False	rs3752034,COSV59162687	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.119G>A	NP_066292.2:p.Arg40His		1.0	Potassium channel, inwardly rectifying, Kir, N-terminal,Potassium channel, inwardly rectifying, Kir, N-terminal					.	.	.		7.9385e-05	12.0	151162.0	0.0	50	0.97	PASS,PASS	sas,eas	0.000209996	1.0	2.96454e-05	2.0	0.293869	48968.0	166632.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.483084	7111.0	0.268857	19783.0	0.0257485	4004	0.094	280.0	0.33918	3231.0		23.3	2.883065	0.269	4	14	18	MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	4.0	-13.0	3.0	-19.0						0.0599	0.0	40.547457460	0.976	1.17	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429379	chr17	21318821	A	C	chr17:21318821	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0/1	0.21	70_19	89	99	False	rs1714865,COSV59164775	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.167A>C	NP_066292.2:p.Glu56Ala		1.0	.,.					.	.	.		0.0	0.0	152310.0	0.0	70	1.0	AC0				0.0	0.0	0.25576	38500.0	150532.0	0.0	100	1.0	InbreedingCoeff	afr	0.341322	3233.0	0.312716	21129.0	0.0076011	1182	0.083	251.0	0.27399	2610.0		22.0	2.295298	0.283	6	12	18	LRT_pred,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	-44.0	2.0	-16.0	-45.0						0.0599	0.0	34.893533698	0.997	1.306	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429380	chr17	21318897	G	C	chr17:21318897	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0/1	0.29	68_28	97	99	False	rs1657739,COSV59166881	EXONIC	YES	NM_021012.5	Transcript	protein_coding	synonymous_variant		3/3	NM_021012.5:c.243G>C	NP_066292.2:p.Arg81%3D		1.0						.	.	.		5.25472e-05	8.0	152244.0	0.0	68	1.0	PASS	eas	0.000384172	2.0	2.93902e-05	2.0	0.49992	124803.0	249646.0	0.0	100	1.0	InbreedingCoeff_RF	afr	0.5	8052.0	0.499947	56460.0	0.0286424	4454	0.137	402.0	0.49916	4755.0		11.19	0.704788		0	0	0			KCNJ12	0.0	0.0	0.0	0.0	4.0	-1.0	3.0	-1.0						0.0599	0.0	6.586176324			.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429387	chr17	21319007	G	A	chr17:21319007	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0/1	0.33	69_35	105	99	False	rs1657740,COSV59162539	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.353G>A	NP_066292.2:p.Arg118Gln		1.0	.,.					.	.	.		3.94021e-05	6.0	152276.0	0.0	54	1.0	PASS	amr	6.53851e-05	1.0	5.87769e-05	4.0	0.499828	124644.0	249374.0	0.0	100	1.0	InbreedingCoeff	sas	0.499967	15237.0	0.499858	56434.0	0.0302436	4703	0.158	460.0	0.49927	4756.0		11.93	0.796593	0.088	1	17	18	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	KCNJ12	0.0	0.0	0.0	0.0	2.0	26.0	2.0	-25.0						0.0599	0.0	0.235039220	0.73	1.169	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429392	chr17	21319121	C	T	chr17:21319121	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0/1	0.44	45_35	80	99	False	rs1714864,COSV59162867	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.467C>T	NP_066292.2:p.Pro156Leu		1.0	.,.					.	.	.		0.0	0.0	152296.0	0.0	57	1.0	AC0				0.0	0.0	0.499868	124541.0	249148.0	0.0	100	1.0	InbreedingCoeff	eas	0.5	9177.0	0.499965	56577.0	0.0290153	4512	0.185	563.0	0.49937	4757.0		28.8	4.119805	0.632	14	6	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	-43.0	-4.0	-17.0	1.0						0.0599	0.0	26.103281974	0.951	1.021	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429395	chr17	21319230	G	C	chr17:21319230	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0/1	0.38	58_35	93	99	False	rs1657742,COSV59162549	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.576G>C	NP_066292.2:p.Gln192His		1.0	.,.					.	.	.		1.9734e-05	3.0	152022.0	0.0	44	0.99	PASS,InbreedingCoeff	amr,amr	6.54536e-05	1.0	1.46968e-05	1.0	0.499264	120747.0	241850.0	0.0	100	1.0	InbreedingCoeff	eas	0.49989	9127.0	0.499163	54253.0	0.0268160	4170	0.115	324.0	0.49822	4746.0		23.1	2.802329	0.262	11	7	18	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	15.0	-26.0	-24.0	43.0						0.0599	0.0	93.824270006	1.0	1.17	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429399	chr17	21319302	T	C	chr17:21319302	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0/1	0.72	32_84	116	99	False	rs1657743,COSV59168745	EXONIC	YES	NM_021012.5	Transcript	protein_coding	synonymous_variant		3/3	NM_021012.5:c.648T>C	NP_066292.2:p.Gly216%3D		1.0						.	.	.		0.000193372	26.0	134456.0	0.0	37	0.96	AS_VQSR	eas	0.00167304	7.0	9.93049e-05	6.0	0.500004	125645.0	251288.0	1.0	100	1.0	InbreedingCoeff	nfe	0.500009	56813.0	0.500009	56813.0	0.0300185	4668	0.146	432.0	0.5	4763.0		11.92	0.795386		0	0	0			KCNJ12	0.0	0.0	0.0	0.0	46.0	-1.0	33.0	-6.0						0.0599	0.0	11.487689946			.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429400	chr17	21319311	C	T	chr17:21319311	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0/1	0.37	74_43	117	99	False	rs72846668,COSV59163274	EXONIC	YES	NM_021012.5	Transcript	protein_coding	synonymous_variant		3/3	NM_021012.5:c.657C>T	NP_066292.2:p.Arg219%3D		1.0						.	.	.		0.000638308	78.0	122198.0	0.0	43	0.95	AS_VQSR,InbreedingCoeff	eas,nfe	0.00391032	15.0	0.000506476	28.0	0.483777	54900.0	113482.0	0.0	100	1.0	InbreedingCoeff	sas	0.48746	6103.0	0.483951	26415.0	0.0077104	1199	0.123	355.0	0.34075	3246.0		11.58	0.753438		0	0	0			KCNJ12	0.0	0.0	0.0	0.0	-10.0	37.0	-2.0	-38.0						0.0599	0.0	29.139785081			.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429402	chr17	21319399	A	G	chr17:21319399	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0/1	0.23	78_23	101	99	False	rs4985866,COSV59162501	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.745A>G	NP_066292.2:p.Ile249Val		1.0	.,.					.	.	.		3.94032e-05	6.0	152272.0	0.0	44	0.98	PASS,InbreedingCoeff	eas,eas	0.000192308	1.0	7.34732e-05	5.0	0.321072	56187.0	174998.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.484698	7697.0	0.279553	21473.0	0.0137296	2135	0.063	192.0	0.34117	3250.0		17.61	1.718702	0.115	5	13	18	LRT_pred,FATHMM_pred,PrimateAI_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	0.0	27.0	-1.0	11.0						0.0599	0.0	62.390150711	0.998	1.311	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429408	chr17	21319473	G	A	chr17:21319473	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0/1	0.38	54_33	87	99	False	rs1657744,COSV59168799	EXONIC	YES	NM_021012.5	Transcript	protein_coding	synonymous_variant		3/3	NM_021012.5:c.819G>A	NP_066292.2:p.Glu273%3D		1.0						.	.	.		1.31351e-05	2.0	152264.0	0.0	60	1.0	PASS	afr	4.82556e-05	2.0	0.0	0.0	0.499868	125299.0	250664.0	0.0	100	1.0	InbreedingCoeff	sas	0.499967	15298.0	0.499965	56805.0	0.0336519	5233	0.167	527.0	0.49979	4761.0		12.29	0.843956		0	0	0			KCNJ12	0.0	0.0	0.0	0.0	15.0	1.0	-27.0	1.0						0.0599	0.0				.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429420	chr17	21319767	C	T	chr17:21319767	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	1/2	0.37	35_39_43	117	99	False	rs1612176,COSV59162626,COSV59163167	EXONIC	YES	NM_021012.5	Transcript	protein_coding	synonymous_variant		3/3	NM_021012.5:c.1113C>T	NP_066292.2:p.Ser371%3D		1.0						.	.	.		1.31313e-05	2.0	152308.0	0.0	68	1.0	PASS	sas	0.000206697	1.0	0.0	0.0	0.471801	116179.0	246246.0	0.0	100	1.0	InbreedingCoeff	amr	0.486025	16624.0	0.475152	53256.0	0.2347464	36504	0.075	225.0	0.479	4563.0		7.46	0.319315		0	0	0			KCNJ12	0.0	0.0	0.0	0.0	22.0	-39.0	-27.0	-39.0						0.0599	0.0				.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429421	chr17	21319785	C	T	chr17:21319785	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0/1	0.38	68_42	110	99	False	rs1657745,COSV59168851	EXONIC	YES	NM_021012.5	Transcript	protein_coding	synonymous_variant		3/3	NM_021012.5:c.1131C>T	NP_066292.2:p.Tyr377%3D		1.0						.	.	.		0.000111631	17.0	152288.0	0.0	73	1.0	PASS	afr	0.000265278	11.0	4.40813e-05	3.0	0.499992	125441.0	250886.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56746.0	0.5	56746.0	0.0336454	5232	0.146	438.0	0.49685	4733.0		3.68	0.065319		0	0	0			KCNJ12	0.0	0.0	0.0	0.0	24.0	4.0	-45.0	8.0						0.0599	0.0				.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429425	chr17	21319860	C	T	chr17:21319860	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	1/2	0.41	28_41_32	101	99	False	rs2917720,COSV59162637,COSV59165835	EXONIC	YES	NM_021012.5	Transcript	protein_coding	synonymous_variant		3/3	NM_021012.5:c.1206C>T	NP_066292.2:p.Asp402%3D		1.0						.	.	.		3.28278e-05	5.0	152310.0	0.0	65	1.0	PASS	eas	0.000384172	2.0	1.46933e-05	1.0	0.450363	107635.0	238996.0	0.0	76	0.99	InbreedingCoeff	amr	0.474325	15943.0	0.447614	48200.0	0.2643855	41113	0.068	199.0	0.40657	3873.0		1.022	-0.147545		0	0	0			KCNJ12	0.0	0.0	0.0	0.0	16.0	36.0	20.0	15.0						0.0599	0.0				.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
429428	chr17	21319943	A	G	chr17:21319943	KCNJ12	potassium voltage-gated channel subfamily J member 12	6008.0	SNV	0/1	0.41	70_48	118	99	False	rs5021699,COSV59162965	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.1289A>G	NP_066292.2:p.Glu430Gly		1.0	.,.					.	.	.		1.31309e-05	2.0	152312.0	0.0	66	1.0	PASS	nfe	2.93867e-05	2.0	2.93867e-05	2.0	0.498178	116764.0	234382.0	1.0	37	0.92	InbreedingCoeff	amr	0.49931	16638.0	0.49808	52152.0	0.0301986	4696	0.09	233.0	0.48887	4657.0		27.1	3.928835	0.314	12	8	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	0.0	-47.0	0.0	-4.0						0.0599	0.0		0.99	1.201	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];
430098	chr17	11899000	AA		chr17:11899000-11899001	ZNF18	zinc finger protein 18	6024.0	deletion	0/1	0.19	11_3	16	42	False	rs1196560442	SPLICING	YES	NM_144680.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/8		NM_144680.4:c.-204-5_-204-4del			-1.0						.	.	.		0.000170092	12.0	70550.0	0.0	31	0.88	PASS	nfe	0.000114325	4.0	0.000114325	4.0					0	0.0																	0	0	0			ZNF18	0.0	0.06	0.0	0.0	38.0	-3.0	-3.0	-40.0							0.0				.			testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;testis;	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding	TTC32[25416956];CPNE7[unassigned1304];CCNC[21516116;25416956];ZNF446[unassigned1304];
430585	chr2	29416264	A	G	chr2:29416264	ALK	ALK receptor tyrosine kinase	6038.0	SNV	0/1	0.69	8_18	26	99	False	rs571671456	EXONIC	YES	NM_004304.5	Transcript	protein_coding	synonymous_variant		29/29	NM_004304.5:c.4689T>C	NP_004295.2:p.Thr1563%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	Neuroblastoma_3	{Neuroblastoma, susceptibility to, 3}, 613014 (3)	Neuroblastoma;Neuroblastoma;Inflammatory myofibroblastic tumor;Differentiated thyroid carcinoma;ALK-positive large B-cell lymphoma;Selection of therapeutic option in non-small cell lung carcinoma;ALK-positive anaplastic large cell lymphoma	Disease-causing somatic mutation(s) in;Major susceptibility factor in;Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in;Biomarker tested in;Disease-causing somatic mutation(s) in	Elevated urinary catecholamines;Neoplasm of the nervous system;Elevated urinary catecholamines;Neoplasm of the nervous system		6.56892e-06	1.0	152232.0	0.0	32	0.96	PASS	nfe	1.46977e-05	1.0	1.46977e-05	1.0	3.98238e-06	1.0	251106.0	0.0	100	1.0	PASS	nfe	8.81679e-06	1.0	8.81679e-06	1.0	0.0000129	2	0.0	1.0				4.31	0.102915		0	0	0			ALK	0.0	0.0	0.0	0.0	-30.0	-13.0	-15.0	-29.0						0.202	0.52	65.668610832			integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; neoplasm; pigmentation phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	.	activation of MAPK activity;signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;cell population proliferation;phosphorylation;peptidyl-tyrosine phosphorylation;hippocampus development;adult behavior;swimming behavior;NIK/NF-kappaB signaling;regulation of cell population proliferation;regulation of apoptotic process;regulation of neuron differentiation;protein autophosphorylation;neuron development;positive regulation of NF-kappaB transcription factor activity;regulation of dopamine receptor signaling pathway;response to environmental enrichment	plasma membrane;integral component of plasma membrane;protein-containing complex;receptor complex;extracellular exosome	NF-kappaB-inducing kinase activity;protein tyrosine kinase activity;transmembrane receptor protein tyrosine kinase activity;protein binding;ATP binding;identical protein binding	VAV3[17998938];ALK[25517749];MAP3K3[14743216];LTK[26418745];HSP90AB1[22939624];PTPRJ[19167335];PTPRG[19167335];PTPRB[19167335];PKM[24606918];PTPRZ1[17681947];HIST1H1E[30021884];ALKAL2[26418745];ALKAL1[26418745];HIST1H1B[30021884];
431764	chr16	11217724	C	A	chr16:11217724	CLEC16A	C-type lectin domain containing 16A	6068.0	SNV	0/1	0.32	25_12	37	99	False		EXONIC	YES	NM_015226.3	Transcript	protein_coding	missense_variant		21/24	NM_015226.3:c.2394C>A	NP_056041.1:p.His798Gln		1.0	.,.					.	.	.						33	0.98											82	1.0														22.6	2.507074	0.527	16	5	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,fathmm-XF_coding_pred	CLEC16A	0.0	0.0	0.0	0.0	25.0	-23.0	-1.0	48.0						0.775	0.01	76.530214162	0.992	-0.674	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			pons;amygdala;testis;	.	autophagy;endosome to lysosome transport;cellular response to starvation;endosomal transport;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of autophagosome maturation;positive regulation of autophagosome maturation;negative regulation of mitophagy;positive regulation of TORC1 signaling;negative regulation of macroautophagy by TORC1 signaling	late endosome;Golgi apparatus;cytosol;integral component of membrane;vesicle;endolysosome membrane	molecular_function;Rab GTPase binding	RNF41[26496610];
432897	chr19	4171445	C	T	chr19:4171445	CREB3L3	cAMP responsive element binding protein 3 like 3	6072.0	SNV	0/1	0.69	8_18	26	99	False	rs143545033	EXONIC	YES	NM_032607.3	Transcript	protein_coding	synonymous_variant		9/10	NM_032607.3:c.1041C>T	NP_115996.1:p.Thr347%3D		1.0					Hypertriglyceridemia 2, 619324 (3), Autosomal dominant	.	.	.		0.000782421	119.0	152092.0	0.0	32	0.96	PASS	nfe	0.00138203	94.0	0.00138203	94.0	0.000715945	180.0	251416.0	0.0	97	1.0	PASS	nfe	0.00135425	154.0	0.00135425	154.0	0.0006881	107	0.001	2.0	0.00079	9.0		1.275	-0.114678		0	0	0			CREB3L3	0.0	0.01	0.0	0.01	31.0	-21.0	-2.0	31.0						0.262	0.0	0.000000000			mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; immune system phenotype; homeostasis/metabolism phenotype; 			.	Melanogenesis;Prostate cancer	positive regulation of acute inflammatory response;endoplasmic reticulum unfolded protein response;positive regulation of transcription by RNA polymerase II;positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	Golgi membrane;nucleus;nucleoplasm;endoplasmic reticulum;endoplasmic reticulum membrane;cytosol;membrane;integral component of membrane	transcription regulatory region sequence-specific DNA binding;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protein binding;cAMP response element binding;protein homodimerization activity;protein heterodimerization activity	KHDRBS1[21988832];GPR25[unassigned1304];TRAF3IP3[unassigned1304];CEP19[unassigned1304];PELI2[21988832];DPY30[unassigned1304];SEC61A2[unassigned1304];NFIL3[20102225];CREB3L3[20102225];SLC39A9[unassigned1304];SLC38A7[unassigned1304];STX5[unassigned1304];MS4A13[unassigned1304];KPNA2[21988832];USP7[16713569];SGTB[unassigned1304];BAD[21988832];RIOK3[21988832];MCRS1[unassigned1304];TCEANC[unassigned1304];SGTA[unassigned1304];C16orf58[unassigned1304];CYB561A3[unassigned1304];CREB3[20102225];CREB1[20102225];TMEM239[unassigned1304];YIPF6[unassigned1304];PELI1[unassigned1304];RHAG[unassigned1304];FATE1[unassigned1304];ATF6[16469704];
433126	chr12	32908187	G	C	chr12:32908187	YARS2	tyrosyl-tRNA synthetase 2	6084.0	SNV	0/1	0.67	13_26	39	99	False	rs780385787	EXONIC	YES	NM_001040436.3	Transcript	protein_coding	missense_variant		1/5	NM_001040436.3:c.622C>G	NP_001035526.1:p.Leu208Val		-1.0					Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3), Autosomal recessive	Mitochondrial myopathy and sideroblastic anemia	Disease-causing germline mutation(s) in	Exercise intolerance;Growth delay;Sideroblastic anemia;Progressive;Failure to thrive;Elevated hepatic transaminase;Strabismus;Increased serum lactate;Progressive muscle weakness;Generalized amyotrophy;Respiratory insufficiency due to muscle weakness;Hypertrophic cardiomyopathy;Ptosis;Dysphagia;Autosomal recessive inheritance;Lactic acidosis;Nystagmus;Hepatomegaly;Micrognathia;Distichiasis;Intellectual disability;High palate;Kyphosis;Glaucoma;Lactic acidosis;Long philtrum;Scoliosis;Myopathy;EMG abnormality;Microcephaly;Delayed puberty;Muscular hypotonia;Mitochondrial myopathy;Anemia;Generalized limb muscle atrophy;Short nose						32	0.97											100	1.0							0.0000064	1						24.9	3.47617	0.734	13	8	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred	YARS2	0.0	0.0	0.0	0.01	-45.0	15.0	1.0	-44.0						0.846	0.0	0.000000000	0.55	1.176	.			superior cervical ganglion;skeletal muscle;	Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis	translation;tRNA aminoacylation for protein translation;tRNA aminoacylation;mitochondrial tyrosyl-tRNA aminoacylation	mitochondrion;mitochondrial matrix;cytosol;nuclear body	tRNA binding;RNA binding;tyrosine-tRNA ligase activity;protein binding;ATP binding;protein homodimerization activity;tyrosine binding	OFD1[26638075];FAM9B[25416956];JUN[25609649];USP49[19615732];MGST3[29568061];FBF1[26638075];AGTRAP[unassigned1304];MRPL58[20186120];MLLT1[30021884];HSCB[28380382];YARS2[17997975];COQ10A[27499296];HSPD1[29568061];CDC20[17353931];MRPL50[26496610];CNTRL[26638075];TRMT61B[29568061];L1RE1[24267889];PDK1[29568061];
433535	chr7	151945007	C	T	chr7:151945007	KMT2C	lysine methyltransferase 2C	6100.0	SNV	0/1	0.27	50_20	75	99	False	rs2479172,COSV51279050	EXONIC	YES	NM_170606.3	Transcript	protein_coding	missense_variant		14/59	NM_170606.3:c.2512G>A	NP_733751.2:p.Gly838Ser		-1.0	.,.				Kleefstra syndrome 2, 617768 (3), Autosomal dominant	Kleefstra syndrome due to a point mutation	Disease-causing germline mutation(s) (loss of function) in	Global developmental delay;Self-injurious behavior;Thick eyebrow;Microcephaly;Bifid uvula;Abnormal facial shape;Seizure;Everted lower lip vermilion;Delayed speech and language development;Scoliosis;Growth delay;Midface retrusion;Autistic behavior;Generalized hypotonia;Kyphosis;Muscular hypotonia;Intellectual disability;Plagiocephaly;Autosomal dominant inheritance;Autosomal dominant germline de novo mutation		0.00267097	344.0	128792.0	0.0	48	0.95	AS_VQSR	sas	0.00653766	25.0	0.00135606	81.0	0.493976	116518.0	235878.0	0.0	100	1.0	InbreedingCoeff	afr	0.499186	7973.0	0.49016	51060.0	0.0127907	1989	0.085	269.0				31.0	4.34322	0.395	15	5	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred	KMT2C	0.0	0.0	0.01	0.16	-2.0	-5.0	36.0	-20.0							1.0		1.0	1.026	cellular phenotype; growth/size/body region phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			.	.	regulation of megakaryocyte differentiation;positive regulation of transcription by RNA polymerase II;histone H3-K4 methylation	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	DNA binding;transcription coactivator activity;RNA binding;protein binding;transferase activity, transferring acyl groups;histone-lysine N-methyltransferase activity;histone binding;histone methyltransferase activity (H3-K4 specific);metal ion binding	JUN[20936779];PAXIP1[17500065];TSC22D1[21900206];RING1[27705803];CLPB[30021884];NCOA6[12482968;23870121;17021013;19047629;19433796];AK1[17353931];ASH2L[12482968;23870121;17500065;26886794];MAPK14[20936779];CDC73[19136632];PAGR1[17500065];ERP44[26496610];TCOF1[30021884];RBBP5[12482968;17500065;26886794];MTNR1B[26514267];WDR5[27705803;17500065];CALR[30021884];PABPC1[30021884];TP53[19433796];APPL2[25814554];
433537	chr7	151945140	C	T	chr7:151945140	KMT2C	lysine methyltransferase 2C	6100.0	SNV	0/1	0.16	42_9	57	99	False	rs2537263,COSV51275902	EXONIC	YES	NM_170606.3	Transcript	protein_coding	synonymous_variant		14/59	NM_170606.3:c.2379G>A	NP_733751.2:p.Ser793%3D		-1.0					Kleefstra syndrome 2, 617768 (3), Autosomal dominant	Kleefstra syndrome due to a point mutation	Disease-causing germline mutation(s) (loss of function) in	Global developmental delay;Self-injurious behavior;Thick eyebrow;Microcephaly;Bifid uvula;Abnormal facial shape;Seizure;Everted lower lip vermilion;Delayed speech and language development;Scoliosis;Growth delay;Midface retrusion;Autistic behavior;Generalized hypotonia;Kyphosis;Muscular hypotonia;Intellectual disability;Plagiocephaly;Autosomal dominant inheritance;Autosomal dominant germline de novo mutation		3.28317e-05	5.0	152292.0	0.0	44	1.0	PASS	nfe	5.87769e-05	4.0	5.87769e-05	4.0	0.431736	74908.0	173504.0	0.0	100	1.0	InbreedingCoeff	afr	0.476452	6070.0	0.403139	29234.0	0.0051831	806	0.077	216.0				6.995	0.283243		0	0	0			KMT2C	0.0	0.0	0.0	0.0	-29.0	10.0	39.0	-13.0							1.0				cellular phenotype; growth/size/body region phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			.	.	regulation of megakaryocyte differentiation;positive regulation of transcription by RNA polymerase II;histone H3-K4 methylation	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	DNA binding;transcription coactivator activity;RNA binding;protein binding;transferase activity, transferring acyl groups;histone-lysine N-methyltransferase activity;histone binding;histone methyltransferase activity (H3-K4 specific);metal ion binding	JUN[20936779];PAXIP1[17500065];TSC22D1[21900206];RING1[27705803];CLPB[30021884];NCOA6[12482968;23870121;17021013;19047629;19433796];AK1[17353931];ASH2L[12482968;23870121;17500065;26886794];MAPK14[20936779];CDC73[19136632];PAGR1[17500065];ERP44[26496610];TCOF1[30021884];RBBP5[12482968;17500065;26886794];MTNR1B[26514267];WDR5[27705803;17500065];CALR[30021884];PABPC1[30021884];TP53[19433796];APPL2[25814554];
433538	chr7	151945167	G	T	chr7:151945167	KMT2C	lysine methyltransferase 2C	6100.0	SNV	0/1	0.19	37_9	48	99	False	rs2537264,COSV51349661	EXONIC	YES	NM_170606.3	Transcript	protein_coding	synonymous_variant		14/59	NM_170606.3:c.2352C>A	NP_733751.2:p.Ser784%3D		-1.0					Kleefstra syndrome 2, 617768 (3), Autosomal dominant	Kleefstra syndrome due to a point mutation	Disease-causing germline mutation(s) (loss of function) in	Global developmental delay;Self-injurious behavior;Thick eyebrow;Microcephaly;Bifid uvula;Abnormal facial shape;Seizure;Everted lower lip vermilion;Delayed speech and language development;Scoliosis;Growth delay;Midface retrusion;Autistic behavior;Generalized hypotonia;Kyphosis;Muscular hypotonia;Intellectual disability;Plagiocephaly;Autosomal dominant inheritance;Autosomal dominant germline de novo mutation		0.000566085	81.0	143088.0	0.0	43	0.98	PASS	sas	0.00137363	6.0	0.000323635	21.0	0.476504	95420.0	200250.0	0.0	100	1.0	InbreedingCoeff	afr	0.495272	7332.0	0.46463	39724.0	0.0038841	604	0.04	111.0				4.968	0.143285		0	0	0			KMT2C	0.0	0.0	0.0	0.0	31.0	-17.0	18.0	12.0							1.0				cellular phenotype; growth/size/body region phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			.	.	regulation of megakaryocyte differentiation;positive regulation of transcription by RNA polymerase II;histone H3-K4 methylation	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	DNA binding;transcription coactivator activity;RNA binding;protein binding;transferase activity, transferring acyl groups;histone-lysine N-methyltransferase activity;histone binding;histone methyltransferase activity (H3-K4 specific);metal ion binding	JUN[20936779];PAXIP1[17500065];TSC22D1[21900206];RING1[27705803];CLPB[30021884];NCOA6[12482968;23870121;17021013;19047629;19433796];AK1[17353931];ASH2L[12482968;23870121;17500065;26886794];MAPK14[20936779];CDC73[19136632];PAGR1[17500065];ERP44[26496610];TCOF1[30021884];RBBP5[12482968;17500065;26886794];MTNR1B[26514267];WDR5[27705803;17500065];CALR[30021884];PABPC1[30021884];TP53[19433796];APPL2[25814554];
434031	chr14	94845830		AC	chr14:94845829-94845830	SERPINA1	serpin family A member 1	6101.0	insertion	0|1	0.13	31_5	38	99	False	rs1425620023	EXONIC	YES	NM_001127701.2	Transcript	protein_coding	frameshift_variant		6/7	NM_001127701.2:c.1036_1037insGT	NP_001121173.1:p.Thr346SerfsTer7		-1.0					Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3), Autosomal recessive; Emphysema due to AAT deficiency, 613490 (3), Autosomal recessive; Emphysema-cirrhosis, due to AAT deficiency, 613490 (3), Autosomal recessive	Alpha-1-antitrypsin deficiency;Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hepatitis;Hepatomegaly;Hepatic failure;Jaundice;Emphysema;Nephrotic syndrome;Hepatocellular carcinoma;Elevated hepatic transaminase;Chronic pulmonary obstruction;Dyspnea;Emphysema;Autosomal recessive inheritance;Cirrhosis		0.000204898	30.0	146414.0	0.0	34	0.97	AS_VQSR	amr	0.000349748	5.0	7.62079e-05	5.0					100	1.0														32.0	4.492844		0	0	0																	0.00462	0.0	55.232631739			.			kidney;liver;beta cell islets;whole blood;fetal lung;fetal liver;	Complement and coagulation cascades	platelet degranulation;endoplasmic reticulum to Golgi vesicle-mediated transport;acute-phase response;blood coagulation;negative regulation of endopeptidase activity;neutrophil degranulation;post-translational protein modification;cellular protein metabolic process;COPII vesicle coating	Golgi membrane;extracellular region;extracellular space;endoplasmic reticulum;endoplasmic reticulum lumen;Golgi apparatus;COPII-coated ER to Golgi transport vesicle;platelet alpha granule lumen;endoplasmic reticulum-Golgi intermediate compartment membrane;intracellular membrane-bounded organelle;collagen-containing extracellular matrix;extracellular exosome;ficolin-1-rich granule lumen	protease binding;serine-type endopeptidase inhibitor activity;protein binding;identical protein binding	SMAD4[21988832];GSDMB[21988832];SERPINA1[11057674;21909074;18923394;22405009];ECHS1[21988832];SDC2[21988832];MIS12[20360068];ATP5F1C[21988832];RCHY1[21988832];PPP1CA[25593058];RAP2A[18624398];SLX4[19596235];CANX[17380188];SSR1[17380188];TCF3[10915743];ELANE[16321984];
434042	chr14	94845834	C	T	chr14:94845834	SERPINA1	serpin family A member 1	6101.0	SNV	0|1	0.14	29_5	36	99	False	rs796815235	EXONIC	YES	NM_001127701.2	Transcript	protein_coding	synonymous_variant		6/7	NM_001127701.2:c.1032G>A	NP_001121173.1:p.Gly344%3D		-1.0					Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3), Autosomal recessive; Emphysema due to AAT deficiency, 613490 (3), Autosomal recessive; Emphysema-cirrhosis, due to AAT deficiency, 613490 (3), Autosomal recessive	Alpha-1-antitrypsin deficiency;Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hepatitis;Hepatomegaly;Hepatic failure;Jaundice;Emphysema;Nephrotic syndrome;Hepatocellular carcinoma;Elevated hepatic transaminase;Chronic pulmonary obstruction;Dyspnea;Emphysema;Autosomal recessive inheritance;Cirrhosis		0.000122095	18.0	147426.0	0.0	34	0.96	AS_VQSR	amr	0.000208073	3.0	3.0238e-05	2.0					100	1.0							0.0000064	1						4.651	0.123615		0	0	0			SERPINA1	0.0	0.0	0.0	0.0	29.0	-8.0	-33.0	30.0						0.00462	0.0	2.132002583			.			kidney;liver;beta cell islets;whole blood;fetal lung;fetal liver;	Complement and coagulation cascades	platelet degranulation;endoplasmic reticulum to Golgi vesicle-mediated transport;acute-phase response;blood coagulation;negative regulation of endopeptidase activity;neutrophil degranulation;post-translational protein modification;cellular protein metabolic process;COPII vesicle coating	Golgi membrane;extracellular region;extracellular space;endoplasmic reticulum;endoplasmic reticulum lumen;Golgi apparatus;COPII-coated ER to Golgi transport vesicle;platelet alpha granule lumen;endoplasmic reticulum-Golgi intermediate compartment membrane;intracellular membrane-bounded organelle;collagen-containing extracellular matrix;extracellular exosome;ficolin-1-rich granule lumen	protease binding;serine-type endopeptidase inhibitor activity;protein binding;identical protein binding	SMAD4[21988832];GSDMB[21988832];SERPINA1[11057674;21909074;18923394;22405009];ECHS1[21988832];SDC2[21988832];MIS12[20360068];ATP5F1C[21988832];RCHY1[21988832];PPP1CA[25593058];RAP2A[18624398];SLX4[19596235];CANX[17380188];SSR1[17380188];TCF3[10915743];ELANE[16321984];
434056	chr14	94845837	G	A	chr14:94845837	SERPINA1	serpin family A member 1	6101.0	SNV	0|1	0.14	29_5	36	99	False	rs760494093,COSV63345887	EXONIC	YES	NM_001127701.2	Transcript	protein_coding	synonymous_variant		6/7	NM_001127701.2:c.1029C>T	NP_001121173.1:p.Ser343%3D		-1.0		Benign	criteria_provided,_single_submitter	Alpha-1-antitrypsin_deficiency	Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3), Autosomal recessive; Emphysema due to AAT deficiency, 613490 (3), Autosomal recessive; Emphysema-cirrhosis, due to AAT deficiency, 613490 (3), Autosomal recessive	Alpha-1-antitrypsin deficiency;Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hepatitis;Hepatomegaly;Hepatic failure;Jaundice;Emphysema;Nephrotic syndrome;Hepatocellular carcinoma;Elevated hepatic transaminase;Chronic pulmonary obstruction;Dyspnea;Emphysema;Autosomal recessive inheritance;Cirrhosis		0.000115064	17.0	147744.0	0.0	34	0.96	AS_VQSR	amr	0.000276702	4.0	3.01823e-05	2.0	3.18183e-05	8.0	251428.0	0.0	100	1.0	PASS	sas	6.53253e-05	2.0	3.51753e-05	4.0	0.0000257	4						0.06	-0.553608		0	0	0			SERPINA1	0.0	0.0	0.0	0.0	-11.0	26.0	27.0	-36.0						0.00462	0.0	66.323177249			.			kidney;liver;beta cell islets;whole blood;fetal lung;fetal liver;	Complement and coagulation cascades	platelet degranulation;endoplasmic reticulum to Golgi vesicle-mediated transport;acute-phase response;blood coagulation;negative regulation of endopeptidase activity;neutrophil degranulation;post-translational protein modification;cellular protein metabolic process;COPII vesicle coating	Golgi membrane;extracellular region;extracellular space;endoplasmic reticulum;endoplasmic reticulum lumen;Golgi apparatus;COPII-coated ER to Golgi transport vesicle;platelet alpha granule lumen;endoplasmic reticulum-Golgi intermediate compartment membrane;intracellular membrane-bounded organelle;collagen-containing extracellular matrix;extracellular exosome;ficolin-1-rich granule lumen	protease binding;serine-type endopeptidase inhibitor activity;protein binding;identical protein binding	SMAD4[21988832];GSDMB[21988832];SERPINA1[11057674;21909074;18923394;22405009];ECHS1[21988832];SDC2[21988832];MIS12[20360068];ATP5F1C[21988832];RCHY1[21988832];PPP1CA[25593058];RAP2A[18624398];SLX4[19596235];CANX[17380188];SSR1[17380188];TCF3[10915743];ELANE[16321984];
434067	chr14	94845846	A	G	chr14:94845846	SERPINA1	serpin family A member 1	6101.0	SNV	0|1	0.13	32_5	39	99	False	rs796723983	EXONIC	YES	NM_001127701.2	Transcript	protein_coding	synonymous_variant		6/7	NM_001127701.2:c.1020T>C	NP_001121173.1:p.Ala340%3D		-1.0					Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3), Autosomal recessive; Emphysema due to AAT deficiency, 613490 (3), Autosomal recessive; Emphysema-cirrhosis, due to AAT deficiency, 613490 (3), Autosomal recessive	Alpha-1-antitrypsin deficiency;Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hepatitis;Hepatomegaly;Hepatic failure;Jaundice;Emphysema;Nephrotic syndrome;Hepatocellular carcinoma;Elevated hepatic transaminase;Chronic pulmonary obstruction;Dyspnea;Emphysema;Autosomal recessive inheritance;Cirrhosis		7.4149e-05	11.0	148350.0	0.0	34	0.96	AS_VQSR	amr	0.000206072	3.0	1.50313e-05	1.0					100	1.0							0.0000064	1						9.441	0.503984		0	0	0			SERPINA1	0.0	0.0	0.0	0.0	9.0	-20.0	-45.0	18.0						0.00462	0.0	66.323177249			.			kidney;liver;beta cell islets;whole blood;fetal lung;fetal liver;	Complement and coagulation cascades	platelet degranulation;endoplasmic reticulum to Golgi vesicle-mediated transport;acute-phase response;blood coagulation;negative regulation of endopeptidase activity;neutrophil degranulation;post-translational protein modification;cellular protein metabolic process;COPII vesicle coating	Golgi membrane;extracellular region;extracellular space;endoplasmic reticulum;endoplasmic reticulum lumen;Golgi apparatus;COPII-coated ER to Golgi transport vesicle;platelet alpha granule lumen;endoplasmic reticulum-Golgi intermediate compartment membrane;intracellular membrane-bounded organelle;collagen-containing extracellular matrix;extracellular exosome;ficolin-1-rich granule lumen	protease binding;serine-type endopeptidase inhibitor activity;protein binding;identical protein binding	SMAD4[21988832];GSDMB[21988832];SERPINA1[11057674;21909074;18923394;22405009];ECHS1[21988832];SDC2[21988832];MIS12[20360068];ATP5F1C[21988832];RCHY1[21988832];PPP1CA[25593058];RAP2A[18624398];SLX4[19596235];CANX[17380188];SSR1[17380188];TCF3[10915743];ELANE[16321984];
434082	chr14	94845850	C	T	chr14:94845850	SERPINA1	serpin family A member 1	6101.0	SNV	0|1	0.12	33_5	40	99	False	rs186298255,COSV63346165	EXONIC	YES	NM_001127701.2	Transcript	protein_coding	missense_variant		6/7	NM_001127701.2:c.1016G>A	NP_001121173.1:p.Gly339Glu		-1.0	Serpin domain&Serpin domain,Serpin domain&Serpin domain,Serpin domain&Serpin domain,Serpin domain&Serpin domain,Serpin domain&Serpin domain,Serpin domain&Serpin domain,Serpin domain&Serpin domain,Serpin domain&Serpin domain,Serpin domain&Serpin domain,.				Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3), Autosomal recessive; Emphysema due to AAT deficiency, 613490 (3), Autosomal recessive; Emphysema-cirrhosis, due to AAT deficiency, 613490 (3), Autosomal recessive	Alpha-1-antitrypsin deficiency;Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hepatitis;Hepatomegaly;Hepatic failure;Jaundice;Emphysema;Nephrotic syndrome;Hepatocellular carcinoma;Elevated hepatic transaminase;Chronic pulmonary obstruction;Dyspnea;Emphysema;Autosomal recessive inheritance;Cirrhosis		7.4104e-05	11.0	148440.0	0.0	34	0.96	AS_VQSR	amr	0.000205987	3.0	1.502e-05	1.0					100	1.0							0.0000064	1						0.293	-0.332248	0.032	1	18	19	FATHMM_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SERPINA1	0.0	0.0	0.0	0.0	43.0	-50.0	-49.0	14.0						0.00462	0.0	66.323177249	0.016	-0.722	.			kidney;liver;beta cell islets;whole blood;fetal lung;fetal liver;	Complement and coagulation cascades	platelet degranulation;endoplasmic reticulum to Golgi vesicle-mediated transport;acute-phase response;blood coagulation;negative regulation of endopeptidase activity;neutrophil degranulation;post-translational protein modification;cellular protein metabolic process;COPII vesicle coating	Golgi membrane;extracellular region;extracellular space;endoplasmic reticulum;endoplasmic reticulum lumen;Golgi apparatus;COPII-coated ER to Golgi transport vesicle;platelet alpha granule lumen;endoplasmic reticulum-Golgi intermediate compartment membrane;intracellular membrane-bounded organelle;collagen-containing extracellular matrix;extracellular exosome;ficolin-1-rich granule lumen	protease binding;serine-type endopeptidase inhibitor activity;protein binding;identical protein binding	SMAD4[21988832];GSDMB[21988832];SERPINA1[11057674;21909074;18923394;22405009];ECHS1[21988832];SDC2[21988832];MIS12[20360068];ATP5F1C[21988832];RCHY1[21988832];PPP1CA[25593058];RAP2A[18624398];SLX4[19596235];CANX[17380188];SSR1[17380188];TCF3[10915743];ELANE[16321984];
434093	chr14	94845852	A	G	chr14:94845852	SERPINA1	serpin family A member 1	6101.0	SNV	0|1	0.13	32_5	39	99	False	rs371761828	EXONIC	YES	NM_001127701.2	Transcript	protein_coding	synonymous_variant		6/7	NM_001127701.2:c.1014T>C	NP_001121173.1:p.Asn338%3D		-1.0					Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3), Autosomal recessive; Emphysema due to AAT deficiency, 613490 (3), Autosomal recessive; Emphysema-cirrhosis, due to AAT deficiency, 613490 (3), Autosomal recessive	Alpha-1-antitrypsin deficiency;Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hepatitis;Hepatomegaly;Hepatic failure;Jaundice;Emphysema;Nephrotic syndrome;Hepatocellular carcinoma;Elevated hepatic transaminase;Chronic pulmonary obstruction;Dyspnea;Emphysema;Autosomal recessive inheritance;Cirrhosis		6.74145e-05	10.0	148336.0	0.0	34	0.96	AS_VQSR	eas	0.000199124	1.0	1.50236e-05	1.0	3.97706e-06	1.0	251442.0	0.0	100	1.0	PASS	afr	6.15157e-05	1.0	0.0	0.0	0.0000064	1						2.977	0.022702		0	0	0			SERPINA1	0.0	0.0	0.0	0.0	41.0	-26.0	-44.0	12.0						0.00462	0.0	84.781059914			.			kidney;liver;beta cell islets;whole blood;fetal lung;fetal liver;	Complement and coagulation cascades	platelet degranulation;endoplasmic reticulum to Golgi vesicle-mediated transport;acute-phase response;blood coagulation;negative regulation of endopeptidase activity;neutrophil degranulation;post-translational protein modification;cellular protein metabolic process;COPII vesicle coating	Golgi membrane;extracellular region;extracellular space;endoplasmic reticulum;endoplasmic reticulum lumen;Golgi apparatus;COPII-coated ER to Golgi transport vesicle;platelet alpha granule lumen;endoplasmic reticulum-Golgi intermediate compartment membrane;intracellular membrane-bounded organelle;collagen-containing extracellular matrix;extracellular exosome;ficolin-1-rich granule lumen	protease binding;serine-type endopeptidase inhibitor activity;protein binding;identical protein binding	SMAD4[21988832];GSDMB[21988832];SERPINA1[11057674;21909074;18923394;22405009];ECHS1[21988832];SDC2[21988832];MIS12[20360068];ATP5F1C[21988832];RCHY1[21988832];PPP1CA[25593058];RAP2A[18624398];SLX4[19596235];CANX[17380188];SSR1[17380188];TCF3[10915743];ELANE[16321984];
434094	chr14	94845867	A	G	chr14:94845867	SERPINA1	serpin family A member 1	6101.0	SNV	0|1	0.11	29_4	35	81	False	rs181491831	EXONIC	YES	NM_001127701.2	Transcript	protein_coding	synonymous_variant		6/7	NM_001127701.2:c.999T>C	NP_001121173.1:p.Thr333%3D		-1.0					Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3), Autosomal recessive; Emphysema due to AAT deficiency, 613490 (3), Autosomal recessive; Emphysema-cirrhosis, due to AAT deficiency, 613490 (3), Autosomal recessive	Alpha-1-antitrypsin deficiency;Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hepatitis;Hepatomegaly;Hepatic failure;Jaundice;Emphysema;Nephrotic syndrome;Hepatocellular carcinoma;Elevated hepatic transaminase;Chronic pulmonary obstruction;Dyspnea;Emphysema;Autosomal recessive inheritance;Cirrhosis		0.000100735	15.0	148906.0	0.0	33	0.96	AS_VQSR	amr	0.000204638	3.0	1.49817e-05	1.0					100	1.0							0.0000064	1						6.179	0.223272		0	0	0			SERPINA1	0.0	0.0	0.0	0.0	26.0	-4.0	-1.0	-3.0						0.00462	0.0	84.781059914			.			kidney;liver;beta cell islets;whole blood;fetal lung;fetal liver;	Complement and coagulation cascades	platelet degranulation;endoplasmic reticulum to Golgi vesicle-mediated transport;acute-phase response;blood coagulation;negative regulation of endopeptidase activity;neutrophil degranulation;post-translational protein modification;cellular protein metabolic process;COPII vesicle coating	Golgi membrane;extracellular region;extracellular space;endoplasmic reticulum;endoplasmic reticulum lumen;Golgi apparatus;COPII-coated ER to Golgi transport vesicle;platelet alpha granule lumen;endoplasmic reticulum-Golgi intermediate compartment membrane;intracellular membrane-bounded organelle;collagen-containing extracellular matrix;extracellular exosome;ficolin-1-rich granule lumen	protease binding;serine-type endopeptidase inhibitor activity;protein binding;identical protein binding	SMAD4[21988832];GSDMB[21988832];SERPINA1[11057674;21909074;18923394;22405009];ECHS1[21988832];SDC2[21988832];MIS12[20360068];ATP5F1C[21988832];RCHY1[21988832];PPP1CA[25593058];RAP2A[18624398];SLX4[19596235];CANX[17380188];SSR1[17380188];TCF3[10915743];ELANE[16321984];
434763	chr10	24813614	T	A	chr10:24813614	KIAA1217	KIAA1217	6105.0	SNV	0/1	0.44	18_14	32	99	False		EXONIC	YES	NM_019590.5	Transcript	protein_coding	missense_variant		13/21	NM_019590.5:c.2819T>A	NP_062536.2:p.Met940Lys		1.0	.,.,.,.,.,.,.,.,.,.,.					.	.	.						33	0.97											53	0.99														4.304	0.102522	0.168	1	18	19	LIST-S2_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	KIAA1217	0.0	0.0	0.01	0.0	-34.0	20.0	46.0	-8.0						0.533	0.01	0.0	0.513	1.108	renal/urinary system phenotype; skeleton phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; embryo phenotype; 			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;globus pallidus;	.	embryonic skeletal system development	cytoplasm	molecular_function	PRKDC[30021884];LRRK1[24947832];ECI2[29426014];FHL2[21516116;25416956];GCC1[16189514];ALKBH7[unassigned1304];GOLGA2[25416956;unassigned1304];EXOSC5[16189514];FXR2[16189514];KRT27[unassigned1304];VPS52[25416956];NCK2[16189514];NINL[26638075];EXOC8[unassigned1304];NEK4[25798074];HSBP1[25416956];SEC16A[26496610];TEX11[16189514];SIAH1[25416956];INCA1[unassigned1304];ECH1[29426014];PTK6[unassigned1304];TRAF2[unassigned1304];TRAF1[25416956];KRT31[unassigned1304];SORBS3[16189514];RINT1[unassigned1304];ABI2[25416956;unassigned1304];KRT15[16189514;25416956];ABI1[unassigned1304];CNTROB[26638075];
435340	chr17	21207813	T	G	chr17:21207813	MAP2K3	mitogen-activated protein kinase kinase 3	6114.0	SNV	0/1	0.15	59_13	86	99	False	rs74575904,COSV57561160	EXONIC	YES	NM_145109.3	Transcript	protein_coding	missense_variant		8/12	NM_145109.3:c.644T>G	NP_659731.1:p.Leu215Trp		1.0	Protein kinase domain&Protein kinase domain&Protein kinase domain,.,.,.	Uncertain_significance	criteria_provided,_single_submitter	not_specified		.	.	.						71	1.0							0.0113392	1697.0	149658.0	0.0	100	1.0	RF	nfe	0.015988	984.0	0.015988	984.0	0.0173500	2698	0.024	73.0	0.01035	118.0		31.0	4.31164	0.915	15	5	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred	MAP2K3	0.0	0.01	0.0	0.0	1.0	-43.0	-27.0	49.0						0.736	0.0	83.560641417	0.999	1.138	cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];
435343	chr17	21207835	G	A	chr17:21207835	MAP2K3	mitogen-activated protein kinase kinase 3	6114.0	SNV	0/1	0.14	62_13	90	99	False	rs76111309,COSV57561178	EXONIC	YES	NM_145109.3	Transcript	protein_coding	synonymous_variant		8/12	NM_145109.3:c.666G>A	NP_659731.1:p.Thr222%3D		1.0						.	.	.		0.00012476	19.0	152292.0	0.0	70	1.0	PASS	sas	0.00165426	8.0	0.000161665	11.0	0.062201	8400.0	135046.0	0.0	94	1.0	InbreedingCoeff_RF	nfe	0.0863214	4810.0	0.0863214	4810.0	0.0160832	2501	0.037	107.0	0.01578	180.0		8.918	0.450035		0	0	0			MAP2K3	0.0	0.0	0.0	0.0	2.0	-30.0	34.0	30.0						0.736	0.0	83.560641417			cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];
435366	chr17	21208413	C	T	chr17:21208413	MAP2K3	mitogen-activated protein kinase kinase 3	6114.0	SNV	0/1	0.35	60_33	93	99	False	rs1657695,COSV57570678	EXONIC	YES	NM_145109.3	Transcript	protein_coding	synonymous_variant		9/12	NM_145109.3:c.747C>T	NP_659731.1:p.Ser249%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00124896	190.0	152126.0	0.0	45	1.0	PASS	afr	0.00166578	69.0	0.00150084	102.0	0.49987	115671.0	231402.0	0.0	100	1.0	InbreedingCoeff_RF	afr	0.5	7442.0	0.499924	52408.0	0.0352917	5488	0.183	596.0	0.2909	3318.0		5.864	0.201594		0	0	0			MAP2K3	0.0	0.0	0.0	0.0	27.0	-50.0	39.0	27.0						0.736	0.0	87.157101722			cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];
435383	chr17	21215446	C	T	chr17:21215446	MAP2K3	mitogen-activated protein kinase kinase 3	6114.0	SNV	0/1	0.52	30_33	63	99	False	rs62055363	SPLICING	YES	NM_145109.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	9/11		NM_145109.3:c.775-8C>T			1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		1.31413e-05	2.0	152192.0	0.0	32	0.97	PASS	afr	2.41173e-05	1.0	0.0	0.0	0.499523	118239.0	236704.0	5.0	30	0.67	InbreedingCoeff	nfe	0.49964	54178.0	0.49964	54178.0	0.0323979	5038	0.128	372.0	0.46914	4469.0		0.725	-0.198554		0	0	0			MAP2K3	0.0	0.0	0.0	0.0	-43.0	8.0	8.0	26.0	2.25802545323353e-05	0.002	9.963	-0.406	9.557	0.736	0.0				cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];
435388	chr17	21215537	C	A	chr17:21215537	MAP2K3	mitogen-activated protein kinase kinase 3	6114.0	SNV	0/1	0.48	32_30	62	99	False	rs55736474,COSV57570716	EXONIC	YES	NM_145109.3	Transcript	protein_coding	synonymous_variant		10/12	NM_145109.3:c.858C>A	NP_659731.1:p.Ser286%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00179383	273.0	152188.0	3.0	32	0.97	PASS	afr	0.00632026	262.0	2.93988e-05	2.0	0.499891	123690.0	247434.0	3.0	41	0.91	InbreedingCoeff	afr	0.499937	7979.0	0.499866	55936.0	0.0219737	3417	0.213	669.0	0.47103	4487.0		9.665	0.528205		0	0	0			MAP2K3	0.0	0.0	0.0	0.0	-29.0	7.0	32.0	-18.0						0.736	0.0	34.893533698			cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];
435391	chr17	21215552	C	T	chr17:21215552	MAP2K3	mitogen-activated protein kinase kinase 3	6114.0	SNV	0|1	0.52	30_33	63	99	False	rs56369732,COSV57569597	EXONIC	YES	NM_145109.3	Transcript	protein_coding	synonymous_variant		10/12	NM_145109.3:c.873C>T	NP_659731.1:p.Ala291%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		3.28563e-05	5.0	152178.0	0.0	32	0.97	PASS	sas	0.000206954	1.0	4.40982e-05	3.0	0.499935	123601.0	247234.0	0.0	41	0.89	InbreedingCoeff	eas	0.499944	8971.0	0.499937	55907.0	0.0219930	3420	0.214	672.0	0.47502	4525.0		6.502	0.246293		0	0	0			MAP2K3	0.0	0.0	0.0	0.0	19.0	-44.0	38.0	41.0						0.736	0.0	60.327738465			cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];
435395	chr17	21215557	G	A	chr17:21215557	MAP2K3	mitogen-activated protein kinase kinase 3	6114.0	SNV	0|1	0.51	31_32	63	99	False	rs35206134,COSV57561435	EXONIC	YES	NM_145109.3	Transcript	protein_coding	missense_variant		10/12	NM_145109.3:c.878G>A	NP_659731.1:p.Arg293His		1.0	Protein kinase domain&Protein kinase domain&Protein kinase domain,.,.,.,.	Benign	criteria_provided,_single_submitter	not_provided		.	.	.		4.59945e-05	7.0	152192.0	0.0	32	0.97	PASS	amr	0.00013089	2.0	5.87924e-05	4.0	0.499903	123584.0	247216.0	0.0	40	0.89	InbreedingCoeff	sas	0.499934	15043.0	0.499884	55920.0	0.0220123	3423	0.213	671.0	0.4747	4522.0		18.92	1.895575	0.047	2	18	20	PolyPhen,Polyphen2_HDIV_pred	SIFT,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MAP2K3	0.0	0.0	0.0	0.0	-25.0	-49.0	33.0	12.0						0.736	0.0	95.750275165	0.749	-0.595	cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];
435410	chr17	21216846	G	C	chr17:21216846	MAP2K3	mitogen-activated protein kinase kinase 3	6114.0	SNV	0/1	0.46	21_18	39	99	False	rs1657688,COSV57561194	EXONIC	YES	NM_145109.3	Transcript	protein_coding	synonymous_variant		11/12	NM_145109.3:c.957G>C	NP_659731.1:p.Leu319%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.000964538	141.0	146184.0	0.0	32	0.93	AS_VQSR	sas	0.00325885	14.0	0.00128755	84.0	0.499899	123861.0	247772.0	1.0	90	0.99	InbreedingCoeff	amr	0.499971	17180.0	0.499938	56067.0	0.0364235	5664	0.125	380.0	0.47265	5391.0		12.25	0.837926		0	0	0			MAP2K3	0.0	0.0	0.0	0.0	-32.0	-42.0	-5.0	7.0						0.736	0.0	54.938639654			cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];
435430	chr17	21217513	G	A	chr17:21217513	MAP2K3	mitogen-activated protein kinase kinase 3	6114.0	SNV	0/1	0.44	34_27	61	99	False	rs2363198,COSV57561451	EXONIC	YES	NM_145109.3	Transcript	protein_coding	missense_variant		12/12	NM_145109.3:c.1015G>A	NP_659731.1:p.Val339Met		1.0	.,.,.,.	Benign	criteria_provided,_single_submitter	not_provided		.	.	.		2.62923e-05	4.0	152136.0	0.0	32	0.97	PASS	nfe	5.88149e-05	4.0	5.88149e-05	4.0	0.499996	125623.0	251248.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56842.0	0.5	56842.0	0.0357869	5565	0.182	542.0	0.47054	5367.0		23.7	3.066878	0.404	9	11	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	MAP2K3	0.0	0.0	0.0	0.0	-21.0	-18.0	14.0	-1.0						0.736	0.0	0.096954234	0.997	0.161	cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];
436969	chr5	180030376	C	G	chr5:180030376	FLT4	fms related tyrosine kinase 4	6140.0	SNV	0/1	0.38	23_14	37	99	False	rs146806202,COSV56118431	EXONIC	YES	NM_182925.5	Transcript	protein_coding	missense_variant		30/30	NM_182925.5:c.3908G>C	NP_891555.2:p.Gly1303Ala		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Hemangioma, capillary infantile, somatic, 602089 (3); Lymphatic malformation 1, 153100 (3), Autosomal dominant; Congenital heart defects, multiple types, 7, 618780 (3), Autosomal dominant	Milroy disease	Disease-causing germline mutation(s) in	Autosomal dominant inheritance;Capillary hemangioma;Specific learning disability;Ankle swelling;Pedal edema;Toenail dysplasia;Behavioral abnormality;Lichenification;Abnormal facial shape;Hyperkeratosis;Erysipelas;Angiosarcoma;Predominantly lower limb lymphedema;Neoplasm of the skin;Cellulitis;Epicanthus;Hydrocele testis;Varicose veins;Congenital onset;Papilloma;Prominent superficial veins;Predominantly lower limb lymphedema;Nonimmune hydrops fetalis;Hemangioma;Hyperkeratosis over edematous areas;Urethral stricture;Autosomal dominant inheritance;Hypoplasia of lymphatic vessels;Hydrocele testis;Cellulitis;Upslanting toenail	25741868.0	0.00257495	392.0	152236.0	1.0	33	0.99	PASS	sas	0.00847458	41.0	0.00339516	231.0	0.0032313	801.0	247888.0	4.0	73	0.91	PASS	sas	0.0100216	306.0	0.00343392	381.0	0.0029838	464	0.003	10.0	0.00447	51.0		7.168	0.296681	0.016	1	16	17	MutationAssessor_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FLT4	0.0	0.0	0.0	0.0	6.0	5.0	6.0	13.0						0.0227	1.0	0.0	0.193	0.05	embryo phenotype; liver/biliary system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; 			placenta;	Cytokine-cytokine receptor interaction	positive regulation of protein phosphorylation;positive regulation of endothelial cell proliferation;vasculature development;lymph vessel development;lymphangiogenesis;sprouting angiogenesis;respiratory system process;transmembrane receptor protein tyrosine kinase signaling pathway;positive regulation of cell population proliferation;positive regulation of vascular endothelial growth factor production;positive regulation of endothelial cell migration;positive regulation of phosphatidylinositol 3-kinase signaling;peptidyl-tyrosine phosphorylation;cellular response to vascular endothelial growth factor stimulus;vascular endothelial growth factor signaling pathway;negative regulation of apoptotic process;positive regulation of MAPK cascade;positive regulation of JNK cascade;protein autophosphorylation;vascular endothelial growth factor receptor signaling pathway;lung alveolus development;blood vessel morphogenesis;regulation of blood vessel remodeling;positive regulation of ERK1 and ERK2 cascade;positive regulation of protein kinase C signaling	extracellular region;nucleoplasm;plasma membrane;integral component of plasma membrane;receptor complex	transmembrane receptor protein tyrosine kinase activity;vascular endothelial growth factor-activated receptor activity;protein binding;ATP binding;growth factor binding;protein phosphatase binding;VEGF-C-activated receptor activity;vascular endothelial growth factor binding;protein homodimerization activity	ATF7IP[15231748];HSP90AB1[22939624];PKM[24606918];LRRK1[24947832];KDR[16530705;20224550;21130043];VEGFC[21130043];IKBKG[20098747];
437100	chr17	61432165	T	C	chr17:61432165	TANC2	tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2	6145.0	SNV	0/1	0.48	12_11	23	99	False	rs745661784,COSV101267723	EXONIC	YES	NM_025185.4	Transcript	protein_coding	missense_variant		13/26	NM_025185.4:c.1774T>C	NP_079461.2:p.Phe592Leu		1.0	.,.				Intellectual developmental disorder with autistic features and language delay, with or without seizures, 618906 (3), Autosomal dominant	.	.	.		0.000118306	18.0	152148.0	0.0	32	0.96	PASS	amr	0.00065445	10.0	7.35186e-05	5.0	5.57424e-05	12.0	215276.0	0.0	42	0.68	PASS	amr	0.000116614	3.0	5.86155e-05	6.0	0.0000643	10						23.1	2.763509	0.798	8	11	19	LRT_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	TANC2	0.0	0.19	0.0	0.0	-21.0	8.0	-3.0	8.0						0.262	1.0	0.0	1.0	1.138	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			.	.	in utero embryonic development	glutamatergic synapse;postsynaptic density, intracellular component	.	RTKN[unassigned1312];YWHAB[24255178];MAST3[unassigned1312];DENND1A[unassigned1312];PPM1H[unassigned1312];ZBTB21[unassigned1312];CBY1[unassigned1312];NR2C2[26496610];GIGYF2[unassigned1312];SIPA1L1[unassigned1312];SH3PXD2A[unassigned1312];INPP5E[unassigned1312];KIF13B[unassigned1312];SRGAP2[unassigned1312];RALGPS2[unassigned1312];BRAP[25820252];KSR1[unassigned1312];DENND4C[unassigned1312];CDC5L[20467437];CGN[unassigned1312];KCTD3[unassigned1312];PTPN13[unassigned1312];CDC25C[unassigned1312];SH3RF3[unassigned1312];GIGYF1[unassigned1312];LRFN1[unassigned1312];NF1[unassigned1312];MAPRE1[27173435;unassigned1312];EIF4E2[unassigned1312];LPIN3[unassigned1312];
443037	chr8	101715588		TTTAAACAGTTGGAACAC	chr8:101715587-101715588	PABPC1	poly(A) binding protein cytoplasmic 1	6182.0	insertion	0|1	0.12	22_3	25	60	False		SPLICING	YES	NM_002568.4	Transcript	protein_coding	splice_region_variant,3_prime_UTR_variant			NM_002568.4:c.*2-1_*2insGTGTTCCAACTGTTTAAA			-1.0						.	.	.		0.00012956	19.0	146650.0	0.0	32	0.85	AS_VQSR	sas	0.000640478	3.0	9.13325e-05	6.0					0	0.0																	0	0	0																		1.0				.			salivary gland;tonsil;trachea;white blood cells;tongue;testis - seminiferous tubule;testis - interstitial;tumor;adipose tissue;whole blood;testis;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;mRNA polyadenylation;translational initiation;gene silencing by RNA;regulation of mRNA stability;positive regulation of viral genome replication;positive regulation of translation;mRNA stabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	nucleus;cytoplasm;cytosol;focal adhesion;cytoplasmic stress granule;membrane;cytoplasmic ribonucleoprotein granule;extracellular exosome;catalytic step 2 spliceosome;ribonucleoprotein complex	RNA binding;mRNA 3'-UTR binding;protein binding;protein C-terminus binding;poly(A) binding;poly(U) RNA binding;translation activator activity	EIF4A2[17353931];EIF4A1[20133758];IRS1[23770097];EIF4A3[23084401];CTNND1[28877994];PARK7[29128334];IFIT1[21642987];DUX4[26816005];IFIT3[21642987];IFIT2[21642987];TUBB3[27291054];GABARAPL2[20562859];GABARAPL1[20562859];HLA-B[17353931];DICER1[21858095];PRKAB1[17353931];JMJD6[24498420];ATXN2L[23209657];VDAC1[29128334];RBM8A[16452507];COX15[29128334];KMT2C[30021884];STK4[23386615];NDRG1[17220478];GSPT2[18447585;23340509;14685257];GSPT1[18256688;20418951];GABARAP[20562859];ATXN2[15663938;17392519;20181956];PCBP1[10373504];PCBP2[10373504];ZC3H18[29298432];SRPK2[23602568];CBX6[21282530];JUN[25609649];SMAD3[18729074];VCAM1[22623428];PDHA1[29128334];NBEAL2[29187380];ESR1[21182205];MEX3C[22863774];CLK3[23602568];NFKB2[14743216];CLK2[23602568];SRPK1[23602568];SNW1[20467437];HNRNPK[22365833];PAN3[23340509;17595167];AGO4[19167051];AGO1[17932509;19716330];LHX1[30021884];CDK2[17353931];AGO2[17932509;19716330;28877994];HNRNPD[16556936];GRB2[12577067];EIF4G3[9857202];MAP3K14[14743216];EIF4G1[9857202;12086624;19716330;16772376];BCAR3[17353931];SMG1[16452507];DDX3X[18596238;21883093;22872150];PINX1[17353931];ARRB2[17620599];YBX1[22118625];USE1[19369418];RBM4[22365833;17284590];MAP1LC3A[20562859];DNM1L[29128334];IKBKE[17353931];YWHAG[15324660;17353931];L1RE1[24267889];UPF1[21145460;19417104;23665581];NCBP1[23665581];H2AFX[20000738];DYNLL1[17353931];TRAF6[17353931];SGK1[17353931];DLD[29128334];STAU1[15121898];RPL10[26496610];WBP4[16055720];PARN[17595167];DLST[29128334];U2AF1[22365833];TOB2[23340509];TOB1[20595394];HSD17B10[29128334];NXF1[18596238];PUF60[17353931];IFI16[25665578];PABPN1[23665581];NSD1[30021884];IGF2BP1[19029303];PAIP2[16601676;14685257];EIF4E[23665581];PAIP1[9548260;11997512;14685257;24396066;11051545];WWOX[16055720];RRP1B[20926688];PLEKHA7[28877994];MAPK13[19135240];TNRC6C[21063388;19716330;21981923;20181956;23340509;20098421];PPP2R2B[19156129];MNDA[25665578];TNRC6A[21063388;28877994];BCAR1[28007913];TNRC6B[21063388;21981923];
443038	chr8	101715589	T	A	chr8:101715589	PABPC1	poly(A) binding protein cytoplasmic 1	6182.0	SNV	0|1	0.12	22_3	25	60	False	rs1313505600	SPLICING	YES	NM_002568.4	Transcript	protein_coding	splice_acceptor_variant	14/14		NM_002568.4:c.*2-2A>T			-1.0						.	.	.		0.0	0.0	149346.0	0.0	33	0.96	AC0_AS_VQSR				0.0	0.0					0	0.0														33.0	5.30999		0	0	0			PABPC1	0.02	0.93	0.0	0.0	-11.0	-2.0	21.0	-11.0	0.999989917668626	0.922	0.41	8.367	8.777		1.0				.			salivary gland;tonsil;trachea;white blood cells;tongue;testis - seminiferous tubule;testis - interstitial;tumor;adipose tissue;whole blood;testis;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;mRNA polyadenylation;translational initiation;gene silencing by RNA;regulation of mRNA stability;positive regulation of viral genome replication;positive regulation of translation;mRNA stabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	nucleus;cytoplasm;cytosol;focal adhesion;cytoplasmic stress granule;membrane;cytoplasmic ribonucleoprotein granule;extracellular exosome;catalytic step 2 spliceosome;ribonucleoprotein complex	RNA binding;mRNA 3'-UTR binding;protein binding;protein C-terminus binding;poly(A) binding;poly(U) RNA binding;translation activator activity	EIF4A2[17353931];EIF4A1[20133758];IRS1[23770097];EIF4A3[23084401];CTNND1[28877994];PARK7[29128334];IFIT1[21642987];DUX4[26816005];IFIT3[21642987];IFIT2[21642987];TUBB3[27291054];GABARAPL2[20562859];GABARAPL1[20562859];HLA-B[17353931];DICER1[21858095];PRKAB1[17353931];JMJD6[24498420];ATXN2L[23209657];VDAC1[29128334];RBM8A[16452507];COX15[29128334];KMT2C[30021884];STK4[23386615];NDRG1[17220478];GSPT2[18447585;23340509;14685257];GSPT1[18256688;20418951];GABARAP[20562859];ATXN2[15663938;17392519;20181956];PCBP1[10373504];PCBP2[10373504];ZC3H18[29298432];SRPK2[23602568];CBX6[21282530];JUN[25609649];SMAD3[18729074];VCAM1[22623428];PDHA1[29128334];NBEAL2[29187380];ESR1[21182205];MEX3C[22863774];CLK3[23602568];NFKB2[14743216];CLK2[23602568];SRPK1[23602568];SNW1[20467437];HNRNPK[22365833];PAN3[23340509;17595167];AGO4[19167051];AGO1[17932509;19716330];LHX1[30021884];CDK2[17353931];AGO2[17932509;19716330;28877994];HNRNPD[16556936];GRB2[12577067];EIF4G3[9857202];MAP3K14[14743216];EIF4G1[9857202;12086624;19716330;16772376];BCAR3[17353931];SMG1[16452507];DDX3X[18596238;21883093;22872150];PINX1[17353931];ARRB2[17620599];YBX1[22118625];USE1[19369418];RBM4[22365833;17284590];MAP1LC3A[20562859];DNM1L[29128334];IKBKE[17353931];YWHAG[15324660;17353931];L1RE1[24267889];UPF1[21145460;19417104;23665581];NCBP1[23665581];H2AFX[20000738];DYNLL1[17353931];TRAF6[17353931];SGK1[17353931];DLD[29128334];STAU1[15121898];RPL10[26496610];WBP4[16055720];PARN[17595167];DLST[29128334];U2AF1[22365833];TOB2[23340509];TOB1[20595394];HSD17B10[29128334];NXF1[18596238];PUF60[17353931];IFI16[25665578];PABPN1[23665581];NSD1[30021884];IGF2BP1[19029303];PAIP2[16601676;14685257];EIF4E[23665581];PAIP1[9548260;11997512;14685257;24396066;11051545];WWOX[16055720];RRP1B[20926688];PLEKHA7[28877994];MAPK13[19135240];TNRC6C[21063388;19716330;21981923;20181956;23340509;20098421];PPP2R2B[19156129];MNDA[25665578];TNRC6A[21063388;28877994];BCAR1[28007913];TNRC6B[21063388;21981923];
443039	chr8	101718932	C	G	chr8:101718932	PABPC1	poly(A) binding protein cytoplasmic 1	6182.0	SNV	0/1	0.15	32_6	41	91	False	rs62513920,COSV59397490	EXONIC	YES	NM_002568.4	Transcript	protein_coding	missense_variant		11/15	NM_002568.4:c.1549G>C	NP_002559.2:p.Val517Leu		-1.0	.,.,.,.,.					.	.	.		0.00566181	717.0	126638.0	0.0	33	0.93	PASS	sas	0.00852713	33.0	0.00461533	266.0	0.134312	21650.0	161192.0	0.0	74	1.0	InbreedingCoeff	sas	0.228921	4317.0	0.116349	8275.0	0.0001801	28	0.091	267.0				23.1	2.766368	0.173	8	10	18	LRT_pred,MutationAssessor_pred,MutationTaster_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	PABPC1	0.0	0.0	0.0	0.0	18.0	2.0	-38.0	1.0							1.0	46.917108052	1.0	1.013	.			salivary gland;tonsil;trachea;white blood cells;tongue;testis - seminiferous tubule;testis - interstitial;tumor;adipose tissue;whole blood;testis;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;mRNA polyadenylation;translational initiation;gene silencing by RNA;regulation of mRNA stability;positive regulation of viral genome replication;positive regulation of translation;mRNA stabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	nucleus;cytoplasm;cytosol;focal adhesion;cytoplasmic stress granule;membrane;cytoplasmic ribonucleoprotein granule;extracellular exosome;catalytic step 2 spliceosome;ribonucleoprotein complex	RNA binding;mRNA 3'-UTR binding;protein binding;protein C-terminus binding;poly(A) binding;poly(U) RNA binding;translation activator activity	EIF4A2[17353931];EIF4A1[20133758];IRS1[23770097];EIF4A3[23084401];CTNND1[28877994];PARK7[29128334];IFIT1[21642987];DUX4[26816005];IFIT3[21642987];IFIT2[21642987];TUBB3[27291054];GABARAPL2[20562859];GABARAPL1[20562859];HLA-B[17353931];DICER1[21858095];PRKAB1[17353931];JMJD6[24498420];ATXN2L[23209657];VDAC1[29128334];RBM8A[16452507];COX15[29128334];KMT2C[30021884];STK4[23386615];NDRG1[17220478];GSPT2[18447585;23340509;14685257];GSPT1[18256688;20418951];GABARAP[20562859];ATXN2[15663938;17392519;20181956];PCBP1[10373504];PCBP2[10373504];ZC3H18[29298432];SRPK2[23602568];CBX6[21282530];JUN[25609649];SMAD3[18729074];VCAM1[22623428];PDHA1[29128334];NBEAL2[29187380];ESR1[21182205];MEX3C[22863774];CLK3[23602568];NFKB2[14743216];CLK2[23602568];SRPK1[23602568];SNW1[20467437];HNRNPK[22365833];PAN3[23340509;17595167];AGO4[19167051];AGO1[17932509;19716330];LHX1[30021884];CDK2[17353931];AGO2[17932509;19716330;28877994];HNRNPD[16556936];GRB2[12577067];EIF4G3[9857202];MAP3K14[14743216];EIF4G1[9857202;12086624;19716330;16772376];BCAR3[17353931];SMG1[16452507];DDX3X[18596238;21883093;22872150];PINX1[17353931];ARRB2[17620599];YBX1[22118625];USE1[19369418];RBM4[22365833;17284590];MAP1LC3A[20562859];DNM1L[29128334];IKBKE[17353931];YWHAG[15324660;17353931];L1RE1[24267889];UPF1[21145460;19417104;23665581];NCBP1[23665581];H2AFX[20000738];DYNLL1[17353931];TRAF6[17353931];SGK1[17353931];DLD[29128334];STAU1[15121898];RPL10[26496610];WBP4[16055720];PARN[17595167];DLST[29128334];U2AF1[22365833];TOB2[23340509];TOB1[20595394];HSD17B10[29128334];NXF1[18596238];PUF60[17353931];IFI16[25665578];PABPN1[23665581];NSD1[30021884];IGF2BP1[19029303];PAIP2[16601676;14685257];EIF4E[23665581];PAIP1[9548260;11997512;14685257;24396066;11051545];WWOX[16055720];RRP1B[20926688];PLEKHA7[28877994];MAPK13[19135240];TNRC6C[21063388;19716330;21981923;20181956;23340509;20098421];PPP2R2B[19156129];MNDA[25665578];TNRC6A[21063388;28877994];BCAR1[28007913];TNRC6B[21063388;21981923];
443202	chr22	29533536	G	A	chr22:29533536	KREMEN1	kringle containing transmembrane protein 1	6191.0	SNV	0/1	0.69	10_22	32	99	False	rs146915661	EXONIC	YES	NM_032045.5	Transcript	protein_coding	missense_variant		6/10	NM_032045.5:c.838G>A	NP_114434.3:p.Val280Ile		1.0	.,.,CUB domain&CUB domain&CUB domain&CUB domain				Ectodermal dysplasia 13, hair/tooth type, 617392 (3), Autosomal recessive	.	.	Thin eyebrow;Depressed nasal bridge;Thick vermilion border;Low anterior hairline;Sparse eyelashes;Autosomal recessive inheritance;Wide nasal bridge;Oligodontia;Hypertelorism		0.0012618	192.0	152164.0	0.0	33	0.97	PASS	amr	0.00353357	54.0	0.00135238	92.0	0.000865627	216.0	249530.0	0.0	62	1.0	PASS	nfe	0.00119191	135.0	0.00119191	135.0	0.0009453	147	0.003	8.0				23.9	3.121955	0.141	8	13	21	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	KREMEN1	0.01	0.0	0.0	0.0	-46.0	26.0	-3.0	-1.0						0.554	0.37	0.0	0.249	1.176	limbs/digits/tail phenotype; normal phenotype; skeleton phenotype; 			.	.	apoptotic process;cell communication;Wnt signaling pathway;negative regulation of ossification;limb development;regulation of canonical Wnt signaling pathway;negative regulation of canonical Wnt signaling pathway	plasma membrane;membrane;integral component of membrane	protein binding	DKK1[17804805];
443772	chr2	219609920	C	T	chr2:219609920	TTLL4	tubulin tyrosine ligase like 4	6199.0	SNV	0/1	0.42	19_14	33	99	False	rs114873637	EXONIC	YES	NM_014640.5	Transcript	protein_coding	missense_variant		6/20	NM_014640.5:c.1750C>T	NP_055455.3:p.Pro584Ser		1.0	.,.,.,.					.	.	.		0.000394363	60.0	152144.0	0.0	32	0.95	PASS	nfe	0.000617411	42.0	0.000617411	42.0	0.000676116	170.0	251436.0	2.0	97	1.0	PASS	nfe	0.00115197	131.0	0.00115197	131.0	0.0008939	139	0.001	4.0				19.73	2.000277	0.134	3	16	19	MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	TTLL4	0.0	0.0	0.01	0.0	33.0	-41.0	36.0	-4.0						0.775	0.0	0.0	0.975	-0.302	growth/size/body region phenotype; 			ciliary ganglion;dorsal root ganglion;atrioventricular node;skin;superior cervical ganglion;trigeminal ganglion;testis;skeletal muscle;	.	protein polyglutamylation;peptidyl-glutamic acid modification	cytosol;microtubule;cilium	ATP binding;tubulin binding;protein-glutamic acid ligase activity;tubulin-glutamic acid ligase activity	PCM1[26638075];
445369	chr16	72013919	G	A	chr16:72013919	PKD1L3	polycystin 1 like 3, transient receptor potential channel interacting	6221.0	SNV	0/1	0.53	15_17	32	99	False	rs1296761460	EXONIC	YES	NM_181536.2	Transcript	protein_coding	synonymous_variant		8/31	NM_181536.2:c.1258C>T	NP_853514.1:p.Leu420%3D		-1.0						.	.	.		1.31397e-05	2.0	152210.0	0.0	32	0.96	PASS	nfe	2.93971e-05	2.0	2.93971e-05	2.0	1.89756e-05	3.0	158098.0	0.0	38	0.6	PASS	amr	4.04498e-05	1.0	3.2496e-05	2.0								7.116	0.292619		0	0	0			PKD1L3	0.0	0.0	0.0	0.0	-14.0	-3.0	-28.0	-13.0											nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); taste/olfaction phenotype; 			.	.	detection of chemical stimulus involved in sensory perception of sour taste;kidney development;cation transport;sensory perception of sour taste;detection of mechanical stimulus;calcium ion transmembrane transport;cellular response to acidic pH	plasma membrane;cell surface;membrane;cation channel complex;receptor complex;extracellular exosome	cation channel activity;calcium channel activity;protein binding;cation transmembrane transporter activity;carbohydrate binding;sour taste receptor activity	PKD2L1[18535624];VHL[17353931];AP2M1[30021884];
446110	chr9	102590525	AAC		chr9:102590525-102590527	NR4A3	nuclear receptor subfamily 4 group A member 3	6244.0	deletion	0/1	0.56	12_15	27	99	False	rs573092297	EXONIC	YES	NM_173200.3	Transcript	protein_coding	inframe_deletion		4/9	NM_173200.3:c.235_237del	NP_775292.1:p.Asn79del		1.0					Chondrosarcoma, extraskeletal myxoid, 612237 (3)	Extraskeletal myxoid chondrosarcoma	Part of a fusion gene in	Somatic mutation;Chondrosarcoma		0.00146033	222.0	152020.0	0.0	31	0.95	PASS	nfe	0.00257361	175.0	0.00257361	175.0	0.00129774	326.0	251206.0	0.0	77	1.0	PASS	nfe	0.00201723	229.0	0.00201723	229.0	0.0010804	168	0.002	5.0	0.00199	19.0		20.6	2.095799		0	0	0			NR4A3	0.0	0.0	0.0	0.0	-29.0	41.0	-25.0	27.0						0.0341					homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; neoplasm; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; 			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;adrenal cortex;skeletal muscle;globus pallidus;	.	negative regulation of transcription by RNA polymerase II;mesoderm formation;transcription initiation from RNA polymerase II promoter;gastrulation;axon guidance;pyruvate oxidation;positive regulation of cardiac muscle hypertrophy;positive regulation of glucose transmembrane transport;hippocampus development;intracellular receptor signaling pathway;adult behavior;animal organ regeneration;positive regulation of mast cell cytokine production;common myeloid progenitor cell proliferation;positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway;response to hydrogen peroxide;mast cell degranulation;steroid hormone mediated signaling pathway;negative regulation of neuron apoptotic process;cellular response to leptin stimulus;cellular respiration;fat cell differentiation;regulation of megakaryocyte differentiation;positive regulation of cell cycle;positive regulation of transcription by RNA polymerase II;positive regulation of fatty acid oxidation;platelet-derived growth factor receptor signaling pathway;regulation of smooth muscle cell proliferation;positive regulation of smooth muscle cell proliferation;semicircular canal morphogenesis;positive regulation of epithelial cell proliferation;neuromuscular process controlling balance;vestibular reflex;regulation of type B pancreatic cell proliferation;cellular response to corticotropin-releasing hormone stimulus;cellular response to catecholamine stimulus;energy homeostasis;positive regulation of monocyte aggregation;negative regulation of hydrogen peroxide-induced neuron death;positive regulation of vascular smooth muscle cell proliferation;positive regulation of vascular associated smooth muscle cell migration;positive regulation of leukocyte apoptotic process;positive regulation of feeding behavior	nucleus;nucleoplasm;transcription factor complex;mast cell granule	RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription coactivator binding;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;steroid hormone receptor activity;nuclear receptor activity;protein binding;zinc ion binding;protein kinase binding;histone acetyltransferase binding;glucocorticoid receptor binding;cAMP response element binding;protein homodimerization activity;sequence-specific DNA binding	KPRP[unassigned1304];ZNF330[unassigned1304];CHRD[unassigned1304];UBE3A[unassigned1304];PCSK5[unassigned1304];LOC151121[unassigned1304];LCE2D[unassigned1304];CYSRT1[unassigned1304];EFEMP1[unassigned1304];ADAMTSL4[unassigned1304];KRTAP5-11[unassigned1304];SIX3[12543801];TSPAN4[unassigned1304];VWC2L[unassigned1304];KRTAP5-3[unassigned1304];KRTAP4-4[unassigned1304];KRTAP4-2[unassigned1304];CDKN2D[unassigned1304];HSD3B7[unassigned1304];KRTAP5-9[unassigned1304];KRTAP10-5[unassigned1304];KRTAP12-3[unassigned1304];KRTAP9-3[unassigned1304];KRTAP9-2[unassigned1304];KRTAP5-6[unassigned1304];KRTAP12-4[unassigned1304];KRTAP10-8[unassigned1304];MACO1[unassigned1304];VASN[unassigned1304];KRTAP9-8[unassigned1304];LCE2B[unassigned1304];ALPP[unassigned1304];CYP21A2[unassigned1304];SMOC1[unassigned1304];KRTAP4-11[unassigned1304];PIN1[unassigned1304];RECK[unassigned1304];NECTIN2[unassigned1304];
447785	chr1	12776218	C	C	chr1:12776218	AADACL3	arylacetamide deacetylase like 3	6283.0	SNV	1/1	1.0	0_36	36	99	False	rs3000860	EXONIC	YES	NM_001103170.3	Transcript	protein_coding	synonymous_variant		1/4	NM_001103170.3:c.39A>C	NP_001096640.2:p.Cys13%3D		1.0						.	.	.						0	0.0											0	0.0							0.0000379,0.0000379,0.0000379,0.1693718	1,1,1,26338	0.35	1087.0				0.131	-0.445948		0	0	0			AADACL3	0.0	0.0	0.0	0.0	14.0	2.0	23.0	-39.0						0.92	0.0				.			.	.	.	integral component of membrane	carboxylic ester hydrolase activity	.
448618	chr6	57244780	G	A	chr6:57244780	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.61	24_37	61	99	False	rs5011403,COSV67291502	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		6/14	NM_000947.5:c.541G>A	NP_000938.2:p.Glu181Lys		1.0						.	.	.		1.31617e-05	2.0	151956.0	0.0	30	0.96	PASS	amr	6.54965e-05	1.0	1.47128e-05	1.0	0.499472	97508.0	195222.0	15.0	37	0.6	InbreedingCoeff	amr	0.5	14399.0	0.499189	41220.0	0.0364171	5663	0.199	619.0				20.4	2.068049		3	7	10	BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-XF_coding_pred	PRIM2	0.0	0.0	0.0	0.0	3.0	-48.0	9.0	14.0							0.0	95.193827403	0.469	1.176	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448622	chr6	57246884	A	G	chr6:57246884	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.67	16_32	48	99	False	rs6913546,COSV67291508	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		7/14	NM_000947.5:c.611A>G	NP_000938.2:p.Asp204Gly		1.0						.	.	.						31	0.97							0.499907	124265.0	248576.0	0.0	66	1.0	InbreedingCoeff	afr	0.5	7736.0	0.499902	56324.0	0.0364042	5661	0.182	569.0				16.74	1.580964		1	9	10	fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-XF_coding_pred	PRIM2	0.0	0.0	0.0	0.0	0.0	-21.0	-1.0	13.0							0.0	32.921440911	0.969	-1.039	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448828	chr6	57393125	G	G	chr6:57393125	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.62	27_44	71	99	False	rs927192	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		9/14	NM_000947.5:c.775A>G	NP_000938.2:p.Gly259%3D		1.0						.	.	.		0.000835713	127.0	151966.0	1.0	31	0.96	PASS	afr	0.00280099	116.0	7.36095e-05	5.0	0.500985	101184.0	201970.0	204.0	28	0.59	InbreedingCoeff	eas	0.501361	7369.0	0.501074	43395.0	0.0244753	3806	0.201	634.0				21.4	2.200223		0	0	0			PRIM2	0.07	0.0	0.0	0.0	-13.0	2.0	7.0	-13.0							0.0	98.093753612			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448829	chr6	57393160	G	A	chr6:57393160	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.35	52_28	80	99	False	rs76686926,COSV67291476	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		9/14	NM_000947.5:c.810G>A	NP_000938.2:p.Lys270%3D		1.0						.	.	.						32	0.95							0.481636	66694.0	138474.0	0.0	31	0.6	InbreedingCoeff_RF	sas	0.487071	8288.0	0.481641	29750.0	0.0141154	2195	0.17	524.0				15.02	1.268604		0	0	0			PRIM2	0.0	0.33	0.0	0.14	11.0	-48.0	-48.0	24.0							0.0	98.093753612			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448837	chr6	57398154	C	C	chr6:57398154	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.73	22_60	82	99	False	rs80081867	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		10/14	NM_000947.5:c.857T>C	NP_000938.2:p.Pro286%3D		1.0						.	.	.						32	0.97							0.491001	114422.0	233038.0	8.0	82	1.0	InbreedingCoeff	nfe	0.492382	52611.0	0.492382	52611.0	0.0202889	3155	0.211	665.0				23.0	2.732579		0	0	0			PRIM2	0.0	0.0	0.0	0.0	-22.0	14.0	-14.0	14.0							0.0	32.921440911			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448838	chr6	57398157	G	G	chr6:57398157	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.72	23_59	82	99	False	rs9476080	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		10/14	NM_000947.5:c.860A>G	NP_000938.2:p.Cys287%3D		1.0						.	.	.						32	0.97							0.490922	114596.0	233430.0	8.0	85	1.0	InbreedingCoeff	nfe	0.492318	52681.0	0.492318	52681.0	0.0201088	3127	0.211	664.0				22.7	2.563688		0	0	0			PRIM2	0.01	0.0	0.0	0.0	11.0	2.0	11.0	-25.0							0.0	32.921440911			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448839	chr6	57398163	G	G	chr6:57398163	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.71	24_59	83	99	False	rs9476081	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		10/14	NM_000947.5:c.866A>G	NP_000938.2:p.Arg289%3D		1.0						.	.	.						32	0.97							0.489434	113859.0	232634.0	9.0	92	1.0	InbreedingCoeff	nfe	0.491147	52373.0	0.491147	52373.0	0.0201795	3138	0.201	632.0				20.8	2.125118		0	0	0			PRIM2	0.0	0.0	0.0	0.0	-31.0	5.0	-1.0	5.0							0.0	14.937332107			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448840	chr6	57398187		A	chr6:57398186-57398187	PRIM2	DNA primase subunit 2	6297.0	insertion	0/1	0.34	53_27	80	99	False	rs147954160	EXONIC	YES	NM_000947.5	Transcript	protein_coding	frameshift_variant		10/14	NM_000947.5:c.893dup	NP_000938.2:p.Asn298LysfsTer45		1.0						.	.	.						32	0.97							0.461417	63838.0	138352.0	0.0	100	1.0	InbreedingCoeff_RF	nfe	0.46781	30373.0	0.46781	30373.0	0.0030224,0.0221538	470,3445	0.032	100.0				35.0	5.952242		0	0	0			PRIM2	0.0	0.0	0.0	0.0	-18.0	36.0	-18.0	34.0							0.0	57.919392056			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448841	chr6	57398201	C	C	chr6:57398201	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.71	24_58	82	99	False	rs62398997	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		10/14	NM_000947.5:c.904T>C	NP_000938.2:p.Arg302%3D		1.0						.	.	.						32	0.97							0.492428	110296.0	223984.0	14.0	100	1.0	InbreedingCoeff	sas	0.493805	14028.0	0.493387	50059.0	0.0356068	5537	0.164	516.0				20.6	2.094072		0	0	0			PRIM2	0.0	0.0	0.0	0.0	-33.0	39.0	19.0	39.0							0.0	44.368133529			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448842	chr6	57398226	G	G	chr6:57398226	PRIM2	DNA primase subunit 2	6297.0	SNV	1/2	0.37	24_30_28	82	81	False	rs77436138	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		10/14	NM_000947.5:c.929T>G	NP_000938.2:p.Gly310%3D		1.0						.	.	.						32	0.97							0.344938	70181.0	203460.0	1.0	100	1.0	InbreedingCoeff	nfe	0.357232	33289.0	0.357232	33289.0	0.0099161	1542	0.065	191.0				21.8	2.262626		0	0	0			PRIM2	0.0	0.0	0.0	0.0	7.0	38.0	45.0	-6.0							0.0	0.0			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448843	chr6	57398226	G	A	chr6:57398226	PRIM2	DNA primase subunit 2	6297.0	SNV	1/2	0.34	24_30_28	82	81	False	rs77436138	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		10/14	NM_000947.5:c.929T>A	NP_000938.2:p.Gly310Asp		1.0						.	.	.						32	0.97							0.147262	29962.0	203460.0	0.0	100	1.0	InbreedingCoeff	afr	0.195757	2344.0	0.136426	12713.0	0.0045594	709	0.061	180.0				24.8	3.438127		2	0	2	SIFT,PolyPhen		PRIM2	0.0	0.0	0.0	0.0	-17.0	38.0	-12.0	-6.0							0.0	0.0			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448844	chr6	57398264	G	G	chr6:57398264	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.76	18_56	74	99	False	rs62398998	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		10/14	NM_000947.5:c.967A>G	NP_000938.2:p.Ala323%3D		1.0						.	.	.						33	0.97							0.496516	116143.0	233916.0	26.0	95	1.0	InbreedingCoeff	nfe	0.497011	53214.0	0.497011	53214.0	0.0342049	5319	0.148	446.0				19.35	1.950996		0	0	0			PRIM2	0.03	0.0	0.0	0.0	0.0	-24.0	-44.0	33.0							0.0	44.368133529			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448845	chr6	57398270	C	T	chr6:57398270	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.42	43_31	74	99	False	rs62398999,COSV67291773	EXONIC	YES	NM_000947.5	Transcript	protein_coding	stop_gained		10/14	NM_000947.5:c.973C>T	NP_000938.2:p.Gln325Ter		1.0						.	.	.						32	0.96							0.464235	84383.0	181768.0	0.0	91	1.0	InbreedingCoeff	nfe	0.470419	39471.0	0.470419	39471.0	0.0313047	4868	0.118	339.0				37.0	7.262467		3	0	3	BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred		PRIM2	0.0	0.01	0.01	0.01	-50.0	-6.0	-50.0	47.0							0.0	44.368133529	1.0	1.012	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448849	chr6	57467084	A	G	chr6:57467084	PRIM2	DNA primase subunit 2	6297.0	SNV	0|1	0.36	55_31	86	99	False	rs9885913,COSV67291485	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		11/14	NM_000947.5:c.1025A>G	NP_000938.2:p.Asp342Gly		1.0						.	.	.		6.57151e-06	1.0	152172.0	0.0	32	0.96	PASS	eas	0.000192604	1.0	0.0	0.0	0.499564	115649.0	231500.0	0.0	61	1.0	InbreedingCoeff	sas	0.499932	14647.0	0.499404	51957.0	0.0187905	2922	0.196	605.0				25.1	3.526431		8	3	11	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred	PRIM2	0.04	0.0	0.0	0.0	6.0	-4.0	-1.0	5.0							0.0	48.768084866	1.0	1.221	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448850	chr6	57467093	A	G	chr6:57467093	PRIM2	DNA primase subunit 2	6297.0	SNV	0|1	0.37	53_31	84	99	False	rs9885916,COSV67291488	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		11/14	NM_000947.5:c.1034A>G	NP_000938.2:p.Tyr345Cys		1.0						.	.	.						32	0.96							0.499516	116545.0	233316.0	0.0	65	1.0	InbreedingCoeff	sas	0.499966	14686.0	0.499363	52484.0	0.0187905	2922	0.095	252.0				25.7	3.693188		8	3	11	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred	PRIM2	0.0	0.0	0.0	0.0	-13.0	-3.0	35.0	-4.0							0.0	21.873700008	0.998	1.221	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448851	chr6	57467100	C	C	chr6:57467100	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.68	28_59	87	99	False	rs4535533	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		11/14	NM_000947.5:c.1041G>C	NP_000938.2:p.Tyr347%3D		1.0						.	.	.		1.97249e-05	3.0	152092.0	0.0	32	0.95	PASS	eas	0.000192753	1.0	0.0	0.0	0.500016	124606.0	249204.0	4.0	69	1.0	InbreedingCoeff	nfe	0.500027	56501.0	0.500027	56501.0	0.0253884	3948	0.097	254.0				9.193	0.477967		0	0	0			PRIM2	0.01	0.01	0.0	0.0	15.0	-10.0	-11.0	-10.0							0.0	21.873700008			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448852	chr6	57467107	C	T	chr6:57467107	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.35	58_31	89	99	False	rs9885751,COSV67291491	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		11/14	NM_000947.5:c.1048C>T	NP_000938.2:p.Arg350Cys		1.0						.	.	.		6.5735e-05	10.0	152126.0	0.0	32	0.96	PASS,PASS	amr,nfe	0.000327311	5.0	0.0	0.0	0.49948	118154.0	236554.0	0.0	73	1.0	InbreedingCoeff	sas	0.5	14697.0	0.499328	53504.0	0.0218901	3404	0.095	251.0				17.94	1.765823		8	3	11	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred	PRIM2	0.0	0.0	0.0	0.0	-17.0	-27.0	-18.0	-17.0							0.0		1.0	0.957	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448853	chr6	57467175	G	G	chr6:57467175	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.34	62_32	94	99	False	rs4406234	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		11/14	NM_000947.5:c.1116A>G	NP_000938.2:p.Leu372%3D		1.0						.	.	.						32	0.95							0.49998	122649.0	245308.0	0.0	88	1.0	InbreedingCoeff	eas	0.5	8824.0	0.499982	55860.0	0.0310024	4821	0.179	552.0				13.36	0.99013		0	0	0			PRIM2	0.0	0.0	0.0	0.0	-18.0	15.0	31.0	35.0							0.0				.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448860	chr6	57499043		T	chr6:57499042-57499043	PRIM2	DNA primase subunit 2	6297.0	insertion	0/1	0.27	69_26	95	99	False	rs5876654	SPLICING	YES	NM_000947.5	Transcript	protein_coding	splice_region_variant,intron_variant	13/13		NM_000947.5:c.1299+14dup			1.0						.	.	.		7.16353e-06	1.0	139596.0	0.0	29	0.87	PASS,AS_VQSR	amr,nfe	7.17051e-05	1.0	0.0	0.0	0.495547	76447.0	154268.0	0.0	22	0.53	InbreedingCoeff_RF	sas	0.496874	10172.0	0.495029	31471.0	0.0042507,0.0203918	661,3171	0.018	58.0				11.21	0.70729		0	0	0			PRIM2	0.0	0.0	0.02	0.0	-43.0	-1.0	-7.0	-3.0							0.0				.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448862	chr6	57512476	A	A	chr6:57512476	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.65	27_52	80	99	False	rs4307164	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		14/14	NM_000947.5:c.1304G>A	NP_000938.2:p.Asp435%3D		1.0						.	.	.		6.57333e-06	1.0	152130.0	0.0	29	0.91	PASS	afr	2.41359e-05	1.0	0.0	0.0	0.50025	123968.0	247812.0	62.0	96	1.0	InbreedingCoeff	eas	0.501058	9001.0	0.50034	55898.0	0.0310153	4823	0.188	592.0				15.1	1.282483		0	0	0			PRIM2	0.01	0.0	0.0	0.0	-4.0	47.0	41.0	-5.0							0.0				.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448863	chr6	57512529	C	A	chr6:57512529	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.27	54_20	75	99	False	rs5001076,COSV67291545	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		14/14	NM_000947.5:c.1357C>A	NP_000938.2:p.Arg453Ser		1.0						.	.	.	25961151	6.57479e-06	1.0	152096.0	0.0	30	0.95	PASS				0.0	0.0	0.499037	117630.0	235714.0	0.0	100	1.0	InbreedingCoeff	sas	0.499966	14610.0	0.498797	53509.0	0.0185847	2890	0.185	568.0				13.61	1.026598		2	7	9	SIFT,LIST-S2_pred	PolyPhen,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	PRIM2	0.0	0.0	0.0	0.0	2.0	-6.0	-30.0	15.0							0.0		0.985	0.961	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448864	chr6	57512565	C	C	chr6:57512565	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.59	29_44	75	99	False	rs4294008	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		14/14	NM_000947.5:c.1393T>C	NP_000938.2:p.Pro465%3D		1.0						.	.	.						31	0.95							0.500261	124593.0	249056.0	65.0	100	1.0	InbreedingCoeff	eas	0.501391	9012.0	0.500292	56445.0	0.0364299	5665	0.192	608.0				0.382	-0.293619		0	0	0			PRIM2	0.0	0.0	0.0	0.0	-42.0	13.0	-40.0	-48.0							0.0				.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
448865	chr6	57512678	A	A	chr6:57512678	PRIM2	DNA primase subunit 2	6297.0	SNV	0/1	0.57	32_43	76	99	False	rs4398719	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		14/14	NM_000947.5:c.1506G>A	NP_000938.2:p.Glu502%3D		1.0						.	.	.						31	0.96							0.500181	124336.0	248582.0	46.0	100	1.0	InbreedingCoeff	eas	0.500835	9001.0	0.500214	56200.0	0.0337419	5247	0.204	645.0				5.254	0.161463		0	0	0			PRIM2	0.0	0.0	0.0	0.0	32.0	25.0	32.0	24.0							0.0				.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];
449616	chr4	46930510	C	T	chr4:46930510	GABRA4	gamma-aminobutyric acid type A receptor alpha4 subunit	6310.0	SNV	0/1	0.55	13_16	29	99	False	rs115206335,COSV51927189	EXONIC	YES	NM_000809.4	Transcript	protein_coding	missense_variant		9/9	NM_000809.4:c.1397G>A	NP_000800.2:p.Arg466Gln		-1.0	Neurotransmitter-gated ion-channel transmembrane domain					.	.	.		0.00100641	153.0	152026.0	2.0	32	0.97	PASS	sas	0.00166044	8.0	0.00154425	105.0	0.00134298	337.0	250934.0	2.0	93	1.0	PASS	sas	0.00215588	66.0	0.00166699	189.0	0.0012733	198	0.002	5.0				3.111	0.031035	0.076	1	18	19	M-CAP_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GABRA4	0.0	0.0	0.0	0.0	-49.0	-5.0	-4.0	1.0						0.024	0.98	0.0	0.001	0.125	normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); 			ciliary ganglion;caudate nucleus;pons;atrioventricular node;trigeminal ganglion;superior cervical ganglion;cingulate cortex;parietal lobe;skeletal muscle;medulla oblongata;	Neuroactive ligand-receptor interaction	signal transduction;gamma-aminobutyric acid signaling pathway;chemical synaptic transmission;central nervous system development;ion transmembrane transport;regulation of membrane potential;nervous system process;synaptic transmission, GABAergic;regulation of postsynaptic membrane potential;chloride transmembrane transport;regulation of response to drug	plasma membrane;integral component of plasma membrane;cell junction;dendrite membrane;chloride channel complex;neuron projection;synapse;postsynapse;GABA-ergic synapse;integral component of postsynaptic specialization membrane;GABA-A receptor complex	GABA-A receptor activity;extracellular ligand-gated ion channel activity;inhibitory extracellular ligand-gated ion channel activity;chloride channel activity;benzodiazepine receptor activity;GABA-gated chloride ion channel activity;transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential	DGAT1[21988832];
449627	chr4	46973210	T	C	chr4:46973210	GABRA4	gamma-aminobutyric acid type A receptor alpha4 subunit	6310.0	SNV	0/1	0.54	16_19	35	99	False	rs1019175962	EXONIC	YES	NM_000809.4	Transcript	protein_coding	missense_variant		7/9	NM_000809.4:c.764A>G	NP_000800.2:p.Lys255Arg		-1.0	Neurotransmitter-gated ion-channel ligand-binding domain					.	.	.						32	0.96											45	0.97														24.8	3.459259	0.306	14	7	21	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred	GABRA4	0.0	0.04	0.01	0.0	-23.0	42.0	43.0	-5.0						0.024	0.98	21.873700008	1.0	1.118	normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); 			ciliary ganglion;caudate nucleus;pons;atrioventricular node;trigeminal ganglion;superior cervical ganglion;cingulate cortex;parietal lobe;skeletal muscle;medulla oblongata;	Neuroactive ligand-receptor interaction	signal transduction;gamma-aminobutyric acid signaling pathway;chemical synaptic transmission;central nervous system development;ion transmembrane transport;regulation of membrane potential;nervous system process;synaptic transmission, GABAergic;regulation of postsynaptic membrane potential;chloride transmembrane transport;regulation of response to drug	plasma membrane;integral component of plasma membrane;cell junction;dendrite membrane;chloride channel complex;neuron projection;synapse;postsynapse;GABA-ergic synapse;integral component of postsynaptic specialization membrane;GABA-A receptor complex	GABA-A receptor activity;extracellular ligand-gated ion channel activity;inhibitory extracellular ligand-gated ion channel activity;chloride channel activity;benzodiazepine receptor activity;GABA-gated chloride ion channel activity;transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential	DGAT1[21988832];
449716	chr9	35736644	A	G	chr9:35736644	CREB3	cAMP responsive element binding protein 3	6316.0	SNV	0/1	0.43	20_15	35	99	False	rs200877201,COSV59207463	EXONIC	YES	NM_006368.5	Transcript	protein_coding	missense_variant		9/9	NM_006368.5:c.1037A>G	NP_006359.3:p.Gln346Arg		1.0						.	.	.		0.000374581	57.0	152170.0	0.0	32	0.98	PASS	amr	0.00215912	33.0	0.000249912	17.0	0.000311726	78.0	250220.0	0.0	100	0.99	PASS	amr	0.00104137	36.0	0.000256542	29.0	0.0002379	37	0.004	14.0				15.22	1.305311	0.074	1	16	17	M-CAP_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CREB3	0.0	0.0	0.0	0.0	43.0	2.0	-19.0	38.0						0.612	0.0	0.0	0.221	1.312	.			.	Melanogenesis;Prostate cancer	chemotaxis;positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response;viral process;endoplasmic reticulum unfolded protein response;positive regulation of transcription by RNA polymerase II;positive regulation of monocyte chemotaxis;negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	Golgi membrane;nucleus;nucleoplasm;endoplasmic reticulum;endoplasmic reticulum membrane;cytosol;integral component of membrane	RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protein binding;cAMP response element binding	CYBC1[21516116];ICAM4[21516116];AQP4[25910212];AQP5[21516116];TMEM140[21516116];AQP2[25910212];AQP1[21516116;25910212];SCAMP5[21516116];KRTCAP2[21516116];GJA1[25910212];RIMS3[21516116];SCP2[21516116];CREB3L3[20102225];CREB3L4[25241761];BCAP29[21516116];FAM3A[21516116];FAM3C[21516116];TMEM14A[21516116];TMEM14B[21516116];TMEM14C[21516116];ALG8[25910212];IGFBP5[25910212];SLC30A2[21516116;25910212];STX8[16189514;21516116];SACM1L[21516116];SLC35C2[21516116];STX7[21516116];ALG3[21516116;25910212];TAP1[21516116];ACSL5[21516116];CNPY3[21516116];TM4SF4[21516116];CGRRF1[21516116];HCFC1[10629049;10871379;15705566;9271389;18391022];DNAJC30[21516116];DDIT3[20102225];MALL[16189514];UNC50[21516116];SERPING1[25910212];ADTRP[21516116];PLPP1[21516116];CES1[21516116];CELA3A[21516116];GYPA[25910212];SHMT2[21516116];SLC41A3[21516116];MGST2[25910212];CT45A5[21516116];AGER[25910212];UBE2J1[21516116];C2[25910212];APH1A[21516116];PTDSS1[21516116];SYNGR1[21516116;25910212];EBP[25910212];TSPAN7[21516116];NEU1[25910212];SLC19A3[21516116];TSPAN4[21516116];HMOX1[21516116];APOD[21516116;25910212];PLTP[25910212];FDFT1[25910212];CCR1[15001559];FIS1[21516116];JUN[20195357];BTN2A2[21516116];CYP4F2[25910212];PTCH1[25910212];C16orf58[21516116];DOLK[21516116];MARCH5[21516116];ACSF2[21516116];TMEM230[21516116];VANGL1[25910212];SQLE[21988832];TMEM234[21516116];APPBP2[16189514];TMEM115[21516116];RHEB[21516116];P4HA2[21516116];FXYD3[21516116];CD207[25910212];CREBRF[18391022];FXYD6[21516116];SERINC1[21516116];TMEM19[21516116];ITM2B[21516116];LAT[21516116];BCL2L1[21516116];CREBZF[15705566];LMBR1L[21516116];PNLIPRP1[21516116];TRAM1[21516116];TECR[21516116];SLC2A1[25910212];TMEM51[21516116];CTSW[21516116];SLC2A3[21516116];SLC2A4[25910212];USE1[21516116];TMEM100[21516116];ABHD16A[21516116];MFSD5[21516116];SEC61G[21516116];TIMM17B[21516116];CCR5[15001559];EMD[16189514;25910212];PSENEN[21516116];VKORC1[21516116];BATF3[20102225];PLLP[21516116];SFTPC[25910212];APOA2[21516116];RRAS2[21988832];RPS3A[21516116];CREB3[10675342;21516116];DCSTAMP[20546900];NRG4[21516116];SLC7A9[25910212];LTA[25910212];CLDN19[25910212];SLC29A1[21516116];SEC22B[21516116];MS4A1[21516116];SLC29A3[25910212];SLC29A2[21516116];BCAT2[21988832];C1S[25910212];ZDHHC21[21516116];AGPAT3[21516116];PLN[25910212];OS9[20546900];NFIL3[20102225];RAB23[21516116];SPOCK3[21516116];BNIP2[16189514];RABAC1[21988832];RPRM[21516116];BIK[21516116];BNIP3[21516116];CMTM5[21516116];LHFPL5[25910212];ORMDL1[21516116];FMO1[25910212];SLC50A1[21516116];FMO3[25910212];LILRB5[21516116];CLCN7[21516116];CLCN5[25910212];ZDHHC9[25910212];LPCAT2[21516116];PMP22[25910212];PLP1[25910212];PTPN9[21516116];CFHR5[25910212];SCLY[21516116];TAF4[17483474];CYB561[21516116];
452775	chr16	56916388	G	A	chr16:56916388	SLC12A3	solute carrier family 12 member 3	6388.0	SNV	0/1	0.52	13_14	27	99	False	rs563131364,COSV99343937,COSV99344468	EXONIC	YES	NM_000339.3	Transcript	protein_coding	missense_variant		13/26	NM_000339.3:c.1648G>A	NP_000330.3:p.Ala550Thr		1.0	.,.,Amino acid permease/ SLC12A domain,Amino acid permease/ SLC12A domain				Gitelman syndrome, 263800 (3), Autosomal recessive	Gitelman syndrome	Disease-causing germline mutation(s) (loss of function) in	Tinnitus;Syncope;Proteinuria;Polydipsia;Tubulointerstitial nephritis;Rhabdomyolysis;Iron deficiency anemia;Chondrocalcinosis;Constipation;Type II diabetes mellitus;Raynaud phenomenon;ST segment depression;Cerebral calcification;Scleroderma;Palpitations;Hashimoto thyroiditis;Hypomagnesemia;Focal seizures, afebril;Varicose veins;Pericardial effusion;Headache;Insulin resistance;Muscle weakness;Respiratory distress;Focal segmental glomerulosclerosis;Blurred vision;Gout;Insomnia;Parathyroid adenoma;Paralysis;Renal Fanconi syndrome;Maternal diabetes;Abdominal pain;Salt craving;Mitochondrial encephalopathy;Decreased urinary potassium;Prolonged PR interval;Failure to thrive;Renal tubular acidosis;Paresthesia;Type I diabetes mellitus;Urinary incontinence;Low-to-normal blood pressure;Abnormal T-wave;Arthralgia;Nocturia;Prominent U wave;Nausea and vomiting;Hypocalcemia;Hyperhidrosis;Metabolic alkalosis;Prolonged QT interval;Primary hyperaldosteronism;Neoplasm of the pancreas;Enuresis;Diarrhea;Hypokalemia;Delayed puberty;Myalgia;Vertigo;Renal potassium wasting;Graves disease;Hypermagnesemia;Diabetic ketoacidosis;Ventricular fibrillation;Excessive daytime sleepiness;Muscle spasm;Salt craving;Failure to thrive;Juvenile onset;Recurrent fever;Blurred vision;Enuresis;Palpitations;Vertigo;Paralysis;Vomiting;Ventricular tachycardia;Nocturia;Hypotension;Prolonged QT interval;Tetany;Increased circulating renin level;Hypomagnesemia;Muscle spasm;Polyuria;Muscle weakness;Abdominal pain;Hypokalemia;Generalized muscle weakness;Rhabdomyolysis;Delayed puberty;Autosomal recessive inheritance;Constipation;Arthralgia;Paresthesia;Hypokalemic alkalosis;Chondrocalcinosis;Ataxia;Renal potassium wasting;Fatigue;Seizure;Hypocalciuria;Renal magnesium wasting;Polydipsia		0.000282958	43.0	151966.0	0.0	31	0.95	PASS	amr	0.0015076	23.0	7.351e-05	5.0	0.000194853	49.0	251472.0	0.0	100	1.0	PASS	amr	0.00106961	37.0	7.91125e-05	9.0	0.0001029	16	0.004	13.0	0.00175	20.0		31.0	4.312519	0.975	20	1	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PrimateAI_pred	SLC12A3	0.0	0.01	0.0	0.0	11.0	-10.0	25.0	21.0						0.0228	0.0	0.0	0.998	1.176	renal/urinary system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			ciliary ganglion;kidney;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	ion transport;sodium ion transport;cell volume homeostasis;sodium ion transmembrane transport;chloride ion homeostasis;potassium ion homeostasis;sodium ion homeostasis;chloride transmembrane transport;potassium ion import across plasma membrane	cytosol;plasma membrane;integral component of plasma membrane;membrane;apical plasma membrane;extracellular exosome	transporter activity;protein binding;sodium:potassium:chloride symporter activity;sodium ion transmembrane transporter activity;sodium:chloride symporter activity;potassium:chloride symporter activity	.
457260	chr9	124914581	G	A	chr9:124914581	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	6429.0	SNV	0/1	0.57	12_16	28	99	False	rs768617042,COSV99057655	EXONIC	YES	NM_014222.3	Transcript	protein_coding	missense_variant		2/4	NM_014222.3:c.158C>T	NP_055037.1:p.Pro53Leu		-1.0					Mitochondrial complex I deficiency, nuclear type 37, 619272 (3), Autosomal recessive	.	.	.		1.97267e-05	3.0	152078.0	0.0	33	0.96	PASS	afr	2.41616e-05	1.0	0.0	0.0	2.78396e-05	7.0	251440.0	0.0	77	1.0	PASS	amr	2.89101e-05	1.0	8.79306e-06	1.0	0.0000064	1						28.9	4.13215	0.905	20	1	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PrimateAI_pred	NDUFA8	0.0	0.0	0.0	0.0	-15.0	9.0	-6.0	-36.0						0.381	0.2	0.0	0.961	1.176	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; homeostasis/metabolism phenotype; 			.	Oxidative phosphorylation	mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I assembly	mitochondrion;mitochondrial inner membrane;mitochondrial respiratory chain complex I;mitochondrial intermembrane space	NADH dehydrogenase (ubiquinone) activity;protein-containing complex binding	NDUFA11[24344204];GOLT1B[26496610];PLGRKT[29568061];COX4I1[29568061];HSPD1[29568061];KLC3[26496610];CHCHD2[27499296];AIFM1[29568061];MYC[17314511];MIC13[27499296];COX14[29568061];TIMMDC1[24344204];NDUFA6[12611891];KSR1[27086506];CCDC58[27499296];NDUFA2[19688755];RIPK4[26972000];NDUFAF8[27499296];TBC1D4[23455924];SCO1[29568061];NDUFAF4[27499296];NDUFS3[21310150];NDUFAF3[24344204];ATM[26496610];SFXN1[29568061];CNTROB[26496610];NIT1[27499296];GLIPR1L2[30021884];RAB7A[26496610];
457273	chr19	2351565	C	T	chr19:2351565	SPPL2B	signal peptide peptidase like 2B	6430.0	SNV	0/1	0.45	20_18	40	99	False	rs62119750	EXONIC	YES	NM_152988.3	Transcript	protein_coding	synonymous_variant		15/16	NM_152988.3:c.1485C>T	NP_694533.1:p.Gly495%3D		1.0						.	.	.		0.00233801	356.0	152266.0	1.0	33	0.99	PASS	amr	0.00719236	110.0	0.00296849	202.0	0.00231919	572.0	246638.0	0.0	51	0.97	PASS	amr	0.00435388	150.0	0.00307156	342.0	0.0018135	282	0.008	25.0				15.37	1.33365		0	0	0																						immune system phenotype; hematopoietic system phenotype; 			.	.	membrane protein ectodomain proteolysis;regulation of tumor necrosis factor-mediated signaling pathway;membrane protein intracellular domain proteolysis;membrane protein proteolysis;regulation of immune response	Golgi membrane;nucleoplasm;lysosomal membrane;centrosome;plasma membrane;endosome membrane;actin cytoskeleton;membrane;Golgi-associated vesicle membrane;integral component of cytoplasmic side of endoplasmic reticulum membrane;integral component of lumenal side of endoplasmic reticulum membrane	protein binding;aspartic endopeptidase activity, intramembrane cleaving;protein homodimerization activity	TFRC[23384347];
457353	chr7	117365146	T	C	chr7:117365146	CTTNBP2	cortactin binding protein 2	6435.0	SNV	0/1	0.54	21_25	46	99	False	rs143800569	EXONIC	YES	NM_033427.3	Transcript	protein_coding	synonymous_variant		18/23	NM_033427.3:c.4221A>G	NP_219499.1:p.Leu1407%3D		-1.0						.	.	.		0.000361224	55.0	152260.0	0.0	33	0.98	PASS	amr	0.000850229	13.0	0.000558462	38.0	0.000294401	74.0	251358.0	0.0	100	1.0	PASS	nfe	0.000492724	56.0	0.000492724	56.0	0.0002251	35	0.0	1.0	0.00053	6.0		7.531	0.324965		0	0	0			CTTNBP2	0.0	0.0	0.14	0.0	-36.0	-40.0	-40.0	27.0							0.0	79.697520579			skeleton phenotype; 			ciliary ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	.	brain development;regulation of modification of postsynaptic actin cytoskeleton	cell cortex;synaptic vesicle;dendritic spine;postsynaptic actin cytoskeleton;glutamatergic synapse	SH3 domain binding	FAM86C1[unassigned1304];HSF2BP[unassigned1304];STRN4[18782753];ARNTL2[unassigned1304];STRN3[18782753;24366813];PPP2CA[18782753];PPP2CB[18782753];STRIP1[18782753];STRIP2[18782753];PPP2R1B[18782753];PPP2R1A[18782753;28330616];PDCD10[18782753];CCT8[18782753];MAGEA11[unassigned1304];CCT5[18782753];APPL1[23414517];PKNOX2[unassigned1304];CCT3[18782753];CCT2[18782753];ZRANB1[19615732];INCA1[unassigned1304];CTTNBP2NL[18782753;24255178];MOB4[19156129;18782753];CCT6A[18782753];STK24[18782753;23455922];STK25[18782753;23455922];STK26[18782753;23455922];TCP1[18782753];KRT14[unassigned1304];STRN[18782753;24366813];PLEC[30021884];
459293	chr22	19906454	T	C	chr22:19906454	TXNRD2	thioredoxin reductase 2	6475.0	SNV	0/1	0.45	15_13	29	99	False	rs200076623,COSV57635791	EXONIC	YES	NM_006440.5	Transcript	protein_coding	synonymous_variant		4/18	NM_006440.5:c.303A>G	NP_006431.2:p.Ala101%3D		-1.0		Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Primary_dilated_cardiomyopathy|Cardiovascular_phenotype|not_provided	?Glucocorticoid deficiency 5, 617825 (3), Autosomal recessive	Familial isolated dilated cardiomyopathy;Familial glucocorticoid deficiency	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Decreased circulating dehydroepiandrosterone level;Leydig cell neoplasia;Renal salt wasting;Hypotension;Azoospermia;Ketotic hypoglycemia;Congenital hypothyroidism;Weight loss;Tall stature;Abnormality of circulating adrenocorticotropin level;Recurrent urinary tract infections;Hypoglycemic seizures;Vomiting;Diarrhea;Hypernatriuria;Anorexia;Constipation;Tetraplegia;Precocious puberty;Episodic abdominal pain;Impaired cortisol response to insulin stimulation test;Testicular adrenal rest tumor;Decreased circulating cortisol level;Hypertrophic cardiomyopathy;Hypoglycemic coma;Hyperkalemia;Intellectual disability;Generalized hyperpigmentation;Decreased circulating aldosterone level;Cryptorchidism;Hyponatremia;Failure to thrive;Chronic fatigue;Palmoplantar keratoderma;EMG abnormality;Lipoatrophy;Dilated cardiomyopathy;Elevated serum creatine kinase;Abnormality of neutrophils;Sensorineural hearing impairment;Myopathy;Abnormal response to ACTH stimulation test;Autosomal recessive inheritance;Decreased circulating cortisol level;Hyperpigmentation of the skin		0.000658224	100.0	151924.0	1.0	29	0.9	PASS	amr	0.00117909	18.0	0.00107391	73.0	0.000567181	141.0	248598.0	0.0	67	0.99	PASS	nfe	0.000999929	113.0	0.000999929	113.0	0.0004823	75	0.002	5.0	0.00202	23.0		5.258	0.161716		0	0	0			TXNRD2	0.0	0.0	0.0	0.0	17.0	-46.0	-45.0	39.0						0.597	0.0	96.767421307			cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; liver/biliary system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;parietal lobe;skeletal muscle;globus pallidus;	Pyrimidine metabolism	response to oxygen radical;electron transport chain;cellular response to oxidative stress;cell redox homeostasis;cellular oxidant detoxification	cytoplasm;mitochondrion;mitochondrial matrix;cytosol	thioredoxin-disulfide reductase activity;protein binding;electron transfer activity;flavin adenine dinucleotide binding	NDUFA13[24344204];HSCB[28380382];
460599	chr10	134188640	C	T	chr10:134188640	LRRC27	leucine rich repeat containing 27	6501.0	SNV	0/1	0.59	13_19	32	99	False	rs138390679	EXONIC	YES	NM_001143757.2	Transcript	protein_coding	missense_variant		11/11	NM_001143757.2:c.1487C>T	NP_001137229.1:p.Ala496Val		1.0	.,.,.					.	.	.		0.00170801	260.0	152224.0	0.0	33	0.98	PASS	nfe	0.00326307	222.0	0.00326307	222.0	0.001631	410.0	251380.0	1.0	50	0.99	PASS	nfe	0.00307801	350.0	0.00307801	350.0	0.0016591	258	0.001	3.0				14.63	1.195886	0.047	1	18	19	SIFT	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRRC27	0.0	0.0	0.0	0.0	39.0	-12.0	-2.0	50.0						0.985	0.0	0.0	0.001	0.941	.			.	.	.	.	.	HIST1H2AE[30021884];MEOX2[unassigned1304];
460958	chr17	9281873	A	G	chr17:9281873	STX8	syntaxin 8	6509.0	SNV	0/1	0.45	16_14	31	99	False	rs138013675	EXONIC	YES	NM_004853.3	Transcript	protein_coding	synonymous_variant		7/8	NM_004853.3:c.639T>C	NP_004844.1:p.Ser213%3D		-1.0						.	.	.		0.00162967	248.0	152178.0	0.0	32	0.97	PASS	amr	0.00419122	64.0	0.00220491	150.0	0.00127274	320.0	251426.0	0.0	73	1.0	PASS	amr	0.00248627	86.0	0.00175867	200.0	0.0011511	179	0.007	23.0				4.877	0.137565		0	0	0			STX8	0.0	0.0	0.0	0.0	-4.0	30.0	-4.0	30.0						0.374	0.0	34.39461562			skeleton phenotype; normal phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype; 			pons;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;testis;parietal lobe;medulla oblongata;	SNARE interactions in vesicular transport	intracellular protein transport;vesicle fusion;endosome to lysosome transport;early endosome to late endosome transport;vesicle docking;cellular response to interferon-gamma;regulation of protein localization to plasma membrane	lysosomal membrane;endosome;early endosome;late endosome;endoplasmic reticulum;trans-Golgi network;cytosol;integral component of plasma membrane;endomembrane system;integral component of membrane;SNARE complex;late endosome membrane;vesicle;phagocytic vesicle;perinuclear region of cytoplasm;recycling endosome	SNARE binding;SNAP receptor activity;protein binding;chloride channel inhibitor activity;syntaxin binding;ubiquitin protein ligase binding	MS4A3[unassigned1304];RETREG3[unassigned1304];TMEM179B[unassigned1304];GORAB[unassigned1304];CEP164[26638075];STMN4[unassigned1304];CLEC9A[unassigned1304];HSCB[24606901];TSPAN12[unassigned1304];ASGR2[unassigned1304];SCAMP5[19234194];MCEE[unassigned1304];CREB3L1[unassigned1304];FAM174A[unassigned1304];WDR91[16169070];FFAR2[unassigned1304];SLC18A1[unassigned1304];TMEM14B[unassigned1304];NSF[20562859];CERS4[unassigned1304];TMED8[unassigned1304];MMGT1[unassigned1304];GPX8[unassigned1304];OCRL[25107275];VAMP8[19557002];CREB3[16189514;21516116];VAMP7[19557002];CLDN9[unassigned1304];TMEM216[26638075];CD300E[unassigned1304];FKBP7[unassigned1304];VAMP4[19557002];ERGIC3[unassigned1304];VAMP5[unassigned1304];STX1A[unassigned1304];VAMP3[19557002];ATP6V1A[21674799];SAR1A[unassigned1304];MGST3[unassigned1304];TMPRSS2[unassigned1304];MFF[unassigned1304];CPLX4[unassigned1304];GPR152[unassigned1304];TGOLN2[29568061];BCL2L13[unassigned1304];EBP[unassigned1304];KCNMB1[unassigned1304];TMEM205[unassigned1304];NCR3LG1[unassigned1304];BSND[unassigned1304];STX5[unassigned1304];STX4[25416956;unassigned1304];STX2[unassigned1304];VTI1B[16189514;21516116;unassigned1304];MCL1[unassigned1304];SLC10A6[unassigned1304];TMEM86B[unassigned1304];BIK[unassigned1304];FAM209A[unassigned1304];PEX12[unassigned1304];TMEM17[26638075];GJB1[unassigned1304];JSRP1[unassigned1304];STAR[unassigned1304];DHRS9[unassigned1304];TMEM237[unassigned1304];NDUFAF2[unassigned1304];RAB9A[29568061];
461039	chr17	33310495	C	A	chr17:33310495	LIG3	DNA ligase 3	6510.0	SNV	0/1	0.52	15_16	31	99	False	rs61749869,COSV52007323	EXONIC	YES	NM_013975.4	Transcript	protein_coding	synonymous_variant		2/20	NM_013975.4:c.471C>A	NP_039269.2:p.Ile157%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Mitochondrial DNA depletion syndrome 20 (MNGIE type), 619780 (3)	.	.	.	30022792	0.00131508	200.0	152082.0	0.0	32	0.97	PASS	nfe	0.00208738	142.0	0.00208738	142.0	0.00108333	271.0	250154.0	3.0	72	0.98	PASS	nfe	0.00180288	204.0	0.00180288	204.0	0.0010482	163	0.001	2.0	0.0007	8.0		7.558	0.327083		0	0	0			LIG3	0.0	0.0	0.0	0.0	2.0	-28.0	-43.0	-5.0						0.853	0.0	54.938639654			cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; growth/size/body region phenotype; embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			pons;testis - seminiferous tubule;testis - interstitial;trigeminal ganglion;superior cervical ganglion;testis;skeletal muscle;	Base excision repair	double-strand break repair via homologous recombination;lagging strand elongation;transcription-coupled nucleotide-excision repair;base-excision repair, DNA ligation;nucleotide-excision repair, DNA gap filling;double-strand break repair;cell cycle;V(D)J recombination;mitochondrial DNA repair;cell division;DNA biosynthetic process;negative regulation of mitochondrial DNA replication;double-strand break repair via alternative nonhomologous end joining	nucleus;nucleoplasm;cytoplasm;mitochondrion	DNA binding;DNA ligase activity;DNA ligase (ATP) activity;protein binding;ATP binding;zinc ion binding	MDC1[29656893];FOXE1[25609649];SRC[17474147];MAX[25609649];PNKP[17353931];FOXK2[25609649];PIK3R1[17474147];PTPRH[28330616];HSP90B1[30021884];PYCARD[24407287];EXOSC4[26496610];HIST1H3A[29568061];EMC2[26496610];LMNA[29568061];ABL1[17474147];PLCG1[17474147];TMPO[26496610];CBX8[21282530];FOXB1[25609649];FOXD3[25609649];JUN[25609649];PARP1[24778456];HSPA5[30021884];MMGT1[26496610];PYHIN1[25665578];XRCC1[17353931;26496610];FOXP1[25609649];AIM2[25665578];APLF[17396150];BAX[26496610];CRK[17474147];SPC24[26496610];
468667	chr19	44249040	T	C	chr19:44249040	SMG9	SMG9, nonsense mediated mRNA decay factor	6613.0	SNV	0/1	0.52	13_14	27	99	False	rs376987052	SPLICING	YES	NM_019108.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/13		NM_019108.4:c.589-4A>G			-1.0					Heart and brain malformation syndrome, 616920 (3), Autosomal recessive	.	.	Hand clenching;Prominent forehead;Posteriorly rotated ears;Depressed nasal bridge;Muscular hypotonia of the trunk;Microcephaly;Global brain atrophy;Polyhydramnios;Growth delay;Gastroesophageal reflux;Hypertelorism;Cleft lip;Prominent occiput;Autosomal recessive inheritance;Anteverted nares;Poor eye contact;Global developmental delay;Camptodactyly of finger;Microphthalmia;Hypoplasia of the corpus callosum;Thick lower lip vermilion;Ventricular septal defect;Everted lower lip vermilion;Hyperactive deep tendon reflexes;Seizure;Wide anterior fontanel;High, narrow palate;Delayed CNS myelination;Cerebral atrophy;Dandy-Walker malformation;Visual impairment;Low-set ears;Abnormality of the pinna;Generalized hypotonia;Wide nasal bridge;Prominent metopic ridge;Narrow forehead;Aplasia/Hypoplasia of the corpus callosum;Interrupted aortic arch		7.89785e-05	12.0	151940.0	0.0	32	0.97	PASS	nfe	0.000161836	11.0	0.000161836	11.0	8.01841e-05	20.0	249426.0	0.0	29	0.83	PASS	nfe	0.000177236	20.0	0.000177236	20.0	0.0000707	11						9.691	0.531068		0	0	0			SMG9	0.0	0.0	0.0	0.0	45.0	-4.0	-33.0	-2.0	9.48440237594102e-05	0.006	8.849	-0.027	8.821		0.0				vision/eye phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; renal/urinary system phenotype; immune system phenotype; liver/biliary system phenotype; respiratory system phenotype; embryo phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; 			testis - seminiferous tubule;trigeminal ganglion;superior cervical ganglion;testis;globus pallidus;cerebellum;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;eye development;brain development;heart development	cytosol	protein binding;identical protein binding	SMG1[20371770;19417104;20817927;26496610];PHF1[unassigned1304];SMG9[20817927];HSF2BP[unassigned1304];SMG8[19417104;20817927;26496610];DCAF1[26496610];GOLGA2[unassigned1304];FNTB[unassigned1304];GSG1[unassigned1304];ARFIP2[unassigned1304];TRIM27[unassigned1304];TRIM23[25416956;unassigned1304];UPF1[19417104];PLEKHG4[unassigned1304];DDX11[26496610];AGTRAP[unassigned1304];MTUS2[unassigned1304];KRT34[unassigned1304];TRAF2[25416956;unassigned1304];TSC1[unassigned1304];SYP[unassigned1304];KRT31[25416956;unassigned1304];PRKAR1B[unassigned1304];PFDN5[unassigned1304];ZMYND12[unassigned1304];GLYR1[unassigned1304];RBM8A[19417104];AK8[unassigned1304];PRPSAP1[26496610];CTAG1A[unassigned1304];RASSF10[unassigned1304];SLC17A9[unassigned1304];PPP2R3C[unassigned1304];CEP76[unassigned1304];STIL[26638075];CCDC57[unassigned1304];CMTM4[unassigned1304];INCA1[unassigned1304];KRTAP10-8[unassigned1304];PNMA3[unassigned1304];SLC50A1[unassigned1304];DGAT2L6[unassigned1304];TTC19[unassigned1304];TRIP6[unassigned1304];REL[unassigned1304];TCF4[unassigned1304];CNTROB[26638075];ZNF655[unassigned1304];NFKBID[unassigned1304];
469148	chr5	139815809	C	G	chr5:139815809	ANKHD1	ankyrin repeat and KH domain containing 1	6634.0	SNV	0/1	0.51	18_19	37	99	False	rs61758138,COSV51843433	EXONIC	YES	NM_017747.3	Transcript	protein_coding	missense_variant		2/34	NM_017747.3:c.427C>G	NP_060217.1:p.Gln143Glu		1.0	.,.,.,.,.,.,.					.	.	.	29197136	0.00477705	727.0	152186.0	6.0	32	0.97	PASS	nfe	0.00657063	447.0	0.00657063	447.0	0.00517692	1200.0	231798.0	6.0	23	0.58	PASS	nfe	0.00718437	764.0	0.00718437	764.0	0.0051188	796	0.003	10.0				25.2	3.548963	0.401	10	11	21	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	ANKHD1	0.0	0.0	0.0	0.0	-35.0	3.0	33.0	2.0						0.407	1.0	0.000000000,0.000000000	1.0	1.026	.			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;trigeminal ganglion;atrioventricular node;superior cervical ganglion;parietal lobe;skeletal muscle;adrenal cortex;	.	innate immune response	cytoplasm	RNA binding;protein binding	YWHAE[20936779];SCHIP1[20195357];FHL3[27107012];LENG8[unassigned1304];SKA3[26496610];FOXQ1[25609649];GOLGA2[unassigned1304];ATXN1[16713569];MAGEA1[26496610];HIF1AN[26972000];PRR20D[unassigned1304];DISC1[12812986];ZNF346[21988832];MAPK6[26972000];NINL[26638075];YWHAG[20936779];CDT1[26496610];HSPA8[29568061];JUN[25609649];VCAM1[22623428];KRTAP15-1[unassigned1304];SEC16A[26496610];FOS[25609649];NFKB1[25609649];NEURL4[29426014];HGS[unassigned1304];FGFR1OP[26638075];NFKBIE[14743216;21988832];BAP1[19615732];C9orf72[29950492];
469241	chr9	113170289	C	T	chr9:113170289	SVEP1	sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1	6636.0	SNV	0/1	0.46	25_21	46	99	False	rs143931457,COSV104400591	EXONIC	YES	NM_153366.4	Transcript	protein_coding	missense_variant		38/48	NM_153366.4:c.7591G>A	NP_699197.3:p.Glu2531Lys		-1.0	Sushi/SCR/CCP domain&Sushi/SCR/CCP domain&Sushi/SCR/CCP domain&Sushi/SCR/CCP domain,Sushi/SCR/CCP domain&Sushi/SCR/CCP domain&Sushi/SCR/CCP domain&Sushi/SCR/CCP domain					.	.	.		0.0058355	888.0	152172.0	4.0	32	0.97	PASS	nfe	0.00773211	526.0	0.00773211	526.0	0.00606606	1510.0	248926.0	9.0	64	0.99	PASS	nfe	0.00816128	921.0	0.00816128	921.0	0.0057812	899	0.008	26.0				9.524	0.512917	0.075	1	15	16	LIST-S2_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SVEP1	0.0	0.0	0.0	0.0	-4.0	36.0	-3.0	-33.0						0.325	0.59	0.000000000	0.979	0.13	integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; 			ciliary ganglion;pons;trigeminal ganglion;superior cervical ganglion;atrioventricular node;adipose tissue;placenta;skeletal muscle;globus pallidus;	.	cell adhesion	extracellular region;cytoplasm;membrane	chromatin binding;calcium ion binding	ATF7IP[15231748];MTNR1A[26514267];SMAD3[15231748];ZFYVE9[15231748];SMAD9[15231748];SKIL[15231748];
470452	chr11	62494465		CCGCCGGGCCCGGCCCCGCCG	chr11:62494464-62494465	HNRNPUL2	heterogeneous nuclear ribonucleoprotein U like 2	6658.0	insertion	0/1	0.43	12_9	21	99	False	rs1209396514	EXONIC	YES	NM_001079559.3	Transcript	protein_coding	inframe_insertion		1/14	NM_001079559.3:c.144_164dup	NP_001073027.1:p.Gly49_Gly55dup		-1.0						.	.	.		0.00484437	734.0	151516.0	1.0	32	0.96	PASS	nfe	0.00766939	520.0	0.00766939	520.0	4.97661e-05	1.0	20094.0	0.0	2	0.01	PASS	nfe	0.000141323	1.0	0.000141323	1.0	0.0000322,0.0000514	5,8						19.94	2.026117		0	0	0																	0.0912	1.0				.			pons;ciliary ganglion;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	biological_process	nucleus;nucleoplasm;membrane	RNA binding	EIF4A2[17353931];FOXB1[25609649];JUN[25609649];PDHA1[29128334];SMARCB1[30108113];FOXE1[25609649];COX15[29128334];FOXG1[25609649];SEC16A[26496610];FOXL2[25609649];YBX1[25497084];FOXL1[25609649];DDX41[25920683];MKI67[26949251];HSD17B10[29128334];FOXQ1[25609649];FOXS1[25609649];MAP1LC3A[20562859];RNF169[21252943];HTR7[19486527];MATR3[26496610];HNRNPH2[26496610];HNRNPA1[26496610];
470642	chr7	6068336	T	A	chr7:6068336	EIF2AK1	eukaryotic translation initiation factor 2 alpha kinase 1	6665.0	SNV	0/1	0.44	20_16	36	99	False	rs182474233	SPLICING	YES	NM_014413.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	12/14		NM_014413.4:c.1448-8A>T			-1.0					?Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome, 618878 (3), Autosomal dominant	.	.	.		0.000558314	85.0	152244.0	0.0	33	0.98	PASS	nfe	0.00113175	77.0	0.00113175	77.0	0.000768159	193.0	251250.0	0.0	51	0.98	PASS	nfe	0.00139891	159.0	0.00139891	159.0	0.0008489	132	0.0	1.0				7.525	0.324502		0	0	0			EIF2AK1	0.07	0.02	0.0	0.0	-8.0	33.0	-30.0	33.0	0.0006924877973661	0.026	4.97	-1.337	3.634	0.796	0.0				homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; 			occipital lobe;subthalamic nucleus;superior cervical ganglion;fetal liver;bone marrow;cerebellum;	.	acute inflammatory response;phagocytosis;negative regulation of cell population proliferation;regulation of translational initiation by eIF2 alpha phosphorylation;regulation of eIF2 alpha phosphorylation by heme;macrophage differentiation;negative regulation of translational initiation by iron;protoporphyrinogen IX metabolic process;protein autophosphorylation;negative regulation of hemoglobin biosynthetic process;iron ion homeostasis;response to iron ion starvation	cytoplasm	protein kinase activity;eukaryotic translation initiation factor 2alpha kinase activity;ATP binding;heme binding;protein homodimerization activity	HSPA8[29568061];RBM14[unassigned1312];HSP90AB1[22939624];MFAP1[unassigned1312];CDC37[11036079];POLD1[unassigned1312];ATRX[unassigned1312];EAF1[unassigned1312];DDX20[unassigned1312];AP3B1[unassigned1312];NAF1[unassigned1312];HIST1H1B[30021884];
470988	chr18	48190466	C	T	chr18:48190466	MAPK4	mitogen-activated protein kinase 4	6669.0	SNV	0/1	0.36	16_9	25	99	False	rs763775905,COSV104704834	EXONIC	YES	NM_002747.4	Transcript	protein_coding	synonymous_variant		2/6	NM_002747.4:c.138C>T	NP_002738.2:p.Val46%3D		1.0						.	.	.						32	0.96							1.20288e-05	3.0	249402.0	0.0	100	1.0	PASS	sas	3.26776e-05	1.0	8.83158e-06	1.0	0.0000064	1						4.082	0.08925		0	0	0			MAPK4	0.0	0.0	0.0	0.0	36.0	-18.0	-3.0	36.0						0.27	0.32	34.394615620			growth/size/body region phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; 			.	.	MAPK cascade;protein phosphorylation;cell cycle;regulation of gene expression;intracellular signal transduction;cellular response to organic substance	nucleus;nucleoplasm;cytoplasm;cytosol	protein serine/threonine kinase activity;MAP kinase activity;protein binding;ATP binding;protein kinase binding;protein homodimerization activity;protein heterodimerization activity	HSP90AB1[22939624];FAM57A[23602568];TECR[23602568];FASTKD5[23602568];CALML3[21988832];MAPKAPK5[23602568];ATP1A1[23602568];ERC1[23602568];CRK[21988832];PSMA7[23602568];PFKP[23602568];
471364	chr11	64597001	G	A	chr11:64597001	CDC42BPG	CDC42 binding protein kinase gamma	6696.0	SNV	0/1	0.44	18_14	32	99	False	rs118073941	EXONIC	YES	NM_017525.3	Transcript	protein_coding	synonymous_variant		30/37	NM_017525.3:c.3909C>T	NP_059995.2:p.Gly1303%3D		-1.0						.	.	.		0.00225959	344.0	152240.0	0.0	34	0.99	PASS	nfe	0.00358602	244.0	0.00358602	244.0	0.00159245	395.0	248046.0	0.0	44	0.95	PASS	nfe	0.00276688	309.0	0.00276688	309.0	0.0015562	242	0.002	7.0				0.354	-0.304871		0	0	0			CDC42BPG	0.0	0.0	0.0	0.0	-5.0	-13.0	2.0	-11.0						0.862	0.0	37.795534032			.			ciliary ganglion;superior cervical ganglion;atrioventricular node;globus pallidus;	.	protein phosphorylation;actin cytoskeleton reorganization;intracellular signal transduction	microtubule organizing center;cytosol;cell leading edge	magnesium ion binding;protein serine/threonine kinase activity;protein binding;ATP binding	CDC42[15194684];TBK1[21903422];SFN[15778465];RHOQ[15194684];
472166	chr10	99498360	C	T	chr10:99498360	ZFYVE27	zinc finger FYVE-type containing 27	6721.0	SNV	0/1	0.54	19_22	41	99	False	rs17419023,COSV100519453	EXONIC	YES	NM_001385876.1	Transcript	protein_coding	synonymous_variant		2/13	NM_001385876.1:c.126C>T	NP_001372805.1:p.Leu42%3D		1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Spastic_paraplegia|Spastic_paraplegia_33,_autosomal_dominant|not_specified	Spastic paraplegia 33, autosomal dominant, 610244 (3), Autosomal dominant	.	.	Spastic paraplegia;Spastic gait;Ankle clonus;Babinski sign;Autosomal dominant inheritance;Lower limb spasticity;Talipes equinovarus;Lower limb muscle weakness		0.00506872	770.0	151912.0	4.0	32	0.96	PASS	nfe	0.00840299	571.0	0.00840299	571.0	0.00488676	1229.0	251496.0	6.0	100	1.0	PASS	nfe	0.00707568	805.0	0.00707568	805.0	0.0046558	724	0.015	49.0	0.01201	137.0		10.12	0.578525		0	0	0			ZFYVE27	0.0	0.0	0.0	0.09	12.0	-32.0	10.0	46.0						0.35	0.0	76.708318039			.			cingulate cortex;atrioventricular node;	.	vesicle-mediated transport;neuron projection development;positive regulation of axon extension;neurotrophin TRK receptor signaling pathway;endoplasmic reticulum tubular network formation;protein localization to plasma membrane	nucleoplasm;endoplasmic reticulum;cytosol;integral component of membrane;integral component of endoplasmic reticulum membrane;axon;dendrite;growth cone membrane;recycling endosome membrane;endoplasmic reticulum tubular network	protein binding;protein self-association;metal ion binding	NUMA1[30021884];GIMAP1[unassigned1304];GIMAP5[unassigned1304];IER3IP1[unassigned1304];TMEM243[unassigned1304];PIP4P2[unassigned1304];TMEM65[unassigned1304];TMEM128[unassigned1304];CCT5[19289470];CCT4[19289470];TMEM14C[unassigned1304];CCT3[19289470];SLC30A8[unassigned1304];SACM1L[unassigned1304];STX7[unassigned1304];ORMDL1[unassigned1304];OTOP3[unassigned1304];RAB11A[17082457];YIF1A[unassigned1304];VAPA[19289470];PQLC1[unassigned1304];VAPB[19289470];FKBP8[17082457;18459960];SEC22A[unassigned1304];RAB7A[25855459];
478732	chr2	96525640	G	T	chr2:96525640	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0/1	0.39	59_37	96	99	False	rs77864759,COSV69431264	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		82/89	NM_001310154.3:c.4963C>A	NP_001297083.1:p.Leu1655Ile		-1.0						.	.	.		0.00331442	493.0	148744.0	0.0	32	0.97	PASS	nfe	0.0043507	290.0	0.0043507	290.0	0.460007	46837.0	101818.0	0.0	75	0.6	InbreedingCoeff	amr	0.468753	8371.0	0.464326	18886.0	0.0004309	67	0.016	44.0				8.493	0.408828	0.059	0	16	16		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.0	0.0	0.0	0.0	11.0	15.0	17.0	-31.0									0.0	-0.66	.			.	.	.	.	ion channel inhibitor activity	.
478733	chr2	96525643	T	C	chr2:96525643	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0/1	0.36	63_35	98	99	False	rs75198192,COSV69431273	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		82/89	NM_001310154.3:c.4960A>G	NP_001297083.1:p.Thr1654Ala		-1.0						.	.	.						32	0.97							0.388358	39444.0	101566.0	4.0	79	0.6	InbreedingCoeff	sas	0.465186	7937.0	0.372385	14380.0	0.0025337	394	0.005	14.0				11.89	0.792074	0.026	0	16	16		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.0	0.0	0.02	0.0	12.0	-34.0	-34.0	14.0									0.009	-0.501	.			.	.	.	.	ion channel inhibitor activity	.
478734	chr2	96525652	T	C	chr2:96525652	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0/1	0.73	26_71	97	99	False	rs77710257,COSV69431279	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		82/89	NM_001310154.3:c.4951A>G	NP_001297083.1:p.Lys1651Glu		-1.0						.	.	.		0.00293162	435.0	148382.0	0.0	32	0.97	PASS	nfe	0.00378559	251.0	0.00378559	251.0	0.499867	78919.0	157880.0	19.0	80	0.6	InbreedingCoeff	afr	0.500815	4301.0	0.499659	30792.0	0.0030803	479	0.016	43.0				6.628	0.255488	0.018	0	16	16		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.0	0.0	0.0	0.01	-1.0	3.0	49.0	-43.0									0.054	-0.628	.			.	.	.	.	ion channel inhibitor activity	.
478735	chr2	96525659	C	T	chr2:96525659	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0/1	0.39	60_39	99	99	False	rs72931750,COSV69432772	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	synonymous_variant		82/89	NM_001310154.3:c.4944G>A	NP_001297083.1:p.Ser1648%3D		-1.0						.	.	.		0.00271133	401.0	147898.0	0.0	32	0.97	PASS	nfe	0.00341844	226.0	0.00341844	226.0	0.449358	40826.0	90854.0	0.0	71	0.6	InbreedingCoeff	amr	0.471848	7643.0	0.450399	16381.0	0.0930973	14477	0.017	48.0				0.708	-0.202246		0	0	0			ANKRD36C	0.0	0.0	0.0	0.01	-2.0	47.0	48.0	-50.0											.			.	.	.	.	ion channel inhibitor activity	.
478736	chr2	96525718	G	T	chr2:96525718	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0|1	0.72	23_60	83	99	False	rs77057279,COSV69431292	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		82/89	NM_001310154.3:c.4885C>A	NP_001297083.1:p.Leu1629Met		-1.0						.	.	.		0.0	0.0	151508.0	0.0	32	0.97	AC0_AS_VQSR				0.0	0.0	0.275249	15382.0	55884.0	0.0	55	0.6	InbreedingCoeff_RF	afr	0.39699	1187.0	0.287463	6081.0	0.0002058	32	0.001	3.0				0.024	-0.675172	0.057	0	16	16		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.0	0.0	0.0	0.0	30.0	47.0	39.0	30.0									0.034	-0.032	.			.	.	.	.	ion channel inhibitor activity	.
478737	chr2	96525718		T	chr2:96525717-96525718	ANKRD36C	ankyrin repeat domain 36C	6766.0	insertion	0|1	0.72	23_60	83	99	False	rs111957693,COSV69433825	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	frameshift_variant		82/89	NM_001310154.3:c.4885_4886insA	NP_001297083.1:p.Leu1629HisfsTer4		-1.0						.	.	.						32	0.97							0.239032	16606.0	69472.0	0.0	56	0.6	InbreedingCoeff_RF	afr	0.35502	1266.0	0.243007	6481.0	0.0082956	1290						25.0	3.508234		0	0	0			ANKRD36C	0.0	0.0	0.0	0.0	39.0	48.0	40.0	31.0											.			.	.	.	.	ion channel inhibitor activity	.
478738	chr2	96525723	C	T	chr2:96525723	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0|1	0.73	23_61	84	99	False	rs77757712,COSV69431297	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		82/89	NM_001310154.3:c.4880G>A	NP_001297083.1:p.Arg1627Gln		-1.0						.	.	.		1.31648e-05	2.0	151920.0	0.0	32	0.97	PASS	amr	6.56254e-05	1.0	1.47124e-05	1.0	0.216075	11990.0	55490.0	0.0	55	0.6	InbreedingCoeff_RF	afr	0.344501	946.0	0.222094	4636.0	0.0001479	23	0.002	5.0				7.398	0.314524	0.022	0	16	16		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.0	0.02	0.0	0.0	25.0	50.0	34.0	25.0									0.017	-0.032	.			.	.	.	.	ion channel inhibitor activity	.
478739	chr2	96525736	T	C	chr2:96525736	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0/1	0.69	26_58	84	99	False	rs78585559,COSV69431250	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		82/89	NM_001310154.3:c.4867A>G	NP_001297083.1:p.Arg1623Gly		-1.0						.	.	.						32	0.97							0.156546	9559.0	61062.0	0.0	54	0.6	InbreedingCoeff_RF	afr	0.251325	664.0	0.163269	3876.0	0.0001286	20	0.002	5.0				11.2	0.70606	0.091	0	17	17		SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.08	0.0	0.0	0.0	37.0	-2.0	-29.0	-2.0									0.01	0.775	.			.	.	.	.	ion channel inhibitor activity	.
478740	chr2	96525750	T	A	chr2:96525750	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0|1	0.7	26_61	87	99	False	rs76379993,COSV69431309	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		82/89	NM_001310154.3:c.4853A>T	NP_001297083.1:p.His1618Leu		-1.0						.	.	.						32	0.97							0.0787829	6380.0	80982.0	0.0	55	0.6	RF	afr	0.163036	479.0	0.0748127	2337.0	0.0000965	15	0.001	2.0				15.61	1.379799	0.273	2	16	18	SIFT,PROVEAN_pred	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.0	0.0	0.0	0.0	-16.0	23.0	-16.0	-2.0									0.455	0.775	.			.	.	.	.	ion channel inhibitor activity	.
478741	chr2	96525755	A	T	chr2:96525755	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0|1	0.71	25_62	87	99	False	rs77658288,COSV69431315	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		82/89	NM_001310154.3:c.4848T>A	NP_001297083.1:p.Asp1616Glu		-1.0						.	.	.						32	0.97							0.120396	8505.0	70642.0	0.0	54	0.6	RF	afr	0.234059	602.0	0.124963	3393.0	0.0001029	16	0.001	4.0				14.4	1.156106	0.048	0	18	18		SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.02	0.0	0.0	0.0	18.0	-21.0	-7.0	2.0									0.406	-0.517	.			.	.	.	.	ion channel inhibitor activity	.
478742	chr2	96525768	G	A	chr2:96525768	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0|1	0.7	25_57	82	99	False	rs78780931,COSV69431322	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		82/89	NM_001310154.3:c.4835C>T	NP_001297083.1:p.Thr1612Ile		-1.0						.	.	.						32	0.97							0.13927	9374.0	67308.0	0.0	45	0.59	InbreedingCoeff_RF	afr	0.302381	762.0	0.135759	3429.0	0.0000836	13	0.002	6.0				1.363	-0.104721	0.032	0	16	16		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.0	0.02	0.0	0.0	-12.0	5.0	2.0	-20.0									0.549	0.035	.			.	.	.	.	ion channel inhibitor activity	.
478743	chr2	96525771	A	C	chr2:96525771	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0|1	0.7	25_57	82	99	False	rs74941794,COSV69431339	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	stop_gained		82/89	NM_001310154.3:c.4832T>G	NP_001297083.1:p.Leu1611Ter		-1.0						.	.	.						32	0.97							0.141998	9331.0	65712.0	0.0	43	0.59	InbreedingCoeff_RF	afr	0.303457	755.0	0.137201	3413.0	0.0000900	14	0.002	6.0				27.0	3.92038		3	3	6	BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred	MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.0	0.02	0.0	0.0	9.0	2.0	-23.0	2.0									0.535	-0.571	.			.	.	.	.	ion channel inhibitor activity	.
478744	chr2	96525782	T	C	chr2:96525782	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0/1	0.68	24_50	74	99	False	rs75657861,COSV69431540	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	synonymous_variant		82/89	NM_001310154.3:c.4821A>G	NP_001297083.1:p.Leu1607%3D		-1.0						.	.	.		0.00162267	247.0	152218.0	1.0	32	0.97	PASS	afr	0.00556975	231.0	4.40969e-05	3.0	0.144533	9375.0	64864.0	0.0	36	0.58	InbreedingCoeff_RF	afr	0.32086	806.0	0.136791	3373.0	0.0001608	25	0.002	5.0				0.061	-0.550754		0	0	0			ANKRD36C	0.02	0.0	0.0	0.0	40.0	-2.0	-34.0	-1.0											.			.	.	.	.	ion channel inhibitor activity	.
478745	chr2	96525794	C	A	chr2:96525794	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0/1	0.62	27_45	72	99	False	rs79908880,COSV69431346	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		82/89	NM_001310154.3:c.4809G>T	NP_001297083.1:p.Lys1603Asn		-1.0						.	.	.		1.97239e-05	3.0	152100.0	0.0	32	0.97	PASS	nfe	2.94048e-05	2.0	2.94048e-05	2.0	0.135307	9298.0	68718.0	0.0	35	0.58	InbreedingCoeff_RF	afr	0.322343	831.0	0.124727	3199.0	0.0145527	2263	0.002	6.0				0.001	-1.355559	0.086	0	16	16		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.04	0.08	0.0	0.0	-21.0	28.0	-21.0	-46.0									0.003	0.039	.			.	.	.	.	ion channel inhibitor activity	.
478746	chr2	96525830	C	T	chr2:96525830	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0/1	0.19	55_13	68	99	False	rs530528524	SPLICING	YES	NM_001310154.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	81/88		NM_001310154.3:c.4781-8G>A			-1.0						.	.	.						32	0.97							0.00463382	604.0	130346.0	0.0	25	0.55	RF	nfe	0.00291362	148.0	0.00291362	148.0	0.0073053	1136	0.0	1.0				20.2	2.043375		0	0	0			ANKRD36C	0.86	0.55	0.0	0.0	-2.0	-8.0	-28.0	0.0	0.99493661413377	0.756	3.553	5.389	8.942						.			.	.	.	.	ion channel inhibitor activity	.
478862	chr2	96594840	T	C	chr2:96594840	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0|1	0.53	27_31	58	99	False	rs76434426,COSV54759408	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		26/89	NM_001310154.3:c.1817A>G	NP_001297083.1:p.Glu606Gly		-1.0	.,.					.	.	.						32	0.95							0.00236411	393.0	166236.0	0.0	57	0.96	PASS	afr	0.00689722	71.0	0.00201217	158.0	0.0030289	471	0.001	3.0				12.59	0.882799	0.045	2	13	15	SIFT,PolyPhen	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.0	0.0	0.0	0.09	-20.0	15.0	8.0	-20.0									0.001	0.558	.			.	.	.	.	ion channel inhibitor activity	.
478863	chr2	96594858	A	G	chr2:96594858	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0|1	0.55	27_33	60	99	False	rs80159651,COSV54757457	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		26/89	NM_001310154.3:c.1799T>C	NP_001297083.1:p.Ile600Thr		-1.0	.,.					.	.	.						32	0.95							0.0022773	367.0	161156.0	0.0	52	0.93	PASS	sas	0.00371397	67.0	0.00156033	119.0	0.0001608	25	0.001	3.0				1.195	-0.124324	0.006	0	15	15		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.02	0.0	0.01	0.0	34.0	26.0	-38.0	-42.0									0.0	-0.299	.			.	.	.	.	ion channel inhibitor activity	.
478864	chr2	96594874	C	A	chr2:96594874	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0|1	0.65	24_44	68	99	False	rs79434735	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		26/89	NM_001310154.3:c.1783G>T	NP_001297083.1:p.Asp595Tyr		-1.0	.,.					.	.	.						32	0.95							0.000701431	134.0	191038.0	0.0	45	0.88	RF	sas	0.00120235	27.0	0.000418125	38.0	0.0001543	24	0.017	55.0				8.888	0.447027	0.029	3	12	15	SIFT,PolyPhen,LIST-S2_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.1	0.1	0.0	0.0	-19.0	18.0	-19.0	-1.0									0.001	-0.296	.			.	.	.	.	ion channel inhibitor activity	.
478865	chr2	96594878	G	C	chr2:96594878	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0|1	0.66	24_46	70	99	False	rs375866621,COSV54761884	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		26/89	NM_001310154.3:c.1779C>G	NP_001297083.1:p.Asp593Glu		-1.0	.,.					.	.	.		6.6031e-06	1.0	151444.0	0.0	32	0.95	PASS	nfe	1.47811e-05	1.0	1.47811e-05	1.0	0.000470605	91.0	193368.0	0.0	42	0.89	RF	sas	0.000603656	14.0	0.000294618	27.0	0.0001543	24	0.012	39.0				0.506	-0.252436	0.009	1	14	15	PolyPhen	SIFT,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.0	0.02	0.0	0.0	6.0	14.0	14.0	2.0									0.0	-1.102	.			.	.	.	.	ion channel inhibitor activity	.
478866	chr2	96594881	G	A	chr2:96594881	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0|1	0.66	25_48	73	99	False	rs111499669	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	synonymous_variant		26/89	NM_001310154.3:c.1776C>T	NP_001297083.1:p.Asp592%3D		-1.0						.	.	.		7.92456e-05	12.0	151428.0	0.0	32	0.95	PASS	eas	0.00019478	1.0	0.000133093	9.0	0.000374709	76.0	202824.0	0.0	41	0.89	PASS	eas	0.000791035	12.0	0.000240974	23.0	0.0001543	24	0.011	35.0				0.064	-0.54385		0	0	0			ANKRD36C	0.04	0.09	0.0	0.0	-26.0	11.0	-26.0	-1.0											.			.	.	.	.	ion channel inhibitor activity	.
478867	chr2	96594883	C	T	chr2:96594883	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0|1	0.66	24_47	71	99	False	rs111462973	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	missense_variant		26/89	NM_001310154.3:c.1774G>A	NP_001297083.1:p.Asp592Asn		-1.0	.,.					.	.	.						32	0.95							0.000199205	41.0	205818.0	0.0	41	0.9	RF	sas	0.000159719	4.0	0.000103197	10.0	0.0001543	24	0.001	3.0				5.495	0.177112	0.017	2	13	15	SIFT,PolyPhen	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.03	0.06	0.0	0.0	-28.0	9.0	3.0	5.0									0.002	0.508	.			.	.	.	.	ion channel inhibitor activity	.
479403	chr2	96619713	C	A	chr2:96619713	ANKRD36C	ankyrin repeat domain 36C	6766.0	SNV	0/1	0.13	27_4	31	87	False	rs62154617,COSV71727158	EXONIC	YES	NM_001310154.3	Transcript	protein_coding	stop_gained		14/89	NM_001310154.3:c.1177G>T	NP_001297083.1:p.Glu393Ter		-1.0						.	.	.		0.000679506	99.0	145694.0	0.0	49	0.99	PASS	amr	0.00204283	29.0	0.000714841	46.0	0.000917988	127.0	138346.0	0.0	24	0.56	PASS	amr	0.00206721	47.0	0.000952515	54.0	0.0016270	253	0.005	17.0				26.4	3.818538		4	2	6	MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred	fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36C	0.0	0.0	0.0	0.0	37.0	40.0	-7.0	-26.0									0.0	-0.833	.			.	.	.	.	ion channel inhibitor activity	.
481721	chr16	30017965	C	T	chr16:30017965	DOC2A	double C2 domain alpha	6792.0	SNV	0/1	0.24	25_9	37	99	False	rs796885773,COSV100451329	EXONIC	YES	NM_001282062.1	Transcript	protein_coding	synonymous_variant		10/12	NM_001282062.1:c.912G>A	NP_001268991.1:p.Lys304%3D		-1.0						.	.	.						31	0.92											100	1.0							0.0000064	1						10.38	0.607656		0	0	0			DOC2A	0.0	0.0	0.0	0.0	-19.0	8.0	34.0	-8.0						0.601	0.02	29.227379471			nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			ciliary ganglion;amygdala;superior cervical ganglion;globus pallidus;	.	chemical synaptic transmission;nervous system development;synaptic vesicle exocytosis;regulation of calcium ion-dependent exocytosis	nucleus;nucleolus;lysosome;cell junction;neuron projection;extrinsic component of synaptic vesicle membrane	calcium ion binding;protein binding;calcium-dependent phospholipid binding	VDAC1[30021884];
481727	chr16	30017986	G	T	chr16:30017986	DOC2A	double C2 domain alpha	6792.0	SNV	0/1	0.24	25_9	37	99	False	rs376074837	EXONIC	YES	NM_001282062.1	Transcript	protein_coding	synonymous_variant		10/12	NM_001282062.1:c.891C>A	NP_001268991.1:p.Pro297%3D		-1.0						.	.	.						31	0.93											100	1.0							0.0000064	1						0.084	-0.506926		0	0	0			DOC2A	0.01	0.02	0.0	0.0	-2.0	38.0	-2.0	-29.0						0.601	0.02	2.044949972			nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			ciliary ganglion;amygdala;superior cervical ganglion;globus pallidus;	.	chemical synaptic transmission;nervous system development;synaptic vesicle exocytosis;regulation of calcium ion-dependent exocytosis	nucleus;nucleolus;lysosome;cell junction;neuron projection;extrinsic component of synaptic vesicle membrane	calcium ion binding;protein binding;calcium-dependent phospholipid binding	VDAC1[30021884];
482936	chr7	38816352	T	C	chr7:38816352	VPS41	VPS41, HOPS complex subunit	6818.0	SNV	0/1	0.55	10_12	22	99	False	rs147712027	EXONIC	YES	NM_014396.4	Transcript	protein_coding	missense_variant		11/29	NM_014396.4:c.809A>G	NP_055211.2:p.Tyr270Cys		-1.0	.,.				Spinocerebellar ataxia, autosomal recessive 29, 619389 (3), Autosomal recessive	.	.	.						32	0.96							7.98397e-06	2.0	250502.0	0.0	40	0.98	PASS	nfe	1.76725e-05	2.0	1.76725e-05	2.0	0.0000193	3	0.0	1.0				26.1	3.766565	0.542	14	7	21	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred	VPS41	0.0	0.0	0.0	0.0	-1.0	24.0	-45.0	-49.0						0.971	0.0	0.0	1.0	1.138	cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; embryo phenotype; 			caudate nucleus;amygdala;prefrontal cortex;cingulate cortex;trigeminal ganglion;superior cervical ganglion;pons;fetal brain;occipital lobe;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	intracellular protein transport;autophagy;endosome to lysosome transport;endosomal vesicle fusion;regulation of SNARE complex assembly;vacuole fusion, non-autophagic;regulated exocytosis;late endosome to lysosome transport	lysosomal membrane;early endosome;late endosome;Golgi apparatus;Golgi-associated vesicle;endosome membrane;microtubule cytoskeleton;AP-3 adaptor complex;clathrin-coated vesicle;HOPS complex;late endosome membrane;clathrin complex	protein binding;microtubule binding;identical protein binding;protein self-association;metal ion binding	ZNF512B[15231748];VPS18[23901104;26496610];KDM5C[26496610];HSP90AB1[22939624];STX17[24554770];VPS33B[23918659];HIST2H2BC[30021884];ESR2[21182203];TCEAL4[26496610];UBE2U[19690564];VPS41[24210660];NABP2[26496610];VIPAS39[19109425];RILP[25445562];MON1B[20434987];VPS16[26496610];
483840	chr3	8787313	C	G	chr3:8787313	CAV3	caveolin 3	6852.0	SNV	0/1	0.47	8_7	15	99	False	rs116840776,CM980306	EXONIC	YES	NM_033337.3	Transcript	protein_coding	missense_variant		2/2	NM_033337.3:c.216C>G	NP_203123.1:p.Cys72Trp		1.0	.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Cardiomyopathy|Elevated_circulating_creatine_kinase_concentration|Limb-girdle_muscular_dystrophy|Long_QT_syndrome|Familial_hypertrophic_cardiomyopathy_1|Long_QT_syndrome_9|Distal_myopathy,_Tateyama_type|Caveolinopathy|Rippling_muscle_disease_2|Long_QT_syndrome_1|not_specified|Cardiovascular_phenotype|not_provided	Myopathy, distal, Tateyama type, 614321 (3), Autosomal dominant; Creatine phosphokinase, elevated serum, 123320 (3), Autosomal dominant; Cardiomyopathy, familial hypertrophic, 192600 (3), Autosomal dominant, Digenic dominant; Rippling muscle disease 2, 606072 (3), Autosomal dominant; Long QT syndrome 9, 611818 (3), Autosomal dominant	Isolated asymptomatic elevation of creatine phosphokinase;Autosomal dominant limb-girdle muscular dystrophy type 1C;Distal myopathy, Tateyama type;Rippling muscle disease;Romano-Ward syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in	Autosomal dominant inheritance;Adult onset;EMG abnormality;Exercise-induced muscle cramps;Heterogeneous;Muscle hyperirritability;Skeletal muscle hypertrophy;Elevated serum creatine kinase;Percussion-induced rapid rolling muscle contractions;Exercise-induced muscle stiffness;Muscle mounding;Exercise-induced myalgia;Muscle spasm;Autosomal dominant inheritance;Muscular dystrophy;Fatigue;Increased muscle fatiguability;Inflammatory myopathy;EMG: myopathic abnormalities;Myalgia;Elevated serum creatine kinase;Exercise-induced muscle cramps;Mitochondrial myopathy;Abnormal muscle fiber morphology;Sudden death;Abnormality of metabolism/homeostasis;Congestive heart failure;Asymmetric septal hypertrophy;Arrhythmia;Autosomal dominant inheritance;Subvalvular aortic stenosis;Autosomal dominant inheritance;Ventricular arrhythmia;Prolonged QT interval;Cardiac arrest;Sinus bradycardia;Autosomal dominant inheritance;Neck muscle weakness;Pes cavus;Elevated serum creatine kinase;Calf muscle hypertrophy;Progressive distal muscle weakness;Percussion-induced rapid rolling muscle contractions;Intrinsic hand muscle atrophy;Calf muscle pseudohypertrophy;Palpitations;Clumsiness;EMG: myopathic abnormalities;Abnormal circulating creatine kinase concentration;Myalgia;Progressive pes cavus;Increased variability in muscle fiber diameter;Calf muscle hypoplasia;Abnormal muscle fiber protein expression;Weakness of the intrinsic hand muscles;Neck muscle weakness;Hypercholesterolemia;Abnormality of prenatal development or birth;Syncope;Torsade de pointes;Abnormal cardiac exercise stress test;Hypokalemia;Abnormal T-wave;Sudden cardiac death;Sinus bradycardia;Prolonged QTc interval;Abnormal autonomic nervous system physiology;Seizure	24033266,23861362,17210839,17060380,23465283,15580566,11251997,9536092,19380584	0.00168202	256.0	152198.0	2.0	32	0.97	PASS	amr	0.0039267	60.0	0.00241063	164.0	0.00136611	343.0	251078.0	1.0	56	0.98	PASS	sas	0.00228953	70.0	0.00165583	188.0	0.0011640	181	0.003	9.0	0.00281	32.0		24.0	3.167608	0.66	15	6	21	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred	CAV3	0.0	0.0	0.01	0.0	-39.0	35.0	-39.0	4.0						0.0466	0.34	0.0	1.0	0.129	cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; 			superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;globus pallidus;	Focal adhesion	plasma membrane repair;regulation of heart rate;negative regulation of protein kinase activity;triglyceride metabolic process;endocytosis;muscle contraction;plasma membrane organization;actin filament organization;positive regulation of cytosolic calcium ion concentration;muscle organ development;myoblast fusion;regulation of heart contraction;protein localization;positive regulation of cell population proliferation;negative regulation of cardiac muscle hypertrophy;positive regulation of myotube differentiation;regulation of skeletal muscle contraction;regulation of transforming growth factor beta receptor signaling pathway;cell differentiation;positive regulation of microtubule polymerization;cytoplasmic microtubule organization;membrane raft organization;T-tubule organization;detection of muscle stretch;regulation of signal transduction by receptor internalization;regulation of membrane potential;glucose homeostasis;cholesterol homeostasis;negative regulation of MAP kinase activity;negative regulation of MAPK cascade;negative regulation of cell size;muscle cell cellular homeostasis;negative regulation of nitric-oxide synthase activity;regulation of nerve growth factor receptor activity;nucleus localization;regulation of protein kinase B signaling;negative regulation of calcium ion transport;cardiac muscle cell development;regulation of cardiac muscle contraction;negative regulation of sarcomere organization;regulation of ventricular cardiac muscle cell membrane repolarization;heart trabecula formation;regulation of ventricular cardiac muscle cell membrane depolarization;regulation of branching involved in mammary gland duct morphogenesis;negative regulation of cell growth involved in cardiac muscle cell development;caveola assembly;cellular response to organonitrogen compound;protein localization to plasma membrane;ventricular cardiac muscle cell action potential;regulation of calcium ion import;regulation of cardiac muscle cell action potential involved in regulation of contraction;regulation of p38MAPK cascade;regulation of membrane depolarization during cardiac muscle cell action potential;negative regulation of membrane depolarization during cardiac muscle cell action potential;negative regulation of potassium ion transmembrane transporter activity;regulation of calcium ion transmembrane transporter activity;negative regulation of potassium ion transmembrane transport;negative regulation of protein localization to cell surface;positive regulation of ubiquitin-dependent protein catabolic process;regulation of sodium ion transmembrane transporter activity;positive regulation of caveolin-mediated endocytosis	Golgi membrane;cytoplasm;endoplasmic reticulum;plasma membrane;integral component of plasma membrane;caveola;focal adhesion;cell surface;intercalated disc;dystrophin-associated glycoprotein complex;Z disc;T-tubule;neuromuscular junction;vesicle;protein-containing complex;sarcolemma;intracellular membrane-bounded organelle;membrane raft	structural molecule activity;calcium channel regulator activity;protein binding;protein C-terminus binding;sodium channel regulator activity;potassium channel inhibitor activity;protein-containing complex scaffold activity;alpha-tubulin binding;ion channel binding;protein-containing complex binding;nitric-oxide synthase binding;connexin binding	GOLM1[27569582];CAVIN3[19262564];PCBP1[21988832];PTGES3[21988832];PBX3[unassigned1304];ADRB2[28298427];RBFA[unassigned1304];
485309	chr3	46719860	T	C	chr3:46719860	ALS2CL	ALS2 C-terminal like	6871.0	SNV	0/1	0.52	11_12	23	99	True	rs140347863	EXONIC	YES	NM_001190707.2	Transcript	protein_coding	missense_variant		16/26	NM_001190707.2:c.1646A>G	NP_001177636.1:p.Asn549Ser		-1.0	.,.					.	.	.		0.000768836	117.0	152178.0	0.0	33	0.98	PASS	amr	0.00176655	27.0	0.000955742	65.0	0.000821706	206.0	250698.0	0.0	38	0.94	PASS	amr	0.00174398	60.0	0.000828953	94.0	0.0007074	110	0.002	8.0	0.00289	33.0		23.7	3.079231	0.244	5	14	19	SIFT,LRT_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	ALS2CL	0.01	0.02	0.0	0.0	-1.0	19.0	-1.0	14.0						0.956	0.0	0.0	1.0	1.049	.			ciliary ganglion;pons;kidney;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;cingulate cortex;parietal lobe;skeletal muscle;medulla oblongata;cerebellum;	.	endosome organization;positive regulation of GTPase activity	cytosol	GTPase activator activity;Rab guanyl-nucleotide exchange factor activity;identical protein binding	RAB5C[unassigned1304];RAB31[unassigned1304];PPP1R32[unassigned1304];RSPH14[unassigned1304];EEF1AKMT3[unassigned1304];RAB22A[unassigned1304];
489772	chr16	1842505	C	T	chr16:1842505	IGFALS	insulin like growth factor binding protein acid labile subunit	6919.0	SNV	0/1	0.51	19_20	39	99	False	rs754923693	EXONIC	YES	NM_001146006.2	Transcript	protein_coding	missense_variant		2/2	NM_001146006.2:c.28G>A	NP_001139478.1:p.Glu10Lys		-1.0					Acid-labile subunit, deficiency of, 615961 (3), Autosomal recessive	Short stature due to primary acid-labile subunit deficiency	Disease-causing germline mutation(s) in	Delayed puberty;Mild postnatal growth retardation;Insulin insensitivity;Decreased serum insulin-like growth factor 1;Reduced insulin like growth factor binding protein acid labile subunit level;Truncal obesity;Delayed skeletal maturation;Decreased serum insulin-like growth factor 1;Insulin resistance;Delayed puberty;Micrognathia		6.56789e-06	1.0	152256.0	0.0	34	0.99	PASS	eas	0.000192382	1.0	0.0	0.0	0.0	0.0	60604.0	0.0	4	0.21	AC0				0.0	0.0	0.0000064	1						9.86	0.549797	0.064	1	14	15	SIFT	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	IGFALS	0.0	0.02	0.0	0.0	-3.0	11.0	9.0	-40.0						0.542	0.0		0.0	-0.096	reproductive system phenotype; skeleton phenotype; limbs/digits/tail phenotype; growth/size/body region phenotype; 			ciliary ganglion;pons;liver;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Neurodegenerative Diseases;Amyotrophic lateral sclerosis (ALS)	cell adhesion;signal transduction;cellular protein metabolic process	extracellular region;extracellular space;nucleoplasm;extracellular matrix;insulin-like growth factor ternary complex;extracellular exosome	insulin-like growth factor binding	.
491193	chr11	134062648	C	A	chr11:134062648	NCAPD3	non-SMC condensin II complex subunit D3	6977.0	SNV	0/1	0.44	20_16	36	99	False	rs151013524,COSV101599415	EXONIC	YES	NM_015261.3	Transcript	protein_coding	missense_variant		16/35	NM_015261.3:c.1981G>T	NP_056076.1:p.Asp661Tyr		-1.0		Uncertain_significance	criteria_provided,_single_submitter	not_provided	Microcephaly 22, primary, autosomal recessive, 617984 (3), Autosomal recessive	Autosomal recessive primary microcephaly	Disease-causing germline mutation(s) in	Vesicoureteral reflux;Gray matter heterotopia;Sloping forehead;Pachygyria;Abnormal cortical bone morphology;Intellectual disability, severe;Short stature;Thin upper lip vermilion;Global developmental delay;Microcephaly;Agenesis of corpus callosum;Upslanted palpebral fissure;Hyperreflexia;Ventriculomegaly;Unilateral renal agenesis;Hypoplasia of the frontal lobes;Limb hypertonia;Microcephaly;Seizure;Short stature;Autosomal recessive inheritance		0.00234507	357.0	152234.0	0.0	33	0.98	PASS	amr	0.00484166	74.0	0.00298354	203.0	0.00196116	493.0	251382.0	1.0	91	1.0	PASS	amr	0.00332447	115.0	0.00270941	308.0	0.0017041	265	0.005	16.0				23.8	3.111133	0.561	12	9	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred	NCAPD3	0.0	0.0	0.1	0.0	-8.0	45.0	2.0	-11.0						0.733	0.07	0.0	0.047	1.026	.			.	.	mitotic chromosome condensation;meiotic chromosome condensation;cell division;chromosome separation	condensed chromosome, centromeric region;nuclear condensin complex;nucleoplasm;membrane;nuclear pericentric heterochromatin	chromatin binding;protein binding;methylated histone binding;histone binding	LGALS3BP[26496610];NCAPH2[17268547;26496610];FOXG1[25609649];RIPK4[26972000];XRCC3[26496610];NCAPG2[26496610];FOXL1[25609649];ESCO2[26496610];HSCB[28380382];BRCA1[29656893];MRPL45[26496610];PRSS23[16169070];SMC4[26496610];CISD3[26496610];SMC2[26496610];NLN[26496610];SLX4[19596235];MYC[17353931];TEKT1[25416956];NES[26496610];PLEC[30021884];
491562	chr10	96602710	G	A	chr10:96602710	CYP2C19	cytochrome P450 family 2 subfamily C member 19	7013.0	SNV	0/1	0.46	22_19	41	99	False	rs144036596,CM116498,COSV100990323,COSV64907282	EXONIC	YES	NM_000769.4	Transcript	protein_coding	missense_variant		7/9	NM_000769.4:c.1078G>A	NP_000760.1:p.Asp360Asn		1.0					Proguanil poor metabolizer, 609535 (3), Autosomal recessive; Mephenytoin poor metabolizer, 609535 (3), Autosomal recessive; Clopidogrel, impaired responsiveness to, 609535 (3), Autosomal recessive; Omeprazole poor metabolizer, 609535 (3), Autosomal recessive	Voriconazole toxicity;Resistance to clopidogrel;Antidepressant or antipsychotic toxicity or dose selection	Biomarker tested in;Biomarker tested in;Biomarker tested in	Autosomal recessive inheritance		0.000289108	44.0	152192.0	0.0	33	0.97	PASS	amr	0.000588928	9.0	0.000352754	24.0	0.000222806	56.0	251340.0	0.0	90	1.0	PASS	amr	0.000346981	12.0	0.000307985	35.0	0.0003022	47	0.001	4.0	0.00059	5.0		17.41	1.689869	0.298	2	13	15	PolyPhen,PROVEAN_pred	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CYP2C19	0.0	0.0	0.0	0.0	17.0	-32.0	-16.0	41.0						0.923	0.0	0.000000000	0.524	1.12	.			.	Arachidonic acid metabolism;Linoleic acid metabolism;Retinol metabolism;Monoterpenoid biosynthesis;Limonene and pinene degradation;Metabolism of xenobiotics by cytochrome P450;Drug metabolism - cytochrome P450	organic acid metabolic process;xenobiotic metabolic process;steroid metabolic process;monoterpenoid metabolic process;drug metabolic process;epoxygenase P450 pathway;exogenous drug catabolic process;heterocycle metabolic process;oxidation-reduction process;omega-hydroxylase P450 pathway	cytoplasm;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle	monooxygenase activity;iron ion binding;arachidonic acid epoxygenase activity;steroid hydroxylase activity;oxidoreductase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;oxygen binding;enzyme binding;heme binding	.
491589	chr16	2012800	G	A	chr16:2012800	RPS2	ribosomal protein S2	7016.0	SNV	0/1	0.68	8_17	25	99	False	rs199947835,COSV104574963	EXONIC	YES	NM_002952.4	Transcript	protein_coding	synonymous_variant		5/7	NM_002952.4:c.486C>T	NP_002943.2:p.Ile162%3D		-1.0						.	.	.						32	0.98							1.62856e-05	4.0	245616.0	0.0	33	0.87	PASS	sas	0.000131354	4.0	0.0	0.0	0.0000064	1	0.001	2.0				5.896	0.203739		0	0	0			RPS2	0.0	0.0	0.0	0.0	-15.0	-34.0	-6.0	-50.0							0.24	4.294850198			.			.	Ribosome	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;rRNA processing;translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane;positive regulation of ubiquitin-protein transferase activity	nucleus;nucleoplasm;nucleolus;cytosol;focal adhesion;membrane;cytosolic small ribosomal subunit;extracellular exosome	RNA binding;mRNA binding;structural constituent of ribosome;protein binding;fibroblast growth factor binding;enzyme binding;cadherin binding	GRB7[21900206];GSK3B[21900206];CDKN1A[21900206];STAU1[15303970];RPL10[26496610];LRRK2[24725412];HNRNPU[26496610];NAT10[30021884];ARRB1[17620599];NEDD8[18274552];DUX4[26816005];GABARAP[20562859];METTL14[29507755];MAP1LC3A[20562859];MYC[21150319];ERBB2[24189400];ANXA7[21900206];SMN1[21900206];TK1[21900206];SOX5[21988832];NOP56[26496610];GABARAPL2[20562859;21900206];NOM1[21576267];MPP3[16169070];GABARAPL1[20562859];JUN[25609649];NPM1[26496610];RPS9[30021884];VCAM1[22623428;19738201];NEK4[25798074];GADD45A[21900206];PRMT3[unassigned1304];RRP1B[20926688];DICER1[21858095];MLH1[20706999];SENP3[18259216];ESR1[21182205];MEX3C[22863774];DNM2[21900206];AGO1[17932509];CDC37[24189400];AGO2[17932509];DUX4L9[26816005];
496718	chr16	30750116	C	T	chr16:30750116	SRCAP	Snf2 related CREBBP activator protein	7065.0	SNV	0/1	0.48	12_11	23	99	False	rs149217909	EXONIC	YES	NM_006662.3	Transcript	protein_coding	missense_variant		34/34	NM_006662.3:c.8755C>T	NP_006653.2:p.Leu2919Phe		1.0	.,.	Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities, 619595 (3), Autosomal dominant; Floating-Harbor syndrome, 136140 (3), Autosomal dominant	Floating-Harbor syndrome	Disease-causing germline mutation(s) in	Abnormality of cardiovascular system morphology;Intrauterine growth retardation;Short clavicles;Abnormal fingernail morphology;Hypoplasia of penis;Prominent nose;Triangular face;Delayed skeletal maturation;Broad columella;Thin vermilion border;Underdeveloped nasal alae;Broad thumb;Enlarged joints;Abnormal soft palate morphology;Congenital pseudoarthrosis of the clavicle;Wide mouth;Feeding difficulties in infancy;Trigonocephaly;Deeply set eye;Short philtrum;Telecanthus;Constipation;Posteriorly rotated ears;Joint stiffness;Intellectual disability;Clinodactyly of the 5th finger;Long eyelashes;Malabsorption;High pitched voice;Joint hyperflexibility;Camptodactyly of finger;Expressive language delay;Strabismus;Recurrent otitis media;Bulbous nose;Wide nasal bridge;Generalized hirsutism;Brachydactyly;Global developmental delay;Congenital posterior urethral valve;Short neck;Short stature;Nasal speech;Neurological speech impairment;Generalized cerebral atrophy/hypoplasia;Short neck;Strabismus;Epididymal cyst;Wide mouth;Cone-shaped epiphyses of the phalanges of the hand;Triangular face;Congenital posterior urethral valve;Cognitive impairment;Long eyelashes;Conductive hearing impairment;Hirsutism;Short stature;Delayed skeletal maturation;Hydronephrosis;Thin vermilion border;Prominent nose;Expressive language delay;Persistent left superior vena cava;Varicocele;Cryptorchidism;Atrial septal defect;Joint laxity;Inguinal hernia;Celiac disease;Umbilical hernia;Recurrent otitis media;Downturned corners of mouth;Mesocardia;Clinodactyly of the 5th finger;Nephrocalcinosis;Hypospadias;Coarctation of aorta;Low posterior hairline;Deeply set eye;Autosomal dominant inheritance;Posteriorly rotated ears;Hypermetropia;Smooth philtrum	25741868	0.00131399	200.0	152208.0	1.0	32	0.97	PASS	nfe	0.00216043	147.0	0.00216043	147.0	0.00119139	299.0	250968.0	0.0	58	0.97	PASS	nfe	0.00216698	246.0	0.00216698	246.0	0.0013697	213	0.001	4.0	0.00167	19.0		17.09	1.639531	0.055	5	15	20	SIFT,M-CAP_pred,MetaLR_pred,FATHMM_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	SRCAP	0.0	0.0	0.0	0.0	12.0	-41.0	49.0	-21.0						0.00579	1.0	0.000000000	0.96	0.058	.			ciliary ganglion;pons;appendix;atrioventricular node;superior cervical ganglion;trigeminal ganglion;cingulate cortex;parietal lobe;skeletal muscle;	.	chromatin remodeling;regulation of transcription by RNA polymerase II;viral process;gene silencing;histone acetylation;ATP-dependent chromatin remodeling;histone exchange;positive regulation of nucleic acid-templated transcription	Swr1 complex;nucleus;nucleoplasm;Golgi apparatus;nuclear body;protein-containing complex;perinuclear region of cytoplasm	DNA binding;transcription coactivator activity;helicase activity;histone acetyltransferase activity;protein binding;ATP binding;ATPase activity;histone binding	JUN[25609649];BHLHB9[unassigned1304];USHBP1[unassigned1304];ANKRD11[unassigned1304];ATG9A[16169070];ACTL6A[15647280];DIS3L[26496610];YEATS4[26496610];CCNC[unassigned1304];MIPOL1[unassigned1304];RNF168[26496610];MAU2[26496610];ZNHIT1[16230350;15647280];NCOR1[11013263];VPS72[15647280];RUVBL2[16230350];RUVBL1[16230350];NUF2[26496610];MED20[unassigned1304];CEP70[unassigned1304];TRIM54[unassigned1304];ZBTB7A[26816381];PDK1[26496610];PTPN3[unassigned1304];
497128	chr13	73355059	G	A	chr13:73355059	DIS3	DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease	7074.0	SNV	0/1	0.55	14_17	31	99	False		EXONIC	YES	NM_014953.5	Transcript	protein_coding	missense_variant		2/21	NM_014953.5:c.311C>T	NP_055768.3:p.Pro104Leu		-1.0	PIN domain&PIN domain					.	.	.						32	0.93											45	0.94														23.1	2.776602	0.261	11	8	19	SIFT,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred	DIS3	0.0	0.0	0.0	0.0	5.0	30.0	-22.0	20.0						0.962	0.0	3.007910099	0.681	1.176	vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			.	.	rRNA processing;RNA catabolic process;rRNA catabolic process;regulation of mRNA stability;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;CUT catabolic process;RNA phosphodiester bond hydrolysis, exonucleolytic	nuclear exosome (RNase complex);cytoplasmic exosome (RNase complex);exosome (RNase complex);nucleus;nucleoplasm;nucleolus;cytosol;membrane	3'-5'-exoribonuclease activity;RNA binding;endonuclease activity;guanyl-nucleotide exchange factor activity;protein binding	AHNAK[30021884];LRRK2[24725412];PRCC[unassigned1312];HSCB[28380382];BABAM1[19615732];EXOSC7[20531386];EXOSC5[20531386];EXOSC10[15231747;20531386;21255825;23756462];EXOSC4[20531386];SEPT7[unassigned1312];NTMT1[15231747];EXOSC9[20531386];EXOSC8[15231747;20531386];CHORDC1[unassigned1312];TP53BP1[29656893];EXOSC3[20531389;20531386;21255825];EXOSC2[20531386];EXOSC1[20531386];SCYL2[unassigned1312];SH3GLB1[unassigned1312];ZBTB17[15231747];JUN[25609649];SEPT11[unassigned1312];DIS3[23756462];SORT1[26496610];NME2[17353931];RRP1B[20926688];COPZ1[unassigned1312];CDK5[unassigned1312];SARNP[unassigned1312];SUB1[unassigned1312];DRG1[unassigned1312];PLEC[30021884];
497314	chr9	133556917	G	A	chr9:133556917	PRDM12	PR/SET domain 12	7080.0	SNV	0/1	0.33	8_4	12	99	False	rs1377019647	EXONIC	YES	NM_021619.3	Transcript	protein_coding	missense_variant		5/5	NM_021619.3:c.965G>A	NP_067632.2:p.Arg322Gln		1.0	Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type				Neuropathy, hereditary sensory and autonomic, type VIII, 616488 (3), Autosomal recessive	.	.	Recurrent infections;Autosomal recessive inheritance;Corneal ulceration;Corneal scarring;Hypohidrosis						32	0.94							2.40281e-05	1.0	41618.0	0.0	6	0.01	PASS	sas	0.000114758	1.0	0.0	0.0								25.3	3.584403	0.464	10	10	20	SIFT,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	PRDM12	0.0	0.0	0.0	0.0	2.0	-10.0	28.0	0.0							0.3		1.0	1.058	growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; 			skeletal muscle;heart;	.	regulation of transcription by RNA polymerase II;sensory perception of pain;neurogenesis;neuron projection development;methylation;detection of temperature stimulus involved in sensory perception of pain;positive regulation of histone H3-K9 methylation;positive regulation of histone H3-K9 dimethylation	nucleus	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;methyltransferase activity;chromatin DNA binding;sequence-specific DNA binding;metal ion binding;histone methyltransferase binding	.
497323	chr2	99985946	C	T	chr2:99985946	EIF5B	eukaryotic translation initiation factor 5B	7081.0	SNV	0/1	0.5	14_15	30	99	False	rs200710461,COSV99078781	SPLICING	YES	NM_015904.4	Transcript	protein_coding	splice_donor_variant	8/23		NM_015904.4:c.1477+2C>T			1.0						.	.	.		0.000203797	31.0	152112.0	0.0	32	0.98	PASS	amr	0.000523766	8.0	0.00010292	7.0	0.00023445	58.0	247388.0	0.0	32	0.87	PASS	amr	0.000323682	11.0	0.00019541	22.0	0.0002058	32						13.08	0.95034		0	0	0			EIF5B	0.0	0.0	0.13	0.87	-34.0	-2.0	-2.0	2.0			8.564	-7.754	0.81	0.634	0.9				.			ciliary ganglion;olfactory bulb;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;superior cervical ganglion;cingulate cortex;trigeminal ganglion;parietal lobe;skeletal muscle;medulla oblongata;	.	translational initiation;regulation of translational initiation	nucleus;cytoplasm;cytosol	RNA binding;translation initiation factor activity;GTPase activity;protein binding;GTP binding;metal ion binding	BECN1[20562859];GPI[unassigned1312];PRKAA1[20562859];THRB[30021884];NUMA1[30021884];FOXK2[25609649];PYGL[unassigned1312];HMMR[30021884];NR3C1[20195357];MRPL12[unassigned1312];ETS1[20195357];ZNF207[unassigned1312];SNRPB2[unassigned1312];CPNE3[unassigned1312];SMAD2[20195357];FOXD4[25609649];PDIA3[unassigned1312];TRAP1[unassigned1312];JUN[25609649];EIF1AY[12569173];CSNK2A1[22113938];PIH1D1[24656813];CBX1[21888893];XRCC3[26496610];IDH2[unassigned1312];ANXA5[unassigned1312];FN1[19738201];CDC5L[20467437];PA2G4[unassigned1312];SND1[unassigned1312];MAPK13[19135240];CRNN[unassigned1312];CS[unassigned1312];NELL1[21723284];SNW1[20467437];TFCP2[25416956];UBE2N[unassigned1312];HDGF[21907836];CALM1[unassigned1312];
497348	chr1	156503876	G	A	chr1:156503876	IQGAP3	IQ motif containing GTPase activating protein 3	7083.0	SNV	0/1	0.62	12_20	32	99	False	rs34620734,COSV63252114	EXONIC	YES	NM_178229.5	Transcript	protein_coding	synonymous_variant		30/38	NM_178229.5:c.3798C>T	NP_839943.3:p.Asp1266%3D		-1.0						.	.	.		0.000249786	38.0	152130.0	0.0	32	0.96	PASS	amr	0.000785443	12.0	0.000249897	17.0	0.000198975	50.0	251288.0	0.0	100	1.0	PASS	amr	0.000549419	19.0	0.000237438	27.0	0.0001350	21	0.002	5.0	0.00114	13.0		7.583	0.329087		0	0	0			IQGAP3	0.0	0.01	0.0	0.0	25.0	42.0	33.0	-38.0						0.641	0.0	18.016300198			.			ciliary ganglion;testis - interstitial;subthalamic nucleus;superior cervical ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;skeletal muscle;globus pallidus;	Regulation of actin cytoskeleton	G1/S transition of mitotic cell cycle;activation of MAPK activity;Ras protein signal transduction;regulation of cell size;positive regulation of gene expression;negative regulation of gene expression;positive regulation of mammary gland epithelial cell proliferation;regulation of GTPase activity;ERK1 and ERK2 cascade;cellular response to organic substance	cytosol;cell-cell junction;lateral plasma membrane	calmodulin binding;Rho GTPase binding;myosin VI light chain binding	IQCB1[21565611];CCDC198[27107012];LRRK2[24725412];RIPK4[26972000];EPS15L1[30021884];TANK[unassigned1774];PTBP3[22575643];CDC42[26496610];KATNAL2[26929214];MYC[17314511];RAC1[27173435;unassigned1312];CALM1[25416956;unassigned1312];KIFAP3[27173435;unassigned1312];
497521	chr1	36786277	G	C	chr1:36786277	SH3D21	SH3 domain containing 21	7090.0	SNV	0/1	0.41	20_14	34	99	False	rs144425061,COSV99583981	EXONIC	YES	NM_001162530.2	Transcript	protein_coding	synonymous_variant		14/16	NM_001162530.2:c.2013G>C	NP_001156002.1:p.Ala671%3D		1.0						.	.	.		0.00395402	602.0	152250.0	3.0	32	0.99	PASS	nfe	0.00592299	403.0	0.00592299	403.0	0.0046945	1172.0	249654.0	6.0	70	0.99	PASS	nfe	0.00626271	702.0	0.00626271	702.0	0.0047266	735	0.003	10.0				1.008	-0.149587		0	0	0			SH3D21	0.0	0.0	0.0	0.0	40.0	-29.0	4.0	46.0							0.0	56.630256538			.			superior cervical ganglion;	.	.	nucleus;nucleoplasm;plasma membrane	.	JUN[25609649];EGFR[20029029];
499160	chr10	45919586	A	G	chr10:45919586	ALOX5	arachidonate 5-lipoxygenase	7117.0	SNV	0/1	0.62	10_16	26	99	False	rs568327472	EXONIC	YES	NM_000698.5	Transcript	protein_coding	missense_variant		5/14	NM_000698.5:c.652A>G	NP_000689.1:p.Thr218Ala		1.0	.,Lipoxygenase, C-terminal				{Atherosclerosis, susceptibility to} (3); {Asthma, diminished response to antileukotriene treatment in}, 600807 (3), Autosomal dominant	.	.	Autosomal dominant inheritance;Multifactorial inheritance;Asthma		5.91319e-05	9.0	152202.0	0.0	32	0.97	PASS	sas	0.000414422	2.0	5.87976e-05	4.0	0.000210783	53.0	251444.0	0.0	69	1.0	PASS	amr	0.000549451	19.0	0.000202216	23.0	0.0001865	29	0.001	3.0	0.00026	3.0		23.0	2.707639	0.167	12	8	20	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred	ALOX5	0.0	0.0	0.0	0.0	-4.0	-24.0	9.0	6.0						0.255	0.0	0.000000000	0.999	1.312	hematopoietic system phenotype; immune system phenotype; skeleton phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; 			.	Arachidonic acid metabolism;Linoleic acid metabolism	leukotriene production involved in inflammatory response;leukotriene metabolic process;cytokine-mediated signaling pathway;leukotriene biosynthetic process;lipoxygenase pathway;interleukin-18-mediated signaling pathway;long-chain fatty acid biosynthetic process;neutrophil degranulation;oxidation-reduction process	extracellular region;extracellular space;nuclear envelope;nuclear envelope lumen;nucleoplasm;cytosol;nuclear matrix;nuclear membrane;secretory granule lumen;ficolin-1-rich granule lumen	arachidonate 5-lipoxygenase activity;iron ion binding;protein binding	NUTM1[25416956];YES1[24860872];CARD9[unassigned1304];GATC[unassigned1304];MEOX2[unassigned1304];MEOX1[25416956];OOEP[unassigned1304];FGR[24860872];HCK[24860872];SYCE1[25416956;25910212];CEP57L1[25416956;25910212];HSD17B1[unassigned1304];MAPKAPK2[24860872];TBC1D7[unassigned1304];COTL1[11297527;16924104];REL[25416956];HHIPL2[25416956;25910212];C10orf67[unassigned1304];LCN1[unassigned1304];CEP63[25416956;unassigned1304;25910212];PRKACA[24860872];CCDC174[unassigned1304];CAMK2G[24860872];MAD1L1[25416956;unassigned1304;25910212];
499369	chr12	2936425	G	A	chr12:2936425	NRIP2	nuclear receptor interacting protein 2	7122.0	SNV	0/1	0.49	18_17	35	99	False	rs117603123	EXONIC	YES	NM_031474.3	Transcript	protein_coding	missense_variant		6/6	NM_031474.3:c.794C>T	NP_113662.1:p.Ala265Val		-1.0						.	.	.		0.00216137	329.0	152218.0	1.0	33	0.98	PASS	nfe	0.00349794	238.0	0.00349794	238.0	0.00193235	485.0	250990.0	1.0	40	0.98	PASS	nfe	0.00309191	351.0	0.00309191	351.0	0.0019228	299	0.008	25.0				23.3	2.891963	0.081	3	15	18	SIFT,MutationAssessor_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	NRIP2	0.0	0.0	0.0	0.0	49.0	40.0	2.0	-48.0						0.369	0.0	0.000000000	0.501	1.176	.			ciliary ganglion;olfactory bulb;occipital lobe;testis - interstitial;dorsal root ganglion;superior cervical ganglion;atrioventricular node;cerebellum peduncles;cerebellum;thalamus;	.	proteolysis	nucleus;cytoplasm	aspartic-type endopeptidase activity;protein binding	SF3A2[17332742];CCNG2[21988832];ELF5[21988832];ZNF76[unassigned1304];BANP[25416956;unassigned1304];HDAC7[unassigned1304];
501483	chr1	54870607	G	A	chr1:54870607	SSBP3	single stranded DNA binding protein 3	7139.0	SNV	0/1	0.61	14_22	36	99	False	rs368326638	SPLICING	YES	NM_145716.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/17		NM_145716.4:c.57-4C>T			-1.0						.	.	.		0.000598495	91.0	152048.0	1.0	31	0.95	PASS	amr	0.00111359	17.0	0.000838112	57.0	0.000554837	139.0	250524.0	1.0	69	0.95	PASS	amr	0.000869464	30.0	0.000821947	93.0	0.0004630	72	0.002	5.0				8.528	0.412199		0	0	0			SSBP3	0.0	0.0	0.01	0.0	-4.0	-9.0	-3.0	-9.0	3.51732052059754e-05	0.0	9.707	-0.893	8.815		1.0				cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			pons;prefrontal cortex;cingulate cortex;superior cervical ganglion;trigeminal ganglion;globus pallidus;medulla oblongata;	.	hematopoietic progenitor cell differentiation;positive regulation of cell population proliferation;prechordal plate formation;midbrain-hindbrain boundary initiation;positive regulation of transcription by RNA polymerase II;head development;head morphogenesis;protein-containing complex assembly;positive regulation of anterior head development	nucleus;protein-containing complex	RNA polymerase II proximal promoter sequence-specific DNA binding;single-stranded DNA binding;protein binding	BLK[unassigned1304];YES1[25416956;unassigned1304];LDB1[25416956;unassigned1304];DTNB[unassigned1304];SS18L1[unassigned1304];LDB2[18330356];NXT2[25416956;unassigned1304];NUDCD1[29021621];EWSR1[25416956];TAL1[19497860];ULK2[20562859];PIN1[25416956;unassigned1304];IL36RN[25416956;unassigned1304];TBC1D23[25416956];TRIM33[20603019];
503086	chr4	40122453	C	T	chr4:40122453	N4BP2	NEDD4 binding protein 2	7191.0	SNV	0/1	0.41	19_13	32	99	False	rs78417585,COSV54704169	EXONIC	YES	NM_018177.6	Transcript	protein_coding	missense_variant		9/18	NM_018177.6:c.2722C>T	NP_060647.2:p.Pro908Ser		1.0						.	.	.		0.00674405	1026.0	152134.0	6.0	32	0.97	PASS	nfe	0.00885216	602.0	0.00885216	602.0	0.00835514	2095.0	250744.0	18.0	53	0.99	PASS	nfe	0.00962218	1090.0	0.00962218	1090.0	0.0079676	1239	0.01	31.0				7.006	0.284107	0.015	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	N4BP2	0.0	0.0	0.01	0.0	-47.0	-42.0	-6.0	38.0						0.918	0.0	0.0	0.326	1.015	.			.	.	phosphorylation;nucleic acid phosphodiester bond hydrolysis	cytosol	endonuclease activity;protein binding;ATP binding;ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity	CAMK2D[29426014];TOLLIP[20936779];RPGRIP1L[26638075];PLEC[30021884];
509182	chr10	70930963	A	G	chr10:70930963	VPS26A	VPS26, retromer complex component A	7235.0	SNV	0/1	0.44	14_11	25	99	False	rs61750775	EXONIC	YES	NM_004896.5	Transcript	protein_coding	missense_variant		9/9	NM_004896.5:c.922A>G	NP_004887.2:p.Asn308Asp		1.0	.,.					.	.	.		0.000808126	123.0	152204.0	0.0	32	0.97	PASS	amr	0.00176725	27.0	0.00108769	74.0	0.000804102	202.0	251212.0	1.0	75	0.95	PASS	amr	0.00139106	48.0	0.000976305	111.0	0.0007138	111	0.002	7.0				21.3	2.179297	0.213	5	13	18	LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	VPS26A	0.0	0.03	0.0	0.0	28.0	-48.0	-29.0	-48.0						0.279	0.66	0.0	1.0	1.312	cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); craniofacial phenotype; growth/size/body region phenotype; 			prefrontal cortex;testis - interstitial;superior cervical ganglion;testis;	.	intracellular protein transport;Wnt signaling pathway;regulation of macroautophagy;retrograde transport, endosome to Golgi;retrograde transport, endosome to plasma membrane	lysosome;endosome;early endosome;cytosol;endosome membrane;retromer complex;retromer, cargo-selective complex;vesicle;tubular endosome	protein binding;protein transporter activity	WASHC4[26496610];RPL4[30021884];VPS29[11102511;26496610;16732284;17891154];WASHC5[26496610];RBM26[26496610];FKBP15[26496610];CELF1[26496610];BHLHE41[26496610];ILK[17353931];NOLC1[26496610];WASHC2C[26496610];CD99L2[26496610];WASHC2A[26496610];BAG6[26496610];RBM4[26496610];SNX1[11102511];FAM102B[26496610];C2orf69[26496610];SNX2[11102511;15078903];CAPZB[26496610];SMYD2[17353931];SYMPK[26496610];ZSCAN12[unassigned1304];RIOK2[23455922];VPS35[11102511;15078903;26496610;unassigned1304;16732284;17891154;24747528];LCMT2[26496610];ENTR1[26496610];MPDZ[26496610];UBL4A[26496610];CRTAP[26496610];ZER1[26496610];CPSF6[26496610];ANKRD27[26496610];UTP4[26496610];FN1[19738201];P3H1[26496610];MIF[26496610];BCS1L[26496610];IGF2R[15078903];NFKB1[26496610];PLEKHA7[28877994];COX6B1[26496610];MORF4L1[unassigned1304];TBC1D5[20923837;26496610];INTS7[26496610];RAI14[26496610];
510822	chr21	34922515	G	A	chr21:34922515	SON	SON DNA binding protein	7269.0	SNV	0/1	0.37	17_10	27	99	False	rs138817883	EXONIC	YES	NM_138927.4	Transcript	protein_coding	missense_variant		3/12	NM_138927.4:c.978G>A	NP_620305.3:p.Met326Ile		1.0	.,.,.	Likely_benign	criteria_provided,_single_submitter	not_provided	ZTTK syndrome, 617140 (3), Autosomal dominant	Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome	Disease-causing germline mutation(s) (loss of function) in	Thin upper lip vermilion;Cerebellar hypoplasia;Feeding difficulties;Deeply set eye;Hypoplasia of the corpus callosum;Depressed nasal bridge;Small hand;Short philtrum;Short foot;Frontal bossing;Flexion contracture;Abnormal heart morphology;Abnormality of cardiovascular system morphology;Facial asymmetry;Craniosynostosis;Autosomal dominant inheritance;Unilateral renal agenesis;Abnormality of the ribs;Abnormality of the dentition;Horseshoe kidney;Failure to thrive;Narrow mouth;Global developmental delay;Hemivertebrae;Cleft palate;Cerebral visual impairment;Downslanted palpebral fissures;Generalized hypotonia;Arachnoid cyst;Intellectual disability;Hypermetropia;Optic atrophy;Low-set ears;Short stature;Developmental regression;Strabismus;Seizure;Joint hypermobility;Scoliosis;Kyphosis;High palate;Ventriculomegaly;Wide nasal bridge;Deeply set eye;Atrial septal defect;Horseshoe kidney;Hypoplasia of the corpus callosum;Hypermetropia;Respiratory failure;Unilateral renal agenesis;Unilateral lung agenesis;Hearing impairment;Optic atrophy;Facial asymmetry;Blue sclerae;Kyphoscoliosis;Auditory hallucinations;Prominent forehead;Fetal distress;Protruding ear;Simplified gyral pattern;Smooth philtrum;Cerebellar hemisphere hypoplasia;Absent gallbladder;Epicanthus;Emphysema;Gastrointestinal dysmotility;Optic nerve hypoplasia;Autistic behavior;Frontal bossing;Gastrostomy tube feeding in infancy;Bifid uvula;Full cheeks;Global developmental delay;Decreased circulating IgG level;Low-set ears;Failure to thrive in infancy;Hyperextensibility at elbow;Ischemic stroke;Nystagmus;Transient ischemic attack;Broad lateral eyebrow;Metopic synostosis;Slender long bone;Dilation of lateral ventricles;Infantile muscular hypotonia;Patent ductus arteriosus after birth at term;Exotropia;Secretory IgA deficiency;Recurrent infections;Periventricular leukomalacia;Relative macrocephaly;Sagittal craniosynostosis;Arachnoid cyst;Hyperextensible hand joints;Depressed nasal bridge;Gastroparesis;Gastroesophageal reflux;Developmental regression;Absent thumb;Esotropia;Downslanted palpebral fissures;Arachnodactyly;Curly hair;Intellectual disability, severe;Hemivertebrae;Bilateral renal dysplasia;Rib fusion;Chronic diarrhea;Global brain atrophy;Cerebral visual impairment;Short philtrum;Abnormal common carotid artery morphology;Submucous cleft soft palate;Progressive visual loss;Myopia;Proportionate short stature;Intrauterine growth retardation;Sparse eyebrow;Thin vermilion border;Soft, doughy skin;Lumbar hyperlordosis;Short nose;Arnold-Chiari malformation;Wide nasal bridge;Narrow forehead;Spasticity;Generalized non-motor (absence) seizure;Polymicrogyria;Cervical ribs;Progressive ventriculomegaly;Hypoplasia of the maxilla;Dysplastic corpus callosum;Downturned corners of mouth;Dysphagia		0.00119545	182.0	152244.0	0.0	33	0.99	PASS	amr	0.00425337	65.0	0.00138134	94.0	0.00107771	271.0	251460.0	0.0	99	1.0	PASS	amr	0.00179243	62.0	0.00162649	185.0	0.0009260	144	0.002	5.0				22.9	2.689319	0.064	2	18	20	SIFT,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred															0.198	1.0	0.0	1.0	1.176	.			ciliary ganglion;uterus;white blood cells;subthalamic nucleus;atrioventricular node;superior cervical ganglion;trigeminal ganglion;placenta;	.	microtubule cytoskeleton organization;mitotic cytokinesis;mRNA processing;RNA splicing;negative regulation of apoptotic process;regulation of RNA splicing;regulation of mRNA splicing, via spliceosome;regulation of cell cycle	nuclear speck	DNA binding;RNA binding;protein binding;RS domain binding	SRPK2[23602568];SRPK3[23602568];YWHAB[15324660];EIF4A3[23084401];HDAC11[23752268];PRPF40A[15231748];DDX41[25920683];MKI67[26949251];CLK2[23602568];SRPK1[23602568];NUDCD1[29021621];CLIP4[23414517];MAGOH[23084401];SNIP1[15231748];MAPT[26402096];KIFAP3[26496610];YWHAG[15324660;17353931];RUNX1T1[18952841];
513107	chr18	43577721	G	C	chr18:43577721	PSTPIP2	proline-serine-threonine phosphatase interacting protein 2	7310.0	SNV	0/1	0.5	6_6	12	99	False	rs182087986	EXONIC	YES	NM_024430.4	Transcript	protein_coding	synonymous_variant		9/15	NM_024430.4:c.636C>G	NP_077748.3:p.Ala212%3D		-1.0						.	.	.		1.5604e-05	2.0	128172.0	0.0	20	0.51	PASS	amr	0.000188253	2.0	0.0	0.0	8.09697e-06	2.0	247006.0	0.0	82	0.99	PASS	amr	2.89168e-05	1.0	8.84752e-06	1.0	0.0000064	1			0.00037	3.0		12.57	0.880181		0	0	0			PSTPIP2	0.0	0.0	0.01	0.0	-32.0	28.0	17.0	-12.0						0.63	0.11	9.13205381			cellular phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; 			superior cervical ganglion;	.	cell migration;actin filament polymerization	cytoplasm;cytosol;cytoskeleton;actin filament;plasma membrane	cytoskeletal protein binding;actin filament binding	KRT18[26871637];SHC1[19380743];DNAJC5[29997244];CDC5L[20467437];STK38L[30108113];GRB2[19380743;21706016];
514889	chr1	144852476	T	C	chr1:144852476	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.6	25_39	65	99	False	rs1616066,COSV57703953	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		40/40	NM_001350520.1:c.7509A>G	NP_001337449.1:p.Pro2503%3D		-1.0						.	.	.		3.28537e-05	5.0	152190.0	0.0	28	0.9	PASS	sas	0.000207125	1.0	2.93927e-05	2.0	0.499984	125303.0	250614.0	1.0	100	0.99	InbreedingCoeff	afr	0.5	8095.0	0.499982	56592.0	0.0314526	4891	0.132	380.0				6.48	0.244704		0	0	0			PDE4DIP	0.0	0.04	0.0	0.0	23.0	-33.0	9.0	47.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
515431	chr1	144854180	T	C	chr1:144854180	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.24	70_22	92	99	False	rs4997148,COSV57703964	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		39/40	NM_001350520.1:c.7470A>G	NP_001337449.1:p.Ala2490%3D		-1.0						.	.	.		0.000135137	20.0	147998.0	0.0	28	0.89	AS_VQSR,PASS	eas,afr	0.000587314	3.0	0.000121326	8.0	0.49858	109553.0	219730.0	1.0	100	0.98	InbreedingCoeff	amr	0.498792	15279.0	0.498446	48757.0	0.0096332	1498	0.117	359.0				10.93	0.673951		0	0	0			PDE4DIP	0.02	0.0	0.07	0.0	31.0	-15.0	-15.0	3.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
515511	chr1	144854528	G	G	chr1:144854528	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0|1	0.24	45_14	59	99	False	rs833192,COSV57674763	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		38/40	NM_001350520.1:c.7428T>C	NP_001337449.1:p.Ile2476%3D		-1.0						.	.	.		0.000230494	35.0	151848.0	0.0	34	0.96	PASS	afr	0.000482882	20.0	0.000103053	7.0	0.473723	74293.0	156828.0	0.0	100	1.0	InbreedingCoeff	eas	0.49271	7637.0	0.460189	29684.0	0.0100319	1560	0.048	148.0				11.24	0.710559		0	0	0			PDE4DIP	0.0	0.0	0.01	0.16	23.0	0.0	-10.0	0.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
515524	chr1	144854537	C	C	chr1:144854537	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0|1	0.22	46_13	59	99	False	rs3851872,COSV57703052	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		38/40	NM_001350520.1:c.7419A>G	NP_001337449.1:p.Glu2473%3D		-1.0						.	.	.	28522829	0.000203811	31.0	152102.0	0.0	34	0.97	PASS	eas	0.00038625	2.0	0.000205852	14.0	0.480455	76648.0	159532.0	0.0	100	1.0	InbreedingCoeff	eas	0.492666	7591.0	0.471819	31794.0	0.0105721	1644	0.052	161.0				9.113	0.469735		0	0	0			PDE4DIP	0.0	0.0	0.0	0.09	50.0	-19.0	-19.0	-9.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
515530	chr1	144854581	T	C	chr1:144854581	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.24	41_13	54	99	False	rs78371650,COSV57672314	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		38/40	NM_001350520.1:c.7375A>G	NP_001337449.1:p.Thr2459Ala		-1.0						.	.	.		0.000400873	61.0	152168.0	0.0	31	0.92	PASS,PASS	afr,sas	0.00125428	52.0	7.35229e-05	5.0	0.487253	59250.0	121600.0	0.0	100	1.0	InbreedingCoeff_RF	sas	0.497668	8537.0	0.482813	23906.0	0.0023279	362	0.032	101.0				0.673	-0.209683		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	6.0	21.0	1.0	-32.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
515540	chr1	144854594	G	T	chr1:144854594	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.21	44_12	56	99	False	rs79028512,COSV57675041	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		38/40	NM_001350520.1:c.7362C>A	NP_001337449.1:p.Leu2454%3D		-1.0						.	.	.		0.0	0.0	152160.0	0.0	31	0.92	AC0,PASS	afr	0.00107046	44.0	0.0	0.0	0.493841	71517.0	144818.0	0.0	100	1.0	InbreedingCoeff	amr	0.49802	11065.0	0.494384	29666.0	0.0157874	2455	0.044	138.0				5.938	0.206602		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	8.0	-7.0	-12.0	21.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
515545	chr1	144854598	C	T	chr1:144854598	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.46	30_26	56	99	False	rs3863691,COSV57672336	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		38/40	NM_001350520.1:c.7358G>A	NP_001337449.1:p.Arg2453Gln		-1.0						.	.	.		3.2903e-05	5.0	151962.0	0.0	30	0.92	PASS,PASS	afr,sas	7.25093e-05	3.0	1.4705e-05	1.0	0.5	125090.0	250180.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56575.0	0.5	56575.0	0.0157617	2451	0.051	159.0				0.568	-0.235226		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	-11.0	4.0	17.0	-49.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
515774	chr1	144855866	A	G	chr1:144855866	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.46	37_32	69	99	False	rs1698582,COSV57680805	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		37/40	NM_001350520.1:c.7173T>C	NP_001337449.1:p.Gly2391%3D		-1.0						.	.	.		0.000414599	63.0	151954.0	0.0	30	0.92	PASS	eas	0.000777001	4.0	0.000470547	32.0	0.483844	72205.0	149232.0	1.0	53	0.99	InbreedingCoeff	eas	0.492787	6832.0	0.479341	30164.0	0.0159417	2479	0.027	82.0				2.145	-0.033858		0	0	0			PDE4DIP	0.02	0.01	0.0	0.0	17.0	10.0	11.0	2.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
516365	chr1	144865850	G	T	chr1:144865850	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.49	38_37	76	99	False	rs1613780,COSV57672370	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		31/40	NM_001350520.1:c.6216C>A	NP_001337449.1:p.Asp2072Glu		-1.0						.	.	.						24	0.71							0.5	125676.0	251352.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56832.0	0.5	56832.0	0.0371566	5778	0.204	644.0				12.55	0.878033		0	0	0			PDE4DIP	0.0	0.0	0.0	0.01	-40.0	32.0	-44.0	-40.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
516403	chr1	144866643	G	A	chr1:144866643	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.44	32_25	57	99	False	rs1620560,COSV57672397	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		30/40	NM_001350520.1:c.6085C>T	NP_001337449.1:p.Arg2029Cys		-1.0						.	.	.		6.58085e-06	1.0	151956.0	0.0	28	0.92	PASS	nfe	1.47016e-05	1.0	1.47016e-05	1.0	0.499992	125627.0	251258.0	0.0	100	1.0	InbreedingCoeff	afr	0.5	8125.0	0.499982	56796.0	0.0365393	5682	0.207	656.0				23.1	2.795841		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	-12.0	30.0	-49.0	-33.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
516443	chr1	144868170	C	T	chr1:144868170	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.62	18_30	48	99	False	rs1628310,COSV57672418	SPLICING	YES	NM_001350520.1	Transcript	protein_coding	missense_variant,splice_region_variant		29/40	NM_001350520.1:c.5755G>A	NP_001337449.1:p.Ala1919Thr		-1.0						.	.	.						22	0.66							0.5	125641.0	251282.0	0.0	91	1.0	InbreedingCoeff	nfe	0.5	56799.0	0.5	56799.0	0.0333561	5187	0.201	626.0				18.77	1.875075		0	0	0			PDE4DIP	0.02	0.0	0.0	0.0	-28.0	2.0	-28.0	-18.0			7.781	0.471	8.253	0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
516663	chr1	144871738	C	A	chr1:144871738	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0|1	0.44	30_24	54	99	False	rs1698605,COSV57672434	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		28/40	NM_001350520.1:c.5710G>T	NP_001337449.1:p.Ala1904Ser		-1.0						.	.	.						25	0.88							0.499996	125148.0	250298.0	0.0	65	1.0	InbreedingCoeff	nfe	0.5	56622.0	0.5	56622.0	0.0173629	2700	0.19	585.0				27.3	3.950838		0	0	0			PDE4DIP	0.0	0.0	0.02	0.0	-9.0	17.0	-42.0	-38.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
516673	chr1	144871755	A	T	chr1:144871755	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0|1	0.43	25_19	44	99	False	rs1778159,COSV57672446	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		28/40	NM_001350520.1:c.5693T>A	NP_001337449.1:p.Val1898Glu		-1.0						.	.	.						25	0.88							0.499996	125322.0	250646.0	0.0	79	1.0	InbreedingCoeff	afr	0.5	8078.0	0.499991	56657.0	0.0203210	3160	0.19	584.0				17.46	1.697287		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	41.0	0.0	-1.0	13.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
516678	chr1	144871782	A	G	chr1:144871782	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.4	27_18	45	99	False	rs1778158,COSV57672459	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		28/40	NM_001350520.1:c.5666T>C	NP_001337449.1:p.Leu1889Pro		-1.0						.	.	.						25	0.88							0.5	125355.0	250710.0	0.0	89	1.0	InbreedingCoeff	nfe	0.5	56700.0	0.5	56700.0	0.0156909	2440	0.198	617.0				21.9	2.27564		0	0	0			PDE4DIP	0.0	0.01	0.0	0.0	-50.0	14.0	-50.0	-14.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
516687	chr1	144871818	G	A	chr1:144871818	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.21	44_12	56	99	False	rs587669053	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		28/40	NM_001350520.1:c.5630C>T	NP_001337449.1:p.Pro1877Leu		-1.0						.	.	.		9.19649e-05	14.0	152232.0	0.0	26	0.88	PASS	amr	0.000850785	13.0	0.0	0.0	0.0	0.0	251390.0	0.0	79	1.0	AC0				0.0	0.0	0.0000257	4						18.98	1.902572		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	3.0	-22.0	20.0	-50.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
516697	chr1	144871889	A	C	chr1:144871889	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.38	36_22	58	99	False	rs1698606	SPLICING	YES	NM_001350520.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	27/39		NM_001350520.1:c.5567-8T>G			-1.0						.	.	.		6.56996e-06	1.0	152208.0	0.0	25	0.87	AS_VQSR	nfe	1.46959e-05	1.0	1.46959e-05	1.0	0.49998	123700.0	247410.0	0.0	41	0.87	InbreedingCoeff	afr	0.5	8075.0	0.499991	56010.0	0.0365457	5683	0.163	504.0				11.48	0.740576		0	0	0			PDE4DIP	0.0	0.08	0.0	0.0	-1.0	-8.0	-8.0	-34.0	8.18634908050367e-05	0.01	9.299	-0.276	9.023	0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
516782	chr1	144873887	C	T	chr1:144873887	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.57	23_31	54	99	False	rs1699787,COSV57704265	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		27/40	NM_001350520.1:c.5556G>A	NP_001337449.1:p.Gln1852%3D		-1.0						.	.	.	26887787					29	0.95							0.5	125708.0	251416.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56855.0	0.5	56855.0	0.0340313	5292	0.206	653.0				11.9	0.793268		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	-2.0	23.0	-10.0	-13.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
516853	chr1	144874760	T	C	chr1:144874760	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.59	28_41	69	99	False	rs1610774,COSV57704290	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		26/40	NM_001350520.1:c.5334A>G	NP_001337449.1:p.Glu1778%3D		-1.0						.	.	.		7.58914e-05	11.0	144944.0	0.0	29	0.93	PASS	afr	0.000130263	5.0	3.06204e-05	2.0	0.500004	125718.0	251434.0	1.0	100	1.0	InbreedingCoeff	nfe	0.500009	56861.0	0.500009	56861.0	0.0365071	5677	0.207	655.0				12.19	0.830986		0	0	0			PDE4DIP	0.0	0.03	0.0	0.0	-1.0	24.0	-31.0	-35.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
516858	chr1	144874815	T	C	chr1:144874815	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.26	43_15	58	99	False	rs1778155,COSV57681140	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		26/40	NM_001350520.1:c.5279A>G	NP_001337449.1:p.His1760Arg		-1.0						.	.	.	26959706,25961151	3.28433e-05	5.0	152238.0	0.0	29	0.95	PASS	afr	0.000120546	5.0	0.0	0.0	0.397831	89142.0	224070.0	0.0	100	1.0	InbreedingCoeff	eas	0.496466	8850.0	0.374192	37503.0	0.0286166	4450	0.111	337.0				0.399	-0.287429		0	0	0			PDE4DIP	0.0	0.02	0.0	0.0	5.0	-31.0	1.0	24.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
516915	chr1	144877176	C	T	chr1:144877176	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.56	23_29	52	99	False	rs2762875,COSV57672477	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		24/40	NM_001350520.1:c.4997G>A	NP_001337449.1:p.Arg1666Gln		-1.0						.	.	.						18	0.31							0.49996	125245.0	250510.0	0.0	100	1.0	InbreedingCoeff	eas	0.5	9191.0	0.499973	56584.0	0.0339863	5285	0.201	625.0				19.54	1.976035		0	0	0			PDE4DIP	0.05	0.0	0.02	0.0	-2.0	-12.0	22.0	-16.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
517041	chr1	144879264	G	G	chr1:144879264	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.74	15_45	61	99	False	rs2798901,COSV57672501	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		23/40	NM_001350520.1:c.4672T>C	NP_001337449.1:p.Arg1558%3D		-1.0						.	.	.						0	0.0							0.69194	173706.0	251042.0	48185.0	100	1.0	InbreedingCoeff	eas	0.924913	17011.0	0.639127	72445.0	0.0720367	11202	0.291	907.0				13.71	1.041682		0	0	0			PDE4DIP	0.0	0.0	0.0	0.02	35.0	-47.0	-14.0	30.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
517149	chr1	144882581	A	G	chr1:144882581	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.4	26_17	43	99	False	rs1699836,COSV57704362	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		20/40	NM_001350520.1:c.3927T>C	NP_001337449.1:p.Ile1309%3D		-1.0						.	.	.						20	0.57							0.499972	125638.0	251290.0	0.0	100	1.0	InbreedingCoeff	afr	0.5	8128.0	0.499991	56838.0	0.0333689	5189	0.173	539.0				1.871	-0.055846		0	0	0			PDE4DIP	0.01	0.0	0.01	0.0	6.0	-17.0	-21.0	44.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
517160	chr1	144882823	C	T	chr1:144882823	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.57	20_26	46	99	False	rs1698647,COSV57672559	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		20/40	NM_001350520.1:c.3685G>A	NP_001337449.1:p.Ala1229Thr		-1.0						.	.	.		6.73319e-05	10.0	148518.0	0.0	20	0.6	AS_VQSR	eas	0.000817996	4.0	1.49272e-05	1.0	0.499976	125590.0	251192.0	0.0	100	1.0	InbreedingCoeff	afr	0.5	8124.0	0.499991	56802.0	0.0365393	5682	0.194	614.0				28.0	4.033896		0	0	0			PDE4DIP	0.0	0.0	0.0	0.05	43.0	-47.0	8.0	-47.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
517386	chr1	144886197	A	T	chr1:144886197	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.34	33_17	50	99	False	rs1698624,COSV57672583	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		19/40	NM_001350520.1:c.3526T>A	NP_001337449.1:p.Phe1176Ile		-1.0						.	.	.						28	0.94							0.49998	125539.0	251088.0	1.0	100	1.0	InbreedingCoeff	nfe	0.5	56784.0	0.5	56784.0	0.0365200	5679	0.207	656.0				0.434	-0.274797		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	43.0	-9.0	1.0	38.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
518185	chr1	144912233	C	T	chr1:144912233	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.52	27_29	56	99	False	rs1629011,COSV57672613	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		11/40	NM_001350520.1:c.2531G>A	NP_001337449.1:p.Arg844His		-1.0						.	.	.						19	0.39							0.5	125689.0	251378.0	0.0	76	1.0	InbreedingCoeff	nfe	0.5	56853.0	0.5	56853.0	0.0371566	5778	0.107	321.0				19.18	1.928911		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	-12.0	46.0	48.0	7.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
518370	chr1	144915561	G	A	chr1:144915561	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.54	25_29	54	99	False	rs1778111,COSV57672649	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	stop_gained		10/40	NM_001350520.1:c.2353C>T	NP_001337449.1:p.Arg785Ter		-1.0						.	.	.						27	0.92							0.5	125741.0	251482.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56881.0	0.5	56881.0	0.0325844	5067	0.199	629.0				34.0	5.71634		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	-21.0	41.0	2.0	-47.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
518387	chr1	144915624	G		chr1:144915624	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	deletion	0/1	0.32	38_18	56	99	False	rs66512216,COSV57700531,COSV57704493	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	frameshift_variant		10/40	NM_001350520.1:c.2290del	NP_001337449.1:p.Leu764CysfsTer12		-1.0						.	.	.						27	0.92							0.158191	35124.0	222036.0	0.0	74	1.0	RF	eas	0.37446	5718.0	0.136633	13924.0	0.0005080,0.0081220	79,1263	0.091	286.0				23.2	2.806536		0	0	0			PDE4DIP	0.02	0.02	0.0	0.0	43.0	33.0	-26.0	-45.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
518473	chr1	144916748	C	G	chr1:144916748	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.47	29_26	55	99	False	rs1747930,COSV57672692	SPLICING	YES	NM_001350520.1	Transcript	protein_coding	missense_variant,splice_region_variant		9/40	NM_001350520.1:c.2096G>C	NP_001337449.1:p.Ser699Thr		-1.0						.	.	.		6.60005e-06	1.0	151514.0	0.0	28	0.94	AS_VQSR	afr	2.43262e-05	1.0	0.0	0.0	0.499996	125653.0	251308.0	0.0	77	1.0	InbreedingCoeff	afr	0.5	8107.0	0.499991	56837.0	0.0365393	5682	0.198	614.0				31.0	4.317591		0	0	0			PDE4DIP	0.02	0.02	0.0	0.0	1.0	-1.0	-43.0	1.0	0.966933262579569	0.886	6.31	-0.122	6.187	0.984		18.016300198			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
518502	chr1	144917546	A	G	chr1:144917546	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.54	21_25	46	99	False	rs1698682,COSV57704562	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		8/40	NM_001350520.1:c.2047T>C	NP_001337449.1:p.Leu683%3D		-1.0						.	.	.						23	0.71							0.499996	125735.0	251472.0	0.0	100	1.0	InbreedingCoeff	afr	0.5	8128.0	0.499991	56874.0	0.0365393	5682	0.207	656.0				12.61	0.885383		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	33.0	-37.0	-47.0	-43.0						0.984		42.247670036			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
518518	chr1	144917841	T	C	chr1:144917841	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.5	21_21	42	99	False	rs1698681,COSV57672908	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		7/40	NM_001350520.1:c.1934A>G	NP_001337449.1:p.His645Arg		-1.0						.	.	.						21	0.65							0.499996	125728.0	251458.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56875.0	0.5	56875.0	0.0329574	5125	0.187	582.0				16.75	1.582734		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	7.0	-9.0	-22.0	-2.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
518550	chr1	144918957	T	A	chr1:144918957	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.51	22_23	45	99	False	rs1061308,COSV57672941	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		6/40	NM_001350520.1:c.1718A>T	NP_001337449.1:p.Glu573Val		-1.0						.	.	.						24	0.81							0.5	125733.0	251466.0	0.0	96	1.0	InbreedingCoeff_RF	nfe	0.5	56874.0	0.5	56874.0	0.0363142	5647	0.21	653.0				28.0	4.0315		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	10.0	13.0	2.0	3.0						0.984					behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
518804	chr1	144922583	G	A	chr1:144922583	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.41	33_23	56	99	False	rs1359300,COSV57672974	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		3/40	NM_001350520.1:c.1313C>T	NP_001337449.1:p.Ser438Leu		-1.0						.	.	.		0.000125003	19.0	151996.0	0.0	25	0.8	PASS	nfe	0.000206161	14.0	0.000206161	14.0	0.5	125719.0	251438.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56865.0	0.5	56865.0	0.0365007	5676	0.197	623.0				22.4	2.412487		0	0	0			PDE4DIP	0.0	0.0	0.0	0.02	-11.0	45.0	13.0	-17.0						0.984		0.248138958			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
519262	chr1	144930596	C	A	chr1:144930596	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.53	27_31	58	99	False	rs2762867,COSV57704759	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		1/40	NM_001350520.1:c.1113G>T	NP_001337449.1:p.Pro371%3D		-1.0						.	.	.		1.31534e-05	2.0	152052.0	0.0	31	0.96	PASS	amr	6.54879e-05	1.0	1.47059e-05	1.0	0.499992	125680.0	251364.0	0.0	100	0.99	InbreedingCoeff	afr	0.5	8120.0	0.499982	56854.0	0.0365650	5686	0.207	654.0				13.01	0.940496		0	0	0			PDE4DIP	0.0	0.0	0.0	0.01	-13.0	-12.0	23.0	-12.0						0.984		2.651095876			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
519280	chr1	144930940	T	C	chr1:144930940	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.52	25_27	52	99	False	rs2147326,COSV57673001	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		1/40	NM_001350520.1:c.769A>G	NP_001337449.1:p.Lys257Glu		-1.0						.	.	.						31	0.97							0.5	125745.0	251490.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56884.0	0.5	56884.0	0.0365521	5684	0.207	652.0				14.73	1.21444		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	0.0	-36.0	-21.0	31.0						0.984		18.016300198			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
519285	chr1	144931330	C	T	chr1:144931330	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.47	27_24	51	99	False	rs2762745,COSV57673006	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		1/40	NM_001350520.1:c.379G>A	NP_001337449.1:p.Ala127Thr		-1.0						.	.	.						31	0.96							0.5	125740.0	251480.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56881.0	0.5	56881.0	0.0365585	5685	0.207	653.0				19.71	1.996595		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	-12.0	7.0	29.0	-31.0						0.984		18.016300198			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
519305	chr1	144931699	T	A	chr1:144931699	PDE4DIP	phosphodiesterase 4D interacting protein	7345.0	SNV	0/1	0.25	45_15	60	99	False	rs144526186,COSV57722651	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		1/40	NM_001350520.1:c.10A>T	NP_001337449.1:p.Ile4Phe		-1.0						.	.	.		0.00196458	142.0	72280.0	0.0	20	0.52	AS_VQSR,PASS	amr,amr	0.00306592	24.0	0.00238232	91.0	0.00222192	554.0	249334.0	0.0	64	0.94	PASS	nfe	0.00315359	355.0	0.00315359	355.0	0.0003087	48	0.009	30.0			1.0	18.19	1.799002		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	-8.0	32.0	-8.0	-25.0						0.984		0.0			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];
527229	chr22	44527487	C	T	chr22:44527487	PARVB	parvin beta	7353.0	SNV	0/1	0.41	13_9	22	99	False	rs766017006	EXONIC	YES	NM_001003828.3	Transcript	protein_coding	missense_variant		6/14	NM_001003828.3:c.596C>T	NP_001003828.1:p.Ala199Val		1.0	.,Calponin homology domain&Calponin homology domain&Calponin homology domain,Calponin homology domain&Calponin homology domain,Calponin homology domain&Calponin homology domain,.					.	.	.		6.57125e-06	1.0	152178.0	0.0	32	0.96	PASS	nfe	1.46985e-05	1.0	1.46985e-05	1.0	7.98971e-06	2.0	250322.0	0.0	32	0.93	PASS	nfe	1.7686e-05	2.0	1.7686e-05	2.0	0.0000064	1						21.5	2.20934	0.03	6	12	18	M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,ClinPred_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-XF_coding_pred	PARVB	0.0	0.0	0.0	0.0	-6.0	20.0	20.0	13.0						0.782	0.0	0.000000000	0.09	-2.088	homeostasis/metabolism phenotype; normal phenotype; hematopoietic system phenotype; growth/size/body region phenotype; skeleton phenotype; immune system phenotype; 			trigeminal ganglion;superior cervical ganglion;skeletal muscle;heart;	Focal adhesion	establishment or maintenance of cell polarity;cell projection assembly;lamellipodium assembly;actin cytoskeleton reorganization;substrate adhesion-dependent cell spreading;establishment or maintenance of cell polarity regulating cell shape	cytoplasm;cytosol;plasma membrane;focal adhesion;actin cytoskeleton;Z disc;lamellipodium	actin binding;protein binding	SNW1[20467437];HNRNPA2B1[30021884];ILK[17353931;23455922;26496610];CDC5L[20467437];STK4[23386615];
528245	chr3	51981779	C	T	chr3:51981779	PARP3	poly(ADP-ribose) polymerase family member 3	7394.0	SNV	0/1	0.46	13_11	24	99	False		EXONIC	YES	NM_001370240.1	Transcript	protein_coding	missense_variant		10/11	NM_001370240.1:c.1300C>T	NP_001357169.1:p.His434Tyr		1.0	Poly(ADP-ribose) polymerase, catalytic domain&Poly(ADP-ribose) polymerase, catalytic domain,Poly(ADP-ribose) polymerase, catalytic domain&Poly(ADP-ribose) polymerase, catalytic domain,.					.	.	.						32	0.97											66	1.0														16.65	1.565592	0.032	2	18	20	SIFT,PolyPhen	Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PARP3	0.0	0.0	0.0	0.0	30.0	-23.0	24.0	-9.0						0.947	0.0	15.458907880	0.007	0.103	homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			.	Base excision repair	telomere maintenance;DNA repair;double-strand break repair;protein ADP-ribosylation;positive regulation of DNA ligation;regulation of mitotic spindle organization;protein poly-ADP-ribosylation;negative regulation of telomerase RNA reverse transcriptase activity;protein localization to site of double-strand break	nucleus;nucleolus;centriole;site of double-strand break	catalytic activity;NAD+ ADP-ribosyltransferase activity;protein ADP-ribosylase activity	MTHFD2[17353931];RPA3[17353931];HIST2H3D[17353931;30021884];MEOX2[unassigned1304];HIST2H2BE[17353931];
530390	chr12	50367335	C	G	chr12:50367335	AQP6	aquaporin 6	7417.0	SNV	0/1	0.51	17_18	35	99	False	rs139985595,COSV59646702	EXONIC	YES	NM_001652.4	Transcript	protein_coding	missense_variant		1/4	NM_001652.4:c.379C>G	NP_001643.2:p.Arg127Gly		1.0	.,.,.					.	.	.		0.00331095	504.0	152222.0	5.0	33	0.99	PASS	nfe	0.00527615	359.0	0.00527615	359.0	0.00282759	666.0	235536.0	2.0	30	0.72	PASS	nfe	0.00409248	428.0	0.00409248	428.0	0.0023729	369	0.003	11.0				23.9	3.124803	0.109	13	8	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred	AQP6	0.0	0.0	0.0	0.0	-20.0	28.0	23.0	-43.0						0.128	0.21	0.000000000	0.989	1.026	vision/eye phenotype; renal/urinary system phenotype; 			.	.	water transport;excretion;nitrate transport;odontogenesis;transmembrane transport	plasma membrane;integral component of plasma membrane;integral component of membrane;apical plasma membrane;cytoplasmic vesicle membrane	nitrate transmembrane transporter activity;water channel activity	IFITM3[unassigned1304];SLC35B2[unassigned1304];CYBC1[unassigned1304];SLC35B4[unassigned1304];TTMP[unassigned1304];TFRC[unassigned1304];ARL6IP1[unassigned1304];THSD7B[unassigned1304];SLC35B1[unassigned1304];TMEM97[unassigned1304];AQP1[unassigned1304];SCAMP5[unassigned1304];SCAMP4[unassigned1304];BSG[unassigned1304];VSTM1[unassigned1304];MS4A13[unassigned1304];THSD7A[unassigned1304];STARD3[unassigned1304];ST6GAL2[unassigned1304];SACM1L[unassigned1304];UNC93A[unassigned1304];STX1B[unassigned1304];PLPP6[unassigned1304];CLDN4[unassigned1304];SNORC[unassigned1304];NINJ2[unassigned1304];NINJ1[unassigned1304];CTXN3[unassigned1304];PEX11G[unassigned1304];DEFB103A[unassigned1304];GYPC[unassigned1304];FAXDC2[unassigned1304];SMIM1[unassigned1304];LPAR3[unassigned1304];UBE2J2[unassigned1304];AGMO[unassigned1304];NEU1[unassigned1304];SYNDIG1[unassigned1304];HMOX1[unassigned1304];FDFT1[unassigned1304];PRRT2[unassigned1304];ICMT[unassigned1304];TMEM86B[unassigned1304];TMEM50A[unassigned1304];TPRG1[unassigned1304];TREX1[unassigned1304];CYP4F2[unassigned1304];SLC35E4[unassigned1304];SLC16A12[unassigned1304];C16orf58[unassigned1304];LNPEP[unassigned1304];SLC16A13[unassigned1304];TMEM199[unassigned1304];FA2H[unassigned1304];FXYD3[unassigned1304];SFXN3[unassigned1304];PEMT[unassigned1304];PAEP[unassigned1304];FXYD6[unassigned1304];SFXN1[unassigned1304];SFXN2[unassigned1304];SFXN5[unassigned1304];GPR25[unassigned1304];TMEM51[unassigned1304];SLC35F1[unassigned1304];CYB561D1[unassigned1304];JPH1[unassigned1304];C5orf46[unassigned1304];SERP2[unassigned1304];ARV1[unassigned1304];SEC61G[unassigned1304];UBXN8[unassigned1304];GAST[unassigned1304];IFNGR1[unassigned1304];AGTRAP[unassigned1304];TIMM23[unassigned1304];EMP1[unassigned1304];SLC35G2[unassigned1304];EMP3[unassigned1304];TMEM42[unassigned1304];MMP14[unassigned1304];SLC7A8[unassigned1304];DWORF[unassigned1304];CLDN19[unassigned1304];TLCD1[unassigned1304];VAMP4[unassigned1304];ATP6V0C[unassigned1304];PIGF[unassigned1304];VAMP5[unassigned1304];MGLL[unassigned1304];VAMP3[unassigned1304];STX12[unassigned1304];CLDND2[unassigned1304];DERL1[unassigned1304];ZDHHC24[unassigned1304];TMEM74[unassigned1304];ZDHHC21[unassigned1304];STATH[unassigned1304];SLC7A1[unassigned1304];FAM105A[unassigned1304];RHD[unassigned1304];TMEM69[unassigned1304];GPR152[unassigned1304];GPR151[unassigned1304];ERMP1[unassigned1304];DHRSX[unassigned1304];ORMDL2[unassigned1304];FAM177A1[unassigned1304];ORMDL3[unassigned1304];STX6[unassigned1304];UBTD2[unassigned1304];STX5[unassigned1304];STX3[unassigned1304];EMC6[unassigned1304];ZNF587[unassigned1304];CORIN[unassigned1304];CGREF1[unassigned1304];CDW52[unassigned1304];YIPF1[unassigned1304];AOC2[unassigned1304];YIPF2[unassigned1304];C4orf3[unassigned1304];SMAGP[unassigned1304];YIPF4[unassigned1304];ORMDL1[unassigned1304];PDZK1IP1[unassigned1304];SYNJ2BP[unassigned1304];AIG1[unassigned1304];DEFB108B[unassigned1304];TMEM60[unassigned1304];TMUB2[unassigned1304];SLCO3A1[unassigned1304];VMA21[unassigned1304];YIPF6[unassigned1304];PLP1[unassigned1304];CD68[unassigned1304];PPGB[unassigned1304];TOMM6[unassigned1304];TMEM229B[unassigned1304];VKORC1L1[unassigned1304];TMEM167B[unassigned1304];CD81[unassigned1304];GOLT1A[unassigned1304];CCL4L1[unassigned1304];GIMAP1[unassigned1304];NRM[unassigned1304];GIMAP5[unassigned1304];TMEM140[unassigned1304];TMEM262[unassigned1304];TOMM22[unassigned1304];TMEM144[unassigned1304];SLC39A9[unassigned1304];SLC39A7[unassigned1304];SLC39A2[unassigned1304];TMEM14A[unassigned1304];SLC38A1[unassigned1304];SLC30A8[unassigned1304];SLC30A2[unassigned1304];ADIPOQ[unassigned1304];TAP1[unassigned1304];CYB561A3[unassigned1304];LEMD1[unassigned1304];CXorf66[unassigned1304];TMX2[unassigned1304];TBC1D20[unassigned1304];DNAJC30[unassigned1304];LY6D[unassigned1304];MAL[unassigned1304];ABCG1[unassigned1304];SLC41A2[unassigned1304];SLC41A1[unassigned1304];CYP4F22[unassigned1304];EFNA5[unassigned1304];TMEM243[unassigned1304];TMEM128[unassigned1304];TMEM120B[unassigned1304];MGAM[unassigned1304];BTN2A2[unassigned1304];WFS1[unassigned1304];TMEM120A[unassigned1304];TNFRSF10C[unassigned1304];NKG7[unassigned1304];SLC52A1[unassigned1304];DGAT2L6[unassigned1304];MARCH5[unassigned1304];MARCH2[unassigned1304];TMEM234[unassigned1304];CNIH1[unassigned1304];PQLC2[unassigned1304];TMEM19[unassigned1304];COX20[unassigned1304];RTP2[unassigned1304];BMP10[unassigned1304];ITGAM[unassigned1304];USE1[unassigned1304];TMEM100[unassigned1304];FUNDC2[unassigned1304];TMEM222[unassigned1304];THBD[unassigned1304];GRM2[unassigned1304];ADGRE2[unassigned1304];ABHD16A[unassigned1304];PRB1[unassigned1304];MFSD5[unassigned1304];TMEM107[unassigned1304];MYADML2[unassigned1304];TMEM189-UBE2V1[unassigned1304];JAGN1[unassigned1304];GKN1[unassigned1304];APOA2[unassigned1304];LSS[unassigned1304];RFT1[unassigned1304];TMEM218[unassigned1304];SEC22B[unassigned1304];SFT2D2[unassigned1304];SEC22A[unassigned1304];SFT2D1[unassigned1304];LEPROT[unassigned1304];GOSR2[unassigned1304];PERM1[unassigned1304];SELENOK[unassigned1304];AGPAT3[unassigned1304];TMEM203[unassigned1304];MAL2[unassigned1304];OSTCL[unassigned1304];CDIPT[unassigned1304];CYB5B[unassigned1304];CMTM7[unassigned1304];PTPN1[unassigned1304];SLC35A1[unassigned1304];OR1D4[unassigned1304];CMTM3[unassigned1304];ATP13A1[unassigned1304];PRAF2[unassigned1304];HSD3B1[unassigned1304];TSPO2[unassigned1304];VAPA[unassigned1304];VAPB[unassigned1304];SCD[unassigned1304];ALOX5AP[unassigned1304];SCGB1A1[unassigned1304];RAB18[unassigned1304];KCNK1[unassigned1304];
531473	chr16	89986030	G	A	chr16:89986030	MC1R	melanocortin 1 receptor	7449.0	SNV	0/1	0.5	20_20	40	99	False	rs201192930,CM015387,COSV59627171	EXONIC	YES	NM_002386.4	Transcript	protein_coding	missense_variant		1/1	NM_002386.4:c.364G>A	NP_002377.4:p.Val122Met		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,.	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Cutaneous_malignant_melanoma_5	[Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3); [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3), Autosomal recessive; [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3), Autosomal recessive; {Melanoma, cutaneous malignant, 5}, 613099 (3); {Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive; {UV-induced skin damage}, 266300 (3), Autosomal recessive	Large congenital melanocytic nevus;Familial melanoma;Oculocutaneous albinism type 2	Modifying germline mutation in;Major susceptibility factor in;Modifying germline mutation in	Nystagmus;Albinism;Basal cell carcinoma;Squamous cell carcinoma of the skin;Photophobia;Visual impairment;Abnormality of the optic nerve;Freckling;Iris hypopigmentation;Strabismus;Melanoma;Congenital giant melanocytic nevus;Hypopigmented skin patches;Cutaneous melanoma;Pruritus;Seizure;Subcutaneous nodule;Hydrocephalus;Generalized hirsutism;Rhabdomyosarcoma;Retinopathy;Neoplasm of the stomach;Abnormality of the lymphatic system;Neoplasm of the breast;Freckling;Neoplasm of the pancreas;Abnormality of extrapyramidal motor function;Dry skin;Melanoma;Nevus;Abnormal hair morphology;Exotropia;Strabismus;Myopia;Albinism;Hypopigmentation of the fundus;Blue irides;Reduced visual acuity;Red hair;Autosomal recessive inheritance;Freckles in sun-exposed areas;Nystagmus;Hypoplasia of the fovea		0.00052559	80.0	152210.0	1.0	33	0.98	PASS	amr	0.000981547	15.0	0.000338076	23.0	0.00082515	202.0	244804.0	0.0	99	1.0	PASS	amr	0.00121746	42.0	0.000471153	53.0	0.0006238	97	0.003	10.0	0.00254	29.0		15.32	1.325701	0.053	1	16	17	fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	MC1R	0.0	0.0	0.0	0.0	14.0	-18.0	-10.0	-1.0							0.0	0.000000000,0.000000000	0.048	1.146	growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype; craniofacial phenotype; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; pigmentation phenotype; neoplasm; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; 			.	Neuroactive ligand-receptor interaction;Melanogenesis	G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;adenylate cyclase-activating G protein-coupled receptor signaling pathway;multicellular organism development;UV protection;positive regulation of protein kinase A signaling;sensory perception of pain;negative regulation of tumor necrosis factor production;intracellular signal transduction;melanin biosynthetic process;pigmentation;positive regulation of transcription by RNA polymerase II;positive regulation of protein kinase B signaling;UV-damage excision repair;positive regulation of protein kinase C signaling	plasma membrane;integral component of plasma membrane	melanocortin receptor activity;melanocyte-stimulating hormone receptor activity;protein binding;G protein-coupled peptide receptor activity;ubiquitin protein ligase binding	MRAP[19329486];PSMD2[25036637];MRAP2[19329486];
539231	chr3	164783041	T	C	chr3:164783041	SI	sucrase-isomaltase	7548.0	SNV	0/1	0.35	13_7	20	99	False	rs759240554	SPLICING	YES	NM_001041.4	Transcript	protein_coding	splice_region_variant,intron_variant	7/47		NM_001041.4:c.807+8A>G			-1.0					Sucrase-isomaltase deficiency, congenital, 222900 (3), Autosomal recessive	Congenital sucrase-isomaltase deficiency with starch intolerance;Congenital sucrase-isomaltase deficiency without starch intolerance;Congenital sucrase-isomaltase deficiency with minimal starch tolerance;Congenital sucrase-isomaltase deficiency with starch and lactose intolerance;Congenital sucrase-isomaltase deficiency without sucrose intolerance	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Malabsorption;Nephrolithiasis;Diarrhea;Abnormality of metabolism/homeostasis		4.62987e-05	7.0	151192.0	0.0	28	0.86	PASS	amr	0.000265322	4.0	2.9522e-05	2.0	6.4191e-05	16.0	249256.0	0.0	34	0.88	PASS	amr	0.000411136	14.0	8.86226e-06	1.0	0.0000193	3	0.001	4.0	0.00071	8.0		7.948	0.359621		0	0	0			SI	0.0	0.0	0.07	0.0	13.0	24.0	13.0	8.0	0.0009265729454531	0.018				0.0899	0.0				.			trigeminal ganglion;superior cervical ganglion;testis;	Starch and sucrose metabolism	carbohydrate metabolic process;polysaccharide digestion	Golgi apparatus;plasma membrane;brush border;integral component of membrane;apical plasma membrane;extracellular exosome	alpha-1,4-glucosidase activity;oligo-1,6-glucosidase activity;sucrose alpha-glucosidase activity;carbohydrate binding	ADRB2[28298427];DHRS2[30021884];
541247	chr1	160267363	C	T	chr1:160267363	COPA	coatomer protein complex subunit alpha	7605.0	SNV	0/1	0.57	13_17	30	99	False	rs1051839166,COSV54105294	EXONIC	YES	NM_001098398.2	Transcript	protein_coding	missense_variant		20/33	NM_001098398.2:c.2177G>A	NP_001091868.1:p.Arg726His		-1.0	.,.,Coatomer, WD associated region,.,.	Uncertain_significance	criteria_provided,_single_submitter	Autoimmune_interstitial_lung,_joint,_and_kidney_disease	{Autoimmune interstitial lung, joint, and kidney disease}, 616414 (3), Autosomal dominant	Autoimmune interstitial lung disease-arthritis syndrome	Disease-causing germline mutation(s) in	Pulmonary hemorrhage;Tachypnea;Cough;Autosomal dominant inheritance;Respiratory distress;Elevated erythrocyte sedimentation rate;Arthralgia;Incomplete penetrance;Crescentic glomerulonephritis;Interstitial pulmonary abnormality;Arthritis		1.31458e-05	2.0	152140.0	0.0	32	0.96	PASS				0.0	0.0	7.96311e-06	2.0	251158.0	0.0	47	0.99	PASS				0.0	0.0								28.4	4.078317	0.663	15	6	21	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,DEOGEN2_pred	COPA	0.0	0.02	0.0	0.0	23.0	9.0	33.0	-17.0						0.312	1.0	0.000000000	0.997	1.016	.			ciliary ganglion;prefrontal cortex;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;placenta;parietal lobe;	.	intracellular protein transport;endoplasmic reticulum to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;intra-Golgi vesicle-mediated transport;regulation of signaling receptor activity;pancreatic juice secretion	Golgi membrane;extracellular space;cytoplasm;endoplasmic reticulum membrane;cytosol;membrane;COPI vesicle coat;transport vesicle;extracellular exosome	hormone activity;structural molecule activity	TMED10[9472029];STK4[23386615];DUX4[26816005];DDA1[20562859];CEP128[26638075];FOXQ1[25609649];TGOLN2[29568061];DSN1[26496610];HERC2[29426014];NUDCD1[25036637;29021621];IFI16[25665578];ATG101[20562859];NPHP1[26638075];IKBKG[14743216];OFD1[26638075];FOXB1[25609649];TMED9[9472029];JUN[25609649];USP49[19615732];VCAM1[22623428];PDHA1[29128334];SORT1[26496610];SACM1L[14527956];PYHIN1[25665578];XRCC3[26496610];CDC5L[20467437];FOXL1[25609649];RRP1B[20926688];MLH1[20706999];SDHA[29128334];SOD1[29128334];SPART[19765186];FOXR1[25609649];SNW1[20467437];AIM2[25665578];TMEM17[26638075];MTNR1B[17215244;26514267];TMEM237[26638075];AGO1[17932509];AGO2[17932509];MKS1[26638075];MNDA[25665578];MATR3[26496610];SLC25A11[16169070];DLD[29128334];COPE[16169070];OTUB1[26752685];
541787	chr1	117663811	T	G	chr1:117663811	TRIM45	tripartite motif containing 45	7623.0	SNV	0/1	0.56	14_18	32	99	False	rs1488582309	EXONIC	YES	NM_025188.4	Transcript	protein_coding	synonymous_variant		1/6	NM_025188.4:c.13A>C	NP_079464.2:p.Arg5%3D		-1.0						.	.	.		1.9713e-05	3.0	152184.0	0.0	32	0.96	PASS	amr	6.54193e-05	1.0	0.0	0.0					71	0.68														9.497	0.51003		0	0	0			TRIM45	0.0	0.0	0.02	0.0	47.0	-2.0	-20.0	-2.0						0.162	0.0	0.000000000			homeostasis/metabolism phenotype; vision/eye phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype; immune system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;globus pallidus;	.	bone development	nucleoplasm;cytosol;intercellular bridge	zinc ion binding	TEPSIN[unassigned1304];GABARAPL2[20562859;unassigned1304];ZMYND19[unassigned1304];TAX1BP1[unassigned1304];TFIP11[unassigned1304];AARSD1[unassigned1304];MEOX2[unassigned1304];
542133	chr12	96986286	G	A	chr12:96986286	CFAP54	cilia and flagella associated protein 54	7638.0	SNV	0/1	0.33	20_10	30	99	False	rs577028628	EXONIC	YES	NM_001367885.1	Transcript	protein_coding	synonymous_variant		24/69	NM_001367885.1:c.3231G>A	NP_001354814.1:p.Leu1077%3D		1.0						.	.	.		0.000506439	77.0	152042.0	0.0	32	0.96	PASS	sas	0.000621633	3.0	0.000617756	42.0	0.00111763	69.0	61738.0	1.0	4	0.03	PASS	sas	0.000587314	6.0	0.000579098	17.0	0.0002637	41	0.0	1.0				10.18	0.585331		0	0	0			CFAP54	0.15	0.07	0.0	0.0	39.0	-18.0	-18.0	23.0											craniofacial phenotype; cellular phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; respiratory system phenotype; 			.	.	spermatogenesis;cell differentiation;cilium assembly;cilium movement involved in cell motility	axoneme	.	NPM1[30021884];AP2B1[30021884];
545258	chr1	11708890	G	T	chr1:11708890	FBXO2	F-box protein 2	7701.0	SNV	0/1	0.5	18_18	36	99	False	rs769661860	SPLICING	YES	NM_012168.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/5		NM_012168.6:c.757-5C>A			-1.0						.	.	.		6.57142e-06	1.0	152174.0	0.0	33	0.97	PASS	amr	6.54365e-05	1.0	0.0	0.0	2.79901e-05	7.0	250088.0	0.0	73	0.99	PASS	amr	0.000173561	6.0	0.0	0.0	0.0000129	2	0.001	2.0				12.04	0.811179		0	0	0			FBXO2	0.0	0.0	0.0	0.0	44.0	-5.0	-4.0	-18.0	0.119831393455214	0.256	7.334	1.949	9.283		0.27				nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			caudate nucleus;temporal lobe;amygdala;prefrontal cortex;cingulate cortex;cerebellum peduncles;pons;occipital lobe;subthalamic nucleus;whole brain;spinal cord;parietal lobe;hypothalamus;medulla oblongata;thalamus;	Ubiquitin mediated proteolysis	protein polyubiquitination;cellular protein modification process;proteolysis;glycoprotein catabolic process;negative regulation of cell population proliferation;protein ubiquitination;ubiquitin-dependent ERAD pathway;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;regulation of protein ubiquitination;post-translational protein modification	cytoplasm;endoplasmic reticulum;cytosol;SCF ubiquitin ligase complex;organelle membrane;dendritic spine	amyloid-beta binding;ubiquitin-protein transferase activity;protein binding;carbohydrate binding	IQCB1[21565611];SDCBP[unassigned1304];PAX4[unassigned1304];VSTM1[unassigned1304];DDIT4L[unassigned1304];MAPT[26402096];PFDN6[unassigned1304];SKP1[27705803;25416956;unassigned1304];
545835	chr2	236877171		GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	chr2:236877170-236877171	AGAP1	ArfGAP with GTPase domain, ankyrin repeat and PH domain 1	7719.0	insertion	0|1	0.27	11_4	15	99	False		EXONIC	YES	NM_001037131.3	Transcript	protein_coding	inframe_insertion		13/18	NM_001037131.3:c.1549_1550insGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG	NP_001032208.1:p.Leu516_Asp517insGlyGlyGlyGlyGlyGlyGlyGlyGlyGlyGlyGlyGlyGlyGlyGlyGlyGlyGlyGlyGlyGly		1.0						.	.	.		6.87342e-06	1.0	145488.0	0.0	25	0.7	AS_VQSR	nfe	1.50634e-05	1.0	1.50634e-05	1.0					37	0.7																	0	0	0																	0.315	1.0	73.000675728,0.000000000			vision/eye phenotype; skeleton phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); craniofacial phenotype; homeostasis/metabolism phenotype; 			amygdala;occipital lobe;subthalamic nucleus;cingulate cortex;parietal lobe;cerebellum;	.	protein transport;positive regulation of GTPase activity	nucleus;cytoplasm	GTPase activity;GTPase activator activity;GTP binding;phospholipid binding;metal ion binding	RTKN[unassigned1312];MAST3[unassigned1312];DENND1A[unassigned1312];ZBTB21[unassigned1312];CBY1[unassigned1312];TESK2[unassigned1312];HSCB[28380382];EDC3[unassigned1312];FAM110A[unassigned1312];SYDE1[unassigned1312];SIPA1L1[unassigned1312];SH3PXD2A[unassigned1312];FAM110B[unassigned1312];KIF13B[unassigned1312];FAM53C[unassigned1312];KIF1C[unassigned1312];TK1[21900206];MAGI1[unassigned1312];KSR1[unassigned1312];NAV1[unassigned1312];KCTD3[unassigned1312];GAB2[unassigned1312];CDC25B[unassigned1312];PRPF4[26496610];GIGYF1[unassigned1312];TIAM1[unassigned1312];DEPDC1B[unassigned1312];MELK[unassigned1312];ZNF638[unassigned1312];TBC1D25[unassigned1312];EIF4E2[unassigned1312];PHLDB2[unassigned1312];HDAC4[unassigned1312];GRB7[21900206];MAPKAP1[unassigned1312];PPM1H[unassigned1312];RASAL2[unassigned1312];CAMSAP2[unassigned1312];LIMA1[unassigned1312];SH3BP4[unassigned1312];MAP3K21[unassigned1312];SMN1[21900206];SRGAP2[unassigned1312];NADK[unassigned1312];SRSF12[unassigned1312];ANKRD34A[unassigned1312];USP21[unassigned1312];DENND4C[unassigned1312];RAB3IP[unassigned1312];PLEKHA5[unassigned1312];CGN[unassigned1312];DCLK1[unassigned1312];PLEKHA7[unassigned1312];AFDN[unassigned1312];LRFN1[unassigned1312];RSPH14[unassigned1304];NF1[unassigned1312];ZNF534[unassigned1304];CDK16[unassigned1312];
552484	chr16	2231918	C	T	chr16:2231918	CASKIN1	CASK interacting protein 1	7874.0	SNV	0/1	0.51	19_20	39	99	False	rs374168893	EXONIC	YES	NM_020764.4	Transcript	protein_coding	missense_variant		17/20	NM_020764.4:c.1642G>A	NP_065815.1:p.Val548Met		-1.0	Sterile alpha motif domain&Sterile alpha motif domain&Sterile alpha motif domain&Caskin1/2, SAM repeat 2					.	.	.		6.57056e-06	1.0	152194.0	0.0	32	0.97	PASS	amr	6.54022e-05	1.0	0.0	0.0	1.60595e-05	4.0	249074.0	0.0	71	1.0	PASS	amr	5.79878e-05	2.0	8.85536e-06	1.0	0.0000129	2						23.4	2.919428	0.039	3	15	18	SIFT,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	CASKIN1	0.04	0.0	0.0	0.0	-30.0	12.0	-40.0	-38.0							1.0	0.0	0.974	1.026	homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; pigmentation phenotype; renal/urinary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; 			.	.	signal transduction	cytoplasm;membrane	protein binding;identical protein binding	CASKIN1[21763699;22153505];CASK[21763699;22153505];
556071	chr2	32235893	T	G	chr2:32235893	MEMO1	mediator of cell motility 1	7963.0	SNV	0/1	0.5	12_12	24	99	False	rs879424783	EXONIC	YES	NM_001385196.1	Transcript	protein_coding	synonymous_variant		1/10	NM_001385196.1:c.151A>C	NP_001372125.1:p.Arg51%3D		-1.0						.	.	.		0.00209279	318.0	151950.0	0.0	32	0.97	PASS	nfe	0.00366435	249.0	0.00366435	249.0					0	0.0							0.0007582	20						16.15	1.479853		0	0	0																	0.207	0.88				cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; pigmentation phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; 			.	.	regulation of microtubule-based process;regulation of cell motility	nucleus;cytosol	protein binding	VCAM1[22623428];DDIT4L[unassigned1304];ZBTB22[unassigned1304];GGA2[unassigned1304];LOX[25118846];RFX6[unassigned1304];ERBB2[21840311];TRIP6[25416956];REL[25416956];LNX1[25416956;unassigned1304];EMILIN3[unassigned1304];TACC1[21516116;25416956;unassigned1304];TCF4[25416956;unassigned1304];CAMTA2[unassigned1304];TRIM27[25416956];ZNF655[unassigned1304];DISC1[17043677];RBM45[25416956];LZTS2[25416956];
556243	chr19	36228042	C	T	chr19:36228042	KMT2B	lysine methyltransferase 2B	7966.0	SNV	0/1	0.52	15_16	31	99	False	rs368560676	EXONIC	YES	NM_014727.3	Transcript	protein_coding	synonymous_variant		33/37	NM_014727.3:c.7428C>T	NP_055542.1:p.Ala2476%3D		1.0					Dystonia 28, childhood-onset, 617284 (3), Autosomal dominant	.	.	Microcephaly;Toe walking;Cognitive impairment;Global developmental delay;Motor delay;Incomplete penetrance;Progressive;Short stature;Abnormality of eye movement;Retrocollis;Bulbous nose;Dysarthria;Myoclonus;Laryngeal dystonia;Oromandibular dystonia;Autosomal dominant inheritance;Astigmatism;Spasticity		6.57056e-06	1.0	152194.0	0.0	32	0.98	PASS	sas	0.000206782	1.0	0.0	0.0	8.22362e-06	2.0	243202.0	0.0	25	0.7	PASS	eas	5.64653e-05	1.0	9.10664e-06	1.0	0.0000064	1						12.82	0.91342		0	0	0			KMT2B	0.0	0.02	0.0	0.0	22.0	7.0	38.0	22.0							1.0	99.17866664			growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; embryo phenotype; liver/biliary system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	.	ovarian follicle development;regulation of transcription by RNA polymerase II;memory;oocyte differentiation;gene silencing;ovulation;regulation of megakaryocyte differentiation;chromatin-mediated maintenance of transcription;histone H3-K4 methylation;regulation of histone H3-K4 methylation;histone H3-K4 trimethylation	nucleus;nucleoplasm;histone methyltransferase complex	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;zinc ion binding;histone-lysine N-methyltransferase activity;histone methyltransferase activity (H3-K4 specific)	ZNF512B[15231748];GRB7[21900206];CDKN1A[21900206];KMT2A[18840606];AKAP8[23995757];PIK3R3[25814554];FOXK2[25609649];PSIP1[23995757];DPY30[23995757];ASH2L[23995757;26886794];NREP[21900206];RAP1B[21900206];SEPT8[21900206];PSTPIP1[17353931];ATXN1[16713569];HIST1H3A[29568061];RBBP5[23995757];KHSRP[23995757];ABL1[17474147];WDR5[27705803;24788516;23995757];ANXA7[21900206];RCC1[21900206];FYN[17474147];SMN1[21900206];TK1[21900206];TP53BP1[19433796];TOPBP1[17913746];RPP14[21900206];NCK1[17474147];MEN1[22327296;23995757];SMAD3[15231748];ANXA1[21900206];TSC22D1[21900206];CSNK2A1[27705803];NCOA6[17021013;19047629;19433796];THOC2[26496610];ATP1B1[21900206];WDR77[23995757];HCFC1[23995757];BCL6[16147992];HNRNPF[23995757];MAP1B[23995757];PIN1[21900206];GRB2[17474147];QRICH2[23995757];CRK[17474147];
556346	chr12	70970181	G	T	chr12:70970181	PTPRB	protein tyrosine phosphatase, receptor type B	7971.0	SNV	0/1	0.35	10_7	20	99	False	rs763497780,COSV54233655	EXONIC	YES	NM_001109754.4	Transcript	protein_coding	synonymous_variant		11/34	NM_001109754.4:c.2823C>A	NP_001103224.1:p.Ser941%3D		-1.0						.	.	.		5.9216e-05	9.0	151986.0	0.0	30	0.92	PASS	amr	0.000393339	6.0	4.41176e-05	3.0	9.77e-05	24.0	245650.0	0.0	42	0.8	PASS	amr	0.000526994	18.0	3.59395e-05	4.0	0.0000643	10	0.0	1.0				11.36	0.725454		0	0	0			PTPRB	0.0	0.0	0.01	0.04	-19.0	24.0	16.0	-19.0						0.753	0.94	94.089293071			homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; 			atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;globus pallidus;	Adherens junction	angiogenesis;protein dephosphorylation;phosphate-containing compound metabolic process;dephosphorylation;peptidyl-tyrosine dephosphorylation;neutrophil degranulation	plasma membrane;integral component of plasma membrane;specific granule membrane;receptor complex;tertiary granule membrane	transmembrane receptor protein tyrosine phosphatase activity;protein binding	ALK[19167335];FLT1[22016384];PXN[19167335];WAS[19167335];RRBP1[30021884];CBL[19167335];EGFR[19167335];CORO1C[28330616];GHR[12907755;19167335];PCMT1[28330616];CDH2[19167335];ERBB2[19167335];MAPK1[12840032];CSK[19167335];MAPK3[19167335;12840032];ILKAP[28330616];PDGFRB[19167335];NTRK1[19167335];NSF[19167335];PDPK1[19167335];INSR[19167335];GAB1[19167335];RPA1[28330616];GRIN2B[19167335];EPOR[19167335];PTPRB[15978577];TEC[19167335];LCK[19167335];MADD[30021884];CTNNB1[19167335];TEK[19167335];CALM1[28330616];MET[16101282];
557126	chr10	16967417	T	C	chr10:16967417	CUBN	cubilin	7998.0	SNV	0/1	0.42	22_16	38	99	False	rs144360241,COSV64714287,COSV64717187	EXONIC	YES	NM_001081.4	Transcript	protein_coding	missense_variant		43/67	NM_001081.4:c.6469A>G	NP_001072.2:p.Asn2157Asp		-1.0	CUB domain&CUB domain&CUB domain&CUB domain	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Imerslund-Gräsbeck_syndrome|Imerslund-Gräsbeck_syndrome_1|not_provided	[Proteinuria, chronic benign], 618884 (3), Autosomal recessive; Imerslund-Grasbeck syndrome 1, 261100 (3), Autosomal recessive	Imerslund-Gr�sbeck syndrome	Disease-causing germline mutation(s) in	Vitamin B12 deficiency;Autosomal recessive inheritance;Sensory impairment;Confusion;Paresthesia;Dementia;Childhood onset;Proteinuria;Malabsorption of Vitamin B12;Megaloblastic anemia	27197912,30220432	0.00525686	800.0	152182.0	3.0	34	0.96	PASS	nfe	0.00646735	440.0	0.00646735	440.0	0.00561964	1409.0	250728.0	8.0	60	0.99	PASS	nfe	0.00673267	763.0	0.00673267	763.0	0.0051317	798	0.005	17.0	0.0057	65.0		23.8	3.089666	0.31	8	12	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	CUBN	0.0	0.0	0.0	0.0	6.0	1.0	0.0	-3.0						0.913	0.0		0.637	1.137	growth/size/body region phenotype; homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; renal/urinary system phenotype; 			.	.	in utero embryonic development;tissue homeostasis;thigmotaxis;receptor-mediated endocytosis;hyperosmotic response;response to nutrient;cholesterol metabolic process;adult locomotory behavior;cobalamin metabolic process;response to bacterium;cobalamin transport;endocytic hemoglobin import;high-density lipoprotein particle clearance;regulation of locomotion;vitamin D metabolic process;cobalamin catabolic process;lipoprotein transport;positive regulation of synaptic transmission, glutamatergic;protein homotrimerization	lysosomal membrane;endoplasmic reticulum;Golgi apparatus;Golgi-associated vesicle;cytosol;plasma membrane;clathrin-coated pit;ionotropic glutamate receptor complex;endosome membrane;membrane;apical plasma membrane;coated vesicle;endocytic vesicle;endocytic vesicle membrane;extrinsic component of external side of plasma membrane;brush border membrane;neuron projection membrane;lysosomal lumen;synapse;extracellular exosome	transporter activity;calcium ion binding;protein binding;drug binding;channel regulator activity;hemoglobin binding;cobalamin binding;signaling receptor activity;cargo receptor activity;protein homodimerization activity	CUBN[20237569];GIF[20237569];RRP1B[19710015];
557711	chr19	1483945		G	chr19:1483944-1483945	PCSK4	proprotein convertase subtilisin/kexin type 4	8019.0	insertion	0/1	0.73	3_8	11	61	False	rs1043967396	SPLICING	YES	NM_017573.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	9/14		NM_017573.4:c.1170-5dup			-1.0						.	.	.		0.000139126	21.0	150942.0	0.0	32	0.98	PASS	amr	0.000462107	7.0	0.00017783	12.0	0.000124445	6.0	48214.0	0.0	3	0.12	PASS	nfe	0.000232126	5.0	0.000232126	5.0								8.792	0.437542		0	0	0			PCSK4	0.0	0.0	0.0	0.0	-24.0	40.0	41.0	-48.0						0.235	0.0				homeostasis/metabolism phenotype; reproductive system phenotype; 			testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;testis;skeletal muscle;	.	binding of sperm to zona pellucida;acrosome reaction;fertilization;protein processing;peptide hormone processing;reproductive process;sperm capacitation	acrosomal vesicle;acrosomal membrane;trans-Golgi network;membrane;integral component of membrane;integral component of Golgi membrane	serine-type endopeptidase activity;protein binding	ASPH[unassigned1304];ABCF1[30021884];
559372	chr16	67805994		AA	chr16:67805993-67805994	RANBP10	RAN binding protein 10	8060.0	insertion	0/1	0.23	10_3	13	50	False	rs35741053	SPLICING	YES	NM_020850.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/13		NM_020850.3:c.348-6_348-5dup			-1.0						.	.	.		0.000418084	30.0	71756.0	0.0	20	0.49	PASS	eas	0.000611995	1.0	0.00046804	14.0	0.0333552	2237.0	67066.0	5.0	32	0.75	PASS	eas	0.0422941	264.0	0.0338733	1100.0	0.0000193,0.0000129,0.0000064,0.0081155	3,2,1,1262						14.89	1.243422		0	0	0																	0.12	0.95				homeostasis/metabolism phenotype; cellular phenotype; hematopoietic system phenotype; 			ciliary ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;bone marrow;	.	.	ubiquitin ligase complex;nucleus;cytosol	protein binding	WDR26[27173435;unassigned1312];NOTCH1[23022380];THSD7B[12421765];MEGF10[12421765];IGSF1[12421765];HTRA2[27173435;unassigned1312];RMND5B[unassigned1312];MAEA[27173435;unassigned1312];RMND5A[27173435;unassigned1312];HAUS8[27173435;unassigned1312];CTAG1A[unassigned1304];IGFBP6[unassigned1304];LARGE1[27173435;unassigned1312];MAGEA11[unassigned1304];RAB8A[unassigned1312];AXIN1[17510365];RANBP9[27173435;unassigned1312];ARMC8[27173435;unassigned1312];MKLN1[unassigned1312];GID4[27173435;unassigned1312];PSMA2[27173435;unassigned1312];GID8[unassigned1312];CACHD1[12421765];RNPS1[17353931];EFHC2[27173435;unassigned1312];YPEL5[27173435;unassigned1312];CNTNAP4[12421765];
559595	chr2	37487403	C	T	chr2:37487403	PRKD3	protein kinase D3	8064.0	SNV	0/1	0.41	17_12	29	99	False	rs200951892	EXONIC	YES	NM_005813.6	Transcript	protein_coding	missense_variant		15/19	NM_005813.6:c.2009G>A	NP_005804.1:p.Arg670Gln		-1.0	Protein kinase domain&Protein kinase domain&Protein kinase domain,Protein kinase domain&Protein kinase domain&Protein kinase domain					.	.	.		0.000118496	18.0	151904.0	0.0	32	0.96	PASS	afr	0.000266073	11.0	2.94118e-05	2.0	4.37975e-05	11.0	251156.0	0.0	42	0.97	PASS	afr	0.000184706	3.0	2.64015e-05	3.0	0.0000450	7	0.0	1.0				28.7	4.10791	0.419	8	13	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	PRKD3	0.0	0.0	0.0	0.02	-37.0	11.0	4.0	-37.0						0.342	0.01	0.0	1.0	1.026	endocrine/exocrine gland phenotype; immune system phenotype; skeleton phenotype; limbs/digits/tail phenotype; hematopoietic system phenotype; 			ciliary ganglion;tonsil;white blood cells;testis - seminiferous tubule;testis - interstitial;prefrontal cortex;trigeminal ganglion;superior cervical ganglion;testis;adrenal cortex;	.	protein phosphorylation;protein kinase C-activating G protein-coupled receptor signaling pathway;sphingolipid biosynthetic process;protein kinase D signaling	nucleoplasm;cytosol;membrane	protein serine/threonine kinase activity;protein kinase C activity;protein binding;ATP binding;kinase activity;metal ion binding	MYH3[23414517];PKM[24606918];CHM[19615732];PRKD2[26496610];POLL[unassigned1304];DLAT[21988832];IKBKG[20098747];VAMP2[17196367];NUDT3[21900206];SKA2[21988832];TAF1[23414517];
559898	chr17	5036205	A	C	chr17:5036205	USP6	ubiquitin specific peptidase 6	8071.0	SNV	0|1	0.27	24_9	33	99	False	rs80328123,COSV51472927	SPLICING	YES	NM_001304284.2	Transcript	protein_coding	missense_variant,splice_region_variant		13/38	NM_001304284.2:c.196A>C	NP_001291213.1:p.Lys66Gln		1.0	.,.					Nodular fasciitis	Part of a fusion gene in	.						32	0.97							0.0360789	4439.0	123036.0	0.0	90	1.0	InbreedingCoeff_RF	nfe	0.0520758	2594.0	0.0520758	2594.0	0.0023858	371	0.012	39.0				0.009	-0.795498	0.047	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	USP6	0.0	0.15	0.0	0.0	3.0	0.0	0.0	27.0	0.0006185459337319	0.05	4.044	0.682	4.726	0.996	0.0		0.01	-1.645	.			amygdala;testis - seminiferous tubule;fetal brain;subthalamic nucleus;testis - interstitial;prefrontal cortex;atrioventricular node;testis;parietal lobe;	.	cellular protein modification process;ubiquitin-dependent protein catabolic process;intracellular protein transport;protein deubiquitination;regulation of vesicle-mediated transport;activation of GTPase activity	cytoplasm;lysosome;plasma membrane;recycling endosome	nucleic acid binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;GTPase activator activity;protein binding;calmodulin binding;Rab GTPase binding	USP32[19615732];MYL2[16555005];ANKRD44[16555005];ATXN7L3[16713569];MDFI[19060904];
559899	chr17	5036210	T	G	chr17:5036210	USP6	ubiquitin specific peptidase 6	8071.0	SNV	0|1	0.27	24_9	33	99	False	rs762931474,COSV51472955	EXONIC	YES	NM_001304284.2	Transcript	protein_coding	missense_variant		13/38	NM_001304284.2:c.201T>G	NP_001291213.1:p.Ile67Met		1.0	.,.					Nodular fasciitis	Part of a fusion gene in	.						32	0.97							0.0333146	4031.0	120998.0	0.0	88	1.0	InbreedingCoeff_RF	nfe	0.0484803	2367.0	0.0484803	2367.0	0.0017106	266	0.008	24.0				0.811	-0.181801	0.042	1	18	19	LRT_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	USP6	0.0	0.02	0.0	0.0	-45.0	-5.0	-5.0	22.0						0.996	0.0		0.015	0.133	.			amygdala;testis - seminiferous tubule;fetal brain;subthalamic nucleus;testis - interstitial;prefrontal cortex;atrioventricular node;testis;parietal lobe;	.	cellular protein modification process;ubiquitin-dependent protein catabolic process;intracellular protein transport;protein deubiquitination;regulation of vesicle-mediated transport;activation of GTPase activity	cytoplasm;lysosome;plasma membrane;recycling endosome	nucleic acid binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;GTPase activator activity;protein binding;calmodulin binding;Rab GTPase binding	USP32[19615732];MYL2[16555005];ANKRD44[16555005];ATXN7L3[16713569];MDFI[19060904];
559901	chr17	5036211	C	T	chr17:5036211	USP6	ubiquitin specific peptidase 6	8071.0	SNV	0|1	0.27	24_9	33	99	False	rs201674756,COSV51472972	EXONIC	YES	NM_001304284.2	Transcript	protein_coding	missense_variant		13/38	NM_001304284.2:c.202C>T	NP_001291213.1:p.Arg68Trp		1.0	.,.					Nodular fasciitis	Part of a fusion gene in	.		3.28601e-05	5.0	152160.0	0.0	32	0.97	PASS	sas	0.000207297	1.0	1.4699e-05	1.0	0.0304666	3833.0	125810.0	0.0	88	1.0	InbreedingCoeff	nfe	0.04412	2251.0	0.04412	2251.0	0.0017041	265	0.008	24.0				17.45	1.69509	0.054	3	16	19	Polyphen2_HDIV_pred,LRT_pred,MutationAssessor_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	USP6	0.0	0.3	0.0	0.02	-3.0	-6.0	-6.0	21.0						0.996	0.0		0.015	0.124	.			amygdala;testis - seminiferous tubule;fetal brain;subthalamic nucleus;testis - interstitial;prefrontal cortex;atrioventricular node;testis;parietal lobe;	.	cellular protein modification process;ubiquitin-dependent protein catabolic process;intracellular protein transport;protein deubiquitination;regulation of vesicle-mediated transport;activation of GTPase activity	cytoplasm;lysosome;plasma membrane;recycling endosome	nucleic acid binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;GTPase activator activity;protein binding;calmodulin binding;Rab GTPase binding	USP32[19615732];MYL2[16555005];ANKRD44[16555005];ATXN7L3[16713569];MDFI[19060904];
559903	chr17	5036214	C	T	chr17:5036214	USP6	ubiquitin specific peptidase 6	8071.0	SNV	0|1	0.27	24_9	33	99	False	rs114647990,COSV51473183	EXONIC	YES	NM_001304284.2	Transcript	protein_coding	missense_variant		13/38	NM_001304284.2:c.205C>T	NP_001291213.1:p.Arg69Trp		1.0	.,.					Nodular fasciitis	Part of a fusion gene in	.		1.31498e-05	2.0	152094.0	0.0	32	0.97	PASS	sas	0.000207814	1.0	1.47024e-05	1.0	0.0295291	3658.0	123878.0	0.0	87	1.0	InbreedingCoeff_RF	nfe	0.0430217	2159.0	0.0430217	2159.0	0.0024244	377	0.014	45.0				16.28	1.502784	0.093	2	17	19	LRT_pred,MutationAssessor_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	USP6	0.0	0.34	0.01	0.02	-2.0	-9.0	-2.0	18.0						0.996	0.0		0.01	0.124	.			amygdala;testis - seminiferous tubule;fetal brain;subthalamic nucleus;testis - interstitial;prefrontal cortex;atrioventricular node;testis;parietal lobe;	.	cellular protein modification process;ubiquitin-dependent protein catabolic process;intracellular protein transport;protein deubiquitination;regulation of vesicle-mediated transport;activation of GTPase activity	cytoplasm;lysosome;plasma membrane;recycling endosome	nucleic acid binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;GTPase activator activity;protein binding;calmodulin binding;Rab GTPase binding	USP32[19615732];MYL2[16555005];ANKRD44[16555005];ATXN7L3[16713569];MDFI[19060904];
559905	chr17	5036224	C	G	chr17:5036224	USP6	ubiquitin specific peptidase 6	8071.0	SNV	0|1	0.3	23_10	33	99	False	rs72830922,COSV51472989	EXONIC	YES	NM_001304284.2	Transcript	protein_coding	missense_variant		13/38	NM_001304284.2:c.215C>G	NP_001291213.1:p.Thr72Arg		1.0	.,.					Nodular fasciitis	Part of a fusion gene in	.						32	0.97							0.0616261	7246.0	117580.0	0.0	89	1.0	InbreedingCoeff_RF	nfe	0.0873431	4244.0	0.0873431	4244.0	0.0041864	651	0.048	151.0				0.004	-0.923307	0.022	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	USP6	0.0	0.0	0.0	0.01	1.0	-19.0	-3.0	8.0						0.996	0.0		0.001	-1.581	.			amygdala;testis - seminiferous tubule;fetal brain;subthalamic nucleus;testis - interstitial;prefrontal cortex;atrioventricular node;testis;parietal lobe;	.	cellular protein modification process;ubiquitin-dependent protein catabolic process;intracellular protein transport;protein deubiquitination;regulation of vesicle-mediated transport;activation of GTPase activity	cytoplasm;lysosome;plasma membrane;recycling endosome	nucleic acid binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;GTPase activator activity;protein binding;calmodulin binding;Rab GTPase binding	USP32[19615732];MYL2[16555005];ANKRD44[16555005];ATXN7L3[16713569];MDFI[19060904];
559907	chr17	5036274	C	A	chr17:5036274	USP6	ubiquitin specific peptidase 6	8071.0	SNV	0|1	0.46	21_18	39	99	False	rs78465432,COSV51473005	EXONIC	YES	NM_001304284.2	Transcript	protein_coding	missense_variant		13/38	NM_001304284.2:c.265C>A	NP_001291213.1:p.His89Asn		1.0	.,.					Nodular fasciitis	Part of a fusion gene in	.						32	0.97							0.407096	56202.0	138056.0	0.0	95	1.0	InbreedingCoeff_RF	nfe	0.434902	28019.0	0.434902	28019.0	0.0184754	2873	0.136	419.0				0.003	-0.97476	0.031	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	USP6	0.0	0.0	0.02	0.0	-17.0	11.0	11.0	-42.0						0.996	0.0		0.005	-1.581	.			amygdala;testis - seminiferous tubule;fetal brain;subthalamic nucleus;testis - interstitial;prefrontal cortex;atrioventricular node;testis;parietal lobe;	.	cellular protein modification process;ubiquitin-dependent protein catabolic process;intracellular protein transport;protein deubiquitination;regulation of vesicle-mediated transport;activation of GTPase activity	cytoplasm;lysosome;plasma membrane;recycling endosome	nucleic acid binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;GTPase activator activity;protein binding;calmodulin binding;Rab GTPase binding	USP32[19615732];MYL2[16555005];ANKRD44[16555005];ATXN7L3[16713569];MDFI[19060904];
559909	chr17	5036281	G	C	chr17:5036281	USP6	ubiquitin specific peptidase 6	8071.0	SNV	0|1	0.48	22_20	42	99	False	rs76236903,COSV51473024	EXONIC	YES	NM_001304284.2	Transcript	protein_coding	missense_variant		13/38	NM_001304284.2:c.272G>C	NP_001291213.1:p.Ser91Thr		1.0	.,.					Nodular fasciitis	Part of a fusion gene in	.						32	0.97							0.436095	72534.0	166326.0	0.0	88	1.0	InbreedingCoeff	amr	0.459038	11016.0	0.45674	35190.0	0.0188934	2938	0.137	425.0				0.084	-0.506597	0.038	1	17	18	LRT_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	USP6	0.0	0.0	0.1	0.0	-4.0	1.0	4.0	-49.0						0.996	0.0		0.002	-1.301	.			amygdala;testis - seminiferous tubule;fetal brain;subthalamic nucleus;testis - interstitial;prefrontal cortex;atrioventricular node;testis;parietal lobe;	.	cellular protein modification process;ubiquitin-dependent protein catabolic process;intracellular protein transport;protein deubiquitination;regulation of vesicle-mediated transport;activation of GTPase activity	cytoplasm;lysosome;plasma membrane;recycling endosome	nucleic acid binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;GTPase activator activity;protein binding;calmodulin binding;Rab GTPase binding	USP32[19615732];MYL2[16555005];ANKRD44[16555005];ATXN7L3[16713569];MDFI[19060904];
560081	chr2	210682603	C	G	chr2:210682603	UNC80	unc-80 homolog, NALCN channel complex subunit	8076.0	SNV	0/1	0.6	14_21	35	99	False	rs182186415	EXONIC	YES	NM_001371986.1	Transcript	protein_coding	synonymous_variant		11/65	NM_001371986.1:c.1620C>G	NP_001358915.1:p.Ser540%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3), Autosomal recessive	Hypotonia-speech impairment-severe cognitive delay syndrome	Disease-causing germline mutation(s) (loss of function) in	Low-set, posteriorly rotated ears;Tented upper lip vermilion;Cachexia;Self-injurious behavior;Thin upper lip vermilion;Nasogastric tube feeding in infancy;Muscular hypotonia of the trunk;Tapered distal phalanges of finger;Spastic tetraplegia;Enlarged naris;Intellectual disability, severe;Motor delay;Small hand;Short stature;Smooth philtrum;Wide nasal bridge;Elbow flexion contracture;Esotropia;Nystagmus;Dyskinesia;Micrognathia;Conspicuously happy disposition;Triangular face;Plagiocephaly;Frontal bossing;Microcephaly;Constipation;Talipes equinovarus;Short neck;Severe failure to thrive;Hypoplasia of the corpus callosum;Seizure;Knee flexion contracture;Obstructive sleep apnea;Anteverted nares;EEG abnormality;Hip contracture;Global developmental delay;Intrauterine growth retardation;Downslanted palpebral fissures;Neonatal hypotonia;Hyperesthesia;EMG: myopathic abnormalities;Infantile muscular hypotonia;Short philtrum;Prominent nasal bridge;Absent speech;Scoliosis;Arachnodactyly;Central hypotonia;Ptosis;Broad forehead;Osteopenia;Short neck;Intrauterine growth retardation;Microcephaly;Low-set ears;Frontal bossing;Triangular face;Generalized hypotonia;Brachycephaly;Autosomal recessive inheritance;Short philtrum;Prominent forehead;Profound static encephalopathy;Hypoplasia of the corpus callosum;Profound global developmental delay;Seizure;Prominent nasal bridge;Dyskinesia;Epicanthus;Thin upper lip vermilion;Tapered finger;Nystagmus;Prominent nose;Esotropia;Intellectual disability, profound;Cerebral atrophy;Hip contracture;Absent speech;Anteverted nares;Severe global developmental delay;Inability to walk;Feeding difficulties;Appendicular hypotonia;Global brain atrophy;Cachexia;Plagiocephaly;High forehead;Scoliosis;Downslanted palpebral fissures;Poor speech;Bulbous nose;Smooth philtrum;Open mouth;Failure to thrive in infancy;Constipation;Spasticity;Posteriorly rotated ears;Facial hypotonia		0.00369557	562.0	152074.0	0.0	32	0.95	PASS	nfe	0.00590985	402.0	0.00590985	402.0	0.00364772	571.0	156536.0	0.0	40	0.59	PASS	nfe	0.00634291	384.0	0.00634291	384.0	0.0012090	188	0.009	29.0	0.00824	94.0		2.552	-0.004786		0	0	0			UNC80	0.0	0.0	0.1	0.0	-45.0	48.0	18.0	-40.0						0.64	0.14	69.752672498			.			ciliary ganglion;amygdala;tongue;dorsal root ganglion;superior cervical ganglion;skin;cingulate cortex;atrioventricular node;trigeminal ganglion;globus pallidus;	.	ion transmembrane transport	plasma membrane;integral component of membrane	.	GABARAPL2[20562859];TIMMDC1[24344204];GABARAP[20562859];
560441	chr1	148342488	T	C	chr1:148342488	NBPF26	NBPF member 26	8090.0	SNV	0/1	0.38	40_24	64	99	False	rs1553247985,COSV64996833	EXONIC	YES	NM_001351372.1	Transcript	protein_coding	missense_variant		4/30	NM_001351372.1:c.548A>G	NP_001338301.1:p.Gln183Arg		-1.0						.	.	.						0	0.0							0.358178	75784.0	211582.0	11.0	100	1.0	InbreedingCoeff	eas	0.45764	7098.0	0.350087	33761.0	0.0053311	829	0.056	168.0				12.49	0.86958		0	0	0			NBPF20	0.0	0.0	0.0	0.0	5.0	42.0	-18.0	23.0											.			.	.	.	cytoplasm	.	.
560454	chr1	148344660	G	C	chr1:148344660	NBPF26	NBPF member 26	8090.0	SNV	0/1	0.19	62_15	77	99	False	rs61809890	EXONIC	YES	NM_001351372.1	Transcript	protein_coding	synonymous_variant		2/30	NM_001351372.1:c.258C>G	NP_001338301.1:p.Leu86%3D		-1.0						.	.	.						0	0.0							0.010233	1977.0	193198.0	0.0	100	0.99	RF	eas	0.0263486	296.0	0.00773943	705.0	0.0001543	24	0.0	1.0				0.587	-0.230205		0	0	0			NBPF20	0.0	0.0	0.0	0.0	2.0	-20.0	-20.0	-2.0											.			.	.	.	cytoplasm	.	.
560711	chr7	158473516	C	A	chr7:158473516	NCAPG2	non-SMC condensin II complex subunit G2	8096.0	SNV	0/1	0.59	12_17	29	99	False	rs145268029	SPLICING	YES	NM_001281933.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	9/27		NM_001281933.2:c.925-8G>T			-1.0					Khan-Khan-Katsanis syndrome, 618460 (3), Autosomal recessive	.	.	Corneal scarring;Frontal bossing;Tricuspid regurgitation;Pigmentary retinopathy;Colpocephaly;Congenital onset;Visual impairment;Hypertonia;Cerebellar vermis hypoplasia;Failure to thrive;Renal hypoplasia;Flexion contracture;Patent ductus arteriosus;Patent foramen ovale;Autosomal recessive inheritance;Micrognathia;Strabismus;Buphthalmos;Absent speech;Hydronephrosis;Nystagmus;Tented upper lip vermilion;Microcephaly;Peters anomaly;Intrauterine growth retardation;Feeding difficulties;Short nose;Clinodactyly;Delayed ability to walk;Vesicoureteral reflux;Scoliosis;Short stature;Epiblepharon;Postaxial polydactyly;Dysphagia;Generalized hypotonia;Sacral dimple;Global developmental delay;Triangular mouth		0.00191386	289.0	151004.0	2.0	33	0.96	PASS	afr	0.00650015	267.0	4.42778e-05	3.0	0.000586011	128.0	218426.0	0.0	31	0.64	PASS	afr	0.00699633	103.0	0.000104946	11.0	0.0006817	106	0.001	2.0				0.437	-0.273788		0	0	0			NCAPG2	0.01	0.0	0.0	0.0	-8.0	-35.0	-3.0	1.0	1.555694882413e-05	0.002	11.76	-0.481	11.279	0.619	0.98				embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype; 			ciliary ganglion;testis - interstitial;testis;	.	inner cell mass cell proliferation;transcription by RNA polymerase II;cell cycle;erythrocyte differentiation;chromosome condensation;negative regulation of erythrocyte differentiation;cell division;positive regulation of protein tyrosine kinase activity;positive regulation of signaling receptor activity	condensin complex;nucleoplasm;membrane;nuclear speck	methylated histone binding;bHLH transcription factor binding;molecular function regulator	NEK6[17353931];MYC[17353931];NCAPH2[17268547];CCP110[unassigned1312];NCAPD3[26496610];BRCA1[29656893];RAF1[unassigned1312];TANK[unassigned1774];PHLDA3[17353931];
560843	chr5	34945012	G	A	chr5:34945012	DNAJC21	DnaJ heat shock protein family (Hsp40) member C21	8097.0	SNV	0/1	0.46	14_12	26	99	False	rs144600070	EXONIC	YES	NM_194283.4	Transcript	protein_coding	missense_variant		8/13	NM_194283.4:c.1024G>A	NP_919259.3:p.Val342Met		1.0	Matrin/U1-C-like, C2H2-type zinc finger,Matrin/U1-C-like, C2H2-type zinc finger,.,.,Matrin/U1-C-like, C2H2-type zinc finger,Matrin/U1-C-like, C2H2-type zinc finger,Matrin/U1-C-like, C2H2-type zinc finger	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Bone marrow failure syndrome 3, 617052 (3), Autosomal recessive	Shwachman-Diamond syndrome	Disease-causing germline mutation(s) in	Short stature;Persistence of hemoglobin F;Metaphyseal widening;Nephrocalcinosis;Anemia;Respiratory distress;Proximal femoral epiphysiolysis;Failure to thrive;Narrow greater sciatic notch;Enlargement of the costochondral junction;Global developmental delay;Neonatal respiratory distress;Steatorrhea;Acute myeloid leukemia;Thrombocytopenia;Autosomal recessive inheritance;Metaphyseal chondrodysplasia;Anterior rib cupping;Narrow chest;Neutropenia;Coxa vara;Myelodysplasia;Pancytopenia;Recurrent infections;Delayed skeletal maturation;Proximal femoral metaphyseal irregularity;Metaphyseal sclerosis;Small for gestational age;Elevated hepatic transaminase;Specific learning disability;Exocrine pancreatic insufficiency;Intellectual disability, mild;Irregular ossification at anterior rib ends;Ovoid vertebral bodies;Myocardial necrosis;Hepatomegaly;Hypermetropia;Cryptorchidism;Myopia;Hyperkeratosis;Downslanted palpebral fissures;Joint hypermobility;Epicanthus;Abnormality of skin pigmentation;Amelogenesis imperfecta;Failure to thrive;Small nail;Sparse hair;Cupped ear;Recurrent infections;Hypertelorism;Aplastic anemia;Retinal dystrophy;Short stature;Metaphyseal dysplasia;Hyperactivity;Hypoplasia of dental enamel;Intrauterine growth retardation;Autosomal recessive inheritance;Exocrine pancreatic insufficiency;Aplasia/Hypoplasia of the eyebrow;Micrognathia;Eczema;Astigmatism;Global developmental delay;Hernia;Microdontia;Pancytopenia;Bone marrow hypocellularity;Reduced bone mineral density;Hypodontia;Acute myeloid leukemia;Abnormal facial shape;Phenotypic variability;Microcephaly;Nail dystrophy;Hearing impairment;Congenital hip dislocation;Generalized hypotonia;Scoliosis;Short thorax;Short stature;Recurrent aphthous stomatitis;Anemia;Abnormality of the metaphysis;Exocrine pancreatic insufficiency;Global developmental delay;Ichthyosis;Carious teeth;Hepatomegaly;Myelodysplasia;Failure to thrive;Recurrent infections;Osteopenia;Eczema;Intellectual disability;Pectus carinatum;Bone marrow hypocellularity;Thrombocytopenia;Gait disturbance;Delayed skeletal maturation;Acute myeloid leukemia;Type I diabetes mellitus;Malabsorption;Aplastic anemia;Neutropenia;Microdontia		0.00303648	462.0	152150.0	2.0	32	0.97	PASS	nfe	0.00504204	343.0	0.00504204	343.0	0.00323374	813.0	251412.0	6.0	100	0.99	PASS	nfe	0.00532093	605.0	0.00532093	605.0	0.0033440	520	0.002	6.0				26.2	3.787399	0.442	11	9	20	SIFT,PolyPhen,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	DNAJC21	0.0	0.0	0.0	0.0	21.0	-33.0	28.0	-1.0						0.958	0.0	0.0	1.0	1.176	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;testis;	.	protein folding	nucleolus;ribosome	RNA binding;protein binding;zinc ion binding	RPL10[26496610];HSPB1[25277244];HTT[17500595];MTERF1[20195357];HIST1H2BH[30021884];CTCF[30021884];NIPSNAP1[26496610];VAV2[18654987];EZH2[26496610];
561524	chr19	17988795	G	A	chr19:17988795	SLC5A5	solute carrier family 5 member 5	8122.0	SNV	0/1	0.57	16_24	42	99	False	rs142014480	EXONIC	YES	NM_000453.3	Transcript	protein_coding	missense_variant		7/15	NM_000453.3:c.862G>A	NP_000444.1:p.Gly288Ser		1.0		Uncertain_significance	criteria_provided,_single_submitter	Thyroid_dyshormonogenesis_1|not_provided	Thyroid dyshormonogenesis 1, 274400 (3), Autosomal recessive	Familial thyroid dyshormonogenesis	Disease-causing germline mutation(s) in	Macroglossia;Autosomal recessive inheritance;Lethargy;Umbilical hernia;Growth delay;Dry skin;Constipation;Goiter;Intellectual disability;Hypothyroidism;Macroglossia;Large fontanelles;Constipation;Hypothyroidism;Short stature;Muscular hypotonia;Intellectual disability;Abdominal distention;Hypersomnia;Jaundice;Coarse facial features;Umbilical hernia;Fatigue;Goiter;Global developmental delay		0.000999001	152.0	152152.0	1.0	32	0.97	PASS	amr	0.00583454	89.0	0.00023519	16.0	0.000510245	128.0	250860.0	0.0	100	1.0	PASS	amr	0.00202394	70.0	0.000202322	23.0	0.0003473	54	0.002	5.0	0.00245	28.0		26.8	3.883877	0.613	15	6	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	SLC5A5	0.01	0.06	0.0	0.0	-45.0	-3.0	-4.0	-3.0						0.109	0.74	0.0	0.987	1.075	homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; 			pons;ciliary ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	thyroid hormone generation;ion transport;sodium ion transport;iodide transport;transmembrane transport;cellular response to cAMP;cellular response to gonadotropin stimulus	nucleus;plasma membrane;integral component of membrane;extracellular exosome;extracellular vesicle	sodium:iodide symporter activity;iodide transmembrane transporter activity	CYSRT1[unassigned1304];NOTCH2NLA[unassigned1304];
561582	chr5	139751899	G	A	chr5:139751899	SLC4A9	solute carrier family 4 member 9	8125.0	SNV	0/1	0.58	13_18	31	99	False	rs181215246	EXONIC	YES	NM_001258428.2	Transcript	protein_coding	missense_variant		20/22	NM_001258428.2:c.2815G>A	NP_001245357.1:p.Glu939Lys		1.0	.,.,.,.					.	.	.		0.000262729	40.0	152248.0	0.0	32	0.98	PASS	amr	0.00117786	18.0	0.000235135	16.0	0.000343496	84.0	244544.0	1.0	27	0.71	PASS	amr	0.000943224	31.0	0.000385284	43.0	0.0003730	58	0.002	7.0				23.9	3.154176	0.283	6	13	19	SIFT,M-CAP_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	SLC4A9	0.0	0.04	0.0	0.0	3.0	-18.0	-3.0	14.0						0.681	0.0	0.0	1.0	1.176	renal/urinary system phenotype; digestive/alimentary phenotype; 			ciliary ganglion;atrioventricular node;superior cervical ganglion;	.	inorganic anion transport;bicarbonate transport;regulation of intracellular pH;anion transmembrane transport	plasma membrane;integral component of plasma membrane;apical part of cell	inorganic anion exchanger activity;sodium:bicarbonate symporter activity;anion:anion antiporter activity	.
561723	chr1	152185818	CA		chr1:152185818-152185819	HRNR	hornerin	8131.0	deletion	0|1	0.18	9_2	11	57	False	rs768388262	EXONIC	YES	NM_001009931.3	Transcript	protein_coding	frameshift_variant		3/3	NM_001009931.3:c.8286_8287del	NP_001009931.1:p.His2762GlnfsTer9		-1.0						.	.	.		0.00597741	361.0	60394.0	1.0	0	0.14	AS_VQSR	amr	0.00758329	61.0	0.00709752	123.0	0.117582	15803.0	134400.0	7788.0	26	0.53	RF	nfe	0.193548	8753.0	0.193548	8753.0	0.0000064	1	0.001	4.0				22.6	2.542416		0	0	0			HRNR	0.0	0.0	0.0	0.0	-1.0	26.0	-2.0	-39.0							0.0				.			.	.	keratinization;cell envelope organization;neutrophil degranulation;establishment of skin barrier	cornified envelope;extracellular region;nucleus;cytoplasm;azurophil granule lumen;keratohyalin granule;perinuclear region of cytoplasm;collagen-containing extracellular matrix;extracellular exosome	calcium ion binding;structural constituent of epidermis;transition metal ion binding	OTUD4[19615732];IQCB1[21565611];PPP1R16B[28330616];GSTK1[17353931];PDHA1[29128334];WTAP[29507755];NEK4[25798074];PINX1[17353931];METTL3[29507755];FOXN3[25609649];PARK7[29128334];YWHAZ[15161933];SOD1[29128334];NR5A1[24635384];COQ2[29128334];METTL14[29507755];RAD51C[17353931];SOAT1[29128334];AGO2[17932509];BTK[21080425];CDK1[29128334];VDAC1[29128334];CDKN3[28330616];
565853	chr2	24494721	G	T	chr2:24494721	ITSN2	intersectin 2	8184.0	SNV	0/1	0.22	18_5	23	99	False	rs749857755	EXONIC	YES	NM_006277.3	Transcript	protein_coding	missense_variant		19/40	NM_006277.3:c.2171C>A	NP_006268.2:p.Thr724Lys		-1.0	.,.,.,.					.	.	.		0.000125348	19.0	151578.0	0.0	32	0.96	PASS	amr	0.000328688	5.0	0.00016196	11.0	8.50567e-05	21.0	246894.0	0.0	61	0.9	PASS	amr	0.000439136	15.0	4.51949e-05	5.0	0.0000514	8	0.0	1.0	0.0001	1.0		14.18	1.117668	0.017	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ITSN2	0.0	0.0	0.0	0.0	40.0	44.0	3.0	-47.0						0.926	0.02	0.0	0.882	0.224	homeostasis/metabolism phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; 			ciliary ganglion;appendix;tongue;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;testis;pons;thyroid;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	endocytosis;positive regulation of signal transduction;viral process;regulation of Rho protein signal transduction;positive regulation of dendrite extension	cytoplasm;centrosome;extracellular exosome	SH3/SH2 adaptor activity;Rho guanyl-nucleotide exchange factor activity;calcium ion binding;protein binding	MEGF10[unassigned5];GOLT1B[26496610];FBF1[26638075];BCCIP[16169070];FASLG[19807924];PTN[16169070];EGFR[24658140];TM9SF4[26496610];TGOLN2[29568061];KIAA1549[12421765];LAMP1[29568061];MRPL9[26496610];NINL[26638075];MAP4K3[20936779];YTHDF1[18654987];SEMA6A[12421765];VCAM1[22623428];MCRS1[17353931];PPP4R3A[26496610];SYNJ2[12421765];RNF41[26496610];LSM8[15231747];TBL3[16169070];SOS1[20936779];EZR[29568061];EZH2[26496610];
568883	chr9	131771551	G	A	chr9:131771551	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	8211.0	SNV	0/1	0.29	30_12	42	99	False	rs17455482	EXONIC	YES	NM_001369913.1	Transcript	protein_coding	missense_variant		12/13	NM_001369913.1:c.974C>T	NP_001356842.1:p.Ala325Val		-1.0	.,.,.,.,.					.	.	.		0.00128714	196.0	152276.0	0.0	33	0.99	PASS	sas	0.00310045	15.0	0.00214561	146.0	0.00136078	245.0	180044.0	2.0	16	0.44	PASS	sas	0.00309339	74.0	0.00181605	136.0	0.0010868	169						13.85	1.064551	0.038	2	15	17	MutationTaster_pred,fathmm-MKL_coding_pred	LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	SH3GLB2	0.0	0.0	0.0	0.0	-34.0	45.0	-1.0	-16.0						0.487	0.37	0.0	0.116	0.222	.			.	.	.	nucleoplasm;cytoplasm;cytosol	protein binding;identical protein binding;cadherin binding	BECN1[20562859];KDM1A[23455924];UBA5[20562859];STK4[24255178];GOLGA2[27107012];NXF1[unassigned1304];PPP6R2[24255178];KRTAP5-11[unassigned1304];MAGEA1[16189514;27107012];PGK1[20562859];STK38L[30108113];SH3GLB1[20562859;23414517;25416956;27107012;unassigned1304];SH3GLB2[20562859;27107012];GIT2[21988832];YES1[unassigned1304];KRTAP9-3[unassigned1304];CCDC158[16189514];KRTAP4-5[unassigned1304];KRTAP10-8[unassigned1304];LGALS14[unassigned1304];WDYHV1[unassigned1304];PA2G4[20562859];TRAF1[27107012];GADD45G[21988832];TBC1D7[unassigned1304];EFHC1[25910212];CEP83[26638075];PICK1[unassigned1304];FKBP4[20562859];EZR[29568061];LNX2[27107012];
569101	chr17	47233957	G	A	chr17:47233957	B4GALNT2	beta-1,4-N-acetyl-galactosaminyltransferase 2	8229.0	SNV	0/1	0.42	19_14	33	99	False	rs149941656,COSV55925194,COSV55926433	EXONIC	YES	NM_153446.3	Transcript	protein_coding	missense_variant		5/11	NM_153446.3:c.670G>A	NP_703147.2:p.Val224Ile		1.0	.,.,.				[Blood group, Sid system], 615018 (3); Sd(a) polyagglutination syndrome, 615018 (3)	.	.	.		0.000177468	27.0	152140.0	0.0	32	0.96	PASS	amr	0.000392876	6.0	0.000220478	15.0	0.000139582	35.0	250748.0	1.0	53	0.96	PASS	amr	0.0002931	10.0	0.000140691	16.0	0.0001350	21	0.001	2.0	0.0021	20.0		0.011	-0.770898	0.074	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	B4GALNT2	0.0	0.0	0.0	0.0	26.0	-29.0	3.0	8.0						0.975	0.0	0.0	0.001	-2.263	hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;superior cervical ganglion;globus pallidus;	.	UDP-N-acetylglucosamine metabolic process;protein N-linked glycosylation via asparagine;UDP-N-acetylgalactosamine metabolic process;negative regulation of cell-cell adhesion;lipid glycosylation	Golgi membrane;integral component of membrane;integral component of Golgi membrane	acetylgalactosaminyltransferase activity	BSCL2[unassigned1304];ARL13B[unassigned1304];OTX2[unassigned1304];FAM209A[unassigned1304];
570794	chr3	37365630	G	A	chr3:37365630	GOLGA4	golgin A4	8270.0	SNV	0/1	0.51	19_20	39	99	False	rs76787280	EXONIC	YES	NM_001172713.2	Transcript	protein_coding	synonymous_variant		15/23	NM_001172713.2:c.2319G>A	NP_001166184.1:p.Glu773%3D		1.0						.	.	.		0.00464453	707.0	152222.0	7.0	32	0.97	PASS	nfe	0.00731944	498.0	0.00731944	498.0	0.00440407	1103.0	250450.0	6.0	67	0.99	PASS	amr	0.00700475	242.0	0.00682992	772.0	0.0044565	693	0.015	47.0				10.22	0.589919		0	0	0			GOLGA4	0.0	0.0	0.0	0.0	-21.0	46.0	-21.0	-48.0						0.918	0.0	15.574771829			.			thyroid;testis - interstitial;superior cervical ganglion;trigeminal ganglion;testis;	.	vesicle-mediated transport;Golgi to plasma membrane protein transport;positive regulation of axon extension	Golgi membrane;cytoplasm;Golgi apparatus;trans-Golgi network;cytosol;intracellular membrane-bounded organelle;extracellular exosome	protein binding;GTPase binding	LIN54[17531812];ANKRD27[22705394];INTS14[26496610];TMEM63B[26496610];TSC1[30021884];MCC[17353931];SCAF1[30021884];ESR2[21182203];TGOLN2[29568061];KDELC1[30021884];RFWD3[30021884];GOLGB1[30021884];HNRNPD[26496610];NDN[17353931];GEMIN5[26496610];BIRC6[18329369];VHL[26496610];TP63[20085233];EXOC1[17043677];BET1[29568061];S100A10[30021884];
570795	chr3	37366445	C	T	chr3:37366445	GOLGA4	golgin A4	8270.0	SNV	0|1	0.46	19_16	35	99	False	rs754558185	EXONIC	YES	NM_001172713.2	Transcript	protein_coding	missense_variant		15/23	NM_001172713.2:c.3134C>T	NP_001166184.1:p.Thr1045Ile		1.0	.,.,.,.					.	.	.		2.63044e-05	4.0	152066.0	0.0	32	0.97	PASS	amr	0.000196515	3.0	0.0	0.0	1.20618e-05	3.0	248720.0	0.0	53	0.96	PASS	amr	8.71941e-05	3.0	0.0	0.0	0.0000129	2						13.9	1.072077	0.028	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GOLGA4	0.0	0.0	0.0	0.0	21.0	-43.0	-15.0	34.0						0.918	0.0	43.605385108	0.929	-0.3	.			thyroid;testis - interstitial;superior cervical ganglion;trigeminal ganglion;testis;	.	vesicle-mediated transport;Golgi to plasma membrane protein transport;positive regulation of axon extension	Golgi membrane;cytoplasm;Golgi apparatus;trans-Golgi network;cytosol;intracellular membrane-bounded organelle;extracellular exosome	protein binding;GTPase binding	LIN54[17531812];ANKRD27[22705394];INTS14[26496610];TMEM63B[26496610];TSC1[30021884];MCC[17353931];SCAF1[30021884];ESR2[21182203];TGOLN2[29568061];KDELC1[30021884];RFWD3[30021884];GOLGB1[30021884];HNRNPD[26496610];NDN[17353931];GEMIN5[26496610];BIRC6[18329369];VHL[26496610];TP63[20085233];EXOC1[17043677];BET1[29568061];S100A10[30021884];
572133	chr6	119136599	A	G	chr6:119136599	MCM9	minichromosome maintenance 9 homologous recombination repair factor	8289.0	SNV	0/1	0.42	18_13	31	99	False		EXONIC	YES	NM_001378357.1	Transcript	protein_coding	synonymous_variant		14/14	NM_001378357.1:c.2820T>C	NP_001365286.1:p.His940%3D		-1.0					Ovarian dysgenesis 4, 616185 (3), Autosomal recessive	46,XX ovarian dysgenesis-short stature syndrome	Disease-causing germline mutation(s) (loss of function) in	Autosomal recessive inheritance;Primary amenorrhea;Delayed skeletal maturation;Short stature;Decreased body weight						32	0.96											27	0.56														0.193	-0.391416		0	0	0			MCM9	0.0	0.0	0.0	0.0	38.0	-36.0	-10.0	0.0							0.0	36.459292018			liver/biliary system phenotype; reproductive system phenotype; hematopoietic system phenotype; neoplasm; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;testis - seminiferous tubule;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;globus pallidus;cerebellum;	.	double-strand break repair via homologous recombination;DNA replication;cellular response to DNA damage stimulus;female gamete generation;DNA duplex unwinding;recombinational interstrand cross-link repair;mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication;protein localization to chromatin	nucleus;chromosome;MCM8-MCM9 complex	DNA binding;DNA helicase activity;chromatin binding;protein binding;ATP binding;enzyme binding;MutLbeta complex binding;MutSalpha complex binding;MutSbeta complex binding;protein-containing complex binding	MCMBP[25036637];MESD[unassigned1304];
575028	chr1	36636672	G	A	chr1:36636672	MAP7D1	MAP7 domain containing 1	8317.0	SNV	0/1	0.44	9_7	16	99	False	rs143240955	EXONIC	YES	NM_018067.5	Transcript	protein_coding	synonymous_variant		2/17	NM_018067.5:c.147G>A	NP_060537.3:p.Pro49%3D		1.0						.	.	.		0.00476898	430.0	90166.0	1.0	23	0.59	PASS	nfe	0.00578642	259.0	0.00578642	259.0	0.00317398	742.0	233776.0	4.0	51	0.97	PASS	nfe	0.00374773	401.0	0.00374773	401.0	0.0024437	380	0.002	7.0				7.741	0.342011		0	0	0			MAP7D1	0.0	0.0	0.0	0.0	2.0	22.0	-28.0	0.0						0.472	0.97	2.536380176			.			pons;caudate nucleus;amygdala;occipital lobe;prefrontal cortex;whole brain;cingulate cortex;parietal lobe;cerebellum;hypothalamus;medulla oblongata;thalamus;	.	microtubule cytoskeleton organization	spindle;cytosol;microtubule cytoskeleton	.	RBM48[16169070];DCTN1[26638075];CCDC47[30021884];ATN1[16713569];UBE3A[29426014];MKI67[26949251];TUBA1C[26496610];MAP1LC3A[20562859];TUBA1A[27291054];HIST1H3A[29568061];TUBB3[27291054];MYC[17353931;21150319];LDHD[26496610];KIAA0753[26638075];POC1A[26638075];CEP170[26638075];SNRPB2[30021884];MAPK6[29426014];JUN[25609649];USP20[19615732];KSR1[27086506];RPS6[29568061];LCA5[26638075];SPICE1[26638075];APOA1[16169070];FOXL1[25609649];COPS6[16169070];NEURL4[29426014];CLIP4[23414517];CANX[29568061];VOPP1[16169070];CEP162[26638075];
577001	chr12	7171603	C	A	chr12:7171603	C1S	complement C1s	8340.0	SNV	0/1	0.44	10_8	18	99	False	rs782542532	EXONIC	YES	NM_201442.4	Transcript	protein_coding	missense_variant		5/12	NM_201442.4:c.424C>A	NP_958850.1:p.Pro142Thr		1.0	EGF-like calcium-binding, conserved site&EGF-like calcium-binding domain,EGF-like calcium-binding, conserved site&EGF-like calcium-binding domain,EGF-like calcium-binding, conserved site&EGF-like calcium-binding domain,EGF-like calcium-binding, conserved site&EGF-like calcium-binding domain,EGF-like calcium-binding, conserved site&EGF-like calcium-binding domain	Uncertain_significance	criteria_provided,_single_submitter	not_provided	C1s deficiency, 613783 (3); Ehlers-Danlos syndrome, periodontal type, 2, 617174 (3), Autosomal dominant	Immunodeficiency due to a classical component pathway complement deficiency;Ehlers-Danlos syndrome, periodontitis type	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in	Micrognathia;Hyperextensible skin;Atrophic scars;Joint hyperflexibility;Hypermelanotic macule;Microdontia;Short stature;Premature loss of primary teeth;Agenesis of permanent teeth;Atrophy of alveolar ridges;Gingival overgrowth;Periodontitis;Joint hypermobility;Scoliosis;Umbilical hernia;Arthralgia;Inguinal hernia;Fragile skin;Periodontitis;Neoplasm;Bruising susceptibility;Autosomal dominant inheritance;Gingival bleeding;Joint hypermobility;Hashimoto thyroiditis;Abnormality of complement system;Hepatitis;Systemic lupus erythematosus		1.31492e-05	2.0	152100.0	0.0	32	0.96	PASS	amr	6.54365e-05	1.0	1.47016e-05	1.0	3.97674e-05	10.0	251462.0	0.0	100	1.0	PASS	amr	0.000202371	7.0	2.63746e-05	3.0	0.0000257	4			0.00026	3.0		19.51	1.971934	0.068	8	11	19	LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	C1S	0.0	0.01	0.0	0.0	-32.0	-14.0	11.0	-14.0						0.189	0.86	0.0	0.351	1.026	.			ciliary ganglion;ovary;olfactory bulb;appendix;liver;dorsal root ganglion;atrioventricular node;adipose tissue;superior cervical ganglion;trigeminal ganglion;	Complement and coagulation cascades;Systemic lupus erythematosus	proteolysis;complement activation;complement activation, classical pathway;regulation of complement activation;innate immune response	extracellular region;extracellular space;blood microparticle	serine-type endopeptidase activity;calcium ion binding;protein binding;identical protein binding	CREB3[25910212];C1S[2387866;12788922];C1R[2387866;12788922;17996945];REEP4[unassigned1304];
581784	chr10	5009193	T	C	chr10:5009193	AKR1C1	aldo-keto reductase family 1 member C1	8426.0	SNV	0/1	0.49	19_18	37	99	False	rs11548049,COSV66499051	EXONIC	YES	NM_001353.6	Transcript	protein_coding	synonymous_variant		3/9	NM_001353.6:c.327T>C	NP_001344.2:p.Asp109%3D		1.0						.	.	.	19877174	0.00713525	1086.0	152202.0	4.0	33	0.97	PASS	nfe	0.00871674	593.0	0.00871674	593.0	0.00601066	1509.0	251054.0	8.0	52	0.99	PASS	nfe	0.00895046	1015.0	0.00895046	1015.0	0.0011897	185	0.003	9.0				0.789	-0.185948		0	0	0			AKR1C1	0.0	0.0	0.0	0.0	32.0	42.0	42.0	-25.0						0.911	0.0				.			.	Metabolism of xenobiotics by cytochrome P450	retinoid metabolic process;xenobiotic metabolic process;digestion;steroid metabolic process;bile acid metabolic process;bile acid and bile salt transport;intestinal cholesterol absorption;epithelial cell differentiation;progesterone metabolic process;retinal metabolic process;cholesterol homeostasis;daunorubicin metabolic process;doxorubicin metabolic process;response to organophosphorus;protein homooligomerization;oxidation-reduction process;cellular response to jasmonic acid stimulus	cytosol;extracellular exosome	alditol:NADP+ 1-oxidoreductase activity;aldo-keto reductase (NADP) activity;protein binding;alcohol dehydrogenase (NADP+) activity;steroid dehydrogenase activity;oxidoreductase activity;oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;phenanthrene 9,10-monooxygenase activity;carboxylic acid binding;bile acid binding;17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity;androsterone dehydrogenase (B-specific) activity;ketosteroid monooxygenase activity;trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;indanol dehydrogenase activity	COMMD8[21900206];FN1[19738201];MAPK3[18624398];PTPN3[25416956;unassigned1304];
584907	chr19	21720001	A	G	chr19:21720001	ZNF429	zinc finger protein 429	8494.0	SNV	0/1	0.52	12_13	25	99	False	rs111400547	EXONIC	YES	NM_001001415.4	Transcript	protein_coding	synonymous_variant		4/4	NM_001001415.4:c.1146A>G	NP_001001415.2:p.Ser382%3D		1.0						.	.	.		0.00384054	584.0	152062.0	6.0	33	0.97	PASS	afr	0.00997585	413.0	0.00111742	76.0	0.00299728	747.0	249226.0	12.0	62	0.99	PASS	sas	0.0118487	362.0	0.00141493	160.0	0.0031189	485	0.002	6.0				0.706	-0.202503		0	0	0			ZNF429	0.0	0.0	0.0	0.0	-49.0	-44.0	18.0	31.0						0.791	0.0	23.536853263			.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	.
585218	chr17	78357670	T	C	chr17:78357670	RNF213	ring finger protein 213	8508.0	SNV	0/1	0.39	20_13	33	99	False	rs775185701	EXONIC	YES	NM_001256071.3	Transcript	protein_coding	missense_variant		59/68	NM_001256071.3:c.14264T>C	NP_001243000.2:p.Ile4755Thr		1.0	.,.				{Moyamoya disease 2, susceptibility to}, 607151 (3), Autosomal recessive, Autosomal dominant	Moyamoya disease	Major susceptibility factor in	Ventriculomegaly;Abnormality of the cerebral vasculature;Telangiectasia;Intellectual disability;Seizure		6.57168e-06	1.0	152168.0	0.0	32	0.97	PASS				0.0	0.0	3.97836e-06	1.0	251360.0	0.0	100	1.0	PASS	amr	2.89084e-05	1.0	0.0	0.0	0.0000064	1	0.001	2.0				23.2	2.816062	0.177	4	14	18	SIFT,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred	RNF213	0.0	0.0	0.0	0.01	-46.0	11.0	-4.0	-20.0						0.208	0.0	0.0	0.24	1.138	homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			ciliary ganglion;uterus;dorsal root ganglion;atrioventricular node;superior cervical ganglion;	.	protein polyubiquitination;angiogenesis;sprouting angiogenesis;ubiquitin-dependent protein catabolic process;protein ubiquitination;protein homooligomerization;protein autoubiquitination;negative regulation of non-canonical Wnt signaling pathway	nucleolus;cytoplasm;cytosol;membrane	ubiquitin-protein transferase activity;ATPase activity;metal ion binding	PTPN1[26496610];RNASEH2B[26496610];MCRS1[17353931];CBX2[21282530];HLA-C[17353931];KRT40[25416956];GOLGA2[25416956];PLAC9[21988832];MRPL50[26496610];UBXN11[25416956];NUDCD1[29021621];TRIP6[25416956];REL[25416956];TRIM27[25416956];HIST1H1A[30021884];TRIM23[25416956];
587279	chr11	66975155	C	T	chr11:66975155	KDM2A	lysine demethylase 2A	8559.0	SNV	0/1	0.48	15_14	29	99	False	rs1459977535	EXONIC	YES	NM_012308.3	Transcript	protein_coding	missense_variant		6/21	NM_012308.3:c.482C>T	NP_036440.1:p.Ser161Phe		1.0	.,JmjC domain&JmjC domain,JmjC domain&JmjC domain					.	.	.		6.57505e-06	1.0	152090.0	0.0	32	0.95	PASS	nfe	1.46994e-05	1.0	1.46994e-05	1.0					20	0.55														24.7	3.405017	0.19	8	12	20	SIFT,LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	KDM2A	0.0	0.0	0.0	0.03	48.0	10.0	4.0	10.0						0.0344	1.0	99.858280241	1.0	1.022	embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; 			testis - seminiferous tubule;testis - interstitial;trigeminal ganglion;testis;cerebellum;	.	double-strand break repair via nonhomologous end joining;regulation of transcription by RNA polymerase II;oxidation-reduction process;histone H3-K36 demethylation	nucleoplasm	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;zinc ion binding;histone demethylase activity;histone demethylase activity (H3-K36 specific)	ZNF512B[15231748];SMAD3[15231748];RAB5C[26496610];CBX4[26496610];ECH1[29426014];UBE3A[29426014];FOS[20936779];UBE2G2[21988832];ENO1[23414517];FBXO32[23414517];RBPJ[25609649];RELA[20080798];SMAD7[15231748];BCL6[16147992];REEP5[26496610];KIF20B[26496610];SKP1[15070733;27705803];
587527	chr17	74005802	C	T	chr17:74005802	EVPL	envoplakin	8567.0	SNV	0/1	0.54	12_14	26	99	False	rs146508997	EXONIC	YES	NM_001320747.2	Transcript	protein_coding	missense_variant		22/22	NM_001320747.2:c.3550G>A	NP_001307676.1:p.Glu1184Lys		-1.0	.,.					.	.	.		0.00513804	782.0	152198.0	6.0	32	0.96	PASS	amr	0.00830608	127.0	0.00767331	522.0	0.00468714	1175.0	250686.0	3.0	79	0.99	PASS	nfe	0.00673029	763.0	0.00673029	763.0	0.0045851	713	0.01	31.0				22.4	2.437761	0.244	10	9	19	SIFT,PolyPhen,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	EVPL	0.0	0.0	0.0	0.0	33.0	3.0	-48.0	1.0						0.859	0.0		0.886	1.026	integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); 			tongue;	.	epidermis development;peptide cross-linking;keratinocyte differentiation;wound healing;intermediate filament cytoskeleton organization;cornification	cornified envelope;cytoplasm;cytosol;intermediate filament;membrane;desmosome;intermediate filament cytoskeleton;extracellular exosome	structural molecule activity;intermediate filament binding;protein binding, bridging;cadherin binding	TSNAX[26496610];PLEKHA5[20936779];CORO1C[30021884];
587540	chr19	13218417	T	C	chr19:13218417	TRMT1	tRNA methyltransferase 1	8570.0	SNV	0/1	0.31	22_10	32	99	False	rs148858467,COSV99317236	EXONIC	YES	NM_017722.5	Transcript	protein_coding	synonymous_variant		13/16	NM_017722.5:c.1554A>G	NP_060192.1:p.Pro518%3D		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	Intellectual developmental disorder, autosomal recessive 68, 618302 (3), Autosomal recessive	.	.	Generalized hypotonia;Global developmental delay;Infantile onset;Autosomal recessive inheritance;Pes planus;Wide nasal bridge;Delayed ability to walk;Narrow palpebral fissure;Delayed speech and language development;Cerebellar atrophy;Abnormal facial shape;Periventricular leukomalacia;Small for gestational age;Synophrys;Seizure;Broad eyebrow;Microcephaly		0.00549176	836.0	152228.0	1.0	31	0.97	PASS	nfe	0.00993504	676.0	0.00993504	676.0	0.00547153	1319.0	241066.0	6.0	93	0.72	PASS	nfe	0.00918805	994.0	0.00918805	994.0	0.0053761	836	0.009	28.0	0.00869	16.0		0.339	-0.311207		0	0	0			TRMT1	0.0	0.01	0.01	0.0	47.0	44.0	-29.0	33.0						0.0725	0.0	96.590142229			mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			pons;white blood cells;testis - seminiferous tubule;prefrontal cortex;	.	tRNA N2-guanine methylation;tRNA modification	nucleus;nucleoplasm	tRNA binding;RNA binding;tRNA (guanine-N2-)-methyltransferase activity;protein binding;metal ion binding	MAGEA11[16189514;21516116;25416956;unassigned1304];TERF1[21044950];CISD3[27499296];HSPD1[29568061];
589400	chr3	52003540	G	A	chr3:52003540	ABHD14B	abhydrolase domain containing 14B	8632.0	SNV	0/1	0.56	16_20	36	99	False	rs149746591	EXONIC	YES	NM_032750.3	Transcript	protein_coding	missense_variant		4/4	NM_032750.3:c.535C>T	NP_116139.1:p.Arg179Trp		-1.0	.,.,.,.,.					.	.	.		6.57065e-06	1.0	152192.0	0.0	33	0.98	PASS	nfe	1.46998e-05	1.0	1.46998e-05	1.0	1.60632e-05	4.0	249016.0	0.0	78	1.0	PASS	sas	9.80072e-05	3.0	8.97618e-06	1.0	0.0000129	2						24.9	3.460924	0.258	11	10	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	ABHD14B	0.0	0.0	0.0	0.0	-18.0	-2.0	-2.0	-10.0						0.495	0.12	0.0	0.836	-0.745	.			kidney;liver;	.	positive regulation of transcription by RNA polymerase II;3'-phosphoadenosine 5'-phosphosulfate metabolic process	nucleus;nucleolus;cytoplasm;cytosol;extracellular exosome	protein binding;hydrolase activity	MTNR1A[26514267];
592085	chr1	151110223	G	A	chr1:151110223	SEMA6C	semaphorin 6C	8679.0	SNV	0/1	0.52	14_15	29	99	False	COSV100501374	EXONIC	YES	NM_001178061.3	Transcript	protein_coding	synonymous_variant		10/20	NM_001178061.3:c.720C>T	NP_001171532.1:p.Phe240%3D		-1.0						.	.	.						32	0.95											49	0.99														13.56	1.019359		0	0	0																		0.0				integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			superior cervical ganglion;skeletal muscle;	Axon guidance	neural crest cell migration;axon guidance;positive regulation of cell migration;negative regulation of axon extension involved in axon guidance;negative chemotaxis;semaphorin-plexin signaling pathway	extracellular space;integral component of plasma membrane	semaphorin receptor binding;neuropilin binding;chemorepellent activity	FAM209A[unassigned1304];
592686	chr17	20130771	G	A	chr17:20130771	SPECC1	sperm antigen with calponin homology and coiled-coil domains 1	8683.0	SNV	0/1	0.43	13_10	23	99	False	rs199989384,COSV54962571	EXONIC	YES	NM_001386083.1	Transcript	protein_coding	missense_variant		7/17	NM_001386083.1:c.1933G>A	NP_001373012.1:p.Ala645Thr		1.0	.,.,.,.,.,.,.					.	.	.		0.000262916	40.0	152140.0	0.0	32	0.96	PASS	sas	0.00394355	19.0	0.000191098	13.0	0.000518486	130.0	250730.0	4.0	37	0.91	PASS	sas	0.00304299	93.0	0.000202707	23.0	0.0004501	70	0.0	1.0	0.00031	3.0		22.5	2.466205	0.135	5	12	17	LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	SPECC1	0.0	0.0	0.0	0.0	-36.0	-45.0	-36.0	-16.0							0.11	0.0	0.998	1.176	.			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	.	actin cytoskeleton organization	nucleus;microtubule organizing center;membrane;filamentous actin	.	CBX7[21282530];ACTR2[26496610];ATP6AP2[26496610];IQGAP1[26496610];KSR2[27086506];MYO19[26496610];PLEKHA7[28877994];PPP1CB[26496610];ANLN[26496610];LIMA1[26496610];MYO1C[26496610];MYO5C[26496610];CAPZA2[26496610];WDR5[27705803];MYO18A[26496610];MYH9[26496610];FLNA[26496610];GRB2[12577067];SYNPO[26496610];MAPRE1[26496610];RAB5A[26496610];DBN1[26496610];
592863	chr16	4390914	C	A	chr16:4390914	CORO7-PAM16	CORO7-PAM16 readthrough	8688.0	SNV	0/1	0.46	19_16	35	99	False	rs142976385	SPLICING	YES	NM_001201479.2	Transcript	protein_coding	splice_region_variant,intron_variant	30/30		NM_001201479.2:c.3060+7G>T			-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00423422	644.0	152094.0	1.0	33	0.97	PASS	nfe	0.0071771	488.0	0.0071771	488.0	0.00390111	979.0	250954.0	3.0	100	1.0	PASS	nfe	0.00598253	678.0	0.00598253	678.0	0.0038777	603	0.003	8.0				12.4	0.857591		0	0	0			CORO7-PAM16	0.0	0.0	0.0	0.0	-18.0	12.0	7.0	8.0	0.0008855183511974	0.026					0.0				.			.	.	.	.	.	.
593426	chr12	49935517	C	G	chr12:49935517	KCNH3	potassium voltage-gated channel subfamily H member 3	8700.0	SNV	0/1	0.55	22_27	49	99	False		EXONIC	YES	NM_012284.3	Transcript	protein_coding	missense_variant		3/15	NM_012284.3:c.415C>G	NP_036416.1:p.Arg139Gly		1.0	PAS-associated, C-terminal					.	.	.						33	0.98											70	1.0											0.00011	1.0		23.0	2.748533	0.12	9	10	19	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-XF_coding_pred	KCNH3	0.01	0.0	0.0	0.0	-32.0	4.0	40.0	44.0						0.0322	1.0	11.864938143	1.0	1.016	homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; 			.	.	potassium ion transport;regulation of ion transmembrane transport;regulation of membrane potential;potassium ion transmembrane transport	plasma membrane;integral component of plasma membrane;integral component of membrane	voltage-gated potassium channel activity;protein binding	LRRC59[30021884];
597436	chr16	847846	G	A	chr16:847846	CHTF18	chromosome transmission fidelity factor 18	8735.0	SNV	0/1	0.4	12_8	20	99	False	rs371911391	EXONIC	YES	NM_022092.3	Transcript	protein_coding	synonymous_variant		22/22	NM_022092.3:c.2799G>A	NP_071375.1:p.Thr933%3D		1.0						.	.	.		0.000552116	84.0	152142.0	0.0	33	0.97	PASS	amr	0.00346768	53.0	0.000264651	18.0	0.000430761	99.0	229826.0	0.0	39	0.7	PASS	amr	0.0010425	34.0	0.000409644	42.0	0.0003537	55	0.002	7.0				0.25	-0.354884		0	0	0			CHTF18	0.27	0.06	0.0	0.0	2.0	13.0	2.0	42.0											growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			.	.	DNA replication;cell cycle;positive regulation of DNA-directed DNA polymerase activity	nucleoplasm;cytosol;membrane;Ctf18 RFC-like complex	DNA clamp loader activity;protein binding;ATP binding;single-stranded DNA-dependent ATPase activity	FAM83H[26496610];MYC[17314511];STAT3[25814554];XRCC3[26496610];MKI67[26949251];CRK[25814554];
597442	chr11	614243	C	T	chr11:614243	IRF7	interferon regulatory factor 7	8736.0	SNV	0/1	0.68	12_25	37	99	False	rs41313489,COSV99042613	EXONIC	YES	NM_004031.4	Transcript	protein_coding	missense_variant		5/10	NM_004031.4:c.649G>A	NP_004022.2:p.Asp217Asn		-1.0	Interferon regulatory factor DNA-binding domain,.,Interferon regulatory factor DNA-binding domain,Interferon regulatory factor DNA-binding domain,Interferon regulatory factor DNA-binding domain,.	Likely_benign	criteria_provided,_single_submitter	Immunodeficiency_39|not_provided	?Immunodeficiency 39, 616345 (3), Autosomal recessive	.	.	Immunodeficiency;Autosomal recessive inheritance		0.00314705	479.0	152206.0	0.0	32	0.97	PASS	amr	0.00863535	132.0	0.00426295	290.0	0.00245155	609.0	248414.0	0.0	74	0.91	PASS	amr	0.00418167	144.0	0.00351043	393.0	0.0023987	373	0.008	27.0	0.00869	16.0		9.94	0.55883	0.026	4	15	19	M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	IRF7	0.0	0.02	0.0	0.0	-7.0	50.0	-17.0	5.0						0.0953	0.0	0.0	0.016	-0.097	immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; homeostasis/metabolism phenotype; 			white blood cells;superior cervical ganglion;	Toll-like receptor signaling pathway	negative regulation of transcription by RNA polymerase II;regulation of adaptive immune response;transcription by RNA polymerase II;cellular response to DNA damage stimulus;response to virus;immunoglobulin mediated immune response;establishment of viral latency;regulation of type I interferon production;positive regulation of type I interferon production;interferon-alpha production;interferon-beta production;positive regulation of interferon-alpha production;positive regulation of interferon-beta production;regulation of MyD88-dependent toll-like receptor signaling pathway;regulation of MyD88-independent toll-like receptor signaling pathway;TRIF-dependent toll-like receptor signaling pathway;MDA-5 signaling pathway;innate immune response;type I interferon biosynthetic process;regulation of monocyte differentiation;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;regulation of immune response;defense response to virus;interferon-gamma-mediated signaling pathway;type I interferon signaling pathway;positive regulation of type I interferon-mediated signaling pathway;negative regulation of macrophage apoptotic process	nucleus;nucleoplasm;cytoplasm;cytosol;endosome membrane	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding	PIAS4[15251447];HACE1[21903422];UBE2B[19549727];CHUK[18922877];IQSEC1[21903422];INSR[21988832];CCDC47[21903422];ARAF[21903422];AIP[21903422];LTN1[21903422];TRMT2A[21903422];PALD1[21903422];TBK1[17599067];MAFB[20581830];IRAK1[21903422];P4HA1[21903422];TRAF6[21743479];TLK2[21903422];MAPT[26402096];GCLM[21988832];ACADS[21988832];IKBKE[19153231];TRMT61B[21903422];
598891	chr1	22974076	G	A	chr1:22974076	C1QC	complement C1q C chain	8762.0	SNV	0/1	0.43	19_15	35	99	False	rs200292688,COSV65889917	EXONIC	YES	NM_001347619.2	Transcript	protein_coding	missense_variant		3/3	NM_001347619.2:c.538G>A	NP_001334548.1:p.Val180Met		1.0	C1q domain&C1q domain&C1q domain,C1q domain&C1q domain&C1q domain,C1q domain&C1q domain&C1q domain	Uncertain_significance	criteria_provided,_multiple_submitters,_no_conflicts	C1q_deficiency|not_provided	C1q deficiency, 613652 (3), Autosomal recessive	Immunodeficiency due to a classical component pathway complement deficiency	Disease-causing germline mutation(s) in	Membranoproliferative glomerulonephritis;Decreased serum complement factor I;Recurrent infections;Autosomal recessive inheritance;Systemic lupus erythematosus		5.91444e-05	9.0	152170.0	0.0	32	0.97	PASS	amr	0.000130822	2.0	0.000102893	7.0	0.000123273	31.0	251474.0	0.0	100	1.0	PASS	nfe	0.000175809	20.0	0.000175809	20.0	0.0001350	21			9e-05	1.0		23.5	2.986868	0.172	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	C1QC	0.0	0.0	0.0	0.0	17.0	-11.0	26.0	-5.0						0.231	0.02	0.0	0.997	1.176	.			.	Complement and coagulation cascades;Alzheimer's disease;Systemic lupus erythematosus	proteolysis;immune response;complement activation;complement activation, classical pathway;regulation of complement activation;negative regulation of granulocyte differentiation;innate immune response;negative regulation of macrophage differentiation	extracellular region;collagen trimer;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;protein binding	TFAP2A[24835590];C1QB[28325905];C1QA[21054788;12960167;28325905];C1QBP[28018340];APOA1[15174051];ZNF534[unassigned1304];CD33[28325905];C1QC[7240];UBQLN2[unassigned1304];PPP1CA[25593058];
599067	chr11	10536618	T	C	chr11:10536618	RNF141	ring finger protein 141	8770.0	SNV	0/1	0.55	13_16	29	99	False	rs776551148	SPLICING	YES	NM_016422.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/5		NM_016422.4:c.543-5A>G			-1.0						.	.	.		6.56754e-06	1.0	152264.0	0.0	33	0.97	PASS	amr	6.54108e-05	1.0	0.0	0.0	2.08772e-05	5.0	239496.0	0.0	34	0.77	PASS	amr	6.37592e-05	2.0	1.83446e-05	2.0	0.0000064	1	0.0	1.0				14.07	1.098745		0	0	0			RNF141	0.0	0.1	0.0	0.0	-8.0	-5.0	-45.0	-5.0	0.0003149385465399	0.018	6.678	0.861	7.539	0.524	0.0				reproductive system phenotype; 			testis - seminiferous tubule;testis - interstitial;trigeminal ganglion;testis;parietal lobe;	.	regulation of transcription, DNA-templated;protein autoubiquitination	membrane	DNA binding;ubiquitin-protein transferase activity;metal ion binding	TRIM8[22493164];PLK3[unassigned1304];MVK[unassigned1304];TRIM24[22493164];DTX3[22493164];
599535	chr3	113084922	T	C	chr3:113084922	CFAP44	cilia and flagella associated protein 44	8795.0	SNV	0/1	0.62	8_13	21	99	False	rs35480872	EXONIC	YES	NM_001164496.2	Transcript	protein_coding	synonymous_variant		19/35	NM_001164496.2:c.2679A>G	NP_001157968.1:p.Leu893%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided	?Spermatogenic failure 20, 617593 (3), Autosomal recessive	Non-syndromic male infertility due to sperm motility disorder	Disease-causing germline mutation(s) (loss of function) in	Infertility;Short sperm flagella;Absent sperm flagella;Autosomal recessive inheritance;Coiled sperm flagella		0.00150482	229.0	152178.0	0.0	32	0.97	PASS	nfe	0.00241056	164.0	0.00241056	164.0	0.00142779	358.0	250738.0	1.0	51	0.98	PASS	amr	0.00225747	78.0	0.00208021	236.0	0.0013183	205	0.007	21.0				0.739	-0.195805		0	0	0			CFAP44	0.0	0.01	0.05	0.0	-8.0	-3.0	-36.0	38.0								39.60897848			reproductive system phenotype; cellular phenotype; 			.	.	sperm axoneme assembly;cilium-dependent cell motility	cytoplasm;cytoskeleton;motile cilium	.	RSL1D1[30021884];HIST1H2BH[30021884];HIF1AN[26972000];
600490	chr4	142649121	C	T	chr4:142649121	IL15	interleukin 15	8823.0	SNV	0/1	0.42	18_13	31	99	False	rs144093178	EXONIC	YES	NM_000585.5	Transcript	protein_coding	missense_variant		6/8	NM_000585.5:c.224C>T	NP_000576.1:p.Thr75Met		1.0	.,.,.,.,.,.					.	.	.		0.000414528	63.0	151980.0	1.0	32	0.97	PASS	nfe	0.000706152	48.0	0.000706152	48.0	0.00025744	56.0	217526.0	0.0	25	0.57	PASS	nfe	0.0003956	41.0	0.0003956	41.0	0.0002572	40	0.001	2.0				26.2	3.782685	0.855	17	3	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,PrimateAI_pred,ClinPred_pred	IL15	0.0	0.0	0.0	0.0	7.0	-28.0	20.0	16.0							0.92	0.0	0.924	1.026	renal/urinary system phenotype; immune system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	Cytokine-cytokine receptor interaction;Jak-STAT signaling pathway	natural killer cell differentiation;NK T cell proliferation;inflammatory response;immune response;signal transduction;tyrosine phosphorylation of STAT protein;cell-cell signaling;aging;positive regulation of cell population proliferation;regulation of signaling receptor activity;skeletal muscle atrophy;hyaluronan metabolic process;positive regulation of interleukin-17 production;positive regulation of natural killer cell proliferation;positive regulation of natural killer cell differentiation;positive regulation of tissue remodeling;interleukin-15-mediated signaling pathway;positive regulation of T cell proliferation;positive regulation of tyrosine phosphorylation of STAT protein;extrathymic T cell selection;regulation of T cell differentiation;cell maturation;lymph node development;negative regulation of smooth muscle cell proliferation;regulation of defense response to virus by host;positive regulation of inflammatory response;positive regulation of immune response;cellular response to vitamin D;negative regulation of cold-induced thermogenesis;positive regulation of protein O-linked glycosylation	extracellular region;extracellular space;nucleoplasm;cytoplasm;endosome;Golgi apparatus;cytosol;cell surface;nuclear speck	cytokine activity;cytokine receptor binding;protein binding	IL15RA[16284400;23104097];STAT5B[21988832];ZNRD1[21988832];TRAF3[21988832];IL2RB[23104097;25416956];
603857	chr10	105037589	G	T	chr10:105037589	INA	internexin neuronal intermediate filament protein alpha	8906.0	SNV	0/1	0.48	22_20	42	99	False	COSV63975900	EXONIC	YES	NM_032727.4	Transcript	protein_coding	synonymous_variant		1/3	NM_032727.4:c.621G>T	NP_116116.1:p.Thr207%3D		1.0						.	.	.						32	0.98											26	0.55														14.04	1.094287		0	0	0			INA	0.0	0.0	0.0	0.0	22.0	-29.0	3.0	27.0						0.191	0.29	69.465056429			nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; 			.	Cell Communication	substantia nigra development;cell differentiation;neurofilament cytoskeleton organization;postsynaptic actin cytoskeleton organization;postsynaptic intermediate filament cytoskeleton organization;cellular response to leukemia inhibitory factor	extracellular space;nucleoplasm;neurofilament;nuclear membrane;cytoplasmic ribonucleoprotein granule;myelin sheath;intermediate filament cytoskeleton;Schaffer collateral - CA1 synapse;postsynapse	structural constituent of cytoskeleton;structural constituent of postsynaptic actin cytoskeleton;structural constituent of postsynaptic intermediate filament cytoskeleton	JUN[25609649];PDHA1[29128334];STAU1[15121898];KSR1[27086506];ODF2[26638075];STAT1[26966684];DLST[29128334];ARRB1[17620599];CNTROB[26638075];SQSTM1[20562859];NFKB1[25609649];PLEC[30021884];
605098	chr12	114362510	TTC		chr12:114362510-114362512	RBM19	RNA binding motif protein 19	8932.0	deletion	0/1	0.46	14_12	26	99	False	rs764565638	EXONIC	YES	NM_001146699.2	Transcript	protein_coding	inframe_deletion		18/25	NM_001146699.2:c.2295_2297del	NP_001140171.1:p.Lys765del		-1.0						.	.	.		0.000236574	36.0	152172.0	1.0	33	0.95	PASS	nfe	0.000470381	32.0	0.000470381	32.0	0.000214719	54.0	251492.0	0.0	98	1.0	PASS	nfe	0.000430701	49.0	0.000430701	49.0	0.0001608	25						19.45	1.963857		0	0	0			RBM19	0.0	0.0	0.02	0.0	40.0	2.0	-7.0	-9.0						0.924	0.0	0.0			embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype; 			dorsal root ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;	.	regulation of alternative mRNA splicing, via spliceosome;multicellular organism development;positive regulation of embryonic development;mRNA cis splicing, via spliceosome	nucleoplasm;chromosome;nucleolus;cytoplasm;membrane;nuclear speck	RNA binding	FBL[29568061];RPS6[29568061];MNDA[25665578];PTPN12[15231748];
605107	chr12	114397662	A	G	chr12:114397662	RBM19	RNA binding motif protein 19	8932.0	SNV	0/1	0.56	15_19	34	99	False		SPLICING	YES	NM_001146699.2	Transcript	protein_coding	splice_region_variant,intron_variant	4/24		NM_001146699.2:c.378+8T>C			-1.0						.	.	.						33	0.97											79	0.99														12.91	0.926257		0	0	0			RBM19	0.0	0.0	0.0	0.0	46.0	37.0	-26.0	8.0	0.0517093492438576	0.398				0.924	0.0				embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype; 			dorsal root ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;	.	regulation of alternative mRNA splicing, via spliceosome;multicellular organism development;positive regulation of embryonic development;mRNA cis splicing, via spliceosome	nucleoplasm;chromosome;nucleolus;cytoplasm;membrane;nuclear speck	RNA binding	FBL[29568061];RPS6[29568061];MNDA[25665578];PTPN12[15231748];
605367	chr1	236762931	A		chr1:236762931	HEATR1	HEAT repeat containing 1	8944.0	deletion	0/1	0.67	7_14	21	99	False	rs34496316	SPLICING	YES	NM_018072.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/44		NM_018072.6:c.360-7del			-1.0						.	.	.		0.00356127	541.0	151912.0	3.0	32	0.96	PASS	nfe	0.00622169	423.0	0.00622169	423.0	0.00354386	830.0	234208.0	1.0	32	0.68	PASS	nfe	0.00591754	641.0	0.00591754	641.0	0.0000193,0.0034083	3,530	0.004	14.0				5.831	0.199339		0	0	0			HEATR1	0.0	0.04	0.0	0.0	20.0	-6.0	-6.0	-5.0						0.195	1.0				.			.	.	maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing;positive regulation of transcription by RNA polymerase I;positive regulation of rRNA processing	fibrillar center;nucleoplasm;nucleolus;mitochondrion;membrane;90S preribosome;small-subunit processome;t-UTP complex	RNA binding;protein binding	FOXB1[25609649];JUN[25609649];VCAM1[22623428];FOXE1[25609649];FOXG1[25609649];HDAC11[23752268];FOXH1[25609649];RPS6[29568061];FOXI1[25609649];OCRL[25107275];FOXL1[25609649];SMC6[26496610];RRP1B[20926688];TANK[unassigned1774];TTBK1[17353931];FOXQ1[25609649];FBL[29568061];PTP4A3[17353931];XRN1[15231747];MYC[17353931];VPS52[25416956];STOM[27173435;unassigned1312];C18orf21[30021884];AAGAB[25416956];
607181	chr17	2202520	A	G	chr17:2202520	SMG6	SMG6, nonsense mediated mRNA decay factor	9004.0	SNV	0/1	0.4	21_14	35	99	False	rs202060632	EXONIC	YES	NM_017575.5	Transcript	protein_coding	synonymous_variant		2/19	NM_017575.5:c.1527T>C	NP_060045.4:p.Tyr509%3D		-1.0						.	.	.		2.62871e-05	4.0	152166.0	0.0	31	0.96	PASS	amr	0.000130959	2.0	0.0	0.0	1.19732e-05	3.0	250560.0	0.0	100	0.97	PASS	amr	8.68307e-05	3.0	0.0	0.0	0.0000257	4						6.723	0.262502		0	0	0			SMG6	0.0	0.0	0.0	0.0	41.0	-17.0	37.0	32.0						0.24	1.0	50.041217679			embryo phenotype; growth/size/body region phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype; 			caudate nucleus;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA export from nucleus;telomere maintenance via telomerase;regulation of telomere maintenance;regulation of telomere maintenance via telomerase;regulation of dephosphorylation;regulation of RNA stability;regulation of telomerase activity;RNA phosphodiester bond hydrolysis, endonucleolytic;negative regulation of telomere capping	chromosome, telomeric region;nucleus;telomerase holoenzyme complex;nucleolus;cytoplasm;cytosol;exon-exon junction complex	RNA binding;endoribonuclease activity;protein binding;telomeric DNA binding;ribonucleoprotein complex binding;metal ion binding;telomerase RNA binding;DNA polymerase binding	UPF1[21145460];PPP1CC[21382349];TERT[12699629];NEK4[25798074];CBX3[21888893];PHB[30021884];MEOX2[unassigned1304];
607280	chr4	105411979	C	T	chr4:105411979	CXXC4	CXXC finger protein 4	9008.0	SNV	0/1	0.56	17_22	39	99	False	rs185047970	EXONIC	YES	NM_025212.4	Transcript	protein_coding	synonymous_variant		2/3	NM_025212.4:c.981G>A	NP_079488.2:p.Arg327%3D		-1.0						.	.	.		0.000256252	39.0	152194.0	0.0	32	0.97	PASS	amr	0.00065445	10.0	0.000220452	15.0	0.00021874	55.0	251440.0	0.0	83	1.0	PASS	amr	0.000462561	16.0	0.000254954	29.0	0.0001929	30	0.001	3.0				15.26	1.314049		0	0	0			CXXC4	0.0	0.0	0.0	0.0	35.0	9.0	8.0	1.0								65.35274542			.			.	Wnt signaling pathway	zygotic specification of dorsal/ventral axis;Wnt signaling pathway;negative regulation of Wnt signaling pathway	cytoplasm;cytoplasmic vesicle	DNA binding;zinc ion binding;PDZ domain binding	TIA1[26496610];RAD51[26496610];ZNFX1[26496610];BRD9[26496610];PUS7[26496610];GPN3[26496610];
609264	chr22	42524795	A	G	chr22:42524795	CYP2D6	cytochrome P450 family 2 subfamily D member 6	9062.0	SNV	0/1	0.24	35_11	46	99	False	rs28371713,COSV62242916	EXONIC	YES	NM_000106.6	Transcript	protein_coding	synonymous_variant		4/9	NM_000106.6:c.657T>C	NP_000097.3:p.Phe219%3D		-1.0					{Codeine sensitivity}, 608902 (3), Autosomal recessive; {Debrisoquine sensitivity}, 608902 (3), Autosomal recessive	Codeine toxicity;Resistance to tamoxifene;Antidepressant or antipsychotic toxicity or dose selection	Biomarker tested in;Biomarker tested in;Biomarker tested in	Neoplasm;Abnormality of metabolism/homeostasis;Autosomal recessive inheritance	26858644	0.00420823	626.0	148756.0	21.0	32	0.92	PASS	afr	0.00851815	338.0	0.00209024	140.0	0.287005	54124.0	188582.0	112.0	100	0.84	InbreedingCoeff_RF	amr	0.381637	9976.0	0.295157	24648.0	0.0098261	1528	0.075	230.0	0.14656	627.0		0.532	-0.244841		0	0	0			CYP2D6	0.02	0.0	0.0	0.0	45.0	-10.0	-11.0	-9.0							0.0				.			.	Drug metabolism - cytochrome P450;Parkinson's disease	organic acid metabolic process;xenobiotic metabolic process;steroid metabolic process;coumarin metabolic process;alkaloid metabolic process;alkaloid catabolic process;monoterpenoid metabolic process;drug metabolic process;arachidonic acid metabolic process;isoquinoline alkaloid metabolic process;drug catabolic process;exogenous drug catabolic process;long-chain fatty acid biosynthetic process;heterocycle metabolic process;negative regulation of binding;oxidation-reduction process;oxidative demethylation;negative regulation of cellular organofluorine metabolic process	cytoplasm;mitochondrion;endoplasmic reticulum;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle	monooxygenase activity;iron ion binding;drug binding;steroid hydroxylase activity;oxidoreductase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;heme binding;aromatase activity	.
610505	chr7	72873872	T	C	chr7:72873872	BAZ1B	bromodomain adjacent to zinc finger domain 1B	9091.0	SNV	0/1	0.58	14_19	33	99	False	rs141412243	EXONIC	YES	NM_001370402.1	Transcript	protein_coding	synonymous_variant		13/19	NM_001370402.1:c.3426A>G	NP_001357331.1:p.Glu1142%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided		Williams syndrome	Role in the phenotype of	Atrial septal defect;Joint hyperflexibility;Hyperacusis;Abnormality of the ankles;Type II diabetes mellitus;Redundant skin;Abnormal dermatoglyphics;Thick lower lip vermilion;Elevated serum creatine kinase;Cerebral ischemia;Arthralgia;Multiple renal cysts;Joint stiffness;Muscular hypotonia;Hypoplastic toenails;Prematurely aged appearance;Visual impairment;Peptic ulcer;Sudden cardiac death;Sensorineural hearing impairment;Corneal opacity;Aortic arch aneurysm;Hypoplasia of the zygomatic bone;Macrotia;Autism;Short nose;Coarse facial features;Tetralogy of Fallot;Abnormal form of the vertebral bodies;Radioulnar synostosis;Failure to thrive in infancy;Polycystic ovaries;Tremor;Renovascular hypertension;Patellar dislocation;Renal duplication;Abnormal endocardium morphology;Intellectual disability;Nephrocalcinosis;Osteopenia;Abnormality of pelvic girdle bone morphology;Pectus excavatum;Bicuspid aortic valve;Precocious puberty;Abnormality of the gastric mucosa;Phonophobia;Gingival overgrowth;Gastroesophageal reflux;Spasticity;Cholelithiasis;Increased nuchal translucency;Dental malocclusion;Pulmonic stenosis;Down-sloping shoulders;Functional abnormality of male internal genitalia;Genu valgum;Proteinuria;Vesicoureteral reflux;Ventricular septal defect;Posterior embryotoxon;Long philtrum;Scoliosis;Micrognathia;Glaucoma;Joint laxity;Spina bifida occulta;Pointed chin;Abnormality of dental enamel;Dysgraphia;Macroglossia;Cerebral cortical atrophy;Megalocornea;Nausea and vomiting;Blue irides;Dysphonia;Wide mouth;Depressivity;Nephrolithiasis;Malabsorption;Vertebral segmentation defect;Patent ductus arteriosus;Pes planus;Strabismus;Attention deficit hyperactivity disorder;Obsessive-compulsive behavior;Developmental regression;Dysmetria;Obesity;Congestive heart failure;Protruding ear;Periorbital edema;Overfriendliness;Chronic otitis media;Pelvic kidney;Narrow face;Osteoporosis;Abnormal tubulointerstitial morphology;Short stature;Broad forehead;Delayed skeletal maturation;Everted lower lip vermilion;Hypertrophic cardiomyopathy;Cataract;Nevus flammeus;Insomnia;Bladder diverticulum;Overriding aorta;Hypercalcemia;Mitral valve prolapse;Renal hypoplasia;Urethral stenosis;Hyperlordosis;Hoarse voice;Low-set, posteriorly rotated ears;Myopathy;Hypoplasia of penis;Cryptorchidism;Recurrent urinary tract infections;Stroke;Recurrent respiratory infections;Anxiety;Carious teeth;Increased bone mineral density;Abnormal fingernail morphology;Kyphosis;Umbilical hernia;Renal insufficiency;Supravalvular aortic stenosis;Hallux valgus;Abnormal carotid artery morphology;Sacral dimple;High forehead;Myocardial infarction;Clinodactyly of the 5th finger;Microcephaly;Colonic diverticula;Epicanthus;Mitral regurgitation;Abdominal pain;Blepharophimosis;Tracheoesophageal fistula;Adducted thumb;Open bite;Microdontia;Abnormality of the diencephalon;Hypodontia;Hypercalciuria;Flat cornea;Constipation;Wide nasal bridge;Death in early adulthood;Hypothyroidism;Atrophy/Degeneration involving the corticospinal tracts;Retinal arteriolar tortuosity;Rectal prolapse;Abnormal circulating lipid concentration;Abnormality of the neck;Hyperreflexia;Hypogonadotropic hypogonadism;Abnormality of extrapyramidal motor function;Peripheral pulmonary artery stenosis;Dysarthria;Inguinal hernia;Myopia;Aplasia/Hypoplasia of the iris;High hypermetropia;Arnold-Chiari malformation;Nystagmus-induced head nodding;Gait imbalance;Elfin facies;Lacrimation abnormality;Cardiomegaly		0.00189202	288.0	152218.0	0.0	32	0.97	PASS	nfe	0.00354183	241.0	0.00354183	241.0	0.00193617	480.0	247912.0	1.0	56	0.88	PASS	nfe	0.00369145	415.0	0.00369145	415.0	0.0021800	339	0.002	6.0	0.00168	16.0		9.849	0.548618		0	0	0			BAZ1B	0.0	0.0	0.0	0.0	-6.0	9.0	9.0	-6.0						0.245	1.0	0.0			muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; immune system phenotype; skeleton phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			pons;ciliary ganglion;temporal lobe;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;cingulate cortex;parietal lobe;skeletal muscle;globus pallidus;	.	chromatin assembly or disassembly;chromatin remodeling;regulation of transcription by RNA polymerase II;cellular response to DNA damage stimulus;histone phosphorylation;peptidyl-tyrosine phosphorylation;positive regulation of gene expression, epigenetic	condensed chromosome;nucleoplasm;pericentric heterochromatin;nuclear body;nuclear replication fork	protein tyrosine kinase activity;non-membrane spanning protein tyrosine kinase activity;protein binding;ATP binding;zinc ion binding;histone kinase activity;histone binding	IGHM[15174051];RPL10[26496610];HDAC11[23752268];HNRNPU[26496610];BAZ2A[16514417];FBL[29568061];ING3[26496610];HIST1H3A[29568061];HIST1H1E[30021884];LYAR[30021884];EXOSC1[26496610];PHLDA3[17353931];HIST1H1C[30021884];DAXX[26496610];PYHIN1[25665578];SMARCA5[11980720;16514417;30021884];BAZ1A[11980720];RRP1B[20926688];SMARCA1[30021884];NR4A2[20195357];MYH1[16514417];MTNR1A[26514267];POLR1B[16514417];HIST1H2BH[30021884];TRIM33[20603019];
612116	chr1	206516261	C	T	chr1:206516261	SRGAP2	SLIT-ROBO Rho GTPase activating protein 2	9121.0	SNV	0/1	0.3	19_8	27	99	False	rs201036189	EXONIC	YES	NM_015326.5	Transcript	protein_coding	missense_variant		1/20	NM_015326.5:c.64C>T	NP_056141.2:p.Arg22Trp		1.0	FCH domain&F-BAR domain&FCH domain,FCH domain&F-BAR domain&FCH domain,FCH domain&F-BAR domain&FCH domain					.	.	.						19	0.45							0.499667	111138.0	222424.0	1.0	35	0.64	InbreedingCoeff	eas	0.499875	8006.0	0.499593	49050.0	0.0027974	435	0.045	144.0	0.44631	823.0		28.2	4.057073		7	6	13	LRT_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred																		0.999	0.947	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			cerebellum peduncles;cerebellum;	Axon guidance	lamellipodium assembly involved in ameboidal cell migration;signal transduction;cell population proliferation;extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration;negative regulation of cell migration;substrate adhesion-dependent cell spreading;positive regulation of GTPase activity;filopodium assembly;neuron projection morphogenesis;actin filament severing;regulation of small GTPase mediated signal transduction;negative regulation of cell death;dendritic spine development;negative regulation of neuron migration	nucleus;cytoplasm;cytosol;plasma membrane;postsynaptic density;lamellipodium;cell junction;dendritic spine head;postsynaptic membrane;phagocytic vesicle	GTPase activator activity;protein binding;identical protein binding;protein homodimerization activity;Rac GTPase binding	RTKN[unassigned1312];YWHAB[24255178];MAST3[unassigned1312];CEP19[26638075];DENND1A[unassigned1312];ZBTB21[unassigned1312];CBY1[unassigned1312];TESK2[unassigned1312];FASLG[16318909;19807924];GPHN[26365803];EDC3[unassigned1312];ROBO1[26365803];RPTOR[unassigned1312];FAM110A[unassigned1312];SRGAP2C[22559944];SYDE1[unassigned1312];PCM1[26638075];SIPA1L1[unassigned1312];SH3PXD2A[unassigned1312];CHEK1[unassigned1312];FAM110B[unassigned1312];FAM53C[unassigned1312];KIF13B[unassigned1312];KIF1C[unassigned1312];KIF1B[unassigned1312];RAC1[20810653];YWHAG[15324660;17353931];YWHAH[17979178];RALGPS2[unassigned1312];MAGI1[unassigned1312];PRMT5[20810653];KSR1[unassigned1312];NAV1[unassigned1312];KCTD3[unassigned1312];GAB2[unassigned1312];CDC25C[unassigned1312];YWHAZ[15161933];HIST2H2BF[30021884];TANC2[unassigned1312];CDC25B[unassigned1312];TIAM1[unassigned1312];GIGYF1[unassigned1312];DEPDC1B[unassigned1312];MELK[unassigned1312];ZNF638[unassigned1312];TBC1D25[unassigned1312];EIF4E2[unassigned1312];AURKAIP1[29568061];EZR[29568061];PHLDB2[unassigned1312];UBA52[30021884];HDAC4[unassigned1312];MAPKAP1[unassigned1312];PPM1H[unassigned1312];HTT[17500595];AGAP1[unassigned1312];RASAL2[unassigned1312];GIGYF2[unassigned1312];CAMSAP2[unassigned1312];HDAC7[unassigned1312];LIMA1[unassigned1312];PAK1[20810653];LARP1[unassigned1312];INPP5E[unassigned1312];MAP3K21[unassigned1312];SH3BP4[unassigned1312];DISC1[17043677];SRGAP2[20810653;26365803];RAB11FIP2[unassigned1312];NADK[unassigned1312];SRSF12[unassigned1312];ANKRD34A[unassigned1312];STARD13[unassigned1312];OSBPL6[unassigned1312];DENND4A[unassigned1312];USP21[unassigned1312];DENND4C[unassigned1312];RAB3IP[unassigned1312];PLEKHA5[unassigned1312];YLPM1[26365803];CGN[unassigned1312];PTPN13[unassigned1312];PTPN14[unassigned1312];DCLK1[unassigned1312];PLEKHA7[unassigned1312];SH3RF3[unassigned1312];AFDN[unassigned1312];FMNL1[21148482];LRFN1[unassigned1312];NF1[unassigned1312];LPIN3[unassigned1312];CDK16[unassigned1312];
612430	chr1	206566904	T	C	chr1:206566904	SRGAP2	SLIT-ROBO Rho GTPase activating protein 2	9121.0	SNV	0/1	0.47	31_28	59	99	False	rs2919105,COSV55332743	SPLICING	YES	NM_015326.5	Transcript	protein_coding	splice_region_variant,synonymous_variant		4/20	NM_015326.5:c.447T>C	NP_056141.2:p.Arg149%3D		1.0						.	.	.		3.97498e-05	6.0	150944.0	0.0	20	0.53	PASS	afr	0.00014595	6.0	0.0	0.0	0.499907	123253.0	246552.0	1.0	66	1.0	InbreedingCoeff	eas	0.499943	8844.0	0.499893	55815.0	0.0313175	4870	0.212	679.0	0.47722	880.0		17.08	1.637898		0	0	0														11.177	-0.139	11.039						mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			cerebellum peduncles;cerebellum;	Axon guidance	lamellipodium assembly involved in ameboidal cell migration;signal transduction;cell population proliferation;extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration;negative regulation of cell migration;substrate adhesion-dependent cell spreading;positive regulation of GTPase activity;filopodium assembly;neuron projection morphogenesis;actin filament severing;regulation of small GTPase mediated signal transduction;negative regulation of cell death;dendritic spine development;negative regulation of neuron migration	nucleus;cytoplasm;cytosol;plasma membrane;postsynaptic density;lamellipodium;cell junction;dendritic spine head;postsynaptic membrane;phagocytic vesicle	GTPase activator activity;protein binding;identical protein binding;protein homodimerization activity;Rac GTPase binding	RTKN[unassigned1312];YWHAB[24255178];MAST3[unassigned1312];CEP19[26638075];DENND1A[unassigned1312];ZBTB21[unassigned1312];CBY1[unassigned1312];TESK2[unassigned1312];FASLG[16318909;19807924];GPHN[26365803];EDC3[unassigned1312];ROBO1[26365803];RPTOR[unassigned1312];FAM110A[unassigned1312];SRGAP2C[22559944];SYDE1[unassigned1312];PCM1[26638075];SIPA1L1[unassigned1312];SH3PXD2A[unassigned1312];CHEK1[unassigned1312];FAM110B[unassigned1312];FAM53C[unassigned1312];KIF13B[unassigned1312];KIF1C[unassigned1312];KIF1B[unassigned1312];RAC1[20810653];YWHAG[15324660;17353931];YWHAH[17979178];RALGPS2[unassigned1312];MAGI1[unassigned1312];PRMT5[20810653];KSR1[unassigned1312];NAV1[unassigned1312];KCTD3[unassigned1312];GAB2[unassigned1312];CDC25C[unassigned1312];YWHAZ[15161933];HIST2H2BF[30021884];TANC2[unassigned1312];CDC25B[unassigned1312];TIAM1[unassigned1312];GIGYF1[unassigned1312];DEPDC1B[unassigned1312];MELK[unassigned1312];ZNF638[unassigned1312];TBC1D25[unassigned1312];EIF4E2[unassigned1312];AURKAIP1[29568061];EZR[29568061];PHLDB2[unassigned1312];UBA52[30021884];HDAC4[unassigned1312];MAPKAP1[unassigned1312];PPM1H[unassigned1312];HTT[17500595];AGAP1[unassigned1312];RASAL2[unassigned1312];GIGYF2[unassigned1312];CAMSAP2[unassigned1312];HDAC7[unassigned1312];LIMA1[unassigned1312];PAK1[20810653];LARP1[unassigned1312];INPP5E[unassigned1312];MAP3K21[unassigned1312];SH3BP4[unassigned1312];DISC1[17043677];SRGAP2[20810653;26365803];RAB11FIP2[unassigned1312];NADK[unassigned1312];SRSF12[unassigned1312];ANKRD34A[unassigned1312];STARD13[unassigned1312];OSBPL6[unassigned1312];DENND4A[unassigned1312];USP21[unassigned1312];DENND4C[unassigned1312];RAB3IP[unassigned1312];PLEKHA5[unassigned1312];YLPM1[26365803];CGN[unassigned1312];PTPN13[unassigned1312];PTPN14[unassigned1312];DCLK1[unassigned1312];PLEKHA7[unassigned1312];SH3RF3[unassigned1312];AFDN[unassigned1312];FMNL1[21148482];LRFN1[unassigned1312];NF1[unassigned1312];LPIN3[unassigned1312];CDK16[unassigned1312];
613322	chr7	142458451	A	T	chr7:142458451	PRSS1	serine protease 1	9144.0	SNV	0/1	0.24	35_12	49	99	False	rs111033566,CM021670,CM971250,COSV61191509	EXONIC	YES	NM_002769.5	Transcript	protein_coding	missense_variant		2/5	NM_002769.5:c.86A>T	NP_002760.1:p.Asn29Ile		1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain	Pathogenic	criteria_provided,_multiple_submitters,_no_conflicts	Hereditary_pancreatitis|Vitamin_D-dependent_rickets_type_II_with_alopecia|Trypsinogen_deficiency|Inborn_genetic_diseases|not_specified	Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification	22379635,10204851,185115,6023921,9322498,9633818,10835640,10872414,10982192,11719509,11788572,11842279,11950817,12011155,12853682,15028953,16632094,21415673,22539344,24002981					37	0.95							0.283147	44150.0	155926.0	0.0	100	1.0	InbreedingCoeff	sas	0.319222	5550.0	0.312187	23035.0	0.0030996	482	0.11	353.0	0.01233	139.0		16.97	1.619389	0.152	5	12	17	LRT_pred,MutationTaster_pred,FATHMM_pred,DEOGEN2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	PRSS1	0.0	0.01	0.0	0.0	11.0	29.0	28.0	2.0						0.125	0.0		0.106	0.02	.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];
613323	chr7	142458486	C	T	chr7:142458486	PRSS1	serine protease 1	9144.0	SNV	0/1	0.15	38_7	47	99	False	rs369646357,COSV61191036	EXONIC	YES	NM_002769.5	Transcript	protein_coding	synonymous_variant		2/5	NM_002769.5:c.121C>T	NP_002760.1:p.Leu41%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Hereditary_pancreatitis|Inborn_genetic_diseases|not_provided	Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification		0.000351716	50.0	142160.0	0.0	37	0.96	AS_VQSR	nfe	0.000482971	31.0	0.000482971	31.0	0.000114799	28.0	243904.0	1.0	100	1.0	RF	afr	0.000440973	7.0	0.000172282	19.0	0.0002058	32	0.006	19.0	0.01462	165.0		10.07	0.572117		0	0	0			PRSS1	0.0	0.01	0.01	0.0	-7.0	-6.0	-7.0	46.0						0.125	0.0				.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];
613388	chr7	142460335	A	G	chr7:142460335	PRSS1	serine protease 1	9144.0	SNV	0/1	0.24	34_11	46	99	False	rs201550522,CM138023,COSV61190021	EXONIC	YES	NM_002769.5	Transcript	protein_coding	missense_variant		4/5	NM_002769.5:c.508A>G	NP_002760.1:p.Lys170Glu		1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Hereditary_pancreatitis|Inborn_genetic_diseases|not_specified	Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification	31510946	0.000322034	49.0	152158.0	2.0	40	0.98	PASS	sas	0.00892857	43.0	0.0	0.0	0.418793	98150.0	234364.0	2.0	100	1.0	InbreedingCoeff	nfe	0.433882	46618.0	0.433882	46618.0	0.0081413	1266	0.115	362.0	0.42504	4848.0		0.001	-1.424741	0.115	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS1	0.0	0.0	0.0	0.0	10.0	-41.0	47.0	1.0						0.125	0.0		0.0	-6.171	.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];
613389	chr7	142460369	G	A	chr7:142460369	PRSS1	serine protease 1	9144.0	SNV	0|1	0.24	35_11	46	99	False	rs201719096,COSV61190000	EXONIC	YES	NM_002769.5	Transcript	protein_coding	missense_variant		4/5	NM_002769.5:c.542G>A	NP_002760.1:p.Ser181Asn		1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain	Benign	no_assertion_criteria_provided	Hereditary_pancreatitis|not_specified	Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification		6.57281e-05	10.0	152142.0	0.0	40	0.98	PASS	eas	0.00116777	6.0	1.46972e-05	1.0	0.3847	72676.0	188916.0	0.0	100	1.0	InbreedingCoeff_RF	nfe	0.412377	38149.0	0.412377	38149.0	0.0038906	605	0.11	348.0	0.42679	4868.0		0.168	-0.410767	0.014	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS1	0.0	0.0	0.0	0.01	29.0	1.0	32.0	49.0						0.125	0.0		0.0	-1.318	.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];
613399	chr7	142460744	G	C	chr7:142460744	PRSS1	serine protease 1	9144.0	SNV	0|1	0.2	28_7	35	99	False	rs150930992,COSV61190193	EXONIC	YES	NM_002769.5	Transcript	protein_coding	missense_variant		5/5	NM_002769.5:c.617G>C	NP_002760.1:p.Cys206Ser		1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain	Benign	criteria_provided,_single_submitter	Hereditary_pancreatitis	Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification						37	0.97							0.000328605	70.0	213022.0	0.0	100	1.0	RF	afr	0.00137652	17.0	0.000362334	35.0	0.0023086	359	0.026	78.0	0.01572	179.0		21.1	2.151828	0.481	12	5	17	SIFT,PolyPhen,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred	PRSS1	0.0	0.0	0.0	0.0	11.0	-25.0	-25.0	-5.0						0.125	0.0		0.092	-1.355	.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];
613400	chr7	142460752	C	G	chr7:142460752	PRSS1	serine protease 1	9144.0	SNV	0|1	0.19	28_7	36	99	False	rs140793689,COSV61190202	EXONIC	YES	NM_002769.5	Transcript	protein_coding	missense_variant		5/5	NM_002769.5:c.625C>G	NP_002760.1:p.Gln209Glu		1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain				Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification						36	0.97							0.000174013	37.0	212628.0	0.0	100	1.0	RF	afr	0.000558927	7.0	0.000145382	14.0	0.0023536	366	0.015	46.0	0.01466	167.0		0.001	-1.180296	0.014	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS1	0.0	0.0	0.0	0.0	1.0	3.0	-33.0	3.0						0.125	0.0		0.0	-3.751	.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];
614566	chr7	142562052		CCTCCT	chr7:142562051-142562052	EPHB6	EPH receptor B6	9159.0	insertion	0/1	0.55	14_17	31	99	False	rs143667567	EXONIC	YES	NM_004445.6	Transcript	protein_coding	inframe_insertion		7/20	NM_004445.6:c.513_518dup	NP_004436.4:p.Ser175_Ser176dup		1.0						.	.	.		0.00162036	244.0	150584.0	0.0	14	0.46	PASS	afr	0.00527763	215.0	0.000118256	8.0					100	0.99							0.0000707,0.0090994,0.0003151	11,1415,49			0.07505	856.0					0	0	0																	0.241	0.25	57.273198959			cellular phenotype; normal phenotype; reproductive system phenotype; hematopoietic system phenotype; immune system phenotype; 			.	Axon guidance	transmembrane receptor protein tyrosine kinase signaling pathway;axon guidance;peptidyl-tyrosine phosphorylation;ephrin receptor signaling pathway	extracellular region;cytosol;plasma membrane;integral component of plasma membrane;neuron projection;receptor complex	protein tyrosine kinase activity;transmembrane receptor protein tyrosine kinase activity;ephrin receptor activity;transmembrane-ephrin receptor activity;ATP binding;signaling receptor activity	SMAD2[20195357];PRMT5[unassigned1304];HSP90AB1[22939624];MSX2[unassigned1304];INCA1[25416956;unassigned1304];POU6F2[unassigned1304];DDIT4L[unassigned1304];ASB12[unassigned1304];NOTCH2NLA[25416956];SAT1[16169070];AFDN[9707552];NIF3L1[25416956];BCL6[16147992];TRIM39[25416956;unassigned1304];MARC1[unassigned1304];REL[25416956;unassigned1304];TCF4[25416956;unassigned1304];TRIB3[unassigned1304];TEKT5[unassigned1304];GLYR1[unassigned1304];
614812	chr22	19494970	A	C	chr22:19494970	CDC45	cell division cycle 45	9171.0	SNV	0/1	0.59	13_19	32	99	False		EXONIC	YES	NM_001178010.2	Transcript	protein_coding	missense_variant		12/20	NM_001178010.2:c.982A>C	NP_001171481.1:p.Thr328Pro		1.0	.,.,.,.				Meier-Gorlin syndrome 7, 617063 (3), Autosomal recessive	Ear-patella-short stature syndrome	Disease-causing germline mutation(s) (loss of function) in	Hearing impairment;Myopia;Clubbing;Urethral stricture;Thin eyebrow;Proptosis;Atrial septal defect;High palate;Duodenal stenosis;Arnold-Chiari type I malformation;Choanal atresia;Clitoral hypertrophy;Decreased body weight;Pulmonary hypoplasia;Anal stenosis;Scoliosis;Aplasia/Hypoplasia of the patella;Complete atrioventricular canal defect;Cleft palate;Ventricular septal defect;2-3 toe syndactyly;Short stature;Strabismus;Narrow mouth;Microtia;Hypospadias;Vesicoureteral reflux;Sagittal craniosynostosis;Bowing of the legs;Joint laxity;Wide anterior fontanel;Autosomal recessive inheritance;Cryptorchidism;Preaxial polydactyly;Progressive microcephaly;Micropenis;Anal atresia;Global developmental delay;Hypoplastic labia minora;Micrognathia;Hypoplasia of penis;Mandibular aplasia;Posteriorly rotated ears;Elbow dislocation;Breast aplasia;Global developmental delay;Atresia of the external auditory canal;Delayed skeletal maturation;Severe short stature;Cryptorchidism;Intrauterine growth retardation;Low-set ears;Abnormality of epiphysis morphology;Thick vermilion border;Hypoplastic labia majora;Joint hyperflexibility;Respiratory failure;Patellar aplasia;Microtia, third degree;Anotia;Hearing impairment;Failure to thrive;Clinodactyly of the 5th finger;Bifid uvula;Camptodactyly of finger;Craniosynostosis;Aplastic clavicle;Hypospadias;Abnormality of the ribs;Hypoplasia of the maxilla;Respiratory distress;Narrow mouth;High, narrow palate;Epispadias;Clitoral hypoplasia;Submucous cleft hard palate;Retrognathia;Microcephaly;Slender long bone;Feeding difficulties;Intellectual disability;Clitoral hypertrophy;Specific learning disability						33	0.98											97	1.0														23.3	2.860362	0.402	9	10	19	LRT_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,LIST-S2_pred	CDC45	0.19	0.09	0.0	0.0	7.0	-19.0	10.0	22.0							0.07	0.000000000	0.755	1.312	embryo phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype; 			tumor;	Cell cycle	DNA replication checkpoint;G1/S transition of mitotic cell cycle;regulation of transcription involved in G1/S transition of mitotic cell cycle;double-strand break repair via break-induced replication;DNA replication;DNA replication initiation;regulation of chromatin silencing at telomere;DNA duplex unwinding;positive regulation of G1/S transition of mitotic cell cycle;mitotic DNA replication preinitiation complex assembly	nucleus;nucleoplasm;nuclear pre-replicative complex;cytoplasm;centrosome;DNA replication preinitiation complex;replication fork protection complex	chromatin binding;DNA replication origin binding;single-stranded DNA binding;protein binding;3'-5' DNA helicase activity	L3MBTL1[21149733];CDKN1A[15232106;25241761];MCM10[15232106];PDS5B[22293751];BRCA2[22293751];CIAO1[17353931];ORC5[15232106];PPP4C[17353931];ORC3[15232106];POLD1[23910567];TOPBP1[17887956];CLSPN[23910567];CEP55[25416956;unassigned1304];TRAPPC3[21988832];ZRANB1[unassigned1304];TSC22D1[17353931];CDKN2A[15232106];GINS4[19805216];RPA2[23910567];DDIT4L[unassigned1304];ALB[15174051];MCM6[19805216];SQSTM1[20562859];CAMK1G[21988832];MCM2[19805216;26167883];
614887	chr5	139815809	C	G	chr5:139815809	ANKHD1-EIF4EBP3	ANKHD1-EIF4EBP3 readthrough	9175.0	SNV	0/1	0.51	18_19	37	99	False	rs61758138,COSV51843433	EXONIC	YES	NM_020690.6	Transcript	protein_coding	missense_variant		2/36	NM_020690.6:c.427C>G	NP_065741.3:p.Gln143Glu		1.0	.,.,.,.,.,.,.					.	.	.	29197136	0.00477705	727.0	152186.0	6.0	32	0.97	PASS	nfe	0.00657063	447.0	0.00657063	447.0	0.00517692	1200.0	231798.0	6.0	23	0.58	PASS	nfe	0.00718437	764.0	0.00718437	764.0	0.0051188	796	0.003	10.0				25.2	3.548963	0.401	10	11	21	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	ANKHD1-EIF4EBP3	0.0	0.0	0.0	0.0	-35.0	3.0	33.0	2.0							1.0	0.000000000,0.000000000	1.0	1.026	.			.	.	.	.	.	.
616077	chr7	140374064	G	C	chr7:140374064	ADCK2	aarF domain containing kinase 2	9202.0	SNV	0/1	0.6	14_21	35	99	False	rs140400082,COSV99301481	SPLICING	YES	NM_052853.4	Transcript	protein_coding	splice_donor_variant	1/7		NM_052853.4:c.933+1G>C			1.0						.	.	.		0.00281985	429.0	152136.0	1.0	32	0.96	PASS	amr	0.00445318	68.0	0.00408631	278.0	0.00363953	889.0	244262.0	2.0	46	0.85	PASS	nfe	0.00541635	591.0	0.00541635	591.0	0.0040321	627	0.007	23.0				33.0	5.149976		0	0	0			ADCK2	0.0	0.0	0.08	0.97	5.0	-5.0	8.0	-1.0	0.999989917668626	0.924	1.449	8.273	9.722	0.896	0.0				homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			subthalamic nucleus;whole brain;dorsal root ganglion;trigeminal ganglion;skin;superior cervical ganglion;atrioventricular node;parietal lobe;skeletal muscle;adrenal cortex;globus pallidus;	.	protein phosphorylation	integral component of membrane	protein serine/threonine kinase activity;protein binding;ATP binding	STOML2[27499296];ARF1[27499296];CHCHD3[27499296];ADCK1[27499296];C1QBP[27499296];IMMT[27499296];COQ8A[27499296];MLYCD[27499296];SLC25A5[27499296];TOMM5[27499296];
617280	chr2	132905706	A	G	chr2:132905706	ANKRD30BL	ankyrin repeat domain 30B like	9213.0	SNV	0|1	0.29	27_11	38	99	False	rs142209162,COSV54614223	EXONIC	YES	NM_001358416.1	Transcript	protein_coding	stop_lost		6/6	NM_001358416.1:c.775T>C	NP_001345345.1:p.Ter259GlnextTer29		-1.0						.	.	.						28	0.87							0.0545953	4618.0	84586.0	0.0	57	0.71	RF	amr	0.0801333	1010.0	0.0598195	2042.0	0.0002058	32	0.031	88.0				2.794	0.011139		0	4	4		MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	ANKRD30BL	0.0	0.0	0.0	0.0	-3.0	-27.0	-44.0	-8.0									0.025	0.329	.			.	.	.	.	.	.
621637	chr10	5683848	G	A	chr10:5683848	ASB13	ankyrin repeat and SOCS box containing 13	9284.0	SNV	0/1	0.67	8_16	24	99	False	rs61756319,COSV63092127	EXONIC	YES	NM_024701.4	Transcript	protein_coding	synonymous_variant		5/6	NM_024701.4:c.594C>T	NP_078977.2:p.Ile198%3D		-1.0						.	.	.		0.00254948	388.0	152188.0	0.0	32	0.95	PASS	amr	0.00634651	97.0	0.00342446	233.0	0.00249789	628.0	251412.0	0.0	67	0.99	PASS	amr	0.00390467	135.0	0.00353463	402.0	0.0028231	439	0.012	39.0				6.114	0.218699		0	0	0			ASB13	0.0	0.0	0.0	0.0	-16.0	20.0	21.0	-14.0						0.431	0.26	2.479659119			.			liver;	.	protein ubiquitination;intracellular signal transduction;post-translational protein modification	cytosol	protein binding	VAC14[25416956;unassigned1304];KRTAP11-1[unassigned1304];ZNF581[unassigned1304];KRTAP15-1[unassigned1304];POU6F2[unassigned1304];DNM1[16169070];NUDT3[16169070;21900206];HAPLN2[unassigned1304];DUSP23[21900206];ZMIZ2[25416956];OXER1[unassigned1304];UBAP2[unassigned1304];TRIP13[16189514;unassigned1304];HIF1AN[16189514;26972000];MARK3[16169070];
623070	chr12	26275827	C	G	chr12:26275827	BHLHE41	basic helix-loop-helix family member e41	9317.0	SNV	0/1	0.4	18_12	30	99	False	rs61754129,COSV99658260	EXONIC	YES	NM_030762.3	Transcript	protein_coding	synonymous_variant		5/5	NM_030762.3:c.621G>C	NP_110389.1:p.Ala207%3D		-1.0					[Short sleep, familial natural, 1], 612975 (3), Autosomal dominant	.	.	.		0.00466211	707.0	151648.0	2.0	31	0.95	PASS	sas	0.00958733	46.0	0.00621722	422.0	0.00717013	1063.0	148254.0	11.0	21	0.52	PASS	sas	0.0125209	284.0	0.00655945	363.0	0.0037169	578	0.006	21.0	0.00606	69.0		11.02	0.683707		0	0	0			BHLHE41	0.0	0.0	0.0	0.0	-7.0	-46.0	-30.0	31.0								72.332221163			hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; 			caudate nucleus;amygdala;occipital lobe;prefrontal cortex;whole brain;spinal cord;cerebellum;hypothalamus;medulla oblongata;	Circadian rhythm	negative regulation of transcription by RNA polymerase II;somitogenesis;Notch signaling pathway;cell population proliferation;animal organ morphogenesis;negative regulation of myotube differentiation;negative regulation of transcription by competitive promoter binding;cell differentiation;circadian regulation of gene expression;negative regulation of transcription, DNA-templated;regulation of neurogenesis	nucleus	RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II activating transcription factor binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;transcription corepressor activity;protein binding;transcription factor binding;protein homodimerization activity;histone deacetylase binding;bHLH transcription factor binding;MRF binding;sequence-specific DNA binding;protein heterodimerization activity;E-box binding;sequence-specific double-stranded DNA binding	KLC3[26496610];CDCA5[26496610];MKNK2[26496610];MYH13[26496610];ATM[26496610];VPS26A[26496610];POLK[26496610];HIF1A[22801492];LLGL2[26496610];
625237	chr1	12907282	G	C	chr1:12907282	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.28	28_11	40	99	False	rs139731855,COSV58609836	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.861C>G	NP_001013653.1:p.Thr287%3D		-1.0						.	.	.						30	0.87							0.0914692	13094.0	143152.0	68.0	100	1.0	InbreedingCoeff_RF	nfe	0.098475	5605.0	0.098475	5605.0	0.0002444	38	0.073	213.0				0.359	-0.3028		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	-10.0	-30.0	-33.0	-9.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625238	chr1	12907284	T	C	chr1:12907284	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.28	28_11	40	99	False	rs149796618,COSV58609567	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.859A>G	NP_001013653.1:p.Thr287Ala		-1.0						.	.	.						30	0.87							0.143169	18338.0	128086.0	284.0	100	1.0	InbreedingCoeff	nfe	0.165754	8538.0	0.165754	8538.0	0.0002508	39	0.071	205.0				0.092	-0.494748	0.095	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-34.0	-12.0	-35.0	-30.0						0.881	0.01		0.002	-2.207	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625239	chr1	12907285	G	C	chr1:12907285	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.28	28_11	40	99	False	rs148930640,COSV58609633	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.858C>G	NP_001013653.1:p.Ser286Arg		-1.0						.	.	.						30	0.87							0.0876991	12575.0	143388.0	69.0	100	1.0	InbreedingCoeff	nfe	0.0941591	5365.0	0.0941591	5365.0	0.0002379	37	0.072	208.0				6.689	0.259995	0.18	2	14	16	SIFT,MutationTaster_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-26.0	-13.0	-31.0	-36.0						0.881	0.01		0.002	0.262	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625240	chr1	12907316	T	C	chr1:12907316	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0/1	0.29	23_10	34	99	False	rs112607517,COSV58609639	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.827A>G	NP_001013653.1:p.Glu276Gly		-1.0						.	.	.		1.33216e-05	2.0	150132.0	0.0	30	0.87	PASS	nfe	2.95779e-05	2.0	2.95779e-05	2.0	0.0851479	12529.0	147144.0	57.0	100	1.0	RF	afr	0.0968827	864.0	0.0888032	5344.0	0.0012218	190	0.051	155.0				17.07	1.635624	0.116	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-8.0	45.0	23.0	-38.0						0.881	0.01		0.009	-0.83	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625241	chr1	12907350	C	T	chr1:12907350	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.28	20_8	29	99	False	rs2359486,COSV58609648	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.793G>A	NP_001013653.1:p.Asp265Asn		-1.0						.	.	.						30	0.86							0.0224513	3199.0	142486.0	38.0	100	1.0	RF	amr	0.0542169	1188.0	0.0176183	1046.0	0.0018006	280	0.025	79.0				12.13	0.822435	0.134	1	16	17	SIFT	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-21.0	11.0	22.0	5.0						0.881	0.01		0.005	0.238	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625242	chr1	12907351	A	G	chr1:12907351	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.28	20_8	29	99	False	rs2359485,COSV58612832	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.792T>C	NP_001013653.1:p.Asp264%3D		-1.0						.	.	.						30	0.86							0.0229617	3255.0	141758.0	38.0	100	1.0	PASS	amr	0.0549027	1196.0	0.0182883	1080.0	0.0017942	279	0.025	78.0				0.332	-0.314057		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	10.0	-7.0	-11.0	21.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625243	chr1	12907370	A	T	chr1:12907370	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.25	17_6	24	99	False	rs2076063,COSV58609657	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.773T>A	NP_001013653.1:p.Val258Asp		-1.0						.	.	.		4.00673e-05	6.0	149748.0	0.0	30	0.86	PASS	sas	0.000214777	1.0	4.4426e-05	3.0	0.060616	6680.0	110202.0	362.0	100	1.0	InbreedingCoeff_RF	amr	0.131638	2216.0	0.0569163	2570.0	0.0018520	288	0.019	60.0				8.506	0.410086	0.074	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-26.0	-9.0	50.0	2.0						0.881	0.01		0.004	-0.84	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625244	chr1	12907380	C	A	chr1:12907380	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.18	17_4	22	99	False	rs141207681,COSV58609675	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.763G>T	NP_001013653.1:p.Asp255Tyr		-1.0						.	.	.						30	0.86							0.00537224	1197.0	222812.0	60.0	100	1.0	RF	amr	0.0202795	621.0	0.00203436	207.0	0.0016913	263	0.002	5.0				17.61	1.719663	0.216	4	13	17	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-19.0	29.0	2.0	-8.0						0.881	0.01		0.002	0.238	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625245	chr1	12907385	G	A	chr1:12907385	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.17	15_3	18	81	False	rs150590256,COSV58609612	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.758C>T	NP_001013653.1:p.Pro253Leu		-1.0						.	.	.						30	0.86							0.00922345	1798.0	194938.0	132.0	100	1.0	PASS	amr	0.0318678	835.0	0.00466561	413.0	0.1323760	20585	0.08	254.0				5.359	0.168265	0.175	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-41.0	-24.0	-13.0	35.0						0.881	0.01		0.001	-0.739	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625246	chr1	12907400	G	A	chr1:12907400	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.16	16_3	19	78	False	rs149302457,COSV58611257	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.743C>T	NP_001013653.1:p.Ala248Val		-1.0						.	.	.						30	0.86							0.00859993	1886.0	219304.0	80.0	100	1.0	RF	amr	0.0272279	828.0	0.00411733	411.0	0.0424684	6604	0.004	13.0				22.0	2.293508	0.163	4	13	17	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-39.0	9.0	38.0	-28.0						0.881	0.01		0.005	0.268	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625247	chr1	12907408	T	A	chr1:12907408	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.16	16_3	19	78	False	rs146075045,COSV58611265	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.735A>T	NP_001013653.1:p.Glu245Asp		-1.0						.	.	.						30	0.86							0.0101337	2167.0	213842.0	100.0	100	1.0	RF	amr	0.0310067	908.0	0.00521901	509.0	0.0809433	12587	0.004	13.0				0.003	-0.985592	0.014	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	1.0	-47.0	12.0	30.0						0.881	0.01		0.002	-0.751	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625248	chr1	12907438	A	G	chr1:12907438	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.23	17_5	22	99	False	rs115476478,COSV58609795	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.705T>C	NP_001013653.1:p.His235%3D		-1.0						.	.	.						30	0.86							0.0171505	3710.0	216320.0	100.0	100	1.0	PASS	amr	0.040272	1208.0	0.0109528	1079.0	0.0009968	155	0.008	24.0				0.367	-0.299327		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	-29.0	5.0	7.0	0.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625249	chr1	12907446	C	T	chr1:12907446	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.29	17_7	24	99	False	rs116578678,COSV58612137	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.697G>A	NP_001013653.1:p.Glu233Lys		-1.0						.	.	.						30	0.86							0.023954	5186.0	216498.0	109.0	100	1.0	RF	amr	0.0491588	1461.0	0.0170038	1681.0	0.0009775	152	0.002	7.0				14.69	1.206582	0.146	0	16	16		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-3.0	-37.0	3.0	1.0						0.881	0.01		0.001	0.238	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625250	chr1	12907450	T	C	chr1:12907450	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.33	16_8	24	99	False	rs148279364	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.693A>G	NP_001013653.1:p.Lys231%3D		-1.0						.	.	.						30	0.86							0.0236462	5103.0	215806.0	109.0	100	1.0	RF	amr	0.0489435	1450.0	0.0166528	1643.0	0.0009325	145	0.002	7.0				1.505	-0.089739		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	-1.0	-2.0	-12.0	4.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625252	chr1	12907458	T	A	chr1:12907458	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.33	18_9	27	99	False	rs200282759,COSV58609578,COSV58610987	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.685A>T	NP_001013653.1:p.Met229Leu		-1.0						.	.	.						30	0.86							0.0223289	4757.0	213042.0	111.0	100	1.0	PASS	amr	0.0482474	1393.0	0.0155591	1519.0	0.0007974	124	0.002	6.0				0.632	-0.219265	0.08	0	17	17		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	12.0	7.0	43.0	-20.0						0.881	0.01		0.001	-0.874	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625253	chr1	12907465	A	G	chr1:12907465	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.34	19_10	29	99	False	rs75730135,COSV58612164	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.678T>C	NP_001013653.1:p.Ser226%3D		-1.0						.	.	.						30	0.86							0.020688	4383.0	211862.0	117.0	100	1.0	RF	amr	0.0465741	1335.0	0.0140124	1361.0	0.0017684	275	0.002	6.0				5.945	0.207063		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.01	-17.0	-36.0	-27.0	42.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625254	chr1	12907469	C	G	chr1:12907469	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.37	19_11	30	99	False	rs200710956,COSV58612173	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.674G>C	NP_001013653.1:p.Ser225Thr		-1.0						.	.	.						30	0.86							0.0201771	4297.0	212964.0	119.0	100	1.0	RF	amr	0.0455331	1317.0	0.0134603	1312.0	0.0008424	131	0.002	6.0				14.88	1.242055	0.093	1	16	17	MutationTaster_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	1.0	-4.0	32.0	38.0						0.881	0.01		0.012	0.238	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625255	chr1	12907483	T	A	chr1:12907483	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0/1	0.35	20_11	31	99	False	rs142509787,COSV58612182	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.660A>T	NP_001013653.1:p.Ser220%3D		-1.0						.	.	.						30	0.86							0.0266759	5711.0	214088.0	132.0	100	1.0	PASS	amr	0.052336	1519.0	0.0200476	1970.0	0.0007009	109	0.002	6.0				6.527	0.248111		0	0	0			HNRNPCL1	0.0	0.0	0.01	0.0	41.0	-2.0	24.0	4.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625256	chr1	12907495	T	C	chr1:12907495	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.33	22_11	33	99	False	rs6669073,COSV58609619	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.648A>G	NP_001013653.1:p.Lys216%3D		-1.0						.	.	.						30	0.86							0.0378919	8125.0	214426.0	134.0	100	1.0	RF	amr	0.0645675	1823.0	0.0316048	3134.0	0.0027974	435	0.002	6.0				0.829	-0.178564		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.01	29.0	-10.0	6.0	12.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625257	chr1	12907498	C	T	chr1:12907498	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.33	22_11	33	99	False	rs6702440,COSV58610500,COSV58614335	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.645G>A	NP_001013653.1:p.Val215%3D		-1.0						.	.	.		1.33308e-05	2.0	150028.0	0.0	30	0.86	PASS	eas	0.000388651	2.0	0.0	0.0	0.0390672	8360.0	213990.0	137.0	100	1.0	PASS	amr	0.0662079	1857.0	0.0328171	3255.0	0.0028102	437	0.002	6.0				2.06	-0.040385		0	0	0			HNRNPCL1	0.0	0.0	0.07	0.0	-17.0	26.0	3.0	-11.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625258	chr1	12907513	T	C	chr1:12907513	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.36	21_12	33	99	False	rs201121299,COSV58612123,COSV58612215	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.630A>G	NP_001013653.1:p.Lys210%3D		-1.0						.	.	.						30	0.86							0.047697	10308.0	216114.0	143.0	100	1.0	PASS	afr	0.0792256	974.0	0.0412953	4142.0	0.0012797	199	0.001	3.0				5.778	0.195797		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	11.0	-5.0	-12.0	-6.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625259	chr1	12907518	T	A	chr1:12907518	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.33	22_11	33	99	False	rs201750607,COSV58611281	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.625A>T	NP_001013653.1:p.Ser209Cys		-1.0						.	.	.						30	0.86							0.0455548	9792.0	214950.0	146.0	100	0.99	RF	afr	0.0762446	925.0	0.0391372	3903.0	0.0012411	193	0.001	3.0				22.5	2.46992	0.169	5	13	18	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	48.0	-2.0	-17.0	-14.0						0.881	0.01		0.004	-0.773	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625260	chr1	12907519	C	A	chr1:12907519	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.33	22_11	33	99	False	rs6702447,COSV58612069	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.624G>T	NP_001013653.1:p.Gln208His		-1.0						.	.	.						30	0.86							0.0454071	9754.0	214812.0	146.0	100	0.99	RF	afr	0.0762446	925.0	0.0389827	3884.0	0.0012476	194	0.001	3.0				18.95	1.89941	0.123	4	14	18	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.01	-3.0	47.0	4.0	-12.0						0.881	0.01		0.004	0.238	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625261	chr1	12907612	A	T	chr1:12907612	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.18	28_6	34	99	False	rs2994091,COSV100509002,COSV58612891	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.531T>A	NP_001013653.1:p.Gly177%3D		-1.0						.	.	.		0.000100095	15.0	149858.0	1.0	30	0.86	PASS	amr	0.000207182	3.0	0.000118452	8.0	0.00616859	1325.0	214798.0	154.0	100	0.99	RF	amr	0.0201364	567.0	0.00388412	384.0	0.0009067	141	0.0	1.0				7.446	0.318221		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.02	-46.0	-13.0	-48.0	2.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625262	chr1	12907620	A	G	chr1:12907620	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.16	27_5	32	99	False	rs2994092,COSV58609772	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.523T>C	NP_001013653.1:p.Leu175%3D		-1.0						.	.	.		3.33244e-05	5.0	150040.0	0.0	30	0.86	PASS	amr	6.88895e-05	1.0	5.91751e-05	4.0	0.00439891	960.0	218236.0	162.0	100	0.99	RF	amr	0.0166028	468.0	0.00246722	248.0	0.0006624	103	0.0	1.0				3.506	0.054895		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	-21.0	-7.0	-34.0	-6.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625263	chr1	12907781	T	C	chr1:12907781	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.27	33_12	45	99	False	rs28441396,COSV58609685	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.362A>G	NP_001013653.1:p.Asp121Gly		-1.0						.	.	.		0.000100053	15.0	149920.0	0.0	30	0.86	PASS	eas	0.000388802	2.0	1.47964e-05	1.0	0.420962	41080.0	97586.0	495.0	100	1.0	InbreedingCoeff_RF	amr	0.477888	8926.0	0.394996	15378.0	0.0004566	71	0.02	61.0				5.772	0.195425	0.295	1	14	15	PROVEAN_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	1.0	-13.0	1.0	-6.0						0.881	0.01		0.0	-2.059	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625264	chr1	12907798	A	C	chr1:12907798	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.34	33_17	50	99	False	rs150096254,COSV58609693	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.345T>G	NP_001013653.1:p.Phe115Leu		-1.0						.	.	.		3.33253e-05	5.0	150036.0	0.0	30	0.86	AS_VQSR	afr	9.7924e-05	4.0	1.47916e-05	1.0	0.497033	74881.0	150656.0	538.0	100	1.0	InbreedingCoeff_RF	amr	0.51318	11992.0	0.494468	32627.0	0.0001736	27	0.004	13.0				4.698	0.126473	0.157	0	15	15		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	43.0	-30.0	34.0	-42.0						0.881	0.01		0.0	-1.936	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625265	chr1	12907802	C	T	chr1:12907802	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.35	33_18	51	99	False	rs138087690,COSV58609703	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.341G>A	NP_001013653.1:p.Gly114Asp		-1.0						.	.	.		1.99904e-05	3.0	150072.0	0.0	30	0.86	AS_VQSR	afr	4.8962e-05	2.0	1.47872e-05	1.0	0.500383	90265.0	180392.0	552.0	100	1.0	InbreedingCoeff_RF	amr	0.513034	13895.0	0.498461	40163.0	0.0010997	171	0.004	14.0				2.312	-0.021486	0.094	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-34.0	-1.0	-24.0	-27.0						0.881	0.01		0.002	-0.803	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625266	chr1	12907803	C	T	chr1:12907803	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0|1	0.35	33_18	51	99	False	rs141460546,COSV58609713	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.340G>A	NP_001013653.1:p.Gly114Ser		-1.0						.	.	.		1.99944e-05	3.0	150042.0	0.0	30	0.86	AS_VQSR	afr	4.89812e-05	2.0	1.47885e-05	1.0	0.500604	92851.0	185478.0	553.0	100	1.0	InbreedingCoeff	amr	0.512995	14093.0	0.498632	41549.0	0.0011832	184	0.006	18.0				14.1	1.104053	0.078	0	15	15		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-2.0	-35.0	29.0	5.0						0.881	0.01		0.002	-0.914	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625267	chr1	12907837	C	T	chr1:12907837	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0/1	0.43	32_24	56	99	False	rs1736811,COSV58610534	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.306G>A	NP_001013653.1:p.Ala102%3D		-1.0						.	.	.		0.00581923	872.0	149848.0	32.0	30	0.85	PASS	afr	0.00976822	397.0	0.00445359	301.0	0.502707	124787.0	248230.0	718.0	100	1.0	InbreedingCoeff	amr	0.513682	17683.0	0.500878	56476.0	0.0164819	2563	0.102	313.0				2.615	-0.000564		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	-2.0	19.0	-5.0	20.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625268	chr1	12907885	T	C	chr1:12907885	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	9354.0	SNV	0/1	0.54	25_29	54	99	False	rs848418,COSV58610545	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.258A>G	NP_001013653.1:p.Ala86%3D		-1.0						.	.	.						0	0.0							0.495257	122795.0	247942.0	5.0	100	1.0	InbreedingCoeff	eas	0.499018	9145.0	0.496719	55415.0	0.0503267	7826	0.23	693.0				5.936	0.206461		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	-11.0	-2.0	-28.0	24.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];
625673	chr9	33385667	A	G	chr9:33385667	AQP7	aquaporin 7	9355.0	SNV	0/1	0.29	45_18	63	99	False	rs79779983,COSV53002866	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		8/9	NM_001376191.1:c.723T>C	NP_001363120.1:p.Gly241%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.97							0.0194069	3051.0	157212.0	0.0	100	1.0	RF	afr	0.0216599	202.0	0.0211162	1378.0	0.0093117	1448	0.021	62.0	0.01976	225.0		8.123	0.375034		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
625681	chr9	33385690	G	T	chr9:33385690	AQP7	aquaporin 7	9355.0	SNV	0|1	0.26	49_17	66	99	False	rs139024279,COSV53002906	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.700C>A	NP_001363120.1:p.Arg234Ser		-1.0	.,.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	not_specified	[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.	24033266	1.97267e-05	3.0	152078.0	0.0	32	0.97	PASS	nfe	4.41163e-05	3.0	4.41163e-05	3.0	0.00368508	787.0	213564.0	0.0	100	1.0	PASS	nfe	0.00410381	395.0	0.00410381	395.0	0.0416581	6478	0.008	24.0	0.0194	221.0		23.4	2.906002	0.551	9	9	18	SIFT,PolyPhen,LRT_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred															0.227	0.0		0.64	1.176	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
625689	chr9	33385698	A	G	chr9:33385698	AQP7	aquaporin 7	9355.0	SNV	0|1	0.26	48_17	65	99	False	rs145516206,COSV53002949	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.692T>C	NP_001363120.1:p.Leu231Pro		-1.0	.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.97							0.00236866	524.0	221222.0	0.0	100	1.0	RF	nfe	0.002902	288.0	0.002902	288.0	0.0407578	6338	0.005	17.0	0.01834	209.0		24.2	3.253676	0.738	12	7	19	SIFT,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred															0.227	0.0		0.997	0.326	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
625707	chr9	33385709	C	T	chr9:33385709	AQP7	aquaporin 7	9355.0	SNV	0|1	0.22	53_15	68	99	False	rs116294914,COSV53004230	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		8/9	NM_001376191.1:c.681G>A	NP_001363120.1:p.Pro227%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		6.56953e-06	1.0	152218.0	0.0	32	0.97	PASS	afr	2.4122e-05	1.0	0.0	0.0	0.00147231	337.0	228892.0	0.0	100	1.0	PASS	afr	0.00742713	106.0	0.00169515	173.0	0.0311760	4848	0.003	9.0	0.01982	226.0		3.62	0.061726		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
625722	chr9	33385712	G	A	chr9:33385712	AQP7	aquaporin 7	9355.0	SNV	0|1	0.21	52_14	66	99	False	rs115575789,COSV53004274	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		8/9	NM_001376191.1:c.678C>T	NP_001363120.1:p.Asn226%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.97							0.00262685	602.0	229172.0	0.0	100	1.0	RF	afr	0.0148343	214.0	0.00314127	321.0	0.0344814	5362	0.002	7.0	0.01868	213.0		8.919	0.450089		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
625726	chr9	33385733	C	T	chr9:33385733	AQP7	aquaporin 7	9355.0	SNV	0|1	0.16	49_9	58	99	False	rs201117022,COSV53002993	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.657G>A	NP_001363120.1:p.Met219Ile		-1.0	.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.97							0.00033132	77.0	232404.0	0.0	100	1.0	RF	afr	0.000680828	10.0	0.000366491	38.0	0.0002508	39	0.003	9.0	0.01815	207.0		19.24	1.936554	0.159	5	12	17	LRT_pred,MutationTaster_pred,FATHMM_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred															0.227	0.0		0.989	1.026	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
625745	chr9	33385740	A	T	chr9:33385740	AQP7	aquaporin 7	9355.0	SNV	0|1	0.14	48_8	56	99	False	rs201773300,COSV53005868	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.650T>A	NP_001363120.1:p.Leu217His		-1.0	.,.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	not_specified	[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.	24033266					33	0.97							0.00355752	800.0	224876.0	0.0	100	1.0	RF	afr	0.0227976	324.0	0.00385148	384.0	0.0002379	37	0.012	37.0	0.0242	276.0		15.83	1.420845	0.412	9	8	17	LRT_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred															0.227	0.0		0.186	1.312	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
625758	chr9	33385750	C	T	chr9:33385750	AQP7	aquaporin 7	9355.0	SNV	0|1	0.12	45_6	51	99	False	rs114484742,COSV53003053	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.640G>A	NP_001363120.1:p.Gly214Arg		-1.0	.,.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	not_specified	[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.	24033266	9.19891e-05	14.0	152192.0	0.0	32	0.97	PASS	amr	0.000196258	3.0	8.81808e-05	6.0	0.00532544	1170.0	219700.0	0.0	100	1.0	RF	afr	0.0250652	346.0	0.00648776	631.0	0.0477287	7422	0.014	44.0	0.03402	388.0		22.3	2.379962	0.612	9	9	18	SIFT,LRT_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred															0.227	0.0		0.028	1.026	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
625771	chr9	33385828	C	T	chr9:33385828	AQP7	aquaporin 7	9355.0	SNV	0/1	0.31	29_13	42	99	False	rs73478963,COSV53003116	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.562G>A	NP_001363120.1:p.Ala188Thr		-1.0	.,.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		0.000164262	25.0	152196.0	0.0	33	0.97	PASS	sas	0.00207125	10.0	0.000146972	10.0	0.0566472	9012.0	159090.0	0.0	80	1.0	PASS	afr	0.0905728	857.0	0.0679295	4651.0	0.0020257	315	0.108	335.0	0.07172	818.0		23.6	3.009094	0.459	9	9	18	SIFT,LRT_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred															0.227	0.0		0.999	1.026	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
625780	chr9	33385852	C	T	chr9:33385852	AQP7	aquaporin 7	9355.0	SNV	0/1	0.34	29_15	44	99	False	rs202183465,COSV53002807	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.538G>A	NP_001363120.1:p.Gly180Arg		-1.0	.,.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		2.62843e-05	4.0	152182.0	0.0	32	0.97	PASS	nfe	4.4093e-05	3.0	4.4093e-05	3.0	0.060306	9500.0	157530.0	0.0	60	0.99	PASS	afr	0.0832018	738.0	0.0694494	4667.0	0.0008681	135	0.059	174.0	0.08311	948.0		22.5	2.448262	0.309	10	7	17	SIFT,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred															0.227	0.0		0.343	1.026	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
625784	chr9	33385863	G	T	chr9:33385863	AQP7	aquaporin 7	9355.0	SNV	0/1	0.4	26_17	43	99	False	rs62542746,COSV53003796	SPLICING	YES	NM_001376191.1	Transcript	protein_coding	missense_variant,splice_region_variant		8/9	NM_001376191.1:c.527C>A	NP_001363120.1:p.Ala176Glu		-1.0	.,.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		2.62902e-05	4.0	152148.0	0.0	33	0.97	PASS	nfe	4.41073e-05	3.0	4.41073e-05	3.0	0.374555	46710.0	124708.0	0.0	52	0.97	InbreedingCoeff	nfe	0.409083	24698.0	0.409083	24698.0	0.0069387	1079	0.126	397.0	0.11266	1285.0		10.21	0.588029	0.111	5	12	17	FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred										0.0002674219597193	0.034	3.039	0.059	3.097	0.227	0.0		0.001	-1.508	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
625869	chr9	33386144	G	A	chr9:33386144	AQP7	aquaporin 7	9355.0	SNV	0|1	0.22	28_8	36	99	False	rs76209395,COSV53003500	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		7/9	NM_001376191.1:c.456C>T	NP_001363120.1:p.Val152%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		0.00011171	17.0	152180.0	0.0	32	0.97	PASS	sas	0.000207383	1.0	0.000205761	14.0	0.0848771	6607.0	77842.0	0.0	100	1.0	InbreedingCoeff_RF	nfe	0.110081	3977.0	0.110081	3977.0	0.0006559	102	0.009	30.0	0.15379	1576.0		1.682	-0.072511		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
625883	chr9	33386146	C	A	chr9:33386146	AQP7	aquaporin 7	9355.0	SNV	0|1	0.22	28_8	36	99	False	rs76608797,COSV53003541	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		7/9	NM_001376191.1:c.454G>T	NP_001363120.1:p.Val152Phe		-1.0	.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.97							0.0442306	5322.0	120324.0	0.0	100	1.0	InbreedingCoeff	nfe	0.0599449	3349.0	0.0599449	3349.0	0.0002765	43	0.002	6.0	0.16354	1676.0		5.965	0.208447	0.055	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.227	0.0		0.001	0.179	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
625901	chr9	33386167	G	C	chr9:33386167	AQP7	aquaporin 7	9355.0	SNV	0/1	0.31	29_13	42	99	False	rs79172651,COSV53003583	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		7/9	NM_001376191.1:c.433C>G	NP_001363120.1:p.Gln145Glu		-1.0	.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		0.000164236	25.0	152220.0	0.0	32	0.97	PASS	nfe	0.000323349	22.0	0.000323349	22.0	0.0751158	8917.0	118710.0	0.0	95	1.0	InbreedingCoeff_RF	nfe	0.081907	4460.0	0.081907	4460.0	0.0038777	603	0.037	118.0	0.20051	2054.0		0.028	-0.653391	0.024	0	17	17		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.227	0.0		0.0	-2.234	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
626006	chr9	33386400	A	G	chr9:33386400	AQP7	aquaporin 7	9355.0	SNV	0|1	0.18	32_7	39	99	False	rs771895202,COSV53004383	SPLICING	YES	NM_001376191.1	Transcript	protein_coding	splice_donor_variant	6/8		NM_001376191.1:c.406+2T>C			-1.0		Benign	criteria_provided,_single_submitter	not_specified	[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.	24033266					32	0.97							0.0116749	1853.0	158716.0	0.0	30	0.72	PASS	nfe	0.0171972	1275.0	0.0171972	1275.0	0.0016205	252	0.1	322.0	0.3985	4083.0		25.6	3.664875		0	0	0												0.999847007062202	0.836	0.586	7.754	8.34	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
626021	chr9	33386430	C	T	chr9:33386430	AQP7	aquaporin 7	9355.0	SNV	0/1	0.18	31_7	38	99	False	rs74589499,COSV53004415	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		6/9	NM_001376191.1:c.378G>A	NP_001363120.1:p.Ala126%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		5.91568e-05	9.0	152138.0	0.0	32	0.97	PASS	afr	0.000120802	5.0	4.40917e-05	3.0	0.00944502	1741.0	184330.0	0.0	52	0.75	RF	nfe	0.014824	1259.0	0.014824	1259.0	0.0226875	3528	0.072	229.0	0.2684	2750.0		0.267	-0.345504		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
626026	chr9	33386465	A	G	chr9:33386465	AQP7	aquaporin 7	9355.0	SNV	0|1	0.19	26_6	32	99	False	rs74668961,COSV53003174	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		6/9	NM_001376191.1:c.343T>C	NP_001363120.1:p.Tyr115His		-1.0	.,.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	not_specified	[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.	24033266					32	0.97							0.00728821	1159.0	159024.0	0.0	77	0.82	RF	nfe	0.0112786	826.0	0.0112786	826.0	0.0405199	6301	0.14	443.0	0.14484	1484.0		23.9	3.157079	0.68	13	6	19	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred															0.227	0.0		0.085	1.312	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
626040	chr9	33386469	C	T	chr9:33386469	AQP7	aquaporin 7	9355.0	SNV	0|1	0.19	26_6	32	99	False	rs78695486,COSV53016926,COSV53018087	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		6/9	NM_001376191.1:c.339G>A	NP_001363120.1:p.Pro113%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		0.000282504	43.0	152210.0	0.0	32	0.97	PASS	afr	0.000241266	10.0	0.000132271	9.0	0.00794843	1132.0	142418.0	0.0	78	0.84	PASS	nfe	0.0113985	751.0	0.0113985	751.0	0.0497801	7741	0.178	568.0	0.1343	1376.0		1.007	-0.149692		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
626049	chr9	33386510	C	T	chr9:33386510	AQP7	aquaporin 7	9355.0	SNV	0|1	0.29	27_11	38	99	False	rs77962308,COSV53003236	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		6/9	NM_001376191.1:c.298G>A	NP_001363120.1:p.Ala100Thr		-1.0	.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		0.0	0.0	152216.0	0.0	32	0.98	AC0				0.0	0.0	0.209967	18501.0	88114.0	1.0	59	0.88	InbreedingCoeff	afr	0.272746	1307.0	0.248104	9751.0	0.0019678	306	0.065	207.0	0.13029	1335.0		0.027	-0.657105	0.02	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.227	0.0		0.003	-0.618	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
626071	chr9	33386511	A	G	chr9:33386511	AQP7	aquaporin 7	9355.0	SNV	0|1	0.29	27_11	38	99	False	rs72707424,COSV53016707	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		6/9	NM_001376191.1:c.297T>C	NP_001363120.1:p.Phe99%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		0.0	0.0	152250.0	0.0	32	0.98	AC0				0.0	0.0	0.22178	19058.0	85932.0	1.0	60	0.88	InbreedingCoeff_RF	afr	0.292079	1357.0	0.262456	10061.0	0.0019742	307	0.067	214.0	0.13215	1354.0		2.951	0.0211		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
626078	chr9	33386526	G	A	chr9:33386526	AQP7	aquaporin 7	9355.0	SNV	0/1	0.32	27_13	40	99	False	rs79202054,COSV53016746	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		6/9	NM_001376191.1:c.282C>T	NP_001363120.1:p.Asn94%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		0.00010509	16.0	152250.0	0.0	32	0.98	PASS	afr	0.000265239	11.0	2.93945e-05	2.0	0.281051	28914.0	102878.0	0.0	46	0.84	InbreedingCoeff_RF	afr	0.342291	2038.0	0.316725	14843.0	0.0005145	80	0.132	406.0	0.21316	2184.0		2.514	-0.007382		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
626278	chr9	33386989	C	G	chr9:33386989	AQP7	aquaporin 7	9355.0	SNV	0/1	0.37	41_24	65	99	False	rs77244521,COSV53008689	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		5/9	NM_001376191.1:c.246G>C	NP_001363120.1:p.Val82%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.97							0.479246	49117.0	102488.0	0.0	100	1.0	InbreedingCoeff	sas	0.491116	6910.0	0.468693	19043.0	0.0101605	1580	0.066	180.0	0.3617	3706.0		5.499	0.177348		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
626288	chr9	33387004	T	C	chr9:33387004	AQP7	aquaporin 7	9355.0	SNV	0/1	0.38	39_24	63	99	False	rs76863051,COSV53008126	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		5/9	NM_001376191.1:c.231A>G	NP_001363120.1:p.Gly77%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		0.0	0.0	152164.0	0.0	32	0.97	AC0_AS_VQSR				0.0	0.0	0.493278	57828.0	117232.0	0.0	100	1.0	InbreedingCoeff_RF	sas	0.497163	8237.0	0.490189	23133.0	0.0086429	1344	0.086	234.0	0.35633	3651.0		10.99	0.681162		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
626305	chr9	33387047	T	G	chr9:33387047	AQP7	aquaporin 7	9355.0	SNV	0/1	0.3	33_14	47	99	False	rs4008658,COSV53003999	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		5/9	NM_001376191.1:c.188A>C	NP_001363120.1:p.Lys63Thr		-1.0	.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		5.91677e-05	9.0	152110.0	0.0	32	0.97	PASS	amr	0.000523629	8.0	1.46994e-05	1.0	0.498584	107424.0	215458.0	0.0	96	1.0	InbreedingCoeff	sas	0.499298	13509.0	0.498478	49118.0	0.0137296	2135	0.087	236.0	0.32657	3346.0		0.013	-0.748308	0.012	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.227	0.0		0.0	-2.606	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
626321	chr9	33387073	G	A	chr9:33387073	AQP7	aquaporin 7	9355.0	SNV	0/1	0.24	35_11	46	99	False	rs73645276,COSV53011131	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		5/9	NM_001376191.1:c.162C>T	NP_001363120.1:p.Ser54%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		7.22809e-05	11.0	152184.0	0.0	32	0.97	PASS	sas	0.000620861	3.0	7.34905e-05	5.0	0.495225	73940.0	149306.0	0.0	83	1.0	InbreedingCoeff_RF	sas	0.496021	8726.0	0.494118	33184.0	0.0130993	2037	0.107	297.0	0.31593	3237.0		10.97	0.677901		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
626828	chr9	33395108	G	A	chr9:33395108	AQP7	aquaporin 7	9355.0	SNV	0/1	0.22	21_6	27	99	False	rs2381003,COSV53003625	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		4/9	NM_001376191.1:c.112C>T	NP_001363120.1:p.Leu38%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						31	0.95							0.021046	2717.0	129098.0	0.0	68	1.0	RF	afr	0.0317668	219.0	0.0279362	1440.0	0.0015241	237	0.017	56.0				5.563	0.181586		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];
628153	chr9	38411554	T	G	chr9:38411554	IGFBPL1	insulin like growth factor binding protein like 1	9384.0	SNV	0/1	0.41	13_9	22	99	False	rs756657827	SPLICING	YES	NM_001007563.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/4		NM_001007563.3:c.688-8A>C			-1.0						.	.	.		1.31442e-05	2.0	152158.0	0.0	32	0.97	PASS	amr	6.54622e-05	1.0	0.0	0.0	2.39814e-05	6.0	250194.0	0.0	36	0.91	PASS	amr	8.74789e-05	3.0	2.64938e-05	3.0	0.0000257	4						1.988	-0.046094		0	0	0			IGFBPL1	0.14	0.0	0.09	0.0	-8.0	-2.0	-35.0	-8.0	2.30718947637959e-05	0.0	11.823	-1.764	10.058		0.01				.			.	.	regulation of cell growth;cellular response to tumor cell	extracellular space	molecular_function;insulin-like growth factor binding	.
628233	chr10	37418816	C	T	chr10:37418816	ANKRD30A	ankyrin repeat domain 30A	9390.0	SNV	0/1	0.56	11_14	25	99	False	rs775423794	SPLICING	YES	NM_052997.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/35		NM_052997.3:c.222-5C>T			1.0						.	.	.		1.31556e-05	2.0	152026.0	0.0	33	0.95	PASS	afr	2.41546e-05	1.0	1.47067e-05	1.0	3.13627e-05	6.0	191310.0	0.0	15	0.34	PASS	afr	0.000178571	2.0	3.24268e-05	3.0	0.0000193	3						5.375	0.169291		0	0	0			ANKRD30A	0.08	0.03	0.0	0.0	-12.0	-34.0	-2.0	5.0	0.0001865508656178	0.006	8.102	-1.232	6.87	0.991	0.0				.			ciliary ganglion;subthalamic nucleus;testis - interstitial;atrioventricular node;superior cervical ganglion;skin;trigeminal ganglion;globus pallidus;	.	regulation of transcription, DNA-templated	nucleus	DNA binding;DNA-binding transcription factor activity	.
628647	chr5	94820554	A	T	chr5:94820554	TTC37	tetratricopeptide repeat domain 37	9402.0	SNV	0/1	0.62	10_16	26	99	False	rs372529043	SPLICING	YES	NM_014639.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	37/42		NM_014639.4:c.3932-5T>A			-1.0					Trichohepatoenteric syndrome 1, 222470 (3), Autosomal recessive	Syndromic diarrhea	Disease-causing germline mutation(s) in	Hepatic fibrosis;Jaundice;Bifid uvula;Renal cortical microcysts;Thrombocytosis;Fine hair;Increased mean platelet volume;Short stature;Narrow mouth;Frontal bossing;Ventricular septal defect;Galactosuria;Failure to thrive;Neurodevelopmental delay;Abnormality of the pancreas;Small for gestational age;Depressed nasal ridge;Hypospadias;Long philtrum;Downslanted palpebral fissures;Underdeveloped supraorbital ridges;Autosomal recessive inheritance;Microtia;Wide nose;Hepatic failure;Hepatomegaly;Low-set ears;Curly hair;Polyhydramnios;Prominent forehead;Hypermethioninemia;Cognitive impairment;Aortic regurgitation;Hypertelorism;Sparse hair;Hypoalbuminemia;Villous atrophy;Large placenta;Abnormality of iron homeostasis;Increased serum iron;Woolly hair;Pulmonic stenosis;Abnormalities of placenta or umbilical cord;Intractable diarrhea;Trichorrhexis nodosa;Abnormality of the immune system;Intrauterine growth retardation;Tetralogy of Fallot;Anteverted nares;Cirrhosis;Wide mouth;Brittle hair;Proptosis;Hypoplasia of the thymus;Dependency on intravenous nutrition;Broad forehead;Dry skin;Bloody diarrhea;Wide nasal bridge;Thrombocytosis;Recurrent infections;Peripheral pulmonary artery stenosis;Hepatomegaly;Hepatic fibrosis;Cafe-au-lait spot;Colitis;Polycystic kidney dysplasia;Prominent forehead;Patent ductus arteriosus;Glaucoma;Ventricular septal defect;Villous atrophy;Generalized hypopigmentation;Atrial septal defect;Aortic regurgitation;Intrauterine growth retardation;Cirrhosis;Abnormal facial shape;Uncombable hair;Hypertelorism;Small for gestational age;Short stature;Global developmental delay;Hypopigmentation of hair;Lymphopenia;Inguinal hernia;Bicuspid aortic valve;Immunodeficiency;Renal hypoplasia;Gastritis;Intellectual disability, mild;Abnormality of iron homeostasis;Hepatoblastoma;Hypothyroidism;Tetralogy of Fallot;Trichorrhexis nodosa;Panhypogammaglobulinemia;Increased mean platelet volume;Splenomegaly;Intractable diarrhea;Woolly hair;Brittle hair		6.57022e-06	1.0	152202.0	0.0	31	0.95	PASS	nfe	1.46998e-05	1.0	1.46998e-05	1.0	2.38781e-05	6.0	251276.0	0.0	80	1.0	PASS	nfe	5.27872e-05	6.0	5.27872e-05	6.0	0.0000257	4	0.0	1.0	0.00018	2.0		5.728	0.192453		0	0	0			TTC37	0.0	0.12	0.0	0.0	-11.0	-5.0	-5.0	-15.0	0.0007364976820457	0.078	7.38	0.869	8.249	0.944	0.0				.			prefrontal cortex;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;atrioventricular node;	.	exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay	nucleus;nucleoplasm;cytoplasm;cytosol;transcriptionally active chromatin;Ski complex	protein binding	NPM1[26496610];RPL10[26496610];SMAD9[15231748];HNRNPU[26496610];IMMT[30021884];WDR61[16024656];HSCB[28380382];NEURL4[29426014];OGDH[30021884];PAF1[16024656];CEP162[26638075];SKIV2L[16024656];HIST1H2BH[30021884];
630431	chr6	136582417	G	A	chr6:136582417	BCLAF1	BCL2 associated transcription factor 1	9453.0	SNV	0/1	0.27	23_9	33	99	False	rs62431283,COSV50356765	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		12/13	NM_014739.3:c.2743C>T	NP_055554.1:p.Arg915Cys		-1.0	.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	not_specified		.	.	.	24033266					32	0.97							0.484593	73380.0	151426.0	4.0	78	1.0	InbreedingCoeff_RF	sas	0.493946	10036.0	0.481553	32945.0	0.0012861	200	0.038	119.0				28.9	4.133855	0.296	10	10	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred	BCLAF1	0.0	0.0	0.0	0.0	-45.0	14.0	-31.0	-14.0						0.873			1.0	1.176	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];
630460	chr6	136582497	G	T	chr6:136582497	BCLAF1	BCL2 associated transcription factor 1	9453.0	SNV	0/1	0.31	32_18	59	99	False	rs62431284,COSV50356777	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		12/13	NM_014739.3:c.2663C>A	NP_055554.1:p.Thr888Asn		-1.0	.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	not_specified		.	.	.	24033266					32	0.96							0.497374	123282.0	247866.0	7.0	100	1.0	InbreedingCoeff	sas	0.499901	15221.0	0.498292	56311.0	0.0161025	2504	0.192	598.0				26.3	3.807733	0.191	10	10	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	BCLAF1	0.0	0.0	0.0	0.0	-18.0	18.0	19.0	18.0						0.873			1.0	1.176	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];
630490	chr6	136590640	A	C	chr6:136590640	BCLAF1	BCL2 associated transcription factor 1	9453.0	SNV	0/1	0.24	22_8	33	99	False	rs62431286,COSV50356784	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		9/13	NM_014739.3:c.2154T>G	NP_055554.1:p.Ser718Arg		-1.0	.,.,.,.,.,.,.,.					.	.	.						32	0.96							0.49863	110650.0	221908.0	11.0	68	0.99	InbreedingCoeff	sas	0.499541	14137.0	0.498956	50200.0	0.0067715	1053	0.153	480.0				26.9	3.904407	0.142	10	10	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred	BCLAF1	0.0	0.0	0.0	0.0	41.0	46.0	41.0	-15.0						0.873		92.67902945	1.0	1.312	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];
630513	chr6	136590698	C	T	chr6:136590698	BCLAF1	BCL2 associated transcription factor 1	9453.0	SNV	0/1	0.21	27_8	38	99	False	rs62431287,COSV50356735	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		9/13	NM_014739.3:c.2096G>A	NP_055554.1:p.Arg699His		-1.0	.,.,.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	not_specified		.	.	.	24033266	1.31784e-05	2.0	151764.0	0.0	32	0.96	PASS	afr	2.41791e-05	1.0	1.47384e-05	1.0	0.496865	113151.0	227730.0	8.0	59	0.99	InbreedingCoeff	sas	0.499158	14221.0	0.498828	52359.0	0.0036784	572	0.156	483.0				28.0	4.039401	0.239	7	13	20	SIFT,PolyPhen,PROVEAN_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	BCLAF1	0.02	0.0	0.0	0.0	-7.0	48.0	41.0	-17.0						0.873		5.235035379	0.994	1.026	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];
630542	chr6	136590712	C	T	chr6:136590712	BCLAF1	BCL2 associated transcription factor 1	9453.0	SNV	0/1	0.21	27_8	38	99	False	rs62431288,COSV50356842	EXONIC	YES	NM_014739.3	Transcript	protein_coding	synonymous_variant		9/13	NM_014739.3:c.2082G>A	NP_055554.1:p.Arg694%3D		-1.0						.	.	.						32	0.96							0.498789	114871.0	230300.0	10.0	53	0.99	InbreedingCoeff	sas	0.499653	14407.0	0.498715	52011.0	0.0024437	380	0.158	491.0				10.79	0.656695		0	0	0			BCLAF1	0.01	0.0	0.0	0.0	-21.0	21.0	-31.0	22.0						0.873		70.29453265			homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];
630588	chr6	136597281	A	T	chr6:136597281	BCLAF1	BCL2 associated transcription factor 1	9453.0	SNV	0|1	0.38	29_23	61	99	False	rs1967445,COSV62140199	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		5/13	NM_014739.3:c.1382T>A	NP_055554.1:p.Leu461His		-1.0	.,.,.,.,.,.,.					.	.	.						31	0.93							0.498904	124699.0	249946.0	4.0	100	1.0	InbreedingCoeff	sas	0.499967	15266.0	0.499665	56628.0	0.0051060	794	0.204	646.0				21.8	2.251941	0.023	2	16	18	LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	BCLAF1	0.0	0.0	0.0	0.0	20.0	-6.0	46.0	34.0						0.873			1.0	1.312	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];
630611	chr6	136597288	A	C	chr6:136597288	BCLAF1	BCL2 associated transcription factor 1	9453.0	SNV	0|1	0.37	29_23	62	99	False	rs1967446,COSV62140206	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		5/13	NM_014739.3:c.1375T>G	NP_055554.1:p.Tyr459Asp		-1.0	.,.,.,.,.,.,.					.	.	.						31	0.93							0.49902	124724.0	249938.0	4.0	100	1.0	InbreedingCoeff	amr	0.499971	17171.0	0.499735	56632.0	0.0181732	2826	0.196	620.0				22.9	2.697426	0.414	5	13	18	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred	BCLAF1	0.0	0.0	0.0	0.0	31.0	-13.0	31.0	39.0						0.873			1.0	1.312	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];
630678	chr6	136599822	C	G	chr6:136599822	BCLAF1	BCL2 associated transcription factor 1	9453.0	SNV	0/1	0.39	26_19	49	99	False	rs9942517,COSV62140218	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		4/13	NM_014739.3:c.197G>C	NP_055554.1:p.Gly66Ala		-1.0	.,.,.,.,.,.,.,.					.	.	.		0.000212501	31.0	145882.0	0.0	31	0.94	AS_VQSR	afr	0.000771523	29.0	1.48863e-05	1.0	0.499672	125038.0	250240.0	0.0	89	1.0	InbreedingCoeff	amr	0.499971	17212.0	0.499558	56486.0	0.0227004	3530	0.211	669.0				25.4	3.608464	0.387	13	6	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,PROVEAN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,ClinPred_pred	BCLAF1	0.0	0.0	0.0	0.0	30.0	32.0	46.0	-18.0						0.873			1.0	1.026	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];
630695	chr6	136599836	G	A	chr6:136599836	BCLAF1	BCL2 associated transcription factor 1	9453.0	SNV	0|1	0.36	29_18	50	99	False	rs9942518,COSV62141128	EXONIC	YES	NM_014739.3	Transcript	protein_coding	synonymous_variant		4/13	NM_014739.3:c.183C>T	NP_055554.1:p.Tyr61%3D		-1.0						.	.	.						31	0.95							0.4981	123489.0	247920.0	0.0	84	1.0	InbreedingCoeff	amr	0.499883	17097.0	0.499406	56321.0	0.0204689	3183	0.186	584.0				11.49	0.742209		0	0	0			BCLAF1	0.0	0.0	0.01	0.0	32.0	18.0	32.0	-32.0						0.873					homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];
630734	chr6	136599842	G	A	chr6:136599842	BCLAF1	BCL2 associated transcription factor 1	9453.0	SNV	0|1	0.35	29_17	48	99	False	rs9942519,COSV62141130	EXONIC	YES	NM_014739.3	Transcript	protein_coding	synonymous_variant		4/13	NM_014739.3:c.177C>T	NP_055554.1:p.Arg59%3D		-1.0						.	.	.		0.000761543	114.0	149696.0	0.0	31	0.95	PASS	afr	0.00271284	107.0	1.47193e-05	1.0	0.499668	124948.0	250062.0	2.0	80	0.99	InbreedingCoeff	amr	0.499971	17197.0	0.499513	56423.0	0.0208355	3240	0.186	584.0				8.487	0.408339		0	0	0			BCLAF1	0.0	0.0	0.0	0.0	-9.0	12.0	26.0	-38.0						0.873					homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];
630755	chr6	136599911		GTATCGCTTCTTTCTAGAATG	chr6:136599910-136599911	BCLAF1	BCL2 associated transcription factor 1	9453.0	insertion	0/1	0.21	30_8	39	99	False	rs778718614,COSV100787221,COSV62140625	EXONIC	YES	NM_014739.3	Transcript	protein_coding	inframe_insertion		4/13	NM_014739.3:c.108_109insCATTCTAGAAAGAAGCGATAC	NP_055554.1:p.Ser36_Arg37insHisSerArgLysLysArgTyr		-1.0						.	.	.						31	0.95							0.00360952	729.0	201966.0	0.0	30	0.65	RF	sas	0.00536536	126.0	0.00346631	334.0	0.0001479	23						19.26	1.939265		0	0	0																	0.873					homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];
631637	chr19	55697831	C	A	chr19:55697831	PTPRH	protein tyrosine phosphatase, receptor type H	9484.0	SNV	0/1	0.59	9_13	22	99	False	rs74901631,COSV54750045	SPLICING	YES	NM_002842.5	Transcript	protein_coding	splice_donor_variant	15/19		NM_002842.5:c.2643+1G>T			-1.0						.	.	.		0.000257257	38.0	147712.0	0.0	32	0.94	PASS	amr	0.00041511	6.0	0.000356962	24.0	0.000159185	40.0	251280.0	0.0	69	1.0	PASS	nfe	0.000246414	28.0	0.000246414	28.0	0.0001093	17	0.0	1.0				34.0	5.524525		0	0	0			PTPRH	0.0	0.0	0.11	0.82	-5.0	1.0	-4.0	1.0	0.999990361384395	0.938	-3.044	8.504	5.46	0.573	0.0				neoplasm; 			ciliary ganglion;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	protein dephosphorylation;apoptotic process;peptidyl-tyrosine dephosphorylation	cytoplasm;integral component of plasma membrane;apical plasma membrane;microvillus membrane	transmembrane receptor protein tyrosine phosphatase activity;protein binding	GHR[12907755];MCRIP1[28330616];DHPS[25416956];KRTAP10-8[25416956];LANCL1[28330616];LIG3[28330616];PTPRH[15978577];MLH1[20706999];ILKAP[28330616];CORO1C[28330616];
632237	chr4	1377609	C	T	chr4:1377609	UVSSA	UV stimulated scaffold protein A	9502.0	SNV	0|1	0.67	13_26	39	99	False	rs749924619	EXONIC	YES	NM_001317935.2	Transcript	protein_coding	synonymous_variant		13/14	NM_001317935.2:c.1917C>T	NP_001304864.1:p.Leu639%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	UV-sensitive syndrome 3, 614640 (3), Autosomal recessive	UV-sensitive syndrome	Disease-causing germline mutation(s) in	Cutaneous photosensitivity;Freckling;Telangiectasia;Autosomal recessive inheritance;Infantile onset;Dry skin;Increased cellular sensitivity to UV light		3.94389e-05	6.0	152134.0	0.0	33	0.97	PASS	eas	0.000192753	1.0	1.47029e-05	1.0	0.000159506	40.0	250774.0	0.0	75	1.0	PASS	eas	0.000924516	17.0	3.52715e-05	4.0	0.0000965	15			9e-05	1.0		0.018	-0.709962		0	0	0			UVSSA	0.04	0.03	0.0	0.15	12.0	-47.0	12.0	11.0							0.0	15.369061467			.			.	.	transcription-coupled nucleotide-excision repair;response to UV;protein ubiquitination	nucleoplasm;chromosome	RNA polymerase II complex binding;protein binding	BAG6[26496610];SYNCRIP[26496610];KPNA3[unassigned1304];MAGEA4[unassigned1304];
636304	chr8	121437595	C	T	chr8:121437595	MRPL13	mitochondrial ribosomal protein L13	9588.0	SNV	0/1	0.48	13_12	25	99	False	rs61753788	EXONIC	YES	NM_014078.6	Transcript	protein_coding	missense_variant		4/7	NM_014078.6:c.257G>A	NP_054797.2:p.Gly86Glu		-1.0	.,.					.	.	.		0.00331374	504.0	152094.0	2.0	32	0.97	PASS	nfe	0.00403036	274.0	0.00403036	274.0	0.00382925	960.0	250702.0	7.0	50	0.94	PASS	nfe	0.00466482	529.0	0.00466482	529.0	0.0034276	533	0.005	15.0				29.3	4.175396	0.849	15	4	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred	MRPL13	0.0	0.01	0.0	0.0	-7.0	3.0	4.0	-49.0						0.593	0.0	0.0	0.999	1.026	.			.	Ribosome	translation;negative regulation of translation;mitochondrial translational elongation;mitochondrial translational termination	mitochondrion;mitochondrial inner membrane;mitochondrial ribosome;mitochondrial large ribosomal subunit;ribosome	RNA binding;mRNA binding;structural constituent of ribosome;protein binding	PDHA1[29128334];TIGD6[26496610];MGST3[29568061];RPS6[29568061];FN1[19738201];MRPL58[20186120];YBX1[22118625];COQ7[27499296];HSPD1[29568061];COQ5[27499296];COQ3[27499296];MRPL50[26496610];MRPL1[26496610];TRAF6[17353931];SDHAF4[27499296];MRPL9[26496610];AURKAIP1[29568061];NIT1[27499296];TRMT61B[29568061];PDK1[29568061];
636852	chr11	1253969	A	G	chr11:1253969	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.39	40_27	69	99	False	rs72846370,COSV71589756	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		17/49	NM_002458.3:c.2034A>G	NP_002449.2:p.Val678%3D		1.0		Benign	criteria_provided,_single_submitter	not_specified	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis	24033266					35	0.98							0.173726	22000.0	126636.0	0.0	37	0.75	InbreedingCoeff_RF	sas	0.249111	4341.0	0.188416	10228.0	0.0019485	303	0.016	54.0	0.32991	3763.0		6.657	0.257617		0	0	0			MUC5B	0.0	0.0	0.0	0.0	-5.0	4.0	31.0	24.0						0.243	1.0	92.056945532			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636853	chr11	1253976	A	G	chr11:1253976	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.39	40_27	69	99	False	rs76956995,COSV71589766	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		17/49	NM_002458.3:c.2041A>G	NP_002449.2:p.Ser681Gly		1.0	Uncharacterised domain, cysteine-rich&Uncharacterised domain, cysteine-rich	Likely_benign	no_assertion_criteria_provided	Idiopathic_Pulmonary_Fibrosis	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						35	0.98							0.0917424	11190.0	121972.0	0.0	32	0.73	RF	sas	0.152159	2283.0	0.0983973	5157.0	0.0019099	297	0.014	46.0	0.32334	3688.0		8.669	0.425615	0.186	1	16	17	PolyPhen	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.0	0.0	0.0	-3.0	-12.0	17.0	28.0						0.243	1.0	92.056945532	0.161	-0.143	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636854	chr11	1253980	A	G	chr11:1253980	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.38	39_25	66	99	False	rs202127660,COSV71589772	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		17/49	NM_002458.3:c.2045A>G	NP_002449.2:p.Asp682Gly		1.0	Uncharacterised domain, cysteine-rich&Uncharacterised domain, cysteine-rich	Likely_benign	no_assertion_criteria_provided	Idiopathic_Pulmonary_Fibrosis	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						35	0.98							0.0514392	6630.0	128890.0	0.0	30	0.72	RF	sas	0.0916195	1360.0	0.0540738	3029.0	0.0018906	294	0.015	50.0	0.32062	3657.0		8.451	0.404947	0.026	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.0	0.0	0.0	33.0	-16.0	13.0	20.0						0.243	1.0	92.056945532	0.331	-0.126	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636855	chr11	1258175	C	T	chr11:1258175	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.46	42_36	78	99	False	rs80092233,COSV71594278	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3078C>T	NP_002449.2:p.Cys1026%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis		0.000184051	28.0	152132.0	0.0	33	0.98	PASS	afr	0.00060334	25.0	4.41228e-05	3.0	0.0885192	8418.0	95098.0	0.0	12	0.11	RF	sas	0.165559	1345.0	0.0757978	3311.0	0.0586287	9117	0.025	83.0	0.13607	1552.0		10.46	0.617746		0	0	0			MUC5B	0.02	0.0	0.0	0.0	45.0	-20.0	-2.0	47.0						0.243	1.0	79.364435481			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636856	chr11	1258192	A	T	chr11:1258192	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.47	37_33	70	99	False	rs76589014,COSV71590129	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		25/49	NM_002458.3:c.3095A>T	NP_002449.2:p.Asn1032Ile		1.0	von Willebrand factor, type D domain&von Willebrand factor, type D domain&von Willebrand factor, type D domain				{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.0830945	8409.0	101198.0	0.0	14	0.19	RF	sas	0.151244	1422.0	0.073025	3411.0	0.0017877	278	0.017	57.0	0.15772	1799.0		22.3	2.396167	0.259	6	13	19	SIFT,PolyPhen,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	MUC5B	0.01	0.01	0.0	0.0	28.0	-32.0	30.0	37.0						0.243	1.0	82.418554501	0.0	-0.103	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636857	chr11	1258197	A	G	chr11:1258197	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.46	38_32	70	99	False	rs78674028,COSV71590132	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		25/49	NM_002458.3:c.3100A>G	NP_002449.2:p.Ile1034Val		1.0	von Willebrand factor, type D domain&von Willebrand factor, type D domain&von Willebrand factor, type D domain				{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.0846457	8750.0	103372.0	0.0	14	0.24	RF	sas	0.149278	1468.0	0.0764333	3613.0	0.0017877	278	0.015	48.0	0.16334	1863.0		0.015	-0.730612	0.027	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.04	0.0	0.0	-42.0	23.0	25.0	23.0						0.243	1.0	82.418554501	0.011	-0.887	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636858	chr11	1258199	C	T	chr11:1258199	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.5	38_38	76	99	False	rs80200632,COSV71593511	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3102C>T	NP_002449.2:p.Ile1034%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.087391	8841.0	101166.0	0.0	15	0.25	RF	sas	0.151806	1471.0	0.0794113	3658.0	0.0017877	278	0.019	63.0	0.17894	2041.0		9.203	0.479041		0	0	0			MUC5B	0.26	0.04	0.0	0.01	21.0	-39.0	21.0	23.0						0.243	1.0	82.418554501			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636859	chr11	1258217	T	G	chr11:1258217	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.53	35_40	75	99	False	rs74648489,COSV71593514	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3120T>G	NP_002449.2:p.Arg1040%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.0729777	7053.0	96646.0	0.0	17	0.39	RF	sas	0.11619	1154.0	0.0717829	3097.0	0.0017813	277	0.022	73.0	0.24198	2760.0		1.011	-0.149128		0	0	0			MUC5B	0.0	0.08	0.0	0.02	42.0	3.0	12.0	5.0						0.243	1.0	46.691060751			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636860	chr11	1258226	C	T	chr11:1258226	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.53	36_41	77	99	False	rs55700357,COSV71593518,COSV71594601	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3129C>T	NP_002449.2:p.Ser1043%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis		0.00270043	411.0	152198.0	4.0	33	0.98	PASS	afr	0.00921459	382.0	0.000117623	8.0	0.0676875	6268.0	92602.0	1.0	18	0.43	RF	sas	0.104322	980.0	0.0660662	2714.0	0.0019163	298	0.026	84.0	0.276	3148.0		1.647	-0.075862		0	0	0			MUC5B	0.0	0.01	0.0	0.0	22.0	-6.0	3.0	-4.0						0.243	1.0	46.691060751			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636861	chr11	1258240	C	T	chr11:1258240	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.51	35_37	72	99	False	rs77287508,COSV71589719,COSV71592058	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		25/49	NM_002458.3:c.3143C>T	NP_002449.2:p.Ala1048Val		1.0	von Willebrand factor, type D domain				{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.0526244	4620.0	87792.0	0.0	19	0.47	RF	sas	0.071087	654.0	0.0548993	2147.0	0.0018006	280	0.025	82.0	0.32877	3750.0		0.295	-0.330964	0.006	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.01	0.0	0.0	19.0	-20.0	-18.0	-11.0						0.243	1.0	93.75406107	0.0	-1.288	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636862	chr11	1258241	A	G	chr11:1258241	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.51	35_36	71	99	False	rs79773885,COSV71589729	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3144A>G	NP_002449.2:p.Ala1048%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.0575908	4647.0	80690.0	0.0	19	0.48	RF	sas	0.0761398	658.0	0.0606495	2159.0	0.0018006	280	0.025	81.0	0.32991	3763.0		0.206	-0.382512		0	0	0			MUC5B	0.01	0.0	0.0	0.0	-21.0	18.0	0.0	-19.0						0.243	1.0	93.75406107			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636863	chr11	1258283	G	A	chr11:1258283	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.52	37_40	77	99	False	rs78669250,COSV71589742,COSV71594415	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3186G>A	NP_002449.2:p.Pro1062%3D		1.0		Benign	criteria_provided,_single_submitter	not_specified	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis	24033266	2.62864e-05	4.0	152170.0	0.0	33	0.98	PASS	amr	6.54279e-05	1.0	1.47037e-05	1.0	0.326614	38447.0	117714.0	0.0	22	0.58	InbreedingCoeff	sas	0.361131	5084.0	0.33916	17618.0	0.0035176	547	0.065	201.0	0.4659	5314.0		0.471	-0.262977		0	0	0			MUC5B	0.06	0.0	0.0	0.0	2.0	19.0	2.0	43.0						0.243	1.0	95.973112222			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636864	chr11	1258286	C	T	chr11:1258286	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.53	37_42	79	99	False	rs77996005,COSV71589885	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3189C>T	NP_002449.2:p.Asp1063%3D		1.0		Benign	criteria_provided,_single_submitter	not_specified	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis	24033266	0.000111686	17.0	152212.0	0.0	33	0.98	PASS	sas	0.000413736	2.0	0.000117606	8.0	0.334102	41561.0	124396.0	0.0	23	0.59	InbreedingCoeff	sas	0.366136	5432.0	0.348686	19313.0	0.0019485	303	0.067	207.0	0.46703	5327.0		1.116	-0.134464		0	0	0			MUC5B	0.0	0.0	0.0	0.0	16.0	-27.0	-40.0	40.0						0.243	1.0	95.973112222			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636865	chr11	1258295	A	G	chr11:1258295	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.51	38_39	77	99	False	rs79118814,COSV71589886	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3198A>G	NP_002449.2:p.Ala1066%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_specified	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis	24033266					33	0.98							0.368597	53375.0	144806.0	0.0	24	0.62	InbreedingCoeff	sas	0.400329	6812.0	0.383733	25410.0	0.0019549	304	0.08	242.0	0.47396	5406.0		2.588	-0.002327		0	0	0			MUC5B	0.0	0.0	0.0	0.0	7.0	37.0	31.0	-3.0						0.243	1.0	95.973112222			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636866	chr11	1260145	T	C	chr11:1260145	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0/1	0.48	33_30	63	99	False	rs75799984,COSV71591607	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3342T>C	NP_002449.2:p.Cys1114%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98											79	0.58							0.0015241	237	0.016	51.0	0.01797	205.0		7.954	0.360193		0	0	0			MUC5B	0.0	0.0	0.0	0.0	-44.0	-29.0	-4.0	22.0						0.243	1.0	63.144663278			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636867	chr11	1260157	G	C	chr11:1260157	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.45	32_26	58	99	False	rs78678736	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3354G>C	NP_002449.2:p.Ser1118%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98											87	0.59							0.0015112	235	0.01	34.0	0.04506	514.0		5.136	0.153911		0	0	0			MUC5B	0.0	0.0	0.0	0.0	-41.0	-32.0	10.0	-43.0						0.243	1.0	63.144663278			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636868	chr11	1260160	T	G	chr11:1260160	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.43	34_26	60	99	False	rs78177850	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3357T>G	NP_002449.2:p.Gly1119%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98											87	0.58							0.0015305	238	0.01	34.0	0.04673	533.0		6.169	0.222565		0	0	0			MUC5B	0.0	0.0	0.0	0.0	-35.0	-44.0	-46.0	-2.0						0.243	1.0	63.144663278			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636869	chr11	1260163	C	T	chr11:1260163	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.41	34_24	58	99	False	rs79220674,COSV101500982,COSV71591608	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3360C>T	NP_002449.2:p.Gly1120%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis		4.59963e-05	7.0	152186.0	0.0	33	0.98	PASS	afr	9.65437e-05	4.0	2.93971e-05	2.0	5.31237e-05	10.0	188240.0	0.0	87	0.59	PASS	afr	0.000190042	2.0	4.96524e-05	4.0	0.0015884	247	0.01	32.0	0.04524	516.0		1.596	-0.080665		0	0	0			MUC5B	0.0	0.0	0.0	0.0	43.0	-47.0	-5.0	4.0						0.243	1.0	0.460690294			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636870	chr11	1260175	T	C	chr11:1260175	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0/1	0.43	34_26	60	99	False	rs75760167,COSV71589947	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3372T>C	NP_002449.2:p.Cys1124%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98											94	0.59							0.0014855	231	0.01	34.0	0.01867	213.0		7.99	0.363316		0	0	0			MUC5B	0.0	0.0	0.0	0.0	-4.0	31.0	-4.0	50.0						0.243	1.0	60.874268431			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636871	chr11	1260193	T	C	chr11:1260193	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0/1	0.41	37_26	63	99	False	rs74763753,COSV71589949	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3390T>C	NP_002449.2:p.Ala1130%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98											90	0.58							0.0014148	220	0.009	31.0	0.01508	172.0		9.552	0.515922		0	0	0			MUC5B	0.0	0.0	0.0	0.0	-20.0	13.0	32.0	34.0						0.243	1.0	82.422249921			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636872	chr11	1260214	C	T	chr11:1260214	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.38	40_24	64	99	False	rs79585387,COSV71596776	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3411C>T	NP_002449.2:p.His1137%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98											84	0.58							0.0014083	219	0.006	19.0	0.03069	350.0		0.065	-0.541187		0	0	0			MUC5B	0.0	0.0	0.0	0.01	-8.0	11.0	43.0	13.0						0.243	1.0	0.0			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636873	chr11	1260217	C	A	chr11:1260217	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.37	40_23	63	99	False	rs79638064,COSV71592285	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		26/49	NM_002458.3:c.3414C>A	NP_002449.2:p.Asp1138Glu		1.0	Uncharacterised domain, cysteine-rich&Uncharacterised domain, cysteine-rich				{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.0	0.0	178860.0	0.0	85	0.58	AC0				0.0	0.0	0.0014019	218	0.007	23.0	0.03139	358.0		2.651	0.001815	0.081	1	17	18	M-CAP_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.0	0.0	0.01	-11.0	8.0	44.0	8.0						0.243	1.0	0.04722779	0.014	-0.214	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636874	chr11	1260219	C	T	chr11:1260219	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.36	39_22	61	99	False	rs75935363,COSV71592287	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		26/49	NM_002458.3:c.3416C>T	NP_002449.2:p.Ala1139Val		1.0	Uncharacterised domain, cysteine-rich&Uncharacterised domain, cysteine-rich				{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis		6.57194e-05	10.0	152162.0	0.0	33	0.98	PASS	afr	9.65298e-05	4.0	4.41073e-05	3.0	5.57631e-05	10.0	179330.0	0.0	84	0.58	PASS	afr	0.000103907	1.0	1.33053e-05	1.0	0.0014083	219	0.007	23.0	0.032	365.0		4.687	0.125836	0.031	1	17	18	M-CAP_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.0	0.0	0.0	-13.0	8.0	6.0	8.0						0.243	1.0	0.0	0.007	0.016	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636875	chr11	1260220	G	A	chr11:1260220	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0|1	0.37	38_22	60	99	False	rs61733358,COSV71596777	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3417G>A	NP_002449.2:p.Ala1139%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis		1.31418e-05	2.0	152186.0	0.0	33	0.98	PASS				0.0	0.0	0.00012612	23.0	182366.0	1.0	86	0.58	PASS	sas	0.00044865	11.0	2.60342e-05	2.0	0.0014533	226	0.007	23.0	0.03235	369.0		0.435	-0.2745		0	0	0			MUC5B	0.0	0.0	0.0	0.0	2.0	7.0	37.0	5.0						0.243	1.0	88.302115862			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636877	chr11	1265817	C	T	chr11:1265817	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0/1	0.41	20_14	34	99	False	rs201828261,COSV71591496	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		31/49	NM_002458.3:c.7707C>T	NP_002449.2:p.Ser2569%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis		0.000698803	106.0	151688.0	0.0	30	0.91	PASS	nfe	0.00122321	83.0	0.00122321	83.0	0.000587979	146.0	248308.0	0.0	100	1.0	RF	nfe	0.00104982	118.0	0.00104982	118.0	0.0003151	49	0.002	5.0	0.00052	5.0		0.029	-0.650731		0	0	0			MUC5B	0.0	0.0	0.0	0.0	8.0	29.0	-8.0	27.0						0.243	1.0				immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
636878	chr11	1269764	G	T	chr11:1269764	MUC5B	mucin 5B, oligomeric mucus/gel-forming	9608.0	SNV	0/1	0.55	10_12	22	99	False	rs201915227,COSV71590444,COSV71591562,COSV71594669	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		31/49	NM_002458.3:c.11654G>T	NP_002449.2:p.Arg3885Leu		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis		0.00277679	420.0	151254.0	2.0	30	0.92	PASS	afr	0.00790013	324.0	0.00026544	18.0	0.001268	315.0	248422.0	7.0	100	1.0	PASS	afr	0.00810636	125.0	0.000230939	26.0	0.0000965	15			0.00073	7.0		0.003	-1.004915	0.129	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.0	0.0	0.0	-9.0	-14.0	-9.0	-5.0						0.243	1.0		0.0	-3.989	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.
637794	chr16	3021328	G	A	chr16:3021328	PAQR4	progestin and adipoQ receptor family member 4	9645.0	SNV	0/1	0.47	20_18	38	99	False	rs148564217	EXONIC	YES	NM_152341.5	Transcript	protein_coding	missense_variant		2/3	NM_152341.5:c.337G>A	NP_689554.2:p.Ala113Thr		1.0	.,.,.,.					.	.	.		0.00157681	240.0	152206.0	2.0	34	0.99	PASS	nfe	0.00301364	205.0	0.00301364	205.0	0.00158033	395.0	249948.0	2.0	96	1.0	PASS	nfe	0.00269439	305.0	0.00269439	305.0	0.0014726	229	0.004	11.0				16.27	1.500339	0.003	1	18	19	fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	PAQR4	0.0	0.01	0.0	0.0	-28.0	-17.0	29.0	-5.0						0.708	0.0	0.0	0.841	-0.483	.			caudate nucleus;amygdala;occipital lobe;prefrontal cortex;whole brain;spinal cord;parietal lobe;hypothalamus;thalamus;	.	.	integral component of membrane	signaling receptor activity	.
638973	chr18	70209125	C	T	chr18:70209125	CBLN2	cerebellin 2 precursor	9670.0	SNV	0/1	0.67	10_20	30	99	False	rs1216860574,COSV54050813	EXONIC	YES	NM_182511.4	Transcript	protein_coding	missense_variant		3/5	NM_182511.4:c.271G>A	NP_872317.1:p.Ala91Thr		-1.0	C1q domain&C1q domain,C1q domain&C1q domain					.	.	.						33	0.97							0.0	0.0	241820.0	0.0	30	0.81	AC0				0.0	0.0								25.7	3.693036	0.267	13	8	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	CBLN2	0.0	0.01	0.0	0.0	1.0	23.0	27.0	-5.0						0.0867	0.32	85.364968608	1.0	1.026	.			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;globus pallidus;	.	positive regulation of synapse assembly;regulation of presynapse assembly	extracellular space;glutamatergic synapse	.	.
639770	chr1	11594594	G	A	chr1:11594594	DISP3	dispatched RND transporter family member 3	9707.0	SNV	0/1	0.62	15_25	40	99	False	rs61750330	EXONIC	YES	NM_020780.2	Transcript	protein_coding	missense_variant		18/21	NM_020780.2:c.3532G>A	NP_065831.1:p.Val1178Ile		1.0						.	.	.		0.000637311	97.0	152202.0	0.0	33	0.98	PASS	nfe	0.00119044	81.0	0.00119044	81.0	0.000546362	132.0	241598.0	0.0	32	0.83	PASS	nfe	0.00103596	113.0	0.00103596	113.0	0.0005595	87	0.001	3.0				16.09	1.468694	0.23	2	15	17	M-CAP_pred,FATHMM_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PTCHD2	0.0	0.0	0.23	0.85	15.0	-1.0	3.0	-1.0								0.0	0.953	0.063	.			.	.	smoothened signaling pathway;cholesterol metabolic process;regulation of lipid transport;cholesterol homeostasis;negative regulation of neuron differentiation;positive regulation of lipid metabolic process;positive regulation of neural precursor cell proliferation	cytoplasm;endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane;cytoplasmic vesicle membrane;nuclear membrane	molecular_function	RPS14[30021884];MYCBP[16169070];CA2[16169070];MTNR1B[26514267];DDX21[30021884];RASGRP2[16169070];MDFI[16169070];
640124	chr15	65412138	T	C	chr15:65412138	PDCD7	programmed cell death 7	9717.0	SNV	0/1	0.56	12_15	27	99	False	rs1333932777	EXONIC	YES	NM_005707.2	Transcript	protein_coding	synonymous_variant		3/5	NM_005707.2:c.1164A>G	NP_005698.1:p.Glu388%3D		-1.0						.	.	.		6.57073e-06	1.0	152190.0	0.0	32	0.96	PASS	nfe	1.46959e-05	1.0	1.46959e-05	1.0					68	0.96														11.35	0.724156		0	0	0			PDCD7	0.0	0.0	0.0	0.0	28.0	-46.0	1.0	10.0							0.05	52.92679078			.			.	.	mRNA splicing, via spliceosome;apoptotic process;RNA splicing;response to glucocorticoid	nucleoplasm;U12-type spliceosomal complex	.	RPL10[26496610];FEZ1[16169070];EIF3J[30021884];PRPF40A[15231748];HIST1H2BH[30021884];HAP1[16169070];SMNDC1[17353931];MARK2[26496610];PTBP3[22575643];
640213	chr1	43032115	A	G	chr1:43032115	CCDC30	coiled-coil domain containing 30	9719.0	SNV	0/1	0.36	14_8	22	99	False	rs149520698	EXONIC	YES	NM_001080850.3	Transcript	protein_coding	missense_variant		7/17	NM_001080850.3:c.824A>G	NP_001074319.1:p.His275Arg		1.0	.,.,.					.	.	.		0.000308792	47.0	152206.0	0.0	32	0.97	PASS	amr	0.000981675	15.0	0.000367453	25.0	0.000231341	58.0	250712.0	0.0	54	0.98	PASS	amr	0.00037703	13.0	0.000370913	42.0	0.0002765	43	0.001	4.0				24.8	3.449638	0.537	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	CCDC30	0.0	0.0	0.0	0.0	-1.0	7.0	-1.0	31.0						0.969	0.0	0.0	1.0	1.312	.			trigeminal ganglion;superior cervical ganglion;skeletal muscle;globus pallidus;	.	.	.	.	BRAP[25820252];CCT6A[30021884];
644297	chrX	2833605	C	T	chrX:2833605	ARSD	arylsulfatase D	9762.0	SNV	0/1	0.17	14_5	30	99	False	rs111939179,COSV54198347	EXONIC	YES	NM_001669.4	Transcript	protein_coding	stop_gained		6/10	NM_001669.4:c.992G>A	NP_001660.2:p.Trp331Ter		-1.0	Sulfatase, N-terminal					.	.	.						23	0.61							0.0	0.0	131297.0	0.0	55	0.99	AC0_RF				0.0	0.0	0.1203828	18720	0.021	63.0				35.0	6.138005		4	1	5	BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred,fathmm-MKL_coding_pred	MutationTaster_pred	ARSD	0.0	0.0	0.0	0.11	-8.0	41.0	43.0	-8.0						0.0885	0.29		0.729	0.758	.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644298	chrX	2833628	A	C	chrX:2833628	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.17	15_5	29	99	False	rs373216270,COSV54199329,COSV54199393	EXONIC	YES	NM_001669.4	Transcript	protein_coding	synonymous_variant		6/10	NM_001669.4:c.969T>G	NP_001660.2:p.Gly323%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.						24	0.61							0.0	0.0	131354.0	0.0	63	0.99	AC0_RF				0.0	0.0	0.0007395	115	0.035	107.0				0.525	-0.24682		0	0	0			ARSD	0.0	0.0	0.0	0.01	-31.0	36.0	20.0	-31.0						0.0885	0.29				.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644301	chrX	2833631	A	G	chrX:2833631	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.21	15_6	29	99	False	rs377542415,COSV54199259	EXONIC	YES	NM_001669.4	Transcript	protein_coding	synonymous_variant		6/10	NM_001669.4:c.966T>C	NP_001660.2:p.Tyr322%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.						24	0.61							0.0	0.0	132635.0	0.0	68	0.99	AC0_RF				0.0	0.0	0.0007395	115	0.032	100.0				0.233	-0.364909		0	0	0			ARSD	0.0	0.0	0.01	0.0	33.0	-34.0	-34.0	17.0						0.0885	0.29				.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644303	chrX	2833638	C	T	chrX:2833638	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.23	16_7	31	99	False	rs370769167,COSV54198357	EXONIC	YES	NM_001669.4	Transcript	protein_coding	missense_variant		6/10	NM_001669.4:c.959G>A	NP_001660.2:p.Gly320Asp		-1.0	Sulfatase, N-terminal					.	.	.						23	0.61							7.66771e-06	1.0	130417.0	0.0	70	0.99	RF	sas	0.00010523	1.0	0.0	0.0	0.0007395	115	0.039	120.0				22.8	2.64565	0.687	16	3	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MutationTaster_pred,MetaRNN_pred,PrimateAI_pred	ARSD	0.0	0.0	0.0	0.0	26.0	-41.0	-41.0	-8.0						0.0885	0.29		0.005	0.758	.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644305	chrX	2833643	C	A	chrX:2833643	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.24	17_8	33	99	False	rs115332247,COSV54198367	EXONIC	YES	NM_001669.4	Transcript	protein_coding	missense_variant		6/10	NM_001669.4:c.954G>T	NP_001660.2:p.Gln318His		-1.0	Sulfatase, N-terminal					.	.	.						23	0.61							1.54494e-05	2.0	129455.0	0.0	72	0.99	RF	sas	0.000106259	1.0	0.0	0.0	0.0007460	116	0.044	134.0				0.058	-0.557435	0.127	4	14	18	M-CAP_pred,MetaLR_pred,FATHMM_pred,DEOGEN2_pred	SIFT,PolyPhen,LRT_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ARSD	0.0	0.0	0.0	0.0	21.0	-1.0	-46.0	5.0						0.0885	0.29		0.0	-1.294	.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644526	chrX	2835863	G	T	chrX:2835863	ARSD	arylsulfatase D	9762.0	SNV	0/1	0.28	18_9	32	99	False	rs78034736,COSV54198377	EXONIC	YES	NM_001669.4	Transcript	protein_coding	missense_variant		5/10	NM_001669.4:c.845C>A	NP_001660.2:p.Ala282Asp		-1.0	Sulfatase, N-terminal					.	.	.		8.8713e-06	1.0	112723.0	0.0	23	0.63	PASS	afr	3.21678e-05	1.0	0.0	0.0	5.97387e-05	7.0	117177.0	0.0	31	0.85	InbreedingCoeff	sas	0.000251921	2.0	5.89194e-05	3.0	0.0030096	468	0.088	279.0				23.5	2.980152	0.612	12	6	18	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred	ARSD	0.0	0.0	0.0	0.0	0.0	-19.0	-18.0	38.0						0.0885	0.29		0.001	0.028	.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644528	chrX	2835964	G	A	chrX:2835964	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.32	14_10	31	99	False	rs73632972,COSV54198056	EXONIC	YES	NM_001669.4	Transcript	protein_coding	synonymous_variant		5/10	NM_001669.4:c.744C>T	NP_001660.2:p.Phe248%3D		-1.0						.	.	.		8.84048e-06	1.0	113116.0	0.0	24	0.63	PASS	nfe	1.87329e-05	1.0	1.87329e-05	1.0	0.0	0.0	120103.0	0.0	71	0.93	AC0_RF				0.0	0.0	0.0007588	118	0.097	302.0				1.121	-0.133793		0	0	0			ARSD	0.0	0.0	0.0	0.0	-36.0	-2.0	13.0	-2.0						0.0885	0.29				.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644530	chrX	2835985	G	A	chrX:2835985	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.3	16_10	33	99	False	rs748243474,COSV54200219	EXONIC	YES	NM_001669.4	Transcript	protein_coding	synonymous_variant		5/10	NM_001669.4:c.723C>T	NP_001660.2:p.Phe241%3D		-1.0						.	.	.		8.83033e-06	1.0	113246.0	0.0	24	0.63	PASS	nfe	1.8721e-05	1.0	1.8721e-05	1.0	8.12473e-06	1.0	123081.0	0.0	73	0.9	RF	nfe	1.86161e-05	1.0	1.86161e-05	1.0	0.0008553	133	0.034	105.0				5.41	0.171578		0	0	0			ARSD	0.0	0.02	0.0	0.0	18.0	34.0	18.0	-8.0						0.0885	0.29				.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644533	chrX	2835989	A	C	chrX:2835989	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.32	17_11	34	99	False	rs143238998,COSV54198393	EXONIC	YES	NM_001669.4	Transcript	protein_coding	missense_variant		5/10	NM_001669.4:c.719T>G	NP_001660.2:p.Phe240Cys		-1.0	Sulfatase, N-terminal					.	.	.		8.83267e-06	1.0	113216.0	0.0	23	0.63	PASS	nfe	1.87252e-05	1.0	1.87252e-05	1.0	8.09815e-06	1.0	123485.0	0.0	72	0.89	RF	nfe	1.85684e-05	1.0	1.85684e-05	1.0	0.0008167	127	0.03	96.0				16.15	1.478667	0.121	7	9	16	SIFT,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred	PolyPhen,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ARSD	0.0	0.0	0.0	0.0	30.0	33.0	-47.0	-12.0						0.0885	0.29		0.017	0.961	.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644535	chrX	2835993	G	A	chrX:2835993	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.33	16_11	33	99	False	rs755296450,COSV54201280	EXONIC	YES	NM_001669.4	Transcript	protein_coding	synonymous_variant		5/10	NM_001669.4:c.715C>T	NP_001660.2:p.Leu239%3D		-1.0						.	.	.		8.83361e-06	1.0	113204.0	0.0	23	0.63	PASS	nfe	1.87241e-05	1.0	1.87241e-05	1.0	1.61819e-05	2.0	123595.0	0.0	72	0.88	RF	eas	9.93443e-05	1.0	1.85453e-05	1.0	0.0008103	126	0.026	82.0				6.229	0.226793		0	0	0			ARSD	0.0	0.01	0.0	0.0	10.0	26.0	10.0	-16.0						0.0885	0.29				.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644537	chrX	2835995	C	A	chrX:2835995	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.34	15_11	32	99	False	rs150899882,COSV54198404	EXONIC	YES	NM_001669.4	Transcript	protein_coding	missense_variant		5/10	NM_001669.4:c.713G>T	NP_001660.2:p.Cys238Phe		-1.0	Sulfatase, N-terminal					.	.	.		8.83306e-06	1.0	113211.0	0.0	24	0.63	PASS	nfe	1.87234e-05	1.0	1.87234e-05	1.0	8.08662e-06	1.0	123661.0	0.0	70	0.87	RF	nfe	1.8536e-05	1.0	1.8536e-05	1.0	0.0007267	113	0.026	82.0				1.722	-0.068872	0.036	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ARSD	0.0	0.0	0.0	0.0	24.0	29.0	-18.0	1.0						0.0885	0.29		0.003	-0.451	.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644538	chrX	2835999	CCACGCCGG		chrX:2835999-2836007	ARSD	arylsulfatase D	9762.0	deletion	0|1	0.32	17_11	34	99	False	rs113556864	EXONIC	YES	NM_001669.4	Transcript	protein_coding	inframe_deletion		5/10	NM_001669.4:c.701_709del	NP_001660.2:p.Ala234_Val236del		-1.0						.	.	.		8.83431e-06	1.0	113195.0	0.0	23	0.63	PASS	nfe	1.8722e-05	1.0	1.8722e-05	1.0	7.96895e-06	1.0	125487.0	0.0	63	0.8	RF	nfe	1.82129e-05	1.0	1.82129e-05	1.0	0.0006752	105	0.02	62.0				9.08	0.466346		0	0	0																	0.0885	0.29				.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644540	chrX	2836041	A	T	chrX:2836041	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.37	17_13	35	99	False	rs67272620,COSV54198142	EXONIC	YES	NM_001669.4	Transcript	protein_coding	missense_variant		5/10	NM_001669.4:c.667T>A	NP_001660.2:p.Phe223Ile		-1.0	Sulfatase, N-terminal					.	.	.		8.82153e-06	1.0	113359.0	0.0	25	0.65	PASS	sas	0.000357398	1.0	0.0	0.0	7.57939e-05	9.0	118743.0	0.0	64	0.75	PASS	sas	0.000476985	4.0	7.79514e-05	4.0	0.0007910	123	0.067	200.0				0.262	-0.348439	0.085	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ARSD	0.0	0.03	0.0	0.0	-2.0	-22.0	-38.0	-22.0						0.0885	0.29		0.001	-0.435	.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644543	chrX	2836047	C	T	chrX:2836047	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.36	18_13	36	99	False	rs67359049,COSV54198148	EXONIC	YES	NM_001669.4	Transcript	protein_coding	missense_variant		5/10	NM_001669.4:c.661G>A	NP_001660.2:p.Gly221Ser		-1.0	Sulfatase, N-terminal					.	.	.		1.76535e-05	2.0	113292.0	0.0	24	0.65	PASS	sas	0.000356888	1.0	1.87203e-05	1.0	6.82018e-05	8.0	117299.0	0.0	61	0.73	RF	sas	0.000605107	5.0	3.95343e-05	2.0	0.0007781	121	0.071	211.0				14.2	1.121255	0.232	5	13	18	PolyPhen,Polyphen2_HDIV_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred	SIFT,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ARSD	0.01	0.0	0.0	0.0	-28.0	45.0	-26.0	0.0						0.0885	0.29		0.001	-0.144	.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644544	chrX	2836060	G	A	chrX:2836060	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.41	15_13	32	99	False	rs113318393,COSV54198912	EXONIC	YES	NM_001669.4	Transcript	protein_coding	synonymous_variant		5/10	NM_001669.4:c.648C>T	NP_001660.2:p.Ala216%3D		-1.0						.	.	.		4.41673e-05	5.0	113206.0	0.0	25	0.65	PASS	eas	0.000280426	1.0	1.87287e-05	1.0	7.02204e-05	8.0	113927.0	0.0	54	0.69	PASS	sas	0.000496709	4.0	2.05082e-05	1.0	0.0008103	126	0.075	219.0				1.081	-0.139265		0	0	0			ARSD	0.01	0.0	0.0	0.0	-41.0	-7.0	-41.0	-39.0						0.0885	0.29				.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644546	chrX	2836084	C	G	chrX:2836084	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.41	15_12	29	99	False	rs73632973,COSV99471907	EXONIC	YES	NM_001669.4	Transcript	protein_coding	synonymous_variant		5/10	NM_001669.4:c.624G>C	NP_001660.2:p.Ala208%3D		-1.0						.	.	.		0.000255863	29.0	113342.0	0.0	25	0.65	PASS	nfe	0.000318334	17.0	0.000318334	17.0	0.000379881	42.0	110561.0	0.0	47	0.65	PASS	sas	0.00089172	7.0	0.000636308	30.0	0.1365238	21230	0.087	256.0				0.607	-0.22528		0	0	0			ARSD	0.0	0.0	0.0	0.0	-26.0	8.0	20.0	-37.0						0.0885	0.29				.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644548	chrX	2836138	G	A	chrX:2836138	ARSD	arylsulfatase D	9762.0	SNV	0/1	0.41	15_12	29	99	False	rs73632974,COSV54198275	EXONIC	YES	NM_001669.4	Transcript	protein_coding	synonymous_variant		5/10	NM_001669.4:c.570C>T	NP_001660.2:p.Pro190%3D		-1.0						.	.	.		0.000123664	14.0	113210.0	0.0	24	0.65	PASS	sas	0.00142197	4.0	5.61777e-05	3.0	0.000231546	25.0	107970.0	0.0	36	0.62	InbreedingCoeff	sas	0.00146471	11.0	0.000108148	5.0	0.0008038	125	0.086	272.0				1.886	-0.054527		0	0	0			ARSD	0.0	0.0	0.0	0.0	10.0	6.0	47.0	20.0						0.0885	0.29				.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644550	chrX	2836181	A	T	chrX:2836181	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.2	14_4	20	99	False	rs73632975,COSV54198310	EXONIC	YES	NM_001669.4	Transcript	protein_coding	missense_variant		5/10	NM_001669.4:c.527T>A	NP_001660.2:p.Met176Lys		-1.0	Sulfatase, N-terminal					.	.	.		8.85983e-06	1.0	112869.0	0.0	24	0.65	PASS	nfe	1.87505e-05	1.0	1.87505e-05	1.0	3.57887e-05	4.0	111767.0	0.0	29	0.64	InbreedingCoeff	amr	5.003e-05	1.0	4.14285e-05	2.0	0.0007910	123	0.098	310.0				22.7	2.587059	0.473	7	9	16	SIFT,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred	ARSD	0.01	0.02	0.0	0.0	-2.0	-33.0	4.0	-33.0						0.0885	0.29		0.47	0.961	.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644553	chrX	2836184	C	T	chrX:2836184	ARSD	arylsulfatase D	9762.0	SNV	0|1	0.19	14_4	21	99	False	rs73632976,COSV54198319	EXONIC	YES	NM_001669.4	Transcript	protein_coding	missense_variant		5/10	NM_001669.4:c.524G>A	NP_001660.2:p.Gly175Asp		-1.0	Sulfatase, N-terminal					.	.	.		1.77247e-05	2.0	112837.0	0.0	25	0.65	PASS	nfe	3.75073e-05	2.0	3.75073e-05	2.0	6.28022e-05	7.0	111461.0	0.0	28	0.64	InbreedingCoeff	afr	0.000109999	1.0	8.31411e-05	4.0	0.0009260	144	0.094	296.0				24.2	3.25214	0.677	12	6	18	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred	Polyphen2_HVAR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,LIST-S2_pred	ARSD	0.0	0.0	0.0	0.0	-13.0	-36.0	-35.0	1.0						0.0885	0.29		0.438	0.758	.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644555	chrX	2836211	A	T	chrX:2836211	ARSD	arylsulfatase D	9762.0	SNV	0/1	0.19	14_4	21	85	False	rs73632977,COSV54198326	EXONIC	YES	NM_001669.4	Transcript	protein_coding	missense_variant		5/10	NM_001669.4:c.497T>A	NP_001660.2:p.Leu166Gln		-1.0	Sulfatase, N-terminal					.	.	.		1.76979e-05	2.0	113008.0	0.0	24	0.65	PASS	nfe	3.74784e-05	2.0	3.74784e-05	2.0	0.00011634	13.0	111741.0	0.0	22	0.57	InbreedingCoeff_RF	amr	0.000150075	3.0	8.29858e-05	4.0	0.0007974	124	0.096	303.0				18.39	1.825152	0.106	7	11	18	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ARSD	0.0	0.0	0.0	0.0	-2.0	-26.0	-2.0	-26.0						0.0885	0.29		0.007	0.083	.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
644556	chrX	2836238	G	A	chrX:2836238	ARSD	arylsulfatase D	9762.0	SNV	0/1	0.28	15_7	25	99	False	rs73632978,COSV54198457	EXONIC	YES	NM_001669.4	Transcript	protein_coding	missense_variant		5/10	NM_001669.4:c.470C>T	NP_001660.2:p.Ser157Phe		-1.0	Sulfatase, N-terminal					.	.	.		8.86022e-05	10.0	112864.0	0.0	24	0.65	PASS	afr	0.000192821	6.0	5.62345e-05	3.0	0.000142378	15.0	105353.0	0.0	17	0.41	PASS	afr	0.000442478	4.0	0.000109455	5.0	0.0007974	124	0.082	255.0				9.681	0.529975	0.095	3	13	16	PROVEAN_pred,FATHMM_pred,DEOGEN2_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ARSD	0.0	0.0	0.0	0.0	30.0	16.0	16.0	7.0						0.0885	0.29		0.003	0.867	.			pons;ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;prostate;skeletal muscle;	Androgen and estrogen metabolism;Sphingolipid metabolism	.	lysosome;endoplasmic reticulum lumen	arylsulfatase activity;metal ion binding	.
648113	chr2	152448658		A	chr2:152448657-152448658	NEB	nebulin	9863.0	insertion	0/1	0.24	32_10	42	99	False		SPLICING	YES	NM_001271208.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	94/182		NM_001271208.2:c.14722-6dup			-1.0					Nemaline myopathy 2, autosomal recessive, 256030 (3), Autosomal recessive; Arthrogryposis multiplex congenita 6, 619334 (3), Autosomal recessive	Severe congenital nemaline myopathy;Intermediate nemaline myopathy;Typical nemaline myopathy;Childhood-onset nemaline myopathy;Distal nebulin myopathy;Lethal multiple pterygium syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Neuromuscular dysphagia;Scoliosis;Limb muscle weakness;EMG: myopathic abnormalities;Slender build;Narrow face;Generalized hypotonia;Clumsiness;Fetal akinesia sequence;Pes cavus;Generalized limb muscle atrophy;Reduced vital capacity;Increased muscle lipid content;Nemaline bodies;Cardiomyopathy;Breech presentation;Narrow chest;Muscle stiffness;Waddling gait;Micrognathia;Difficulty walking;Areflexia;Long face;Feeding difficulties;Hyporeflexia;Hypertelorism;Neck muscle weakness;Polyhydramnios;Increased variability in muscle fiber diameter;Mildly elevated creatine kinase;Motor delay;Spinal rigidity;Ptosis;High palate;Bulbar signs;Type 1 muscle fiber predominance;Respiratory insufficiency due to muscle weakness;Arthrogryposis multiplex congenita;Exercise intolerance;Facial diplegia;Bradykinesia;Scapular winging;Fatigable weakness of bulbar muscles;Nemaline bodies;Increased connective tissue;Severe muscular hypotonia;Edema of the dorsum of hands;Dysphagia;Abnormality of the diaphragm;Thin ribs;Decreased fetal movement;Adducted thumb;Motor delay;Premature birth;Breech presentation;Skeletal muscle atrophy;Polyhydramnios;Pulmonary hypoplasia;Axial muscle weakness;Low-set ears;Hypospadias;Large fontanelles;Hypokinesia;Ophthalmoplegia;Arthrogryposis multiplex congenita;Micropenis;Type 1 muscle fiber predominance;Respiratory failure;Facial diplegia;Multiple prenatal fractures;Abnormality of the rib cage;EMG: neuropathic changes;Cleft palate;Neonatal hypotonia;Respiratory insufficiency due to muscle weakness;Hyperlordosis;Apnea;Low-set ears;Type 1 muscle fiber predominance;Late-onset distal muscle weakness;Generalized muscle weakness;Flexion contracture;Facial palsy;High palate;Hand clenching;Arthrogryposis multiplex congenita;Spinal rigidity;Limb muscle weakness;Nemaline bodies;Inability to walk;Proximal muscle weakness;Infantile onset;Neck flexor weakness;Hyporeflexia;Slender build;Areflexia;Waddling gait;Heterogeneous;Frequent falls;Motor delay;Talipes;Scoliosis;Hypertelorism;Feeding difficulties;Bulbar palsy;Autosomal recessive inheritance;Polyhydramnios;Mildly elevated creatine kinase;Long philtrum;EMG: myopathic abnormalities;Decreased fetal movement;Myopathic facies;Mitochondrial depletion;Dysphagia;Areflexia;Dysphagia;Severe muscular hypotonia;Ophthalmoplegia;Respiratory failure;Skeletal muscle atrophy;Nemaline bodies;Long philtrum;Hyporeflexia;Low-set ears;Difficulty walking;Decreased fetal movement;EMG: myopathic abnormalities;High, narrow palate;Motor delay;Abnormality of the thorax;Hypokinesia;Arthrogryposis multiplex congenita;Type 1 muscle fiber predominance;Generalized muscle weakness;Facial diplegia;Hypertelorism;Premature birth;Multiple prenatal fractures;Myopathic facies;Polyhydramnios;Spinal rigidity;Scoliosis;Hypokinesia;Myopathy;Hyperlordosis;Short neck;Genu valgum;High palate;Arthrogryposis multiplex congenita;Hyporeflexia;Foot dorsiflexor weakness;Ptosis;Narrow face;Respiratory insufficiency;Genu varum;Narrow chest;Fatiguable weakness of proximal limb muscles;Elevated serum creatine kinase;Polyhydramnios;Type 1 muscle fiber predominance;Axial muscle weakness;Fatigable weakness of respiratory muscles;Kyphosis;Hip dislocation;Limb-girdle muscle weakness;Feeding difficulties;Micrognathia;Increased variability in muscle fiber diameter;Nemaline bodies;Fatigable weakness of distal limb muscles;Waddling gait;Neck flexor weakness;Nocturnal hypoventilation;Neonatal hypotonia;Pectus excavatum;Facial diplegia;Cardiomyopathy;Progressive distal muscle weakness;Progressive proximal muscle weakness;Fatty replacement of skeletal muscle;Slender build;Weakness of long finger extensor muscles;Weakness of facial musculature;Exertional dyspnea;EMG: myopathic abnormalities;Weakness of the intrinsic hand muscles;Foot dorsiflexor weakness;Sternocleidomastoid amyotrophy;Ankle flexion contracture;Nemaline bodies;High palate;Neck flexor weakness						26	0.86											60	0.6																	0	0	0			NEB	0.0	0.0	0.0	0.0	-5.0	4.0	-9.0	-5.0						0.995	0.0				mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; vision/eye phenotype; muscle phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; 			fetal thyroid;ciliary ganglion;thyroid;tongue;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skin;skeletal muscle;	.	muscle organ development;somatic muscle development;muscle filament sliding;regulation of actin filament length;muscle fiber development;cardiac muscle thin filament assembly	cytosol;actin cytoskeleton;Z disc;extracellular exosome	protein binding;structural constituent of muscle;actin filament binding	ROCK1[21281639];DOCK9[23414517];DYSF[23414517];TULP3[23414517];ENO3[23414517];STYXL1[17353931];MYPN[12482578];MYOM2[23414517];ACTB[30021884];TTN[16902413;12482578];STK3[23455922];S100A10[30021884];SVIL[18639526];TRIM63[18157088];SMURF2[18157088];NEK4[25798074];AKTIP[23414517];STRADB[23414517];PTPN11[23414517];MAPK14[23602568];KLHL41[23414517];HIST2H2BE[30021884];HIST1H4A[30021884];APC[20936779];CAPZA1[16902413];ABI1[15048123];ACO1[23414517];VIM[30021884];SOS1[12482578];OPTN[23414517];LIMS1[23414517];
650182	chr14	31771579	G	A	chr14:31771579	HEATR5A	HEAT repeat containing 5A	9881.0	SNV	0/1	0.6	8_12	20	99	True	rs372690763	EXONIC	YES	NM_015473.4	Transcript	protein_coding	missense_variant		33/36	NM_015473.4:c.5386C>T	NP_056288.2:p.Arg1796Trp		-1.0						.	.	.		1.31707e-05	2.0	151852.0	0.0	31	0.93	PASS	amr	6.56944e-05	1.0	0.0	0.0	0.0	0.0	232682.0	0.0	78	0.66	AC0				0.0	0.0	0.0000064	1						24.3	3.281849	0.37	13	5	18	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred	HEATR5A	0.0	0.01	0.0	0.0	-12.0	-7.0	44.0	-15.0								25.489999947	0.718	0.129	.			.	.	endocytosis;protein localization;retrograde transport, endosome to Golgi	cytosol;endocytic vesicle	.	CSDE1[26496610];WDYHV1[unassigned1304];
650884	chr19	36297505	G	C	chr19:36297505	PRODH2	proline dehydrogenase 2	9900.0	SNV	0/1	0.58	10_14	24	99	False	rs199648657	SPLICING	YES	NM_021232.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	6/9		NM_021232.2:c.835-7C>G			-1.0						.	.	.		5.25659e-05	8.0	152190.0	0.0	32	0.97	PASS	nfe	8.81938e-05	6.0	8.81938e-05	6.0	0.000107581	27.0	250974.0	0.0	92	1.0	PASS	nfe	0.000185188	21.0	0.000185188	21.0	0.0001286	20	0.0	1.0				4.93	0.140903		0	0	0			PRODH2	0.01	0.27	0.0	0.0	-38.0	-7.0	5.0	-11.0	7.00433108229305e-05	0.096	9.255	1.38	10.635	0.93	0.0				.			pons;ciliary ganglion;kidney;liver;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	proline catabolic process;proline catabolic process to glutamate;glyoxylate metabolic process;oxidation-reduction process	mitochondrion;mitochondrial inner membrane	proline dehydrogenase activity;oxidoreductase activity, acting on the CH-NH group of donors;FAD binding	.
653015	chr11	1213209	T	C	chr11:1213209	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0|1	0.24	86_27	113	99	False	rs377214284	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	synonymous_variant		18/38	NM_001304359.2:c.2325T>C	NP_001291288.1:p.Ser775%3D		1.0						.	.	.						33	0.97							2.5598e-05	5.0	195328.0	0.0	100	0.98	RF	nfe	4.64608e-05	4.0	4.64608e-05	4.0	0.0001543	24	0.02	63.0				1.364	-0.104556		0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653016	chr11	1213210	G	A	chr11:1213210	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0|1	0.24	86_27	113	99	False	rs760860269	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	missense_variant		18/38	NM_001304359.2:c.2326G>A	NP_001291288.1:p.Val776Ile		1.0						.	.	.						33	0.97							2.42349e-05	5.0	206314.0	0.0	100	0.98	RF	nfe	4.28495e-05	4.0	4.28495e-05	4.0	0.0001543	24	0.02	64.0				1.597	-0.080584		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred																		0.004	0.634	immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653017	chr11	1213245	T	A	chr11:1213245	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0|1	0.84	23_125	148	99	False	rs67624660	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	missense_variant		18/38	NM_001304359.2:c.2361T>A	NP_001291288.1:p.Ser787Arg		1.0						.	.	.		1.31396e-05	2.0	152212.0	0.0	33	0.97	PASS	afr	2.41231e-05	1.0	1.46985e-05	1.0	0.363113	13234.0	36446.0	0.0	100	0.98	InbreedingCoeff	nfe	0.414794	8490.0	0.414794	8490.0	0.0098004	1524	0.088	263.0				0.43	-0.276195		1	6	7	SIFT	PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred																		0.0	-5.38	immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653018	chr11	1213257	T	C	chr11:1213257	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0|1	0.85	23_127	150	99	False	rs76779582	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	synonymous_variant		18/38	NM_001304359.2:c.2373T>C	NP_001291288.1:p.Pro791%3D		1.0						.	.	.						33	0.97							0.255527	12667.0	49572.0	0.0	100	0.98	InbreedingCoeff	nfe	0.31037	8069.0	0.31037	8069.0	0.0002894	45	0.041	117.0				5.096	0.151362		0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653019	chr11	1213259	T	G	chr11:1213259	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0|1	0.85	23_127	150	99	False	rs75991767	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	missense_variant		18/38	NM_001304359.2:c.2375T>G	NP_001291288.1:p.Leu792Arg		1.0						.	.	.						33	0.97							0.259469	12345.0	47578.0	0.0	100	0.98	InbreedingCoeff	nfe	0.316323	7829.0	0.316323	7829.0	0.0002830	44	0.022	64.0				0.6	-0.226935		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred																		0.0	-0.806	immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653020	chr11	1213264	G	A	chr11:1213264	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0|1	0.85	23_133	156	99	False	rs72846341	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	missense_variant		18/38	NM_001304359.2:c.2380G>A	NP_001291288.1:p.Ala794Thr		1.0						.	.	.		1.31394e-05	2.0	152214.0	0.0	33	0.97	PASS	afr	4.82579e-05	2.0	0.0	0.0	0.293313	12379.0	42204.0	0.0	100	0.98	InbreedingCoeff	nfe	0.347505	7855.0	0.347505	7855.0	0.0049002	762	0.003	9.0				0.917	-0.163575		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred																		0.0	-1.831	immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653021	chr11	1213275	G	A	chr11:1213275	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0/1	0.13	127_19	146	99	False	rs71251383	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	synonymous_variant		18/38	NM_001304359.2:c.2391G>A	NP_001291288.1:p.Lys797%3D		1.0						.	.	.						33	0.97							0.000125197	26.0	207672.0	0.0	100	0.98	RF	afr	0.000251383	3.0	0.000233868	22.0	0.0002186	34						12.44	0.863203		0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653022	chr11	1213287	G	A	chr11:1213287	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0/1	0.2	122_30	152	99	False	rs112774721	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	synonymous_variant		18/38	NM_001304359.2:c.2403G>A	NP_001291288.1:p.Val801%3D		1.0						.	.	.		6.57142e-06	1.0	152174.0	0.0	32	0.97	PASS	nfe	1.46977e-05	1.0	1.46977e-05	1.0	0.00111781	138.0	123456.0	0.0	100	0.98	RF	afr	0.00398551	33.0	0.00161651	91.0	0.0147263	2290	0.043	124.0				10.1	0.575687		0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653023	chr11	1213296	A	G	chr11:1213296	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0|1	0.23	117_35	152	99	False	rs78466479	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	synonymous_variant		18/38	NM_001304359.2:c.2412A>G	NP_001291288.1:p.Pro804%3D		1.0						.	.	.						32	0.96							5.84222e-05	13.0	222518.0	0.0	100	0.98	PASS	nfe	0.000129286	13.0	0.000129286	13.0	0.0001415	22	0.001	2.0				0.012	-0.76197		0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653024	chr11	1213302	T	C	chr11:1213302	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0|1	0.25	114_38	152	99	False	rs371630624	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	synonymous_variant		18/38	NM_001304359.2:c.2418T>C	NP_001291288.1:p.Pro806%3D		1.0						.	.	.	31205927	0.00130073	198.0	152222.0	0.0	32	0.96	PASS	nfe	0.00191081	130.0	0.00191081	130.0	0.00141777	312.0	220064.0	0.0	100	0.98	PASS	sas	0.00208305	61.0	0.00156281	156.0	0.0002058	32	0.001	4.0				0.051	-0.574208		0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653025	chr11	1213311	C	T	chr11:1213311	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0/1	0.35	83_48	139	99	False	rs80058880	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	synonymous_variant		18/38	NM_001304359.2:c.2427C>T	NP_001291288.1:p.His809%3D		1.0						.	.	.		0.000151258	23.0	152058.0	0.0	32	0.96	PASS,PASS	sas,afr	0.00248859	12.0	0.000117675	8.0	0.000594246	102.0	171646.0	0.0	100	0.98	PASS	afr	0.0014714	16.0	0.00102545	71.0	0.0001286	20	0.003	9.0				4.167	0.094321		0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653026	chr11	1213314	C	T	chr11:1213314	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0/1	0.65	52_96	148	99	False	rs73395695	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	synonymous_variant		18/38	NM_001304359.2:c.2430C>T	NP_001291288.1:p.Gly810%3D		1.0						.	.	.		0.000414141	63.0	152122.0	0.0	32	0.96	PASS,PASS	eas,sas	0.00832043	43.0	2.93962e-05	2.0	0.193084	13943.0	72212.0	0.0	100	0.98	InbreedingCoeff_RF	nfe	0.251622	8765.0	0.251622	8765.0	0.0049259	766	0.064	182.0				0.01	-0.78381		0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653027	chr11	1213317	G	A	chr11:1213317	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0|1	0.28	107_42	149	99	False	rs76191775	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	synonymous_variant		18/38	NM_001304359.2:c.2433G>A	NP_001291288.1:p.Gly811%3D		1.0						.	.	.		1.97163e-05	3.0	152158.0	0.0	33	0.95	PASS	afr	7.24463e-05	3.0	0.0	0.0	0.000174312	33.0	189316.0	0.0	100	0.98	RF	nfe	0.000391581	32.0	0.000391581	32.0	0.0001350	21	0.005	14.0				0.093	-0.492891		0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653030	chr11	1213424	A	G	chr11:1213424	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0|1	0.86	22_138	161	99	False	rs61867531	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	missense_variant		18/38	NM_001304359.2:c.2540A>G	NP_001291288.1:p.Asn847Ser		1.0	WxxW domain					.	.	.		0.00111697	170.0	152198.0	1.0	33	0.97	PASS	afr	0.00388495	161.0	2.93962e-05	2.0	0.500083	114756.0	229474.0	19.0	100	0.98	InbreedingCoeff	afr	0.500144	6970.0	0.500132	52995.0	0.0047716	742	0.098	291.0				9.148	0.473356		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred																		0.0	-0.715	immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653031	chr11	1213428	T	C	chr11:1213428	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0/1	0.79	33_126	160	99	False	rs61867532	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	synonymous_variant		18/38	NM_001304359.2:c.2544T>C	NP_001291288.1:p.Ile848%3D		1.0						.	.	.		6.5741e-05	10.0	152112.0	0.0	33	0.97	PASS	eas	0.000769823	4.0	1.47011e-05	1.0	0.491091	94644.0	192722.0	9.0	100	0.98	InbreedingCoeff	sas	0.493671	12715.0	0.491566	45226.0	0.0036398	566	0.108	332.0				5.699	0.190591		0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653032	chr11	1213440	T	C	chr11:1213440	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0|1	0.86	21_138	160	99	False	rs61867533	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	synonymous_variant		18/38	NM_001304359.2:c.2556T>C	NP_001291288.1:p.Gly852%3D		1.0						.	.	.		0.00274939	418.0	152034.0	1.0	33	0.97	PASS	afr	0.00908695	376.0	5.88218e-05	4.0	0.500135	114667.0	229272.0	32.0	100	0.98	InbreedingCoeff	afr	0.500649	6948.0	0.500179	52974.0	0.0061542	957	0.125	381.0				15.32	1.324951		0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653034	chr11	1213461	T	G	chr11:1213461	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0/1	0.4	61_64	160	99	False	rs61867534	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	synonymous_variant		18/38	NM_001304359.2:c.2577T>G	NP_001291288.1:p.Arg859%3D		1.0						.	.	.		0.00685355	1041.0	151892.0	7.0	32	0.95	PASS,PASS	nfe,amr	0.00973146	661.0	0.00973146	661.0	0.421547	57832.0	137190.0	0.0	100	0.98	InbreedingCoeff	nfe	0.440961	32236.0	0.440961	32236.0	0.0082442	1282	0.062	177.0				0.184	-0.398248		0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653036	chr11	1213533	C	T	chr11:1213533	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	SNV	0/1	0.86	24_143	167	99	False	rs73395699	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	synonymous_variant		18/38	NM_001304359.2:c.2649C>T	NP_001291288.1:p.Arg883%3D		1.0						.	.	.		0.00276632	421.0	152188.0	1.0	33	0.97	PASS	afr	0.00926596	384.0	2.93979e-05	2.0	0.475361	67062.0	141076.0	32.0	100	0.98	InbreedingCoeff	sas	0.48061	7312.0	0.479929	35317.0	0.0220959	3436	0.083	262.0				0.173	-0.406623		0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653037	chr11	1216441		GTCGGGCCCACCACAGTTGGGTCTACCACC	chr11:1216440-1216441	MUC5AC	mucin 5AC, oligomeric mucus/gel-forming	9945.0	insertion	0|1	0.58	14_19	33	99	False	rs779862403	EXONIC	YES	NM_001304359.2	Transcript	protein_coding	inframe_insertion		25/38	NM_001304359.2:c.3891_3892insGTTGGGTCTACCACCGTCGGGCCCACCACA	NP_001291288.1:p.Val1288_Thr1297dup		1.0						.	.	.		0.00639971	965.0	150788.0	84.0	32	0.93	PASS	nfe	0.00978994	659.0	0.00978994	659.0	0.00232243	518.0	223042.0	25.0	62	0.97	PASS	nfe	0.00329522	336.0	0.00329522	336.0	0.0001093,0.0000064	17,1									0	0	0																						immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;phosphatidylinositol-mediated signaling	extracellular space;cytoplasm;Golgi lumen;plasma membrane;extracellular exosome;mucus layer	extracellular matrix structural constituent	MYC[21150319];IGHA2[unassigned1312];CST4[unassigned1312];
653375	chr11	117079612	C	T	chr11:117079612	PCSK7	proprotein convertase subtilisin/kexin type 7	9966.0	SNV	0/1	0.35	40_22	62	99	False	rs145370185,COSV54064395	SPLICING	YES	NM_004716.4	Transcript	protein_coding	splice_donor_variant	13/16		NM_004716.4:c.1691+1G>A			-1.0						.	.	.		0.000978718	149.0	152240.0	0.0	28	0.9	PASS	nfe	0.00151426	103.0	0.00151426	103.0	0.00111471	276.0	247598.0	0.0	48	0.84	PASS	nfe	0.00179556	202.0	0.00179556	202.0	0.0012154	189	0.002	5.0				32.0	4.661882		0	0	0			PCSK7	0.0	0.0	0.0	0.91	-4.0	9.0	-18.0	1.0	0.999978117620847	0.888	-2.893	8.182	5.289	0.358	0.19				.			bone marrow;hypothalamus;	.	protein processing;peptide hormone processing	trans-Golgi network;membrane;integral component of Golgi membrane	serine-type endopeptidase activity;peptidase activity	.
653444	chr3	12942761	G	A	chr3:12942761	IQSEC1	IQ motif and Sec7 domain 1	9973.0	SNV	0/1	0.5	10_10	20	99	False	rs571426372	EXONIC	YES	NM_001376938.2	Transcript	protein_coding	synonymous_variant		17/17	NM_001376938.2:c.3390C>T	NP_001363867.1:p.Ala1130%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Intellectual developmental disorder with short stature and behavioral abnormalities, 618687 (3), Autosomal recessive	.	.	Dystonia;Cerebral atrophy;Cerebral visual impairment;Autistic behavior;Intellectual disability, mild;Generalized hypotonia;Hypoplasia of the corpus callosum;Poor speech;Multifocal epileptiform discharges;Large basal ganglia;Stereotypy;Hypsarrhythmia;Microcephaly;Motor delay;Hyperactivity;Absent septum pellucidum;Delayed speech and language development;Intellectual disability, moderate;Chorea;Nasogastric tube feeding;Impulsivity;Sleep disturbance;Epileptic spasm;Short attention span;Global developmental delay;Depressivity;Intellectual disability, severe;Cortical dysplasia;Polymicrogyria;Abnormal facial shape;Generalized-onset seizure;Dyskinesia;Focal-onset seizure;Spasticity		0.00143746	207.0	144004.0	1.0	31	0.89	PASS	sas	0.00747508	36.0	0.00188657	128.0	0.00215995	302.0	139818.0	6.0	27	0.55	PASS	sas	0.00691409	155.0	0.00245313	123.0	0.0005788	90	0.004	12.0				5.93	0.206036		0	0	0			IQSEC1	0.0	0.0	0.0	0.0	-13.0	50.0	2.0	-23.0						0.159	1.0	0.0			nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			caudate nucleus;ciliary ganglion;amygdala;temporal lobe;testis - seminiferous tubule;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;cingulate cortex;cerebellum peduncles;cerebellum;pons;occipital lobe;subthalamic nucleus;whole brain;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;thalamus;	.	actin cytoskeleton organization;regulation of ARF protein signal transduction;positive regulation of GTPase activity;positive regulation of keratinocyte migration;positive regulation of adherens junction organization	nucleolus;cytoplasm;membrane;intracellular membrane-bounded organelle	ARF guanyl-nucleotide exchange factor activity;protein binding;lipid binding	MAP1LC3B[20562859];DLG1[24550280];MAP1LC3A[20562859];MCM7[23764002];IRAK2[21903422];GNAQ[27265506];RIPK4[26972000];IRF7[21903422];SRPRA[26496610];TCTE1[26638075];MAGEA3[unassigned1304];ARF6[27265506];
655935	chr3	12881028	C	T	chr3:12881028	RPL32	ribosomal protein L32	10000.0	SNV	0/1	0.66	14_27	41	99	False	rs11553822,COSV99062559	SPLICING	YES	NM_000994.4	Transcript	protein_coding	missense_variant,splice_region_variant		3/4	NM_000994.4:c.98G>A	NP_000985.1:p.Arg33His		-1.0	Ribosomal protein L32e, conserved site,Ribosomal protein L32e, conserved site,.,Ribosomal protein L32e, conserved site,Ribosomal protein L32e, conserved site,Ribosomal protein L32e, conserved site,Ribosomal protein L32e, conserved site					.	.	.		0.0021431	326.0	152116.0	0.0	33	0.97	PASS	amr	0.00393185	60.0	0.00333598	227.0	0.00217531	547.0	251458.0	0.0	100	1.0	PASS	amr	0.00332447	115.0	0.00298938	340.0	0.0018263	284	0.005	16.0				15.5	1.35983	0.094	2	16	18	PrimateAI_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	RPL32	0.0	0.0	0.0	0.0	1.0	-34.0	-21.0	-34.0	0.0004087675374638	0.004	7.544	0.769	8.313		0.76		0.854	0.936	.			.	Ribosome	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation;translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane	cytosol;membrane;cytosolic large ribosomal subunit;polysomal ribosome	RNA binding;structural constituent of ribosome	RPL10[26496610];COX15[29128334];RTCA[17353931];PINX1[17353931];HNRNPU[26496610];KIF11[26496610];MKI67[26949251];TGOLN2[29568061];FBL[29568061];PSTPIP1[17353931];SART3[unassigned1312];HIST1H3A[29568061];ZC3H18[29298432];LYAR[17353931];PAK2[17353931];IKBKE[17353931];NOP56[26496610];NPM1[26496610];VCAM1[22623428];PDHA1[29128334];NEK4[25798074];ALYREF[unassigned1312];DDX56[17353931];RPS6[29568061];HLA-B[17353931];RRP1B[20926688];LSM4[unassigned1312];ESR2[21182203];LSM8[unassigned1312];PRPF4[unassigned1312];PRPF3[unassigned1312];CANX[29568061];MAGEB2[17353931];HDGF[21907836];PPIH[unassigned1312];FAU[unassigned1312];AURKAIP1[29568061];EZR[29568061];MAP3K14[14743216];EIF1B[17353931];RPL26L1[unassigned1312];
657470	chr3	3886784	C	T	chr3:3886784	LRRN1	leucine rich repeat neuronal 1	10037.0	SNV	0/1	0.45	21_17	38	99	False	rs113168029,COSV100076361	EXONIC	YES	NM_001324188.2	Transcript	protein_coding	synonymous_variant		3/3	NM_001324188.2:c.459C>T	NP_001311117.1:p.Asn153%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00573942	873.0	152106.0	6.0	32	0.95	PASS	nfe	0.00976097	664.0	0.00976097	664.0	0.00500781	1257.0	251008.0	4.0	100	1.0	PASS	nfe	0.00866175	982.0	0.00866175	982.0	0.0055497	863	0.011	35.0				10.44	0.615007		0	0	0			LRRN1	0.0	0.0	0.0	0.0	35.0	1.0	35.0	36.0						0.386	0.88	39.60897848			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;	.	positive regulation of synapse assembly	extracellular space;integral component of membrane;extracellular matrix	.	TRAF1[unassigned1304];
658704	chr5	70341287	GTTT		chr5:70341287-70341290	GTF2H2	general transcription factor IIH subunit 2	10089.0	deletion	0/1	0.17	19_4	23	99	False	rs1439331865	EXONIC	YES	NM_001515.3	Transcript	protein_coding	frameshift_variant		12/16	NM_001515.3:c.802_805del	NP_001506.1:p.Lys268ProfsTer18		-1.0						.	.	.		0.000672577	83.0	123406.0	0.0	16	0.23	PASS	nfe	0.000983903	61.0	0.000983903	61.0	0.000213986	10.0	46732.0	0.0	0	0.07	RF	afr	0.000463822	2.0	0.000393524	7.0	0.0000257	4						33.0	5.336427		0	0	0			GTF2H2	0.1	0.0	0.17	0.0	48.0	10.0	-15.0	-36.0							0.72				.			pons;testis - seminiferous tubule;subthalamic nucleus;superior cervical ganglion;trigeminal ganglion;	Basal transcription factors;Nucleotide excision repair	G protein-coupled receptor internalization;transcription-coupled nucleotide-excision repair;nucleotide-excision repair;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, preincision complex assembly;nucleotide-excision repair, DNA incision, 5'-to lesion;regulation of transcription by RNA polymerase II;transcription initiation from RNA polymerase I promoter;termination of RNA polymerase I transcription;transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;transcription elongation from RNA polymerase II promoter;7-methylguanosine mRNA capping;translation;protein phosphorylation;response to UV;nucleotide-excision repair, DNA incision;global genome nucleotide-excision repair;positive regulation of DNA helicase activity	core TFIIH complex portion of holo TFIIH complex;transcription factor TFIIH core complex;nucleus;nucleoplasm;transcription factor TFIID complex;transcription factor TFIIH holo complex;nuclear speck	nucleic acid binding;DNA-binding transcription factor activity;protein kinase activity;protein binding;DNA-dependent ATPase activity;translation factor activity, RNA binding;zinc ion binding;RNA polymerase II CTD heptapeptide repeat kinase activity;protein N-terminus binding	CDK7[23602568;29568061];CCNH[26340423];ERCC2[27193682];ERCC8[7664335];GTF2H1[21988832];GTF2H4[19172752];GTF2H5[26496610;16669699;19172752];
663720	chr20	29623254	G	A	chr20:29623254	FRG1BP	FSHD region gene 1 family member B, pseudogene	10111.0	SNV	0|1	0.15	69_12	81	99	False	rs371493541,COSV53963975,COSV53974225	SPLICING	YES	NR_145491.1	Transcript	transcribed_pseudogene	splice_region_variant,non_coding_transcript_exon_variant		3/8	NR_145491.1:n.455G>A			1.0						.	.	.		0.0	0.0	151996.0	0.0	40	1.0	AC0				0.0	0.0	0.352232	17296.0	49104.0	0.0	76	0.97	InbreedingCoeff_RF	sas	0.378693	3025.0	0.365218	7514.0	0.0000257	4	0.003	8.0				20.5	2.088526		0	0	0														1.929	5.877	7.806						.			.	.	.	.	.	.
663746	chr20	29625985	G	A	chr20:29625985	FRG1BP	FSHD region gene 1 family member B, pseudogene	10111.0	SNV	0/1	0.16	191_37	234	99	False	rs79368216,COSV53952586,COSV53969366	SPLICING	YES	NR_145491.1	Transcript	transcribed_pseudogene	splice_donor_variant,non_coding_transcript_variant	4/7		NR_145491.1:n.567+1G>A			1.0						.	.	.						92	1.0							0.0200995	3110.0	154730.0	0.0	100	0.99	PASS	nfe	0.0374773	2352.0	0.0374773	2352.0	0.0001672	26	0.03	91.0				23.2	2.829917		0	0	0														0.441	8.182	8.623						.			.	.	.	.	.	.
663833	chr7	141831367	T	C	chr7:141831367	MGAM2	maltase-glucoamylase 2 (putative)	10113.0	SNV	0/1	0.48	13_12	25	99	False	rs149525866	EXONIC	YES	NM_001293626.2	Transcript	protein_coding	synonymous_variant		5/48	NM_001293626.2:c.360T>C	NP_001280555.1:p.Asn120%3D		1.0						.	.	.		0.00124166	189.0	152216.0	0.0	32	0.97	PASS	amr	0.00320765	49.0	0.00171958	117.0	0.00162646	228.0	140182.0	0.0	33	0.58	PASS	amr	0.00318732	78.0	0.00232952	132.0	0.0002894	45	0.007	23.0				9.516	0.512036		0	0	0			MGAM2	0.02	0.01	0.0	0.0	-49.0	26.0	47.0	-28.0								18.607769544			.			.	.	carbohydrate metabolic process	integral component of membrane	glucan 1,4-alpha-glucosidase activity;carbohydrate binding	SMC4[30021884];
664021	chr1	204380464	G	A	chr1:204380464	PPP1R15B	protein phosphatase 1 regulatory subunit 15B	10118.0	SNV	0/1	0.33	26_13	39	99	False	rs12094135	EXONIC	YES	NM_032833.5	Transcript	protein_coding	missense_variant		1/2	NM_032833.5:c.76C>T	NP_116222.4:p.Pro26Ser		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Microcephaly, short stature, and impaired glucose metabolism 2, 616817 (3), Autosomal recessive	Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome	Disease-causing germline mutation(s) (loss of function) in	Pectus excavatum;Intellectual disability, severe;Brisk reflexes;Epicanthus;Short nose;Intrauterine growth retardation;High pitched voice;Full cheeks;Downslanted palpebral fissures;Pes valgus;Micrognathia;Delayed myelination;Narrow face;Hypothyroidism;Short philtrum;Seizure;Cerebellar hypoplasia;Small for gestational age;Dorsocervical fat pad;Sparse hair;Broad-based gait;Sensorineural hearing impairment;Macrotia;Diabetes mellitus;Clinodactyly;Proportionate short stature;Round face;Hypotelorism;Oligodontia;Blue sclerae;Wide nose;Ketosis;Narrow forehead;Severe postnatal growth retardation;Hypoglycemia;Downturned corners of mouth;Hypoplasia of the brainstem;Slender toe;Severe demyelination of the white matter;Deviation of the 5th toe;Distal muscle weakness;Thin upper lip vermilion;Delayed puberty;Long philtrum;Joint laxity;Narrow mouth;Congenital microcephaly;Fine hair;Hypoplasia of the corpus callosum;Muscular hypotonia of the trunk;Short neck;Hypoplasia of teeth;Global developmental delay;Low anterior hairline;Spastic paraparesis;Synophrys;Slender finger;Poor speech;Kyphoscoliosis;Down-sloping shoulders;Anteverted nares;Downslanted palpebral fissures;Kinetic tremor;Short stature;Renal hypoplasia;Macrotia;High pitched voice;Delayed skeletal maturation;Delayed puberty;Delayed myelination;Hypoplasia of the corpus callosum;Sensorineural hearing impairment;Kyphoscoliosis;Cryptorchidism;Micrognathia;Small for gestational age;Epicanthus;Spasticity;Oligodontia;Pectus excavatum;Blue sclerae;Dysarthria;Downturned corners of mouth;Gait ataxia;Truncal ataxia;Down-sloping shoulders;Brisk reflexes;Autosomal recessive inheritance;Prominent superficial veins;Recurrent hypoglycemia;Hyperlordosis;Full cheeks;Hypoplasia of the brainstem;Hypotelorism;Hearing impairment;Abnormal vertebral morphology;Hypothyroidism;Narrow mouth;Fine hair;Intellectual disability, severe;Microcephaly;Intrauterine growth retardation;Sparse hair;Seizure;Increased vertebral height		0.00135978	207.0	152230.0	2.0	32	0.98	PASS	afr	0.00458185	190.0	8.81886e-05	6.0	0.000467914	117.0	250046.0	1.0	91	0.99	PASS	afr	0.00532461	83.0	7.95728e-05	9.0	0.0005337	83						6.31	0.232486	0.06	0	16	16		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PPP1R15B	0.0	0.0	0.0	0.0	-19.0	8.0	-19.0	-30.0						0.349	0.16	0.000000000	0.001	0.2	integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			.	.	negative regulation of protein phosphorylation;ER overload response;positive regulation of phosphoprotein phosphatase activity;response to endoplasmic reticulum stress;response to hydrogen peroxide;peptidyl-serine dephosphorylation;negative regulation of PERK-mediated unfolded protein response;negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation	protein phosphatase type 1 complex;cytoplasm;endoplasmic reticulum	protein binding;protein phosphatase regulator activity	PPP1CB[26496610];PPP1CC[21382349;28330616];PPP1CA[15231748;21382349;22321011;28330616];TRIM23[unassigned1304];
664787	chrX	152087570	AGG		chrX:152087570-152087572	ZNF185	zinc finger protein 185 with LIM domain	10127.0	deletion	0/1	0.15	11_2	13	51	False	rs781814997	EXONIC	YES	NM_001178106.1	Transcript	protein_coding	inframe_deletion		7/24	NM_001178106.1:c.494_496del	NP_001171577.1:p.Glu165del		1.0						.	.	.		0.000408197	45.0	110241.0	0.0	23	0.6	PASS	eas	0.00743707	26.0	0.000152358	8.0	0.00430929	527.0	122294.0	0.0	36	0.83	PASS	eas	0.0126709	114.0	0.004135	228.0	0.0000257,0.0336519,0.0001029	4,5233,16						5.55	0.180742		0	0	0			ZNF185	0.0	0.03	0.0	0.0	7.0	-24.0	21.0	-18.0						0.269	0.0	0.000000000,17.430255104			.			tongue;	.	.	cytoplasm;focal adhesion;actin cytoskeleton	zinc ion binding;actin filament binding	CBX8[unassigned1304];MCM7[23764002];ACTBL2[30021884];LMO2[unassigned1304];PIH1D2[unassigned1304];HSF2BP[unassigned1304];AARSD1[unassigned1304];PRR23B[unassigned1304];CEP76[unassigned1304];PRPF8[30021884];
664926	chr10	50121526	C	T	chr10:50121526	LRRC18	leucine rich repeat containing 18	10133.0	SNV	0/1	0.5	12_12	24	99	False	rs148385977	EXONIC	YES	NM_001378102.1	Transcript	protein_coding	synonymous_variant		3/4	NM_001378102.1:c.675G>A	NP_001365031.1:p.Lys225%3D		-1.0						.	.	.		0.00193729	239.0	123368.0	0.0	29	0.81	PASS	sas	0.00912017	34.0	0.00256716	142.0	0.00252695	630.0	249312.0	2.0	100	1.0	PASS	sas	0.00899114	272.0	0.0023999	272.0	0.0023536	366	0.002	6.0				3.826	0.074011		0	0	0			LRRC18	0.0	0.0	0.0	0.0	-24.0	6.0	-3.0	6.0						0.642	0.0	62.829788432			.			uterus;testis - interstitial;testis;	.	inorganic anion transport;anion transmembrane transport	cytoplasm;ion channel complex	volume-sensitive anion channel activity	P4HB[30021884];KCTD17[16189514];MEOX2[unassigned1304];FRS3[unassigned1304];
665944	chr7	23731209	G		chr7:23731209	FAM221A	family with sequence similarity 221 member A	10142.0	deletion	0/1	0.65	11_20	31	99	False	rs553824715	EXONIC	YES	NM_199136.5	Transcript	protein_coding	frameshift_variant		4/7	NM_199136.5:c.633del	NP_954587.2:p.Ile212LeufsTer9		1.0						.	.	.		0.00396262	603.0	152172.0	3.0	32	0.96	PASS	nfe	0.00682253	464.0	0.00682253	464.0	0.00374188	941.0	251478.0	3.0	82	1.0	PASS	nfe	0.00617989	703.0	0.00617989	703.0	0.0000450,0.0039292	7,611	0.005	15.0				33.0	5.100348		0	0	0			FAM221A	0.0	0.0	0.0	0.0	-36.0	-22.0	0.0	-13.0							0.0	0.000000000			.			.	.	.	.	.	KRTAP21-2[unassigned1304];DDIT4L[unassigned1304];CDPF1[unassigned1304];NOTCH2NLA[unassigned1304];MEOX2[unassigned1304];PLEKHA7[28877994];CYSRT1[unassigned1304];LHX3[unassigned1304];PRRG2[unassigned1304];KRTAP4-11[unassigned1304];SUMO3[unassigned1304];ZNF417[unassigned1304];HOXA1[unassigned1304];ANKS1A[unassigned1304];PFDN5[unassigned1304];KRTAP1-1[unassigned1304];
665952	chr11	102647452	A	C	chr11:102647452	MMP10	matrix metallopeptidase 10	10144.0	SNV	0/1	0.4	18_12	30	99	False	rs17860971	EXONIC	YES	NM_002425.3	Transcript	protein_coding	missense_variant		5/10	NM_002425.3:c.678T>G	NP_002416.1:p.Phe226Leu		-1.0	Peptidase M10, metallopeptidase&Peptidase, metallopeptidase&Peptidase M10A, catalytic domain					.	.	.		0.00177405	270.0	152194.0	1.0	32	0.96	PASS	nfe	0.00292544	199.0	0.00292544	199.0	0.00141261	355.0	251308.0	0.0	77	0.99	PASS	nfe	0.00231327	263.0	0.00231327	263.0	0.0014726	229	0.002	7.0				1.341	-0.107163	0.082	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MMP10	0.0	0.01	0.0	0.0	-1.0	-8.0	48.0	-8.0						0.928	0.0	0.000000000	0.829	-0.052	immune system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; respiratory system phenotype; 			testis - interstitial;uterus corpus;	.	proteolysis;extracellular matrix disassembly;extracellular matrix organization;collagen catabolic process	extracellular region;extracellular space;extracellular matrix	metalloendopeptidase activity;serine-type endopeptidase activity;zinc ion binding	MAPT[26402096];
668606	chr4	338129	G	A	chr4:338129	ZNF141	zinc finger protein 141	10251.0	SNV	0/1	0.1	36_5	48	91	False	rs75245145,COSV53657618	EXONIC	YES	NM_003441.4	Transcript	protein_coding	missense_variant		3/4	NM_003441.4:c.136G>A	NP_003432.1:p.Ala46Thr		1.0	Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box				?Polydactyly, postaxial, type A6, 615226 (3), Autosomal recessive	Postaxial polydactyly type A	Disease-causing germline mutation(s) in	Broad phalanges of the 5th finger;Postaxial hand polydactyly;Autosomal recessive inheritance						32	0.96							0.000509412	122.0	239492.0	0.0	42	0.97	RF	afr	0.0027828	40.0	0.000385682	42.0	0.0011447	178	0.004	12.0				11.42	0.732719	0.045	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF141	0.09	0.01	0.0	0.0	16.0	-5.0	-5.0	20.0							0.16		0.244	0.418	.			.	.	regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;anatomical structure morphogenesis;limb morphogenesis	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	.
668614	chr4	338198		GA	chr4:338197-338198	ZNF141	zinc finger protein 141	10251.0	insertion	0|1	0.1	35_5	49	99	False	rs782422805,COSV53659632	EXONIC	YES	NM_003441.4	Transcript	protein_coding	frameshift_variant		3/4	NM_003441.4:c.204_205insGA	NP_003432.1:p.Lys69GlufsTer4		1.0		Benign	criteria_provided,_single_submitter	not_specified	?Polydactyly, postaxial, type A6, 615226 (3), Autosomal recessive	Postaxial polydactyly type A	Disease-causing germline mutation(s) in	Broad phalanges of the 5th finger;Postaxial hand polydactyly;Autosomal recessive inheritance						32	0.96							0.0	0.0	250848.0	0.0	44	0.99	AC0_RF				0.0	0.0	0.0011125	173						19.49	1.969823		0	0	0																		0.16				.			.	.	regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;anatomical structure morphogenesis;limb morphogenesis	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	.
668618	chr4	338200	G	C	chr4:338200	ZNF141	zinc finger protein 141	10251.0	SNV	0|1	0.1	35_5	49	99	False	rs79869819,COSV53659646	EXONIC	YES	NM_003441.4	Transcript	protein_coding	missense_variant		3/4	NM_003441.4:c.207G>C	NP_003432.1:p.Lys69Asn		1.0	Krueppel-associated box,Krueppel-associated box,Krueppel-associated box				?Polydactyly, postaxial, type A6, 615226 (3), Autosomal recessive	Postaxial polydactyly type A	Disease-causing germline mutation(s) in	Broad phalanges of the 5th finger;Postaxial hand polydactyly;Autosomal recessive inheritance						32	0.96							0.0	0.0	250536.0	0.0	42	0.99	AC0_RF				0.0	0.0	0.0011125	173						15.29	1.319412	0.061	1	17	18	SIFT	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF141	0.0	0.0	0.0	0.0	8.0	-30.0	19.0	23.0							0.16		0.046	0.418	.			.	.	regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;anatomical structure morphogenesis;limb morphogenesis	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	.
668625	chr4	338202	TC		chr4:338202-338203	ZNF141	zinc finger protein 141	10251.0	deletion	0|1	0.1	36_5	50	99	False	rs782668952,COSV99549447	EXONIC	YES	NM_003441.4	Transcript	protein_coding	frameshift_variant		3/4	NM_003441.4:c.209_210del	NP_003432.1:p.Ile70SerfsTer34		1.0		Benign	criteria_provided,_single_submitter	not_specified	?Polydactyly, postaxial, type A6, 615226 (3), Autosomal recessive	Postaxial polydactyly type A	Disease-causing germline mutation(s) in	Broad phalanges of the 5th finger;Postaxial hand polydactyly;Autosomal recessive inheritance						32	0.96							0.0	0.0	250848.0	0.0	42	0.98	AC0_RF				0.0	0.0	0.0011125	173						22.8	2.605053		0	0	0			ZNF141	0.0	0.0	0.0	0.03	18.0	-36.0	0.0	18.0							0.16				.			.	.	regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;anatomical structure morphogenesis;limb morphogenesis	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	.
668626	chr4	338205	T	C	chr4:338205	ZNF141	zinc finger protein 141	10251.0	SNV	0|1	0.1	35_5	49	99	False	rs80052234,COSV53659663	EXONIC	YES	NM_003441.4	Transcript	protein_coding	missense_variant		3/4	NM_003441.4:c.212T>C	NP_003432.1:p.Val71Ala		1.0	Krueppel-associated box,Krueppel-associated box,Krueppel-associated box				?Polydactyly, postaxial, type A6, 615226 (3), Autosomal recessive	Postaxial polydactyly type A	Disease-causing germline mutation(s) in	Broad phalanges of the 5th finger;Postaxial hand polydactyly;Autosomal recessive inheritance						32	0.96							0.0	0.0	249468.0	0.0	40	0.98	AC0_RF				0.0	0.0	0.0010804	168						11.87	0.790031	0.125	1	16	17	PROVEAN_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF141	0.0	0.0	0.01	0.0	-40.0	14.0	18.0	-20.0							0.16		0.096	0.403	.			.	.	regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;anatomical structure morphogenesis;limb morphogenesis	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	.
672083	chr10	11374575	TCCAGTCTTCCTCTTCGGCATGCCCTGGAAGCTTCT		chr10:11374575-11374610	CELF2	CUGBP Elav-like family member 2	10304.0	deletion	1/1	1.0	0_19	19	59	False		SPLICING	YES	NM_001326343.2	Transcript	protein_coding	splice_acceptor_variant,splice_donor_variant,splice_donor_5th_base_variant,splice_polypyrimidine_tract_variant,intron_variant	14/14		NM_001326343.2:c.*3560_*3595del			1.0					Developmental and epileptic encephalopathy 97, 619561 (3), Autosomal dominant	.	.	.						0	0.0											0	0.0							0.0013269,0.2957389,0.0003033,0.0014406,0.0004549,0.0002275,0.0002275,0.0000379,0.0003791	35,7801,8,38,12,6,6,1,10						23.6	3.011868		0	0	0																		1.0				.			pons;amygdala;white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;whole brain;trigeminal ganglion;superior cervical ganglion;cingulate cortex;globus pallidus;medulla oblongata;	.	regulation of alternative mRNA splicing, via spliceosome;mRNA splice site selection;RNA processing;regulation of heart contraction	nucleus;cytoplasm;ribonucleoprotein complex	RNA binding;mRNA binding;pre-mRNA binding	PCBP1[16713569];FN1[19738201];GRB2[17474147];PTBP3[22575643];PDK1[26496610];
672224	chr17	2235469	C	T	chr17:2235469	TSR1	TSR1, ribosome maturation factor	10309.0	SNV	0/1	0.42	14_10	24	99	False	rs62066968	EXONIC	YES	NM_018128.5	Transcript	protein_coding	missense_variant		8/15	NM_018128.5:c.1490G>A	NP_060598.3:p.Arg497Gln		-1.0	Ribosome biogenesis protein BMS1/TSR1, C-terminal&Ribosome biogenesis protein BMS1/TSR1, C-terminal					.	.	.		0.00338393	515.0	152190.0	2.0	32	0.98	PASS	amr	0.00635066	97.0	0.00480543	327.0	0.00367754	909.0	247176.0	5.0	67	0.83	PASS	amr	0.00578718	191.0	0.00525643	592.0	0.0037041	576	0.015	46.0				27.0	3.91907	0.412	12	9	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	TSR1	0.0	0.0	0.0	0.0	-2.0	33.0	-6.0	-18.0						0.985	0.0	0.0	0.998	1.018	.			ciliary ganglion;pons;testis - interstitial;subthalamic nucleus;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	nucleoplasm;nucleolus;cytosol;preribosome, small subunit precursor	RNA binding;GTPase activity;GTP binding;U3 snoRNA binding	RPL10[26496610];DCTN1[26638075];CEP19[26638075];PINX1[17353931];HNRNPU[26496610];YBX1[25497084];GABARAP[20562859];FBL[29568061];HIST1H3A[29568061];IFI16[25665578];SUMO3[17000644];SMNDC1[17353931];LYAR[17353931];HIST1H1B[30021884];CBX8[21282530];NOP56[26496610];JUN[25609649];NPM1[26496610];RHBDD2[unassigned1304];RPS6[29568061];CIDEB[unassigned1304];PRKAB1[17353931];YWHAZ[15161933];IBTK[26496610];RNF169[21252943];CDK2AP1[26496610];HDGF[21907836];MAP3K14[14743216];EIF1B[17353931];CENPQ[26496610];
672712	chr2	75882196	G	T	chr2:75882196	MRPL19	mitochondrial ribosomal protein L19	10316.0	SNV	0/1	0.15	11_2	13	39	False		EXONIC	YES	NM_014763.4	Transcript	protein_coding	missense_variant		6/6	NM_014763.4:c.664G>T	NP_055578.2:p.Val222Leu		1.0	.,.,.,.					.	.	.		2.31014e-05	3.0	129862.0	0.0	28	0.78	AS_VQSR	sas	0.000246427	1.0	1.57134e-05	1.0					21	0.54														27.2	3.94001	0.581	18	2	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PrimateAI_pred,DEOGEN2_pred	MRPL19	0.0	0.04	0.0	0.0	12.0	-6.0	12.0	-6.0						0.417	0.0	76.984447579	0.993	1.176	.			.	.	mitochondrial translational elongation;mitochondrial translational termination	nucleus;mitochondrion;mitochondrial inner membrane;mitochondrial large ribosomal subunit;nuclear membrane	structural constituent of ribosome	JUN[25609649];TRIM63[18157088];VCAM1[22623428];SMURF2[18157088];MGST3[29568061];LRRK2[29513927];MRPL58[20186120];YBX1[22118625];CENPA[26496610];HSPD1[29568061];MRPL50[26496610];MRPL1[26496610];MAGEC1[17137291];MRPL9[26496610];AURKAIP1[29568061];
684275	chr12	52627270	C	T	chr12:52627270	KRT7	keratin 7	10333.0	SNV	0/1	0.45	22_18	40	99	False	rs138391469,COSV100081931	EXONIC	YES	NM_005556.4	Transcript	protein_coding	missense_variant		1/9	NM_005556.4:c.190C>T	NP_005547.3:p.Arg64Cys		1.0	Keratin type II head					.	.	.		0.000546412	83.0	151900.0	0.0	33	0.96	PASS	amr	0.00170335	26.0	0.000706464	48.0	0.000591466	143.0	241772.0	0.0	33	0.88	PASS	amr	0.0012858	44.0	0.00079733	86.0	0.0004437	69	0.001	3.0				30.0	4.276364	0.196	11	10	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	KRT7	0.0	0.0	0.0	0.0	21.0	6.0	5.0	-40.0						0.286	0.0	0.0	0.895	1.022	cellular phenotype; homeostasis/metabolism phenotype; renal/urinary system phenotype; 			salivary gland;fetal thyroid;lung;trachea;thyroid;skin;smooth muscle;placenta;prostate;fetal lung;skeletal muscle;	Cell Communication	viral process;keratinization;cornification	nucleus;cytoplasm;cytosol;intermediate filament;keratin filament;extracellular exosome	structural molecule activity;protein binding	ATF2[22304920];IGHG1[15174051];METTL14[29507755];PCNA[20849852];KDM1A[23455924];GRB2[12577067];NES[26496610];EIF3A[11169732];
687403	chr5	141023893	G	A	chr5:141023893	FCHSD1	FCH and double SH3 domains 1	10374.0	SNV	0/1	0.56	18_23	41	99	False	rs200176870	EXONIC	YES	NM_033449.3	Transcript	protein_coding	synonymous_variant		17/20	NM_033449.3:c.1755C>T	NP_258260.1:p.Asp585%3D		-1.0						.	.	.		0.00197813	301.0	152164.0	0.0	33	0.97	PASS	nfe	0.00352848	240.0	0.00352848	240.0	0.00185283	461.0	248808.0	1.0	77	0.98	PASS	nfe	0.00306961	346.0	0.00306961	346.0	0.0021864	340	0.004	14.0				5.046	0.148153		0	0	0			FCHSD1	0.0	0.0	0.0	0.0	-17.0	13.0	-1.0	4.0						0.949	0.0	0.0			.			.	.	neuromuscular synaptic transmission;regulation of actin filament polymerization	neuromuscular junction;recycling endosome	.	LRRK2[29513927];
687887	chr10	24873929	C	T	chr10:24873929	ARHGAP21	Rho GTPase activating protein 21	10387.0	SNV	0/1	0.39	20_13	33	99	False	rs781358377	EXONIC	YES	NM_020824.4	Transcript	protein_coding	synonymous_variant		26/26	NM_020824.4:c.5289G>A	NP_065875.3:p.Thr1763%3D		-1.0						.	.	.		5.25721e-05	8.0	152172.0	0.0	32	0.96	PASS	amr	6.54536e-05	1.0	5.87803e-05	4.0	3.58426e-05	9.0	251098.0	0.0	100	1.0	PASS	amr	0.000144567	5.0	3.52703e-05	4.0	0.0000064	1						0.562	-0.236712		0	0	0			ARHGAP21	0.0	0.0	0.0	0.0	-8.0	17.0	31.0	-14.0						0.464	1.0				homeostasis/metabolism phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; 			.	.	Golgi organization;signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction;establishment of Golgi localization;maintenance of Golgi location;organelle transport along microtubule	Golgi membrane;Golgi apparatus;cytosol;plasma membrane;actin cytoskeleton;cell junction;cytoplasmic vesicle membrane	GTPase activator activity;protein binding	ZNF177[25416956];CEP120[26638075];TULP3[23414517];ARRB2[17620599];IQGAP1[26496610];HSCB[28380382];CEP128[26638075];PPP1CB[26496610];LIMA1[26496610];CNTRL[26638075];MYO18A[26496610];FLNA[26496610];SFN[15778465];SYNPO[26496610];NINL[26638075];EGLN3[26972000];CEP135[26638075];ODF2[26638075];CEP152[26638075];AXIN1[26496610];SPICE1[26638075];YWHAZ[15161933];MYO19[26496610];TCTE1[26638075];ANLN[26496610];MYO1C[26496610];APC[26496610];SP1[20195357];EEF1D[20195357];MYO5C[26496610];CAPZA2[26496610];MYH9[26496610];CTNNB1[17510365];DBN1[26496610];
688689	chr11	5699466	G	A	chr11:5699466	TRIM5	tripartite motif containing 5	10408.0	SNV	0/1	0.5	16_16	32	99	False	rs140131201	EXONIC	YES	NM_033034.3	Transcript	protein_coding	missense_variant		4/8	NM_033034.3:c.712C>T	NP_149023.2:p.Arg238Trp		-1.0	.,.,.					.	.	.		0.00174839	266.0	152140.0	1.0	33	0.97	PASS	afr	0.00581676	241.0	0.000161717	11.0	0.00052175	131.0	251078.0	0.0	36	0.96	PASS	afr	0.006033	98.0	0.000114517	13.0	0.0006238	97	0.001	2.0				16.91	1.61038	0.354	4	16	20	SIFT,MutationAssessor_pred,PROVEAN_pred,LIST-S2_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TRIM5	0.0	0.0	0.0	0.05	-32.0	39.0	49.0	-10.0						0.531	0.0	0.0	0.007	1.083	.			atrioventricular node;trigeminal ganglion;	.	activation of innate immune response;pattern recognition receptor signaling pathway;autophagy;viral process;regulation of lipopolysaccharide-mediated signaling pathway;regulation of protein localization;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of MAPK cascade;innate immune response;negative regulation of viral entry into host cell;positive regulation of DNA-binding transcription factor activity;positive regulation of NF-kappaB transcription factor activity;defense response to virus;interferon-gamma-mediated signaling pathway;protein K63-linked ubiquitination;negative regulation of viral release from host cell	P-body;nucleus;cytoplasm;cytosol;omegasome	ubiquitin-protein transferase activity;protein binding;zinc ion binding;signaling pattern recognition receptor activity;protein kinase binding;protein binding, bridging;identical protein binding;protein homodimerization activity	HIP2[19549727];UBE2D4[19549727];TSGA10IP[unassigned1304];UBE2D2[12878161;19549727];UBE2D3[19549727];UBE2D1[19549727];TRIM5[22493164;22829933];BTBD2[12878161];UBASH3A[unassigned1304];UBE2H[19549727];YES1[unassigned1304];WDYHV1[unassigned1304];ZWINT[20360068];MTURN[unassigned1304];MPP7[unassigned1304];EHHADH[unassigned1304];UBE2U[19549727];UBE2N[19549727];UBE2V2[19549727];SNAI1[25203322];MKRN3[22493164];UBE2V1[19549727];MNAT1[22493164];TRIM32[22493164];UBE2K[unassigned1304];TRIM34[22493164];
689599	chr7	102106462	C	T	chr7:102106462	LRWD1	leucine rich repeats and WD repeat domain containing 1	10437.0	SNV	0/1	0.5	17_17	34	99	False	rs140741148,COSV52961095	EXONIC	YES	NM_152892.3	Transcript	protein_coding	synonymous_variant		2/15	NM_152892.3:c.279C>T	NP_690852.1:p.Leu93%3D		1.0						.	.	.		0.000722838	110.0	152178.0	1.0	31	0.96	PASS	sas	0.00124224	6.0	0.000778931	53.0	0.00105566	265.0	251028.0	1.0	59	0.99	PASS	sas	0.0013721	42.0	0.000687649	78.0	0.0008553	133	0.001	2.0				3.077	0.028932		0	0	0			LRWD1	0.0	0.0	0.0	0.0	12.0	-38.0	35.0	36.0						0.815	0.0	10.328767441			.			.	.	DNA replication initiation;chromatin organization;establishment of protein localization to chromatin	kinetochore;condensed chromosome kinetochore;nucleus;nuclear origin of replication recognition complex;pericentric heterochromatin;nucleolus;cytoplasm;microtubule organizing center;telomeric heterochromatin;intracellular membrane-bounded organelle	chromatin binding;protein binding;methyl-CpG binding;methylated histone binding	FOXE1[25609649];TUBGCP2[26496610];FOXG1[25609649];PRR3[26496610];FOXM1[25609649];ADD1[26496610];FOXQ1[25609649];ORC5[26496610];ORC4[26496610];FOXS1[25609649];HIST1H3A[29568061];ORC1[26496610];ORC3[26496610];ORC2[26496610];TEAD2[25609649];FOXB1[25609649];NUDC[25036637];CDC5L[20467437];TUBG1[26496610];MZT2A[26496610];SNW1[20467437];LCOR[26496610];TUBGCP6[26496610];TUBGCP3[26496610];MPHOSPH8[26496610];
690131	chr4	190874234	C	T	chr4:190874234	FRG1	FSHD region gene 1	10464.0	SNV	0/1	0.23	38_13	56	99	False	rs200620299,COSV56995288	EXONIC	YES	NM_004477.3	Transcript	protein_coding	missense_variant		4/9	NM_004477.3:c.271C>T	NP_004468.1:p.Pro91Ser		1.0	.,.					Facioscapulohumeral dystrophy	Candidate gene tested in	Facial palsy;Intellectual disability;Sensorineural hearing impairment;Scapular winging;Beevor's sign;Slow progression;Childhood onset;Exudative retinal detachment;Shoulder girdle muscle atrophy;Scapulohumeral muscular dystrophy;Abdominal wall muscle weakness;Tongue atrophy;Elevated serum creatine kinase;Retinal telangiectasia;External ophthalmoplegia;Calf muscle hypertrophy;Shoulder girdle muscle weakness;Dysphagia;Seizure;Restrictive ventilatory defect;Autosomal dominant inheritance;Abnormal eyelash morphology;Hyperlordosis;Abnormality of cardiovascular system morphology;Elevated serum creatine kinase;Palpebral edema;Skeletal muscle atrophy;Sensorineural hearing impairment;EMG abnormality;Abnormal retinal vascular morphology;Mask-like facies						33	0.97							0.424997	52346.0	123168.0	0.0	24	0.6	InbreedingCoeff_RF	afr	0.458353	3808.0	0.428914	24316.0	0.0001222	19	0.017	49.0	0.34076	627.0		25.6	3.659337	0.646	12	6	18	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_addAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred	FRG1	0.0	0.0	0.0	0.0	5.0	-11.0	47.0	46.0						0.975	0.0		0.998	1.025	.			.	.	mRNA splicing, via spliceosome;rRNA processing;muscle organ development	nucleolus;Cajal body;Z disc;striated muscle dense body;catalytic step 2 spliceosome	RNA binding;protein binding;actin filament binding	JUN[25609649];SART3[19615732];HIST1H3A[29568061];RBPMS[21516116];CWC22[22365833];EXOSC8[25416956];LZTS2[25416956];MKI67[26949251];KRT40[25416956];PTBP3[22575643];GNMT[unassigned1304];
690143	chr4	190876242	G	A	chr4:190876242	FRG1	FSHD region gene 1	10464.0	SNV	0/1	0.26	16_6	23	99	False	rs1061653,COSV56995306	EXONIC	YES	NM_004477.3	Transcript	protein_coding	missense_variant		5/9	NM_004477.3:c.368G>A	NP_004468.1:p.Gly123Glu		1.0	.,.					Facioscapulohumeral dystrophy	Candidate gene tested in	Facial palsy;Intellectual disability;Sensorineural hearing impairment;Scapular winging;Beevor's sign;Slow progression;Childhood onset;Exudative retinal detachment;Shoulder girdle muscle atrophy;Scapulohumeral muscular dystrophy;Abdominal wall muscle weakness;Tongue atrophy;Elevated serum creatine kinase;Retinal telangiectasia;External ophthalmoplegia;Calf muscle hypertrophy;Shoulder girdle muscle weakness;Dysphagia;Seizure;Restrictive ventilatory defect;Autosomal dominant inheritance;Abnormal eyelash morphology;Hyperlordosis;Abnormality of cardiovascular system morphology;Elevated serum creatine kinase;Palpebral edema;Skeletal muscle atrophy;Sensorineural hearing impairment;EMG abnormality;Abnormal retinal vascular morphology;Mask-like facies		6.63905e-06	1.0	150624.0	0.0	33	0.96	AS_VQSR	afr	2.44153e-05	1.0	0.0	0.0	0.493998	116047.0	234914.0	0.0	100	1.0	InbreedingCoeff	eas	0.49786	8607.0	0.493245	53157.0	0.0016784	261	0.053	156.0	0.27885	493.0		22.9	2.698922	0.473	7	8	15	LRT_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred	FRG1	0.0	0.01	0.0	0.0	21.0	-3.0	-16.0	-1.0						0.975	0.0		0.992	0.173	.			.	.	mRNA splicing, via spliceosome;rRNA processing;muscle organ development	nucleolus;Cajal body;Z disc;striated muscle dense body;catalytic step 2 spliceosome	RNA binding;protein binding;actin filament binding	JUN[25609649];SART3[19615732];HIST1H3A[29568061];RBPMS[21516116];CWC22[22365833];EXOSC8[25416956];LZTS2[25416956];MKI67[26949251];KRT40[25416956];PTBP3[22575643];GNMT[unassigned1304];
690148	chr4	190878577	A	G	chr4:190878577	FRG1	FSHD region gene 1	10464.0	SNV	0/1	0.14	73_14	103	99	False	rs75883191,COSV56995871	EXONIC	YES	NM_004477.3	Transcript	protein_coding	missense_variant		6/9	NM_004477.3:c.457A>G	NP_004468.1:p.Asn153Asp		1.0	.,.,.					Facioscapulohumeral dystrophy	Candidate gene tested in	Facial palsy;Intellectual disability;Sensorineural hearing impairment;Scapular winging;Beevor's sign;Slow progression;Childhood onset;Exudative retinal detachment;Shoulder girdle muscle atrophy;Scapulohumeral muscular dystrophy;Abdominal wall muscle weakness;Tongue atrophy;Elevated serum creatine kinase;Retinal telangiectasia;External ophthalmoplegia;Calf muscle hypertrophy;Shoulder girdle muscle weakness;Dysphagia;Seizure;Restrictive ventilatory defect;Autosomal dominant inheritance;Abnormal eyelash morphology;Hyperlordosis;Abnormality of cardiovascular system morphology;Elevated serum creatine kinase;Palpebral edema;Skeletal muscle atrophy;Sensorineural hearing impairment;EMG abnormality;Abnormal retinal vascular morphology;Mask-like facies		1.31351e-05	2.0	152264.0	0.0	34	0.97	PASS	amr	0.000130822	2.0	0.0	0.0	0.000889504	189.0	212478.0	0.0	39	0.77	PASS	afr	0.00404978	41.0	0.000923594	88.0	0.0000193	3	0.017	55.0	0.00109	2.0		23.0	2.706318	0.535	7	11	18	SIFT,PolyPhen,LRT_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	FRG1	0.0	0.0	0.0	0.0	1.0	5.0	1.0	48.0						0.975	0.0		1.0	1.191	.			.	.	mRNA splicing, via spliceosome;rRNA processing;muscle organ development	nucleolus;Cajal body;Z disc;striated muscle dense body;catalytic step 2 spliceosome	RNA binding;protein binding;actin filament binding	JUN[25609649];SART3[19615732];HIST1H3A[29568061];RBPMS[21516116];CWC22[22365833];EXOSC8[25416956];LZTS2[25416956];MKI67[26949251];KRT40[25416956];PTBP3[22575643];GNMT[unassigned1304];
690882	chr5	65077154	T	C	chr5:65077154	NLN	neurolysin	10489.0	SNV	0/1	0.53	15_17	32	99	False		EXONIC	YES	NM_020726.5	Transcript	protein_coding	missense_variant		6/13	NM_020726.5:c.728T>C	NP_065777.1:p.Leu243Ser		1.0	.,.					.	.	.						33	0.98											52	0.98														27.2	3.94061	0.901	16	5	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred	NLN	0.01	0.0	0.0	0.0	-38.0	32.0	-33.0	-15.0						0.936	0.0	61.443540998	1.0	1.138	cellular phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	Renin-angiotensin system	regulation of gluconeogenesis;proteolysis;peptide metabolic process;regulation of skeletal muscle fiber differentiation	extracellular region;mitochondrial intermembrane space;plasma membrane	metalloendopeptidase activity;peptide binding;metal ion binding	PDHA1[29128334];CBX1[21888893];KRT8[30021884];RASSF8[26496610];DLST[29128334];HSCB[28380382];DYNLL1[26496610];HIF1A[26496610];RUFY1[26496610];KLC4[26496610];ZNF526[26496610];GAR1[26496610];NCAPD3[26496610];MRPL9[26496610];
690973	chr7	149418035	C	T	chr7:149418035	KRBA1	KRAB-A domain containing 1	10496.0	SNV	0/1	0.42	21_15	36	99	False	rs201698982	EXONIC	YES	NM_001290187.2	Transcript	protein_coding	synonymous_variant		4/18	NM_001290187.2:c.369C>T	NP_001277116.1:p.Ser123%3D		1.0						.	.	.		0.000236574	36.0	152172.0	0.0	33	0.99	PASS	amr	0.000719895	11.0	0.000191148	13.0	0.000278921	69.0	247382.0	0.0	51	0.97	PASS	amr	0.000871384	30.0	0.000267876	30.0	0.0002251	35	0.002	7.0				3.557	0.057951		0	0	0			KRBA1	0.0	0.0	0.0	0.0	-28.0	-31.0	-2.0	46.0							0.0	1.190313358			.			.	.	biological_process	cellular_component	molecular_function	GSK3B[20368287];GSK3A[20368287];PLK1[21988832];FNTB[unassigned1304];
691098	chr16	72992582		TCTTCCTCCTCCTCT	chr16:72992581-72992582	ZFHX3	zinc finger homeobox 3	10500.0	insertion	0/1	0.54	11_13	24	99	False	rs376713069	EXONIC	YES	NM_001386735.1	Transcript	protein_coding	inframe_insertion		9/17	NM_001386735.1:c.1449_1463dup	NP_001373664.1:p.Glu483_Glu487dup		-1.0					Prostate cancer, somatic, 176807 (3)	.	.	Autosomal dominant inheritance;Somatic mutation;Prostate cancer		0.00326819	496.0	151766.0	2.0	33	0.96	PASS	nfe	0.00515115	350.0	0.00515115	350.0	0.00135585	340.0	250766.0	3.0	73	1.0	PASS	amr	0.00341831	118.0	0.00160539	182.0	0.0005016,0.0000772	78,12			0.00246	28.0		15.77	1.409289		0	0	0																	0.086	1.0	0.0			neoplasm; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; 			fetal thyroid;superior cervical ganglion;prostate;	.	negative regulation of transcription by RNA polymerase II;regulation of transcription, DNA-templated;transcription by RNA polymerase II;brain development;muscle organ development;circadian regulation of gene expression;regulation of neuron differentiation;positive regulation of cell adhesion;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;response to transforming growth factor beta;regulation of locomotor rhythm	nucleus;nucleoplasm;transcription factor complex;cytoplasm;nuclear body	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;zinc ion binding;enzyme binding;transcription regulatory region DNA binding	TTC23[unassigned1304];USHBP1[unassigned1304];C11orf49[unassigned1304];DEUP1[unassigned1304];KRT40[25416956];LMNB2[unassigned1304];GOLGA2[unassigned1304];GOLGA6L9[unassigned1304];ALKBH4[23145062];MYC[21150319];CEP70[unassigned1304];TRIM27[unassigned1304];NINL[16189514];PIBF1[unassigned1304];ZNF620[unassigned1304];RBM11[unassigned1304];POU2F1[unassigned1304];MSX2[unassigned1304];POU6F2[unassigned1304];MTUS2[unassigned1304];KRT34[unassigned1304];KRT31[unassigned1304];AES[unassigned1304];COPS6[unassigned1304];CNOT2[unassigned1304];BHLHE40[unassigned1304];SPECC1L[unassigned1304];PICK1[unassigned1304];TACC1[unassigned1304];EFHC2[unassigned1304];TRIM54[unassigned1304];WRAP53[26496610];
697272	chr13	99907201	C	T	chr13:99907201	GPR18	G protein-coupled receptor 18	10631.0	SNV	0/1	0.4	15_10	25	99	False		EXONIC	YES	NM_005292.4	Transcript	protein_coding	missense_variant		3/3	NM_005292.4:c.926G>A	NP_005283.1:p.Ser309Asn		-1.0	.,.,.					.	.	.		6.57618e-06	1.0	152064.0	0.0	32	0.96	PASS	nfe	1.47007e-05	1.0	1.47007e-05	1.0					70	1.0														27.1	3.92471	0.592	12	9	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,MetaRNN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	GPR18	0.0	0.0	0.0	0.0	-10.0	43.0	-26.0	-36.0						0.922	0.0	11.809070186	0.997	1.026	hematopoietic system phenotype; immune system phenotype; homeostasis/metabolism phenotype; 			tonsil;white blood cells;testis - interstitial;superior cervical ganglion;trigeminal ganglion;testis;	.	CD8-positive, alpha-beta intraepithelial T cell differentiation;CD8-positive, gamma-delta intraepithelial T cell differentiation;negative regulation of leukocyte chemotaxis;G protein-coupled receptor signaling pathway;negative regulation of tumor necrosis factor production;positive regulation of Rho protein signal transduction;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	plasma membrane;integral component of plasma membrane;integral component of membrane;cytoplasmic vesicle membrane	G protein-coupled receptor activity	.
698179	chr7	158621972	C	T	chr7:158621972	ESYT2	extended synaptotagmin 2	10687.0	SNV	0/1	0.39	14_9	23	99	False	rs376287662	EXONIC	YES	NM_001367773.1	Transcript	protein_coding	synonymous_variant		1/23	NM_001367773.1:c.138G>A	NP_001354702.1:p.Leu46%3D		-1.0						.	.	.		0.00109938	167.0	151904.0	1.0	33	0.96	PASS	afr	0.0038638	160.0	0.0	0.0	0.0001056	12.0	113636.0	0.0	9	0.36	PASS	afr	0.00357398	10.0	2.2605e-05	1.0	0.0001158	18						13.62	1.028492		0	0	0			ESYT2	0.0	0.0	0.0	0.0	-2.0	20.0	-9.0	-11.0						0.522	0.01				immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cellular phenotype; 			.	.	lipid transport;endocytosis;endoplasmic reticulum-plasma membrane tethering	endoplasmic reticulum membrane;integral component of plasma membrane;membrane;intrinsic component of endoplasmic reticulum membrane;extrinsic component of cytoplasmic side of plasma membrane;organelle membrane contact site;endoplasmic reticulum-plasma membrane contact site	calcium ion binding;protein binding;calcium-dependent phospholipid binding;phosphatidylethanolamine binding;phosphatidylcholine binding;phosphatidylinositol binding;identical protein binding;cadherin binding	PPP1R15A[29109149];NOP56[26496610];ATP6AP2[26496610];FN1[19738201];HSCB[28380382];MAPK15[23602568];ELL2[26496610];FGD1[26496610];CAMKK2[20562859];CLN3[20562859];TUBA1C[26496610];NCSTN[26496610];TMEM17[26638075];TUBA1A[29568061];IRF3[25609649];CANX[29568061];ESYT3[23791178;27065097];PAEP[26496610];ESYT2[23791178;24847877];ESYT1[23791178;27065097];MPHOSPH8[26496610];BET1[29568061];
698999	chr19	36379479	C	T	chr19:36379479	NFKBID	NFKB inhibitor delta	10704.0	SNV	0/1	0.6	12_18	30	99	False	rs142460503	EXONIC	YES	NM_032721.3	Transcript	protein_coding	synonymous_variant		12/12	NM_032721.3:c.1380G>A	NP_116110.2:p.Pro460%3D		-1.0						.	.	.		0.00107791	164.0	152146.0	0.0	31	0.97	PASS	afr	0.00164172	68.0	0.00135223	92.0	0.00072536	131.0	180600.0	0.0	36	0.59	PASS	afr	0.00194832	19.0	0.0012335	94.0	0.0008103	126						9.76	0.538664		0	0	0			NFKBID	0.0	0.0	0.0	0.0	26.0	15.0	-4.0	25.0						0.317	0.8	93.040747989			homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; hematopoietic system phenotype; digestive/alimentary phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;	.	inflammatory response;negative regulation of NF-kappaB transcription factor activity;negative regulation of T cell differentiation in thymus;negative regulation of I-kappaB kinase/NF-kappaB signaling;T cell receptor signaling pathway;positive regulation of thymocyte apoptotic process;positive regulation of T-helper 17 cell differentiation	nucleus	protein binding;NF-kappaB binding	PRDM6[unassigned1304];FAM107A[unassigned1304];FOXI1[unassigned1304];IKZF3[unassigned1304];TSEN54[unassigned1304];TCL1A[unassigned1304];TRIM29[unassigned1304];GRB10[unassigned1304];TEKT4[unassigned1304];HOXA1[unassigned1304];TEKT5[unassigned1304];C12orf66[unassigned1304];SAMD11[unassigned1304];LMO3[unassigned1304];LMO2[unassigned1304];RFX2[unassigned1304];ANXA11[unassigned1304];LGALS14[unassigned1304];KRT76[unassigned1304];KRT75[unassigned1304];RUNX1[unassigned1304];GPANK1[unassigned1304];PKP1[unassigned1304];TSSK3[unassigned1304];HOXB5[unassigned1304];BEX2[unassigned1304];UTP23[unassigned1304];DTX3[unassigned1304];KRT40[25416956];PATZ1[unassigned1304];HOXC9[unassigned1304];HOXC8[unassigned1304];SMAD4[unassigned1304];ZBTB16[unassigned1304];INCA1[unassigned1304];SH2D1B[unassigned1304];MRPL28[unassigned1304];ESR2[unassigned1304];GFAP[unassigned1304];QARS[unassigned1304];LHX3[unassigned1304];HNRNPF[unassigned1304];TCF4[unassigned1304];HOXD3[unassigned1304];CTRC[unassigned1304];C1orf94[25416956;unassigned1304];RTP5[unassigned1304];SMG9[unassigned1304];MEOX2[unassigned1304];FARS2[unassigned1304];TRIM9[25416956];ADAMTSL4[unassigned1304];SNAPC3[unassigned1304];ZIC1[unassigned1304];NCK2[unassigned1304];ELOA[unassigned1304];PLEKHN1[unassigned1304];CCHCR1[unassigned1304];TCF19[unassigned1304];SS18[25416956];RBM14[unassigned1304];PRMT7[unassigned1304];RING1[unassigned1304];CCDC36[unassigned1304];KRT34[unassigned1304];TFIP11[unassigned1304];TRAF2[unassigned1304];PAX6[unassigned1304];PATL1[unassigned1304];MRPL53[unassigned1304];GIGYF1[unassigned1304];RAD51D[unassigned1304];SCNM1[unassigned1304];LCK[unassigned1304];HNRNPH1[unassigned1304];NUP54[unassigned1304];ARHGEF2[unassigned1304];EFHC2[unassigned1304];C4orf45[unassigned1304];SLU7[unassigned1304];HDAC4[unassigned1304];DDX25[unassigned1304];CRYBA2[unassigned1304];RBM4B[unassigned1304];FAAP20[unassigned1304];KRTAP6-2[unassigned1304];C1orf109[unassigned1304];GADD45GIP1[unassigned1304];PTCD1[unassigned1304];MYEF2[unassigned1304];IRX6[unassigned1304];NICN1[unassigned1304];GLYCTK[unassigned1304];SAMD4A[unassigned1304];DMRT3[unassigned1304];SORBS3[unassigned1304];PSMB8[unassigned1304];POU4F2[unassigned1304];POMC[unassigned1304];KRT19[unassigned1304];TRIML2[unassigned1304];RBM41[unassigned1304];VIM[unassigned1304];
704771	chr16	50102785	A	T	chr16:50102785	HEATR3	HEAT repeat containing 3	10776.0	SNV	0/1	0.43	12_10	23	99	False	rs200316648	SPLICING	YES	NM_182922.4	Transcript	protein_coding	splice_region_variant,intron_variant	3/14		NM_182922.4:c.399+7A>T			1.0						.	.	.		0.000505953	77.0	152188.0	1.0	32	0.97	PASS	amr	0.00392773	60.0	0.000176372	12.0	0.000497153	124.0	249420.0	1.0	47	0.9	PASS	amr	0.00291743	99.0	0.000185444	21.0	0.0003858	60	0.005	17.0				1.579	-0.082377		0	0	0			HEATR3	0.0	0.0	0.0	0.0	-42.0	-7.0	-7.0	20.0	0.0001918391600574	0.0				0.752	0.0				homeostasis/metabolism phenotype; 			amygdala;white blood cells;superior cervical ganglion;atrioventricular node;	.	protein import into nucleus;ribosomal large subunit biogenesis	cell	unfolded protein binding	DSP[26496610];GSTK1[17353931];JUN[25609649];SGTB[26496610];KDM1B[26496610];NONO[30021884];LNPEP[26496610];HSCB[28380382];NCAPH[26496610];PTP4A3[17353931];MYC[17353931];TRAF6[17353931];SMS[26496610];HNRNPD[26496610];NCK1[26496610];
705996	chr21	30715079	G	A	chr21:30715079	BACH1	BTB domain and CNC homolog 1	10806.0	SNV	0/1	0.45	16_13	29	99	False	rs768969111	EXONIC	YES	NM_206866.3	Transcript	protein_coding	synonymous_variant		5/5	NM_206866.3:c.2136G>A	NP_996749.1:p.Ala712%3D		1.0						.	.	.		6.57289e-06	1.0	152140.0	0.0	33	0.97	PASS	afr	2.41383e-05	1.0	0.0	0.0	1.59949e-05	4.0	250080.0	0.0	53	1.0	PASS	afr	0.000123962	2.0	0.0	0.0	0.0000064	1						4.898	0.138883		0	0	0			BACH1	0.0	0.0	0.0	0.0	2.0	7.0	5.0	19.0						0.766	0.01	0.0			cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;testis - interstitial;atrioventricular node;trigeminal ganglion;superior cervical ganglion;whole blood;	.	regulation of transcription involved in G1/S transition of mitotic cell cycle;regulation of transcription involved in G2/M transition of mitotic cell cycle;negative regulation of transcription by RNA polymerase II;DNA repair;regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;regulation of transcription from RNA polymerase II promoter in response to hypoxia	nucleus;cytoplasm;cytosol	RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;heme binding	ATF1[20102225];ATF2[20102225];HMMR[26496610];NLK[23602568];VIRMA[26496610];PABPN1[26496610];TMEM208[26496610];FAM83D[26496610];CSNK1A1[23455922];FOS[20102225];PPHLN1[26496610];PLRG1[26496610];PTBP3[22575643];BATF[20102225];MAF[20102225];MAFB[20102225];CREB1[20102225];DDX39B[26496610];DDIT3[20102225];MAFG[20102225;26496610];NME8[27173435;unassigned1312];MAFF[26496610];HIST3H3[30021884];TAF4B[26496610];TRIP11[unassigned1312];ANAPC5[21988832];ATF7[20102225];MAFK[26496610];
706019	chr6	133046003	G	A	chr6:133046003	VNN3	vanin 3	10808.0	SNV	0/1	0.38	15_9	24	99	False	rs45513492	EXONIC	YES	NM_001291702.2	Transcript	protein_coding	synonymous_variant		5/7	NM_001291702.2:c.171C>T	NP_001278631.1:p.Tyr57%3D		-1.0						.	.	.		0.00560432	853.0	152204.0	5.0	33	0.97	PASS	nfe	0.00886217	603.0	0.00886217	603.0	0.00602503	1396.0	231700.0	9.0	100	0.98	PASS	nfe	0.00870007	941.0	0.00870007	941.0	0.0050610	787	0.014	45.0				10.88	0.66793		0	0	0			VNN3	0.0	0.0	0.01	0.0	-8.0	-43.0	-23.0	-34.0							0.03	0.553055577			.			superior cervical ganglion;trigeminal ganglion;	.	biological_process;pantothenate metabolic process	cellular_component;extracellular region;plasma membrane;anchored component of membrane	pantetheine hydrolase activity	.
706888	chr1	36212547	G	T	chr1:36212547	CLSPN	claspin	10831.0	SNV	0/1	0.37	22_13	35	99	False	rs34390044,COSV52051602	EXONIC	YES	NM_022111.4	Transcript	protein_coding	missense_variant		15/25	NM_022111.4:c.2674C>A	NP_071394.2:p.Pro892Thr		-1.0	.,.,.,.					.	.	.	32888493	0.00610606	929.0	152144.0	13.0	32	0.96	PASS	nfe	0.00720334	490.0	0.00720334	490.0	0.00755931	1901.0	251478.0	19.0	94	1.0	PASS	nfe	0.00755977	860.0	0.00755977	860.0	0.0064886	1009	0.004	14.0				14.53	1.177651	0.012	1	18	19	fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	CLSPN	0.04	0.02	0.0	0.0	31.0	-20.0	-18.0	22.0						0.701	0.99	0.0	0.66	0.222	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			.	.	DNA damage checkpoint;DNA replication;DNA repair;mitotic G2 DNA damage checkpoint;protein deubiquitination;peptidyl-serine phosphorylation;activation of protein kinase activity;mitotic DNA replication checkpoint	nucleoplasm;Golgi apparatus	DNA binding;protein binding;anaphase-promoting complex binding	MPP1[26496610];EGLN3[26972000];RPA1[24126761];LTN1[26496610];RPA2[24126761];PRIMPOL[24126761];CDK9[20930849];LACC1[27478939];FZR1[18662541];GJB2[26496610];CDC45[23910567];RPA3[24126761];CHEK1[16963448];RAD9A[20424596];MYH7[26496610];
708351	chr10	101835746	G	A	chr10:101835746	CPN1	carboxypeptidase N subunit 1	10908.0	SNV	0/1	0.35	22_12	34	99	False	rs768101001,COSV64942312	EXONIC	YES	NM_001308.3	Transcript	protein_coding	synonymous_variant		2/9	NM_001308.3:c.342C>T	NP_001299.1:p.Ile114%3D		-1.0					Carboxypeptidase N deficiency, 212070 (3), Autosomal recessive	.	.	Autosomal recessive inheritance;Angioedema						32	0.97							1.19304e-05	3.0	251458.0	0.0	100	1.0	PASS	afr	6.15233e-05	1.0	8.79152e-06	1.0	0.0000064	1						2.437	-0.012622		0	0	0			CPN1	0.0	0.0	0.0	0.0	-16.0	47.0	34.0	-18.0						0.716	0.0	24.802902514			immune system phenotype; 			.	.	peptide metabolic process;bradykinin catabolic process;protein processing;regulation of complement activation;response to glucocorticoid	extracellular region;extracellular space	metallocarboxypeptidase activity;zinc ion binding	CDC42[18624398];PRKDC[30021884];CLEC4G[18624398];
708556	chr20	50090626	C	T	chr20:50090626	NFATC2	nuclear factor of activated T cells 2	10917.0	SNV	0/1	0.41	17_12	29	99	False	rs6013192	EXONIC	YES	NM_173091.4	Transcript	protein_coding	synonymous_variant		5/10	NM_173091.4:c.1599G>A	NP_775114.1:p.Thr533%3D		-1.0						.	.	.		0.000302258	46.0	152188.0	0.0	32	0.97	PASS	afr	0.000892728	37.0	0.0	0.0	0.000127246	32.0	251482.0	0.0	75	1.0	PASS	afr	0.000738189	12.0	8.79044e-06	1.0	0.0000965	15	0.001	2.0	0.00031	3.0		7.358	0.311361		0	0	0			NFATC2	0.0	0.0	0.0	0.11	-2.0	38.0	9.0	-24.0						0.238	1.0	83.7086725			respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; hematopoietic system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; cellular phenotype; immune system phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; 			.	MAPK signaling pathway;Wnt signaling pathway;Axon guidance;VEGF signaling pathway;Natural killer cell mediated cytotoxicity;T cell receptor signaling pathway;B cell receptor signaling pathway	negative regulation of transcription by RNA polymerase II;cytokine production;regulation of transcription, DNA-templated;cellular response to DNA damage stimulus;myotube cell development;cell migration;positive regulation of B cell proliferation;calcineurin-NFAT signaling cascade;Fc-epsilon receptor signaling pathway;response to drug;regulation of regulatory T cell differentiation;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;B cell receptor signaling pathway;positive regulation of myoblast fusion;negative regulation of vascular smooth muscle cell differentiation	nuclear chromatin;nucleus;nucleoplasm;transcription factor complex;cytoplasm;cytosol;nuclear transcription factor complex;ribonucleoprotein complex	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;chromatin binding;DNA-binding transcription factor activity;protein binding;transcription factor binding;phosphatase binding	JUN[20557936;25609649];CREBBP[19060202];RIPK2[17353931];CSE1L[21983832];LRRK2[21983832];USP22[24561192];NFATC2[18462673;19060202];IQGAP1[21983832];VRK2[23105117];FOS[18172215];PPP3CA[24954618];CREB1[25609649];PPP2R1A[21983832];MED31[16169070];VIM[16169070];TNPO1[21983832];
709599	chr1	13183109	T	C	chr1:13183109	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.18	27_6	33	99	False	rs369043510	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.764A>G	NP_001130033.3:p.Asp255Gly		-1.0						.	.	.		1.3183e-05	2.0	151710.0	0.0	31	0.93	PASS	afr	4.86523e-05	2.0	0.0	0.0	0.18989	29477.0	155232.0	6.0	97	1.0	InbreedingCoeff_RF	eas	0.290513	3736.0	0.169941	11540.0	0.0003601	56						6.294	0.231384		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.01	0.0	-50.0	-18.0	1.0	-6.0									0.002	-1.797	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709600	chr1	13183110	C	A	chr1:13183110	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.18	28_6	34	99	False	rs371451661	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.763G>T	NP_001130033.3:p.Asp255Tyr		-1.0						.	.	.		6.59048e-06	1.0	151734.0	0.0	31	0.93	PASS	afr	2.4338e-05	1.0	0.0	0.0	0.187054	29391.0	157126.0	5.0	97	1.0	InbreedingCoeff_RF	eas	0.285002	3713.0	0.167997	11536.0	0.0003601	56						0.423	-0.278547		1	6	7	SIFT	PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	-24.0	29.0	2.0	-9.0									0.003	0.258	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709601	chr1	13183115	G	A	chr1:13183115	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.18	28_6	34	99	False	rs111369527	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.758C>T	NP_001130033.3:p.Pro253Leu		-1.0						.	.	.		6.59613e-06	1.0	151604.0	0.0	31	0.93	PASS	afr	2.43653e-05	1.0	0.0	0.0	0.192251	30215.0	157164.0	6.0	100	1.0	InbreedingCoeff_RF	eas	0.289227	3764.0	0.173285	11860.0	0.0006431	100	0.0	1.0				2.747	0.008113		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	-7.0	-24.0	2.0	42.0									0.001	-1.689	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709602	chr1	13183130	G	A	chr1:13183130	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.2	28_7	35	99	False	rs376039645	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.743C>T	NP_001130033.3:p.Ala248Val		-1.0						.	.	.		6.59248e-06	1.0	151688.0	0.0	31	0.93	PASS	afr	2.43534e-05	1.0	0.0	0.0	0.231198	31750.0	137328.0	7.0	100	1.0	InbreedingCoeff_RF	eas	0.328509	3745.0	0.213432	12680.0	0.0004952	77	0.0	1.0				1.197	-0.12406		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.04	0.0	-5.0	-39.0	38.0	-29.0									0.013	0.29	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709603	chr1	13183138	T	A	chr1:13183138	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.19	29_7	36	99	False	rs369308948	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.735A>T	NP_001130033.3:p.Glu245Asp		-1.0						.	.	.		6.589e-06	1.0	151768.0	0.0	31	0.93	PASS	afr	2.43191e-05	1.0	0.0	0.0	0.245295	32691.0	133272.0	7.0	100	1.0	InbreedingCoeff	eas	0.335605	3693.0	0.2289	13213.0	0.0037555	584	0.001	3.0				6.509	0.246819		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	1.0	-47.0	30.0	24.0									0.004	-1.727	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709604	chr1	13183165	T	C	chr1:13183165	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.23	30_9	39	99	False	rs373520162	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.708A>G	NP_001130033.3:p.Val236%3D		-1.0						.	.	.		0.000171799	26.0	151340.0	0.0	31	0.92	PASS	eas	0.000594766	3.0	0.000176788	12.0	0.357921	41483.0	115900.0	7.0	100	1.0	InbreedingCoeff_RF	eas	0.426801	4064.0	0.350445	18111.0	0.0002058	32	0.002	7.0				5.658	0.187822		0	0	0			HNRNPCL2	0.0	0.0	0.0	0.1	-26.0	-4.0	-19.0	3.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709605	chr1	13183168	A	G	chr1:13183168	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.26	29_10	39	99	False	rs377681267	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.705T>C	NP_001130033.3:p.His235%3D		-1.0						.	.	.		2.63988e-05	4.0	151522.0	0.0	31	0.92	PASS				0.0	0.0	0.374861	44646.0	119100.0	8.0	100	1.0	InbreedingCoeff_RF	amr	0.434985	7199.0	0.370847	19982.0	0.0001929	30	0.002	7.0				2.216	-0.02847		0	0	0			HNRNPCL2	0.0	0.0	0.0	0.0	-29.0	-7.0	0.0	16.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709606	chr1	13183176	C	T	chr1:13183176	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.25	30_10	40	99	False	rs115395118	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.697G>A	NP_001130033.3:p.Glu233Lys		-1.0						.	.	.						31	0.92							0.421284	55430.0	131574.0	9.0	100	1.0	InbreedingCoeff_RF	amr	0.469955	8822.0	0.417376	25197.0	0.0002315	36	0.003	10.0				1.435	-0.096905		1	6	7	SIFT	PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.01	0.02	39.0	-8.0	3.0	-8.0									0.001	0.258	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709607	chr1	13183180	T	C	chr1:13183180	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.24	32_10	42	99	False	rs138475976	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.693A>G	NP_001130033.3:p.Lys231%3D		-1.0						.	.	.						31	0.92							0.432818	58491.0	135140.0	9.0	100	1.0	InbreedingCoeff_RF	amr	0.474557	8990.0	0.430793	27152.0	0.0001929	30	0.004	12.0				1.422	-0.098318		0	0	0			HNRNPCL2	0.0	0.0	0.02	0.0	-1.0	-2.0	-12.0	4.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709608	chr1	13183187	A	G	chr1:13183187	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.24	32_10	42	99	False	rs149345149	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.686T>C	NP_001130033.3:p.Met229Thr		-1.0						.	.	.						31	0.92							0.458297	68871.0	150276.0	9.0	100	1.0	InbreedingCoeff	amr	0.482984	10190.0	0.457723	32816.0	0.0001608	25	0.003	9.0				0.246	-0.357256		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.01	0.0	28.0	8.0	-19.0	44.0									0.001	-0.638	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709609	chr1	13183188	T	A	chr1:13183188	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.23	33_10	43	99	False	rs144308453	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.685A>T	NP_001130033.3:p.Met229Leu		-1.0						.	.	.						31	0.92							0.460539	70422.0	152912.0	9.0	100	1.0	InbreedingCoeff	amr	0.483798	10421.0	0.460068	33619.0	0.0001608	25	0.003	8.0				0.422	-0.279188		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.01	0.0	12.0	27.0	49.0	-20.0									0.0	-0.8	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709610	chr1	13183195	A	G	chr1:13183195	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.23	33_10	43	99	False	rs140894230	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.678T>C	NP_001130033.3:p.Ser226%3D		-1.0						.	.	.						31	0.92							0.47259	77034.0	163004.0	9.0	100	1.0	InbreedingCoeff_RF	amr	0.489756	11474.0	0.471807	36733.0	0.0001608	25	0.005	16.0				4.895	0.138704		0	0	0			HNRNPCL2	0.0	0.0	0.04	0.05	-17.0	-36.0	-27.0	36.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709611	chr1	13183199	C	G	chr1:13183199	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.24	31_10	41	99	False	rs146955784	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.674G>C	NP_001130033.3:p.Ser225Thr		-1.0						.	.	.		6.59152e-06	1.0	151710.0	0.0	31	0.92	PASS	nfe	1.47054e-05	1.0	1.47054e-05	1.0	0.475891	80043.0	168196.0	9.0	100	1.0	InbreedingCoeff	amr	0.492797	11972.0	0.47473	38061.0	0.0001608	25	0.005	16.0				0.194	-0.390963		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	49.0	-4.0	32.0	38.0									0.008	-0.787	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709612	chr1	13183213	T	A	chr1:13183213	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0/1	0.3	28_12	40	99	False	rs28373323	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.660A>T	NP_001130033.3:p.Ser220%3D		-1.0						.	.	.						31	0.92							0.483303	93496.0	193452.0	10.0	100	1.0	InbreedingCoeff	amr	0.496336	14222.0	0.482114	43506.0	0.0001608	25	0.007	22.0				0.629	-0.219887		0	0	0			HNRNPCL2	0.0	0.0	0.02	0.0	-5.0	-2.0	24.0	4.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709613	chr1	13183225	T	C	chr1:13183225	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.29	29_12	41	99	False	rs28634306	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.648A>G	NP_001130033.3:p.Lys216%3D		-1.0						.	.	.						31	0.92							0.49341	106313.0	215466.0	11.0	100	1.0	InbreedingCoeff	amr	0.499372	15900.0	0.492281	48594.0	0.0001672	26	0.007	22.0				4.261	0.099967		0	0	0			HNRNPCL2	0.0	0.0	0.03	0.02	29.0	-10.0	6.0	12.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709614	chr1	13183228	C	T	chr1:13183228	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.31	29_13	42	99	False	rs144054379	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.645G>A	NP_001130033.3:p.Val215%3D		-1.0						.	.	.						31	0.92							0.494026	108823.0	220278.0	11.0	100	1.0	InbreedingCoeff	amr	0.499439	16036.0	0.492824	49652.0	0.0001672	26	0.007	22.0				0.476	-0.26139		0	0	0			HNRNPCL2	0.0	0.0	0.23	0.0	-17.0	20.0	3.0	-11.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709615	chr1	13183237	C	T	chr1:13183237	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.33	26_13	39	99	False	rs141111983	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.636G>A	NP_001130033.3:p.Glu212%3D		-1.0						.	.	.		0.000100045	15.0	149932.0	0.0	31	0.92	PASS	eas	0.00126316	6.0	8.90525e-05	6.0	0.496417	116666.0	235016.0	11.0	100	1.0	InbreedingCoeff	amr	0.49979	16694.0	0.495226	52806.0	0.0004630	72	0.007	22.0				5.463	0.175029		0	0	0			HNRNPCL2	0.0	0.0	0.11	0.23	17.0	22.0	-6.0	0.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709616	chr1	13183238	T	C	chr1:13183238	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.33	26_13	39	99	False	rs75918656	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.635A>G	NP_001130033.3:p.Glu212Gly		-1.0						.	.	.		0.00012003	18.0	149962.0	0.0	31	0.92	PASS	eas	0.0012621	6.0	0.000103925	7.0	0.496556	117217.0	236060.0	12.0	100	1.0	InbreedingCoeff	amr	0.499821	16737.0	0.495394	53021.0	0.0004630	72	0.007	22.0				6.729	0.262974		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.21	0.0	10.0	-16.0	-1.0									0.004	-0.8	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709617	chr1	13183243	T	C	chr1:13183243	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.32	26_12	38	99	False	rs79873981	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.630A>G	NP_001130033.3:p.Lys210%3D		-1.0						.	.	.						31	0.92							0.497474	118555.0	238314.0	11.0	100	1.0	InbreedingCoeff	amr	0.49991	16756.0	0.496568	53682.0	0.0001672	26	0.007	22.0				1.808	-0.061277		0	0	0			HNRNPCL2	0.0	0.0	0.02	0.0	-48.0	16.0	-12.0	-6.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709618	chr1	13183248	T	A	chr1:13183248	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.34	23_12	35	99	False	rs79256404	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.625A>T	NP_001130033.3:p.Ser209Cys		-1.0						.	.	.						31	0.92							0.498422	119678.0	240114.0	11.0	100	1.0	InbreedingCoeff	amr	0.499881	16782.0	0.497795	54187.0	0.0001608	25	0.007	22.0				0.924	-0.162445		1	6	7	SIFT	PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	48.0	-2.0	2.0	-11.0									0.022	0.28	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709620	chr1	13183439	C	C	chr1:13183439	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0/1	0.61	23_37	61	99	False	rs28713604	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.434A>G	NP_001130033.3:p.Arg145%3D		-1.0						.	.	.						0	0.0							0.753455	189167.0	251066.0	63635.0	100	1.0	InbreedingCoeff	sas	0.818351	25053.0	0.74262	84274.0	0.0643135	10001	0.288	894.0				8.782	0.436576		0	0	0			HNRNPCL2	0.0	0.0	0.0	0.0	12.0	-5.0	-38.0	-2.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709621	chr1	13183511	T	C	chr1:13183511	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.49	26_26	53	99	False	rs1737105	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.362A>G	NP_001130033.3:p.Asp121Gly		-1.0						.	.	.		0.00130745	198.0	151440.0	1.0	31	0.92	PASS	eas	0.00193199	10.0	0.00133871	91.0	0.499895	123481.0	247014.0	16.0	100	1.0	InbreedingCoeff	sas	0.500066	15155.0	0.499785	55918.0	0.0118582	1844	0.072	205.0				3.836	0.074576		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	1.0	-13.0	1.0	-6.0									0.002	-0.751	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709622	chr1	13183528	A	C	chr1:13183528	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.41	29_21	51	99	False	rs76937665	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.345T>G	NP_001130033.3:p.Phe115Leu		-1.0						.	.	.		0.000112116	17.0	151628.0	0.0	31	0.92	PASS	eas	0.000386698	2.0	5.88339e-05	4.0	0.499536	112028.0	224264.0	13.0	100	1.0	InbreedingCoeff	sas	0.500036	13956.0	0.499404	51074.0	0.0020257	315	0.033	99.0				2.9	0.017874		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	40.0	-30.0	-23.0	-42.0									0.001	-1.897	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709623	chr1	13183532	C	T	chr1:13183532	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.37	32_19	52	99	False	rs77505369	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.341G>A	NP_001130033.3:p.Gly114Asp		-1.0						.	.	.		0.000105542	16.0	151598.0	0.0	31	0.92	PASS	amr	0.000328386	5.0	5.88218e-05	4.0	0.499369	106102.0	212472.0	13.0	100	1.0	InbreedingCoeff	sas	0.5	13298.0	0.499282	48653.0	0.0019935	310	0.029	90.0				2.348	-0.018929		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	-34.0	-1.0	-24.0	30.0									0.003	-0.746	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709624	chr1	13183533	C	T	chr1:13183533	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.37	32_19	52	99	False	rs77556803	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.340G>A	NP_001130033.3:p.Gly114Ser		-1.0						.	.	.		0.000105546	16.0	151592.0	0.0	31	0.92	PASS	amr	0.000328429	5.0	5.88305e-05	4.0	0.499332	104693.0	209666.0	13.0	100	1.0	InbreedingCoeff	sas	0.5	13153.0	0.499231	48029.0	0.0019871	309	0.029	91.0				3.493	0.05412		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	-2.0	-35.0	29.0	-28.0									0.004	-0.773	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
709625	chr1	13183567	C	T	chr1:13183567	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	10925.0	SNV	0|1	0.23	30_9	39	99	False	rs78160026	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.306G>A	NP_001130033.3:p.Ala102%3D		-1.0						.	.	.		0.00170365	258.0	151440.0	5.0	31	0.92	PASS	afr	0.00319559	131.0	0.00102996	70.0	0.420579	41226.0	98022.0	13.0	100	1.0	InbreedingCoeff	sas	0.440323	5342.0	0.425615	19025.0	0.0019807	308	0.036	111.0				7.033	0.286132		0	0	0			HNRNPCL2	0.0	0.0	0.0	0.0	-2.0	19.0	-5.0	20.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];
711316	chr14	104436887	C	A	chr14:104436887	TDRD9	tudor domain containing 9	10963.0	SNV	0/1	0.52	14_15	29	99	False	rs776156806,COSV59152875	EXONIC	YES	NM_153046.3	Transcript	protein_coding	synonymous_variant		6/36	NM_153046.3:c.775C>A	NP_694591.2:p.Arg259%3D		1.0					?Spermatogenic failure 30, 618110 (3), Autosomal recessive	Male infertility with azoospermia or oligozoospermia due to single gene mutation	Disease-causing germline mutation(s) in	Decreased testicular size;Increased circulating gonadotropin level;Obstructive azoospermia;Non-obstructive azoospermia;Cryptozoospermia;Azoospermia;Autosomal recessive inheritance						32	0.96							1.27554e-05	2.0	156796.0	0.0	30	0.59	PASS	amr	8.1215e-05	2.0	0.0	0.0			0.0	1.0				11.46	0.737936		0	0	0			TDRD9	0.0	0.03	0.0	0.0	2.0	-9.0	32.0	29.0						0.988	0.0	0.0			endocrine/exocrine gland phenotype; cellular phenotype; reproductive system phenotype; 			ciliary ganglion;testis - seminiferous tubule;subthalamic nucleus;testis - interstitial;trigeminal ganglion;superior cervical ganglion;testis;	.	male meiotic nuclear division;male meiosis I;multicellular organism development;spermatogenesis;fertilization;negative regulation of transposition;cell differentiation;gene silencing by RNA;piRNA metabolic process;DNA methylation involved in gamete generation	nucleus;cytoplasm;piP-body	RNA binding;ATP binding;ATPase activity;ATP-dependent 3'-5' RNA helicase activity	DNAJC7[26496610];
711327	chr14	104506581	G	A	chr14:104506581	TDRD9	tudor domain containing 9	10963.0	SNV	0/1	0.38	13_8	21	99	False	rs543866438	EXONIC	YES	NM_153046.3	Transcript	protein_coding	synonymous_variant		33/36	NM_153046.3:c.3765G>A	NP_694591.2:p.Gly1255%3D		1.0					?Spermatogenic failure 30, 618110 (3), Autosomal recessive	Male infertility with azoospermia or oligozoospermia due to single gene mutation	Disease-causing germline mutation(s) in	Decreased testicular size;Increased circulating gonadotropin level;Obstructive azoospermia;Non-obstructive azoospermia;Cryptozoospermia;Azoospermia;Autosomal recessive inheritance		6.57013e-06	1.0	152204.0	0.0	32	0.97	PASS	nfe	1.46959e-05	1.0	1.46959e-05	1.0	6.38007e-06	1.0	156738.0	0.0	21	0.52	PASS	nfe	1.64312e-05	1.0	1.64312e-05	1.0	0.0000129	2						0.607	-0.225312		0	0	0			TDRD9	0.03	0.01	0.0	0.0	-48.0	11.0	-40.0	-35.0						0.988	0.0	20.456183014			endocrine/exocrine gland phenotype; cellular phenotype; reproductive system phenotype; 			ciliary ganglion;testis - seminiferous tubule;subthalamic nucleus;testis - interstitial;trigeminal ganglion;superior cervical ganglion;testis;	.	male meiotic nuclear division;male meiosis I;multicellular organism development;spermatogenesis;fertilization;negative regulation of transposition;cell differentiation;gene silencing by RNA;piRNA metabolic process;DNA methylation involved in gamete generation	nucleus;cytoplasm;piP-body	RNA binding;ATP binding;ATPase activity;ATP-dependent 3'-5' RNA helicase activity	DNAJC7[26496610];
716167	chr2	128699628	G	A	chr2:128699628	SAP130	Sin3A associated protein 130	11077.0	SNV	0|1	0.74	5_14	19	72	False	rs776924885,COSV52096074	EXONIC	YES	NM_001145928.2	Transcript	protein_coding	synonymous_variant		21/21	NM_001145928.2:c.3204C>T	NP_001139400.1:p.Asn1068%3D		-1.0						.	.	.						28	0.86							2.40227e-05	6.0	249764.0	0.0	77	0.85	PASS	amr	5.86373e-05	2.0	1.76775e-05	2.0	0.0000257	4						0.012	-0.76562		0	0	0			SAP130	0.0	0.0	0.0	0.0	45.0	44.0	45.0	-15.0						0.0147	1.0	88.212370527			cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; 			pons;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;testis;medulla oblongata;cerebellum;	.	negative regulation of transcription by RNA polymerase II	nuclear speck;Sin3-type complex	.	HDAC2[23752268];SMAD3[15231748];HDAC1[23752268;26496610];MAX[25609649];FOXK2[25609649];FOXK1[25609649];SYN1[26496610];TCTE1[26638075];SAP30[26496610];GOLGA2[29568061];TPX2[26496610];SIN3B[26496610];CCR9[28298427];KIF20A[26496610];TP53BP1[29656893];
722549	chr1	45887466	C	T	chr1:45887466	TESK2	testis associated actin remodelling kinase 2	11171.0	SNV	0/1	0.59	9_13	22	99	False	rs147189690	EXONIC	YES	NM_007170.3	Transcript	protein_coding	missense_variant		3/11	NM_007170.3:c.275G>A	NP_009101.2:p.Ser92Asn		-1.0	.,Serine-threonine/tyrosine-protein kinase, catalytic domain&Protein kinase domain					.	.	.		0.000571849	87.0	152138.0	0.0	32	0.96	PASS	nfe	0.000940568	64.0	0.000940568	64.0	0.000577048	144.0	249546.0	1.0	86	1.0	PASS	nfe	0.000935834	106.0	0.000935834	106.0	0.0005595	87	0.0	1.0				15.17	1.295533	0.04	1	17	18	fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	TESK2	0.0	0.0	0.0	0.0	-4.0	28.0	-28.0	29.0						0.565	0.0	0.0	0.55	-0.718	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;	.	protein phosphorylation;spermatogenesis;peptidyl-tyrosine phosphorylation;actin cytoskeleton organization;focal adhesion assembly	nucleus;nucleoplasm;cytoplasm;nuclear body	protein kinase activity;protein serine/threonine kinase activity;protein serine/threonine/tyrosine kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;metal ion binding	HSP90AB1[22939624;25036637];RTKN[unassigned1312];MAST3[unassigned1312];DENND1A[unassigned1312];CBY1[unassigned1312];ZBTB21[unassigned1312];EDC3[unassigned1312];RPTOR[unassigned1312];FAM110A[unassigned1312];SYDE1[unassigned1312];SIPA1L1[unassigned1312];SH3PXD2A[unassigned1312];FAM110B[unassigned1312];FAM53C[unassigned1312];KIF13B[unassigned1312];KIF1C[unassigned1312];MAGI1[unassigned1312];HSP90AA1[25036637];KSR1[unassigned1312];NAV1[unassigned1312];KCTD3[unassigned1312];GAB2[unassigned1312];CDC25C[unassigned1312];CDC25B[unassigned1312];GIGYF1[unassigned1312];TIAM1[unassigned1312];DEPDC1B[unassigned1312];MELK[unassigned1312];CDC37[25036637];ZNF638[unassigned1312];TBC1D25[unassigned1312];EIF4E2[unassigned1312];PHLDB2[unassigned1312];FKBP5[25036637];HDAC4[unassigned1312];MAPKAP1[unassigned1312];PPM1H[unassigned1312];AGAP1[unassigned1312];RASAL2[unassigned1312];GIGYF2[unassigned1312];HDAC7[unassigned1312];CAMSAP2[unassigned1312];LIMA1[unassigned1312];LARP1[unassigned1312];INPP5E[unassigned1312];MAP3K21[unassigned1312];SH3BP4[unassigned1312];SRGAP2[unassigned1312];NADK[unassigned1312];SRSF12[unassigned1312];ANKRD34A[unassigned1312];STARD13[unassigned1312];USP21[unassigned1312];DENND4A[unassigned1312];RAB3IP[unassigned1312];DENND4C[unassigned1312];MBD2[27593931];PLEKHA5[unassigned1312];CGN[unassigned1312];PTPN14[unassigned1312];DCLK1[unassigned1312];PLEKHA7[unassigned1312];SH3RF3[unassigned1312];AFDN[unassigned1312];LRFN1[unassigned1312];NF1[unassigned1312];LPIN3[unassigned1312];CDK16[unassigned1312];
722634	chr8	62412051	GAG		chr8:62412051-62412053	CLVS1	clavesin 1	11175.0	deletion	0/1	0.55	10_12	22	99	False	rs35623706	EXONIC	YES	NM_173519.3	Transcript	protein_coding	inframe_deletion		6/6	NM_173519.3:c.1018_1020del	NP_775790.1:p.Glu340del		1.0						.	.	.		0.00476491	725.0	152154.0	6.0	32	0.95	PASS	nfe	0.00827479	563.0	0.00827479	563.0	0.00508429	1277.0	251166.0	7.0	66	1.0	PASS	nfe	0.00877208	996.0	0.00877208	996.0	0.0000450,0.0045529	7,708	0.006	19.0				24.7	3.416467		0	0	0			CLVS1	0.0	0.03	0.0	0.0	-29.0	-36.0	-24.0	-27.0						0.0763	0.85	0.0			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;skin;superior cervical ganglion;skeletal muscle;globus pallidus;	.	lysosome organization	endosome;trans-Golgi network;clathrin-coated vesicle;early endosome membrane;trans-Golgi network membrane	phosphatidylinositol-3,5-bisphosphate binding	LRRK1[24947832];AHSP[unassigned1304];
723582	chr12	42748968	A	C	chr12:42748968	PPHLN1	periphilin 1	11206.0	SNV	0/1	0.32	15_7	22	99	False	rs141677892	EXONIC	YES	NM_001364827.2	Transcript	protein_coding	missense_variant		4/12	NM_001364827.2:c.243A>C	NP_001351756.1:p.Glu81Asp		1.0	.,.,.,.,.,.,.,.,.,.,.,.,.,.					.	.	.		0.00171498	261.0	152188.0	0.0	32	0.96	PASS	nfe	0.0028957	197.0	0.0028957	197.0	0.00201302	506.0	251364.0	1.0	60	1.0	PASS	nfe	0.00327131	372.0	0.00327131	372.0	0.0021671	337	0.002	6.0				15.64	1.385793	0.065	1	15	16	MutationTaster_pred	LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PPHLN1	0.0	0.0	0.0	0.0	12.0	-5.0	0.0	41.0						0.0364	0.0	0.0	1.0	1.312	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			pons;ciliary ganglion;testis - seminiferous tubule;testis - interstitial;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;testis;globus pallidus;medulla oblongata;	.	keratinization;negative regulation of transcription, DNA-templated	nucleoplasm;chromosome;Golgi apparatus;cytosol	RNA binding;protein binding	FAM208A[26022416];MKI67[26949251];TOMM20[16169070];BACH1[26496610];SEPT8[21900206];FAM83H[26496610];PPP1CC[26496610];BCLAF1[26496610];TP53BP2[21900206];UFD1[21900206];CBR1[26496610];CCDC57[25416956];METTL3[26496610];MTUS2[25416956];SNCAIP[19730898];CLK2[23602568];RGMA[26496610];TSGA10[25416956];NEDD1[26496610];NAGK[21900206];CDK6[22094256];CDC37[21900206];CENPJ[26496610];MATR3[26496610];VIM[15383276];ITGB1BP2[23414517];SQSTM1[21900206];MPHOSPH8[26496610;26022416];VCL[26496610];ITGB3BP[26496610];BCL2L1[21900206];
724951	chr7	30492190	G	A	chr7:30492190	NOD1	nucleotide binding oligomerization domain containing 1	11262.0	SNV	0/1	0.62	10_16	26	99	False	rs5743341	EXONIC	YES	NM_006092.4	Transcript	protein_coding	synonymous_variant		6/14	NM_006092.4:c.843C>T	NP_006083.1:p.Phe281%3D		-1.0						.	.	.		0.00206937	315.0	152220.0	1.0	33	0.97	PASS	afr	0.00670396	278.0	0.000191109	13.0	0.000809675	203.0	250718.0	0.0	93	0.99	PASS	afr	0.00753365	122.0	0.000202951	23.0	0.0007653	119	0.002	6.0	0.00272	31.0		10.82	0.659693		0	0	0			NOD1	0.0	0.0	0.0	0.0	-22.0	11.0	42.0	-48.0						0.857	0.0	0.0			immune system phenotype; hematopoietic system phenotype; 			ciliary ganglion;temporal lobe;skin;	Epithelial cell signaling in Helicobacter pylori infection	activation of MAPK activity;positive regulation of dendritic cell antigen processing and presentation;apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process;defense response;inflammatory response;signal transduction;JNK cascade;detection of biotic stimulus;detection of bacterium;positive regulation of interleukin-1 beta production;positive regulation of interleukin-6 production;positive regulation of tumor necrosis factor production;intracellular signal transduction;interleukin-8 biosynthetic process;defense response to bacterium;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;innate immune response;positive regulation of JNK cascade;defense response to Gram-positive bacterium;positive regulation of nitric-oxide synthase activity;positive regulation of NF-kappaB transcription factor activity;protein complex oligomerization;positive regulation of ERK1 and ERK2 cascade;nucleotide-binding oligomerization domain containing signaling pathway;interleukin-1-mediated signaling pathway;cellular response to muramyl dipeptide;positive regulation of NIK/NF-kappaB signaling;positive regulation of xenophagy	cytoplasm;cytosol;basolateral plasma membrane;apical plasma membrane	protein binding;ATP binding;cysteine-type endopeptidase activator activity involved in apoptotic process;identical protein binding;protein homodimerization activity;peptidoglycan binding;protein-containing complex binding;CARD domain binding	HSP90AA1[16083881;25036637];GABRB1[21988832];HSP90AB1[25036637];FKBPL[25036637];RIPK2[10329646;17054981;29997244];MAGED1[17353931];PTGES3[25036637];XIAP[19667203];NOD1[18186648];CACYBP[25036637];OLFM4[20534456];CASP9[10329646];NUDCD3[25036637];PPP5C[25036637];PSMD2[25036637];CDC37[25036637];SOX8[21988832];SUGT1[23935490;17420470];HSPA1A[16083881];FKBP5[25036637];
727148	chr2	98177141	A	T	chr2:98177141	ANKRD36B	ankyrin repeat domain 36B	11311.0	SNV	0|1	0.22	32_9	41	99	False	rs367884437	EXONIC	YES	NM_025190.4	Transcript	protein_coding	synonymous_variant		8/44	NM_025190.4:c.852T>A	NP_079466.3:p.Pro284%3D		-1.0						.	.	.		7.90254e-05	12.0	151850.0	0.0	29	0.9	PASS	afr	0.000241523	10.0	1.4741e-05	1.0	8.75752e-05	21.0	239794.0	0.0	66	0.96	PASS	sas	0.000459559	14.0	1.81009e-05	2.0	0.0000965	15						0.616	-0.222929		0	0	0			ANKRD36B	0.0	0.0	0.0	0.0	22.0	-14.0	-13.0	-9.0											.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];
727149	chr2	98177148	T	C	chr2:98177148	ANKRD36B	ankyrin repeat domain 36B	11311.0	SNV	0|1	0.24	32_10	42	99	False	rs1296833529	EXONIC	YES	NM_025190.4	Transcript	protein_coding	missense_variant		8/44	NM_025190.4:c.845A>G	NP_079466.3:p.Glu282Gly		-1.0	.,.					.	.	.						29	0.9							0.0	0.0	239552.0	0.0	66	0.96	AC0				0.0	0.0								14.52	1.175746		1	9	10	SIFT	PolyPhen,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ANKRD36B	0.0	0.0	0.0	0.13	-20.0	15.0	8.0	-20.0									0.002	0.547	.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];
727150	chr2	98177166	A	G	chr2:98177166	ANKRD36B	ankyrin repeat domain 36B	11311.0	SNV	0|1	0.23	34_10	44	99	False	rs796425921	EXONIC	YES	NM_025190.4	Transcript	protein_coding	missense_variant		8/44	NM_025190.4:c.827T>C	NP_079466.3:p.Ile276Thr		-1.0	.,.					.	.	.						29	0.9											62	0.95							0.0000064	1						2.591	-0.002185		0	11	11		SIFT,PolyPhen,Polyphen2_HDIV_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ANKRD36B	0.06	0.0	0.02	0.0	34.0	29.0	-38.0	34.0									0.001	-1.078	.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];
727151	chr2	98177182	C	A	chr2:98177182	ANKRD36B	ankyrin repeat domain 36B	11311.0	SNV	0|1	0.2	32_8	40	99	False	rs1392452020	EXONIC	YES	NM_025190.4	Transcript	protein_coding	missense_variant		8/44	NM_025190.4:c.811G>T	NP_079466.3:p.Asp271Tyr		-1.0	.,.					.	.	.						29	0.89											57	0.94														11.99	0.804826		3	9	12	SIFT,PolyPhen,Polyphen2_HDIV_pred	Polyphen2_HVAR_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ANKRD36B	0.05	0.15	0.0	0.0	-19.0	18.0	-19.0	-50.0									0.002	0.498	.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];
727152	chr2	98177186	G	C	chr2:98177186	ANKRD36B	ankyrin repeat domain 36B	11311.0	SNV	0|1	0.2	32_8	40	99	False	rs754904396	EXONIC	YES	NM_025190.4	Transcript	protein_coding	missense_variant		8/44	NM_025190.4:c.807C>G	NP_079466.3:p.Asp269Glu		-1.0	.,.					.	.	.		0.000151785	23.0	151530.0	0.0	29	0.89	PASS	afr	0.000363284	15.0	5.90493e-05	4.0	6.73401e-05	16.0	237600.0	0.0	56	0.95	PASS	sas	0.000230157	7.0	4.54893e-05	5.0	0.0000064	1						0.83	-0.178361		0	10	10		SIFT,PolyPhen,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ANKRD36B	0.0	0.03	0.0	0.0	6.0	14.0	14.0	-23.0									0.0	-0.313	.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];
727153	chr2	98177189	G	A	chr2:98177189	ANKRD36B	ankyrin repeat domain 36B	11311.0	SNV	0|1	0.19	34_8	42	99	False	rs572503391	EXONIC	YES	NM_025190.4	Transcript	protein_coding	synonymous_variant		8/44	NM_025190.4:c.804C>T	NP_079466.3:p.Asp268%3D		-1.0						.	.	.		4.62296e-05	7.0	151418.0	0.0	29	0.89	PASS	sas	0.0002079	1.0	1.47706e-05	1.0	5.47341e-05	13.0	237512.0	0.0	53	0.95	PASS	sas	0.000197135	6.0	2.72901e-05	3.0	0.0000064	1						0.272	-0.342877		0	0	0			ANKRD36B	0.02	0.13	0.0	0.0	-26.0	11.0	-26.0	-1.0											.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];
727154	chr2	98177191	C	T	chr2:98177191	ANKRD36B	ankyrin repeat domain 36B	11311.0	SNV	0|1	0.2	33_8	41	99	False	rs1236607023	EXONIC	YES	NM_025190.4	Transcript	protein_coding	missense_variant		8/44	NM_025190.4:c.802G>A	NP_079466.3:p.Asp268Asn		-1.0	.,.					.	.	.						29	0.89							4.21379e-06	1.0	237316.0	0.0	53	0.95	PASS	amr	2.92278e-05	1.0	0.0	0.0								10.12	0.578086		0	11	11		SIFT,PolyPhen,Polyphen2_HDIV_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ANKRD36B	0.01	0.1	0.0	0.0	-28.0	9.0	3.0	5.0									0.002	0.498	.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];
730400	chr1	1647778	C	G	chr1:1647778	CDK11A	cyclin dependent kinase 11A	11381.0	SNV	0/1	0.51	14_23	45	99	False	rs72901773,COSV62265990	SPLICING	YES	NM_001313896.2	Transcript	protein_coding	splice_region_variant,intron_variant	5/19		NM_001313896.2:c.458+7G>C			-1.0						.	.	.						32	0.89							0.470877	101441.0	215430.0	209.0	86	1.0	InbreedingCoeff	nfe	0.477648	46969.0	0.477648	46969.0	0.0000193,0.0096268	3,1497	0.153	493.0	0.47926	901.0		2.26	-0.025291		0	0	0			CDK11A	0.0	0.0	0.01	0.0	15.0	-41.0	7.0	33.0	1.93029776648406e-05	0.02					0.0				.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];
730404	chr1	1647814	T	C	chr1:1647814	CDK11A	cyclin dependent kinase 11A	11381.0	SNV	0/1	0.55	12_27	49	99	False	rs72901775,COSV62264481	EXONIC	YES	NM_001313896.2	Transcript	protein_coding	synonymous_variant		5/20	NM_001313896.2:c.429A>G	NP_001300825.1:p.Glu143%3D		-1.0						.	.	.		6.62515e-06	1.0	150940.0	0.0	32	0.9	PASS	afr	2.43487e-05	1.0	0.0	0.0	0.468971	102290.0	218116.0	217.0	100	1.0	InbreedingCoeff	nfe	0.475687	47464.0	0.475687	47464.0	0.0200767	3122	0.173	565.0	0.49947	939.0		10.43	0.614453		0	0	0			CDK11A	0.0	0.0	0.02	0.0	-1.0	-29.0	-29.0	-3.0							0.0	20.395010472			.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];
730411	chr1	1647871	T	C	chr1:1647871	CDK11A	cyclin dependent kinase 11A	11381.0	SNV	0/1	0.43	13_19	44	99	False	rs72909014,COSV62264925	EXONIC	YES	NM_001313896.2	Transcript	protein_coding	synonymous_variant		5/20	NM_001313896.2:c.372A>G	NP_001300825.1:p.Arg124%3D		-1.0						.	.	.		6.61735e-06	1.0	151118.0	0.0	32	0.9	PASS	nfe	1.47658e-05	1.0	1.47658e-05	1.0	0.464098	98736.0	212748.0	209.0	87	1.0	InbreedingCoeff	nfe	0.470811	46147.0	0.470811	46147.0	0.0170156	2646	0.169	549.0	0.5016	943.0		0.197	-0.388613		0	0	0			CDK11A	0.0	0.0	0.0	0.0	46.0	33.0	46.0	-16.0							0.0	20.395010472			.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];
730416	chr1	1647894		TTTCTT	chr1:1647893-1647894	CDK11A	cyclin dependent kinase 11A	11381.0	insertion	0/1	0.36	12_15	42	99	False	rs144636354	EXONIC	YES	NM_001313896.2	Transcript	protein_coding	inframe_insertion		5/20	NM_001313896.2:c.344_349dup	NP_001300825.1:p.Lys115_Glu116dup		-1.0						.	.	.						32	0.9							0.400609	75377.0	188156.0	135.0	69	0.99	InbreedingCoeff_RF	sas	0.419059	10598.0	0.415297	34625.0	0.0001865,0.0155301	29,2415	0.063	207.0	0.5016	943.0		13.84	1.062714		0	0	0																		0.0				.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];
730557	chr1	1650797	A	G	chr1:1650797	CDK11A	cyclin dependent kinase 11A	11381.0	SNV	0|1	0.51	16_25	49	99	False	rs1059830,COSV62264363	SPLICING	YES	NM_001313896.2	Transcript	protein_coding	missense_variant,splice_region_variant		4/20	NM_001313896.2:c.325T>C	NP_001300825.1:p.Trp109Arg		-1.0	.,.,.,.					.	.	.						33	0.91							0.499263	106344.0	213002.0	174.0	41	0.62	InbreedingCoeff	nfe	0.50002	50748.0	0.50002	50748.0	0.0130157	2024	0.17	531.0				19.32	1.947336	0.125	0	17	17		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CDK11A	0.0	0.0	0.12	0.08	0.0	-30.0	-30.0	0.0			4.487	-1.297	3.191		0.0	89.701620717	0.489	-0.325	.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];
730564	chr1	1650801	T	C	chr1:1650801	CDK11A	cyclin dependent kinase 11A	11381.0	SNV	0|1	0.52	15_25	48	99	False	rs1137004,COSV62265927	EXONIC	YES	NM_001313896.2	Transcript	protein_coding	synonymous_variant		4/20	NM_001313896.2:c.321A>G	NP_001300825.1:p.Glu107%3D		-1.0						.	.	.						33	0.91							0.49935	106017.0	212310.0	177.0	40	0.62	InbreedingCoeff	nfe	0.500148	50685.0	0.500148	50685.0	0.0110865,0.0015305	1724,238	0.17	531.0				18.08	1.784029		0	0	0			CDK11A	0.0	0.0	0.02	0.04	-32.0	-2.0	-34.0	-4.0							0.0	89.701620717			.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];
730568	chr1	1650832	A	G	chr1:1650832	CDK11A	cyclin dependent kinase 11A	11381.0	SNV	0/1	0.47	17_23	49	99	False	rs72909030,COSV62264367	EXONIC	YES	NM_001313896.2	Transcript	protein_coding	missense_variant		4/20	NM_001313896.2:c.290T>C	NP_001300825.1:p.Val97Ala		-1.0	.,.,.,.,.,.,.					.	.	.		6.62497e-06	1.0	150944.0	0.0	33	0.9	AS_VQSR	afr	2.43475e-05	1.0	0.0	0.0	0.498437	108394.0	217468.0	178.0	35	0.63	InbreedingCoeff	nfe	0.499156	51474.0	0.499156	51474.0	0.0258643	4022	0.2	632.0				18.13	1.790671	0.045	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CDK11A	0.0	0.0	0.01	0.0	22.0	6.0	-35.0	2.0							0.0	30.804515156	0.991	-0.325	.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];
731478	chr11	60971041	A	G	chr11:60971041	PGA3	pepsinogen 3, group I (pepsinogen A)	11422.0	SNV	0/1	0.35	20_11	31	99	False	rs78669446	EXONIC	YES	NM_001079807.4	Transcript	protein_coding	missense_variant		1/9	NM_001079807.4:c.5A>G	NP_001073275.1:p.Lys2Arg		1.0						.	.	.		0.00489478	742.0	151590.0	1.0	30	0.91	PASS	nfe	0.00761264	516.0	0.00761264	516.0	0.00452738	1136.0	250918.0	1.0	100	1.0	PASS	nfe	0.0070522	799.0	0.0070522	799.0	0.0004694	73	0.002	5.0			1.0	16.77	1.586151	0.087	1	16	17	fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	PGA3	0.0	0.0	0.02	0.0	-23.0	2.0	0.0	17.0							0.65	0.0	0.997	1.294	.			.	.	proteolysis;digestion;protein catabolic process;cellular protein metabolic process	extracellular exosome;multivesicular body lumen	aspartic-type endopeptidase activity;peptidase activity	.
732735	chr3	47036843	C	T	chr3:47036843	NBEAL2	neurobeachin like 2	11463.0	SNV	0/1	0.5	18_18	36	99	True	rs201777850,COSV52755464	EXONIC	YES	NM_015175.3	Transcript	protein_coding	missense_variant		13/54	NM_015175.3:c.1618C>T	NP_055990.1:p.Arg540Trp		1.0		Uncertain_significance	criteria_provided,_single_submitter	Gray_platelet_syndrome	Gray platelet syndrome, 139090 (3), Autosomal recessive	Gray platelet syndrome	Disease-causing germline mutation(s) (loss of function) in	Splenomegaly;Epistaxis;Abnormality of the menstrual cycle;Myelodysplasia;Thrombocytopenia;Bruising susceptibility;Thrombocytopenia;Autosomal dominant inheritance;Impaired thrombin-induced platelet aggregation;Myelofibrosis;Splenomegaly;Menorrhagia;Progressive;Impaired collagen-induced platelet aggregation;Prolonged bleeding time;Epistaxis;Reduced von Willebrand factor activity;Autosomal recessive inheritance;Bruising susceptibility;Reduced quantity of Von Willebrand factor		0.000190476	29.0	152250.0	0.0	33	0.99	PASS	nfe	0.000338076	23.0	0.000338076	23.0	0.000231189	56.0	242226.0	0.0	100	0.8	PASS	nfe	0.000431034	47.0	0.000431034	47.0	0.0002315	36			0.00053	6.0		22.6	2.503674	0.098	5	15	20	SIFT,LRT_pred,M-CAP_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	NBEAL2	0.0	0.0	0.0	0.0	7.0	-21.0	7.0	44.0						0.763	0.86	0.0	0.332	1.026	skeleton phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); neoplasm; hematopoietic system phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			tongue;trigeminal ganglion;superior cervical ganglion;whole blood;skeletal muscle;cerebellum;	.	platelet formation;neutrophil degranulation	endoplasmic reticulum;plasma membrane;tertiary granule membrane;ficolin-1-rich granule membrane	protein binding	FMR1[29187380];RTCB[29187380];HNRNPR[29187380];RPL10A[29187380];CCAR2[29187380];AMOT[29187380];TUBB6[29187380];LSM12[29187380];RUVBL2[29187380];RUVBL1[29187380];ZNF326[29187380];UBAP2L[29187380];RPS13[29187380];DDX17[29187380];RPS8[29187380];AIP[29187380];LARP4B[29187380];ATXN2L[29187380];ILF3[29187380];MTHFD1[29187380];ZNF318[29187380];RPL24[29187380];ALDH7A1[29187380];SHMT1[29187380];NOP2[30021884];ZC3HAV1[29187380];NTPCR[29187380];GIGYF2[29187380];BAG6[29187380];BAG4[29187380];ATXN2[29187380];LARP1[29187380];FXR2[29187380];BAG2[29187380];UBR5[29187380];UBC[29187380];CPSF4[29187380];CPSF7[29187380];CPSF1[29187380];SEC16A[29187380];NONO[29187380];ALYREF[29187380];HELZ[29187380];PUM1[29187380];LARP4[29187380];ELL2[26496610];GPN1[29187380];QKI[29187380];PRRC2A[29187380];CHERP[29187380];MOV10[29187380];CAPRIN1[29187380];AGO2[29187380];HNRNPD[29187380];FARSA[29187380];OGT[29187380];EIF4G3[29187380];SUGP2[29187380];EIF4G1[29187380];CPEB4[29187380];DOCK7[29187380];AKAP8L[29187380];HSPB1[29187380];YBX3[29187380];ELAVL2[29187380];CDC73[29187380];TRO[29187380];TUBA1A[29187380];QSOX2[26496610];RBM7[29187380];RFC5[29187380];NCOA1[29187380];UPF1[29187380];RBM14[29187380];TUBB[29187380];PABPC4[29187380];ZFR[29187380];SORD[29187380];TUBG1[29187380];RANGAP1[29187380];YWHAZ[26496610];TUBB2A[29187380];NCOR1[29187380];HAX1[29187380];SLTM[29187380];DNAJC7[29187380];THRAP3[29187380];POLR1C[29187380];LCOR[26496610];RBMS1[29187380];CDC42EP1[29187380];PABPC1[29187380];VAC14[29187380];STAU1[29187380];NUFIP2[29187380];GTF3C5[29187380];STAU2[29187380];CAMK2A[29187380];SRBD1[29187380];AKAP8[29187380];TUBA3C[29187380];PABPN1[29187380];FIP1L1[29187380];DNAJB6[29187380];POLR2B[29187380];FAM120A[29187380];POLR2E[29187380];RALY[29187380];IGF2BP3[29187380];RBBP7[29187380];IGF2BP2[29187380];CCT8[29187380];HNRNPA0[29187380];RTRAF[29187380];APOL2[29187380];RANBP2[29187380];HNRNPA3[29187380];YTHDF2[29187380];HUWE1[29187380];YLPM1[29187380];TUBB4B[29187380];TUBB4A[29187380];HNRNPAB[29187380];DNAJA1[29187380];NUDT21[29187380];PIKFYVE[29187380];SERBP1[29187380];PSMC2[29187380];DNAJA2[29187380];TARDBP[29187380];CRLF3[29187380];RBMX[29187380];TNRC6A[29187380];HSPA1A[29187380];
733596	chr7	87908773	T	A	chr7:87908773	STEAP4	STEAP4 metalloreductase	11486.0	SNV	0/1	0.61	9_14	23	99	False	rs183185041	EXONIC	YES	NM_001205315.2	Transcript	protein_coding	synonymous_variant		6/6	NM_001205315.2:c.1320A>T	NP_001192244.1:p.Pro440%3D		-1.0						.	.	.		0.000670277	102.0	152176.0	0.0	32	0.98	PASS	nfe	0.00121991	83.0	0.00121991	83.0	0.000561217	140.0	249458.0	0.0	91	1.0	PASS	nfe	0.00106005	120.0	0.00106005	120.0	0.0006238	97	0.002	6.0				10.51	0.623211		0	0	0			STEAP4	0.0	0.0	0.0	0.0	-8.0	-2.0	27.0	-1.0						0.524	0.0	94.080074736			adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; 			atrioventricular node;trigeminal ganglion;	.	copper ion import;fat cell differentiation;iron ion homeostasis;oxidation-reduction process;iron ion import across cell outer membrane	Golgi membrane;endosome;Golgi apparatus;plasma membrane;integral component of membrane;early endosome membrane;extracellular exosome	cupric reductase activity;metal ion binding;ferric-chelate reductase (NADPH) activity	AKT2[21988832];HIST1H1A[30021884];
733611	chr18	14782589	A	G	chr18:14782589	ANKRD30B	ankyrin repeat domain 30B	11487.0	SNV	0|1	0.12	30_4	34	78	False	rs1485446370	EXONIC	YES	NM_001367607.1	Transcript	protein_coding	missense_variant		12/44	NM_001367607.1:c.1546A>G	NP_001354536.1:p.Met516Val		1.0						.	.	.		1.31422e-05	2.0	152182.0	0.0	33	0.97	PASS	afr	4.82602e-05	2.0	0.0	0.0	4.45593e-06	1.0	224420.0	0.0	20	0.53	PASS	afr	6.8956e-05	1.0	0.0	0.0								1.996	-0.045478	0.026	0	16	16		M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD30B	0.0	0.0	0.0	0.02	-6.0	-49.0	-34.0	24.0							0.0		0.0	-0.554	.			.	.	biological_process	cellular_component	molecular_function	.
733613	chr18	14782592	G	A	chr18:14782592	ANKRD30B	ankyrin repeat domain 30B	11487.0	SNV	0|1	0.12	30_4	34	78	False	rs1194701960	EXONIC	YES	NM_001367607.1	Transcript	protein_coding	missense_variant		12/44	NM_001367607.1:c.1549G>A	NP_001354536.1:p.Glu517Lys		1.0						.	.	.						33	0.97											20	0.52														1.233	-0.119704	0.01	0	16	16		M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD30B	0.0	0.0	0.02	0.0	-5.0	-9.0	21.0	-37.0							0.0		0.0	-1.875	.			.	.	biological_process	cellular_component	molecular_function	.
733615	chr18	14782595		ACA	chr18:14782594-14782595	ANKRD30B	ankyrin repeat domain 30B	11487.0	insertion	0|1	0.12	30_4	34	78	False	rs1356061002	EXONIC	YES	NM_001367607.1	Transcript	protein_coding	inframe_insertion		12/44	NM_001367607.1:c.1552_1553insCAA	NP_001354536.1:p.Glu517_Ile518insThr		1.0						.	.	.						33	0.97											20	0.51																	0	0	0																		0.0				.			.	.	biological_process	cellular_component	molecular_function	.
733616	chr18	14782604	G	A	chr18:14782604	ANKRD30B	ankyrin repeat domain 30B	11487.0	SNV	0|1	0.15	28_5	33	99	False	rs1417386767	EXONIC	YES	NM_001367607.1	Transcript	protein_coding	missense_variant		12/44	NM_001367607.1:c.1561G>A	NP_001354536.1:p.Glu521Lys		1.0						.	.	.						33	0.97											19	0.49														5.43	0.172872	0.014	0	16	16		M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD30B	0.0	0.0	0.0	0.01	9.0	1.0	-19.0	9.0							0.0		0.0	-1.926	.			.	.	biological_process	cellular_component	molecular_function	.
733618	chr18	14782612	A	C	chr18:14782612	ANKRD30B	ankyrin repeat domain 30B	11487.0	SNV	0|1	0.15	29_5	34	99	False	rs1460025994	SPLICING	YES	NM_001367607.1	Transcript	protein_coding	missense_variant,splice_region_variant		12/44	NM_001367607.1:c.1569A>C	NP_001354536.1:p.Glu523Asp		1.0						.	.	.						33	0.97											19	0.47														12.0	0.806022	0.115	0	16	16		M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD30B	0.0	0.0	0.0	0.07	1.0	-9.0	-6.0	1.0	0.0606589151529664	0.45	10.653	-0.086	10.567		0.0		0.013	-0.579	.			.	.	biological_process	cellular_component	molecular_function	.
734580	chr5	150133123	G	A	chr5:150133123	DCTN4	dynactin subunit 4	11519.0	SNV	0/1	0.65	11_20	31	99	False	rs1362011615	EXONIC	YES	NM_001135643.2	Transcript	protein_coding	synonymous_variant		3/14	NM_001135643.2:c.303C>T	NP_001129115.1:p.Thr101%3D		-1.0						Cystic fibrosis	Modifying germline mutation in	Pulmonary fibrosis;Hepatomegaly;Decreased circulating antibody level;Recurrent respiratory infections;Immunodeficiency;Malabsorption;Biliary cirrhosis;Exocrine pancreatic insufficiency						32	0.97							3.97772e-06	1.0	251400.0	0.0	54	1.0	PASS	nfe	8.79446e-06	1.0	8.79446e-06	1.0								11.4	0.730585		0	0	0			DCTN4	0.0	0.0	0.0	0.0	23.0	16.0	16.0	-24.0						0.524	0.95	65.017561937			.			.	.	endoplasmic reticulum to Golgi vesicle-mediated transport;nuclear migration;antigen processing and presentation of exogenous peptide antigen via MHC class II	kinetochore;spindle pole;stress fiber;nucleus;cytoplasm;centrosome;cytosol;dynactin complex;focal adhesion;cell cortex;sarcomere	protein binding;protein N-terminus binding	GOLGA2[21516116;25416956;26871637];DYNC1H1[26496610];PNMA1[25416956];DCTN2[27173435;unassigned1312];CALCOCO2[25416956];DCTN1[26638075;27173435;unassigned1312];CAPZA2[26496610];MTUS2[21516116;25416956];ANK2[19109891];HMG20A[26871637];RAB11A[29568061];
735863	chr6	49705091	G	A	chr6:49705091	CRISP3	cysteine rich secretory protein 3	11540.0	SNV	0/1	0.38	15_9	24	99	False	rs151190811	EXONIC	YES	NM_001368123.1	Transcript	protein_coding	synonymous_variant		2/8	NM_001368123.1:c.112C>T	NP_001355052.1:p.Leu38%3D		-1.0						.	.	.		0.00053919	82.0	152080.0	0.0	32	0.95	PASS	nfe	0.000926225	63.0	0.000926225	63.0	0.00059269	149.0	251396.0	1.0	56	1.0	PASS	nfe	0.000985014	112.0	0.000985014	112.0	0.0005595	87	0.0	1.0				1.948	-0.049397		0	0	0			CRISP3	0.0	0.18	0.0	0.0	-40.0	20.0	50.0	22.0						0.921	0.0	77.702770097			.			salivary gland;trachea;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;atrioventricular node;testis;skeletal muscle;bone marrow;	.	defense response;neutrophil degranulation;innate immune response	extracellular region;extracellular space;extracellular matrix;specific granule lumen;specific granule;tertiary granule lumen	molecular_function	GPR152[unassigned1304];
736628	chr19	54962467	G	A	chr19:54962467	LENG8	leukocyte receptor cluster member 8	11564.0	SNV	1/1	1.0	0_26	26	78	False	rs1035451,rs936193582,COSV58729331	SPLICING	YES	NM_001375638.1	Transcript	protein_coding	splice_region_variant,5_prime_UTR_variant		2/15	NM_001375638.1:c.-55G>A			1.0						.	.	.						0	0.0											0	0.0							0.1285176	19985	0.328	1022.0				12.55	0.878039		0	0	0			LENG8	0.01	0.15	0.0	0.0	4.0	0.0	4.0	48.0	0.0002549548128494	0.13	7.835	0.924	8.759	0.319	1.0				.			.	.	.	nucleus	protein binding	"INTS11[unassigned1304];RHOXF2[16189514;unassigned1304];KDM1A[23455924];SUV39H1[23455924];ATN1[16713569;unassigned1304];MIA3[unassigned1304];MKI67[26949251];KIAA1107[26496610];FAM166B[unassigned1304];LASP1[unassigned1304];CYSRT1[unassigned1304];TFG[unassigned1304];DMRTB1[19060904];MYOZ3[unassigned1304];IKBKG[unassigned1304];MAPK1IP1L[19060904;unassigned1304];PRMT6[23455924];PRMT5[23455924];PCID2[unassigned1304];MSX2[unassigned1304];ARID5A[unassigned1304];HIST2H2BE[30021884];AES[unassigned1304];PYGO1[20936779];CLUHP3[unassigned1304];TRAF4[unassigned1304];NCBP3[unassigned1304;26382858];CFAP53[unassigned1304];SNRPA[25416956;unassigned1304];HIST1H2BD[30021884];VGLL3[unassigned1304];TSG101[unassigned1304];MAGED1[unassigned1304];CAMK2A[unassigned1304];OAZ1[26496610];SKA1[26496610];HMGXB4[unassigned1304];BAG3[unassigned1304];CEP70[25416956];SMYD1[23455924];DVL3[unassigned1304];GSE1[unassigned1304];SMN1[16189514;unassigned1304];C10orf55[unassigned1304];SOCS7[unassigned1304];CPSF7[unassigned1304];INCA1[unassigned1304];ZFC3H1[26496610];""Em[unassigned1304];RRP1B[20926688];ZWINT[26496610];ANKHD1[unassigned1304];PER2[unassigned1304];HNRNPM[unassigned1304];TNIP1[unassigned1304];MNDA[25665578];FAM22F[unassigned1304];"
737680	chr21	44840138	G	A	chr21:44840138	SIK1	salt inducible kinase 1	11588.0	SNV	0/1	0.44	24_19	43	99	False	rs17004546,COSV54257824	EXONIC	YES	NM_173354.5	Transcript	protein_coding	synonymous_variant		8/14	NM_173354.5:c.948C>T	NP_775490.2:p.Gly316%3D		-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Seizure|Epileptic_encephalopathy,_early_infantile,_30|not_provided	Developmental and epileptic encephalopathy 30, 616341 (3), Autosomal dominant	Early infantile epileptic encephalopathy;Early myoclonic encephalopathy;West syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Lethargy;Generalized myoclonic seizure;Global developmental delay;Epileptic encephalopathy;Hypsarrhythmia;Dysphagia;Hyperreflexia;Focal tonic seizure;Infantile spasms;Myoclonus;Muscular hypotonia;Recurrent respiratory infections;Poor suck;Eyelid myoclonias;Renal dysplasia;Ureterocele;Strabismus;Micropenis;Hypsarrhythmia;Depressed nasal bridge;Autistic behavior;Generalized tonic seizure;Focal seizures, afebril;Generalized non-motor (absence) seizure;Precocious puberty;Absent thumbnail;EEG with burst suppression;Cerebellar atrophy;Uni- and bilateral multifocal epileptiform discharges;Myoclonus;Developmental regression;Spasticity;Umbilical hernia;EEG with spike-wave complexes;Broad finger;Microcephaly;Self-injurious behavior;Bilateral tonic-clonic seizure;Febrile seizure (within the age range of 3 months to 6 years);Broad phalanx of the toes;Sloping forehead;Diffuse cerebral atrophy;Pachygyria;Generalized clonic seizure;Infantile spasms;Sleep disturbance;Intellectual disability;Atonic seizure;Diffuse white matter abnormalities;Dystonia;Hypoplasia of the corpus callosum;Infantile muscular hypotonia;Short finger;Hyperactivity;Ventricular septal defect;Episodic ataxia;Poor head control;Failure to thrive;Anteverted nares;Cleft palate;Dyskinesia;Delayed myelination;Global developmental delay;Choreoathetosis;Tremor;Autosomal dominant inheritance;Bilateral tonic-clonic seizure;Global developmental delay;Encephalopathy;Feeding difficulties;Generalized myoclonic seizure;Epileptic encephalopathy;Death in infancy;Absent speech;Hypsarrhythmia;Stereotypy;Respiratory distress;Myoclonus;Infantile spasms;Developmental regression;Hypsarrhythmia;Abnormality of skin morphology		0.0	0.0	50.0	0.0	0	0.0	AC0_AS_VQSR				0.0	0.0	0.0482274	12009.0	249008.0	396.0	46	0.98	PASS	sas	0.0874885	2674.0	0.0496422	5550.0	0.0458831	7135	0.04	119.0				3.278	0.041161		0	0	0			SIK1	0.0	0.0	0.0	0.0	2.0	26.0	2.0	-24.0						0.325	0.99	20.568521354			skeleton phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; 			superior cervical ganglion;skin;adrenal cortex;	.	regulation of sodium ion transport;protein phosphorylation;cell cycle;regulation of mitotic cell cycle;regulation of myotube differentiation;negative regulation of triglyceride biosynthetic process;negative regulation of TOR signaling;negative regulation of CREB transcription factor activity;intracellular signal transduction;cellular response to glucose starvation;entrainment of circadian clock by photoperiod;regulation of cell differentiation;negative regulation of gluconeogenesis;protein autophosphorylation;rhythmic process;cardiac muscle cell differentiation;positive regulation of anoikis	nucleus;cytoplasm;nucleotide-activated protein kinase complex	magnesium ion binding;protein serine/threonine kinase activity;protein binding;ATP binding;cAMP response element binding protein binding;protein kinase binding;14-3-3 protein binding	YWHAE[16306228];CRTC2[16306228];RPL3[21988832];NMNAT1[21988832];CD247[24502978];TIMM10[unassigned1304];SUPT5H[21988832];YWHAZ[16306228];MESD[unassigned1304];PITX1[unassigned1304];PRTFDC1[unassigned1304];LHX8[unassigned1304];
738516	chr5	40959622	C	A	chr5:40959622	C7	complement C7	11609.0	SNV	0/1	0.46	18_16	35	99	False	rs121964920,CM960235,COSV57470996	EXONIC	YES	NM_000587.4	Transcript	protein_coding	missense_variant		12/18	NM_000587.4:c.1561C>A	NP_000578.2:p.Arg521Ser		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Complement_component_7_deficiency|C7_and_C6_deficiency,_combined_subtotal|not_provided	C7 deficiency, 610102 (3)	Immunodeficiency due to a late component of complement deficiency	Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Complement deficiency;Recurrent meningococcal disease	8871666,16771861	0.00247883	377.0	152088.0	1.0	32	0.97	PASS	nfe	0.00433658	295.0	0.00433658	295.0	0.00232526	574.0	246854.0	1.0	32	0.87	PASS	nfe	0.00421243	471.0	0.00421243	471.0	0.0027073	421	0.003	11.0	0.0014	16.0		23.7	3.049023	0.729	15	6	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-XF_coding_pred	FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-MKL_coding_pred	C7	0.0	0.0	0.0	0.0	26.0	-17.0	6.0	0.0						0.598	0.0	0.000000000	0.482	0.121	.			kidney;ovary;uterus;appendix;lymph node;pancreas;placenta;adrenal gland;fetal lung;adrenal cortex;	Complement and coagulation cascades;Systemic lupus erythematosus	cellular sodium ion homeostasis;complement activation;complement activation, alternative pathway;complement activation, classical pathway;cytolysis;regulation of complement activation	extracellular region;membrane attack complex;extracellular exosome	.	.
738761	chr19	33293569	A	G	chr19:33293569	TDRD12	tudor domain containing 12	11627.0	SNV	0/1	0.5	16_18	36	99	False	rs572794853	EXONIC	YES	NM_001366102.1	Transcript	protein_coding	synonymous_variant		20/33	NM_001366102.1:c.2205A>G	NP_001353031.1:p.Thr735%3D		1.0						.	.	.		0.000321962	49.0	152192.0	0.0	31	0.95	PASS	nfe	0.000455655	31.0	0.000455655	31.0	0.000386106	53.0	137268.0	0.0	34	0.58	PASS	nfe	0.000427017	23.0	0.000427017	23.0	0.0000836	13						0.017	-0.719509		0	0	0			TDRD12	0.02	0.01	0.01	0.0	-7.0	2.0	38.0	-7.0								26.959216432			reproductive system phenotype; endocrine/exocrine gland phenotype; 			.	.	male meiotic nuclear division;multicellular organism development;spermatogenesis;fertilization;cell differentiation;gene silencing by RNA;piRNA metabolic process;DNA methylation involved in gamete generation	cellular_component;PET complex	molecular_function;nucleic acid binding;helicase activity;ATP binding	RPN1[30021884];TP53[22653443];
744995	chr3	125271280	C	T	chr3:125271280	OSBPL11	oxysterol binding protein like 11	11707.0	SNV	0/1	0.41	19_13	32	99	False	rs200816516,COSV56176325,COSV99954435	EXONIC	YES	NM_022776.5	Transcript	protein_coding	missense_variant		9/13	NM_022776.5:c.1399G>A	NP_073613.2:p.Glu467Lys		-1.0						.	.	.		0.00011173	17.0	152152.0	0.0	32	0.96	PASS	amr	0.000196309	3.0	0.000146994	10.0	8.75225e-05	22.0	251364.0	0.0	75	1.0	PASS	nfe	0.00014954	17.0	0.00014954	17.0	0.0001029	16	0.001	2.0				17.15	1.649136	0.096	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OSBPL11	0.0	0.0	0.31	0.0	-3.0	-2.0	-2.0	48.0						0.484	0.9	0.000000000	0.094	1.026	.			dorsal root ganglion;superior cervical ganglion;adipose tissue;trigeminal ganglion;whole blood;skeletal muscle;	.	positive regulation of sequestering of triglyceride;sterol transport;fat cell differentiation	nucleoplasm;Golgi apparatus;cytosol;membrane;late endosome membrane;intracellular membrane-bounded organelle	lipid binding;sterol transporter activity;sterol binding	OSBPL9[19615732];TGOLN2[29568061];TMEM17[26638075];VAPA[26496610];TMEM216[26638075];CANX[29568061];RAB11A[29568061];
746635	chr19	44571309	G	A	chr19:44571309	ZNF223	zinc finger protein 223	11758.0	SNV	0/1	0.35	13_7	20	99	False	rs777005275,COSV69691221	EXONIC	YES	NM_013361.6	Transcript	protein_coding	missense_variant		5/5	NM_013361.6:c.1328G>A	NP_037493.3:p.Arg443His		1.0	Zinc finger C2H2-type&Zinc finger C2H2-type					.	.	.		1.97161e-05	3.0	152160.0	0.0	32	0.97	PASS	amr	6.5445e-05	1.0	1.47003e-05	1.0	1.19897e-05	3.0	250214.0	0.0	80	0.95	PASS	afr	6.16219e-05	1.0	8.82659e-06	1.0	0.0000193	3						17.0	1.625243	0.016	3	17	20	SIFT,PolyPhen,Polyphen2_HDIV_pred	Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF223	0.0	0.0	0.0	0.0	25.0	6.0	-40.0	-1.0						0.888	0.0	0.0	0.0	-1.16	.			.	.	regulation of transcription, DNA-templated;biological_process	nucleus	DNA binding;DNA-binding transcription factor activity;protein binding;metal ion binding	CARD10[unassigned1304];KRTAP10-7[25416956];ZC4H2[25416956];CABP5[unassigned1304];CCNDBP1[unassigned1304];MDFI[25416956;unassigned1304];
747016	chr18	21057228	C	T	chr18:21057228	RIOK3	RIO kinase 3	11771.0	SNV	0/1	0.68	7_15	22	99	False	rs56282762,COSV59772975	EXONIC	YES	NM_003831.5	Transcript	protein_coding	missense_variant		11/13	NM_003831.5:c.1340C>T	NP_003822.2:p.Ser447Leu		1.0	RIO kinase,RIO kinase,.,.					.	.	.		0.0036482	555.0	152130.0	0.0	32	0.96	PASS	nfe	0.00630697	429.0	0.00630697	429.0	0.00349155	878.0	251464.0	6.0	88	1.0	PASS	nfe	0.0054948	625.0	0.0054948	625.0	0.0036141	562	0.006	18.0				24.3	3.279276	0.106	5	15	20	M-CAP_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	RIOK3	0.0	0.0	0.0	0.02	-8.0	4.0	0.0	4.0						0.896	0.0	0.0	0.994	1.002	.			testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;testis;	.	protein phosphorylation;chromosome segregation;maturation of SSU-rRNA;negative regulation of protein homooligomerization;positive regulation of interferon-beta production;negative regulation of MDA-5 signaling pathway;negative regulation of I-kappaB kinase/NF-kappaB signaling;innate immune response;positive regulation of innate immune response;defense response to virus;cellular response to dsRNA;cellular response to virus;cellular response to dsDNA	cytosol;preribosome, small subunit precursor	protein serine/threonine kinase activity;protein binding;ATP binding;metal ion binding;caspase binding	ARL1[17353931];TULP3[23414517];SUPT6H[26496610];TM9SF4[26496610];CDC42[21988832];IFIH1[25865883];FBL[17353931];BCL2L11[21988832];TBK1[24807708];CREB3L3[21988832];CASP10[21988832;19557502];ZMAT3[26496610];RUVBL2[17353931];PSMB1[17353931];MAGEA6[17353931];PAK2[21988832];SSR4[17353931];OSBPL5[26496610];MMGT1[26496610];XRCC3[26496610];MYO1C[26496610];IRF3[24807708];PSMC4[17353931];UBE2N[25260751];UBA1[25260751];UBE2V1[25260751];CALM1[17353931];
749205	chr10	123843357	G	T	chr10:123843357	TACC2	transforming acidic coiled-coil containing protein 2	11805.0	SNV	0/1	0.39	22_14	36	99	False	rs77657275,COSV100554602	EXONIC	YES	NM_206862.4	Transcript	protein_coding	missense_variant		4/23	NM_206862.4:c.1342G>T	NP_996744.4:p.Ala448Ser		1.0	.,.,.,.,.					.	.	.		0.00394249	600.0	152188.0	2.0	32	0.97	PASS	nfe	0.00661492	450.0	0.00661492	450.0	0.00443418	1115.0	251456.0	7.0	100	1.0	PASS	nfe	0.00588225	669.0	0.00588225	669.0	0.0043857	682	0.003	9.0				5.677	0.189079	0.032	1	16	17	SIFT	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	TACC2	0.0	0.0	0.0	0.0	13.0	-38.0	49.0	35.0						0.843	0.0	0.0	0.0	-0.5	normal phenotype; 			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;skin;atrioventricular node;trigeminal ganglion;superior cervical ganglion;placenta;skeletal muscle;globus pallidus;	.	microtubule cytoskeleton organization;mitotic spindle organization;cell population proliferation;cerebral cortex development	nucleoplasm;cytoplasm;microtubule organizing center;cytosol;plasma membrane	nuclear hormone receptor binding	CTR9[26496610];TTK[15304323];SLAIN2[26496610];FTSJ1[17353931];CKAP5[20360068;26496610];GRAMD4[unassigned1304];TOMM20[29568061];CLK2[unassigned1304];TGM1[unassigned1304];TUBA1A[27291054];CANX[29568061];CLVS2[unassigned1304];HMG20B[16169070];TACC1[26496610];KIF21A[26496610];BORCS6[unassigned1304];
749211	chr10	123846924	C	T	chr10:123846924	TACC2	transforming acidic coiled-coil containing protein 2	11805.0	SNV	0/1	0.5	15_15	30	99	False	rs201869943	EXONIC	YES	NM_206862.4	Transcript	protein_coding	stop_gained		4/23	NM_206862.4:c.4909C>T	NP_996744.4:p.Gln1637Ter		1.0	.,.,.,.,.					.	.	.		0.000289002	44.0	152248.0	0.0	33	0.98	PASS	amr	0.000523218	8.0	0.000102887	7.0	0.000449855	113.0	251192.0	1.0	71	1.0	PASS	amr	0.000520653	18.0	0.000149732	17.0	0.0002315	36	0.0	1.0				35.0	6.34975		4	2	6	MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred	LRT_pred,fathmm-MKL_coding_pred	TACC2	0.0	0.0	0.0	0.0	3.0	-44.0	-23.0	33.0						0.843	0.0	0.0	0.001	1.026	normal phenotype; 			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;skin;atrioventricular node;trigeminal ganglion;superior cervical ganglion;placenta;skeletal muscle;globus pallidus;	.	microtubule cytoskeleton organization;mitotic spindle organization;cell population proliferation;cerebral cortex development	nucleoplasm;cytoplasm;microtubule organizing center;cytosol;plasma membrane	nuclear hormone receptor binding	CTR9[26496610];TTK[15304323];SLAIN2[26496610];FTSJ1[17353931];CKAP5[20360068;26496610];GRAMD4[unassigned1304];TOMM20[29568061];CLK2[unassigned1304];TGM1[unassigned1304];TUBA1A[27291054];CANX[29568061];CLVS2[unassigned1304];HMG20B[16169070];TACC1[26496610];KIF21A[26496610];BORCS6[unassigned1304];
749467	chr20	61511361	C	T	chr20:61511361	DIDO1	death inducer-obliterator 1	11813.0	SNV	0/1	0.44	15_12	27	99	False	rs1384248873	EXONIC	YES	NM_033081.3	Transcript	protein_coding	missense_variant		16/16	NM_033081.3:c.5947G>A	NP_149072.2:p.Ala1983Thr		-1.0	.,.					.	.	.		2.62816e-05	4.0	152198.0	0.0	33	0.98	PASS	nfe	5.88028e-05	4.0	5.88028e-05	4.0	8.03335e-06	2.0	248962.0	0.0	99	0.99	PASS	nfe	1.77528e-05	2.0	1.77528e-05	2.0								18.55	1.84675	0.014	1	18	19	fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred															0.38	1.0	0.0	0.013	0.125	hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; immune system phenotype; cellular phenotype; 			ciliary ganglion;pons;testis - seminiferous tubule;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;placenta;testis;skeletal muscle;	.	transcription, DNA-templated;apoptotic signaling pathway	nucleus;cytoplasm;spindle	RNA binding;metal ion binding	SRPK2[23602568];PARP2[21812934];LRRK2[29513927];SRSF1[16189514];ARAF[21988832];WWP1[16189514];CDC5L[20467437];WWP2[16189514];MKI67[26949251];HNRNPK[16189514];SNW1[20467437];HIST1H3A[29568061];TNKS2[22153077];DVL3[16189514];OGT[27705803];KCNK4[21988832];
749475	chr20	61525292	G	A	chr20:61525292	DIDO1	death inducer-obliterator 1	11813.0	SNV	0/1	0.58	11_15	26	99	False	rs144215924	EXONIC	YES	NM_033081.3	Transcript	protein_coding	synonymous_variant		12/16	NM_033081.3:c.2827C>T	NP_149072.2:p.Leu943%3D		-1.0						.	.	.		0.00111664	170.0	152242.0	1.0	32	0.98	PASS	nfe	0.0019545	133.0	0.0019545	133.0	0.000916305	230.0	251008.0	2.0	71	1.0	PASS	nfe	0.00170044	193.0	0.00170044	193.0	0.0009260	144	0.001	3.0				0.543	-0.241914		0	0	0			DIDO1	0.0	0.0	0.0	0.0	26.0	23.0	2.0	47.0						0.38	1.0	73.084437232			hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; immune system phenotype; cellular phenotype; 			ciliary ganglion;pons;testis - seminiferous tubule;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;placenta;testis;skeletal muscle;	.	transcription, DNA-templated;apoptotic signaling pathway	nucleus;cytoplasm;spindle	RNA binding;metal ion binding	SRPK2[23602568];PARP2[21812934];LRRK2[29513927];SRSF1[16189514];ARAF[21988832];WWP1[16189514];CDC5L[20467437];WWP2[16189514];MKI67[26949251];HNRNPK[16189514];SNW1[20467437];HIST1H3A[29568061];TNKS2[22153077];DVL3[16189514];OGT[27705803];KCNK4[21988832];
750049	chr10	75415604	T	C	chr10:75415604	SYNPO2L	synaptopodin 2 like	11841.0	SNV	0/1	0.39	17_11	28	99	False	rs759026761	EXONIC	YES	NM_001114133.3	Transcript	protein_coding	missense_variant		1/4	NM_001114133.3:c.77A>G	NP_001107605.1:p.Glu26Gly		-1.0	PDZ domain&PDZ domain&PDZ domain					.	.	.		0.000184843	28.0	151480.0	0.0	28	0.83	PASS	nfe	0.000353513	24.0	0.000353513	24.0	0.000159922	25.0	156326.0	0.0	39	0.59	PASS	nfe	0.000347487	21.0	0.000347487	21.0	0.0000193	3	0.001	4.0				23.4	2.920735	0.662	6	12	18	SIFT,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	SYNPO2L	0.0	0.0	0.0	0.02	-5.0	-20.0	39.0	-28.0						0.794	0.03	0.0	1.0	1.129	.			.	.	heart morphogenesis;positive regulation of actin filament bundle assembly;positive regulation of Rho protein signal transduction;sarcomere organization;positive regulation of stress fiber assembly	nucleus;nucleoplasm;cytosol;actin cytoskeleton;nuclear speck;Z disc;cell junction	actin binding	GOLGA2[unassigned1304];PSMB4[unassigned1304];ACTN3[unassigned1304];ACTN2[unassigned1304];ACTN1[unassigned1304];SORBS3[unassigned1304];TOMM20[30021884];
751480	chr14	52735290	C	G	chr14:52735290	PTGDR	prostaglandin D2 receptor	11860.0	SNV	0/1	0.52	20_22	42	99	False	rs144706723	EXONIC	YES	NM_000953.3	Transcript	protein_coding	missense_variant		1/2	NM_000953.3:c.758C>G	NP_000944.1:p.Ala253Gly		1.0	GPCR, rhodopsin-like, 7TM,.				{Asthma, susceptibility to, 1}, 607277 (3)	.	.	.		0.00325848	496.0	152218.0	2.0	33	0.98	PASS	amr	0.00536298	82.0	0.00496781	338.0	0.002774	682.0	245854.0	2.0	81	0.97	PASS	nfe	0.00429412	470.0	0.00429412	470.0	0.0029710	462	0.006	19.0	0.00763	87.0		11.85	0.787542	0.062	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PTGDR	0.0	0.0	0.0	0.0	0.0	-35.0	-31.0	43.0						0.742	0.0	0.0	0.003	-0.313	hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; immune system phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			superior cervical ganglion;skeletal muscle;	Neuroactive ligand-receptor interaction	inflammatory response;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;male sex determination;sleep;adenosine metabolic process;cellular response to prostaglandin D stimulus	plasma membrane;integral component of membrane	prostaglandin J receptor activity;prostaglandin D receptor activity;protein binding	SCRIB[30126976];SNTA1[30126976];
751809	chr4	90169443	G	A	chr4:90169443	GPRIN3	GPRIN family member 3	11877.0	SNV	0/1	0.4	21_14	35	99	False	rs757395251	EXONIC	YES	NM_198281.3	Transcript	protein_coding	synonymous_variant		2/2	NM_198281.3:c.1819C>T	NP_938022.2:p.Leu607%3D		-1.0						.	.	.		6.57022e-06	1.0	152202.0	0.0	32	0.97	PASS	nfe	1.46977e-05	1.0	1.46977e-05	1.0	1.59158e-05	4.0	251322.0	0.0	100	1.0	PASS	nfe	3.52069e-05	4.0	3.52069e-05	4.0	0.0000257	4						7.389	0.313751		0	0	0			GPRIN3	0.0	0.0	0.0	0.0	-34.0	35.0	-29.0	-18.0						0.71	0.0	21.873700008			.			.	.	.	.	.	.
752439	chr18	51818389	G	A	chr18:51818389	POLI	DNA polymerase iota	11887.0	SNV	0/1	0.65	8_15	23	99	True	rs201315797,COSV54188873,COSV54192258,COSV99471138	EXONIC	YES	NM_007195.3	Transcript	protein_coding	missense_variant		9/10	NM_007195.3:c.1385G>A	NP_009126.2:p.Arg462His		1.0	.,.,.,.					.	.	.		0.000204006	31.0	151956.0	0.0	32	0.96	PASS	nfe	0.000367615	25.0	0.000367615	25.0	0.000149524	37.0	247452.0	0.0	46	0.88	PASS	nfe	0.000322604	36.0	0.000322604	36.0	0.0001350	21						0.136	-0.44069	0.007	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	POLI	0.0	0.0	0.0	0.0	2.0	11.0	5.0	19.0						0.968	0.0	0.0	0.0	-1.679	neoplasm; hematopoietic system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; 			testis - seminiferous tubule;testis - interstitial;testis;	.	DNA replication;DNA repair;translesion synthesis;error-prone translesion synthesis	nucleoplasm;nuclear speck;cytoplasmic ribonucleoprotein granule	damaged DNA binding;DNA-directed DNA polymerase activity;protein binding;metal ion binding	DAZAP2[16189514;19060904];RNF11[15231748];PCNA[16763556];CALCOCO2[16189514];XRCC1[18923427];ZBTB44[25416956];MFHAS1[29513927];TRIM39[21516116;25416956];MTNR1B[26514267];TRAF6[25416956];UBC[16763556];TMEM239[25416956];DVL2[16189514];UBE2N[25260751];UBA1[25260751];HOMER3[unassigned1304];UBE2V1[25260751];TRIM23[19060904];
753357	chr9	136918402	G	T	chr9:136918402	BRD3	bromodomain containing 3	11915.0	SNV	0/1	0.57	13_17	30	99	False	rs140746159,COSV57701341	EXONIC	YES	NM_007371.4	Transcript	protein_coding	synonymous_variant		2/12	NM_007371.4:c.198C>A	NP_031397.1:p.Ile66%3D		-1.0						.	.	.		0.000532104	81.0	152226.0	0.0	33	0.97	PASS	amr	0.00170068	26.0	0.000676113	46.0	0.000642354	160.0	249084.0	0.0	69	1.0	PASS	amr	0.0022559	78.0	0.000608708	68.0	0.0005723	89	0.004	14.0				7.11	0.292161		0	0	0			BRD3	0.0	0.0	0.0	0.0	-24.0	14.0	37.0	-15.0						0.226	0.77	60.633006836			.			superior cervical ganglion;cerebellum;	.	chromatin organization;regulation of transcription by RNA polymerase II	nucleus	chromatin binding;protein binding;lysine-acetylated histone binding	SRPK2[23602568];RPL4[30021884];AR[24759320];MAP1LC3B[21900206];JUN[25609649];MYC[20195357];TACC1[26496610];KPNA3[unassigned1304];ESR2[25604459];
753400	chr5	41150035	A	G	chr5:41150035	C6	complement C6	11922.0	SNV	0/1	0.58	8_11	19	99	False	rs76202909,CS951368	SPLICING	YES	NM_001115131.4	Transcript	protein_coding	splice_donor_variant	16/17		NM_001115131.4:c.2381+2T>C			-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	not_provided	C6 deficiency, 612446 (3); Combined C6/C7 deficiency (3)	Immunodeficiency due to a late component of complement deficiency	Disease-causing germline mutation(s) in	Complement deficiency;Autosomal recessive inheritance;Recurrent meningococcal disease	31453292	0.00225447	343.0	152142.0	1.0	32	0.97	PASS	nfe	0.00407221	277.0	0.00407221	277.0	0.00219251	550.0	250854.0	0.0	85	1.0	PASS	nfe	0.00382171	433.0	0.00382171	433.0	0.0024115	375	0.002	7.0	0.00123	14.0		32.0	4.773605		0	0	0			C6	0.0	0.0	0.01	0.94	14.0	2.0	27.0	2.0	0.992789300732162	0.602	1.39	7.754	9.144	0.273	0.0				homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			liver;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;fetal liver;	Complement and coagulation cascades;Systemic lupus erythematosus	in utero embryonic development;positive regulation of activation of membrane attack complex;complement activation;complement activation, classical pathway;cytolysis;regulation of complement activation;innate immune response;positive regulation of angiogenesis	extracellular region;membrane attack complex;extracellular exosome	protein binding	SART3[21988832];ABL1[17474147];FYN[17474147];GRB2[17474147];NCK1[17474147];
753767	chr3	151085969	G	A	chr3:151085969	MED12L	mediator complex subunit 12 like	11949.0	SNV	0/1	0.52	15_16	31	99	False	rs146195573,COSV56379780	EXONIC	YES	NM_053002.5	Transcript	protein_coding	synonymous_variant		23/43	NM_053002.5:c.3375G>A	NP_443728.3:p.Ala1125%3D		1.0					Nizon-Isidor syndrome, 618872 (3), Autosomal dominant	.	.	.		0.000328705	50.0	152112.0	0.0	31	0.95	PASS	amr	0.00248887	38.0	0.000132337	9.0	0.000175187	44.0	251160.0	0.0	55	1.0	PASS	amr	0.00057867	20.0	0.000149774	17.0	0.0000772	12	0.001	2.0				0.043	-0.597782		0	0	0			MED12L	0.0	0.0	0.0	0.0	-31.0	46.0	-31.0	46.0						0.345	1.0	92.912269477			.			ciliary ganglion;dorsal root ganglion;atrioventricular node;skin;superior cervical ganglion;trigeminal ganglion;globus pallidus;	.	regulation of transcription by RNA polymerase II;positive regulation of nucleic acid-templated transcription	nucleus;mediator complex	transcription coactivator activity;beta-catenin binding	MAPK9[unassigned1304];CDK8[29568061];TTC23[unassigned1304];MYC[21150319];CDC5L[20467437];MSRB3[unassigned1304];LAMTOR5[23414517];AES[unassigned1304];CKS1B[unassigned1304];HSPD1[30021884];
754322	chr3	118948830	T	C	chr3:118948830	B4GALT4	beta-1,4-galactosyltransferase 4	11967.0	SNV	0/1	0.63	13_22	35	99	False	rs72655933	EXONIC	YES	NM_212543.2	Transcript	protein_coding	synonymous_variant		4/9	NM_212543.2:c.117A>G	NP_997708.1:p.Gln39%3D		-1.0						.	.	.		0.00304293	463.0	152156.0	0.0	33	0.97	PASS	nfe	0.00495355	337.0	0.00495355	337.0	0.00284351	715.0	251450.0	2.0	91	1.0	PASS	nfe	0.00503772	573.0	0.00503772	573.0	0.0030674	477	0.003	11.0	0.00367	35.0		6.128	0.219683		0	0	0			B4GALT4	0.0	0.01	0.0	0.0	-1.0	43.0	42.0	15.0						0.659	0.0	68.549146194			.			skin;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	Keratan sulfate biosynthesis;Glycosphingolipid biosynthesis - neo-lactoseries;Glycan structures - biosynthesis 1;Glycan structures - biosynthesis 2	carbohydrate metabolic process;protein glycosylation;membrane lipid metabolic process;keratan sulfate biosynthetic process	Golgi membrane;Golgi apparatus;integral component of membrane;Golgi cisterna membrane	beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity;N-acetyllactosamine synthase activity;galactosyltransferase activity;metal ion binding	.
755258	chr16	23464265	G	C	chr16:23464265	COG7	component of oligomeric golgi complex 7	11978.0	SNV	0/1	0.57	18_24	42	99	False	rs1276014294	EXONIC	YES	NM_153603.4	Transcript	protein_coding	missense_variant		1/17	NM_153603.4:c.51C>G	NP_705831.1:p.Ile17Met		-1.0					Congenital disorder of glycosylation, type IIe, 608779 (3), Autosomal recessive	COG7-CDG	Disease-causing germline mutation(s) in	Hypertrophic cardiomyopathy;Muscular hypotonia;Abnormality of immune system physiology;Cerebral atrophy;Elevated serum creatine kinase;Wide nose;Progressive microcephaly;Cerebellar atrophy;Hypoplasia of the corpus callosum;Short palpebral fissure;Elevated hepatic transaminase;Profound global developmental delay;Seizure;Narrow mouth;Flat forehead;Jaundice;Low-set ears;Feeding difficulties;Hepatomegaly;Gastroesophageal reflux;Thick vermilion border;Inverted nipples;Adducted thumb;Intrauterine growth retardation;Abnormal heart morphology;Retrognathia;Hyporeflexia;Smooth philtrum;Micrognathia;Hypertrichosis;Narrow forehead;Delayed myelination;Hydronephrosis;Autosomal recessive inheritance;Neurogenic bladder;Short neck;Abnormal facial shape;Short stature;Low anterior hairline;Splenomegaly;Generalized hypotonia;Abnormality of the pinna;Protruding tongue;Short nose;Hypoglycemia;Overlapping fingers;Upslanted palpebral fissure;Hearing impairment;Failure to thrive;Respiratory insufficiency;Skeletal muscle atrophy;Decreased liver function;Congestive heart failure		1.31389e-05	2.0	152220.0	0.0	33	0.98	PASS	amr	0.00013089	2.0	0.0	0.0	1.19364e-05	3.0	251332.0	0.0	62	1.0	PASS	amr	8.67403e-05	3.0	0.0	0.0			0.0	1.0				23.5	2.987689	0.384	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,MetaRNN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	COG7	0.0	0.0	0.0	0.0	-15.0	8.0	1.0	-30.0						0.743	0.0	0.000000000	1.0	0.245	.			parietal lobe;hypothalamus;	.	protein glycosylation;intracellular protein transport;endoplasmic reticulum to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;Golgi organization;protein localization to organelle;protein localization to Golgi apparatus;protein stabilization	Golgi membrane;nucleolus;Golgi apparatus;Golgi transport complex;trans-Golgi network membrane	protein binding	COG8[19536132];SCFD1[19536132];COG5[15047703;26871637];COG4[15047703;19536132];COG3[19536132];TAX1BP1[25416956;26871637;unassigned1304];EMILIN1[26871637];KIFC3[26871637;unassigned1304];MEOX2[26871637];
755675	chr3	9796510	G	C	chr3:9796510	OGG1	8-oxoguanine DNA glycosylase	11995.0	SNV	0/1	0.46	13_11	24	99	False	rs55667729	EXONIC	YES	NM_016821.3	Transcript	protein_coding	missense_variant		4/7	NM_016821.3:c.688G>C	NP_058214.1:p.Glu230Gln		1.0	HhH-GPD domain&HhH-GPD domain&HhH-GPD domain,HhH-GPD domain&HhH-GPD domain&HhH-GPD domain,HhH-GPD domain&HhH-GPD domain&HhH-GPD domain,HhH-GPD domain&HhH-GPD domain&HhH-GPD domain,.,HhH-GPD domain&HhH-GPD domain&HhH-GPD domain,HhH-GPD domain&HhH-GPD domain&HhH-GPD domain				Renal cell carcinoma, clear cell, somatic, 144700 (3)	Hereditary clear cell renal cell carcinoma	Candidate gene tested in	Sporadic;Renal cell carcinoma	31891019	0.000998555	152.0	152220.0	1.0	33	0.98	PASS	afr	0.00328059	136.0	8.81834e-05	6.0	0.00038791	95.0	244902.0	1.0	79	0.79	PASS	afr	0.00292208	45.0	7.21983e-05	8.0	0.0004116	64	0.0	1.0	0.00088	10.0		15.05	1.273076	0.024	1	18	19	LIST-S2_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OGG1	0.0	0.0	0.0	0.0	3.0	-30.0	26.0	-3.0						0.557	0.0	0.000000000	0.077	0.222	neoplasm; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; 			kidney;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;	Base excision repair	acute inflammatory response;base-excision repair;base-excision repair, AP site formation;regulation of transcription, DNA-templated;cellular response to DNA damage stimulus;response to oxidative stress;aging;response to radiation;response to light stimulus;response to estradiol;nucleotide-excision repair, DNA incision;negative regulation of apoptotic process;depurination;depyrimidination;response to ethanol;response to folic acid;cellular response to cadmium ion;negative regulation of double-strand break repair via single-strand annealing	nucleus;nucleoplasm;mitochondrion;nuclear matrix;nuclear speck;protein-containing complex	damaged DNA binding;endonuclease activity;protein binding;microtubule binding;oxidized purine nucleobase lesion DNA N-glycosylase activity;oxidized purine DNA binding;8-oxo-7,8-dihydroguanine DNA N-glycosylase activity;class I DNA-(apurinic or apyrimidinic site) endonuclease activity	XPC[16957781];SNRPF[17353931];CHGB[16169070];
756023	chr3	119120803	G	A	chr3:119120803	ARHGAP31	Rho GTPase activating protein 31	12007.0	SNV	0/1	0.56	14_18	32	99	False	rs759956423	EXONIC	YES	NM_020754.4	Transcript	protein_coding	missense_variant		10/12	NM_020754.4:c.1204G>A	NP_065805.2:p.Gly402Arg		1.0					Adams-Oliver syndrome 1, 100300 (3), Autosomal dominant	Adams-Oliver syndrome	Disease-causing germline mutation(s) (gain of function) in	Bicuspid aortic valve;Talipes equinovarus;Alopecia;Aortic valve stenosis;Encephalocele;Polymicrogyria;Ventricular septal defect;Aplasia cutis congenita on trunk or limbs;Cutis marmorata;Atrial septal defect;Seizure;Hypoplastic left heart;Autosomal dominant inheritance;Supernumerary nipple;Hypertension;Cleft upper lip;Microphthalmia;Aplasia cutis congenita over posterior parietal area;Ventriculomegaly;Cleft palate;Generalized hypotonia;Toe syndactyly;Cortical dysplasia;Tetralogy of Fallot;Pachygyria;Intellectual disability;Pulmonic stenosis;Pulmonary artery stenosis;Hypoplasia of the corpus callosum;Imperforate hymen;Esotropia;Periventricular leukomalacia;Global developmental delay;Brachydactyly;Pulmonary arterial hypertension;Microcephaly;Muscular hypotonia;Calvarial skull defect;Supernumerary nipple;Small nail;Seizure;Tetralogy of Fallot;Talipes;Ascites;Cirrhosis;Absent fingernail;Aplastic/hypoplastic toenail;Abnormality of the metacarpal bones;Thrombocytopenia;Arteriovenous malformation;Strabismus;Congenital hepatic fibrosis;Microphthalmia;Failure to thrive;Hemiparesis;Pulmonary arterial hypertension;Sparse hair;Abnormal pulmonary valve morphology;Leukopenia;Intellectual disability;Premature birth;Cutis marmorata;Alopecia;Hydrocephalus;Split hand;Esophageal varix;Pulmonary artery atresia;Absent toe;Absent hand;Encephalocele;Cataract;Calvarial skull defect;Porencephalic cyst;Gastrointestinal hemorrhage;Portal hypertension;Finger syndactyly;Short distal phalanx of finger;Hypoplastic fingernail;Periventricular leukomalacia;Aplasia cutis congenita;EEG abnormality;Brachydactyly;Hypertonia						32	0.96							4.00808e-06	1.0	249496.0	0.0	100	1.0	PASS	nfe	8.83033e-06	1.0	8.83033e-06	1.0	0.0000064	1						28.7	4.114316	0.325	9	12	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred	ARHGAP31	0.0	0.0	0.0	0.0	-43.0	41.0	32.0	-39.0						0.239	1.0	0.000000000	0.997	1.176	.			ciliary ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	.	small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction	cytosol;focal adhesion;lamellipodium	GTPase activator activity;SH3 domain binding	NEURL4[29426014];ITSN1[18539136];RAC1[20936779];
759595	chr3	13370326	T	C	chr3:13370326	NUP210	nucleoporin 210	12099.0	SNV	0/1	0.36	21_12	33	99	False	rs1001092884	EXONIC	YES	NM_024923.4	Transcript	protein_coding	missense_variant		31/40	NM_024923.4:c.4231A>G	NP_079199.2:p.Asn1411Asp		-1.0						.	.	.						33	0.98											68	1.0									0.001	2.0				18.91	1.893533	0.193	5	14	19	MutationAssessor_pred,MutationTaster_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred	NUP210	0.0	0.0	0.0	0.0	-1.0	-10.0	-27.0	28.0						0.793	0.0	10.613500760	1.0	1.138	.			ciliary ganglion;thymus;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;bone marrow;	.	mRNA export from nucleus;viral process	nuclear envelope;nuclear pore;endoplasmic reticulum membrane;membrane;integral component of membrane;nuclear membrane	protein dimerization activity	GABARAPL2[20562859];GABARAPL1[20562859];VCAM1[22623428];SEH1L[26496610];UBE2I[26496610];NUP107[26496610];FN1[19738201];NUP153[26496610];GABARAP[20562859];EXOSC5[15231747];MAP1LC3B[20562859];METTL14[29507755];LAMP1[29568061];TCTN1[26638075];CEP162[26638075];ZNF302[30021884];KPNB1[26496610];
760704	chr5	140720474	A	G	chr5:140720474	PCDHGA2	protocadherin gamma subfamily A, 2	12121.0	SNV	0/1	0.43	24_18	42	99	False	rs148082357,COSV53898564	EXONIC	YES	NM_018915.4	Transcript	protein_coding	missense_variant		1/4	NM_018915.4:c.1936A>G	NP_061738.1:p.Ile646Val		1.0	.,Cadherin-like&Cadherin-like					.	.	.		0.00643015	978.0	152096.0	8.0	33	0.97	PASS	nfe	0.00917512	624.0	0.00917512	624.0	0.00428956	1071.0	249676.0	14.0	100	0.99	PASS	nfe	0.0064263	724.0	0.0064263	724.0	0.0006817	106	0.004	12.0			1.0	5.622	0.1855	0.034	0	17	17		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PCDHGA2	0.0	0.0	0.0	0.0	-15.0	6.0	-1.0	12.0						0.904	0.0	0.000000000	0.094	-0.168	.			.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules	integral component of plasma membrane	calcium ion binding	.
761083	chr17	33806812	C	A	chr17:33806812	SLFN12L	schlafen family member 12 like	12132.0	SNV	0/1	0.48	11_10	21	99	False	rs12451876,COSV53468491	EXONIC	YES	NM_001363830.1	Transcript	protein_coding	synonymous_variant		3/5	NM_001363830.1:c.504G>T	NP_001350759.1:p.Thr168%3D		-1.0						.	.	.		0.00154591	235.0	152014.0	0.0	33	0.97	PASS	nfe	0.00214668	146.0	0.00214668	146.0	0.00172708	425.0	246080.0	1.0	38	0.84	PASS	nfe	0.00182571	202.0	0.00182571	202.0	0.0014662	228	0.033	103.0				0.199	-0.387147		0	0	0			SLFN12L	0.0	0.0	0.0	0.0	-12.0	8.0	17.0	-27.0							0.0	32.003957900			homeostasis/metabolism phenotype; 			.	.	.	integral component of membrane	ATP binding	TP53BP1[29656893];
761576	chr10	18931433	C	T	chr10:18931433	NSUN6	NOP2/Sun RNA methyltransferase family member 6	12145.0	SNV	0/1	0.32	21_10	31	99	False	rs61737266	EXONIC	YES	NM_182543.5	Transcript	protein_coding	missense_variant		3/11	NM_182543.5:c.283G>A	NP_872349.1:p.Val95Met		-1.0	.,.					.	.	.		0.00126847	193.0	152152.0	0.0	32	0.96	PASS	afr	0.00197876	82.0	0.00122016	83.0	0.000941062	235.0	249718.0	0.0	50	0.81	PASS	afr	0.00179344	29.0	0.00127997	145.0	0.0009582	149	0.001	4.0				22.3	2.381954	0.066	3	16	19	SIFT,MutationTaster_pred,LIST-S2_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NSUN6	0.0	0.05	0.0	0.03	-28.0	11.0	-32.0	-28.0						0.729	0.0	0.000000000,0.000000000	0.865	-0.776	.			.	.	tRNA modification;tRNA methylation	cytoplasm;cytosol	tRNA binding;tRNA (cytosine-5-)-methyltransferase activity	BCKDHA[30021884];
761986	chr10	46965727	G	A	chr10:46965727	SYT15	synaptotagmin 15	12161.0	SNV	0/1	0.83	8_38	46	90	False	rs1889849,COSV65431103	EXONIC	YES	NM_031912.5	Transcript	protein_coding	synonymous_variant		5/8	NM_031912.5:c.810C>T	NP_114118.2:p.Ala270%3D		-1.0						.	.	.		7.01243e-06	1.0	142604.0	0.0	22	0.61	AS_VQSR	amr	6.89655e-05	1.0	0.0	0.0	0.50662	122987.0	242760.0	2400.0	61	0.99	InbreedingCoeff	afr	0.529404	7958.0	0.50875	56400.0	0.0363077	5646	0.208	654.0				6.84	0.271326		0	0	0			SYT15	0.0	0.0	0.0	0.0	-24.0	-12.0	-8.0	-23.0						0.99	0.0	24.802902514			.			.	.	regulation of dopamine secretion;vesicle-mediated transport;calcium ion regulated exocytosis;regulation of calcium ion-dependent exocytosis;cellular response to calcium ion	plasma membrane;integral component of membrane;exocytic vesicle	SNARE binding;phosphatidylserine binding;calcium ion binding;calcium-dependent phospholipid binding;clathrin binding	GPR152[unassigned1304];ATP6V0E1[unassigned1304];NEK4[25798074];GPX8[unassigned1304];FAM209A[unassigned1304];CLEC2D[unassigned1304];
761996	chr10	46967672	C	T	chr10:46967672	SYT15	synaptotagmin 15	12161.0	SNV	0/1	0.79	12_44	56	99	False	rs2152530,COSV65432959	EXONIC	YES	NM_031912.5	Transcript	protein_coding	synonymous_variant		4/8	NM_031912.5:c.405G>A	NP_114118.2:p.Pro135%3D		-1.0						.	.	.		0.0	0.0	135660.0	0.0	20	0.55	AC0_AS_VQSR				0.0	0.0	0.512233	126707.0	247362.0	3059.0	100	0.99	InbreedingCoeff	afr	0.565707	8489.0	0.509829	57059.0	0.0372145	5787	0.169	486.0				0.745	-0.194583		0	0	0			SYT15	0.0	0.02	0.0	0.0	-2.0	46.0	-2.0	-10.0						0.99	0.0	25.968552785			.			.	.	regulation of dopamine secretion;vesicle-mediated transport;calcium ion regulated exocytosis;regulation of calcium ion-dependent exocytosis;cellular response to calcium ion	plasma membrane;integral component of membrane;exocytic vesicle	SNARE binding;phosphatidylserine binding;calcium ion binding;calcium-dependent phospholipid binding;clathrin binding	GPR152[unassigned1304];ATP6V0E1[unassigned1304];NEK4[25798074];GPX8[unassigned1304];FAM209A[unassigned1304];CLEC2D[unassigned1304];
762270	chr11	64137762	G	A	chr11:64137762	RPS6KA4	ribosomal protein S6 kinase A4	12181.0	SNV	0/1	0.42	14_10	24	99	False	rs745576434	EXONIC	YES	NM_003942.3	Transcript	protein_coding	synonymous_variant		15/17	NM_003942.3:c.1863G>A	NP_003933.1:p.Ala621%3D		1.0						.	.	.		6.57229e-06	1.0	152154.0	0.0	33	0.97	PASS				0.0	0.0	1.32217e-05	3.0	226900.0	0.0	33	0.75	PASS	amr	7.51767e-05	2.0	0.0	0.0	0.0000129	2						12.15	0.825934		0	0	0			RPS6KA4	0.0	0.06	0.0	0.0	2.0	-44.0	6.0	11.0							1.0	63.129008282			mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			ciliary ganglion;pons;superior cervical ganglion;trigeminal ganglion;cingulate cortex;cerebellum;	MAPK signaling pathway	negative regulation of cytokine production;regulation of transcription, DNA-templated;protein phosphorylation;inflammatory response;histone phosphorylation;positive regulation of CREB transcription factor activity;positive regulation of histone phosphorylation;positive regulation of histone acetylation;intracellular signal transduction;histone H3-S10 phosphorylation;histone H3-S28 phosphorylation;positive regulation of transcription by RNA polymerase II;positive regulation of NF-kappaB transcription factor activity;interleukin-1-mediated signaling pathway	nucleus;nucleoplasm;cytoplasm;cytosol	magnesium ion binding;protein serine/threonine kinase activity;ribosomal protein S6 kinase activity;protein binding;ATP binding	XRCC6[30021884];SNW1[20467437];CDC37[24189400];CDC5L[20467437];RRP1B[20926688];MAPK14[9792677;23602568;25852190];MAPK3[9792677];
762446	chr2	218953991	T	G	chr2:218953991	RUFY4	RUN and FYVE domain containing 4	12197.0	SNV	0/1	0.47	17_15	32	99	False	rs201137688,COSV60245986	EXONIC	YES	NM_198483.4	Transcript	protein_coding	missense_variant		12/13	NM_198483.4:c.1519T>G	NP_940885.2:p.Trp507Gly		1.0	.,.					.	.	.		0.00141988	216.0	152126.0	0.0	32	0.96	PASS	nfe	0.00246972	168.0	0.00246972	168.0	0.00124543	310.0	248910.0	1.0	39	0.96	PASS	nfe	0.00210944	238.0	0.00210944	238.0	0.0010804	168	0.001	4.0			1.0	28.5	4.091792	0.82	11	10	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	RUFY4	0.0	0.02	0.0	0.0	-12.0	-16.0	-12.0	-6.0							0.0	0.0	0.602	1.138	.			.	.	autophagosome assembly;positive regulation of macroautophagy;cellular response to interleukin-4	autophagosome;cytoplasmic vesicle	protein binding;phosphatidylinositol-3-phosphate binding;metal ion binding	CDKN2D[unassigned1304];MAP1LC3C[unassigned1304];LNX1[25416956;unassigned1304];NDC80[25416956;unassigned1304];
765783	chr4	13604226	C	A	chr4:13604226	BOD1L1	biorientation of chromosomes in cell division 1 like 1	12296.0	SNV	0/1	0.43	16_12	28	99	False	rs765371992	EXONIC	YES	NM_148894.3	Transcript	protein_coding	missense_variant		10/26	NM_148894.3:c.4298G>T	NP_683692.2:p.Gly1433Val		-1.0						.	.	.						33	0.97							7.96806e-06	2.0	251002.0	0.0	82	1.0	PASS	sas	3.26691e-05	1.0	8.82161e-06	1.0	0.0000129	2						9.018	0.460047	0.06	2	19	21	PolyPhen,MutationAssessor_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	BOD1L1	0.0	0.0	0.0	0.0	-36.0	42.0	2.0	1.0							1.0	0.0	0.074	-0.369	.			.	.	DNA repair;cellular response to DNA damage stimulus;replication fork processing	nucleoplasm;chromosome	.	ANKRD13B[26496610];SEMA3B[26496610];CXXC1[26496610];KEAP1[26496610];SGF29[26496610];FAM83H[26496610];AKR7A2[26496610];PRDX5[26496610];TRIM29[26496610];RBBP5[26496610];MKNK1[26496610];WDR5[27705803];MTREX[26496610];GTSE1[26496610];HIST1H1C[30021884];NCBP1[26496610];SETD1A[26496610];DLEC1[30021884];CNPY3[30021884];PLEKHA7[28877994];VAV2[18654987];MYL6[26496610];KLHL7[26496610];TACC3[26496610];L1TD1[26496610];TAF6[26496610];
769180	chr10	47087474	T	T	chr10:47087474	NPY4R	neuropeptide Y receptor Y4	12329.0	SNV	0/1	0.82	12_53	65	99	False	rs1400624272,COSV65398057	EXONIC	YES	NM_005972.6	Transcript	protein_coding	synonymous_variant		3/3	NM_005972.6:c.691C>T	NP_005963.4:p.Leu231%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						0	0.0							0.759215	190806.0	251320.0	65149.0	100	1.0	InbreedingCoeff	eas	0.98929	18197.0	0.69711	79260.0	0.0592782	9218	0.301	952.0				9.829	0.546295		0	0	0			NPY4R	0.0	0.0	0.0	0.0	36.0	-24.0	-26.0	2.0							0.0	59.348343019			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; normal phenotype; skeleton phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			.	Neuroactive ligand-receptor interaction	G protein-coupled receptor signaling pathway;neuropeptide signaling pathway	plasma membrane;integral component of plasma membrane;membrane	pancreatic polypeptide receptor activity;G protein-coupled receptor activity;peptide hormone binding	.
769183	chr10	47087501	T	T	chr10:47087501	NPY4R	neuropeptide Y receptor Y4	12329.0	SNV	0/1	0.33	46_23	69	99	False	rs1352903918,COSV65397589	EXONIC	YES	NM_005972.6	Transcript	protein_coding	synonymous_variant		3/3	NM_005972.6:c.718C>T	NP_005963.4:p.Cys240%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						22	0.68							0.275916	58327.0	211394.0	30.0	100	1.0	InbreedingCoeff_RF	eas	0.470188	7949.0	0.259311	24188.0	0.0184818	2874	0.086	262.0				22.5	2.457436	0.646	0	0	0			NPY4R	0.0	0.0	0.0	0.0	-2.0	33.0	-25.0	10.0							0.0	7.530829162			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; normal phenotype; skeleton phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			.	Neuroactive ligand-receptor interaction	G protein-coupled receptor signaling pathway;neuropeptide signaling pathway	plasma membrane;integral component of plasma membrane;membrane	pancreatic polypeptide receptor activity;G protein-coupled receptor activity;peptide hormone binding	.
769185	chr10	47087680	T	T	chr10:47087680	NPY4R	neuropeptide Y receptor Y4	12329.0	SNV	0/1	0.79	14_53	67	99	False	rs1438263240,COSV65398346	EXONIC	YES	NM_005972.6	Transcript	protein_coding	synonymous_variant		3/3	NM_005972.6:c.897C>T	NP_005963.4:p.His299%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						0	0.0							0.759139	190837.0	251386.0	65148.0	100	1.0	InbreedingCoeff	eas	0.98929	18197.0	0.697052	79259.0	0.0548989	8537	0.326	1032.0				7.14	0.294516		0	0	0			NPY4R	0.0	0.0	0.0	0.0	20.0	-39.0	18.0	-39.0							0.0	7.530829162			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; normal phenotype; skeleton phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			.	Neuroactive ligand-receptor interaction	G protein-coupled receptor signaling pathway;neuropeptide signaling pathway	plasma membrane;integral component of plasma membrane;membrane	pancreatic polypeptide receptor activity;G protein-coupled receptor activity;peptide hormone binding	.
769186	chr10	47087731	T	T	chr10:47087731	NPY4R	neuropeptide Y receptor Y4	12329.0	SNV	0/1	0.71	19_46	65	99	False	rs1375949574	EXONIC	YES	NM_005972.6	Transcript	protein_coding	synonymous_variant		3/3	NM_005972.6:c.948C>T	NP_005963.4:p.Cys316%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						0	0.0							0.759132	190867.0	251428.0	65156.0	100	1.0	InbreedingCoeff	eas	0.98929	18197.0	0.697012	79267.0	0.0815284	12678	0.361	1141.0				7.316	0.308088		0	0	0			NPY4R	0.0	0.0	0.0	0.0	43.0	-31.0	-33.0	-3.0							0.0	24.802902514			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; normal phenotype; skeleton phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			.	Neuroactive ligand-receptor interaction	G protein-coupled receptor signaling pathway;neuropeptide signaling pathway	plasma membrane;integral component of plasma membrane;membrane	pancreatic polypeptide receptor activity;G protein-coupled receptor activity;peptide hormone binding	.
769189	chr10	47087830	A	A	chr10:47087830	NPY4R	neuropeptide Y receptor Y4	12329.0	SNV	0/1	0.7	17_39	56	99	False	rs1440744958,COSV65398349	EXONIC	YES	NM_005972.6	Transcript	protein_coding	synonymous_variant		3/3	NM_005972.6:c.1047G>A	NP_005963.4:p.Ser349%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						0	0.0							0.758867	190808.0	251438.0	65092.0	100	1.0	InbreedingCoeff	eas	0.98929	18197.0	0.697056	79272.0	0.0813162	12645	0.352	1114.0				0.176	-0.40422		0	0	0			NPY4R	0.0	0.0	0.0	0.0	23.0	-23.0	44.0	21.0							0.0	2.479659119			behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; normal phenotype; skeleton phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			.	Neuroactive ligand-receptor interaction	G protein-coupled receptor signaling pathway;neuropeptide signaling pathway	plasma membrane;integral component of plasma membrane;membrane	pancreatic polypeptide receptor activity;G protein-coupled receptor activity;peptide hormone binding	.
769244	chr11	47256845	G	A	chr11:47256845	DDB2	damage specific DNA binding protein 2	12330.0	SNV	0/1	0.53	15_18	34	99	False	rs761699363,COSV99921639	EXONIC	YES	NM_000107.3	Transcript	protein_coding	missense_variant		7/10	NM_000107.3:c.905G>A	NP_000098.1:p.Arg302Gln		1.0	WD40-repeat-containing domain,.	Uncertain_significance	criteria_provided,_single_submitter	Xeroderma_pigmentosum,_group_E	Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3), Autosomal recessive	Xeroderma pigmentosum	Disease-causing germline mutation(s) in	Entropion;Conjunctivitis;Poikiloderma;Melanoma;Autosomal recessive inheritance;Squamous cell carcinoma of the skin;Keratitis;Defective DNA repair after ultraviolet radiation damage;Telangiectasia;Ectropion;Dermal atrophy;Photophobia;Basal cell carcinoma;Cutaneous photosensitivity;Flat nasal alae;Short stature;Ectropion;Abnormality of the dentition;Cataract;Freckling;Delayed skeletal maturation;Peripheral neuropathy;Reduced tendon reflexes;Intellectual disability, progressive;Hypopigmented skin patches;Fatigue;Melanocytic nevus;Poikiloderma;Strabismus;Ataxia;Abnormality of extrapyramidal motor function;EEG abnormality;Alopecia;Pterygium;Fever;Cognitive impairment;Hyperkeratosis;Thin skin;Cerebral cortical atrophy;Cutaneous photosensitivity;Arthralgia;Spasticity;Neoplasm of the eye;Keratitis;Telangiectasia of the skin;Dermal atrophy;Blepharitis;Craniofacial hyperostosis;Decreased testicular size;Hypogonadism;Optic atrophy;Developmental regression;Melanoma;Hypermelanotic macule;Entropion;Sensorineural hearing impairment;Failure to thrive;Conjunctival telangiectasia;Aminoaciduria;Opacification of the corneal stroma;Erythema;Dry skin;Microcephaly;Ankyloblepharon;Seizure;Cryptorchidism;Photophobia;Papilloma		1.97106e-05	3.0	152202.0	0.0	32	0.97	PASS	sas	0.000207555	1.0	1.46968e-05	1.0	7.95311e-06	2.0	251474.0	0.0	100	1.0	PASS	amr	2.89084e-05	1.0	8.79028e-06	1.0	0.0000129	2	0.001	2.0				19.95	2.027515	0.068	3	17	20	MutationAssessor_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	DDB2	0.0	0.01	0.0	0.0	2.0	-14.0	-24.0	-43.0						0.693	0.01	0.0	0.988	-0.13	neoplasm; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; cellular phenotype; 			atrioventricular node;	Nucleotide excision repair;p53 signaling pathway;Ubiquitin mediated proteolysis	protein polyubiquitination;nucleotide-excision repair, DNA damage recognition;DNA repair;nucleotide-excision repair;pyrimidine dimer repair;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, preincision complex assembly;nucleotide-excision repair, DNA incision, 5'-to lesion;response to UV;response to UV-B;protein deubiquitination;nucleotide-excision repair, DNA incision;histone H2A monoubiquitination;post-translational protein modification;protein autoubiquitination;global genome nucleotide-excision repair;UV-damage excision repair	nucleoplasm;cell junction;Cul4B-RING E3 ubiquitin ligase complex;protein-containing complex;Cul4-RING E3 ubiquitin ligase complex	DNA binding;damaged DNA binding;ubiquitin-protein transferase activity;protein binding;protein-containing complex binding	CDKN1A[19541625];GPS1[26496610];COPS7A[26496610];XPC[22039351];DDA1[20562859;26496610];HSPD1[26496610];HYKK[30021884];SUMO3[17000644];E2F1[9418871];CCT8[26496610];TPPP[30021884];CCT7[26496610];CCT5[26496610];CCT4[26496610];CCT3[26496610];CCT2[26496610];METTL3[29507755];RBX1[26496610;16473935];CUL4A[17041588;26496610;16473935];DDB1[17041588;9418871;19109893;16473935;17360488;19966799;22039351;22822215];CCT6A[26496610];COPS4[26496610];COPS3[26496610];COPS6[19615732;26496610];COPS5[19615732;18850735;26496610];TCP1[26496610];COPS8[26496610];CUL4B[17041588;26496610];
770595	chr14	100594923	A	C	chr14:100594923	EVL	Enah/Vasp-like	12384.0	SNV	0|1	0.17	15_3	18	75	False	rs1245254985	EXONIC	YES	NM_016337.3	Transcript	protein_coding	synonymous_variant		6/14	NM_016337.3:c.555A>C	NP_057421.1:p.Pro185%3D		1.0						.	.	.		0.00156648	198.0	126398.0	0.0	31	0.83	AS_VQSR	sas	0.00780798	27.0	0.000829933	48.0	4.53766e-05	10.0	220378.0	0.0	32	0.87	RF	amr	0.000159449	5.0	1.02449e-05	1.0								12.25	0.838029		0	0	0			EVL	0.01	0.0	0.0	0.0	-9.0	-49.0	-14.0	-21.0						0.185	0.99	72.178355845			homeostasis/metabolism phenotype; cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; 			.	.	actin filament organization;cell surface receptor signaling pathway;nervous system development;axon guidance;actin polymerization or depolymerization;animal organ morphogenesis;negative regulation of epithelial cell migration;actin nucleation;protein homotetramerization;positive regulation of stress fiber assembly;cellular response to interferon-gamma;negative regulation of ruffle assembly	cytoplasm;cytosol;cytoskeleton;focal adhesion;membrane;lamellipodium;phagocytic vesicle	actin binding;protein binding;profilin binding;SH3 domain binding	FYB1[19798671];HTT[23275563];BAIAP2[24076653];TERF1[21044950];ZDHHC17[24705354];SPTA1[16336193];HCK[12029088];TRIM9[25416956;unassigned1304];RAD51[19725871];ABI3[25416956;unassigned1304];ZYX[unassigned1304];POT1[21044950];EVL[25416956];ZNF655[unassigned1304];SPTAN1[16336193];
770606	chr21	19642347	C	T	chr21:19642347	TMPRSS15	transmembrane serine protease 15	12385.0	SNV	0/1	0.44	10_8	18	99	False	rs192022515,COSV53040788	EXONIC	YES	NM_002772.3	Transcript	protein_coding	missense_variant		25/25	NM_002772.3:c.2999G>A	NP_002763.3:p.Arg1000His		-1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain				Enterokinase deficiency, 226200 (3), Autosomal recessive	Congenital enteropathy due to enteropeptidase deficiency	Disease-causing germline mutation(s) in	Diarrhea;Autosomal recessive inheritance;Hypoproteinemia;Failure to thrive;Hypoproteinemic edema		0.000249951	38.0	152030.0	0.0	32	0.95	PASS	amr	0.000852124	13.0	0.000191143	13.0	0.000270455	68.0	251428.0	0.0	83	1.0	PASS	amr	0.000954254	33.0	0.00026381	30.0	0.0001865	29	0.003	9.0	0.00342	39.0		21.6	2.227949	0.103	5	15	20	M-CAP_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,LIST-S2_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TMPRSS15	0.0	0.0	0.0	0.0	-2.0	-27.0	40.0	-27.0							0.0	0.000000000	0.832	0.138	immune system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 			ciliary ganglion;pons;appendix;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skin;skeletal muscle;globus pallidus;	.	proteolysis;receptor-mediated endocytosis	brush border;membrane;integral component of membrane	serine-type endopeptidase activity;scavenger receptor activity;protein binding	PYCARD[24407287];TNFRSF11A[23954298];
774121	chrX	92928109	GCT		chrX:92928109-92928111	NAP1L3	nucleosome assembly protein 1 like 3	12485.0	deletion	0/1	0.13	13_2	15	45	False	rs762061463	EXONIC	YES	NM_004538.6	Transcript	protein_coding	inframe_deletion		1/1	NM_004538.6:c.193_195del	NP_004529.2:p.Ser65del		-1.0						.	.	.		9.08405e-06	1.0	110083.0	0.0	22	0.58	PASS	nfe	1.90248e-05	1.0	1.90248e-05	1.0	0.000162832	26.0	159674.0	0.0	33	0.74	RF	afr	0.000295392	3.0	0.000186217	13.0	0.0000064,0.0012090	1,188						8.056	0.36907		0	0	0			NAP1L3	0.0	0.0	0.0	0.0	49.0	46.0	-41.0	1.0						0.279	0.41	0.000000000			.			.	.	nucleosome assembly	nucleus	.	BEND7[21516116];PPIB[30021884];TSPYL4[25416956];
774785	chr19	10685159	T	G	chr19:10685159	AP1M2	adaptor related protein complex 1 subunit mu 2	12514.0	SNV	0/1	0.46	15_13	28	99	False	rs199653684	EXONIC	YES	NM_001300887.2	Transcript	protein_coding	missense_variant		11/12	NM_001300887.2:c.1189A>C	NP_001287816.1:p.Met397Leu		-1.0	Mu homology domain&Mu homology domain,.,Mu homology domain&Mu homology domain,Mu homology domain&Mu homology domain					.	.	.		7.2299e-05	11.0	152146.0	0.0	32	0.98	PASS	nfe	0.000147011	10.0	0.000147011	10.0	8.50533e-05	15.0	176360.0	0.0	19	0.49	PASS	nfe	0.00019122	14.0	0.00019122	14.0	0.0000386	6						18.18	1.797106	0.153	6	13	19	LRT_pred,M-CAP_pred,MutationTaster_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	AP1M2	0.0	0.0	0.0	0.0	9.0	-6.0	-6.0	-41.0						0.755	0.0	0.000000000	1.0	0.997	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			fetal thyroid;kidney;thyroid;superior cervical ganglion;placenta;	.	protein targeting;vesicle targeting;antigen processing and presentation of exogenous peptide antigen via MHC class II;regulation of defense response to virus by virus	Golgi membrane;lysosomal membrane;cytosol;clathrin adaptor complex;cytoplasmic vesicle membrane;clathrin-coated vesicle membrane;trans-Golgi network membrane;intracellular membrane-bounded organelle	protein binding	APP[21163940];ERBB3[24189400];MAST1[21163940];AP2B1[16189514;25416956];ECSIT[21163940];NDRG1[17220478];PLEKHA7[28877994];
776201	chr22	30517685	C	T	chr22:30517685	HORMAD2	HORMA domain containing 2	12557.0	SNV	0/1	0.66	10_19	29	99	False	rs774933830	EXONIC	YES	NM_001329457.2	Transcript	protein_coding	synonymous_variant		10/12	NM_001329457.2:c.475C>T	NP_001316386.1:p.Leu159%3D		1.0						.	.	.		9.85934e-05	15.0	152140.0	0.0	32	0.97	PASS	amr	0.000524109	8.0	7.35013e-05	5.0	5.35853e-05	13.0	242604.0	0.0	28	0.72	PASS	amr	0.000148641	5.0	4.56371e-05	5.0	0.0000386	6	0.002	5.0				12.13	0.822248		0	0	0			HORMAD2	0.0	0.0	0.0	0.0	33.0	27.0	-10.0	16.0						0.785	0.0	60.476998659			cellular phenotype; endocrine/exocrine gland phenotype; reproductive system phenotype; 			ciliary ganglion;testis - interstitial;atrioventricular node;superior cervical ganglion;testis;skeletal muscle;	.	meiotic sister chromatid cohesion;meiotic cell cycle	synaptonemal complex;nucleus;chromosome	.	NSD2[unassigned1304];
777063	chr1	233515305	C	T	chr1:233515305	MAP3K21	mitogen-activated protein kinase kinase kinase 21	12582.0	SNV	0/1	0.66	11_21	32	99	False	rs770191441	EXONIC	YES	NM_032435.3	Transcript	protein_coding	synonymous_variant		9/10	NM_032435.3:c.2553C>T	NP_115811.2:p.Leu851%3D		1.0						.	.	.		1.97109e-05	3.0	152200.0	0.0	33	0.97	PASS	nfe	4.40917e-05	3.0	4.40917e-05	3.0	3.97962e-06	1.0	251280.0	0.0	99	1.0	PASS	nfe	8.80483e-06	1.0	8.80483e-06	1.0	0.0000064	1						1.008	-0.149578		0	0	0			RP5-862P8.2	0.0	0.0	0.0	0.0	36.0	-22.0	-14.0	27.0								7.947566600			.			.	.	activation of MAPKK activity;protein phosphorylation;activation of JUN kinase activity;protein autophosphorylation	cellular_component	MAP kinase kinase kinase activity;protein binding;ATP binding;protein homodimerization activity	RTKN[unassigned1312];YWHAB[17353931;24255178];MAST3[unassigned1312];DENND1A[unassigned1312];ZBTB21[unassigned1312];CBY1[unassigned1312];TESK2[unassigned1312];IKBKB[26859459];FAM110A[unassigned1312];SYDE1[unassigned1312];SIPA1L1[unassigned1312];SH3PXD2A[unassigned1312];FAM110B[unassigned1312];KIF13B[unassigned1312];FAM53C[unassigned1312];KIF1C[unassigned1312];HIF1AN[26972000;29426014];RALGPS2[unassigned1312];HIST1H1C[30021884];MAGI1[unassigned1312];CHUK[26859459];KSR1[unassigned1312];KCTD3[unassigned1312];CDC25C[unassigned1312];CDC25B[unassigned1312];GIGYF1[unassigned1312];TIAM1[unassigned1312];ZNF638[unassigned1312];EIF4E2[unassigned1312];PHLDB2[unassigned1312];HDAC4[unassigned1312];MAPKAP1[unassigned1312];PPM1H[unassigned1312];AGAP1[unassigned1312];RASAL2[unassigned1312];GIGYF2[unassigned1312];CAMSAP2[unassigned1312];LIMA1[unassigned1312];EXOSC9[26496610];INPP5E[unassigned1312];SRGAP2[unassigned1312];NADK[unassigned1312];SRSF12[unassigned1312];ANKRD34A[unassigned1312];USP21[unassigned1312];DENND4C[unassigned1312];CGN[unassigned1312];DCLK1[unassigned1312];PLEKHA7[unassigned1312];LRFN1[unassigned1312];TACC3[26496610];NF1[unassigned1312];MAP3K10[20936779];CDK16[unassigned1312];
777543	chr19	8993017	G	T	chr19:8993017	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.16	32_6	38	99	False	rs111468097,COSV66689562	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		67/84	NM_024690.2:c.41742C>A	NP_078966.2:p.Pro13914%3D		-1.0						.	.	.		6.19828e-05	8.0	129068.0	0.0	32	0.85	PASS	eas	0.000225023	1.0	0.0	0.0					53	0.95							0.0000064	1						0.004	-0.940366		0	0	0			MUC16	0.02	0.0	0.02	0.0	25.0	-9.0	-10.0	25.0						0.998		6.169915974			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777544	chr19	8993020	T	C	chr19:8993020	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.19	30_7	37	99	False	rs796526726	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		67/84	NM_024690.2:c.41739A>G	NP_078966.2:p.Val13913%3D		-1.0						.	.	.		4.65954e-05	6.0	128768.0	0.0	32	0.85	AS_VQSR	eas	0.000227066	1.0	0.0	0.0					53	0.95							0.0000257	4						0.002	-1.03854		0	0	0			MUC16	0.0	0.0	0.0	0.0	22.0	-12.0	-17.0	-13.0						0.998		1.772665448			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777545	chr19	8993033	T	G	chr19:8993033	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.14	36_6	42	99	False	rs796735167,COSV66690394	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		67/84	NM_024690.2:c.41726A>C	NP_078966.2:p.His13909Pro		-1.0	SEA domain					.	.	.		1.37571e-05	2.0	145380.0	0.0	33	0.94	AS_VQSR	afr	5.06201e-05	2.0	0.0	0.0					50	0.93							0.0000064	1						16.98	1.621087	0.06	2	14	16	SIFT,PolyPhen	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.05	0.0	0.07	-26.0	9.0	10.0	-26.0						0.998		11.065761130	0.003	-0.066	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777546	chr19	8993036	G	T	chr19:8993036	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.14	37_6	43	99	False	rs1175263485,COSV66690397	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		67/84	NM_024690.2:c.41723C>A	NP_078966.2:p.Thr13908Asn		-1.0	SEA domain					.	.	.		6.85138e-06	1.0	145956.0	0.0	33	0.94	AS_VQSR	afr	2.52131e-05	1.0	0.0	0.0					50	0.93														17.49	1.702241	0.057	1	15	16	PolyPhen	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.02	0.0	0.03	0.0	6.0	-29.0	-29.0	6.0						0.998		40.085683608	0.024	-0.02	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777547	chr19	8993041	A	G	chr19:8993041	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.14	38_6	44	99	False	rs796540521,COSV66690400	SPLICING	YES	NM_024690.2	Transcript	protein_coding	splice_region_variant,synonymous_variant		67/84	NM_024690.2:c.41718T>C	NP_078966.2:p.Gly13906%3D		-1.0						.	.	.		5.0162e-05	7.0	139548.0	0.0	33	0.91	AS_VQSR	amr	0.000142939	2.0	1.59048e-05	1.0	4.02214e-06	1.0	248624.0	0.0	49	0.93	PASS	amr	2.91698e-05	1.0	0.0	0.0	0.0000064	1						0.001	-1.357429		0	0	0			MUC16	0.0	0.11	0.0	0.11	-34.0	1.0	1.0	-34.0	9.85664055049213e-05	0.006	11.698	1.022	12.721	0.998		40.085683608			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777548	chr19	8993048	C	G	chr19:8993048	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.15	33_6	39	99	False	rs771781486,COSV66689532	SPLICING	YES	NM_024690.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	66/83		NM_024690.2:c.41717-6G>C			-1.0						.	.	.		5.48916e-05	7.0	127524.0	0.0	32	0.84	AS_VQSR	sas	0.000245098	1.0	1.74453e-05	1.0	4.0246e-06	1.0	248472.0	0.0	48	0.92	PASS	afr	6.46914e-05	1.0	0.0	0.0	0.0000064	1						0.51	-0.25117		0	0	0			MUC16	0.04	0.0	0.06	0.0	-6.0	-41.0	-41.0	-6.0	1.15904271084893e-05	0.0	14.465	-1.744	12.721	0.998					reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777590	chr19	8999421	G	C	chr19:8999421	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.12	34_5	40	99	False	rs75266616,COSV66689890	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		56/84	NM_024690.2:c.40754C>G	NP_078966.2:p.Thr13585Ser		-1.0	SEA domain&SEA domain&SEA domain					.	.	.		0.00496685	394.0	79326.0	0.0	35	0.69	PASS	sas	0.00611951	17.0	0.00493812	162.0	0.000910559	212.0	232824.0	0.0	40	0.88	PASS	sas	0.00142816	40.0	0.000904641	95.0	0.0020514	319	0.008	24.0				20.9	2.134954	0.037	1	15	16	PolyPhen	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	-1.0	-10.0	-29.0	-26.0						0.998		45.211109758	0.015	-0.232	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777594	chr19	8999462	C	T	chr19:8999462	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.11	38_5	44	96	False	rs764880286,COSV66689536	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		56/84	NM_024690.2:c.40713G>A	NP_078966.2:p.Leu13571%3D		-1.0						.	.	.		0.00282648	306.0	108262.0	0.0	44	0.88	PASS	sas	0.00356164	13.0	0.00294003	136.0	0.000311958	73.0	234006.0	0.0	41	0.91	RF	sas	0.000382635	11.0	0.000363407	38.0	0.0000257	4	0.004	14.0				0.081	-0.51145		0	0	0			MUC16	0.0	0.0	0.0	0.0	-18.0	36.0	49.0	0.0						0.998		58.568645801			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777595	chr19	8999468	C	G	chr19:8999468	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.11	38_5	44	96	False	rs1041137567,COSV66689770,COSV66690405	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		56/84	NM_024690.2:c.40707G>C	NP_078966.2:p.Trp13569Cys		-1.0	SEA domain&SEA domain&SEA domain					.	.	.		0.000867095	116.0	133780.0	0.0	47	0.97	PASS	sas	0.00116171	5.0	0.000576967	35.0					41	0.9														23.5	2.965897	0.306	7	9	16	SIFT,PolyPhen,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,ClinPred_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	30.0	-24.0	2.0	43.0						0.998		54.512780917	0.021	0.093	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777596	chr19	8999474	T	C	chr19:8999474	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.11	38_5	44	96	False	rs199946350,COSV66694439	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		56/84	NM_024690.2:c.40701A>G	NP_078966.2:p.Leu13567%3D		-1.0						.	.	.		0.00484367	466.0	96208.0	0.0	41	0.82	PASS	amr	0.00675096	63.0	0.00361131	152.0	0.00901687	1468.0	162806.0	0.0	40	0.89	PASS	sas	0.0145507	295.0	0.0081385	566.0	0.0000579	9	0.002	5.0				0.001	-1.289572		0	0	0			MUC16	0.0	0.0	0.0	0.0	24.0	40.0	1.0	37.0						0.998		54.512780917			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777598	chr19	8999498	G	T	chr19:8999498	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.12	33_5	41	99	False	rs760351137,COSV66694822	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		56/84	NM_024690.2:c.40677C>A	NP_078966.2:p.Ser13559Arg		-1.0	SEA domain&SEA domain&SEA domain					.	.	.		0.00299145	328.0	109646.0	0.0	37	0.86	PASS	amr	0.00351351	39.0	0.00255123	124.0	4.13962e-06	1.0	241568.0	0.0	35	0.8	RF	nfe	9.13843e-06	1.0	9.13843e-06	1.0	0.0000064,0.0000643	1,10						11.71	0.769492	0.097	2	14	16	PolyPhen,M-CAP_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	46.0	-15.0	13.0	37.0						0.998		0.870085410	0.0	-0.241	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777599	chr19	8999509	C	T	chr19:8999509	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.14	32_5	37	99	False	rs756428204,COSV66692413	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		56/84	NM_024690.2:c.40666G>A	NP_078966.2:p.Asp13556Asn		-1.0	SEA domain&SEA domain&SEA domain					.	.	.		0.00335191	368.0	109788.0	0.0	39	0.89	AS_VQSR	amr	0.00369769	41.0	0.00306465	146.0	8.34808e-06	2.0	239576.0	0.0	33	0.75	RF	amr	3.04822e-05	1.0	9.20997e-06	1.0	0.0000900	14	0.0	0.0				18.17	1.795977	0.04	2	14	16	PolyPhen,M-CAP_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	-11.0	-1.0	3.0	2.0						0.998		31.548980547	0.005	0.102	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777600	chr19	8999514	C	T	chr19:8999514	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.13	34_5	39	99	False	rs548751371,COSV101109391	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		56/84	NM_024690.2:c.40661G>A	NP_078966.2:p.Arg13554His		-1.0	SEA domain&SEA domain&SEA domain					.	.	.		0.00533031	513.0	96242.0	0.0	37	0.82	AS_VQSR	amr	0.00783094	73.0	0.00393959	168.0	0.000106246	25.0	235302.0	0.0	32	0.73	PASS	afr	0.000782881	12.0	3.74308e-05	4.0	0.0005209	81	0.001	2.0				9.206	0.479301	0.142	1	15	16	PolyPhen	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	40.0	50.0	40.0	-3.0						0.998		0.000000000	0.0	-2.396	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777601	chr19	8999520	G	A	chr19:8999520	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.13	34_5	39	99	False	rs866888569,COSV101109723	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		56/84	NM_024690.2:c.40655C>T	NP_078966.2:p.Thr13552Ile		-1.0	SEA domain&SEA domain&SEA domain					.	.	.		0.00182706	208.0	113844.0	0.0	38	0.91	AS_VQSR	amr	0.00243436	28.0	0.00160372	80.0	1.76586e-05	4.0	226518.0	0.0	31	0.69	RF	amr	3.41623e-05	1.0	2.88168e-05	3.0	0.0000322	5						18.29	1.812464	0.112	2	14	16	PolyPhen,M-CAP_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	-22.0	34.0	-9.0	34.0						0.998		31.227446668	0.007	1.112	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777602	chr19	8999521	T	G	chr19:8999521	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.12	35_5	40	99	False	rs868660041,COSV66695760	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		56/84	NM_024690.2:c.40654A>C	NP_078966.2:p.Thr13552Pro		-1.0	SEA domain&SEA domain&SEA domain					.	.	.		0.00159781	181.0	113280.0	0.0	38	0.9	AS_VQSR	amr	0.00200873	23.0	0.00144689	72.0	2.21735e-05	5.0	225494.0	0.0	30	0.67	RF	nfe	3.85847e-05	4.0	3.85847e-05	4.0	0.0000322	5						16.33	1.510696	0.107	3	13	16	SIFT,PolyPhen,M-CAP_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	33.0	43.0	-9.0	-10.0						0.998		31.227446668	0.008	0.165	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777603	chr19	8999527	T	C	chr19:8999527	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.13	33_5	38	99	False	rs865958386	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		56/84	NM_024690.2:c.40648A>G	NP_078966.2:p.Ile13550Val		-1.0	SEA domain&SEA domain&SEA domain					.	.	.		0.00143271	171.0	119354.0	0.0	38	0.91	AS_VQSR	eas	0.00193705	8.0	0.00128622	68.0	0.0	0.0	222044.0	0.0	30	0.67	AC0				0.0	0.0	0.0000064	1						11.4	0.730218	0.063	1	15	16	PolyPhen	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	37.0	-29.0	1.0	27.0						0.998		30.912858885	0.003	-0.649	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777604	chr19	8999528	G	A	chr19:8999528	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.13	33_5	38	99	False	rs773173867	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		56/84	NM_024690.2:c.40647C>T	NP_078966.2:p.Ala13549%3D		-1.0						.	.	.		0.00139552	166.0	118952.0	0.0	38	0.91	AS_VQSR	eas	0.00218235	9.0	0.00121267	64.0	0.0	0.0	221842.0	0.0	30	0.67	AC0				0.0	0.0	0.0000129	2						0.01	-0.789727		0	0	0			MUC16	0.0	0.0	0.0	0.0	26.0	36.0	2.0	-17.0						0.998		30.912858885			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777644	chr19	9006366	C	T	chr19:9006366	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.13	45_7	54	99	False	rs1208194926	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		45/84	NM_024690.2:c.39652G>A	NP_078966.2:p.Gly13218Ser		-1.0	SEA domain&SEA domain					.	.	.		1.34479e-05	2.0	148722.0	0.0	55	0.99	AS_VQSR	amr	6.71231e-05	1.0	1.49966e-05	1.0					88	1.0														19.62	1.986168	0.046	1	15	16	PolyPhen	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.01	0.15	0.0	0.13	-2.0	45.0	45.0	-22.0						0.998		28.755760600	0.005	-1.735	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777645	chr19	9006367	A	G	chr19:9006367	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.13	45_7	54	99	False	rs1255855907	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		45/84	NM_024690.2:c.39651T>C	NP_078966.2:p.Ser13217%3D		-1.0						.	.	.		1.34369e-05	2.0	148844.0	0.0	55	0.99	AS_VQSR	amr	6.70961e-05	1.0	1.4988e-05	1.0					87	1.0														0.021	-0.688752		0	0	0			MUC16	0.06	0.0	0.04	0.0	44.0	-23.0	-23.0	44.0						0.998		28.755760600			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777647	chr19	9006382	A	G	chr19:9006382	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.11	45_6	53	99	False	rs1213401272	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		45/84	NM_024690.2:c.39636T>C	NP_078966.2:p.Val13212%3D		-1.0						.	.	.		6.67218e-06	1.0	149876.0	0.0	54	0.99	AS_VQSR	nfe	1.49089e-05	1.0	1.49089e-05	1.0					90	1.0														0.002	-1.0528		0	0	0			MUC16	0.06	0.0	0.04	0.0	29.0	-24.0	-38.0	29.0						0.998		22.908947238			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777648	chr19	9006384	C	T	chr19:9006384	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.11	45_6	53	99	False	rs956052891	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		45/84	NM_024690.2:c.39634G>A	NP_078966.2:p.Val13212Ile		-1.0	SEA domain&SEA domain					.	.	.		6.66649e-06	1.0	150004.0	0.0	54	0.99	AS_VQSR	nfe	1.48916e-05	1.0	1.48916e-05	1.0					90	1.0														8.024	0.366315	0.193	1	15	16	PolyPhen	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.01	0.0	0.0	0.0	27.0	9.0	-40.0	27.0						0.998		22.908947238	0.001	-0.364	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777649	chr19	9006391	G	A	chr19:9006391	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.12	44_6	52	99	False	rs1409781786,COSV66691503,COSV66694769	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		45/84	NM_024690.2:c.39627C>T	NP_078966.2:p.Ser13209%3D		-1.0						.	.	.		6.6515e-06	1.0	150342.0	0.0	54	1.0	AS_VQSR	nfe	1.48646e-05	1.0	1.48646e-05	1.0					88	1.0														0.005	-0.883989		0	0	0			MUC16	0.0	0.01	0.0	0.0	-33.0	20.0	2.0	-47.0						0.998		11.065761130			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777650	chr19	9006392	C	T	chr19:9006392	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.12	43_6	51	99	False	rs777059958,COSV66691851	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		45/84	NM_024690.2:c.39626G>A	NP_078966.2:p.Ser13209Asn		-1.0	SEA domain&SEA domain					.	.	.		0.000158167	18.0	113804.0	0.0	46	0.82	PASS	sas	0.000280899	1.0	0.000156452	8.0	3.21303e-05	8.0	248986.0	0.0	88	1.0	PASS	sas	0.000261421	8.0	0.0	0.0	0.0000257	4						9.279	0.486876	0.019	1	15	16	PolyPhen	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.04	0.0	0.02	0.0	19.0	-48.0	-48.0	19.0						0.998		0.000000000	0.0	-1.502	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777659	chr19	9006769	ATA		chr19:9006769-9006771	MUC16	mucin 16, cell surface associated	12595.0	deletion	0|1	0.16	21_4	25	99	False	rs1294316563	SPLICING	YES	NM_024690.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	43/83		NM_024690.2:c.39482-5_39482-3del			-1.0						.	.	.		0.00151125	196.0	129694.0	0.0	22	0.64	AS_VQSR	amr	0.00287312	37.0	0.000862872	50.0					45	0.81														2.043	-0.041771		0	0	0			MUC16	0.03	0.0	0.0	0.0	23.0	35.0	-18.0	23.0						0.998					reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777731	chr19	9012848	G	A	chr19:9012848	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.17	24_5	30	73	False	rs112005168,COSV67475778	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		34/84	NM_024690.2:c.38596C>T	NP_078966.2:p.Leu12866%3D		-1.0						.	.	.		0.000384975	47.0	122086.0	0.0	34	0.84	PASS	sas	0.00105152	4.0	0.000424574	23.0					92	1.0							0.0000257	4						0.005	-0.890797		0	0	0			MUC16	0.03	0.0	0.0	0.0	-6.0	50.0	-4.0	-44.0						0.998		0.000000000			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777732	chr19	9012895		G	chr19:9012894-9012895	MUC16	mucin 16, cell surface associated	12595.0	insertion	0|1	0.16	26_5	32	99	False	rs1440813244	EXONIC	YES	NM_024690.2	Transcript	protein_coding	frameshift_variant		34/84	NM_024690.2:c.38549dup	NP_078966.2:p.Gly12851TrpfsTer65		-1.0						.	.	.		0.000569283	84.0	147554.0	0.0	37	0.98	AS_VQSR	sas	0.00108085	5.0	0.000560589	37.0					70	1.0							0.0004952	77						35.0	6.283835		0	0	0			MUC16	0.09	0.0	0.0	0.0	29.0	1.0	29.0	-50.0						0.998		6.169915974,0.000000000			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777733	chr19	9012898	G		chr19:9012898	MUC16	mucin 16, cell surface associated	12595.0	deletion	0|1	0.14	29_5	35	99	False	rs1269236781,COSV67475785	SPLICING	YES	NM_024690.2	Transcript	protein_coding	frameshift_variant,splice_region_variant		34/84	NM_024690.2:c.38546del	NP_078966.2:p.Ser12849LeufsTer61		-1.0						.	.	.		0.000850569	76.0	89352.0	0.0	33	0.8	AS_VQSR	sas	0.00190114	6.0	0.000947688	35.0					66	1.0							0.0004694	73						38.0	7.393991		0	0	0			MUC16	0.99	0.98	0.0	0.0	0.0	1.0	0.0	1.0						0.998		0.000000000			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777749	chr19	9019295	A	G	chr19:9019295	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.31	24_11	35	99	False	rs377069963	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		23/84	NM_024690.2:c.37592T>C	NP_078966.2:p.Phe12531Ser		-1.0						.	.	.		1.35265e-05	2.0	147858.0	0.0	32	0.95	AS_VQSR	nfe	2.9777e-05	2.0	2.9777e-05	2.0	4.01494e-06	1.0	249070.0	0.0	44	0.99	PASS	nfe	8.85677e-06	1.0	8.85677e-06	1.0	0.0000064	1						5.149	0.154743	0.037	0	16	16		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.03	0.0	0.02	0.0	45.0	-13.0	-20.0	-24.0						0.998		73.982881149	0.002	-0.187	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777750	chr19	9019306	T	A	chr19:9019306	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.35	24_13	37	99	False	rs796820920,COSV67475789	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		23/84	NM_024690.2:c.37581A>T	NP_078966.2:p.Ser12527%3D		-1.0						.	.	.		0.0	0.0	149980.0	0.0	32	0.96	AC0_AS_VQSR				0.0	0.0					45	0.99							0.0000064	1						0.003	-0.983911		0	0	0			MUC16	0.03	0.0	0.03	0.0	34.0	-2.0	-31.0	-35.0						0.998		0.000000000			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777751	chr19	9019313	C	G	chr19:9019313	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.36	25_14	39	99	False	rs796118737,COSV67464394	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		23/84	NM_024690.2:c.37574G>C	NP_078966.2:p.Gly12525Ala		-1.0						.	.	.		6.70889e-06	1.0	149056.0	0.0	32	0.95	AS_VQSR	sas	0.000212495	1.0	0.0	0.0					43	0.98							0.0000064	1						15.99	1.449636	0.042	1	15	16	PolyPhen	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.09	0.0	0.07	-9.0	27.0	27.0	-38.0						0.998		45.211109758	0.002	0.525	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777752	chr19	9019315	A	C	chr19:9019315	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.36	25_14	39	99	False	rs796746912	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		23/84	NM_024690.2:c.37572T>G	NP_078966.2:p.Leu12524%3D		-1.0						.	.	.		6.67601e-06	1.0	149790.0	0.0	32	0.96	AS_VQSR	sas	0.000211595	1.0	0.0	0.0					44	0.98							0.0000064	1						0.003	-0.950305		0	0	0			MUC16	0.0	0.03	0.0	0.04	7.0	25.0	25.0	-40.0						0.998		45.211109758			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777753	chr19	9019320	C	G	chr19:9019320	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.37	24_14	38	99	False	rs796881038	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		23/84	NM_024690.2:c.37567G>C	NP_078966.2:p.Asp12523His		-1.0						.	.	.		6.68735e-06	1.0	149536.0	0.0	32	0.95	AS_VQSR	sas	0.000211864	1.0	0.0	0.0	4.01494e-06	1.0	249070.0	0.0	42	0.98	PASS				0.0	0.0	0.0000064	1						4.927	0.140676	0.083	0	16	16		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.11	0.0	0.11	2.0	20.0	20.0	-45.0						0.998		0.000000000	0.002	0.525	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777754	chr19	9019348	A	G	chr19:9019348	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.51	23_24	47	99	False	rs796538927,COSV99063968	SPLICING	YES	NM_024690.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	22/83		NM_024690.2:c.37547-8T>C			-1.0						.	.	.		6.69344e-06	1.0	149400.0	0.0	32	0.95	AS_VQSR	afr	2.47036e-05	1.0	0.0	0.0					36	0.93							0.0000064	1						0.665	-0.211557		0	0	0			MUC16	0.03	0.11	0.0	0.0	30.0	-8.0	34.0	-8.0	2.11371215015037e-05	0.006	2.184	0.327	2.511	0.998					reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777757	chr19	9024473	A	G	chr19:9024473	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.13	33_5	38	99	False	rs75858437,COSV99063975	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		17/84	NM_024690.2:c.37060T>C	NP_078966.2:p.Ser12354Pro		-1.0						.	.	.		6.86625e-06	1.0	145640.0	0.0	32	0.94	AS_VQSR	nfe	1.51856e-05	1.0	1.51856e-05	1.0					54	1.0							0.0000064	1						0.003	-0.960165	0.068	0	16	16		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.01	0.0	0.02	-36.0	23.0	23.0	-12.0						0.998		28.755760600	0.0	-0.776	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777758	chr19	9024481	C	T	chr19:9024481	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.13	34_5	39	99	False	rs79703408,COSV101202252	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		17/84	NM_024690.2:c.37052G>A	NP_078966.2:p.Ser12351Asn		-1.0						.	.	.		0.0	0.0	145408.0	0.0	32	0.94	AC0				0.0	0.0					54	1.0							0.0000064	1						0.923	-0.162563	0.077	0	16	16		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.01	0.0	0.0	0.01	15.0	-1.0	-35.0	-20.0						0.998		22.908947238	0.0	-0.114	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777759	chr19	9024951	T	A	chr19:9024951	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.19	26_6	32	90	False	rs72486383,COSV67479540	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		16/84	NM_024690.2:c.36911A>T	NP_078966.2:p.His12304Leu		-1.0	SEA domain&SEA domain&SEA domain					.	.	.		1.61873e-05	2.0	123554.0	0.0	31	0.83	AS_VQSR	afr	5.98659e-05	2.0	0.0	0.0	0.0	0.0	248788.0	0.0	52	0.99	AC0_RF				0.0	0.0	0.0000064	1						1.343	-0.106899	0.067	1	15	16	PROVEAN_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	-34.0	47.0	-19.0	24.0						0.998		71.305694962	0.037	-0.326	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777760	chr19	9024988	C	G	chr19:9024988	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.16	32_6	38	99	False	rs77554148,COSV67464751	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		16/84	NM_024690.2:c.36874G>C	NP_078966.2:p.Asp12292His		-1.0	SEA domain&SEA domain&SEA domain					.	.	.		1.57632e-05	2.0	126878.0	0.0	32	0.84	AS_VQSR	nfe	3.55505e-05	2.0	3.55505e-05	2.0					36	0.81							0.0004051	63	0.002	7.0				14.41	1.157297	0.058	2	14	16	SIFT,PolyPhen	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	-10.0	-1.0	0.0	-1.0						0.998		57.150603200	0.009	0.093	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777761	chr19	9024995	G	A	chr19:9024995	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.15	35_6	41	99	False	rs375977247,COSV67464756,COSV67475470	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		16/84	NM_024690.2:c.36867C>T	NP_078966.2:p.Pro12289%3D		-1.0						.	.	.		0.000118427	15.0	126660.0	0.0	31	0.84	AS_VQSR	nfe	0.000231399	13.0	0.000231399	13.0	7.11357e-05	17.0	238980.0	0.0	35	0.8	PASS	nfe	0.000145727	16.0	0.000145727	16.0	0.0004759	74	0.001	3.0				0.002	-1.064509		0	0	0			MUC16	0.0	0.0	0.0	0.0	3.0	-8.0	-8.0	-1.0						0.998		9.114995848			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777762	chr19	9024998	C	T	chr19:9024998	MUC16	mucin 16, cell surface associated	12595.0	SNV	0|1	0.15	34_6	40	99	False	rs369351886,COSV67464760	SPLICING	YES	NM_024690.2	Transcript	protein_coding	splice_region_variant,synonymous_variant		16/84	NM_024690.2:c.36864G>A	NP_078966.2:p.Arg12288%3D		-1.0						.	.	.		7.97499e-06	1.0	125392.0	0.0	31	0.83	AS_VQSR	nfe	1.80063e-05	1.0	1.80063e-05	1.0	8.3717e-06	2.0	238900.0	0.0	34	0.8	PASS	nfe	1.82392e-05	2.0	1.82392e-05	2.0	0.0004309	67	0.001	3.0				0.001	-1.689146		0	0	0			MUC16	0.0	0.0	0.0	0.0	11.0	0.0	28.0	-11.0	0.0023685232848647	0.1	8.28	0.368	8.648	0.998		0.000000000			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777780	chr19	9049339	C	T	chr19:9049339	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.47	17_15	32	99	False	rs11883220,COSV104707745,COSV67484660	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		5/84	NM_024690.2:c.32292G>A	NP_078966.2:p.Thr10764%3D		-1.0						.	.	.		0.00192381	292.0	151782.0	0.0	32	0.95	PASS	amr	0.00439056	67.0	0.00226697	154.0	0.00206095	513.0	248914.0	1.0	100	1.0	PASS	nfe	0.00273243	308.0	0.00273243	308.0	0.0018263	284	0.116	367.0				0.007	-0.832702		0	0	0			MUC16	0.0	0.0	0.0	0.0	-5.0	2.0	47.0	-37.0						0.998		6.169915974			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777781	chr19	9071579	T	G	chr19:9071579	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.43	12_9	21	99	False	rs376037407	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		3/84	NM_024690.2:c.15867A>C	NP_078966.2:p.Ser5289%3D		-1.0						.	.	.		0.000940356	143.0	152070.0	0.0	32	0.96	PASS	amr	0.00380029	58.0	0.000926416	63.0	0.00082043	204.0	248650.0	0.0	80	1.0	PASS	amr	0.00133364	46.0	0.0011994	135.0	0.0007138	111	0.003	11.0				0.04	-0.60598		0	0	0			MUC16	0.0	0.0	0.0	0.0	-43.0	-16.0	23.0	-16.0						0.998		45.211109758			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
777791	chr19	9087564	G	T	chr19:9087564	MUC16	mucin 16, cell surface associated	12595.0	SNV	0/1	0.38	18_11	29	99	False		EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		1/84	NM_024690.2:c.4251C>A	NP_078966.2:p.Val1417%3D		-1.0						.	.	.						32	0.96											100	1.0														0.293	-0.332333		0	0	0			MUC16	0.0	0.0	0.0	0.0	-39.0	-8.0	3.0	-3.0						0.998		83.108364874			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];
780167	chr9	33794736	A	G	chr9:33794736	PRSS3	serine protease 3	12676.0	SNV	0|1	0.12	35_5	40	99	False	rs878896528	SPLICING	YES	NM_001197097.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/5		NM_001197097.3:c.-46-8A>G			1.0						.	.	.		0.0	0.0	147410.0	0.0	33	0.96	AC0_AS_VQSR				0.0	0.0					0	0.0							0.0015369	239						4.541	0.116864		0	0	0												2.45277156108894e-05	0.0	2.144	-0.052	2.092	0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780658	chr9	33796734	C	A	chr9:33796734	PRSS3	serine protease 3	12676.0	SNV	0/1	0.16	31_6	37	98	False	rs750158157,COSV61553106,COSV61554242	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		3/6	NM_001197097.3:c.176C>A	NP_001184026.3:p.Ser59Tyr		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.		1.33767e-05	2.0	149514.0	0.0	36	0.98	AS_VQSR	afr	4.97909e-05	2.0	0.0	0.0	3.98241e-06	1.0	251104.0	0.0	100	1.0	PASS	nfe	8.8157e-06	1.0	8.8157e-06	1.0	0.0007845	122						7.821	0.348791	0.066	2	17	19	M-CAP_pred,FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS3	0.02	0.0	0.0	0.0	-19.0	28.0	33.0	-20.0						0.152	0.0		0.052	-0.055	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780667	chr9	33796799	A	T	chr9:33796799	PRSS3	serine protease 3	12676.0	SNV	0|1	0.24	35_12	49	99	False	rs200709040,COSV61553597	SPLICING	YES	NM_001197097.3	Transcript	protein_coding	missense_variant,splice_region_variant		3/6	NM_001197097.3:c.241A>T	NP_001184026.3:p.Thr81Ser		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.		0.000631186	75.0	118824.0	0.0	34	0.84	AS_VQSR	sas	0.000785752	3.0	0.000489947	27.0	0.00172707	356.0	206130.0	0.0	81	1.0	RF	nfe	0.00195451	177.0	0.00195451	177.0	0.0019935,0.0000064	310,1	0.015	48.0				6.21	0.225431	0.114	1	17	18	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS3	0.0	0.0	0.03	0.01	-37.0	41.0	-32.0	1.0	0.0250244649468014	0.436	9.901	1.034	10.934	0.152	0.0		0.556	-0.834	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780768	chr9	33797881	G	A	chr9:33797881	PRSS3	serine protease 3	12676.0	SNV	0|1	0.2	37_9	46	99	False	rs372122039,COSV61554648	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	synonymous_variant		4/6	NM_001197097.3:c.297G>A	NP_001184026.3:p.Glu99%3D		1.0						.	.	.		0.0	0.0	149816.0	0.0	35	0.97	AC0_AS_VQSR				0.0	0.0	2.19892e-05	5.0	227384.0	0.0	100	1.0	RF	afr	0.000225394	3.0	0.0	0.0	0.0003473	54	0.019	58.0				7.26	0.303749		0	0	0			PRSS3	0.0	0.02	0.0	0.0	22.0	48.0	-45.0	48.0						0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780775	chr9	33797929		CC	chr9:33797928-33797929	PRSS3	serine protease 3	12676.0	insertion	0/1	0.31	35_16	51	99	False	rs779080843,COSV61553068,COSV61555268	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	frameshift_variant		4/6	NM_001197097.3:c.344_345insCC	NP_001184026.3:p.Arg115SerfsTer11		1.0						.	.	.						34	0.85											100	1.0							0.0018135	282						16.69	1.573405		0	0	0																	0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780782	chr9	33797931	AC		chr9:33797931-33797932	PRSS3	serine protease 3	12676.0	deletion	0|1	0.3	35_16	53	99	False	rs797012348	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	frameshift_variant		4/6	NM_001197097.3:c.349_350del	NP_001184026.3:p.Thr117SerfsTer4		1.0						.	.	.		0.00141055	155.0	109886.0	0.0	32	0.77	PASS	afr	0.00240983	62.0	0.000946348	49.0	0.0	0.0	251460.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0018263	284	0.011	36.0				16.44	1.53065		0	0	0			PRSS3	0.1	0.0	0.0	0.0	-1.0	-27.0	-11.0	47.0						0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780793	chr9	33797987	G	T	chr9:33797987	PRSS3	serine protease 3	12676.0	SNV	0|1	0.38	29_20	52	99	False	rs137945391,COSV61553457	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		4/6	NM_001197097.3:c.403G>T	NP_001184026.3:p.Ala135Ser		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.						39	0.99							0.0	0.0	245756.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0020321	316	0.014	44.0				0.006	-0.865741	0.033	1	18	19	M-CAP_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS3	0.02	0.0	0.0	0.0	40.0	1.0	5.0	-1.0						0.152	0.0		0.001	-0.522	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780795	chr9	33797999	A	G	chr9:33797999	PRSS3	serine protease 3	12676.0	SNV	0|1	0.39	27_19	49	99	False	rs142141488,COSV61553468	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		4/6	NM_001197097.3:c.415A>G	NP_001184026.3:p.Thr139Ala		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.						41	0.99							0.0	0.0	245684.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0019228	299	0.014	43.0				0.115	-0.46413	0.155	1	18	19	PROVEAN_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS3	0.0	0.02	0.0	0.0	1.0	28.0	-5.0	-9.0						0.152	0.0		0.002	0.025	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780803	chr9	33798037	T	C	chr9:33798037	PRSS3	serine protease 3	12676.0	SNV	0|1	0.33	27_15	45	99	False	rs774408268,COSV61554351	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	synonymous_variant		4/6	NM_001197097.3:c.453T>C	NP_001184026.3:p.Thr151%3D		1.0						.	.	.		0.00245692	278.0	113150.0	0.0	38	0.92	AS_VQSR	afr	0.00402943	115.0	0.00134548	70.0	0.0	0.0	247586.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0018006	280	0.002	7.0				4.945	0.141812		0	0	0			PRSS3	0.01	0.0	0.03	0.0	-10.0	43.0	40.0	2.0						0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780807	chr9	33798042	G	C	chr9:33798042	PRSS3	serine protease 3	12676.0	SNV	0|1	0.34	26_15	44	99	False	rs141382822,COSV61553491	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		4/6	NM_001197097.3:c.458G>C	NP_001184026.3:p.Cys153Ser		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.						41	0.99							4.14206e-06	1.0	241426.0	0.0	100	1.0	PASS	nfe	9.11959e-06	1.0	9.11959e-06	1.0	0.0107200	1667	0.003	10.0				21.2	2.171422	0.652	15	5	20	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,FATHMM_pred,MetaRNN_pred,LIST-S2_pred	PRSS3	0.0	0.01	0.0	0.01	13.0	-15.0	42.0	35.0						0.152	0.0		0.034	0.795	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780898	chr9	33798574	G	A	chr9:33798574	PRSS3	serine protease 3	12676.0	SNV	0|1	0.22	18_5	23	99	False	rs201773718,COSV61552937	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		5/6	NM_001197097.3:c.587G>A	NP_001184026.3:p.Ser196Asn		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.		0.000736648	84.0	114030.0	0.0	31	0.82	AS_VQSR	afr	0.00191755	52.0	0.000355512	19.0	0.0260244	2383.0	91568.0	0.0	100	1.0	InbreedingCoeff_RF	nfe	0.0368014	1371.0	0.0368014	1371.0	0.0001222	19	0.005	15.0				6.877	0.274178	0.049	0	17	17		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS3	0.0	0.0	0.01	0.01	30.0	1.0	46.0	-34.0						0.152	0.0		0.093	0.021	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780931	chr9	33799071	G	A	chr9:33799071	PRSS3	serine protease 3	12676.0	SNV	0|1	0.16	38_7	45	99	False	rs147767884,COSV61553402	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		6/6	NM_001197097.3:c.679G>A	NP_001184026.3:p.Val227Ile		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.		0.00311668	363.0	116470.0	0.0	33	0.91	AS_VQSR	afr	0.00505867	144.0	0.00168282	92.0	1.70801e-05	4.0	234190.0	0.0	98	1.0	RF	nfe	1.89923e-05	2.0	1.89923e-05	2.0	0.0000707	11	0.004	12.0				0.002	-1.110912	0.0	1	17	18	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS3	0.0	0.0	0.0	0.0	-9.0	1.0	-25.0	-45.0						0.152	0.0		0.022	-0.547	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780936	chr9	33799086	C	T	chr9:33799086	PRSS3	serine protease 3	12676.0	SNV	0|1	0.18	36_8	44	99	False	rs150624305,COSV61555767	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		6/6	NM_001197097.3:c.694C>T	NP_001184026.3:p.His232Tyr		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.		0.0006268	84.0	134014.0	0.0	33	0.94	AS_VQSR	afr	0.000955635	33.0	0.000290276	18.0	8.20197e-06	2.0	243844.0	0.0	100	1.0	RF	nfe	1.82007e-05	2.0	1.82007e-05	2.0	0.0000064	1	0.003	8.0				7.031	0.285991	0.056	1	17	18	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS3	0.0	0.0	0.0	0.0	-24.0	-17.0	-40.0	41.0						0.152	0.0		0.577	-0.034	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780939	chr9	33799094	T		chr9:33799094	PRSS3	serine protease 3	12676.0	deletion	0|1	0.14	37_6	43	99	False	rs751223571,COSV61555291	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	frameshift_variant		6/6	NM_001197097.3:c.702del	NP_001184026.3:p.Cys234TrpfsTer?		1.0						.	.	.		0.000194051	28.0	144292.0	0.0	33	0.91	AS_VQSR	afr	0.000259242	10.0	6.11883e-05	4.0	1.62748e-05	4.0	245778.0	0.0	100	1.0	RF	nfe	3.60672e-05	4.0	3.60672e-05	4.0	0.0000257	4	0.002	6.0				28.6	4.101625		0	0	0			PRSS3	0.0	0.0	0.0	0.0	-31.0	16.0	34.0	-31.0						0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780946	chr9	33799098	T	C	chr9:33799098	PRSS3	serine protease 3	12676.0	SNV	0|1	0.15	35_6	41	99	False	rs780299520,COSV61555777	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		6/6	NM_001197097.3:c.706T>C	NP_001184026.3:p.Trp236Arg		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.		0.000127396	18.0	141292.0	0.0	33	0.95	AS_VQSR	afr	0.000161022	6.0	1.54991e-05	1.0	4.07262e-06	1.0	245542.0	0.0	100	1.0	RF	nfe	9.02723e-06	1.0	9.02723e-06	1.0	0.0000579	9	0.001	4.0				14.22	1.125068	0.073	1	17	18	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS3	0.0	0.0	0.0	0.0	-36.0	30.0	-36.0	29.0						0.152	0.0		0.475	-0.107	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780947	chr9	33799099	G	A	chr9:33799099	PRSS3	serine protease 3	12676.0	SNV	0|1	0.15	35_6	41	99	False	rs755075387,COSV61555791,COSV61558516	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	stop_gained		6/6	NM_001197097.3:c.707G>A	NP_001184026.3:p.Trp236Ter		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.		0.0001166	17.0	145798.0	0.0	33	0.96	AS_VQSR	afr	0.000153523	6.0	1.51681e-05	1.0	4.05318e-06	1.0	246720.0	0.0	100	1.0	RF	nfe	8.9786e-06	1.0	8.9786e-06	1.0	0.0000386	6	0.001	2.0				24.6	3.381362		4	3	7	MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred	LRT_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS3	0.0	0.0	0.0	0.0	-37.0	10.0	28.0	-11.0						0.152	0.0		0.418	-0.435	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780954	chr9	33799103	G	A	chr9:33799103	PRSS3	serine protease 3	12676.0	SNV	0|1	0.15	34_6	40	99	False	rs748100687,COSV61555019	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	synonymous_variant		6/6	NM_001197097.3:c.711G>A	NP_001184026.3:p.Lys237%3D		1.0						.	.	.		5.53549e-05	8.0	144522.0	0.0	33	0.95	AS_VQSR	afr	7.79666e-05	3.0	0.0	0.0	3.26544e-05	8.0	244990.0	0.0	100	1.0	RF	nfe	7.24349e-05	8.0	7.24349e-05	8.0	0.0000386	6	0.001	4.0				6.295	0.231405		0	0	0			PRSS3	0.0	0.0	0.0	0.0	6.0	-41.0	5.0	24.0						0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
780955	chr9	33799163	C	A	chr9:33799163	PRSS3	serine protease 3	12676.0	SNV	0/1	0.16	32_6	38	99	False	rs376841271,COSV61554200	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	synonymous_variant		6/6	NM_001197097.3:c.771C>A	NP_001184026.3:p.Ile257%3D		1.0						.	.	.		0.00014672	20.0	136314.0	0.0	33	0.91	AS_VQSR	sas	0.000666963	3.0	6.42158e-05	4.0	0.0180565	3008.0	166588.0	0.0	76	1.0	PASS	amr	0.0292649	668.0	0.0198742	1447.0	0.1133026	17619	0.013	39.0				1.93	-0.050869		0	0	0			PRSS3	0.0	0.0	0.0	0.0	36.0	12.0	-36.0	23.0						0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];
781683	chr10	93940771	T	A	chr10:93940771	CPEB3	cytoplasmic polyadenylation element binding protein 3	12685.0	SNV	0/1	0.49	20_19	39	99	False	rs143457838	EXONIC	YES	NM_014912.5	Transcript	protein_coding	missense_variant		4/10	NM_014912.5:c.1171A>T	NP_055727.3:p.Met391Leu		-1.0	.,.,.					.	.	.		0.00216183	329.0	152186.0	1.0	32	0.96	PASS	amr	0.00530105	81.0	0.00313106	213.0	0.00185385	460.0	248132.0	1.0	34	0.82	PASS	nfe	0.00287949	324.0	0.00287949	324.0	0.0018778	292	0.004	12.0				22.1	2.326845	0.189	4	15	19	LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	CPEB3	0.0	0.01	0.0	0.0	-3.0	5.0	-30.0	-41.0						0.0637	0.99	0.0	1.0	1.138	nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; homeostasis/metabolism phenotype; 			pons;kidney;thyroid;trigeminal ganglion;superior cervical ganglion;skeletal muscle;cerebellum;	.	negative regulation of transcription by RNA polymerase II;translation;long-term memory;negative regulation of translation;positive regulation of translation;regulation of synaptic plasticity;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;regulation of dendritic spine development;positive regulation of dendritic spine development;3'-UTR-mediated mRNA destabilization;cellular response to amino acid stimulus;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;negative regulation of cytoplasmic translational elongation;positive regulation of mRNA polyadenylation;negative regulation of cytoplasmic translation	nucleus;cytoplasm;postsynaptic density;CCR4-NOT complex;cell junction;dendrite;neuron projection;synapse;postsynaptic membrane;apical dendrite;messenger ribonucleoprotein complex	translation repressor activity, mRNA regulatory element binding;RNA binding;mRNA 3'-UTR binding;protein binding;translation factor activity, RNA binding;RNA stem-loop binding;mRNA 3'-UTR AU-rich region binding;ribosome binding	EGLN3[26972000];CNOT7[21336257];TOB2[21336257];TOB1[21336257];
783121	chr8	8865478	A	T	chr8:8865478	ERI1	exoribonuclease 1	12715.0	SNV	0|1	0.2	7_2	10	63	False	rs141307506,COSV51572778,COSV99031937	SPLICING	YES	NM_153332.4	Transcript	protein_coding	splice_acceptor_variant	1/6		NM_153332.4:c.109-2A>T			1.0						.	.	.		0.00086732	86.0	99156.0	0.0	20	0.49	AS_VQSR	eas	0.00231788	7.0	0.000559997	29.0	2.20836e-05	4.0	181130.0	0.0	23	0.54	PASS	afr	7.79059e-05	1.0	1.10774e-05	1.0	0.0000064	1						33.0	5.428641		0	0	0			ERI1	0.93	1.0	0.0	0.0	14.0	2.0	-2.0	14.0	0.999962958601995	0.794	0.46	8.367	8.826	0.806	0.0				mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; cellular phenotype; 			caudate nucleus;ciliary ganglion;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;thalamus;	.	exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);DNA catabolic process, exonucleolytic;rRNA processing;gene silencing by RNA;rRNA 3'-end processing;histone mRNA catabolic process	nucleus;nucleoplasm;nucleolus;cytoplasm;histone pre-mRNA 3'end processing complex	3'-5'-exoribonuclease activity;protein binding;3'-5' exonuclease activity;rRNA binding;ribosome binding;metal ion binding;histone pre-mRNA stem-loop binding	CEP170P1[26496610];SLBP[23329046];NUDCD1[29021621];CDCA5[26496610];PHB2[30021884];SYN1[26496610];
783421	chr19	40520080	C	T	chr19:40520080	ZNF546	zinc finger protein 546	12723.0	SNV	0/1	0.52	11_12	23	99	False	rs759476122,COSV61259728	EXONIC	YES	NM_178544.5	Transcript	protein_coding	synonymous_variant		7/7	NM_178544.5:c.903C>T	NP_848639.2:p.Tyr301%3D		1.0						.	.	.		6.65885e-06	1.0	150176.0	0.0	32	0.96	PASS	afr	2.45773e-05	1.0	0.0	0.0	2.38846e-05	6.0	251208.0	0.0	87	1.0	PASS	eas	0.000163239	3.0	0.0	0.0	0.0000064	1						6.288	0.230948		0	0	0			ZNF546	0.0	0.0	0.0	0.0	23.0	-26.0	-4.0	-14.0						0.883	0.0	23.536853263			.			ciliary ganglion;subthalamic nucleus;testis - interstitial;atrioventricular node;trigeminal ganglion;	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	CBX4[21282530];
786200	chrX	71813048	C	T	chrX:71813048	PHKA1	phosphorylase kinase regulatory subunit alpha 1	12787.0	SNV	1/1	1.0	0_19	19	57	False	rs782453258,COSV100263771	EXONIC	YES	NM_002637.4	Transcript	protein_coding	missense_variant		29/32	NM_002637.4:c.3149G>A	NP_002628.2:p.Arg1050His		-1.0	.,.,.,.,.	Likely_benign	criteria_provided,_single_submitter	Glycogen_storage_disease_IXd	Muscle glycogenosis, 300559 (3), X-linked recessive	Glycogen storage disease due to muscle phosphorylase kinase deficiency	Disease-causing germline mutation(s) in	Exercise intolerance;X-linked recessive inheritance;Skeletal muscle atrophy;Muscle weakness;Exercise-induced myoglobinuria;Exercise-induced muscle stiffness;Exercise-induced myalgia;Elevated serum creatine kinase		4.45482e-05	5.0	112238.0	0.0	24	0.62	PASS	nfe	5.63126e-05	3.0	5.63126e-05	3.0	5.9953e-05	11.0	183477.0	0.0	57	1.0	PASS	nfe	0.000122057	10.0	0.000122057	10.0	0.0000836	13						24.0	3.167348	0.677	15	4	19	SIFT,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,PrimateAI_pred,DEOGEN2_pred	PHKA1	0.0	0.0	0.0	0.0	-6.0	47.0	-4.0	-5.0						0.0318	0.88	0.0	1.0	1.026	homeostasis/metabolism phenotype; muscle phenotype; 			.	Calcium signaling pathway;Insulin signaling pathway	glycogen metabolic process;generation of precursor metabolites and energy;protein phosphorylation	cytosol;plasma membrane;phosphorylase kinase complex	phosphorylase kinase activity;calmodulin binding	PARD6B[26496610];HERC2[29426014];PHKG2[23455922;26496610];TUBGCP4[unassigned1304];HSCB[28380382];
788521	chr8	123964912	G	A	chr8:123964912	ZHX2	zinc fingers and homeoboxes 2	12850.0	SNV	0/1	0.54	17_20	37	99	False	rs142123946,COSV58710782	EXONIC	YES	NM_001362797.2	Transcript	protein_coding	missense_variant		4/5	NM_001362797.2:c.1162G>A	NP_001349726.1:p.Val388Ile		1.0						.	.	.		0.00270842	412.0	152118.0	1.0	31	0.96	PASS	nfe	0.00443948	302.0	0.00443948	302.0	0.00388207	976.0	251412.0	5.0	99	1.0	PASS	amr	0.00566638	196.0	0.00532897	606.0	0.0039420	613	0.007	23.0				23.9	3.153343	0.19	6	15	21	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	ZHX2	0.0	0.0	0.0	0.0	34.0	-21.0	-11.0	-22.0						0.0883	0.41	0.000000000	0.998	1.097	homeostasis/metabolism phenotype; 			dorsal root ganglion;	.	negative regulation of transcription by RNA polymerase II;mRNA catabolic process;somatic stem cell population maintenance;negative regulation of neuron differentiation;negative regulation of transcription, DNA-templated;retinal bipolar neuron differentiation	nucleus;nucleoplasm;cytosol;plasma membrane	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transcription corepressor activity;protein binding;identical protein binding;protein homodimerization activity;metal ion binding;protein heterodimerization activity	ZHX2[12741956];ATXN1[16713569];NFYA[12741956];AIFM1[30021884];PARP2[21812934];TP53BP1[29656893];NAGPA[21988832];DHRS2[21988832];ZHX1[12741956;26496610];LAT[21988832];
791002	chr2	121103900	G	C	chr2:121103900	INHBB	inhibin subunit beta B	12978.0	SNV	0|1	0.25	12_4	16	75	False		EXONIC	YES	NM_002193.4	Transcript	protein_coding	missense_variant		1/2	NM_002193.4:c.136G>C	NP_002184.2:p.Gly46Arg		1.0						.	.	.						32	0.93											2	0.0														21.2	2.174513	0.277	6	13	19	SIFT,M-CAP_pred,MutationTaster_pred,FATHMM_pred,PrimateAI_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	INHBB	0.0	0.0	0.0	0.0	21.0	1.0	21.0	27.0							0.92		0.508	0.825	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; digestive/alimentary phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; muscle phenotype; craniofacial phenotype; 			superior cervical ganglion;testis;	Cytokine-cytokine receptor interaction;TGF-beta signaling pathway	ovarian follicle development;defense response;cellular response to starvation;response to wounding;regulation of signaling receptor activity;positive regulation of pathway-restricted SMAD protein phosphorylation;cell differentiation;cellular response to insulin stimulus;activin receptor signaling pathway;regulation of apoptotic process;regulation of MAPK cascade;cellular response to leptin stimulus;adhesion of symbiont to host cell;fat cell differentiation;negative regulation of insulin secretion;positive regulation of follicle-stimulating hormone secretion;negative regulation of follicle-stimulating hormone secretion;negative regulation of hepatocyte growth factor biosynthetic process;cell development;oocyte development;positive regulation of ovulation;SMAD protein signal transduction;positive regulation of apoptotic signaling pathway	extracellular region;extracellular space;perinuclear region of cytoplasm;cell periphery	cytokine activity;transforming growth factor beta receptor binding;hormone activity;protein binding;growth factor activity;protein homodimerization activity;host cell surface receptor binding	ACVR1C[25241761];FNTA[21988832];
791003	chr2	121103902	A	C	chr2:121103902	INHBB	inhibin subunit beta B	12978.0	SNV	0|1	0.25	12_4	16	75	False		EXONIC	YES	NM_002193.4	Transcript	protein_coding	synonymous_variant		1/2	NM_002193.4:c.138A>C	NP_002184.2:p.Gly46%3D		1.0						.	.	.						32	0.93											2	0.0														11.01	0.682969		0	0	0			INHBB	0.0	0.0	0.0	0.0	48.0	19.0	-2.0	25.0							0.92				behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; digestive/alimentary phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; muscle phenotype; craniofacial phenotype; 			superior cervical ganglion;testis;	Cytokine-cytokine receptor interaction;TGF-beta signaling pathway	ovarian follicle development;defense response;cellular response to starvation;response to wounding;regulation of signaling receptor activity;positive regulation of pathway-restricted SMAD protein phosphorylation;cell differentiation;cellular response to insulin stimulus;activin receptor signaling pathway;regulation of apoptotic process;regulation of MAPK cascade;cellular response to leptin stimulus;adhesion of symbiont to host cell;fat cell differentiation;negative regulation of insulin secretion;positive regulation of follicle-stimulating hormone secretion;negative regulation of follicle-stimulating hormone secretion;negative regulation of hepatocyte growth factor biosynthetic process;cell development;oocyte development;positive regulation of ovulation;SMAD protein signal transduction;positive regulation of apoptotic signaling pathway	extracellular region;extracellular space;perinuclear region of cytoplasm;cell periphery	cytokine activity;transforming growth factor beta receptor binding;hormone activity;protein binding;growth factor activity;protein homodimerization activity;host cell surface receptor binding	ACVR1C[25241761];FNTA[21988832];
795954	chr15	42116750	G	T	chr15:42116750	MAPKBP1	mitogen-activated protein kinase binding protein 1	13097.0	SNV	0/1	0.42	18_13	31	99	False	rs561678673	EXONIC	YES	NM_001128608.2	Transcript	protein_coding	missense_variant		31/32	NM_001128608.2:c.4300G>T	NP_001122080.1:p.Val1434Leu		1.0	.,.,.				Nephronophthisis 20, 617271 (3), Autosomal recessive	Juvenile nephronophthisis;Late-onset nephronophthisis	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Autosomal recessive inheritance;Nephronophthisis;Variable expressivity;Renal cyst;Stage 5 chronic kidney disease;Progressive		9.85105e-05	15.0	152268.0	0.0	32	0.98	PASS	amr	0.000457756	7.0	7.34775e-05	5.0	0.000151634	34.0	224224.0	0.0	33	0.63	PASS	amr	0.000799017	26.0	7.91766e-05	8.0	0.0000707	11	0.001	4.0				7.876	0.353477	0.018	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MAPKBP1	0.0	0.0	0.0	0.0	29.0	-1.0	-4.0	-1.0						0.52	1.0	0.0	0.161	-0.136	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); limbs/digits/tail phenotype; skeleton phenotype; homeostasis/metabolism phenotype; 			amygdala;olfactory bulb;fetal brain;occipital lobe;prefrontal cortex;testis;skeletal muscle;cerebellum peduncles;cerebellum;	.	negative regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of defense response to bacterium;negative regulation of interleukin-8 secretion	nucleus;cytoplasm;mitotic spindle pole	protein binding	"KRTAP26-1[unassigned1304];KEAP1[25416956];MEOX2[25416956;unassigned1304];CYSRT1[unassigned1304];ADAMTSL4[25416956;unassigned1304];HOXA1[unassigned1304];TRIM27[25416956];KRTAP3-2[25416956];TEKT5[unassigned1304];KRTAP3-1[unassigned1304];METTL15[unassigned1304];KRTAP1-1[unassigned1304];MYOG[unassigned1304];KRTAP5-9[25416956;unassigned1304];KRTAP9-4[25416956];GLRX3[25416956;unassigned1304];KRTAP9-3[unassigned1304];KRTAP5-7[unassigned1304];KRTAP9-2[25416956];KRTAP5-6[unassigned1304];TEX11[25416956;unassigned1304];TCF12[25416956];KRT35[unassigned1304];ALG13[25416956];KRT34[unassigned1304];KRT31[25416956;unassigned1304];PLSCR3[unassigned1304];CLUHP3[unassigned1304];KRTAP4-12[25416956;unassigned1304];KRT38[unassigned1304];ADAM12[unassigned1304];PLA2G10[unassigned1304];RBCK1[unassigned1304];MDFI[25416956;unassigned1304];KPRP[unassigned1304];WDR62[26496610];KRT86[unassigned1304];KRT40[25416956];RGS20[25416956];TRIM42[unassigned1304];KRTAP12-3[unassigned1304];KRTAP10-7[25416956;unassigned1304];KRTAP10-9[25416956];KRTAP10-8[25416956;unassigned1304];SIAH1[25416956];""Em[unassigned1304];NOTCH2NLA[25416956;unassigned1304];APTX[16713569];FOXN1[unassigned1304];TRIP6[25416956];SPRY3[unassigned1304];SPRY2[25416956];TCF4[25416956;unassigned1304];YPEL5[unassigned1304];"
797163	chr15	23686014	CTGCCGCCACATCTTCTT		chr15:23686014-23686031	GOLGA6L2	golgin A6 family-like 2	13155.0	deletion	0|1	0.16	21_4	25	94	False	rs762625563	EXONIC	YES	NM_001304388.2	Transcript	protein_coding	inframe_deletion		8/8	NM_001304388.2:c.1591_1608del	NP_001291317.1:p.Lys531_Gln536del		-1.0						.	.	.		0.00152328	225.0	147708.0	0.0	33	0.81	AS_VQSR	sas	0.00260983	12.0	0.00130654	87.0	0.000833024	121.0	145254.0	0.0	87	0.57	RF	afr	0.000826219	6.0	0.000699778	39.0	0.0000064	1						2.653	0.00198		0	0	0																		0.0				.			.	.	.	.	.	KRT33B[unassigned1304];NUMA1[30021884];GORASP2[unassigned1304];HSPA4[30021884];NEK6[unassigned1304];KRT31[unassigned1304];SDHA[30021884];SPERT[25416956];KRT40[25416956];CDR2[27173435;unassigned1312];MAGEB4[unassigned1304];HIST2H2BE[30021884];
800688	chr8	30469817	T	C	chr8:30469817	GTF2E2	general transcription factor IIE subunit 2	13199.0	SNV	0/1	0.38	18_11	29	99	False	rs2978277	SPLICING	YES	NM_002095.6	Transcript	protein_coding	missense_variant,splice_region_variant		5/8	NM_002095.6:c.548A>G	NP_002086.1:p.Lys183Arg		-1.0	.,.	Likely_benign	criteria_provided,_single_submitter	not_provided	Trichothiodystrophy 6, nonphotosensitive, 616943 (3), Autosomal recessive	Trichothiodystrophy	Disease-causing germline mutation(s) in	Short stature;Autosomal recessive inheritance;Delayed skeletal maturation;Broad-based gait;Slow-growing hair;Dry skin;Microcornea;Mild intrauterine growth retardation;Nystagmus;Tiger tail banding;Intellectual disability, moderate;Ichthyosis;Long-tract signs;Bilateral sensorineural hearing impairment;Microcephaly;Pes cavus;Motor delay;Small for gestational age;Brittle hair;Coxa valga;Esotropia;Coronal craniosynostosis;Hypoplasia of dental enamel;Intention tremor;Low-set nipples;Tiger tail banding;Aplasia/Hypoplasia of the nails;Hypoplasia of mandible relative to maxilla;Microcephaly;Nystagmus;Prematurely aged appearance;Psychomotor retardation;Cardiomyopathy;Dry skin;Dystrophic fingernails;Diffuse cerebellar atrophy;Concave nail;Dysarthria;Gait ataxia;Panhypogammaglobulinemia;Clubbing;Generalized hypotonia;Dysphonia;Generalized hyperreflexia;Ventriculomegaly;Cutaneous photosensitivity;Thoracic kyphosis;Neutropenia;Ventricular septal defect;Fragile nails;Absence of subcutaneous fat;Numerous pigmented freckles;Epicanthus;Spasticity;Increased mean corpuscular hemoglobin concentration;Partial agenesis of the corpus callosum;Peripheral neuropathy;Ridged nail;Periventricular leukomalacia;Brittle hair;Bird-like facies;Macular degeneration;Paraplegia/paraparesis;Craniosynostosis;Developmental cataract;Carious teeth;Anemia;Generalized-onset seizure;Bronchospasm;Hypotelorism;Eczema;Cryptorchidism;Hyporeflexia;Cerebral cortical atrophy;Photophobia;Intrauterine growth retardation;Squamous cell carcinoma;Ectropion;Coarse facial features;Abnormality of prenatal development or birth;Bilateral sensorineural hearing impairment;Esotropia;High, narrow palate;Osteopenia;Alopecia of scalp;Congenital exfoliative erythroderma;Joint dislocation;Delayed skeletal maturation;Impaired social reciprocity;Microcornea;Global developmental delay;Sparse scalp hair;Abnormal pyramidal sign;Astigmatism;Multiple joint contractures;Defective DNA repair after ultraviolet radiation damage;Protruding ear;Hypertelorism;Ichthyosis;Increased bone mineral density;Gonadal dysgenesis;Recurrent bronchopulmonary infections;Retrognathia;Umbilical hernia;Cerebral dysmyelination;Bilateral microphthalmos;Myopia;Keratoconjunctivitis sicca;Split nail	30595370	0.00319254	486.0	152230.0	3.0	32	0.95	PASS	nfe	0.00571639	389.0	0.00571639	389.0	0.00331027	824.0	248922.0	7.0	41	0.88	PASS	nfe	0.00600542	678.0	0.00600542	678.0	0.0037169	578	0.006	18.0				26.1	3.769269	0.898	6	13	19	LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	GTF2E2	0.0	0.0	0.0	0.0	-1.0	42.0	5.0	-1.0	0.999684128665753	0.98	4.622	2.835	7.457	0.594	0.01	0.0	1.0	1.118	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;atrioventricular node;testis;globus pallidus;	Basal transcription factors	transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;snRNA transcription by RNA polymerase II	nucleus;nucleoplasm;transcription factor TFIID complex;transcription factor TFIIE complex;cytosol;nuclear speck	TFIIH-class transcription factor complex binding;DNA binding;RNA binding;protein binding	CDK8[29568061];CDK7[29568061];HIST1H3A[29568061];KAT5[unassigned1304];EXOC8[unassigned1304];ERCC2[27193682];POLR2E[27193682];PICK1[unassigned1304];HSCB[24606901];MCC[21988832];GTF2E1[16547462;unassigned1304];HIST1H1C[30021884];
802464	chr15	80263318	C	T	chr15:80263318	BCL2A1	BCL2 related protein A1	13262.0	SNV	0/1	0.44	18_14	32	99	False	rs984707768	EXONIC	YES	NM_004049.4	Transcript	protein_coding	synonymous_variant		1/2	NM_004049.4:c.144G>A	NP_004040.1:p.Val48%3D		-1.0						.	.	.		1.97101e-05	3.0	152206.0	0.0	33	0.97	PASS	amr	0.000130993	2.0	1.46985e-05	1.0	1.19356e-05	3.0	251348.0	0.0	100	1.0	PASS	amr	5.78202e-05	2.0	8.79941e-06	1.0			0.0	1.0				0.424	-0.278341		0	0	0			BCL2A1	0.0	0.0	0.0	0.0	-50.0	13.0	39.0	-30.0						0.461	0.48	34.893533698			.			whole blood;	.	aging;intrinsic apoptotic signaling pathway in response to DNA damage;cerebral cortex development;negative regulation of apoptotic process;extrinsic apoptotic signaling pathway in absence of ligand;negative regulation of intrinsic apoptotic signaling pathway	mitochondrial outer membrane	protein binding;protein homodimerization activity;protein heterodimerization activity;BH domain binding	NR4A1[18835031];SLC9A3R1[27107012];FAM9B[25416956];BCL2L11[16697956;unassigned1304];RTL10[23055042];BIK[25416956;unassigned1304];BAK1[25416956;unassigned1304];BID[16697956];CT45A1[unassigned1304];BBC3[16697956];
802984	chr1	145592254	TATCTATCATCTATCTATCTATCTATCTATCTATCTATC		chr1:145592254-145592292	POLR3C	RNA polymerase III subunit C	13281.0	sequence_alteration	1/2	0.59	0_10_7	17	99	False		SPLICING	YES	NM_001303456.1	Transcript	protein_coding	splice_acceptor_variant,splice_donor_5th_base_variant,splice_polypyrimidine_tract_variant,3_prime_UTR_variant,intron_variant	15/15	16/16	NM_001303456.1:c.*394+4_*397del			-1.0						.	.	.						32	0.94											0	0.0							0.0001137,0.0003412,0.0057245,0.0001137,0.3341421,0.0016301,0.0006066,0.0007582,0.0004549,0.0002275,0.0000379,0.0000379,0.0000379,0.0000379	3,9,151,3,8814,43,16,20,12,6,1,1,1,1						1.008	-0.149575		0	0	0																	0.857	0.0				.			ciliary ganglion;pons;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;testis;skeletal muscle;globus pallidus;	.	regulation of transcription by RNA polymerase III;transcription by RNA polymerase III;positive regulation of interferon-beta production;innate immune response;positive regulation of innate immune response;defense response to virus	nucleoplasm;RNA polymerase III complex;cytosol	RNA polymerase III activity;single-stranded DNA binding;DNA-directed 5'-3' RNA polymerase activity;protein binding	CAMK2B[unassigned1304];SP100[unassigned1304];UBXN1[unassigned1304];ROCK1[25416956];RPN1[30021884];COIL[unassigned1304];NCKIPSD[unassigned1304];GOLGA2[unassigned1304];LMNA[29568061];KPNA6[unassigned1304];TNR[25416956];POLR2F[26496610];TRIM27[25416956;unassigned1304];DISC1[unassigned1304];LZTS1[unassigned1304];KPNA3[unassigned1304];RBBP8NL[unassigned1304];KPNA1[unassigned1304];ENKD1[unassigned1304];POLR3GL[unassigned1304;20154270;21358628];ANKRD23[unassigned1304];INCA1[unassigned1304];PNMA5[25416956];POU6F2[unassigned1304];KLHL2[unassigned1304];TRAF2[unassigned1304];PAX6[unassigned1304];KRT75[unassigned1304];HAUS1[unassigned1304];CDK8[29568061];KATNBL1[unassigned1304];POLR3E[26496610];POLR3F[21358628];PICK1[unassigned1304];POLR3G[unassigned1304;20154270;21358628];CEP63[25416956;unassigned1304];ROPN1[25416956];CEP44[unassigned1304];KIAA0408[unassigned1304];
804399	chrX	6451865	TCCACCTCGCTCTCCTGACTCAGTGGTTCCTCCACCTGGCTCTCCTGACTCAGTGGTTCT		chrX:6451865-6451924	VCX3A	variable charge X-linked 3A	13349.0	deletion	0/1	0.8	1_4	5	35	False		EXONIC	YES	NM_016379.4	Transcript	protein_coding	inframe_deletion		3/3	NM_016379.4:c.423_482del	NP_057463.2:p.Ser148_Glu167del		-1.0						.	.	.		0.00443345	215.0	48495.0	0.0	16	0.37	AS_VQSR	eas	0.00740284	12.0	0.00363508	93.0	0.000124535	7.0	56209.0	0.0	59	0.91	RF	eas	0.000324359	1.0	7.58438e-05	2.0					0.00079	9.0		6.947	0.279544		0	0	0																		0.51				.			.	.	brain development	nucleus;nucleolus	.	DDIT4L[unassigned1304];
804982	chr16	89288548	A	G	chr16:89288548	ZNF778	zinc finger protein 778	13368.0	SNV	0/1	0.35	17_9	26	99	False	rs201528958,COSV99076558	EXONIC	YES	NM_001201407.2	Transcript	protein_coding	missense_variant		3/7	NM_001201407.2:c.74A>G	NP_001188336.1:p.Gln25Arg		1.0	.,.,.	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00204363	311.0	152180.0	3.0	32	0.96	PASS	amr	0.00373085	57.0	0.00105814	72.0	0.00168974	413.0	244416.0	1.0	33	0.73	PASS	afr	0.00267974	41.0	0.00122936	137.0	0.0014919	232	0.003	11.0				13.02	0.941872	0.023	1	17	18	SIFT	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF778	0.0	0.0	0.0	0.0	-45.0	43.0	43.0	40.0						0.965	0.0	0.0	0.021	-0.127	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding	CYB5R2[unassigned1304];VCP[26496610];KRTAP10-7[25416956];
805171	chr19	47231205	G	A	chr19:47231205	STRN4	striatin 4	13374.0	SNV	0/1	0.4	27_18	45	99	False	rs201398357	EXONIC	YES	NM_001039877.2	Transcript	protein_coding	missense_variant		8/18	NM_001039877.2:c.1099C>T	NP_001034966.1:p.Pro367Ser		-1.0	.,.,.					.	.	.		0.000111675	17.0	152228.0	0.0	33	0.98	PASS	amr	0.00111184	17.0	0.0	0.0	3.19563e-05	8.0	250342.0	0.0	53	0.97	PASS	amr	0.000173863	6.0	1.76857e-05	2.0	0.0000064	1						24.3	3.294475	0.21	8	13	21	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	STRN4	0.0	0.0	0.0	0.0	-10.0	-4.0	36.0	-8.0						0.22	1.0	0.0	0.997	1.176	.			pons;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;testis;skeletal muscle;	.	biological_process	cytoplasm;membrane;dendrite;dendritic spine;FAR/SIN/STRIPAK complex	protein binding;calmodulin binding;protein-containing complex binding;protein phosphatase 2A binding;armadillo repeat domain binding	TRAF3IP3[18782753];CEP19[26638075];HSCB[28380382];ECSIT[16169070];GOLGA2[29568061];PCM1[26638075];PPP2R1B[18782753];RASSF3[24366813];MSANTD2[16169070];PPP2R1A[18782753;26496610;28330616];FGFR1OP2[26496610];CCT3[18782753];CCT2[18782753];DFFA[16169070];WIPI2[16169070];MIF[16169070];DYNLL1[18782753;26496610];DYNLL2[18782753];CTTNBP2NL[18782753;24255178];SIKE1[18782753;26496610];DDX39B[16169070];CLDN12[16169070];TCP1[18782753];CRK[25814554];SLC25A6[16169070];PLPPR3[16169070];CTTNBP2[18782753];AK5[16169070];STK4[24255178];STRN3[18782753;24366813;24255178;26496610];STK3[24255178];PPP2CA[18782753;26496610;28330616];PPP2CB[18782753;26496610];STRIP1[18782753];PDCD10[18782753];CCT8[18782753];CCT7[18782753];RPL18[30021884];CCT5[18782753];CCT4[18782753];KLHDC2[16169070];ZRANB1[19615732];JUN[20195357];PBDC1[16169070];HMGA1[30021884];ASNS[16169070];WNT7A[16169070];PPBP[16169070];MCC[17353931];CCT6A[18782753];MOB4[18782753];GDF9[16169070];NBEA[16169070];STK24[17353931;18782753;23455922];STK25[18782753;23455922];STK26[18782753;23455922];SLMAP[24366813;24255178];PI4KA[16169070];STRN[18782753;24366813;26496610];SPRN[16169070];
807613	chr18	57570053	A	G	chr18:57570053	PMAIP1	phorbol-12-myristate-13-acetate-induced protein 1	13448.0	SNV	0/1	0.3	19_8	27	99	False	rs186289188	EXONIC	YES	NM_001382616.1	Transcript	protein_coding	synonymous_variant		3/3	NM_001382616.1:c.384A>G	NP_001369545.1:p.Gln128%3D		1.0						.	.	.		0.00103794	158.0	152224.0	0.0	33	0.98	PASS	nfe	0.00174892	119.0	0.00174892	119.0	0.000800233	192.0	239930.0	0.0	46	0.78	PASS	nfe	0.00131729	141.0	0.00131729	141.0	0.0008681	135	0.002	6.0	0.00451	8.0		0.204	-0.383683		0	0	0			PMAIP1	0.0	0.0	0.0	0.0	1.0	8.0	-16.0	40.0							0.46	47.53634965			mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			white blood cells;tumor;trigeminal ganglion;uterus corpus;	p53 signaling pathway	release of cytochrome c from mitochondria;protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process;cellular response to DNA damage stimulus;proteasomal protein catabolic process;positive regulation of glucose metabolic process;negative regulation of mitochondrial membrane potential;positive regulation of protein oligomerization;cellular response to glucose starvation;regulation of apoptotic process;T cell homeostasis;positive regulation of apoptotic process;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;response to dsRNA;positive regulation of DNA damage response, signal transduction by p53 class mediator;regulation of mitochondrial membrane permeability;defense response to virus;cellular response to hypoxia;intrinsic apoptotic signaling pathway by p53 class mediator;reactive oxygen species metabolic process;positive regulation of release of cytochrome c from mitochondria;intrinsic apoptotic signaling pathway;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;positive regulation of intrinsic apoptotic signaling pathway	nucleus;mitochondrion;mitochondrial outer membrane;cytosol	protein binding	RAB2A[unassigned1304];GSK3B[21900206];BCL2L11[23374347];MYCN[26859456];ZBTB16[16169070];BCL2[21454712];PPBP[16169070];BCL2L2[15694340];MCL1[15901672;20085765;21132008;21454712];BCL2L1[15694340;21454712];
808960	chr8	145726315	C	G	chr8:145726315	PPP1R16A	protein phosphatase 1 regulatory subunit 16A	13510.0	SNV	0/1	0.55	17_21	38	99	False	rs547692332	EXONIC	YES	NM_032902.7	Transcript	protein_coding	missense_variant		11/13	NM_032902.7:c.998C>G	NP_116291.1:p.Ser333Cys		1.0	.,.					.	.	.		6.57384e-06	1.0	152118.0	0.0	34	0.98	PASS	amr	6.5445e-05	1.0	0.0	0.0					8	0.31							0.0000064	1						19.97	2.029159	0.072	5	14	19	SIFT,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	PPP1R16A	0.0	0.0	0.0	0.0	-13.0	25.0	39.0	37.0						0.515	0.05		0.976	0.119	.			thyroid;liver;	.	regulation of phosphoprotein phosphatase activity	plasma membrane	protein binding;protein phosphatase regulator activity	MYOM1[unassigned1304];TTC23[unassigned1304];DDX27[16169070];ATP23[unassigned1304];CDCA7L[unassigned1304];SUV39H1[unassigned1304];MRPL12[unassigned1304];PAPSS1[16169070];PPP1CB[21516116;25416956;unassigned1304;28330616];PPP1CC[unassigned1304];ZFYVE26[unassigned1304];PUF60[16169070];KAT5[unassigned1304];CDH24[16169070];FSD1[16169070];UNKL[unassigned1304];BATF2[unassigned1304];PRKAB2[unassigned1304];CCDC116[unassigned1304];TXNRD1[16169070];PBDC1[16169070];NEK6[unassigned1304];CKMT1A[unassigned1304];PPP1R16A[25416956];RFLNB[16169070];TFIP11[21516116];NUTF2[unassigned1304];IL16[unassigned1304];C3orf36[unassigned1304];KRTAP19-5[unassigned1304];RGMA[16169070];HLA-E[16169070];PPP1CA[22321011];AES[25416956];PHP14[16169070];SCNM1[unassigned1304];TRIP6[16189514;19060904];NDUFAB1[unassigned1304];TPP2[25416956];TSSK3[unassigned1304];ZNF414[unassigned1304];PRPF31[unassigned1304];LY6H[16169070];C1orf216[unassigned1304];IDO1[16169070];AVPI1[unassigned1304];
809159	chr2	29124976	C	T	chr2:29124976	WDR43	WD repeat domain 43	13519.0	SNV	0/1	0.48	14_13	27	99	False	rs147302501,COSV99943203	EXONIC	YES	NM_015131.3	Transcript	protein_coding	missense_variant		2/18	NM_015131.3:c.349C>T	NP_055946.1:p.His117Tyr		1.0	.,WD40-repeat-containing domain					.	.	.		0.00132579	201.0	151608.0	1.0	32	0.96	PASS	nfe	0.00235343	160.0	0.00235343	160.0	0.00138289	311.0	224892.0	0.0	37	0.72	PASS	nfe	0.00231416	247.0	0.00231416	247.0	0.0013569	211	0.003	8.0				26.9	3.899149	0.202	8	13	21	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	WDR43	0.0	0.0	0.01	0.08	14.0	20.0	-43.0	14.0							1.0	0.0	0.992	1.026	.			superior cervical ganglion;skeletal muscle;	.	rRNA processing;positive regulation of transcription by RNA polymerase I;positive regulation of rRNA processing	fibrillar center;nucleoplasm;nucleolus	RNA binding;protein binding	UTP15[24219289];FBL[29568061];JUN[25609649];MCM7[23764002];IFI16[25665578];CERK[26496610];UTP4[22916032;24219289];RPS6[29568061];RRP1B[20926688];MAPK3[26496610];
809890	chr6	99936163	T	C	chr6:99936163	USP45	ubiquitin specific peptidase 45	13549.0	SNV	0/1	0.54	11_13	24	99	False	rs61733471	EXONIC	YES	NM_001346021.3	Transcript	protein_coding	synonymous_variant		7/18	NM_001346021.3:c.627A>G	NP_001332950.1:p.Ala209%3D		-1.0					?Leber congenital amaurosis 19, 618513 (3), Autosomal recessive	.	.	Abnormality of neuronal migration;Severely reduced visual acuity;Aplasia/Hypoplasia of the cerebellar vermis;Encephalocele;Seizure;Abnormal electroretinogram;Muscular hypotonia;Abnormality of retinal pigmentation;Abnormality of the optic disc;Nystagmus;Global developmental delay;Cataract;Hearing impairment;Keratoconus;Intellectual disability;Hemiplegia/hemiparesis;Optic disc pallor;Decreased light- and dark-adapted electroretinogram amplitude;Nystagmus;Autosomal recessive inheritance;Retinal degeneration;Attenuation of retinal blood vessels;Visual impairment		0.0021155	322.0	152210.0	0.0	33	0.97	PASS	nfe	0.00348314	237.0	0.00348314	237.0	0.00213516	516.0	241668.0	0.0	23	0.63	PASS	nfe	0.00341837	380.0	0.00341837	380.0	0.0019935	310	0.002	5.0				11.0	0.682073		0	0	0			USP45	0.0	0.0	0.0	0.0	31.0	-4.0	-43.0	13.0						0.929	0.0	63.80342242			.			ciliary ganglion;appendix;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;skin;atrioventricular node;skeletal muscle;globus pallidus;	.	DNA repair;ubiquitin-dependent protein catabolic process;protein deubiquitination;global genome nucleotide-excision repair	nucleus;nucleoplasm;cytoplasm	thiol-dependent ubiquitin-specific protease activity;zinc ion binding	RTCA[19615732];SRBD1[19615732];WIZ[26496610];PIK3CG[19615732];MYL12B[19615732];CORO1C[19615732];FARS2[19615732];CFL1[30021884];FLNA[19615732];POLR2G[19615732];RALY[19615732];RBM7[26496610];MYH10[19615732];SF3A2[19615732];TMOD3[19615732];ZFR[19615732];YLPM1[19615732];SAFB[19615732];HIST2H2BF[30021884];MYL6[19615732];PPP5C[26496610];CDK1[19615732];IGKV4-1[19615732];MYH9[19615732];HIST1H2BH[30021884];NOP53[19615732];RBMX[19615732];
810090	chr13	42874891	C	T	chr13:42874891	AKAP11	A-kinase anchoring protein 11	13550.0	SNV	0/1	0.63	7_12	19	99	False	rs113799034	EXONIC	YES	NM_016248.4	Transcript	protein_coding	missense_variant		8/13	NM_016248.4:c.2009C>T	NP_057332.1:p.Thr670Met		1.0						.	.	.		0.00254364	387.0	152144.0	0.0	32	0.98	PASS	amr	0.00936599	143.0	0.00277933	189.0	0.00252495	633.0	250698.0	5.0	65	1.0	PASS	amr	0.00724092	250.0	0.00272138	308.0	0.0026044	405	0.013	42.0				25.6	3.66344	0.431	11	10	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	AKAP11	0.0	0.0	0.0	0.0	17.0	-36.0	-26.0	17.0						0.444	0.9	0.0	0.958	1.026	renal/urinary system phenotype; skeleton phenotype; immune system phenotype; limbs/digits/tail phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype; 			caudate nucleus;temporal lobe;amygdala;prefrontal cortex;superior cervical ganglion;cingulate cortex;pons;occipital lobe;fetal brain;subthalamic nucleus;whole brain;spinal cord;parietal lobe;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	intracellular signal transduction	nucleolus;cytoplasm;peroxisome;microtubule organizing center;cytosol;plasma membrane	protein binding;protein phosphatase 1 binding;protein kinase A binding	GSK3B[23602568;29568061];SLX4[19596235];SMYD2[17353931];DYRK1B[23602568];FGFR1OP[26638075];HIST1H2BH[30021884];PHB[20195357];HSCB[28380382];PRKACA[23455922];PRKACB[23455922];HIST2H2BE[30021884];HIST1H1C[30021884];
810180	chr19	4053974	G	A	chr19:4053974	ZBTB7A	zinc finger and BTB domain containing 7A	13563.0	SNV	0/1	0.52	15_16	31	99	False	rs138413340	EXONIC	YES	NM_015898.4	Transcript	protein_coding	synonymous_variant		2/3	NM_015898.4:c.1257C>T	NP_056982.1:p.Phe419%3D		-1.0					Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin, 619769 (3), Autosomal dominant	.	.	.		0.00181376	276.0	152170.0	0.0	33	0.98	PASS	amr	0.00294541	45.0	0.00292552	199.0	0.00184043	444.0	241248.0	2.0	33	0.8	PASS	amr	0.00285311	97.0	0.00281402	311.0	0.0018070	281	0.008	24.0				11.64	0.760105		0	0	0			ZBTB7A	0.0	0.0	0.0	0.0	9.0	-5.0	9.0	-5.0								57.022945445			immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; 			ciliary ganglion;temporal lobe;prefrontal cortex;trigeminal ganglion;cingulate cortex;superior cervical ganglion;cerebellum peduncles;pons;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	.	negative regulation of transcription by RNA polymerase II;regulation of alternative mRNA splicing, via spliceosome;regulation of glycolytic process;chromatin organization;chromatin remodeling;transcription, DNA-templated;regulation of transcription, DNA-templated;cellular response to DNA damage stimulus;B cell differentiation;negative regulation of transforming growth factor beta receptor signaling pathway;protein localization to nucleus;regulation of apoptotic process;erythrocyte maturation;fat cell differentiation;negative regulation of Notch signaling pathway;negative regulation of transcription, DNA-templated;regulation of DNA-binding transcription factor activity;positive regulation of NF-kappaB transcription factor activity;negative regulation of androgen receptor signaling pathway;double-strand break repair via classical nonhomologous end joining;regulation of transcription regulatory region DNA binding	nucleus;cytoplasm;NuRD complex;site of double-strand break;DNA-dependent protein kinase complex	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription corepressor binding;DNA binding;DNA-binding transcription factor activity;transcription corepressor activity;protein binding;activating transcription factor binding;histone acetyltransferase binding;SMAD binding;metal ion binding;androgen receptor binding	HOMEZ[25416956];KHDRBS1[24514149];HDAC2[26816381];SRCAP[26816381];HDAC1[24514149;26816381];ZMYND8[21988832];CHD8[26816381];ZBTB45[26816381];CHD3[26816381];ZBTB22[26816381];BAZ1A[26816381];ZBTB5[26816381];MKI67[26949251];GATAD2B[26816381];MTA2[26816381];
810475	chr10	133106536	G	C	chr10:133106536	TCERG1L	transcription elongation regulator 1 like	13578.0	SNV	0/1	0.61	15_23	38	99	False	rs41282900	EXONIC	YES	NM_174937.4	Transcript	protein_coding	missense_variant		3/12	NM_174937.4:c.608C>G	NP_777597.2:p.Ser203Cys		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00248465	378.0	152134.0	1.0	33	0.97	PASS	nfe	0.00399882	272.0	0.00399882	272.0	0.00306753	770.0	251016.0	5.0	47	0.98	PASS	nfe	0.00381861	433.0	0.00381861	433.0	0.0026109	406	0.006	20.0				19.73	1.999281	0.156	3	16	19	SIFT,PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	TCERG1L	0.0	0.0	0.0	0.0	-4.0	-45.0	-4.0	-34.0						0.965	0.0	0.0	0.959	0.18	.			.	.	.	nucleus	.	.
810942	chr16	1291564	C	T	chr16:1291564	TPSAB1	tryptase alpha/beta 1	13588.0	SNV	0|1	0.15	17_3	20	64	False	rs1064777,COSV58781973	EXONIC	YES	NM_003294.4	Transcript	protein_coding	synonymous_variant		4/6	NM_003294.4:c.363C>T	NP_003285.2:p.Asp121%3D		1.0						.	.	.		0.000912948	105.0	115012.0	0.0	16	0.3	AS_VQSR	eas	0.00280724	9.0	0.0007102	37.0	0.000355359	69.0	194170.0	0.0	26	0.59	RF	eas	0.000966686	13.0	0.000570624	47.0	0.0013312	207						1.529	-0.08728		0	0	0			TPSAB1	0.0	0.0	0.0	0.01	-26.0	-11.0	-2.0	27.0							0.0				cellular phenotype; hematopoietic system phenotype; immune system phenotype; skeleton phenotype; 			.	.	proteolysis;defense response;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix	serine-type endopeptidase activity;protein binding;serine-type peptidase activity	PIK3R1[17474147];TPSAB1[29661938];NCK1[17474147];
811981	chr1	67787301	C	T	chr1:67787301	IL12RB2	interleukin 12 receptor subunit beta 2	13619.0	SNV	0/1	0.58	15_21	36	99	False	rs149390309	EXONIC	YES	NM_001374259.2	Transcript	protein_coding	synonymous_variant		4/17	NM_001374259.2:c.93C>T	NP_001361188.1:p.Gly31%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.000959743	146.0	152124.0	1.0	32	0.96	PASS	amr	0.00602252	92.0	0.000455708	31.0	0.000907846	228.0	251144.0	1.0	100	1.0	PASS	amr	0.00346961	120.0	0.000563738	64.0	0.0006366	99	0.006	19.0	0.00857	97.0		0.367	-0.29945		0	0	0			IL12RB2	0.0	0.01	0.01	0.01	-1.0	-16.0	-2.0	24.0						0.739	0.0	2.536380176			liver/biliary system phenotype; neoplasm; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; digestive/alimentary phenotype; renal/urinary system phenotype; homeostasis/metabolism phenotype; immune system phenotype; endocrine/exocrine gland phenotype; 			trigeminal ganglion;skeletal muscle;	Cytokine-cytokine receptor interaction;Jak-STAT signaling pathway	cell surface receptor signaling pathway;positive regulation of cell population proliferation;peptidyl-tyrosine phosphorylation;response to lipopolysaccharide;interferon-gamma production;positive regulation of interferon-gamma production;interleukin-12-mediated signaling pathway;interleukin-35-mediated signaling pathway	plasma membrane;integral component of plasma membrane;external side of plasma membrane;receptor complex	cytokine receptor activity;protein kinase binding;cytokine binding	SOCS3[14559241];RAB34[30021884];STAT4[10415122;9890938];
812868	chr14	33293523	G	A	chr14:33293523	AKAP6	A-kinase anchoring protein 6	13627.0	SNV	0|1	0.59	16_23	39	99	False	rs144838103	EXONIC	YES	NM_004274.5	Transcript	protein_coding	synonymous_variant		13/14	NM_004274.5:c.6504G>A	NP_004265.3:p.Glu2168%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00235945	359.0	152154.0	0.0	32	0.96	PASS	nfe	0.00373409	254.0	0.00373409	254.0	0.00214305	535.0	249644.0	2.0	74	0.97	PASS	nfe	0.00338847	381.0	0.00338847	381.0	0.0020514	319	0.003	8.0				0.209	-0.380433		0	0	0			AKAP6	0.0	0.0	0.0	0.0	15.0	1.0	-20.0	-33.0						0.282	1.0	0.000000000			growth/size/body region phenotype; cellular phenotype; muscle phenotype; craniofacial phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; 			ciliary ganglion;pituitary;temporal lobe;trigeminal ganglion;cingulate cortex;superior cervical ganglion;testis;pons;subthalamic nucleus;testis - interstitial;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	.	action potential;protein targeting;regulation of protein kinase A signaling;regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;cAMP-mediated signaling;positive regulation of cell growth;positive regulation of phosphoprotein phosphatase activity;positive regulation of release of sequestered calcium ion into cytosol;regulation of membrane repolarization;positive regulation of ryanodine-sensitive calcium-release channel activity;positive regulation of cell growth involved in cardiac muscle cell development;positive regulation of calcineurin-NFAT signaling cascade;cellular response to cAMP;cellular response to cytokine stimulus;positive regulation of potassium ion transmembrane transport;positive regulation of delayed rectifier potassium channel activity	nuclear envelope;cytoplasm;caveola;junctional sarcoplasmic reticulum membrane;intercalated disc;sarcoplasmic reticulum;T-tubule;nuclear membrane;calcium channel complex;perinuclear region of cytoplasm	protein binding;adenylate cyclase binding;protein-containing complex scaffold activity;protein kinase A regulatory subunit binding;protein membrane anchor;ion channel binding;protein kinase A binding	RYR2[10830164];SRC[17474147];DTNBP1[17043677];ABL1[17474147];FYN[17474147];GRB2[17474147];PIK3R1[17474147];CRK[17474147];OPTN[23414517];NCK1[17474147];
813968	chr14	74083880	T	C	chr14:74083880	ACOT6	acyl-CoA thioesterase 6	13660.0	SNV	0/1	0.54	16_19	35	99	False	rs771159562	EXONIC	YES	NM_001365788.1	Transcript	protein_coding	missense_variant		2/3	NM_001365788.1:c.644T>C	NP_001352717.1:p.Met215Thr		1.0	BAAT/Acyl-CoA thioester hydrolase C-terminal,BAAT/Acyl-CoA thioester hydrolase C-terminal,BAAT/Acyl-CoA thioester hydrolase C-terminal					.	.	.		1.31415e-05	2.0	152190.0	0.0	32	0.96	PASS	amr	0.000130924	2.0	0.0	0.0	2.40608e-05	6.0	249368.0	0.0	95	1.0	PASS	amr	0.000173461	6.0	0.0	0.0	0.0000064	1						23.6	3.024042	0.694	10	9	19	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	ACOT6	0.0	0.0	0.0	0.0	-15.0	8.0	16.0	-38.0						0.794	0.0	0.000000000	0.595	1.138	normal phenotype; 			.	.	fatty acid metabolic process;acyl-CoA metabolic process	peroxisomal matrix;cytosol	acyl-CoA hydrolase activity;carboxylic ester hydrolase activity	.
815585	chr1	115197385	A		chr1:115197385	DENND2C	DENN domain containing 2C	13717.0	deletion	0/1	0.31	8_5	16	99	False	rs562839824	SPLICING	YES	NM_001256404.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/20		NM_001256404.2:c.-573-3del			-1.0						.	.	.		0.0046058	537.0	116592.0	0.0	29	0.69	AS_VQSR	amr	0.00660066	72.0	0.0036535	200.0					0	0.0							0.0005307,0.0017439	14,46						6.513	0.247109		0	0	0			DENND2C	0.0	0.0	0.0	0.0	-2.0	-22.0	-9.0	-22.0						0.972	0.0				cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			.	.	.	.	Rab guanyl-nucleotide exchange factor activity	YES1[unassigned1304];HIST1H2BH[30021884];
816104	chr12	42538320	G	A	chr12:42538320	GXYLT1	glucoside xylosyltransferase 1	13724.0	SNV	0|1	0.09	22_3	35	60	False	rs112525075,COSV55135896	EXONIC	YES	NM_173601.2	Transcript	protein_coding	synonymous_variant		1/8	NM_173601.2:c.129C>T	NP_775872.1:p.Ala43%3D		-1.0						.	.	.		0.00656696	649.0	98828.0	0.0	34	0.89	AS_VQSR	sas	0.00824176	27.0	0.00607409	262.0	4.17746e-05	3.0	71814.0	0.0	4	0.17	PASS	afr	0.00112613	1.0	7.56086e-05	2.0	0.0006624	103						13.33	0.986049		0	0	0			GXYLT1	0.0	0.0	0.0	0.0	34.0	31.0	2.0	3.0						0.217	0.99				.			ciliary ganglion;dorsal root ganglion;skin;trigeminal ganglion;superior cervical ganglion;	.	O-glycan processing	integral component of membrane	UDP-xylosyltransferase activity	RIPK2[17353931];TRAF6[17353931];CANX[29568061];FBXO11[17353931];ATG5[17353931];
816438	chr10	32197760	C	T	chr10:32197760	ARHGAP12	Rho GTPase activating protein 12	13738.0	SNV	0/1	0.43	13_10	23	99	False	rs140446285,COSV100261002	EXONIC	YES	NM_018287.7	Transcript	protein_coding	synonymous_variant		3/20	NM_018287.7:c.24G>A	NP_060757.4:p.Gly8%3D		-1.0						.	.	.		0.00431833	657.0	152142.0	1.0	32	0.97	PASS	amr	0.00523766	80.0	0.00476288	324.0	0.00456346	1085.0	237758.0	10.0	46	0.8	PASS	amr	0.00544157	183.0	0.00458674	509.0	0.0042700	664	0.014	43.0				8.796	0.437989		0	0	0			ARHGAP12	0.0	0.0	0.0	0.0	-4.0	37.0	-13.0	38.0						0.667	0.0	72.209956941			normal phenotype; 			pons;ciliary ganglion;subthalamic nucleus;dorsal root ganglion;skin;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	morphogenesis of an epithelial sheet;phagocytosis, engulfment;actin filament organization;signal transduction;regulation of GTPase activity;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction;negative regulation of small GTPase mediated signal transduction	phagocytic cup;cytoplasm;cytosol	GTPase activator activity	SRPK2[23602568];MAPK11[23602568];TRIP10[25416956;unassigned1304];GRB2[21706016];WASL[unassigned1304];SHANK2[unassigned1304];SRPK1[23602568];
817330	chr9	139960833	T	A	chr9:139960833	SAPCD2	suppressor APC domain containing 2	13774.0	SNV	0/1	0.51	19_20	39	99	False	rs375764463	SPLICING	YES	NM_178448.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/5		NM_178448.4:c.572-7A>T			-1.0						.	.	.		1.97081e-05	3.0	152222.0	0.0	34	0.98	PASS	amr	0.000196284	3.0	0.0	0.0	2.05916e-05	4.0	194254.0	0.0	18	0.44	PASS	amr	0.000132231	4.0	0.0	0.0								0.073	-0.525482		0	0	0			SAPCD2	0.01	0.01	0.0	0.0	-13.0	-7.0	-7.0	-6.0	1.31378247454735e-05	0.022	10.85	-1.609	9.241		0.0				normal phenotype; 			.	.	establishment of mitotic spindle orientation;positive regulation of cell population proliferation;regulation of establishment of planar polarity;symmetric cell division;negative regulation of protein localization to cell cortex	nucleus;nucleolus;cytosol;bicellular tight junction;apical plasma membrane;apical junction complex;apical cortex	protein binding	RALBP1[unassigned1304];KRT3[unassigned1304];EXOC7[unassigned1304];USHBP1[unassigned1304];GMNN[unassigned1304];RASSF9[24366813];TANK[unassigned1774];BFSP2[unassigned1304];CYSRT1[unassigned1304];UBA1[26496610];C1orf109[unassigned1304];GPRASP2[unassigned1304];MDFI[unassigned1304];VCL[unassigned1304];ATF4[unassigned1304];
818465	chr1	169524452	G	A	chr1:169524452	F5	coagulation factor V	13821.0	SNV	0/1	0.52	14_15	29	99	False	rs147952496	EXONIC	YES	NM_000130.5	Transcript	protein_coding	synonymous_variant		7/25	NM_000130.5:c.1086C>T	NP_000121.2:p.Asp362%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Thrombophilia 2 due to activated protein C resistance, 188055 (3), Autosomal dominant; {Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3), Autosomal dominant; {Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3), Autosomal dominant; {Budd-Chiari syndrome}, 600880 (3), Autosomal recessive; {Stroke, ischemic, susceptibility to}, 601367 (3), Multifactorial; Factor V deficiency, 227400 (3), Autosomal recessive	Budd-Chiari syndrome;Congenital factor V deficiency;Cerebral sinovenous thrombosis;East Texas bleeding disorder	Candidate gene tested in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) (gain of function) in	Recurrent spontaneous abortion;Autosomal dominant inheritance;Cirrhosis;Autosomal recessive inheritance;Hepatocellular carcinoma;Budd-Chiari syndrome;Stroke;Adult onset;Autosomal dominant inheritance;Prolonged partial thromboplastin time;Resistance to activated protein C;Preeclampsia;Deep venous thrombosis;Hypercoagulability;Autosomal recessive inheritance;Prolonged prothrombin time;Prolonged partial thromboplastin time;Prolonged bleeding time;Prolonged whole-blood clotting time;Menorrhagia;Epistaxis;Bruising susceptibility;Reduced coagulation factor V activity;Hematuria;Prolonged bleeding after surgery;Prolonged bleeding after dental extraction;Joint hemorrhage;Metrorrhagia;Hematochezia;Gingival bleeding;Hemoptysis;Persistent bleeding after trauma;Menorrhagia;Oral cavity bleeding;Epistaxis;Intracranial hemorrhage;Prolonged bleeding following circumcision;Bruising susceptibility;Spontaneous hematomas;Post-partum hemorrhage;Cholecystitis;Weight loss;Gastrointestinal infarctions;Ascites;Esophageal varix;Acute hepatic failure;Gastrointestinal hemorrhage;Abdominal pain;Hepatomegaly;Peritonitis;Elevated hepatic transaminase;Portal hypertension;Splenomegaly;Jaundice;Malabsorption;Intestinal obstruction;Cirrhosis;Fever		0.000545586	83.0	152130.0	0.0	32	0.96	PASS	amr	0.00091623	14.0	0.000793767	54.0	0.000361884	91.0	251462.0	0.0	100	1.0	PASS	amr	0.000635985	22.0	0.000553895	63.0	0.0002830	44	0.002	6.0	0.00123	14.0		10.85	0.663747		0	0	0			F5	0.0	0.0	0.01	0.02	40.0	16.0	40.0	-32.0						0.0863	0.0	74.821878940			integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			.	Complement and coagulation cascades	platelet degranulation;endoplasmic reticulum to Golgi vesicle-mediated transport;blood coagulation;blood circulation;post-translational protein modification;cellular protein metabolic process;COPII vesicle coating	Golgi membrane;extracellular region;extracellular space;endoplasmic reticulum lumen;plasma membrane;membrane;COPII-coated ER to Golgi transport vesicle;platelet alpha granule lumen;endoplasmic reticulum-Golgi intermediate compartment membrane;extracellular vesicle	copper ion binding;protein binding	FAM20C[22582013];
819153	chr10	116060005	G	C	chr10:116060005	AFAP1L2	actin filament associated protein 1 like 2	13852.0	SNV	0/1	0.65	12_22	34	99	False	rs144048981	EXONIC	YES	NM_001287824.2	Transcript	protein_coding	synonymous_variant		16/20	NM_001287824.2:c.2064C>G	NP_001274753.1:p.Thr688%3D		-1.0						.	.	.		0.00345118	525.0	152122.0	2.0	33	0.96	PASS	nfe	0.00546866	372.0	0.00546866	372.0	0.00312567	786.0	251466.0	2.0	100	1.0	PASS	nfe	0.00532775	606.0	0.00532775	606.0	0.0030932	481	0.005	15.0				0.976	-0.154314		0	0	0			AFAP1L2	0.0	0.0	0.0	0.0	24.0	-15.0	-32.0	42.0						0.636	0.45	12.324504447			integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			atrioventricular node;superior cervical ganglion;skeletal muscle;	.	inflammatory response;regulation of mitotic cell cycle;regulation of interleukin-6 production;positive regulation of interleukin-8 production;positive regulation of epidermal growth factor receptor signaling pathway;positive regulation of transcription, DNA-templated;positive regulation of protein tyrosine kinase activity	cytoplasm;cytosol;plasma membrane	SH3 domain binding;protein tyrosine kinase activator activity;signaling adaptor activity;SH2 domain binding	ACD[21044950];TINF2[21044950];POT1[21044950];TERF1[21044950];TERF2[21044950];
819690	chr7	100550079	G	C	chr7:100550079	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.33	29_27	82	99	False	rs28379747,COSV60211612	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.660A>C	NP_005951.1:p.Ser220%3D		1.0						.	.	.						0	0.0							0.419673	91169.0	217238.0	1.0	100	0.98	InbreedingCoeff	nfe	0.426656	42599.0	0.426656	42599.0	0.0257550	4005	0.077	232.0				0.781	-0.187401		0	0	0			MUC3A	0.0	0.0	0.0	0.0	12.0	-31.0	-6.0	-39.0								83.460541628			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819702	chr7	100550301	T	A	chr7:100550301	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.16	73_14	87	99	False	rs1186371500	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.882T>A	NP_005951.1:p.Ser294%3D		1.0						.	.	.		0.0	0.0	152278.0	0.0	50	1.0	AC0_AS_VQSR				0.0	0.0					100	0.98														3.8	0.072455		0	0	0			MUC3A	0.0	0.0	0.0	0.0	-12.0	23.0	37.0	47.0								36.222312096			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819713	chr7	100550340	T	A	chr7:100550340	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.26	52_18	70	99	False	rs748329732,COSV60210369	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.921T>A	NP_005951.1:p.Gly307%3D		1.0						.	.	.		9.24402e-06	1.0	108178.0	0.0	45	0.79	AS_VQSR	afr	3.43761e-05	1.0	0.0	0.0	0.0	0.0	227590.0	0.0	83	0.94	AC0_RF				0.0	0.0	0.0000064	1						1.202	-0.123479		0	0	0			MUC3A	0.0	0.0	0.0	0.0	-16.0	-2.0	30.0	-2.0								3.450155638			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819716	chr7	100550355	C	A	chr7:100550355	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.19	48_13	67	99	False	rs77135444	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.936C>A	NP_005951.1:p.Thr312%3D		1.0						.	.	.		7.92519e-05	7.0	88326.0	0.0	37	0.64	AS_VQSR	sas	0.00040032	1.0	0.0	0.0	4.9392e-05	11.0	222708.0	0.0	72	0.87	PASS	sas	3.32513e-05	1.0	1.96634e-05	2.0	0.0000064	1						0.129	-0.447644		0	0	0			MUC3A	0.0	0.01	0.0	0.0	42.0	45.0	-7.0	-17.0								0.530009741			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819719	chr7	100550376	C	G	chr7:100550376	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.21	51_16	75	99	False	rs764198010	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.957C>G	NP_005951.1:p.Thr319%3D		1.0						.	.	.		0.000303604	17.0	55994.0	0.0	0	0.46	AS_VQSR	afr	0.000444219	7.0	7.8456e-05	2.0	0.0	0.0	207670.0	0.0	57	0.72	AC0				0.0	0.0	0.0000129	2						3.082	0.029202		0	0	0			MUC3A	0.01	0.0	0.0	0.0	21.0	5.0	23.0	-38.0								30.376663156			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819720	chr7	100550385	C	A	chr7:100550385	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.2	64_16	80	99	False	rs768264348	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.966C>A	NP_005951.1:p.Pro322%3D		1.0						.	.	.		0.00361241	17.0	4706.0	0.0	0	0.05	AS_VQSR	afr	0.00406504	6.0	0.00167224	3.0	4.95197e-06	1.0	201940.0	0.0	52	0.68	RF	sas	3.47899e-05	1.0	0.0	0.0	0.0000064	1						0.376	-0.295943		0	0	0			MUC3A	0.0	0.0	0.0	0.0	-4.0	12.0	14.0	-47.0								31.211350972			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819721	chr7	100550399	G	C	chr7:100550399	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.19	68_16	84	99	False	rs776023456,COSV104635313,COSV60214016	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.980G>C	NP_005951.1:p.Arg327Thr		1.0	.,.					.	.	.		0.000333537	12.0	35978.0	0.0	0	0.31	AS_VQSR	amr	0.000598802	2.0	0.000184275	3.0	0.0	0.0	187670.0	0.0	43	0.63	AC0_RF				0.0	0.0	0.0000064	1						7.23	0.301456	0.171	0	12	12		SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC3A	0.0	0.08	0.0	0.0	-32.0	1.0	-29.0	0.0								12.681957484	0.0	-0.418	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819722	chr7	100550400	G	A	chr7:100550400	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.16	70_13	83	99	False	rs761106421,COSV60223907	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.981G>A	NP_005951.1:p.Arg327%3D		1.0						.	.	.		6.56607e-06	1.0	152298.0	0.0	64	1.0	PASS	nfe	1.46946e-05	1.0	1.46946e-05	1.0	5.52224e-06	1.0	181086.0	0.0	42	0.63	RF	nfe	1.25628e-05	1.0	1.25628e-05	1.0	0.0000707	11						1.632	-0.077278		0	0	0			MUC3A	0.0	0.04	0.0	0.0	-33.0	-3.0	-30.0	-1.0								12.681957484			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819723	chr7	100550421	C	A	chr7:100550421	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.18	64_14	78	99	False	rs757446266,COSV60210036	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1002C>A	NP_005951.1:p.Thr334%3D		1.0						.	.	.		0.00013231	4.0	30232.0	0.0	0	0.26	PASS	eas	0.00106383	1.0	7.4228e-05	1.0	0.0	0.0	167226.0	0.0	30	0.59	AC0_RF				0.0	0.0	0.0000064	1						0.801	-0.183693		0	0	0			MUC3A	0.0	0.0	0.0	0.0	-24.0	-21.0	-22.0	-21.0								0.444230716			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819725	chr7	100550427	C	T	chr7:100550427	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.18	61_13	74	99	False	rs758310043	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1008C>T	NP_005951.1:p.Tyr336%3D		1.0						.	.	.		8.82561e-05	3.0	33992.0	0.0	0	0.29	AS_VQSR	eas	0.000904159	1.0	0.0	0.0	0.0	0.0	163084.0	0.0	29	0.58	AC0_RF				0.0	0.0	0.0000064	1						6.88	0.274374		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819726	chr7	100550428	A	T	chr7:100550428	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.18	61_13	74	99	False	rs4729627	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1009C>T	NP_005951.1:p.Thr337Ser		1.0						.	.	.						0	0.0							0.0	0.0	157904.0	0.0	28	0.58	AC0				0.0	0.0	0.0000064	1						1.845	-0.058027		1	0	1	SIFT																					.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819728	chr7	100550437	C	T	chr7:100550437	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.13	62_9	71	99	False	rs75838996	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1018C>T	NP_005951.1:p.Pro340Ser		1.0	.,.					.	.	.		0.00228539	237.0	103702.0	0.0	58	0.88	AS_VQSR	sas	0.00643087	20.0	0.00149105	69.0	0.00190749	280.0	146790.0	0.0	25	0.56	RF	nfe	0.00319769	193.0	0.00319769	193.0	0.0064757	1007	0.003	8.0				4.145	0.09298		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-1.964	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819731	chr7	100550447	C	T	chr7:100550447	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.23	51_15	66	99	False	rs776762595	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1028C>T	NP_005951.1:p.Thr343Ile		1.0	.,.					.	.	.						64	1.0							3.29572e-05	5.0	151712.0	0.0	23	0.53	RF	afr	0.000126135	1.0	3.15159e-05	2.0	0.0018649	290	0.001	2.0				3.294	0.042135		1	5	6	SIFT	MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	0.911	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819734	chr7	100550452	A	T	chr7:100550452	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.25	48_16	64	99	False	rs763292509	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1033A>T	NP_005951.1:p.Thr345Ser		1.0	.,.					.	.	.						65	1.0							3.35534e-05	5.0	149016.0	0.0	21	0.52	PASS	sas	8.53534e-05	2.0	4.84888e-05	3.0	0.0018713	291	0.001	3.0				3.853	0.075613		1	5	6	SIFT	MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	0.135	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819737	chr7	100550457	C	G	chr7:100550457	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.13	55_8	63	99	False	rs781058334	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1038C>G	NP_005951.1:p.Asp346Glu		1.0	.,.					.	.	.		0.000472082	58.0	122860.0	0.0	59	0.94	AS_VQSR	afr	0.000623404	21.0	0.000345467	19.0	0.0	0.0	139108.0	0.0	19	0.5	AC0				0.0	0.0	0.0001929	30						1.325	-0.10896		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-0.879	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819745	chr7	100550490	G	A	chr7:100550490	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.33	37_18	55	99	False	rs796897629	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1071G>A	NP_005951.1:p.Met357Ile		1.0	.,.					.	.	.		2.77223e-05	3.0	108216.0	0.0	54	0.78	AS_VQSR	afr	0.00010193	3.0	0.0	0.0					0	0.0							0.0017749	276	0.002	7.0				0.952	-0.158		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.001	-0.289	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819746	chr7	100550508	A	T	chr7:100550508	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.63	16_27	43	99	False	rs146219126	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1089A>T	NP_005951.1:p.Thr363%3D		1.0						.	.	.						48	0.98											0	0.0							0.0007203	19						0.236	-0.362879		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819747	chr7	100550510	A	T	chr7:100550510	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.47	16_20	43	99	False	rs796842434	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1091A>T	NP_005951.1:p.Glu364Val		1.0	.,.					.	.	.						43	0.74											0	0.0							0.0006066	16						1.968	-0.047793		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-2.719	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819748	chr7	100550514	T	C	chr7:100550514	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.49	21_20	41	99	False	rs78262970	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1095T>C	NP_005951.1:p.Thr365%3D		1.0						.	.	.						57	1.0											0	0.0							0.0049283	130						4.532	0.116329		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819749	chr7	100550520	C	T	chr7:100550520	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.46	21_18	39	99	False	rs77013428	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1101C>T	NP_005951.1:p.Leu367%3D		1.0						.	.	.		6.56607e-06	1.0	152298.0	0.0	58	1.0	PASS	nfe	1.46946e-05	1.0	1.46946e-05	1.0					0	0.0							0.0007582,0.0000379	20,1						1.432	-0.097223		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819750	chr7	100550522	C	G	chr7:100550522	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.49	21_20	41	99	False	rs76664943	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1103C>G	NP_005951.1:p.Pro368Arg		1.0	.,.					.	.	.						58	1.0											0	0.0							0.0007961	21						4.263	0.100092		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-0.879	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819751	chr7	100550543	C	T	chr7:100550543	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.53	15_17	32	99	False	rs76777205	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1124C>T	NP_005951.1:p.Pro375Leu		1.0	.,.					.	.	.		0.0	0.0	131696.0	0.0	53	0.89	AC0_AS_VQSR				0.0	0.0					0	0.0							0.0005307	14						8.885	0.446771		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.001	0.678	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819752	chr7	100550544	A	C	chr7:100550544	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.53	15_17	32	99	False	rs75037819	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1125A>C	NP_005951.1:p.Pro375%3D		1.0						.	.	.						61	1.0											0	0.0							0.0007961	21						3.341	0.045008		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819753	chr7	100550552	A	T	chr7:100550552	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.58	13_18	31	99	False	rs77957081	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1133A>T	NP_005951.1:p.Glu378Val		1.0	.,.					.	.	.						61	0.99											0	0.0							0.0006445	17						8.979	0.456111		1	5	6	SIFT	MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.041	0.871	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819754	chr7	100550562	G	A	chr7:100550562	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.59	12_17	29	99	False	rs78069287	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1143G>A	NP_005951.1:p.Thr381%3D		1.0						.	.	.		4.92174e-05	7.0	142226.0	0.0	61	0.96	PASS	afr	7.78412e-05	3.0	6.24844e-05	4.0					0	0.0							0.0003412	9						0.975	-0.154468		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819755	chr7	100550563	A	G	chr7:100550563	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.59	12_17	29	99	False	rs77561545	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1144A>G	NP_005951.1:p.Thr382Ala		1.0	.,.					.	.	.						61	1.0											0	0.0							0.0003412	9						5.23	0.159892		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-0.505	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819756	chr7	100550564	C	T	chr7:100550564	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.57	12_16	28	99	False	rs75269566	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1145C>T	NP_005951.1:p.Thr382Ile		1.0	.,.					.	.	.						61	0.99											0	0.0							0.0003412	9						6.819	0.269763		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.001	0.684	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819757	chr7	100550568	T	A	chr7:100550568	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.59	11_16	27	99	False	rs78115301	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1149T>A	NP_005951.1:p.Pro383%3D		1.0						.	.	.						62	1.0											0	0.0							0.0003033	8						6.053	0.214483		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819759	chr7	100550571	G	A	chr7:100550571	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.62	10_16	26	99	False	rs146166922	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1152G>A	NP_005951.1:p.Met384Ile		1.0	.,.					.	.	.						48	1.0											0	0.0							0.0003412	9						3.63	0.062332		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-3.567	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819760	chr7	100550589	C	G	chr7:100550589	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.6	10_15	25	99	False	rs80123018	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1170C>G	NP_005951.1:p.Thr390%3D		1.0						.	.	.		0.00108932	1.0	918.0	0.0	0	0.01	PASS	amr	0.00806452	1.0	0.0	0.0					0	0.0							0.0003412	9						4.205	0.096616		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819761	chr7	100550595	T	C	chr7:100550595	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.58	10_14	24	99	False	rs80315860	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1176T>C	NP_005951.1:p.Thr392%3D		1.0						.	.	.						64	0.98											0	0.0							0.0004928	13						0.037	-0.61723		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819762	chr7	100550596	G	A	chr7:100550596	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.61	9_14	23	99	False	rs74991890	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1177G>A	NP_005951.1:p.Glu393Lys		1.0	.,.					.	.	.		8.67182e-06	1.0	115316.0	0.0	60	0.82	PASS				0.0	0.0					0	0.0							0.0003412	9	0.0	1.0				3.804	0.07266		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-0.464	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819764	chr7	100550607	C	A	chr7:100550607	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.7	7_16	23	99	False	rs77396152	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1188C>A	NP_005951.1:p.Ser396%3D		1.0						.	.	.						65	0.94											0	0.0							0.0011752	31	0.001	2.0				0.068	-0.535252		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819765	chr7	100550619	C	T	chr7:100550619	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.68	6_15	22	99	False	rs78047302	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1200C>T	NP_005951.1:p.Pro400%3D		1.0						.	.	.						40	0.55											0	0.0							0.0002275	6						7.112	0.29232		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819766	chr7	100550626		ACT	chr7:100550625-100550626	MUC3A	mucin 3A, cell surface associated	13855.0	insertion	0|1	0.56	7_9	16	99	False	rs200551861	EXONIC	YES	NM_005960.2	Transcript	protein_coding	inframe_insertion		2/16	NM_005960.2:c.1206_1207insACT	NP_005951.1:p.Phe402_Ser403insThr		1.0						.	.	.						59	0.91											0	0.0														5.569	0.181962		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819767	chr7	100550631		A	chr7:100550630-100550631	MUC3A	mucin 3A, cell surface associated	13855.0	insertion	0/1	0.56	7_9	16	99	False	rs879601056	EXONIC	YES	NM_005960.2	Transcript	protein_coding	frameshift_variant		2/16	NM_005960.2:c.1212dup	NP_005951.1:p.Ser405IlefsTer163		1.0						.	.	.						57	0.97											0	0.0														4.391	0.107783		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819768	chr7	100550633		CG	chr7:100550632-100550633	MUC3A	mucin 3A, cell surface associated	13855.0	insertion	0/1	0.65	6_11	17	99	False	rs879357469	EXONIC	YES	NM_005960.2	Transcript	protein_coding	frameshift_variant		2/16	NM_005960.2:c.1214_1215insGC	NP_005951.1:p.Thr406GlnfsTer25		1.0						.	.	.						65	0.87											0	0.0																	0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819769	chr7	100550639	TCTACT		chr7:100550639-100550644	MUC3A	mucin 3A, cell surface associated	13855.0	deletion	0/1	0.87	2_13	15	45	False	rs1174575398	EXONIC	YES	NM_005960.2	Transcript	protein_coding	inframe_deletion		2/16	NM_005960.2:c.1220_1225del	NP_005951.1:p.Ile407_Ser409delinsThr		1.0						.	.	.						66	1.0											0	0.0														6.413	0.239877		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819770	chr7	100550647		GAG	chr7:100550646-100550647	MUC3A	mucin 3A, cell surface associated	13855.0	insertion	0|1	0.77	3_10	13	26	False	rs879539337	EXONIC	YES	NM_005960.2	Transcript	protein_coding	inframe_insertion		2/16	NM_005960.2:c.1227_1228insGAG	NP_005951.1:p.Ser409_Thr410insGlu		1.0						.	.	.						70	1.0											0	0.0														4.107	0.090744		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819771	chr7	100550649	AGT		chr7:100550649-100550651	MUC3A	mucin 3A, cell surface associated	13855.0	deletion	0/1	0.77	1_10	13	3	False	rs1413067205	SPLICING	YES	NM_005960.2	Transcript	protein_coding	inframe_deletion,splice_region_variant,splice_polypyrimidine_tract_variant		2/16	NM_005960.2:c.1230_1232del	NP_005951.1:p.Val411del		1.0						.	.	.						58	0.82											0	0.0														4.108	0.09079		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819772	chr7	100550653	A	C	chr7:100550653	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	1/1	0.83	0_10	12	39	False	rs1395988162	EXONIC	YES	NM_005960.2	Transcript	protein_coding	coding_sequence_variant	2/15		NM_005960.2:c.1233+1A>C			1.0						.	.	.						71	1.0											0	0.0							0.0001896	5						6.724	0.262604		0	0	0														-37.008	0.091	-36.918						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819773	chr7	100550766	C	C	chr7:100550766	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	1|1	1.0	0_13	13	39	False	rs28654698	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		3/16	NM_005960.2:c.5862A>C	NP_005951.1:p.Ser1954%3D		1.0						.	.	.						0	0.0							0.524064	53878.0	102808.0	4217.0	42	0.91	InbreedingCoeff	nfe	0.532526	27833.0	0.532526	27833.0	0.0015948,0.0000193	248,3	0.013	34.0				4.441	0.11081		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819777	chr7	100550816	G	A	chr7:100550816	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.34	17_11	32	99	False	rs62483690	EXONIC	YES	NM_005960.2	Transcript	protein_coding	coding_sequence_variant	4/15		NM_005960.2:c.1389+2G>A			1.0						.	.	.						0	0.02							0.111315	9726.0	87374.0	0.0	100	0.98	RF	nfe	0.16352	6150.0	0.16352	6150.0	0.0001286	20	0.011	34.0				4.767	0.130725		0	0	0														-25.479	0.536	-24.942						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819778	chr7	100550827	T	C	chr7:100550827	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.29	18_9	31	99	False	rs760531164	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		5/16	NM_005960.2:c.6919T>C	NP_005951.1:p.Phe2307Leu		1.0	.,.					.	.	.		0.0	0.0	150066.0	0.0	453	0.99	AC0				0.0	0.0	0.0204796	3872.0	189066.0	0.0	100	0.98	RF	nfe	0.0309787	2519.0	0.0309787	2519.0	0.1120679	17427						5.643	0.186838		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-2.421	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819819	chr7	100552017	T	T	chr7:100552017	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.3	43_18	61	99	False	rs1554457672,rs9691167	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		5/16	NM_005960.2:c.8109C>T	NP_005951.1:p.Phe2703%3D		1.0						.	.	.						0	0.0							0.337996	59999.0	177514.0	91.0	33	0.63	InbreedingCoeff	eas	0.385389	6288.0	0.361906	30998.0	0.0415488	6461	0.098	279.0				1.462	-0.09414		0	0	0																			18.631753385			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819826	chr7	100552251	C	C	chr7:100552251	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.7	13_30	43	99	False	rs1306209366,rs9691900,COSV60218624	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		5/16	NM_005960.2:c.8343T>C	NP_005951.1:p.Ser2781%3D		1.0						.	.	.						0	0.0							0.604686	110770.0	183186.0	19230.0	51	0.67	InbreedingCoeff_RF	eas	0.648305	10863.0	0.618662	53956.0	0.0535613,0.0036784	8329,572	0.234	731.0				1.263	-0.116167		0	0	0																			25.450761380			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819945	chr7	100607851	G	G	chr7:100607851	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.43	31_23	54	99	False	rs6960854	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		9/16	NM_005960.2:c.9339C>G	NP_005951.1:p.Leu3113%3D		1.0						.	.	.						0	0.0							0.506417	115698.0	228464.0	1470.0	53	0.98	InbreedingCoeff	sas	0.5297	16016.0	0.503168	53045.0	0.0281600	4379	0.191	592.0	0.50542	932.0		0.804	-0.183199		0	0	0																			36.222312096			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819946	chr7	100607871	T	T	chr7:100607871	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.43	34_26	60	99	False	rs6960868,COSV60214561	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		9/16	NM_005960.2:c.9359C>T	NP_005951.1:p.Val3120%3D		1.0						.	.	.						0	0.0							0.48172	101747.0	211216.0	725.0	44	0.97	InbreedingCoeff	afr	0.501103	6815.0	0.492856	48709.0	0.0205718	3199	0.169	514.0	0.44306	817.0		0.576	-0.232979		0	0	0																			76.912027051			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819977	chr7	100608370	C	C	chr7:100608370	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.35	30_16	46	99	False	rs73714276,COSV60212649	SPLICING	YES	NM_005960.2	Transcript	protein_coding	splice_region_variant,synonymous_variant		10/16	NM_005960.2:c.9446A>C	NP_005951.1:p.Ala3149%3D		1.0						.	.	.						0	0.0							0.499642	90680.0	181490.0	232.0	73	0.77	InbreedingCoeff	afr	0.503881	5063.0	0.500058	43396.0	0.0219223	3409	0.15	481.0	0.49187	907.0		22.5	2.449534		0	0	0														10.068	-0.911	9.158			66.875343337			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819994	chr7	100608778	C	C	chr7:100608778	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.47	32_28	60	99	False	rs73163792	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		11/16	NM_005960.2:c.9498T>C	NP_005951.1:p.Pro3166%3D		1.0						.	.	.						0	0.0							0.499785	111517.0	223130.0	16.0	51	0.97	InbreedingCoeff	afr	0.499926	6798.0	0.499903	51641.0	0.0176973	2752	0.104	314.0	0.49729	917.0		13.05	0.945263		0	0	0																			36.222312096			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819995	chr7	100608779	T	T	chr7:100608779	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.47	32_28	60	99	False	rs73163793	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		11/16	NM_005960.2:c.9499C>T	NP_005951.1:p.Leu3167%3D		1.0						.	.	.						0	0.0							0.49978	111412.0	222922.0	16.0	51	0.97	InbreedingCoeff	afr	0.499926	6792.0	0.499864	51595.0	0.0176330	2742	0.08	245.0	0.49729	917.0		10.86	0.664641		0	0	0																			36.222312096			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819996	chr7	100608823	G	T	chr7:100608823	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.22	53_15	68	99	False	rs35790618,COSV60217016	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		11/16	NM_005960.2:c.9543G>T	NP_005951.1:p.Ser3181%3D		1.0						.	.	.						0	0.0							0.249954	38426.0	153732.0	10.0	49	0.97	InbreedingCoeff_RF	amr	0.352382	8121.0	0.26018	18005.0	0.0178195	2771	0.091	275.0	0.22234	410.0		13.93	1.077165		0	0	0																			13.184926778			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819997	chr7	100608826	G	G	chr7:100608826	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.51	33_35	68	99	False	rs73163794,rs756600581	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		11/16	NM_005960.2:c.9546C>G	NP_005951.1:p.Gly3182%3D		1.0						.	.	.						0	0.0							0.499338	108575.0	217438.0	12.0	48	0.97	InbreedingCoeff	afr	0.499546	6600.0	0.499443	50216.0	0.0356968	5551	0.158	489.0	0.49295	909.0		14.73	1.214737		0	0	0																			13.184926778			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819998	chr7	100608868	G	G	chr7:100608868	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.55	29_36	65	99	False	rs67377634,COSV60215686	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		11/16	NM_005960.2:c.9588A>G	NP_005951.1:p.Leu3196%3D		1.0						.	.	.						0	0.0							0.494375	96768.0	195738.0	9.0	33	0.9	InbreedingCoeff	afr	0.495696	5759.0	0.495236	44807.0	0.0186941	2907	0.176	541.0	0.48536	895.0		13.16	0.960759		0	0	0																			63.343682261			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
819999	chr7	100608884	A	A	chr7:100608884	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0|1	0.57	29_38	67	99	False	rs73163797,COSV60213519	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		11/16	NM_005960.2:c.9604G>A	NP_005951.1:p.Thr3202%3D		1.0						.	.	.						0	0.0							0.492477	90404.0	183570.0	8.0	28	0.8	InbreedingCoeff	sas	0.494121	12607.0	0.493238	41288.0	0.0127971	1990	0.152	447.0	0.47939	884.0		8.662	0.424945		0	0	0																			0.485211871			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
820038	chr7	100610069	T	T	chr7:100610069	MUC3A	mucin 3A, cell surface associated	13855.0	SNV	0/1	0.72	13_33	46	99	False	rs10258821,COSV60210855,COSV60211223	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		14/16	NM_005960.2:c.9895C>T	NP_005951.1:p.Tyr3299%3D		1.0						.	.	.						0	0.0							0.480961	107743.0	224016.0	6921.0	100	0.98	InbreedingCoeff	amr	0.598144	20179.0	0.467049	48476.0	0.0317484	4937	0.126	410.0	0.4756	877.0		11.26	0.713501		0	0	0																			3.450155638			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
820048	chr7	100611293		CTGC	chr7:100611292-100611293	MUC3A	mucin 3A, cell surface associated	13855.0	insertion	0|1	0.32	19_9	28	99	False	rs1556450198	SPLICING	YES	NM_005960.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	15/15		NM_005960.2:c.5314-7_5314-6insTGCC			1.0						.	.	.						0	0.0											0	0.0									0.002	6.0				3.857	0.075826		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
820049	chr7	100611296	CCGG		chr7:100611296-100611299	MUC3A	mucin 3A, cell surface associated	13855.0	deletion	0|1	0.31	20_9	29	99	False	rs1556450200	SPLICING	YES	NM_005960.2	Transcript	protein_coding	splice_acceptor_variant,splice_polypyrimidine_tract_variant,intron_variant	15/15		NM_005960.2:c.5314-4_5314-1del			1.0						.	.	.						0	0.0											0	0.0									0.001	4.0				3.967	0.082399		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];
820586	chr1	28176708	C	T	chr1:28176708	PPP1R8	protein phosphatase 1 regulatory subunit 8	13861.0	SNV	0/1	0.39	17_11	28	99	False	rs150551499,COSV52580380	EXONIC	YES	NM_014110.5	Transcript	protein_coding	synonymous_variant		7/7	NM_014110.5:c.807C>T	NP_054829.2:p.Pro269%3D		1.0						.	.	.		0.00105125	160.0	152200.0	0.0	32	0.97	PASS	nfe	0.00154321	105.0	0.00154321	105.0	0.00108209	272.0	251366.0	0.0	76	1.0	PASS	nfe	0.00160121	182.0	0.00160121	182.0	0.0010353	161	0.002	6.0				10.6	0.634064		0	0	0			PPP1R8	0.0	0.0	0.0	0.0	9.0	47.0	7.0	-11.0							0.95	25.309348899			endocrine/exocrine gland phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; liver/biliary system phenotype; embryo phenotype; 			white blood cells;placenta;spinal cord;thalamus;	Tyrosine metabolism;Phenylalanine metabolism;Glycerophospholipid metabolism;1- and 2-Methylnaphthalene degradation;Benzoate degradation via CoA ligation;Limonene and pinene degradation;Alkaloid biosynthesis II	mRNA processing;RNA catabolic process;cell population proliferation;RNA splicing;negative regulation of phosphoprotein phosphatase activity;production of miRNAs involved in gene silencing by miRNA;negative regulation of protein dephosphorylation;RNA phosphodiester bond hydrolysis	nucleus;nucleoplasm;spliceosomal complex;cytoplasm;nuclear speck	DNA binding;RNA binding;mRNA binding;endonuclease activity;protein serine/threonine phosphatase inhibitor activity;protein binding;ribonuclease E activity	PPIL1[22365833];RBM48[16169070];SF3A2[17332742];SETDB1[16169070];LRRK2[24510904];NME2[17353931];HMGA1[18850631];CDC5L[10827081];CRMP1[16169070];PPP1CA[15231748;18842582;22365833;27173435;unassigned1304;unassigned1312;28330616;22940584;25593058];WDR77[22365833];PPP1CB[17353931;26496610;28330616];PPP1CC[21382349;24366813;26496610;unassigned1304;28330616];ERG28[16169070];APPBP2[25416956;unassigned1304];STC2[16169070];RTN4IP1[unassigned1304];TP53BP1[29656893];GBP2[16169070];CTNNBL1[22365833];
821786	chr12	123001881	C	T	chr12:123001881	RSRC2	arginine and serine rich coiled-coil 2	13878.0	SNV	0/1	0.5	13_13	26	99	False	rs572371574,COSV100063500	EXONIC	YES	NM_023012.6	Transcript	protein_coding	synonymous_variant		5/10	NM_023012.6:c.495G>A	NP_075388.2:p.Ser165%3D		-1.0						.	.	.		6.57687e-06	1.0	152048.0	0.0	32	0.95	PASS	sas	0.000207125	1.0	0.0	0.0	2.78346e-05	7.0	251486.0	0.0	100	1.0	PASS	sas	0.000163313	5.0	0.0	0.0	0.0000514	8						6.311	0.232557		0	0	0			RSRC2	0.0	0.0	0.0	0.0	-3.0	-9.0	-10.0	-35.0						0.22	0.99				.			ciliary ganglion;amygdala;testis - seminiferous tubule;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;cingulate cortex;testis;pons;testis - interstitial;atrioventricular node;parietal lobe;medulla oblongata;	.	.	.	RNA binding	SRPK2[23602568];CCDC155[25416956];MCM7[23764002];CMTM5[25416956;unassigned1304];FOXK2[25609649];SAMD4B[unassigned1304];NAV1[unassigned1304];SRPK1[23602568];GOLGA2[25416956];RINT1[25416956];PNMA1[25416956];CTAG1A[unassigned1304];AKAP9[unassigned1304];UBQLN1[25416956];POT1[26496610];UBQLN4[16713569];TRIM54[25416956];PFDN5[unassigned1304];DEDD[20195357];TRIM23[25416956];UBQLN2[unassigned1304];PLEC[30021884];
821905	chr5	176024191	G	A	chr5:176024191	GPRIN1	G protein regulated inducer of neurite outgrowth 1	13888.0	SNV	0/1	0.62	8_13	21	99	False	rs1225232343	EXONIC	YES	NM_052899.3	Transcript	protein_coding	missense_variant		2/2	NM_052899.3:c.2645C>T	NP_443131.2:p.Ala882Val		-1.0	G protein-regulated inducer of neurite outgrowth, C-terminal					Autosomal dominant non-syndromic intellectual disability;Bilateral generalized polymicrogyria	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Global developmental delay;Strabismus;Absent speech;Intellectual disability, severe;Epileptic encephalopathy;Cerebral cortical atrophy;Spasticity;Inability to walk;Autosomal recessive inheritance;Generalized hypotonia;Frontal bossing;Involuntary movements;Seizure;Poor eye contact;Dystonia;Midface retrusion;Self-injurious behavior;Hypoplasia of the corpus callosum;Oculogyric crisis;Chorea;Absent speech;Hyperreflexia;Cerebral atrophy;Intellectual disability, severe;Spasticity;Hypoplasia of the corpus callosum;Polymicrogyria;Self-injurious behavior;Intellectual disability;Dyskinesia;Feeding difficulties;Severe muscular hypotonia;Inability to walk;Myoclonus;Infantile onset;Cerebral visual impairment;Constipation;Hyperkinetic movements;EEG abnormality;Autosomal dominant inheritance;Scoliosis;Seizure;Microcephaly		3.97225e-05	6.0	151048.0	0.0	32	0.95	PASS	amr	0.000197811	3.0	2.95552e-05	2.0	1.66839e-05	1.0	59938.0	0.0	5	0.12	PASS	nfe	3.22393e-05	1.0	3.22393e-05	1.0	0.0000064	1						16.21	1.48905	0.098	3	15	18	M-CAP_pred,PrimateAI_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	GPRIN1	0.0	0.0	0.0	0.0	-21.0	6.0	2.0	-25.0						0.487	0.79		0.527	-0.256	.			.	Calcium signaling pathway;Neuroactive ligand-receptor interaction;Long-term potentiation	neuron projection development	plasma membrane;growth cone	phosphoprotein binding	LAMP1[29568061];ZNF281[26496610];HNRNPD[26496610];YEATS4[26496610];EZR[29568061];
824708	chr8	121473482	A	G	chr8:121473482	MTBP	MDM2 binding protein	14008.0	SNV	0/1	0.49	22_21	43	99	False	rs1167067658	EXONIC	YES	NM_022045.5	Transcript	protein_coding	missense_variant		9/22	NM_022045.5:c.964A>G	NP_071328.2:p.Ile322Val		1.0	MDM2-binding protein, central domain					.	.	.						32	0.97							4.00413e-06	1.0	249742.0	0.0	39	0.95	PASS	amr	2.91256e-05	1.0	0.0	0.0								14.5	1.172151	0.045	0	18	18		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MTBP	0.0	0.0	0.01	0.0	10.0	43.0	10.0	-3.0						0.174	0.0	0.000000000	0.479	0.254	neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			.	.	cell cycle arrest;traversing start control point of mitotic cell cycle;negative regulation of cell population proliferation;regulation of protein ubiquitination;protein localization to kinetochore;negative regulation of mitotic nuclear division	kinetochore;chromatin	.	CDK8[26496610;29568061];ZEB2[26028330];
827220	chr1	145471549	A	C	chr1:145471549	ANKRD34A	ankyrin repeat domain 34A	14051.0	SNV	1/1	1.0	0_22	22	66	False	rs833944	SPLICING	YES	NM_001039888.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/3		NM_001039888.4:c.-896-4A>C			1.0						.	.	.						0	0.0											0	0.0							0.8805444	23227	0.008	24.0				15.59	1.376909		0	0	0			ANKRD34A	0.0	0.03	0.0	0.0	-35.0	4.0	46.0	4.0	0.0005361185053816	0.118	9.257	0.73	9.987	0.0382	0.97				.			amygdala;subthalamic nucleus;whole brain;cingulate cortex;globus pallidus;cerebellum;	.	.	.	.	HDAC4[unassigned1312];RTKN[unassigned1312];MAST3[unassigned1312];MAPKAP1[unassigned1312];DENND1A[unassigned1312];PPM1H[unassigned1312];ZBTB21[unassigned1312];CBY1[unassigned1312];TESK2[unassigned1312];AGAP1[unassigned1312];RASAL2[unassigned1312];IER3IP1[16169070];FAM110A[unassigned1312];SYDE1[unassigned1312];LIMA1[unassigned1312];SIPA1L1[unassigned1312];SH3PXD2A[unassigned1312];FAM110B[unassigned1312];FAM53C[unassigned1312];KIF13B[unassigned1312];KIF1C[unassigned1312];MAP3K21[unassigned1312];SH3BP4[unassigned1312];SRGAP2[unassigned1312];NADK[unassigned1312];SRSF12[unassigned1312];MAGI1[unassigned1312];KSR1[unassigned1312];USP21[unassigned1312];RAB3IP[unassigned1312];DENND4C[unassigned1312];GAB2[unassigned1312];KCTD3[unassigned1312];DCLK1[unassigned1312];PLEKHA7[unassigned1312];CDC25B[unassigned1312];GIGYF1[unassigned1312];AFDN[unassigned1312];TIAM1[unassigned1312];DEPDC1B[unassigned1312];MELK[unassigned1312];ZNF638[unassigned1312];LRFN1[unassigned1312];NF1[unassigned1312];TBC1D25[unassigned1312];EIF4E2[unassigned1312];PHLDB2[unassigned1312];CDK16[unassigned1312];
827438	chr11	75141041	G	A	chr11:75141041	KLHL35	kelch like family member 35	14064.0	SNV	0/1	0.54	13_15	28	99	False	rs769016500,COSV61127292	EXONIC	YES	NM_001039548.2	Transcript	protein_coding	missense_variant		1/6	NM_001039548.2:c.634C>T	NP_001034637.2:p.Arg212Cys		-1.0	BTB/Kelch-associated&BTB/Kelch-associated					.	.	.		0.00064534	98.0	151858.0	0.0	33	0.98	PASS	nfe	0.00107495	73.0	0.00107495	73.0	0.00059278	29.0	48922.0	0.0	1	0.03	PASS	nfe	0.00117559	22.0	0.00117559	22.0	0.0000900	14	0.002	5.0				22.8	2.608142	0.079	5	13	18	SIFT,M-CAP_pred,PROVEAN_pred,PrimateAI_pred,LIST-S2_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	KLHL35	0.0	0.0	0.0	0.0	2.0	-22.0	40.0	-13.0							0.0		0.995	1.07	.			.	.	.	.	protein binding	NUDCD3[25036637];ALAS1[25416956];GOLGA6L9[unassigned1304];APPBP2[25416956;unassigned1304];FAM25C[unassigned1304];CALCOCO2[unassigned1304];UBTD2[unassigned1304];NCK2[unassigned1304];
831438	chr1	207317891	G	C	chr1:207317891	C4BPA	complement component 4 binding protein alpha	14145.0	SNV	0/1	0.39	14_9	23	99	False	rs1166665068	SPLICING	YES	NM_000715.4	Transcript	protein_coding	missense_variant,splice_region_variant		12/12	NM_000715.4:c.1623G>C	NP_000706.1:p.Glu541Asp		1.0						.	.	.						31	0.96											25	0.64														12.94	0.92975	0.102	6	15	21	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred,ClinPred_pred,fathmm-XF_coding_pred	SIFT,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	C4BPA	0.0	0.07	0.0	0.0	11.0	1.0	-2.0	1.0			9.64	-1.171	8.469	0.62	0.01	35.983638104	0.072	-0.167	.			.	Complement and coagulation cascades	complement activation, classical pathway;regulation of complement activation;innate immune response;positive regulation of protein catabolic process;negative regulation of complement activation, classical pathway;regulation of opsonization	extracellular region;extracellular space;plasma membrane;other organism cell;blood microparticle	RNA binding;protein binding	TSNAX[26496610];SMARCD1[21988832];GIT2[21988832];ARMC6[26496610];NCBP2[26382858];SEC16A[26496610];FXYD6[21988832];MYH11[26496610];LBP[21988832];GTF2I[21988832];
832162	chr19	54744710	C	T	chr19:54744710	LILRB3	leukocyte immunoglobulin like receptor B3	14163.0	SNV	0|1	0.24	53_17	70	99	False	rs1132600,COSV54428407	EXONIC	YES	NM_001320960.2	Transcript	protein_coding	missense_variant		5/14	NM_001320960.2:c.952G>A	NP_001307889.1:p.Ala318Thr		-1.0	.,.					.	.	.		6.59083e-05	10.0	151726.0	0.0	47	0.98	AS_VQSR	afr	0.000170782	7.0	1.46985e-05	1.0	0.0162698	3653.0	224526.0	0.0	70	0.97	PASS	afr	0.0462158	585.0	0.014872	1506.0	0.0040321	627	0.003	10.0				0.003	-1.009809	0.126	0	14	14		LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.928	0.03		0.0	-3.089	cellular phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; 			whole blood;	B cell receptor signaling pathway	adaptive immune response;defense response;cell surface receptor signaling pathway;neutrophil degranulation;negative regulation of osteoclast differentiation	plasma membrane;integral component of plasma membrane;secretory granule membrane	amyloid-beta binding;transmembrane signaling receptor activity;protein binding;signaling receptor activity	FDPS[26769854];KRT19[26769854];KRT18[26769854];KRT8[26769854];PTPN6[18802077];ACTB[26769854];
832173	chr19	54744711	C	G	chr19:54744711	LILRB3	leukocyte immunoglobulin like receptor B3	14163.0	SNV	0|1	0.24	53_17	70	99	False	rs1132599,COSV54428418	EXONIC	YES	NM_001320960.2	Transcript	protein_coding	missense_variant		5/14	NM_001320960.2:c.951G>C	NP_001307889.1:p.Met317Ile		-1.0	.,.					.	.	.		0.000547421	83.0	151620.0	0.0	46	0.98	PASS	afr	0.00183132	75.0	0.0	0.0	0.0166539	3729.0	223912.0	0.0	72	0.97	RF	afr	0.0502173	624.0	0.0149189	1510.0	0.0044115	686	0.074	235.0				0.007	-0.847257	0.052	0	14	14		LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.928	0.03		0.001	-0.281	cellular phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; 			whole blood;	B cell receptor signaling pathway	adaptive immune response;defense response;cell surface receptor signaling pathway;neutrophil degranulation;negative regulation of osteoclast differentiation	plasma membrane;integral component of plasma membrane;secretory granule membrane	amyloid-beta binding;transmembrane signaling receptor activity;protein binding;signaling receptor activity	FDPS[26769854];KRT19[26769854];KRT18[26769854];KRT8[26769854];PTPN6[18802077];ACTB[26769854];
832181	chr19	54744722	T	C	chr19:54744722	LILRB3	leukocyte immunoglobulin like receptor B3	14163.0	SNV	0|1	0.24	55_17	72	99	False	rs1132597,COSV54428432	EXONIC	YES	NM_001320960.2	Transcript	protein_coding	missense_variant		5/14	NM_001320960.2:c.940A>G	NP_001307889.1:p.Asn314Asp		-1.0	Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin-like domain&Immunoglobulin subtype					.	.	.		0.000395273	60.0	151794.0	0.0	47	0.98	PASS	afr	0.000705322	29.0	0.000102893	7.0	0.0259386	5186.0	199934.0	1.0	90	0.98	RF	afr	0.0877225	956.0	0.0215318	1955.0	0.0008424	131	0.08	246.0				7.388	0.313702	0.068	0	14	14		LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.928	0.03		0.0	-0.381	cellular phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; 			whole blood;	B cell receptor signaling pathway	adaptive immune response;defense response;cell surface receptor signaling pathway;neutrophil degranulation;negative regulation of osteoclast differentiation	plasma membrane;integral component of plasma membrane;secretory granule membrane	amyloid-beta binding;transmembrane signaling receptor activity;protein binding;signaling receptor activity	FDPS[26769854];KRT19[26769854];KRT18[26769854];KRT8[26769854];PTPN6[18802077];ACTB[26769854];
832187	chr19	54744732	G	A	chr19:54744732	LILRB3	leukocyte immunoglobulin like receptor B3	14163.0	SNV	0|1	0.22	57_16	73	99	False	rs79245076	EXONIC	YES	NM_001320960.2	Transcript	protein_coding	synonymous_variant		5/14	NM_001320960.2:c.930C>T	NP_001307889.1:p.Ser310%3D		-1.0						.	.	.		0.000302186	46.0	152224.0	0.0	47	0.98	PASS	nfe	0.000426308	29.0	0.000426308	29.0	0.0170125	3560.0	209258.0	1.0	100	0.99	RF	sas	0.0405417	928.0	0.0166549	1555.0	0.0006431	100	0.055	170.0				3.151	0.033447		0	0	0																	0.928	0.03				cellular phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; 			whole blood;	B cell receptor signaling pathway	adaptive immune response;defense response;cell surface receptor signaling pathway;neutrophil degranulation;negative regulation of osteoclast differentiation	plasma membrane;integral component of plasma membrane;secretory granule membrane	amyloid-beta binding;transmembrane signaling receptor activity;protein binding;signaling receptor activity	FDPS[26769854];KRT19[26769854];KRT18[26769854];KRT8[26769854];PTPN6[18802077];ACTB[26769854];
832308	chr6	43642956	G	A	chr6:43642956	MRPS18A	mitochondrial ribosomal protein S18A	14169.0	SNV	0/1	0.39	19_12	31	99	False	rs371004644	EXONIC	YES	NM_018135.4	Transcript	protein_coding	synonymous_variant		5/6	NM_018135.4:c.429C>T	NP_060605.1:p.Ser143%3D		-1.0						.	.	.						32	0.97							1.67705e-05	3.0	178886.0	0.0	25	0.59	PASS	nfe	3.45296e-05	3.0	3.45296e-05	3.0	0.0000193	3						3.18	0.035236		0	0	0			MRPS18A	0.0	0.02	0.0	0.01	16.0	33.0	-31.0	-17.0						0.272	0.0	36.780745035			.			.	.	translation;mitochondrial translation;mitochondrial translational elongation;mitochondrial translational termination	mitochondrion;mitochondrial inner membrane;mitochondrial large ribosomal subunit;mitochondrial small ribosomal subunit	structural constituent of ribosome;small ribosomal subunit rRNA binding	JUN[25609649];MRPL50[26496610];MRPL1[26496610];MGST3[29568061];MRPL58[20186120];FOXL2[25609649];MRPL9[26496610];AURKAIP1[29568061];NIPSNAP1[26496610];TRMT61B[29568061];PDK1[29568061];
832861	chr16	29000867	C	T	chr16:29000867	LAT	linker for activation of T cells	14188.0	SNV	0/1	0.59	15_22	37	99	False	rs147113499,COSV62795678	EXONIC	YES	NM_001014989.2	Transcript	protein_coding	synonymous_variant		10/13	NM_001014989.2:c.621C>T	NP_001014989.2:p.Tyr207%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Immunodeficiency 52, 617514 (3), Autosomal recessive	Severe combined immunodeficiency due to LAT deficiency	Disease-causing germline mutation(s) in	Thrombocytopenia;Immune dysregulation;Decreased circulating antibody level;Lymphadenopathy;Autosomal recessive inheritance;Splenomegaly;Recurrent infections;Hemolytic anemia;Immunodeficiency;Failure to thrive;Chronic lung disease		0.000887306	135.0	152146.0	0.0	32	0.97	PASS	amr	0.00314218	48.0	0.000602746	41.0	0.000608626	151.0	248100.0	0.0	50	0.83	PASS	amr	0.0018708	64.0	0.000536068	60.0	0.0004309	67	0.002	6.0				14.61	1.192731		0	0	0			LAT	0.01	0.0	0.0	0.0	16.0	-19.0	-41.0	43.0						0.0956	0.1	0.933210783			cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; digestive/alimentary phenotype; immune system phenotype; renal/urinary system phenotype; respiratory system phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			thymus;trigeminal ganglion;	Natural killer cell mediated cytotoxicity;T cell receptor signaling pathway;Fc epsilon RI signaling pathway	MAPK cascade;adaptive immune response;lymphocyte homeostasis;inflammatory response;immune response;integrin-mediated signaling pathway;Ras protein signal transduction;positive regulation of signal transduction;gene expression;calcium-mediated signaling;intracellular signal transduction;Fc-epsilon receptor signaling pathway;T cell activation;mast cell degranulation;positive regulation of protein kinase activity;T cell receptor signaling pathway;regulation of T cell activation	immunological synapse;Golgi apparatus;plasma membrane;cell-cell junction;COP9 signalosome;integral component of membrane;mast cell granule;membrane raft	SH3/SH2 adaptor activity;Ras guanyl-nucleotide exchange factor activity;protein binding;protein kinase binding	TMEM45B[unassigned1304];CYBC1[unassigned1304];MS4A7[unassigned1304];PTPRJ[11259588];ZDHHC7[unassigned1304];CD3G[unassigned1304];CLDN2[unassigned1304];MEOX2[unassigned1304];ASGR2[unassigned1304];MFSD5[unassigned1304];MAP1LC3C[unassigned1304];FFAR3[unassigned1304];GJA8[unassigned1304];SLC18A1[unassigned1304];CD53[unassigned1304];CCDC155[27107012];ZHX2[21988832];CAMLG[unassigned1304];SLC35C2[unassigned1304];MRPS18B[unassigned1304];THEMIS[23460737;21189249];OPRM1[unassigned1304];SSMEM1[unassigned1304];SLC51B[unassigned1304];TMEM80[unassigned1304];BSCL2[unassigned1304];THAP4[unassigned1304];CREB3[21516116];CLDN5[unassigned1304];SLPI[unassigned1304];LCK[16938345];CLDN7[unassigned1304];CDIP1[unassigned1304];FKBP7[unassigned1304];LCP2[24584089];KCTD17[unassigned1304];SAR1A[unassigned1304];GPR42[unassigned1304];PIK3R1[10811803];MFF[unassigned1304];KIR2DL3[unassigned1304];EGFR[24658140];LEUTX[unassigned1304];GPR152[unassigned1304];BCL2L13[unassigned1304];GPR151[unassigned1304];SH3BP2[17306257];PLCG2[24642916];SLC19A3[unassigned1304];FYN[16938345];PLCG1[16938345;10811803;9489702;24642916];PTPN1[12857726];TM4SF18[unassigned1304];OR1D4[unassigned1304];SLC14A2[unassigned1304];SYT2[unassigned1304];SGTB[unassigned1304];GOLM1[unassigned1304];SGTA[25416956;unassigned1304];LHFPL5[unassigned1304];LHFPL1[unassigned1304];TNFRSF10D[unassigned1304];MFSD14B[unassigned1304];GJB1[unassigned1304];JSRP1[unassigned1304];TMEM237[unassigned1304];ALB[15174051];NDUFAF2[unassigned1304];GRB2[16938345;10811803;9489702;23460737;16906159];SLC26A6[unassigned1304];
834423	chr11	609002	G	A	chr11:609002	PHRF1	PHD and ring finger domains 1	14235.0	SNV	0/1	0.48	16_15	31	99	False	rs202144590,COSV99213960	EXONIC	YES	NM_001286581.2	Transcript	protein_coding	synonymous_variant		14/18	NM_001286581.2:c.3546G>A	NP_001273510.1:p.Glu1182%3D		1.0						.	.	.		0.00318697	485.0	152182.0	0.0	32	0.96	PASS	amr	0.00870077	133.0	0.00430756	293.0	0.00250958	550.0	219160.0	0.0	56	0.64	PASS	amr	0.00428033	134.0	0.00360735	350.0	0.0021286	331	0.007	22.0				0.391	-0.290333		0	0	0			PHRF1	0.0	0.0	0.0	0.0	13.0	1.0	2.0	-5.0						0.131	0.95	13.107986033			.			.	.	transcription by RNA polymerase II;mRNA processing	membrane	protein domain specific binding;metal ion binding;RNA polymerase binding	CSNK2B[21988832];NLRP3[26496610];DLST[29128334];KIF21A[26496610];AGPAT2[21988832];CD44[26496610];PPP1CA[19389623];HIST1H1C[30021884];KTN1[30021884];
834470	chr2	207569628	T	C	chr2:207569628	DYTN	dystrotelin	14242.0	SNV	0/1	0.51	17_18	35	99	False	rs1335721253	EXONIC	YES	NM_001093730.1	Transcript	protein_coding	missense_variant		5/12	NM_001093730.1:c.422A>G	NP_001087199.1:p.Tyr141Cys		-1.0	EF-hand domain, type 2					.	.	.		6.56953e-06	1.0	152218.0	0.0	32	0.97	PASS	afr	2.4122e-05	1.0	0.0	0.0	4.01916e-06	1.0	248808.0	0.0	45	0.97	PASS	sas	3.27332e-05	1.0	0.0	0.0								16.27	1.49996	0.115	3	17	20	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred	SIFT,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	DYTN	0.02	0.0	0.0	0.0	18.0	-15.0	18.0	9.0						0.682	0.0	0.0	0.073	0.205	.			.	.	.	plasma membrane	zinc ion binding	.
834781	chr11	47470355	C	T	chr11:47470355	RAPSN	receptor associated protein of the synapse	14257.0	SNV	0/1	0.45	16_15	33	99	False	rs72905825,COSV100100470	EXONIC	YES	NM_005055.5	Transcript	protein_coding	synonymous_variant		1/8	NM_005055.5:c.162G>A	NP_005046.2:p.Ser54%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Fetal_akinesia_sequence|Myasthenic_syndrome,_congenital,_11,_associated_with_acetylcholine_receptor_deficiency|not_specified|not_provided	Fetal akinesia deformation sequence 2, 618388 (3), Autosomal recessive; Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3), Autosomal recessive	Fetal akinesia deformation sequence;Lethal multiple pterygium syndrome;Postsynaptic congenital myasthenic syndromes	Disease-causing germline mutation(s) (loss of function) in;Candidate gene tested in;Disease-causing germline mutation(s) in	High palate;Long face;Neonatal hypotonia;Ptosis;Autosomal recessive inheritance;Respiratory insufficiency;Arthrogryposis multiplex congenita;Congenital onset;Gowers sign;Decreased fetal movement;Easy fatigability;Feeding difficulties;Skeletal muscle atrophy;Cyanosis;Thoracic kyphoscoliosis;High palate;Reduced tendon reflexes;Easy fatigability;Respiratory failure;EMG: myopathic abnormalities;Restrictive ventilatory defect;Ankle weakness;Fatigable weakness of neck muscles;Weakness of the intrinsic hand muscles;Decreased size of nerve terminals;Neck flexor weakness;Ophthalmoparesis;Reduced vital capacity;Fatigable weakness of respiratory muscles;Exertional dyspnea;Drowsiness;Abnormality of masticatory muscle;Shoulder girdle muscle weakness;Type 1 muscle fiber predominance;Triceps weakness;Weakness of long finger extensor muscles;Ptosis;Decreased miniature endplate potentials;Facial palsy;EMG: decremental response of compound muscle action potential to repetitive nerve stimulation;Delayed gross motor development;Diplopia;Hip flexor weakness;Orthopnea;Pterygium;Generalized amyotrophy;Cryptorchidism;Pulmonary hypoplasia;Dandy-Walker malformation;Intestinal hypoplasia;Micrognathia;Posteriorly rotated ears;Arthrogryposis multiplex congenita;Multiple joint contractures;Respiratory insufficiency;Hypertelorism;Intrauterine growth retardation;Scoliosis;Hypokinesia;Absent palmar crease;Cleft palate;Cystic hygroma;Akinesia;Depressed nasal bridge;Camptodactyly of finger;Polyhydramnios;Excessive daytime somnolence;Fetal akinesia sequence	25741868	0.00333036	507.0	152236.0	0.0	33	0.98	PASS	nfe	0.00512949	349.0	0.00512949	349.0	0.00340615	852.0	250136.0	2.0	94	1.0	PASS	nfe	0.00458213	519.0	0.00458213	519.0	0.0031318	487	0.008	26.0	0.0057	65.0		9.996	0.565136		0	0	0			RAPSN	0.0	0.0	0.0	0.0	-2.0	-4.0	-36.0	-30.0						0.256	0.03	2.368861211			muscle phenotype; homeostasis/metabolism phenotype; respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			ciliary ganglion;uterus corpus;skin;trigeminal ganglion;skeletal muscle;	.	chemical synaptic transmission;synaptic transmission, cholinergic;positive regulation of neuron apoptotic process;positive regulation of neuromuscular synaptic transmission;regulation of postsynaptic membrane organization;establishment of protein localization to postsynaptic membrane	Golgi apparatus;centrosome;cytosol;plasma membrane;cell junction;neuromuscular junction;postsynaptic specialization membrane	acetylcholine receptor binding;ionotropic glutamate receptor binding;protein membrane anchor;metal ion binding	DLG1[30126976];HSP90AB1[22939624];UBE2Z[19549727];
836581	chr1	68947919	A	G	chr1:68947919	DEPDC1	DEP domain containing 1	14312.0	SNV	0/1	0.53	15_17	32	99	False	rs181962816	EXONIC	YES	NM_001114120.3	Transcript	protein_coding	synonymous_variant		8/12	NM_001114120.3:c.1572T>C	NP_001107592.1:p.Tyr524%3D		-1.0						.	.	.		0.00113118	172.0	152054.0	0.0	32	0.97	PASS	amr	0.00301837	46.0	0.00150088	102.0	0.000903401	224.0	247952.0	0.0	100	0.98	PASS	amr	0.00203915	70.0	0.00121236	136.0	0.0007845	122	0.006	20.0				7.457	0.319105		0	0	0			DEPDC1	0.0	0.0	0.0	0.0	38.0	-14.0	-39.0	50.0						0.503	0.0	17.725433453			.			.	.	intracellular signal transduction;positive regulation of GTPase activity;negative regulation of transcription, DNA-templated	nucleus;transcriptional repressor complex	GTPase activator activity;protein binding	MORC3[26496610];KDM3B[26496610];FOXM1[25609649];
836919	chr8	22428590	G	A	chr8:22428590	SORBS3	sorbin and SH3 domain containing 3	14324.0	SNV	0/1	0.58	13_18	31	99	False	rs11543182	EXONIC	YES	NM_005775.5	Transcript	protein_coding	synonymous_variant		18/21	NM_005775.5:c.1599G>A	NP_005766.3:p.Leu533%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00398826	606.0	151946.0	6.0	32	0.95	PASS	nfe	0.00419192	285.0	0.00419192	285.0	0.00502913	1238.0	246166.0	15.0	57	0.98	PASS	nfe	0.00503593	555.0	0.00503593	555.0	0.0043407	675	0.009	27.0				2.615	-0.000583		0	0	0			SORBS3	0.0	0.0	0.0	0.0	20.0	-20.0	-38.0	36.0						0.905	0.0	19.863609894			cellular phenotype; homeostasis/metabolism phenotype; 			trigeminal ganglion;superior cervical ganglion;skeletal muscle;cerebellum;	.	negative regulation of transcription by RNA polymerase II;muscle contraction;actin filament organization;cell adhesion;cell-substrate adhesion;positive regulation of MAPK cascade;positive regulation of cytoskeleton organization;positive regulation of stress fiber assembly	nucleus;cytosol;cytoskeleton;focal adhesion	structural constituent of cytoskeleton;protein binding;transcription factor binding;vinculin binding	CPNE8[unassigned1304];RTKN[19294487];ZBTB25[16189514];CCNH[unassigned1304];WIPF2[unassigned1304];NAB2[unassigned1304];INPPL1[16302969];PLOD3[unassigned1304];CBLB[16189514];CCDC102B[unassigned1304];TEPSIN[unassigned1304];CDC23[unassigned1304];AKT2[unassigned1304];INSC[unassigned1304];CPNE1[unassigned1304];FAM53C[unassigned1304];MGC50722[unassigned1304];DIP2A[25416956];OIP5[unassigned1304];TRIM27[25416956];CPNE2[25416956;unassigned1304];PRKACA[16483316];CCNL1[unassigned1304];ANKS1A[unassigned1304];TBC1D22B[25416956];PPFIA3[unassigned1304];TNS2[unassigned1304];TRIM23[25416956;unassigned1304];DDX17[16189514];IMP3[unassigned1304];COG4[unassigned1304];USP2[unassigned1304];GEM[unassigned1304];NRBP1[unassigned1304];KIAA1217[16189514];ZC2HC1C[unassigned1304];GPANK1[unassigned1304];TXLNA[unassigned1304];HNRNPUL1[25416956];HGS[unassigned1304];RIN1[unassigned1304];KIAA0408[16189514;25416956];VCL[unassigned1304];ROPN1[unassigned1304];DDX6[unassigned1304];ANAPC15[26496610];ZC4H2[25416956];NCKIPSD[25416956];CRACR2A[unassigned1304];HNRNPDL[30021884];DVL2[16189514];ABL1[16831423];SAFB2[12660241];ZBED1[16189514];DVL3[unassigned1304];ZBTB7B[25416956];VARS2[25416956;unassigned1304];SOCS7[15242778;unassigned1304];PIBF1[unassigned1304];ENKD1[unassigned1304];AKIRIN2[unassigned1304];CPSF7[16189514];NEK6[unassigned1304];TCEANC[unassigned1304];OSGIN1[unassigned1304];PHETA1[unassigned1304];CHERP[unassigned1304];TSGA10[unassigned1304];HNRNPK[16189514;25416956;unassigned1304];QARS[unassigned1304];DLG5[12657639];HNRNPF[unassigned1304];ALB[15174051];FNDC11[unassigned1304];MKRN3[unassigned1304];ZNF414[unassigned1304];CCDC22[26496610];NFKBID[unassigned1304];SETD5[unassigned1304];RARG[15734736];CCDC120[unassigned1304];SH2D4A[25416956;unassigned1304];PHF1[unassigned1304];FASLG[19807924];WASL[16483316;18662323];PPP1R18[unassigned1304];SYNCRIP[26496610];GYS1[unassigned1304];NHSL2[unassigned1304];ADAMTSL4[16189514];IQUB[unassigned1304];PLEKHN1[unassigned1304];CCHCR1[unassigned1304];NCK1[26871637];TEAD4[unassigned1304];VPS37C[25416956;unassigned1304];VPS37B[25416956];CBFA2T2[unassigned1304];EIF3S3[25416956];RAD51D[unassigned1304];SCNM1[unassigned1304];SYNPO2L[unassigned1304];POLR1C[unassigned1304];EFHC1[unassigned1304];NAF1[unassigned1304];KIFC3[unassigned1304];SAXO1[25416956];GAS8[unassigned1304];CATSPER1[unassigned1304];KANK2[unassigned1304];TSGA10IP[unassigned1304];CFAP206[unassigned1304];FAM214B[unassigned1304];GLRA1[unassigned1304];EFS[16189514];KATNA1[26496610];C1orf109[unassigned1304];WASF1[16483316];PAK2[16374509;21516116;25416956];WASF2[16483316];PAK5[25416956];RUNX1T1[unassigned1304];TRIM41[25416956];CDKN2C[unassigned1304];GPKOW[unassigned1304];CCDC57[unassigned1304];FBXL19[unassigned1304];PNMA5[unassigned1304];SORBS3[25416956];ADAT3[unassigned1304];PLEKHA7[28877994];ABI2[unassigned1304];POLE2[unassigned1304];CCDC6[unassigned1304];EIF3H[unassigned1304];KRAS[26496610];RBMX[16189514];SPG21[unassigned1304];PPIL6[unassigned1304];
836968	chr11	1016939	G	A	chr11:1016939	MUC6	mucin 6, oligomeric mucus/gel-forming	14330.0	SNV	0/1	0.12	102_14	116	99	False	rs751140580	EXONIC	YES	NM_005961.3	Transcript	protein_coding	synonymous_variant		31/33	NM_005961.3:c.5862C>T	NP_005952.2:p.Thr1954%3D		-1.0						.	.	.		0.00423625	519.0	122514.0	0.0	249	0.98	PASS	amr	0.00822973	94.0	0.00368962	196.0	0.0	0.0	249710.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0002122	33						0.79	-0.185764		0	0	0			MUC6	0.0	0.0	0.0	0.0	2.0	30.0	32.0	26.0						0.987	0.0	82.158597477			.			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;maintenance of gastrointestinal epithelium	extracellular region;Golgi lumen;plasma membrane	extracellular matrix structural constituent	.
836969	chr11	1016950	C	T	chr11:1016950	MUC6	mucin 6, oligomeric mucus/gel-forming	14330.0	SNV	0/1	0.11	94_12	106	99	False	rs779355790	EXONIC	YES	NM_005961.3	Transcript	protein_coding	missense_variant		31/33	NM_005961.3:c.5851G>A	NP_005952.2:p.Val1951Met		-1.0						.	.	.		0.00141435	179.0	126560.0	0.0	239	0.99	PASS	amr	0.00285426	34.0	0.00107359	59.0	4.00513e-06	1.0	249680.0	0.0	100	1.0	RF	nfe	8.84377e-06	1.0	8.84377e-06	1.0	0.0001865	29						4.987	0.144457	0.053	0	18	18		SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC6	0.0	0.0	0.0	0.0	-9.0	19.0	25.0	15.0						0.987	0.0	55.748692685	0.0	-1.161	.			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;maintenance of gastrointestinal epithelium	extracellular region;Golgi lumen;plasma membrane	extracellular matrix structural constituent	.
837043	chr11	1018112	T	C	chr11:1018112	MUC6	mucin 6, oligomeric mucus/gel-forming	14330.0	SNV	0|1	0.15	47_8	55	99	False	rs12793421	EXONIC	YES	NM_005961.3	Transcript	protein_coding	synonymous_variant		31/33	NM_005961.3:c.4689A>G	NP_005952.2:p.Ser1563%3D		-1.0						.	.	.		0.00661385	581.0	87846.0	0.0	51	0.86	AS_VQSR	afr	0.00949821	212.0	0.00503204	201.0	0.000299334	61.0	203786.0	0.0	100	1.0	RF	amr	0.00110988	26.0	0.000197917	19.0	0.0007009	109						0.569	-0.23484		0	0	0			MUC6	0.0	0.0	0.0	0.0	36.0	-2.0	38.0	-2.0						0.987	0.0	29.903524068			.			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;maintenance of gastrointestinal epithelium	extracellular region;Golgi lumen;plasma membrane	extracellular matrix structural constituent	.
837051	chr11	1018187	G	T	chr11:1018187	MUC6	mucin 6, oligomeric mucus/gel-forming	14330.0	SNV	0|1	0.13	34_5	39	99	False	rs796905108	EXONIC	YES	NM_005961.3	Transcript	protein_coding	synonymous_variant		31/33	NM_005961.3:c.4614C>A	NP_005952.2:p.Thr1538%3D		-1.0						.	.	.		0.00078036	100.0	128146.0	0.0	55	0.94	AS_VQSR	sas	0.00173697	7.0	0.00043293	25.0					100	1.0							0.0000643	10	0.0	1.0				0.222	-0.371942		0	0	0			MUC6	0.0	0.0	0.0	0.0	-39.0	41.0	6.0	31.0						0.987	0.0	59.348343019			.			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;maintenance of gastrointestinal epithelium	extracellular region;Golgi lumen;plasma membrane	extracellular matrix structural constituent	.
837052	chr11	1018191	A	G	chr11:1018191	MUC6	mucin 6, oligomeric mucus/gel-forming	14330.0	SNV	0|1	0.12	36_5	41	99	False	rs796499929	EXONIC	YES	NM_005961.3	Transcript	protein_coding	missense_variant		31/33	NM_005961.3:c.4610T>C	NP_005952.2:p.Val1537Ala		-1.0						.	.	.		0.000780627	94.0	120416.0	0.0	54	0.9	AS_VQSR	afr	0.00114029	37.0	0.000492881	27.0					100	1.0							0.0000514	8	0.0	1.0				3.783	0.07146	0.082	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC6	0.0	0.0	0.0	0.0	12.0	-43.0	27.0	2.0						0.987	0.0	59.348343019	0.0	-2.292	.			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;maintenance of gastrointestinal epithelium	extracellular region;Golgi lumen;plasma membrane	extracellular matrix structural constituent	.
837059	chr11	1018226	TAGC		chr11:1018226-1018229	MUC6	mucin 6, oligomeric mucus/gel-forming	14330.0	deletion	0/1	0.22	28_8	36	99	False	rs1287460696	EXONIC	YES	NM_005961.3	Transcript	protein_coding	frameshift_variant		31/33	NM_005961.3:c.4572_4575del	NP_005952.2:p.Leu1525IlefsTer66		-1.0						.	.	.		0.00177608	231.0	130062.0	0.0	40	0.86	AS_VQSR	afr	0.00233356	83.0	0.00138255	80.0					100	1.0														24.5	3.350239		0	0	0			MUC6	0.0	0.0	0.0	0.0	-34.0	-22.0	-11.0	-7.0						0.987	0.0	76.708318039,0.000000000,7.450055530			.			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;maintenance of gastrointestinal epithelium	extracellular region;Golgi lumen;plasma membrane	extracellular matrix structural constituent	.
837063	chr11	1018248	G	A	chr11:1018248	MUC6	mucin 6, oligomeric mucus/gel-forming	14330.0	SNV	0|1	0.34	29_15	44	99	False	rs1294426710	EXONIC	YES	NM_005961.3	Transcript	protein_coding	missense_variant		31/33	NM_005961.3:c.4553C>T	NP_005952.2:p.Thr1518Ile		-1.0						.	.	.		0.00718331	586.0	81578.0	0.0	46	0.89	AS_VQSR	afr	0.00961715	209.0	0.00492597	181.0					100	1.0														21.3	2.189201	0.23	6	13	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred,fathmm-MKL_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	MUC6	0.0	0.0	0.0	0.0	-20.0	32.0	2.0	-30.0						0.987	0.0	0.000000000	0.018	0.999	.			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;maintenance of gastrointestinal epithelium	extracellular region;Golgi lumen;plasma membrane	extracellular matrix structural constituent	.
837260	chr8	121824011	G	T	chr8:121824011	SNTB1	syntrophin beta 1	14338.0	SNV	0/1	0.53	18_20	38	99	False	rs138763501	EXONIC	YES	NM_021021.4	Transcript	protein_coding	missense_variant		1/7	NM_021021.4:c.73C>A	NP_066301.1:p.Leu25Met		-1.0	Pleckstrin homology domain&Pleckstrin homology domain,Pleckstrin homology domain&Pleckstrin homology domain,.					.	.	.		0.000809189	123.0	152004.0	1.0	32	0.98	PASS	sas	0.0026904	13.0	0.000823869	56.0	0.00162329	258.0	158936.0	1.0	14	0.27	PASS	sas	0.00420826	86.0	0.00119759	87.0	0.0011189	174	0.001	2.0				24.7	3.420096	0.131	6	15	21	SIFT,PolyPhen,M-CAP_pred,MutationAssessor_pred,PrimateAI_pred,fathmm-MKL_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	SNTB1	0.0	0.0	0.0	0.0	-37.0	-10.0	-41.0	2.0						0.482	0.62	0.000000000	0.997	1.083	.			.	.	muscle contraction	cytoplasm;cytoskeleton;focal adhesion;dystrophin-associated glycoprotein complex;protein-containing complex;sarcolemma;synapse	actin binding;structural molecule activity;protein binding;calmodulin binding;PDZ domain binding	ABCA1[16192269];GUCY1A2[30126976];MORC3[26496610];FRMPD4[30126976];ASNSD1[30126976];MAPK12[30126976];SAV1[24255178];TANC1[30126976];CYSLTR2[30126976];SLC16A7[30126976];DMD[7844150;8576247];UTRN[8576247];EZR[29568061];
837349	chr16	29908316	C	G	chr16:29908316	SEZ6L2	seizure related 6 homolog like 2	14346.0	SNV	0/1	0.45	18_15	33	99	False	rs367921747,COSV58099390	EXONIC	YES	NM_001243332.2	Transcript	protein_coding	missense_variant		3/18	NM_001243332.2:c.338G>C	NP_001230261.1:p.Arg113Thr		-1.0	.,.,.,.,.					.	.	.		8.54207e-05	13.0	152188.0	0.0	32	0.96	PASS	sas	0.00165494	8.0	5.88114e-05	4.0	0.000247031	50.0	202404.0	1.0	49	0.61	PASS	sas	0.00131148	36.0	0.000102559	9.0	0.0000064,0.0001865	1,29	0.001	2.0	0.00027	3.0		20.4	2.076767	0.068	4	15	19	LRT_pred,M-CAP_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	SEZ6L2	0.05	0.08	0.0	0.0	-9.0	-45.0	13.0	5.0						0.607	0.13	0.000000000	0.997	1.026	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 			caudate nucleus;pituitary;amygdala;prefrontal cortex;cerebellum peduncles;cerebellum;pons;fetal brain;occipital lobe;subthalamic nucleus;whole brain;parietal lobe;globus pallidus;medulla oblongata;thalamus;	.	.	endoplasmic reticulum membrane;plasma membrane;integral component of membrane	.	FOXA1[21988832];TK1[21988832];ETV5[21988832];UNG[21988832];OASL[21988832];
843304	chr19	55865329	G	A	chr19:55865329	COX6B2	cytochrome c oxidase subunit 6B2	14392.0	SNV	0|1	0.68	13_27	40	99	False	rs199757828	EXONIC	YES	NM_001369798.1	Transcript	protein_coding	missense_variant		3/8	NM_001369798.1:c.118C>T	NP_001356727.1:p.His40Tyr		-1.0	.,.,.,.,.					.	.	.		0.00151252	230.0	152064.0	0.0	30	0.94	PASS	nfe	0.00272187	185.0	0.00272187	185.0	0.00147345	218.0	147952.0	0.0	55	0.58	PASS	nfe	0.00282231	169.0	0.00282231	169.0	0.0005916	92	0.001	2.0				23.0	2.742267	0.2	7	11	18	PolyPhen,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	COX6B2	0.03	0.0	0.0	0.0	-15.0	-20.0	2.0	-48.0						0.569	0.05	0.000000000	0.819	1.013	.			.	Oxidative phosphorylation	.	mitochondrion;mitochondrial intermembrane space;mitochondrial crista	protein binding	FRMD6[25416956];PROP1[unassigned1304];TNS2[25814554];
843319	chr6	142397030	G	A	chr6:142397030	NMBR	neuromedin B receptor	14396.0	SNV	0/1	0.6	10_15	25	99	False	rs142626832	EXONIC	YES	NM_002511.4	Transcript	protein_coding	missense_variant		4/4	NM_002511.4:c.928C>T	NP_002502.2:p.Arg310Trp		-1.0	GPCR, rhodopsin-like, 7TM	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00443769	675.0	152106.0	5.0	32	0.96	PASS	amr	0.00793651	121.0	0.00681992	464.0	0.00457487	1148.0	250936.0	6.0	57	1.0	PASS	nfe	0.0067954	770.0	0.0067954	770.0	0.0045144	702	0.009	28.0				25.2	3.549729	0.432	12	9	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	NMBR	0.0	0.0	0.0	0.0	-11.0	26.0	48.0	-2.0						0.635	0.0	0.000000000	0.989	0.183	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; 			ciliary ganglion;dorsal root ganglion;skin;atrioventricular node;superior cervical ganglion;trigeminal ganglion;	Neuroactive ligand-receptor interaction	G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway;bombesin receptor signaling pathway	cytosol;plasma membrane;integral component of plasma membrane	G protein-coupled receptor activity;bombesin receptor activity	MOB1A[17353931];OAT[17353931];
843587	chr11	67925546	T	C	chr11:67925546	KMT5B	lysine methyltransferase 5B	14412.0	SNV	0/1	0.43	13_10	23	99	False	rs144458991	EXONIC	YES	NM_001369426.1	Transcript	protein_coding	missense_variant		11/11	NM_001369426.1:c.2267A>G	NP_001356355.1:p.Asn756Ser		-1.0	.,.	Likely_benign	criteria_provided,_single_submitter	not_provided	Mental retardation, autosomal dominant 51, 617788 (3), Autosomal dominant	.	.	Febrile seizure (within the age range of 3 months to 6 years);Delayed speech and language development;Global developmental delay;Autosomal dominant inheritance;Cryptorchidism;Intellectual disability;Abnormality of the foot;Autistic behavior	29182452	0.0030219	460.0	152222.0	0.0	32	0.97	PASS	nfe	0.00479116	326.0	0.00479116	326.0	0.00315061	792.0	251380.0	3.0	100	1.0	PASS	nfe	0.00461815	525.0	0.00461815	525.0	0.0027588	429	0.002	7.0	0.00447	51.0		11.26	0.71395	0.079	2	15	17	LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	SUV420H1	0.0	0.0	0.0	0.0	-1.0	-12.0	1.0	30.0								0.000000000	0.993	1.066	cellular phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; skeleton phenotype; immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; 			.	.	muscle organ development;histone H4-K20 trimethylation	condensed nuclear chromosome, centromeric region;nucleus;nucleoplasm	histone-lysine N-methyltransferase activity;histone methyltransferase activity (H4-K20 specific)	TSPYL2[unassigned1304];SMARCD1[21988832];BRD1[27142060];YWHAQ[17353931];KSR1[27086506];YWHAZ[30021884];YWHAG[17353931];
843606	chr11	67925970	G	T	chr11:67925970	KMT5B	lysine methyltransferase 5B	14412.0	SNV	0/1	0.5	15_15	30	99	False	rs148005738	EXONIC	YES	NM_001369426.1	Transcript	protein_coding	synonymous_variant		11/11	NM_001369426.1:c.1843C>A	NP_001356355.1:p.Arg615%3D		-1.0					Mental retardation, autosomal dominant 51, 617788 (3), Autosomal dominant	.	.	Febrile seizure (within the age range of 3 months to 6 years);Delayed speech and language development;Global developmental delay;Autosomal dominant inheritance;Cryptorchidism;Intellectual disability;Abnormality of the foot;Autistic behavior		0.00209133	318.0	152056.0	0.0	32	0.97	PASS	nfe	0.0035582	242.0	0.0035582	242.0	0.00200579	504.0	251272.0	1.0	78	0.99	PASS	nfe	0.00315196	358.0	0.00315196	358.0	0.0017942	279	0.002	6.0	0.00263	30.0		8.795	0.437869		0	0	0			SUV420H1	0.0	0.0	0.0	0.0	50.0	-24.0	21.0	30.0								11.988362743			cellular phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; skeleton phenotype; immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; 			.	.	muscle organ development;histone H4-K20 trimethylation	condensed nuclear chromosome, centromeric region;nucleus;nucleoplasm	histone-lysine N-methyltransferase activity;histone methyltransferase activity (H4-K20 specific)	TSPYL2[unassigned1304];SMARCD1[21988832];BRD1[27142060];YWHAQ[17353931];KSR1[27086506];YWHAZ[30021884];YWHAG[17353931];
845468	chr2	108496506	A	G	chr2:108496506	RGPD4	RANBP2-like and GRIP domain containing 4	14483.0	SNV	0/1	0.46	13_11	24	99	False	rs368994910	EXONIC	YES	NM_182588.3	Transcript	protein_coding	synonymous_variant		21/23	NM_182588.3:c.5007A>G	NP_872394.2:p.Leu1669%3D		1.0						.	.	.		0.000731592	111.0	151724.0	0.0	29	0.89	PASS	sas	0.00144988	7.0	0.00114642	78.0	0.000936054	235.0	251054.0	0.0	100	1.0	PASS	sas	0.00179656	55.0	0.00111107	126.0	0.0007460	116	0.002	5.0				7.736	0.341621		0	0	0			RGPD4	0.0	0.0	0.0	0.0	-7.0	-49.0	24.0	-14.0											.			.	.	NLS-bearing protein import into nucleus;positive regulation of GTPase activity	nucleus;nuclear pore;cytoplasm	GTPase activator activity;Ran GTPase binding	UVRAG[20562859];PLK1[19596235];
846027	chr9	95888759	G	C	chr9:95888759	NINJ1	ninjurin 1	14497.0	SNV	0/1	0.58	10_14	24	99	False	COSV64922584	EXONIC	YES	NM_004148.4	Transcript	protein_coding	synonymous_variant		2/4	NM_004148.4:c.237C>G	NP_004139.2:p.Pro79%3D		-1.0						.	.	.						32	0.96											62	1.0														11.98	0.802886		0	0	0			NINJ1	0.0	0.0	0.0	0.0	47.0	-37.0	1.0	-3.0						0.312	0.06	9.834911360			cellular phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			.	.	positive regulation of cell-matrix adhesion;cell adhesion;nervous system development;tissue regeneration;hyaloid vascular plexus regression	integral component of membrane	protein binding	TIMMDC1[unassigned1304];GOLM1[unassigned1304];GPX8[unassigned1304];AQP6[unassigned1304];FNDC9[unassigned1304];LIME1[unassigned1304];PVR[unassigned1304];KRT40[25416956];CEACAM3[unassigned1304];CD200R1[unassigned1304];MUC1[unassigned1304];EBP[unassigned1304];CYB5R3[unassigned1304];SGCB[unassigned1304];CREB3L1[unassigned1304];TMEM56[unassigned1304];HIVEP1[21988832];FCGR1A[unassigned1304];TMEM14B[unassigned1304];
849044	chr14	77493831	GCGGCGGCGGCGGCGGCCGCCGCTGCTGCCGCCGCCGCCGCCGCTTCCTTAGCCGACAGGGCCACTGTCTTGACCCCGACGG		chr14:77493831-77493912	IRF2BPL	interferon regulatory factor 2 binding protein like	14586.0	deletion	0/1	0.15	22_4	26	99	False	rs1566786983	EXONIC	YES	NM_024496.4	Transcript	protein_coding	frameshift_variant		1/1	NM_024496.4:c.224_305del	NP_078772.1:p.Pro75ArgfsTer50		-1.0					Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures, 618088 (3), Autosomal dominant	.	.	Intellectual disability;Nystagmus;Cerebellar atrophy;Choreoathetosis;Dysmetria;Dysarthria;Loss of speech;Cerebral atrophy;Seizure;Dysphagia;Esotropia;Generalized hypotonia;Dystonia;Developmental regression;Spasticity;Progressive;Global developmental delay;Corpus callosum atrophy;Autosomal dominant inheritance;Weakness of facial musculature		0.000150353	22.0	146322.0	0.0	30	0.83	AS_VQSR	amr	0.000203087	3.0	6.04778e-05	4.0	0.00876261	363.0	41426.0	0.0	4	0.06	RF	eas	0.0837104	37.0	0.00419776	72.0								29.8	4.240266		0	0	0																		0.97	18.345625187,0.000000000,2.884614879,0.000000000,3.032322512			.			skin;cerebellum;	.	negative regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;development of secondary female sexual characteristics	extracellular space;nucleus;nucleoplasm	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;molecular_function;metal ion binding	RNF169[21252943];UBE2Q1[19690564];IRF2[21903422];MKI67[26949251];
852296	chr3	19961364	A	T	chr3:19961364	EFHB	EF-hand domain family member B	14660.0	SNV	0/1	0.42	7_5	12	99	False	rs1342968939	EXONIC	YES	NM_144715.4	Transcript	protein_coding	synonymous_variant		3/13	NM_144715.4:c.957T>A	NP_653316.3:p.Pro319%3D		-1.0						.	.	.		1.31406e-05	2.0	152200.0	0.0	32	0.95	PASS	nfe	2.93997e-05	2.0	2.93997e-05	2.0	7.9673e-06	2.0	251026.0	0.0	76	1.0	PASS	nfe	1.76379e-05	2.0	1.76379e-05	2.0								0.491	-0.25685		0	0	0			EFHB	0.0	0.0	0.0	0.0	43.0	-21.0	-39.0	-33.0						0.983	0.0	81.571935412			.			.	.	.	.	calcium ion binding	.
853070	chr16	30012275	G	T	chr16:30012275	INO80E	INO80 complex subunit E	14689.0	SNV	0/1	0.59	13_19	32	99	False	rs149544726,COSV54231039,COSV99662751	EXONIC	YES	NM_173618.3	Transcript	protein_coding	missense_variant		5/7	NM_173618.3:c.310G>T	NP_775889.1:p.Ala104Ser		1.0	.,.,.,.,.					.	.	.		0.000985584	150.0	152194.0	1.0	32	0.98	PASS	nfe	0.00158758	108.0	0.00158758	108.0	0.000741155	167.0	225324.0	0.0	31	0.69	PASS	nfe	0.00114823	117.0	0.00114823	117.0	0.0006109	95	0.001	4.0				4.347	0.10515	0.009	0	18	18		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	INO80E	0.02	0.01	0.0	0.0	40.0	-21.0	40.0	-5.0						0.344	0.02	0.0	0.751	-0.536	growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			ciliary ganglion;testis - interstitial;subthalamic nucleus;trigeminal ganglion;skin;superior cervical ganglion;globus pallidus;	.	DNA repair;DNA recombination;chromatin remodeling;protein deubiquitination	nucleus;nucleoplasm;nucleolus;Ino80 complex	protein binding	INO80C[16230350;21303910;18922472];INO80B[16230350;21303910;18922472];TNFAIP8[25416956];PRKAA1[25416956];INO80D[16230350;21303910;18922472];YY1[21303910;18922472;27705803;27939641];TBRG1[25416956];TFPT[16230350;21303910;18922472];SDCBP[25416956;unassigned1304];FAM124A[25416956];CDC23[unassigned1304];RUVBL2[16230350;21303910;18922472];NHLH1[21988832];RUVBL1[16230350;21303910;18922472;27939641];IKBKG[21988832];KPNA2[25416956];NFRKB[16230350;21303910;18922472];APPL1[25814554];MCRS1[16230350;21303910;18922472;unassigned1304];ACTR5[16230350;21303910;18922472;26496610];ACTL6A[16230350;21303910;18922472];ADRM1[18922472];ACTR8[16230350;21303910;18922472];INO80[16230350;21303910;18922472];YY1AP1[27939641];UCHL5[19615732;21303910;18922472];GEM[25416956;unassigned1304];AES[unassigned1304];MAB21L3[unassigned1304];PSMA1[25416956];MORN4[25416956];FAM161A[unassigned1304];LNX1[unassigned1304];PICK1[unassigned1304];PIN1[unassigned1304];CRK[25814554];PHF19[unassigned1304];
853145	chr12	7807217	C	T	chr12:7807217	APOBEC1	apolipoprotein B mRNA editing enzyme catalytic subunit 1	14694.0	SNV	0/1	0.53	16_18	34	99	False	rs148640043,COSV99981347	EXONIC	YES	NM_001644.5	Transcript	protein_coding	missense_variant		2/5	NM_001644.5:c.28G>A	NP_001635.2:p.Gly10Ser		-1.0	Cytidine and deoxycytidylate deaminase domain					.	.	.		0.00157224	239.0	152012.0	0.0	32	0.96	PASS	nfe	0.00275032	187.0	0.00275032	187.0	0.0014718	370.0	251392.0	1.0	52	1.0	PASS	nfe	0.0024274	276.0	0.0024274	276.0	0.0015884	247	0.002	6.0	0.00231	22.0		13.57	1.02038	0.036	0	20	20		SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	APOBEC1	0.0	0.16	0.0	0.2	-2.0	11.0	-2.0	-16.0						0.828	0.0	0.0	0.213	0.81	homeostasis/metabolism phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); 			superior cervical ganglion;	Atrazine degradation	RNA processing;mRNA processing;lipid metabolic process;triglyceride metabolic process;response to osmotic stress;cytidine deamination;response to zinc ion;response to gamma radiation;cytidine to uridine editing;mRNA modification;cellular response to insulin stimulus;regulation of cell population proliferation;lipoprotein biosynthetic process;lipoprotein transport;positive regulation of catalytic activity;response to ethanol;mRNA stabilization;response to calcium ion;defense response to virus;DNA cytosine deamination;DNA demethylation;negative regulation of triglyceride metabolic process;negative regulation of methylation-dependent chromatin silencing;positive regulation of mRNA modification	nucleus;nucleoplasm;cytoplasm	RNA binding;mRNA binding;cytidine deaminase activity;cytosine deaminase activity;protein binding;enzyme activator activity;zinc ion binding;AU-rich element binding;protein domain specific binding;ribonucleoprotein complex binding	HNRNPK[unassigned1304];CDK6[unassigned1304];HNRNPF[unassigned1304];KRTAP6-2[unassigned1304];NOTO[unassigned1304];KRTAP6-1[unassigned1304];UFSP2[unassigned1304];HNRNPC[unassigned1304];KRTAP19-5[unassigned1304];
853218	chr1	20879923	G	C	chr1:20879923	FAM43B	family with sequence similarity 43 member B	14697.0	SNV	0/1	0.52	11_12	23	99	False	rs527705374	EXONIC	YES	NM_207334.3	Transcript	protein_coding	missense_variant		1/1	NM_207334.3:c.457G>C	NP_997217.1:p.Gly153Arg		1.0	PTB/PI domain&PTB/PI domain&FAM43A/B, phosphotyrosine-binding domain					.	.	.		0.000355305	54.0	151982.0	0.0	33	0.98	PASS	nfe	0.000676809	46.0	0.000676809	46.0	0.000545789	19.0	34812.0	0.0	2	0.02	PASS	nfe	0.000962861	14.0	0.000962861	14.0	0.0000579	9						22.2	2.333937	0.117	2	15	17	M-CAP_pred,PrimateAI_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FAM43B	0.0	0.0	0.0	0.0	42.0	1.0	41.0	-1.0									0.998	0.988	.			superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	.	.	.	.
854030	chr10	69908113	C	T	chr10:69908113	MYPN	myopalladin	14714.0	SNV	0/1	0.54	19_22	41	99	False	rs145701607,COSV62738221	EXONIC	YES	NM_001256267.2	Transcript	protein_coding	synonymous_variant		6/21	NM_001256267.2:c.1134C>T	NP_001243196.1:p.Ile378%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Dilated_cardiomyopathy_1KK|not_specified|Cardiovascular_phenotype|not_provided	Cardiomyopathy, hypertrophic, 22, 615248 (3), Autosomal dominant; Cardiomyopathy, familial restrictive, 4, 615248 (3), Autosomal dominant; Cardiomyopathy, dilated, 1KK, 615248 (3), Autosomal dominant; Nemaline myopathy 11, autosomal recessive, 617336 (3), Autosomal recessive	Childhood-onset nemaline myopathy;Familial isolated dilated cardiomyopathy;Cap myopathy;Familial isolated restrictive cardiomyopathy	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Neuromuscular dysphagia;Scoliosis;Limb muscle weakness;EMG: myopathic abnormalities;Slender build;Narrow face;Generalized hypotonia;Clumsiness;Fetal akinesia sequence;Pes cavus;Generalized limb muscle atrophy;Reduced vital capacity;Increased muscle lipid content;Nemaline bodies;Cardiomyopathy;Breech presentation;Narrow chest;Muscle stiffness;Waddling gait;Micrognathia;Difficulty walking;Areflexia;Long face;Feeding difficulties;Hyporeflexia;Hypertelorism;Neck muscle weakness;Polyhydramnios;Increased variability in muscle fiber diameter;Mildly elevated creatine kinase;Motor delay;Spinal rigidity;Ptosis;High palate;Bulbar signs;Type 1 muscle fiber predominance;Respiratory insufficiency due to muscle weakness;Arthrogryposis multiplex congenita;Exercise intolerance;Facial diplegia;Bradykinesia;Scapular winging;Fatigable weakness of bulbar muscles;Pectus excavatum;Pes cavus;Facial palsy;Gowers sign;Talipes equinovarus;Cardiomyopathy;High palate;Nemaline bodies;Reduced vital capacity;Slow progression;Autosomal recessive inheritance;Waddling gait;Scapular winging;Autosomal dominant inheritance;Atrial fibrillation;Ventricular septal hypertrophy;Mitral regurgitation;Hypertrophic cardiomyopathy;Congestive heart failure;Dilated cardiomyopathy;Left ventricular hypertrophy;Lumbar hyperlordosis;Aortic root aneurysm;High palate;Lower limb amyotrophy;Reduced tendon reflexes;Motor delay;Gowers sign;Reduced systolic function;Toe walking;Poor head control;Sinus tachycardia;Mitral valve prolapse;Increased variability in muscle fiber diameter;Pectus excavatum;Facial palsy;Generalized hypotonia;Long face;Difficulty running;Thoracic scoliosis;Lower limb muscle weakness;Frequent falls;Central hypoventilation;Nasal speech;Pes valgus;Fatiguable weakness of proximal limb muscles;Difficulty climbing stairs;Pes planus;Easy fatigability;Generalized amyotrophy;Palmoplantar keratoderma;EMG abnormality;Lipoatrophy;Dilated cardiomyopathy;Elevated serum creatine kinase;Abnormality of neutrophils;Sensorineural hearing impairment;Myopathy;Hepatomegaly;Pulmonary venous hypertension;Orthopnea;Tricuspid regurgitation;Hypertrophic cardiomyopathy;Atrial fibrillation;Interstitial cardiac fibrosis;Thromboembolism;Peripheral edema;Mitral regurgitation;Stroke;Left atrial enlargement;Postnatal growth retardation;Left ventricular dysfunction;Syncope;Right atrial enlargement;Pulmonary edema;Recurrent respiratory infections	24033266	0.00523908	797.0	152126.0	3.0	32	0.97	PASS	sas	0.00871369	42.0	0.00805574	548.0	0.00613055	1541.0	251364.0	10.0	91	1.0	PASS	sas	0.00966878	296.0	0.00782061	889.0	0.0058777	914	0.009	30.0	0.00807	92.0		12.59	0.882312		0	0	0			MYPN	0.0	0.11	0.0	0.0	44.0	-3.0	-3.0	15.0						0.578	0.07	17.594630142			muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; 			ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	homophilic cell adhesion via plasma membrane adhesion molecules;axon guidance;sarcomere organization;dendrite self-avoidance	nucleus;plasma membrane;Z disc;axon;I band	actin binding;protein binding;cytoskeletal protein binding;SH3 domain binding;muscle alpha-actinin binding;cell-cell adhesion mediator activity	BAG6[26496610];PDLIM3[23414517];CAPZA2[26496610];NEB[12482578];GTSE1[26496610];
855663	chr1	16531261	G	A	chr1:16531261	ARHGEF19	Rho guanine nucleotide exchange factor 19	14751.0	SNV	0/1	0.46	15_13	28	99	False	rs150370119,COSV99580759	EXONIC	YES	NM_153213.5	Transcript	protein_coding	missense_variant		12/16	NM_153213.5:c.1900C>T	NP_694945.2:p.Arg634Trp		-1.0	Pleckstrin homology domain&Pleckstrin homology domain					.	.	.		0.000164277	25.0	152182.0	0.0	33	0.98	PASS	amr	0.000524109	8.0	0.000205798	14.0	0.000131193	32.0	243916.0	0.0	29	0.76	PASS	nfe	0.000245151	27.0	0.000245151	27.0	0.0000900	14						25.0	3.510502	0.262	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,ClinPred_pred,LIST-S2_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ARHGEF19	0.0	0.0	0.02	0.0	-7.0	-6.0	-31.0	-7.0						0.846	0.0	0.0	0.995	-0.198	.			ciliary ganglion;dorsal root ganglion;skin;atrioventricular node;	.	G protein-coupled receptor signaling pathway;regulation of actin cytoskeleton organization;regulation of Rho protein signal transduction;wound healing;positive regulation of apoptotic process;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction;Wnt signaling pathway, planar cell polarity pathway	cytosol	guanyl-nucleotide exchange factor activity;Rho guanyl-nucleotide exchange factor activity;GTPase activator activity;protein binding	DAAM1[18256687];DVL1[18256687];RAC1[18256687];RHOA[18256687];PAK5[unassigned1304];
855706	chr16	75240087	G	A	chr16:75240087	CTRB2	chymotrypsinogen B2	14755.0	SNV	0/1	0.42	15_11	26	99	False	rs3743611,COSV57315294	EXONIC	YES	NM_001025200.4	Transcript	protein_coding	synonymous_variant		2/7	NM_001025200.4:c.57C>T	NP_001020371.3:p.Cys19%3D		-1.0						.	.	.		0.00471859	718.0	152164.0	3.0	29	0.93	PASS	amr	0.00903023	138.0	0.00558791	380.0	0.00558886	936.0	167476.0	6.0	25	0.55	PASS	sas	0.00709395	172.0	0.00570008	383.0	0.0038649	601	0.009	28.0				8.757	0.434094		0	0	0			CTRB2	0.03	0.04	0.0	0.0	-30.0	21.0	44.0	9.0							0.28				.			beta cell islets;pancreas;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space	serine-type endopeptidase activity;serine-type peptidase activity	.
861346	chr6	41011758	C	T	chr6:41011758	TSPO2	translocator protein 2	14903.0	SNV	0/1	0.53	16_18	34	99	False	rs147405274,COSV55109582	EXONIC	YES	NM_001010873.3	Transcript	protein_coding	missense_variant		4/4	NM_001010873.3:c.395C>T	NP_001010873.1:p.Ala132Val		1.0	.,.					.	.	.		0.00191176	291.0	152216.0	1.0	33	0.98	PASS	amr	0.003663	56.0	0.0029104	198.0	0.00174768	439.0	251190.0	0.0	100	0.98	PASS	nfe	0.00284351	323.0	0.00284351	323.0	0.0017041	265	0.003	10.0				22.0	2.296096	0.157	3	16	19	SIFT,MutationAssessor_pred,PROVEAN_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TSPO2	0.01	0.0	0.0	0.0	24.0	45.0	-47.0	-44.0						0.786	0.0	0.000000000	0.734	1.026	.			.	.	.	endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane	cholesterol binding	RETREG3[unassigned1304];AQP6[unassigned1304];TMEM140[unassigned1304];VSIR[unassigned1304];ASGR2[unassigned1304];MFSD6[unassigned1304];CREB3L1[unassigned1304];FFAR2[unassigned1304];CD53[unassigned1304];SLC34A2[unassigned1304];IGFBP5[unassigned1304];FNDC9[unassigned1304];TMEM80[unassigned1304];NAALADL2[unassigned1304];DKK4[unassigned1304];CLDN4[unassigned1304];ERP29[unassigned1304];MAL[unassigned1304];COL4A5[unassigned1304];PLEKHO1[unassigned1304];RELL2[unassigned1304];ERGIC3[unassigned1304];MS4A1[unassigned1304];LRRC59[unassigned1304];SLC41A3[unassigned1304];GPR42[unassigned1304];MFF[unassigned1304];EFNA5[unassigned1304];CPLX4[unassigned1304];GPR152[unassigned1304];CD79A[unassigned1304];EBP[unassigned1304];CNR2[unassigned1304];ARL13B[unassigned1304];ASZ1[unassigned1304];OSTCL[unassigned1304];STOM[unassigned1304];KLRC1[unassigned1304];FCGR1A[unassigned1304];RPRM[unassigned1304];OR1D4[unassigned1304];GGT7[unassigned1304];SLC10A6[unassigned1304];KCNJ6[unassigned1304];SYT2[unassigned1304];BIK[unassigned1304];AHNAK2[unassigned1304];SPAG4[unassigned1304];PDZK1IP1[unassigned1304];MARCH2[unassigned1304];TMEM54[unassigned1304];GJB5[unassigned1304];CD69[unassigned1304];
861560	chr19	54660654		GGGGG	chr19:54660653-54660654	LENG1	leukocyte receptor cluster member 1	14910.0	insertion	0/1	0.14	12_2	14	47	False		EXONIC	YES	NM_024316.3	Transcript	protein_coding	frameshift_variant		3/4	NM_024316.3:c.418_422dup	NP_077292.2:p.Gly143ArgfsTer127		-1.0						.	.	.		0.000170634	25.0	146512.0	0.0	33	0.97	AS_VQSR	sas	0.00094697	4.0	6.04759e-05	4.0					46	0.96																	0	0	0																	0.88	0.0				.			.	.	biological_process	cellular_component	molecular_function;protein binding	ISY1[unassigned1304];CALCOCO2[25416956];NAB2[25416956;unassigned1304];IKZF3[unassigned1304];CCDC102B[25416956];GOLGA2[25416956;27107012;unassigned1304];UBL5[unassigned1304];GOLGA6L9[unassigned1304];OIP5[unassigned1304];TRIM27[25416956];CCHCR1[unassigned1304];LZTS1[unassigned1304];SCYL1[unassigned1304];TRIM23[unassigned1304];KLF10[21900206];CCDC155[25416956];CARD10[unassigned1304];NCBP2[26496610];KRT35[unassigned1304];MTUS2[25416956;unassigned1304];LDOC1[25416956;unassigned1304];TFIP11[25416956];TRAF2[unassigned1304];TSC1[unassigned1304];KRT31[25416956;unassigned1304];MID2[25416956;unassigned1304];PTBP3[22575643];RABEP1[unassigned1304];PRKAR1B[unassigned1304];CEP57L1[25416956];TRIB3[unassigned1304];KIFC3[25416956;unassigned1304];TRIM54[25416956;unassigned1304];ZMYND12[unassigned1304];ROPN1[25416956;unassigned1304];MAD1L1[unassigned1304];NECAB2[25416956];KANK2[unassigned1304];USHBP1[25416956];SPATA2[unassigned1304];ASB12[unassigned1304];OSGEP[21900206];STX11[25416956];KRT40[25416956;unassigned1304];BEGAIN[unassigned1304];MIPOL1[unassigned1304];PNMA1[16169070];CEP70[25416956;unassigned1304];PSMB1[unassigned1304];FSD2[25416956;unassigned1304];C14orf119[unassigned1304];DISC1[unassigned1304];EVI5[unassigned1304];CDR2[25416956;unassigned1304];PAK5[25416956];BANP[25416956];PRPH[unassigned1304];ZRANB1[unassigned1304];CCDC57[25416956;unassigned1304];CCDC136[25416956];PLK2[26496610];CARD9[25416956;unassigned1304];KRTAP10-8[unassigned1304];PDE4DIP[25416956];MRPL28[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];MEIS3[unassigned1304];LRP2BP[unassigned1304];GFAP[unassigned1304];KRT19[unassigned1304];NAGK[21900206];DES[unassigned1304];HOOK2[unassigned1304];ABI2[unassigned1304];UBXN11[unassigned1304];TMEM239[25416956];REL[unassigned1304];TCF4[25416956];CDR2L[unassigned1304];SPERT[25416956];
861617	chr7	1590477	C	T	chr7:1590477	TMEM184A	transmembrane protein 184A	14916.0	SNV	0/1	0.44	24_19	43	99	False	rs766787488	EXONIC	YES	NM_001097620.2	Transcript	protein_coding	missense_variant		3/9	NM_001097620.2:c.361G>A	NP_001091089.1:p.Asp121Asn		-1.0	.,.,.,.,.					.	.	.		8.54207e-05	13.0	152188.0	0.0	32	0.97	PASS	nfe	0.000161684	11.0	0.000161684	11.0	7.63267e-05	19.0	248930.0	0.0	67	1.0	PASS	nfe	0.000115254	13.0	0.000115254	13.0	0.0000772	12						17.53	1.707523	0.067	4	14	18	MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	TMEM184A	0.0	0.0	0.0	0.01	17.0	40.0	17.0	-45.0						0.75	0.0	0.000000000	0.943	0.999	.			.	.	.	endosome;plasma membrane;integral component of membrane;transport vesicle membrane;cytoplasmic vesicle membrane;secretory granule membrane;early endosome membrane;perinuclear region of cytoplasm	heparin binding	AHNAK[30021884];RCHY1[21988832];
864490	chr18	67562941	G	A	chr18:67562941	CD226	CD226 molecule	15023.0	SNV	0/1	0.37	22_13	35	99	False	rs142661943	EXONIC	YES	NM_001303618.2	Transcript	protein_coding	synonymous_variant		3/6	NM_001303618.2:c.723C>T	NP_001290547.1:p.Ala241%3D		-1.0						.	.	.		0.000295916	45.0	152070.0	0.0	32	0.96	PASS	amr	0.000982704	15.0	0.000352952	24.0	0.000243255	61.0	250766.0	0.0	81	0.98	PASS	amr	0.000636427	22.0	0.000300279	34.0	0.0001543	24	0.002	7.0	0.00271	5.0		0.797	-0.18449		0	0	0			CD226	0.0	0.0	0.0	0.01	-49.0	47.0	-2.0	-4.0						0.469	0.51	68.800996745			homeostasis/metabolism phenotype; immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; neoplasm; 			ciliary ganglion;superior cervical ganglion;trigeminal ganglion;	Cell adhesion molecules (CAMs)	cytokine production;positive regulation of natural killer cell cytokine production;positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target;positive regulation of immunoglobulin mediated immune response;cell adhesion;signal transduction;cell recognition;positive regulation of interferon-gamma production;positive regulation of mast cell activation;positive regulation of natural killer cell mediated cytotoxicity;regulation of immune response;positive regulation of T cell receptor signaling pathway;positive regulation of Fc receptor mediated stimulatory signaling pathway	plasma membrane;integral component of plasma membrane;external side of plasma membrane;cell surface;membrane raft	integrin binding;protein binding;protein kinase binding;cell adhesion molecule binding	CD226[25465800];TIGIT[25465800];PVR[21982860];NECTIN2[21982860];
865386	chr17	56676443	A	G	chr17:56676443	TEX14	testis expressed 14, intercellular bridge forming factor	15069.0	SNV	0/1	0.5	12_12	24	99	False	rs55927508	EXONIC	YES	NM_001201457.2	Transcript	protein_coding	synonymous_variant		14/33	NM_001201457.2:c.2281T>C	NP_001188386.1:p.Leu761%3D		-1.0					Spermatogenic failure 23, 617707 (3), Autosomal recessive	.	.	Infertility;Autosomal recessive inheritance;Azoospermia;Decreased testicular size;Increased circulating gonadotropin level;Obstructive azoospermia;Non-obstructive azoospermia		0.00320753	488.0	152142.0	1.0	32	0.96	PASS	amr	0.00511207	78.0	0.00510219	347.0	0.00275066	691.0	251212.0	1.0	100	1.0	PASS	nfe	0.00454521	516.0	0.00454521	516.0	0.0025594	398	0.008	27.0	0.01008	115.0		0.253	-0.353344		0	0	0			TEX14	0.0	0.0	0.0	0.0	22.0	-27.0	-43.0	4.0						0.36	0.0	0.000000000			reproductive system phenotype; endocrine/exocrine gland phenotype; 			ciliary ganglion;temporal lobe;testis - seminiferous tubule;subthalamic nucleus;testis - interstitial;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;testis;skeletal muscle;globus pallidus;	.	protein phosphorylation;mitotic spindle assembly checkpoint;male meiotic nuclear division;attachment of spindle microtubules to kinetochore;negative regulation of protein binding;negative regulation of cytokinesis;intercellular bridge organization;cell division;mitotic sister chromatid separation;cellular response to leukemia inhibitory factor	kinetochore;condensed chromosome kinetochore;cell;cytoplasm;midbody;intercellular bridge;extracellular exosome	protein kinase activity;protein binding;ATP binding;protein kinase binding	PDIA3[30021884];LHX3[unassigned1304];LMO4[unassigned1304];DDIT4L[unassigned1304];MEOX2[unassigned1304];CEP55[20176808];
865944	chr7	64452074	G	T	chr7:64452074	ERV3-1	endogenous retrovirus group 3 member 1, envelope	15087.0	SNV	0/1	0.54	19_22	41	99	False	rs185422600,COSV51427010	EXONIC	YES	NM_001007253.4	Transcript	protein_coding	missense_variant		2/2	NM_001007253.4:c.1331C>A	NP_001007254.2:p.Pro444Gln		-1.0						.	.	.		0.00187357	285.0	152116.0	0.0	32	0.95	PASS	nfe	0.00296945	202.0	0.00296945	202.0	0.00152885	308.0	201458.0	0.0	62	0.61	PASS	nfe	0.0022984	210.0	0.0022984	210.0	0.0013119	204	0.005	16.0				20.4	2.071678	0.117	4	15	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,PROVEAN_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ERV3-1	0.0	0.0	0.0	0.0	-2.0	-29.0	33.0	-29.0							0.0	0.000000000	0.239	0.256	.			.	.	biological_process	.	molecular_function	.
867656	chr9	35610299	T	G	chr9:35610299	CD72	CD72 molecule	15165.0	SNV	0/1	0.39	19_12	31	99	False	rs193019576	SPLICING	YES	NM_001782.3	Transcript	protein_coding	splice_acceptor_variant	8/8		NM_001782.3:c.*23-2A>C			-1.0						.	.	.		0.00175402	238.0	135688.0	0.0	32	0.96	PASS	amr	0.00493347	66.0	0.00227595	138.0					0	0.0							0.0001929	30	0.001	4.0				29.1	4.162705		0	0	0			CD72	0.05	0.87	0.0	0.0	-19.0	-2.0	-19.0	-2.0	0.999978278263889	0.942	-0.05	8.042	7.992	0.403	0.96				hematopoietic system phenotype; respiratory system phenotype; liver/biliary system phenotype; renal/urinary system phenotype; immune system phenotype; homeostasis/metabolism phenotype; 			.	B cell receptor signaling pathway	cell adhesion	plasma membrane;integral component of plasma membrane	transmembrane signaling receptor activity;signaling receptor binding;protein binding;carbohydrate binding	LRRC25[unassigned1304];GPR152[unassigned1304];GRAMD1C[unassigned1304];LSMEM2[unassigned1304];MS4A3[unassigned1304];CD5[1711157];BIK[unassigned1304];CREB3L1[unassigned1304];MS4A7[unassigned1304];CLDN7[unassigned1304];HMGA1[30021884];NRG1[unassigned1304];
868474	chr6	151914356	C	T	chr6:151914356	CCDC170	coiled-coil domain containing 170	15231.0	SNV	0/1	0.41	20_14	34	99	False	rs267600858,COSV53337046	EXONIC	YES	NM_025059.4	Transcript	protein_coding	missense_variant		8/11	NM_025059.4:c.1408C>T	NP_079335.2:p.Arg470Cys		1.0						.	.	.		1.97197e-05	3.0	152132.0	0.0	32	0.96	PASS	eas	0.000192456	1.0	1.46985e-05	1.0	2.40579e-05	6.0	249398.0	0.0	71	1.0	PASS	amr	0.000144818	5.0	8.83736e-06	1.0	0.0000064	1	0.0	1.0				28.3	4.068941	0.713	13	8	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	CCDC170	0.0	0.0	0.0	0.0	9.0	-20.0	-43.0	-4.0							0.0	0.0	0.992	1.026	.			.	.	.	.	protein binding	RBM17[unassigned1304];CCNH[25416956];RDH11[30021884];
869975	chr10	17496194	GCA		chr10:17496194-17496196	ST8SIA6	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	15266.0	deletion	0/1	0.13	13_2	15	45	False	rs756965327	EXONIC	YES	NM_001004470.3	Transcript	protein_coding	inframe_deletion		1/8	NM_001004470.3:c.59_61del	NP_001004470.1:p.Leu20del		-1.0						.	.	.		8.06213e-05	12.0	148844.0	0.0	32	0.94	PASS	nfe	7.4949e-05	5.0	7.4949e-05	5.0	0.0349026	86.0	2464.0	0.0	0	0.0	PASS	sas	0.0543478	25.0	0.023622	24.0	0.0000322	5	0.015	40.0	0.01048	88.0		17.55	1.710115		0	0	0			ST8SIA6	0.0	0.0	0.0	0.0	-21.0	23.0	-38.0	-39.0						0.859	0.0				.			.	.	ganglioside biosynthetic process;blastocyst hatching;protein O-linked glycosylation;glycoprotein metabolic process;glycolipid biosynthetic process;oligosaccharide metabolic process;carbohydrate biosynthetic process;sialylation	Golgi membrane;integral component of membrane	alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity;sialyltransferase activity	.
870510	chr17	43332889	G	A	chr17:43332889	SPATA32	spermatogenesis associated 32	15294.0	SNV	0/1	0.52	10_11	21	99	False	rs775166106	EXONIC	YES	NM_152343.3	Transcript	protein_coding	synonymous_variant		4/5	NM_152343.3:c.660C>T	NP_689556.2:p.Ser220%3D		-1.0						.	.	.		6.56918e-06	1.0	152226.0	0.0	32	0.97	PASS	amr	6.54108e-05	1.0	0.0	0.0	1.59678e-05	4.0	250504.0	0.0	100	0.98	PASS	amr	8.68508e-05	3.0	8.8358e-06	1.0	0.0000129	2						2.644	0.00135		0	0	0			SPATA32	0.0	0.0	0.0	0.0	16.0	-32.0	-6.0	-32.0							0.0	0.0			.			.	.	spermatogenesis	perinuclear region of cytoplasm	actin binding	PIK3R3[unassigned1304];WDYHV1[unassigned1304];
870822	chr17	62521925	C	T	chr17:62521925	CEP95	centrosomal protein 95	15303.0	SNV	0/1	0.48	12_11	23	99	False	rs782370862,COSV73609474	EXONIC	YES	NM_138363.3	Transcript	protein_coding	missense_variant		9/20	NM_138363.3:c.947C>T	NP_612372.1:p.Pro316Leu		1.0	.,.					.	.	.		6.57722e-06	1.0	152040.0	0.0	32	0.97	PASS	eas	0.000192678	1.0	0.0	0.0	4.15745e-06	1.0	240532.0	0.0	22	0.61	PASS	nfe	9.08909e-06	1.0	9.08909e-06	1.0	0.0000064	1	0.0	1.0				14.72	1.212079	0.039	2	17	19	SIFT,MutationAssessor_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CEP95	0.0	0.0	0.0	0.0	-4.0	-37.0	-37.0	19.0							0.0	3.736380871	0.0	-0.668	.			.	.	.	spindle pole;cytoplasm;centrosome	protein binding	YWHAE[20936779];CCDC125[unassigned1304];CEP120[26638075];TANK[unassigned1774];CEP128[26638075];GOLGA2[unassigned1304];PCM1[26638075];GOLGA6L9[unassigned1304];KRT27[unassigned1304];TP53BP2[unassigned1304];HMG20A[unassigned1304];NINL[26638075];YWHAG[20936779];CARD10[unassigned1304];FAM9B[25416956];CEP135[26638075];SPICE1[26638075];MTUS2[25416956;unassigned1304];TFIP11[unassigned1304];MCC[unassigned1304];LSM3[15231747];SOD1[30021884];HOOK2[unassigned1304];PICK1[unassigned1304];SPERT[25416956];HNRNPA1L2[30021884];
870881	chr16	31075909	C	T	chr16:31075909	ZNF668	zinc finger protein 668	15305.0	SNV	0/1	0.68	8_17	25	99	False	rs61750978,COSV100336226	EXONIC	YES	NM_001172669.2	Transcript	protein_coding	missense_variant		2/4	NM_001172669.2:c.31G>A	NP_001166140.1:p.Asp11Asn		-1.0	.,.					.	.	.		0.00439495	669.0	152220.0	0.0	33	0.98	PASS	amr	0.00706806	108.0	0.00680482	463.0	0.00428859	661.0	154130.0	2.0	74	0.57	PASS	nfe	0.00779197	504.0	0.00779197	504.0	0.0030546	475	0.007	21.0				11.31	0.719116	0.052	0	14	14		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF668	0.0	0.0	0.04	0.0	-16.0	48.0	-16.0	29.0						0.634	0.27	0.0	0.046	0.129	.			trigeminal ganglion;	.	negative regulation of transcription by RNA polymerase II	nucleus	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;metal ion binding	ZNF792[unassigned1304];ZNF165[unassigned1304];SGTB[26496610];ZNF250[unassigned1304];KIF22[26496610];CLCN2[26496610];BYSL[unassigned1304];CEP170P1[26496610];RBM4[26496610];MATR3[26496610];KIF2C[26496610];KIF21A[26496610];PRPF31[unassigned1304];LLGL2[26496610];
872197	chr7	100183609	C	T	chr7:100183609	LRCH4	leucine rich repeats and calponin homology domain containing 4	15330.0	SNV	0/1	0.47	18_16	34	99	False	rs149959065,COSV99575739	EXONIC	YES	NM_002319.5	Transcript	protein_coding	missense_variant		1/18	NM_002319.5:c.115G>A	NP_002310.2:p.Glu39Lys		-1.0						.	.	.		0.000591335	90.0	152198.0	0.0	32	0.98	PASS	amr	0.00130822	20.0	0.000867341	59.0	0.000602808	146.0	242200.0	0.0	37	0.89	PASS	nfe	0.00100546	108.0	0.00100546	108.0	0.0005530	86	0.001	3.0				32.0	4.450038	0.562	13	8	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	LRCH4	0.0	0.0	0.0	0.0	35.0	-1.0	4.0	36.0						0.549	0.0	0.0	1.0	0.962	.			.	.	nervous system development	PML body	protein binding	CCDC155[unassigned1304];RNASEK[unassigned1304];KRTAP10-7[25416956];DOCK7[24255178];KRTAP10-8[25416956];ELOVL7[unassigned1304];NOTCH2NLA[25416956];HSD17B11[unassigned1304];HIST2H2BF[30021884];RTN4[16189514];KRT40[25416956];CYB5R3[unassigned1304];CA8[16169070];SUGT1[24255178];MDFI[16189514;19060904];
872479	chr20	61485507	C	T	chr20:61485507	TCFL5	transcription factor like 5	15349.0	SNV	0/1	0.45	11_9	20	99	False	rs141195716	SPLICING	YES	NM_006602.4	Transcript	protein_coding	missense_variant,splice_region_variant		5/6	NM_006602.4:c.1241G>A	NP_006593.2:p.Arg414His		-1.0	Myc-type, basic helix-loop-helix (bHLH) domain&Myc-type, basic helix-loop-helix (bHLH) domain&Myc-type, basic helix-loop-helix (bHLH) domain,Myc-type, basic helix-loop-helix (bHLH) domain&Myc-type, basic helix-loop-helix (bHLH) domain&Myc-type, basic helix-loop-helix (bHLH) domain					.	.	.		0.00301767	459.0	152104.0	1.0	32	0.96	PASS	amr	0.00576369	88.0	0.00411595	280.0	0.00281326	706.0	250954.0	2.0	42	0.98	PASS	nfe	0.00393652	447.0	0.00393652	447.0	0.0028166	438	0.004	13.0				31.0	4.333718	0.564	14	6	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,PrimateAI_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MutationAssessor_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred	TCFL5	0.0	0.03	0.0	0.0	-2.0	2.0	2.0	29.0			6.099	-0.13	5.969		0.96	0.0	1.0	1.016	.			amygdala;testis - seminiferous tubule;testis - interstitial;prefrontal cortex;whole brain;cingulate cortex;spinal cord;testis;medulla oblongata;	.	negative regulation of transcription by RNA polymerase II;regulation of transcription, DNA-templated;transcription by RNA polymerase II;multicellular organism development;spermatogenesis;cell differentiation;regulation of cell population proliferation;regulation of cell differentiation	male germ cell nucleus;nucleus	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein dimerization activity	.
872953	chr10	45430234	C	T	chr10:45430234	TMEM72	transmembrane protein 72	15382.0	SNV	0/1	0.57	10_13	23	99	False	rs138958742	EXONIC	YES	NM_001123376.3	Transcript	protein_coding	synonymous_variant		5/5	NM_001123376.3:c.480C>T	NP_001116848.1:p.Thr160%3D		1.0						.	.	.		0.00141299	215.0	152160.0	1.0	32	0.97	PASS	amr	0.00327054	50.0	0.00198483	135.0	0.00132683	329.0	247960.0	1.0	76	0.99	PASS	nfe	0.00201652	226.0	0.00201652	226.0	0.0012154	189	0.001	3.0				1.145	-0.130651		0	0	0																	0.203	0.49	14.313954387			.			.	.	.	integral component of membrane	.	BCL2L13[unassigned1304];CERS4[unassigned1304];TMEM237[unassigned1304];FXYD6[unassigned1304];FAM209A[unassigned1304];GJA8[unassigned1304];PIGY[unassigned1304];LENEP[unassigned1304];
873055	chr11	76063418	A	C	chr11:76063418	THAP12	THAP domain containing 12	15390.0	SNV	0/1	0.4	15_10	25	99	False	rs138095393	EXONIC	YES	NM_004705.4	Transcript	protein_coding	missense_variant		5/5	NM_004705.4:c.776T>G	NP_004696.2:p.Phe259Cys		-1.0	Domain of unknown function DUF4371					.	.	.		0.000335028	51.0	152226.0	1.0	32	0.97	PASS	nfe	0.000587907	40.0	0.000587907	40.0	0.000243245	61.0	250776.0	0.0	66	0.99	PASS	nfe	0.00045938	52.0	0.00045938	52.0	0.0000129	2	0.001	2.0				25.1	3.547018	0.511	9	12	21	SIFT,PolyPhen,LRT_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	PRKRIR	0.0	0.0	0.0	0.0	-48.0	-27.0	21.0	17.0									1.0	1.294	.			.	.	regulation of transcription by RNA polymerase II;signal transduction;negative regulation of cell population proliferation	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding;protein dimerization activity	MMGT1[26496610];ZNF526[unassigned1304];TACC1[25416956;unassigned1304];STK4[24255178];KIAA1958[unassigned1304];HIST2H2BF[30021884];STK3[24255178];
875075	chr1	16386002	G	C	chr1:16386002	FAM131C	family with sequence similarity 131 member C	15454.0	SNV	0/1	0.79	6_22	28	84	False	rs748143203,COSV65153159	EXONIC	YES	NM_182623.3	Transcript	protein_coding	missense_variant		6/7	NM_182623.3:c.549C>G	NP_872429.2:p.Ile183Met		-1.0						.	.	.						32	0.92							4.08347e-06	1.0	244890.0	0.0	37	0.87	PASS	amr	2.92826e-05	1.0	0.0	0.0	0.0000064	1						0.75	-0.19359	0.038	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FAM131C	0.0	0.0	0.0	0.0	-13.0	12.0	5.0	-13.0						0.632	0.28		0.0	-0.13	.			.	.	.	.	protein binding	GRN[16189514];VSNL1[16189514;25416956;unassigned1304];EWSR1[16189514];DNAJA3[16189514];LMO3[25416956];HPCAL4[25416956;unassigned1304];MAD1L1[16189514];
875828	chr3	15297787	T	C	chr3:15297787	SH3BP5	SH3 domain binding protein 5	15469.0	SNV	0/1	0.36	21_12	33	99	False	rs116459865,COSV99508699	EXONIC	YES	NM_004844.5	Transcript	protein_coding	missense_variant		9/9	NM_004844.5:c.1174A>G	NP_004835.2:p.Asn392Asp		-1.0	.,.,.					.	.	.		0.00499954	761.0	152214.0	2.0	32	0.97	PASS	nfe	0.00898133	611.0	0.00898133	611.0	0.00428799	1068.0	249068.0	8.0	78	1.0	PASS	nfe	0.00783817	873.0	0.00783817	873.0	0.0044758	696	0.007	23.0				23.6	3.032134	0.082	4	16	20	PolyPhen,Polyphen2_HDIV_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	SH3BP5	0.0	0.0	0.0	0.0	23.0	20.0	16.0	11.0						0.12	0.01	0.0	0.994	1.138	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			superior cervical ganglion;adrenal gland;adrenal cortex;	.	signal transduction;intracellular signal transduction;negative regulation of protein tyrosine kinase activity	nucleoplasm;cytoplasm;mitochondrion;nuclear body	protein kinase inhibitor activity;protein binding;SH3 domain binding	IFT20[unassigned1304];LIMA1[26496610];CEP170P1[unassigned1304];TNKS[17043677];ALB[15174051];BTK[9571151];NAP1L2[unassigned1304];DISC1[17043677];SOS1[17043677];EXOC1[17043677];
876108	chr19	57175307	G	A	chr19:57175307	ZNF835	zinc finger protein 835	15482.0	SNV	0/1	0.56	14_18	32	99	False	rs112794314,COSV73379411	EXONIC	YES	NM_001005850.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001005850.3:c.1260C>T	NP_001005850.2:p.Cys420%3D		-1.0						.	.	.		0.00371711	565.0	152000.0	4.0	33	0.97	PASS	nfe	0.00530976	361.0	0.00530976	361.0	0.00466359	1161.0	248950.0	6.0	67	0.98	PASS	nfe	0.00602666	680.0	0.00602666	680.0	0.0049709	773	0.002	7.0				1.094	-0.137372		0	0	0			ZNF835	0.0	0.0	0.0	0.0	-28.0	40.0	-1.0	4.0							0.0	6.169915974			.			.	.	negative regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II	nucleoplasm	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;transcription regulatory region DNA binding;metal ion binding	ZNF572[unassigned1304];HSF2BP[unassigned1304];DEUP1[unassigned1304];GOLGA2[unassigned1304];CYSRT1[unassigned1304];GOLGA6L9[unassigned1304];ZNF526[unassigned1304];ZNF768[unassigned1304];ZNF524[unassigned1304];IKBKG[unassigned1304];ZNF202[unassigned1304];TRIM23[unassigned1304];TSPYL2[unassigned1304];GRIPAP1[unassigned1304];IL16[unassigned1304];LDOC1[unassigned1304];KRT31[unassigned1304];RUNDC3A[unassigned1304];AES[unassigned1304];RINT1[unassigned1304];TRAF4[unassigned1304];ZNF837[unassigned1304];HAP1[unassigned1304];HOXB1[unassigned1304];KIFC3[unassigned1304];STX1A[unassigned1304];ZNF552[unassigned1304];ZNF792[unassigned1304];TXK[unassigned1304];SHCBP1L[unassigned1304];TULP3[23414517];SPATA2[unassigned1304];PRDM14[unassigned1304];CCNDBP1[unassigned1304];BEGAIN[unassigned1304];STAMBPL1[unassigned1304];ZNF629[unassigned1304];U2AF2[unassigned1304];CEP70[unassigned1304];FSD2[unassigned1304];KRTAP12-3[unassigned1304];TRIM41[unassigned1304];CCDC57[unassigned1304];OSBPL3[unassigned1304];KRTAP4-5[unassigned1304];RYDEN[unassigned1304];MAGOHB[unassigned1304];CLK3[unassigned1304];HOOK2[unassigned1304];ZNF71[unassigned1304];CCDC6[unassigned1304];GOPC[unassigned1304];CDR2L[unassigned1304];CCDC130[unassigned1304];RNF187[unassigned1304];MYF5[unassigned1304];ZNF497[unassigned1304];
877311	chr19	56243611	C	A	chr19:56243611	NLRP9	NLR family pyrin domain containing 9	15550.0	SNV	0/1	0.6	16_24	40	99	False	rs149058876	EXONIC	YES	NM_176820.4	Transcript	protein_coding	missense_variant		2/9	NM_176820.4:c.1586G>T	NP_789790.2:p.Ser529Ile		-1.0	.,.					.	.	.		0.000571579	87.0	152210.0	0.0	32	0.98	PASS	nfe	0.00104353	71.0	0.00104353	71.0	0.000502064	126.0	250964.0	0.0	78	1.0	PASS	nfe	0.000986159	112.0	0.000986159	112.0	0.0003987	62	0.002	6.0				8.219	0.383605	0.166	3	14	17	SIFT,M-CAP_pred,PROVEAN_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NLRP9	0.0	0.0	0.0	0.0	-7.0	33.0	23.0	1.0						0.693	0.0		0.006	-0.552	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; immune system phenotype; digestive/alimentary phenotype; endocrine/exocrine gland phenotype; cellular phenotype; 			.	.	inflammatory response;positive regulation of interleukin-18 production;innate immune response;defense response to virus;pyroptosis	inflammasome complex	protein binding;ATP binding	.
877329	chr1	153431435	T	G	chr1:153431435	S100A7	S100 calcium binding protein A7	15553.0	SNV	0/1	0.52	12_13	25	99	False	rs72708760	EXONIC	YES	NM_002963.4	Transcript	protein_coding	missense_variant		2/3	NM_002963.4:c.55A>C	NP_002954.2:p.Lys19Gln		-1.0	S100/CaBP-9k-type, calcium binding, subdomain&S100/CaBP-9k-type, calcium binding, subdomain&S-100,S100/CaBP-9k-type, calcium binding, subdomain&S100/CaBP-9k-type, calcium binding, subdomain&S-100					.	.	.		0.00379091	577.0	152206.0	2.0	32	0.96	PASS	nfe	0.00577601	393.0	0.00577601	393.0	0.00396649	997.0	251356.0	2.0	67	1.0	PASS	nfe	0.00579881	659.0	0.00579881	659.0	0.0042378	659	0.006	18.0				9.903	0.554619	0.06	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	S100A7	0.01	0.0	0.0	0.0	-11.0	-2.0	-11.0	-1.0							0.55		0.061	0.006	.			.	.	response to reactive oxygen species;angiogenesis;epidermis development;positive regulation of T cell chemotaxis;antimicrobial humoral response;keratinocyte differentiation;response to lipopolysaccharide;neutrophil degranulation;innate immune response;defense response to Gram-negative bacterium;sequestering of metal ion;antimicrobial humoral immune response mediated by antimicrobial peptide;positive regulation of ERK1 and ERK2 cascade;positive regulation of granulocyte chemotaxis;positive regulation of monocyte chemotaxis	extracellular region;extracellular space;nucleus;cytoplasm;endoplasmic reticulum;cytosol;focal adhesion;azurophil granule lumen;collagen-containing extracellular matrix	calcium ion binding;protein binding;zinc ion binding;RAGE receptor binding	MAP3K3[14743216];VCAM1[22623428];L3MBTL2[27705803];S100A7L2[unassigned1304];EED[27705803];PCGF5[27705803];CD81[26212323];RASSF7[24366813];RANBP9[12421467];RASSF9[24366813];PPP2R2A[28330616];LIN9[17531812];IFIT1[21642987];MKI67[26949251];ESR1[21182205];RASSF10[24366813];AEBP2[27705803];PPP2R2B[19156129];CLVS2[unassigned1304];E2F6[27705803];PAK5[17353931];CFTR[17110338];
878519	chr11	77667057	C	G	chr11:77667057	INTS4	integrator complex subunit 4	15609.0	SNV	0/1	0.59	19_27	46	99	False	rs773483938,COSV101417220	EXONIC	YES	NM_033547.4	Transcript	protein_coding	synonymous_variant		8/23	NM_033547.4:c.849G>C	NP_291025.3:p.Ala283%3D		-1.0						.	.	.		1.31411e-05	2.0	152194.0	0.0	32	0.97	PASS	amr	6.54193e-05	1.0	1.46985e-05	1.0	6.02967e-05	15.0	248770.0	0.0	31	0.84	PASS	amr	0.000412395	14.0	0.0	0.0	0.0000257	4						0.862	-0.172714		0	0	0			INTS4	0.0	0.0	0.0	0.0	22.0	-27.0	-21.0	-39.0						0.41	0.65				.			.	Wnt signaling pathway;Hedgehog signaling pathway;Melanogenesis;Basal cell carcinoma	snRNA processing;snRNA transcription by RNA polymerase II	nucleus;nucleoplasm;integrator complex	protein binding	INTS11[28396433];INTS14[26496610];USHBP1[25416956];POU6F2[unassigned1304];PYGM[23414517];MEIS3[unassigned1304];TMEM173[29251827];PPP2CA[26496610;28330616];PPP2CB[26496610];LHX3[unassigned1304];HGS[25416956;26871637];PPP2R1A[26496610;28330616];ZMIZ2[25416956];
880342	chr9	105780601	T	C	chr9:105780601	CYLC2	cylicin 2	15685.0	SNV	0/1	0.48	15_14	29	99	False		SPLICING	YES	NM_001340.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	7/7		NM_001340.5:c.*891-6T>C			1.0						.	.	.						32	0.93											0	0.0														10.84	0.662597		0	0	0			CYLC2	0.0	0.42	0.0	0.0	-28.0	6.0	12.0	21.0	0.0005614977543915	0.062	7.719	1.477	9.196	0.937	0.0				.			.	.	cytoskeleton organization;multicellular organism development;spermatogenesis;cell differentiation	nucleus;cytoskeletal calyx	structural constituent of cytoskeleton	SMAD2[24412244];MAP2K4[24412244];CDKN2A[24412244];MCC[24412244];MLH1[24412244];EGFR[24412244];MLH3[24412244];AURKA[24412244];RSL1D1[30021884];HNRNPM[30021884];NRAS[24412244];STK11[24412244];ERBB2[24412244];BUB1[24412244];MUTYH[24412244];
881111	chr5	54329605	G	A	chr5:54329605	GZMK	granzyme K	15742.0	SNV	0/1	0.75	5_15	20	99	False	rs146429265,COSV50245592	EXONIC	YES	NM_002104.3	Transcript	protein_coding	missense_variant		5/5	NM_002104.3:c.646G>A	NP_002095.1:p.Gly216Ser		1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain					.	.	.		0.00289257	440.0	152114.0	1.0	33	0.98	PASS	nfe	0.00511614	348.0	0.00511614	348.0	0.00259684	613.0	236056.0	2.0	31	0.71	PASS	nfe	0.00427452	467.0	0.00427452	467.0	0.0027138	422	0.002	7.0				23.0	2.750098	0.193	15	6	21	PolyPhen,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HDIV_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred	GZMK	0.03	0.0	0.0	0.0	-12.0	37.0	18.0	-39.0						0.303	0.0	0.000000000	0.954	1.176	.			.	.	proteolysis	extracellular region	serine-type endopeptidase activity;serine-type peptidase activity	PNKP[21988832];LIG4[21988832];TMBIM6[unassigned1304];
881198	chr6	89614482	G	A	chr6:89614482	RNGTT	RNA guanylyltransferase and 5'-phosphatase	15745.0	SNV	0/1	0.71	5_12	17	93	False	rs144619191,COSV55660379	EXONIC	YES	NM_003800.5	Transcript	protein_coding	synonymous_variant		6/16	NM_003800.5:c.636C>T	NP_003791.3:p.Pro212%3D		-1.0						.	.	.		1.97696e-05	3.0	151748.0	0.0	32	0.96	PASS	nfe	2.94221e-05	2.0	2.94221e-05	2.0	1.591e-05	4.0	251414.0	0.0	66	1.0	PASS	sas	6.53296e-05	2.0	0.0	0.0	0.0000193	3	0.001	2.0				7.842	0.350533		0	0	0			RNGTT	0.0	0.0	0.0	0.0	11.0	50.0	-38.0	-48.0						0.263	0.76	5.235035379			.			ciliary ganglion;appendix;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	.	transcription by RNA polymerase II;7-methylguanosine mRNA capping;RNA processing;viral process;peptidyl-tyrosine dephosphorylation;polynucleotide 5' dephosphorylation	nucleus;nucleoplasm	mRNA guanylyltransferase activity;polynucleotide 5'-phosphatase activity;protein tyrosine phosphatase activity;protein binding;GTP binding;protein tyrosine/serine/threonine phosphatase activity;RNA guanylyltransferase activity;triphosphatase activity	JUN[25609649];INTU[27173435;unassigned1312];APPBP2[unassigned1304];MYC[17314511];TP53BP1[29656893];MKI67[26949251];NCK1[25137142];
881468	chr16	19422498	G	A	chr16:19422498	TMC5	transmembrane channel like 5	15765.0	SNV	0/1	0.48	24_22	46	99	False	rs185750271	SPLICING	YES	NM_001105248.1	Transcript	protein_coding	splice_region_variant,5_prime_UTR_variant		1/22	NM_001105248.1:c.-308G>A			1.0						.	.	.		0.00207234	315.0	152002.0	0.0	33	0.98	PASS	nfe	0.00327797	223.0	0.00327797	223.0					0	0.0							0.0024642	65						7.759	0.343594		0	0	0												0.0684421882589692	0.37	9.092	1.82	10.912	0.932	0.0				.			trachea;trigeminal ganglion;prostate;	.	ion transmembrane transport	integral component of plasma membrane;extracellular exosome	ion channel activity;mechanosensitive ion channel activity	NUMBL[21988832];
881630	chr12	122186240	G	A	chr12:122186240	TMEM120B	transmembrane protein 120B	15773.0	SNV	0/1	0.42	14_11	26	99	False	rs181072178	EXONIC	YES	NM_001080825.2	Transcript	protein_coding	missense_variant		3/12	NM_001080825.2:c.197G>A	NP_001074294.2:p.Arg66His		1.0	.,.					.	.	.		0.00500276	760.0	151916.0	2.0	30	0.92	PASS	amr	0.00918274	140.0	0.00604857	411.0	0.00454398	1122.0	246920.0	3.0	54	0.93	PASS	nfe	0.0063156	704.0	0.0063156	704.0	0.0040578	631	0.014	44.0				18.58	1.849459	0.078	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TMEM120B	0.0	0.0	0.0	0.0	-8.0	38.0	-9.0	0.0						0.488	0.26	0.000000000	0.996	1.166	.			.	.	biological_process;fat cell differentiation;protein heterooligomerization	cellular_component;nuclear inner membrane;integral component of membrane	molecular_function;protein binding	SH3GL3[unassigned1304];AQP8[unassigned1304];GORAB[unassigned1304];AQP6[unassigned1304];RNF19B[unassigned1304];COMT[unassigned1304];JPH1[unassigned1304];TMEM143[unassigned1304];TCTN3[26638075];TCTN2[26638075];CREB3L1[unassigned1304];LRRTM2[unassigned1304];FFAR2[unassigned1304];SLC18A1[unassigned1304];TMEM14B[unassigned1304];NOMO1[unassigned1312];BNIP3L[unassigned1304];JAGN1[unassigned1304];ARL15[unassigned1312];IFNGR2[unassigned1304];MRPS18B[unassigned1304];GPX8[unassigned1304];APOA5[unassigned1304];TMEM80[unassigned1304];ZDHHC15[unassigned1304];TMX2[unassigned1304];TMEM139[unassigned1304];FKBP7[unassigned1304];ERGIC3[unassigned1304];GPRC5D[unassigned1304];MGST3[unassigned1304];TMPRSS2[unassigned1304];SLC1A3[unassigned1304];CCNDBP1[25416956];HSD17B11[unassigned1304];RNF5[unassigned1304];AGPAT3[unassigned1312];GPR152[unassigned1304];MUC1[unassigned1304];EBP[unassigned1304];NCLN[unassigned1312];STOM[unassigned1304];SLC17A8[unassigned1304];STX2[unassigned1304];SCN3B[unassigned1304];METTL9[unassigned1312];CD74[unassigned1304];SLC10A6[unassigned1304];KCNJ6[unassigned1304];SLC10A1[unassigned1304];TMEM120A[unassigned1312];GAD2[unassigned1304];GJB1[unassigned1304];REEP4[unassigned1304];TMEM56[unassigned1304];ALOX5AP[unassigned1304];SERINC1[unassigned1312];IL7R[unassigned1304];
881713	chr11	8974866	G	C	chr11:8974866	TMEM9B	TMEM9 domain family member B	15782.0	SNV	0/1	0.65	8_15	23	99	False	rs747268054	EXONIC	YES	NM_020644.3	Transcript	protein_coding	missense_variant		4/5	NM_020644.3:c.325C>G	NP_065695.1:p.Leu109Val		-1.0	.,.,.,.,.					.	.	.		3.28783e-05	5.0	152076.0	0.0	32	0.96	PASS	sas	0.000207039	1.0	4.41073e-05	3.0	1.98931e-05	5.0	251344.0	0.0	52	0.99	PASS	amr	5.78637e-05	2.0	8.79755e-06	1.0	0.0000064	1	0.0	1.0				23.8	3.112484	0.312	14	6	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,DEOGEN2_pred	TMEM9B	0.0	0.0	0.0	0.0	18.0	-22.0	1.0	-32.0							0.91	0.000000000	1.0	1.161	.			parietal lobe;	.	positive regulation of I-kappaB kinase/NF-kappaB signaling	lysosomal membrane;integral component of membrane;early endosome membrane	.	DDX24[16169070];FKBP6[unassigned1304];
881833	chr19	18542816	C	T	chr19:18542816	SSBP4	single stranded DNA binding protein 4	15788.0	SNV	0/1	0.68	9_19	28	99	False	rs201010202,COSV54212388	EXONIC	YES	NM_032627.5	Transcript	protein_coding	missense_variant		9/18	NM_032627.5:c.572C>T	NP_116016.1:p.Pro191Leu		1.0	.,.,.,.					.	.	.		5.255e-05	8.0	152236.0	0.0	34	0.98	PASS	amr	0.000130804	2.0	7.3497e-05	5.0	2.3525e-05	5.0	212540.0	0.0	28	0.66	PASS	amr	3.30644e-05	1.0	2.09341e-05	2.0	0.0000257	4						23.2	2.854339	0.371	8	11	19	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred,PROVEAN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	SSBP4	0.01	0.0	0.0	0.0	-38.0	-6.0	46.0	-39.0						0.13	0.96	31.362608472	0.02	0.073	.			.	.	positive regulation of transcription by RNA polymerase II	nucleus	RNA polymerase II proximal promoter sequence-specific DNA binding;single-stranded DNA binding;protein binding	LDB1[16189514;unassigned1304];NUDCD1[29021621];PIN1[21516116;unassigned1304];PIK3R3[unassigned1304];IL36RN[16189514;unassigned1304];TRIM33[20603019];SPG21[unassigned1304];
881906	chr17	27030706	A	G	chr17:27030706	PROCA1	protein interacting with cyclin A1	15799.0	SNV	0/1	0.56	17_22	39	99	False	rs199835822	EXONIC	YES	NM_001366301.1	Transcript	protein_coding	missense_variant		5/5	NM_001366301.1:c.965T>C	NP_001353230.1:p.Ile322Thr		-1.0	.,.					.	.	.		0.000512901	78.0	152076.0	0.0	32	0.98	PASS	amr	0.00268571	41.0	0.000426408	29.0	0.000361835	91.0	251496.0	0.0	100	1.0	PASS	amr	0.00130088	45.0	0.000325218	37.0	0.0002894	45	0.002	5.0				1.033	-0.145924	0.033	0	17	17		LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PROCA1	0.0	0.0	0.0	0.0	22.0	-22.0	3.0	43.0						0.746	0.0	0.000000000	0.0	-0.435	.			.	.	phospholipid metabolic process;arachidonic acid secretion	.	phospholipase A2 activity;cyclin binding	VIM[30021884];
881943	chr5	140794792	T	C	chr5:140794792	PCDHGA10	protocadherin gamma subfamily A, 10	15803.0	SNV	0/1	0.44	29_23	52	99	False	rs189700811	EXONIC	YES	NM_018913.3	Transcript	protein_coding	missense_variant		1/4	NM_018913.3:c.2050T>C	NP_061736.1:p.Ser684Pro		1.0	.,.					.	.	.		0.00554109	843.0	152136.0	5.0	32	0.98	PASS	nfe	0.00905563	616.0	0.00905563	616.0	0.00539294	1356.0	251440.0	13.0	100	1.0	PASS	nfe	0.00848546	965.0	0.00848546	965.0	0.0055690	866	0.007	22.0				0.018	-0.7119	0.067	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PCDHGA10	0.0	0.0	0.0	0.0	-37.0	0.0	44.0	-2.0						0.476	0.0	0.000000000	0.0	-1.884	.	PCDHB19P	Skin_Sun_Exposed_Lower_leg	.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules	integral component of plasma membrane	calcium ion binding	.
882186	chr4	8022016	G	A	chr4:8022016	ABLIM2	actin binding LIM protein family member 2	15809.0	SNV	0/1	0.57	15_20	35	99	False	rs200296927	EXONIC	YES	NM_001130083.2	Transcript	protein_coding	missense_variant		13/21	NM_001130083.2:c.1282C>T	NP_001123555.1:p.Arg428Trp		-1.0	.,Putative adherens-junction anchoring domain,.,Putative adherens-junction anchoring domain,Putative adherens-junction anchoring domain					.	.	.		0.000315503	48.0	152138.0	0.0	32	0.96	PASS	nfe	0.000602711	41.0	0.000602711	41.0	0.000263568	65.0	246616.0	0.0	54	0.95	PASS	nfe	0.00048494	54.0	0.00048494	54.0	0.0002637	41	0.001	3.0				33.0	4.884948	0.634	13	8	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred	ABLIM2	0.0	0.17	0.0	0.0	-5.0	14.0	2.0	14.0						0.295	0.76	0.000000000	1.0	1.176	.			superior cervical ganglion;parietal lobe;skeletal muscle;	Axon guidance	transcription, DNA-templated;lamellipodium assembly;actin cytoskeleton organization	cytoplasm;actin cytoskeleton	metal ion binding;actin filament binding	C6orf142[26871637];SREBF2[20936779];TTN[23414517];
883038	chr9	131486325	C	G	chr9:131486325	ZDHHC12	zinc finger DHHC-type containing 12	15830.0	SNV	0/1	0.38	20_12	32	99	False	rs143212938	EXONIC	YES	NM_001318015.2	Transcript	protein_coding	synonymous_variant		1/5	NM_001318015.2:c.48G>C	NP_001304944.2:p.Gly16%3D		-1.0						.	.	.		0.00560808	853.0	152102.0	2.0	31	0.97	PASS	amr	0.00949201	145.0	0.00754567	513.0	0.00539026	1324.0	245628.0	4.0	30	0.8	PASS	nfe	0.00752982	832.0	0.00752982	832.0	0.0052282	813	0.016	45.0				13.34	0.986341		0	0	0			ZDHHC12	0.0	0.0	0.0	0.0	-30.0	-46.0	-6.0	12.0						0.557	0.01	0.000000000			.			.	.	protein targeting to membrane;peptidyl-L-cysteine S-palmitoylation;protein palmitoylation	endoplasmic reticulum;Golgi apparatus;integral component of membrane	palmitoyltransferase activity;protein-cysteine S-palmitoyltransferase activity	RXRB[21988832];
883829	chr2	98411412	T	C	chr2:98411412	TMEM131	transmembrane protein 131	15857.0	SNV	0/1	0.41	19_13	32	99	False	rs139263468	EXONIC	YES	NM_015348.2	Transcript	protein_coding	missense_variant		29/41	NM_015348.2:c.3367A>G	NP_056163.1:p.Ile1123Val		-1.0						.	.	.		0.00115601	176.0	152248.0	1.0	32	0.97	PASS	nfe	0.0019103	130.0	0.0019103	130.0	0.0012827	280.0	218290.0	1.0	19	0.49	PASS	nfe	0.0021163	203.0	0.0021163	203.0	0.0014212	221	0.001	2.0				20.8	2.116276	0.051	3	15	18	LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	TMEM131	0.0	0.0	0.03	0.0	41.0	38.0	-19.0	8.0							1.0	0.000000000	1.0	1.138	.			amygdala;	.	biological_process	cellular_component;integral component of membrane	molecular_function	PIGS[26496610];EGLN3[26972000];GABARAPL1[unassigned1304];CTR9[26496610];RACK1[unassigned1304];THOC2[26496610];SOD2[20195357];TOMM20[29568061];
884296	chr19	55831807	G	C	chr19:55831807	TMEM150B	transmembrane protein 150B	15863.0	SNV	0/1	0.47	16_14	30	99	False	rs369382915	EXONIC	YES	NM_001282011.2	Transcript	protein_coding	missense_variant		5/8	NM_001282011.2:c.148C>G	NP_001268940.1:p.Pro50Ala		-1.0	.,.,.					.	.	.		9.20387e-05	14.0	152110.0	0.0	31	0.95	PASS	nfe	0.000147033	10.0	0.000147033	10.0	0.000108756	25.0	229872.0	0.0	30	0.7	PASS	eas	0.000281183	5.0	0.000114388	12.0	0.0001158	18	0.0	1.0				25.1	3.53164	0.841	15	6	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred	MetaLR_pred,FATHMM_pred,PrimateAI_pred,BayesDel_addAF_pred,LIST-S2_pred,fathmm-XF_coding_pred	TMEM150B	0.11	0.04	0.16	0.0	19.0	-6.0	-23.0	19.0						0.669	0.0	0.000000000	0.995	1.065	.			.	.	autophagy;regulation of autophagy	autophagosome membrane;lysosome;integral component of plasma membrane;endosome membrane	.	.
884546	chr11	290466	C	T	chr11:290466	PGGHG	protein-glucosylgalactosylhydroxylysine glucosidase	15880.0	SNV	0/1	0.39	22_14	36	99	False	rs182102503	EXONIC	YES	NM_025092.5	Transcript	protein_coding	synonymous_variant		3/14	NM_025092.5:c.336C>T	NP_079368.3:p.His112%3D		1.0						.	.	.		0.00467719	712.0	152228.0	2.0	33	0.98	PASS	nfe	0.00833309	567.0	0.00833309	567.0	0.00461448	708.0	153430.0	4.0	100	0.58	PASS	nfe	0.00890137	526.0	0.00890137	526.0	0.0017749	276	0.004	12.0				1.925	-0.051269		0	0	0			ATHL1	0.0	0.0	0.0	0.0	17.0	1.0	0.0	-3.0								0.400467887			.			.	.	carbohydrate metabolic process;trehalose catabolic process	cell wall;cytosol	alpha,alpha-trehalase activity;protein-glucosylgalactosylhydroxylysine glucosidase activity	.
886124	chr7	138943330	G	C	chr7:138943330	UBN2	ubinuclein 2	15944.0	SNV	0/1	0.54	18_21	39	99	False	rs202078043	EXONIC	YES	NM_173569.4	Transcript	protein_coding	missense_variant		4/18	NM_173569.4:c.760G>C	NP_775840.3:p.Glu254Gln		1.0	.,.					.	.	.		0.000548398	83.0	151350.0	0.0	32	0.88	PASS	nfe	0.00103038	70.0	0.00103038	70.0	0.000559744	139.0	248328.0	0.0	43	0.9	PASS	nfe	0.000911698	103.0	0.000911698	103.0	0.0006045	94	0.003	9.0				24.0	3.165556	0.128	6	15	21	PolyPhen,LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	UBN2	0.0	0.06	0.0	0.0	16.0	-24.0	45.0	41.0						0.283	1.0	0.0	1.0	1.176	.			ciliary ganglion;dorsal root ganglion;atrioventricular node;superior cervical ganglion;globus pallidus;	.	.	extracellular space;nucleoplasm	.	GOLGA2[29568061];HIRA[19029251];PYHIN1[25665578];ASF1A[26496610];
886506	chr2	24260860	G	A	chr2:24260860	WDCP	WD repeat and coiled coil containing	15965.0	SNV	0/1	0.59	12_17	29	99	False	rs147244110	EXONIC	YES	NM_025203.3	Transcript	protein_coding	missense_variant		2/4	NM_025203.3:c.1505C>T	NP_079479.1:p.Pro502Leu		-1.0	.,.					.	.	.		0.00246448	375.0	152162.0	1.0	33	0.98	PASS	nfe	0.00404257	275.0	0.00404257	275.0	0.00216831	545.0	251348.0	0.0	61	1.0	PASS	nfe	0.00356269	405.0	0.00356269	405.0	0.0023086	359	0.002	6.0				20.5	2.089101	0.245	5	13	18	SIFT,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	C2orf44	0.0	0.0	0.0	0.0	-10.0	-30.0	4.0	-30.0								0.0	0.125	1.176	.			.	.	protein complex oligomerization	.	kinase binding	CEP120[26638075];NLK[23602568];MAPK8[26496610];NUDCD1[29021621];RUVBL2[17353931];MED31[16169070];RUVBL1[17353931];GAR1[26496610];CD14[26496610];DYNC1I1[21900206];HSPA8[29568061];ANXA1[23754495];PDPK1[21900206];SCAF11[26496610];ZNF281[26496610];PLK1[19596235];CSNK1E[21900206];KIF22[26496610];RPGRIP1L[26638075];TCTE1[26638075];SGO1[26496610];HCK[12029088];RPS27[21900206];KIF2A[26496610];PRKAR1A[21900206];TNNT1[21900206];RAB35[16169070];TAB1[21900206];YPEL5[27173435;unassigned1312];CSNK1G2[21900206];CSNK1G1[21900206];
886782	chr9	35753737	A	G	chr9:35753737	MSMP	microseminoprotein, prostate associated	15986.0	SNV	0/1	0.38	16_10	26	99	False		EXONIC	YES	NM_001044264.3	Transcript	protein_coding	synonymous_variant		2/3	NM_001044264.3:c.159T>C	NP_001037729.1:p.Phe53%3D		-1.0						.	.	.		6.57056e-06	1.0	152194.0	0.0	32	0.97	PASS	nfe	1.46985e-05	1.0	1.46985e-05	1.0					46	0.99														12.71	0.898453		0	0	0			MSMP	0.04	0.0	0.04	0.0	28.0	-28.0	-7.0	28.0						0.563	0.44	1.022681186			.			.	.	biological_process	extracellular space;cytoplasm	molecular_function	.
887996	chr17	79409177	G	A	chr17:79409177	BAHCC1	BAH domain and coiled-coil containing 1	16014.0	SNV	0/1	0.56	11_14	25	99	False	rs145916430	EXONIC	YES	NM_001291324.3	Transcript	protein_coding	missense_variant		5/29	NM_001291324.3:c.631G>A	NP_001278253.1:p.Ala211Thr		1.0	.,.					.	.	.		0.00556308	846.0	152074.0	4.0	33	0.97	PASS	afr	0.00627868	260.0	0.00388361	264.0	0.00659265	576.0	87370.0	5.0	7	0.07	PASS	afr	0.00577201	24.0	0.00470958	162.0	0.0026302	409	0.001	4.0				3.495	0.054262		0	15	15		MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	BAHCC1	0.0	0.0	0.0	0.0	-29.0	-13.0	-46.0	-37.0									0.0	0.197	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); 			.	.	.	.	chromatin binding	ATP5IF1[30021884];HDAC1[26496610];MYC[21150319];CLSTN1[12421765];COMMD1[21988832];HIST2H2BE[30021884];SAP30[26496610];
888037	chr5	171520938	G	A	chr5:171520938	STK10	serine/threonine kinase 10	16020.0	SNV	0/1	0.5	12_12	24	99	False	rs150457499	EXONIC	YES	NM_005990.4	Transcript	protein_coding	synonymous_variant		9/19	NM_005990.4:c.1032C>T	NP_005981.3:p.Ser344%3D		-1.0						.	.	.		0.000414419	63.0	152020.0	0.0	32	0.96	PASS	nfe	0.000647078	44.0	0.000647078	44.0	0.000236449	42.0	177628.0	0.0	40	0.66	PASS	nfe	0.000393838	34.0	0.000393838	34.0	0.0002765	43						0.413	-0.282191		0	0	0			STK10	0.0	0.0	0.01	0.0	38.0	24.0	-6.0	15.0						0.868	0.0	7.987977675			immune system phenotype; hematopoietic system phenotype; 			white blood cells;lymph node;trigeminal ganglion;placenta;whole blood;testis;cerebellum;bone marrow;	.	protein phosphorylation;cell cycle;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;neutrophil degranulation;protein autophosphorylation;lymphocyte aggregation;regulation of lymphocyte migration	cytoplasm;plasma membrane;specific granule membrane;extracellular exosome	protein serine/threonine kinase activity;protein binding;ATP binding;identical protein binding;protein homodimerization activity	STK10[18239682];LAMP1[29568061];NONO[30021884];TANK[unassigned1774];
888105	chr19	9491666	C	G	chr19:9491666	ZNF177	zinc finger protein 177	16023.0	SNV	0/1	0.39	14_9	23	99	False	rs771865530	EXONIC	YES	NM_001172651.2	Transcript	protein_coding	stop_gained		8/8	NM_001172651.2:c.659C>G	NP_001166122.1:p.Ser220Ter		1.0	.,.					.	.	.		1.31408e-05	2.0	152198.0	0.0	32	0.97	PASS	afr	2.41255e-05	1.0	1.46985e-05	1.0	6.46169e-05	11.0	170234.0	0.0	45	0.57	PASS	amr	0.000327273	9.0	2.75581e-05	2.0	0.0000322	5	0.0	1.0				32.0	4.53183		2	3	5	BayesDel_noAF_pred,Aloft_pred	BayesDel_addAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF177	0.0	0.0	0.02	0.0	-17.0	3.0	32.0	5.0						0.978	0.0	0.0	0.002	0.731	.			superior cervical ganglion;	.	negative regulation of transcription by RNA polymerase II	nucleus;blood microparticle	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding	LMO1[unassigned1304];SNAP25[unassigned1304];PRKAB2[unassigned1304];CIB3[unassigned1304];MID2[unassigned1304];CT55[unassigned1304];SNAPC5[unassigned1304];ARHGAP21[25416956];PRKAR1B[unassigned1304];TRAF4[unassigned1304];PMVK[unassigned1304];PSMB1[unassigned1304];BOLA2[unassigned1304];CANX[30021884];SLC37A3[21988832];
888341	chr19	54779806	C	T	chr19:54779806	LILRB2	leukocyte immunoglobulin like receptor B2	16026.0	SNV	0/1	0.51	20_21	41	99	False	rs35440540,COSV99042027	SPLICING	YES	NM_005874.5	Transcript	protein_coding	missense_variant,splice_region_variant		13/14	NM_005874.5:c.1649G>A	NP_005865.3:p.Arg550Gln		-1.0	.,.,.,.					.	.	.		0.00145849	222.0	152212.0	0.0	32	0.97	PASS	amr	0.00425114	65.0	0.00182262	124.0	0.00137236	345.0	251392.0	0.0	100	0.99	PASS	amr	0.00248727	86.0	0.00187319	213.0	0.0011125	173	0.007	23.0				0.063	-0.545292	0.041	0	16	16		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LILRB2	0.0	0.0	0.05	0.0	-25.0	37.0	-1.0	-41.0	2.93958201162471e-05	0.028	9.219	-1.595	7.624	0.874	0.0		0.0	-3.061	.			white blood cells;trigeminal ganglion;whole blood;	.	adaptive immune response;negative regulation of antigen processing and presentation;positive regulation of tolerance induction;positive regulation of T cell tolerance induction;immune response-inhibiting cell surface receptor signaling pathway;Fc receptor mediated inhibitory signaling pathway;immune response;cellular defense response;signal transduction;cell surface receptor signaling pathway;cell-cell signaling;learning or memory;positive regulation of interleukin-6 production;heterotypic cell-cell adhesion;positive regulation of protein dephosphorylation;positive regulation of T cell proliferation;negative regulation of T cell proliferation;neutrophil degranulation;positive regulation of regulatory T cell differentiation;regulation of immune response;negative regulation of protein metabolic process;negative regulation of calcium ion transport;cellular response to lipopolysaccharide;regulation of long-term synaptic potentiation;positive regulation of long-term synaptic depression;negative regulation of postsynaptic density organization;regulation of dendritic cell differentiation	extracellular space;cytoplasm;plasma membrane;integral component of plasma membrane;cell surface;membrane;tertiary granule membrane;ficolin-1-rich granule membrane	amyloid-beta binding;protein binding;protein phosphatase 1 binding;MHC class Ib protein binding;inhibitory MHC class I receptor activity;MHC class I protein binding;protein homodimerization activity;protein-containing complex binding;cell adhesion molecule binding	APP[28219245;24052308];NOTCH1[25714926];EBI3[24018270];H2AFX[16455647];HLA-B[27649529;12853576];HLA-C[17056715];HLA-A[27649529];HLA-F[24018270];HLA-G[28348268;16455647;24899623;22802125;17056715];INS[24018270];ANGPTL2[24899623;22660330];PTPN6[18802077];ANGPTL5[24899623;22660330];KPNA2[24018270];B2M[27649529;12853576;16455647;17056715];
891784	chr21	46021179	A	A	chr21:46021179	KRTAP10-7	keratin associated protein 10-7	16138.0	SNV	1/1	1.0	0_32	32	96	False	rs363877,COSV59109234	EXONIC	YES	NM_198689.3	Transcript	protein_coding	synonymous_variant		1/1	NM_198689.3:c.643C>A	NP_941962.1:p.Lys215%3D		1.0						.	.	.						0	0.0											100	1.0							0.0000064,0.0000064,0.0000064,0.7339490,0.0000193,0.0000386,0.0000064	1,1,1,114132,3,6,1	0.603	1869.0				16.87	1.603439		0	0	0			KRTAP10-7	0.0	0.01	0.0	0.0	-37.0	33.0	50.0	35.0							0.01				.			.	.	keratinization	cytosol;keratin filament	protein binding;identical protein binding	MAPKBP1[25416956;unassigned1304];CHIC2[25416956];ZNF175[25416956];SLC23A1[25416956];AQP1[25416956];NUBP2[25416956];UXT[25416956];LCE1A[unassigned1304];LCE1B[25416956;unassigned1304];ZFYVE26[25416956;unassigned1304];RPL36AL[25416956];DHX57[25416956;unassigned1304];ZNF846[25416956];SPATA24[unassigned1304];ZNF844[unassigned1304];HOXA1[unassigned1304];SMCO4[25416956];PTGDS[25416956];ZNF169[25416956];TNS2[25416956];TMEM8A[25416956];GABARAPL2[25416956;unassigned1304];ZNF165[25416956];PRKAB2[25416956;unassigned1304];GABARAPL1[25416956];HPCAL1[25416956];LCE1F[unassigned1304];THAP1[25416956];LCE1D[unassigned1304];LCE2B[unassigned1304];LCE2C[unassigned1304];THAP6[25416956];CARHSP1[25416956];LCE2A[25416956];ZNF837[unassigned1304];ZSCAN21[unassigned1304];TYRO3[25416956];COL8A1[25416956];ZSCAN26[25416956;unassigned1304];FAM76B[25416956];PRR13[25416956];GNE[25416956;unassigned1304];ZNF155[25416956];IGSF8[25416956;unassigned1304];RWDD2B[25416956];ZNF20[25416956];SLC6A20[25416956];ZNF26[25416956];GUCD1[25416956];FAM124B[25416956];ZNHIT1[25416956];ZNF707[25416956];PTPMT1[25416956;unassigned1304];INPP5D[25416956];TTPA[unassigned1304];NPBWR2[25416956];KRTAP5-11[unassigned1304];ZSCAN10[unassigned1304];HOXC8[unassigned1304];ZNF266[25416956];VTI1B[25416956];SMCP[25416956;unassigned1304];ZNF264[unassigned1304];ZNF260[unassigned1304];TREX1[25416956;25910212];ZNF32[25416956];WDYHV1[25416956];NOTCH2NLA[25416956];TYMSOS[unassigned1304];VASN[unassigned1304];C19orf57[25416956];ZBTB9[25416956;unassigned1304];RPS28[25416956];ZNF138[unassigned1304];NOL12[25416956];CTRC[25416956];ZNF256[unassigned1304];PRR35[unassigned1304];ZNF133[25416956];ZNF250[25416956];ZNF491[unassigned1304];SUV39H1[25416956;unassigned1304];ZNF490[25416956;unassigned1304];KRTAP26-1[unassigned1304];KRT20[25416956];PCSK5[25416956];FARS2[25416956;unassigned1304];ING5[25416956];CATIP[25416956];LCE5A[unassigned1304];ZNF41[25416956];RSPO2[25416956;unassigned1304];LINC00612[unassigned1304];ZNF124[25416956];HBZ[25416956];KRTAP9-3[unassigned1304];HSBP1[25416956];KRTAP9-2[25416956;unassigned1304];AEN[25416956];AES[25416956;unassigned1304];KRTAP9-8[unassigned1304];HCK[unassigned1304];SCNM1[25416956];RPUSD3[25416956];PPARD[25416956];AVPI1[25416956];VGLL3[unassigned1304];GRN[25416956];GSTP1[25416956;unassigned1304];RPL11[25416956];PTGER3[25416956];CRCT1[25416956;unassigned1304];DERL2[25416956];ZNF2[25416956];NKD1[unassigned1304];LCE3C[unassigned1304];LCE3D[unassigned1304];LCE3A[unassigned1304];LCE3B[unassigned1304];CHRNG[25416956;25910212];LMNA[25416956];UCP2[25416956];ANKRD36BP1[25416956];ZNF587[25416956;unassigned1304];ZNF223[25416956];ZIM2[unassigned1304];ZNF101[25416956;unassigned1304];NPDC1[25416956;unassigned1304];ZNF581[25416956;unassigned1304];ZNF580[unassigned1304];MCRS1[unassigned1304];STAT3[25814554];DMRT3[25416956];RYDEN[25416956;unassigned1304];LCE3E[25416956;unassigned1304];BYSL[25416956];LCE4A[25416956;unassigned1304];WT1[unassigned1304];CCNG1[25416956];TCEA2[25416956];ZNF337[25416956];ZNF578[25416956;unassigned1304];ZNF697[25416956];LIMS2[25416956];ZNF575[unassigned1304];ZNF696[unassigned1304];ZNF572[25416956];ZBTB24[25416956];KLHL38[25416956;unassigned1304];PVR[25416956];SLC25A48[25416956];CYSRT1[unassigned1304];FADS6[unassigned1304];STK16[25416956];ZNF329[25416956];ZNF444[unassigned1304];PHLDA1[unassigned1304];ZNF564[25416956;unassigned1304];ZNF320[25416956];ZNF440[unassigned1304];PRM2[25416956;unassigned1304];LMO2[25416956];CTNNBIP1[25416956];GEM[25416956;unassigned1304];PDIA5[25416956];FAM161A[25416956];ZFP41[unassigned1304];ZNF439[25416956];ZNF555[25416956];ZNF433[25416956];CSNK1G2[25416956];PDE9A[unassigned1304];CSNK1G1[25416956];ZNF792[25416956];TEDC2[25416956];ZNF670[25416956];CCDC26[25416956];CHRD[25416956;unassigned1304];SPATA8[25416956];RPF1[25416956];SDCBP[25416956];MOBP[25416956;unassigned1304];ALDH3B1[25416956];E4F1[25416956];ZNF425[25416956];KRTAP4-2[25416956];ZNF667[unassigned1304];OTX1[unassigned1304];RNF175[25416956];ZNF786[unassigned1304];ZNF543[25416956];ZNF542[unassigned1304];TXNDC5[25416956;unassigned1304];AP1M1[25416956;unassigned1304];ZNF420[unassigned1304];KRTAP12-1[25416956;unassigned1304];KRTAP12-3[unassigned1304];TOR1A[25416956;25910212];MYPOP[unassigned1304];TFAP2D[unassigned1304];CBX2[25416956];TCEANC[25416956];KRTAP4-5[unassigned1304];C8orf33[25416956];BMP7[25416956];CLK4[25416956;unassigned1304];CLK1[25416956;unassigned1304];MRGBP[25416956;unassigned1304];ZNF419[25416956];ZNF418[25416956];ZNF417[25416956;unassigned1304];PIN1[25416956;unassigned1304];ZNF778[25416956];ZNF414[unassigned1304];LRCH4[25416956];ZNF774[unassigned1304];MXD3[25416956];GLP1R[25416956];ITGB5[unassigned1304];ITGB4[unassigned1304];CDCA7L[25416956];HHEX[25416956];FAM74A4[25416956];ZNF408[unassigned1304];IQUB[25416956];KRTAP5-2[unassigned1304];POLL[25416956];ZNF524[unassigned1304];ZNF764[unassigned1304];KRTAP5-9[25416956];KRTAP5-6[25416956;unassigned1304];BUD31[25416956;unassigned1304];RTN4RL1[25416956];EHHADH[25416956];FAM27E3[25416956];CRY2[unassigned1304];MCM5[25416956];DOCK2[unassigned1304];B4GALT7[25416956];SSX2IP[25416956];CREB5[25416956];SPACA9[25416956];LINC00242[25416956];NUFIP2[25416956;unassigned1304];ZBTB48[unassigned1304];TULP3[25416956];SPG7[25416956];TMA16[25416956];KRT83[25416956];P2RY6[25416956];WNT11[25416956];BAHD1[25416956];PCED1A[25416956];MXI1[25416956];ZNF625[25416956];TRIM42[25416956];CCDC185[25416956];PDLIM5[25416956];E2F6[25416956];CNNM3[unassigned1304];HSD3B7[25416956];KRTAP10-5[25416956];NAA10[25416956];KRTAP10-7[25416956];KRTAP10-9[25416956;unassigned1304];KRTAP10-8[25416956;unassigned1304];ZNF180[25416956];GOLGA8DP[25416956];PFKL[25416956];BCL6B[25416956];SPRY1[25416956;unassigned1304];TNP2[25416956];NAXD[25416956;unassigned1304];NECTIN3[25416956];NECTIN2[25416956];R3HDM2[unassigned1304];
891785	chr21	46021205	T	T	chr21:46021205	KRTAP10-7	keratin associated protein 10-7	16138.0	SNV	1/1	0.97	1_30	31	56	False	rs1569213000,rs389167,COSV59111661	EXONIC	YES	NM_198689.3	Transcript	protein_coding	synonymous_variant		1/1	NM_198689.3:c.669C>T	NP_941962.1:p.Pro223%3D		1.0						.	.	.						0	0.0											100	1.0							0.0000064,0.0000064,0.0000064,0.7734013,0.0000064,0.0000129,0.0000064	1,1,1,120267,1,2,1	0.209	654.0				12.87	0.921349		0	0	0			KRTAP10-7	0.11	0.0	0.0	0.0	7.0	-35.0	9.0	46.0							0.01				.			.	.	keratinization	cytosol;keratin filament	protein binding;identical protein binding	MAPKBP1[25416956;unassigned1304];CHIC2[25416956];ZNF175[25416956];SLC23A1[25416956];AQP1[25416956];NUBP2[25416956];UXT[25416956];LCE1A[unassigned1304];LCE1B[25416956;unassigned1304];ZFYVE26[25416956;unassigned1304];RPL36AL[25416956];DHX57[25416956;unassigned1304];ZNF846[25416956];SPATA24[unassigned1304];ZNF844[unassigned1304];HOXA1[unassigned1304];SMCO4[25416956];PTGDS[25416956];ZNF169[25416956];TNS2[25416956];TMEM8A[25416956];GABARAPL2[25416956;unassigned1304];ZNF165[25416956];PRKAB2[25416956;unassigned1304];GABARAPL1[25416956];HPCAL1[25416956];LCE1F[unassigned1304];THAP1[25416956];LCE1D[unassigned1304];LCE2B[unassigned1304];LCE2C[unassigned1304];THAP6[25416956];CARHSP1[25416956];LCE2A[25416956];ZNF837[unassigned1304];ZSCAN21[unassigned1304];TYRO3[25416956];COL8A1[25416956];ZSCAN26[25416956;unassigned1304];FAM76B[25416956];PRR13[25416956];GNE[25416956;unassigned1304];ZNF155[25416956];IGSF8[25416956;unassigned1304];RWDD2B[25416956];ZNF20[25416956];SLC6A20[25416956];ZNF26[25416956];GUCD1[25416956];FAM124B[25416956];ZNHIT1[25416956];ZNF707[25416956];PTPMT1[25416956;unassigned1304];INPP5D[25416956];TTPA[unassigned1304];NPBWR2[25416956];KRTAP5-11[unassigned1304];ZSCAN10[unassigned1304];HOXC8[unassigned1304];ZNF266[25416956];VTI1B[25416956];SMCP[25416956;unassigned1304];ZNF264[unassigned1304];ZNF260[unassigned1304];TREX1[25416956;25910212];ZNF32[25416956];WDYHV1[25416956];NOTCH2NLA[25416956];TYMSOS[unassigned1304];VASN[unassigned1304];C19orf57[25416956];ZBTB9[25416956;unassigned1304];RPS28[25416956];ZNF138[unassigned1304];NOL12[25416956];CTRC[25416956];ZNF256[unassigned1304];PRR35[unassigned1304];ZNF133[25416956];ZNF250[25416956];ZNF491[unassigned1304];SUV39H1[25416956;unassigned1304];ZNF490[25416956;unassigned1304];KRTAP26-1[unassigned1304];KRT20[25416956];PCSK5[25416956];FARS2[25416956;unassigned1304];ING5[25416956];CATIP[25416956];LCE5A[unassigned1304];ZNF41[25416956];RSPO2[25416956;unassigned1304];LINC00612[unassigned1304];ZNF124[25416956];HBZ[25416956];KRTAP9-3[unassigned1304];HSBP1[25416956];KRTAP9-2[25416956;unassigned1304];AEN[25416956];AES[25416956;unassigned1304];KRTAP9-8[unassigned1304];HCK[unassigned1304];SCNM1[25416956];RPUSD3[25416956];PPARD[25416956];AVPI1[25416956];VGLL3[unassigned1304];GRN[25416956];GSTP1[25416956;unassigned1304];RPL11[25416956];PTGER3[25416956];CRCT1[25416956;unassigned1304];DERL2[25416956];ZNF2[25416956];NKD1[unassigned1304];LCE3C[unassigned1304];LCE3D[unassigned1304];LCE3A[unassigned1304];LCE3B[unassigned1304];CHRNG[25416956;25910212];LMNA[25416956];UCP2[25416956];ANKRD36BP1[25416956];ZNF587[25416956;unassigned1304];ZNF223[25416956];ZIM2[unassigned1304];ZNF101[25416956;unassigned1304];NPDC1[25416956;unassigned1304];ZNF581[25416956;unassigned1304];ZNF580[unassigned1304];MCRS1[unassigned1304];STAT3[25814554];DMRT3[25416956];RYDEN[25416956;unassigned1304];LCE3E[25416956;unassigned1304];BYSL[25416956];LCE4A[25416956;unassigned1304];WT1[unassigned1304];CCNG1[25416956];TCEA2[25416956];ZNF337[25416956];ZNF578[25416956;unassigned1304];ZNF697[25416956];LIMS2[25416956];ZNF575[unassigned1304];ZNF696[unassigned1304];ZNF572[25416956];ZBTB24[25416956];KLHL38[25416956;unassigned1304];PVR[25416956];SLC25A48[25416956];CYSRT1[unassigned1304];FADS6[unassigned1304];STK16[25416956];ZNF329[25416956];ZNF444[unassigned1304];PHLDA1[unassigned1304];ZNF564[25416956;unassigned1304];ZNF320[25416956];ZNF440[unassigned1304];PRM2[25416956;unassigned1304];LMO2[25416956];CTNNBIP1[25416956];GEM[25416956;unassigned1304];PDIA5[25416956];FAM161A[25416956];ZFP41[unassigned1304];ZNF439[25416956];ZNF555[25416956];ZNF433[25416956];CSNK1G2[25416956];PDE9A[unassigned1304];CSNK1G1[25416956];ZNF792[25416956];TEDC2[25416956];ZNF670[25416956];CCDC26[25416956];CHRD[25416956;unassigned1304];SPATA8[25416956];RPF1[25416956];SDCBP[25416956];MOBP[25416956;unassigned1304];ALDH3B1[25416956];E4F1[25416956];ZNF425[25416956];KRTAP4-2[25416956];ZNF667[unassigned1304];OTX1[unassigned1304];RNF175[25416956];ZNF786[unassigned1304];ZNF543[25416956];ZNF542[unassigned1304];TXNDC5[25416956;unassigned1304];AP1M1[25416956;unassigned1304];ZNF420[unassigned1304];KRTAP12-1[25416956;unassigned1304];KRTAP12-3[unassigned1304];TOR1A[25416956;25910212];MYPOP[unassigned1304];TFAP2D[unassigned1304];CBX2[25416956];TCEANC[25416956];KRTAP4-5[unassigned1304];C8orf33[25416956];BMP7[25416956];CLK4[25416956;unassigned1304];CLK1[25416956;unassigned1304];MRGBP[25416956;unassigned1304];ZNF419[25416956];ZNF418[25416956];ZNF417[25416956;unassigned1304];PIN1[25416956;unassigned1304];ZNF778[25416956];ZNF414[unassigned1304];LRCH4[25416956];ZNF774[unassigned1304];MXD3[25416956];GLP1R[25416956];ITGB5[unassigned1304];ITGB4[unassigned1304];CDCA7L[25416956];HHEX[25416956];FAM74A4[25416956];ZNF408[unassigned1304];IQUB[25416956];KRTAP5-2[unassigned1304];POLL[25416956];ZNF524[unassigned1304];ZNF764[unassigned1304];KRTAP5-9[25416956];KRTAP5-6[25416956;unassigned1304];BUD31[25416956;unassigned1304];RTN4RL1[25416956];EHHADH[25416956];FAM27E3[25416956];CRY2[unassigned1304];MCM5[25416956];DOCK2[unassigned1304];B4GALT7[25416956];SSX2IP[25416956];CREB5[25416956];SPACA9[25416956];LINC00242[25416956];NUFIP2[25416956;unassigned1304];ZBTB48[unassigned1304];TULP3[25416956];SPG7[25416956];TMA16[25416956];KRT83[25416956];P2RY6[25416956];WNT11[25416956];BAHD1[25416956];PCED1A[25416956];MXI1[25416956];ZNF625[25416956];TRIM42[25416956];CCDC185[25416956];PDLIM5[25416956];E2F6[25416956];CNNM3[unassigned1304];HSD3B7[25416956];KRTAP10-5[25416956];NAA10[25416956];KRTAP10-7[25416956];KRTAP10-9[25416956;unassigned1304];KRTAP10-8[25416956;unassigned1304];ZNF180[25416956];GOLGA8DP[25416956];PFKL[25416956];BCL6B[25416956];SPRY1[25416956;unassigned1304];TNP2[25416956];NAXD[25416956;unassigned1304];NECTIN3[25416956];NECTIN2[25416956];R3HDM2[unassigned1304];
893657	chr4	15964423	C	T	chr4:15964423	FGFBP2	fibroblast growth factor binding protein 2	16179.0	SNV	0/1	0.51	17_18	35	99	False	rs370553606,COSV52588147,COSV52588575	EXONIC	YES	NM_031950.4	Transcript	protein_coding	synonymous_variant		1/2	NM_031950.4:c.330G>A	NP_114156.1:p.Pro110%3D		-1.0						.	.	.		0.000407364	62.0	152198.0	0.0	33	0.97	PASS	afr	0.000916767	38.0	0.000191064	13.0	0.000297424	68.0	228630.0	0.0	50	0.74	PASS	afr	0.00131086	21.0	0.000283565	30.0	0.0002444	38	0.001	3.0				0.506	-0.252308		0	0	0			FGFBP2	0.0	0.0	0.0	0.0	46.0	38.0	-8.0	0.0						0.854	0.0	47.113571777			.			.	.	cell-cell signaling	extracellular space	growth factor binding	TMBIM6[unassigned1304];HIST1H2BH[30021884];
893906	chr1	25667024	G	T	chr1:25667024	TMEM50A	transmembrane protein 50A	16203.0	SNV	0/1	0.48	16_15	31	99	False	rs147456847	EXONIC	YES	NM_014313.4	Transcript	protein_coding	missense_variant		2/7	NM_014313.4:c.47G>T	NP_055128.1:p.Trp16Leu		1.0						.	.	.		0.000276334	42.0	151990.0	0.0	32	0.97	PASS	nfe	0.000470422	32.0	0.000470422	32.0	0.000278827	70.0	251052.0	0.0	54	0.96	PASS	nfe	0.000527937	60.0	0.000527937	60.0	0.0002765	43	0.001	2.0				22.6	2.53716	0.363	5	14	19	LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	TMEM50A	0.0	0.0	0.0	0.0	-30.0	-28.0	46.0	50.0						0.581	0.33	0.000000000	0.998	1.144	.			.	.	late endosome to vacuole transport via multivesicular body sorting pathway	endoplasmic reticulum;integral component of membrane;neuronal cell body;glial cell projection	.	LEPROT[unassigned1304];SLC30A8[unassigned1304];REEP4[unassigned1304];LEPROTL1[unassigned1304];AQP6[unassigned1304];COMT[unassigned1304];TMEM14B[unassigned1304];HLA-DPA1[unassigned1304];
894495	chr1	145293425	C	A	chr1:145293425	NBPF10	NBPF member 10	16226.0	SNV	0/1	0.3	74_31	105	99	False	rs7366490,COSV61246073	EXONIC	YES	NM_001039703.6	Transcript	protein_coding	missense_variant		1/86	NM_001039703.6:c.20C>A	NP_001034792.4:p.Pro7His		1.0						.	.	.						12	0.27							0.15374	12995.0	84526.0	0.0	100	1.0	InbreedingCoeff	eas	0.394188	1777.0	0.14399	5503.0	0.0005209	81	0.06	179.0				0.268	-0.344967		1	0	1	SIFT		NBPF10	0.0	0.0	0.0	0.0	-20.0	10.0	8.0	-26.0							0.0				.			.	.	.	cytoplasm	RNA binding	NEK4[25798074];
894499	chr1	145293490	G	C	chr1:145293490	NBPF10	NBPF member 10	16226.0	SNV	0|1	0.29	78_32	110	99	False	rs6671335,COSV61245884	EXONIC	YES	NM_001039703.6	Transcript	protein_coding	missense_variant		1/86	NM_001039703.6:c.85G>C	NP_001034792.4:p.Ala29Pro		1.0						.	.	.						22	0.65							0.034099	2782.0	81586.0	0.0	100	1.0	InbreedingCoeff	nfe	0.0378412	1173.0	0.0378412	1173.0	0.0001222	19	0.072	215.0				13.11	0.95365		0	1	1		SIFT	NBPF10	0.0	0.0	0.0	0.0	-29.0	-3.0	7.0	-1.0							0.0				.			.	.	.	cytoplasm	RNA binding	NEK4[25798074];
894500	chr1	145293498	G	C	chr1:145293498	NBPF10	NBPF member 10	16226.0	SNV	0|1	0.3	76_33	109	99	False	rs4409714,COSV61245889	EXONIC	YES	NM_001039703.6	Transcript	protein_coding	missense_variant		1/86	NM_001039703.6:c.93G>C	NP_001034792.4:p.Lys31Asn		1.0						.	.	.		0.000298355	42.0	140772.0	3.0	22	0.66	PASS	nfe	0.000473037	30.0	0.000473037	30.0	0.147425	11646.0	78996.0	0.0	100	1.0	InbreedingCoeff	eas	0.209677	299.0	0.176322	6440.0	0.0002894	45	0.084	251.0				0.01	-0.7934		0	1	1		SIFT	NBPF10	0.0	0.0	0.0	0.0	15.0	-11.0	-4.0	8.0							0.0				.			.	.	.	cytoplasm	RNA binding	NEK4[25798074];
894502	chr1	145293510	C	G	chr1:145293510	NBPF10	NBPF member 10	16226.0	SNV	0/1	0.32	70_33	103	99	False	rs4356110,COSV61246083	EXONIC	YES	NM_001039703.6	Transcript	protein_coding	missense_variant		1/86	NM_001039703.6:c.105C>G	NP_001034792.4:p.Phe35Leu		1.0						.	.	.						22	0.67							0.0265598	2693.0	101394.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.103122	251.0	0.022351	991.0	0.0001286	20	0.051	145.0				1.422	-0.098342		1	0	1	SIFT		NBPF10	0.0	0.0	0.0	0.0	-23.0	3.0	-4.0	3.0							0.0				.			.	.	.	cytoplasm	RNA binding	NEK4[25798074];
894505	chr1	145293566	G	A	chr1:145293566	NBPF10	NBPF member 10	16226.0	SNV	0/1	0.28	86_34	120	99	False	rs7526045,COSV61245161	EXONIC	YES	NM_001039703.6	Transcript	protein_coding	missense_variant		1/86	NM_001039703.6:c.161G>A	NP_001034792.4:p.Arg54Gln		1.0	.,.,.,.					.	.	.		7.65462e-05	1.0	13064.0	0.0	9	0.17	AS_VQSR,PASS,PASS	nfe,sas,amr	0.000159591	1.0	0.000159591	1.0	0.465106	80907.0	173954.0	0.0	100	0.99	InbreedingCoeff	eas	0.490994	7033.0	0.45416	34171.0	0.0008296	129	0.024	77.0				0.039	-0.609633	0.035	0	10	10		SIFT,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	NBPF10	0.0	0.0	0.0	0.0	5.0	1.0	43.0	14.0							0.0		0.0	-4.557	.			.	.	.	cytoplasm	RNA binding	NEK4[25798074];
894555	chr1	145296478	G	T	chr1:145296478	NBPF10	NBPF member 10	16226.0	SNV	0/1	0.32	55_26	81	99	False	rs6663523,COSV61245165	EXONIC	YES	NM_001039703.6	Transcript	protein_coding	missense_variant		3/86	NM_001039703.6:c.400G>T	NP_001034792.4:p.Asp134Tyr		1.0	.,.,.,.,.					.	.	.						12	0.2							0.502464	109910.0	218742.0	3075.0	100	0.99	InbreedingCoeff	eas	0.530194	9447.0	0.496696	47809.0	0.0131122	2039	0.032	100.0				13.68	1.037915	0.012	1	9	10	SIFT	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	NBPF10	0.0	0.02	0.0	0.0	15.0	-15.0	-2.0	-15.0							0.0		0.0	-1.835	.			.	.	.	cytoplasm	RNA binding	NEK4[25798074];
894607	chr1	145299805	A	C	chr1:145299805	NBPF10	NBPF member 10	16226.0	SNV	0|1	0.12	46_6	52	99	False	rs4143500,COSV61657108	EXONIC	YES	NM_001039703.6	Transcript	protein_coding	missense_variant		6/86	NM_001039703.6:c.854A>C	NP_001034792.4:p.Glu285Ala		1.0						.	.	.						0	0.0							0.000148142	36.0	243010.0	0.0	79	0.98	PASS	eas	5.59785e-05	1.0	3.6222e-05	4.0	0.0011704	182	0.003	10.0				12.93	0.928917		0	1	1		SIFT	NBPF10	0.0	0.0	0.0	0.0	-41.0	41.0	15.0	-47.0							0.0				.			.	.	.	cytoplasm	RNA binding	NEK4[25798074];
895507	chr19	53217339	C	A	chr19:53217339	ZNF611	zinc finger protein 611	16259.0	SNV	0/1	0.42	11_8	19	99	False	rs149629821,COSV60542727	EXONIC	YES	NM_030972.3	Transcript	protein_coding	missense_variant		6/7	NM_030972.3:c.119G>T	NP_112234.3:p.Cys40Phe		-1.0	Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box					.	.	.		0.00260937	397.0	152144.0	3.0	32	0.96	PASS	nfe	0.00391015	266.0	0.00391015	266.0	0.00340242	855.0	251292.0	4.0	69	0.98	PASS	amr	0.00466288	161.0	0.00425674	484.0	0.0006045	94	0.004	12.0				3.777	0.071053	0.252	1	17	18	PROVEAN_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF611	0.0	0.0	0.0	0.0	-17.0	9.0	-29.0	-24.0						0.992	0.0		0.01	-0.661	.			ciliary ganglion;dorsal root ganglion;cingulate cortex;superior cervical ganglion;skin;atrioventricular node;globus pallidus;	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	HIST1H2AE[30021884];HIST1H2BH[30021884];HIST2H2BE[30021884];
896228	chr3	172835405	G	A	chr3:172835405	SPATA16	spermatogenesis associated 16	16280.0	SNV	0/1	0.61	12_19	31	99	False	rs372937515,COSV63531597	EXONIC	YES	NM_031955.6	Transcript	protein_coding	synonymous_variant		2/11	NM_031955.6:c.117C>T	NP_114161.3:p.Asn39%3D		-1.0		Uncertain_significance	criteria_provided,_single_submitter	Globozoospermia	?Spermatogenic failure 6, 102530 (3), Autosomal recessive	Male infertility due to globozoospermia	Disease-causing germline mutation(s) in	Globozoospermia;Autosomal recessive inheritance;Infertility		0.000203778	31.0	152126.0	0.0	32	0.97	PASS	amr	0.000523629	8.0	0.000249919	17.0	0.000123362	31.0	251292.0	0.0	100	1.0	PASS	amr	0.000289436	10.0	0.000167142	19.0	0.0000900	14	0.002	5.0	0.00096	11.0		0.2	-0.386428		0	0	0			SPATA16	0.0	0.0	0.0	0.03	-20.0	-48.0	2.0	-48.0						0.942	0.0	85.658366352			endocrine/exocrine gland phenotype; cellular phenotype; reproductive system phenotype; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;atrioventricular node;testis;skeletal muscle;	.	multicellular organism development;spermatogenesis;biological_process;cell differentiation	Golgi apparatus	molecular_function	MYH9[30021884];
896961	chr10	46999592		ATGAGGGAG	chr10:46999591-46999592	GPRIN2	G protein regulated inducer of neurite outgrowth 2	16281.0	insertion	0/1	0.75	18_53	71	99	False	rs112620425	EXONIC	YES	NM_001385299.1	Transcript	protein_coding	inframe_insertion		6/6	NM_001385299.1:c.784_792dup	NP_001372228.1:p.Met262_Glu264dup		1.0						.	.	.	29267878					74	0.91											98	1.0							0.0044629,0.0456644	694,7101	0.057	180.0				6.366	0.236491		0	0	0																		0.0	7.530829162			.			.	.	.	.	protein binding	YWHAE[16189514];PLSCR1[16189514];KRTAP4-12[16189514];SPRY2[16189514];SFN[16189514;15778465];TRIP13[16189514];HTR4[28298427];DYNLL2[16189514];MDFI[16189514];
897769	chr19	9491666	C	G	chr19:9491666	ZNF559-ZNF177	ZNF559-ZNF177 readthrough	16332.0	SNV	0/1	0.39	14_9	23	99	False	rs771865530	EXONIC	YES	NM_001384659.1	Transcript	protein_coding	stop_gained		13/13	NM_001384659.1:c.659C>G	NP_001371588.1:p.Ser220Ter		1.0	.,.					.	.	.		1.31408e-05	2.0	152198.0	0.0	32	0.97	PASS	afr	2.41255e-05	1.0	1.46985e-05	1.0	6.46169e-05	11.0	170234.0	0.0	45	0.57	PASS	amr	0.000327273	9.0	2.75581e-05	2.0	0.0000322	5	0.0	1.0				32.0	4.53183		2	3	5	BayesDel_noAF_pred,Aloft_pred	BayesDel_addAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF559-ZNF177	0.0	0.0	0.02	0.0	-17.0	3.0	32.0	5.0								0.000000000	0.002	0.731	.			superior cervical ganglion;	.	regulation of transcription, DNA-templated	nucleus	nucleic acid binding;metal ion binding	.
898426	chrX	114424343	G	A	chrX:114424343	RBMXL3	RBMX like 3	16391.0	SNV	1/1	1.0	0_11	11	33	False	rs187066706	EXONIC	YES	NM_001145346.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001145346.2:c.339G>A	NP_001138818.1:p.Gly113%3D		1.0						.	.	.		0.00166151	188.0	113150.0	0.0	25	0.67	PASS	amr	0.00295203	32.0	0.00211793	113.0	0.00181103	199.0	109882.0	0.0	27	0.56	PASS	amr	0.00252747	49.0	0.00249039	103.0	0.0004116	64	0.003	11.0				0.248	-0.35626		0	0	0			RBMXL3	0.0	0.0	0.0	0.0	-9.0	34.0	1.0	-22.0								20.791224307			.			.	.	mRNA splicing, via spliceosome	.	mRNA binding	.
899354	chr19	52468476	C	T	chr19:52468476	ZNF350	zinc finger protein 350	16462.0	SNV	0/1	0.39	14_9	23	99	False	rs371531041,COSV54707877	EXONIC	YES	NM_021632.4	Transcript	protein_coding	synonymous_variant		5/5	NM_021632.4:c.1230G>A	NP_067645.3:p.Ala410%3D		-1.0						.	.	.		0.000387668	59.0	152192.0	0.0	32	0.97	PASS	nfe	0.000690709	47.0	0.000690709	47.0	0.00031853	80.0	251154.0	0.0	72	1.0	PASS	amr	0.000693922	24.0	0.00039656	45.0	0.0001994	31	0.002	6.0				0.048	-0.58188		0	0	0			ZNF350	0.0	0.0	0.0	0.0	-28.0	48.0	-21.0	38.0						0.892	0.0	22.908947238			.			superior cervical ganglion;trigeminal ganglion;parietal lobe;skeletal muscle;medulla oblongata;	.	negative regulation of transcription by RNA polymerase II;regulation of transcription, DNA-templated;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II	nucleus;nucleoplasm;nuclear matrix;nuclear body;transcriptional repressor complex	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;transcription regulatory region DNA binding;metal ion binding	ATF7IP[15231748];RNF11[14755250];MTNR1A[26514267];TRIM28[22975076];NEK1[14690447];BRCA1[11090615];
899355	chr19	52472322	G	A	chr19:52472322	ZNF350	zinc finger protein 350	16462.0	SNV	0/1	0.41	16_11	27	99	False	rs4987242	EXONIC	YES	NM_021632.4	Transcript	protein_coding	synonymous_variant		3/5	NM_021632.4:c.78C>T	NP_067645.3:p.Gly26%3D		-1.0						.	.	.		0.0014989	228.0	152112.0	0.0	32	0.96	PASS	nfe	0.0019112	130.0	0.0019112	130.0	0.00182165	458.0	251420.0	0.0	78	1.0	PASS	nfe	0.00170624	194.0	0.00170624	194.0	0.0016077	250	0.001	3.0				0.555	-0.238469		0	0	0			ZNF350	0.0	0.0	0.0	0.0	-10.0	44.0	-27.0	-17.0						0.892	0.0	6.169915974			.			superior cervical ganglion;trigeminal ganglion;parietal lobe;skeletal muscle;medulla oblongata;	.	negative regulation of transcription by RNA polymerase II;regulation of transcription, DNA-templated;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II	nucleus;nucleoplasm;nuclear matrix;nuclear body;transcriptional repressor complex	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;transcription regulatory region DNA binding;metal ion binding	ATF7IP[15231748];RNF11[14755250];MTNR1A[26514267];TRIM28[22975076];NEK1[14690447];BRCA1[11090615];
900510	chr16	24920272	T	G	chr16:24920272	SLC5A11	solute carrier family 5 member 11	16480.0	SNV	0/1	0.3	22_10	33	99	False		EXONIC	YES	NM_001352242.2	Transcript	protein_coding	missense_variant		15/17	NM_001352242.2:c.1505T>G	NP_001339171.1:p.Val502Gly		1.0	.,.,.,.,.,.,.,.					.	.	.						31	0.94											81	1.0														5.749	0.193858	0.033	1	18	19	M-CAP_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SLC5A11	0.0	0.03	0.0	0.0	-23.0	5.0	40.0	23.0						0.198	0.0	0.000000000	0.012	-1.147	.			parietal lobe;hypothalamus;	.	sodium ion transport;apoptotic process;carbohydrate transport;myo-inositol transport;transmembrane transport	plasma membrane;integral component of membrane	glucose:sodium symporter activity;protein binding;polyol transmembrane transporter activity;symporter activity	KPNA3[25416956;25910212];SPTAN1[30021884];
901445	chr14	100795348	G	A	chr14:100795348	SLC25A47	solute carrier family 25 member 47	16549.0	SNV	0/1	0.63	10_17	27	99	False	rs147730585,COSV59925168	EXONIC	YES	NM_207117.4	Transcript	protein_coding	missense_variant		5/6	NM_207117.4:c.613G>A	NP_997000.2:p.Glu205Lys		1.0	.,.					.	.	.		0.000243009	37.0	152258.0	0.0	33	0.98	PASS	nfe	0.000440904	30.0	0.000440904	30.0	0.000251548	59.0	234548.0	0.0	62	0.97	PASS	nfe	0.000417866	45.0	0.000417866	45.0	0.0001736	27	0.001	2.0				19.29	1.943857	0.265	5	13	18	LRT_pred,M-CAP_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	SLC25A47	0.0	0.0	0.0	0.0	3.0	11.0	-3.0	33.0							0.0	0.0	0.535	1.176	.			ciliary ganglion;liver;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;	.	acyl carnitine transport;acyl carnitine transmembrane transport	mitochondrial inner membrane;integral component of membrane	acyl carnitine transmembrane transporter activity	C1QA[21988832];DIABLO[21988832];
901510	chr16	67861837	C	T	chr16:67861837	TSNAXIP1	translin associated factor X interacting protein 1	16555.0	SNV	0/1	0.4	14_10	25	99	False	rs140308084	EXONIC	YES	NM_001288990.3	Transcript	protein_coding	missense_variant		16/16	NM_001288990.3:c.2080C>T	NP_001275919.1:p.Arg694Trp		1.0	.,.,.					.	.	.		0.000124882	19.0	152144.0	0.0	32	0.95	PASS	eas	0.000577145	3.0	0.00014699	10.0	0.000196626	49.0	249204.0	0.0	100	1.0	PASS	eas	0.000544781	10.0	0.000115978	13.0	0.0001415	22	0.0	1.0				23.6	3.012645	0.239	5	15	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,PROVEAN_pred,LIST-S2_pred	Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TSNAXIP1	0.0	0.0	0.0	0.0	-35.0	-12.0	8.0	22.0						0.268	0.0		0.009	0.125	.			.	.	multicellular organism development;spermatogenesis;biological_process;cell differentiation	cellular_component;perinuclear region of cytoplasm	molecular_function	PRPF18[unassigned1304];GRAP2[27107012];HSPB1[25277244];CDC7[unassigned1304];FAM161B[unassigned1304];ROPN1[27107012];SPG21[unassigned1304];
904930	chr19	21926903	T	A	chr19:21926903	ZNF100	zinc finger protein 100	16676.0	SNV	0|1	0.38	15_9	24	99	False	rs200230432,COSV59748114	EXONIC	YES	NM_173531.4	Transcript	protein_coding	missense_variant		4/5	NM_173531.4:c.238A>T	NP_775802.2:p.Thr80Ser		-1.0	Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box					.	.	.		0.00161019	245.0	152156.0	2.0	32	0.95	PASS	nfe	0.00243988	166.0	0.00243988	166.0	0.00152521	378.0	247834.0	2.0	40	0.76	PASS	nfe	0.00237863	268.0	0.00237863	268.0	0.0000450	7	0.001	3.0				0.042	-0.599907	0.035	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF100	0.21	0.14	0.0	0.0	-10.0	14.0	-10.0	14.0						0.707	0.0		0.0	-1.055	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	KRTAP12-2[unassigned1304];
904936	chr19	21926904	G	A	chr19:21926904	ZNF100	zinc finger protein 100	16676.0	SNV	0|1	0.38	15_9	24	99	False	rs201028113,COSV59747918,COSV59748122	EXONIC	YES	NM_173531.4	Transcript	protein_coding	synonymous_variant		4/5	NM_173531.4:c.237C>T	NP_775802.2:p.Leu79%3D		-1.0						.	.	.		0.00161123	245.0	152058.0	2.0	32	0.95	PASS	nfe	0.00244024	166.0	0.00244024	166.0	0.00153534	380.0	247502.0	2.0	39	0.76	PASS	nfe	0.00238996	269.0	0.00238996	269.0	0.0000450	7						0.604	-0.225961		0	0	0			ZNF100	0.0	0.04	0.0	0.0	-11.0	13.0	10.0	13.0						0.707	0.0				.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	KRTAP12-2[unassigned1304];
904939	chr19	21926906	G	C	chr19:21926906	ZNF100	zinc finger protein 100	16676.0	SNV	0|1	0.38	15_9	24	99	False	rs199580880,COSV59748129	EXONIC	YES	NM_173531.4	Transcript	protein_coding	missense_variant		4/5	NM_173531.4:c.235C>G	NP_775802.2:p.Leu79Val		-1.0	Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box					.	.	.		0.00161748	246.0	152088.0	2.0	32	0.95	PASS	nfe	0.00244046	166.0	0.00244046	166.0	0.00153604	377.0	245436.0	2.0	38	0.71	PASS	nfe	0.00238495	267.0	0.00238495	267.0	0.0000450	7						0.001	-1.44841	0.027	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF100	0.25	0.03	0.0	0.0	11.0	-13.0	1.0	8.0						0.707	0.0		0.0	-1.062	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	KRTAP12-2[unassigned1304];
905018	chr19	21948511	C	G	chr19:21948511	ZNF100	zinc finger protein 100	16676.0	SNV	0|1	0.47	9_8	17	99	False	rs550860903	EXONIC	YES	NM_173531.4	Transcript	protein_coding	missense_variant		2/5	NM_173531.4:c.81G>C	NP_775802.2:p.Gln27His		-1.0	.,.,.					.	.	.		0.000315511	48.0	152134.0	2.0	32	0.96	PASS	sas	0.00227743	11.0	0.000308696	21.0	0.000179655	45.0	250480.0	0.0	70	1.0	PASS	sas	0.00065445	20.0	8.81399e-05	10.0	0.0000129	2	0.0	1.0				0.015	-0.734736	0.024	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF100	0.0	0.0	0.0	0.0	-16.0	44.0	-15.0	6.0						0.707	0.0	0.0	0.0	-0.834	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	KRTAP12-2[unassigned1304];
905021	chr19	21948513	G	A	chr19:21948513	ZNF100	zinc finger protein 100	16676.0	SNV	0|1	0.5	9_9	18	99	False	rs569230674	EXONIC	YES	NM_173531.4	Transcript	protein_coding	stop_gained		2/5	NM_173531.4:c.79C>T	NP_775802.2:p.Gln27Ter		-1.0	.,.,.					.	.	.		0.000315511	48.0	152134.0	2.0	32	0.96	PASS	sas	0.00227932	11.0	0.000308705	21.0	0.000163674	41.0	250498.0	0.0	72	1.0	PASS	sas	0.000589044	18.0	8.81383e-05	10.0	0.0000129	2	0.0	1.0				28.4	4.083234		2	4	6	MutationTaster_pred,Aloft_pred	BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF100	0.0	0.0	0.0	0.08	-17.0	42.0	2.0	-17.0						0.707	0.0	0.0	0.0	-0.242	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	KRTAP12-2[unassigned1304];
905025	chr19	21948514	C	A	chr19:21948514	ZNF100	zinc finger protein 100	16676.0	SNV	0|1	0.5	9_9	18	99	False	rs530281593,COSV100841224	EXONIC	YES	NM_173531.4	Transcript	protein_coding	synonymous_variant		2/5	NM_173531.4:c.78G>T	NP_775802.2:p.Val26%3D		-1.0						.	.	.		0.000315507	48.0	152136.0	2.0	32	0.96	PASS	sas	0.00228121	11.0	0.000308696	21.0	0.000159674	40.0	250510.0	0.0	73	1.0	PASS	sas	0.000556428	17.0	7.93203e-05	9.0	0.0000129	2	0.0	1.0				0.526	-0.246551		0	0	0			ZNF100	0.0	0.0	0.0	0.01	41.0	3.0	-15.0	-18.0						0.707	0.0	40.393402115			.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	KRTAP12-2[unassigned1304];
905033	chr19	21948517	C	T	chr19:21948517	ZNF100	zinc finger protein 100	16676.0	SNV	0|1	0.5	9_9	18	99	False	rs548577744	EXONIC	YES	NM_173531.4	Transcript	protein_coding	synonymous_variant		2/5	NM_173531.4:c.75G>A	NP_775802.2:p.Leu25%3D		-1.0						.	.	.		0.000315553	48.0	152114.0	2.0	32	0.96	PASS	sas	0.00228216	11.0	0.000308669	21.0	0.00019556	49.0	250562.0	0.0	76	1.0	PASS	sas	0.000654407	20.0	9.69419e-05	11.0	0.0000193	3	0.0	1.0				1.64	-0.076511		0	0	0			ZNF100	0.0	0.0	0.0	0.06	-21.0	38.0	-5.0	-21.0						0.707	0.0	40.393402115			.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	KRTAP12-2[unassigned1304];
905036	chr19	21948524	C	T	chr19:21948524	ZNF100	zinc finger protein 100	16676.0	SNV	0|1	0.47	10_9	19	99	False	rs201163370	EXONIC	YES	NM_173531.4	Transcript	protein_coding	missense_variant		2/5	NM_173531.4:c.68G>A	NP_775802.2:p.Ser23Asn		-1.0	.,.,.					.	.	.		0.000315433	48.0	152172.0	2.0	32	0.96	PASS	sas	0.00227743	11.0	0.00030866	21.0	0.000235405	59.0	250632.0	0.0	79	1.0	PASS	sas	0.000883046	27.0	9.69351e-05	11.0	0.0000257	4	0.0	1.0				0.012	-0.765398	0.014	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF100	0.0	0.0	0.01	0.0	-14.0	31.0	-28.0	-27.0						0.707	0.0	0.0	0.0	-1.773	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	KRTAP12-2[unassigned1304];
906209	chr16	30771928	C	G	chr16:30771928	CCDC189	coiled-coil domain containing 189	16744.0	SNV	0/1	0.47	19_17	36	99	False	rs200933996	SPLICING	YES	NM_001014979.3	Transcript	protein_coding	missense_variant,splice_region_variant		3/9	NM_001014979.3:c.298G>C	NP_001014979.2:p.Glu100Gln		-1.0	.,.,.					.	.	.		0.000183947	28.0	152218.0	0.0	33	0.96	PASS	nfe	0.000323349	22.0	0.000323349	22.0	0.000114426	19.0	166046.0	0.0	76	0.59	PASS	nfe	0.000241743	16.0	0.000241743	16.0	0.0001736	27	0.001	2.0				8.553	0.414526	0.031	0	16	16		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CCDC189	0.0	0.0	0.07	0.0	-3.0	30.0	2.0	7.0	0.0008812207283987	0.08	-0.887	-1.059	-1.946			0.0	0.913	-0.7	.			.	.	.	.	.	.
908193	chr2	9989546	A	G	chr2:9989546	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	16826.0	SNV	0/1	0.44	14_11	25	99	False	rs145202820	EXONIC	YES	NM_005680.3	Transcript	protein_coding	synonymous_variant		3/15	NM_005680.3:c.162A>G	NP_005671.3:p.Gln54%3D		1.0						.	.	.		0.00056544	86.0	152094.0	0.0	32	0.95	PASS	amr	0.00131096	20.0	0.000838161	57.0	0.000555031	127.0	228816.0	0.0	18	0.43	PASS	nfe	0.000997888	103.0	0.000997888	103.0	0.0006045	94	0.004	13.0				8.817	0.439985		0	0	0			TAF1B	0.0	0.0	0.0	0.0	-44.0	8.0	43.0	47.0						0.941	0.0	59.588945584			.			trigeminal ganglion;superior cervical ganglion;skin;	.	RNA polymerase I preinitiation complex assembly;transcription, DNA-templated;transcription initiation from RNA polymerase I promoter;termination of RNA polymerase I transcription;nucleolar large rRNA transcription by RNA polymerase I;positive regulation of gene expression, epigenetic	nucleus;nucleoplasm;RNA polymerase transcription factor SL1 complex;RNA polymerase I core factor complex	RNA polymerase I CORE element sequence-specific DNA binding;protein binding;TBP-class protein binding;metal ion binding	MPP1[26496610];NAPB[21988832];TBP[17318177;26496610];SET[17318177];MEOX2[unassigned1304];OAZ1[26496610];SRPK1[23602568];TAF1D[19615732];TAF1C[17318177];POLR1A[26496610];TAF1A[17318177];NAF1[26496610];CALR[unassigned1304];FERMT3[26496610];
908438	chr4	148867827	A	G	chr4:148867827	ARHGAP10	Rho GTPase activating protein 10	16840.0	SNV	0/1	0.46	13_11	24	99	False	rs575700520	EXONIC	YES	NM_024605.4	Transcript	protein_coding	missense_variant		15/23	NM_024605.4:c.1363A>G	NP_078881.3:p.Ile455Val		1.0	Rho GTPase-activating protein domain&Rho GTPase-activating protein domain&Rho GTPase-activating protein domain					.	.	.		1.31366e-05	2.0	152246.0	0.0	32	0.97	PASS	nfe	2.93919e-05	2.0	2.93919e-05	2.0	8.01545e-06	2.0	249518.0	0.0	33	0.8	PASS	nfe	1.76622e-05	2.0	1.76622e-05	2.0	0.0000129	2	0.0	1.0				18.74	1.870828	0.082	3	16	19	MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	ARHGAP10	0.0	0.0	0.0	0.0	-39.0	-27.0	-1.0	19.0						0.972	0.0	0.0	0.998	0.324	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); 			ciliary ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;globus pallidus;medulla oblongata;	.	cytoskeleton organization;signal transduction;negative regulation of apoptotic process;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction	cytosol;plasma membrane;perinuclear region of cytoplasm	GTPase activator activity;protein binding	FOXQ1[25609649];PKN3[11432776];NRXN1[unassigned1312];SH3BP2[25814554];ANKS1A[25814554];ARHGAP26[unassigned1312];MKI67[26949251];HIST1H1A[30021884];
908792	chrX	35821279	C	T	chrX:35821279	MAGEB16	MAGE family member B16	16874.0	SNV	1/1	1.0	0_18	18	54	False	rs761760773	EXONIC	YES	NM_001099921.2	Transcript	protein_coding	synonymous_variant		2/2	NM_001099921.2:c.966C>T	NP_001093391.1:p.Ala322%3D		1.0						.	.	.		0.000384416	43.0	111858.0	0.0	23	0.62	PASS	amr	0.000762486	8.0	0.000150283	8.0	0.000597566	79.0	132203.0	0.0	12	0.32	PASS	amr	0.000658576	14.0	0.000171771	10.0	0.0004566	71	0.003	9.0				0.321	-0.319029		0	0	0			MAGEB16	0.0	0.0	0.0	0.0	39.0	-41.0	39.0	-41.0						0.746	0.0	16.48581226			.			.	.	.	.	.	.
909060	chr1	144621555	A	G	chr1:144621555	NBPF9	NBPF member 9	16899.0	SNV	0/1	0.19	39_9	48	99	False	rs61810914	EXONIC	YES	NM_001037675.3	Transcript	protein_coding	missense_variant		8/22	NM_001037675.3:c.884A>G	NP_001032764.2:p.His295Arg		1.0						.	.	.		0.000222982	3.0	13454.0	0.0	0	0.01	PASS	eas	0.00265957	3.0	0.0	0.0	0.0038021	792.0	208306.0	0.0	100	0.99	PASS	amr	0.00771571	208.0	0.00174479	171.0	0.0000900	14	0.001	2.0				4.004	0.084615		0	2	2		SIFT,PolyPhen																				.			.	.	.	cytoplasm	.	.
909062	chr1	144621642	A	G	chr1:144621642	NBPF9	NBPF member 9	16899.0	SNV	0|1	0.17	25_5	30	99	False	rs1556594394	EXONIC	YES	NM_001037675.3	Transcript	protein_coding	missense_variant		8/22	NM_001037675.3:c.971A>G	NP_001032764.2:p.Gln324Arg		1.0	.,.,.,.,.					.	.	.		6.2071e-05	7.0	112774.0	2.0	18	0.41	PASS	afr	0.000205086	4.0	3.45256e-05	2.0	0.0267065	6303.0	236010.0	0.0	100	0.99	PASS	eas	0.0644028	1045.0	0.0178989	1945.0	0.0043600	678	0.034	107.0				8.409	0.401047		0	7	7		SIFT,PolyPhen,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-2.247	.			.	.	.	cytoplasm	.	.
909063	chr1	144621643	G	A	chr1:144621643	NBPF9	NBPF member 9	16899.0	SNV	0|1	0.17	25_5	30	99	False	rs1556594395	EXONIC	YES	NM_001037675.3	Transcript	protein_coding	synonymous_variant		8/22	NM_001037675.3:c.972G>A	NP_001032764.2:p.Gln324%3D		1.0						.	.	.		6.21747e-05	7.0	112586.0	2.0	18	0.41	PASS	afr	0.000205592	4.0	3.45662e-05	2.0	0.0268616	6341.0	236062.0	0.0	100	0.99	PASS	eas	0.0641642	1041.0	0.0178466	1941.0	0.0046108	717	0.034	107.0				4.038	0.086605		0	0	0																						.			.	.	.	cytoplasm	.	.
909376	chr1	144828748	C	T	chr1:144828748	NBPF9	NBPF member 9	16899.0	SNV	0/1	0.22	32_9	41	99	False	rs144947204,COSV56011341	EXONIC	YES	NM_001037675.3	Transcript	protein_coding	synonymous_variant		22/22	NM_001037675.3:c.2790C>T	NP_001032764.2:p.His930%3D		1.0						.	.	.						0	0.0							0.124509	8297.0	66638.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.321226	1362.0	0.116827	3552.0	0.0001672	26	0.003	9.0				0.159	-0.41873		0	0	0			NBPF9	0.0	0.0	0.0	0.0	13.0	-30.0	-31.0	-15.0											.			.	.	.	cytoplasm	.	.
909378	chr1	144828764	G	T	chr1:144828764	NBPF9	NBPF member 9	16899.0	SNV	0/1	0.3	33_14	47	99	False	rs114576842,COSV56011360	EXONIC	YES	NM_001037675.3	Transcript	protein_coding	stop_gained		22/22	NM_001037675.3:c.2806G>T	NP_001032764.2:p.Glu936Ter		1.0						.	.	.						27	0.91							0.210925	12059.0	57172.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.3988	1994.0	0.200741	4819.0	0.0001865	29	0.003	8.0				31.0	4.361736		0	0	0			NBPF9	0.0	0.0	0.08	0.0	-2.0	-3.0	-2.0	-31.0											.			.	.	.	cytoplasm	.	.
909379	chr1	144828765	A	T	chr1:144828765	NBPF9	NBPF member 9	16899.0	SNV	0/1	0.3	27_14	47	99	False	rs1043478,COSV56011395	EXONIC	YES	NM_001037675.3	Transcript	protein_coding	missense_variant		22/22	NM_001037675.3:c.2807A>T	NP_001032764.2:p.Glu936Val		1.0						.	.	.						0	0.0							0.217605	12531.0	57586.0	0.0	100	1.0	InbreedingCoeff	eas	0.404247	2132.0	0.206912	4951.0	0.0001994	31	0.003	8.0				2.477	-0.009894		0	2	2		SIFT,PolyPhen	NBPF9	0.0	0.0	0.0	0.0	-2.0	-4.0	-2.0	-32.0											.			.	.	.	cytoplasm	.	.
909382	chr1	144828784	A	G	chr1:144828784	NBPF9	NBPF member 9	16899.0	SNV	0/1	0.31	34_15	49	99	False	rs78667364,COSV56017629	EXONIC	YES	NM_001037675.3	Transcript	protein_coding	stop_retained_variant		22/22	NM_001037675.3:c.2826A>G	NP_001032764.2:p.Ter942%3D		1.0						.	.	.						27	0.91							0.315066	29758.0	94450.0	0.0	100	1.0	InbreedingCoeff	eas	0.424964	3551.0	0.316544	12494.0	0.0025851	402	0.007	21.0				1.037	-0.145327		0	0	0			NBPF9	0.0	0.0	0.0	0.0	1.0	-23.0	-22.0	50.0											.			.	.	.	cytoplasm	.	.
909674	chr1	35580334	A	G	chr1:35580334	ZMYM1	zinc finger MYM-type containing 1	16909.0	SNV	0/1	0.47	17_15	32	99	False		EXONIC	YES	NM_001289088.2	Transcript	protein_coding	missense_variant		11/11	NM_001289088.2:c.2903A>G	NP_001276017.1:p.Tyr968Cys		1.0	.,.,.,.					.	.	.						33	0.98											24	0.62														23.5	2.98209	0.374	11	10	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	ZMYM1	0.0	0.0	0.0	0.0	50.0	-24.0	-1.0	-7.0							0.0	79.400807469	0.999	1.312	.			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;	.	regulation of transcription by RNA polymerase II;regulation of cell morphogenesis	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;zinc ion binding;protein dimerization activity	CENPU[26496610];RNASEH2B[26496610];HSP90AA1[26496610];DTNB[25852190];ARHGEF26[25852190];CAMK2A[25852190];EEF2[25852190];LIN7C[25852190];SKA1[26496610];HDAC6[26496610];AURKA[26496610];ABLIM1[25852190];DLG1[25852190];VAPA[26496610];KIF2A[26496610];TGS1[26496610];MKNK2[26496610];GAR1[26496610];CHMP4B[26496610];L1TD1[26496610];SNTB2[25852190];
911738	chr16	85689333	A	T	chr16:85689333	GSE1	Gse1 coiled-coil protein	17065.0	SNV	0/1	0.53	20_23	43	99	False	rs151194801,COSV99497456	SPLICING	YES	NM_014615.5	Transcript	protein_coding	missense_variant,splice_region_variant		6/16	NM_014615.5:c.799A>T	NP_055430.1:p.Met267Leu		1.0	.,.,.,.	Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00263234	400.0	151956.0	0.0	32	0.96	PASS	sas	0.00830565	40.0	0.00311911	212.0	0.00317621	747.0	235186.0	4.0	37	0.77	PASS	sas	0.00777889	217.0	0.00329767	344.0	0.0030674	477	0.005	17.0	0.00386	44.0		18.17	1.795417	0.088	4	14	18	LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	GSE1	0.0	0.04	0.0	0.0	-1.0	-20.0	-2.0	31.0	0.0006566364209706	0.0	10.41	-0.293	10.117			0.000000000	0.994	1.312	hematopoietic system phenotype; skeleton phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			.	.	.	.	protein binding	C1orf94[25416956;unassigned1304];BECN1[22081109];HDAC2[21258344;23752268];RBM48[16169070];KDM1A[21258344];ZMYND19[unassigned1304];HDAC1[21258344;23752268;26496610];TULP3[23414517];LENG8[unassigned1304];CFAP206[25416956];GOLGA2[25416956;unassigned1304;29568061];NUDT18[16189514];GSE1[25416956];TEKT4[25416956];HMG20A[26496610];TRIM27[unassigned1304];NINL[26638075];RUNX1T1[25416956];MAPK3[26496610];CARD10[unassigned1304];XRCC6[16169070];RALBP1[25416956];RBPMS[16189514];SFMBT1[27705803];CADPS[unassigned1304];HIST2H2BC[30021884];CDC5L[17043677];TFIP11[unassigned1304];TRAF2[unassigned1304];TRIP6[25416956];TCF4[25609649];CEP63[17043677];RCOR3[16189514;19060904;25416956;unassigned1304];
911818	chr9	127566560	AA		chr9:127566560-127566561	OLFML2A	olfactomedin like 2A	17077.0	deletion	0|1	0.18	18_4	22	99	False		EXONIC	YES	NM_182487.4	Transcript	protein_coding	frameshift_variant		6/8	NM_182487.4:c.1107_1108del	NP_872293.2:p.Thr370ProfsTer26		1.0						.	.	.		1.97879e-05	3.0	151608.0	0.0	14	0.6	AS_VQSR	eas	0.000194932	1.0	1.47358e-05	1.0					36	0.59																	0	0	0			OLFML2A	0.0	0.0	0.0	0.0	16.0	13.0	16.0	41.0						0.197	0.0	12.707635397,0.000000000			.			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;atrioventricular node;trigeminal ganglion;globus pallidus;	.	extracellular matrix organization	extracellular matrix	protein homodimerization activity;extracellular matrix binding	.
911819	chr9	127566567	A	C	chr9:127566567	OLFML2A	olfactomedin like 2A	17077.0	SNV	0|1	0.14	19_3	22	69	False	rs1406030206	EXONIC	YES	NM_182487.4	Transcript	protein_coding	missense_variant		6/8	NM_182487.4:c.1114A>C	NP_872293.2:p.Thr372Pro		1.0	.,.					.	.	.		0.00076256	35.0	45898.0	0.0	0	0.35	AS_VQSR	amr	0.0017762	6.0	0.000433576	10.0	0.0	0.0	168698.0	0.0	32	0.58	AC0				0.0	0.0								15.26	1.313968	0.129	2	17	19	M-CAP_pred,FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OLFML2A	0.0	0.0	0.0	0.0	8.0	2.0	8.0	33.0						0.197	0.0	57.096627428	0.576	1.312	.			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;atrioventricular node;trigeminal ganglion;globus pallidus;	.	extracellular matrix organization	extracellular matrix	protein homodimerization activity;extracellular matrix binding	.
911821	chr9	127566570	A	C	chr9:127566570	OLFML2A	olfactomedin like 2A	17077.0	SNV	0|1	0.13	20_3	23	66	False	rs1323652094	EXONIC	YES	NM_182487.4	Transcript	protein_coding	missense_variant		6/8	NM_182487.4:c.1117A>C	NP_872293.2:p.Thr373Pro		1.0	.,.					.	.	.		7.40211e-05	6.0	81058.0	0.0	22	0.57	AS_VQSR	amr	0.000152718	1.0	7.35907e-05	3.0					32	0.58														20.8	2.122833	0.193	4	16	20	M-CAP_pred,MetaLR_pred,MutationTaster_pred,FATHMM_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OLFML2A	0.0	0.0	0.0	0.0	5.0	2.0	5.0	30.0						0.197	0.0	57.096627428	0.686	1.312	.			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;atrioventricular node;trigeminal ganglion;globus pallidus;	.	extracellular matrix organization	extracellular matrix	protein homodimerization activity;extracellular matrix binding	.
913675	chr11	55653669	A	G	chr11:55653669	TRIM51	tripartite motif-containing 51	17273.0	SNV	0/1	0.46	15_13	28	99	False	rs138301526	EXONIC	YES	NM_032681.4	Transcript	protein_coding	missense_variant		3/7	NM_032681.4:c.482A>G	NP_116070.2:p.Glu161Gly		1.0	.,.					.	.	.		0.00184667	281.0	152166.0	0.0	32	0.96	PASS	nfe	0.00294023	200.0	0.00294023	200.0	0.00235013	590.0	251050.0	2.0	59	0.99	PASS	nfe	0.00355404	403.0	0.00355404	403.0	0.0024823	386	0.006	19.0				13.04	0.944663	0.249	3	16	19	SIFT,MutationAssessor_pred,PROVEAN_pred	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TRIM51	0.0	0.0	0.0	0.0	-46.0	-14.0	34.0	25.0							0.0		0.027	0.276	.			.	.	.	.	zinc ion binding	SPRY2[16189514];MAGEA11[16189514];RNF40[16189514];
913991	chr17	39216297	G	C	chr17:39216297	KRTAP2-3	keratin associated protein 2-3	17300.0	SNV	0|1	0.53	17_19	36	99	False	rs560744781	EXONIC	YES	NM_001165252.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001165252.2:c.6C>G	NP_001158724.1:p.Thr2%3D		-1.0						.	.	.		0.00124674	180.0	144376.0	2.0	30	0.87	PASS	nfe	0.00209305	140.0	0.00209305	140.0	0.00152171	163.0	107116.0	2.0	8	0.26	PASS	nfe	0.00310911	137.0	0.00310911	137.0	0.0002186	34	0.001	4.0				2.527	-0.006461		0	0	0			KRTAP2-3	0.0	0.0	0.0	0.0	19.0	34.0	1.0	47.0							0.08				.			.	.	keratinization	cytosol;keratin filament	protein binding	PIGS[unassigned1304];CHIC2[unassigned1304];ZBTB24[unassigned1304];ITGB4[unassigned1304];ZNF491[unassigned1304];KLHL38[unassigned1304];CTSZ[unassigned1304];ZDHHC1[unassigned1304];HAPLN2[unassigned1304];YY1[unassigned1304];SPRED2[unassigned1304];LCE1B[unassigned1304];HHEX[unassigned1304];CYSRT1[unassigned1304];ADAMTSL3[25416956;unassigned1304];DHX57[unassigned1304];KRTAP5-2[unassigned1304];ZNF524[unassigned1304];HOXA1[unassigned1304];ZNF764[unassigned1304];PHLDA1[unassigned1304];ZNF564[unassigned1304];KRTAP1-1[unassigned1304];ZNF165[unassigned1304];ZNF440[unassigned1304];KRTAP5-9[unassigned1304];PRKAB2[unassigned1304];KRTAP9-3[unassigned1304];KRTAP9-2[unassigned1304];JOSD1[unassigned1304];LCE1E[unassigned1304];LCE1F[unassigned1304];KRTAP9-8[unassigned1304];LCE1D[unassigned1304];C11orf87[unassigned1304];LCE2B[unassigned1304];LCE2C[unassigned1304];HOXB9[unassigned1304];LCE2A[unassigned1304];FAM161A[unassigned1304];KRTAP4-12[unassigned1304];FAM27E3[unassigned1304];KRTAP4-11[unassigned1304];GEMIN4[unassigned1304];CREB5[unassigned1304];CATSPER1[unassigned1304];ZNF672[unassigned1304];ZNF792[unassigned1304];IGSF8[unassigned1304];BEX2[unassigned1304];NUFIP2[unassigned1304];SDC3[unassigned1304];SPATA3[unassigned1304];LCE2D[unassigned1304];NKD1[unassigned1304];LCE3C[unassigned1304];LCE3D[unassigned1304];P2RY6[unassigned1304];LCE3A[unassigned1304];MOBP[unassigned1304];PTPMT1[25416956];BAHD1[unassigned1304];TTPA[unassigned1304];KRTAP5-11[unassigned1304];KRTAP4-4[unassigned1304];OTX1[unassigned1304];TRIM42[unassigned1304];ZNF786[unassigned1304];CNNM3[25416956];ZNF587[25416956;unassigned1304];RHBDL1[unassigned1304];ZIM2[unassigned1304];TXNDC5[unassigned1304];NPDC1[unassigned1304];ZNF264[unassigned1304];KRTAP10-5[25416956];ZNF581[unassigned1304];TFAP2D[unassigned1304];KRTAP12-4[unassigned1304];CBX2[25416956];MCRS1[unassigned1304];TMEM190[25416956];DMRT3[unassigned1304];RYDEN[25416956;unassigned1304];NOTCH2NLA[unassigned1304];TYMSOS[unassigned1304];VASN[unassigned1304];GGN[unassigned1304];RPS28[25416956];BCL6B[unassigned1304];LNX1[unassigned1304];VWC2[unassigned1304];ZNF578[unassigned1304];TNP2[unassigned1304];ZNF575[unassigned1304];
914546	chr16	3085357	G	A	chr16:3085357	BICDL2	BICD family like cargo adaptor 2	17345.0	SNV	0/1	0.56	14_18	32	99	False	rs183014367	EXONIC	YES	NM_001369667.1	Transcript	protein_coding	synonymous_variant		2/10	NM_001369667.1:c.141C>T	NP_001356596.1:p.Pro47%3D		-1.0						.	.	.		0.0064947	988.0	152124.0	9.0	31	0.94	PASS	nfe	0.00919145	625.0	0.00919145	625.0	0.0068848	1547.0	224698.0	9.0	77	0.66	PASS	nfe	0.00956369	950.0	0.00956369	950.0	0.0058198	905	0.013	34.0				0.166	-0.412424		0	0	0			CCDC64B	0.12	0.01	0.0	0.0	-19.0	13.0	-28.0	13.0								3.465301200			.			.	.	vesicle transport along microtubule;Golgi to secretory granule transport	cytoplasm	protein binding;Rab GTPase binding	CDK17[unassigned1304];KLC3[25416956;unassigned1304];API5[unassigned1304];TSGA10IP[unassigned1304];PKP1[unassigned1304];RPL9[unassigned1304];
914619	chrX	140992860	T	C	chrX:140992860	MAGEC1	MAGE family member C1	17357.0	SNV	1/1	1.0	0_27	27	81	False	rs113574601,CM1111566	SPLICING	YES	NM_005462.5	Transcript	protein_coding	start_lost,splice_region_variant		3/4	NM_005462.5:c.2T>C	NP_005453.2:p.Met1?		1.0						.	.	.		0.00312175	351.0	112437.0	2.0	23	0.62	PASS	nfe	0.00469889	250.0	0.00469889	250.0	0.003336	612.0	183453.0	1.0	67	1.0	PASS	nfe	0.00455422	373.0	0.00455422	373.0	0.0027909	434	0.004	13.0				8.513	0.410716	0.044	2	14	16	SIFT,LIST-S2_pred	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred	MAGEC1	0.0	0.0	0.0	0.01	-8.0	50.0	2.0	-28.0	1.20469394445963e-05	0.002	9.891	-1.16	8.731	0.981		0.000000000	0.174	-0.404	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;	.	.	.	protein binding	CTAG1A[17137291];RUSC2[17137291];H2AFZ[17137291];MRPL19[17137291];ECHDC2[17137291];GTF2F1[17137291];ATP5MG[17137291];
914620	chrX	140994156	C	T	chrX:140994156	MAGEC1	MAGE family member C1	17357.0	SNV	0|1	0.18	9_2	11	57	False	rs778994361	EXONIC	YES	NM_005462.5	Transcript	protein_coding	synonymous_variant		4/4	NM_005462.5:c.966C>T	NP_005453.2:p.Ser322%3D		1.0						.	.	.		0.0	0.0	104180.0	0.0	23	0.61	AC0				0.0	0.0	5.52624e-06	1.0	180955.0	0.0	100	0.99	PASS	nfe	1.23977e-05	1.0	1.23977e-05	1.0	0.0000064	1	0.0	1.0				0.284	-0.336709		0	0	0			MAGEC1	0.0	0.0	0.0	0.0	-5.0	28.0	16.0	-48.0						0.981		0.000000000			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;	.	.	.	protein binding	CTAG1A[17137291];RUSC2[17137291];H2AFZ[17137291];MRPL19[17137291];ECHDC2[17137291];GTF2F1[17137291];ATP5MG[17137291];
914621	chrX	140994165	A	T	chrX:140994165	MAGEC1	MAGE family member C1	17357.0	SNV	0|1	0.18	9_2	11	57	False	rs771084617	EXONIC	YES	NM_005462.5	Transcript	protein_coding	missense_variant		4/4	NM_005462.5:c.975A>T	NP_005453.2:p.Arg325Ser		1.0						.	.	.		9.86271e-06	1.0	101392.0	0.0	23	0.6	PASS	afr	3.55215e-05	1.0	0.0	0.0	1.66366e-05	3.0	180325.0	0.0	100	0.99	PASS	nfe	2.48691e-05	2.0	2.48691e-05	2.0	0.0000386	6						0.074	-0.524154	0.078	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MAGEC1	0.0	0.0	0.0	0.0	31.0	-14.0	-2.0	7.0						0.981		0.000000000	0.001	-1.438	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;	.	.	.	protein binding	CTAG1A[17137291];RUSC2[17137291];H2AFZ[17137291];MRPL19[17137291];ECHDC2[17137291];GTF2F1[17137291];ATP5MG[17137291];
914622	chrX	140994166	A	G	chrX:140994166	MAGEC1	MAGE family member C1	17357.0	SNV	0|1	0.17	10_2	12	54	False	rs776548922	EXONIC	YES	NM_005462.5	Transcript	protein_coding	missense_variant		4/4	NM_005462.5:c.976A>G	NP_005453.2:p.Thr326Ala		1.0						.	.	.		9.63354e-06	1.0	103804.0	0.0	23	0.61	PASS	eas	0.000309598	1.0	0.0	0.0	5.52804e-06	1.0	180896.0	0.0	100	0.99	PASS	nfe	1.24017e-05	1.0	1.24017e-05	1.0	0.0000064	1						0.202	-0.385198	0.041	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MAGEC1	0.0	0.0	0.0	0.0	1.0	30.0	18.0	6.0						0.981		0.000000000	0.0	-1.402	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;	.	.	.	protein binding	CTAG1A[17137291];RUSC2[17137291];H2AFZ[17137291];MRPL19[17137291];ECHDC2[17137291];GTF2F1[17137291];ATP5MG[17137291];
914623	chrX	140994171	C	A	chrX:140994171	MAGEC1	MAGE family member C1	17357.0	SNV	1/2	0.17	0_10_2	12	54	False	rs176047,COSV53568277	EXONIC	YES	NM_005462.5	Transcript	protein_coding	missense_variant		4/4	NM_005462.5:c.981C>A	NP_005453.2:p.His327Gln		1.0						.	.	.		1.08613e-05	1.0	92070.0	0.0	20	0.51	PASS	afr	4.20964e-05	1.0	0.0	0.0	6.42438e-06	1.0	155657.0	0.0	100	0.99	PASS	eas	8.43028e-05	1.0	0.0	0.0	0.0000322	5						0.006	-0.866253	0.135	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MAGEC1	0.0	0.0	0.0	0.0	1.0	25.0	1.0	12.0						0.981		0.000000000	0.0	-8.126	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;	.	.	.	protein binding	CTAG1A[17137291];RUSC2[17137291];H2AFZ[17137291];MRPL19[17137291];ECHDC2[17137291];GTF2F1[17137291];ATP5MG[17137291];
914624	chrX	140994175	A	G	chrX:140994175	MAGEC1	MAGE family member C1	17357.0	SNV	0|1	0.17	10_2	12	54	False	rs752016207	EXONIC	YES	NM_005462.5	Transcript	protein_coding	missense_variant		4/4	NM_005462.5:c.985A>G	NP_005453.2:p.Thr329Ala		1.0						.	.	.		0.0	0.0	105363.0	0.0	22	0.59	AC0				0.0	0.0					100	0.99							0.0000064	1						0.343	-0.309157	0.062	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MAGEC1	0.0	0.0	0.0	0.0	-24.0	21.0	-24.0	-3.0						0.981		0.000000000	0.0	-3.608	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;	.	.	.	protein binding	CTAG1A[17137291];RUSC2[17137291];H2AFZ[17137291];MRPL19[17137291];ECHDC2[17137291];GTF2F1[17137291];ATP5MG[17137291];
915552	chr9	130117725	C	T	chr9:130117725	GARNL3	GTPase activating Rap/RanGAP domain like 3	17404.0	SNV	0/1	0.5	24_24	48	99	False	rs138237137	EXONIC	YES	NM_032293.5	Transcript	protein_coding	missense_variant		20/28	NM_032293.5:c.1909C>T	NP_115669.3:p.Pro637Ser		1.0	.,Citron homology (CNH) domain&Citron homology (CNH) domain&Citron homology (CNH) domain					.	.	.		0.000177373	27.0	152222.0	0.0	33	0.98	PASS	amr	0.000327054	5.0	0.000293953	20.0	0.000167041	42.0	251436.0	0.0	88	1.0	PASS	nfe	0.000290166	33.0	0.000290166	33.0	0.0001865	29	0.0	1.0				24.3	3.28554	0.167	14	7	21	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HVAR_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	GARNL3	0.0	0.0	0.0	0.0	-8.0	1.0	26.0	30.0						0.173	0.02	0.000000000	0.982	1.026	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;parietal lobe;globus pallidus;	.	positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction	intracellular membrane-bounded organelle	GTPase activator activity	SLC16A1[30021884];
916561	chr17	70644968	G	A	chr17:70644968	SLC39A11	solute carrier family 39 member 11	17466.0	SNV	0/1	0.44	18_14	32	99	False	rs201576521,COSV55282582	EXONIC	YES	NM_001352692.2	Transcript	protein_coding	synonymous_variant		9/10	NM_001352692.2:c.924C>T	NP_001339621.1:p.Asp308%3D		-1.0						.	.	.		9.19975e-05	14.0	152178.0	0.0	32	0.97	PASS	eas	0.000770119	4.0	8.81964e-05	6.0	0.00017512	44.0	251256.0	0.0	60	1.0	PASS	amr	0.000404929	14.0	0.000114423	13.0	0.0001736	27						3.701	0.066556		0	0	0			SLC39A11	0.0	0.0	0.0	0.0	25.0	2.0	26.0	-26.0						0.86	0.0	1.923785481			.			kidney;trigeminal ganglion;	.	zinc ion transmembrane transport	fungal-type vacuole membrane;nucleus;cytoplasm;Golgi apparatus;plasma membrane;integral component of membrane	zinc ion transmembrane transporter activity	.
918006	chr1	160922469	G	T	chr1:160922469	ITLN2	intelectin 2	17580.0	SNV	0/1	0.52	16_17	33	99	False	rs137982071	EXONIC	YES	NM_080878.3	Transcript	protein_coding	missense_variant		3/8	NM_080878.3:c.134C>A	NP_543154.1:p.Ser45Tyr		-1.0	Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain					.	.	.		1.97119e-05	3.0	152192.0	0.0	32	0.97	PASS	afr	2.4122e-05	1.0	1.4702e-05	1.0	6.76111e-05	17.0	251438.0	0.0	65	1.0	PASS	amr	0.000260176	9.0	7.03445e-05	8.0	0.0000386	6	0.001	3.0				0.003	-0.965939	0.042	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ITLN2	0.02	0.12	0.0	0.0	48.0	-19.0	-50.0	-19.0						0.611	0.0	0.000000000	0.0	-0.249	normal phenotype; 			.	.	.	extracellular region	carbohydrate binding;metal ion binding	.
918224	chr12	53215714	G	A	chr12:53215714	KRT79	keratin 79	17593.0	SNV	0/1	0.35	13_7	20	99	False	rs775020026,COSV57942478	EXONIC	YES	NM_175834.3	Transcript	protein_coding	missense_variant		9/9	NM_175834.3:c.1550C>T	NP_787028.1:p.Ala517Val		-1.0						.	.	.		3.94317e-05	6.0	152162.0	0.0	32	0.97	PASS	amr	0.000130873	2.0	0.0	0.0	1.19416e-05	3.0	251222.0	0.0	100	0.99	PASS	afr	6.15612e-05	1.0	1.76084e-05	2.0	0.0000129	2						20.7	2.106048	0.043	4	16	20	SIFT,LRT_pred,M-CAP_pred,FATHMM_pred	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	KRT79	0.0	0.0	0.0	0.0	-23.0	26.0	2.0	-47.0						0.313	0.0	0.000000000	0.622	0.128	.			.	Cell Communication	keratinization;cornification	cytosol;keratin filament;extracellular exosome	structural molecule activity;protein binding;enzyme binding	USHBP1[25416956];KRT24[unassigned1304];TANK[unassigned1774];KRT33B[25416956;unassigned1304];SYCE3[unassigned1304];KRT28[unassigned1304];KRT27[unassigned1304];NUP62[unassigned1304];KRT25[unassigned1304];EVI5L[unassigned1304];BTRC[19615732];ECH1[29426014];KRT13[25416956];KRT35[unassigned1304];KRT34[unassigned1304];KRT31[25416956;unassigned1304];ESR1[25604459];KRT19[unassigned1304];KRT18[unassigned1304];KRT38[25416956];KRT16[unassigned1304];KRT15[25416956;unassigned1304];KRT36[unassigned1304];KRT14[unassigned1304];KIF2C[26496610];TRIM54[unassigned1304];
919098	chr19	52381744	C	T	chr19:52381744	ZNF577	zinc finger protein 577	17623.0	SNV	0/1	0.66	12_23	35	99	False	rs745588223	EXONIC	YES	NM_001370449.1	Transcript	protein_coding	missense_variant		4/6	NM_001370449.1:c.85G>A	NP_001357378.1:p.Ala29Thr		-1.0	Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,.,.,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box					.	.	.		6.57212e-06	1.0	152158.0	0.0	32	0.95	PASS	amr	6.54707e-05	1.0	0.0	0.0	3.58018e-05	9.0	251384.0	0.0	62	1.0	PASS	amr	0.000260206	9.0	0.0	0.0	0.0000064	1						20.6	2.100462	0.159	2	16	18	SIFT,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	ZNF577	0.03	0.01	0.0	0.0	-17.0	5.0	-50.0	24.0						0.901	0.01	0.000000000	0.718	0.851	.			pons;ciliary ganglion;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;trigeminal ganglion;atrioventricular node;globus pallidus;	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	.
920184	chr19	44792650	C	T	chr19:44792650	ZNF235	zinc finger protein 235	17702.0	SNV	0/1	0.61	13_20	33	99	False	rs148447275,COSV52158753	EXONIC	YES	NM_004234.4	Transcript	protein_coding	missense_variant		5/5	NM_004234.4:c.938G>A	NP_004225.3:p.Arg313His		-1.0	.,.					.	.	.		0.000210291	32.0	152170.0	0.0	33	0.97	PASS	nfe	0.000338116	23.0	0.000338116	23.0	0.000326295	82.0	251306.0	0.0	84	1.0	PASS	nfe	0.000466311	53.0	0.000466311	53.0	0.0003087	48	0.0	1.0				0.005	-0.897003	0.187	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF235	0.0	0.0	0.0	0.0	19.0	5.0	-4.0	25.0						0.861	0.0	0.000000000	0.009	-0.81	.			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;testis;skeletal muscle;	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;metal ion binding	CDC37[21900206];PFDN1[21900206];FAM118B[21900206];MRPL44[21900206];
920713	chr3	23955663	AA		chr3:23955663-23955664	NKIRAS1	NFKB inhibitor interacting Ras like 1	17720.0	sequence_alteration	1/2	0.16	3_5_22	31	42	False	rs5847260	SPLICING	YES	NM_001377358.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/5		NM_001377358.1:c.-273-4_-273-3del			-1.0						.	.	.		0.00549162	794.0	144584.0	0.0	0	0.06	PASS	afr	0.00867184	342.0	0.00344597	227.0					0	0.0							0.0006066,0.0009857	16,26						10.28	0.596651		0	0	0			NKIRAS1	0.0	0.01	0.02	0.0	35.0	-2.0	35.0	-21.0						0.724	0.03				.			.	.	I-kappaB kinase/NF-kappaB signaling	cellular_component;cytoplasm;membrane	GTPase activity;GTP binding	XRCC2[21988832];HSPD1[30021884];
921240	chr7	100635858	C	G	chr7:100635858	MUC12	mucin 12, cell surface associated	17726.0	SNV	0/1	0.2	32_8	40	99	False	rs375864306,COSV65186810	EXONIC	YES	NM_001164462.1	Transcript	protein_coding	missense_variant		2/12	NM_001164462.1:c.2014C>G	NP_001157934.1:p.His672Asp		1.0	.,.					.	.	.		0.000137944	21.0	152236.0	0.0	35	0.97	PASS	amr	0.000589005	9.0	0.000146955	10.0	0.000190611	28.0	146896.0	0.0	100	0.6	PASS	amr	0.000567583	14.0	0.000148246	9.0	0.0000193	3	0.0	1.0				8.754	0.433815	0.037	2	15	17	SIFT,M-CAP_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC12	0.0	0.0	0.0	0.0	-22.0	28.0	27.0	28.0									0.002	0.403	.			ciliary ganglion;kidney;superior cervical ganglion;	.	regulation of cell growth;stimulatory C-type lectin receptor signaling pathway;O-glycan processing	Golgi lumen;plasma membrane;integral component of plasma membrane	molecular_function	CDC42[20936779];RPL36[30021884];MAPK14[20936779];
921928	chr16	685313	G	A	chr16:685313	METTL26	methyltransferase like 26	17754.0	SNV	0/1	0.53	15_17	32	99	False	rs201877690	EXONIC	YES	NM_001040160.3	Transcript	protein_coding	missense_variant		3/5	NM_001040160.3:c.388C>T	NP_001035250.1:p.Leu130Phe		-1.0	.,.					.	.	.		0.000768564	117.0	152232.0	1.0	34	0.98	PASS	amr	0.00274617	42.0	0.00073497	50.0	0.000909902	208.0	228596.0	0.0	32	0.64	PASS	amr	0.00162115	52.0	0.000927536	96.0	0.0007781	121	0.003	8.0				24.6	3.382057	0.458	10	7	17	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	C16orf13	0.0	0.0	0.0	0.0	-11.0	16.0	-32.0	3.0								0.000000000	0.978	1.176	.			.	.	.	.	.	.
922462	chr19	58049064	A	C	chr19:58049064	ZNF549	zinc finger protein 549	17815.0	SNV	0/1	0.44	19_15	34	99	False		EXONIC	YES	NM_001199295.2	Transcript	protein_coding	missense_variant		4/4	NM_001199295.2:c.692A>C	NP_001186224.2:p.Lys231Thr		1.0	.,Zinc finger C2H2-type&Zinc finger C2H2-type					.	.	.						32	0.98											100	0.99									0.0	1.0				10.28	0.5967	0.091	0	20	20		SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF549	0.0	0.0	0.0	0.0	-22.0	-25.0	7.0	-22.0							0.0	49.747443924	0.447	1.009	.			superior cervical ganglion;atrioventricular node;	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	EMD[unassigned1304];
922573	chr5	140567435	A	T	chr5:140567435	PCDHB9	protocadherin beta 9	17824.0	SNV	0|1	0.62	8_13	21	99	False	rs200278970	EXONIC	YES	NM_019119.5	Transcript	protein_coding	missense_variant		1/2	NM_019119.5:c.543A>T	NP_061992.3:p.Lys181Asn		1.0						.	.	.		4.60036e-05	7.0	152162.0	0.0	32	0.95	PASS	amr	6.54536e-05	1.0	1.47003e-05	1.0	5.57258e-05	14.0	251230.0	0.0	100	1.0	PASS	amr	0.000115667	4.0	6.15644e-05	7.0	0.0000579	9	0.0	1.0				8.601	0.41905		0	5	5		MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	PCDHB9	0.01	0.0	0.0	0.0	6.0	35.0	-2.0	-5.0									0.0	-0.723	.			.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;chemical synaptic transmission;synapse assembly;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	integral component of plasma membrane;integral component of membrane	calcium ion binding	UBE3A[unassigned1304];
926819	chr11	48346579	C	A	chr11:48346579	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.46	30_26	56	99	False	rs72911452,COSV60583189	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.6C>A	NP_001004702.2:p.Asp2Glu		1.0	.,.					.	.	.						32	0.97							0.228933	14529.0	63464.0	0.0	100	1.0	InbreedingCoeff	eas	0.267388	1161.0	0.205558	5999.0	0.0179738	2795	0.103	313.0				0.063	-0.545983	0.165	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.0	0.0	0.0	-43.0	20.0	-21.0	0.0						0.694	0.01	46.121634545	0.998	0.179	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926820	chr11	48346588	A	C	chr11:48346588	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.44	33_26	59	99	False	rs75900655,COSV60583195	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.15A>C	NP_001004702.2:p.Gln5His		1.0	.,.					.	.	.						32	0.97							0.355471	20618.0	58002.0	0.0	100	1.0	InbreedingCoeff	afr	0.386199	1388.0	0.330314	8168.0	0.0070545	1097	0.128	368.0				6.251	0.228299	0.107	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.0	0.0	0.0	45.0	37.0	-9.0	45.0						0.694	0.01	24.802902514	0.995	-0.374	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926821	chr11	48346604	T	G	chr11:48346604	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.42	32_23	55	99	False	rs75647397,COSV60583203	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.31T>G	NP_001004702.2:p.Phe11Val		1.0	.,.					.	.	.		1.31425e-05	2.0	152178.0	0.0	32	0.97	PASS	amr	0.000130924	2.0	0.0	0.0	0.420385	26322.0	62614.0	0.0	96	1.0	InbreedingCoeff_RF	afr	0.443382	1762.0	0.403676	10410.0	0.0083728	1302	0.101	292.0				15.34	1.327974	0.132	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.0	0.0	0.01	38.0	21.0	-1.0	29.0						0.694	0.01	46.121634545	0.983	0.099	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926822	chr11	48346615	G	A	chr11:48346615	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.45	30_25	55	99	False	rs73463988,COSV60585298	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.42G>A	NP_001004702.2:p.Gly14%3D		1.0						.	.	.						32	0.97							0.447062	33907.0	75844.0	0.0	94	1.0	InbreedingCoeff_RF	sas	0.463775	4865.0	0.431236	12994.0	0.0194850	3030	0.095	272.0				10.83	0.660795		0	0	0			OR4C3	0.0	0.0	0.01	0.0	2.0	10.0	18.0	-36.0						0.694	0.01	66.594394388			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926823	chr11	48346661	TGCTGATCT		chr11:48346661-48346669	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	deletion	0/1	0.41	36_25	61	99	False	rs138704181	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	inframe_deletion		1/1	NM_001004702.2:c.89_97del	NP_001004702.2:p.Leu30_Ile32del		1.0						.	.	.						32	0.97							0.446916	42129.0	94266.0	0.0	72	1.0	InbreedingCoeff_RF	sas	0.485133	6983.0	0.419153	15652.0	0.0044629,0.0260958,0.0000064	694,4058,1	0.032	101.0				15.73	1.402376		0	0	0																	0.694	0.01	83.430448619			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926824	chr11	48346681	G	A	chr11:48346681	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.44	32_25	57	99	False	rs78490540,COSV60583076	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.108G>A	NP_001004702.2:p.Thr36%3D		1.0						.	.	.		3.28701e-05	5.0	152114.0	0.0	32	0.96	PASS	sas	0.000207211	1.0	2.94023e-05	2.0	0.490813	70573.0	143788.0	0.0	86	1.0	InbreedingCoeff_RF	sas	0.497459	10768.0	0.48628	28958.0	0.0297227	4622	0.086	242.0				3.795	0.072134		0	0	0			OR4C3	0.0	0.0	0.0	0.01	42.0	30.0	-27.0	-48.0						0.694	0.01	2.368861211			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926825	chr11	48346729	G	C	chr11:48346729	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.44	29_23	52	99	False	rs73463990,COSV60586573	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.156G>C	NP_001004702.2:p.Thr52%3D		1.0						.	.	.						32	0.96							0.499988	125134.0	250274.0	1.0	100	1.0	InbreedingCoeff	sas	0.500033	15272.0	0.499982	56547.0	0.0364299	5665	0.193	606.0				0.112	-0.467306		0	0	0			OR4C3	0.0	0.0	0.0	0.0	-24.0	-6.0	-24.0	33.0						0.694	0.01	2.368861211			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926826	chr11	48346791	C	T	chr11:48346791	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.46	30_26	56	99	False	rs73463994,COSV60583214	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.218C>T	NP_001004702.2:p.Ser73Phe		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.499992	125671.0	251346.0	1.0	100	1.0	InbreedingCoeff	amr	0.500029	17293.0	0.499974	56836.0	0.0270668	4209	0.185	578.0				21.9	2.270305	0.391	4	12	16	SIFT,LRT_pred,MutationAssessor_pred,fathmm-MKL_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.0	0.0	0.0	41.0	-6.0	27.0	-29.0						0.694	0.01	17.413679903	0.004	0.9	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926827	chr11	48346822	A	C	chr11:48346822	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.46	26_22	48	99	False	rs73463997,COSV60587301	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.249A>C	NP_001004702.2:p.Ser83%3D		1.0						.	.	.						32	0.96							0.499996	125692.0	251386.0	2.0	100	1.0	InbreedingCoeff	amr	0.500029	17292.0	0.499982	56848.0	0.0279478	4346	0.205	646.0				4.683	0.125563		0	0	0			OR4C3	0.0	0.0	0.0	0.0	10.0	2.0	29.0	2.0						0.694	0.01	7.45005553			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926828	chr11	48346843	C	T	chr11:48346843	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.47	23_20	43	99	False	rs73463998,COSV60587308	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.270C>T	NP_001004702.2:p.Ile90%3D		1.0						.	.	.						32	0.96							0.499992	125686.0	251376.0	2.0	100	1.0	InbreedingCoeff	amr	0.500029	17295.0	0.499982	56840.0	0.0274848	4274	0.206	650.0				7.803	0.347285		0	0	0			OR4C3	0.0	0.0	0.0	0.0	25.0	-11.0	4.0	49.0						0.694	0.01	29.903524068			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926829	chr11	48346916	G	C	chr11:48346916	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.38	26_16	42	99	False	rs77069283,COSV60583093	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.343G>C	NP_001004702.2:p.Val115Leu		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.499972	125455.0	250924.0	0.0	100	1.0	InbreedingCoeff	afr	0.5	8105.0	0.499938	56700.0	0.0043600	678	0.131	391.0				20.4	2.0747	0.187	1	15	16	SIFT	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.01	0.0	0.0	36.0	1.0	-24.0	30.0						0.694	0.01	17.413679903	0.905	1.038	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926830	chr11	48346924	T	C	chr11:48346924	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.42	23_17	40	99	False	rs72911454,COSV60587323	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.351T>C	NP_001004702.2:p.Ala117%3D		1.0						.	.	.						32	0.96							0.499976	125336.0	250684.0	0.0	100	1.0	InbreedingCoeff	eas	0.5	9175.0	0.499965	56642.0	0.0068101	1059	0.126	387.0				11.79	0.778889		0	0	0			OR4C3	0.01	0.0	0.0	0.0	-7.0	28.0	22.0	-32.0						0.694	0.01	29.903524068			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926831	chr11	48346932	G	A	chr11:48346932	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.42	23_17	40	99	False	rs80285195,COSV60583226	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.359G>A	NP_001004702.2:p.Arg120His		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		0.00147318	224.0	152052.0	0.0	32	0.96	PASS	sas	0.00581154	28.0	0.000102914	7.0	0.49998	124940.0	249890.0	6.0	100	1.0	InbreedingCoeff	sas	0.500131	15265.0	0.499947	56480.0	0.0035562	553	0.122	386.0				23.2	2.843786	0.446	5	11	16	MetaLR_pred,MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	OR4C3	0.0	0.0	0.0	0.01	29.0	-15.0	-40.0	14.0						0.694	0.01	7.45005553	0.989	1.038	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926832	chr11	48346961	A	T	chr11:48346961	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.46	26_22	48	99	False	rs75493089,COSV60583115	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.388A>T	NP_001004702.2:p.Asn130Tyr		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.499826	120618.0	241320.0	1.0	100	1.0	InbreedingCoeff	eas	0.5	8590.0	0.499909	54757.0	0.0158195	2460	0.114	362.0				12.97	0.934852	0.217	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.0	0.0	0.0	43.0	-44.0	-2.0	19.0						0.694	0.01	29.903524068	0.795	0.116	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926833	chr11	48346962	A	G	chr11:48346962	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.46	26_22	48	99	False	rs74589050,COSV60583123	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.389A>G	NP_001004702.2:p.Asn130Ser		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.499951	122924.0	245872.0	1.0	100	1.0	InbreedingCoeff	eas	0.5	8900.0	0.499928	55601.0	0.0158710	2468	0.114	362.0				21.4	2.194415	0.392	3	13	16	SIFT,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	OR4C3	0.0	0.0	0.0	0.0	42.0	-45.0	-16.0	18.0						0.694	0.01	29.903524068	0.785	1.156	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926834	chr11	48346996	G	A	chr11:48346996	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.23	41_12	53	99	False	rs12794960,COSV60583858	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.423G>A	NP_001004702.2:p.Met141Ile		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		1.31435e-05	2.0	152166.0	0.0	32	0.96	PASS	eas	0.000385505	2.0	0.0	0.0	0.0303316	6531.0	215320.0	0.0	100	1.0	RF	nfe	0.0417614	3859.0	0.0417614	3859.0	0.0799401	12431	0.079	250.0				15.39	1.337698	0.049	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.01	0.0	0.0	0.0	8.0	-44.0	8.0	-50.0						0.694	0.01	55.686278902	0.301	0.093	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926835	chr11	48346999	T	G	chr11:48346999	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.51	27_28	55	99	False	rs72473367,COSV60587170	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.426T>G	NP_001004702.2:p.Leu142%3D		1.0						.	.	.						32	0.96							0.499879	123575.0	247210.0	1.0	100	1.0	InbreedingCoeff	afr	0.5	7932.0	0.499785	55809.0	0.0328673	5111	0.113	334.0				10.63	0.637313		0	0	0			OR4C3	0.0	0.02	0.06	0.0	-47.0	5.0	0.0	-19.0						0.694	0.01	2.368861211			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926836	chr11	48347014	G	A	chr11:48347014	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.55	25_31	56	99	False	rs72473368,COSV60583237	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	stop_gained		1/1	NM_001004702.2:c.441G>A	NP_001004702.2:p.Trp147Ter		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.499943	123285.0	246598.0	1.0	100	1.0	InbreedingCoeff	sas	0.5	15122.0	0.499901	55712.0	0.0212663	3307	0.16	477.0				36.0	6.627865		6	1	7	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred,fathmm-MKL_coding_pred	fathmm-XF_coding_pred	OR4C3	0.03	0.0	0.0	0.0	31.0	-17.0	24.0	-15.0						0.694	0.01	7.45005553	0.424	1.028	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926837	chr11	48347023	C	T	chr11:48347023	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.53	27_31	58	99	False	rs67077733,COSV60587368	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.450C>T	NP_001004702.2:p.Gly150%3D		1.0						.	.	.		6.57255e-06	1.0	152148.0	0.0	32	0.96	PASS	nfe	1.47042e-05	1.0	1.47042e-05	1.0	0.499947	123478.0	246982.0	2.0	100	1.0	InbreedingCoeff	afr	0.5	7938.0	0.499902	55843.0	0.0332210	5166	0.177	538.0				10.42	0.613231		0	0	0			OR4C3	0.01	0.01	0.0	0.0	22.0	-19.0	-43.0	38.0						0.694	0.01	35.288785949			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926838	chr11	48347067	C	T	chr11:48347067	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.55	28_34	62	99	False	rs73464001,COSV60583244	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.494C>T	NP_001004702.2:p.Pro165Leu		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		1.31458e-05	2.0	152140.0	0.0	32	0.95	PASS	amr	0.000130873	2.0	0.0	0.0	0.499943	123712.0	247452.0	1.0	100	1.0	InbreedingCoeff	eas	0.5	8994.0	0.499902	55937.0	0.0305909	4757	0.197	621.0				25.6	3.654485	0.433	9	9	18	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.0	0.0	0.0	-22.0	7.0	42.0	0.0						0.694	0.01	35.288785949	0.621	0.9	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926839	chr11	48347100	C	T	chr11:48347100	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.54	32_37	69	99	False	rs73465905,COSV60583249	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.527C>T	NP_001004702.2:p.Ala176Val		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.95							0.499885	121362.0	242780.0	0.0	94	1.0	InbreedingCoeff	eas	0.5	8877.0	0.499788	54295.0	0.0267389	4158	0.165	485.0				15.66	1.389022	0.137	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.04	0.0	0.0	0.01	27.0	42.0	-17.0	42.0						0.694	0.01	84.872268861	0.949	0.101	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926840	chr11	48347124	A	G	chr11:48347124	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.5	33_33	66	99	False	rs79019124,COSV60583256	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.551A>G	NP_001004702.2:p.Glu184Gly		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.95							0.499687	108703.0	217542.0	0.0	82	1.0	InbreedingCoeff	eas	0.5	8036.0	0.49942	46470.0	0.0097554	1517	0.111	350.0				23.1	2.770121	0.169	2	14	16	SIFT,MutationAssessor_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.01	0.04	0.0	0.01	19.0	3.0	-41.0	18.0						0.694	0.01	24.802902514	0.024	1.145	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926841	chr11	48347130	C	G	chr11:48347130	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.51	32_34	67	99	False	rs77395846,COSV60583260	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.557C>G	NP_001004702.2:p.Ala186Gly		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.95							0.499603	103085.0	206334.0	0.0	79	1.0	InbreedingCoeff	eas	0.499934	7625.0	0.499297	43337.0	0.0082120	1277	0.045	141.0				22.5	2.495023	0.284	3	13	16	SIFT,MutationAssessor_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	OR4C3	0.01	0.0	0.0	0.0	-3.0	46.0	12.0	-21.0						0.694	0.01	24.802902514	0.419	0.9	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926842	chr11	48347142	C	T	chr11:48347142	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.52	30_33	64	99	False	rs79891698,COSV60583100	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.569C>T	NP_001004702.2:p.Thr190Met		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		5.91584e-05	9.0	152134.0	0.0	32	0.95	PASS	nfe	8.81964e-05	6.0	8.81964e-05	6.0	0.499488	104382.0	208978.0	0.0	78	1.0	InbreedingCoeff	sas	0.499822	14008.0	0.499106	44090.0	0.0019742	307	0.051	160.0				22.6	2.510158	0.408	6	12	18	SIFT,PolyPhen,LRT_pred,MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	OR4C3	0.01	0.01	0.0	0.02	34.0	-15.0	-3.0	0.0						0.694	0.01	51.637905936	0.015	0.9	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926843	chr11	48347144	T	C	chr11:48347144	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.52	30_33	64	99	False	rs79124801,COSV60583106	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.571T>C	NP_001004702.2:p.Tyr191His		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.95							0.499497	105189.0	210590.0	0.0	78	1.0	InbreedingCoeff	sas	0.499893	14065.0	0.499116	44621.0	0.0019742	307	0.05	159.0				3.814	0.073273	0.059	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.01	0.0	0.03	3.0	-17.0	30.0	-2.0						0.694	0.01	51.637905936	0.0	0.107	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926844	chr11	48347267	T	C	chr11:48347267	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.53	23_27	51	99	False	rs73465910,COSV60583276	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.694T>C	NP_001004702.2:p.Cys232Arg		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.499447	105631.0	211496.0	0.0	81	1.0	InbreedingCoeff	amr	0.499803	15223.0	0.499178	45559.0	0.0348544	5420	0.203	641.0				7.675	0.336588	0.414	1	17	18	PROVEAN_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.01	0.0	0.0	0.0	-22.0	-15.0	-23.0	-35.0						0.694	0.01	35.288785949	0.0	-1.943	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926845	chr11	48347306	G	T	chr11:48347306	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.44	22_17	39	99	False	rs73465911,COSV60583284	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.733G>T	NP_001004702.2:p.Val245Phe		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		1.31477e-05	2.0	152118.0	0.0	32	0.96	PASS	nfe	2.93971e-05	2.0	2.93971e-05	2.0	0.496085	86677.0	174722.0	0.0	82	0.99	InbreedingCoeff_RF	sas	0.498784	12306.0	0.493925	35285.0	0.0308417	4796	0.202	633.0				22.7	2.587147	0.337	7	11	18	SIFT,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_addAF_pred,fathmm-MKL_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.0	0.0	0.0	-3.0	-47.0	21.0	-1.0						0.694	0.01	46.121634545	0.713	1.053	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926846	chr11	48347342	G	A	chr11:48347342	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.52	21_23	44	99	False	rs76958755,COSV60583129	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.769G>A	NP_001004702.2:p.Val257Met		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.97							0.445505	40827.0	91642.0	0.0	69	0.94	InbreedingCoeff	sas	0.463871	6150.0	0.439437	16674.0	0.0040321	627	0.121	364.0				0.637	-0.217911	0.091	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.01	0.0	0.0	0.0	28.0	-4.0	-15.0	-1.0						0.694	0.01	59.223313297	0.649	0.216	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926847	chr11	48347346	A	T	chr11:48347346	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.53	21_24	45	99	False	rs74590631,COSV60583294	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.773A>T	NP_001004702.2:p.His258Leu		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.97							0.397426	32550.0	81902.0	0.0	67	0.91	InbreedingCoeff_RF	sas	0.417138	4717.0	0.398622	14006.0	0.0040449	629	0.113	356.0				16.05	1.461317	0.101	1	15	16	SIFT	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.04	0.0	0.0	0.0	24.0	2.0	-19.0	-41.0						0.694	0.01	80.412657112	0.538	-0.058	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926848	chr11	48347358	C	T	chr11:48347358	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.53	22_25	47	99	False	rs76274696,COSV60583302	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.785C>T	NP_001004702.2:p.Thr262Ile		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.97							0.355474	27294.0	76782.0	0.0	69	0.91	InbreedingCoeff_RF	sas	0.374948	3586.0	0.350626	11699.0	0.0036012	560	0.106	334.0				17.07	1.63624	0.234	1	15	16	SIFT	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.05	0.0	0.0	0.0	12.0	1.0	12.0	-31.0						0.694	0.01	80.412657112	0.849	0.921	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926849	chr11	48347363	C	T	chr11:48347363	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0|1	0.54	22_26	48	99	False	rs77814753,COSV60583311	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.790C>T	NP_001004702.2:p.Pro264Ser		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		6.57462e-06	1.0	152100.0	0.0	32	0.97	PASS				0.0	0.0	0.373657	29143.0	77994.0	0.0	70	0.89	InbreedingCoeff_RF	sas	0.392218	3770.0	0.365048	12251.0	0.0034211	532	0.106	335.0				0.006	-0.866978	0.086	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.02	0.0	0.0	0.0	7.0	1.0	-36.0	-38.0						0.694	0.01	80.412657112	0.457	-0.737	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926850	chr11	48347392	T	C	chr11:48347392	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.54	26_30	56	99	False	rs79127479,COSV60586675	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.819T>C	NP_001004702.2:p.Tyr273%3D		1.0						.	.	.						32	0.97							0.363675	33085.0	90974.0	0.0	66	0.79	InbreedingCoeff_RF	sas	0.366979	3992.0	0.362575	14131.0	0.0199609	3104	0.121	378.0				1.091	-0.137879		0	0	0			OR4C3	0.03	0.01	0.0	0.0	-22.0	45.0	1.0	34.0						0.694	0.01	3.920796073			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
926851	chr11	48347419	A	G	chr11:48347419	OR4C3	olfactory receptor family 4 subfamily C member 3	18119.0	SNV	0/1	0.52	26_28	54	99	False	rs73465913,COSV60585745	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.846A>G	NP_001004702.2:p.Pro282%3D		1.0						.	.	.						32	0.97							0.464548	48876.0	105212.0	0.0	47	0.68	InbreedingCoeff	nfe	0.469802	22247.0	0.469802	22247.0	0.0219094	3407	0.128	383.0				0.814	-0.181191		0	0	0			OR4C3	0.02	0.0	0.0	0.0	-49.0	18.0	27.0	-44.0						0.694	0.01	46.627587668			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
927175	chr1	16890441	C	T	chr1:16890441	NBPF1	NBPF member 1	18134.0	SNV	0/1	0.26	67_24	91	99	False	rs3863779,COSV67426360	EXONIC	YES	NM_017940.6	Transcript	protein_coding	synonymous_variant		28/28	NM_017940.6:c.3642G>A	NP_060410.3:p.Gln1214%3D		-1.0						.	.	.		0.0	0.0	668.0	0.0	0	0.0	AC0_AS_VQSR				0.0	0.0	0.207438	30780.0	148382.0	0.0	100	1.0	InbreedingCoeff	amr	0.230055	4562.0	0.227142	14965.0	0.0008489	132	0.019	60.0	0.14387	265.0		0.62	-0.222047		0	0	0			NBPF1	0.0	0.0	0.0	0.01	-41.0	1.0	30.0	1.0											.			.	.	.	cytoplasm	.	KDM1A[unassigned1304];NEK4[25798074];ESR1[26153859];
927176	chr1	16890484	G	C	chr1:16890484	NBPF1	NBPF member 1	18134.0	SNV	0/1	0.3	69_29	98	99	False	rs12117084,COSV67426815,COSV67431722	EXONIC	YES	NM_017940.6	Transcript	protein_coding	missense_variant		28/28	NM_017940.6:c.3599C>G	NP_060410.3:p.Thr1200Arg		-1.0						.	.	.		0.00157233	1.0	636.0	0.0	0	0.0	AS_VQSR	nfe	0.00297619	1.0	0.00297619	1.0	0.308427	43197.0	140056.0	0.0	100	1.0	InbreedingCoeff	nfe	0.34976	21839.0	0.34976	21839.0	0.0044436	691	0.032	99.0	0.13192	243.0		8.362	0.396662		0	7	7		MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NBPF1	0.0	0.0	0.0	0.0	20.0	-23.0	-42.0	21.0									0.0	-1.116	.			.	.	.	cytoplasm	.	KDM1A[unassigned1304];NEK4[25798074];ESR1[26153859];
927178	chr1	16890602	T	G	chr1:16890602	NBPF1	NBPF member 1	18134.0	SNV	0/1	0.24	83_26	109	99	False	rs2990551,COSV55321102	EXONIC	YES	NM_017940.6	Transcript	protein_coding	missense_variant		28/28	NM_017940.6:c.3481A>C	NP_060410.3:p.Met1161Leu		-1.0	.,Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain					.	.	.		0.0	0.0	102.0	0.0	0	0.0	AC0_AS_VQSR				0.0	0.0	0.36328	64092.0	176426.0	1.0	100	1.0	InbreedingCoeff	sas	0.406199	8925.0	0.386181	31646.0	0.0019163	298	0.067	186.0	0.27705	507.0		0.293	-0.332256		0	7	7		MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NBPF1	0.0	0.0	0.0	0.0	-38.0	-30.0	-39.0	-1.0									0.0	-0.501	.			.	.	.	cytoplasm	.	KDM1A[unassigned1304];NEK4[25798074];ESR1[26153859];
927179	chr1	16890639	C	T	chr1:16890639	NBPF1	NBPF member 1	18134.0	SNV	0/1	0.22	89_25	114	99	False	rs1043750,COSV55325017	EXONIC	YES	NM_017940.6	Transcript	protein_coding	synonymous_variant		28/28	NM_017940.6:c.3444G>A	NP_060410.3:p.Leu1148%3D		-1.0						.	.	.		0.0	0.0	22.0	0.0	0	0.0	AC0_AS_VQSR				0.0	0.0	0.463592	87502.0	188748.0	3.0	100	1.0	InbreedingCoeff	eas	0.485951	7160.0	0.469475	40019.0	0.0079998	1244	0.034	103.0	0.3505	633.0		0.615	-0.223265		0	0	0			NBPF1	0.0	0.0	0.0	0.0	36.0	42.0	-4.0	-38.0											.			.	.	.	cytoplasm	.	KDM1A[unassigned1304];NEK4[25798074];ESR1[26153859];
927180	chr1	16890644	C	T	chr1:16890644	NBPF1	NBPF member 1	18134.0	SNV	0/1	0.49	57_55	112	99	False	rs2992339,COSV55321106	EXONIC	YES	NM_017940.6	Transcript	protein_coding	missense_variant		28/28	NM_017940.6:c.3439G>A	NP_060410.3:p.Val1147Ile		-1.0	.,Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain					.	.	.		0.0	0.0	18.0	0.0	0	0.0	AC0_AS_VQSR				0.0	0.0	0.492077	110296.0	224144.0	22.0	100	1.0	InbreedingCoeff	amr	0.496431	16134.0	0.492417	50716.0	0.0089322	1389	0.129	386.0	0.34911	627.0		5.808	0.197792		0	7	7		MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NBPF1	0.01	0.01	0.0	0.0	-9.0	31.0	-43.0	1.0									0.006	0.351	.			.	.	.	cytoplasm	.	KDM1A[unassigned1304];NEK4[25798074];ESR1[26153859];
927197	chr1	16892273		T	chr1:16892272-16892273	NBPF1	NBPF member 1	18134.0	insertion	0|1	0.12	65_9	74	99	False	rs373748839	EXONIC	YES	NM_017940.6	Transcript	protein_coding	frameshift_variant		26/28	NM_017940.6:c.3013+131dup	NP_060410.3:p.Glu1049ArgfsTer3		-1.0						.	.	.		8.88707e-05	13.0	146280.0	0.0	26	0.81	AS_VQSR	sas	0.000229991	1.0	7.58794e-05	5.0	0.0269615	5661.0	209966.0	2.0	20	0.5	RF	amr	0.0375449	1128.0	0.0261128	2390.0	0.0001543	24						23.1	2.791755		0	0	0			NBPF1	0.01	0.0	0.0	0.0	19.0	-32.0	4.0	22.0											.			.	.	.	cytoplasm	.	KDM1A[unassigned1304];NEK4[25798074];ESR1[26153859];
927198	chr1	16892277	G		chr1:16892277	NBPF1	NBPF member 1	18134.0	deletion	0|1	0.16	65_12	77	99	False	rs368729374,COSV55320978,COSV55321179,COSV55326510	EXONIC	YES	NM_017940.6	Transcript	protein_coding	frameshift_variant		26/28	NM_017940.6:c.3013+127del	NP_060410.3:p.Ala1047GlufsTer2		-1.0						.	.	.		9.02389e-05	13.0	144062.0	0.0	25	0.77	AS_VQSR	sas	0.000235516	1.0	7.69373e-05	5.0	0.072971	7299.0	100026.0	4.0	18	0.46	RF	amr	0.092035	1345.0	0.0778962	3171.0	0.0001543	24						22.5	2.472472		0	0	0			NBPF1	0.01	0.0	0.0	0.0	15.0	-36.0	-37.0	3.0											.			.	.	.	cytoplasm	.	KDM1A[unassigned1304];NEK4[25798074];ESR1[26153859];
927220	chr1	16895634	T	G	chr1:16895634	NBPF1	NBPF member 1	18134.0	SNV	0/1	0.54	43_51	94	99	False	rs849614,COSV55321125	EXONIC	YES	NM_017940.6	Transcript	protein_coding	missense_variant		23/28	NM_017940.6:c.2548A>C	NP_060410.3:p.Lys850Gln		-1.0	.,Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain					.	.	.		5.2993e-05	5.0	94352.0	0.0	13	0.15	AS_VQSR	amr	0.000103713	1.0	6.16751e-05	3.0	0.638829	147857.0	231450.0	32950.0	100	0.99	InbreedingCoeff	eas	0.796442	14551.0	0.617996	64724.0	0.0195815	3045	0.055	174.0	0.12106	223.0		0.057	-0.559003		0	7	7		MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NBPF1	0.0	0.0	0.01	0.0	-3.0	-11.0	45.0	5.0									0.0	-1.11	.			.	.	.	cytoplasm	.	KDM1A[unassigned1304];NEK4[25798074];ESR1[26153859];
927744	chr11	86126317	G	C	chr11:86126317	CCDC81	coiled-coil domain containing 81	18138.0	SNV	0/1	0.37	17_10	27	99	False	rs34331151	EXONIC	YES	NM_001156474.2	Transcript	protein_coding	missense_variant		13/15	NM_001156474.2:c.1653G>C	NP_001149946.1:p.Gln551His		1.0	.,.,.					.	.	.		0.00176757	269.0	152186.0	1.0	32	0.97	PASS	amr	0.00346859	53.0	0.00260187	177.0	0.00147969	372.0	251404.0	2.0	75	0.99	PASS	nfe	0.00245352	279.0	0.00245352	279.0	0.0016012	249	0.001	4.0				22.1	2.32498	0.17	8	13	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationAssessor_pred,PROVEAN_pred,fathmm-MKL_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	CCDC81	0.0	0.0	0.0	0.0	3.0	1.0	34.0	38.0						0.995	0.0	0.0	0.951	0.222	.			superior cervical ganglion;testis;	.	.	cytoplasm;centrosome	.	.
927787	chr11	69063153	G	A	chr11:69063153	MYEOV	myeloma overexpressed	18139.0	SNV	0/1	0.68	9_19	28	99	False	rs117131950,COSV99075630	EXONIC	YES	NM_001293291.2	Transcript	protein_coding	missense_variant		3/3	NM_001293291.2:c.236G>A	NP_001280220.1:p.Arg79His		1.0	.,.,.					.	.	.		0.00302975	461.0	152158.0	0.0	32	0.95	PASS	nfe	0.00526223	358.0	0.00526223	358.0	0.00315597	793.0	251270.0	2.0	95	1.0	PASS	sas	0.00457277	140.0	0.00438187	498.0	0.0033761	525	0.007	22.0				0.128	-0.449445	0.055	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.784	0.0	0.0	0.0	-0.468	.			ciliary ganglion;atrioventricular node;	.	.	.	.	DAZAP2[unassigned1304];TRIP13[unassigned1304];
927899	chr19	57765837	C	T	chr19:57765837	ZNF805	zinc finger protein 805	18146.0	SNV	0/1	0.5	17_18	36	99	False	rs1320212192	EXONIC	YES	NM_001023563.4	Transcript	protein_coding	synonymous_variant		4/4	NM_001023563.4:c.1650C>T	NP_001018857.2:p.Arg550%3D		1.0						.	.	.		6.56987e-06	1.0	152210.0	0.0	32	0.97	PASS				0.0	0.0	3.97871e-06	1.0	251338.0	0.0	60	1.0	PASS	amr	2.89184e-05	1.0	0.0	0.0			0.0	1.0				10.26	0.593743		0	0	0			ZNF805	0.0	0.0	0.0	0.0	-48.0	19.0	-37.0	17.0							0.79	22.908947238			.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	.
927930	chr11	12376344	G	T	chr11:12376344	MICALCL	MICAL C-terminal like	18150.0	SNV	0/1	0.53	15_17	32	99	False	rs1036022844	EXONIC	YES	NM_032867.4	Transcript	protein_coding	stop_gained		8/9	NM_032867.4:c.1843G>T	NP_116256.2:p.Glu615Ter		1.0	bMERB domain&bMERB domain,.					.	.	.						32	0.97											39	0.96														53.0	10.028186		5	1	6	MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred,fathmm-MKL_coding_pred	fathmm-XF_coding_pred	MICALCL	0.0	0.05	0.0	0.0	7.0	-13.0	-2.0	32.0						0.949	0.0	76.708318039	0.991	1.176	.			superior cervical ganglion;trigeminal ganglion;	.	multicellular organism development;spermatogenesis;biological_process;cell differentiation	cytoplasm	mitogen-activated protein kinase binding	.
931161	chr12	10165490	T	C	chr12:10165490	CLEC12B	C-type lectin domain family 12 member B	18381.0	SNV	0/1	0.33	22_11	33	99	False	rs200245920	SPLICING	YES	NM_001129998.3	Transcript	protein_coding	splice_region_variant,intron_variant	2/5		NM_001129998.3:c.190+8T>C			1.0						.	.	.		0.000105151	16.0	152162.0	0.0	32	0.94	PASS	nfe	0.000205798	14.0	0.000205798	14.0	5.96901e-05	15.0	251298.0	0.0	58	0.99	PASS	afr	0.000123077	2.0	0.000105584	12.0	0.0000836	13						4.153	0.093489		0	0	0			CLEC12B	0.0	0.0	0.0	0.01	6.0	-2.0	-10.0	-8.0	4.49302493830456e-05	0.0				0.942	0.0				.			.	.	natural killer cell inhibitory signaling pathway;negative regulation of natural killer cell mediated cytotoxicity;negative regulation of signaling receptor activity	external side of plasma membrane;integral component of membrane;protein-containing complex	protein phosphatase binding;carbohydrate binding;receptor inhibitor activity	LSMEM2[unassigned1304];IL1RL1[unassigned1304];LY49L[unassigned1304];JAGN1[unassigned1304];PLLP[unassigned1304];SCD[unassigned1304];VMA21[unassigned1304];MALL[unassigned1304];PMP22[unassigned1304];LPAR3[unassigned1304];OPRM1[unassigned1304];SEC22A[unassigned1304];
931377	chr18	52265117	T	C	chr18:52265117	DYNAP	dynactin associated protein	18392.0	SNV	0|1	0.46	26_24	52	99	True	rs79727013	EXONIC	YES	NM_173629.3	Transcript	protein_coding	missense_variant		3/3	NM_173629.3:c.296T>C	NP_775900.2:p.Met99Thr		1.0	CLLAC-motif containing domain,.,CLLAC-motif containing domain					.	.	.						32	0.96											79	1.0							0.0001543	24						8.732	0.43175	0.04	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	DYNAP	0.0	0.0	0.0	0.0	-12.0	45.0	31.0	-48.0							0.41	23.536853263	0.906	-0.694	.			.	.	positive regulation of cell population proliferation;activation of protein kinase B activity;regulation of apoptotic process;cellular response to ergosterol	Golgi membrane;Golgi apparatus;plasma membrane;integral component of membrane	protein binding	.
931643	chr12	8375089	G	A	chr12:8375089	FAM90A1	family with sequence similarity 90 member A1	18414.0	SNV	0/1	0.52	15_16	31	99	False	rs146432845	EXONIC	YES	NM_018088.3	Transcript	protein_coding	stop_gained		7/7	NM_018088.3:c.724C>T	NP_060558.3:p.Gln242Ter		-1.0	.,.					.	.	.		0.000400815	61.0	152190.0	0.0	34	0.96	PASS	nfe	0.000602711	41.0	0.000602711	41.0	0.000296893	74.0	249248.0	0.0	100	0.99	PASS	amr	0.000549419	19.0	0.000426295	48.0	0.0002058	32	0.001	4.0				36.0	6.625084		2	3	5	MutationTaster_pred,BayesDel_noAF_pred	BayesDel_addAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FAM90A1	0.0	0.0	0.0	0.0	5.0	-33.0	21.0	-47.0						0.897	0.0		0.033	0.358	.			pons;superior cervical ganglion;trigeminal ganglion;parietal lobe;skeletal muscle;	.	.	.	protein binding	PRDM6[unassigned1304];STMN2[unassigned1304];FAM228A[unassigned1304];CCNC[unassigned1304];HSF2BP[unassigned1304];GABPB1[25416956];GOLGA2[25416956;27107012;unassigned1304];EFEMP2[unassigned1304];CYSRT1[unassigned1304];GNPTAB[25416956];POF1B[unassigned1304];KPNA6[unassigned1304];HOMER3[unassigned1304];ZNF688[unassigned1304];CCNL2[unassigned1304];TRIM27[unassigned1304];LZTS2[unassigned1304];LZTS1[unassigned1304];KPNA3[unassigned1304];AP2M1[unassigned1304];VRTN[unassigned1304];TRIM23[25416956;unassigned1304];CCDC155[25416956];COG6[27107012;unassigned1304];ACTN3[unassigned1304];PIH1D1[unassigned1304];LMO2[unassigned1304];ARRDC3[unassigned1304];MTUS2[25416956;unassigned1304];LDOC1[25416956;unassigned1304];OVOL1[unassigned1304];MID2[25416956;unassigned1304];RINT1[25416956];ZC2HC1C[unassigned1304];PRKAR1B[unassigned1304];PSME3[27107012];AKAP9[unassigned1304];TRIB3[unassigned1304];MAD1L1[unassigned1304];BLZF1[unassigned1304];ROPN1[unassigned1304];ZBTB8A[unassigned1304];BHLHB9[unassigned1304];KLHL12[unassigned1304];DTX3[unassigned1304];KRT40[25416956;unassigned1304];FXR1[unassigned1304];HMBOX1[unassigned1304];FXR2[25416956];CEP70[unassigned1304];DVL2[27107012];CEP72[25416956];DVL3[unassigned1304];RPRD1A[unassigned1304];ZBTB7B[unassigned1304];RAB11FIP2[unassigned1304];CEP76[25416956;unassigned1304];CDR2[unassigned1304];BANP[25416956;unassigned1304];ENKD1[unassigned1304];SRPK2[23602568];ZNF143[unassigned1304];SMAD3[unassigned1304];ZBTB14[25416956];CCDC13[unassigned1304];ZBTB16[unassigned1304];SIAH1[25416956];ANKRD23[unassigned1304];PBX2[unassigned1304];DDIT4L[unassigned1304];NOTCH2NLA[unassigned1304];ZWINT[unassigned1304];LRP2BP[unassigned1304];PBX1[unassigned1304];ALS2CR12[unassigned1304];SNW1[unassigned1304];HOOK2[unassigned1304];REL[unassigned1304];LHX6[unassigned1304];TMCC2[25416956];AMOTL2[unassigned1304];ZNF655[unassigned1304];GPSM1[unassigned1304];ISY1[unassigned1304];PPP1R13B[unassigned1304];CALCOCO2[21516116;25416956;unassigned1304];LRRK2[29513927];FHL3[25416956;unassigned1304];CHRDL2[unassigned1304];TRIM9[unassigned1304];PSTPIP1[25416956;unassigned1304];SPRED1[unassigned1304];ZNF526[unassigned1304];FLOT1[unassigned1304];TRIM69[unassigned1304];CEP55[25416956;unassigned1304];KRTAP1-1[unassigned1304];MYOG[unassigned1304];GRIPAP1[unassigned1304];KRT34[unassigned1304];TRAF2[25416956;unassigned1304];TFIP11[unassigned1304];KRT31[25416956;unassigned1304];MSS51[unassigned1304];AES[unassigned1304];ARHGEF9[unassigned1304];RABEP1[unassigned1304];TRAF4[21516116];NOV[unassigned1304];KRT38[25416956];HAND2[unassigned1304];GCSAML[unassigned1304];TAX1BP1[unassigned1304];PICK1[unassigned1304];KIFC3[unassigned1304];PRR23B[unassigned1304];PFDN5[unassigned1304];TRIM54[unassigned1304];ZMYND12[unassigned1304];MDFI[unassigned1304];KANK2[unassigned1304];RBM48[unassigned1304];STX11[25416956];BEGAIN[unassigned1304];MIPOL1[unassigned1304];EXOSC8[25416956;unassigned1304];PLAGL2[unassigned1304];FSD2[25416956;unassigned1304];FYN[unassigned1304];TRIM42[unassigned1304];SH2B2[unassigned1304];PDLIM7[unassigned1304];ZNF343[unassigned1304];ZNF581[unassigned1304];CCDC57[25416956;unassigned1304];CARD9[unassigned1304];KRTAP10-8[unassigned1304];CADPS[unassigned1304];STAC3[25416956;unassigned1304];ZNF76[unassigned1304];MLH1[unassigned1304];MEIS3[unassigned1304];NUDT21[unassigned1304];ABI2[unassigned1304];TRIML2[unassigned1304];MORN3[unassigned1304];LNX1[unassigned1304];VWC2[unassigned1304];FOSB[unassigned1304];GOPC[25416956];ZNF212[25416956;unassigned1304];BCAR1[unassigned1304];
932445	chr11	114421817	G	T	chr11:114421817	NXPE1	neurexophilin and PC-esterase domain family member 1	18450.0	SNV	0/1	0.71	22_55	77	99	False	rs73568242	SPLICING	YES	NM_001367953.1	Transcript	protein_coding	splice_region_variant,intron_variant	4/7		NM_001367953.1:c.99+8C>A			-1.0						.	.	.						32	0.96							0.257918	29088.0	112780.0	2.0	27	0.56	InbreedingCoeff	sas	0.326275	5824.0	0.268091	11774.0	0.0328609	5110	0.179	524.0				2.313	-0.021429		0	0	0			NXPE1	0.0	0.0	0.0	0.01	19.0	8.0	-26.0	8.0	4.10529984002121e-05	0.036					0.0				.			.	.	.	extracellular region	.	.
932446	chr11	114421857	T	C	chr11:114421857	NXPE1	neurexophilin and PC-esterase domain family member 1	18450.0	SNV	0|1	0.65	29_54	83	99	False	rs78453693,COSV52626735	EXONIC	YES	NM_001367953.1	Transcript	protein_coding	missense_variant		4/8	NM_001367953.1:c.67A>G	NP_001354882.1:p.Met23Val		-1.0	.,.,.,.					.	.	.						32	0.96							0.263714	30190.0	114480.0	1.0	31	0.56	InbreedingCoeff	sas	0.331303	5984.0	0.27367	12163.0	0.0339412	5278	0.21	647.0				9.303	0.489443	0.024	0	16	16		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NXPE1	0.0	0.01	0.0	0.3	-32.0	11.0	1.0	-32.0							0.0	46.590584951	0.02	0.148	.			.	.	.	extracellular region	.	.
932449	chr11	114421895	G	A	chr11:114421895	NXPE1	neurexophilin and PC-esterase domain family member 1	18450.0	SNV	0/1	0.65	31_58	89	99	False	rs78257939,COSV52626744	EXONIC	YES	NM_001367953.1	Transcript	protein_coding	missense_variant		4/8	NM_001367953.1:c.29C>T	NP_001354882.1:p.Thr10Met		-1.0	.,.,.,.					.	.	.						32	0.97							0.192863	17608.0	91298.0	2.0	31	0.56	RF	sas	0.25523	3367.0	0.207689	7417.0	0.0086814	1350	0.187	553.0				2.049	-0.041287	0.038	0	16	16		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NXPE1	0.0	0.02	0.0	0.0	-27.0	38.0	38.0	-28.0							0.0	0.0	0.031	-0.089	.			.	.	.	extracellular region	.	.
932450	chr11	114421909	T	C	chr11:114421909	NXPE1	neurexophilin and PC-esterase domain family member 1	18450.0	SNV	0|1	0.66	29_57	86	99	False	rs79082937,COSV52626726	EXONIC	YES	NM_001367953.1	Transcript	protein_coding	synonymous_variant		4/8	NM_001367953.1:c.15A>G	NP_001354882.1:p.Thr5%3D		-1.0						.	.	.						32	0.97							0.121269	9198.0	75848.0	0.0	30	0.56	RF	sas	0.15873	1560.0	0.125957	3654.0	0.0088294	1373	0.15	437.0				3.743	0.069035		0	0	0			NXPE1	0.07	0.0	0.0	0.0	24.0	-44.0	-39.0	24.0							0.0	26.271993662			.			.	.	.	extracellular region	.	.
932452	chr11	114421912	A	G	chr11:114421912	NXPE1	neurexophilin and PC-esterase domain family member 1	18450.0	SNV	0|1	0.66	29_57	86	99	False	rs78658939,COSV52629059	EXONIC	YES	NM_001367953.1	Transcript	protein_coding	synonymous_variant		4/8	NM_001367953.1:c.12T>C	NP_001354882.1:p.Asn4%3D		-1.0						.	.	.		6.57108e-06	1.0	152182.0	0.0	32	0.97	PASS	nfe	1.4702e-05	1.0	1.4702e-05	1.0	0.118461	8881.0	74970.0	0.0	30	0.56	InbreedingCoeff_RF	sas	0.154149	1486.0	0.123044	3522.0	0.0078712	1224	0.15	441.0				0.873	-0.170772		0	0	0			NXPE1	0.01	0.0	0.0	0.0	21.0	-44.0	-45.0	2.0							0.0	26.271993662			.			.	.	.	extracellular region	.	.
932486	chr11	114422169	A	G	chr11:114422169	NXPE1	neurexophilin and PC-esterase domain family member 1	18450.0	SNV	0|1	0.7	25_57	82	99	False	rs77800585	SPLICING	YES	NM_001367953.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/7		NM_001367953.1:c.-69-6T>C			-1.0						.	.	.						32	0.97											0	0.0							0.0009857	26						6.514	0.247182		0	0	0			NXPE1	0.0	0.24	0.0	0.0	48.0	-6.0	48.0	17.0	4.6857887130806e-05	0.0	7.666	1.752	9.418		0.0				.			.	.	.	extracellular region	.	.
932488	chr11	114422171	G		chr11:114422171	NXPE1	neurexophilin and PC-esterase domain family member 1	18450.0	deletion	0|1	0.7	25_57	82	99	False	rs113988266	SPLICING	YES	NM_001367953.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/7		NM_001367953.1:c.-69-8del			-1.0						.	.	.						32	0.97											0	0.0							0.0802563	2117						4.168	0.094385		0	0	0			NXPE1	0.0	0.1	0.0	0.0	47.0	-7.0	16.0	-7.0							0.0				.			.	.	.	extracellular region	.	.
932709	chr11	114423608	A	G	chr11:114423608	NXPE1	neurexophilin and PC-esterase domain family member 1	18450.0	SNV	0/1	0.58	41_57	98	99	False	rs80221895	SPLICING	YES	NM_001367953.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/7		NM_001367953.1:c.-98-6T>C			-1.0						.	.	.						32	0.95											0	0.0							0.0757828	1999						9.566	0.51743		0	0	0			NXPE1	0.0	0.49	0.0	0.5	-34.0	-6.0	34.0	-34.0	7.98693172190235e-05	0.004	9.066	0.542	9.608		0.0				.			.	.	.	extracellular region	.	.
933807	chr1	12854090	T	A	chr1:12854090	PRAMEF1	PRAME family member 1	18542.0	SNV	0|1	0.27	22_8	30	99	False	rs79698223,COSV60004981,COSV60016926	EXONIC	YES	NM_023013.4	Transcript	protein_coding	stop_gained		3/4	NM_023013.4:c.314T>A	NP_075389.2:p.Leu105Ter		1.0						.	.	.						32	0.91							0.247492	30931.0	124978.0	38.0	100	0.99	InbreedingCoeff_RF	nfe	0.291538	15469.0	0.291538	15469.0	0.0001865	29	0.027	72.0				34.0	5.668333		3	3	6	MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	LRT_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRAMEF1	0.0	0.01	0.0	0.0	-23.0	-26.0	-26.0	-11.0						0.994	0.1		0.153	0.65	.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.
933810	chr1	12854097	T	C	chr1:12854097	PRAMEF1	PRAME family member 1	18542.0	SNV	0|1	0.25	21_7	28	99	False	rs76193255,COSV60004995	EXONIC	YES	NM_023013.4	Transcript	protein_coding	synonymous_variant		3/4	NM_023013.4:c.321T>C	NP_075389.2:p.Asp107%3D		1.0		Benign	criteria_provided,_single_submitter	not_specified		.	.	.	24033266					32	0.91							0.302512	46406.0	153402.0	49.0	100	1.0	InbreedingCoeff	nfe	0.345118	23691.0	0.345118	23691.0	0.0108036	1680	0.054	150.0				0.977	-0.154075		0	0	0			PRAMEF1	0.01	0.0	0.0	0.0	-33.0	24.0	-4.0	-18.0						0.994	0.1				.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.
933812	chr1	12854105	A	G	chr1:12854105	PRAMEF1	PRAME family member 1	18542.0	SNV	0|1	0.25	21_7	28	99	False	rs76648802,COSV60005012	EXONIC	YES	NM_023013.4	Transcript	protein_coding	missense_variant		3/4	NM_023013.4:c.329A>G	NP_075389.2:p.Glu110Gly		1.0		Benign	criteria_provided,_single_submitter	not_specified		.	.	.	24033266					32	0.91							0.281472	39383.0	139918.0	49.0	100	1.0	InbreedingCoeff	nfe	0.324347	19754.0	0.324347	19754.0	0.0002315	36	0.021	58.0				13.04	0.944959	0.073	3	16	19	SIFT,PolyPhen,PROVEAN_pred	Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRAMEF1	0.0	0.01	0.0	0.0	-42.0	-41.0	-39.0	10.0						0.994	0.1		0.002	0.736	.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.
933820	chr1	12855647	C	T	chr1:12855647	PRAMEF1	PRAME family member 1	18542.0	SNV	0|1	0.15	35_6	41	99	False	rs200536957,COSV60011476	EXONIC	YES	NM_023013.4	Transcript	protein_coding	synonymous_variant		4/4	NM_023013.4:c.927C>T	NP_075389.2:p.Asp309%3D		1.0						.	.	.		6.58614e-06	1.0	151834.0	0.0	31	0.94	PASS	nfe	1.47128e-05	1.0	1.47128e-05	1.0	0.00903534	1898.0	210064.0	14.0	80	0.99	PASS	eas	0.0263494	330.0	0.00929657	909.0	0.0000193	3						0.026	-0.662072		0	0	0			PRAMEF1	0.0	0.0	0.0	0.0	-50.0	19.0	-2.0	17.0						0.994	0.1				.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.
933821	chr1	12855648	A	G	chr1:12855648	PRAMEF1	PRAME family member 1	18542.0	SNV	0|1	0.15	35_6	41	99	False	rs200816125,COSV60006194	EXONIC	YES	NM_023013.4	Transcript	protein_coding	missense_variant		4/4	NM_023013.4:c.928A>G	NP_075389.2:p.Met310Val		1.0						.	.	.		1.33456e-05	2.0	149862.0	0.0	31	0.93	PASS	amr	6.64011e-05	1.0	1.48903e-05	1.0	0.00927639	1895.0	204282.0	14.0	81	0.99	PASS	eas	0.0276043	327.0	0.00961417	912.0	0.0000193	3						0.018	-0.70797	0.074	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRAMEF1	0.0	0.0	0.0	0.0	-5.0	18.0	-1.0	4.0						0.994	0.1		0.0	-1.505	.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.
933908	chr1	13001312	C	G	chr1:13001312	PRAMEF6	PRAME family member 6	18555.0	SNV	0/1	0.63	11_19	30	99	False	rs61779367,COSV61909822	EXONIC	YES	NM_001010889.2	Transcript	protein_coding	missense_variant		3/4	NM_001010889.2:c.371G>C	NP_001010889.1:p.Cys124Ser		-1.0	.,.					.	.	.		9.14597e-05	9.0	98404.0	0.0	13	0.18	PASS	sas	0.00175685	5.0	0.0	0.0	0.521689	129790.0	248788.0	6786.0	100	0.99	InbreedingCoeff	amr	0.536081	18379.0	0.521717	58858.0	0.0137681	2141	0.131	414.0				3.655	0.063798	0.042	2	16	18	MutationAssessor_pred,PROVEAN_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRAMEF6	0.0	0.0	0.0	0.0	-17.0	15.0	29.0	3.0							0.69		0.0	-2.724	.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.
934124	chr20	62187049	C	T	chr20:62187049	FNDC11	fibronectin type III domain containing 11	18585.0	SNV	0/1	0.56	16_20	36	99	False	rs1410500489,COSV64443186	EXONIC	YES	NM_001319153.2	Transcript	protein_coding	synonymous_variant		2/2	NM_001319153.2:c.33C>T	NP_001306082.1:p.Asp11%3D		1.0						.	.	.						34	0.98							8.09271e-06	2.0	247136.0	0.0	37	0.91	PASS	amr	5.81294e-05	2.0	0.0	0.0								0.845	-0.175623		0	0	0			C20orf195	0.0	0.07	0.0	0.0	25.0	-42.0	-42.0	45.0								83.894284467			normal phenotype; 			.	.	.	.	protein binding	CDA[25416956;unassigned1304];CDKN1A[unassigned1304];MAGEA12[25416956;unassigned1304];CALCOCO2[16189514;25416956];CDCA4[unassigned1304];CCDC102B[25416956];KRT40[25416956];ZNF48[unassigned1304];GOLGA2[25416956];HMBOX1[25416956];ARL5B[unassigned1304];SERTAD1[unassigned1304];CCDC85B[16189514];GPBP1[25416956;unassigned1304];ZBED1[unassigned1304];SSSCA1[16189514];TRIM27[25416956];SMN1[unassigned1304];LZTS2[25416956];PDLIM7[16189514];UBQLN2[unassigned1304];FAM9B[25416956];ZRANB1[unassigned1304];RBPMS[25416956];COG6[unassigned1304];AP1B1[unassigned1304];MTUS2[25416956];KRT34[unassigned1304];TRAF2[21516116];KRTAP19-6[unassigned1304];SORBS3[unassigned1304];SCNM1[unassigned1304];MIS18A[unassigned1304];PSMA1[unassigned1304];ID2[unassigned1304];CINP[unassigned1304];REL[25416956];CERCAM[unassigned1304];SSX2IP[25416956];MDFI[25416956];GLYR1[unassigned1304];
934370	chr21	46011745	T	T	chr21:46011745	KRTAP10-6	keratin associated protein 10-6	18626.0	SNV	1/1	0.88	0_30	34	90	False	rs1555926683,rs1569206313,rs1569206319,rs1569206335,rs233304,COSV59967523	EXONIC	YES	NM_198688.3	Transcript	protein_coding	synonymous_variant		1/1	NM_198688.3:c.621G>A	NP_941961.3:p.Ser207%3D		-1.0						.	.	.						0	0.0											100	1.0							0.0000064,0.0000129,0.0000129,0.6991138,0.0002251,0.0000064	1,2,2,108715,35,1	0.593	1716.0				0.006	-0.851982		0	0	0			KRTAP10-6	0.01	0.01	0.0	0.0	-10.0	25.0	50.0	1.0						0.918	0.0				.			.	.	keratinization	cytosol;keratin filament	.	ZBTB24[unassigned1304];ZNF490[unassigned1304];HHEX[unassigned1304];FAM74A4[unassigned1304];DHX57[unassigned1304];ADAMTSL3[unassigned1304];MFSD3[unassigned1304];ZNF280C[unassigned1304];RSPO2[unassigned1304];SNIP1[unassigned1304];KRTAP5-2[unassigned1304];ZNF600[unassigned1304];ZNF169[unassigned1304];ZNF563[unassigned1304];FOXD4[unassigned1304];ZNF440[unassigned1304];KRTAP5-9[unassigned1304];LCE1E[unassigned1304];LCE1F[unassigned1304];DKK2[unassigned1304];LCE2C[unassigned1304];KIF9[unassigned1304];ZNF319[unassigned1304];HAND1[unassigned1304];ZNF679[unassigned1304];ZNF239[unassigned1304];ZNF479[unassigned1304];MT1B[unassigned1304];ZNF114[unassigned1304];AVPI1[unassigned1304];HOXB5[unassigned1304];ZNF595[unassigned1304];ZNF155[unassigned1304];ZNF672[unassigned1304];ZNF792[unassigned1304];YTHDC1[unassigned1304];PBXIP1[unassigned1304];SPATA3[unassigned1304];ZC3HAV1[unassigned1304];KIAA0040[unassigned1304];LCE2D[unassigned1304];NKD1[unassigned1304];ZNHIT1[unassigned1304];LCE3B[unassigned1304];MOBP[unassigned1304];KRTAP5-11[unassigned1304];ZNF669[unassigned1304];KRTAP4-4[unassigned1304];KRTAP4-2[unassigned1304];ZNF302[unassigned1304];ZNF543[unassigned1304];ZIM2[unassigned1304];STRA6[unassigned1304];NPDC1[unassigned1304];ZNF221[unassigned1304];ZNF264[unassigned1304];KRTAP10-5[unassigned1304];NAA10[unassigned1304];KRTAP4-5[unassigned1304];CLK4[unassigned1304];VASN[unassigned1304];LCE3E[unassigned1304];CLK1[unassigned1304];WT1[unassigned1304];LCE4A[unassigned1304];ZNF418[unassigned1304];NMU[unassigned1304];PIN1[unassigned1304];NAXD[unassigned1304];ZNF138[unassigned1304];ZNF776[unassigned1304];NOL12[unassigned1304];ZNF774[unassigned1304];ZNF696[unassigned1304];
934371	chr21	46011751	T	T	chr21:46011751	KRTAP10-6	keratin associated protein 10-6	18626.0	SNV	1/1	0.88	0_30	34	90	False	rs233305,rs782466433,COSV59954350	EXONIC	YES	NM_198688.3	Transcript	protein_coding	synonymous_variant		1/1	NM_198688.3:c.615G>A	NP_941961.3:p.Thr205%3D		-1.0						.	.	.						0	0.0											100	1.0							0.6881302,0.0000322	107007,5	0.558	1621.0				0.105	-0.476636		0	0	0			KRTAP10-6	0.01	0.01	0.0	0.0	-16.0	19.0	44.0	48.0						0.918	0.0				.			.	.	keratinization	cytosol;keratin filament	.	ZBTB24[unassigned1304];ZNF490[unassigned1304];HHEX[unassigned1304];FAM74A4[unassigned1304];DHX57[unassigned1304];ADAMTSL3[unassigned1304];MFSD3[unassigned1304];ZNF280C[unassigned1304];RSPO2[unassigned1304];SNIP1[unassigned1304];KRTAP5-2[unassigned1304];ZNF600[unassigned1304];ZNF169[unassigned1304];ZNF563[unassigned1304];FOXD4[unassigned1304];ZNF440[unassigned1304];KRTAP5-9[unassigned1304];LCE1E[unassigned1304];LCE1F[unassigned1304];DKK2[unassigned1304];LCE2C[unassigned1304];KIF9[unassigned1304];ZNF319[unassigned1304];HAND1[unassigned1304];ZNF679[unassigned1304];ZNF239[unassigned1304];ZNF479[unassigned1304];MT1B[unassigned1304];ZNF114[unassigned1304];AVPI1[unassigned1304];HOXB5[unassigned1304];ZNF595[unassigned1304];ZNF155[unassigned1304];ZNF672[unassigned1304];ZNF792[unassigned1304];YTHDC1[unassigned1304];PBXIP1[unassigned1304];SPATA3[unassigned1304];ZC3HAV1[unassigned1304];KIAA0040[unassigned1304];LCE2D[unassigned1304];NKD1[unassigned1304];ZNHIT1[unassigned1304];LCE3B[unassigned1304];MOBP[unassigned1304];KRTAP5-11[unassigned1304];ZNF669[unassigned1304];KRTAP4-4[unassigned1304];KRTAP4-2[unassigned1304];ZNF302[unassigned1304];ZNF543[unassigned1304];ZIM2[unassigned1304];STRA6[unassigned1304];NPDC1[unassigned1304];ZNF221[unassigned1304];ZNF264[unassigned1304];KRTAP10-5[unassigned1304];NAA10[unassigned1304];KRTAP4-5[unassigned1304];CLK4[unassigned1304];VASN[unassigned1304];LCE3E[unassigned1304];CLK1[unassigned1304];WT1[unassigned1304];LCE4A[unassigned1304];ZNF418[unassigned1304];NMU[unassigned1304];PIN1[unassigned1304];NAXD[unassigned1304];ZNF138[unassigned1304];ZNF776[unassigned1304];NOL12[unassigned1304];ZNF774[unassigned1304];ZNF696[unassigned1304];
934600	chr1	26691347	G	A	chr1:26691347	ZNF683	zinc finger protein 683	18681.0	SNV	0/1	0.47	18_16	34	99	False	rs142734084	EXONIC	YES	NM_001307925.1	Transcript	protein_coding	synonymous_variant		4/7	NM_001307925.1:c.690C>T	NP_001294854.1:p.Thr230%3D		-1.0						.	.	.		0.000552072	84.0	152154.0	0.0	32	0.95	PASS	nfe	0.000940734	64.0	0.000940734	64.0	0.000935271	192.0	205288.0	1.0	50	0.68	PASS	nfe	0.00175979	168.0	0.00175979	168.0	0.0011189	174						0.19	-0.394182		0	0	0			ZNF683	0.0	0.0	0.0	0.0	-37.0	16.0	-4.0	-27.0						0.992	0.0	26.262472093			immune system phenotype; hematopoietic system phenotype; 			pons;testis - seminiferous tubule;testis - interstitial;subthalamic nucleus;superior cervical ganglion;trigeminal ganglion;atrioventricular node;testis;globus pallidus;	.	adaptive immune response;regulation of transcription by RNA polymerase II;regulation of gene expression;regulation of natural killer cell differentiation;regulation of natural killer cell differentiation involved in immune response;regulation of extrathymic T cell differentiation;innate immune response;regulation of NK T cell differentiation	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding;promoter-specific chromatin binding	ZNF330[unassigned1304];RHOXF2[unassigned1304];CYSRT1[unassigned1304];KRTAP6-2[unassigned1304];PRR20D[unassigned1304];
934997	chr20	44238797	G	A	chr20:44238797	WFDC9	WAP four-disulfide core domain 9	18737.0	SNV	0/1	0.43	20_15	35	99	False	rs763465279,COSV58096491	EXONIC	YES	NM_147198.4	Transcript	protein_coding	synonymous_variant		3/5	NM_147198.4:c.24C>T	NP_671731.1:p.Leu8%3D		-1.0						.	.	.						32	0.96							2.79214e-05	7.0	250704.0	0.0	44	0.99	PASS	amr	8.68106e-05	3.0	3.53557e-05	4.0	0.0000257	4						0.214	-0.377344		0	0	0			WFDC9	0.0	0.0	0.0	0.0	-20.0	31.0	-3.0	-18.0						0.672	0.01	83.02566267			.			.	.	.	extracellular region	protein binding	MEOX2[25416956];
936452	chr11	4510553	C	T	chr11:4510553	OR52K1	olfactory receptor family 52 subfamily K member 1	18862.0	SNV	0/1	0.52	11_12	23	99	False	rs3889581	EXONIC	YES	NM_001005171.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001005171.3:c.423C>T	NP_001005171.2:p.Ser141%3D		1.0						.	.	.		0.00263552	401.0	152152.0	1.0	33	0.97	PASS	afr	0.00593773	246.0	0.00104369	71.0	0.00161115	405.0	251374.0	1.0	85	1.0	PASS	afr	0.00670522	109.0	0.00101159	115.0	0.0014533	226	0.004	14.0				1.366	-0.104329		0	0	0			OR52K1	0.0	0.0	0.0	0.0	13.0	3.0	-4.0	3.0						0.824	0.0	0.0			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
936489	chr15	22368862	G	A	chr15:22368862	OR4M2	olfactory receptor family 4 subfamily M member 2	18865.0	SNV	0|1	0.34	31_16	47	99	False	rs1835183,COSV60307128	EXONIC	YES	NM_001004719.2	Transcript	protein_coding	missense_variant		1/1	NM_001004719.2:c.287G>A	NP_001004719.2:p.Gly96Glu		1.0	GPCR, rhodopsin-like, 7TM					.	.	.						0	0.0							0.634013	155768.0	245686.0	36934.0	100	1.0	InbreedingCoeff	amr	0.691306	23568.0	0.643616	72076.0	0.0445069	6921	0.229	706.0				22.9	2.695646	0.564	5	12	17	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationAssessor_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4M2	0.0	0.0	0.0	0.0	14.0	-36.0	-2.0	-36.0						0.789			0.033	1.037	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
936625	chr11	57947775	C	A	chr11:57947775	OR9Q1	olfactory receptor family 9 subfamily Q member 1	18880.0	SNV	0/1	0.33	18_9	27	99	False	rs148066479	EXONIC	YES	NM_001005212.4	Transcript	protein_coding	missense_variant		3/3	NM_001005212.4:c.859C>A	NP_001005212.1:p.Leu287Ile		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		0.00053239	81.0	152144.0	0.0	32	0.97	PASS	nfe	0.000720313	49.0	0.000720313	49.0	0.000650029	163.0	250758.0	0.0	57	0.97	PASS	nfe	0.000785608	89.0	0.000785608	89.0	0.0005723	89	0.001	4.0				14.06	1.097475	0.139	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR9Q1	0.0	0.0	0.0	0.0	-23.0	11.0	-46.0	0.0							0.01	0.0	0.996	1.026	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;sensory perception of smell;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity;odorant binding	.
945737	chr20	34152273	A	G	chr20:34152273	FER1L4	fer-1 like family member 4, pseudogene	18957.0	SNV	0/1	0.48	12_11	23	99	False	rs147968281	SPLICING	YES	NR_119376.1	Transcript	transcribed_pseudogene	splice_region_variant,non_coding_transcript_exon_variant		38/44	NR_119376.1:n.4934T>C			-1.0						.	.	.						0	0.0											0	0.0							0.0432557	1141						0.848	-0.175183		0	0	0														9.177	0.886	10.063						.			.	.	.	integral component of membrane	.	HIST1H2BD[30021884];
945983	chr6	138539392	T	C	chr6:138539392	PBOV1	prostate and breast cancer overexpressed 1	19008.0	SNV	0/1	0.54	11_13	24	99	False	rs779230396	EXONIC	YES	NM_021635.3	Transcript	protein_coding	synonymous_variant		1/1	NM_021635.3:c.141A>G	NP_067648.1:p.Pro47%3D		-1.0						.	.	.		5.9149e-05	9.0	152158.0	0.0	33	0.97	PASS	sas	0.000206954	1.0	7.35186e-05	5.0	9.44784e-05	23.0	243442.0	0.0	52	0.85	PASS	amr	0.000147964	5.0	0.000119644	13.0	0.0000772	12						2.092	-0.037887		0	0	0			PBOV1	0.0	0.0	0.01	0.0	-12.0	-13.0	-12.0	-13.0						0.75	0.01	9.084037609			.			.	.	.	nucleus;cytoplasm	.	.
946041	chr11	56127803	C		chr11:56127803	OR8J1	olfactory receptor family 8 subfamily J member 1	19038.0	deletion	0|1	0.39	23_15	38	99	False	rs753865345	EXONIC	YES	NM_001005205.3	Transcript	protein_coding	frameshift_variant		2/2	NM_001005205.3:c.81del	NP_001005205.2:p.Phe28SerfsTer10		1.0						.	.	.		0.000394363	60.0	152144.0	0.0	32	0.95	PASS	amr	0.000720555	11.0	0.000602764	41.0	0.000605713	152.0	250944.0	0.0	48	0.98	PASS	amr	0.00156458	54.0	0.000678976	77.0	0.0005466	85	0.0	1.0				24.1	3.204001		0	0	0			OR8J1	0.02	0.0	0.0	0.04	-33.0	43.0	-33.0	-34.0						0.862	0.0				.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;sensory perception of smell;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity;odorant binding	.
946042	chr11	56127804	T	G	chr11:56127804	OR8J1	olfactory receptor family 8 subfamily J member 1	19038.0	SNV	0|1	0.39	23_15	38	99	False	rs149173319,COSV57316758,COSV57317973	EXONIC	YES	NM_001005205.3	Transcript	protein_coding	missense_variant		2/2	NM_001005205.3:c.82T>G	NP_001005205.2:p.Phe28Val		1.0	.,.					.	.	.		0.000394363	60.0	152144.0	0.0	32	0.95	PASS	amr	0.000720178	11.0	0.000602728	41.0	0.000605443	152.0	251056.0	0.0	49	0.99	PASS	amr	0.00156413	54.0	0.000678593	77.0	0.0005273	82	0.001	3.0				25.5	3.649439	0.496	9	12	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	OR8J1	0.0	0.0	0.0	0.01	-35.0	40.0	-1.0	-36.0						0.862	0.0	0.000000000	0.844	1.085	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;sensory perception of smell;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity;odorant binding	.
946051	chr11	5862869	A	C	chr11:5862869	OR52E6	olfactory receptor family 52 subfamily E member 6	19042.0	SNV	0/1	0.56	12_15	27	99	False	rs201073329,COSV61431441,COSV61431529	EXONIC	YES	NM_001005167.2	Transcript	protein_coding	missense_variant		1/1	NM_001005167.2:c.259T>G	NP_001005167.1:p.Phe87Val		-1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		7.88312e-05	12.0	152224.0	0.0	33	0.96	PASS	afr	0.000168846	7.0	7.34862e-05	5.0	6.37872e-05	16.0	250834.0	0.0	100	1.0	PASS	afr	0.000123426	2.0	0.000105889	12.0	0.0000772	12	0.001	2.0				24.3	3.285487	0.472	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,PROVEAN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	OR52E6	0.0	0.01	0.01	0.0	37.0	-18.0	-20.0	-4.0						0.707	0.07	0.000000000	1.0	1.265	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946412	chr11	48387098	A	C	chr11:48387098	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.36	30_17	47	99	False	rs77594589,COSV104409847,COSV60563754	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.920T>G	NP_001335152.1:p.Val307Gly		-1.0						.	.	.						33	0.96							0.485038	39906.0	82274.0	1.0	38	0.58	InbreedingCoeff	sas	0.487413	7319.0	0.487181	17064.0	0.0209255	3254	0.149	466.0				25.6	3.668758	0.545	9	7	16	SIFT,PolyPhen,LRT_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	OR4C5	0.0	0.03	0.0	0.01	5.0	11.0	50.0	-41.0							0.02	56.711980305	0.965	1.165	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946413	chr11	48387107	T	C	chr11:48387107	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.36	32_18	50	99	False	rs77606603,COSV60562114,COSV60562167	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.911A>G	NP_001335152.1:p.Asn304Ser		-1.0						.	.	.						32	0.96							0.476495	34219.0	71814.0	0.0	39	0.58	InbreedingCoeff	sas	0.481695	6447.0	0.480019	15039.0	0.0022122,0.0180896	344,2813	0.131	406.0				22.9	2.657469	0.312	6	10	16	SIFT,PolyPhen,LRT_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	OR4C5	0.02	0.05	0.0	0.0	-1.0	2.0	-1.0	-50.0							0.02	20.364662745	0.693	1.014	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946414	chr11	48387115	G	A	chr11:48387115	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.39	30_19	49	99	False	rs75003399,COSV60562753	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001348223.1:c.903C>T	NP_001335152.1:p.Thr301%3D		-1.0						.	.	.						32	0.96							0.459945	26571.0	57770.0	0.0	38	0.58	InbreedingCoeff_RF	nfe	0.470255	12300.0	0.470255	12300.0	0.0205139	3190	0.128	395.0				8.673	0.426033		0	0	0			OR4C5	0.0	0.07	0.0	0.0	-14.0	-6.0	33.0	-15.0							0.02	0.352488075			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946415	chr11	48387118	G	A	chr11:48387118	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.39	30_19	49	99	False	rs79339252,COSV60562759	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001348223.1:c.900C>T	NP_001335152.1:p.Tyr300%3D		-1.0						.	.	.		1.97169e-05	3.0	152154.0	0.0	32	0.96	PASS	sas	0.000620861	3.0	0.0	0.0	0.45243	25242.0	55792.0	0.0	39	0.58	InbreedingCoeff	nfe	0.463235	11718.0	0.463235	11718.0	0.0199480	3102	0.119	365.0				5.895	0.203647		0	0	0			OR4C5	0.07	0.0	0.0	0.0	-9.0	-40.0	30.0	-18.0							0.02	43.255407816			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946416	chr11	48387154	A	G	chr11:48387154	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.4	30_20	50	99	False	rs72473370,COSV60561688	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001348223.1:c.864T>C	NP_001335152.1:p.Tyr288%3D		-1.0						.	.	.		6.57099e-06	1.0	152184.0	0.0	32	0.96	PASS	afr	2.41266e-05	1.0	0.0	0.0	0.297823	11328.0	38036.0	0.0	51	0.58	InbreedingCoeff_RF	nfe	0.329128	5609.0	0.329128	5609.0	0.0136331,0.0006045	2120,94	0.038	114.0				2.673	0.003293		0	0	0			OR4C5	0.0	0.0	0.0	0.0	-45.0	-37.0	-6.0	16.0							0.02	63.467054300			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946417	chr11	48387164	G	A	chr11:48387164	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.4	30_20	50	99	False	rs72473371,COSV60561704	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.854C>T	NP_001335152.1:p.Ser285Phe		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		1.31473e-05	2.0	152122.0	0.0	32	0.95	PASS	afr	4.82905e-05	2.0	0.0	0.0	0.231171	8312.0	35956.0	0.0	53	0.58	InbreedingCoeff_RF	nfe	0.271085	4127.0	0.271085	4127.0	0.0217551	3383	0.038	115.0				22.6	2.506262	0.223	3	13	16	SIFT,PolyPhen,PROVEAN_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	-47.0	23.0	6.0	-16.0							0.02	63.467054300	0.772	1.046	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946418	chr11	48387201	G	A	chr11:48387201	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.38	29_18	47	99	False	rs77053100,COSV60562873	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	stop_gained		1/1	NM_001348223.1:c.817C>T	NP_001335152.1:p.Arg273Ter		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.95							0.092363	3442.0	37266.0	0.0	56	0.58	InbreedingCoeff_RF	nfe	0.114712	1653.0	0.114712	1653.0	0.0167648	2607	0.056	175.0				29.9	4.253908		5	2	7	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred	fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	43.0	-31.0	43.0	10.0							0.02	3.202982988	0.032	-0.374	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946419	chr11	48387206	T	C	chr11:48387206	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.41	29_20	49	99	False	rs76817095,COSV60561806	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.812A>G	NP_001335152.1:p.Tyr271Cys		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.95							0.0672009	2784.0	41428.0	0.0	56	0.58	InbreedingCoeff_RF	nfe	0.0879659	1383.0	0.0879659	1383.0	0.0170285	2648	0.043	136.0				23.4	2.945069	0.535	4	12	16	SIFT,PolyPhen,PROVEAN_pred,LIST-S2_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	33.0	4.0	5.0	3.0							0.02	35.932387400	0.097	1.014	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946420	chr11	48387210	C	T	chr11:48387210	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.43	27_20	47	99	False	rs78428763,COSV60562447	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.808G>A	NP_001335152.1:p.Val270Met		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.95							0.0455851	2190.0	48042.0	0.0	57	0.58	InbreedingCoeff_RF	nfe	0.0658843	1207.0	0.0658843	1207.0	0.0019356	301	0.039	121.0				9.832	0.546665	0.061	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	29.0	0.0	-1.0	1.0							0.02	35.932387400	0.2	0.902	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946421	chr11	48387211	C	G	chr11:48387211	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.43	27_20	47	99	False	rs79985800,COSV60562457	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.807G>C	NP_001335152.1:p.Leu269Phe		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.95							0.046799	2250.0	48078.0	0.0	56	0.58	InbreedingCoeff_RF	nfe	0.0661283	1212.0	0.0661283	1212.0	0.0019356	301	0.039	123.0				0.001	-1.489294	0.117	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	28.0	-1.0	33.0	0.0							0.02	35.932387400	0.209	-0.821	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946422	chr11	48387237	C	T	chr11:48387237	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.37	33_19	52	99	False	rs72898877,COSV60561510	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.781G>A	NP_001335152.1:p.Val261Ile		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		1.97288e-05	3.0	152062.0	0.0	32	0.95	PASS	afr	4.83232e-05	2.0	1.47037e-05	1.0	0.0152994	1188.0	77650.0	0.0	59	0.58	PASS	nfe	0.0209073	636.0	0.0209073	636.0	0.0064307,0.0000579	1000,9	0.034	105.0				0.025	-0.667655	0.102	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.02	0.0	0.0	2.0	42.0	7.0	-18.0							0.02	0.000000000	0.024	-2.678	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946423	chr11	48387254	A	G	chr11:48387254	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.39	36_23	59	99	False	rs75441735,COSV60561858	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.764T>C	NP_001335152.1:p.Phe255Ser		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		6.57047e-06	1.0	152196.0	0.0	32	0.96	PASS	afr	2.41266e-05	1.0	0.0	0.0	0.0247255	1635.0	66126.0	0.0	58	0.58	RF	amr	0.0290909	320.0	0.0254662	661.0	0.0021093	328	0.024	76.0				20.2	2.044271	0.182	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.03	0.0	0.0	-15.0	25.0	-2.0	-10.0							0.02	13.379174869	0.335	0.124	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946424	chr11	48387258	C	T	chr11:48387258	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.4	37_25	62	99	False	rs78030134,COSV60561864	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.760G>A	NP_001335152.1:p.Ala254Thr		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		8.54903e-05	13.0	152064.0	0.0	32	0.95	PASS	afr	0.000289743	12.0	0.0	0.0	0.0198011	1318.0	66562.0	0.0	58	0.58	PASS	nfe	0.0227009	588.0	0.0227009	588.0	0.0021800	339	0.025	80.0				11.52	0.745833	0.089	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.05	0.0	0.0	-19.0	21.0	1.0	-14.0							0.02	0.038757435	0.212	-0.373	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946425	chr11	48387262	G	A	chr11:48387262	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.4	35_23	58	99	False	rs75430864,COSV60561873	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001348223.1:c.756C>T	NP_001335152.1:p.Thr252%3D		-1.0						.	.	.		6.57099e-06	1.0	152184.0	0.0	32	0.95	PASS	afr	2.41289e-05	1.0	0.0	0.0	0.0195241	1234.0	63204.0	0.0	61	0.58	RF	nfe	0.0232568	573.0	0.0232568	573.0	0.0022893	356	0.022	71.0				10.43	0.61425		0	0	0			OR4C5	0.0	0.05	0.0	0.0	-23.0	17.0	-5.0	-18.0							0.02	2.723876242			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946426	chr11	48387279		ACT	chr11:48387278-48387279	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	insertion	0/1	0.22	36_11	50	99	False	rs139139147	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	protein_altering_variant		1/1	NM_001348223.1:c.739_740insAGT	NP_001335152.1:p.Arg247delinsGlnTrp		-1.0						.	.	.						32	0.96							0.000828555	50.0	60346.0	0.0	60	0.58	RF	nfe	0.00161455	38.0	0.00161455	38.0	0.0001801,0.0000064	28,1						24.0	3.18805		0	0	0																		0.02	0.000000000,0.000000000			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946427	chr11	48387280		TCCTT	chr11:48387279-48387280	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	insertion	0/1	0.22	38_11	49	99	False	rs779563500	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	frameshift_variant		1/1	NM_001348223.1:c.738_739insAAGGA	NP_001335152.1:p.Arg247LysfsTer15		-1.0						.	.	.						32	0.96							0.000769809	43.0	55858.0	0.0	62	0.58	RF	nfe	0.00137944	30.0	0.00137944	30.0	0.0003473	54						23.2	2.820014		0	0	0																		0.02	0.000000000,25.798421959			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946428	chr11	48387285		ATGTGAGTCTTTAGTA	chr11:48387284-48387285	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	insertion	0/1	0.32	33_17	53	99	False	rs1554949478	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	frameshift_variant		1/1	NM_001348223.1:c.733_734insTACTAAAGACTCACAT	NP_001335152.1:p.Ser245LeufsTer42		-1.0						.	.	.						32	0.96							0.000725058	45.0	62064.0	0.0	58	0.58	RF	nfe	0.00126743	30.0	0.00126743	30.0	0.0001672,0.0004952	26,77						28.0	4.033504		0	0	0																		0.02	25.798421959			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946429	chr11	48387301	G	A	chr11:48387301	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.44	35_27	62	99	False	rs76220342,COSV60563570	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001348223.1:c.717C>T	NP_001335152.1:p.Tyr239%3D		-1.0						.	.	.		0.0	0.0	152138.0	0.0	32	0.96	AC0				0.0	0.0	0.176306	8657.0	49102.0	0.0	66	0.58	InbreedingCoeff	sas	0.186391	1008.0	0.185614	3641.0	0.0122376	1903	0.062	180.0				0.398	-0.287478		0	0	0			OR4C5	0.05	0.01	0.0	0.0	-22.0	-1.0	35.0	4.0							0.02	51.702911364			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946430	chr11	48387335	C	A	chr11:48387335	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.39	37_24	61	99	False	rs73460769,COSV60561330	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.683G>T	NP_001335152.1:p.Cys228Phe		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.407666	31586.0	77480.0	0.0	66	0.58	InbreedingCoeff	sas	0.44469	6231.0	0.419326	14216.0	0.0287967	4478	0.109	338.0				24.2	3.254027	0.504	4	12	16	SIFT,PolyPhen,LRT_pred,PROVEAN_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.08	0.0	0.07	-35.0	11.0	13.0	1.0							0.02	36.733100802	0.93	0.9	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946431	chr11	48387370	A	G	chr11:48387370	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.46	38_33	71	99	False	rs73460772,COSV60563380	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001348223.1:c.648T>C	NP_001335152.1:p.Phe216%3D		-1.0						.	.	.						32	0.96							0.491747	48619.0	98870.0	1.0	72	0.58	InbreedingCoeff_RF	sas	0.495699	8643.0	0.490862	20413.0	0.0284366	4422	0.155	484.0				5.8	0.197281		0	0	0			OR4C5	0.0	0.02	0.04	0.0	4.0	-24.0	-34.0	8.0							0.02	30.573240090			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946432	chr11	48387424	G	T	chr11:48387424	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.45	36_30	66	99	False	rs61917478,COSV99082004	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.594C>A	NP_001335152.1:p.Phe198Leu		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		6.57108e-06	1.0	152182.0	0.0	32	0.96	PASS	nfe	1.47016e-05	1.0	1.47016e-05	1.0	0.494484	66697.0	134882.0	12.0	75	0.59	InbreedingCoeff	sas	0.499317	10241.0	0.497404	29503.0	0.0355232	5524	0.165	514.0				22.7	2.589643	0.394	4	12	16	SIFT,PolyPhen,LRT_pred,PROVEAN_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.01	0.0	0.0	-2.0	40.0	-4.0	-21.0							0.02	36.148767579	0.99	-0.198	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946433	chr11	48387490	G	A	chr11:48387490	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.51	28_29	57	99	False	rs77144540	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001348223.1:c.528C>T	NP_001335152.1:p.His176%3D		-1.0						.	.	.		6.57557e-06	1.0	152078.0	0.0	32	0.96	PASS	nfe	1.47007e-05	1.0	1.47007e-05	1.0	0.48656	53833.0	110640.0	2.0	63	0.59	InbreedingCoeff_RF	sas	0.493987	8872.0	0.483892	23792.0	0.0279350	4344	0.131	401.0				0.761	-0.191394		0	0	0			OR4C5	0.0	0.0	0.02	0.0	-15.0	-26.0	48.0	-49.0							0.02	78.836483692			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946434	chr11	48387506	A	G	chr11:48387506	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.52	28_30	58	99	False	rs72898882,COSV60561635	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.512T>C	NP_001335152.1:p.Val171Ala		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		6.58111e-06	1.0	151950.0	0.0	32	0.96	PASS	afr	2.41826e-05	1.0	0.0	0.0	0.463243	44967.0	97070.0	0.0	67	0.59	InbreedingCoeff_RF	sas	0.48102	7907.0	0.456577	19368.0	0.0145141	2257	0.103	304.0				0.148	-0.428514	0.102	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.05	32.0	-42.0	-40.0	32.0							0.02	78.836483692	0.001	-0.262	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946435	chr11	48387526	G	T	chr11:48387526	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.43	34_26	60	99	False	rs78378263,COSV60561341	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001348223.1:c.492C>A	NP_001335152.1:p.Leu164%3D		-1.0						.	.	.						32	0.96							0.431436	30166.0	69920.0	0.0	59	0.59	InbreedingCoeff_RF	sas	0.466814	4867.0	0.41588	12513.0	0.0039549	615	0.049	146.0				8.186	0.380613		0	0	0			OR4C5	0.0	0.0	0.0	0.0	15.0	-3.0	16.0	-18.0							0.02	26.174085249			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946436	chr11	48387535	T	C	chr11:48387535	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.79	12_45	57	99	False	rs72898883,COSV60561345	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001348223.1:c.483A>G	NP_001335152.1:p.Val161%3D		-1.0						.	.	.		0.00630697	959.0	152054.0	7.0	32	0.96	PASS	nfe	0.0094409	642.0	0.0094409	642.0	0.366809	22616.0	61656.0	5.0	60	0.59	InbreedingCoeff_RF	sas	0.422507	3364.0	0.349001	9430.0	0.0042636	663	0.047	143.0				5.802	0.19742		0	0	0			OR4C5	0.0	0.0	0.0	0.29	3.0	35.0	1.0	3.0							0.02	84.989365964			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946437	chr11	48387540	G	T	chr11:48387540	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.8	12_48	60	99	False	rs72898885,COSV60561354	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.478C>A	NP_001335152.1:p.Gln160Lys		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		0.00631164	960.0	152100.0	7.0	32	0.96	PASS	nfe	0.00942342	641.0	0.00942342	641.0	0.325496	20324.0	62440.0	5.0	59	0.59	InbreedingCoeff	sas	0.392438	3010.0	0.308049	8496.0	0.0042507	661	0.038	118.0				13.03	0.943585	0.193	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.06	-2.0	2.0	-32.0	2.0							0.02	84.989365964	0.002	0.072	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946438	chr11	48387580	G	T	chr11:48387580	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.74	15_42	57	99	False	rs78299098,COSV60564164	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001348223.1:c.438C>A	NP_001335152.1:p.Ala146%3D		-1.0						.	.	.		0.00629816	958.0	152108.0	7.0	32	0.96	PASS	nfe	0.0094384	642.0	0.0094384	642.0	0.12749	8691.0	68170.0	4.0	44	0.59	InbreedingCoeff_RF	sas	0.186271	1213.0	0.118922	3664.0	0.0001672	26	0.033	104.0				10.12	0.578399		0	0	0			OR4C5	0.0	0.0	0.0	0.01	-39.0	-10.0	-37.0	-42.0							0.02	51.460541952			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946439	chr11	48387582	C	T	chr11:48387582	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.74	15_42	57	99	False	rs75027745,COSV60562608	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.436G>A	NP_001335152.1:p.Ala146Thr		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		0.00629956	958.0	152074.0	7.0	32	0.96	PASS	nfe	0.00943896	642.0	0.00943896	642.0	0.112072	8151.0	72730.0	4.0	45	0.59	RF	sas	0.158157	1109.0	0.107077	3480.0	0.0551047	8569	0.032	101.0				25.1	3.539921	0.394	7	9	16	SIFT,PolyPhen,LRT_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.01	0.0	-41.0	-12.0	-40.0	-45.0							0.02	51.460541952	0.973	0.915	.	PTPMT1&PTPMT1&PTPMT1	Muscle_Skeletal&Testis&Thyroid	.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946440	chr11	48387584	A	T	chr11:48387584	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.73	15_41	56	99	False	rs75821991,COSV60561764	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.434T>A	NP_001335152.1:p.Val145Glu		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		0.00629501	958.0	152184.0	7.0	32	0.96	PASS	nfe	0.00943729	642.0	0.00943729	642.0	0.105389	7795.0	73964.0	4.0	46	0.59	RF	sas	0.145344	1052.0	0.100979	3322.0	0.0536321	8340	0.041	129.0				25.4	3.601031	0.462	9	7	16	SIFT,PolyPhen,LRT_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	OR4C5	0.0	0.0	0.01	0.0	-2.0	-14.0	-46.0	-42.0							0.02	51.460541952	0.964	1.165	.	PTPMT1&PTPMT1&PTPMT1	Muscle_Skeletal&Testis&Thyroid	.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946441	chr11	48387591	A	G	chr11:48387591	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.73	14_37	51	99	False	rs75297075	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.427T>C	NP_001335152.1:p.Cys143Arg		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		0.00629559	958.0	152170.0	7.0	32	0.96	PASS	nfe	0.0094359	642.0	0.0094359	642.0	0.08308	6231.0	75000.0	4.0	47	0.59	RF	sas	0.109883	825.0	0.0816345	2715.0	0.0562429	8746	0.049	153.0				13.98	1.084053	0.088	1	15	16	MutationTaster_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	-21.0	-50.0	-49.0	16.0							0.02	0.000000000	0.99	0.126	.	PTPMT1&PTPMT1&PTPMT1	Muscle_Skeletal&Testis&Thyroid	.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946442	chr11	48387604	C	T	chr11:48387604	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.38	31_19	50	99	False	rs72898886,COSV60562060	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001348223.1:c.414G>A	NP_001335152.1:p.Val138%3D		-1.0						.	.	.						32	0.96							0.070243	5451.0	77602.0	0.0	54	0.59	RF	amr	0.0972041	1189.0	0.0647146	2188.0	0.0505325	7858	0.055	168.0				3.269	0.040653		0	0	0			OR4C5	0.0	0.0	0.0	0.0	-34.0	-39.0	3.0	-38.0							0.02	83.628966254			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946443	chr11	48387630	C	T	chr11:48387630	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.39	34_22	56	99	False	rs73460777,COSV60562067	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.388G>A	NP_001335152.1:p.Gly130Arg		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.0647602	4373.0	67526.0	0.0	50	0.58	RF	amr	0.0821068	926.0	0.0608427	1730.0	0.0548024	8522	0.183	523.0				22.2	2.348103	0.356	3	13	16	SIFT,PolyPhen,PROVEAN_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	40.0	-9.0	-2.0	38.0							0.02	47.229035456	0.009	0.037	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946444	chr11	48387647	A	G	chr11:48387647	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.39	34_22	56	99	False	rs75615667,COSV60562138	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.371T>C	NP_001335152.1:p.Val124Ala		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		6.57168e-06	1.0	152168.0	0.0	32	0.96	PASS	afr	2.41289e-05	1.0	0.0	0.0	0.0790472	5210.0	65910.0	0.0	44	0.58	RF	amr	0.104397	1211.0	0.0718277	1954.0	0.0095174	1480	0.174	497.0				0.309	-0.324598	0.04	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	23.0	-26.0	-3.0	21.0							0.02	30.692257679	0.168	-0.251	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946445	chr11	48387668	C	G	chr11:48387668	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.47	25_22	47	99	False	rs10769651,COSV60561121	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.350G>C	NP_001335152.1:p.Gly117Ala		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.00722209	862.0	119356.0	0.0	31	0.57	PASS	afr	0.00921909	51.0	0.00770432	375.0	0.0125013	1944	0.024	75.0				14.89	1.242821	0.164	2	14	16	PolyPhen,PROVEAN_pred	SIFT,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	2.0	-47.0	4.0	0.0							0.02	0.000000000	0.911	0.9	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946446	chr11	48387679	A	G	chr11:48387679	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.51	25_26	51	99	False	rs76209049,COSV60561130	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001348223.1:c.339T>C	NP_001335152.1:p.Ile113%3D		-1.0						.	.	.						32	0.96							0.0592781	4181.0	70532.0	0.0	31	0.57	RF	amr	0.0670274	892.0	0.0654933	1827.0	0.0031125	484	0.095	289.0				8.829	0.441191		0	0	0			OR4C5	0.0	0.0	0.0	0.0	-11.0	-9.0	-11.0	-9.0							0.02	42.746701322			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946447	chr11	48387684	T		chr11:48387684	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	deletion	0|1	0.51	24_25	49	99	False	rs67755516	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	frameshift_variant		1/1	NM_001348223.1:c.334del	NP_001335152.1:p.Thr112LeufsTer8		-1.0						.	.	.						32	0.96							0.0510291	3828.0	75016.0	0.0	27	0.56	RF	amr	0.0582922	826.0	0.0575015	1704.0	0.0167648	2607	0.078	246.0				25.5	3.647944		0	0	0			OR4C5	0.0	0.0	0.0	0.0	-13.0	47.0	-13.0	-15.0							0.02	42.746701322			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946448	chr11	48387689	T	C	chr11:48387689	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.48	27_25	52	99	False	rs75371569,COSV60561136	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.329A>G	NP_001335152.1:p.Lys110Arg		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.052891	3959.0	74852.0	0.0	29	0.56	PASS	nfe	0.0616411	1821.0	0.0616411	1821.0	0.0019421	302	0.075	236.0				14.87	1.240679	0.065	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	-19.0	-2.0	-21.0	-2.0							0.02	42.746701322	0.72	0.104	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946449	chr11	48387705	C	T	chr11:48387705	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.31	35_16	51	99	False	rs34926479,COSV60561882	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.313G>A	NP_001335152.1:p.Asp105Asn		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.0519523	4271.0	82210.0	0.0	30	0.57	RF	amr	0.0598377	885.0	0.0529214	1797.0	0.0056140	873	0.099	303.0				23.9	3.145681	0.356	5	11	16	SIFT,PolyPhen,LRT_pred,PROVEAN_pred,LIST-S2_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.01	0.0	0.0	-35.0	41.0	19.0	-33.0							0.02	36.148767579	0.555	0.9	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946450	chr11	48387737	G	C	chr11:48387737	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.52	26_28	54	99	False	rs73460780,COSV60561366	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.281C>G	NP_001335152.1:p.Ser94Cys		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.0941042	6177.0	65640.0	1.0	31	0.57	RF	nfe	0.12795	3351.0	0.12795	3351.0	0.0110608	1720	0.219	652.0				8.545	0.413797	0.141	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.01	0.0	0.0	39.0	9.0	42.0	9.0							0.02	51.222903000	0.754	-0.434	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946451	chr11	48387757	A	C	chr11:48387757	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.53	27_31	58	99	False	rs74557904,COSV60561379	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.261T>G	NP_001335152.1:p.Phe87Leu		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.134129	8893.0	66302.0	3.0	32	0.57	RF	nfe	0.159691	4243.0	0.159691	4243.0	0.0108100	1681	0.226	685.0				9.726	0.53495	0.045	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.02	0.0	0.01	42.0	-11.0	1.0	22.0							0.02	56.923092287	0.936	-0.893	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946452	chr11	48387789	C	G	chr11:48387789	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.49	26_25	51	99	False	rs80222485,COSV60561403	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.229G>C	NP_001335152.1:p.Asp77His		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.0618987	3886.0	62780.0	15.0	37	0.57	RF	nfe	0.0978765	2406.0	0.0978765	2406.0	0.0113438	1764	0.193	563.0				22.0	2.302978	0.113	2	14	16	SIFT,PolyPhen	LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.01	0.0	0.04	0.01	-43.0	44.0	49.0	-10.0							0.02	36.733100802	0.026	0.043	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946453	chr11	48387825	T	G	chr11:48387825	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.42	29_21	50	99	False	rs75650204,COSV60561664	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.193A>C	NP_001335152.1:p.Ile65Leu		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.0768452	4931.0	64168.0	7.0	35	0.57	RF	sas	0.090705	687.0	0.0841664	2088.0	0.0286424	4454	0.054	164.0				8.277	0.38884	0.137	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.02	8.0	-44.0	-46.0	13.0							0.02	8.554739459	0.066	0.12	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946454	chr11	48387833	T	C	chr11:48387833	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.41	29_20	49	99	False	rs79515387,COSV60561670	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.185A>G	NP_001335152.1:p.Asp62Gly		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		1.31472e-05	2.0	152124.0	0.0	32	0.96	PASS	nfe	2.94048e-05	2.0	2.94048e-05	2.0	0.0599896	3934.0	65578.0	4.0	35	0.57	RF	sas	0.0738272	576.0	0.0651934	1652.0	0.0194850	3030	0.052	161.0				17.56	1.712195	0.114	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.69	0.0	0.0	49.0	5.0	-16.0							0.02	13.419646591	0.043	0.046	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946455	chr11	48387850	G	T	chr11:48387850	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.46	27_23	50	99	False	rs73460781,COSV60561678	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	stop_gained		1/1	NM_001348223.1:c.168C>A	NP_001335152.1:p.Tyr56Ter		-1.0						.	.	.						32	0.96							0.0423818	3067.0	72366.0	2.0	35	0.57	RF	sas	0.0507992	464.0	0.0428299	1212.0	0.0250926	3902	0.057	176.0				29.5	4.205181		5	2	7	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred	fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.04	-12.0	-17.0	39.0	-12.0							0.02	2.723876242	0.012	-0.25	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946456	chr11	48387890	T	C	chr11:48387890	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.39	33_22	56	99	False	rs74623688,COSV104409845,COSV60561747	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.128A>G	NP_001335152.1:p.Glu43Gly		-1.0						.	.	.						32	0.97							0.00179288	210.0	117130.0	0.0	29	0.57	PASS	nfe	0.00244268	114.0	0.00244268	114.0	0.0268803	4180	0.019	61.0				14.71	1.211365	0.095	1	15	16	PROVEAN_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	0.0	7.0	50.0	-1.0							0.02	8.044419756	0.006	0.101	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946457	chr11	48387894	C	T	chr11:48387894	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.4	32_22	55	99	False	rs75065468,COSV60561756	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.124G>A	NP_001335152.1:p.Ala42Thr		-1.0						.	.	.		1.97218e-05	3.0	152116.0	0.0	32	0.96	PASS	sas	0.000207469	1.0	1.47003e-05	1.0	0.00119824	144.0	120176.0	0.0	30	0.57	PASS	nfe	0.00152669	73.0	0.00152669	73.0	0.0269061	4184	0.02	63.0				12.75	0.904642	0.093	1	15	16	SIFT	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	-4.0	3.0	-5.0	-26.0							0.02	0.000000000	0.044	-0.318	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946458	chr11	48387900	G	A	chr11:48387900	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.43	32_25	58	99	False	rs74338058,COSV60561780	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	stop_gained		1/1	NM_001348223.1:c.118C>T	NP_001335152.1:p.Gln40Ter		-1.0						.	.	.						32	0.97							0.000744144	92.0	123632.0	0.0	29	0.57	PASS	nfe	0.000995328	49.0	0.000995328	49.0	0.0262566,0.0000193	4083,3	0.019	61.0				29.6	4.21695		4	3	7	MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,Aloft_pred	LRT_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	42.0	-3.0	44.0	-11.0							0.02	51.391404445	0.242	1.028	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946459	chr11	48387918	T		chr11:48387918	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	deletion	0|1	0.41	32_23	56	99	False	rs66829866,COSV60561429	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	frameshift_variant		1/1	NM_001348223.1:c.100del	NP_001335152.1:p.Ile34SerfsTer5		-1.0						.	.	.						32	0.97							0.000351755	45.0	127930.0	0.0	25	0.55	RF	nfe	0.000569454	29.0	0.000569454	29.0	0.0018842	293						24.0	3.173026		0	0	0			OR4C5	0.0	0.0	0.0	0.0	-20.0	-1.0	27.0	-28.0							0.02	8.545323011			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946460	chr11	48387919	G	A	chr11:48387919	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.4	32_22	55	99	False	rs114441034,COSV60561279	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001348223.1:c.99C>T	NP_001335152.1:p.Phe33%3D		-1.0						.	.	.						32	0.97							0.000392711	50.0	127320.0	0.0	26	0.55	RF	nfe	0.000611054	31.0	0.000611054	31.0	0.0091445	1422	0.007	23.0				10.52	0.624755		0	0	0			OR4C5	0.0	0.0	0.0	0.0	-22.0	23.0	25.0	-30.0							0.02	8.545323011			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946461	chr11	48387930	T	C	chr11:48387930	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0/1	0.43	31_24	56	99	False	rs75939575,COSV60561285	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.88A>G	NP_001335152.1:p.Ile30Val		-1.0						.	.	.						32	0.97							0.000347883	45.0	129354.0	0.0	29	0.57	RF	nfe	0.000700798	36.0	0.000700798	36.0	0.0108164	1682	0.007	21.0				0.226	-0.369522	0.045	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	49.0	-40.0	1.0	10.0							0.02	8.545323011	0.001	-0.393	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946462	chr11	48387946		CA	chr11:48387945-48387946	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	insertion	0|1	0.45	31_26	58	99	False	rs139770813,COSV60561316	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	frameshift_variant		1/1	NM_001348223.1:c.72_73insTG	NP_001335152.1:p.Glu25TrpfsTer4		-1.0						.	.	.						32	0.97							0.00064911	84.0	129408.0	0.0	24	0.54	RF	nfe	0.00101345	52.0	0.00101345	52.0	0.0125463	1951						15.59	1.376829		0	0	0																		0.02	0.000000000,13.379174869			.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946463	chr11	48387946	G	T	chr11:48387946	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.45	31_26	58	99	False	rs114053360,COSV60561146,COSV60563603	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.72C>A	NP_001335152.1:p.Phe24Leu		-1.0						.	.	.						32	0.97							0.000684113	87.0	127172.0	0.0	24	0.54	PASS	nfe	0.00104693	53.0	0.00104693	53.0	0.0019099	297	0.004	12.0				0.001	-1.468821	0.152	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.01	0.0	0.0	-2.0	33.0	33.0	-2.0							0.02	13.379174869	0.0	-0.949	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946464	chr11	48387960	T	C	chr11:48387960	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.4	37_25	63	99	False	rs79688019,COSV60561155	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.58A>G	NP_001335152.1:p.Thr20Ala		-1.0						.	.	.						32	0.97							0.00234275	290.0	123786.0	0.0	26	0.55	RF	afr	0.00318066	20.0	0.00288144	143.0	0.0127971	1990	0.025	77.0				0.001	-1.298008	0.077	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.0	19.0	-2.0	-16.0	3.0							0.02	46.742485309	0.0	-1.17	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946465	chr11	48387978	T	A	chr11:48387978	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.45	33_28	62	99	False	rs78160589,COSV60561709	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	stop_gained		1/1	NM_001348223.1:c.40A>T	NP_001335152.1:p.Lys14Ter		-1.0						.	.	.						32	0.97							0.0160824	1746.0	108566.0	0.0	24	0.54	RF	nfe	0.01581	697.0	0.01581	697.0	0.0087586	1362	0.048	148.0				22.5	2.469964		2	5	7	MutationTaster_pred,Aloft_pred	LRT_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.01	0.0	1.0	-40.0	38.0	-34.0							0.02	52.240542404	0.003	0.179	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946466	chr11	48387983	T	C	chr11:48387983	OR4C5	olfactory receptor family 4 subfamily C member 5 (gene/pseudogene)	19057.0	SNV	0|1	0.44	34_28	63	99	False	rs75819836,COSV60561825	EXONIC	YES	NM_001348223.1	Transcript	protein_coding	missense_variant		1/1	NM_001348223.1:c.35A>G	NP_001335152.1:p.His12Arg		-1.0						.	.	.						32	0.97							0.0209352	2234.0	106710.0	0.0	23	0.54	RF	nfe	0.0195003	843.0	0.0195003	843.0	0.0181732	2826	0.05	153.0				0.342	-0.309758	0.091	1	14	15	SIFT	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C5	0.0	0.0	0.0	0.01	-43.0	-4.0	-39.0	33.0							0.02	52.240542404	0.003	-0.324	.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
946588	chr17	20769862	T	A	chr17:20769862	CCDC144NL	coiled-coil domain containing 144 family, N-terminal like	19081.0	SNV	0|1	0.68	31_65	96	99	False	rs79433424,COSV60001282	SPLICING	YES	NR_164128.1	Transcript	transcribed_pseudogene	splice_region_variant,non_coding_transcript_exon_variant		3/4	NR_164128.1:n.713A>T			-1.0						.	.	.						32	0.96							0.0501401	5011.0	99940.0	0.0	44	0.6	PASS	nfe	0.0599007	2607.0	0.0599007	2607.0	0.0001994	31	0.119	350.0				6.245	0.227886		0	0	0			CCDC144NL	0.0	0.0	0.11	0.3	-17.0	-1.0	27.0	-1.0	0.0885380822532824	0.282	4.708	3.528	8.235	0.94	0.0				.			.	.	.	.	.	.
946920	chr22	32838673	G	A	chr22:32838673	BPIFC	BPI fold containing family C	19124.0	SNV	0/1	0.52	13_14	27	99	False	rs150631852	EXONIC	YES	NM_174932.2	Transcript	protein_coding	missense_variant		6/15	NM_174932.2:c.640C>T	NP_777592.1:p.Leu214Phe		-1.0	Lipid-binding serum glycoprotein, N-terminal,.,Lipid-binding serum glycoprotein, N-terminal					.	.	.		0.000650622	99.0	152162.0	0.0	32	0.96	PASS	amr	0.00157089	24.0	0.000867086	59.0	0.000405999	102.0	251232.0	0.0	52	0.97	PASS	amr	0.000665432	23.0	0.00064221	73.0	0.0003858	60	0.004	12.0				23.1	2.800815	0.148	6	14	20	SIFT,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	BPIFC	0.03	0.0	0.06	0.0	45.0	-15.0	-15.0	45.0							0.0	0.000000000	0.974	0.159	.			.	.	.	extracellular space	lipopolysaccharide binding;phospholipid binding	.
946923	chr22	32841944	G	A	chr22:32841944	BPIFC	BPI fold containing family C	19124.0	SNV	0/1	0.38	15_9	24	99	False	rs534216667	EXONIC	YES	NM_174932.2	Transcript	protein_coding	synonymous_variant		4/15	NM_174932.2:c.414C>T	NP_777592.1:p.Val138%3D		-1.0						.	.	.		0.000164366	25.0	152100.0	0.0	31	0.95	PASS	amr	0.00124378	19.0	7.35164e-05	5.0	0.000202806	51.0	251472.0	0.0	57	1.0	PASS	amr	0.00121429	42.0	5.27454e-05	6.0	0.0001222	19	0.002	6.0				6.903	0.276165		0	0	0			BPIFC	0.0	0.06	0.0	0.0	1.0	39.0	39.0	-10.0							0.0	54.110966668			.			.	.	.	extracellular space	lipopolysaccharide binding;phospholipid binding	.
947925	chr16	32265022	G	C	chr16:32265022	TP53TG3D	TP53 target 3D	19294.0	SNV	0/1	0.46	22_19	41	99	False	rs854250	EXONIC	YES	NM_001243722.2	Transcript	protein_coding	synonymous_variant		1/2	NM_001243722.2:c.348G>C	NP_001230651.1:p.Ala116%3D		1.0						.	.	.						18	0.32							0.366792	86466.0	235736.0	198.0	61	0.94	InbreedingCoeff	sas	0.455347	13532.0	0.357863	37426.0	0.0094467	1469	0.058	170.0				0.173	-0.407281		0	0	0			TP53TG3D	0.0	0.0	0.01	0.01	5.0	-36.0	14.0	-26.0							0.64				.			.	.	.	.	.	.
948518	chr8	94694894	A		chr8:94694894	LINC00535	long intergenic non-protein coding RNA 535	19413.0	deletion	0/1	0.18	28_7	40	94	False	rs55759953	SPLICING	YES	NR_033858.1	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	2/10		NR_033858.1:n.577-8del			-1.0						.	.	.		0.00105086	151.0	143692.0	0.0	0	0.04	PASS	nfe	0.00113389	75.0	0.00113389	75.0					0	0.0							0.0001896	5						0.21	-0.379863		0	0	0																						.			.	.	.	.	.	.
949689	chr17	73608009	C	T	chr17:73608009	MYO15B	myosin XVB	19616.0	SNV	0/1	0.5	17_17	34	99	False	rs577181241	EXONIC	YES	NM_001309242.1	Transcript	protein_coding	missense_variant		24/64	NM_001309242.1:c.4433C>T	NP_001296171.1:p.Pro1478Leu		1.0	.,.,.					.	.	.		0.000105164	16.0	152144.0	0.0	31	0.95	PASS	amr	0.00026202	4.0	5.8801e-05	4.0	0.000172335	24.0	139264.0	0.0	55	0.57	PASS	amr	0.000572129	14.0	5.35676e-05	3.0	0.0000193	3						16.55	1.549727		6	4	10	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,MetaRNN_pred,DEOGEN2_pred,fathmm-XF_coding_pred	MYO15B	0.01	0.0	0.0	0.0	-42.0	8.0	7.0	-9.0								0.000000000	0.935	1.006	.			.	.	biological_process	cellular_component;cytoplasm;myosin complex	molecular_function;motor activity;ATP binding	ZBTB8A[16189514];H1F0[30021884];SNW1[20467437];TRIM29[16189514];CDC5L[20467437];SSSCA1[16189514];NADSYN1[16189514];RAD54B[16189514];GFAP[16189514];
949691	chr17	73615288	A	G	chr17:73615288	MYO15B	myosin XVB	19616.0	SNV	0/1	0.54	12_14	26	99	False		EXONIC	YES	NM_001309242.1	Transcript	protein_coding	synonymous_variant		44/64	NM_001309242.1:c.6936A>G	NP_001296171.1:p.Lys2312%3D		1.0						.	.	.						32	0.97											57	0.58														15.96	1.444913		0	0	0			MYO15B	0.0	0.0	0.0	0.0	1.0	-20.0	10.0	-38.0											.			.	.	biological_process	cellular_component;cytoplasm;myosin complex	molecular_function;motor activity;ATP binding	ZBTB8A[16189514];H1F0[30021884];SNW1[20467437];TRIM29[16189514];CDC5L[20467437];SSSCA1[16189514];NADSYN1[16189514];RAD54B[16189514];GFAP[16189514];
952597	chr8	43152515	T	C	chr8:43152515	POTEA	POTE ankyrin domain family member A	19895.0	SNV	0/1	0.41	19_13	32	99	False	rs376393499	EXONIC	YES	NM_001005365.2	Transcript	protein_coding	synonymous_variant		3/14	NM_001005365.2:c.501T>C	NP_001005365.2:p.Thr167%3D		1.0						.	.	.		0.000762456	116.0	152140.0	1.0	33	0.97	PASS	afr	0.00258292	107.0	7.35121e-05	5.0	0.000211523	53.0	250564.0	0.0	55	0.97	PASS	afr	0.00282238	45.0	3.52696e-05	4.0	0.0002251	35	0.0	1.0				1.706	-0.070339		0	0	0																						.			.	.	.	.	.	TFRC[30021884];
953411	chr10	114069056	G	A	chr10:114069056	GUCY2GP	guanylate cyclase 2G, pseudogene	20007.0	SNV	0/1	0.38	15_9	24	99	False		SPLICING	YES	NR_028134.1	Transcript	transcribed_pseudogene	splice_region_variant,non_coding_transcript_exon_variant		18/19	NR_028134.1:n.2781C>T			-1.0						.	.	.						32	0.96											0	0.0														11.86	0.788289		0	0	0														2.504	0.335	2.84						homeostasis/metabolism phenotype; renal/urinary system phenotype; 			.	.	.	.	.	.
953643	chr14	22138328	G	A	chr14:22138328	OR4E1	olfactory receptor family 4 subfamily E member 1 (gene/pseudogene)	20069.0	SNV	1/1	1.0	0_35	35	99	False	rs7144135	EXONIC	YES	NM_001317107.2	Transcript	protein_coding	missense_variant		3/3	NM_001317107.2:c.821C>T	NP_001304036.1:p.Ala274Val		-1.0						.	.	.						0	0.0											0	0.0							0.7496399	19774						11.43	0.734681		0	0	0																						.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
953644	chr14	22138437	A	G	chr14:22138437	OR4E1	olfactory receptor family 4 subfamily E member 1 (gene/pseudogene)	20069.0	SNV	1/1	1.0	0_23	23	69	False	rs970025	EXONIC	YES	NM_001317107.2	Transcript	protein_coding	missense_variant		3/3	NM_001317107.2:c.712T>C	NP_001304036.1:p.Trp238Arg		-1.0						.	.	.						0	0.0											0	0.0							0.0000379,0.7468724	1,19701						13.59	1.024602		0	0	0																						.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
953645	chr14	22138554	G	T	chr14:22138554	OR4E1	olfactory receptor family 4 subfamily E member 1 (gene/pseudogene)	20069.0	SNV	0|1	0.38	16_10	26	99	False	rs10143044	EXONIC	YES	NM_001317107.2	Transcript	protein_coding	missense_variant		3/3	NM_001317107.2:c.595C>A	NP_001304036.1:p.Leu199Ile		-1.0						.	.	.						0	0.0											0	0.0							0.2798923	7383						10.91	0.671316		0	0	0																						.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
953646	chr14	22138562	GT		chr14:22138562-22138563	OR4E1	olfactory receptor family 4 subfamily E member 1 (gene/pseudogene)	20069.0	deletion	1|1	1.0	0_27	27	81	False		EXONIC	YES	NM_001317107.2	Transcript	protein_coding	splice_donor_5th_base_variant,frameshift_variant		3/3	NM_001317107.2:c.586_587del	NP_001304036.1:p.Thr196ProfsTer4		-1.0						.	.	.						0	0.0											0	0.0							0.0454545,0.0013648,0.5641065,0.0313519	1199,36,14880,827						11.7	0.767751		0	0	0																						.			.	.	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.
954224	chr7	55755617	C		chr7:55755617	FKBP9P1	FK506 binding protein 9 pseudogene 1	20145.0	deletion	0/1	0.48	14_13	27	99	False	rs774033655	SPLICING	YES	NR_027339.1	Transcript	transcribed_pseudogene	splice_region_variant,non_coding_transcript_exon_variant		2/4	NR_027339.1:n.480del			-1.0						.	.	.		2.63009e-05	4.0	152086.0	0.0	30	0.94	PASS	amr	6.54793e-05	1.0	4.41047e-05	3.0	3.97655e-05	10.0	251474.0	0.0	75	1.0	PASS	amr	0.000115634	4.0	2.63722e-05	3.0	0.0000129	2						14.63	1.195515		0	0	0																						.			.	.	.	.	calcium ion binding	SUOX[unassigned1304];
954936	chr1	17086086		C	chr1:17086085-17086086	MST1L	macrophage stimulating 1 like	20435.0	insertion	0/1	0.21	30_8	38	99	False	rs200532237	EXONIC	YES	NM_001271733.1	Transcript	protein_coding	frameshift_variant		7/15	NM_001271733.1:c.811dup	NP_001258662.1:p.Ala271GlyfsTer26		-1.0						.	.	.		0.00197893	65.0	32846.0	0.0	2	0.15	AS_VQSR	afr	0.00592593	40.0	0.000807289	14.0	0.271625	38008.0	139928.0	12974.0	16	0.48	RF	eas	0.472122	5487.0	0.22405	13836.0	0.0005723,0.0034726	89,540						5.989	0.210074		0	0	0																						.			.	.	proteolysis;regulation of macrophage chemotaxis;positive regulation of mammary gland epithelial cell proliferation	extracellular region	serine-type endopeptidase activity	HMGA1[30021884];
956384	chr12	40808284	A	G	chr12:40808284	MUC19	mucin 19, oligomeric	20801.0	SNV	0/1	0.53	14_16	30	99	False	rs539134754	EXONIC	YES	NM_173600.2	Transcript	protein_coding	missense_variant		7/172	NM_173600.2:c.577A>G	NP_775871.2:p.Arg193Gly		1.0						.	.	.		0.00107905	164.0	151986.0	0.0	32	0.96	PASS	nfe	0.00180962	123.0	0.00180962	123.0	0.000873809	111.0	127030.0	0.0	20	0.51	PASS	nfe	0.00155564	73.0	0.00155564	73.0	0.0002379	37	0.001	4.0				8.396	0.399773		0	0	0																						endocrine/exocrine gland phenotype; immune system phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane	.	.
956407	chr12	40897323	C	T	chr12:40897323	MUC19	mucin 19, oligomeric	20801.0	SNV	0|1	0.25	24_8	32	99	False	rs78364063	EXONIC	YES	NM_173600.2	Transcript	protein_coding	synonymous_variant		68/172	NM_173600.2:c.18939C>T	NP_775871.2:p.Gly6313%3D		1.0						.	.	.		0.00295527	365.0	123508.0	0.0	33	0.92	AS_VQSR	sas	0.00630252	24.0	0.00299379	159.0					0	0.0							0.0000379	1						0.412	-0.282697		0	0	0																						endocrine/exocrine gland phenotype; immune system phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane	.	.
956408	chr12	40897325	T	C	chr12:40897325	MUC19	mucin 19, oligomeric	20801.0	SNV	0|1	0.25	24_8	32	99	False	rs75590840	EXONIC	YES	NM_173600.2	Transcript	protein_coding	missense_variant		68/172	NM_173600.2:c.18941T>C	NP_775871.2:p.Phe6314Ser		1.0						.	.	.		0.00290228	359.0	123696.0	0.0	33	0.92	PASS	sas	0.00577125	22.0	0.00298715	159.0					0	0.0							0.0000379	1						0.664	-0.211674		0	0	0																						endocrine/exocrine gland phenotype; immune system phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane	.	.
956409	chr12	40897340	G	C	chr12:40897340	MUC19	mucin 19, oligomeric	20801.0	SNV	0|1	0.27	22_8	30	99	False	rs796618446	SPLICING	YES	NM_173600.2	Transcript	protein_coding	splice_region_variant,intron_variant	68/171		NM_173600.2:c.18949+7G>C			1.0						.	.	.		0.00240102	310.0	129112.0	0.0	33	0.91	AS_VQSR	sas	0.00397614	16.0	0.00226293	127.0					0	0.0							0.0000379	1						0.076	-0.52086		0	0	0																						endocrine/exocrine gland phenotype; immune system phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane	.	.
956419	chr12	40898196	T	A	chr12:40898196	MUC19	mucin 19, oligomeric	20801.0	SNV	0/1	0.22	23_7	32	99	False	rs796378990	SPLICING	YES	NM_173600.2	Transcript	protein_coding	missense_variant,splice_region_variant		70/172	NM_173600.2:c.19006T>A	NP_775871.2:p.Ser6336Thr		1.0						.	.	.		0.0	0.0	151958.0	0.0	33	0.96	AC0_AS_VQSR				0.0	0.0					0	0.0							0.0000379	1						0.967	-0.155641		0	0	0														10.725	0.335	11.06						endocrine/exocrine gland phenotype; immune system phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane	.	.
956444	chr12	40902855	T	A	chr12:40902855	MUC19	mucin 19, oligomeric	20801.0	SNV	0|1	0.18	23_5	28	99	False	rs796340531,COSV71966405	EXONIC	YES	NM_173600.2	Transcript	protein_coding	synonymous_variant		77/172	NM_173600.2:c.19404T>A	NP_775871.2:p.Pro6468%3D		1.0						.	.	.		5.92714e-05	9.0	151844.0	0.0	33	0.97	AS_VQSR	amr	0.000196928	3.0	0.0	0.0					0	0.0							0.0000379	1						0.043	-0.596544		0	0	0																						endocrine/exocrine gland phenotype; immune system phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane	.	.
956445	chr12	40902858	G	A	chr12:40902858	MUC19	mucin 19, oligomeric	20801.0	SNV	0|1	0.18	23_5	28	99	False	rs1305621476	EXONIC	YES	NM_173600.2	Transcript	protein_coding	synonymous_variant		77/172	NM_173600.2:c.19407G>A	NP_775871.2:p.Gly6469%3D		1.0						.	.	.		0.0	0.0	151838.0	0.0	33	0.97	AC0_AS_VQSR				0.0	0.0					0	0.0														0.862	-0.172758		0	0	0																						endocrine/exocrine gland phenotype; immune system phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane	.	.
956446	chr12	40902863	G	C	chr12:40902863	MUC19	mucin 19, oligomeric	20801.0	SNV	0|1	0.18	23_5	28	99	False	rs1348486958	EXONIC	YES	NM_173600.2	Transcript	protein_coding	missense_variant		77/172	NM_173600.2:c.19412G>C	NP_775871.2:p.Arg6471Thr		1.0						.	.	.		9.21829e-05	14.0	151872.0	0.0	33	0.97	AS_VQSR	afr	0.000265919	11.0	0.0	0.0					0	0.0														0.306	-0.326072		0	0	0																						endocrine/exocrine gland phenotype; immune system phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane	.	.
956447	chr12	40902864	A	C	chr12:40902864	MUC19	mucin 19, oligomeric	20801.0	SNV	0|1	0.19	22_5	27	99	False	rs1239171133	EXONIC	YES	NM_173600.2	Transcript	protein_coding	missense_variant		77/172	NM_173600.2:c.19413A>C	NP_775871.2:p.Arg6471Ser		1.0						.	.	.		0.0	0.0	151856.0	0.0	33	0.97	AC0_AS_VQSR				0.0	0.0					0	0.0														1.185	-0.12561		0	0	0																						endocrine/exocrine gland phenotype; immune system phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane	.	.
956448	chr12	40902878	G	A	chr12:40902878	MUC19	mucin 19, oligomeric	20801.0	SNV	0|1	0.16	27_5	32	99	False	rs796925819	EXONIC	YES	NM_173600.2	Transcript	protein_coding	missense_variant		77/172	NM_173600.2:c.19427G>A	NP_775871.2:p.Gly6476Asp		1.0						.	.	.		6.58016e-06	1.0	151972.0	0.0	33	0.97	AS_VQSR	nfe	1.47158e-05	1.0	1.47158e-05	1.0					0	0.0							0.0000379	1						0.203	-0.384439		0	0	0																						endocrine/exocrine gland phenotype; immune system phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane	.	.
956449	chr12	40902883	T	C	chr12:40902883	MUC19	mucin 19, oligomeric	20801.0	SNV	0|1	0.16	27_5	32	99	False	rs796068417	EXONIC	YES	NM_173600.2	Transcript	protein_coding	missense_variant		77/172	NM_173600.2:c.19432T>C	NP_775871.2:p.Tyr6478His		1.0						.	.	.		9.21125e-05	14.0	151988.0	0.0	33	0.97	AS_VQSR	afr	0.000265726	11.0	0.0	0.0					0	0.0							0.0000379	1						0.493	-0.256173		0	0	0																						endocrine/exocrine gland phenotype; immune system phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane	.	.
956450	chr12	40902896	G	C	chr12:40902896	MUC19	mucin 19, oligomeric	20801.0	SNV	0|1	0.15	29_5	34	99	False	rs796416456	SPLICING	YES	NM_173600.2	Transcript	protein_coding	splice_region_variant,intron_variant	77/171		NM_173600.2:c.19438+7G>C			1.0						.	.	.		0.0	0.0	151986.0	0.0	33	0.97	AC0_AS_VQSR				0.0	0.0					0	0.0							0.0000379	1						0.43	-0.276462		0	0	0																						endocrine/exocrine gland phenotype; immune system phenotype; digestive/alimentary phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane	.	.
959968	chr21	30660302	T	C	chr21:30660302	LINC00189	long intergenic non-protein coding RNA 189	21068.0	SNV	1/1	1.0	0_29	29	86	False	rs1153275	SPLICING	YES	NR_027072.2	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	1/1		NR_027072.2:n.768-3T>C			1.0						.	.	.						0	0.0											0	0.0							0.0000758,0.0001896,0.8709152,0.0001137,0.0001137,0.0000379	2,5,22973,3,3,1	0.078	246.0				0.559	-0.2376		0	0	0														10.221	-0.286	9.935						.			.	.	.	.	.	.
960567	chr3	129823144	T	C	chr3:129823144	FAM86HP	family with sequence similarity 86 member H, pseudogene	21122.0	SNV	0/1	0.71	10_25	35	99	False	rs201743913	SPLICING	YES	NR_024252.1	Transcript	transcribed_pseudogene	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	2/4		NR_024252.1:n.258-4A>G			-1.0						.	.	.		0.00557242	848.0	152178.0	3.0	33	0.97	PASS	nfe	0.00955489	650.0	0.00955489	650.0					0	0.0							0.0061415	162	0.005	15.0				0.229	-0.367544		0	0	0														8.925	-0.773	8.152						.			.	.	.	.	.	.
961501	chr2	6872400		A	chr2:6872399-6872400	LINC00487	long intergenic non-protein coding RNA 487	21299.0	insertion	1/1	1.0	0_33	33	99	False	rs70942669	SPLICING	YES	NR_038369.1	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	3/5		NR_038369.1:n.436-8dup			-1.0						.	.	.						32	0.97											0	0.0							0.0337402,0.0001516,0.0520510,0.8276973	890,4,1373,21833						1.159	-0.128857		0	0	0																						.			.	.	.	.	.	.
962754	chr21	14441490	C	A	chr21:14441490	ANKRD30BP2	ankyrin repeat domain 30B pseudogene 2	21455.0	SNV	0|1	0.32	28_13	41	99	False	rs7279531	SPLICING	YES	NR_026916.1	Transcript	transcribed_pseudogene	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	10/11		NR_026916.1:n.2888-6C>A			1.0						.	.	.						29	0.75											0	0.0							0.0006066	16						0.953	-0.15789		0	0	0														2.342	5.987	8.329						.			.	.	.	.	.	.
962945	chr7	102837635	C	T	chr7:102837635	DPY19L2P2	DPY19L2 pseudogene 2	21461.0	SNV	0/1	0.58	16_22	38	99	False	rs545622393	SPLICING	YES	NR_027768.1	Transcript	transcribed_pseudogene	splice_region_variant,non_coding_transcript_exon_variant		19/23	NR_027768.1:n.3560G>A			-1.0						.	.	.		0.000775632	118.0	152134.0	0.0	31	0.96	PASS	sas	0.00269374	13.0	0.000749691	51.0					0	0.0							0.0004170	11	0.0	1.0				0.693	-0.205389		0	0	0														11.083	-0.914	10.169						.			.	.	spermatid development;protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan	nuclear inner membrane;integral component of membrane	mannosyltransferase activity	.
965044	chr21	11098686	TCCAGCCGCCA		chr21:11098686-11098696	BAGE2	BAGE family member 2	21772.0	deletion	0|1	0.14	82_16	114	99	False	rs772357297	SPLICING	YES	NR_169269.1	Transcript	lncRNA	splice_region_variant,intron_variant,non_coding_transcript_variant	1/12		NR_169269.1:n.258+7_258+17del			-1.0						.	.	.						12	0.25							0.000901369	170.0	188602.0	0.0	100	1.0	RF	sas	0.00131671	30.0	0.000973181	77.0	0.0010225	159						1.968	-0.04774		0	0	0																						.			.	.	.	extracellular region	.	.
965944	chr22	24051972	T	C	chr22:24051972	GUSBP11	glucuronidase, beta pseudogene 11	21924.0	SNV	1/1	1.0	0_25	25	75	False	rs933132	SPLICING	YES	NR_024448.2	Transcript	transcribed_pseudogene	splice_donor_variant,non_coding_transcript_variant	4/11		NR_024448.2:n.817+1A>G			-1.0						.	.	.						0	0.0											0	0.0							0.8785351,0.0004928	23174,13						10.51	0.62393		0	0	0														10.072	-8.182	1.89						.			.	.	glucuronoside catabolic process	extracellular space	beta-glucuronidase activity;signaling receptor binding;carbohydrate binding	.
969931	chr9	67281836	T	G	chr9:67281836	AQP7P1	aquaporin 7 pseudogene 1	22582.0	SNV	0|1	0.21	95_25	120	99	False	rs75812522	SPLICING	YES	NR_002817.2	Transcript	transcribed_pseudogene	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	2/3		NR_002817.2:n.361-5A>C			-1.0						.	.	.						59	1.0											0	0.0							0.0049663	131	0.002	5.0				6.15	0.221211		0	0	0														4.173	-0.951	3.222						.			.	.	.	.	.	.
974986	chr1	17200217	G	A	chr1:17200217	LOC112267871			SNV	0/1	0.23	64_19	83	99	False	rs2779466	SPLICING	YES	NR_160658.1	Transcript	lncRNA	splice_acceptor_variant,non_coding_transcript_variant	1/1		NR_160658.1:n.919-1G>A			1.0										0.00071977	102.0	141712.0	0.0	42	0.97	AS_VQSR	sas	0.00308203	13.0	0.00060448	38.0					0	0.0							0.0032224	85						16.48	1.537127		0	0	0														-2.207	8.75	6.543														
984691	chr1	93805239	A		chr1:93805239	CCDC18-AS1	CCDC18 antisense RNA 1		deletion	0/1	0.31	10_5	16	38	False	rs76098631	SPLICING	YES	NR_034089.1	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	2/8		NR_034089.1:n.142-3del			-1.0						.	.	.		0.00561177	630.0	112264.0	1.0	32	0.89	AS_VQSR	nfe	0.00563889	300.0	0.00563889	300.0					0	0.0							0.0008340,0.0008719	22,23						0.528	-0.245997		0	0	0																						.			.	.	.	.	.	.
990295	chr1	142699216	TAC		chr1:142699216-142699218	ANKRD20A12P	ankyrin repeat domain 20 family member A12, pseudogene		deletion	0|1	0.22	35_10	45	99	False	rs1569787348	SPLICING	YES	NR_046228.1	Transcript	transcribed_pseudogene	splice_donor_variant,splice_donor_region_variant,intron_variant,non_coding_transcript_variant	4/4		NR_046228.1:n.1291+1_1291+3del			-1.0						.	.	.						0	0.0											0	0.0														21.2	2.172054		0	0	0																						.			.	.	.	.	.	UBE2E3[19549727];HNRNPD[30021884];
992278	chr1	143767513	A	T	chr1:143767513	PPIAL4H	peptidylprolyl isomerase A like 4H		SNV	0|1	0.13	47_7	54	99	False	rs1553321469,COSV70086725	EXONIC	YES	NM_001368128.1	Transcript	protein_coding	missense_variant		1/1	NM_001368128.1:c.336T>A	NP_001355057.1:p.Phe112Leu		-1.0						.	.	.						0	0.0							0.471143	86418.0	183422.0	0.0	64	0.99	InbreedingCoeff_RF	eas	0.474587	6499.0	0.473518	39588.0	0.0046237	719	0.099	304.0				23.6	3.026866		2	0	2	SIFT,PolyPhen		PPIAL4G	0.0	0.01	0.0	0.0	31.0	2.0	4.0	11.0											.			.	.	.	.	.	.
992279	chr1	143767643	T	C	chr1:143767643	PPIAL4H	peptidylprolyl isomerase A like 4H		SNV	0/1	0.37	27_16	43	99	False	rs1553321535,COSV70086733	EXONIC	YES	NM_001368128.1	Transcript	protein_coding	missense_variant		1/1	NM_001368128.1:c.206A>G	NP_001355057.1:p.His69Arg		-1.0						.	.	.						0	0.0							0.241304	33675.0	139554.0	0.0	100	0.99	InbreedingCoeff_RF	eas	0.328465	4251.0	0.2079	13958.0	0.0169963	2643	0.034	103.0				1.462	-0.094101		0	2	2		SIFT,PolyPhen	PPIAL4G	0.0	0.0	0.0	0.0	30.0	-15.0	-14.0	30.0											.			.	.	.	.	.	.
995774	chr1	145273302	A	G	chr1:145273302	NOTCH2NL			SNV	0/1	0.28	88_34	122	99	False	rs10910778,COSV61245492	EXONIC	YES	NM_001364006.1	Transcript	protein_coding	synonymous_variant		3/5	NM_001364006.1:c.195A>G	NP_001350935.1:p.Arg65%3D		1.0														11	0.16							0.31686	35764.0	112870.0	0.0	100	1.0	InbreedingCoeff	eas	0.385725	3156.0	0.342253	16871.0	0.0039099	608	0.057	166.0				12.43	0.861974		0	0	0			NOTCH2NL	0.0	0.0	0.01	0.0	-1.0	11.0	-47.0	11.0						0.595	0.0												
995779	chr1	145273345	T	C	chr1:145273345	NOTCH2NL			SNV	0/1	0.29	100_40	140	99	False	rs10910779,COSV61245674	EXONIC	YES	NM_001364006.1	Transcript	protein_coding	missense_variant		3/5	NM_001364006.1:c.238T>C	NP_001350935.1:p.Ser80Pro		1.0														11	0.17							0.355107	40267.0	113394.0	0.0	100	1.0	InbreedingCoeff	eas	0.419084	3698.0	0.382087	18856.0	0.0024565	382	0.079	234.0				18.43	1.830846	0.062	1	9	10	fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	NOTCH2NL	0.0	0.0	0.0	0.0	-23.0	-32.0	-11.0	-32.0						0.595	0.0		0.966	0.082									
995915	chr1	145281408	C	T	chr1:145281408	NOTCH2NL			SNV	0/1	0.2	104_26	130	99	False	rs3927729,COSV61246008	EXONIC	YES	NM_001364006.1	Transcript	protein_coding	missense_variant		4/5	NM_001364006.1:c.377C>T	NP_001350935.1:p.Pro126Leu		1.0														12	0.25							0.37818	50869.0	134510.0	0.0	100	1.0	InbreedingCoeff	eas	0.431957	4666.0	0.4036	24124.0	0.0020964	326	0.112	345.0				25.7	3.684163	0.734	7	3	10	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	MetaRNN_pred,PrimateAI_pred,ClinPred_pred	NOTCH2NL	0.0	0.0	0.0	0.0	-34.0	41.0	14.0	0.0						0.595	0.0		1.0	0.915									
995928	chr1	145281543	C	T	chr1:145281543	NOTCH2NL			SNV	0/1	0.21	96_26	122	99	False	rs8002,COSV61245135	EXONIC	YES	NM_001364006.1	Transcript	protein_coding	missense_variant		4/5	NM_001364006.1:c.512C>T	NP_001350935.1:p.Thr171Ile		1.0	EGF-like calcium-binding domain&EGF-like calcium-binding, conserved site&EGF-like domain&EGF-like calcium-binding domain&EGF-like domain,EGF-like calcium-binding domain&EGF-like calcium-binding, conserved site&EGF-like domain&EGF-like calcium-binding domain&EGF-like domain								19054571	0.000592488	69.0	116458.0	25.0	9	0.15	PASS,AS_VQSR	afr,amr	0.00348168	69.0	0.0	0.0	0.481132	94477.0	196364.0	0.0	100	1.0	InbreedingCoeff	eas	0.494407	7867.0	0.481279	42470.0	0.0051831	806	0.097	282.0				23.8	3.094471	0.412	1	9	10	MetaLR_pred	MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	NOTCH2NL	0.0	0.0	0.0	0.0	-21.0	29.0	-7.0	-36.0						0.595	0.0		1.0	0.92									
995935	chr1	145281613	C	A	chr1:145281613	NOTCH2NL			SNV	0|1	0.27	98_36	134	99	False	rs12120756,COSV61246020	EXONIC	YES	NM_001364006.1	Transcript	protein_coding	missense_variant		4/5	NM_001364006.1:c.582C>A	NP_001350935.1:p.Ser194Arg		1.0														9	0.13							0.38274	51079.0	133456.0	0.0	100	1.0	InbreedingCoeff	eas	0.436825	4529.0	0.40667	23961.0	0.0034469	536	0.128	382.0				17.76	1.740253	0.112	0	10	10		MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred	NOTCH2NL	0.0	0.0	0.0	0.0	-16.0	41.0	2.0	-18.0						0.595	0.0		0.173	0.056									
995941	chr1	145281633	C	A	chr1:145281633	NOTCH2NL			SNV	0|1	0.25	104_35	139	99	False	rs28576333,COSV61245083	EXONIC	YES	NM_001364006.1	Transcript	protein_coding	missense_variant		4/5	NM_001364006.1:c.602C>A	NP_001350935.1:p.Pro201His		1.0										0.0	0.0	5644.0	0.0	8	0.12	AC0_AS_VQSR				0.0	0.0	0.365157	43637.0	119502.0	0.0	100	1.0	InbreedingCoeff	sas	0.413522	6532.0	0.389785	20109.0	0.0019935	310	0.123	366.0				24.4	3.323894	0.695	3	7	10	MutationTaster_pred,PrimateAI_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	NOTCH2NL	0.0	0.0	0.0	0.0	0.0	21.0	-7.0	-18.0						0.595	0.0		1.0	0.915									
1004202	chr1	158045965	G	A	chr1:158045965	KIRREL			SNV	0/1	0.46	13_11	24	99	False	rs191487619,COSV100779832	EXONIC	YES	NM_018240.7	Transcript	protein_coding	missense_variant		2/15	NM_018240.7:c.115G>A	NP_060710.3:p.Val39Met		1.0	Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype 2&Immunoglobulin subtype	Benign	criteria_provided,_single_submitter	not_specified						0.00531775	809.0	152132.0	6.0	33	0.97	PASS	nfe	0.00842399	573.0	0.00842399	573.0	0.00431553	1084.0	251186.0	5.0	66	1.0	PASS	nfe	0.0066743	758.0	0.0066743	758.0	0.0046301	720	0.005	16.0				24.5	3.343457	0.037	10	10	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HVAR_pred,LRT_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	KIRREL	0.0	0.0	0.0	0.0	-32.0	-6.0	9.0	-22.0						0.108	0.96	0.0	0.99	0.224									
1016313	chr10	5781601	A	G	chr10:5781601	FAM208B	family with sequence similarity 208 member B		SNV	0/1	0.56	17_22	39	99	False	rs777426366	EXONIC	YES	NM_001387328.1	Transcript	protein_coding	missense_variant		16/24	NM_001387328.1:c.2113A>G	NP_001374257.1:p.Lys705Glu		1.0	.,.					.	.	.		1.31432e-05	2.0	152170.0	0.0	32	0.95	PASS	amr	6.54193e-05	1.0	1.46998e-05	1.0	1.20503e-05	3.0	248956.0	0.0	49	0.97	PASS	nfe	2.65515e-05	3.0	2.65515e-05	3.0	0.0000193	3						16.3	1.505772	0.073	3	16	19	SIFT,M-CAP_pred,FATHMM_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FAM208B	0.0	0.0	0.0	0.0	-20.0	-14.0	24.0	-20.0							0.97	0.0	0.404	-0.189	.			pons;testis - interstitial;atrioventricular node;skin;trigeminal ganglion;superior cervical ganglion;testis;skeletal muscle;	.	.	nucleus;nucleoplasm;cytosol	protein binding	GPSM1[unassigned1304];TSEN15[unassigned1304];FAM208B[16189514;25416956];HSF2BP[unassigned1304];MEOX2[unassigned1304];HIST1H1B[30021884];TRIM23[25416956];LMO1[25416956];PPP1R16B[25416956];RFC5[unassigned1304];PRKAB2[25416956];LDOC1[16189514;25416956];ARMC7[unassigned1304];SCAMP1[25416956];KLHL40[unassigned1304];MID2[unassigned1304];KCTD9[25416956;unassigned1304];PACRGL[unassigned1304];PRKAR1B[unassigned1304];HGS[26871637];POLR1C[25416956];PIH1D2[unassigned1304];ERH[21516116;25416956;unassigned1304];KIFC3[unassigned1304];MDFI[unassigned1304];BHLHB9[unassigned1304];USHBP1[unassigned1304];FBF1[25416956];PIK3R3[unassigned1304];CFAP206[unassigned1304];COX5B[21516116;unassigned1304];HSPD1[30021884];SERTAD3[unassigned1304];PNMA1[unassigned1304];CCDC85B[16189514];C1orf109[unassigned1304];CTNNA3[unassigned1304];TRIM42[25416956];LONRF1[unassigned1304];ATRIP[25416956];PIBF1[unassigned1304];NEK6[25416956;unassigned1304];STAT3[25814554];CARD9[25416956;unassigned1304];ZNF76[unassigned1304];MLH1[unassigned1304;25910212];GOLGB1[30021884];MORN3[25416956];MKRN3[unassigned1304];MPHOSPH8[26496610];
1016989	chr10	8956452	C	A	chr10:8956452	LOC105755953			SNV	0/1	0.47	18_16	34	99	False	rs182841271	SPLICING	YES	NR_131944.1	Transcript	lncRNA	splice_region_variant,non_coding_transcript_exon_variant		4/4	NR_131944.1:n.259C>A			1.0										0.00276029	420.0	152158.0	1.0	32	0.97	PASS	sas	0.0076668	37.0	0.00417451	284.0					0	0.0							0.0035636	94						4.54	0.116842		0	0	0														10.072	0.156	10.229														
1021548	chr10	38466830	TT		chr10:38466830-38466831	LOC100129055			deletion	0|1	0.16	38_7	45	99	False	rs1408476115	SPLICING	YES	NR_024524.1	Transcript	transcribed_pseudogene	splice_region_variant,non_coding_transcript_exon_variant		2/7	NR_024524.1:n.293_294del			1.0														32	0.96											0	0.0														6.274	0.229923		0	0	0																														
1042256	chr11	22489386	A	T	chr11:22489386	LINC01495	long intergenic non-protein coding RNA 1495		SNV	0/1	0.56	14_18	32	99	False		SPLICING	YES	NR_120583.1	Transcript	lncRNA	splice_region_variant,intron_variant,non_coding_transcript_variant	3/3		NR_120583.1:n.341+7T>A			-1.0						.	.	.						32	0.96											0	0.0														5.919	0.205323		0	0	0																						.			.	.	.	.	.	.
1048925	chr11	62434295	A	G	chr11:62434295	METTL12			SNV	0/1	0.55	9_11	20	99	False	rs1412316710	EXONIC	YES	NM_001043229.2	Transcript	protein_coding	synonymous_variant		3/3	NM_001043229.2:c.495A>G	NP_001036694.1:p.Thr165%3D		1.0														32	0.97											87	1.0														8.257	0.387099		0	0	0			METTL12	0.0	0.0	0.01	0.0	-5.0	-31.0	-5.0	22.0						0.765	0.01	46.121634545											
1064730	chr12	25185245	C	T	chr12:25185245	LOC645177			SNV	0/1	0.34	21_11	32	99	False	rs753339642	EXONIC	YES	NM_001321724.3	Transcript	protein_coding	stop_gained		13/18	NM_001321724.3:c.1558C>T	NP_001308653.2:p.Arg520Ter		1.0	KASH5-like coiled-coil domain									5.26108e-05	8.0	152060.0	0.0	33	0.97	PASS	afr	7.24463e-05	3.0	5.88218e-05	4.0					0	0.0							0.0000379	1						15.11	1.28504		1	0	1	fathmm-MKL_coding_pred																			0.936	-0.244									
1065206	chr12	25261760		AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA	chr12:25261759-25261760	CASC1	cancer susceptibility 1		insertion	1/1	1.0	0_10	10	29	False		SPLICING	YES	NM_018272.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	15/15		NM_018272.5:c.1894-3_1894-2insTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT			-1.0						.	.	.		0.000681734	33.0	48406.0	9.0	4	0.18	AS_VQSR	amr	0.00259451	7.0	0.000732839	18.0					14	0.26																	0	0	0																	0.96	0.0				homeostasis/metabolism phenotype; neoplasm; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;skin;superior cervical ganglion;testis;	.	.	.	.	HADHA[30021884];ABI2[unassigned1304];NME7[unassigned1304];PPP1CA[19389623];
1075822	chr12	103762691	C	T	chr12:103762691	C12orf42	chromosome 12 open reading frame 42		SNV	0/1	0.37	17_10	27	99	False	rs186161266,COSV59388705	EXONIC	YES	NM_001099336.3	Transcript	protein_coding	missense_variant		4/6	NM_001099336.3:c.233G>A	NP_001092806.1:p.Arg78His		-1.0	.,.,.,.					.	.	.		9.21768e-05	14.0	151882.0	0.0	32	0.96	PASS	amr	0.000263123	4.0	8.82716e-05	6.0	5.38054e-05	12.0	223026.0	0.0	22	0.55	PASS	amr	0.000157272	5.0	4.044e-05	4.0	0.0000450	7	0.0	1.0				11.14	0.699341	0.048	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	C12orf42	0.23	0.0	0.0	0.22	-27.0	-37.0	-2.0	-26.0						0.826	0.0	91.13571454	0.0	-0.864	.			.	.	.	.	.	.
1079541	chr13	19312548	A	G	chr13:19312548	LINC00417			SNV	0|1	0.17	26_6	35	99	False	rs77959098	SPLICING	YES	NR_047508.1	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	2/2		NR_047508.1:n.239-5T>C			-1.0														33	0.96											0	0.0							0.0022746	60						3.489	0.053904		0	0	0														4.896	0.065	4.961														
1080445	chr13	19895677	C	C	chr13:19895677	ANKRD26P3	ankyrin repeat domain 26 pseudogene 3		SNV	1/1	1.0	0_24	24	72	False	rs1330732	SPLICING	YES	NR_027248.3	Transcript	transcribed_pseudogene	splice_region_variant,non_coding_transcript_exon_variant		7/21	NR_027248.3:n.906A>G			-1.0						.	.	.						0	0.0											0	0.0							0.0001516,0.8309955,0.0007203,0.0001137,0.0095913	4,21920,19,3,253	0.011	34.0				0.137	-0.439587		0	0	0														2.312	0.327	2.639						.			.	.	.	.	.	.
1082733	chr13	31002261	C	G	chr13:31002261	UBE2L5P			SNV	0/1	0.48	12_11	23	99	False	rs1001423614	EXONIC	YES	NM_001355247.2	Transcript	protein_coding	missense_variant		4/4	NM_001355247.2:c.134C>G	NP_001342176.1:p.Pro45Arg		1.0	Ubiquitin-conjugating enzyme E2&Ubiquitin-conjugating enzyme E2&Ubiquitin-conjugating enzyme E2,Ubiquitin-conjugating enzyme E2&Ubiquitin-conjugating enzyme E2&Ubiquitin-conjugating enzyme E2,Ubiquitin-conjugating enzyme E2&Ubiquitin-conjugating enzyme E2&Ubiquitin-conjugating enzyme E2									3.94457e-05	6.0	152108.0	0.0	32	0.96	PASS				0.0	0.0					0	0.0														13.69	1.039719		4	1	5	SIFT,PolyPhen,LIST-S2_pred,fathmm-MKL_coding_pred	MetaRNN_pred																		0.856	0.505									
1093345	chr14	19606528	G	A	chr14:19606528	LINC01297	long intergenic non-protein coding RNA 1297		SNV	0|1	0.21	54_14	68	99	False	rs201513902	SPLICING	YES	NR_164166.1	Transcript	lncRNA	splice_region_variant,non_coding_transcript_exon_variant		1/4	NR_164166.1:n.3111G>A			1.0						.	.	.		0.00104382	88.0	84306.0	0.0	14	0.35	AS_VQSR,AS_VQSR	sas,afr	0.00341686	9.0	0.000336846	14.0					0	0.0							0.0050042	132						0.777	-0.188265		0	0	0														9.664	0.574	10.239						.			.	.	.	.	.	.
1093348	chr14	19606528	G	A	chr14:19606528	LINC01297-DUXAP10-NBEAP6			SNV	0|1	0.21	54_14	68	99	False	rs201513902	SPLICING	YES	NR_164310.1	Transcript	lncRNA	splice_region_variant,non_coding_transcript_exon_variant		1/10	NR_164310.1:n.3111G>A			1.0										0.00104382	88.0	84306.0	0.0	14	0.35	AS_VQSR,AS_VQSR	sas,afr	0.00341686	9.0	0.000336846	14.0					0	0.0							0.0050042	132						0.777	-0.188265		0	0	0														9.664	0.574	10.239														
1121059	chr15	23572430	C	T	chr15:23572430	LOC102723623			SNV	0/1	0.8	3_12	15	54	False	rs201800986	EXONIC	YES	NM_001382446.1	Transcript	protein_coding	synonymous_variant		9/10	NM_001382446.1:c.1542G>A	NP_001369375.1:p.Glu514%3D		-1.0										2.47133e-05	2.0	80928.0	0.0	10	0.16	PASS	amr	0.000131268	1.0	0.0	0.0					0	0.0							0.0196376	518	0.036	110.0				6.257	0.228757		0	0	0																														
1121060	chr15	23572552	T	C	chr15:23572552	LOC102723623			SNV	0/1	0.33	8_4	12	69	False	rs201563760	EXONIC	YES	NM_001382446.1	Transcript	protein_coding	missense_variant		9/10	NM_001382446.1:c.1420A>G	NP_001369375.1:p.Met474Val		-1.0														0	0.0											0	0.0							0.0142543	376						6.029	0.212814		0	0	0																														
1121797	chr15	25481607	G	A	chr15:25481607	SNHG14	small nucleolar RNA host gene 14		SNV	0/1	0.52	15_16	31	99	False	rs575146032	SPLICING	YES	NR_146177.1	Transcript	lncRNA	splice_region_variant,intron_variant,non_coding_transcript_variant	123/147		NR_146177.1:n.16111+7G>A			1.0						.	.	.		0.00084748	129.0	152216.0	0.0	33	0.97	PASS	nfe	0.00157251	107.0	0.00157251	107.0					0	0.0							0.0012510	33						5.794	0.196854		0	0	0																						.			.	.	.	.	.	.
1123468	chr15	37161041	T	C	chr15:37161041	LOC145845			SNV	1/1	1.0	0_28	28	84	False	rs11073210	SPLICING	YES	NR_024264.1	Transcript	lncRNA	splice_acceptor_variant,non_coding_transcript_variant	5/6		NR_024264.1:n.688-1A>G			-1.0														0	0.0											0	0.0							0.8794450	23198						1.847	-0.057876		0	0	0														5.521	-8.75	-3.229														
1127936	chr15	83808032	A		chr15:83808032	HDGFRP3			deletion	0/1	0.27	22_8	30	89	False	rs746488383	SPLICING	YES	NM_016073.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/5		NM_016073.4:c.607-5del			-1.0										0.00368154	491.0	133368.0	0.0	32	0.89	PASS	nfe	0.00377297	232.0	0.00377297	232.0	0.295699	25326.0	85648.0	0.0	13	0.44	InbreedingCoeff	sas	0.334959	3091.0	0.298373	13277.0	0.0000257,0.0005273	4,82						12.31	0.845954		0	0	0			RP11-382A20.3	0.03	0.0	0.0	0.0	-4.0	28.0	-4.0	13.0						0.205	0.94												
1130933	chr16	1940131	C	T	chr16:1940131	LINC02124	long intergenic non-protein coding RNA 2124		SNV	0/1	0.41	19_13	32	99	False	rs148335843	SPLICING	YES	NR_146568.1	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	1/1		NR_146568.1:n.183-3C>T			1.0						.	.	.		0.00373512	568.0	152070.0	4.0	31	0.95	PASS	afr	0.00905447	375.0	0.000985149	67.0					0	0.0							0.0024642	65						0.09	-0.497804		0	0	0														8.983	0.401	9.384						.			.	.	.	.	.	.
1133977	chr16	21601499	AAA		chr16:21601499-21601501	LOC101927814			sequence_alteration	1/2	0.29	2_5_10	17	76	False	rs11306339	SPLICING	YES	NR_110930.1	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	2/2		NR_110930.1:n.857-6_857-4del			-1.0										6.91807e-05	9.0	130094.0	0.0	11	0.31	PASS	eas	0.000218055	1.0	4.91465e-05	3.0					0	0.0							0.0001896,0.0001137	5,3						0.614	-0.223408		0	0	0																														
1135815	chr16	32164313	C	A	chr16:32164313	LOC102723753			SNV	0|1	0.27	30_11	41	99	False	rs150031	SPLICING	YES	NR_135178.1	Transcript	transcribed_pseudogene	splice_acceptor_variant,non_coding_transcript_variant	22/24		NR_135178.1:n.3835-1G>T			-1.0														22	0.64											0	0.0							0.0100083	264	0.006	19.0				11.04	0.686751		0	0	0														-1.219	8.598	7.38														
1148268	chr16	79774036	C	T	chr16:79774036	MAFTRR	MAF transcriptional regulator RNA		SNV	0/1	0.57	15_20	35	99	False	rs184045123	SPLICING	YES	NR_104663.1	Transcript	lncRNA	splice_region_variant,intron_variant,non_coding_transcript_variant	5/5		NR_104663.1:n.375+8G>A			-1.0						.	.	.		0.00500677	762.0	152194.0	4.0	33	0.97	PASS	amr	0.00941915	144.0	0.0071143	484.0					0	0.0							0.0057245	151						0.198	-0.387939		0	0	0																						.			.	.	.	.	.	.
1155606	chr17	36233930	G	A	chr17:36233930	YWHAEP7	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon pseudogene 7		SNV	0/1	0.27	15_6	22	99	False	rs2677184	SPLICING	YES	NR_024178.1	Transcript	transcribed_pseudogene	splice_region_variant,non_coding_transcript_exon_variant		3/7	NR_024178.1:n.110C>T			-1.0						.	.	.						0	0.0											0	0.0							0.1037015	16126	0.302	934.0				12.52	0.87404		0	0	0														9.937	-1.448	8.49						.			.	.	.	.	.	.
1157818	chr17	47588478	AAA		chr17:47588478-47588480	LOC100288866			deletion	0/1	0.17	10_2	12	53	False	rs34854378	SPLICING	YES	NR_103773.1	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	1/2		NR_103773.1:n.247-5_247-3del			-1.0										0.000208607	27.0	129430.0	0.0	27	0.67	PASS	eas	0.00103734	5.0	0.000234231	14.0					0	0.0							0.0001137	3						2.79	0.010908		0	0	0			NGFR	0.0	0.0	0.0	0.0	-36.0	28.0	-37.0	-20.0																			
1158821	chr17	56620645	G	T	chr17:56620645	SEPT4	septin 4		SNV	0/1	0.65	11_20	31	99	False		EXONIC	YES	NM_001368771.2	Transcript	protein_coding	synonymous_variant		1/14	NM_001368771.2:c.903C>A	NP_001355700.1:p.Ala301%3D		-1.0						.	.	.						32	0.96											79	1.0														1.745	-0.066823		0	0	0			C17orf47	0.0	0.0	0.0	0.0	-28.0	-16.0	1.0	33.0						0.905	0.01	80.200736504			reproductive system phenotype; cellular phenotype; 			ciliary ganglion;caudate nucleus;amygdala;prefrontal cortex;superior cervical ganglion;cingulate cortex;cerebellum peduncles;cerebellum;pons;occipital lobe;subthalamic nucleus;whole brain;atrioventricular node;parietal lobe;spinal cord;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	apoptotic process;brain development;regulation of exocytosis;sperm mitochondrion organization;positive regulation of protein ubiquitination;regulation of apoptotic process;positive regulation of apoptotic process;sperm capacitation;protein homooligomerization;cytoskeleton-dependent cytokinesis;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;mitochondrion;septin ring;synaptic vesicle;microtubule cytoskeleton;septin complex;myelin sheath;sperm annulus	magnesium ion binding;GTPase activity;structural molecule activity;protein binding;GTP binding;protein-containing complex scaffold activity;protein homodimerization activity	RB1[20195357];NR4A1[20195357];SEPT12[25775403;25588830];SIAH1[21185211];XIAP[21185211];TNIK[17353931];SEPT14[17922164];
1176676	chr19	18376745	C	T	chr19:18376745	KIAA1683			SNV	0/1	0.53	14_16	30	99	False	rs138064943,COSV101149148	EXONIC	YES	NM_001145304.2	Transcript	protein_coding	synonymous_variant		3/4	NM_001145304.2:c.1605G>A	NP_001138776.1:p.Ala535%3D		-1.0										0.000433731	66.0	152168.0	0.0	32	0.96	PASS	amr	0.000720084	11.0	0.000646659	44.0	0.000397997	100.0	251258.0	0.0	69	1.0	PASS	nfe	0.000721984	82.0	0.000721984	82.0	0.0004501	70	0.001	3.0				0.209	-0.380189		0	0	0			KIAA1683	0.0	0.0	0.0	0.0	-29.0	31.0	24.0	0.0						0.782	0.0	49.853179834											
1181094	chr19	34833022	A	G	chr19:34833022	KIAA0355	KIAA0355		SNV	0/1	0.48	13_12	25	99	False	rs145625075	EXONIC	YES	NM_014686.5	Transcript	protein_coding	missense_variant		10/14	NM_014686.5:c.2183A>G	NP_055501.2:p.Gln728Arg		1.0						.	.	.		0.000532467	81.0	152122.0	0.0	32	0.96	PASS	nfe	0.00110288	75.0	0.00110288	75.0	0.000597077	150.0	251224.0	0.0	100	1.0	PASS	nfe	0.00125059	142.0	0.00125059	142.0	0.0005402	84	0.001	3.0				18.12	1.789088	0.12	3	16	19	MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	KIAA0355	0.0	0.0	0.0	0.0	-40.0	35.0	-19.0	-4.0						0.0566	0.88	0.0	0.506	0.312	.			ciliary ganglion;superior cervical ganglion;trigeminal ganglion;	.	.	.	.	YWHAB[24255178];MYH13[26496610];MKS1[26638075];KRBOX4[26496610];
1202050	chr2	89084145	TAAT		chr2:89084145-89084148	ANKRD36BP2	ankyrin repeat domain 36B pseudogene 2		deletion	0|1	0.12	30_4	34	78	False	rs957256893	SPLICING	YES	NR_015424.1	Transcript	transcribed_pseudogene	splice_donor_variant,splice_donor_5th_base_variant,intron_variant,non_coding_transcript_variant	6/16		NR_015424.1:n.571+5_571+8del			1.0						.	.	.		6.57756e-06	1.0	152032.0	0.0	33	0.95	PASS	nfe	1.47158e-05	1.0	1.47158e-05	1.0					0	0.0														10.31	0.599693		0	0	0																						.			.	.	.	.	.	.
1207635	chr2	105714718	G	A	chr2:105714718	UTAT33			SNV	0/1	0.58	8_11	19	99	False	rs972655913	SPLICING	YES	NR_110227.1	Transcript	lncRNA	splice_region_variant,non_coding_transcript_exon_variant		3/4	NR_110227.1:n.165C>T			-1.0										1.97176e-05	3.0	152148.0	0.0	33	0.96	PASS	amr	6.54536e-05	1.0	1.47016e-05	1.0					0	0.0														0.19	-0.393877		0	0	0			MRPS9	0.0	0.01	0.0	0.0	2.0	-43.0	2.0	29.0			9.636	0.106	9.743														
1225159	chr2	242256951	TT		chr2:242256951-242256952	SEPT2	septin 2		deletion	0/1	0.21	8_3	14	70	False	rs750805176	EXONIC	YES	NM_001349287.2	Transcript	protein_coding	frameshift_variant		3/14	NM_001349287.2:c.126_127del	NP_001336216.1:p.Phe42LeufsTer16		1.0						.	.	.		0.000850224	112.0	131730.0	0.0	32	0.88	PASS	afr	0.00156696	56.0	0.000263939	16.0					0	0.0							0.0003033,0.0006445	8,17						1.924	-0.051329		0	0	0			SEPT2	0.01	0.0	0.0	0.0	-36.0	19.0	-36.0	-7.0						0.752	0.87				.			amygdala;olfactory bulb;thyroid;occipital lobe;prefrontal cortex;atrioventricular node;testis;parietal lobe;spinal cord;hypothalamus;	.	smoothened signaling pathway;spermatogenesis;neuron projection development;cilium assembly;cytoskeleton-dependent cytokinesis	exocyst;condensed chromosome kinetochore;nucleus;cytoplasm;spindle;axoneme;cell cortex;septin ring;microtubule cytoskeleton;midbody;septin complex;cleavage furrow;photoreceptor connecting cilium;perinuclear region of cytoplasm;ciliary membrane;extracellular exosome;sperm annulus;non-motile cilium	GTPase activity;protein binding;GTP binding;protein-containing complex scaffold activity;cadherin binding	PLEKHF2[25416956];DAZAP2[16189514];CRAMP1[21900206];PIK3R1[17024187];BAZ2B[unassigned1304];SEPT8[17353931];UBL5[unassigned1304];SEPT6[16189514;17803907;17229681;25416956;25588830;17637674;24633326];SEPT7[25588830;17637674;24633326];NUDCD1[29021621];TGS1[26496610];STMN1[21900206];VHL[17353931];PAK2[17353931];IKBKE[17353931];SEPT11[17353931];JUN[25609649];JUND[20195357];SEPT12[25588830];CSNK2A1[22113938];HSPA5[26496610];COG4[21900206];HLA-B[17353931];FN1[19738201];RRP1B[20926688];MCC[17353931];SEPT14[17922164];SEPT5[25416956;unassigned1304;18330356];MTOR[21900206];PLEKHA7[28877994];SEPT2[17637674];GH1[17353931];ANLN[26496610];DLD[29128334];ARF6[17353931];OTUB1[26752685];EZH2[26496610];
1231051	chr20	35234464	A	T	chr20:35234464	C20orf24			SNV	0/1	0.55	22_27	49	99	False	rs376099313	EXONIC	YES	NM_199483.3	Transcript	protein_coding	missense_variant		1/3	NM_199483.3:c.110A>T	NP_955777.1:p.Asp37Val		1.0	.,.,.,.									2.62857e-05	4.0	152174.0	0.0	33	0.98	PASS	amr	0.000130873	2.0	2.9404e-05	2.0	2.42828e-05	3.0	123544.0	0.0	7	0.2	PASS	amr	0.000101709	2.0	2.12603e-05	1.0	0.0000064	1	0.0	1.0				32.0	4.490587	0.862	13	4	17	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,DEOGEN2_pred	C20orf24	0.0	0.0	0.07	0.0	-29.0	-28.0	-29.0	4.0						0.17	0.86	0.0	0.999	1.228									
1231509	chr20	37054704		AAAAA	chr20:37054703-37054704	SNHG17	small nucleolar RNA host gene 17		insertion	0/1	0.18	4_2	11	99	False	rs3073133	SPLICING	YES	NR_152754.1	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	4/7		NR_152754.1:n.632-12_632-8dup			-1.0						.	.	.		0.0	0.0	83130.0	0.0	16	0.37	AC0				0.0	0.0					0	0.0							0.0005307,0.0001516,0.1313595	14,4,3465						3.597	0.060321		0	0	0																						.			.	.	.	.	.	.
1231682	chr20	37063671	T	T	chr20:37063671	SNHG17	small nucleolar RNA host gene 17		SNV	0/1	0.5	13_13	26	99	False	rs1578462	SPLICING	YES	NR_152754.1	Transcript	lncRNA	splice_region_variant,non_coding_transcript_exon_variant		1/8	NR_152754.1:n.350G>A			-1.0						.	.	.						0	0.0											0	0.0							0.0958432	14904	0.105	303.0				3.308	0.042996		0	0	0														10.674	-0.783	9.891						.			.	.	.	.	.	.
1232127	chr20	39762293	AA		chr20:39762293-39762294	PLCG1-AS1	PLCG1 antisense RNA 1		deletion	0/1	0.25	6_3	12	58	False	rs72043951	SPLICING	YES	NR_109889.1	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	3/6		NR_109889.1:n.552-9_552-8del			-1.0						.	.	.		0.00135395	124.0	91584.0	1.0	24	0.6	PASS	afr	0.00315731	102.0	0.000223626	8.0					0	0.0																	0	0	0																						.			.	.	.	.	.	.
1239574	chr21	15217319	G	C	chr21:15217319	CYP4F29P	cytochrome P450 family 4 subfamily F member 29, pseudogene		SNV	0|1	0.28	21_8	29	99	False	rs796873175	SPLICING	YES	NR_026755.1	Transcript	transcribed_pseudogene	splice_region_variant,intron_variant,non_coding_transcript_variant	4/5		NR_026755.1:n.865+7C>G			-1.0						.	.	.		6.56961e-06	1.0	152216.0	0.0	32	0.97	PASS	nfe	1.46985e-05	1.0	1.46985e-05	1.0					0	0.0							0.0000379	1						0.211	-0.379111		0	0	0																						.			.	.	.	.	.	.
1243648	chr21	41993182	G	A	chr21:41993182	DSCAM-IT1	DSCAM intronic transcript 1		SNV	0/1	0.42	14_10	24	99	False	rs142591555	SPLICING	YES	NR_046774.2	Transcript	lncRNA	splice_region_variant,non_coding_transcript_exon_variant		3/4	NR_046774.2:n.357C>T			-1.0						.	.	.		0.00190072	289.0	152048.0	2.0	30	0.95	PASS	eas	0.00693909	36.0	0.0025283	172.0					0	0.0							0.0020851	55						0.005	-0.875266		0	0	0			DSCAM	0.0	0.0	0.0	0.01	-6.0	-1.0	2.0	-1.0			2.402	1.578	3.98						.			.	.	.	.	.	.
1244746	chr21	44985202	G	A	chr21:44985202	H2BFS	H2B histone family member S		SNV	0/1	0.47	19_17	36	99	False	rs9637217,COSV52355225	EXONIC	YES	NM_017445.3	Transcript	protein_coding	missense_variant		1/1	NM_017445.3:c.83G>A	NP_059141.1:p.Arg28Lys		1.0	Histone H2A/H2B/H3					.	.	.						0	0.0											0	0.0							0.2972932,0.0001137	7842,3	0.005	17.0				11.1	0.693798		0	9	9		SIFT,PolyPhen,MutationTaster_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	H2BFS	0.0	0.0	0.0	0.0	50.0	1.0	49.0	0.0											.			.	.	innate immune response in mucosa;nucleosome assembly;antibacterial humoral response;substantia nigra development;defense response to Gram-positive bacterium;antimicrobial humoral immune response mediated by antimicrobial peptide	nucleosome;extracellular space;nucleus;nucleoplasm;cytosol	DNA binding;protein heterodimerization activity	SPON2[30021884];COX4I2[30021884];CROT[30021884];CHD2[30021884];YY1[30021884];RGS2[30021884];MTG1[30021884];IYD[30021884];CHMP1B[30021884];HIST1H2AE[30021884];PWWP2A[30021884];HMGN2[30021884];HMGN3[30021884];CEP290[30021884];RGS6[30021884];DLGAP4[30021884];HMGN1[30021884];RUBCN[30021884];PLA2G4F[30021884];OVCH1[30021884];H2AFY[30021884];H2AFZ[30021884];HIST1H2AH[30021884];CCDC36[30021884];H2AFX[30021884];H2AFV[30021884];KIF22[30021884];SYTL4[30021884];TMEM82[30021884];TEP1[30021884];ADGRF5[30021884];C1D[30021884];HIST2H3D[30021884];UBA52[30021884];FAIM[30021884];CDH19[30021884];DNAH1[30021884];CDCA2[30021884];STX16[30021884];MVP[30021884];MRPL16[30021884];PRPF8[30021884];MLLT6[30021884];TTN[30021884];HIRIP3[30021884];MIER1[30021884];CLCA2[30021884];PLAGL2[30021884];SHOC2[30021884];RAB11FIP5[30021884];BDNF[30021884];FN1[19738201];HMGA1[30021884];RPL23A[30021884];USF3[30021884];ESR2[21182203];MORN1[30021884];HIST1H4A[30021884];AXL[30021884];HIST3H3[30021884];PDCD4[30021884];ESYT3[30021884];ZNF653[30021884];FERMT3[30021884];
1244748	chr21	44985272	C	T	chr21:44985272	H2BFS	H2B histone family member S		SNV	0/1	0.45	17_14	31	99	False	rs9637218,COSV52355237	EXONIC	YES	NM_017445.3	Transcript	protein_coding	synonymous_variant		1/1	NM_017445.3:c.153C>T	NP_059141.1:p.Pro51%3D		1.0						.	.	.						0	0.0											0	0.0							0.4166730	10991	0.076	215.0				11.64	0.76059		0	0	0			H2BFS	0.08	0.0	0.01	0.0	22.0	-20.0	-21.0	-9.0											.			.	.	innate immune response in mucosa;nucleosome assembly;antibacterial humoral response;substantia nigra development;defense response to Gram-positive bacterium;antimicrobial humoral immune response mediated by antimicrobial peptide	nucleosome;extracellular space;nucleus;nucleoplasm;cytosol	DNA binding;protein heterodimerization activity	SPON2[30021884];COX4I2[30021884];CROT[30021884];CHD2[30021884];YY1[30021884];RGS2[30021884];MTG1[30021884];IYD[30021884];CHMP1B[30021884];HIST1H2AE[30021884];PWWP2A[30021884];HMGN2[30021884];HMGN3[30021884];CEP290[30021884];RGS6[30021884];DLGAP4[30021884];HMGN1[30021884];RUBCN[30021884];PLA2G4F[30021884];OVCH1[30021884];H2AFY[30021884];H2AFZ[30021884];HIST1H2AH[30021884];CCDC36[30021884];H2AFX[30021884];H2AFV[30021884];KIF22[30021884];SYTL4[30021884];TMEM82[30021884];TEP1[30021884];ADGRF5[30021884];C1D[30021884];HIST2H3D[30021884];UBA52[30021884];FAIM[30021884];CDH19[30021884];DNAH1[30021884];CDCA2[30021884];STX16[30021884];MVP[30021884];MRPL16[30021884];PRPF8[30021884];MLLT6[30021884];TTN[30021884];HIRIP3[30021884];MIER1[30021884];CLCA2[30021884];PLAGL2[30021884];SHOC2[30021884];RAB11FIP5[30021884];BDNF[30021884];FN1[19738201];HMGA1[30021884];RPL23A[30021884];USF3[30021884];ESR2[21182203];MORN1[30021884];HIST1H4A[30021884];AXL[30021884];HIST3H3[30021884];PDCD4[30021884];ESYT3[30021884];ZNF653[30021884];FERMT3[30021884];
1244750	chr21	44985473	C	T	chr21:44985473	H2BFS	H2B histone family member S		SNV	0/1	0.44	19_15	34	99	False	rs2838315	EXONIC	YES	NM_017445.3	Transcript	protein_coding	synonymous_variant		1/1	NM_017445.3:c.354C>T	NP_059141.1:p.Ala118%3D		1.0						.	.	.						0	0.0											0	0.0							0.0712972	11087	0.125	393.0				11.54	0.747545		0	0	0			H2BFS	0.0	0.0	0.0	0.01	-26.0	23.0	-37.0	8.0											.			.	.	innate immune response in mucosa;nucleosome assembly;antibacterial humoral response;substantia nigra development;defense response to Gram-positive bacterium;antimicrobial humoral immune response mediated by antimicrobial peptide	nucleosome;extracellular space;nucleus;nucleoplasm;cytosol	DNA binding;protein heterodimerization activity	SPON2[30021884];COX4I2[30021884];CROT[30021884];CHD2[30021884];YY1[30021884];RGS2[30021884];MTG1[30021884];IYD[30021884];CHMP1B[30021884];HIST1H2AE[30021884];PWWP2A[30021884];HMGN2[30021884];HMGN3[30021884];CEP290[30021884];RGS6[30021884];DLGAP4[30021884];HMGN1[30021884];RUBCN[30021884];PLA2G4F[30021884];OVCH1[30021884];H2AFY[30021884];H2AFZ[30021884];HIST1H2AH[30021884];CCDC36[30021884];H2AFX[30021884];H2AFV[30021884];KIF22[30021884];SYTL4[30021884];TMEM82[30021884];TEP1[30021884];ADGRF5[30021884];C1D[30021884];HIST2H3D[30021884];UBA52[30021884];FAIM[30021884];CDH19[30021884];DNAH1[30021884];CDCA2[30021884];STX16[30021884];MVP[30021884];MRPL16[30021884];PRPF8[30021884];MLLT6[30021884];TTN[30021884];HIRIP3[30021884];MIER1[30021884];CLCA2[30021884];PLAGL2[30021884];SHOC2[30021884];RAB11FIP5[30021884];BDNF[30021884];FN1[19738201];HMGA1[30021884];RPL23A[30021884];USF3[30021884];ESR2[21182203];MORN1[30021884];HIST1H4A[30021884];AXL[30021884];HIST3H3[30021884];PDCD4[30021884];ESYT3[30021884];ZNF653[30021884];FERMT3[30021884];
1245379	chr21	46413813		CCCACCTGCCCCATCCCCACCTGCCCCATCCCCCTGCCTGCCCCATCCCCTCACCTGCCCCATCCCCCACCTGCCCCA	chr21:46413812-46413813	LINC00163	long intergenic non-protein coding RNA 163		insertion	0/1	0.61	7_11	18	99	False		SPLICING	YES	NR_033840.1	Transcript	lncRNA	splice_region_variant,intron_variant,non_coding_transcript_variant	1/1		NR_033840.1:n.183+6_183+7insTGGGGCAGGTGGGGGATGGGGCAGGTGAGGGGATGGGGCAGGCAGGGGGATGGGGCAGGTGGGGATGGGGCAGGTGGG			-1.0						.	.	.		0.00355395	530.0	149130.0	0.0	20	0.48	AS_VQSR	sas	0.00448718	21.0	0.00402986	271.0					0	0.0																	0	0	0																						.			.	.	.	.	.	.
1252972	chr22	24345691	C	C	chr22:24345691	GSTTP1			SNV	1/1	1.0	0_13	13	39	False	rs140302,rs1601975166,rs1601975167	EXONIC	YES	NM_001358664.2	Transcript	protein_coding	synonymous_variant		2/5	NM_001358664.2:c.162T>G	NP_001345593.1:p.Leu54%3D		-1.0														0	0.0											0	0.0							0.0002275,0.0886537,0.0001137	6,13786,3	0.249	726.0				10.76	0.652942		0	0	0																														
1257007	chr22	49288477	A	G	chr22:49288477	LINC01310	long intergenic non-protein coding RNA 1310		SNV	1/1	1.0	0_27	27	81	False	rs28688450	SPLICING	YES	NR_038944.1	Transcript	lncRNA	splice_acceptor_variant,non_coding_transcript_variant	3/6		NR_038944.1:n.339-1A>G			1.0						.	.	.						0	0.0											0	0.0							0.9528395	25134						0.059	-0.554444		0	0	0														9.423	-8.75	0.672						.			.	.	.	.	.	.
1263961	chr3	56680925	A	T	chr3:56680925	FAM208A	family with sequence similarity 208 member A		SNV	0/1	0.54	12_14	26	99	False	rs149882815	EXONIC	YES	NM_001365635.2	Transcript	protein_coding	missense_variant		14/24	NM_001365635.2:c.1840T>A	NP_001352564.1:p.Leu614Ile		-1.0	.,.,.,.					.	.	.		0.00110404	168.0	152168.0	0.0	33	0.97	PASS	amr	0.00144073	22.0	0.00132298	90.0	0.00121479	299.0	246134.0	0.0	36	0.85	PASS	amr	0.00133254	45.0	0.00106127	119.0	0.0010804	168	0.003	10.0				23.1	2.775419	0.12	5	13	18	Polyphen2_HDIV_pred,LRT_pred,MutationTaster_pred,ClinPred_pred,fathmm-MKL_coding_pred	Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-XF_coding_pred	FAM208A	0.0	0.0	0.0	0.0	8.0	-22.0	-9.0	8.0							1.0	0.0	1.0	1.312	mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; growth/size/body region phenotype; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;subthalamic nucleus;prefrontal cortex;cingulate cortex;superior cervical ganglion;atrioventricular node;testis;globus pallidus;	.	.	nucleoplasm;chromosome	RNA binding;protein binding	TOM1L1[16169070];TBC1D4[unassigned5];SETDB1[26022416];REEP5[30021884];MATR3[26496610];B9D2[26638075];PPHLN1[26022416];GTF2F2[20195357];MPHOSPH8[26496610;26022416];AP2M1[21988832];TCTE1[26638075];
1272298	chr3	128664388	T	C	chr3:128664388	KIAA1257	KIAA1257		SNV	0/1	0.5	20_20	40	99	False	rs188359434	EXONIC	YES	NM_001348520.2	Transcript	protein_coding	missense_variant		9/15	NM_001348520.2:c.911A>G	NP_001335449.1:p.His304Arg		-1.0						.	.	.		0.000394244	60.0	152190.0	0.0	32	0.97	PASS	amr	0.000851343	13.0	0.000587855	40.0	0.000475939	65.0	136572.0	1.0	42	0.57	PASS	nfe	0.000840901	45.0	0.000840901	45.0	0.0001801	28	0.003	11.0				0.093	-0.493791	0.126	0	11	11		LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	RP11-723O4.6	0.0	0.0	0.0	0.0	20.0	-16.0	-28.0	14.0						0.246	0.0	0.0	0.0	-0.046	.			ciliary ganglion;superior cervical ganglion;	.	.	.	.	.
1278338	chr3	180565418	A		chr3:180565418	LOC101928882			deletion	0/1	0.23	17_5	22	66	False	rs572763613	SPLICING	YES	NR_109986.1	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	1/13		NR_109986.1:n.133-6del			-1.0										0.0034402	467.0	135748.0	1.0	29	0.76	PASS	afr	0.00717388	261.0	0.00141135	89.0					0	0.0							0.0002654,0.0003412	7,9						0.196	-0.389533		0	0	0																														
1304155	chr4	159052039	C	A	chr4:159052039	FAM198B			SNV	0/1	0.57	12_16	28	99	False	rs372554252	EXONIC	YES	NM_001031700.3	Transcript	protein_coding	missense_variant		5/6	NM_001031700.3:c.1275G>T	NP_001026870.2:p.Gln425His		-1.0	.,.,.,.,.									0.000131423	20.0	152180.0	0.0	32	0.97	PASS	amr	0.000261883	4.0	0.000220465	15.0	5.96754e-05	15.0	251360.0	0.0	68	1.0	PASS	amr	0.000144601	5.0	7.0373e-05	8.0	0.0000579	9	0.0	1.0				19.36	1.951911	0.077	3	14	17	LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	FAM198B	0.0	0.0	0.0	0.0	-35.0	-1.0	29.0	-17.0						0.999	0.0	0.0	0.999	0.947									
1336615	chr6	25726720	G	A	chr6:25726720	HIST1H2AA	histone cluster 1 H2A family member a		SNV	0/1	0.6	8_12	20	99	False	rs150563946,COSV51237094	EXONIC	YES	NM_170745.3	Transcript	protein_coding	synonymous_variant		1/1	NM_170745.3:c.36C>T	NP_734466.1:p.Arg12%3D		-1.0						.	.	.		0.000973159	148.0	152082.0	0.0	32	0.94	PASS	amr	0.00163677	25.0	0.000896953	61.0	0.00136976	337.0	246028.0	0.0	66	0.98	PASS	amr	0.00174206	60.0	0.00127273	139.0	0.0010868	169	0.004	14.0				0.207	-0.381549		0	0	0			HIST1H2AA	0.0	0.0	0.0	0.0	-27.0	-50.0	6.0	-31.0						0.729	0.0	0.689697165			.			ciliary ganglion;testis - seminiferous tubule;superior cervical ganglion;testis;	.	chromatin organization	nuclear chromosome, telomeric region;nucleosome;nuclear chromatin;nucleus;extracellular exosome	DNA binding;protein heterodimerization activity	JUN[25609649];NEK4[25798074];SFMBT1[17599839];UBC[20075863];MAGOH[23084401];EIF4A3[23084401];FN1[19738201];RECQL[23396353];BRD7[12489984];EGFR[24189400];NFKB1[25609649];
1354826	chr6	167884956	T	C	chr6:167884956	LOC105378127			SNV	0/1	0.63	10_17	27	99	False	rs7452252	SPLICING	YES	NR_134591.1	Transcript	lncRNA	splice_donor_variant,non_coding_transcript_variant	1/3		NR_134591.1:n.57+1A>G			-1.0														0	0.0											0	0.0							0.8184851	21590						6.217	0.22588		0	0	0														10.425	-8.182	2.243														
1385581	chr8	2448344	AAA		chr8:2448344-2448346	LOC101927815			deletion	0/1	0.29	8_4	14	74	False		SPLICING	YES	NR_125423.1	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	4/4		NR_125423.1:n.441-6_441-4del			-1.0										3.34642e-05	3.0	89648.0	0.0	26	0.74	PASS	nfe	2.30436e-05	1.0	2.30436e-05	1.0					0	0.0																	0	0	0																														
1390506	chr8	28557566	AAA		chr8:28557566-28557568	EXTL3-AS1	EXTL3 antisense RNA 1		sequence_alteration	1/2	0.2	1_3_11	15	60	False	rs58752787	SPLICING	YES	NR_126027.1	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	1/2		NR_126027.1:n.106-8_106-6del			-1.0						.	.	.		7.51397e-05	11.0	146394.0	0.0	11	0.39	PASS	afr	0.000226746	9.0	0.0	0.0					0	0.0														8.009	0.365003		0	0	0																						.			.	.	.	.	.	.
1422801	chr9	88842951	G	A	chr9:88842951	C9orf153	chromosome 9 open reading frame 153		SNV	0/1	0.37	17_10	27	99	False	rs72748767	SPLICING	YES	NM_001276367.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/4		NM_001276367.3:c.67-6C>T			-1.0						.	.	.		0.00325614	489.0	150178.0	4.0	32	0.95	PASS	amr	0.00501849	76.0	0.00216015	146.0	0.00447953	842.0	187966.0	13.0	15	0.24	PASS	amr	0.00391598	88.0	0.00245539	213.0	0.0029774	463	0.005	17.0				5.578	0.182575		0	0	0			C9orf153	0.0	0.06	0.0	0.0	-13.0	-6.0	-13.0	-44.0	2.7789980181634e-05	0.012	9.995	1.334	11.329	0.444	0.23				.			.	.	.	.	.	CFAP206[unassigned1304];
1423133	chr9	90535641	G	C	chr9:90535641	SPATA31C1	SPATA31 subfamily C member 1		SNV	0/1	0.41	16_11	27	99	False		EXONIC	YES	NM_001145124.1	Transcript	protein_coding	synonymous_variant		4/4	NM_001145124.1:c.819G>C	NP_001138596.1:p.Ala273%3D		1.0						.	.	.						32	0.96											100	1.0														0.561	-0.236881		0	0	0																						.			.	.	spermatogenesis;cell differentiation	integral component of membrane	.	.
1426185	chr9	106038434		AAAAAAAAAA	chr9:106038433-106038434	LINC01492	long intergenic non-protein coding RNA 1492		insertion	1/1	0.67	0_4	6	23	False	rs56246410	SPLICING	YES	NR_121578.1	Transcript	lncRNA	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	4/9		NR_121578.1:n.527-13_527-4dup			-1.0						.	.	.		0.000997245	97.0	97268.0	3.0	6	0.15	AS_VQSR	amr	0.00434783	35.0	0.00032612	17.0					0	0.0							0.0002275,0.0001137	6,3						0.904	-0.165698		0	0	0																						.			.	.	.	.	.	.
1431729	chr9	132382043	T	C	chr9:132382043	C9orf50	chromosome 9 open reading frame 50		SNV	0/1	0.78	5_18	23	99	False	rs139758889	EXONIC	YES	NM_199350.3	Transcript	protein_coding	missense_variant		2/7	NM_199350.3:c.575A>G	NP_955382.3:p.Asn192Ser		-1.0						.	.	.		0.00315187	478.0	151656.0	2.0	31	0.95	PASS	amr	0.00604706	92.0	0.00438622	298.0	0.00324094	815.0	251470.0	7.0	100	1.0	PASS	nfe	0.00425487	484.0	0.00425487	484.0	0.0030289	471	0.007	23.0				0.009	-0.794743	0.025	0	17	17		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	C9orf50	0.0	0.0	0.03	0.0	-1.0	-18.0	-24.0	-30.0							0.0	0.0	0.001	-0.201	.			.	.	.	.	.	PPP1CC[21382349];
1432727	chr9	139302016	AAAAA		chr9:139302016-139302020	SDCCAG3			deletion	0/1	0.2	9_3	15	99	False	rs36076555	SPLICING	YES	NM_001039707.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	4/9		NM_001039707.2:c.403-7_403-3del			-1.0										1.79594e-05	2.0	111362.0	0.0	11	0.38	PASS	nfe	3.5548e-05	2.0	3.5548e-05	2.0					14	0.31							0.0009903	154						2.367	-0.017541		0	0	0																	0.919	0.0												
1436457	chrX	51150084	C	T	chrX:51150084	CXorf67	chromosome X open reading frame 67		SNV	1/1	1.0	0_12	12	36	False	rs782776403	EXONIC	YES	NM_203407.3	Transcript	protein_coding	synonymous_variant		1/1	NM_203407.3:c.216C>T	NP_981952.1:p.Ala72%3D		1.0						.	.	.		0.000159891	18.0	112577.0	0.0	23	0.61	PASS	amr	0.000463865	5.0	0.000225526	12.0	0.000123554	22.0	178060.0	0.0	50	0.83	PASS	nfe	0.000227695	18.0	0.000227695	18.0	0.0000900	14						0.115	-0.464404		0	0	0			CXorf67	0.0	0.0	0.0	0.0	-33.0	-4.0	-20.0	0.0							0.87	0.651755097			.			.	.	.	nucleoplasm	.	TRIM41[unassigned1304];SCNM1[unassigned1304];HIST1H3A[29568061];TRAF4[unassigned1304];ZNF417[unassigned1304];TP53BP1[29656893];ENKD1[unassigned1304];
1438336	chrX	73964127	G	A	chrX:73964127	KIAA2022			SNV	1/1	1.0	0_16	16	48	False	rs752314023,COSV50024503	EXONIC	YES	NM_001008537.3	Transcript	protein_coding	missense_variant		3/4	NM_001008537.3:c.265C>T	NP_001008537.1:p.His89Tyr		-1.0	.,.,.	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided						8.06661e-05	9.0	111571.0	0.0	22	0.59	PASS	nfe	0.000112988	6.0	0.000112988	6.0	6.55938e-05	12.0	182944.0	0.0	66	1.0	PASS	nfe	7.36214e-05	6.0	7.36214e-05	6.0	0.0000450	7			0.00026	3.0		23.1	2.792731	0.439	4	14	18	SIFT,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	KIAA2022	0.0	0.0	0.0	0.0	-14.0	8.0	2.0	48.0						0.196	0.95	0.000000000	0.996	1.176									
1442945	chrX	119144752	T	C	chrX:119144752	RHOXF1P1	Rhox homeobox family member 1 pseudogene 1		SNV	1/1	1.0	0_15	15	45	False	rs4825684	SPLICING	YES	NR_131250.1	Transcript	transcribed_pseudogene	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant,non_coding_transcript_variant	3/3		NR_131250.1:n.706-4A>G			-1.0						.	.	.						0	0.0											0	0.0							0.6825385	18004						1.259	-0.116624		0	0	0														7.085	0.271	7.356						.			.	.	.	.	.	.
1443339	chrX	124455281	A	G	chrX:124455281	TEX13C	TEX13 family member C		SNV	0|1	0.14	12_2	14	48	False	rs1485378222	EXONIC	YES	NM_001195272.2	Transcript	protein_coding	missense_variant		1/2	NM_001195272.2:c.1313A>G	NP_001182201.1:p.Asn438Ser		1.0						.	.	.		0.000136335	14.0	102688.0	0.0	24	0.62	AS_VQSR	sas	0.000924214	2.0	0.000120195	6.0	0.0	0.0	97851.0	0.0	70	0.57	AC0_RF				0.0	0.0								0.13	-0.447062		0	7	7		SIFT,PolyPhen,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred	RP13-147D17.3	0.0	0.0	0.0	0.0	1.0	-2.0	28.0	-20.0									0.0	-5.241	.			.	.	.	.	metal ion binding	.
1443341	chrX	124455282	C	A	chrX:124455282	TEX13C	TEX13 family member C		SNV	0|1	0.13	13_2	15	45	False	rs1055983723	EXONIC	YES	NM_001195272.2	Transcript	protein_coding	missense_variant		1/2	NM_001195272.2:c.1314C>A	NP_001182201.1:p.Asn438Lys		1.0						.	.	.		0.000109734	11.0	100242.0	0.0	23	0.61	AS_VQSR	sas	0.000920387	2.0	6.13234e-05	3.0	0.0	0.0	97860.0	0.0	69	0.57	AC0_RF				0.0	0.0								0.358	-0.303137		0	7	7		SIFT,PolyPhen,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred	RP13-147D17.3	0.0	0.0	0.0	0.0	37.0	3.0	-39.0	7.0									0.0	-2.205	.			.	.	.	.	metal ion binding	.
1443343	chrX	124455291	T	C	chrX:124455291	TEX13C	TEX13 family member C		SNV	0/1	0.12	13_2	17	39	False	rs1368952763	EXONIC	YES	NM_001195272.2	Transcript	protein_coding	synonymous_variant		1/2	NM_001195272.2:c.1323T>C	NP_001182201.1:p.Ser441%3D		1.0						.	.	.		0.0016634	95.0	57112.0	0.0	17	0.42	PASS	eas	0.00395257	6.0	0.00139621	40.0	0.0	0.0	77613.0	0.0	70	0.57	AC0_RF				0.0	0.0								0.222	-0.371585		0	0	0			RP13-147D17.3	0.0	0.0	0.0	0.0	-46.0	28.0	20.0	-2.0											.			.	.	.	.	metal ion binding	.
1443986	chrX	129937321	G	A	chrX:129937321	LOC105373338			SNV	1/1	1.0	0_12	12	36	False	rs5932812	SPLICING	YES	NR_135655.1	Transcript	lncRNA	splice_region_variant,intron_variant,non_coding_transcript_variant	2/2		NR_135655.1:n.326+7G>A			1.0														0	0.0											0	0.0							0.0000379,0.6945940	1,18322						7.685	0.337426		0	0	0			ENOX2	0.0	0.0	0.0	0.0	-9.0	22.0	-7.0	44.0																			
